PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fu, WY; Hu, WH; Shi, L; Mundra, JJ; Xiao, GZ; Dustin, ML; Liu, CJ				Fu, Wenyu; Hu, Wenhuo; Shi, Lei; Mundra, Jyoti Joshi; Xiao, GuoZhi; Dustin, Michael L.; Liu, Chuan-ju			Foxo4-and Stat3-dependent IL-10 production by progranulin in regulatory T cells restrains inflammatory arthritis	FASEB JOURNAL			English	Article						TNFR2; JNK; Treg	GRANULIN-EPITHELIN PRECURSOR; COLLAGEN-INDUCED ARTHRITIS; OLIGOMERIC MATRIX PROTEIN; RHEUMATOID-ARTHRITIS; TRANSCRIPTION FACTOR; GROWTH-FACTOR; HOST-DEFENSE; TNF-ALPHA; MICE; DIFFERENTIATION	Progranulin (PGRN) restrains inflammation and is therapeutic against inflammatory arthritis; however, the underlying immunological mechanism remains unknown. In this study, we demonstrated that antiinflammatory cytokine IL-10 was a critical mediator for PGRN-mediated anti-inflammation in collagen-induced arthritisbyusingPGRNandIL-10geneticallymodifiedmousemodels. IL-10greenfluorescentproteinreportermice revealed that regulatory T (Treg) cells were the predominant source of IL-10 in response to PGRN. In addition, PGRN-mediated expansion and activation of Treg cells, as well as IL-10 production, depends on JNK signaling, but not on known PGRN-activated ERK and PI3K pathways. Furthermore, microarray and chromatin immunoprecipitation sequencing screens led to the discovery of forkhead box protein O4 and signal transducer and activator of transcription 3 as the transcription factors required for PGRNinduction of IL-10 in(Treg) cells. These findings define a previously unrecognized signaling pathway that underlies IL-10 production byPGRNin Treg cells and present new insights into the mechanisms by which PGRN resolves inflammation in inflammatory conditions and autoimmune diseases, particularly inflammatory arthritis.-Fu, W., Hu, W., Shi, L., Mundra, J. J. Xiao, G., Dustin, M. L., Liu, C. Foxo4-and Stat3-dependent IL-10 production by progranulin in regulatory T cells restrains inflammatory arthritis.	[Fu, Wenyu; Shi, Lei; Mundra, Jyoti Joshi; Liu, Chuan-ju] NYU, Med Ctr, Dept Orthopaed Surg, New York, NY 10016 USA; [Dustin, Michael L.] NYU, Med Ctr, Skirball Inst Biomol Med, New York, NY 10016 USA; [Hu, Wenhuo] Mem Hosp Res Labs, New York, NY USA; [Xiao, GuoZhi] South Univ Sci & Technol China, Dept Biol, Shenzhen, Peoples R China; [Xiao, GuoZhi] South Univ Sci & Technol China, Shenzhen Key Lab Cell Microenvironm, Shenzhen, Peoples R China; [Xiao, GuoZhi] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Dustin, Michael L.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Liu, Chuan-ju] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Shi, Lei] Shanxi Med Univ, Hosp 2, Taiyuan, Shanxi Sheng, Peoples R China	New York University; New York University; Southern University of Science & Technology; Southern University of Science & Technology; Rush University; University of Oxford; New York University; Shanxi Medical University	Liu, CJ (corresponding author), NYU, Med Ctr, 301 East 17th St, New York, NY 10003 USA.	chuanju.liu@nyumc.org	Liu, Chuan-ju/AAT-8165-2021; Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389; liu, chuanju/0000-0002-7181-8032	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR062207, R01-AR061484, R56-AI100901]; U.S. Department of Defense [W81XWH-16-1-0482]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI100901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062207, R01AR061484] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); U.S. Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases for Grants R01-AR062207, R01-AR061484, and R56-AI100901, as well as W81XWH-16-1-0482 from the U.S. Department of Defense.	Alzabin S, 2012, ANN RHEUM DIS, V71, P1741, DOI 10.1136/annrheumdis-2011-201024; Asquith DL, 2009, EUR J IMMUNOL, V39, P2040, DOI 10.1002/eji.200939578; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Brennan F, 2007, CURR OPIN RHEUMATOL, V19, P296, DOI 10.1097/BOR.0b013e32805e87f1; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Egashira Y, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-105; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Finnegan A, 2003, ARTHRITIS RES THER, V5, pR18, DOI 10.1186/ar601; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Guo FJ, 2010, ARTHRITIS RHEUM-US, V62, P2023, DOI 10.1002/art.27491; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; He ZH, 2002, CANCER RES, V62, P5590; Hedrich CM, 2014, P NATL ACAD SCI USA, V111, P13457, DOI 10.1073/pnas.1408023111; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huber S, 2006, FRONT BIOSCI-LANDMRK, V11, P1014, DOI 10.2741/1859; Jian JL, 2013, FEBS LETT, V587, P3428, DOI 10.1016/j.febslet.2013.09.024; Jian JL, 2013, J LEUKOCYTE BIOL, V93, P199, DOI 10.1189/jlb.0812429; Kamrava M, 2005, ONCOGENE, V24, P7084, DOI 10.1038/sj.onc.1208857; Kawase R, 2013, CARDIOVASC RES, V100, P125, DOI 10.1093/cvr/cvt178; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Konopka J, 2014, FRONT BIOSCI-LANDMRK, V19, P662, DOI 10.2741/4234; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lu LF, 2009, GENE DEV, V23, P1270, DOI 10.1101/gad.1791009; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McGovern JL, 2012, ARTHRITIS RHEUM-US, V64, P3129, DOI 10.1002/art.34565; Monte K, 2008, ARTHRITIS RHEUM-US, V58, P3730, DOI 10.1002/art.24048; Niu Q, 2012, RHEUMATOL INT, V32, P2731, DOI 10.1007/s00296-011-1984-x; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Petkau TL, 2014, TRENDS NEUROSCI, V37, P388, DOI 10.1016/j.tins.2014.04.003; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shoemaker J, 2006, J IMMUNOL, V176, P3470, DOI 10.4049/jimmunol.176.6.3470; Stewart CA, 2013, J CLIN INVEST, V123, P4859, DOI 10.1172/JCI65180; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tsuji-Takayama K, 2008, J IMMUNOL, V181, P3897, DOI 10.4049/jimmunol.181.6.3897; Wang WH, 2012, RHEUMATOL INT, V32, P887, DOI 10.1007/s00296-010-1710-0; Wei FH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112110; Wei FH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07023; Williams A, 2016, ARTHRITIS RHEUMATOL, V68, P2845, DOI 10.1002/art.39816; Xu K, 2007, J BIOL CHEM, V282, P11347, DOI 10.1074/jbc.M608744200; Yan WJ, 2016, J IMMUNOL, V197, P3393, DOI 10.4049/jimmunol.1600862; Ye L, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4544; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao YP, 2015, ANN RHEUM DIS, V74, P2244, DOI 10.1136/annrheumdis-2014-205779; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8; Zhu XF, 2007, GRAEF ARCH CLIN EXP, V245, P1549, DOI 10.1007/s00417-007-0591-8; Ziegler-Heitbrock L, 2003, J IMMUNOL, V171, P285, DOI 10.4049/jimmunol.171.1.285	60	30	31	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1354	1367		10.1096/fj.201601134R	http://dx.doi.org/10.1096/fj.201601134R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28011648	Green Published			2022-12-26	WOS:000398504300009
J	Das, D; Faridounnia, M; Kovacic, L; Kaptein, R; Boelens, R; Folkers, GE				Das, Devashish; Faridounnia, Maryam; Kovacic, Lidija; Kaptein, Robert; Boelens, Rolf; Folkers, Gert E.			Single-stranded DNA Binding by the Helix-Hairpin-Helix Domain of XPF Protein Contributes to the Substrate Specificity of the ERCC1-XPF Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; HOLLIDAY JUNCTION RESOLVASE; FACIO-SKELETAL SYNDROME; PIGMENTOSUM GROUP-F; XERODERMA-PIGMENTOSUM; XPF-ERCC1 COMPLEX; COCKAYNE-SYNDROME; NUCLEAR ABNORMALITIES; SEQUENCE CONTEXTS; DISTINCT ROLES	The nucleotide excision repair protein complex ERCC1-XPF is required for incision of DNA upstream of DNA damage. Functional studies have provided insights into the binding of ERCC1XPF to various DNA substrates. However, because no structure for the ERCC1-XPF-DNA complex has been determined, the mechanism of substrate recognition remains elusive. Here we biochemically characterize the substrate preferences of the helix-hairpin-helix ( HhH) domains of XPF and ERCC-XPF and show that the binding to single-stranded DNA(ssDNA)/ dsDNA junctions is dependent on joint binding to the DNA binding domain of ERCC1 and XPF. We reveal that the homodimeric XPF is able to bind various ssDNA sequences but with a clear preference for guanine-containing substrates. NMR titration experiments and in vitro DNA binding assays also show that, within the heterodimeric ERCC1-XPF complex, XPF specifically recognizes ssDNA. On the other hand, the HhH domain of ERCC1 preferentially binds dsDNA through the hairpin region. The two separate non-overlapping DNA binding domains in the ERCC1-XPF heterodimer jointly bind to an ssDNA/ dsDNA substrate and, thereby, at least partially dictate the incision position during damage removal. Based on structural models, NMR titrations, DNA-binding studies, site-directed mutagenesis, charge distribution, and sequence conservation, we propose that the HhH domain of ERCC1 binds to dsDNA upstream of the damage, and XPF binds to the non-damaged strand within a repair bubble.	[Das, Devashish; Faridounnia, Maryam; Kaptein, Robert; Boelens, Rolf; Folkers, Gert E.] Univ Utrecht, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Kovacic, Lidija] Jozef Stefan Inst, Dept Mol & Biomed Sci, Jamova Cesta 39, Ljubljana 1000, Slovenia	Utrecht University; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Folkers, GE (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	g.e.folkers@uu.nl	Faridounnia, Maryam/X-7736-2018; Boelens, Rolf/B-4702-2009; Folkers, Gert E/C-2863-2009; Das, Devashish/A-4165-2013	Faridounnia, Maryam/0000-0002-6260-7639; Boelens, Rolf/0000-0002-6939-8913; Folkers, Gert E/0000-0003-1070-0505; Das, Devashish/0000-0001-8501-8696	Netherlands Foundation for Chemical Research; Center for Biomedical Genetics; European Commission [031220/Spine2-complexes, 261863/Bio-NMR]; Slovenian Infrastructural Center for Analysis of Molecular Interaction; Slovenian Research Agency [Z1-4071]; Utrecht University	Netherlands Foundation for Chemical Research; Center for Biomedical Genetics; European Commission(European CommissionEuropean Commission Joint Research Centre); Slovenian Infrastructural Center for Analysis of Molecular Interaction; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Utrecht University	This work was supported by The Netherlands Foundation for Chemical Research, the Center for Biomedical Genetics, European Commission Project 031220/Spine2-complexes and Project 261863/Bio-NMR, the Slovenian Infrastructural Center for Analysis of Molecular Interaction, and the Slovenian Research Agency (Z1-4071). Funding for the open access charge was provided by Utrecht University. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Minawi AZ, 2008, NUCLEIC ACIDS RES, V36, P1, DOI 10.1093/nar/gkm888; Araujo SJ, 1999, MUTAT RES-DNA REPAIR, V435, P23, DOI 10.1016/S0921-8777(99)00042-7; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bessho T, 1997, J BIOL CHEM, V272, P3833, DOI 10.1074/jbc.272.6.3833; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Bowles M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks284; Cai Y, 2007, J MOL BIOL, V374, P292, DOI 10.1016/j.jmb.2007.09.034; Cai YQ, 2009, J MOL BIOL, V385, P30, DOI 10.1016/j.jmb.2008.09.087; Choi YJ, 2005, J BIOL CHEM, V280, P28644, DOI 10.1074/jbc.M501083200; Cleaver JE, 2008, MECH AGEING DEV, V129, P492, DOI 10.1016/j.mad.2008.01.005; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Cleaver JE, 1999, HUM MUTAT, V14, P9, DOI 10.1002/(SICI)1098-1004(1999)14:1<9::AID-HUMU2>3.3.CO;2-Y; Cleaver JE, 2002, FRONT BIOSCI-LANDMRK, V7, pD1024, DOI 10.2741/cleaver; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Das D, 2008, PROTEINS, V70, P1551, DOI 10.1002/prot.21635; Das D, 2012, STRUCTURE, V20, P667, DOI 10.1016/j.str.2012.02.009; de Jong RN, 2008, STRUCTURE, V16, P149, DOI 10.1016/j.str.2007.10.018; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; de Laat WL, 1998, NUCLEIC ACIDS RES, V26, P4146, DOI 10.1093/nar/26.18.4146; de Laat WL, 1998, J BIOL CHEM, V273, P7835, DOI 10.1074/jbc.273.14.7835; Faridounnia M, 2015, J BIOL CHEM, V290, P20541, DOI 10.1074/jbc.M114.635169; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Fisher LA, 2008, J BIOL CHEM, V283, P1275, DOI 10.1074/jbc.M708072200; Fisher LA, 2011, J MOL BIOL, V413, P337, DOI 10.1016/j.jmb.2011.08.034; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Gaillard PHL, 2001, NUCLEIC ACIDS RES, V29, P872, DOI 10.1093/nar/29.4.872; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Hayashi T, 1998, MUTAT RES-DNA REPAIR, V407, P269, DOI 10.1016/S0921-8777(98)00013-5; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; MATSUNAGA T, 1995, J BIOL CHEM, V270, P20862, DOI 10.1074/jbc.270.35.20862; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Missura M, 2001, EMBO J, V20, P3554, DOI 10.1093/emboj/20.13.3554; Mocquet V, 2008, EMBO J, V27, P155, DOI 10.1038/sj.emboj.7601948; MU D, 1994, NUCLEIC ACIDS RES, V22, P4869, DOI 10.1093/nar/22.23.4869; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Newman M, 2005, EMBO J, V24, P895, DOI 10.1038/sj.emboj.7600581; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Niedernhofer LJ, 2001, EMBO J, V20, P6540, DOI 10.1093/emboj/20.22.6540; NISHIGORI C, 1986, ARCH DERMATOL, V122, P510, DOI 10.1001/archderm.122.5.510; Nishino T, 2005, STRUCTURE, V13, P1183, DOI 10.1016/j.str.2005.04.024; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; PARK CH, 1995, J BIOL CHEM, V270, P22657, DOI 10.1074/jbc.270.39.22657; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Shao XG, 2000, NUCLEIC ACIDS RES, V28, P2643, DOI 10.1093/nar/28.14.2643; Sijbers AM, 1996, NUCLEIC ACIDS RES, V24, P3370, DOI 10.1093/nar/24.17.3370; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Su Y, 2012, J BIOL CHEM, V287, P21846, DOI 10.1074/jbc.M111.337899; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; SVOBODA DL, 1993, J BIOL CHEM, V268, P1931; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Tripsianes K, 2005, STRUCTURE, V13, P1849, DOI 10.1016/j.str.2005.08.014; Tripsianes K, 2007, NUCLEIC ACIDS RES, V35, P5789, DOI 10.1093/nar/gkm503; Tsodikov OV, 2007, EMBO J, V26, P4768, DOI 10.1038/sj.emboj.7601894; Tsodikov OV, 2005, P NATL ACAD SCI USA, V102, P11236, DOI 10.1073/pnas.0504341102; Wakasugi M, 1999, J BIOL CHEM, V274, P18759, DOI 10.1074/jbc.274.26.18759; Wakasugi M, 1997, J BIOL CHEM, V272, P16030, DOI 10.1074/jbc.272.25.16030; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Yagi T, 1997, MUTAGENESIS, V12, P41, DOI 10.1093/mutage/12.1.41; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	67	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2842	2853		10.1074/jbc.M116.747857	http://dx.doi.org/10.1074/jbc.M116.747857			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28028171	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000395535100024
J	Banjar, H; Ranasinghe, D; Brown, F; Adelson, D; Kroger, T; Leclercq, T; White, D; Hughes, T; Chaudhri, N				Banjar, Haneen; Ranasinghe, Damith; Brown, Fred; Adelson, David; Kroger, Trent; Leclercq, Tamara; White, Deborah; Hughes, Timothy; Chaudhri, Naeem			Modelling Predictors of Molecular Response to Frontline Imatinib for Patients with Chronic Myeloid Leukaemia	PLOS ONE			English	Article							OCT-1 ACTIVITY; CML PATIENTS; MANAGEMENT; SURVIVAL; RECOMMENDATIONS; BIOMARKERS; SCORE	Background Treatment of patients with chronic myeloid leukaemia (CML) has become increasingly difficult in recent years due to the variety of treatment options available and challenge deciding on the most appropriate treatment strategy for an individual patient. To facilitate the treatment strategy decision, disease assessment should involve molecular response to initial treatment for an individual patient. Patients predicted not to achieve major molecular response (MMR) at 24 months to frontline imatinib may be better treated with alternative frontline therapies, such as nilotinib or dasatinib. The aims of this study were to i) understand the clinical prediction 'rules' for predicting MMR at 24 months for CML patients treated with imatinib using clinical, molecular, and cell count observations (predictive factors collected at diagnosis and categorised based on available knowledge) and ii) develop a predictive model for CML treatment management. This predictive model was developed, based on CML patients undergoing imatinib therapy enrolled in the TIDEL II clinical trial with an experimentally identified achieving MMR group and non-achieving MMR group, by addressing the challenge as a machine learning problem. The recommended model was validated externally using an independent data set from King Faisal Specialist Hospital and Research Centre, Saudi Arabia. Principle Findings The common prognostic scores yielded similar sensitivity performance in testing and validation datasets and are therefore good predictors of the positive group. The G-mean and F-score values in our models outperformed the common prognostic scores in testing and validation datasets and are therefore good predictors for both the positive and negative groups. Furthermore, a high PPV above 65% indicated that our models are appropriate for making decisions at diagnosis and pre-therapy. Study limitations include that prior knowledge may change based on varying expert opinions; hence, representing the category boundaries of each predictive factor could dramatically change performance of the models.	[Banjar, Haneen; Ranasinghe, Damith; Brown, Fred; Kroger, Trent] Univ Adelaide, Sch Comp Sci, Adelaide, SA, Australia; [Banjar, Haneen] King Abdulaziz Univ, Dept Comp Sci, Jeddah, Saudi Arabia; [Ranasinghe, Damith] Univ Adelaide, Sch Comp Sci, Auto ID Lab, Adelaide, SA, Australia; [Adelson, David] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Leclercq, Tamara; White, Deborah; Hughes, Timothy] South Australian Hlth & Med Res Inst SAHMRI, Canc Theme, Adelaide, SA, Australia; [Leclercq, Tamara; White, Deborah; Hughes, Timothy] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [White, Deborah] Univ Adelaide, Discipline Paediat, Adelaide, SA, Australia; [White, Deborah; Hughes, Timothy] Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia; [White, Deborah; Hughes, Timothy] Univ Adelaide, Ctr Personalised Canc Med, Adelaide, SA, Australia; [Hughes, Timothy] SA Pathol, Dept Haematol, Adelaide, SA, Australia; [Chaudhri, Naeem] King Faisal Specialist Hosp & Res Ctr, Ctr Oncol, Riyadh, Saudi Arabia	University of Adelaide; King Abdulaziz University; University of Adelaide; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; University of Adelaide; Centre for Cancer Biology; University of South Australia; University of Adelaide; SA Pathology; King Faisal Specialist Hospital & Research Center	Banjar, H (corresponding author), Univ Adelaide, Sch Comp Sci, Adelaide, SA, Australia.; Banjar, H (corresponding author), King Abdulaziz Univ, Dept Comp Sci, Jeddah, Saudi Arabia.	Hrbanjar@kau.edu.sa	Adelson, David L/E-5506-2011; Banjar, Haneen R/H-6404-2018; Ranasinghe, Damith/AAC-1387-2021; Hughes, Tim/AAO-9975-2021	Adelson, David L/0000-0003-2404-5636; Banjar, Haneen R/0000-0003-4475-4878; Ranasinghe, Damith/0000-0002-2008-9255; Hughes, Timothy/0000-0002-0910-3730; White, Deborah/0000-0003-4844-333X	King Abdulaziz University; Novartis Australia	King Abdulaziz University; Novartis Australia(Novartis)	Financial support received by HB for this study was provided in part by a grant from King Abdulaziz University. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. TH received funds from Novartis Australia for the TIDEL II trial. Novartis had no role in the decision to publish and preparation of the manuscript.	Acuna E, 2004, ST CLASS DAT ANAL, P639; Agrawal M, 2010, CURR ONCOL REP, V12, P302, DOI 10.1007/s11912-010-0116-1; Ambler G, 2007, STAT METHODS MED RES, V16, P277, DOI 10.1177/0962280206074466; Apperley JF, 2007, LANCET ONCOL, V8, P1018, DOI 10.1016/S1470-2045(07)70342-X; Baccarani M, 2006, BLOOD, V108, P1809, DOI 10.1182/blood-2006-02-005686; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Branford S, 2013, BLOOD, V121, P3818, DOI 10.1182/blood-2012-10-462291; Breiman L., 1984, CLASSIFICATION REGRE; Cheng T-H, 2006, P 19 IEEE S COMP BAS; Cismondi F, 2013, ARTIF INTELL MED, V58, P63, DOI 10.1016/j.artmed.2013.01.003; Cortes J, 2012, BLOOD, V120, P1390, DOI 10.1182/blood-2012-03-378919; Cruz JA, 2006, CANCER INFORM, V2, P59; Freitas Alex A., 2014, ACM SIGKDD EXPLORATI, V15, P1, DOI DOI 10.1145/2594473.2594475; Gowda A., 2010, INT, V7, P13, DOI [DOI 10.5120/169-295, 10.5120/169-295]; Guilhot F, 2011, BLOOD, V117, P1773, DOI 10.1182/blood-2010-11-317123; Hasford J, 1998, JNCI-J NATL CANCER I, V90, P850, DOI 10.1093/jnci/90.11.850; Hasford J, 2011, BLOOD, V118, P686, DOI 10.1182/blood-2010-12-319038; Hughes T, 2006, BLOOD REV, V20, P29, DOI 10.1016/j.blre.2005.01.008; Jabbour E, 2012, BLOOD, V119, P4524, DOI 10.1182/blood-2011-10-388967; Jabbour E, 2011, BLOOD, V117, P1822, DOI 10.1182/blood-2010-07-293977; Khalil SH, 2010, GENET TEST MOL BIOMA, V14, P67, DOI 10.1089/gtmb.2009.0126; Lasserre J, 2012, PREDICTING OUTCOME R, P255; Mitchell T.M, 2003, MACH LEARN; Oldenhuis CNAM, 2008, EUR J CANCER, V44, P946, DOI 10.1016/j.ejca.2008.03.006; Perner P., 2001, APPL ARTIFICIAL INTE, V15; Prati RC, 2012, NEUR NETW IJCNN 2012; Prejzner W, 2002, MED SCI MONITOR, V8, pBR193; Qian M, 2013, MODERN CLIN TRIAL AN, P127; Quinlan JR, 1987, P IJCAI 87 P 10 INT; Shouval R, 2014, BONE MARROW TRANSPL, V49, P332, DOI 10.1038/bmt.2013.146; SOKAL JE, 1984, BLOOD, V63, P789, DOI 10.1182/blood.V63.4.789.789; Starkweather J, 2014, REPLACE MISSING VALU; Sweet K, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-54; Thamas D, 2007, IMVS NEWSLETTER; TIMOFEEV R., 2004, CLASSIFICATION REGRE; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; Verma D, 2009, BLOOD, V114, P2232, DOI 10.1182/blood-2009-02-204693; White DL, 2007, BLOOD, V110, P4064, DOI 10.1182/blood-2007-06-093617; White DL, 2006, BLOOD, V108, P697, DOI 10.1182/blood-2005-11-4687; White DL, 2011, CURR HEMATOL MALIG R, V6, P88, DOI 10.1007/s11899-011-0087-9; White Deborah L, 2009, Curr Hematol Malig Rep, V4, P59, DOI 10.1007/s11899-009-0009-2; White DL, 2008, BLOOD, V112, P405; White DL, 2009, BLOOD, V114, P507; Yeung DT, 2015, TIDEL 2 1 LINE USE I, P915	44	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168947	10.1371/journal.pone.0168947	http://dx.doi.org/10.1371/journal.pone.0168947			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045960	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000391612300077
J	Bu, LG; Zhang, M; Li, JF; Li, FY; Liu, HS; Li, ZY				Bu, Lingguo; Zhang, Ming; Li, Jianfeng; Li, Fangyi; Liu, Heshan; Li, Zengyong			Effects of Sleep Deprivation on Phase Synchronization as Assessed by Wavelet Phase Coherence Analysis of Prefrontal Tissue Oxyhemoglobin Signals	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; BRAIN FUNCTIONAL CONNECTIVITY; WORKING-MEMORY; ELDERLY SUBJECTS; CORTEX; PERFORMANCE; MODULATION; PRESSURE; NETWORK	Purpose To reveal the physiological mechanism of the decline in cognitive function after sleep deprivation, a within-subject study was performed to assess sleep deprivation effects on phase synchronization, as revealed by wavelet phase coherence (WPCO) analysis of prefrontal tissue oxyhemoglobin signals. Materials and Methods Twenty subjects (10 male and 10 female, 25.5+/-3.5 years old) were recruited to participate in two tests: one without sleep deprivation (group A) and the other with 24 h of sleep deprivation (group B). Before the test, each subject underwent a subjective evaluation using visual analog scales. A cognitive task was performed by judging three random numbers. Continuous recordings of the near-infrared spectroscopy (NIRS) signals were obtained from both the left and right prefrontal lobes during rest, task, and post-task periods. The WPCO of cerebral Delta [HbO(2)] signals were analyzed for these three periods for both groups A and B. Results Six frequency intervals were defined: I: 0.6-2 Hz (cardiac activity), II: 0.145-0.6 Hz (respiratory activity), III: 0.052-0.145 Hz (myogenic activity), IV: 0.021-0.052 Hz (neurogenic activity), V: 0.0095-0.021 Hz (nitric oxide related endothelial activity) and VI: 0.005-0.0095 Hz (non-nitric oxide related endothelial activity). WPCO in intervals III (F = 5.955, p = 0.02) and V (F = 4.7, p = 0.037) was significantly lower in group B than in group A at rest. During the task period, WPCO in intervals III (F = 5.175, p = 0.029) and IV (F = 4.585, p = 0.039) was significantly lower in group B compared with group A. In the post-task recovery period, the WPCO in interval III (F = 6.125, p = 0.02) was significantly lower in group B compared with group A. Reaction time was significantly prolonged, and the accuracy rate and F-1 score both declined after sleep deprivation. Conclusions The decline in WPCO after sleep deprivation indicates reduced phase synchronization between left and right prefrontal oxyhemoglobin oscillations, which may contribute to the diminished cognitive function.	[Bu, Lingguo; Li, Jianfeng; Li, Fangyi; Liu, Heshan] Shandong Univ, Sch Mech Engn, Key Lab High Efficiency & Clean Mech Manufacture, Jinan, Peoples R China; [Zhang, Ming] Hong Kong Polytech Univ, Fac Engn, Interdisciplinary Div Biomed Engn, Kowloon, Hong Kong, Peoples R China; [Li, Zengyong] Natl Res Ctr Rehabil Tech Aids, Key Lab Rehabil Aids Technol & Syst, Minist Civil Affairs, Beijing, Peoples R China	Shandong University; Hong Kong Polytechnic University	Li, ZY (corresponding author), Natl Res Ctr Rehabil Tech Aids, Key Lab Rehabil Aids Technol & Syst, Minist Civil Affairs, Beijing, Peoples R China.	zyongli2000@aliyun.com	Zhang, Ming/F-8331-2011	Zhang, Ming/0000-0002-6027-4594	National Natural Science Foundation of China [31371002, 11272273]; Fundamental Research Funds of National Research Center for Rehabilitation Technical Aids	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of National Research Center for Rehabilitation Technical Aids	This project was supported by the National Natural Science Foundation of China (Grants: 31371002, 11272273) and the Fundamental Research Funds of National Research Center for Rehabilitation Technical Aids. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandrivskyy A., 2004, CARDIOVASC ENG, V4, P89, DOI [10.1023/B:CARE.0000025126.63253.43, DOI 10.1023/B:CARE.0000025126.63253.43]; Bernjak A, 2012, FLUCT NOISE LETT, V11, DOI 10.1142/S0219477512400135; Boonstra TW, 2007, CELL MOL LIFE SCI, V64, P934, DOI 10.1007/s00018-007-6457-8; Buysse D J, 1989, Psychiatry Res, V28, P193; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Courtney SM, 1998, PHILOS T R SOC B, V353, P1819, DOI 10.1098/rstb.1998.0334; Dai XJ, 2012, SLEEP MED, V13, P720, DOI 10.1016/j.sleep.2011.09.019; De Havas JA, 2012, NEUROIMAGE, V59, P1745, DOI 10.1016/j.neuroimage.2011.08.026; Drummond SPA, 2005, PSYCHIAT RES-NEUROIM, V140, P211, DOI 10.1016/j.pscychresns.2005.06.007; Drummond SPA, 2001, J SLEEP RES, V10, P85, DOI 10.1046/j.1365-2869.2001.00245.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Graw P, 2004, PHYSIOL BEHAV, V80, P695, DOI 10.1016/j.physbeh.2003.12.004; Gujar N, 2010, J COGNITIVE NEUROSCI, V22, P1637, DOI 10.1162/jocn.2009.21331; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hamner JW, 2010, STROKE, V41, P102, DOI 10.1161/STROKEAHA.109.557132; Han QY, 2014, MICROVASC RES, V95, P108, DOI 10.1016/j.mvr.2014.08.001; Honma M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012923; Hoshi Y, 2003, NEUROIMAGE, V20, P1493, DOI 10.1016/S1053-8119(03)00412-9; Hripcsak G, 2005, J AM MED INFORM ASSN, V12, P296, DOI 10.1197/jamia.M1733; Johnson EW, 2001, AM J PHYS MED REHAB, V80, P717, DOI 10.1097/00002060-200110000-00001; Keselbrener L, 1996, IEEE T BIO-MED ENG, V43, P789, DOI 10.1109/10.508542; Kuriyama K, 2008, J NEUROSCI, V28, P10145, DOI 10.1523/JNEUROSCI.2039-08.2008; Kvandal P, 2003, MICROVASC RES, V65, P160, DOI 10.1016/S0026-2862(03)00006-2; Li ZY, 2014, PHYSIOL MEAS, V35, P777, DOI 10.1088/0967-3334/35/5/777; Lu CM, 2010, J NEUROSCI METH, V186, P242, DOI 10.1016/j.jneumeth.2009.11.010; Lythe KE, 2012, BEHAV BRAIN RES, V233, P62, DOI 10.1016/j.bbr.2012.04.050; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Rowley AB, 2007, PHYSIOL MEAS, V28, P161, DOI 10.1088/0967-3334/28/2/005; Samann PG, 2010, MAGN RESON MATER PHY, V23, P375, DOI 10.1007/s10334-010-0213-z; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Schweizer TA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00053; Shiogai Y, 2010, PHYS REP, V488, P51, DOI 10.1016/j.physrep.2009.12.003; Smith A, 2003, NEUROIMAGE, V20, P344, DOI 10.1016/S1053-8119(03)00337-9; Soshi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008395; Steinbrink J, 2006, MAGN RESON IMAGING, V24, P495, DOI 10.1016/j.mri.2005.12.034; Tan QT, 2016, MICROVASC RES, V103, P19, DOI 10.1016/j.mvr.2015.10.002; Telzer EH, 2013, NEUROIMAGE, V71, P275, DOI 10.1016/j.neuroimage.2013.01.025; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Tononi G, 2012, J MOL NEUROSCI, V48, pS118; Verweij IM, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-88; Wang BT, 2016, BEHAV BRAIN RES, V312, P238, DOI 10.1016/j.bbr.2016.06.037; Wang W, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00400; Xu LM, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051101; Zhong X, 2005, J APPL PHYSIOL, V98, P2024, DOI 10.1152/japplphysiol.00620.2004	48	16	17	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169279	10.1371/journal.pone.0169279	http://dx.doi.org/10.1371/journal.pone.0169279			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2QJ	28046043	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300158
J	Clemensson, EKH; Clemensson, LE; Riess, O; Nguyen, HP				Clemensson, Erik Karl Hakan; Clemensson, Laura Emily; Riess, Olaf; Huu Phuc Nguyen			The BACHD Rat Model of Huntington Disease Shows Signs of Fronto-Striatal Dysfunction in Two Operant Conditioning Tests of Short-Term Memory	PLOS ONE			English	Article							DELAYED ALTERNATION TASK; REACTION-TIME-TASK; STOP-SIGNAL; EXECUTIVE DYSFUNCTION; RESPONSE-INHIBITION; WORKING-MEMORY; POSITION TASK; TRACK-HD; PERFORMANCE; LESIONS	The BACHD rat is a recently developed transgenic animal model of Huntington disease, a progressive neurodegenerative disorder characterized by extensive loss of striatal neurons. Cognitive impairments are common among patients, and characterization of similar deficits in animal models of the disease is therefore of interest. The present study assessed the BACHD rats' performance in the delayed alternation and the delayed non-matching to position test, two Skinner box-based tests of short-term memory function. The transgenic rats showed impaired performance in both tests, indicating general problems with handling basic aspects of the tests, while short-term memory appeared to be intact. Similar phenotypes have been found in rats with fronto-striatal lesions, suggesting that Huntington disease related neuropathology might be present in the BACHD rats. Further analyses indicated that the performance deficit in the delayed alternation test might be due to impaired inhibitory control, which has also been implicated in Huntington disease patients. The study ultimately suggests that the BACHD rats might suffer from neuropathology and cognitive impairments reminiscent of those of Huntington disease patients.	[Clemensson, Erik Karl Hakan; Clemensson, Laura Emily; Riess, Olaf; Huu Phuc Nguyen] Inst Med Genet & Appl Genom, Tubingen, Germany; [Clemensson, Erik Karl Hakan; Clemensson, Laura Emily; Riess, Olaf; Huu Phuc Nguyen] Ctr Rare Dis, Tubingen, Germany; [Clemensson, Laura Emily] QPS Austria, Grambach, Austria		Nguyen, HP (corresponding author), Inst Med Genet & Appl Genom, Tubingen, Germany.; Nguyen, HP (corresponding author), Ctr Rare Dis, Tubingen, Germany.	hoa.nguyen@med.uni-tuebingen.de	Nguyen, Huu Phuc/HDO-3462-2022	Nguyen, Huu Phuc/0000-0001-6139-788X; Clemensson, Erik/0000-0002-5158-6924	Medical Faculty of the University of Tuebingen; European Union (EU) 7th Framework program (FP7) project "SWITCH-HD" [324495]; EU funds; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Tubingen	Medical Faculty of the University of Tuebingen; European Union (EU) 7th Framework program (FP7) project "SWITCH-HD"; EU funds; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen	The study was funded by yearly funds allocated to the Institute of Medical Genetics and Applied Genomics by the Medical Faculty of the University of Tuebingen. These were used to maintain animals, acquire materials, perform experiments, analyze data and support the authors' salaries. All practical and analytical work was performed at the Institute of Medical Genetics and Applied Genomics in Tuebingen. During data analysis and manuscript preparation, Laura Clemensson and Huu Phuc Nguyen were funded by the European Union (EU) 7th Framework program (FP7/2012), project "SWITCH-HD", under grant agreement No. 324495. It should be noted that this project included an industrial collaboration partner, the commercial company QPS Austria, which at the time employed Laura Clemensson. Still, QPS Austria did not support the current study with either material or funding. Notably, Laura Clemensson's salary was paid by the EU funds, and not by QPS Austria. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen. The funders and QPS Austria had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud N, 2015, NEUROBIOL LEARN MEM, V125, P249, DOI 10.1016/j.nlm.2015.10.003; AGGLETON JP, 1991, BEHAV BRAIN RES, V44, P151, DOI 10.1016/S0166-4328(05)80020-8; Beste C, 2008, NEUROPSYCHOLOGIA, V46, P1290, DOI 10.1016/j.neuropsychologia.2007.12.008; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Cao C, 2006, BEHAV BRAIN RES, V170, P257, DOI 10.1016/j.bbr.2006.02.028; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Chudasama Y, 1997, PSYCHOPHARMACOLOGY, V134, P73, DOI 10.1007/s002130050427; Clemens LE, 2015, BRAIN, V138, P3632, DOI 10.1093/brain/awv290; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Dobrossy M S, 2009, METHODS BEHAV ANAL N; DOBROSSY MD, 1995, NEUROREPORT, V6, P2049; Dunnett SB, 2005, NEUROSCIENCE, V135, P1055, DOI 10.1016/j.neuroscience.2005.07.033; Dunnett SB, 1999, BEHAV BRAIN RES, V106, P13, DOI 10.1016/S0166-4328(99)00076-5; Dunnett SB, 2006, EXP NEUROL, V199, P479, DOI 10.1016/j.expneurol.2006.01.013; Eagle DM, 2008, PSYCHOPHARMACOLOGY, V199, P439, DOI 10.1007/s00213-008-1127-6; Eagle DM, 2008, CEREB CORTEX, V18, P178, DOI 10.1093/cercor/bhm044; Eagle DM, 2003, BEHAV NEUROSCI, V117, P1302, DOI 10.1037/0735-7044.117.6.1302; Faure A, 2011, NEUROBIOL LEARN MEM, V95, P92, DOI 10.1016/j.nlm.2010.11.010; Ho AK, 2003, NEUROLOGY, V61, P1702, DOI 10.1212/01.WNL.0000098878.47789.BD; Izaki Y, 2008, EUR J NEUROSCI, V27, P3029, DOI 10.1111/j.1460-9568.2008.06284.x; Jansson EKH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105662; Lawrence AD, 1996, BRAIN, V119, P1633, DOI 10.1093/brain/119.5.1633; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Lawrence AD, 2000, BRAIN, V123, P1349, DOI 10.1093/brain/123.7.1349; Lawrence AD, 1999, NEUROPSYCHOLOGIA, V37, P1359, DOI 10.1016/S0028-3932(99)00035-4; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Manfre G, 2016, BEHAV BRAIN RES, V299, P6, DOI 10.1016/j.bbr.2015.11.007; Montoya A, 2006, J PSYCHIATR NEUROSCI, V31, P21; Oakeshott S, PLOS CURR; Papp KV, 2013, ARCH CLIN NEUROPSYCH, V28, P156, DOI 10.1093/arclin/acs105; Papp KV, 2011, BRAIN COGNITION, V77, P280, DOI 10.1016/j.bandc.2011.07.009; Paulsen JS, 2011, CURR NEUROL NEUROSCI, V11, P474, DOI 10.1007/s11910-011-0215-x; Peinemann A, 2005, J NEUROL SCI, V239, P11, DOI 10.1016/j.jns.2005.07.007; Porter MC, 2000, BEHAV BRAIN RES, V109, P69, DOI 10.1016/S0166-4328(99)00161-8; Rao JA, 2014, CORTEX, V58, P72, DOI 10.1016/j.cortex.2014.04.018; ROGERS DC, 1992, BEHAV BRAIN RES, V49, P231, DOI 10.1016/S0166-4328(05)80169-X; Stout JC, 2012, J NEUROL NEUROSUR PS, V83, P687, DOI 10.1136/jnnp-2011-301940; Stout JC, 2011, NEUROPSYCHOLOGY, V25, P1, DOI 10.1037/a0020937; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Trueman RC, 2012, BRAIN RES BULL, V88, P156, DOI 10.1016/j.brainresbull.2011.03.012; Urbach YK, 2014, J NEUROSCI METH, V234, P38, DOI 10.1016/j.jneumeth.2014.06.017; White A, 2006, NEUROREPORT, V17, P435, DOI 10.1097/01.wnr.0000203625.09706.5d; Wolf RC, 2009, HUM BRAIN MAPP, V30, P327, DOI 10.1002/hbm.20502; Yhnell E, 2016, J NEUROSCI METH, V265, P72, DOI 10.1016/j.jneumeth.2015.08.022; Yu-Taeger L, 2012, J NEUROSCI, V32, P15426, DOI 10.1523/JNEUROSCI.1148-12.2012; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	49	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169051	10.1371/journal.pone.0169051	http://dx.doi.org/10.1371/journal.pone.0169051			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2QJ	28045968	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300099
J	Li, H; Bennett, MT; Jiang, XM; Zhang, KB; Yang, XH				Li, Hao; Bennett, Michael T.; Jiang, Xuemei; Zhang, Kebin; Yang, Xiaohui			Rural Household Preferences for Active Participation in "Payment for Ecosystem Service" Programs: A Case in the Miyun Reservoir Catchment, China	PLOS ONE			English	Article							LAND CONVERSION PROGRAM; FOR-GREEN PROGRAM; ENVIRONMENTAL SERVICES; CHOICE EXPERIMENT; BIODIVERSITY CONSERVATION; DESIGNING PAYMENTS; FARMERS ATTITUDES; WATER-QUALITY; GRAIN; CONSTRAINTS	Many payment for ecosystem services (PES) programs, such as the Slope Land Conversion Program (SLCP), are passive and require full participation by impacted households. In contrast, this study considers the alternative of "active and incomplete" participation in PES programs, in which participants are not obliged to contract their own land, and have the right to select into the program or not. This type of program has been popular over the last decade in China; however, there have been few studies on the characteristics of willingness to participate and implementation. As such, this paper uses the Choice Experiment (CE) method to explore ways for inducing effective program participation, by analyzing the effects of different regime attributes. The case study used to analyze participation utility was the Jing-Ji Afforestation Program for Ecological and Water Protection (JAPEWP), a typical active-participation forestry PES program, and a key source of water near Beijing in the Miyun Reservoir Catchment (MRC). Analyzing rural household survey data indicated that the program faces a variety of challenges, including long-term maintenance, implementation performance, costeffectiveness, and monitoring approaches. There are also challenges with one-size-fits-all payment strategies, due to ineffective program participation or imperfect implementation regimes. In response, this study proposes several policies, including providing secure and complete land tenure to the participants, creating more local off-farm employment opportunities, designing performance-based monitoring systems that are integrated with financial incentives, applying differentiated payment strategies, providing capacity building to support forestation activities, and establishing a comprehensive implementation regime that would address these challenges. These policy conclusions provide valuable lessons for other active-participation PES programs as well.	[Li, Hao; Zhang, Kebin] Beijing Forestry Univ, Sch Water & Soil Conservat, Beijing, Peoples R China; [Li, Hao] Beijing Forestry Soc, Beijing, Peoples R China; [Bennett, Michael T.] Peking Univ, Coll Environm Sci & Engn, Beijing, Peoples R China; [Jiang, Xuemei] Beijing Forestry Univ, Sch Econ & Management, Beijing, Peoples R China; [Yang, Xiaohui] Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China	Beijing Forestry University; Peking University; Beijing Forestry University; Chinese Academy of Forestry; Institute of Desertification Studies, CAF	Yang, XH (corresponding author), Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China.	yangxh@caf.ac.cn		Li, Hao/0000-0002-1228-7585; Yang, Xiaohui/0000-0002-5453-2702	Beijing Municipal Science AMP; Technology Commission [Z141100006014031, Z141100006014037]; Global Water Initiative; Beijing Municipal Science AMP; Technology Commission; SDC	Beijing Municipal Science AMP; Technology Commission(Beijing Municipal Science & Technology Commission); Global Water Initiative; Beijing Municipal Science AMP; Technology Commission(Beijing Municipal Science & Technology Commission); SDC	The study was funded by the Beijing Municipal Science & Technology Commission (Z141100006014031; Z141100006014037) and the Global Water Initiative administrated by the Forest Trends (US) on behalf of the Swiss Agency for Development and Cooperation (SDC). XY and XJ received the funding of Beijing Municipal Science & Technology Commission and SDC, respectively. The study team used the funding of SDC to collect data and will publish the paper with the funding of Beijing Municipal Science & Technology Commission.	Adamowicz W, 1998, AM J AGR ECON, V80, P64, DOI 10.2307/3180269; Adamowicz W., 1998, INTRO ATTRIBUTE BASE; Adhikari B, 2013, CURR OPIN ENV SUST, V5, P72, DOI 10.1016/j.cosust.2012.11.001; [Anonymous], 2002, SELLING FOREST ENV S; Arriagada RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131544; Torres AB, 2013, ECOSYST SERV, V6, P72, DOI 10.1016/j.ecoser.2013.03.002; Bao ZX, 2012, QUATERN INT, V282, P96, DOI 10.1016/j.quaint.2012.07.012; Beharry-Borg N, 2013, REG ENVIRON CHANGE, V13, P633, DOI 10.1007/s10113-012-0282-9; Bennett G, 2014, GAINING DEPTH STATE; Bennett J, 2001, NEW HOR ENV ECO, P37; Bennett MT, 2008, ECOL ECON, V65, P699, DOI 10.1016/j.ecolecon.2007.09.017; Bennett MT, 2014, FORESTS, V5, P2345, DOI 10.3390/f5092345; Bennett MT, 2011, CHINA ECON REV, V22, P485, DOI 10.1016/j.chieco.2010.12.002; Berninger K, 2010, ENVIRON MANAGE, V46, P117, DOI 10.1007/s00267-010-9507-1; Birol E, 2006, ENVIRON RESOUR ECON, V34, P439, DOI 10.1007/s10640-006-0009-9; Bowlus AJ, 2003, J DEV ECON, V71, P561, DOI 10.1016/S0304-3878(03)00040-3; Brandt L, 2002, CHINA J, V47, P67, DOI 10.2307/3182074; Bremer LL, 2014, ECOSYST SERV, V8, P148, DOI 10.1016/j.ecoser.2014.03.007; Bulte EH, 2008, ENVIRON DEV ECON, V13, P245, DOI 10.1017/S1355770X08004348; Demurger S, 2015, ECOL ECON, V116, P25, DOI 10.1016/j.ecolecon.2015.04.012; Dupraz P, 2003, ENVIRON RESOUR ECON, V25, P171, DOI 10.1023/A:1023910720219; Engel S, 2008, ECOL ECON, V65, P663, DOI 10.1016/j.ecolecon.2008.03.011; Espinosa-Goded M, 2010, J AGR ECON, V61, P259, DOI 10.1111/j.1477-9552.2010.00244.x; Falconer K, 2000, J RURAL STUD, V16, P379, DOI 10.1016/S0743-0167(99)00066-2; Farley J, 2010, ECOL ECON, V69, P2060, DOI 10.1016/j.ecolecon.2010.06.010; Feng ZM, 2005, LAND USE POLICY, V22, P301, DOI 10.1016/j.landusepol.2004.05.004; Fisher J, 2012, ORYX, V46, P45, DOI 10.1017/S0030605311001384; Gauvin C, 2010, ENVIRON MANAGE, V45, P488, DOI 10.1007/s00267-009-9321-9; Geng RZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130607; Groom B, 2010, OXFORD ECON PAP, V62, P132, DOI 10.1093/oep/gpp021; Grosjean P, 2009, WORLD DEV, V37, P268, DOI 10.1016/j.worlddev.2008.05.003; Hanley N, 1998, ENVIRON RESOUR ECON, V11, P413, DOI 10.1023/A:1008287310583; Hegde R, 2015, ENVIRON DEV ECON, V20, P611, DOI 10.1017/S1355770X14000631; Hensher D, 2005, ENVIRON RESOUR ECON, V32, P509, DOI 10.1007/s10640-005-7686-7; Hope RA, 2006, WORLD DEV, V34, P167, DOI 10.1016/j.worlddev.2005.07.014; Hoyos D, 2010, ECOL ECON, V69, P1595, DOI 10.1016/j.ecolecon.2010.04.011; Hu CX, 2006, INT J SUST DEV WORLD, V13, P211, DOI 10.1080/13504500609469673; Ingram JC, 2014, ECOSYST SERV, V7, P10, DOI 10.1016/j.ecoser.2013.12.003; Jacoby HG, 2002, AM ECON REV, V92, P1420, DOI 10.1257/000282802762024575; Jenkins M., 2012, OVERVIEW PAYMENTS EC; Johnson P. N., 1997, Journal of Agricultural and Applied Economics, V29, P163; Konig HJ, 2014, LAND DEGRAD DEV, V25, P385, DOI 10.1002/ldr.2164; Kosoy N, 2008, GEOFORUM, V39, P2073, DOI 10.1016/j.geoforum.2008.08.007; Ku SJ, 2009, ENVIRON MANAGE, V44, P278, DOI 10.1007/s00267-009-9325-5; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Li D, 2016, ENVIRON MONIT ASSESS, V188, P1, DOI DOI 10.1007/S10661-015-5048-7; Li J, 2011, P NATL ACAD SCI USA, V108, P7721, DOI 10.1073/pnas.1101018108; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Liu JG, 2013, P NATL ACAD SCI USA, V110, P16297, DOI 10.1073/pnas.1316036110; Loureiro ML, 2007, FOOD POLICY, V32, P496, DOI 10.1016/j.foodpol.2006.11.006; Mahanty S, 2013, LAND USE POLICY, V31, P38, DOI 10.1016/j.landusepol.2011.10.009; Martin A, 2014, GLOBAL ENVIRON CHANG, V28, P216, DOI 10.1016/j.gloenvcha.2014.07.003; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; Miranda M., 2003, SOCIAL IMPACTS PAYME; Montagnini F, 2011, AMBIO, V40, P285, DOI 10.1007/s13280-010-0114-4; Morrison M, 2002, AM J AGR ECON, V84, P161, DOI 10.1111/1467-8276.00250; Mullan K, 2012, J ENVIRON ECON POLIC, V1, P235, DOI 10.1080/21606544.2012.714968; Nagubadi V., 1996, Journal of Agricultural and Applied Economics, V28, P323; Nunes PALD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126681; O'Hara P, 2009, ENHANCING STAKEHOLDE; Otieno DJ, 2011, J AGR ECON, V62, P207, DOI 10.1111/j.1477-9552.2010.00280.x; Pagiola S, 2005, WORLD DEV, V33, P237, DOI 10.1016/j.worlddev.2004.07.011; Pagiola S, 2010, ENVIRON RESOUR ECON, V47, P371, DOI 10.1007/s10640-010-9383-4; Pascual U, 2014, BIOSCIENCE, V64, P1027, DOI 10.1093/biosci/biu146; Paulrud S, 2010, BIOMASS BIOENERG, V34, P1770, DOI 10.1016/j.biombioe.2010.07.007; Peisert C., 2005, CHINA ENV SER, V7, P33; Sakata Y, 2007, WASTE MANAGE, V27, P639, DOI 10.1016/j.wasman.2006.03.007; Sasao T, 2004, WASTE MANAGE, V24, P753, DOI 10.1016/j.wasman.2004.05.003; Shan N, 2015, AGR FOREST METEOROL, V200, P322, DOI 10.1016/j.agrformet.2014.10.008; Sukamaki J, 2015, LAND ECON, V91, P211; Train K. E., 2003, DISCRETE CHOICE METH; Uchida E, 2005, LAND ECON, V81, P247, DOI 10.3368/le.81.2.247; Uchida E, 2009, AM J AGR ECON, V91, P70, DOI 10.1111/j.1467-8276.2008.01184.x; Uchida E, 2007, ENVIRON DEV ECON, V12, P593, DOI 10.1017/S1355770X07003713; USDA, 2016, CONS PROGR 2016; Wang X, 2015, SCI TOTAL ENVIRON, V536, P739, DOI 10.1016/j.scitotenv.2015.07.088; Whalley J, 2007, J DEV ECON, V83, P392, DOI 10.1016/j.jdeveco.2006.08.003; Wossink GAA, 2003, EUR REV AGRIC ECON, V30, P461, DOI 10.1093/erae/30.4.461; Wu ZT, 2014, ENVIRON SCI TECHNOL, V48, P12108, DOI 10.1021/es502408n; Wunscher T, 2008, ECOL ECON, V65, P822, DOI 10.1016/j.ecolecon.2007.11.014; Wunder S, 2008, ECOL ECON, V65, P834, DOI 10.1016/j.ecolecon.2008.03.010; Wunder S, 2015, ECOL ECON, V117, P234, DOI 10.1016/j.ecolecon.2014.08.016; Xu EQ, 2016, ECOL INDIC, V66, P329, DOI 10.1016/j.ecolind.2016.02.002; Xu JT, 2006, ECOL ECON, V57, P595, DOI 10.1016/j.ecolecon.2005.05.008; Xu ZX, 2009, HYDROL PROCESS, V23, P3619, DOI 10.1002/hyp.7475; Xue J, 2011, PEOPLES DAILY; Yin RS, 2010, ENVIRON MANAGE, V45, P429, DOI 10.1007/s00267-009-9373-x; Yu X, 2010, FOREST LANDSCAPE PAT; Yu Z, 1999, STUDY BENEFITS WATER; Zbinden S, 2005, WORLD DEV, V33, P255, DOI 10.1016/j.worlddev.2004.07.012; Zhai YZ, 2012, J GEOGR SCI, V22, P919, DOI 10.1007/s11442-012-0973-7; Zhan CS, 2011, J PLANT ECOL, V4, P61, DOI 10.1093/jpe/rtr003; Zhang YX, 2010, J ENVIRON SCI, V22, P1297, DOI 10.1016/S1001-0742(09)60253-9; Zheng H, 2013, P NATL ACAD SCI USA, V110, P16681, DOI 10.1073/pnas.1312324110; Zhou Y, 2009, AGR WATER MANAGE, V96, P883, DOI 10.1016/j.agwat.2008.11.011	95	17	17	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169483	10.1371/journal.pone.0169483	http://dx.doi.org/10.1371/journal.pone.0169483			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2QJ	28046106	gold, Green Published			2022-12-26	WOS:000391612300198
J	Meisal, R; Rounge, TB; Christiansen, IK; Eieland, AK; Worren, MM; Molden, TF; Kommedal, O; Hovig, E; Leegaard, TM; Ambur, OH				Meisal, Roger; Rounge, Trine Ballestad; Christiansen, Irene Kraus; Eieland, Alexander Kirkeby; Worren, Merete Molton; Molden, Tor Faksvaag; Kommedal, Oyvind; Hovig, Eivind; Leegaard, Truls Michael; Ambur, Ole Herman			HPV Genotyping of Modified General Primer-Amplicons Is More Analytically Sensitive and Specific by Sequencing than by Hybridization	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE DISTRIBUTION; INVASIVE CERVICAL-CANCER; BROAD-SPECTRUM; PREVALENCE; WOMEN; CLASSIFICATION; METAANALYSIS; URINE; SETS	Sensitive and specific genotyping of human papillomaviruses (HPVs) is important for population-based surveillance of carcinogenic HPV types and for monitoring vaccine effectiveness. Here we compare HPV genotyping by Next Generation Sequencing (NGS) to an established DNA hybridization method. In DNA isolated from urine, the overall analytical sensitivity of NGS was found to be 22% higher than that of hybridization. NGS was also found to be the most specific method and expanded the detection repertoire beyond the 37 types of the DNA hybridization assay. Furthermore, NGS provided an increased resolution by identifying genetic variants of individual HPV types. The same Modified General Primers (MGP)-amplicon was used in both methods. The NGS method is described in detail to facilitate implementation in the clinical microbiology laboratory and includes suggestions for new standards for detection and calling of types and variants with improved resolution.	[Meisal, Roger; Christiansen, Irene Kraus; Eieland, Alexander Kirkeby; Leegaard, Truls Michael; Ambur, Ole Herman] Akershus Univ Hosp, Dept Microbiol & Infect Control, Lorenskog, Norway; [Rounge, Trine Ballestad] Canc Registry Norway, Dept Res, Oslo, Norway; [Worren, Merete Molton] Oslo Univ Hosp, Inst Canc Genet & Informat, Norwegian Radium Hosp, Bioinformat Core Facil, Oslo, Norway; [Molden, Tor Faksvaag] Norwegian Inst Publ Hlth, Dept Vaccines, Oslo, Norway; [Kommedal, Oyvind] Haukeland Hosp, Dept Microbiol, Bergen, Norway; [Hovig, Eivind] Univ Oslo, Dept Informat, Oslo, Norway; [Hovig, Eivind] Oslo Univ Hosp, Inst Canc Res, Norwegian Radium Hosp, Dept Tumor Biol, Oslo, Norway; [Hovig, Eivind] Oslo Univ Hosp, Inst Canc Genet & Informat, Norwegian Radium Hosp, Oslo, Norway; [Leegaard, Truls Michael] Univ Oslo, Div Med & Lab Sci, Oslo, Norway; [Ambur, Ole Herman] Oslo & Akershus Univ Coll Appl Sci, Dept Life Sci & Hlth, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Bergen; Haukeland University Hospital; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Oslo Metropolitan University (OsloMet)	Ambur, OH (corresponding author), Akershus Univ Hosp, Dept Microbiol & Infect Control, Lorenskog, Norway.; Ambur, OH (corresponding author), Oslo & Akershus Univ Coll Appl Sci, Dept Life Sci & Hlth, Oslo, Norway.	ole.herman.ambur@ahus.no	Ambur, Ole/G-6641-2016; Hovig, Eivind/H-2474-2011; Ambur, Ole Herman/O-5342-2019	Ambur, Ole/0000-0001-9870-6375; Hovig, Eivind/0000-0002-9103-1077; Ambur, Ole Herman/0000-0001-9870-6375; Rounge, Trine/0000-0003-2677-2722; Christiansen, Irene Kraus/0000-0001-8850-3304; Meisal, Roger/0000-0003-1002-3655	Head of Dept. Merete Holth; Dept. Microbiology and Infection Control; Norwegian governmental grant	Head of Dept. Merete Holth; Dept. Microbiology and Infection Control; Norwegian governmental grant	Head of Dept. Merete Holth and the Dept. Microbiology and Infection Control for additional financial support. The majority of the work was funded by a Norwegian governmental grant to the National Institute of Public Health for the national surveillance of the HPV vaccination program.	Ambulos Nicholas P Jr, 2016, J Biomol Tech, V27, P46, DOI 10.7171/jbt.16-2702-004; Arbyn M, 2014, J PATHOL, V234, P431, DOI 10.1002/path.4424; Arroyo LS, 2013, J CLIN VIROL, V58, P437, DOI 10.1016/j.jcv.2013.07.013; Barzona L, 2011, J CLIN VIROL, V52, P93, DOI 10.1016/j.jcv.2011.07.006; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Burroni E, 2015, J MED VIROL, V87, P508, DOI 10.1002/jmv.24085; Cai YP, 2013, BIOMED ENVIRON SCI, V26, P40, DOI 10.3967/0895-3988.2013.01.005; Chen Z, 2009, J VIROL, V83, P1443, DOI 10.1128/JVI.02068-08; Cuschieri K, 2013, DIAGN MOL PATHOL, V22, P85, DOI 10.1097/PDM.0b013e31827f3f7e; Cuzick J, 2014, J CLIN VIROL, V60, P44, DOI 10.1016/j.jcv.2014.02.002; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Dictor M, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-1; Eklund C, 2014, J CLIN MICROBIOL, V52, P449, DOI 10.1128/JCM.02453-13; Eklund C, 2012, J CLIN MICROBIOL, V50, P2289, DOI 10.1128/JCM.00840-12; Fonseca AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133635; Gullapalli Rama R, 2012, J Pathol Inform, V3, P40, DOI 10.4103/2153-3539.103013; Hazard K, 2006, INT J CANCER, V119, P1073, DOI 10.1002/ijc.21920; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P9; Karlsen F, 1996, J CLIN MICROBIOL, V34, P2095, DOI 10.1128/JCM.34.9.2095-2100.1996; Kevin B, 2014, J CANC SCI THER, V6, P406; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lavezzo E, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030079; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lindh M, 2007, J CLIN VIROL, V40, P321, DOI 10.1016/j.jcv.2007.09.009; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Militello V, 2013, CLIN MICROBIOL INFEC, V19, pE428, DOI 10.1111/1469-0691.12219; Molden T, 2006, GYNECOL ONCOL, V100, P95, DOI 10.1016/j.ygyno.2005.07.108; Molden T, 2016, PAPILLOMAVIRUS RES; Mori S, 2011, CANCER SCI, V102, P1223, DOI 10.1111/j.1349-7006.2011.01922.x; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Poljak M, 2010, EXPERT REV ANTI-INFE, V8, P1139, DOI [10.1586/eri.10.104, 10.1586/ERI.10.104]; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Schmitt M, 2013, CANC EPIDEMIOL PREV, V22; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; SNIJDERS PJF, 1990, J GEN VIROL, V71, P173, DOI 10.1099/0022-1317-71-1-173; Soderlund-Strand A, 2008, CLIN CHEM, V54, P86, DOI 10.1373/clinchem.2007.092627; Soderlund-Strand A, 2013, CANCER EPIDEM BIOMAR, V22, P242, DOI 10.1158/1055-9965.EPI-12-1003; Soderlund-Strand A, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.056; Soederlund-Strand A, 2009, J CLIN MICROBIOL, V47, P541, DOI 10.1128/JCM.02007-08; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Tjalma WA, 2013, INT J CANCER, V132, P854, DOI 10.1002/ijc.27713; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vorsters A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050750; Yi X, 2014, AM J CLIN PATHOL, V141, P796, DOI 10.1309/AJCP9P2KJSXEKCJB; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	50	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169074	10.1371/journal.pone.0169074	http://dx.doi.org/10.1371/journal.pone.0169074			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045981	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000391612300109
J	Wang, RS; Fang, NY; Guan, CH; He, WW; Bao, YM; Zhang, HS				Wang, Ruisen; Fang, Nengyan; Guan, Changhong; He, Wanwan; Bao, Yongmei; Zhang, Hongsheng			Characterization and Fine Mapping of a Blast Resistant Gene Pi-jnw1 from the japonica Rice Landrace Jiangnanwan	PLOS ONE			English	Article							BROAD-SPECTRUM RESISTANCE; QUANTITATIVE TRAIT LOCI; NECK BLAST; MAGNAPORTHE-GRISEA; DISEASE RESISTANCE; PANICLE BLAST; ORYZA-SATIVA; LEAF; IDENTIFICATION; PROTEIN	Rice blast is a destructive disease caused by Magnaporthe oryzae, and it has a large impact on rice production worldwide. Compared with leaf blast resistance, our understanding of panicle blast resistance is limited. The japonica landrace Jiangnanwan from Taihu Lake region in China shows highly resistance to panicle and leaf blast. In this study, three generations (F-2:5, F-2:6, F-2:7) consisting of 221 RILs (recombination inbreeding lines), developed from the cross of Jiangnanwan and Suyunuo, a susceptible-blast japonica variety, were evaluated for panicle blast resistance in the fields and leaf blast resistance in greenhouse in Nanjing in 2013, 2014 and 2015. A blast resistance gene Pi-jnw1 referring to panicle blast resistance and leaf blast resistance was identified in the three generations and located in the region of RM27273 and RM27381 in chromosome 11. The RIL18 line harboring Pi-jnw1 was selected to be backcrossed with Suyunuo to develop BC2F2 populations. According to the genotyping of 1,150 BC2F2 individuals and panicle blast and leaf blast resistance evaluation of 47 recombinants between RM27150 and RM27381, Pi-jnw1 was finally mapped to the 282 kb region between markers W28 and BS39. This study revealed that Jiangnanwan harboring a panicle blast and leaf blast resistance gene Pi-jnw1 could be a genetic source for breeding new rice cultivars with panicle blast resistance.	[Wang, Ruisen; Fang, Nengyan; Guan, Changhong; He, Wanwan; Bao, Yongmei; Zhang, Hongsheng] Nanjing Agr Univ, Coll Agr, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Bao, YM; Zhang, HS (corresponding author), Nanjing Agr Univ, Coll Agr, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	yongmeibao@njau.edu.cn; hszhang@njau.edu.cn			National Key Project for Transgenic Crops [2016ZX08009-003-001, 2014ZX08009-001B]; Natural Science Foundation of China [30900888, 31171516]; Fundamental Research Funds for the Central Universities [KYZ201302]; Jiangsu Agriculture science and technology innovation fund [CX(12)1003-3, CX(15)1054]	National Key Project for Transgenic Crops; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Jiangsu Agriculture science and technology innovation fund	This research has been supported by grants from the National Key Project for Transgenic Crops (2016ZX08009-003-001, 2014ZX08009-001B), the Natural Science Foundation of China (30900888, 31171516) and the Fundamental Research Funds for the Central Universities (KYZ201302), Jiangsu Agriculture science and technology innovation fund (CX(12)1003-3, CX(15)1054). The funders had no role in study design,	Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; Berruyer R, 2003, THEOR APPL GENET, V107, P1139, DOI 10.1007/s00122-003-1349-2; BONMAN JM, 1992, EUPHYTICA, V63, P115, DOI 10.1007/BF00023917; Chen DH, 1996, PLANT DIS, V80, P52, DOI 10.1094/PD-80-0052; Chen J, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0305-6; Cheng JP, 2014, MOL BREEDING, V34, P501, DOI 10.1007/s11032-014-0053-z; Deng YW, 2006, THEOR APPL GENET, V113, P705, DOI 10.1007/s00122-006-0338-7; Fujii K, 2000, BREEDING SCI, V50, P183, DOI 10.1270/jsbbs.50.183; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Hayashi K, 2010, THEOR APPL GENET, V121, P1357, DOI 10.1007/s00122-010-1393-7; Hua LX, 2012, THEOR APPL GENET, V125, P1047, DOI 10.1007/s00122-012-1894-7; Ishihara T, 2014, RICE, V7, DOI 10.1186/s12284-014-0002-9; Jeon JS, 2003, MOL GENET GENOMICS, V269, P280, DOI 10.1007/s00438-003-0834-2; Koizumi S, 1998, ANN REPORT SOC AGR C, V1998, P27; Kouzai Y, 2013, PLANT MOL BIOL, V81, P287, DOI 10.1007/s11103-012-9998-7; Li Pei-fu, 2007, Zhongguo Shuidao Kexue, V21, P579; Li Pei-Fu, 2007, Yichuan, V29, P1249, DOI 10.1360/yc-007-1249; Liu G, 2002, MOL GENET GENOMICS, V267, P472, DOI 10.1007/s00438-002-0677-2; Liu SF, 2007, TIANJIN AGR SCI, V13, P55, DOI DOI 10.3969/J.ISSN.1006-6500.2007.04.020; Ma J, 2015, MOL PLANT MICROBE IN, V28, P558, DOI 10.1094/MPMI-11-14-0367-R; MACKILL DJ, 1992, PHYTOPATHOLOGY, V82, P746, DOI 10.1094/Phyto-82-746; Manandhar HK, 1998, PHYTOPATHOLOGY, V88, P735, DOI 10.1094/PHYTO.1998.88.7.735; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Puri KD, 2009, EUPHYTICA, V165, P523, DOI 10.1007/s10681-008-9771-9; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; Shi XL, 2010, PHYTOPATHOLOGY, V100, P822, DOI 10.1094/PHYTO-100-8-0822; Sirithunya P, 2002, DNA RES, V9, P79, DOI 10.1093/dnares/9.3.79; VALENT B, 1991, ANNU REV PHYTOPATHOL, V29, P443, DOI 10.1146/annurev.py.29.090191.002303; Wang Jian-Fei, 2002, Yi Chuan Xue Bao, V29, P803; Wu JL, 2005, THEOR APPL GENET, V111, P50, DOI 10.1007/s00122-005-1971-2; Wu YY, 2013, PHYTOPATHOLOGY, V103, P1162, DOI 10.1094/PHYTO-02-13-0044-R; Yuan B, 2011, THEOR APPL GENET, V122, P1017, DOI 10.1007/s00122-010-1506-3; Zenbayashi-Sawata K, 2007, PHYTOPATHOLOGY, V97, P598, DOI 10.1094/PHYTO-97-5-0598; Zhai C, 2011, NEW PHYTOL, V189, P321, DOI 10.1111/j.1469-8137.2010.03462.x; Zhou B, 2006, MOL PLANT MICROBE IN, V19, P1216, DOI 10.1094/MPMI-19-1216; Zhu D, 2016, RICE, V9, DOI 10.1186/s12284-016-0116-3; Zhuang JY, 2002, EUPHYTICA, V128, P363, DOI 10.1023/A:1021272710294	39	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169417	10.1371/journal.pone.0169417	http://dx.doi.org/10.1371/journal.pone.0169417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036378	gold, Green Published, Green Submitted			2022-12-26	WOS:000391229300073
J	Ranford-Cartwright, LC; McGeechan, S; Inch, D; Smart, G; Richterova, L; Mwangi, JM				Ranford-Cartwright, Lisa C.; McGeechan, Sion; Inch, Donald; Smart, Graeme; Richterova, Lenka; Mwangi, Jonathan M.			Characterisation of Species and Diversity of Anopheles gambiae Keele Colony	PLOS ONE			English	Article							MOLECULAR-FORMS; REPRODUCTIVE ISOLATION; INCIPIENT SPECIATION; MICROSATELLITE DNA; MALARIA VECTOR; WEST-AFRICA; CHROMOSOMAL FORMS; COMPLEX DIPTERA; FLIGHT TONE; GENE FLOW	Anopheles gambiae sensu stricto was recently reclassified as two species, An. coluzzii and An. gambiae s.s., in wild-caught mosquitoes, on the basis of the molecular form, denoted M or S, of a marker on the X chromosome. The An. gambiae Keele line is an outbred laboratory colony strain that was developed around 12 years ago by crosses between mosquitoes from 4 existing An. gambiae colonies. Laboratory colonies of mosquitoes often have limited genetic diversity because of small starting populations (founder effect) and subsequent fluctuations in colony size. Here we describe the characterisation of the chromosomal form(s) present in the Keele line, and investigate the diversity present in the colony using microsatellite markers on chromosome 3. We also characterise the large 2La inversion on chromosome 2. The results indicate that only the M-form of the chromosome X marker is present in the Keele colony, which was unexpected given that 3 of the 4 parent colonies were probably S-form. Levels of diversity were relatively high, as indicated by a mean number of microsatellite alleles of 6.25 across 4 microsatellites, in at least 25 mosquitoes. Both karyotypes of the inversion on chromosome 2 (2La/2L+(a)) were found to be present at approximately equal proportions. The Keele colony has a mixed M-and S-form origin, and in common with the PEST strain, we propose continuing to denote it as an An. gambiae s. s. line.	[Ranford-Cartwright, Lisa C.; McGeechan, Sion; Inch, Donald; Smart, Graeme; Richterova, Lenka; Mwangi, Jonathan M.] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Richterova, Lenka] Fac Hosp Bulovka, Dept Clin Microbiol Parasitol, Prague, Czech Republic; [Mwangi, Jonathan M.] US Int Univ, Sch Pharm & Hlth Sci, Nairobi, Kenya	University of Glasgow; Bulovka University Hospital; United States International University Africa	Ranford-Cartwright, LC (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	Lisa.ranford-cartwright@glasgow.ac.uk	Ranford-Cartwright, Lisa C/H-4701-2013; Richterova, Lenka/ABB-4795-2021	Ranford-Cartwright, Lisa C/0000-0003-1992-3940; Mwangi, Jonathan/0000-0003-0157-6776	Wellcome Trust [091791, 089886/Z/09/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust: 091791 (LRC, JMM), 089886/Z/09/Z (LRC, LR) [wellcome.ac.uk]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Elizabeth Peat and Dorothy Armstrong for their careful maintenance of the mosquito colonies at the University of Glasgow. We acknowledge the funding of research in the Ranford-Cartwright laboratory by the Wellcome Trust (091791, 089886/Z/09/Z).	Brogdon WG, 1998, J MED ENTOMOL, V35, P681, DOI 10.1093/jmedent/35.5.681; BRYAN JH, 1982, GENETICA, V59, P167, DOI 10.1007/BF00056539; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Caputo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016415; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Diabate A, 2006, J MED ENTOMOL, V43, P480, DOI 10.1603/0022-2585(2006)43[480:MSOTMM]2.0.CO;2; Diabate A, 2007, J MED ENTOMOL, V44, P60, DOI 10.1603/0022-2585(2007)44[60:ETEOPI]2.0.CO;2; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; Facchinelli L, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0792-2; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Fontaine MC, 2015, SCIENCE, V347, DOI 10.1126/science.1258524; Fouet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034841; Gray EM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-215; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hurd H, 2005, EVOLUTION, V59, P2560, DOI 10.1111/j.0014-3820.2005.tb00969.x; Lanzaro GC, 1998, P NATL ACAD SCI USA, V95, P14260, DOI 10.1073/pnas.95.24.14260; LANZARO GC, 1995, INSECT MOL BIOL, V4, P105, DOI 10.1111/j.1365-2583.1995.tb00014.x; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; Maliti D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110910; MARCHAND RP, 1985, J AM MOSQUITO CONTR, V1, P234; Marsden CD, 2011, MOL ECOL, V20, P4983, DOI 10.1111/j.1365-294X.2011.05339.x; McNeill J., 2012, INT COD NOM ALG FUNG; MOOREFIELD HERBERT H., 1951, MOSQUITO NEWS, V11, P175; MUNSTERMANN LE, 1994, ANN ENTOMOL SOC AM, V87, P157, DOI 10.1093/aesa/87.2.157; Norris DE, 2001, J MED ENTOMOL, V38, P336, DOI 10.1603/0022-2585-38.2.336; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Pinto J, 2013, EVOL APPL, V6, P910, DOI 10.1111/eva.12075; Powell JR, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P101; Reidenbach KR, 2012, GENOME BIOL EVOL, V4, P1202, DOI 10.1093/gbe/evs095; Rocca KAC, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-147; Sanford MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027920; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Tripet F, 2004, J MED ENTOMOL, V41, P375, DOI 10.1603/0022-2585-41.3.375; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Turner TL, 2007, MOL BIOL EVOL, V24, P2132, DOI 10.1093/molbev/msm143; Wang-Sattler R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001249; Wekesa JW, 1998, PHYSIOL ENTOMOL, V23, P289, DOI 10.1046/j.1365-3032.1998.233087.x; White BJ, 2007, AM J TROP MED HYG, V76, P334; Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2; Yaro AS, 2006, J MED ENTOMOL, V43, P833, DOI 10.1603/0022-2585(2006)43[833:ROOFAG]2.0.CO;2; Yaro AS, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-19; Zheng LB, 1996, GENETICS, V143, P941	52	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168999	10.1371/journal.pone.0168999	http://dx.doi.org/10.1371/journal.pone.0168999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033418	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000391226900068
J	Dubey, AK; Barad, S; Luria, N; Kumar, D; Espeso, EA; Prusky, DB				Dubey, Amit K.; Barad, Shiri; Luria, Neta; Kumar, Dilip; Espeso, Eduardo A.; Prusky, Dov B.			Cation-Stress-Responsive Transcription Factors SItA and CrzA Regulate Morphogenetic Processes and Pathogenicity of Colletotrichurn gloeosporioides	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; ASPERGILLUS-NIDULANS; PLASMA-MEMBRANE; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; APPRESSORIUM FORMATION; MAGNAPORTHE-GRISEA; TOLERANCE PATHWAY; HYPHAL GROWTH; DOCKING SITE	Growth of Colletotrichum gloeosporioides in the presence of cation salts NaCI and KCI inhibited fungal growth and anthracnose symptom of colonization. Previous reports indicate that adaptation of Aspergillus nidulans to salt- and osmotic-stress conditions revealed the role of zinc-finger transcription factors SItA and CrzA in cation homeostasis. Homologs of A. nidulans SItA and CrzA were identified in C. gloeosporioides. The C. gloeosporioides CrzA homolog is a 682-amino acid protein, which contains a C2H2 zinc finger DNA-binding domain that is highly conserved among CrzA proteins from yeast and filamentous fungi. The C. gloeosporioides SItA homolog encodes a 775-amino acid protein with strong similarity to A. nidulans SItA and Trichoderma reeseiACE1, and highest conservation in the three zinc finger regions with almost no changes compared to ACE1 sequences. Knockout of C. gloeosporioides crzA (AcrzA) resulted in a phenotype with inhibited growth, sporulation, germination and appressorium formation, indicating the importance of this calciu006D-activated transcription factor in regulating these morphogenetic processes. In contrast, knockout of C. gloeosporioides sltA (AsItA) mainly inhibited appressorium formation. Both mutants had reduced pathogenicity on mango and avocado fruit. Inhibition of the different morphogenetic stages in the AcrzA mutant was accompanied by drastic inhibition of chitin synthase A and B and glucan synthase, which was partially restored with Ca2+ supplementation. Inhibition of appressorium formation in AsItA mutants was accompanied by downregulation of the MAP kinase pmkl and carnitine acetyl transferase (call), genes involved in appressorium formation and colonization, which was restored by Ca2+ supplementation. Furthermore, exposure of C. gloeosporioides AcrzA or AsItA mutants to cations such as Na+, K+ and Li+ at concentrations that the wild type C. gloeosporioides is not affected had further adverse morphogenetic effects on C. gloeosporioides which were partially or fully restored by Ca2+. Overall results suggest that both genes modulating alkali cation homeostasis have significant morphogenetic effects that reduce C. gloeosporioides colonization.	[Dubey, Amit K.; Barad, Shiri; Luria, Neta; Kumar, Dilip; Prusky, Dov B.] Agr Res Org, Volcani Ctr, Dept Postharvest Sci Fresh Produce, Bet Dagan, Israel; [Barad, Shiri] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, Rehovot, Israel; [Espeso, Eduardo A.] CIB, Dept Mol & Cellular Biol, Madrid, Spain	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Prusky, DB (corresponding author), Agr Res Org, Volcani Ctr, Dept Postharvest Sci Fresh Produce, Bet Dagan, Israel.	dovprusk@volcani.agri.gov.il	Espeso, Eduardo A/AAC-7238-2022; Espeso, Eduardo A/C-5259-2011; Kumar, Dilip/GQB-0364-2022	Espeso, Eduardo A/0000-0002-5873-6059; Espeso, Eduardo A/0000-0002-5873-6059; Kumar, Dilip/0000-0003-3721-4718; Kumar, Dilip/0000-0003-4566-1446	US/Israel Binational Agricultural Research Fund (ISBARD) [IS-4773-14]; Ministerio de Economia y Competitividad; Fondo Europeo de Desarrollo Regional (FEDER) [BFU2012-33142, BFU2015-66806R]	US/Israel Binational Agricultural Research Fund (ISBARD)(US-Israel Binational Science Foundation); Ministerio de Economia y Competitividad(Spanish Government); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government)	This work was supported by the US/Israel Binational Agricultural Research Fund (ISBARD), grant no. IS-4773-14, the Ministerio de Economia y Competitividad and Fondo Europeo de Desarrollo Regional (FEDER), grant nos. BFU2012-33142 and BFU2015-66806R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abang MM, 2009, MYCOL RES, V113, P130, DOI 10.1016/j.mycres.2008.09.004; Asrar AWA, 2011, SAUDI J BIOL SCI, V18, P93, DOI 10.1016/j.sjbs.2010.06.007; Barad S, 2014, MOL PLANT MICROBE IN, V27, P66, DOI 10.1094/MPMI-05-13-0138-R; Barhoom S, 2004, FUNGAL GENET BIOL, V41, P317, DOI 10.1016/j.fgb.2003.11.011; Bhambra GK, 2006, MOL MICROBIOL, V61, P46, DOI 10.1111/j.1365-2958.2006.05209.x; Bi FC, 2016, MOL PLANT PATHOL, V17, P1178, DOI 10.1111/mpp.12355; Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; Calcagno-Pizarelli AM, 2011, J CELL SCI, V124, P4064, DOI 10.1242/jcs.088344; Chang PK, 2008, INT J MOL SCI, V9, P2027, DOI 10.3390/ijms9102027; Chen SC, 2010, FUNGAL GENET BIOL, V47, P268, DOI 10.1016/j.fgb.2009.12.008; Chilton IJ, 2008, MYCOL RES, V112, P1435, DOI 10.1016/j.mycres.2008.06.028; Cramer RA, 2008, EUKARYOT CELL, V7, P1085, DOI 10.1128/EC.00086-08; Dinamarco TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037591; Ferreira T, 2001, J BIOL CHEM, V276, P29613, DOI 10.1074/jbc.R100022200; Findon H, 2010, FUNGAL GENET BIOL, V47, P647, DOI 10.1016/j.fgb.2010.04.002; GABER RF, 1992, INT REV CYTOL, V137A, P299; Garzia A, 2010, MOL MICROBIOL, V75, P1314, DOI 10.1111/j.1365-2958.2010.07063.x; Hagiwara D, 2008, CURR GENET, V54, P325, DOI 10.1007/s00294-008-0220-z; HARO R, 1993, PHYSIOL PLANTARUM, V89, P868, DOI 10.1111/j.1399-3054.1993.tb05298.x; Harrington BJ, 2003, LAB MED, V34, P361, DOI 10.1309/EPH2TDT8335GH0R3; Hernandez-Ortiz P, 2013, MOL MICROBIOL, V89, P532, DOI 10.1111/mmi.12294; Juvvadi PR, 2014, FUNGAL BIOL REV, V28, P56, DOI 10.1016/j.fbr.2014.02.004; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kim SY, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1086; MAGALHAES BP, 1991, PROTOPLASMA, V160, P77, DOI 10.1007/BF01539959; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Mellado L, 2016, MOL BIOL CELL, V27, P2598, DOI 10.1091/mbc.E16-01-0049; Mellado L, 2015, FUNGAL GENET BIOL, V82, P116, DOI 10.1016/j.fgb.2015.06.002; Ment D, 2015, MOL PLANT MICROBE IN, V28, P154, DOI 10.1094/MPMI-09-14-0252-R; Miyara I, 2008, MOL PLANT PATHOL, V9, P281, DOI 10.1111/J.1364-3703.2007.00462.X; Miyara I, 2010, MOL PLANT MICROBE IN, V23, P304, DOI 10.1094/MPMI-23-3-0304; Miyazaki T, 2011, FEMS YEAST RES, V11, P449, DOI 10.1111/j.1567-1364.2011.00734.x; O'Neil JD, 2002, MYCOL RES, V106, P491, DOI 10.1017/S0953756202005701; Perrin RM, 2007, PLOS PATHOG, V3, P508, DOI 10.1371/journal.ppat.0030050; PITT D, 1993, J GEN MICROBIOL, V139, P3053, DOI 10.1099/00221287-139-12-3053; Prusky D, 2014, POSTHARVEST PATHOLOG, V7, P43; Prusky D, 2013, ANNU REV PHYTOPATHOL, V51, P155, DOI 10.1146/annurev-phyto-082712-102349; Pusztahelyi T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00573; Ramos-Pamplona M, 2006, MOL MICROBIOL, V61, P61, DOI 10.1111/j.1365-2958.2006.05194.x; Robinson M, 1999, CURR GENET, V36, P98, DOI 10.1007/s002940050478; Rodriguez-Navarro A, 2006, J EXP BOT, V57, P1149, DOI 10.1093/jxb/erj068; Roy J, 2007, MOL CELL, V25, P889, DOI 10.1016/j.molcel.2007.02.014; Ruiz A, 2008, J BIOL CHEM, V283, P13923, DOI 10.1074/jbc.M708683200; Saloheimo A, 2000, J BIOL CHEM, V275, P5817, DOI 10.1074/jbc.275.8.5817; Serrano MA, 2002, PLACENTA, V23, P527, DOI 10.1053/plac.2002.0838; Shafran H, 2008, FUNGAL GENET BIOL, V45, P1147, DOI 10.1016/j.fgb.2008.04.011; Shantappa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068492; Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514; Soriani FM, 2008, MOL MICROBIOL, V67, P1274, DOI 10.1111/j.1365-2958.2008.06122.x; Spathas DH, 1978, ASPERGILLUS NEWSL, V46, P28; Spielvogel A, 2008, BIOCHEM J, V414, P419, DOI 10.1042/BJ20080344; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Thewes S, 2014, EUKARYOT CELL, V13, P694, DOI 10.1128/EC.00038-14; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; TOURNAS V, 1994, CRIT REV MICROBIOL, V20, P243, DOI 10.3109/10408419409113558; TU JC, 1985, MICROBIOS, V44, P87; WIELAND J, 1995, EMBO J, V14, P3870, DOI 10.1002/j.1460-2075.1995.tb00059.x; Yakoby N, 2001, MOL PLANT MICROBE IN, V14, P988, DOI 10.1094/MPMI.2001.14.8.988; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200	60	16	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168561	10.1371/journal.pone.0168561	http://dx.doi.org/10.1371/journal.pone.0168561			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030573	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000056
J	Huh, DA; Choi, YH; Moon, KW				Huh, Da-An; Choi, Yun-Hee; Moon, Kyong Whan			The Effects of Earphone Use and Environmental Lead Exposure on Hearing Loss in the Korean Population: Data Analysis of the Korea National Health and Nutrition Examination Survey (KNHANES), 2010-2013	PLOS ONE			English	Article							OCCUPATIONAL NOISE EXPOSURE; LISTENING LEVELS; ADULTS; EPIDEMIOLOGY; IMPAIRMENT; PREVALENCE; SURVEILLANCE; HYPERTENSION; ADOLESCENTS; RISK	Background Although previous studies have reported that frequent earphone use and lead exposure are risk factors for hearing loss, most of these studies were limited to small populations or animal experiments. Several studies that presented the joint effect of combined exposure of noise and heavy metal on hearing loss were also mainly conducted on occupational workers exposed to high concentration. Objectives We investigated both the individual and joint effects of earphone use and environmental lead exposure on hearing loss in the Korean general population. Methods We analyzed data from 7,596 Koreans provided by the Korea National Health and Nutrition Examination Survey (KNHANES) during the period 2010-2013. The pure-tone average (PTA) of hearing thresholds at 2, 3, and 4 kHz frequencies was computed, and hearing loss was defined as a PTA >= 25 dB in one or both ears. Results A dose-response relationship in hearing loss with earphone use time and blood lead level is observed after adjustment for confounding factors. With a 1-hour increase in earphone use time and 1 mu g/dL increase in blood lead concentration, the odds of hearing loss increased by 1.19 and 1.43 times, respectively. For hearing loss, the additive and multiplicative effect of earphone use and blood lead level were not statistically significant. Conclusions Earphone use and environmental lead exposure have an individual effect on hearing loss in the general population. However, the estimated joint effect of earphone use and lead exposure was not statistically significant.	[Huh, Da-An] Korea Univ, Grad Sch, Dept Publ Hlth Sci, Seoul, South Korea; [Choi, Yun-Hee; Moon, Kyong Whan] Korea Univ, Dept Hlth & Environm Sci, Coll Hlth Sci, Seoul, South Korea	Korea University; Korea University	Moon, KW (corresponding author), Korea Univ, Dept Hlth & Environm Sci, Coll Hlth Sci, Seoul, South Korea.	kwmoon@korea.ac.kr	Moon, Kyong_Whan/ABH-5166-2020	Huh, Da-An/0000-0001-7633-0805	Korea University [K1508311]	Korea University	This study was supported by grants from The Korea University (K1508311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2009, OTOL NEUROTOL, V30, P139, DOI 10.1097/MAO.0b013e318192483c; Bainbridge KE, 2008, ANN INTERN MED, V149, P1, DOI 10.7326/0003-4819-149-1-200807010-00231; Chang TY, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-35; Choi YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097538; Choi YH, 2012, ENVIRON HEALTH PERSP, V120, P1544, DOI 10.1289/ehp.1104863; Chuang HY, 2007, SCI TOTAL ENVIRON, V387, P79, DOI 10.1016/j.scitotenv.2007.07.032; Cruickshanks KJ, 2003, ARCH OTOLARYNGOL, V129, P1041, DOI 10.1001/archotol.129.10.1041; Daniel E, 2007, J SCHOOL HEALTH, V77, P225, DOI 10.1111/j.1746-1561.2007.00197.x; Duck SW, 1997, LARYNGOSCOPE, V107, P1596, DOI 10.1097/00005537-199712000-00004; Fuente A, 2009, J OCCUP ENVIRON MED, V51, P1202, DOI 10.1097/JOM.0b013e3181bae17c; Gallagher G, 1989, HEARING J, V42, P7; Girard SA, 2015, INJURY PREV, V21, pE88, DOI 10.1136/injuryprev-2013-040828; HIRATA M, 1993, ENVIRON RES, V63, P60, DOI 10.1006/enrs.1993.1127; Hodgetts W, 2009, INT J AUDIOL, V48, P825, DOI 10.3109/14992020903082104; Hong HN, 2013, J ACOUST SOC KOREA, V32, P56, DOI 10.7776/ASK.2013.32.1.056; Horikawa C, 2013, J CLIN ENDOCR METAB, V98, P51, DOI 10.1210/jc.2012-2119; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Johnson A-C, 2008, OCCUPATIONAL EXPOSUR, P1; Jokitulppo Jaana, 2003, Noise Health, V5, P53; Jones LG, 2008, J COMP NEUROL, V506, P1003, DOI 10.1002/cne.21563; Kim MG, 2009, YONSEI MED J, V50, P771, DOI 10.3349/ymj.2009.50.6.771; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; LASKY RE, 1995, NEUROTOXICOL TERATOL, V17, P633, DOI 10.1016/0892-0362(95)02006-3; Levey S, 2011, J SPEECH LANG HEAR R, V54, P263, DOI 10.1044/1092-4388(2010/09-0283); Mazlan R, 2002, Malays J Med Sci, V9, P17; Money A, 2011, OCCUP MED-OXFORD, V61, P226, DOI 10.1093/occmed/kqr047; Muchnik C, 2012, INT J AUDIOL, V51, P287, DOI 10.3109/14992027.2011.631590; Narlawar Uday W, 2006, Indian J Physiol Pharmacol, V50, P60; Nelson DI, 2005, AM J IND MED, V48, P446, DOI 10.1002/ajim.20223; Park SK, 2010, HEARING RES, V269, P48, DOI 10.1016/j.heares.2010.07.004; Park YH, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150783, DOI 10.1371/J0URNAL.P0NE.0150]; Pierre Campo KM, 2009, COMBINED EXPOSURE NO; Pouryaghoub G, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-137; Railly MJ, 1998, J OCCUP ENVIRON MED, V40, P667, DOI 10.1097/00043764-199808000-00002; Sabolic I, 2006, NEPHRON PHYSIOL, V104, P107, DOI 10.1159/000095539; Sadhra S, 2002, ANN OCCUP HYG, V46, P455, DOI 10.1093/annhyg/mef051; Shargorodsky J, 2011, ARCH OTOLARYNGOL, V137, P1177, DOI 10.1001/archoto.2011.202; Stanbury M, 2008, J OCCUP ENVIRON MED, V50, P72, DOI 10.1097/JOM.0b013e31815b568c; Stevens G, 2013, EUR J PUBLIC HEALTH, V23, P146, DOI 10.1093/eurpub/ckr176; Trong-neng wu C-ys, 2000, ARCH ENV HLTH, V55; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; Vogel I, 2009, PEDIATRICS, V123, pE953, DOI 10.1542/peds.2008-3179; Vyskocil A, 2012, TOXICOL IND HEALTH, V28, P796, DOI 10.1177/0748233711425067; Wu TN, 1998, PREV MED, V27, P65, DOI 10.1006/pmed.1997.0238; YAMAMURA K, 1989, FUND APPL TOXICOL, V13, P509, DOI 10.1016/0272-0590(89)90287-X; Yamasoba T, 2013, HEARING RES, V303, P30, DOI 10.1016/j.heares.2013.01.021; Yang HY, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010533; 곽혜원, 2012, [Journal of Korean Public Health Nursing, 한국보건간호학회지], V26, P126	48	8	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168718	10.1371/journal.pone.0168718	http://dx.doi.org/10.1371/journal.pone.0168718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030613	gold, Green Submitted, Green Published			2022-12-26	WOS:000391222000066
J	Marcondes-Braga, FG; Batista, GL; Gutz, IGR; Saldiva, PHN; Mangini, S; Issa, VS; Ayub-Ferreira, SM; Bocchi, EA; Pereira, AC; Bacal, F				Marcondes-Braga, Fabiana G.; Batista, Guilherme L.; Gutz, Ivano G. R.; Saldiva, Paulo H. N.; Mangini, Sandrigo; Issa, Victor S.; Ayub-Ferreira, Silvia M.; Bocchi, Edimar A.; Pereira, Alexandre Costa; Bacal, Fernando			Impact of Exhaled Breath Acetone in the Prognosis of Patients with Heart Failure with Reduced Ejection Fraction (HFrEF). One Year of Clinical Follow-up	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; MORTALITY; ADRENOMEDULLIN; BIOMARKERS; PREDICTOR; OUTCOMES; TRIAL	Background The identification of new biomarkers of heart failure (HF) could help in its treatment. Previously, our group studied 89 patients with HF and showed that exhaled breath acetone (EBA) is a new noninvasive biomarker of HF diagnosis. However, there is no data about the relevance of EBA as a biomarker of prognosis. Objectives To evaluate whether EBA could give prognostic information in patients with heart failure with reduced ejection fraction (HFrEF). Methods After breath collection and analysis by gas chromatography-mass spectrometry and by spectrophotometry, the 89 patients referred before were followed by one year. Study physicians, blind to the results of cardiac biomarker testing, ascertained vital status of each study participant at 12 months. Results The composite endpoint death and heart transplantation (HT) were observed in 35 patients (39.3%): 29 patients (32.6%) died and 6 (6.7%) were submitted to HT within 12 months after study enrollment. High levels of EBA (>= 3.7 mu g/L, 50th percentile) were associated with a progressively worse prognosis in 12-month follow-up (log-rank = 11.06, p = 0.001). Concentrations of EBA above 3.7 mu g/L increased the risk of death or HT in 3.26 times (HR = 3.26, 95% CI = 1.56-6.80, p = 0.002) within 12 months. In a multivariable cox regression model, the independent predictors of all-cause mortality were systolic blood pressure, respiratory rate and EBA levels. Conclusions High EBA levels could be associated to poor prognosis in HFrEF patients.	[Marcondes-Braga, Fabiana G.; Mangini, Sandrigo; Bacal, Fernando] Univ Sao Paulo, Dept Heart Transplant, Hosp Clin, Heart Inst InCor,Fac Med, Ave Dr Eneas de Carvalho Aguiar 44,2 Andar, Sao Paulo, Brazil; [Batista, Guilherme L.; Gutz, Ivano G. R.] Univ Sao Paulo, Inst Chem, Ave Prof Lineu Prestes 748,Bloco 12,Sala 1270, Sao Paulo, Brazil; [Saldiva, Paulo H. N.] Univ Sao Paulo, Dept Pathol, Fac Med, Ave Dr Arnaldo 455,1 Andar, Sao Paulo, Brazil; [Issa, Victor S.; Ayub-Ferreira, Silvia M.; Bocchi, Edimar A.] Univ Sao Paulo, Dept Heart Failure, Heart Inst InCor, Hosp Clin,Fac Med, Sao Paulo, Brazil; [Pereira, Alexandre Costa] Univ Sao Paulo, Lab Genet & Mol Cardiol, Fac Med, Ave Dr Eneas de Carvalho Aguiar 44,10 Andar, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Marcondes-Braga, FG (corresponding author), Univ Sao Paulo, Dept Heart Transplant, Hosp Clin, Heart Inst InCor,Fac Med, Ave Dr Eneas de Carvalho Aguiar 44,2 Andar, Sao Paulo, Brazil.	fgmarcondes@yahoo.com.br	Ayub-Ferreira, Silvia/AAK-4196-2020; Marcondes-Braga, Fabiana G/H-7380-2012; Mangini, Sandrigo/S-3083-2016; Pereira, Alexandre/HHN-1038-2022; Saldiva, Paulo HN/D-7385-2012; Gutz, Ivano G. R./H-8748-2012	Ayub-Ferreira, Silvia/0000-0002-9271-8233; Mangini, Sandrigo/0000-0003-0894-1131; Saldiva, Paulo HN/0000-0003-2005-8253; Gutz, Ivano G. R./0000-0001-9759-7920; Lopes Batista, Guilherme/0000-0003-4399-7368; Marcondes-Braga, Fabiana/0000-0002-2533-5638	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The study was supported by a grant from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo).	Anand IS, 2003, CIRCULATION, V107, P1278, DOI 10.1161/01.CIR.0000054164.99881.00; Batista GL, 2010, THESIS; Berger R, 2002, CIRCULATION, V105, P2392, DOI 10.1161/01.CIR.0000016642.15031.34; BERNTSSON S, 1956, ANAL CHEM, V28, P1337, DOI 10.1021/ac60116a036; Bocchi EA, 2009, HEART, V95, P181, DOI 10.1136/hrt.2008.151225; Bocchi EA, 2008, CIRC-HEART FAIL, V1, P115, DOI 10.1161/CIRCHEARTFAILURE.107.744870; Cikach FS, 2012, PROG CARDIOVASC DIS, V55, P34, DOI 10.1016/j.pcad.2012.05.005; de Boer RA, 2011, ANN MED, V43, P60, DOI 10.3109/07853890.2010.538080; Fonarow GC, 2007, J AM COLL CARDIOL, V49, P1943, DOI 10.1016/j.jacc.2007.02.037; GOTTLIEB, 1989, J AM COLL CARDIOL, V14, P812; KUPARI M, 1995, AM J CARDIOL, V76, P1076, DOI 10.1016/S0002-9149(99)80304-X; Lam LL, 2010, ANN INTERN MED, V153, P728, DOI 10.7326/0003-4819-153-11-201012070-00006; Lommi J, 1996, J AM COLL CARDIOL, V28, P665, DOI 10.1016/0735-1097(96)00214-8; Marcondes-Braga FG, 2012, CHEST, V142, P457, DOI 10.1378/chest.11-2892; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Nohria A, 2003, J AM COLL CARDIOL, V41, P1797, DOI 10.1016/S0735-1097(03)00309-7; Pabst F, 2007, J CARDIOTHORAC SURG, V2, DOI 10.1186/1749-8090-2-37; Potocki M, 2010, CRIT CARE, V14, DOI 10.1186/cc9336; Rehman SU, 2008, J AM COLL CARDIOL, V52, P1458, DOI 10.1016/j.jacc.2008.07.042; Richards AM, 2001, J AM COLL CARDIOL, V37, P1781, DOI 10.1016/S0735-1097(01)01269-4; Samara MA, 2013, J AM COLL CARDIOL, V61, P1463, DOI 10.1016/j.jacc.2012.12.033; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; von Haehling S, 2010, EUR J HEART FAIL, V12, P484, DOI 10.1093/eurjhf/hfq031; Xue Y, 2011, EUR J HEART FAIL, V13, P37, DOI 10.1093/eurjhf/hfq210; Yu CM, 1999, EUR J HEART FAIL, V1, P59, DOI 10.1016/S1388-9842(98)00010-5	25	21	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168790	10.1371/journal.pone.0168790	http://dx.doi.org/10.1371/journal.pone.0168790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030609	Green Published, Green Submitted, gold			2022-12-26	WOS:000391222000077
J	Newton, TM; Reid, E				Newton, Timothy M.; Reid, Evan			An Automated Image Analysis System to Quantify Endosomal Tubulation	PLoS One			English	Article							CYTOKINESIS; TRANSPORT	Recycling of cargos from early endosomes requires regulation of endosomal tubule formation and fission. This regulation is disrupted in cells depleted of the microtubule severing enzyme spastin, causing elongation of endosomal tubules and mis-trafficking of recycling endosomal cargos such as the transferrin receptor. Spastin is encoded by SPAST, mutations in which are the most frequent cause of autosomal dominant hereditary spastic paraplegia, a condition characterised by a progressive loss of lower limb function resulting from upper motor neuron axonopathy. Investigation of molecular factors involved in endosomal tubule regulation is hindered by the need for manual counting of endosomal tubules. We report here the development of an open source automated system for the quantification of endosomal tubules, using ImageJ and R. We validate the method in cells depleted of spastin and its binding partner IST1. The additional speed and reproducibility of this system compared with manual counting makes feasible screens of candidates to further understand the mechanisms of endosomal tubule formation and fission.	[Reid, Evan] Univ Cambridge, Dept Med Genet, Cambridge, England; Univ Cambridge, Cambridge Inst Med Res, Cambridge, England	University of Cambridge; University of Cambridge	Reid, E (corresponding author), Univ Cambridge, Dept Med Genet, Cambridge, England.	ealr4@cam.ac.uk	Reid, Evan/F-3250-2010	Reid, Evan/0000-0003-1623-7304; Newton, Timothy/0000-0003-1818-4023	UK Medical Research Council [MR/M00046X/1]; Wellcome Trust Senior Research Fellowship in Clinical Science [082381]; United States Spastic Paraplegia Foundation; Tom Wahlig Stiftung; MRC PhD studentship [G0800117]; Wellcome Trust Strategic Award [100140]; Equipment Grant [093026]; MRC [MR/M00046X/1] Funding Source: UKRI; Medical Research Council [MR/M00046X/1] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust); United States Spastic Paraplegia Foundation; Tom Wahlig Stiftung; MRC PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Strategic Award(Wellcome Trust); Equipment Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants to ER: UK Medical Research Council Project Grant [MR/M00046X/1], www.mrc.ac.uk; Wellcome Trust Senior Research Fellowship in Clinical Science [082381], www.wellcome.ac.uk; Project Grant from United States Spastic Paraplegia Foundation, sp-foundation.org, and from the Tom Wahlig Stiftung. TMN was supported by MRC PhD studentship [G0800117]. CIMR is supported by a Wellcome Trust Strategic Award [100140] and Equipment Grant [093026]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Allison R, 2013, J CELL BIOL, V202, P527, DOI 10.1083/jcb.201211045; Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Lumb JH, 2012, BBA-MOL CELL RES, V1823, P192, DOI 10.1016/j.bbamcr.2011.08.010; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Reid E., 2010, ONLINE METABOLIC MOL; Renvoise B, 2010, MOL BIOL CELL, V21, P3293, DOI 10.1091/mbc.E09-10-0879; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; van Weering JRT, 2010, SEMIN CELL DEV BIOL, V21, P371, DOI 10.1016/j.semcdb.2009.11.009	13	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168294	10.1371/journal.pone.0168294	http://dx.doi.org/10.1371/journal.pone.0168294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006827	Green Submitted, gold, Green Published			2022-12-26	WOS:000392843200042
J	Bracken, LE; Nunn, AJ; Kirkham, JJ; Peak, M; Arnott, J; Smyth, RL; Pirmohamed, M; Turner, MA				Bracken, Louise E.; Nunn, Anthony J.; Kirkham, Jamie J.; Peak, Matthew; Arnott, Janine; Smyth, Rosalind L.; Pirmohamed, Munir; Turner, Mark A.			Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool	PLOS ONE			English	Article							HOSPITAL ADMISSIONS; PREVENTABILITY; CHILDREN	Aim To develop and test a new tool to assess the avoidability of adverse drug reactions that is suitable for use in paediatrics but which is also applicable to a variety of other settings. Methods The study involved multiple phases. Preliminary work involved using the Hallas scale and a modification of the existing Hallas scale, to assess two different sets of adverse drug reaction (ADR) case reports. Phase 1 defined, modified and refined a new tool using multidisciplinary teams. Phase 2 involved the assessment of 50 ADR case reports from a prospective study of paediatric inpatients by individual assessors. Phase 3 compared assessments with the new tool for individuals and groups in comparison to the 'gold standard' (the avoidability outcome set by a panel of senior investigators: an experienced clinical pharmacologist, paediatrician and pharmacist). Main Outcome Measures Inter-rater reliability (IRR), measure of disagreement and utilization of avoidability categories. Results Preliminary work Pilot phase: results for the original Hallas cases were fair and pairwise kappa scores ranged from 0.21 to 0.36. Results for the modified Hallas cases were poor, pairwise kappa scores ranged from 0.06 to 0.16. Phase 1: on initial use of the new tool, agreement between the two multidisciplinary groups was found on 13/20 cases with a kappa score of 0.29 (95% CI-0.04 to 0.62). Phase 2: the assessment of 50 ADR case reports by six individual reviewers yielded pair wise kappa scores ranging from poor to good 0.12 to 0.75 and percentage exact agreement (%EA) ranged from 52-90%. Phase 3: Percentage exact agreement ranged from 35-70%. Overall, individuals had better agreement with the 'gold standard'. Conclusion Avoidability assessment is feasible but needs careful attention to methods. The Liverpool ADR avoidability assessment tool showed mixed IRR. We have developed and validated a method for assessing the avoidability of ADRs that is transparent, more objective than previous methods and that can be used by individuals or groups.	[Bracken, Louise E.; Peak, Matthew; Arnott, Janine; Turner, Mark A.] Alder Hey Childrens NHS Fdn Trust, Inst Pk, Paediat Med Res Unit, Liverpool, Merseyside, England; [Nunn, Anthony J.; Turner, Mark A.] Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England; [Kirkham, Jamie J.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Peak, Matthew] Univ Cent Lancashire, Sch Hlth, Preston PR1 2HE, Lancs, England; [Smyth, Rosalind L.] UCL, Inst Child Hlth, London WC1E 6BT, England; [Pirmohamed, Munir] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England; [Turner, Mark A.] Liverpool Womens NHS Fdn Trust, Liverpool, Merseyside, England	Alder Hey Children's NHS Foundation Trust; University of Liverpool; University of Liverpool; University of Central Lancashire; University of London; University College London; University of Liverpool	Bracken, LE (corresponding author), Alder Hey Childrens NHS Fdn Trust, Inst Pk, Paediat Med Res Unit, Liverpool, Merseyside, England.	louise.bracken@alderhey.nhs.uk	Pirmohamed, Munir/H-6004-2011; Kirkham, Jamie/AAD-4490-2019	Pirmohamed, Munir/0000-0002-7534-7266; Kirkham, Jamie/0000-0003-2579-9325; Bracken, Louise/0000-0002-9632-2252; Turner, Mark/0000-0002-5299-8656; Peak, Matthew/0000-0003-1909-3211	National Institute of Health Research (NIHR) [RP-PG-0606-1170]; NIHR; MRC [MR/L006758/1] Funding Source: UKRI; Medical Research Council [MR/L006758/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10064] Funding Source: researchfish	National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	All authors were funded by the National Institute of Health Research (NIHR) under its Programme Grants for Applied Research Scheme (grant number RP-PG-0606-1170). This article presents independent research funded by the NIHR. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of Health.	Altman D.G., 1991, PRACTICAL STATISTIC; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Conroy EJ, 2015, INT J PHARM PRACT, V23, P447, DOI 10.1111/ijpp.12197; Davies EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004439; Dormann H, 2003, DRUG SAFETY, V26, P353, DOI 10.2165/00002018-200326050-00004; Ferner RE, 2010, DRUG SAFETY, V33, P985, DOI 10.2165/11538270-000000000-00000; Gallagher RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050127; Gallagher RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028096; Hakkarainen KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033236; Hakkarainen KM, 2012, DRUG SAFETY, V35, P105, DOI 10.2165/11596570-000000000-00000; HALLAS J, 1990, J INTERN MED, V228, P83, DOI 10.1111/j.1365-2796.1990.tb00199.x; Le J, 2006, PEDIATRICS, V118, P555, DOI 10.1542/peds.2005-2429; Lovborg H, 2012, EUR J CLIN PHARMACOL, V68, P1183, DOI 10.1007/s00228-012-1237-2; McDonnell PJ, 2002, ANN PHARMACOTHER, V36, P1331, DOI 10.1345/aph.1A333; Olivier P, 2005, THERAPIE, V60, P39, DOI 10.2515/therapie:2005005; Schumock G T, 1992, Hosp Pharm, V27, P538; Smyth R, 2014, PROGRAMME GRANTS APP, V2; Smyth RMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024061; Thiesen S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-237	20	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169393	10.1371/journal.pone.0169393	http://dx.doi.org/10.1371/journal.pone.0169393			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046035	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000391612300181
J	Darrouzet-Nardi, AF; Masters, WA				Darrouzet-Nardi, Amelia F.; Masters, William A.			Nutrition Smoothing: Can Proximity to Towns and Cities Protect Rural Children against Seasonal Variation in Agroclimatic Conditions at Birth?	PLOS ONE			English	Article							LONG-TERM CONSEQUENCES; EARLY-CHILDHOOD; ECONOMIC-GROWTH; SHOCKS EVIDENCE; EARLY-LIFE; HEALTH; HEIGHT; INCOME; CONFLICT; PATTERNS	A large literature links early-life environmental shocks to later outcomes. This paper uses seasonal variation across the Democratic Republic of the Congo to test for nutrition smoothing, defined here as attaining similar height, weight and mortality outcomes despite different agroclimatic conditions at birth. We find that gaps between siblings and neighbors born at different times of year are larger in more remote rural areas, farther from the equator where there are greater seasonal differences in rainfall and temperature. For those born at adverse times in places with pronounced seasonality, the gains associated with above-median proximity to nearby towns are similar to rising one quintile in the national distribution of household wealth for mortality, and two quintiles for attained height. Smoothing of outcomes could involve a variety of mechanisms to be addressed in future work, including access to food markets, health services, public assistance and temporary migration to achieve more uniform dietary intake, or less exposure and improved recovery from seasonal diseases.	[Darrouzet-Nardi, Amelia F.] Allegheny Coll, Dept Global Hlth Studies, Meadville, PA 16335 USA; [Masters, William A.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA	Allegheny College; Tufts University	Masters, WA (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.	william.masters@tufts.edu	Masters, William A./A-4796-2017	Masters, William A./0000-0002-4546-7291; Finaret, Amelia/0000-0003-0573-8699	U.S. Borlaug Fellowship in Global Food Security [12065162]; United States Agency for International Development through the Feed the Future Innovation Lab for Nutrition [AID-OAA-L-1 00005]; Feed the Future Policy Impact Study Consortium [TA-CA-15-008]; Bill & Melinda Gates Foundation through the International Food Policy Research Institute [301052.001.001.515.01.01]	U.S. Borlaug Fellowship in Global Food Security(United States Agency for International Development (USAID)); United States Agency for International Development through the Feed the Future Innovation Lab for Nutrition(United States Agency for International Development (USAID)); Feed the Future Policy Impact Study Consortium(United States Agency for International Development (USAID)); Bill & Melinda Gates Foundation through the International Food Policy Research Institute	The first author's work on this project was financially supported by U.S. Borlaug Fellowship in Global Food Security (Award No. 12065162), and the second author's work was supported by the United States Agency for International Development through the Feed the Future Innovation Lab for Nutrition (grant number AID-OAA-L-1 00005) and the Feed the Future Policy Impact Study Consortium (subaward under USDA Cooperative Agreement TA-CA-15-008), as well as the Bill & Melinda Gates Foundation through the International Food Policy Research Institute (project number 301052.001.001.515.01.01).	Akresh R, 2012, J DEV ECON, V99, P330, DOI 10.1016/j.jdeveco.2012.04.001; Alderman H, 2006, OXFORD ECON PAP, V58, P450, DOI 10.1093/oep/gpl008; Almond D, 2011, J ECON PERSPECT, V25, P153, DOI 10.1257/jep.25.3.153; Angrist JD, 2001, J ECON PERSPECT, V15, P69, DOI 10.1257/jep.15.4.69; [Anonymous], IMPACT AIR POLLUTION; Banerjee A, 2010, REV ECON STAT, V92, P714, DOI 10.1162/REST_a_00024; Barrett CB, 2001, FOOD POLICY, V26, P315, DOI 10.1016/S0306-9192(01)00014-8; Basu K, 2015, J DEV ECON, V115, P200, DOI 10.1016/j.jdeveco.2015.02.001; Bellemare MF, 2013, AM J AGR ECON, V95, P877, DOI 10.1093/ajae/aat018; Bertrand M, Q J EC, V119, P249; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Buckles KS, 2013, REV ECON STAT, V95, P711, DOI 10.1162/REST_a_00314; Bundervoet T, 2009, J HUM RESOUR, V44, P536; Burgess R, 2010, AM ECON REV, V100, P449, DOI 10.1257/aer.100.2.449; Chodick G, 2009, HUM BIOL, V81, P463, DOI 10.3378/027.081.0405; Cummins JR., 2013, WORKING PAPER; Currie J, 2013, P NATL ACAD SCI USA, V110, P13228, DOI 10.1073/pnas.1307582110; Deaton A, 2007, P NATL ACAD SCI USA, V104, P13232, DOI 10.1073/pnas.0611500104; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; DiNardo J., 2010, MICROECONOMETRICS, P139; Esri Inc, 2013, ARCGIS DESKT VERS 10; Ferreira FHG, 2009, WORLD BANK RES OBSER, V24, P147, DOI 10.1093/wbro/lkp006; Food and Agriculture Organization of the United Nations, 2014, FAOSTAT DAT; Food and Agriculture Organization of the United Nations (FAO), 2014, MULT AFR DAT ENV RES; FOSTER AD, 1995, ECON J, V105, P551, DOI 10.2307/2235017; Gajigo O, 2012, 2012 C AUG 2012 AUG, P18; Giles J, 2015, J DEV ECON, V114, P97, DOI 10.1016/j.jdeveco.2014.12.001; Godoy R, 2008, AM J HUM BIOL, V20, P23, DOI 10.1002/ajhb.20679; Gordis L, 2009, EPIDEMIOLOGY, P249; Grebmer K. V., 2011, CHALLENGE HUNGER TAM; Greena WH, 2012, ECONOMETRIC ANAL, P98; Heckert M, 2012, ENVIRON PLANN A, V44, P3010, DOI 10.1068/a4595; Hillbruner C, 2008, FOOD NUTR BULL, V29, P221, DOI 10.1177/156482650802900308; Hoddinott J, 2001, OXFORD B ECON STAT, V63, P409, DOI 10.1111/1468-0084.t01-1-00227; ICF International, MEAS DHS 2008 2014 D; Jensen R, 2000, AM ECON REV, V90, P399, DOI 10.1257/aer.90.2.399; Jones AM, 2007, HEALTH ECON, V16, P1127, DOI 10.1002/hec.1302; Kandala NB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-261; Klemick H, 2009, AM J AGR ECON, V91, P347, DOI 10.1111/j.1467-8276.2009.01252.x; Leigh A, 2011, ECON LETT, V113, P150, DOI 10.1016/j.econlet.2011.05.037; MacCini S, 2009, AM ECON REV, V99, P1006, DOI 10.1257/aer.99.3.1006; Martorell Reynaldo, 1999, Food and Nutrition Bulletin, V20, P288; Masters WA, 2001, J ECON GROWTH, V6, P167, DOI 10.1023/A:1011398431524; Minoiu C, 2012, AM ECON REV, V102, P294, DOI 10.1257/aer.102.3.294; Moore SE, 2004, INT J EPIDEMIOL, V33, P137, DOI 10.1093/ije/dyh007; MORDUCH J, 1995, J ECON PERSPECT, V9, P103, DOI 10.1257/jep.9.3.103; Mulmi P, 2016, EC HUMAN BIOL, P63; Nunn N, 2012, REV ECON STAT, V94, P20, DOI 10.1162/REST_a_00161; PanterBrick C, 1997, ANN HUM BIOL, V24, P1, DOI 10.1080/03014469700004732; Pomeroy E, 2014, AM J PHYS ANTHROPOL, V154, P115, DOI 10.1002/ajpa.22484; Rabassa M, 2014, J AFR ECON, V23, P464, DOI 10.1093/jae/eju005; Raleigh C, 2010, J PEACE RES, V47, P651, DOI 10.1177/0022343310378914; Reiner RC, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0849-2; Rocha R, 2015, J DEV ECON, V112, P72, DOI 10.1016/j.jdeveco.2014.10.003; Sassi M, 2015, J DEV STUD, V51, P1667, DOI 10.1080/00220388.2015.1046441; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; Skoufias E, 2012, ECON HUM BIOL, V10, P54, DOI 10.1016/j.ehb.2011.06.001; StataCorp, 2011, STAT STAT SOFTW REL, P173; Thai TQ, 2014, J DEV STUD, V50, P1025, DOI 10.1080/00220388.2014.903247; Tollens E., 2003, CURRENT SITUATION FO; Ulimwengu J, 2012, IFPRI DISCUSSION PAP; UNICEF, 2011, BRIEF DEM REP CONG; Victora C.G, 2010, PEDIATRICS; Vollmer S, 2014, LANCET GLOB HEALTH, V2, pE225, DOI 10.1016/S2214-109X(14)70025-7; Walker SP, 2015, J NUTR, V145, P823, DOI 10.3945/jn.114.200261; World Health Organization, 2000, NUTR HLTH DEV 2000 N; Yamano T, 2005, AM J AGR ECON, V87, P273, DOI 10.1111/j.1467-8276.2005.00721.x	67	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168759	10.1371/journal.pone.0168759	http://dx.doi.org/10.1371/journal.pone.0168759			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2QJ	28045998	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300051
J	Kreu, S; Jazrawi, A; Miller, J; Baigi, A; Chew, M				Kreu, Simon; Jazrawi, Allan; Miller, Jan; Baigi, Amir; Chew, Michelle			Alkalosis in Critically III Patients with Severe Sepsis and Septic Shock	PLOS ONE			English	Article							METABOLIC ALKALOSIS	Introduction Although metabolic alkalosis is a common occurrence in intensive care units (ICUs), no study has evaluated its prevalence or outcomes in patients with severe sepsis or septic shock. Methods This is a retrospective cohort study of critically ill patients suffering from severe sepsis and septic shock admitted to the ICUs of Halmstad and Varberg County hospitals. From 910 patient records, 627 patients met the inclusion criteria. We investigated the relationship between metabolic alkalosis and mortality. Further, we studied the relationship between metabolic alkalosis and ICU length of stay (LOS). Results Metabolic alkalosis was associated with decreased 30-day and 12-month mortalities. This effect was however lost when a multivariate analysis was conducted, correcting for age, gender, pH on admission, base excess (BE) on admission, Simplified Acute Physiology Score III (SAPS III) and acute kidney injury (AKI). We then analyzed for any dose-response effect between the severity of metabolic alkalosis and mortality and found no relationship. Bivariate analysis showed that metabolic alkalosis had a significant effect on the length of ICU stay. When adjusting for age, sex, pH at admission, BE at admission, SAPS III and AKI in a multivariate analysis, metabolic alkalosis significantly contributed to prolonged ICU length of stay. In two separate sensitivity analyses pure metabolic alkalosis and late metabolic alkalosis (time of onset > 48 hours) were the only significant predictor of increased ICU length of stay. Conclusion Metabolic alkalosis did not have any effect on 30-day and 12-month mortalities after adjusting for age, sex, SAPS III-score, pH and BE on admission and AKI in a multivariate analysis. The presence of metabolic alkalosis was independently associated with an increased ICU length of stay.	[Kreu, Simon; Jazrawi, Allan; Miller, Jan; Chew, Michelle] Lund Univ, Inst Clin Sci Malmo, Lund, Sweden; [Kreu, Simon] Orebro Univ Hosp, Dept Cardiothorac & Vasc Surg, Orebro, Sweden; [Jazrawi, Allan] Vastmanland Cty Hosp, Dept Gen Surg, Vasteras, Sweden; [Baigi, Amir] Gothenburg Univ, Inst Med Gen Med & Publ Hlth, Gothenburg, Sweden; [Chew, Michelle] Linkoping Univ Hosp, Dept Anaesthesia & Intens Care, Linkoping, Sweden	Lund University; Orebro University; Vasteras Central Hospital; University of Gothenburg; Linkoping University	Kreu, S (corresponding author), Lund Univ, Inst Clin Sci Malmo, Lund, Sweden.; Kreu, S (corresponding author), Orebro Univ Hosp, Dept Cardiothorac & Vasc Surg, Orebro, Sweden.	simonkreu@regionorebrolan.se		Kreu, Simon/0000-0002-6888-6173	Region Halland County Council [RS147]	Region Halland County Council	This work was financed by a grant from the Region Halland County Council (RS147).	Dubin A, 2007, CRIT CARE MED, V35, P1264, DOI 10.1097/01.CCM.0000259536.11943.90; Edwards SL, 2008, INTENSIVE CRIT CARE, V24, P38, DOI DOI 10.1016/J.ICCN.2007.05.003; HODGKIN JE, 1980, CRIT CARE MED, V8, P725, DOI 10.1097/00003246-198012000-00005; Liborio AB, 2015, INTENS CARE MED, V41, P572, DOI 10.1007/s00134-015-3682-8; Maehle K, 2014, CRIT CARE, V18, DOI 10.1186/cc13802; Palmer BF, 1997, J AM SOC NEPHROL, V8, P1462; Raphael KL, 2016, CLIN J AM SOC NEPHRO, V11, P308, DOI 10.2215/CJN.06200615; Webster NR, 1999, CRIT REV CL LAB SCI, V36, P497, DOI 10.1080/10408369991239286	8	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168563	10.1371/journal.pone.0168563	http://dx.doi.org/10.1371/journal.pone.0168563			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045915	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300033
J	Lindtjorn, B; Mitiku, D; Zidda, Z; Yaya, Y				Lindtjorn, Bernt; Mitiku, Demissew; Zidda, Zillo; Yaya, Yaliso			Reducing Maternal Deaths in Ethiopia: Results of an Intervention Programme in Southwest Ethiopia	PLOS ONE			English	Article							OBSTETRIC CARE; WEST ETHIOPIA; MORTALITY; QUALITY; LESSONS	Background In a large population in Southwest Ethiopia (population 700,000), we carried out a complex set of interventions with the aim of reducing maternal mortality. This study evaluated the effects of several coordinated interventions to help improve effective coverage and reduce maternal deaths. Together with the Ministry of Health in Ethiopia, we designed a project to strengthen the health-care system. A particular emphasis was given to upgrade existing institutions so that they could carry out Basic (BEmOC) and Comprehensive Emergency Obstetric Care (CEmOC). Health institutions were upgraded by training non clinical physicians and midwives by providing the institutions with essential and basic equipment, and by regular monitoring and supervision by staff competent in emergency obstetric work. Results In this implementation study, the maternal mortality ratio (MMR) was the primary outcome. The study was carried out from 2010 to 2013 in three districts, and we registered 38,312 births. The MMR declined by 64% during the intervention period from 477 to 219 deaths per 100,000 live births (OR 0.46; 95% CI 0.24-0.88). The decline in MMR was higher for the districts with CEmOC, while the mean number of antenatal visits for each woman was 2.6 (Inter Quartile Range 2-4). The percentage of pregnant women who attended four or more antenatal controls increased by 20%, with the number of women who delivered at home declining by 10.5% (P<0.001). Similarly, the number of deliveries at health posts, health centres and hospitals increased, and we observed a decline in the use of traditional birth attendants. Households living near to all-weather roads had lower maternal mortality rates (MMR 220) compared with households without roads (MMR 598; OR 2.72 (95% CI 1.614.61)). Conclusions Our results show that it is possible to achieve substantial reductions in maternal mortality rates over a short period of time if the effective coverage of well-known interventions is implemented.	[Lindtjorn, Bernt; Yaya, Yaliso] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Mitiku, Demissew] Gidole Hosp, Gidole, Ethiopia; [Zidda, Zillo] Arba Minch Hosp, Arba Minch, Ethiopia	University of Bergen	Lindtjorn, B (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.	bernt.lindtjorn@uib.no	Lindtjorn, Bernt/K-9465-2018	Lindtjorn, Bernt/0000-0002-6267-6984	University of Bergen in Norway; Norwegian Lutheran Mission in Norway	University of Bergen in Norway; Norwegian Lutheran Mission in Norway	The main funding came through the University of Bergen in Norway, and through the Norwegian Lutheran Mission in Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admasu K, 2011, INT J GYNECOL OBSTET, V115, P101, DOI 10.1016/j.ijgo.2011.07.010; Bryce J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001423; Clarke M, 2012, MAKING TRANSPORT WOR; Federal democratic republic of Ethiopia Ministry of Health, 2015, HLTH SECT TRANSF PLA; FMOH-Ethiopia. Federal Democratic Rpublic of Ethiopia Ministry of Health, 2010, FED DEM RPUBL ETH MI; FMOH-Ethiopia. Federal Ministry of Health of Ethiopia, 2007, GUID HLTH EXT PROGR; Forshaw J, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1098-2; Freedman LP, 2007, LANCET, V370, P1383, DOI 10.1016/S0140-6736(07)61581-5; Gabrysch S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000394; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gaym Asheber, 2012, Ethiop Med J, V50, P209; Girma M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-459; Godefay H, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010410; Godefay H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144975; Graham WJ, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-12; Hanson C, 2015, LANCET GLOB HEALTH, V3, pE387, DOI 10.1016/S2214-109X(15)00048-0; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Kaye D, 2003, East Afr Med J, V80, P144; Kayombo Edmund J, 2013, Tanzan J Health Res, V15, P134; KWAST BE, 1986, STUD FAMILY PLANN, V17, P288, DOI 10.2307/1966906; Lassi ZS, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31408; Meyers J, 2004, FORCED MIGRATION REV, V19, P16; Neily J, 2012, AM SURGEON, V78, P1276; Oladapo OT, 2016, BJOG-INT J OBSTET GY, V123, P928, DOI 10.1111/1471-0528.13450; Otolorin E, 2015, INT J GYNECOL OBSTET, V130, pS46, DOI 10.1016/j.ijgo.2015.03.007; Pereira C, 2011, INT J GYNECOL OBSTET, V114, P180, DOI 10.1016/j.ijgo.2011.05.004; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; SMITH R, 1994, BRIT MED J, V309, P1247, DOI 10.1136/bmj.309.6964.1247; Tesfaye R, 2016, OBSTET GYNECOL INT, V2016, DOI 10.1155/2016/5798068; Tevlin R, 2013, SURG-J R COLL SURG E, V11, P338, DOI 10.1016/j.surge.2013.07.008; UNICEF, 2013, UN CHILDR FUND EV CH; Wagner C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011277; World Health Organization, 2005, HLTH MILL DEV GOALS; World Health Organization, 2004, NUMB REV MAT DEATHS; World Health Organization, 1992, INT STAT CLASS DIS H; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB; Yaya Y., 2015, MATERNAL NEONATAL MO; Yaya Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119321; Yaya Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096294; Yaya Y, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-136; YOSEPH S, 1988, ETHIOPIAN MED J, V26, P115	43	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169304	10.1371/journal.pone.0169304	http://dx.doi.org/10.1371/journal.pone.0169304			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046036	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300163
J	Stahmeyer, JT; Rossol, S; Liersch, S; Guerra, I; Krauth, C				Stahmeyer, Jona T.; Rossol, Siegbert; Liersch, Sebastian; Guerra, Ines; Krauth, Christian			Cost-Effectiveness of Treating Hepatitis C with Sofosbuvir/Ledipasvir in Germany	PLOS ONE			English	Article							GENOTYPE 1 INFECTION; TREATMENT-NAIVE PATIENTS; SUSTAINED VIROLOGICAL RESPONSE; TREATMENT-EXPERIENCED PATIENTS; INTERFERON-ALPHA 2A; PEGYLATED INTERFERON; CHRONIC HCV; PLUS RIBAVIRIN; PEGINTERFERON ALPHA-2B; PHASE-3 TRIAL	Background Infections with the hepatitis C virus (HCV) are a global public health problem. Long-term consequences are the development of liver cirrhosis and hepatocellular carcinoma. Newly introduced direct acting antivirals, especially interferon-free regimens, have improved rates of sustained viral response above 90% in most patient groups and allow treating patients who were ineligible for treatment in the past. These new regimens have replaced former treatment and are recommended by current guidelines. However, there is an ongoing discussion on high pharmaceutical prices. Our aim was to assess the long-term cost-effectiveness of treating hepatitis C genotype 1 patients with sofosbuvir/ledipasvir (SOF/LDV) treatment in Germany. Material and Methods We used a Markov cohort model to simulate disease progression and assess cost-effectiveness. The model calculates lifetime costs and outcomes (quality-adjusted life years, QALYs) of SOF/LDV and other strategies. Patients were stratified by treatment status (treatment -naive and treatment-experienced) and absence/presence of cirrhosis. Different treatment strategies were compared to prior standard of care. Sensitivity analyses were performed to evaluate model robustness. Results Base-case analyses results show that in treatment-naive non-cirrhotic patients treatment with SOF/LDV dominates the prior standard of care (is more effective and less costly). In cirrhotic patients an incremental cost-effectiveness ratio (ICER) of 3,383 (sic)/QALY was estimated. In treatment-experienced patients ICERs were 26,426 (sic)/QALY and 1,397 (sic)/QALY for treatment-naive and treatment-experienced patients, respectively. Robustness of results was confirmed in sensitivity analyses. Conclusions Our analysis shows that treatment with SOF/LDV is cost-effective compared to prior standard of care in all patient groups considering international costs per QALY thresholds.	[Stahmeyer, Jona T.; Liersch, Sebastian; Krauth, Christian] Inst Epidemiol Social Med & Hlth Syst Res, Hannover, Germany; [Stahmeyer, Jona T.; Liersch, Sebastian; Krauth, Christian] Hannover Med Sch, Hannover, Germany; [Rossol, Siegbert] Dept Internal Med, Frankfurt, Germany; [Rossol, Siegbert] Krankenhaus NW Frankfurt, Frankfurt, Germany; [Rossol, Siegbert] Steinbacher Hohl 2-26, Frankfurt, Germany; [Guerra, Ines] Real World Strategy & Analyt, Uxbridge, Middx, England; [Guerra, Ines] MAPI Grp, Uxbridge, Middx, England; [Guerra, Ines] 3rd Floor Beaufort House, Uxbridge, Middx, England	Hannover Medical School; Krankenhaus Nordwest	Stahmeyer, JT (corresponding author), Hannover Med Sch, Hannover, Germany.	Stahmeyer.Jona@mh-hannover.de		Liersch, Sebastian/0000-0002-8613-4434	Gilead Sciences	Gilead Sciences(Gilead Sciences)	This research was conducted with funding from Gilead Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ines Guerra is employed by MAPI Group. MAPI Group provided support in the form of salary for author IG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Andreone P, 2014, GASTROENTEROLOGY, V147, P359, DOI 10.1053/j.gastro.2014.04.045; Backus LI, 2014, ALIMENT PHARM THER, V39, P93, DOI 10.1111/apt.12546; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bourliere M, 2014, AASLD 2014; Bruggmann P, 2014, J VIRAL HEPATITIS, V21, P5, DOI 10.1111/jvh.12247; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; Curry MP, 2015, AASLD 2015; Drummond M, 2009, VALUE HEALTH, V12, P409, DOI 10.1111/j.1524-4733.2008.00489.x; European Medicines Agency, 2014, DAKL SUMM PROD CHAR; European Medicines Agency, 2014, VICT SUMM PROD CHAR; European Medicines Agency, 2014, HARV SUMM PROD CHAR; European Medicines Agency, 2014, OL SUMM PROD CHAR; European Medicines Agency, 2016, EXV SUMM PROD CHAR; European Medicines Agency, 2014, INC SUMM PROD CHAR; European Medicines Agency, 2014, SOV SUMM PROD CHAR; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Federal Statistical Office, 2012, PER DEUTSCHL; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Forns X, 2014, GASTROENTEROLOGY, V146, P1669, DOI 10.1053/j.gastro.2014.02.051; Grishchenko M, 2009, INT J TECHNOL ASSESS, V25, P171, DOI 10.1017/S0266462309090229; Hsu CS, 2013, NEW ENGL J MED, V369, P678, DOI 10.1056/NEJMc1307641; Huppe D, 2008, Z GASTROENTEROL, V46, P34, DOI 10.1055/s-2007-963691; Huppe D, 2015, HEPNET J, V9, P12; Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, 2009, ALLG METH BEW VERH Z; Jacobson IM, 2014, LANCET, V384, P403, DOI 10.1016/S0140-6736(14)60494-3; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; LAUER-FISCHER GmbH, 2016, LAUER TAX ONL GERM D; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Manns M, 2014, LANCET, V384, P414, DOI 10.1016/S0140-6736(14)60538-9; Mauss S, 2015, AASLD 2015; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Najafzadeh M, 2015, ANN INTERN MED, V162, P407, DOI 10.7326/M14-1152; NICE technology appraisal guidance TA252, 2012, TEL TREATM GEN 1 CHR; NICE technology appraisal guidance TA253, 2012, BOC TREATM GEN 1 CHR; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Poethko-Muller C, 2013, BUNDESGESUNDHEITSBLA, V56, P707, DOI 10.1007/s00103-013-1673-x; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Sarrazin C, 2015, Z GASTROENTEROL, V53, P320, DOI 10.1055/s-0034-1399322; Shepherd J, 2007, HEALTH TECHNOL ASSES, V11, P1; Siebert U, 2003, GUT, V52, P425, DOI 10.1136/gut.52.3.425; Siebert U., 2003, PERFORMANCE DIFFEREN, P175; Siebert Uwe, 2005, Eur J Health Econ, V6, P112, DOI 10.1007/s10198-005-0280-7; Stahmeyer JT, 2014, Z GASTROENTEROL, V52, P1041, DOI 10.1055/s-0034-1366289; Stahmeyer JT, 2015, J COMP EFFECT RES, V4, P267, DOI 10.2217/cer.15.13; Stahmeyer JT, 2013, J HLTH EC OUTCOMES H, V1, P239; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; US Department of Veterans Affairs, 2016, FDA APPR SOT; Vera-Llonch M, 2013, ALIMENT PHARM THER, V38, P124, DOI 10.1111/apt.12354; Ward JW, 2015, NEW ENGL J MED, V373, P2678, DOI 10.1056/NEJMe1513245; Wasem J, 2006, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V49, P57, DOI 10.1007/s00103-005-1190-7; WHO, 2014, GUID SCREEN CAR TREA; Younossi ZM, 2015, ALIMENT PHARM THER, V41, P544, DOI 10.1111/apt.13081; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561; Zeuzem S, 2014, GASTROENTEROLOGY, V146, P430, DOI 10.1053/j.gastro.2013.10.058; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zhang S, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0320-4	63	20	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169401	10.1371/journal.pone.0169401	http://dx.doi.org/10.1371/journal.pone.0169401			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046099	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300183
J	Choi, HG; Park, B; Sim, S; Ahn, SH				Choi, Hyo Geun; Park, Bumjung; Sim, Songyong; Ahn, Soon-Hyun			Tonsillectomy Does Not Reduce Upper Respiratory Infections: A National Cohort Study	PLOS ONE			English	Article							CHILDREN; ADENOTONSILLECTOMY; PHARYNGITIS; OUTCOMES	Objectives The objective of this study was to compare post-operative visits for upper respiratory infections (URIs) between tonsillectomy and non-tonsillectomy participants (controls). Methods Using the national cohort study from the Korean Health Insurance Review and Assessment Service, 1: 4 matched (age, sex, income, region, and pre-operative URI visit) tonsillectomy participants (5,831) and control participants (23,324) were selected. Post-operative visits for URI were measured from 1 to 9 years post-op. The equivalence test was used. The margin of equivalence of the difference (Tonsillectomy-Control group group) was set to -0.5 to 0.5. Results There was no difference between the tonsillectomy and control group in 1-to 9-year post-op visits (-0.5 < 95% CI of difference < 0.5). URI visits gradually decreased from 5.5/2 years (pre-op) to 2.1/year (at 1 year post-op) and 1.4/year (at 9 years post-op) in both tonsillectomy and control groups. In the subgroup analysis (children Vs adolescent and adults; rare Vs frequent pre-operative URI), there was no difference in the number of post-op visits for URI between the tonsillectomy and control groups (-0.5 < 95% CI of difference < 0.5). Conclusion Tonsillectomy does not provide a decrease in the number of post-operative visits for URI, and URI decreased over time whether or not a tonsillectomy was performed.	[Choi, Hyo Geun; Park, Bumjung] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [Sim, Songyong] Hallym Univ, Dept Stat, Chunchon, South Korea; [Ahn, Soon-Hyun] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Bundang, South Korea	Hallym University; Hallym University; Seoul National University (SNU)	Ahn, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Bundang, South Korea.	ahnsh30@snu.ac.kr	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation (NRF) of Korea [NRF-2015-R1D1A1A01060860]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea)	This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860) from the National Research Foundation (NRF) of Korea. There was no additional external funding received for this study.	Alho OP, 2007, BMJ-BRIT MED J, V334, P939, DOI 10.1136/bmj.39140.632604.55; Barraclough J, 2014, OTOLARYNG HEAD NECK, V150, P722, DOI 10.1177/0194599814522593; Boss EF, 2012, J PEDIATR-US, V160, P814, DOI 10.1016/j.jpeds.2011.11.041; Burton MJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001802.pub3; Burton MJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001802.pub2; Choi HG, 2014, EUR ARCH OTO-RHINO-L, V271, P2293, DOI 10.1007/s00405-013-2759-7; Erickson BK, 2009, OTOLARYNG HEAD NECK, V140, P894, DOI 10.1016/j.otohns.2009.01.044; Hultcrantz E, 2013, ORL J OTO-RHINO-LARY, V75, P184, DOI 10.1159/000342322; Jensen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056418; Koskenkorva T, 2013, CAN MED ASSOC J, V185, pE331, DOI 10.1503/cmaj.121852; Lock C, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14130; Paradise Jack L, 2002, Pediatrics, V110, P7, DOI 10.1542/peds.110.1.7; PARADISE JL, 1984, NEW ENGL J MED, V310, P674, DOI 10.1056/NEJM198403153101102; Patel HH, 2014, INT J PEDIATR OTORHI, V78, P2151, DOI 10.1016/j.ijporl.2014.09.030; STAFFORD N, 1986, J LARYNGOL OTOL, V100, P175, DOI 10.1017/S0022215100098935; Stelter Klaus, 2014, GMS Curr Top Otorhinolaryngol Head Neck Surg, V13, pDoc07, DOI 10.3205/cto000110; Tsou YA, 2013, INT J PEDIATR OTORHI, V77, P677, DOI 10.1016/j.ijporl.2013.01.011; van Staaij BK, 2005, ARCH DIS CHILD, V90, P19, DOI 10.1136/adc.2003.047530; van Staaij BK, 2004, BMJ-BRIT MED J, V329, P651, DOI 10.1136/bmj.38210.827917.7C; Windfuhr JP, 2013, ORL J OTO-RHINO-LARY, V75, P166, DOI 10.1159/000342317	20	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169264	10.1371/journal.pone.0169264	http://dx.doi.org/10.1371/journal.pone.0169264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036375	Green Published, gold, Green Submitted			2022-12-26	WOS:000391229300069
J	Li, Y; Zhang, J; Li, T; Liu, HG; Wang, YZ				Li, Yan; Zhang, Ji; Li, Tao; Liu, Honggao; Wang, Yuanzhong			A Comprehensive and Comparative Study of Wolfiporia extensa Cultivation Regions by Fourier Transform Infrared Spectroscopy and Ultra-Fast Liquid Chromatography	PLOS ONE			English	Article							DISCRIMINANT-ANALYSIS; CHEMICAL-COMPOSITION; PLEUROTUS-OSTREATUS; QUALITY-CONTROL; CANCER CELLS; FT-RAMAN; MUSHROOM; IDENTIFICATION; FINGERPRINTS; METABOLITES	Nowadays, Wolfiporia extensa as a popular raw material in food and medicine industry has received increasing interests. Due to supply shortage, this species of edible and medicinal mushroom has been cultivated in some provinces of China. In the present study, cultivated W. extensa collected from six regions in Yunnan Province of China were analyzed by an integrated method based on Fourier transform infrared (FT-IR) spectroscopy and ultra-fast liquid chromatography (UFLC) coupled with multivariate analysis including partial least squares discriminant analysis (PLS-DA) and hierarchical cluster analysis (HCA) in order to investigate the differences and similarities in different origins and parts. In the tested mushroom samples, characteristic FT-IR spectra were obtained for acquiring comprehensive fuzz chemical information and pachymic acid was determinated as a biomarker in the meantime. From the results, the comparison of samples was achieved successfully according to their geographical regions and different parts. All the samples displayed regional dependence and the inner parts showed better quality consistency. In addition, the chemical constituents of cultivated W. extensa could be also affected by the cultivation methods. Meanwhile, there was an interesting finding that the soil properties of cultivation regions may have a relationship with the chemical constituents of the epidermis of soil-cultured W. extensa, rather than the inner parts. Collectively, it demonstrated that the present study could provide comprehensive chemical evidence for the critical complement of quality evaluation on the cultivatedW. extensa. Moreover, it may be available for the further researches of complicated mushrooms in practice.	[Li, Yan; Zhang, Ji; Wang, Yuanzhong] Yunnan Acad Agr Sci, Inst Med Plants, Kunming, Yunnan, Peoples R China; [Li, Yan; Zhang, Ji; Wang, Yuanzhong] Yunnan Tech Ctr Qual Chinese Mat Med, Kunming, Yunnan, Peoples R China; [Li, Tao] Yuxi Normal Univ, Coll Resources & Environm, Yuxi, Yunnan, Peoples R China; [Liu, Honggao] Yunnan Agr Univ, Coll Agron & Biotechnol, Kunming, Yunnan, Peoples R China	Yunnan Academy of Agricultural Sciences; Yuxi Normal University; Yunnan Agricultural University	Wang, YZ (corresponding author), Yunnan Acad Agr Sci, Inst Med Plants, Kunming, Yunnan, Peoples R China.; Wang, YZ (corresponding author), Yunnan Tech Ctr Qual Chinese Mat Med, Kunming, Yunnan, Peoples R China.; Liu, HG (corresponding author), Yunnan Agr Univ, Coll Agron & Biotechnol, Kunming, Yunnan, Peoples R China.	honggaoliu@126.com; boletus@126.com	Lv, Yuanjie/AER-0767-2022; Wang, Yuan/HHC-1520-2022; Zhang, Ji/B-2830-2013	Zhang, Ji/0000-0002-7737-0785; Wang, Yuanzhong/0000-0001-5376-757X	National Natural Science Foundation of China [31460538, 31260496, 31660591]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was sponsored by the National Natural Science Foundation of China (31460538, 31260496 and 31660591).	Akinyele JB, 2012, MALAYS J MICROBIOL, V8, P135, DOI 10.21161/mjm.03912; Barbosa PCS, 2012, J BRAZIL CHEM SOC, V23, P1823, DOI 10.1590/S0103-50532012005000049; Briciu RD, 2012, FOOD CHEM, V130, P994; Casale M, 2016, TALANTA, V160, P729, DOI 10.1016/j.talanta.2016.08.004; Chen Y, 2008, ANAL CHIM ACTA, V623, P146, DOI 10.1016/j.aca.2008.06.018; Chen Y, 2012, J AGR FOOD CHEM, V60, P4243, DOI 10.1021/jf300076j; Choong YK, 2014, J MOL STRUCT, V1069, P188, DOI 10.1016/j.molstruc.2014.04.001; De Gussem K, 2005, SPECTROCHIM ACTA A, V61, P2896, DOI 10.1016/j.saa.2004.10.038; Dong JZ, 2013, FOOD CHEM, V137, P164, DOI 10.1016/j.foodchem.2012.10.021; Ezekiel CN, 2013, INT J FOOD MICROBIOL, V162, P231, DOI 10.1016/j.ijfoodmicro.2013.01.025; Gapter L, 2005, BIOCHEM BIOPH RES CO, V332, P1153, DOI 10.1016/j.bbrc.2005.05.044; Giner EM, 2000, PLANTA MED, V66, P221, DOI 10.1055/s-2000-8563; Gong F, 2004, J CHROMATOGR A, V1029, P173, DOI 10.1016/j.chroma.2003.12.049; Guo L., 2012, BIOMEDICINE PREVENTI, V2, P42, DOI [10.1016/j.bionut.2011.07.002, DOI 10.1016/J.BIONUT.2011.07.002]; Guo LP, 2013, SCI CHINA LIFE SCI, V56, P1047, DOI 10.1007/s11427-013-4562-5; Islam MT., 2016, WORLD APPL SCI J, V34, P1066; Jing J, 2013, TRAC-TREND ANAL CHEM, V44, P39, DOI 10.1016/j.trac.2012.11.006; Jing P, 2014, J AGR FOOD CHEM, V62, P12128, DOI 10.1021/jf504349r; KANEMATS.A, 1970, YAKUGA ZASSHI, V90, P475, DOI 10.1248/yakushi1947.90.4_475; Kim JK, 2013, J CEREAL SCI, V57, P14, DOI 10.1016/j.jcs.2012.09.012; Kizil R, 2002, J AGR FOOD CHEM, V50, P3912, DOI 10.1021/jf011652p; Li Y, 2016, SPECTROCHIM ACTA A, V165, P61, DOI 10.1016/j.saa.2016.04.012; [李妍 Li Yan], 2016, [食品科学, Food Science], V37, P222; Li YQ, 2016, FOOD ANAL METHOD, V9, P202, DOI 10.1007/s12161-015-0187-6; Ling Y, 2012, BIOMED CHROMATOGR, V26, P1109, DOI 10.1002/bmc.1756; Liu YC, 2016, RSC ADV, V6, P366, DOI 10.1039/c5ra21468h; Ma F, 2014, SPECTROSC SPECT ANAL, V34, P376, DOI 10.3964/j.issn.1000-0593(2014)02-0376-05; Maquelin K, 2002, J MICROBIOL METH, V51, P255, DOI 10.1016/S0167-7012(02)00127-6; Mohacek-Grosev V, 2001, SPECTROCHIM ACTA A, V57, P2815, DOI 10.1016/S1386-1425(01)00584-4; O'Gorman A, 2010, J AGR FOOD CHEM, V58, P7770, DOI 10.1021/jf101123a; Oyetayo V. O., 2013, Jordan Journal of Biological Sciences (JJBS), V6, P223; Pan Y, 2015, J LIQ CHROMATOGR R T, V38, P1407, DOI 10.1080/10826076.2015.1053912; Phan CW, 2015, CRIT REV BIOTECHNOL, V35, P355, DOI 10.3109/07388551.2014.887649; Rosmiza M.Z., 2016, MEDITERR J SOC SCI, V7, P406, DOI [DOI 10.5901/MJSS.2016.V7N1S1P406, 10.5901/mjss.2016.v7n1s1p406]; Roy S, 2015, AM J BIOSCIENCE, V3, P178, DOI [10.11648/j.ajbio.20150305.13, DOI 10.11648/J.AJBIO.20150305.13]; SEKKAL M, 1995, J MOL STRUCT, V349, P349, DOI 10.1016/0022-2860(95)08781-P; State Pharmacopoeia Commission, 2015, CHINESE PHARMACOPOEI, P240; Sun J, 2016, INT J MED MUSHROOMS, V18, P433, DOI 10.1615/IntJMedMushrooms.v18.i5.70; TAI T, 1995, PHYTOCHEMISTRY, V40, P225, DOI 10.1016/0031-9422(95)00182-7; TAI T, 1995, PHYTOCHEMISTRY, V39, P1165, DOI 10.1016/0031-9422(95)00110-S; TAI T, 1991, PHYTOCHEMISTRY, V30, P2796, DOI 10.1016/0031-9422(91)85149-T; TAI T, 1993, PHYTOCHEMISTRY, V32, P1239, DOI 10.1016/S0031-9422(00)95099-4; Vijaykumar G, 2014, INDIAN J TRADIT KNOW, V13, P434; Villares A, 2012, AGRICULTURE-BASEL, V2, P452, DOI 10.3390/agriculture2040452; Wang XM, 2014, FOOD CHEM, V151, P279, DOI 10.1016/j.foodchem.2013.11.062; Wang YF, 2004, CARBOHYD RES, V339, P327, DOI 10.1016/j.carres.2003.10.006; Wang YZ, 2013, J ETHNOPHARMACOL, V147, P265, DOI 10.1016/j.jep.2013.03.027; Wang YZ, 2012, INT J MED MUSHROOMS, V14, P79, DOI 10.1615/IntJMedMushr.v14.i1.80; Wong KH, 2013, J PHARMACEUT BIOMED, V84, P5, DOI 10.1016/j.jpba.2013.05.040; Wu X.L., 2013, MED FUNGI CHINA; Xu J, 2014, CHINESE J SPECTROSC, V31, P531; Yang Yong-Hong, 2012, Zhong Yao Cai, V35, P1557; Yu XW, 2013, CHIN J CHROMATOGR, V31, P691, DOI 10.3724/SP.J.1123.2012.12039; Zhang JS, 2015, J PHARMACEUT BIOMED, V115, P395, DOI 10.1016/j.jpba.2015.07.035; Zhao SQ, 2014, SPECTROSC SPECT ANAL, V34, P3401; Zhao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089100; Zhao ZZ, 2012, J ETHNOPHARMACOL, V140, P476, DOI 10.1016/j.jep.2012.01.048; Zhbankov R. G., 1997, J MOL STRUCT, V436-437, P654; Zhu Y., 2015, AM J ANAL CHEM, V6, P480, DOI DOI 10.4236/AJAC.2015.65047; Zhu Y, 2016, SPECTROCHIM ACTA A, V159, P68, DOI 10.1016/j.saa.2016.01.018	60	15	17	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168998	10.1371/journal.pone.0168998	http://dx.doi.org/10.1371/journal.pone.0168998			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036354	Green Published, Green Submitted, gold			2022-12-26	WOS:000391229300046
J	Black, V; Black, AD; Rees, HV; Guidozzi, F; Scorgie, F; Chersich, MF				Black, Vivian; Black, Andrew D.; Rees, Helen V.; Guidozzi, Franco; Scorgie, Fiona; Chersich, Matthew F.			Increased Access to Antiretroviral Therapy Is Associated with Reduced Maternal Mortality in Johannesburg, South Africa: An Audit from 2003-2012	PLOS ONE			English	Article							ANTENATAL CARE; COUNTRIES	Objective To assess the impact of expanded access to antiretroviral treatment (ART) on maternal mortality in Johannesburg, South Africa between 2003 and 2012. Methods Audit of patient files, birth registers and death certificates at a tertiary level referral hospital. Cause of death was assigned independently, by two reviewers. We compared causes of deaths and the maternal mortality ratios (MMR, deaths/100,000 live births) over three periods corresponding to changes in government policy on ART provision: period one, 2003-2004 (pre-ART); period two, 2005-2009 (ART eligibility with CD4 count <200cells/mu L or WHO stage 4 disease); and period three, 2010-2012 (eligibility with CD4 count <350 cells/mu L). Results There were 232 deaths and 80,376 deliveries in the three periods. The proportion of pregnant women tested for HIV rose from 43.4% in 2003 to 94.6% in 2012. MMR was 301, 327 and 232 in the three periods, (p = 0.10). The third period MMR was lower than the first and second combined (p = 0.03). Among HIV-positive women, the MMR fell from 836 in the first time period to 431 in the third (p = 0.008) but among HIV negative women it remained unchanged over the three periods, averaging 148. Even in the third period, however, the MMR among HIV-infected women was 3-fold higher than in other women. Mortality from direct obstetric causes such as hemorrhage did not decline over time, but deaths from tuberculosis and HIV-associated malignancy did. In 38.3% of deaths, women had not attended antenatal care. Conclusion Higher coverage of HIV testing and ART has substantially reduced MMR in this hospital setting. Though the gap in MMR between women with and without HIV narrowed, a third of deaths still remain attributable to HIV. Lowering overall MMR will require further strengthening of HIV services, increased antenatal care coverage, and improved care for obstetric emergencies at all levels of care.	[Black, Vivian; Black, Andrew D.; Rees, Helen V.; Scorgie, Fiona; Chersich, Matthew F.] Univ Witwatersrand, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Black, Vivian] Univ Witwatersrand, Fac Hlth Sci, Clin Microbiol & Infect Dis, Johannesburg, South Africa; [Guidozzi, Franco] Univ Witwatersrand, Fac Hlth Sci, Dept Obstet & Gynaecol, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Black, V (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa.; Black, V (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Clin Microbiol & Infect Dis, Johannesburg, South Africa.	Vivian.black@nhls.ac.za		Rees, Helen/0000-0003-1442-6734; Scorgie, Fiona/0000-0003-2560-8234; chersich, matthew/0000-0002-4320-9168	President's Emergency Plan for AIDS Relief (PEPFAR)	President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Study activities and service delivery were supported by the President's Emergency Plan for AIDS Relief (PEPFAR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	All Africa, 2010, S AFR UNP VCT COUNS; Amnesty International, 2014, STRUGGL MAT HLTH BAR; [Anonymous], 2013, 2012 NAT ANT SENT HI; Black V, 2008, JAIDS-J ACQ IMM DEF, V49, P276, DOI 10.1097/QAI.0b013e318189a769; Black V, 2011, SAMJ S AFR MED J, V101, P407; Bodibe K., 2012, LACK PAY FRUSTRATES; Buchmann E, 2014, BJOG; Department of Health Republic of South Africa, 2014, JOINT REV HIV TB PMT; Department of Health SA, 2015, SAV MOTH 2011 2013 6; Dorrington RE, 2012, RAPID MORTALITY SURV; ESMOE, 2014, ESS STEPS MAN OBST E; Fawcus SR, 2005, BJOG-INT J OBSTET GY, V112, P1257, DOI 10.1111/j.1471-0528.2005.00601.x; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Graham W, 2003, WORKSH HIV AIDS AD M; Harris B, 2011, J PUBLIC HEALTH POL, V32, pS102, DOI 10.1057/jphp.2011.35; Kassebaum N.J, 2014, LANCET; Kirkwood BR, 2003, ESSENTIAL MED STAT; Lawn SD, 2012, AIDS, V26, P2121, DOI 10.1097/QAD.0b013e3283565dd1; National Committee for the Confidential Enquiries into Maternal Deaths, 2011, SAV MOTH 2008 2010 5; Pattinson R, 2013, 10 INTERIM REPORT CO; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Sebitloane HM, 2008, BEST PRACT RES CL OB, V22, P489, DOI 10.1016/j.bpobgyn.2007.11.003; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Solarin I, 2013, MATERN CHILD HLTH J, V17, P359, DOI 10.1007/s10995-012-1019-6; UNAIDS, 2016, AIDS INF; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; Wabiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073864; World Health Organization, 2009, NUMB REV MAT DEATHS; World Health Organization, 2006, REPR HLTH IND GUID T	29	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168199	10.1371/journal.pone.0168199	http://dx.doi.org/10.1371/journal.pone.0168199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033409	Green Submitted, Green Published, gold			2022-12-26	WOS:000391226900018
J	Fadaei, R; Moradi, N; Baratchian, M; Aghajani, H; Malek, M; Fazaeli, AA; Fallah, S				Fadaei, Reza; Moradi, Nariman; Baratchian, Mehdi; Aghajani, Hassan; Malek, Mojtaba; Fazaeli, Ali Akbar; Fallah, Soudabeh			Association of C1q/TNF-Related Protein-3 (CTRP3) and CTRP13 Serum Levels with Coronary Artery Disease in Subjects with and without Type 2 Diabetes Mellitus	PLOS ONE			English	Article							PPAR-GAMMA; ADIPOKINE; OBESITY; FAMILY; ACTIVATION; EXPRESSION; INFLAMMATION; ADIPONECTIN; CORS-26; KINASE	C1q/TNF-Related Protein-3 (CTRP3) and CTRP13 are two newly discovered adipokines regulating glucose and lipid metabolism. But their role in type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) is still in infancy. The aim of this study was to investigate the associations of gene expression and serum levels of CTRP3 and CTRP13 with CAD, metabolic and inflammatory markers in patients with and without T2DM. Serum levels of CTRP3, CTRP13, adiponectin and inflammatory cytokines and their gene expression in peripheral blood mononuclear cells (PBMCs) were determined in 172 subjects categorized as group I (without T2DM and CAD), group II (with CAD but no T2DM), group III (with T2DM but no CAD) and group IV (with T2DM and CAD). Serum levels and gene expression of CTRP3, CTRP13 and adiponectin in the group I were higher compared to other groups. Inflammatory cytokines in the control group were lower than other groups too. CTRP3 serum levels have an independent association with BMI, smoking and CTRP3 gene expression; also CTRP13 serum levels has an independent association with BMI, HDL-C, insulin, HOMA-IR, HbA 1c and INF-alpha. Decreased serum levels of CTRP3 and CTRP13 were also associated with CAD. It appears that the decreased levels of CTRP3 and especially CTRP13 were associated with increased risk of T2DM and CAD. These findings suggest an emerging role of these adipokines in the pathogenesis of CAD, but further studies are necessary to establish this concept.	[Fadaei, Reza; Moradi, Nariman; Fallah, Soudabeh] Iran Univ Med Sci, Dept Biochem, Fac Med, Tehran, Iran; [Fadaei, Reza; Fazaeli, Ali Akbar] Univ Tehran Med Sci, Dept Clin Biochem, Fac Med, Tehran, Iran; [Baratchian, Mehdi] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA; [Aghajani, Hassan] Univ Tehran Med Sci, Intervent Cardiol Dept, Tehran Heart Ctr, Tehran, Iran; [Malek, Mojtaba] Iran Univ Med Sci, Inst Endocrinol & Metab, Res Ctr Prevent Cardiovasc Dis, Tehran, Iran; [Fallah, Soudabeh] Iran Univ Med Sci, Rasool Akram Hosp, Res Ctr Pediat Infect Dis, Tehran, Iran	Iran University of Medical Sciences; Tehran University of Medical Sciences; Cleveland Clinic Foundation; Tehran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences	Fallah, S (corresponding author), Iran Univ Med Sci, Dept Biochem, Fac Med, Tehran, Iran.; Fallah, S (corresponding author), Iran Univ Med Sci, Rasool Akram Hosp, Res Ctr Pediat Infect Dis, Tehran, Iran.	fallah.s@iums.ac.ir	malek, mojtaba/ABI-6237-2020; Fadaei, Reza/M-9456-2016; Fazaeli, Aliakbar/AAL-7819-2020; fazaeli, aliakbar/B-1952-2019	Fazaeli, Aliakbar/0000-0001-7860-3950; /0000-0002-7377-6577; Malek, Mojtaba/0000-0002-8277-3351; Moradi, Nariman/0000-0001-7760-4804; Aghajani, Hassan/0000-0002-2181-4850; Fadaei, Reza/0000-0002-4989-1137	Iran University of Medical Science [25388-30-04-93]	Iran University of Medical Science	This work was supported by a grant (25388-30-04-93) from Iran University of Medical Science. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Ban B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112931; Byerly MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062862; Carr MC, 2004, J CLIN ENDOCR METAB, V89, P2601, DOI 10.1210/jc.2004-0432; Choi KM, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-14; Choi KM, 2012, DIABETES, V61, P2932, DOI 10.2337/db12-0217; Compton SA, 2010, ENDOCRINOLOGY, V151, P5095, DOI 10.1210/en.2010-0916; Davis Kathryn E, 2008, Biochem J, V416, pe7, DOI 10.1042/BJ20082033; Deng WQ, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0029-0; Emamgholipour S, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0099-z; Fadaei R, 2016, HORM METAB RES, V48, P269, DOI 10.1055/s-0035-1564133; Flehmig G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099785; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Li XS, 2015, 2015 INTERNATIONAL CONFERENCE ON INDUSTRIAL INFORMATICS - COMPUTING TECHNOLOGY, INTELLIGENT TECHNOLOGY, INDUSTRIAL INFORMATION INTEGRATION (ICIICII), P1, DOI 10.1109/ICIICII.2015.88; Li X, 2014, ENDOKRYNOL POL, V65, P252, DOI 10.5603/EP.2014.0034; Mattu HS, 2013, J ENDOCRINOL, V216, pT17, DOI 10.1530/JOE-12-0232; Moore DF, 2005, CIRCULATION, V111, P212, DOI 10.1161/01.CIR.0000152105.79665.C6; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Petersen PS, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12735; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; Schaffler A, 2004, BBA-GENE STRUCT EXPR, V1678, P150, DOI 10.1016/j.bbaexp.2004.02.006; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seldin MM, 2014, REV ENDOCR METAB DIS, V15, P111, DOI 10.1007/s11154-013-9255-7; Shabani P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118650; Shimada T, 2009, AM J PHYSIOL-ENDOC M, V296, pE721, DOI 10.1152/ajpendo.90829.2008; Tan BK, 2014, CLIN ENDOCRINOL, V81, P841, DOI 10.1111/cen.12438; Tan BK, 2013, J CLIN ENDOCR METAB, V98, pE1891, DOI 10.1210/jc.2013-2227; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Wagner RM, 2016, PEERJ, V4, DOI 10.7717/peerj.2573; Wang HZ, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0266-7; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Weigert J, 2005, FEBS LETT, V579, P5565, DOI 10.1016/j.febslet.2005.09.022; Wolf RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133955; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yi W, 2012, CIRCULATION, V125, P3159, DOI 10.1161/CIRCULATIONAHA.112.099937; Yoo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055744; Yuasa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099846	42	41	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168773	10.1371/journal.pone.0168773	http://dx.doi.org/10.1371/journal.pone.0168773			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033351	Green Published, Green Submitted, gold			2022-12-26	WOS:000391226900046
J	Littlefair, JE; Knell, RJ				Littlefair, Joanne E.; Knell, Robert J.			Within- and Trans-Generational Effects of Variation in Dietary Macronutrient Content on Life-History Traits in the Moth Plodia interpunctella	PLOS ONE			English	Article							PROPHENOLOXIDASE-ACTIVATING SYSTEM; TRADE-OFFS; BODY-SIZE; PHENOTYPIC PLASTICITY; NUTRITIONAL IMBALANCE; RESOURCE-ALLOCATION; GEOMETRIC ANALYSIS; PROTEIN-QUALITY; FITNESS; FECUNDITY	It is increasingly clear that parental environment can play an important role in determining offspring phenotype. These "transgenerational effects" have been linked to many different components of the environment, including toxin exposure, infection with pathogens and parasites, temperature and food quality. In this study, we focus on the latter, asking how variation in the quantity and quality of nutrition affects future generations. Previous studies have shown that artificial diets are a useful tool to examine the within-generation effects of variation in macronutrient content on life history traits, and could therefore be applied to investigations of the transgenerational effects of parental diet. Synthetic diets varying in total macronutrient content and protein: carbohydrate ratios were used to examine both within-and trans-generational effects on life history traits in a generalist stored product pest, the Indian meal moth Plodia interpunctella. The macronutrient composition of the diet was important for shaping within-generation life history traits, including pupal weight, adult weight, and phenoloxidase activity, and had indirect effects via maternal weight on fecundity. Despite these clear within-generation effects on the biology of P. interpunctella, diet composition had no transgenerational effects on the life history traits of offspring. P. interpunctella mothers were able to maintain their offspring quality, possibly at the expense of their own somatic condition, despite high variation in dietary macronutrient composition. This has important implications for the plastic biology of this successful generalist pest.	[Littlefair, Joanne E.; Knell, Robert J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	University of London; Queen Mary University London	Littlefair, JE (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	j.littlefair@qmul.ac.uk		Littlefair, Joanne/0000-0002-4481-0211	Drapers' Company	Drapers' Company	JL received a PhD scholarship from the Drapers' Company (http://www.thedrapers.co.uk/ Compary/Supporting-Education.aspx). This experiment was conducted as part of her PhD research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; [Anonymous], 1973, MILLENNIUM ECOSYSTEM; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Auld SKJR, 2012, FUNCT ECOL, V26, P434, DOI 10.1111/j.1365-2435.2011.01959.x; Babic B, 2008, J INSECT PHYSIOL, V54, P286, DOI 10.1016/j.jinsphys.2007.09.010; Bonduriansky R, 2007, J EVOLUTION BIOL, V20, P2379, DOI 10.1111/j.1420-9101.2007.01419.x; Bonduriansky R, 2016, FUNCT ECOL; BOWEN SH, 1995, ECOLOGY, V76, P899, DOI 10.2307/1939355; BRABY MF, 1995, OIKOS, V72, P189, DOI 10.2307/3546221; Calvo D, 2005, ANN ENTOMOL SOC AM, V98, P191, DOI 10.1603/0013-8746(2005)098[0191:FSRAOR]2.0.CO;2; Carson-Cohen A, 2004, INSECT DIETS SCI TEC; Catalan TP, 2011, EVOL ECOL RES, V13, P711; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Clissold FJ, 2013, J EXP BIOL, V216, P329, DOI 10.1242/jeb.076489; Clissold FJ, 2010, P ROY SOC B-BIOL SCI, V277, P1751, DOI 10.1098/rspb.2009.2045; Crawley M. J, 2002, STAT COMPUTING INTRO; Crean AJ, 2014, ECOL LETT, V17, P1545, DOI 10.1111/ele.12373; Cruz-Rivera E, 2000, ECOLOGY, V81, P201; Eslin P, 1996, J INSECT PHYSIOL, V42, P549, DOI 10.1016/0022-1910(95)00134-4; Frago E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088039; Franzke A, 2013, BEHAV ECOL, V24, P734, DOI 10.1093/beheco/ars205; Frost PC, 2010, OECOLOGIA, V162, P865, DOI 10.1007/s00442-009-1517-4; Garbutt JS, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0356; Giron D, 2003, ECOL LETT, V6, P273, DOI 10.1046/j.1461-0248.2003.00429.x; Graham AL, 2011, FUNCT ECOL, V25, P5, DOI 10.1111/j.1365-2435.2010.01777.x; Graham RI, 2014, J INSECT PHYSIOL, V69, P27, DOI 10.1016/j.jinsphys.2014.05.015; Harrison SJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0539; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; KARLSSON B, 1990, FUNCT ECOL, V4, P609, DOI 10.2307/2389728; LAMPERT W, 1994, LIMNOL OCEANOGR, V39, P997, DOI 10.4319/lo.1994.39.5.0997; Laughton AM, 2011, APIDOLOGIE, V42, P140, DOI 10.1051/apido/2010046; Lee KP, 2008, FUNCT ECOL, V22, P1052, DOI 10.1111/j.1365-2435.2008.01459.x; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Lee KP, 2004, PHYSIOL ENTOMOL, V29, P108, DOI 10.1111/j.0307-6962.2004.00371.x; Lee KP, 2002, J INSECT PHYSIOL, V48, P655, DOI 10.1016/S0022-1910(02)00088-4; Lee KP, 2007, J EXP BIOL, V210, P3236, DOI 10.1242/jeb.008060; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Littlefair JE, 2016, ENTOMOL EXP APPL, V159, P305, DOI [10.1111/eea.12441, 10.1111/ee]; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; Mohandass S, 2007, J STORED PROD RES, V43, P302, DOI 10.1016/j.jspr.2006.08.002; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nation J. L., 2008, INSECT PHYSL BIOCH; O'Brien DM, 2005, PHYSIOL BIOCHEM ZOOL, V78, P819, DOI 10.1086/431191; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; R Development Core Team, R LANG ENV STAT COMP; Raubenheimer D, 2006, ANIM BEHAV, V71, P1253, DOI 10.1016/j.anbehav.2005.07.024; Raubenheimer D, 2007, J COMP PHYSIOL B, V177, P849, DOI 10.1007/s00360-007-0180-5; Rogers DW, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-236; Runagall-McNaull A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11783; Saastamoinen M, 2013, OECOLOGIA, V171, P93, DOI 10.1007/s00442-012-2412-y; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; SIMPSON SJ, 1995, J INSECT PHYSIOL, V41, P545, DOI 10.1016/0022-1910(95)00006-G; SIMPSON SJ, 1985, PHYSIOL ENTOMOL, V10, P443, DOI 10.1111/j.1365-3032.1985.tb00066.x; Simpson SJ, 2012, NATURE NUTR UNIFYING; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Srygley RB, 2011, ANIM BEHAV, V81, P395, DOI 10.1016/j.anbehav.2010.11.006; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Stjernman M, 2011, J EVOLUTION BIOL, V24, P2357, DOI 10.1111/j.1420-9101.2011.02363.x; STOCKHOFF BA, 1993, J INSECT PHYSIOL, V39, P677, DOI 10.1016/0022-1910(93)90073-Z; Therneau T, 2012, COXME MIXED EFFECTS; Triggs A, 2012, J ANIM ECOL, V81, P386, DOI 10.1111/j.1365-2656.2011.01920.x; Triggs AM, 2012, FUNCT ECOL, V26, P1409, DOI 10.1111/j.1365-2435.2012.02051.x; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Uller T, 2013, J EVOLUTION BIOL, V26, P2161, DOI 10.1111/jeb.12212; Uller T, 2008, TRENDS ECOL EVOL, V23, P432, DOI 10.1016/j.tree.2008.04.005; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131; Zuur Alain F., 2009, P1	69	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168869	10.1371/journal.pone.0168869	http://dx.doi.org/10.1371/journal.pone.0168869			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033396	gold, Green Published, Green Submitted			2022-12-26	WOS:000391226900052
J	Steidl, E; Pilatus, U; Hattingen, E; Steinbach, JP; Zanella, F; Ronellenfitsch, MW; Bahr, O				Steidl, Eike; Pilatus, Ulrich; Hattingen, Elke; Steinbach, Joachim P.; Zanella, Friedhelm; Ronellenfitsch, Michael W.; Baehr, Oliver			Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A H-1-Magnetic Resonance Spectroscopy Study	PLOS ONE			English	Article							H-1 MR SPECTROSCOPY; MAGNETIC-RESONANCE; ENERGY-METABOLISM; IN-VIVO; MOLECULAR-MECHANISMS; CHRONIC HYPONATREMIA; ORGANIC OSMOLYTES; IMAGING FINDINGS; GLYCINE; TUMORS	Background Antiangiogenic treatment of glioblastomas with Bevacizumab lacks predictive markers. Myoinositol (MI) is an organic osmolyte, with intracellular concentration changes depending on the extracellular osmolality. Since Bevacizumab markedly reduces tumor edema and influences the tumor microenvironment, we investigated whether the MI concentration in the tumor changes during therapy. Methods We used 1 H-magnetic resonance spectroscopy to measure the MI concentrations in the tumor and contralateral control tissue of 39 prospectively recruited patients with recurrent glioblastomas before and 8-12 weeks after starting therapy. 30 patients received Bevacizumab and 9 patients were treated with CCNU/VM26 as control. We performed a survival analysis to evaluate MI as a predictive biomarker for Bevacizumab therapy. Results MI concentrations increased significantly during Bevacizumab therapy in tumor (p < .001) and control tissue (p = .001), but not during CCNU/VM26 treatment. For the Bevacizumab cohort, higher MI concentrations in the control tissue at baseline (p = .021) and higher differences between control and tumor tissue (delta MI, p = .011) were associated with longer survival. A Kaplan-Meier analysis showed a median OS of 164 days for patients with a deltaMI < 1,817 mmol/l and 275 days for patients with a deltaMI > 1,817 mmol/l. No differences were observed for the relative changes or the post treatment concentrations. Additionally calculated creatine concentrations showed no differences in between subgroups or between pre and post treatment measurements. Conclusion Our data suggest that recurrent glioblastoma shows a strong metabolic reaction to Bevaci-zumab. Further, our results support the hypothesis that MI might be a marker for early tumor cell invasion. Pre-therapeutic MI concentrations are predictive of overall survival in patients with recurrent glioblastoma treated with Bevacizumab.	[Steidl, Eike; Steinbach, Joachim P.; Ronellenfitsch, Michael W.; Baehr, Oliver] Goethe Univ Frankfurt, Ctr Neurol & Neurosurg, Dr Senckenberg Inst Neurooncol, Frankfurt, Germany; [Steidl, Eike; Pilatus, Ulrich; Hattingen, Elke; Zanella, Friedhelm] Goethe Univ Frankfurt, Ctr Neurol & Neurosurg, Inst Neuroradiol, Frankfurt, Germany; [Steidl, Eike; Steinbach, Joachim P.; Ronellenfitsch, Michael W.; Baehr, Oliver] German Canc Consortium DKTK, Heidelberg, Germany; [Steidl, Eike; Steinbach, Joachim P.; Ronellenfitsch, Michael W.; Baehr, Oliver] German Canc Res Ctr, Heidelberg, Germany; [Hattingen, Elke] Univ Hosp Bonn, Dept Radiol, Neuroradiol, Bonn, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Bonn	Steidl, E (corresponding author), Goethe Univ Frankfurt, Ctr Neurol & Neurosurg, Dr Senckenberg Inst Neurooncol, Frankfurt, Germany.; Steidl, E (corresponding author), Goethe Univ Frankfurt, Ctr Neurol & Neurosurg, Inst Neuroradiol, Frankfurt, Germany.; Steidl, E (corresponding author), German Canc Consortium DKTK, Heidelberg, Germany.; Steidl, E (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	steidl@med.uni-frankfurt.de	Ronellenfitsch, Michael/AAW-8201-2020	Ronellenfitsch, Michael/0000-0002-1402-6290; Hattingen, Elke/0000-0002-8392-9004				Abel K, 2001, J CELL SCI, V114, P2207; Banerjee A, 2012, MAGN RESON MED, V68, P325, DOI 10.1002/mrm.24368; Bastin ME, 2006, AM J NEURORADIOL, V27, P402; Bittsansky M, 2012, GEN PHYSIOL BIOPHYS, V31, P101, DOI 10.4149/gpb_2012_007; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Bulik M, 2013, CLIN NEUROL NEUROSUR, V115, P146, DOI 10.1016/j.clineuro.2012.11.002; Busch M, 2011, MAGN RESON MED, V65, P18, DOI 10.1002/mrm.22612; Candiota AP, 2011, JBR-BTR, V94, P319, DOI 10.5334/jbr-btr.698; Castillo M, 2000, AM J NEURORADIOL, V21, P1645; Choi C, 2011, MAGN RESON MED, V66, P609, DOI 10.1002/mrm.22857; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Emblem KE, 2013, NAT MED, V19, P1178, DOI 10.1038/nm.3289; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Gil-Gil MJ, 2013, CLIN MED INSIGHTS-ON, V7, P123, DOI 10.4137/CMO.S8503; Gilbert MR, 2013, J CLIN ONCOL ASCO AN, V31, P1, DOI [10.1200/jco.2013.31., DOI 10.1200/JCO.2013.31]; Hattingen E, 2008, NMR BIOMED, V21, P233, DOI 10.1002/nbm.1186; Hattingen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056439; Hattingen E, 2011, NEURO-ONCOLOGY, V13, P1349, DOI 10.1093/neuonc/nor132; Hattingen E, 2009, MAGN RESON MATER PHY, V22, P33, DOI 10.1007/s10334-008-0145-z; Henriksson R, 2013, J CLIN ONCOL, V31; Iwamoto FM, 2009, NEUROLOGY, V73, P1200, DOI 10.1212/WNL.0b013e3181bc0184; Kallenberg K, 2009, RADIOLOGY, V253, P805, DOI 10.1148/radiol.2533071654; Kostaras X, 2014, CURR ONCOL, V21, pE493, DOI 10.3747/co.21.1769; Kreis R, 1997, PROG NUCL MAG RES SP, V31, P155, DOI 10.1016/S0079-6565(97)00014-9; Kreis R, 2016, MAGN RESON MED, V75, P15, DOI 10.1002/mrm.25568; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; LIEN YHH, 1991, J CLIN INVEST, V88, P303, DOI 10.1172/JCI115292; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mader I, 2008, EUR J RADIOL, V67, P250, DOI 10.1016/j.ejrad.2008.02.033; MATSUKADO Y, 1961, J NEUROSURG, V18, P636, DOI 10.3171/jns.1961.18.5.0636; Papadopoulos MC, 2004, NEUROSCIENCE, V129, P1011, DOI 10.1016/j.neuroscience.2004.05.044; Pope WB, 2005, AM J NEURORADIOL, V26, P2466; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Ratai EM, 2013, NEURO-ONCOLOGY, V15, P936, DOI 10.1093/neuonc/not044; Restuccia T, 2004, HEPATOLOGY, V39, P1613, DOI 10.1002/hep.20237; Righi V, 2010, INT J ONCOL, V36, P301, DOI 10.3892/ijo_00000500; Rovira A, 2008, AM J NEURORADIOL, V29, P1612, DOI 10.3174/ajnr.A1139; Srinivasan R, 2010, NEURO-ONCOLOGY, V12, P1152, DOI 10.1093/neuonc/noq075; Sterns RH, 2006, AM J MED, V119, pS12, DOI 10.1016/j.amjmed.2006.05.003; Varallyay CG, 2009, J CEREBR BLOOD F MET, V29, P853, DOI 10.1038/jcbfm.2008.162; VIDEEN JS, 1995, J CLIN INVEST, V95, P788, DOI 10.1172/JCI117728; Wick W, 2015, NEUROONCOLOGY; Zhang LJ, 2013, AM J NEURORADIOL, V34, P707, DOI 10.3174/ajnr.A2968; Zwingmann C, 2007, J NEUROSCI RES, V85, P3429, DOI 10.1002/jnr.21445	45	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168113	10.1371/journal.pone.0168113	http://dx.doi.org/10.1371/journal.pone.0168113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033329	Green Published, Green Submitted, gold			2022-12-26	WOS:000391226900015
J	Colleter, R; Dedouit, F; Duchesne, S; Mokrane, FZ; Gendrot, V; Gerard, P; Dabernat, H; Crubezy, E; Telmon, N				Colleter, Rozenn; Dedouit, Fabrice; Duchesne, Sylvie; Mokrane, Fatima-Zohra; Gendrot, Veronique; Gerard, Patrice; Dabernat, Henri; Crubezy, Eric; Telmon, Norbert			Procedures and Frequencies of Embalming and Heart Extractions in Modern Period in Brittany. Contribution to the Evolution of Ritual Funerary in Europe	PLOS ONE			English	Article							LONG BONES; RADIOGRAPHS; CHILDREN; STATURE	The evolution of funeral practices from the Middle Ages through the Modern era in Europe is generally seen as a process of secularization. The study, through imaging and autopsy, of two mummies, five lead urns containing hearts, and more than six hundred skeletons of nobles and clergymen from a Renaissance convent in Brittany has led us to reject this view. In addition to exceptional embalming, we observed instances in which hearts alone had been extracted, a phenomenon that had never before been described, and brains alone as well, and instances in which each spouse's heart had been placed on the other's coffin. In some identified cases we were able to establish links between the religious attitudes of given individuals and either ancient Medieval practices or more modern ones generated by the Council of Trent. All of these practices, which were a function of social status, were rooted in religion. They offer no evidence of secularization whatsoever.	[Colleter, Rozenn; Duchesne, Sylvie] Natl Inst Prevent Archaeol Res INRAP, Cesson Sevigne, France; [Colleter, Rozenn; Dedouit, Fabrice; Duchesne, Sylvie; Mokrane, Fatima-Zohra; Gerard, Patrice; Dabernat, Henri; Crubezy, Eric; Telmon, Norbert] Univ Toulouse, French Natl Ctr Sci Res, UMR 5288, Toulouse, France; [Dedouit, Fabrice] CURML, Unit Forens & Anthropol Imaging, Lausanne, Switzerland; [Mokrane, Fatima-Zohra] CHU Toulouse Rangueil, Dept Radiol, Toulouse, France; [Gendrot, Veronique] French Reg Archaeol Serv, Rennes, Bretagne, France; [Gendrot, Veronique] French Natl Ctr Sci Res, UMR 6566, Rennes, France; [Telmon, Norbert] CHU Toulouse Rangueil, Medicolegal Dept, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); CHU de Toulouse	Colleter, R (corresponding author), Natl Inst Prevent Archaeol Res INRAP, Cesson Sevigne, France.; Colleter, R; Crubezy, E (corresponding author), Univ Toulouse, French Natl Ctr Sci Res, UMR 5288, Toulouse, France.	rozenn.colleter@inrap.fr; crubezy.eric@free.fr	Duchesne, Sylvie/AAA-7467-2022; DEDOUIT, Fabrice/AAH-7634-2019; Crubézy, Eric/AAB-5165-2022	Duchesne, Sylvie/0000-0003-0138-8409; Crubézy, Eric/0000-0001-9417-9053; Mokrane, Fatima-Zohra/0000-0003-1610-1474; Colleter, Rozenn/0000-0003-2711-115X; Gerard, Patrice/0000-0002-6018-6092				Albert Jean-Pierre, 1990, ODEURS SAINTETE MYTH; Alexandre-Bidon D, 1993, REVEILLER MORTS MORT; Aries P, 1975, W ATTITUDES DEATH MI, V3; Aries Philippe, 2008, HOUR OUR DEATH; Bande A, 2009, CAPETIENS SEPULTURES; BEN-AMOS Avner, 2000, FUNERALS POLITICS ME; Birkner R., 1980, IMAGE RADIOLOGIQUE T; Blanchard P, 2014, REV ARCHEOLOGIQUE CE, P53; Brown E A, 1981, Viator, V12, P221; Bruzek J, 2002, AM J PHYS ANTHROPOL, V117, P157, DOI 10.1002/ajpa.10012; Charlier P, 2015, MED SCI LAW; Charlier Philippe, 2006, Med Secoli, V18, P777; Chroscicki Juliusz A., 2012, FUNERAILLES PRINCIER; Ciranni Rosalba, 2005, Med Secoli, V17, P251; Colleter R, 2011, ACT 3 C INT PATH RES, P449; Croix A, 1981, BRETAGNE 16 SIECLES; croix Alain., 1981, LA CROIX, V1, P299; Crubezy E, 1990, COLLECTION ONE WORLD, V18, P189; Depierre G, 1989, HOMMES MILIEU APPROC, P121; Devriendt W, 2012, ARCHEOLOGIE MEDIEV, V42, P23; Dietz A, 1998, KLEINE KULTURGESCHIC; Dionis P, 1765, COURS OPERATIONS CHI; Dittmar JM, 2015, J ARCHAEOL SCI-REP, V3, P73, DOI 10.1016/j.jasrep.2015.05.019; DUDAY H, 1990, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V2, P29, DOI 10.3406/bmsap.1990.1740; Fornaciari A, 2008, MUMMIES SCI WORLD MU, P521; Fornaciari Gino, 2007, Med Secoli, V19, P521; Gannal J.-N., 1841, HIST EMBAUMEMENTS PR; Gaude-Ferragu M, 2005, CENDRES MORT FUNERAI; Georges P, 2009, ACTES DU 2E COLLOQUE, P233; Giesey RE, 1960, ROYAL FUNERAL CEREMO; Girault P-G, 2014, FUNERAILLES ANNE BRE; Giuffra V, 2011, J ARCHAEOL SCI, V38, P1949, DOI 10.1016/j.jas.2011.04.009; Gryglewski Ryszard W, 2002, Arch Hist Filoz Med, V65, P47; Hadjouis D, 2011, ACT 3 C INT PATH, P31; Isbled B, 1992, MOI CLAUDE BORDEAUX; Kuzminsky SC, 2012, J ARCHAEOL SCI, V39, P2744, DOI 10.1016/j.jas.2012.04.020; Maat G J, 1997, Ned Tijdschr Geneeskd, V141, P2501; Mafart B, 2004, INT J OSTEOARCHAEOL, V14, P67, DOI 10.1002/oa.692; Martin H, 1975, PAUVRETE VOLONTAIRE; Metcalf P., 1995, CELEBRATIONS DEATH A; Mokrane FZ, 2016, FORENSIC SCI INT, V268, P14, DOI 10.1016/j.forsciint.2016.08.035; Molleson T., 1993, SPITALFIELDS PROJECT; MOORREES CF, 1963, AM J PHYS ANTHROPOL, V21, P205, DOI 10.1002/ajpa.1330210212; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; MURAIL P, 2005, B MEM SOC ANTHRO PAR, V17, P167, DOI DOI 10.4000/BMSAP.1157; PALKAMA A, 1962, ANN MED EXP BIOL FEN, V40, P219; Pare Ambroise, 1652, OEVRES AMBROISE PARE, V11th; Regnier C, 2009, MEDICOGRAPHIA, V31, P429; Schmitt Aurore, 2005, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V17, P89; Sorensen MLS., 2010, BODY PARTS BODIES WH; Stone Lawrence Stone, 1967, CRISIS ARISTOCRACY 1; TELKKA A, 1962, ANN MED EXP BIOL FEN, V40, P91; Toller H, 1977, BRIT ARCHAEOLOGICAL; VALENTIN F, 1995, AM J PHYS ANTHROPOL, V98, P375, DOI 10.1002/ajpa.1330980310; VIRTAMA P, 1962, ANN MED EXP BIOL FEN, V40, P283; Vovelle M, 2000, MORT OCCIDENT 1300 N; Westerhof Danielle, 2008, DEATH NOBLE BODY MED	57	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167988	10.1371/journal.pone.0167988	http://dx.doi.org/10.1371/journal.pone.0167988			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030554	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000028
J	Setamou, M; Simpson, CR; Alabi, OJ; Nelson, SD; Telagamsetty, S; Jifon, JL				Setamou, Mamoudou; Simpson, Catherine R.; Alabi, Olufemi J.; Nelson, Shad D.; Telagamsetty, Srilakshmi; Jifon, John L.			Quality Matters: Influences of Citrus Flush Physicochemical Characteristics on Population Dynamics of the Asian Citrus Psyllid (Hemiptera: Liviidae)	PLOS ONE			English	Article							DIAPHORINA-CITRI; AMINO-ACIDS; PHLOEM-SAP; NUTRITIONAL QUALITY; GREENING DISEASE; PLANT-GROWTH; BIOLOGY; PERFORMANCE; TRANSITION; HOMOPTERA	Studies were conducted to relate the influence of the physical characteristics, leaf nutrient content and phloem sap amino acid concentration of citrus flush shoots on the densities of various Diaphorina citri life stages. Adult D. citri preferentially selected young shoots for feeding and numbers of D. citri immatures were positively correlated with flush shoot softness. Young flush shoots had higher concentrations of macro and micro nutrients relative to mature ones and this was associated with higher densities of all D. citri life stages. All D. citri life stages were positively correlated with higher nitrogen-carbon (N:C), nitrogen: sulfur (N: S) and nitrogen: calcium (N:Ca) ratios in leaf tissue, while densities of adults were negatively related to calcium, manganese and boron levels. Concentrations of total and essential amino acids were highest in phloem sap of young expanding flush shoots in both grapefruit and lemon, but dramatically declined as flush shoots matured. The sulfur-containing amino acids cystine, methionine and taurine occurred only in younger flush shoots. In contrast, cystathionine was only present in phloem sap of mature shoots. These results clearly indicate that young citrus flush shoots are a nutritionally richer diet relative to mature shoots, thus explaining their preference by D. citri for feeding and reproduction. Conversely, tissue hardness and the lower nutritional quality of mature flush shoots may limit oviposition and immature development. The data suggest that both physical characteristics and nutritional composition of flush shoots and their phloem sap are important factors regulating host colonization and behavior of D. citri, and this interaction can impact the dynamics and spread of HLB in citrus groves.	[Setamou, Mamoudou; Simpson, Catherine R.; Nelson, Shad D.; Telagamsetty, Srilakshmi] Texas A&M Univ, Kingsville Citrus Ctr, Dept Agr Agribusiness & Environm Sci, Weslaco, TX 78596 USA; [Alabi, Olufemi J.] Texas A&M AgriLife Res & Extens Ctr, Dept Plant Pathol & Microbiol, Weslaco, TX USA; [Jifon, John L.] Texas A&M AgriLife Res & Extens Ctr, Dept Hort, Weslaco, TX USA	Texas A&M University System; Texas A&M University Kingsville; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Setamou, M (corresponding author), Texas A&M Univ, Kingsville Citrus Ctr, Dept Agr Agribusiness & Environm Sci, Weslaco, TX 78596 USA.	mamoudou.setamou@tamuk.edu	Alabi, Olufemi J./ABD-9930-2020	Alabi, Olufemi J./0000-0002-2471-7052; Setamou, Mamoudou/0000-0002-4777-4826; Jifon, John/0000-0003-0618-6056; Simpson, Catherine/0000-0002-8164-4275	United States Department of Agriculture (USDA-NIFA) Hispanic Serving Institution Award [2011-38422-30803]; multi-institutional collaborative grant 'BGREEN' project; Texas Citrus Producers Board	United States Department of Agriculture (USDA-NIFA) Hispanic Serving Institution Award; multi-institutional collaborative grant 'BGREEN' project; Texas Citrus Producers Board	This research was supported by a student research funding from the United States Department of Agriculture (USDA-NIFA) Hispanic Serving Institution Award #2011-38422-30803, a multi-institutional collaborative grant 'BGREEN' project. This research was also supported by the Texas Citrus Producers Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabi LJ, 2014, PLANT HLTH PROG, P184, DOI DOI 10.1094/PHP-RS-14-0028; Ammar ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064938; [Anonymous], 2015, J CITRUS PATHOL; Arredondo IMJ, 2009, ABUNDANCE POPULATION; Baldwin IT, 2001, CURR OPIN PLANT BIOL, V4, P351, DOI 10.1016/S1369-5266(00)00184-9; Bi JL, 2007, J CHEM ECOL, V33, P1692, DOI 10.1007/s10886-007-9346-6; BI JL, 1995, J CHEM ECOL, V21, P1511, DOI 10.1007/BF02035149; Blackmer JL, 1999, ENTOMOL EXP APPL, V93, P29, DOI 10.1023/A:1003886107024; Bove JM, 2006, J PLANT PATHOL, V88, P7; Conway JM, 2003, ORGAN RES METHODS, V6, P147, DOI 10.1177/1094428103251541; Corbesier L, 2001, PLANT CELL ENVIRON, V24, P367, DOI 10.1046/j.1365-3040.2001.00683.x; DAGRACA JV, 1991, ANNU REV PHYTOPATHOL, V29, P109, DOI 10.1146/annurev.py.29.090191.000545; DEYL Z, 1986, J CHROMATOGR, V379, P177, DOI 10.1016/S0378-4347(00)80685-4; DOUGLAS AE, 1993, ECOL ENTOMOL, V18, P31, DOI 10.1111/j.1365-2311.1993.tb01076.x; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Fekkes D, 1996, J CHROMATOGR B, V682, P3, DOI 10.1016/0378-4347(96)00057-6; Gottwald T. R., 2007, Plant Health Progress, P1, DOI 10.1094/PHP-2007-0405-01-RS; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Hodges A, 2012, EC IMPACTS CITRUS GR; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Karley AJ, 2002, J EXP BIOL, V205, P3009; KING RW, 1974, PLANT PHYSIOL, V53, P96, DOI 10.1104/pp.53.1.96; LeBoucher J, 1997, CLIN CHEM, V43, P1421; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Liu YH, 2000, ANN APPL BIOL, V137, P201, DOI 10.1111/j.1744-7348.2000.tb00060.x; Marchi S, 2005, J AM SOC HORTIC SCI, V130, P928, DOI 10.21273/JASHS.130.6.928; Marschner H., 2012, MARSCHNERS MINERAL N, V89; Marschner H, 2012, MARSCHNERS MINERAL N, V95; Martini X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129373; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; SAS Institute, 2008, SAS PROC GUID VERS 9; Setamou M, 2008, J ECON ENTOMOL, V101, P1478, DOI 10.1603/0022-0493(2008)101[1478:DPASPF]2.0.CO;2; Setamou M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131917; Setamou M, 2012, J INSECT BEHAV, V25, P264, DOI 10.1007/s10905-011-9295-3; Spann T.M., 2010, CITRUS IND, P1, DOI [10.1016/j.porgcoat.2009.09.005, DOI 10.1016/J.PORGCOAT.2009.09.005]; Spiegel-Roy P, 1996, BIOL CITRUS; Stansly P, 2013, CITRUS IND, P1; Tetyuk O, 2013, JOVE-J VIS EXP, DOI 10.3791/51111; Tsagkarakis AE, 2012, J AM SOC HORTIC SCI, V137, P3, DOI 10.21273/JASHS.137.1.3; Underwood W, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00085; Yasuda K, 2005, JPN J APPL ENTOMOL Z, V49, P146, DOI 10.1303/jjaez.2005.146; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	45	45	45	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168997	10.1371/journal.pone.0168997	http://dx.doi.org/10.1371/journal.pone.0168997			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030637	Green Submitted, gold, Green Published			2022-12-26	WOS:000391222000098
J	Yamaji, K; Watanabe, Y; Masuya, H; Shigeto, A; Yui, H; Haruma, T				Yamaji, Keiko; Watanabe, Yumiko; Masuya, Hayato; Shigeto, Arisa; Yui, Hiroshi; Haruma, Toshikatsu			Root Fungal Endophytes Enhance Heavy-Metal Stress Tolerance of Clethra barbinervis Growing Naturally at Mining Sites via Growth Enhancement, Promotion of Nutrient Uptake and Decrease of Heavy-Metal Concentration	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; RHIZOSCYPHUS-ERICAE; COLONIZATION; PHYTOSTABILIZATION; HYPERACCUMULATION; ACCUMULATION; RHIZOSPHERE; PROTECTION; DIVERSITY; SYMBIOSIS	Clethra barbinervis Sieb. et Zucc. is a tree species that grows naturally at several mine sites and seems to be tolerant of high concentrations of heavy metals, such as Cu, Zn, and Pb. The purpose of this study is to clarify the mechanism(s) underlying this species' ability to tolerate the sites' severe heavy-metal pollution by considering C. barbinervis interaction with root fungal endophytes. We measured the heavy metal concentrations of root-zone soil, leaves, branches, and fine roots collected from mature C. barbinervis at Hitachi mine. We isolated fungal endophytes from surface-sterilized root segments, and we examined the growth, and heavy metal and nutrient absorption of C. barbinervis seedlings growing in sterilized mine soil with or without root fungal endophytes. Field analyses showed that C. barbinervis contained considerably high amounts of Cu, Zn, and Pb in fine roots and Zn in leaves. The fungi, Phialocephala fortinii, Rhizodermea veluwensis, and Rhizoscyphus sp. were frequently isolated as dominant fungal endophyte species. Inoculation of these root fungal endophytes to C. barbinervis seedlings growing in sterilized mine soil indicated that these fungi significantly enhanced the growth of C. barbinervis seedlings, increased K uptake in shoots and reduced the concentrations of Cu, Ni, Zn, Cd, and Pb in roots. Without root fungal endophytes, C. barbinervis could hardly grow under the heavy-metal contaminated condition, showing chlorosis, a symptom of heavy-metal toxicity. Our results indicate that the tree C. barbinervis can tolerate high heavy-metal concentrations due to the support of root fungal endophytes including P. fortinii, R. veluwensis, and Rhizoscyphus sp. via growth enhancement, K uptake promotion and decrease of heavy metal concentrations.	[Yamaji, Keiko; Watanabe, Yumiko; Shigeto, Arisa; Yui, Hiroshi; Haruma, Toshikatsu] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Masuya, Hayato] Forestry & Forest Prod Res Inst, Tohoku Res Ctr, Morioka, Iwate, Japan	University of Tsukuba; Forestry & Forest Products Research Institute - Japan	Yamaji, K (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	yamaji.keiko.fp@u.tsukuba.ac.jp	Masuya, Hayato/AAN-8998-2021		Nippon Life Science Insurance Foundation; JSPS KAKENHI [25292080]	Nippon Life Science Insurance Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Nippon Life Science Insurance Foundation (no grant number, URL: http://www.nihonseimei-zaidan.or.jp/kankyo/02_gaiyo.html). This work was also supported by the JSPS KAKENHI (grant number: 25292080, URL: https://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DB, 1991, BIOL FERT SOILS, V12, P39, DOI 10.1007/BF00369386; [Anonymous], MICROBIAL SIDEROPHOR; [Anonymous], JAPANESE SOC SOIL SC; [Anonymous], RES REP NATL I ENV S; [Anonymous], REC LARG CHIMN HIT M; [Anonymous], 2014, ENV SUSTAINABILITY, DOI [10.1007/978-81-322-2056-5_16, DOI 10.1007/978-81-322-2056-5_16]; [Anonymous], 1974, JPN J HUMANIT NAT SC; [Anonymous], T MYCOLOGICAL SOC JA; [Anonymous], UN SOIL CLASS SYST J; [Anonymous], J GEOLOGICAL SOC JAP, DOI DOI 10.5575/geosoc.109.533; [Anonymous], TRACE ELEMENTS SOILS; [Anonymous], 1997, METH SOIL ENV AN; [Anonymous], 2006, SOIL MICROORG; [Anonymous], 2006, MICROBIAL ROOT ENDOP; Barrow JR, 2003, MYCORRHIZA, V13, P239, DOI 10.1007/s00572-003-0222-0; Bultreys Alain, 2007, V12, P67; Burd GI, 1998, APPL ENVIRON MICROB, V64, P3663; Burd GI, 2000, CAN J MICROBIOL, V46, P237, DOI 10.1139/cjm-46-3-237; Deram A, 2008, SOIL BIOL BIOCHEM, V40, P845, DOI 10.1016/j.soilbio.2007.09.023; Ernst Wilfried H. O., 2006, Forest Snow and Landscape Research, V80, P251; Ernst WHO, 2008, PLANT CELL ENVIRON, V31, P123, DOI 10.1111/j.1365-3040.2007.01746.x; Fogarty RV, 1996, ENZYME MICROB TECH, V19, P311, DOI 10.1016/0141-0229(96)00002-6; Frerot H, 2006, PLANT SOIL, V282, P53, DOI 10.1007/s11104-005-5315-4; GADD GM, 1993, NEW PHYTOL, V124, P25, DOI 10.1111/j.1469-8137.1993.tb03796.x; GADD GM, 1988, APPL MICROBIOL BIOT, V29, P610, DOI 10.1007/BF00260993; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Glick BR, 2003, BIOTECHNOL ADV, V21, P383, DOI 10.1016/S0734-9750(03)00055-7; Gonzalez-Chavez MC, 2004, ENVIRON POLLUT, V130, P317, DOI 10.1016/j.envpol.2004.01.004; Gonzalez-Guerrero M, 2008, CAN J MICROBIOL, V54, P103, DOI [10.1139/W07-119, 10.1139/w07-119]; Grelet GA, 2010, NEW PHYTOL, V188, P210, DOI 10.1111/j.1469-8137.2010.03353.x; Hildebrandt U, 2007, PHYTOCHEMISTRY, V68, P139, DOI 10.1016/j.phytochem.2006.09.023; Jeffries P, 2003, BIOL FERT SOILS, V37, P1, DOI 10.1007/s00374-002-0546-5; Joner EJ, 1997, NEW PHYTOL, V135, P353, DOI 10.1046/j.1469-8137.1997.00633.x; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Kramer U, 2010, ANNU REV PLANT BIOL, V61, P517, DOI 10.1146/annurev-arplant-042809-112156; Kubota M, 2001, CAN J BOT, V79, P300, DOI 10.1139/cjb-79-3-300; Kubota Mayumi, 2004, Mycoscience, V45, P206, DOI 10.1007/s10267-003-0176-2; Larcher W, 2003, PHYSL PLANT ECOLOGY; Li T, 2011, SCI TOTAL ENVIRON, V409, P1069, DOI 10.1016/j.scitotenv.2010.12.012; Likar M, 2011, FOR SCI, V80, P189, DOI 10.1007/978-94-007-1599-8_12; Mandyam K, 2005, STUD MYCOL, P173; Marquez LM, 2007, SCIENCE, V315, P513, DOI 10.1126/science.1136237; Masuya H, 2012, ENVIRON ENTOMOL, V41, P255, DOI 10.1603/EN11090; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Mendez MO, 2008, ENVIRON HEALTH PERSP, V116, P278, DOI 10.1289/ehp.10608; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Nagata S, 2015, PLANT SPEC BIOL, V30, P116, DOI 10.1111/1442-1984.12039; Newsham KK, 1999, NEW PHYTOL, V144, P517, DOI 10.1046/j.1469-8137.1999.00537.x; ODELL TE, 1993, NEW PHYTOL, V124, P93, DOI 10.1111/j.1469-8137.1993.tb03800.x; Postma JWM, 2007, SOIL BIOL BIOCHEM, V39, P400, DOI 10.1016/j.soilbio.2006.08.007; Redman RS, 1999, PLANT PHYSIOL, V119, P795, DOI 10.1104/pp.119.2.795; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Redman RS, 2001, NEW PHYTOL, V151, P705, DOI 10.1046/j.0028-646x.2001.00210.x; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; ROWAN DD, 1986, J CHEM ECOL, V12, P647, DOI 10.1007/BF01012099; Schulz Barbara J. E., 2006, V9, P1; SENESI N, 1987, SCI TOTAL ENVIRON, V62, P241, DOI 10.1016/0048-9697(87)90506-7; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Tanaka A, 2005, MOL MICROBIOL, V57, P1036, DOI 10.1111/j.1365-2958.2005.04747.x; Tonin C, 2001, MYCORRHIZA, V10, P161, DOI 10.1007/s005720000072; Upson R, 2007, NEW PHYTOL, V176, P460, DOI 10.1111/j.1469-8137.2007.02178.x; Verkley GJM, 2010, PERSOONIA, V24, P130; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Wang JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22028; Whiting SN, 2001, ENVIRON SCI TECHNOL, V35, P3144, DOI 10.1021/es001938v; Zhang YJ, 2008, J MICROBIOL, V46, P624, DOI 10.1007/s12275-008-0163-6	66	64	67	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0169089	10.1371/journal.pone.0169089	http://dx.doi.org/10.1371/journal.pone.0169089			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030648	gold, Green Published, Green Submitted			2022-12-26	WOS:000391222000104
J	Bedard, M; Roy, V; Montagne, M; Lavigne, P				Bedard, Mikael; Roy, Vincent; Montagne, Martin; Lavigne, Pierre			Structural Insights into c-Myc-interacting Zinc Finger Protein-1 (Miz-1) Delineate Domains Required for DNA Scanning and Sequence-specific Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence anisotropy; nuclear magnetic resonance (NMR); protein dynamic; protein-DNA interaction; protein-protein interaction; structural biology; transcription factor; zinc finger	TRANSCRIPTION FACTOR IIIA; HUWE1 UBIQUITIN LIGASE; N-15 NMR RELAXATION; BACKBONE DYNAMICS; ROTATIONAL DIFFUSION; LINKER SEQUENCES; RECOGNITION; AFFINITY; MACROMOLECULES; SPECTROSCOPY	c-Myc-interacting zinc finger protein-1 (Miz-1) is a poly-Cys2His2 zinc finger (ZF) transcriptional regulator of many cell cycle genes. A Miz-1 DNA sequence consensus has recently been identified and has also unveiled Miz-1 functions in other cellular processes, underscoring its importance in the cell. Miz-1 contains 13 ZFs, but it is unknown why Miz-1 has so many ZFs and whether they recognize and bind DNA sequences in a typical fashion. Here, we used NMR to deduce the role of Miz-1 ZFs 1-4 in detecting the Miz-1 consensus sequence and preventing nonspecific DNA binding. In the construct containing the first 4 ZFs, we observed that ZFs 3 and 4 form an unusual compact and stable structure that restricts their motions. Disruption of this compact structure by an electrostatically mismatched A86K mutation profoundly affected the DNA binding properties of the WT construct. On the one hand, Miz1-4(WT) was found to bind the Miz-1 DNA consensus sequence weakly and through ZFs 1-3 only. On the other hand, the four ZFs in the structurally destabilized Miz1-4(A86K) mutant bound to the DNA consensus with a 30-fold increase in affinity (100 nm). The formation of such a thermodynamically stable but nonspecific complex is expected to slow down the rate of DNA scanning by Miz-1 during the search for its consensus sequence. Interestingly, we found that the motif stabilizing the compact structure between ZFs 3 and 4 is conserved and enriched in other long poly-ZF proteins. As discussed in detail, our findings support a general role of compact inter-ZF structures in minimizing the formation of off-target DNA complexes.	Univ Sherbrooke, Inst Pharmacol Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1H 5N4, Canada; McGill Univ, Grp Rech Axe Struct Prot GRASP, Montreal, PQ H3G 0B1, Canada	University of Sherbrooke; McGill University	Lavigne, P (corresponding author), Univ Laval, Regrp Strategique Fonct Struct & Ingn Prot PROTEO, Quebec City, PQ G1V 0A6, Canada.; Lavigne, P (corresponding author), Univ Sherbrooke, Inst Pharmacol Sherbrooke, 3001 12e Ave Nord,Campus Sante, Sherbrooke, PQ J1H 5N4, Canada.	pierre.lavigne@usherbrooke.ca			Natural Science and Engineering Research Council (NSERC) of Canada; Regroupement Strategique sur la Fonction, la Structure, et l'Ingenierie des Proteines (PROTEO); Groupe de Recherche Axe sur la Structure des Proteines (GRASP)	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Regroupement Strategique sur la Fonction, la Structure, et l'Ingenierie des Proteines (PROTEO); Groupe de Recherche Axe sur la Structure des Proteines (GRASP)	This work was supported by the Natural Science and Engineering Research Council (NSERC) of Canada (grant to P. L. and studentships to M. B.) and by the Regroupement Strategique sur la Fonction, la Structure, et l'Ingenierie des Proteines (PROTEO). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a graduate studentship from the Groupe de Recherche Axe sur la Structure des Proteines (GRASP).	Adhikary S, 2003, MOL CELL BIOL, V23, P7648, DOI 10.1128/MCB.23.21.7648-7657.2003; Baber JL, 2001, J AM CHEM SOC, V123, P3953, DOI 10.1021/ja0041876; BabuRajendran N, 2010, NUCLEIC ACIDS RES, V38, P3477, DOI 10.1093/nar/gkq046; Barrilleaux BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101151; Bedard M, 2012, J BIOMOL NMR, V54, P317, DOI 10.1007/s10858-012-9670-1; Bernard D, 2013, J BIOMOL NMR, V57, P103, DOI 10.1007/s10858-013-9770-6; Bieri M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-421; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V51, P9, DOI 10.1007/s12013-008-9007-6; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Breslin MB, 2002, NUCLEIC ACIDS RES, V30, P1038, DOI 10.1093/nar/30.4.1038; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUSCHWEILER R, 1995, SCIENCE, V268, P886, DOI 10.1126/science.7754375; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Chen P, 2016, DIGEST DIS SCI, V61, P758, DOI 10.1007/s10620-015-3951-y; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; CHOO Y, 1993, NUCLEIC ACIDS RES, V21, P3341, DOI 10.1093/nar/21.15.3341; CLEMENS KR, 1994, J MOL BIOL, V244, P23, DOI 10.1006/jmbi.1994.1701; Do-Umehara HC, 2013, NAT IMMUNOL, V14, P461, DOI 10.1038/ni.2566; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Friedman JI, 2009, NUCLEIC ACIDS RES, V37, P3493, DOI 10.1093/nar/gkp161; Gagne SM, 1998, J MOL BIOL, V278, P667, DOI 10.1006/jmbi.1998.1723; Greisman HA, 1997, SCIENCE, V275, P657, DOI 10.1126/science.275.5300.657; Huang YS, 2015, BIOCHEM J, V466, P499, DOI 10.1042/BJ20141143; Kaplan T, 2005, PLOS COMPUT BIOL, V1, P5, DOI 10.1371/journal.pcbi.0010001; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Laity JH, 2000, J MOL BIOL, V295, P719, DOI 10.1006/jmbi.1999.3406; Lee BM, 2006, J MOL BIOL, V357, P275, DOI 10.1016/j.jmb.2005.12.010; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; Lu D, 2003, NATURE, V426, P96, DOI 10.1038/nature02088; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Mulder FAA, 2001, J AM CHEM SOC, V123, P967, DOI 10.1021/ja003447g; Nolte RT, 1998, P NATL ACAD SCI USA, V95, P2938, DOI 10.1073/pnas.95.6.2938; OMICHINSKI JG, 1992, BIOCHEMISTRY-US, V31, P3907, DOI 10.1021/bi00131a004; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Persikov AV, 2014, NUCLEIC ACIDS RES, V42, P97, DOI 10.1093/nar/gkt890; Peter S, 2014, EMBO MOL MED, V6, P1525, DOI 10.15252/emmm.201403927; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Potter BM, 2005, J BIOL CHEM, V280, P28529, DOI 10.1074/jbc.M505217200; Rashkovan M, 2014, P NATL ACAD SCI USA, V111, pE5411, DOI 10.1073/pnas.1412107111; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Ryan RF, 1998, NUCLEIC ACIDS RES, V26, P703, DOI 10.1093/nar/26.3.703; Schaub FX, 2014, EMBO MOL MED, V6, P1509, DOI 10.15252/emmm.201404735; Schmidt D, 2004, MOL BIOL EVOL, V21, P2326, DOI 10.1093/molbev/msh246; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; THUKRAL SK, 1991, P NATL ACAD SCI USA, V88, P9188, DOI 10.1073/pnas.88.20.9188; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Tochio Naoya, 2015, Journal of Structural and Functional Genomics, V16, P55, DOI 10.1007/s10969-015-9196-3; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wanzel M, 2008, NAT CELL BIOL, V10, P1051, DOI 10.1038/ncb1764; Wiese KE, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014290; Wolf E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3535; Wolfe SA, 1999, J MOL BIOL, V285, P1917, DOI 10.1006/jmbi.1998.2421; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Zandarashvili L, 2015, P NATL ACAD SCI USA, V112, pE5142, DOI 10.1073/pnas.1507726112; Zandarashvili L, 2012, P NATL ACAD SCI USA, V109, pE1724, DOI 10.1073/pnas.1121500109	63	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3323	3340		10.1074/jbc.M116.748699	http://dx.doi.org/10.1074/jbc.M116.748699			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28035002	hybrid, Green Published			2022-12-26	WOS:000395538800023
J	Afolayan, AJ; Alexander, M; Holme, RL; Michalkiewicz, T; Rana, U; Teng, RJ; Zemanovic, S; Sahoo, D; Pritchard, KA; Konduri, GG				Afolayan, Adeleye J.; Alexander, Maxwell; Holme, Rebecca L.; Michalkiewicz, Teresa; Rana, Ujala; Teng, Ru-Jeng; Zemanovic, Sara; Sahoo, Daisy; Pritchard, Kirkwood A., Jr.; Konduri, Girija G.			Domain Mapping of Heat Shock Protein 70 Reveals That Glutamic Acid 446 and Arginine 447 Are Critical for Regulating Superoxide Dismutase 2 Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OXIDATIVE STRESS; BINDING DOMAIN; PROTEIN; HYPERTENSION; EXPRESSION; ASSOCIATION; DEFICIENCY; INHIBITOR; RESIDUES; CROSS	Stress-inducible heat shock protein 70 (hsp70) interacts with superoxide dismutase 2 (SOD2) in the cytosol after synthesis to transfer the enzyme to the mitochondria for subsequent activation. However, the structural basis for this interaction remains to be defined. To map the SOD2-binding site in hsp70, mutants of hsp70 were made and tested for their ability to bind SOD2. These studies showed that SOD2 binds in the amino acid 393-537 region of the chaperone. To map the hsp70-binding site in SOD2, we used a series of pulldown assays and showed that hsp70 binds to the amino-terminal domain of SOD2. To better define the binding site, we used a series of decoy peptides derived from the primary amino acid sequence in the SOD2-binding site in hsp70. This study shows that SOD2 specifically binds to hsp70 at (445)GERAMT(450). Small peptides containing GERAMT inhibited the transfer of SOD2 to the mitochondria and decreased SOD2 activity in vitro and in vivo. To determine the amino acid residues in hsp70 that are critical for SOD2i nteractions, we substituted each amino acid residue for alanine or more conservative residues, glutamine or asparagine, in the GERAMT-binding site. Substitutions of E446A/Q and R447A/Q inhibited the ability of the GERAMT peptide to bind SOD2 and preserved SOD2 function more than other substitutions. Together, these findings indicate that the GERAMT sequence is critical for hsp70-mediated regulation of SOD2 and that Glu(446) and Arg(447) cooperate with other amino acid residues in the GERAMT-binding site for proper chaperone-dependent regulation of SOD2 antioxidant function.	[Afolayan, Adeleye J.; Alexander, Maxwell; Michalkiewicz, Teresa; Rana, Ujala; Teng, Ru-Jeng; Zemanovic, Sara; Konduri, Girija G.] Med Coll Wisconsin, Dept Pediat, Cardiovasc Res Ctr, Milwaukee, WI 53226 USA; [Afolayan, Adeleye J.; Alexander, Maxwell; Holme, Rebecca L.; Michalkiewicz, Teresa; Rana, Ujala; Teng, Ru-Jeng; Zemanovic, Sara; Sahoo, Daisy; Pritchard, Kirkwood A., Jr.; Konduri, Girija G.] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA; [Pritchard, Kirkwood A., Jr.] Med Coll Wisconsin, Dept Surg, Div Pediat Surg, Milwaukee, WI 53226 USA; [Holme, Rebecca L.; Sahoo, Daisy] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Afolayan, AJ (corresponding author), 999 N 92nd St,CCC Suite 410, Milwaukee, WI 53226 USA.	aafolaya@mcw.edu			Children's Hospital Research Institute [DOP 33017]; Department of Pediatrics of the Medical College of Wisconsin [CRI FP9523]; National Institutes of Health [KO8HL133379, RO1 HL057268]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL133379, R01HL057268, R01HL128371, R01HL112270] Funding Source: NIH RePORTER	Children's Hospital Research Institute; Department of Pediatrics of the Medical College of Wisconsin; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by The Children's Hospital Research Institute Grant DOP 33017 and Department of Pediatrics of the Medical College of Wisconsin Grant CRI FP9523 (to A. J.A. and G.G.K.), and National Institutes of Health Grants KO8HL133379 (to A.J.A.) and RO1 HL057268 (to G.G.K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adesina SE, 2015, FREE RADICAL BIO MED, V87, P36, DOI 10.1016/j.freeradbiomed.2015.05.042; Afolayan AJ, 2014, AM J PHYSIOL-LUNG C, V306, pL351, DOI 10.1152/ajplung.00264.2013; Afolayan AJ, 2012, AM J PHYSIOL-LUNG C, V303, pL870, DOI 10.1152/ajplung.00098.2012; Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098; Bag A, 2008, CANCER EPIDEM BIOMAR, V17, P3298, DOI 10.1158/1055-9965.EPI-08-0235; Balaburski GM, 2013, MOL CANCER RES, V11, P219, DOI 10.1158/1541-7786.MCR-12-0547-T; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bauer D, 2015, P NATL ACAD SCI USA, V112, P10389, DOI 10.1073/pnas.1504625112; Choi S, 2005, J BIOCHEM MOL BIOL, V38, P111; CRAIG EA, 1993, SCIENCE, V260, P1902, DOI 10.1126/science.8100364; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; Duncan Emma J, 2015, Subcell Biochem, V78, P243, DOI 10.1007/978-3-319-11731-7_12; Farrow KN, 2010, RESP PHYSIOL NEUROBI, V174, P272, DOI 10.1016/j.resp.2010.08.018; Farrow KN, 2010, AM J PHYSIOL-LUNG C, V299, pL109, DOI 10.1152/ajplung.00309.2009; Farrow KN, 2008, AM J PHYSIOL-LUNG C, V295, pL979, DOI 10.1152/ajplung.90238.2008; Finka A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00029; Karnati S, 2013, HISTOCHEM CELL BIOL, V140, P105, DOI 10.1007/s00418-013-1099-4; Konduri GG, 2007, AM J PHYSIOL-HEART C, V292, pH1812, DOI 10.1152/ajpheart.00425.2006; Konzack A, 2014, BIOCHEM SOC T, V42, P1012, DOI 10.1042/BST20140076; Koyama H, 2013, MOLECULES, V18, P1383, DOI 10.3390/molecules18021383; Kudla J, 2016, PLANT CELL, V28, P1002, DOI 10.1105/tpc.16.00043; Kuo HT, 2015, AMINO ACIDS, V47, P885, DOI 10.1007/s00726-015-1916-2; Lepur A, 2016, J BIOMOL SCREEN, V21, P1100, DOI 10.1177/1087057116659438; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Leung HS, 2006, VASC PHARMACOL, V44, P299, DOI 10.1016/j.vph.2006.01.010; Lindahl PA, 2016, BIOCHEMISTRY-US, V55, P4140, DOI 10.1021/acs.biochem.6b00216; Mayer MP, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00058; Maynard SJ, 2014, J AM CHEM SOC, V136, P16683, DOI 10.1021/ja510265e; NEUPERT W, 1990, CELL, V63, P447, DOI 10.1016/0092-8674(90)90437-J; Rodriguez-Iturbe B, 2007, J APPL PHYSIOL, V102, P255, DOI 10.1152/japplphysiol.00513.2006; Sartoretto JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044627; Schlecht R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078443; Sekhar A, 2016, P NATL ACAD SCI USA, V113, pE2794, DOI 10.1073/pnas.1601846113; Sekhar A, 2015, P NATL ACAD SCI USA, V112, P10395, DOI 10.1073/pnas.1508504112; Sharma H., 2016, RNA BIOL, V7, P1; SHEFFIELD WP, 1990, J BIOL CHEM, V265, P11069; Sun L, 2014, CELL PHYSIOL BIOCHEM, V34, P1614, DOI 10.1159/000366364; Xu H, 2007, J BIOL CHEM, V282, P37567, DOI 10.1074/jbc.M706464200; Xu Y, 2015, ONCOGENE, V34, P4229, DOI 10.1038/onc.2014.355; Xu Y, 2008, MOL CANCER RES, V6, P1881, DOI 10.1158/1541-7786.MCR-08-0253; Zhang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103518; Zhou RH, 2012, ARTERIOSCL THROM VAS, V32, P745, DOI 10.1161/ATVBAHA.111.243121	42	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2369	2378		10.1074/jbc.M116.756122	http://dx.doi.org/10.1074/jbc.M116.756122			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28028182	Green Published, hybrid			2022-12-26	WOS:000395530300027
J	Moreau, C; Terrasse, R; Thielens, NM; Vernet, T; Gaboriaud, C; Di Guilmi, AM				Moreau, Christophe; Terrasse, Remi; Thielens, Nicole M.; Vernet, Thierry; Gaboriaud, Christine; Di Guilmi, Anne Marie			Deciphering Key Residues Involved in the Virulence-promoting Interactions between Streptococcus pneumoniae and Human Plasminogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEIN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CRYSTAL-STRUCTURE; ALPHA-ENOLASE; REVEALS; ADHESIN	Bacterial pathogens recruit circulating proteins to their own surfaces, co-opting the host protein functions as a mechanism of virulence. Particular attention has focused on the binding of plasminogen (Plg) to bacterial surfaces, as it has been shown that this interaction contributes to bacterial adhesion to host cells, invasion of host tissues, and evasion of the immune system. Several bacterial proteins are known to serve as receptors for Plg including glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a cytoplasmic enzyme that appears on the cell surface in this moonlighting role. Although Plg typically binds to these receptors via several lysine-binding domains, the specific interactions that occur have not been documented in all cases. However, identification of the relevant residues could help define strategies for mitigating the virulence of important human pathogens, such as Streptococcus pneumoniae (Sp). To shed light on this question, we have described a combination of peptide-spot array screening, competition and SPR assays, high-resolution crystallography, and mutational analyses to characterize the interaction between SpGAPDH and Plg. We identified three SpGAPDH lysine residues that were instrumental in defining the kinetic and thermodynamic parameters of the interaction. Altogether, the integration of the data presented in this work allows us to propose a structural model for the molecular interaction of the SpGAPDH-Plg complex.	[Moreau, Christophe; Terrasse, Remi; Thielens, Nicole M.; Vernet, Thierry; Gaboriaud, Christine; Di Guilmi, Anne Marie] Univ Grenoble Alpes, IBS, CEA, CNRS, F-38044 Grenoble, France; [Moreau, Christophe] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Terrasse, Remi] Jacobs Univ Bremen, D-28759 Bremen, Germany	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Oxford; Jacobs University	Gaboriaud, C; Di Guilmi, AM (corresponding author), Univ Grenoble Alpes, IBS, CEA, CNRS, F-38044 Grenoble, France.	christine.gaboriaud@ibs.fr; anne-marie.di-guilmi@ibs.fr	Thielens, Nicole M/F-2512-2013	Thielens, Nicole M/0000-0002-7354-0302; Di Guilmi, Anne Marie/0000-0001-7335-3470; gaboriaud, christine/0000-0001-5308-0516	French Infrastructure for Integrated Structural Biology Initiative FRISBI [ANR-10-INSB-05-02]; Grenoble Alliance for Integrated Structural Cell Biology GRAL within the Grenoble Partnership for Structural Biology (PSB) [ANR-10-LABX-49-01]	French Infrastructure for Integrated Structural Biology Initiative FRISBI; Grenoble Alliance for Integrated Structural Cell Biology GRAL within the Grenoble Partnership for Structural Biology (PSB)	We thank Isabelle Bally and Jean-Baptiste Reiser for assistance and access to the SPR facility. We acknowledge the platforms of the Grenoble Instruct Centre (Integrated Structural Biology Grenoble (ISBG); UMS 3518 CNRS-CEA-UGA-EMBL) supported by the French Infrastructure for Integrated Structural Biology Initiative FRISBI (ANR-10-INSB-05-02) and by the Grenoble Alliance for Integrated Structural Cell Biology GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB). Access to the European Synchrotron Radiation Facility beamline ID23-eh1 is acknowledged.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal V, 2013, J BIOL CHEM, V288, P6849, DOI 10.1074/jbc.M112.405530; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Attali C, 2008, INFECT IMMUN, V76, P466, DOI 10.1128/IAI.01261-07; Ayres CA, 2014, ACTA CRYSTALLOGR F, V70, P1333, DOI 10.1107/S2053230X14019517; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Bergmann S, 2013, INT J MED MICROBIOL, V303, P452, DOI 10.1016/j.ijmm.2013.06.002; Bhattacharya S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/482096; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Deryugina EI, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/564259; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frolet C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-190; Fulde M, 2014, THROMB HAEMOSTASIS, V111, P401, DOI 10.1160/TH13-05-0421; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Law RHP, 2013, CURR OPIN STRUC BIOL, V23, P836, DOI 10.1016/j.sbi.2013.10.006; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Sanderson-Smith ML, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/272148; Seifert KN, 2003, CAN J MICROBIOL, V49, P350, DOI 10.1139/W03-042; Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056; Terrasse R, 2012, J BIOL CHEM, V287, P42620, DOI 10.1074/jbc.M112.423731; Xue Y, 2012, J THROMB HAEMOST, V10, P1385, DOI 10.1111/j.1538-7836.2012.04765.x; Yamaguchi M, 2008, J BIOL CHEM, V283, P36272, DOI 10.1074/jbc.M807087200	32	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2217	2225		10.1074/jbc.M116.764209	http://dx.doi.org/10.1074/jbc.M116.764209			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28011643	Green Published, hybrid			2022-12-26	WOS:000395530300015
J	Dohertry, O; Conway, T; Conway, R; Murray, G; Casey, V				Dohertry, Orla; Conway, Thomas; Conway, Richard; Murray, Gerard; Casey, Vincent			An Objective Measure of Noseband Tightness and Its Measurement Using a Novel Digital Tightness Gauge	PLOS ONE			English	Article							PRESSURE; THRESHOLDS; HORSES; PAIN	Noseband tightness is difficult to assess in horses participating in equestrian sports such as dressage, show jumping and three-day-eventing. There is growing concern that nosebands are commonly tightened to such an extent as to restrict normal equine behaviour and possibly cause injury. In the absence of a clear agreed definition of noseband tightness, a simple model of the equine nose-noseband interface environment was developed in order to guide further studies in this area. The normal force component of the noseband tensile force was identified as the key contributor to sub-noseband tissue compression. The model was used to inform the design of a digital tightness gauge which could reliably measure the normal force component of the noseband tensile force. A digital tightness gauge was developed to measure this parameter under nosebands fitted to bridled horses. Results are presented for field tests using two prototype designs. Prototype version three was used in field trial 1 (n = 15, frontal nasal plane sub-noseband site). Results of this trial were used to develop an ergonomically designed prototype, version 4, which was tested in a second field trial (n = 12, frontal nasal plane and lateral sub-noseband site). Nosebands were set to three tightness settings in each trial as judged by a single rater using an International Society for Equitation Science (ISES) taper gauge. Normal forces in the range 7-95 N were recorded at the frontal nasal plane while a lower range 1-28 N was found at the lateral site for the taper gauge range used in the trials. The digital tightness gauge was found to be simple to use, reliable, and safe and its use did not agitate the animals in any discernable way. A simple six point tightness scale is suggested to aid regulation implementation and the control of noseband tightness using normal force measurement as the objective tightness discriminant.	[Dohertry, Orla] Univ Limerick, Dept Life Sci, Limerick, Ireland; [Conway, Thomas; Conway, Richard] Univ Limerick, Dept Elect & Comp Engn, Limerick, Ireland; [Murray, Gerard] Aaron Value Adding Serv Ltd, Unit M7,Smithstown Ind Estate, Shannon, Co Clare, Ireland; [Casey, Vincent] Univ Limerick, Dept Phys, Limerick, Ireland	University of Limerick; University of Limerick; University of Limerick	Casey, V (corresponding author), Univ Limerick, Dept Phys, Limerick, Ireland.	vincent.casey@ul.ie	Casey, Vincent/L-1140-2013	Casey, Vincent/0000-0002-0701-526X; Conway, Thomas/0000-0003-1975-5019	Enterprise Ireland (EI), an Irish Government Funding Body, under its Competitive Feasibility Fund programme [155913]; EI	Enterprise Ireland (EI), an Irish Government Funding Body, under its Competitive Feasibility Fund programme; EI	GM and VC received partial funding from Enterprise Ireland (EI), an Irish Government Funding Body, under its Competitive Feasibility Fund programme which is designed to support industry-academia projects at a pre-commercial stage but which have high technology start-up potential: grant 155913, funder Website: http://www.enterprise-ireland.com/en/About-Us/Our-Locations/Shannon-Office.html. GM's role was to manufacture, test and validate prototype tightness gauge printed circuit boards designed by RC, TC and VC. The funder (EI) provided support restricted to a maximum of 50% of materials and travel costs directly related to gauge prototype development and production but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Salaries and wages of all involved in the project were specifically excluded from this grant as all were already in salaried positions. The specific roles of these authors (GM and VC) and other authors are articulated in the 'author contributions' section.	Adams RA, 2003, CALCULUS COMPLETE CO; Casey V, 2016, A tightness gauge for estimating the tightness of a restrictive strap, Patent No. [2016/0142, 20160142]; Casey V, 2013, J VET BEHAV, V8, P479, DOI 10.1016/j.jveb.2013.06.003; Casey V, 2011, APPLIED BIOMEDICAL ENGINEERING, P243; Doherty O, 2016, 12 INT C INT SOC EQ, P53; Egenvall A, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0182-3; Egenvall A, 2012, J VET BEHAV, V7, P157, DOI 10.1016/j.jveb.2011.08.006; Eisersio E M, 2013, THESIS; Estebe JP, 2000, ANAESTHESIA, V55, P21, DOI 10.1046/j.1365-2044.2000.01128.x; FEI, 2016, DRESS RUL; FEI (International Equestrian Federation), 2013, COD COND WELF HORS; Fenner K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154179; GREENSPAN JD, 1991, SOMATOSENS MOT RES, V8, P137, DOI 10.3109/08990229109144738; ISES, 2012, POS STAT REC NOS; Kragh JF, 2013, J SPEC OPER MED PEER, V13, P5; Ley SJ, 1996, RES VET SCI, V61, P172, DOI 10.1016/S0034-5288(96)90096-X; Manfredi JM, 2009, COMP EXERC PHYSIOL, V6, P143, DOI 10.1017/S1755254010000036; McGreevy P, 2012, J VET BEHAV, V7, P142, DOI 10.1016/j.jveb.2011.08.001; McLean AN, 2005, ANTHROZOOS, V18, P245, DOI 10.2752/089279305785594072; Micklem W., 2012, COMPLETE HORSE RIDIN; Muir S., 2012, COMPLETE HORSE RIDER; Noordin S, 2009, J BONE JOINT SURG AM, V91A, P2958, DOI 10.2106/JBJS.I.00634; O'Brien SBG, 2002, Q J MECH APPL MATH, V55, P409, DOI 10.1093/qjmam/55.3.409; O'Muiris E, 2015, J MED BIOL ENG, V35, P670, DOI 10.1007/s40846-015-0076-x; OVAM, 2012, SECT EQ HEAD; Porter JM, 2003, APPL ERGON, V34, P207, DOI 10.1016/S0003-6870(03)00009-7; Pospisil K, 2014, EQUINE VET J, V46, P46, DOI [10.1111/evj.12267_142, DOI 10.1111/EVJ.12267_142]; Randle H, 2013, J VET BEHAV, V8, P59, DOI 10.1016/j.jveb.2013.02.002; WELSH EM, 1995, RES VET SCI, V58, P61, DOI 10.1016/0034-5288(95)90090-X	29	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168996	10.1371/journal.pone.0168996	http://dx.doi.org/10.1371/journal.pone.0168996			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045955	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300085
J	Fan, CY; Huang, WY; Lin, KT; Lin, CS; Chao, HL; Yang, JF; Lin, CL; Kao, CH				Fan, Chao-Yueh; Huang, Wen-Yen; Lin, Kuen-Tze; Lin, Chun-Shu; Chao, Hsing-Lung; Yang, Jen-Fu; Lin, Cheng-Li; Kao, Chia-Hung			Lower Urinary Tract Infection and Subsequent Risk of Prostate Cancer: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							INFLAMMATION; DISEASES; CARCINOGENESIS; EPIDEMIOLOGY	Purpose We investigated whether lower urinary tract infection (LUTI), including cystitis or urethritis, is associated with an increased risk of developing prostate cancer (PCa), in a nationwide population- based cohort study. Methods We identified 14,273 men newly diagnosed with LUTI (9347 with cystitis, and 4926 with urethritis) between 1998 and 2011, from the Taiwan Longitudinal Health Insurance Database 2000. Each patient was randomly frequency-matched with 4 men without LUTI, based on age and index year of diagnosis. Cox's proportional hazard regression analysis was performed to estimate the effect of LUTI on the PCa risk. Results The risk of developing PCa was significantly higher in the cystitis cohort (adjusted HR = 1.46, 95% CI = 1.20-1.78) and in the urethritis cohort (adjusted HR = 1.72, 95% CI = 1.26-2.34) than in the group without LUTI. Further analyses indicated that patients with more than 5 medical visits for LUTI per year had a significantly greater risk of developing PCa. Conclusion We found that cystitis or urethritis may play an etiological role in the development of PCa in Taiwanese men, particularly in those with repeated medical visits for cystitis or urethritis. Further studies are warranted on the association between LUTI and PCa in other countries, particularly where the prevalence of PCa is high.	[Fan, Chao-Yueh; Huang, Wen-Yen; Lin, Kuen-Tze; Lin, Chun-Shu; Chao, Hsing-Lung; Yang, Jen-Fu] Natl Def Med Ctr, Triserv Gen Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Huang, Wen-Yen] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Kao, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ, Sch Med, Coll Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.; Kao, CH (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	d10040@mail.cmuh.org.tw	huang, wen/GXW-0661-2022		Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan; Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (Taiwan) [MOHW105-TDU-B-212-134003]; Tri-service General Hospital [TSGH-C106-038]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan; Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (Taiwan); Tri-service General Hospital	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan, and Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (MOHW105-TDU-B-212-134003, Taiwan), and study project of Tri-service General Hospital (TSGH-C106-038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, TSGH-C106-038 project in Tri-Service General Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan, and Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (MOHW105-TDU-B-212-134003, Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Boehm K, 2016, WORLD J UROL, V34, P425, DOI 10.1007/s00345-015-1625-1; Caini S, 2014, CANCER EPIDEMIOL, V38, P329, DOI 10.1016/j.canep.2014.06.002; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cullen Jennifer, 2012, J Carcinog, V11, P7, DOI 10.4103/1477-3163.94025; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Griebling TL, 2005, J UROLOGY, V173, P1288, DOI 10.1097/01.ju.0000155595.98120.8e; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Jiang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085179; Lightfoot N, 2004, ANN EPIDEMIOL, V14, P655, DOI 10.1016/j.annepidem.2003.11.006; Lin JC, 2016, INFLAMM BOWEL DIS; Lonkar P, 2011, INT J CANCER, V128, P1999, DOI 10.1002/ijc.25815; Nakai Y, 2013, INT J UROL, V20, P150, DOI 10.1111/j.1442-2042.2012.03101.x; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Nelson WG, 2012, MANAGEMENT PROSTATE, P103; Nicolle LE, 2001, INFECT MED, V18, P153; Patel DA, 2005, CANCER CAUSE CONTROL, V16, P263, DOI 10.1007/s10552-004-3486-6; Pelucchi C, 2006, EUR J CANCER PREV, V15, P254, DOI 10.1097/01.cej.0000198897.40303.d4; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Sfanos KS, 2012, HISTOPATHOLOGY, V60, P199, DOI 10.1111/j.1365-2559.2011.04033.x; Sharp VJ, 2010, AM FAM PHYSICIAN, V82, P397; Sim HG, 2005, EUR J CANCER, V41, P834, DOI 10.1016/j.ejca.2004.12.033; Tu YF, 2014, SEIZURE-EUR J EPILEP, V23, P651, DOI 10.1016/j.seizure.2014.05.005; Wu SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003065	25	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168254	10.1371/journal.pone.0168254	http://dx.doi.org/10.1371/journal.pone.0168254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046120	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300017
J	Ives, AR; Paull, C; Hulthen, A; Downes, S; Andow, DA; Haygood, R; Zalucki, MP; Schellhorn, NA				Ives, Anthony R.; Paull, Cate; Hulthen, Andrew; Downes, Sharon; Andow, David A.; Haygood, Ralph; Zalucki, Myron P.; Schellhorn, Nancy A.			Spatio-Temporal Variation in Landscape Composition May Speed Resistance Evolution of Pests to Bt Crops	PLOS ONE			English	Article							HELIOTHIS-VIRESCENS LEPIDOPTERA; PUNCTIGERA WALLENGREN LEPIDOPTERA; HELICOVERPA SPP. LEPIDOPTERA; ARMIGERA HUBNER LEPIDOPTERA; INSECT RESISTANCE; HOST-PLANT; TRANSGENIC CROPS; MULTIPLE TOXINS; NOCTUIDAE; COTTON	Transgenic crops that express insecticide genes from Bacillus thuringiensis (Bt) are used worldwide against moth and beetle pests. Because these engineered plants can kill over 95% of susceptible larvae, they can rapidly select for resistance. Here, we use a model for a pyramid two-toxin Bt crop to explore the consequences of spatio-temporal variation in the area of Bt crop and non-Bt refuge habitat. We show that variability over time in the proportion of suitable non-Bt breeding habitat, Q, or in the total area of Bt and suitable non-Bt habitat, K, can increase the overall rate of resistance evolution by causing short-term surges of intense selection. These surges can be exacerbated when temporal variation in Q and/or K cause high larval densities in refuges that increase density-dependent mortality; this will give resistant larvae in Bt fields a relative advantage over susceptible larvae that largely depend on refuges. We address the effects of spatio-temporal variation in a management setting for two bollworm pests of cotton, Helicoverpa armigera and H. punctigera, and field data on landscape crop distributions from Australia. Even a small proportion of Bt fields available to egg-laying females when refuges are sparse may result in high exposure to Bt for just a single generation per year and cause a surge in selection. Therefore, rapid resistance evolution can occur when Bt crops are rare rather than common in the landscape. These results highlight the need to understand spatio-temporal fluctuations in the landscape composition of Bt crops and non-Bt habitats in order to design effective resistance management strategies.	[Ives, Anthony R.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Paull, Cate; Hulthen, Andrew; Schellhorn, Nancy A.] CSIRO, Brisbane, Qld, Australia; [Downes, Sharon] CSIRO, Narrabri, NSW, Australia; [Andow, David A.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Haygood, Ralph] Ronin Inst, Montclair, NJ USA; [Zalucki, Myron P.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	University of Wisconsin System; University of Wisconsin Madison; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Minnesota System; University of Minnesota Twin Cities; University of Queensland	Ives, AR (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	arives@wisc.edu	Paull, Cate/D-7771-2011; Schellhorn, Nancy/B-6716-2009; Hulthen, Andrew/AAU-5585-2021; Zalucki, Myron P/G-7983-2012; Downes, Sharon Joy/C-1770-2008	Paull, Cate/0000-0001-5062-088X; Hulthen, Andrew/0000-0002-0298-4977; Zalucki, Myron P/0000-0001-9603-7577; Downes, Sharon Joy/0000-0002-3729-1732	Cotton Research & Development Corporation (AU); Direct For Biological Sciences [1240804] Funding Source: National Science Foundation	Cotton Research & Development Corporation (AU)(Cotton R&D Corp); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Cotton Research & Development Corporation (AU) was an investor in this project, for financial support to CP, AH, SD and NAS, and for travel funds for ARI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker GH, 2011, B ENTOMOL RES, V101, P9, DOI 10.1017/S0007485310000106; Benbrook Charles M., 2012, Environmental Sciences Europe, V24, P24, DOI 10.1186/2190-4715-24-24; Caprio MA, 1998, J ECON ENTOMOL, V91, P1021, DOI 10.1093/jee/91.5.1021; Caprio MA, 2001, J ECON ENTOMOL, V94, P698, DOI 10.1603/0022-0493-94.3.698; Castanera P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154200; COMINS HN, 1986, AGR ECOSYST ENVIRON, V16, P129, DOI 10.1016/0167-8809(86)90099-X; Cotton Research Development Corporation, 2014, CRDC ANN REP 2013 20; Cunningham JP, 2014, J ECON ENTOMOL, V107, P881, DOI 10.1603/EC14036; Downes Sharon, 2012, GM Crops Food, V3, P228, DOI 10.4161/gmcr.20194; Downes S, 2012, J INVERTEBR PATHOL, V110, P281, DOI 10.1016/j.jip.2012.04.005; ESRI, 2018, ARCGIS DESKTOP RELEA; Fitt Gary P., 2008, V5, P303, DOI 10.1007/978-1-4020-8373-0_11; FITT GP, 1995, COMPUT ELECTRON AGR, V13, P177, DOI 10.1016/0168-1699(95)00024-X; Franzmann BA, 2008, AUST J EXP AGR, V48, P1594, DOI 10.1071/EA08071; Gahan LJ, 2005, J ECON ENTOMOL, V98, P1357, DOI 10.1603/0022-0493-98.4.1357; GASTON LYLE K., 1964, ANN ENTOMOL SOC AMER, V57, P779, DOI 10.1093/aesa/57.6.779; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GOULD F, 1986, ENVIRON ENTOMOL, V15, P1, DOI 10.1093/ee/15.1.1; GOULD F, 1991, AM SCI, V79, P496; GOULD F, 1995, J ECON ENTOMOL, V88, P1545, DOI 10.1093/jee/88.6.1545; Gould F, 1998, NOW NEVER SERIOUS NE, P67; Gould F, 2006, J ECON ENTOMOL, V99, P2091, DOI 10.1603/0022-0493-99.6.2091; GREGG PC, 1995, INSECT MIGRATION: TRACKING RESOURCES THROUGH SPACE AND TIME, P151; HOPPER KR, 1991, ENVIRON ENTOMOL, V20, P292, DOI 10.1093/ee/20.1.292; Huang JK, 2005, SCIENCE, V308, P688, DOI 10.1126/science.1108972; Ives AR, 2011, ECOL APPL, V21, P503, DOI 10.1890/09-1869.1; Ives AR, 2002, ECOL LETT, V5, P792, DOI 10.1046/j.1461-0248.2002.00392.x; Jallow MFA, 1996, AUST J ZOOL, V44, P503, DOI 10.1071/ZO9960503; Jallow MFA, 1998, AUST J ZOOL, V46, P291, DOI 10.1071/ZO98010; Kakimoto T, 2003, ANN ENTOMOL SOC AM, V96, P793, DOI 10.1603/0013-8746(2003)096[0793:ELPLDA]2.0.CO;2; Kriticos DJ, 2015, PLOS ONE, V10; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Maelzer DA, 1996, B ENTOMOL RES, V89, P455; MANI GS, 1985, GENETICS, V109, P761; MathWorks I, 2014, MATLAB 8 0 ED; Matten SM, 2004, TRANSGENIC CROP PROTECTION: CONCEPTS AND STRATEGIES, P261; Matthews M, 1999, HELIOTHINE MOTHS AUS; Monsanto Australia Limited, 2014, RES MAN PLAN BOLLG 2; MURRAY DAH, 1994, ENTOMOPHAGA, V39, P251, DOI 10.1007/BF02373029; Murray DAH, 1992, INVESTIGATION DEV SU; Onstad DW, 1998, J ECON ENTOMOL, V91, P585, DOI 10.1093/jee/91.3.585; Peck SL, 1999, J ECON ENTOMOL, V92, P1, DOI 10.1093/jee/92.1.1; Rajapakse CNK, 2007, ARTHROPOD-PLANT INTE, V1, P17, DOI 10.1007/s11829-007-9003-6; RAYMOND M, 1989, GENETICS, V123, P543; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Sequeira RV, 2002, CROP PROT, V21, P439, DOI 10.1016/S0261-2194(01)00126-0; Sigsgaard L, 2002, BIOCONTROL, V47, P151, DOI 10.1023/A:1014577114915; Storer NP, 2003, J ECON ENTOMOL, V96, P156, DOI 10.1603/0022-0493-96.1.156; TABASHNIK BE, 1982, ENVIRON ENTOMOL, V11, P1137, DOI 10.1093/ee/11.6.1137; Tabashnik BE, 2004, J EVOLUTION BIOL, V17, P904, DOI 10.1111/j.1420-9101.2004.00695.x; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; TEAKLE RE, 1985, J ECON ENTOMOL, V78, P1373, DOI 10.1093/jee/78.6.1373; Titmarsh IJ, 1992, MORTALITY IMMATURE L; USEPA, 2001, BIOP REG ACT DOC BAC; WARDHAUGH KG, 1980, B ENTOMOL RES, V70, P113, DOI 10.1017/S0007485300009822; ZALUCKI MP, 1986, AUST J ZOOL, V34, P779, DOI 10.1071/ZO9860779; Zalucki MP, 2009, AUST J ENTOMOL, V48, P85, DOI 10.1111/j.1440-6055.2009.00690.x; Zhao JZ, 2003, NAT BIOTECHNOL, V21, P1493, DOI 10.1038/nbt907	59	17	17	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169167	10.1371/journal.pone.0169167	http://dx.doi.org/10.1371/journal.pone.0169167			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046073	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300134
J	Liao, MN; Yu, G; Guo, Y				Liao, Mengna; Yu, Ge; Guo, Ya			Eutrophication in Poyang Lake (Eastern China) over the Last 300 Years in Response to Changes in Climate and Lake Biomass	PLOS ONE			English	Article							LONG-TERM CHANGES; SHALLOW LAKES; ECOSYSTEM MODEL; NUTRIENT DYNAMICS; YANGTZE FLOODPLAIN; TOTAL PHOSPHORUS; PHYTOPLANKTON; PRODUCTIVITY; VEGETATION; PALEOLIMNOLOGY	Poyang Lake is suffering from persistent eutrophication, which is degrading the local ecosystem. A better understanding of the mechanisms that drive eutrophication in lake systems is essential to fight the ongoing deterioration. In this study, hydraulic residence time (HRT) was used to evaluate Poyang Lake's trophic state. A hydrology and ecosystem forced model was constructed to simulate long-term changes in algae and aquatic plant biomass and total phosphorous (TP). A comparison analysis revealed that between 1812 and 1828 (i.e., a consistent-change stage), climate and hydrology were the main driving forces, while algae and aquatic plant biomass contributed only 20.9% to the trophic changes in Poyang Lake. However, between 1844 and 1860 the biomass predominated contributing 63.6%. This could be attributed to nutrient absorption by algae and aquatic plants. A correlation analysis of the water TP and algae and aquatic plant biomass revealed a strong positive relationship. However, the algae and aquatic plant growth rate tended to decline after the biomass reached half of the maximum. This research reconstructs the long-term trophic evolution of Poyang Lake and provides a better understanding of the relationship between climatic and hydrological changes and lake ecosystems.	[Liao, Mengna] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liao, Mengna] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China; [Yu, Ge; Guo, Ya] Chinese Acad Sci, State Key Lab Lake Sci & Environm, Nanjing Inst Geog & Limnol, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang Normal University; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS	Yu, G (corresponding author), Chinese Acad Sci, State Key Lab Lake Sci & Environm, Nanjing Inst Geog & Limnol, Nanjing, Jiangsu, Peoples R China.	geyu@niglas.ac.an		Liao, Mengna/0000-0002-1571-4116	Global Change Research Program of the China Ministry of Science and Technology [2013CB956501]; National Key Research and Development Program [2016YFC0502101]	Global Change Research Program of the China Ministry of Science and Technology; National Key Research and Development Program	This work was supported by Global Change Research Program of the China Ministry of Science and Technology (2013CB956501) and National Key Research and Development Program (2016YFC0502101).	Alefs J, 1999, J PALEOLIMNOL, V21, P395, DOI 10.1023/A:1008098118867; ANDERSON MR, 1986, FRESHWATER BIOL, V16, P735, DOI 10.1111/j.1365-2427.1986.tb01014.x; [Anonymous], 2013, J ENV ENG TECHNOL, DOI DOI 10.3969/J.ISSN.1674-991X.2013.04.054; Appleby P.C., 2002, TRACKING ENV CHANGE, P171, DOI [DOI 10.1007/0-306-47669-X_9, 10.1007/0-306-47669-X_9]; BARKO JW, 1986, J AQUAT PLANT MANAGE, V24, P1; BATTARBEE RW, 1982, LIMNOL OCEANOGR, V27, P184, DOI 10.4319/lo.1982.27.1.0184; Bennion H, 1996, ENVIRON SCI TECHNOL, V30, P2004, DOI 10.1021/es9508030; Bennion H, 2001, J PALEOLIMNOL, V26, P181, DOI 10.1023/A:1011137625746; Birks H.J.B., 1995, STAT MODELING QUATER, P116, DOI DOI 10.1002/JQS.3390010111; Birks HJB, 1998, J PALEOLIMNOL, V20, P307, DOI 10.1023/A:1008038808690; Brenner M, 1999, J PALEOLIMNOL, V21, P215, DOI 10.1023/A:1008079500375; Burkett VR, 2005, ECOL COMPLEX, V2, P357, DOI 10.1016/j.ecocom.2005.04.010; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Carpenter SR, 2005, P NATL ACAD SCI USA, V102, P10002, DOI 10.1073/pnas.0503959102; Carvalho L, 2003, HYDROBIOLOGIA, V506, P789, DOI 10.1023/B:HYDR.0000008600.84544.0a; Chen X, 2011, HYDROBIOLOGIA, V661, P223, DOI 10.1007/s10750-010-0526-y; Claussen M, 1999, GEOPHYS RES LETT, V26, P2037, DOI 10.1029/1999GL900494; Coops H, 2003, HYDROBIOLOGIA, V506, P23, DOI 10.1023/B:HYDR.0000008595.14393.77; Degobbis D, 2000, INT J ENVIRON POLLUT, V13, P495, DOI 10.1504/IJEP.2000.002332; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Dingman S., 2002, PHYS HYDROLOGY; Dong XH, 2008, J PALEOLIMNOL, V40, P413, DOI 10.1007/s10933-007-9170-6; Edition Board of Atlas of Poyang Lake, 1993, ATL POYANG LAK; FEE EJ, 1979, LIMNOL OCEANOGR, V24, P401, DOI 10.4319/lo.1979.24.3.0401; Ferreira JG, 2005, ECOL MODEL, V187, P513, DOI 10.1016/j.ecolmodel.2005.03.013; Fitz HC, 1996, ECOL MODEL, V88, P263, DOI 10.1016/0304-3800(95)00112-3; Fragoso CR, 2011, ENVIRON MODELL SOFTW, V26, P1337, DOI 10.1016/j.envsoft.2011.05.004; FREYBUNESS F, 1995, THEOR APPL CLIMATOL, V50, P117, DOI 10.1007/BF00866111; Grimm EC., 1991, A USERS NOTEBOOK; Guan S. F., 1987, ACTA HYDROBIOL SIN, V11, P219; Havens KE, 2001, ENVIRON POLLUT, V111, P263, DOI 10.1016/S0269-7491(00)00074-9; Hu Chunhua, 2010, Hupo Kexue, V22, P723; IPCC Data Distribution Center, 2007, AR4 GCM DAT; Janse JH, 2010, ECOL MODEL, V221, P654, DOI 10.1016/j.ecolmodel.2009.07.023; Janse JH, 2008, LIMNOLOGICA, V38, P203, DOI 10.1016/j.limno.2008.06.001; Janse JH, 1997, HYDROBIOLOGIA, V342, P1, DOI 10.1023/A:1017018812215; JANSE JH, 1992, HYDROBIOLOGIA, V233, P119, DOI 10.1007/BF00016101; JASSER I, 1995, HYDROBIOLOGIA, V306, P21, DOI 10.1007/BF00007855; Jin X.C., 1990, LAKE EUTROPHICATION, V2nd; Jorgensen SE, 1988, GUIDELINES LAKE MANA, V1, P37; Juggins S, 2007, C2 VERSION 1 5 SOFTW; Kagalou I, 2008, J ENVIRON MANAGE, V87, P497, DOI 10.1016/j.jenvman.2007.01.039; Kalff J, 2002, LIMNOLOGY INLAND WAT; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kong FX, 2011, FORMATION PROCESS EN; Krammer K., 1986, SUSSWASSERFLORA MITT, V2/1, P1; Krammer K., 1991, SUSSWASSERFLORA MITT, V4, P437; Krammer K., 1991, SUSSWASSERFLORA MITT, V2/3, P576; Krammer K., 1988, SUSSWASSER FLORA MIT; Lau SSS, 2002, SCI TOTAL ENVIRON, V288, P167, DOI 10.1016/S0048-9697(01)00957-3; Li YL, 2014, J HYDROL ENG, V19, P607, DOI 10.1061/(ASCE)HE.1943-5584.0000835; [梁英琼 LIANG Ying-qiong], 2010, [西南大学学报. 自然科学版, Journal of Southwest University. Natural Science Edition], V32, P15; [刘健 LIU Jian], 2009, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V18, P19; Liu Jian, 2009, Hupo Kexue, V21, P570; Liu Q, 2012, ECOHYDROLOGY, V5, P316, DOI 10.1002/eco.222; Liu ZY, 2006, J CLIMATE, V19, P787, DOI 10.1175/JCLI3658.1; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; Meyers PA, 1999, J PALEOLIMNOL, V21, P345, DOI 10.1023/A:1008073732192; Mooij WM, 2007, HYDROBIOLOGIA, V584, P443, DOI 10.1007/s10750-007-0600-2; Moreno A, 2002, EARTH PLANET SC LETT, V196, P147, DOI 10.1016/S0012-821X(01)00605-7; Morowitz Harold., 1986, BIOL PHILOS, V1, P473, DOI [10.1007/BF00140964, DOI 10.1007/BF00140964]; Moss B., 1996, GUIDE RESTORATION NU; Mulderij G, 2005, AQUAT BOT, V82, P284, DOI 10.1016/j.aquabot.2005.04.001; Naito W, 2002, WATER RES, V36, P1, DOI 10.1016/S0043-1354(01)00200-7; Nara F, 2005, QUATERN INT, V136, P71, DOI 10.1016/j.quaint.2004.11.009; Palmer W.C., 1958, MON WEATHER REV, V86, P123, DOI DOI 10.1175/1520-0493(1958)086; Poyang Lake Administration of Jiangxi Province, 2011, SPEC REP APPL PROT F; Qin BQ, 2006, CHINESE SCI BULL, V51, P2401, DOI 10.1007/s11434-006-2096-y; Ramstack JM, 2003, J PALEOLIMNOL, V29, P79, DOI 10.1023/A:1022869205291; Roeckner E, 2006, J CLIMATE, V19, P3771, DOI 10.1175/JCLI3824.1; Rubin ES., 2001, INTRO ENG ENV; Sanchez-Carrillo S, 2001, WATER AIR SOIL POLL, V131, P97, DOI 10.1023/A:1011903300635; Sayer CD, 2010, FRESHWATER BIOL, V55, P487, DOI 10.1111/j.1365-2427.2010.02388.x; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheffer M, 2007, HYDROBIOLOGIA, V584, P455, DOI 10.1007/s10750-007-0616-7; SHIGESADA N, 1979, J THEOR BIOL, V79, P83, DOI 10.1016/0022-5193(79)90258-3; [唐静波 TANG Jingbo], 2007, [数学的实践与认识, Mathematics in Practice and Theory], V37, P77; TERBRAAK CJF, 1995, CHEMOMETR INTELL LAB, V28, P165, DOI 10.1016/0169-7439(95)00002-E; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; Wang R, 2012, NATURE, V492, P419, DOI 10.1038/nature11655; Wang S., 1998, LAKES CHINA; Wu JL, 2007, J PALEOLIMNOL, V38, P13, DOI 10.1007/s10933-006-9058-x; Wu Y.H., 1999, MAR GEOL QUAT GEOL, V19, P85; Xie Z.D., 2006, RES SURVEY ENV, V027, P60; Xu C.Y., 2013, THESIS; Yang Guishan, 2010, Hupo Kexue, V22, P799; Yang XD, 2008, FRESHWATER BIOL, V53, P1273, DOI 10.1111/j.1365-2427.2007.01921.x; Yang XD, 2006, SCI CHINA SER D, V49, P51, DOI 10.1007/s11430-006-8105-9; Yao J, 2009, ACTA AGR JIANGXI, V21, P125; Ye XC, 2011, QUATERN INT, V244, P221, DOI 10.1016/j.quaint.2010.07.004; [于革 Yu Ge], 2013, [第四纪研究, Quaternary Sciences], V33, P1148; Zhou WB, 2011, EFFECTS RIVER AND LA; Zhu HH, 1997, POYANG LAKE HYDROLOG	95	10	13	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169319	10.1371/journal.pone.0169319	http://dx.doi.org/10.1371/journal.pone.0169319			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046083	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300165
J	Siebenhuener, K; Eschmann, E; Kienast, A; Schneider, D; Minders, CE; Saller, R; Zimmerli, L; Blaser, J; Battegay, E; Holzer, BM				Siebenhuener, Klarissa; Eschmann, Emmanuel; Kienast, Alexander; Schneider, Dominik; Minders, Christoph E.; Saller, Reinhard; Zimmerli, Lukas; Blaser, Jurg; Battegay, Edouard; Holzer, Barbara M.			Chronic Pain: How Challenging Are DDIs in the Analgesic Treatment of Inpatients with Multiple Chronic Conditions?	PLOS ONE			English	Article							PRIMARY-CARE PATIENTS; ST JOHNS WORT; CANCER PAIN; DRUG-INTERACTIONS; ADJUVANT ANALGESICS; CLINICAL GUIDELINES; BLOOD-PRESSURE; MULTIMORBIDITY; POPULATION; PREVALENCE	Background Chronic pain is common in multimorbid patients. However, little is known about the implications of chronic pain and analgesic treatment on multimorbid patients. This study aimed to assess chronic pain therapy with regard to the interaction potential in a sample of inpatients with multiple chronic conditions. Methods and Findings We conducted a retrospective study with all multimorbid inpatients aged >= 18 years admitted to the Department of Internal Medicine of University Hospital Zurich in 2011 (n = 1,039 patients). Data were extracted from the electronic health records and reviewed. We identified 433 hospitalizations of patients with chronic pain and analyzed their combinations of chronic conditions (multimorbidity). We then classified all analgesic prescriptions according to the World Health Organization (WHO) analgesic ladder. Furthermore, we used a Swiss drug-drug interactions knowledge base to identify potential interactions between opioids and other drug classes, in particular coanalgesics and other concomitant drugs. Chronic pain was present in 38% of patients with multimorbidity. On average, patients with chronic pain were aged 65.7 years and had a mean number of 6.6 diagnoses. Hypertension was the most common chronic condition. Chronic back pain was the most common painful condition. Almost 90% of patients were exposed to polypharmacotherapy. Of the chronic pain patients, 71.1% received opioids for moderate to severe pain, 43.4% received coanalgesics. We identified 3,186 potential drug-drug interactions, with 17% classified between analgesics (without coanalgesics). Conclusions Analgesic drugs-related DDIs, in particular opioids, in multimorbid patients are often complex and difficult to assess by using DDI knowledge bases alone. Drug-multimorbidity interactions are not sufficiently investigated and understood. Today, the scientific literature is scarce for chronic pain in combination with multiple coexisting medical conditions and medication regimens. Our work may provide useful information to enable further investigations in multimorbidity research within the scope of potential interactions and chronic pain.	[Siebenhuener, Klarissa; Kienast, Alexander; Battegay, Edouard; Holzer, Barbara M.] Univ Zurich Hosp, Dept Internal Med, Zurich, Switzerland; [Siebenhuener, Klarissa; Saller, Reinhard; Zimmerli, Lukas; Battegay, Edouard; Holzer, Barbara M.] Univ Zurich, Ctr Competence Multimorbid, Zurich, Switzerland; [Eschmann, Emmanuel; Blaser, Jurg] Univ Zurich Hosp, Res Ctr Med Informat, Directorate Res & Educ, Zurich, Switzerland; [Schneider, Dominik] Maennedorf Hosp, Dept Internal Med, Canton Zurich, Switzerland; [Minders, Christoph E.] Univ Zurich Hosp, Horten Ctr, Zurich, Switzerland; [Saller, Reinhard] Univ Zurich Hosp, Inst Complementary & Integrat Med, Zurich, Switzerland; [Zimmerli, Lukas] Cantonal Hosp, Internal Med, Olten, Switzerland; [Battegay, Edouard] Univ Zurich, Univ Res Prior Program Dynam Hlth Aging, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Kantonsspital Olten; University of Zurich	Holzer, BM (corresponding author), Univ Zurich Hosp, Dept Internal Med, Zurich, Switzerland.; Holzer, BM (corresponding author), Univ Zurich, Ctr Competence Multimorbid, Zurich, Switzerland.	barbara.holzer@usz.ch	blaser, juerg/B-9980-2015	blaser, juerg/0000-0002-4928-1291; Holzer, Barbara/0000-0001-6929-3145; Eschmann, Emmanuel/0000-0002-1469-6163	Mundipharma Medical Company	Mundipharma Medical Company	The study was supported by Mundipharma Medical Company. The sponsor had no role in the study design, the choice of statistical analyses, decision to publish or preparation of the manuscript.	[Anonymous], [No title captured]; Bair MJ, 2011, POSTGRAD MED, V123, P140, DOI 10.3810/pgm.2011.11.2504; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Boyd CM, 2010, PUBLIC HEALTH REV, V32, P451, DOI 10.1007/BF03391611; Brochet B, 1998, AGE AGEING, V27, P279, DOI 10.1093/ageing/27.3.279; Bruehl S, 2010, J BEHAV MED, V33, P168, DOI 10.1007/s10865-009-9241-4; Burness CB, 2014, DRUGS, V74, P353, DOI 10.1007/s40265-014-0177-9; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Davis MP, 2005, LANCET ONCOL, V6, P696, DOI 10.1016/S1470-2045(05)70317-X; Dubovsky AN, 2012, PSYCHOSOMATICS, V53, P103, DOI 10.1016/j.psym.2011.12.007; Eisenberg A, 2011, J PAIN PALLIAT CARE, V25, P288, DOI DOI 10.3109/15360288.2011.600429; FEUERSTEIN G, 1987, CIRCULATION, V75, P125; Fitzcharles MA, 2010, DRUG AGING, V27, P471, DOI 10.2165/11536530-000000000-00000; Frechen S, 2012, DRUG SAFETY, V35, P745, DOI 10.2165/11631280-000000000-00000; Gosch M, 2015, Z GERONTOL GERIATR, V48, P483, DOI 10.1007/s00391-015-0922-z; Grimby C, 1999, ARCH GERONTOL GERIAT, V29, P29, DOI 10.1016/S0167-4943(99)00021-7; Grond S, 2004, CLIN PHARMACOKINET, V43, P879, DOI 10.2165/00003088-200443130-00004; Gualtierotti R, 2013, EXPERT OPIN PHARMACO, V14, P1875, DOI 10.1517/14656566.2013.816286; Guido M, 2006, CURR PHARM DESIGN, V12, P1001, DOI 10.2174/138161206776055895; Gunn JM, 2012, SOC PSYCHIAT PSYCHIA; Guthrie B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0322-7; Guthrie Bruce, 2011, BMJ, V342, pd3514, DOI 10.1136/bmj.d3514; Guthrie B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6341; Hafner V, 2010, CLIN PHARMACOL THER, V87, P191, DOI 10.1038/clpt.2009.206; Hansten P D, 2001, J Am Pharm Assoc (Wash), V41, P161; IASP, 1986, PAIN S, V3; Jiang HY, 2015, CLIN GASTROENTEROL H, V13, P42, DOI 10.1016/j.cgh.2014.06.021; Lussier D, 2004, ONCOLOGIST, V9, P571, DOI 10.1634/theoncologist.9-5-571; Maltoni M, 2005, SUPPORT CARE CANCER, V13, P888, DOI 10.1007/s00520-005-0807-6; Mellbye A, 2012, ACTA ANAESTH SCAND, V56, P1267, DOI 10.1111/j.1399-6576.2012.02766.x; Mitra R, 2012, AM J HOSP PALLIAT ME, V29, P70, DOI 10.1177/1049909111413256; Mueller SC, 2009, EUR J CLIN PHARMACOL, V65, P81, DOI 10.1007/s00228-008-0554-y; Muller-Schwefe GHH, 2011, CURR MED RES OPIN, V27, P2099, DOI 10.1185/03007995.2011.621935; Nieminen TH, 2010, EUR J PAIN, V14, P854, DOI 10.1016/j.ejpain.2009.12.007; Nieuwstraten C, 2006, CAN J PSYCHIAT, V51, P300, DOI 10.1177/070674370605100506; Nobili A, 2009, J CLIN PHARM THER, V34, P377, DOI 10.1111/j.1365-2710.2009.01021.x; O'Halloran J, 2004, FAM PRACT, V21, P381, DOI 10.1093/fampra/cmh407; Overholser Brian R, 2011, Am J Manag Care, V17 Suppl 11, pS276; Payne RA, 2014, EUR J CLIN PHARMACOL, V70, P575, DOI 10.1007/s00228-013-1639-9; Pergolizzi Joseph, 2008, Pain Pract, V8, P287, DOI 10.1111/j.1533-2500.2008.00204.x; Portenoy RK, UPTODATE; Ripamonti CI, 2012, ANN ONCOL, V23, P139, DOI 10.1093/annonc/mds233; Russo CM, 1998, ANNU REV MED, V49, P123; Russo E, 2014, PHYTOTHER RES, V28, P643, DOI 10.1002/ptr.5050; Samer CF, 2006, PERS MED, V3, P271, DOI 10.2217/17410541.3.3.271; Schafer I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045390; Scherer M, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0468-1; Seidling HM, 2014, INT J MED INFORM, V83, P285, DOI 10.1016/j.ijmedinf.2013.12.006; Smith H, 2010, DRUG AGING, V27, P417, DOI 10.2165/11536540-000000000-00000; ten Klooster PM, 2006, PAIN, V121, P151, DOI 10.1016/j.pain.2005.12.021; Todd KH, 1996, ANN EMERG MED, V27, P485, DOI 10.1016/S0196-0644(96)70238-X; Turtle EJ, 2013, BRIT J CLIN PHARMACO, V75, P1396, DOI 10.1111/bcp.12032; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van den Bussche H, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-54; van Oostrom SH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-715; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Vandraas KF, 2010, EUR J CLIN PHARMACOL, V66, P823, DOI 10.1007/s00228-010-0825-2; VENTAFRIDDA V, 1987, CANCER, V59, P850, DOI 10.1002/1097-0142(19870215)59:4<850::AID-CNCR2820590432>3.0.CO;2-1; Violan C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-251; World Health Organization, 1996, CANC PAIN REL GUID O	60	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168987	10.1371/journal.pone.0168987	http://dx.doi.org/10.1371/journal.pone.0168987			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2QJ	28046033	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000391612300083
J	Akhtar, N; Jabeen, I				Akhtar, Noreen; Jabeen, Ishrat			A 2D-QSAR and Grid-Independent Molecular Descriptor (GRIND) Analysis of Quinoline-Type Inhibitors of Akt2: Exploration of the Binding Mode in the Pleckstrin Homology (PH) Domain	PLOS ONE			English	Article							ALLOSTERIC DUAL AKT-1; KINASE-B-GAMMA; ENHANCES PROLIFERATION; SIGNALING PATHWAY; IN-VIVO; POTENT; DISCOVERY; DOCKING; PHOSPHORYLATION; ACTIVATION	Protein kinase B-beta (PKB beta/Akt2) is a serine/threonine-specific protein kinase that has emerged as one of the most important regulators of cell growth, differentiation, and division. Upregulation of Akt2 in various human carcinomas, including ovarian, breast, and pancreatic, is a well-known tumorigenesis phenomenon. Early on, the concept of the simultaneous administration of anticancer drugs with inhibitors of Akt2 was advocated to overcome cell proliferation in the chemotherapeutic treatment of cancer. However, clinical studies have not lived up to the high expectations, and several phase II and phase III clinical studies have been terminated prematurely because of severe side effects related to the non-selective isomeric inhibition of Akt2. The notion that the sequence identity of pleckstrin homology (PH) domains within Akt-isoforms is less than 30% might indicate the possibility of the development of selective antagonists against the Akt2 PH domain. Therefore, in this study, various in silico tools were utilized to explore the hypothesis that quinoline-type inhibitors bind in the Akt2 PH domain. A Grid-Independent Molecular Descriptor (GRIND) analysis indicated that two hydrogen bond acceptors, two hydrogen bond donors and one hydrophobic feature at a certain distance from each other were important for the selective inhibition of Akt2. Our docking results delineated the importance of Lys30 as an anchor point for mapping the distances of important amino acid residues in the binding pocket, including Lys14, Glu17, Arg25, Asn53, Asn54 and Arg86. The binding regions identified complement the GRIND-based pharmacophoric features.	[Akhtar, Noreen; Jabeen, Ishrat] Natl Univ Sci & Technol, RCMS, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan	Jabeen, I (corresponding author), Natl Univ Sci & Technol, RCMS, Islamabad, Pakistan.	ishrat.jabeen@rcms.nust.edu.pk	Jabeen, Ishrat/AAD-1389-2022		NUST Indigenous Scholarships [0920/05/Sch-2ndBatch/G]	NUST Indigenous Scholarships	Support was provided by NUST Indigenous Scholarships No. 0920/05/Sch-2nd Batch/G.	Al-Bazz YO, 2009, EUR J CANCER, V45, P694, DOI 10.1016/j.ejca.2008.11.044; Albini A, 2005, FASEB J, V19, P527, DOI 10.1096/fj.05-5128fje; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; [Anonymous], 2013, MOL OP ENV MOE; BARONI M, 1993, QUANT STRUCT-ACT REL, V12, P9, DOI 10.1002/qsar.19930120103; BELLACOSA A, 1995, INT J CANCER, V64, P280, DOI 10.1002/ijc.2910640412; Bilodeau MT, 2008, BIOORG MED CHEM LETT, V18, P3178, DOI 10.1016/j.bmcl.2008.04.074; Blessy Christina N.M.M., 2012, INT J PHARM SCI REV, V17, P56; Bogoyevitch MA, 2007, DRUG DISCOV TODAY, V12, P622, DOI 10.1016/j.drudis.2007.06.008; Brodbeck D, 1999, J BIOL CHEM, V274, P9133, DOI 10.1074/jbc.274.14.9133; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Calleja Veronique, 2009, J Chem Biol, V2, P11, DOI 10.1007/s12154-009-0016-8; Cariaga-Martinez AE, 2013, CELL SIGNAL, V25, P1586, DOI 10.1016/j.cellsig.2013.03.019; Chen HM, 2006, J CHEM INF MODEL, V46, P401, DOI 10.1021/ci0503255; Chen J, 2010, BLOOD, V115, P4237, DOI 10.1182/blood-2009-11-255323; Chen SF, 2014, J MOL GRAPH MODEL, V48, P36, DOI 10.1016/j.jmgm.2013.12.002; Chen SF, 2013, J MOL MODEL, V19, P5097, DOI 10.1007/s00894-013-1997-3; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cherrin C, 2010, CANCER BIOL THER, V9, P493, DOI 10.4161/cbt.9.7.11100; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cleasby ME, 2007, MOL ENDOCRINOL, V21, P215, DOI 10.1210/me.2006-0154; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Du-Cuny L, 2009, BIOORGAN MED CHEM, V17, P6983, DOI 10.1016/j.bmc.2009.08.022; duah A, 2008, J CHEMINFORMATICS, V48, P1813, DOI [10.1021/ci800037t, DOI 10.1021/CI800037T]; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Elisseeff A., 2003, NATO SCI SERIES 3, V190, P111; Fei J, 2013, INT J MED SCI, V10, P265, DOI 10.7150/ijms.5344; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Gan L, 2015, J LIPID RES, V56, P1471, DOI 10.1194/jlr.M057679; Gillet VJ, 2011, WIRES COMPUT MOL SCI, V1, P580, DOI 10.1002/wcms.33; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Huang BX, 2006, MOL CELL PROTEOMICS, V5, P1045, DOI 10.1074/mcp.M600026-MCP200; Jabeen I, 2012, J MED CHEM, V55, P3261, DOI 10.1021/jm201705f; Jo H, 2011, P NATL ACAD SCI USA, V108, P6486, DOI 10.1073/pnas.1019062108; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; JONES PF, 1991, CELL REGUL, V2, P1001, DOI 10.1091/mbc.2.12.1001; Kammasud N, 2009, BIOORG MED CHEM LETT, V19, P745, DOI 10.1016/j.bmcl.2008.12.023; Kumar CC, 2005, ONCOGENE, V24, P7493, DOI 10.1038/sj.onc.1209087; Labute P, 2001, J MED CHEM, V44, P1483, DOI 10.1021/jm0002634; Li YW, 2009, BIOORG MED CHEM LETT, V19, P834, DOI 10.1016/j.bmcl.2008.12.017; Lin Xiao-Dong, 2006, Hepatobiliary Pancreat Dis Int, V5, P16; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Liu J., 2014, EURASIP J ADV SIG PR, V2014, P1, DOI DOI 10.1016/J.EJMECH.2013.11.036; Liu M, 2015, SENSORS-BASEL, V15, P26567, DOI 10.3390/s151026567; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Mahadevan D, 2008, MOL CANCER THER, V7, P2621, DOI 10.1158/1535-7163.MCT-07-2276; Meng XY, 2011, CURR COMPUT-AID DRUG, V7, P146; Meuillet EJ, 2011, CURR MED CHEM, V18, P2727; Meuillet EJ, 2003, MOL CANCER THER, V2, P389; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Morrow JK, 2011, RECENT PAT ANTI-CANC, V6, P146; Muddassar M, 2009, J MOL MODEL, V15, P183, DOI 10.1007/s00894-008-0416-7; Muniyan S, 2014, CANCER LETT, V353, P59, DOI 10.1016/j.canlet.2014.07.002; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Reuveni H, 2002, BIOCHEMISTRY-US, V41, P10304, DOI 10.1021/bi0202530; Riemenschneider MJ, 2006, CANCER RES, V66, P5618, DOI 10.1158/0008-5472.CAN-06-0364; Romano G, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/317186; Ruggeri BA, 1998, MOL CARCINOGEN, V21, P81, DOI 10.1002/(SICI)1098-2744(199802)21:2<81::AID-MC1>3.0.CO;2-R; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schmuker M, 2004, MOL DIVERS, V8, P421, DOI 10.1023/B:MODI.0000047503.82461.e8; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siu T, 2008, BIOORG MED CHEM LETT, V18, P4191, DOI 10.1016/j.bmcl.2008.05.084; Siu T, 2008, BIOORG MED CHEM LETT, V18, P4186, DOI 10.1016/j.bmcl.2008.05.085; Stanton DT, 1999, J CHEM INF COMP SCI, V39, P21, DOI 10.1021/ci9801015; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Vyas V.K., 2013, ARABIAN J CHEM; Vyas VK, 2013, MED CHEM RES, V22, P6046, DOI 10.1007/s00044-013-0593-5; Vyas VK, 2013, J MOL GRAPH MODEL, V42, P17, DOI 10.1016/j.jmgm.2013.01.010; Wassermann AM, 2012, COMPUTATIONAL ANAL S; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu ZC, 2008, BIOORG MED CHEM LETT, V18, P1274, DOI 10.1016/j.bmcl.2008.01.054; Wu ZC, 2008, BIOORG MED CHEM LETT, V18, P2211, DOI 10.1016/j.bmcl.2007.10.023; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zhao ZJ, 2008, BIOORG MED CHEM LETT, V18, P49, DOI 10.1016/j.bmcl.2007.11.015; Zhao ZJ, 2005, BIOORG MED CHEM LETT, V15, P905, DOI 10.1016/j.bmcl.2004.12.062; Zhu GD, 2006, BIOORG MED CHEM LETT, V16, P3150, DOI 10.1016/j.bmcl.2006.03.041; Zhu YL, 2014, MOL MED REP, V10, P737, DOI 10.3892/mmr.2014.2314	80	5	5	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168806	10.1371/journal.pone.0168806	http://dx.doi.org/10.1371/journal.pone.0168806			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036396	Green Submitted, Green Published, gold			2022-12-26	WOS:000391229300031
J	Romay-Barja, M; Ncogo, P; Nseng, G; Santana-Morales, MA; Herrador, Z; Berzosa, P; Valladares, B; Riloha, M; Benito, A				Romay-Barja, Maria; Ncogo, Policarpo; Nseng, Gloria; Santana-Morales, Maria A.; Herrador, Zaida; Berzosa, Pedro; Valladares, Basilio; Riloha, Matilde; Benito, Agustin			Caregivers' Malaria Knowledge, Beliefs and Attitudes, and Related Factors in the Bata District, Equatorial Guinea	PLOS ONE			English	Article							VECTOR CONTROL; PREVALENCE; COMMUNITY; PERCEPTIONS; PREVENTION; CHILDREN; DETERMINANTS; TRANSMISSION; MANAGEMENT; COVERAGE	Objectives Adequate community knowledge about malaria is crucial in order to improve prevention by reducing exposure to the disease. Malaria is a major cause of morbidity and mortality among children of less than five years of age in Equatorial Guinea. However, information concerning the accuracy of community knowledge is insufficient. This study aimed at assessing the depth of caregivers' knowledge of malaria, their beliefs and attitudes about this disease, and their socioeconomic determinants in the Bata district of Equatorial Guinea. Methodology A cross-sectional study was conducted in the district of Bata, involving 440 houses selected from 18 rural villages and 26 urban neighbourhoods. A combined "Malaria Knowledge Score" was generated based on caregivers' knowledge about transmission, symptoms, prevention, the treatment of children, and best place to seek treatment. Multivariate logistic regressions analyses were performed to assess those factors that are associated with knowledge about malaria. Results A total of 428 caregivers were interviewed; 255 (59.6%) and 173 (40.4%) lived in urban and rural areas respectively. Significant differences between rural and urban households were observed in caregivers' malaria knowledges and beliefs. Almost 42% of urban and 65% of rural caregivers were unaware as to how malaria is transmitted (OR = 2.69; 95% CI: 1.78-4.05). Together with rurality, the factors most significantly associated with the Malaria Knowledge were the level of education of the caregiver and the socioeconomic status of the household. Conclusions Improvements in educational programs are needed to empower the most vulnerable households such that they can pro-actively implement malaria control measures. This could be achieved by a comprehensive communication strategy aimed at changing individual and community behaviours, and delivered by suitably trained community health workers and indoor residual spraying personnel.	[Romay-Barja, Maria; Herrador, Zaida; Berzosa, Pedro; Benito, Agustin] Inst Salud Carlos III, Ctr Nacl Med Trop, Madrid, Spain; [Romay-Barja, Maria; Santana-Morales, Maria A.; Herrador, Zaida; Berzosa, Pedro; Valladares, Basilio; Benito, Agustin] RICET, Madrid, Spain; [Ncogo, Policarpo] Ctr Referencia Control Endemias, Malabo, Guinea; [Nseng, Gloria; Benito, Agustin] Minist Salud & Bienestar Social, Malabo, Guinea; [Santana-Morales, Maria A.; Valladares, Basilio] Univ La Laguna, Inst Univ Enfermedades Trop & Salud Publ Canarias, Tenerife, Spain	Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); Universidad de la Laguna	Romay-Barja, M (corresponding author), Inst Salud Carlos III, Ctr Nacl Med Trop, Madrid, Spain.; Romay-Barja, M (corresponding author), RICET, Madrid, Spain.	mromay@isciii.es		Benito, Agustin/0000-0001-8229-5540; Herrador, Zaida/0000-0002-6508-3818; Romay-Barja, Maria/0000-0002-0177-6885; Berzosa, Pedro/0000-0002-8768-717X	Agencia Espanola de Cooperacion Internacional (AECID) [TREG1415/11]; Tropical Diseases Research Network (RICET) [RD12/0018/0001]	Agencia Espanola de Cooperacion Internacional (AECID); Tropical Diseases Research Network (RICET)	This study was funded by the Agencia Espanola de Cooperacion Internacional (AECID), TREG1415/11, http://www.aecid.es/ES; and the Tropical Diseases Research Network (RICET), RD12/0018/0001, http://www.ricet.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedotun AA, 2010, J VECTOR DIS, V47, P155; Akenji TKN, 2005, T ROY SOC TROP MED H, V99, P325, DOI 10.1016/j.trstmh.2003.12.016; [Anonymous], 2012, EQ GUIN DHS 2011 FIN; Canavati SE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1276-8; Clouston SAP, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1010-y; de Castro MC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-161; Deressa W, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-259; Dhawan G, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-303; Einterz EM, 2003, T ROY SOC TROP MED H, V97, P51, DOI 10.1016/S0035-9203(03)90020-4; Erhun W, 2006, AFRICAN J BIOMEDICAL, V8, P25; Geissbuhler Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005107; Gobena T, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20461; Guerra-Neira Ana, 2006, Int J Health Geogr, V5, P27, DOI 10.1186/1476-072X-5-27; Guyant P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0802-4; Hanafi-Bojd AA, 2011, SE ASIAN J TROP MED, V42, P491; Hlongwana KW, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-29; Hwang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011692; Imbahale SS, 2010, ACTA TROP, V115, P248, DOI 10.1016/j.actatropica.2010.04.005; Jima D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-58; Keiser J, 2004, AM J TROP MED HYG, V71, P118, DOI 10.4269/ajtmh.2004.71.118; Kimbi HK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-883; Kinung'hi SM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-395; KLEIN RE, 1995, AM J TROP MED HYG, V52, P383, DOI 10.4269/ajtmh.1995.52.383; Koenker H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-1; Legesse Y., 2007, ETHIOP J HEALTH DEV, V21, DOI 10.4314/ejhd.v21i2.10044; Mazigo Humphrey D, 2010, Malar Res Treat, V2010, P794261, DOI 10.4061/2010/794261; Mboera Leonard E G, 2007, East Afr J Public Health, V4, P33; Molyneux CS, 1999, TROP MED INT HEALTH, V4, P836, DOI 10.1046/j.1365-3156.1999.00489.x; Mukabana WR, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-9; Ncogo P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0986-7; Nganda RY, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-42; Nsagha Dickson Shey, 2011, Pan Afr Med J, V9, P8; Opiyo P, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-48; Regmi Krishna, 2016, Infection Ecology & Epidemiology, V6, P30822, DOI 10.3402/iee.v6.30822; Rehman AM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-154; Romay-Barja M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1239-0; Romay-Barja M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135887; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sharma Arun Kumar, 2007, Journal of Vector Borne Diseases, V44, P189; Shayo EH, 2015, ACTA TROP, V144, P41, DOI 10.1016/j.actatropica.2015.01.003; Spjeldnaes AO, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-200; WHO, EM SPREAD ART RES CA; World Health Organization, WORLD HLTH STAT; World Health Organization, WORLD MALARIA REPORT; Yimer F, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0749-5	45	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168668	10.1371/journal.pone.0168668	http://dx.doi.org/10.1371/journal.pone.0168668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036341	gold, Green Published			2022-12-26	WOS:000391229300021
J	Schaff, CT; Gruse, J; Maciej, J; Mielenz, M; Wirthgen, E; Hoeflich, A; Schmicke, M; Pfuhl, R; Jawor, P; Stefaniak, T; Hammon, HM				Schaeff, Christine T.; Gruse, Jeannine; Maciej, Josefine; Mielenz, Manfred; Wirthgen, Elisa; Hoeflich, Andreas; Schmicke, Marion; Pfuhl, Ralf; Jawor, Paulina; Stefaniak, Tadeusz; Hammon, Harald M.			Effects of Feeding Milk Replacer Ad Libitum or in Restricted Amounts for the First Five Weeks of Life on the Growth, Metabolic Adaptation, and Immune Status of Newborn Calves	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; FACTOR-BINDING-PROTEINS; HOLSTEIN HEIFER CALVES; ACUTE-PHASE PROTEINS; I IGF-I; SOMATOTROPIC AXIS; PLASMA-CONCENTRATIONS; GENE-EXPRESSION; DAIRY CALVES; RUMINAL DEVELOPMENT	The pre-weaning period is critical for calf health and growth, and intensive milk feeding programs may assist postnatal development by improving body growth and organ maturation. The aim of the present work was to study the effects of ad libitum milk replacer (MR) feeding on the growth, metabolic adaptation, health, and immune status of newborn calves. Twenty-eight newborn Holstein and Holstein x Charolais crossbred calves were fed ad libitum (ADLIB) or in restricted amounts (6 liters per day; RES) during the first five weeks of life. The MR intake in the ADLIB treatment was gradually reduced at weeks 6 and 7, and all calves then received 6 liters of MR per day until day 60. Blood samples were collected to measure the plasma concentrations of metabolites, insulin, insulin-like growth factor (IGF)-I and IGF binding proteins (IGFBP), immunoglobulins, and acute phase proteins. The expression of mRNA associated with both the somatotropic axis and gluconeogenic enzymes was measured in the liver on day 60. Intensive feeding improved MR intake and growth in ADLIB without influencing concentrate intake. Carcass weight, perirenal fat, and muscle mass were greater in ADLIB. Plasma concentrations of glucose, triglycerides, insulin, and IGF-I were greater, whereas plasma concentrations of beta-hydroxybutyrate, total protein, albumin, urea, IGFBP-2 and -4, and fibrinogen were lower at distinct time points in ADLIB. The hepatic mRNA expression of cytosolic phosphoenolpyruvate carboxykinase was greater in ADLIB. Most metabolic and endocrine differences occurred during the MR feeding period, but a slightly greater concentrate intake was associated with increased plasma IGF-I and insulin at the end of the study. The immune and health status of the calves were not affected by MR feeding. However, increased plasma fibrinogen in the RES group suggested differences in the acute phase response.	[Schaeff, Christine T.; Gruse, Jeannine; Maciej, Josefine; Mielenz, Manfred; Hammon, Harald M.] Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol Oskar Kellner, Dummerstorf, Germany; [Wirthgen, Elisa; Hoeflich, Andreas] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany; [Wirthgen, Elisa] Ligandis GbR, Gulzow Pruzen, Germany; [Schmicke, Marion] Univ Vet Med, Clin Cattle, Hannover, Germany; [Pfuhl, Ralf] Leibniz Inst Farm Anim Biol FBN, Inst Muscle Biol & Growth, Dummerstorf, Germany; [Jawor, Paulina; Stefaniak, Tadeusz] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Immunol Pathophysiol & Vet Prevent Med, Wroclaw, Poland	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); University of Veterinary Medicine Hannover, Foundation; Forschungsinstitut fur Nutztierbiologie (FBN); Wroclaw University of Environmental & Life Sciences	Hammon, HM (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol Oskar Kellner, Dummerstorf, Germany.	hammon@fbn-dummerstorf.de	Jawor, Paulina E/M-4500-2014; Hammon, Harald/AAD-9990-2020; Mielenz, Manfred/ABB-2293-2021	Jawor, Paulina E/0000-0003-3141-6722; Wirthgen, Elisa/0000-0002-8696-1675; Stefaniak, Tadeusz/0000-0002-8982-211X; Pfuhl, Ralf/0000-0001-5008-479X	Core Budget of the Leibniz Institute for Farm Animal Biology (FBN); Open Access fund of the Leibniz Institute for Farm Animal Biology (FBN); Ligandis GbR, Gulzow-Prozen, Germany	Core Budget of the Leibniz Institute for Farm Animal Biology (FBN); Open Access fund of the Leibniz Institute for Farm Animal Biology (FBN); Ligandis GbR, Gulzow-Prozen, Germany	This work was financially supported by the Core Budget of the Leibniz Institute for Farm Animal Biology (FBN). The publication of this article was funded by the Open Access fund of the Leibniz Institute for Farm Animal Biology (FBN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ligandis GbR, Gulzow-Prozen, Germany, provided support in the form of salaries for the author EW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abdelsamei AH, 2005, J ANIM SCI, V83, P940; Akers RM, 2006, J DAIRY SCI, V89, P1222, DOI 10.3168/jds.S0022-0302(06)72191-9; Amburgh M. E. van, 2013, Cow Longevity Conference, Hamra Farm, Tumba, Sweden, 28th-29th August, 2013, P178; Bach A, 2012, J ANIM SCI, V90, P1835, DOI 10.2527/jas.2011-4516; Baldwin R L, 2004, J DAIRY SCI, V87, pE55, DOI [10.3168/jds.2012-5970, DOI 10.3168/JDS.S0022-0302(04)70061-2]; BarPeled U, 1997, J DAIRY SCI, V80, P2523, DOI 10.3168/jds.S0022-0302(97)76205-2; Bartlett KS, 2006, J ANIM SCI, V84, P1454, DOI 10.2527/2006.8461454x; Brameld JM, 1999, J NUTR, V129, P1298, DOI 10.1093/jn/129.7.1298; Breier B. H., 2000, Ruminant physiology: digestion, metabolism, growth and reproduction, P187, DOI 10.1079/9780851994635.0187; BREIER BH, 1988, J ENDOCRINOL, V119, P43, DOI 10.1677/joe.0.1190043; Brown EG, 2005, J DAIRY SCI, V88, P585, DOI 10.3168/jds.S0022-0302(05)72722-3; Brown EG, 2005, J DAIRY SCI, V88, P595, DOI 10.3168/jds.S0022-0302(05)72723-5; Butler ST, 2003, J ENDOCRINOL, V176, P205, DOI 10.1677/joe.0.1760205; Clark R, 1997, ENDOCR REV, V18, P157, DOI 10.1210/er.18.2.157; Connor EE, 2000, J ANIM SCI, V78, P2913; Cordano P, 2000, DOMEST ANIM ENDOCRIN, V19, P191, DOI 10.1016/S0739-7240(00)00073-4; Daniels KM, 2008, J DAIRY SCI, V91, P2628, DOI 10.3168/jds.2007-0859; Davis TA, 2009, CURR OPIN CLIN NUTR, V12, P78, DOI 10.1097/MCO.0b013e32831cef9f; de Passille AM, 2016, APPL ANIM BEHAV SCI, V175, P2, DOI 10.1016/j.applanim.2014.10.002; Drackley JK, 2008, VET CLIN N AM-FOOD A, V24, P55, DOI 10.1016/j.cvfa.2008.01.001; Egli CP, 1998, J VET MED A, V45, P99, DOI 10.1111/j.1439-0442.1998.tb00806.x; Ellingsen K, 2016, PHYSIOL BEHAV, V154, P169, DOI 10.1016/j.physbeh.2015.11.025; ELSASSER TH, 1989, J ANIM SCI, V67, P128; Etherton TD, 1998, PHYSIOL REV, V78, P745, DOI 10.1152/physrev.1998.78.3.745; Furman-Fratczak K, 2011, J DAIRY SCI, V94, P5536, DOI 10.3168/jds.2010-3253; Gatford KL, 1998, J ENDOCRINOL, V157, P373, DOI 10.1677/joe.0.1570373; Geiger AJ, 2016, J DAIRY SCI, V99, P3995, DOI 10.3168/jds.2015-10405; Govoni KE, 2004, J ANIM SCI, V82, P1646; Govoni KE, 2003, J ANIM SCI, V81, P2811; Graber M, 2010, J DAIRY SCI, V93, P5200, DOI 10.3168/jds.2010-3265; Graham TW, 2010, J ANIM SCI, V88, P2585, DOI 10.2527/jas.2009-2610; Gruse J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146932; Gruse J, 2015, J NUTR, V145, P2486, DOI 10.3945/jn.115.218271; Gulliksen SM, 2009, J DAIRY SCI, V92, P2782, DOI 10.3168/jds.2008-1807; Hadorn U, 1997, J NUTR, V127, P2011, DOI 10.1093/jn/127.10.2011; Hajimohammadi Ali, 2013, Comp Clin Path, V22, P227, DOI 10.1007/s00580-011-1390-5; Hammon H, 1997, AM J PHYSIOL-ENDOC M, V273, pE130, DOI 10.1152/ajpendo.1997.273.1.E130; Hammon HM, 2012, DOMEST ANIM ENDOCRIN, V43, P171, DOI 10.1016/j.domaniend.2012.02.005; Hammon HM, 2009, J DAIRY SCI, V92, P1554, DOI 10.3168/jds.2008-1634; Hammon HM, 2005, J DAIRY SCI, V88, P2107, DOI 10.3168/jds.S0022-0302(05)72887-3; Hammon HM, 2003, J ENDOCRINOL, V179, P427, DOI 10.1677/joe.0.1790427; Hammon HM, 2002, J DAIRY SCI, V85, P3352, DOI 10.3168/jds.S0022-0302(02)74423-8; Hammon HM, 2000, J DAIRY SCI, V83, P85, DOI 10.3168/jds.S0022-0302(00)74859-4; Hill TM, 2010, J DAIRY SCI, V93, P1105, DOI 10.3168/jds.2009-2458; Hugi D, 1997, J VET MED A, V44, P99, DOI 10.1111/j.1439-0442.1997.tb01091.x; Jasper J, 2002, J DAIRY SCI, V85, P3054, DOI 10.3168/jds.S0022-0302(02)74391-9; JONES GE, 1984, RES VET SCI, V37, P87, DOI 10.1016/S0034-5288(18)31933-7; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kadegowda AKG, 2009, J DAIRY SCI, V92, P2007, DOI 10.3168/jds.2008-1655; KERR DE, 1991, CAN J ANIM SCI, V71, P695, DOI 10.4141/cjas91-085; Khan MA, 2007, J DAIRY SCI, V90, P3376, DOI 10.3168/jds.2007-0104; Khan MA, 2007, J DAIRY SCI, V90, P876, DOI 10.3168/jds.S0022-0302(07)71571-0; Khan MA, 2011, J DAIRY SCI, V94, P1071, DOI 10.3168/jds.2010-3733; Kristensen NB, 2007, J DAIRY SCI, V90, P4346, DOI 10.3168/jds.2006-885; Kuhn C, 2002, ARCH TIERZUCHT, V45, P317; Laeger T, 2014, J DAIRY SCI, V97, P2876, DOI 10.3168/jds.2013-7671; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Maccari P, 2015, J ANIM PHYSIOL AN N, V99, P737, DOI 10.1111/jpn.12241; MCGUIRE MA, 1995, AM J PHYSIOL-ENDOC M, V269, pE723, DOI 10.1152/ajpendo.1995.269.4.E723; Mee JF, 2008, VET CLIN N AM-FOOD A, V24, P1, DOI 10.1016/j.cvfa.2007.10.002; Meyerholz MM, 2015, J VET SCI, V16, P413, DOI 10.4142/jvs.2015.16.4.413; Moallem U, 2010, J DAIRY SCI, V93, P2639, DOI 10.3168/jds.2009-3007; Naeem A, 2012, J DAIRY SCI, V95, P1807, DOI 10.3168/jds.2011-4709; NAHMS (National Animal Health Monitoring System), 2011, DAIR 2011 DAIR HEIF; Obeidat BS, 2013, J DAIRY SCI, V96, P7155, DOI 10.3168/jds.2013-6699; Ollivett TL, 2012, JAVMA-J AM VET MED A, V241, P1514, DOI 10.2460/javma.241.11.1514; PELL JM, 1993, ENDOCRINOLOGY, V132, P1797, DOI 10.1210/en.132.4.1797; Pfaffl MW, 2002, DOMEST ANIM ENDOCRIN, V22, P91, DOI 10.1016/S0739-7240(01)00128-X; Piechotta M, 2014, J VET SCI, V15, P343, DOI 10.4142/jvs.2014.15.3.343; Rauprich ABE, 2000, J ANIM SCI, V78, P896; Renaville R, 2002, DOMEST ANIM ENDOCRIN, V23, P351, DOI 10.1016/S0739-7240(02)00170-4; Renaville R, 2000, DOMEST ANIM ENDOCRIN, V18, P165, DOI 10.1016/S0739-7240(99)00076-4; Rincker LED, 2011, J DAIRY SCI, V94, P3554, DOI 10.3168/jds.2010-3923; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sadri H, 2010, J ANIM PHYSIOL AN N, V94, pe194, DOI 10.1111/j.1439-0396.2010.01005.x; Saremi B, 2012, J DAIRY SCI, V95, P3131, DOI 10.3168/jds.2011-4803; Sauter SN, 2003, AM J PHYSIOL-ENDOC M, V285, pE252, DOI 10.1152/ajpendo.00557.2002; SCHEPER J, 1985, DLG SCHNITTFUHRUNG Z; Shen ZM, 2004, J NUTR, V134, P11, DOI 10.1093/jn/134.1.11; Sirotkin AV, 2002, J ANIM FEED SCI, V11, P265; SKAAR TC, 1994, J ANIM SCI, V72, P421, DOI 10.2527/1994.722421x; Smith JM, 2002, J ANIM SCI, V80, P1528; Steinhoff-Wagner J, 2011, J DAIRY SCI, V94, P5111, DOI 10.3168/jds.2011-4355; Svensson C, 2006, J DAIRY SCI, V89, P4769, DOI 10.3168/jds.S0022-0302(06)72526-7; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Tothova C, 2014, VET MED-CZECH, V59, P163, DOI 10.17221/7478-VETMED; Vacher PY, 1995, BIOL NEONATE, V68, P354, DOI 10.1159/000244256; Vestergaard M, 2003, J ANIM SCI, V81, P2189; Vieira AD, 2008, APPL ANIM BEHAV SCI, V109, P180, DOI 10.1016/j.applanim.2007.03.006; Weaver DM, 2000, J VET INTERN MED, V14, P569, DOI 10.1892/0891-6640(2000)014&lt;0569:PTOCII&gt;2.3.CO;2; Wood D., 2010, SCHALMS VET HEMATOLO, V6th ed., P829	91	53	54	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168974	10.1371/journal.pone.0168974	http://dx.doi.org/10.1371/journal.pone.0168974			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036351	Green Submitted, gold, Green Published			2022-12-26	WOS:000391229300043
J	Toledano, S; Lu, HY; Palacio, A; Ziv, K; Kessler, O; Schaal, S; Neufeld, G; Barak, Y				Toledano, Shire; Lu, Huayi; Palacio, Agustina; Ziv, Keren; Kessler, Ofra; Schaal, Shlomit; Neufeld, Gera; Barak, Yoreh			A Sema3C Mutant Resistant to Cleavage by Furin (FR-Sema3C) Inhibits Choroidal Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; BIPOLAR CELLS; SEMAPHORIN 3E; MOUSE MODEL; RECEPTOR; NEUROPILIN-1; VEGF; EXPRESSION; ANGIOGENESIS	In age-related macular degeneration (AMD), abnormal sub retinal choroidal neovascularization (CNV) is a major cause of blindness. FR-sema3C is a point mutated form of semaphorin-3C that is resistant to cleavage by furin like pro-protein convertases (FPPC). We have found in previous work that FR-sema3C functions as an anti-angiogenic factor. In this study we investigated the possible use of FR-sema3C as an inhibitor of CNV. FR-sema3C inhibits VEGF as well as PDGF-BB signal transduction in endothelial cells and to less extent bFGF induced signal transduction using a mechanism that does not depend upon the binding of VEGF like the drugs that are currently the mainstay treatment for AMD. CNV was induced in eyes of C57 black mice by laser photocoagulation. Intravitreal injection of FR-Sema3C or aflibercept (VEGF-trap) was then used to inhibit CNV formation. Invading choroidal vessels were visualized a week later by injection of FITC-dextran into the circulation, followed by the measurement of the area of the invading blood vessels. Injection of 0.1 mu g FR-Sema3C inhibited CNV by 55% (P<0.01) and was as effective as 5 mu g aflibercept. FR-sema3C did not display any adverse effects on retinal function following its injection into eyes of healthy mice as assessed by optokinetic reflex (OKR) and Electro-retinogram (ERG) criteria. Furthermore, FR-sema3C did not induce apoptosis in the retina as determined by TUNEL nor was there any discernable structural damage to the retina as assessed by several immuno-histochemical criteria. Our results suggest that FR-sema3C could perhaps be used for the treatment of AMD, and that it may perhaps be of benefit to patients that do not respond well to current treatments relying on VEGF sequestering agents.	[Toledano, Shire; Ziv, Keren; Kessler, Ofra; Neufeld, Gera] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc Res & Vasc Biol Ctr, Haifa, Israel; [Lu, Huayi] Jilin Univ, Hosp 2, Changchun, Jilin Province, Peoples R China; [Lu, Huayi; Palacio, Agustina; Schaal, Shlomit] Univ Louisville, Dept Ophthalmol & Visual Sci, Louisville, KY 40292 USA; [Schaal, Shlomit] Univ Massachusetts, Dept Ophthalmol & Visual Sci, Sch Med, Amherst, MA 01003 USA; [Barak, Yoreh] Rambam Med Ctr, Dept Ophthalmol, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Jilin University; University of Louisville; University of Massachusetts System; University of Massachusetts Amherst; Rambam Health Care Campus; Technion Israel Institute of Technology	Neufeld, G (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc Res & Vasc Biol Ctr, Haifa, Israel.; Schaal, S (corresponding author), Univ Louisville, Dept Ophthalmol & Visual Sci, Louisville, KY 40292 USA.; Schaal, S (corresponding author), Univ Massachusetts, Dept Ophthalmol & Visual Sci, Sch Med, Amherst, MA 01003 USA.; Barak, Y (corresponding author), Rambam Med Ctr, Dept Ophthalmol, Haifa, Israel.	s.schaal@umassmed.edu; gera@tx.technion.ac.il; yorehb@gmail.com	Palacio, Agustina/ABD-7463-2021; Neufeld, Gera/F-1524-2019	Toledano, Shira/0000-0002-2590-6066; Barak, Yoreh/0000-0002-6941-862X	ISF [940/11]; BSF [2013213]; Rappaport family grant	ISF(Israel Science Foundation); BSF(US-Israel Binational Science Foundation); Rappaport family grant	This work was supported by ISF grant 940/11 to GN (http://www.isf.org.il/#/), BSF grant to YB and SS GRANT# 2013213, (http://www.bsf.org.il/BSFPublic/DefaultPage1.aspx?PageId=22&innerTextID=22), and Rappaport family grant to GN (http://www.rappaport.org.il/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Bai YJ, 2014, MOL VIS, V20, P1258; Banu N, 2006, FASEB J, V20, P2150, DOI 10.1096/fj.05-5698fje; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Brown MM, 2006, CURR OPIN OPHTHALMOL, V17, P257; Campa C, 2008, INVEST OPHTH VIS SCI, V49, P1178, DOI 10.1167/iovs.07-1194; Campagne MV, 2014, J PATHOL, V232, P151, DOI 10.1002/path.4266; Campochiaro PA, 2013, J MOL MED, V91, P311, DOI 10.1007/s00109-013-0993-5; Casazza A, 2010, J CLIN INVEST, V120, P2684, DOI 10.1172/JCI42118; Casini G, 1996, VISUAL NEUROSCI, V13, P817, DOI 10.1017/S0952523800009081; Cohen T, 1992, GROWTH FACTORS, V7, P131, DOI 10.3109/08977199209046402; Cui JZ, 2003, CAN J OPHTHALMOL, V38, P41, DOI 10.1016/S0008-4182(03)80007-8; Dias JRD, 2011, BRIT J OPHTHALMOL, V95, P1631, DOI 10.1136/bjo.2010.186361; Dhar K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-209; Fantin A, 2015, CELL REP, V11, P1577, DOI 10.1016/j.celrep.2015.05.018; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Frank RN, 1996, AM J OPHTHALMOL, V122, P393, DOI 10.1016/S0002-9394(14)72066-5; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Gluzman-Poltorak Z, 2000, J BIOL CHEM, V275, P18040, DOI 10.1074/jbc.M909259199; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Guttmann-Raviv N, 2007, J BIOL CHEM, V282, P26294, DOI 10.1074/jbc.M609711200; Jonas JB, 2012, ACTA OPHTHALMOL, V90, pe381, DOI 10.1111/j.1755-3768.2012.02414.x; Kessler O, 2004, CANCER RES, V64, P1008, DOI 10.1158/0008-5472.CAN-03-3090; Lally DR, 2012, CURR OPIN OPHTHALMOL, V23, P182, DOI 10.1097/ICU.0b013e328352411c; Lampropoulou A, 2014, BIOCHEM SOC T, V42, P1623, DOI 10.1042/BST20140244; Li Q, 2002, EXP EYE RES, V74, P615, DOI 10.1006/exer.2002.1170; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Lu HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087530; Lu Q., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/201462, DOI 10.1155/2012/201462]; Man JH, 2014, CELL REP, V9, P1812, DOI 10.1016/j.celrep.2014.10.055; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Martin G, 2004, GRAEF ARCH CLIN EXP, V242, P321, DOI 10.1007/s00417-003-0838-y; Miyato H, 2012, CANCER SCI, V103, P1961, DOI 10.1111/cas.12003; Mumblat Y, 2015, CANCER RES, V75, P2177, DOI 10.1158/0008-5472.CAN-14-2464; NEUFELD G, 1988, J CELL PHYSIOL, V136, P537, DOI 10.1002/jcp.1041360321; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Pellet-Many C, 2011, BIOCHEM J, V435, P609, DOI 10.1042/BJ20100580; PENN JS, 1988, INVEST OPHTH VIS SCI, V29, P1623; Pennesi ME, 2012, MOL ASPECTS MED, V33, P487, DOI 10.1016/j.mam.2012.06.003; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Rizzolio S, 2012, CANCER RES, V72, P5801, DOI 10.1158/0008-5472.CAN-12-0995; Sabag AD, 2014, J CELL SCI, V127, P5240, DOI 10.1242/jcs.155960; Saishin Y, 2003, J CELL PHYSIOL, V195, P241, DOI 10.1002/jcp.10246; Scalabrino ML, 2015, HUM MOL GENET, V24, P6229, DOI 10.1093/hmg/ddv341; Schaal S, 2008, OPHTHALMOLOGY, V115, P2199, DOI 10.1016/j.ophtha.2008.07.007; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Suda K, 2014, INVEST OPHTH VIS SCI, V55, P4700, DOI 10.1167/iovs.14-14087; Sulpice E, 2008, BLOOD, V111, P2036, DOI 10.1182/blood-2007-04-084269; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; TESSLER S, 1990, J CELL PHYSIOL, V145, P310, DOI 10.1002/jcp.1041450216; West DC, 2005, J BIOL CHEM, V280, P13457, DOI 10.1074/jbc.M410924200; Yang W, 2015, ASCE-ASME J RISK U B, V1, DOI 10.1115/1.4029751; Yu WZ, 2013, MOL VIS, V19, P1397; Zacchigna S, 2008, J CLIN INVEST, V118, P2062, DOI 10.1172/JCI32832; Zhang F, 2009, P NATL ACAD SCI USA, V106, P6152, DOI 10.1073/pnas.0813061106	60	5	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168122	10.1371/journal.pone.0168122	http://dx.doi.org/10.1371/journal.pone.0168122			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036336	Green Submitted, Green Published, gold			2022-12-26	WOS:000391229300012
J	Xiao, Y; Li, Z; Li, C; Zhang, Z; Guo, JS				Xiao, Yan; Li, Zhe; Li, Chao; Zhang, Zhen; Guo, Jinsong			Effect of Small-Scale Turbulence on the Physiology and Morphology of Two Bloom-Forming Cyanobacteria	PLOS ONE			English	Article							CHLORELLA-VULGARIS; SHEAR-STRESS; CELL-SIZE; PHYTOPLANKTON; MICROCYSTIS; PHOSPHORUS; RESPONSES; GROWTH; FLOW; STRATEGIES	The main goal of the present work is to test the hypothesis that small-scale turbulence affected physiological activities and the morphology of cyanobacteria in high turbulence environments. Using quantified turbulence in a stirring device, we conducted one set of experiments on cultures of two strains of cyanobacteria with different phenotypes; i.e., unicellular Microcystis flos-aquae and colonial Anabaena flos-aquae. The effect of small-scale turbulence examined varied from 0 to 8.01x10(-2) m(2) s(-3), covering the range of turbulence intensities experienced by cyanobacteria in the field. The results of photosynthesis activity and the cellular chlorophyll a in both strains did not change significantly among the turbulence levels, indicating that the potential indirect effects of a light regime under the gradient of turbulent mixing could be ignored. However, the experiments demonstrated that small-scale turbulence significantly modulated algal nutrient uptake and growth in comparison to the stagnant control. Cellular N and C of the two stains showed approximately the same responses, resulting in a similar pattern of C/N ratios. Moreover, the change in the phosphate uptake rate was similar to that of growth in two strains, which implied that growth characteristic responses to turbulence may be dependent on the P strategy, which was correlated with accumulation of polyphosphate. Additionally, our results also showed the filament length of A. flos-aquae decreased in response to high turbulence, which could favor enhancement of the nutrient uptake. These findings suggested that both M. flos-aquae and A. flos-aquae adjust their growth rates in response to turbulence levels in the ways of asynchronous cellular stoichiometry of C, N, and P, especially the phosphorus strategy, to improve the nutrient application efficiency. The fact that adaptation strategies of cyanobacteria diversely to turbulence depending on their physiological conditions presents a good example to understand the direct cause-effect relationship between hydrodynamic forces and algae.	[Xiao, Yan; Li, Zhe; Zhang, Zhen; Guo, Jinsong] Chinese Acad Sci, Key Lab Reservoir Water Environm, Chongqing Inst Green & Intelligent Technol, Chongqing, Peoples R China; [Li, Chao] East China Univ Sci & Technol, Coll Biotechnol, State Key Lab Bioreactor Engn, Shanghai, Peoples R China	Chinese Academy of Sciences; Chongqing Institute of Green & Intelligent Technology, CAS; East China University of Science & Technology	Li, Z (corresponding author), Chinese Acad Sci, Key Lab Reservoir Water Environm, Chongqing Inst Green & Intelligent Technol, Chongqing, Peoples R China.	lizhe@cigit.ac.cn	Li, Chao/J-4529-2012; Li, Zhe/J-4626-2016	Li, Chao/0000-0001-5241-7914; Li, Zhe/0000-0003-1743-7906	National Natural Science Foundation [51309220, 51679226]; Chongqing Natural Science Program [cstc2015jcyjBX0006]; Western Action Program [KZCX2-XB3-14]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Program; Western Action Program	This work was supported by grants from the National Natural Science Foundation (No. 51309220, 51679226), the Chongqing Natural Science Program (cstc2015jcyjBX0006), and the Western Action Program founded by the Chinese Academy of Sciences (No. KZCX2-XB3-14).	APHA, 1995, STANDARD METHODS EXA; Barton A. D., 2014, LIMNOL OCEANOGR FLUI, V4, P34, DOI [10.1215/21573689-2651533, DOI 10.1215/21573689-2651533]; Beardall J, 2009, NEW PHYTOL, V181, P295, DOI 10.1111/j.1469-8137.2008.02660.x; Becker V, 2009, HYDROBIOLOGIA, V628, P137, DOI 10.1007/s10750-009-9751-7; Burford MA, 2006, FRESHWATER BIOL, V51, P2143, DOI 10.1111/j.1365-2427.2006.01630.x; Ebert U, 2001, B MATH BIOL, V63, P1095, DOI 10.1006/bulm.2001.0261; Eixler S, 2006, PHYCOLOGIA, V45, P53, DOI 10.2216/04-79.1; Eixler S, 2005, HYDROBIOLOGIA, V533, P135, DOI 10.1007/s10750-004-2406-9; Estrada M, 1997, SCI MAR, V61, P125; Guadayol O, 2009, LIMNOL OCEANOGR-METH, V7, P287, DOI 10.4319/lom.2009.7.287; Guillard R.R.L., 1973, HDB PHYCOLOGICAL MET, P289; Guven B, 2006, SCI TOTAL ENVIRON, V368, P898, DOI 10.1016/j.scitotenv.2006.03.035; Harrison P. J., 1988, EXPT PHYCOLOGY LAB M, P186; Huisman J, 2002, AM NAT, V159, P245, DOI 10.1086/338511; Iversen KR, 2010, J PLANKTON RES, V32, P197, DOI 10.1093/plankt/fbp113; Juhl AR, 2002, J PHYCOL, V38, P683, DOI 10.1046/j.1529-8817.2002.00165.x; Karp-Boss L, 2000, LIMNOL OCEANOGR, V45, P1594, DOI 10.4319/lo.2000.45.7.1594; KarpBoss L, 1996, OCEANOGR MAR BIOL, V34, P71; Klausmeier CA, 2008, ECOL RES, V23, P479, DOI 10.1007/s11284-008-0470-8; LAZIER JRN, 1989, DEEP-SEA RES, V36, P1721, DOI 10.1016/0198-0149(89)90068-X; Leupold M, 2013, J APPL PHYCOL, V25, P485, DOI 10.1007/s10811-012-9882-5; Li C, 2013, BIOCHEM ENG J, V70, P140, DOI 10.1016/j.bej.2012.10.012; Li FP, 2013, SCI TOTAL ENVIRON, V447, P64, DOI 10.1016/j.scitotenv.2012.12.066; Litchman E, 2010, HYDROBIOLOGIA, V653, P15, DOI 10.1007/s10750-010-0341-5; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Michels MHA, 2010, BIOPROC BIOSYST ENG, V33, P921, DOI 10.1007/s00449-010-0415-9; Moisander PH, 2002, LIMNOL OCEANOGR, V47, P108, DOI 10.4319/lo.2002.47.1.0108; Moisander PH, 2009, HARMFUL ALGAE, V8, P889, DOI 10.1016/j.hal.2009.04.005; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Ohalloran IP, 2008, SOIL SAMPLING METHOD; Oliver RL, 2000, ECOLOGY CYANOBACTERI, P105; PAERL HW, 1983, APPL ENVIRON MICROB, V46, P252, DOI 10.1128/AEM.46.1.252-259.1983; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; Peters F, 2000, MAR ECOL PROG SER, V205, P291, DOI 10.3354/meps205291; Petersen JE, 1998, MAR ECOL PROG SER, V171, P23, DOI 10.3354/meps171023; Prairie J.C., 2012, LIMNOL OCEANOGR FLUI, V2, P121, DOI DOI 10.1215/21573689-1964713; REYNOLDS CS, 1983, J PLANKTON RES, V5, P203, DOI 10.1093/plankt/5.2.203; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; SAVIDGE G, 1981, J MAR BIOL ASSOC UK, V61, P477, DOI 10.1017/S0025315400047093; Shen H, 2007, HYDROBIOLOGIA, V592, P475, DOI 10.1007/s10750-007-0794-3; Sivonen Kaarina, 1996, Phycologia, V35, P12, DOI 10.2216/i0031-8884-35-6S-12.1; Smayda TJ, 2001, J PLANKTON RES, V23, P447, DOI 10.1093/plankt/23.5.447; Sommaruga R, 2009, MICROB ECOL, V57, P667, DOI 10.1007/s00248-008-9425-4; STEINBERG C, 1990, J PLANKTON RES, V12, P661, DOI 10.1093/plankt/12.3.661; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sullivan JM, 2003, HARMFUL ALGAE, V2, P183, DOI 10.1016/S1568-9883(03)00039-8; Sullivan JM, 2003, J PHYCOL, V39, P83, DOI 10.1046/j.1529-8817.2003.02094.x; THOMAS WH, 1995, J PHYCOL, V31, P50, DOI 10.1111/j.0022-3646.1995.00050.x; Visser PM, 1997, HYDROBIOLOGIA, V349, P99, DOI 10.1023/A:1003001713560; Wang PL, 2012, MICROB ECOL, V63, P369, DOI 10.1007/s00248-011-9917-5; Wu ZX, 2007, ENVIRON POLLUT, V147, P324, DOI 10.1016/j.envpol.2006.05.022; Wu ZX, 2008, HYDROBIOLOGIA, V596, P47, DOI 10.1007/s10750-007-9056-7; Xie MH, 2014, IND ENG CHEM RES, V53, P5941, DOI 10.1021/ie400831s; Yoshiyama K, 2008, AM NAT, V171, P59, DOI 10.1086/523950; Yu Q, 2015, WATER-SUI, V7, P2184, DOI 10.3390/w7052184; Zhu Yi-ping, 2010, Huanjing Kexue, V31, P69	56	25	27	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168925	10.1371/journal.pone.0168925	http://dx.doi.org/10.1371/journal.pone.0168925			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036368	Green Published, gold, Green Submitted			2022-12-26	WOS:000391229300039
J	Li, N; Hennelly, SP; Stubben, CJ; Micheva-Viteva, S; Hu, B; Shou, YL; Vuyisich, M; Tung, CS; Chain, PS; Sanbonmatsu, KY; Hong-Geller, E				Li, Nan; Hennelly, Scott P.; Stubben, Chris J.; Micheva-Viteva, Sofiya; Hu, Bin; Shou, Yulin; Vuyisich, Momchilo; Tung, Chang-Shung; Chain, Patrick S.; Sanbonmatsu, Karissa Y.; Hong-Geller, Elizabeth			Functional and Structural Analysis of a Highly-Expressed Yersinia pestis Small RNA following Infection of Cultured Macrophages	PLOS ONE			English	Article							III SECRETION; AMINOGLYCOSIDE ANTIBIOTICS; TERTIARY STRUCTURE; HFQ; ACCURATE; REGULATOR; DISCOVERY; BINDING	Non-coding small RNAs (sRNAs) are found in practically all bacterial genomes and play important roles in regulating gene expression to impact bacterial metabolism, growth, and virulence. We performed transcriptomics analysis to identify sRNAs that are differentially expressed in Yersinia pestis that invaded the human macrophage cell line THP-1, compared to pathogens that remained extracellular in the presence of host. Using ultra high-throughput sequencing, we identified 37 novel and 143 previously known sRNAs in Y. pestis. In particular, the sRNA Ysr170 was highly expressed in intracellular Yersinia and exhibited a log2 fold change similar to 3.6 higher levels compared to extracellular bacteria. We found that knock-down of Ysr170 expression attenuated infection efficiency in cell culture and growth rate in response to different stressors. In addition, we applied selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) analysis to determine the secondary structure of Ysr170 and observed structural changes resulting from interactions with the aminoglycoside antibiotic gentamycin and the RNA chaperone Hfq. Interestingly, gentamicin stabilized helix 4 of Ysr170, which structurally resembles the native gentamicin 16S ribosomal binding site. Finally, we modeled the tertiary structure of Ysr170 binding to gentamycin using RNA motif modeling. Integration of these experimental and structural methods can provide further insight into the design of small molecules that can inhibit function of sRNAs required for pathogen virulence.	[Li, Nan; Stubben, Chris J.; Micheva-Viteva, Sofiya; Hu, Bin; Shou, Yulin; Vuyisich, Momchilo; Chain, Patrick S.; Hong-Geller, Elizabeth] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87544 USA; [Hennelly, Scott P.; Tung, Chang-Shung; Sanbonmatsu, Karissa Y.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Li, Nan] Sichuan Univ, Chengdu, Peoples R China; [Stubben, Chris J.] Univ Utah, Salt Lake City, UT USA; [Hu, Bin] SRA Int, Atlanta, GA USA; [Vuyisich, Momchilo] Viome Inc, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Sichuan University; Utah System of Higher Education; University of Utah; SRA International	Hong-Geller, E (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87544 USA.	ehong@lanl.gov	Chain, Patrick/O-4140-2019	Chain, Patrick/0000-0003-3949-3634; Hu, Bin/0000-0002-0278-8466; Stubben, Chris/0000-0002-3390-4888	Laboratory Directed Research and Development Directed Research (LDRD-DR) [20110051]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110310] Funding Source: NIH RePORTER	Laboratory Directed Research and Development Directed Research (LDRD-DR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Laboratory Directed Research and Development Directed Research (LDRD-DR) #20110051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Beauregard A, 2013, RNA BIOL, V10, P397, DOI 10.4161/rna.23590; BISWAS DK, 1972, P NATL ACAD SCI USA, V69, P2141, DOI 10.1073/pnas.69.8.2141; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; CLOUETDORVAL B, 1995, BIOCHEMISTRY-US, V34, P11186, DOI 10.1021/bi00035a025; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; De Gregorio E, 2006, J BACTERIOL, V188, P7876, DOI 10.1128/JB.00942-06; Faner MA, 2013, METHODS, V63, P144, DOI 10.1016/j.ymeth.2013.04.023; Fang N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00685; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129; Geng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006213; Henderson CA, 2013, RNA, V19, P1089, DOI 10.1261/rna.034595.112; Hennelly SP, 2013, NUCLEIC ACIDS RES, V41, P1922, DOI 10.1093/nar/gks978; Karabiber F, 2013, RNA, V19, P63, DOI 10.1261/rna.036327.112; Kawamoto H, 2006, MOL MICROBIOL, V61, P1013, DOI 10.1111/j.1365-2958.2006.05288.x; Kim H, 2012, MOL BIOSYST, V8, P2857, DOI 10.1039/c2mb25333j; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Koo JT, 2011, P NATL ACAD SCI USA, V108, pE709, DOI 10.1073/pnas.1101655108; Kwuan L, 2013, INFECT IMMUN, V81, P905, DOI 10.1128/IAI.01014-12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Livny J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003197; McClure R, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt444; Mei HY, 1998, BIOCHEMISTRY-US, V37, P14204, DOI 10.1021/bi981308u; Micheva-Viteva SN, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-249; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Noah JW, 1999, J BIOL CHEM, V274, P16576, DOI 10.1074/jbc.274.23.16576; Novikova IV, 2013, J MOL BIOL, V425, P3731, DOI 10.1016/j.jmb.2013.02.030; Ribeiro ED, 2012, NUCLEIC ACIDS RES, V40, P8072, DOI 10.1093/nar/gks510; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Schiano CA, 2014, J BACTERIOL, V196, P1659, DOI 10.1128/JB.01456-13; Shepherd DP, 2013, ANAL CHEM; Stubben CJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-385; Tok JBH, 1999, BIOCHEMISTRY-US, V38, P199, DOI 10.1021/bi9819428; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Tung CS, 2002, NAT STRUCT BIOL, V9, P750, DOI 10.1038/nsb841; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Vincent HA, 2012, NUCLEIC ACIDS RES, V40, P8698, DOI 10.1093/nar/gks582; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Yan YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074495; ZAPP ML, 1993, CELL, V74, P969, DOI 10.1016/0092-8674(93)90720-B	43	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168915	10.1371/journal.pone.0168915	http://dx.doi.org/10.1371/journal.pone.0168915			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030576	gold, Green Published, Green Submitted			2022-12-26	WOS:000391222000084
J	Muric, G; Jorswieck, E; Scheunert, C				Muric, Goran; Jorswieck, Eduard; Scheunert, Christian			Using LTI Dynamics to Identify the Influential Nodes in a Network	PLOS ONE			English	Article							COMPLEX; IDENTIFICATION; SPREADERS	Networks are used for modeling numerous technical, social or biological systems. In order to better understand the system dynamics, it is a matter of great interest to identify the most important nodes within the network. For a large set of problems, whether it is the optimal use of available resources, spreading information efficiently or even protection from malicious attacks, the most important node is the most influential spreader, the one that is capable of propagating information in the shortest time to a large portion of the network. Here we propose the Node Imposed Response (NiR), a measure which accurately evaluates node spreading power. It outperforms betweenness, degree, k-shell and h-index centrality in many cases and shows the similar accuracy to dynamics-sensitive centrality. We utilize the system-theoretic approach considering the network as a Linear Time-Invariant system. By observing the system response we can quantify the importance of each node. In addition, our study provides a robust tool set for various protective strategies.	[Muric, Goran; Jorswieck, Eduard; Scheunert, Christian] Tech Univ Dresden, Commun Lab, Commun Theory, Saxony, Germany; [Muric, Goran] Leibniz Inst Ecol Urban & Reg Dev, Dresden Leibniz Grad Sch, Dresden, Saxony, Germany	Technische Universitat Dresden; Leibniz Institut fur okologische Raumentwicklung	Muric, G (corresponding author), Tech Univ Dresden, Commun Lab, Commun Theory, Saxony, Germany.; Muric, G (corresponding author), Leibniz Inst Ecol Urban & Reg Dev, Dresden Leibniz Grad Sch, Dresden, Saxony, Germany.	g.muric@dlgs.ioer.de	Jorswieck, Eduard Axel/A-2516-2009; Muric, Goran/ABD-2839-2020; Jorswieck, Eduard/O-8092-2019	Jorswieck, Eduard Axel/0000-0001-7893-8435; Muric, Goran/0000-0002-3700-2347; Jorswieck, Eduard/0000-0001-7893-8435	Dresden Leibniz Graduate School; German Research Foundation (DFG) within the Cluster of Excellence "Center for Advancing Electronics Dresden (cfaed)" - Deutsche Forschungsgemeinschaft (DE) [EXC 1056]	Dresden Leibniz Graduate School; German Research Foundation (DFG) within the Cluster of Excellence "Center for Advancing Electronics Dresden (cfaed)" - Deutsche Forschungsgemeinschaft (DE)(German Research Foundation (DFG))	The work of Goran Muric is supported by Dresden Leibniz Graduate School (http://www.dlgs-dresden.de/). The work of Eduard Jorswieck is partly supported by the German Research Foundation (DFG) within the Cluster of Excellence "Center for Advancing Electronics Dresden (cfaed)" - Deutsche Forschungsgemeinschaft (DE) grant no. EXC 1056 (http://www.dfg.de/en/research_funding/programmes/list/projectdetails/index.jsp?id=194636624).	Alvarez-Hamelin J. I., 2005, ADV NEURAL INFORM PR, P41; [Anonymous], 2010, SOCIAL EC NETWORKS; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Batagelj V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036113; Bauer F, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/68007; Benzi M, 2015, SIAM J MATRIX ANAL A, V36, P686, DOI 10.1137/130950550; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Borgatti SP, 2006, SOC NETWORKS, V28, P466, DOI 10.1016/j.socnet.2005.11.005; Carmi S, 2007, P NATL ACAD SCI USA, V104, P11150, DOI 10.1073/pnas.0701175104; Diestel R., 2006, GRAPH THEORY, Vthird; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Estrada E, 2010, J THEOR BIOL, V263, P556, DOI 10.1016/j.jtbi.2010.01.014; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HAKIMI SL, 1962, J SOC IND APPL MATH, V10, P496, DOI 10.1137/0110037; Hoffmann H., 2015, VIOLIN M SIMPLE VIOL; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Klemm K, 2012, SCI REPORTS, V2, P8; Knight S, 2011, IEEE J SEL AREA COMM, V29, P1765, DOI 10.1109/JSAC.2011.111002; Lawyer G, 2015, SCI REP-UK, V5, DOI 10.1038/srep08665; Leskovec J., 2014, SNAP DATASETS STANFO; Liu JG, 2016, SCI REP-UK, V6, DOI 10.1038/srep21380; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lu LY, 2016, PHYS REP, V650, P1, DOI 10.1016/j.physrep.2016.06.007; Lu L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10168; Malliaros FD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19307; Milena M, 2002, ARACNE 2002; Muric G, 2015, IEEE CONF WIREL MOB, P138, DOI 10.1109/WiMOB.2015.7347953; Pei S, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/12/P12002; Piraveenan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053095; Proakis J. G., 2007, DIGITAL SIGNAL PROCE; Sikic M, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-31025-5; Taylor A, 2009, ACM T MATH SOFTWARE, V35, DOI 10.1145/1462173.1462175; Viana MP, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036105; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang B, INTERNET TOPOLOGY PR	38	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168514	10.1371/journal.pone.0168514	http://dx.doi.org/10.1371/journal.pone.0168514			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030548	Green Submitted, Green Published, gold			2022-12-26	WOS:000391222000052
J	Sofin, Y; Danker-Hopfe, H; Neu, P				Sofin, Yvonne; Danker-Hopfe, Heidi; Neu, Peter			The Effect of Significant International Sports Events on Qualified Detoxification Treatment Outcome - Do Drop-Out Rates Change during UEFA European Championship?	PLOS ONE			English	Article								No previous studies have evaluated the influence of significant international sports events on qualified detoxification treatment outcome. This prospective study examines the impact of the 2012 UEFA European Football Championship on inpatient treatment outcome of alcohol dependent patients. Hospital admission and premature drop-out rates of consecutively admitted alcohol dependent patients were determined before, during and immediately after the UEFA Championship in the year 2012. The admission rate of male patients increased significantly after the European Football Championship had ended whereas for female patients, no change in admission rate was found. Daily average discharge rate was calculated. No statistically relevant differences between the treatment days before, during and after the UEFA Championship was found for the discharges. During the tournament, exclusively male patients dropped out. Our results are consistent with an interpretation of an association between European Football Championship and detoxification treatment outcome. Further research to replicate and extend our findings is necessary.	[Sofin, Yvonne; Neu, Peter] Jewish Hosp Berlin, Clin Psychiat & Psychotherapy, Berlin, Germany; [Danker-Hopfe, Heidi] Charite Sch Med, Competence Ctr Sleep Med, Campus Benjamin Franklin, Berlin, Germany; [Neu, Peter] Charite Sch Med, Campus Benjamin Franklin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Neu, P (corresponding author), Jewish Hosp Berlin, Clin Psychiat & Psychotherapy, Berlin, Germany.; Neu, P (corresponding author), Charite Sch Med, Campus Benjamin Franklin, Berlin, Germany.	peter.neu@jkb-online.de		Danker-Hopfe, Heidi/0000-0001-7001-1715				Adams J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-473; Bedendo A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-247; Braune NJ, 2008, FORTSCHR NEUROL PSYC, V76, P217, DOI 10.1055/s-2008-1038116; Martinez-Raga J, 2002, ALCOHOL ALCOHOLISM, V37, P277, DOI 10.1093/alcalc/37.3.277; Moore Simon C, 2007, Crim Behav Ment Health, V17, P118, DOI 10.1002/cbm.647; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353	6	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167446	10.1371/journal.pone.0167446	http://dx.doi.org/10.1371/journal.pone.0167446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030560	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000008
J	Sundstrom, A; Bar-Sagi, D; Mishra, B				Sundstrom, Andrew; Bar-Sagi, Dafna; Mishra, Bud			Simulating Heterogeneous Tumor Cell Populations	PLOS ONE			English	Article							METABOLIC HETEROGENEITY; CANCER; MODEL; HYPOXIA; MYC; GLUCOSE; FIBROBLASTS; HALLMARKS; CARCINOMA; IMPACT	Certain tumor phenomena, like metabolic heterogeneity and local stable regions of chronic hypoxia, signify a tumor's resistance to therapy. Although recent research has shed light on the intracellular mechanisms of cancer metabolic reprogramming, little is known about how tumors become metabolically heterogeneous or chronically hypoxic, namely the initial conditions and spatiotemporal dynamics that drive these cell population conditions. To study these aspects, we developed a minimal, spatially-resolved simulation framework for modeling tissue-scale mixed populations of cells based on diffusible particles the cells consume and release, the concentrations of which determine their behavior in arbitrarily complex ways, and on stochastic reproduction. We simulate cell populations that self-sort to facilitate metabolic symbiosis, that grow according to tumor-stroma signaling patterns, and that give rise to stable local regions of chronic hypoxia near blood vessels. We raise two novel questions in the context of these results: (1) How will two metabolically symbiotic cell subpopulations self-sort in the presence of glucose, oxygen, and lactate gradients? We observe a robust pattern of alternating striations. (2) What is the proper time scale to observe stable local regions of chronic hypoxia? We observe the stability is a function of the balance of three factors related to O-2-diffusion rate, local vessel release rate, and viable and hypoxic tumor cell consumption rate. We anticipate our simulation framework will help researchers design better experiments and generate novel hypotheses to better understand dynamic, emergent whole-tumor behavior.	[Sundstrom, Andrew] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Bar-Sagi, Dafna] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [Sundstrom, Andrew; Mishra, Bud] Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA	Icahn School of Medicine at Mount Sinai; New York University	Sundstrom, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.; Sundstrom, A (corresponding author), Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA.	andrew.sundstrom@mssm.edu	Sundstrom, Andrew/AAI-3621-2021	Sundstrom, Andrew/0000-0002-3378-4513; Bar-Sagi, Dafna/0000-0003-2597-8948	National Science Foundation [DGE-0333389, CNS-0926166]	National Science Foundation(National Science Foundation (NSF))	AS was supported by National Science Foundation - DGE-0333389 - IGERT: Program in Computation - http://www.nsf.gov/. BM was supported by National Science Foundation - CNS-0926166 - Collaborative Research: Next Generation Model Checking and Abstract Interpretation with a Focus on Embedded Control and Systems Biology - http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andasari V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033726; [Anonymous], 2013, CELL; Bauer AL, 2007, BIOPHYS J, V92, P3105, DOI 10.1529/biophysj.106.101501; Bock M, 2010, B MATH BIOL, V72, P1696, DOI 10.1007/s11538-009-9498-3; Cantor JR, 2012, CANCER DISCOV, pOF1; Chen N, 2007, COMPUT PHYS COMMUN, V176, P670, DOI 10.1016/j.cpc.2007.03.007; Cirri P, 2011, AM J CANCER RES, V1, P482; Cleveland C, 2012, AIP ADV, V2, P1; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; Dang CV, 2009, CELL CYCLE, V8, P3243, DOI 10.4161/cc.8.20.9522; Emily M, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-37; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Giaccia AJ, 2010, CURR TOP MICROBIOL, V345, P31, DOI 10.1007/82_2010_73; Glazier JA, 2007, SINGLE CELL BASED MO, P79, DOI [10.1007/978-3-7643-8123-3_4, DOI 10.1007/978-3-7643-8123-3_4]; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Green DR, 2011, MEANS END APOPTOSIS; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatzikirou H, 2008, CURR TOP DEV BIOL, V81, P401, DOI 10.1016/S0070-2153(07)81014-3; Hockel M, 1996, CANCER RES, V56, P4509; Hoppensteadt FC, 2011, COURANT LECT NOTES A, V22; Hu J, 2013, NAT BIOTECHNOL, P1; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jamali Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012097; Jeon J, 2010, BIOPHYS J, V98, P37, DOI 10.1016/j.bpj.2009.10.002; Jha SK, 2009, LECT N BIOINFORMAT, V5688, P218, DOI 10.1007/978-3-642-03845-7_15; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; LAND AH, 1960, ECONOMETRICA, V28, P497, DOI 10.2307/1910129; Lea A, 2014, P NATL ACAD SCI USA, V111, P12486, DOI 10.1073/pnas.1402012111; Locasale JW, 2012, TRENDS ENDOCRIN MET, V23, P545, DOI 10.1016/j.tem.2012.07.005; Locasale JW, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-88; Lyssiotis CA, 2012, CELL, V151, P1155, DOI 10.1016/j.cell.2012.11.020; Maree AFM, 2007, SINGLE CELL BASED MO, P79; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Michalewicz Z., 2004, SOLVE IT MODERN HEUR, DOI [DOI 10.1007/978-3-662-07807-5, 10.1007/978-3-662-07807-5]; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; Nakajima EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102452; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Osinsky S, 2011, CLIN TRANSL ONCOL, V13, P133, DOI 10.1007/s12094-011-0630-0; Plank MJ, 2012, J R SOC INTERFACE, V9, P2983, DOI 10.1098/rsif.2012.0319; Scianna M, 2016, COMPUT BIOL MED, V76, P94, DOI 10.1016/j.compbiomed.2016.06.027; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; SEGEBARTH CM, 1990, MAGN RESON MED, V13, P62, DOI 10.1002/mrm.1910130108; Semenza GL, 2008, J CLIN INVEST, V118, P3835, DOI 10.1172/JCI37373; Simon MC, 2010, DIVERSE EFFECTS HYPO, V345, DOI [10.1007/978-3-642-13329-9, DOI 10.1007/978-3-642-13329-9]; Son SH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-585; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; SULSKY D, 1984, J THEOR BIOL, V106, P275, DOI 10.1016/0022-5193(84)90031-6; Szabo A, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00087; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Umeda T, 2004, J THEOR BIOL, V226, P215, DOI 10.1016/j.jtbi.2003.08.016; Vander Heiden MG, 2013, J CLIN INVEST, V123, P3648, DOI 10.1172/JCI72391; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vazquez A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-58; von Neumann J, 1966, THEORY SELF PRODUCIN; Voss-Bohme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042852; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P319; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xu HN, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-73; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058	65	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168984	10.1371/journal.pone.0168984	http://dx.doi.org/10.1371/journal.pone.0168984			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030620	gold, Green Submitted, Green Published			2022-12-26	WOS:000391222000095
J	Alford, L; Androdias, A; Franco, T; Pierre, JS; Burel, F; van Baaren, J				Alford, Lucy; Androdias, Annabelle; Franco, Thomas; Pierre, Jean-Sebastien; Burel, Francoise; van Baaren, Joan			Potential Host Manipulation by the Aphid Parasitoid Aphidius avenae to Enhance Cold Tolerance	PLoS One			English	Article							RUSSIAN WHEAT APHID; BEHAVIORAL THERMOREGULATION; THERMAL TOLERANCE; ALARM PHEROMONE; MYZUS-PERSICAE; PEA APHIDS; HYMENOPTERA; STRATEGIES; TEMPERATURES; HARDINESS	During parasitoid development, the immature parasitoid is confined to the host species. As a result, any potential to modify the physiology or behaviour of the host could play an important role in parasitoid fitness. The potential for host manipulation by the aphid parasitoid Aphidius avenae to increase cold thermotolerance was investigated using the aphid host species Metopolophium dirhodum and Sitobion avenae. Aphids were parasitized at L3/L4 instar stage (5 d old) and allowed to develop into pre-reproductive adults (10 d old) containing a 5 d old parasitoid larva. A control group was created of non-parasitized pre-reproductive adults (10 d old). The inherent physiological thermotolerance (LT50) and potential behavioural thermoregulation (behaviour in a declining temperature regime) of parasitized and non-parasitized aphids were investigated. Results revealed no effect of parasitism on the physiological thermotolerance of S. avenae and M. dirhodum. Significant differences in the behaviour of parasitized and non-parasitized aphids were observed, in addition to differences between host species, and such behaviours are discussed in view of the potential for host manipulation.	[Alford, Lucy; Androdias, Annabelle; Franco, Thomas; Pierre, Jean-Sebastien; Burel, Francoise; van Baaren, Joan] Univ Rennes 1, UMR 6553, ECOBIO, Ave Gen Leclerc, Rennes, France; [Alford, Lucy] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Davidson Bldg, Glasgow, Lanark, Scotland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes; University of Glasgow	Alford, L (corresponding author), Univ Rennes 1, UMR 6553, ECOBIO, Ave Gen Leclerc, Rennes, France.; Alford, L (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Davidson Bldg, Glasgow, Lanark, Scotland.	l.alford.02@cantab.net		Alford, Lucy/0000-0002-2967-4274; van baaren, joan/0000-0002-8552-9645	Marie Curie Intra-European Fellowship [FP7-PEOPLE-2012-IEF-326943]	Marie Curie Intra-European Fellowship(European Commission)	This work was funded by a Marie Curie Intra-European Fellowship for the project 'Climland' (FP7-PEOPLE-2012-IEF-326943) awarded to L Alford, F Burel and J van Baaren.	Alford L, 2012, J APPL ENTOMOL, V135, P332, DOI 10.1111/j.1439-0418.2011.01658.x; Alford L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114982; Alford L, 2012, AGR FOREST ENTOMOL, V14, P69, DOI 10.1111/j.1461-9563.2011.00553.x; Alleyne M, 1997, J INSECT PHYSIOL, V43, P407, DOI 10.1016/S0022-1910(96)00086-8; Andrade TO, 2013, ENTOMOL EXP APPL, V147, P167, DOI 10.1111/eea.12055; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; Barton M, 2014, J THERM BIOL, V41, P65, DOI 10.1016/j.jtherbio.2014.02.004; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; BRODEUR J, 1992, ECOL ENTOMOL, V17, P97, DOI 10.1111/j.1365-2311.1992.tb01164.x; BRODEUR J, 1989, SCIENCE, V244, P226, DOI 10.1126/science.244.4901.226; BRODEUR J, 1994, ANIM BEHAV, V48, P187, DOI 10.1006/anbe.1994.1225; BUTTS RA, 1992, J ECON ENTOMOL, V85, P1140, DOI 10.1093/jee/85.4.1140; CLEGG JM, 1982, CAN J ZOOL, V60, P2245, DOI 10.1139/z82-289; Colinet H, 2005, ECOL ENTOMOL, V30, P473, DOI 10.1111/j.0307-6946.2005.00716.x; Digilio MC, 2000, J INSECT PHYSIOL, V46, P1041, DOI 10.1016/S0022-1910(99)00216-4; Dixon AFG, 1998, APHID ECOLOGY OPTIMI; EGGLETON P, 1992, PHILOS T R SOC B, V337, P1, DOI 10.1098/rstb.1992.0079; Eoche-Bosy D, 2016, ENTOMOL EXP IN PRESS; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; HANCE T, 1993, CAN J ZOOL, V71, P759, DOI 10.1139/z93-100; HARRINGTON R, 1990, J ANIM ECOL, V59, P1177, DOI 10.2307/5039; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; Hazell SP, 2010, J INSECT PHYSIOL, V56, P115, DOI 10.1016/j.jinsphys.2009.08.020; Hazell SP, 2008, PHYSIOL ENTOMOL, V33, P389, DOI 10.1111/j.1365-3032.2008.00637.x; He XZ, 2011, J INSECT BEHAV, V24, P447, DOI 10.1007/s10905-011-9271-y; Hughes GE, 2010, PHYSIOL ENTOMOL, V35, P373, DOI 10.1111/j.1365-3032.2010.00754.x; Hughes GE, 2009, BIOCONTROL, V54, P785, DOI 10.1007/s10526-009-9230-0; Josso C, 2011, NATURWISSENSCHAFTEN, V98, P705, DOI 10.1007/s00114-011-0813-0; KINDLMANN P, 1989, FUNCT ECOL, V3, P531, DOI 10.2307/2389567; Lagos NA, 2001, J THERM BIOL, V26, P133, DOI 10.1016/S0306-4565(00)00033-4; LARSEN KJ, 1994, J INSECT PHYSIOL, V40, P859, DOI 10.1016/0022-1910(94)90019-1; Le Lann C, 2011, PHYSIOL ENTOMOL, V36, P21, DOI 10.1111/j.1365-3032.2010.00758.x; Libersat F, 2009, ANNU REV ENTOMOL, V54, P189, DOI 10.1146/annurev.ento.54.110807.090556; Losey JE, 1998, ECOL ENTOMOL, V23, P53, DOI 10.1046/j.1365-2311.1998.00102.x; Ma G, 2012, J INSECT PHYSIOL, V58, P1456, DOI 10.1016/j.jinsphys.2012.08.012; MCALLISTER MK, 1987, NATURE, V328, P797, DOI 10.1038/328797b0; MONTGOMERY ME, 1977, ENTOMOL EXP APPL, V22, P236, DOI 10.1007/BF00302860; Nowierski RM, 2002, BIOCONTROL, V47, P279, DOI 10.1023/A:1014824725240; Poulin R, 1995, INT J PARASITOL, V25, P1371, DOI 10.1016/0020-7519(95)00100-X; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; Powell SJ, 2008, ECOL ENTOMOL, V33, P95, DOI 10.1111/j.1365-2311.2007.00947.x; Powell SJ, 2005, J EXP BIOL, V208, P2615, DOI 10.1242/jeb.01685; Powell SJ, 2004, J INSECT PHYSIOL, V50, P277, DOI 10.1016/j.jinsphys.2004.01.003; REITZ SR, 1994, ENTOMOL EXP APPL, V71, P33, DOI 10.1007/BF02380567; Rivers DB, 2000, J INSECT PHYSIOL, V46, P99, DOI 10.1016/S0022-1910(99)00106-7; Seyahooei MA, 2009, OIKOS, V118, P1148, DOI 10.1111/j.1600-0706.2009.17508.x; SHIROTA Y, 1983, ENTOMOL EXP APPL, V34, P27, DOI 10.1007/BF00300896; Sinclair BJ, 2006, PHYSIOL ENTOMOL, V31, P98, DOI 10.1111/j.1365-3032.2005.00481.x; Sinclair BJ, 2015, J THERM BIOL, V53, P180, DOI 10.1016/j.jtherbio.2015.11.003; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Terblanche JS, 2008, J INSECT PHYSIOL, V54, P114, DOI 10.1016/j.jinsphys.2007.08.007; van Baaren J, 2004, ETHOL ECOL EVOL, V16, P231; Ward D, 1996, ANN ENTOMOL SOC AM, V89, P442, DOI 10.1093/aesa/89.3.442; Worland MR, 2010, J THERM BIOL, V35, P255, DOI 10.1016/j.jtherbio.2010.05.008	55	5	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168693	10.1371/journal.pone.0168693	http://dx.doi.org/10.1371/journal.pone.0168693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006018	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000392843200083
J	Schultz, V; Suflita, M; Liu, XY; Zhang, X; Yu, YL; Li, LY; Green, DE; Xu, YM; Zhang, FM; DeAngelis, PL; Liu, J; Linhardt, RJ				Schultz, Victor; Suflita, Mathew; Liu, Xinyue; Zhang, Xing; Yu, Yanlei; Li, Lingyun; Green, Dixy E.; Xu, Yongmei; Zhang, Fuming; DeAngelis, Paul L.; Liu, Jian; Linhardt, Robert J.			Heparan Sulfate Domains Required for Fibroblast Growth Factor 1 and 2 Signaling through Fibroblast Growth Factor Receptor 1c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT HEPARINS; CHEMOENZYMATIC SYNTHESIS; HEPARIN/HEPARAN SULFATE; HEPAROSAN SYNTHASES; TERNARY COMPLEXES; CELL-ADHESION; FACTOR FAMILY; FGF; SPECIFICITY; EXPRESSION	A small library of well defined heparan sulfate (HS) polysaccharides was chemoenzymatically synthesized and used for a detailed structure-activity study of fibroblast growth factor (FGF) 1 and FGF2 signaling through FGF receptor (FGFR) 1c. The HS polysaccharide tested contained both undersulfated (NA) domains and highly sulfated (NS) domains as well as very well defined non-reducing termini. This study examines differences in the HS selectivity of the positive canyons of the FGF1(2)-FGFR1c(2) and FGF2(2)-FGFR1c(2) HS binding sites of the symmetric FGF(2)-FGFR(2)-HS2 signal transduction complex. The results suggest that FGF1(2)-FGFR1c(2) binding site prefers a longer NS domain at the non-reducing terminus than FGF2(2)-FGFR1c(2). In addition, FGF2(2)-FGFR1c(2) can tolerate an HS chain having an N-acetylglucosamine residue at its non-reducing end. These results clearly demonstrate the different specificity of FGF1(2)-FGFR1c(2) and FGF2(2)-FGFR1c(2) for well defined HS structures and suggest that it is now possible to chemoenzymatically synthesize precise HS polysaccharides that can selectively mediate growth factor signaling. These HS polysaccharides might be useful in both understanding and controlling the growth, proliferation, and differentiation of cells in stem cell therapies, wound healing, and the treatment of cancer.	[Schultz, Victor; Liu, Xinyue; Zhang, Xing; Yu, Yanlei; Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Suflita, Mathew; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Li, Lingyun] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Green, Dixy E.; DeAngelis, Paul L.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA; [Xu, Yongmei; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; State University of New York (SUNY) System; Wadsworth Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of North Carolina; University of North Carolina Chapel Hill	Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, 110 8th Ave, Troy, NY 12180 USA.	linhar@rpi.edu	Yu, Yanlei/AAQ-4432-2020; Liu, Xinyue/AAR-6887-2021; Yu, Yanlei/GNH-4836-2022	Liu, Xinyue/0000-0002-0934-4155; 	National Institutes of Health [HL094463, HL62244]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062244, R01HL125371, R01HL094463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL094463 and HL62244. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baik JY, 2015, BIOTECHNOL J, V10, P1067, DOI 10.1002/biot.201400665; Brown A, 2013, BIOPHYS J, V104, P1720, DOI 10.1016/j.bpj.2013.02.051; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Chen JH, 2005, J BIOL CHEM, V280, P42817, DOI 10.1074/jbc.M504338200; DeAngelis Paul L, 2013, Methods Mol Biol, V1022, P215, DOI 10.1007/978-1-62703-465-4_17; DeAngelis PL, 2013, GLYCOBIOLOGY, V23, P764, DOI 10.1093/glycob/cwt016; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Faham S, 1998, CURR OPIN STRUC BIOL, V8, P578, DOI 10.1016/S0959-440X(98)80147-4; Gallagher JT, 1997, BIOCHEM SOC T, V25, P1206, DOI 10.1042/bst0251206; GALLAGHER JT, 1992, INT J BIOCHEM, V24, P553, DOI 10.1016/0020-711X(92)90326-V; GRIFFIN CC, 1995, CARBOHYD RES, V276, P183, DOI 10.1016/0008-6215(95)00166-Q; Habuchi H, 1998, J BIOL CHEM, V273, P9208, DOI 10.1074/jbc.273.15.9208; Hileman RE, 1997, GLYCOBIOLOGY, V7, P231; Ibrahimi OA, 2005, MOL CELL BIOL, V25, P671, DOI 10.1128/MCB.25.2.671-684.2005; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Jastrebova N, 2010, J BIOL CHEM, V285, P26842, DOI 10.1074/jbc.M109.093542; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; Jing W, 2004, J BIOL CHEM, V279, P42345, DOI 10.1074/jbc.M402744200; Kane TA, 2006, J BIOL CHEM, V281, P33192, DOI 10.1074/jbc.M606897200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kusche-Gullberg M, 2012, J BIOL CHEM, V287, P21950, DOI 10.1074/jbc.M112.350389; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Li GY, 2013, BIOPOLYMERS, V99, P675, DOI 10.1002/bip.22263; Li JP, 1997, J BIOL CHEM, V272, P28158, DOI 10.1074/jbc.272.44.28158; Li LY, 2012, ANAL CHEM, V84, P8822, DOI 10.1021/ac302232c; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Liu J, 2012, CURR OPIN STRUC BIOL, V22, P550, DOI 10.1016/j.sbi.2012.07.004; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; Maruyama T, 1998, CARBOHYD RES, V306, P35, DOI 10.1016/S0008-6215(97)10060-X; Masuko S, 2012, J ORG CHEM, V77, P1449, DOI 10.1021/jo202322k; Melder RJ, 1996, NAT MED, V2, P992, DOI 10.1038/nm0996-992; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; MONTESANO R, 1986, P NATL ACAD SCI USA, V83, P7297, DOI 10.1073/pnas.83.19.7297; Mulloy B, 2001, CURR OPIN STRUC BIOL, V11, P623, DOI 10.1016/S0959-440X(00)00257-8; Naimy H, 2011, J BIOL CHEM, V286, P19311, DOI 10.1074/jbc.M110.204693; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; Otto NJ, 2012, J BIOL CHEM, V287, P7203, DOI 10.1074/jbc.M111.311704; PERVIN A, 1995, GLYCOBIOLOGY, V5, P83, DOI 10.1093/glycob/5.1.83; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Powell AK, 2002, J BIOL CHEM, V277, P28554, DOI 10.1074/jbc.M111754200; Puvirajesinghe TM, 2012, CHEM BIOL, V19, P553, DOI 10.1016/j.chembiol.2012.03.011; Ramani VC, 2013, FEBS J, V280, P2294, DOI 10.1111/febs.12168; Robinson CJ, 2005, J BIOL CHEM, V280, P42274, DOI 10.1074/jbc.M505720200; ROSENBERG RD, 1978, P NATL ACAD SCI USA, V75, P3065, DOI 10.1073/pnas.75.7.3065; RUSNATI M, 1994, BIOCHEM BIOPH RES CO, V203, P450, DOI 10.1006/bbrc.1994.2203; Safaiyan F, 2000, BIOCHEMISTRY-US, V39, P10823, DOI 10.1021/bi000411s; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Sanchez-Heras E, 2006, J BIOL CHEM, V281, P35208, DOI 10.1074/jbc.M608655200; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sheng JZ, 2012, J BIOL CHEM, V287, P20996, DOI 10.1074/jbc.M112.359885; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Sismey-Ragatz AE, 2007, J BIOL CHEM, V282, P28321, DOI 10.1074/jbc.M701599200; Smits NC, 2010, J BIOL CHEM, V285, P41143, DOI 10.1074/jbc.M110.153791; Staples GO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016689; Sterner E, 2014, J BIOL CHEM, V289, P9754, DOI 10.1074/jbc.M113.546937; Sterner E, 2013, BIOCHEMISTRY-US, V52, P9009, DOI 10.1021/bi401284r; Su HS, 1996, APPL ENVIRON MICROB, V62, P2723, DOI 10.1128/AEM.62.8.2723-2734.1996; Sun XJ, 2015, ANAL CHEM, V87, P6220, DOI 10.1021/acs.analchem.5b00913; Thao KNN, 2011, FEBS LETT, V585, P2698, DOI 10.1016/j.febslet.2011.07.024; Varki A, 2009, ESSENTIALS GLYCOBIOL, P1; Williams KJ, 2006, J BIOL CHEM, V281, P5391, DOI 10.1074/jbc.M510439200; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; Yang B, 2012, J CHROMATOGR A, V1225, P91, DOI 10.1016/j.chroma.2011.12.063; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhang Z, 2001, J BIOL CHEM, V276, P41921, DOI 10.1074/jbc.M106608200; Zhou XX, 2011, GLYCOBIOLOGY, V21, P771, DOI 10.1093/glycob/cwr001	71	34	36	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2495	2509		10.1074/jbc.M116.761585	http://dx.doi.org/10.1074/jbc.M116.761585			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28031461	hybrid, Green Published			2022-12-26	WOS:000395530300036
J	Bayart, E; Pouzoulet, F; Calmels, L; Dadoun, J; Allot, F; Plagnard, J; Ravanat, JL; Bridier, A; Denoziere, M; Bourhis, J; Deutsch, E				Bayart, Emilie; Pouzoulet, Frederic; Calmels, Lucie; Dadoun, Jonathan; Allot, Fabien; Plagnard, Johann; Ravanat, Jean-Luc; Bridier, Andre; Denoziere, Marc; Bourhis, Jean; Deutsch, Eric			Enhancement of IUdR Radiosensitization by Low-Energy Photons Results from Increased and Persistent DNA Damage	PLOS ONE			English	Article							HALOGENATED PYRIMIDINES; HIGH-LET; X-RAY; CHROMOSOME-DAMAGE; RADIATION; IODODEOXYURIDINE; CELLS; REPAIR; FOCI; H2AX	Low-energy X-rays induce Auger cascades by photoelectric absorption in iodine present in the DNA of cells labeled with 5-iodo-2'-deoxyuridine (IUdR). This photoactivation therapy results in enhanced cellular sensitivity to radiation which reaches its maximum with 50 keV photons. Synchrotron core facilities are the only way to generate such monochromatic beams. However, these structures are not adapted for the routine treatment of patients. In this study, we generated two beams emitting photon energy means of 42 and 50 keV respectively, from a conventional 225 kV X-ray source. Viability assays performed after pre-exposure to 10 mu M of IUdR for 48h suggest that complex lethal damage is generated after low energy photons irradiation compared to 137 Cs irradiation (662KeV). To further decipher the molecular mechanisms leading to IUdR-mediated radiosensitization, we analyzed the content of DNA damage-induced foci in two glioblastoma cell lines and showed that the decrease in survival under these conditions was correlated with an increase in the content of DNA damage-induced foci in cell lines. Moreover, the follow-up of repair kinetics of the induced double-strand breaks showed the maximum delay in cells labeled with IUdR and exposed to X-ray irradiation. Thus, there appears to be a direct relationship between the reduction of radiation survival parameters and the production of DNA damage with impaired repair of these breaks. These results further support the clinical potential use of a halogenated pyrimidine analog combined with low-energy X-ray therapy.	[Bayart, Emilie; Deutsch, Eric] Univ Paris Saclay, INSERM U1030, Gustave Roussy, Villejuif, France; [Pouzoulet, Frederic] Inst Curie, Dept Rech Translat, Plateforme Radiotherapie Expt, Orsay, France; [Calmels, Lucie; Dadoun, Jonathan; Allot, Fabien; Bridier, Andre] Univ Paris Saclay, Dept Radiotherapie, Gustave Roussy, Villejuif, France; [Plagnard, Johann; Denoziere, Marc] CEA, Lab Natl Henri Becquerel, DRT LIST, Gif Sur Yvette, France; [Ravanat, Jean-Luc] Univ Grenoble Alpes, Lab Les Acides Nucle, INAC SCIB, Grenoble, France; [Ravanat, Jean-Luc] CEA, INAC SCIB, Grenoble, France; [Bourhis, Jean] CHU Vaudois, Dept Oncol, Radiat Oncol Serv, Lausanne, Switzerland; [Deutsch, Eric] Univ Paris Saclay, Fac Med Kremlin Bicetre, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; CEA; UDICE-French Research Universities; Universite Paris Saclay; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Bayart, E (corresponding author), Univ Paris Saclay, INSERM U1030, Gustave Roussy, Villejuif, France.	emilie.bayart@gustaveroussy.fr	Bayart, Emilie/AAV-6534-2020; Ravanat, Jean-Luc/E-3452-2018	Ravanat, Jean-Luc/0000-0002-7123-6358; Pouzoulet, Frederic/0000-0003-4819-2876; Bourhis, Jean/0000-0001-5162-1171; deutsch, eric/0000-0002-8223-3697; BAYART, Emilie/0000-0001-5865-5542	Agence nationale de la recherche [ANR-2010-BLAN-1532]	Agence nationale de la recherche(French National Research Agency (ANR))	This work was supported by ANR-2010-BLAN-1532, Agence nationale de la recherche, http://www.agence-nationale-recherche.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Financial support was from project ANR-2010-BLAN-1532 "Raphaelo".	Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Antonelli F, 2015, RADIAT RES, V183, P417, DOI 10.1667/RR13855.1; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chapman JD, 1980, RAD BIOL CANCER RES, P21; Corde S, 2004, BRIT J CANCER, V91, P544, DOI 10.1038/sj.bjc.6601951; Costes SV, 2006, RADIAT RES, V165, P505, DOI 10.1667/RR3538.1; Desai N, 2005, RADIAT RES, V164, P518, DOI 10.1667/RR3431.1; Dugas JP, 2011, INT J RADIAT ONCOL, V79, P255, DOI 10.1016/j.ijrobp.2010.07.023; Epstein A H, 1992, BJR Suppl, V24, P209; FAIRCHILD RG, 1982, INVEST RADIOL, V17, P407, DOI 10.1097/00004424-198207000-00020; FAIRCHILD RG, 1984, STRAHLENTHER ONKOL, V160, P758; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; FORNACE AJ, 1990, INT J RADIAT ONCOL, V18, P873, DOI 10.1016/0360-3016(90)90410-L; ILIAKIS G, 1989, RADIAT RES, V119, P286, DOI 10.2307/3577620; JACKSON D, 1987, AM J CLIN ONCOL-CANC, V10, P437, DOI 10.1097/00000421-198710000-00014; Karlsson KH, 2004, RADIAT RES, V161, P517, DOI 10.1667/RR3171; Karnas SJ, 2001, RADIAT ENVIRON BIOPH, V40, P199, DOI 10.1007/s004110100099; Karnas SJ, 1999, PHYS MED BIOL, V44, P2537, DOI 10.1088/0031-9155/44/10/312; Kassis AI, 2005, J NUCL MED, V46, p4S; Kinsella TJ, 2007, INT J RADIAT ONCOL, V69, P1254, DOI 10.1016/j.ijrobp.2007.08.004; KINSELLA TJ, 1987, INT J RADIAT ONCOL, V13, P733, DOI 10.1016/0360-3016(87)90292-6; Lasio G, 2014, RADIAT ENVIRON BIOPH, V53, P671, DOI 10.1007/s00411-014-0565-2; LASTER BH, 1993, RADIAT RES, V133, P219, DOI 10.2307/3578359; LAWRENCE TS, 1990, INT J RADIAT ONCOL, V18, P1393, DOI 10.1016/0360-3016(90)90313-9; Leatherbarrow EL, 2006, INT J RADIAT BIOL, V82, P111, DOI 10.1080/09553000600599783; MANNIRONI C, 1989, NUCLEIC ACIDS RES, V17, P9113, DOI 10.1093/nar/17.22.9113; MARINO P, 1995, CANCER, V76, P593, DOI 10.1002/1097-0142(19950815)76:4<593::AID-CNCR2820760409>3.0.CO;2-N; MILLER EM, 1992, RADIAT RES, V131, P81, DOI 10.2307/3578320; Miller RA, 1999, INT J RADIAT ONCOL, V45, P981, DOI 10.1016/S0360-3016(99)00274-6; MILLER RW, 1987, INT J RADIAT ONCOL, V13, P1193, DOI 10.1016/0360-3016(87)90194-5; MITCHELL JB, 1989, INT J RADIAT BIOL, V56, P827, DOI 10.1080/09553008914552111; NATH R, 1990, INT J RADIAT ONCOL, V18, P1377, DOI 10.1016/0360-3016(90)90311-7; NATH R, 1987, INT J RADIAT ONCOL, V13, P1071, DOI 10.1016/0360-3016(87)90047-2; NATH R, 1990, RADIAT RES, V124, P249, DOI 10.2307/3577836; Pignol JP, 2003, INT J RADIAT ONCOL, V55, P1082, DOI 10.1016/S0360-3016(02)04508-X; POMPLUN E, 1994, RADIAT ENVIRON BIOPH, V33, P279, DOI 10.1007/BF01210450; RODRIGUEZ R, 1991, INT J RADIAT ONCOL, V21, P859, DOI 10.1016/0360-3016(91)90710-L; SANO K, 1968, J NEUROSURG, V28, P530, DOI 10.3171/jns.1968.28.6.0530; SCHAAKEKONING C, 1992, NEW ENGL J MED, V326, P524, DOI 10.1056/NEJM199202203260805; Schmid TE, 2010, INT J RADIAT BIOL, V86, P682, DOI 10.3109/09553001003734543; Seo Y, 2004, CLIN CANCER RES, V10, P7520, DOI 10.1158/1078-0432.CCR-04-1144; Shinohara K, 1996, ACTA ONCOL, V35, P869, DOI 10.3109/02841869609104039; Steel GG, 1996, PHYS MED BIOL, V41, P205, DOI 10.1088/0031-9155/41/2/001; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; SUNDELLBERGMAN S, 1990, ACTA ONCOL, V29, P623, DOI 10.3109/02841869009090063; TYM R, 1964, INT J RADIAT BIOL RE, V8, P589, DOI 10.1080/09553006414550721; Urtasun RC, 1996, INT J RADIAT ONCOL, V36, P1163, DOI 10.1016/S0360-3016(96)00429-4; URTASUN RC, 1993, INT J RADIAT ONCOL, V27, P207, DOI 10.1016/0360-3016(93)90229-O; WANG Y, 1994, INT J RADIAT BIOL, V66, P133, DOI 10.1080/09553009414551031; WANG Y, 1992, INT J RADIAT ONCOL, V23, P353, DOI 10.1016/0360-3016(92)90753-5; WARD JF, 1986, INT J RADIAT ONCOL, V12, P1027, DOI 10.1016/0360-3016(86)90220-8; Young SW, 1996, P NATL ACAD SCI USA, V93, P6610, DOI 10.1073/pnas.93.13.6610	52	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168395	10.1371/journal.pone.0168395	http://dx.doi.org/10.1371/journal.pone.0168395			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045991	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300022
J	Cerda, R; Avelino, J; Gary, C; Tixier, P; Lechevallier, E; Allinne, C				Cerda, Rolando; Avelino, Jacques; Gary, Christian; Tixier, Philippe; Lechevallier, Esther; Allinne, Clementine			Primary and Secondary Yield Losses Caused by Pests and Diseases: Assessment and Modeling in Coffee	PLOS ONE			English	Article							TROPICAL ASIA; CROP LOSSES; CONSTRAINTS; RUST; QUANTIFICATION; DYNAMICS	The assessment of crop yield losses is needed for the improvement of production systems that contribute to the incomes of rural families and food security worldwide. However, efforts to quantify yield losses and identify their causes are still limited, especially for perennial crops. Our objectives were to quantify primary yield losses (incurred in the current year of production) and secondary yield losses (resulting from negative impacts of the previous year) of coffee due to pests and diseases, and to identify the most important predictors of coffee yields and yield losses. We established an experimental coffee parcel with full-sun exposure that consisted of six treatments, which were defined as different sequences of pesticide applications. The trial lasted three years (2013-2015) and yield components, dead productive branches, and foliar pests and diseases were assessed as predictors of yield. First, we calculated yield losses by comparing actual yields of specific treatments with the estimated attainable yield obtained in plots which always had chemical protection. Second, we used structural equation modeling to identify the most important predictors. Results showed that pests and diseases led to high primary yield losses (26%) and even higher secondary yield losses (38%). We identified the fruiting nodes and the dead productive branches as the most important and useful predictors of yields and yield losses. These predictors could be added in existing mechanistic models of coffee, or can be used to develop new linear mixed models to estimate yield losses. Estimated yield losses can then be related to production factors to identify corrective actions that farmers can implement to reduce losses. The experimental and modeling approaches of this study could also be applied in other perennial crops to assess yield losses.	[Cerda, Rolando; Lechevallier, Esther; Allinne, Clementine] CIRAD, UMR Syst, 2 Pl Pierre Viala, Montpellier, France; [Cerda, Rolando; Avelino, Jacques; Tixier, Philippe; Allinne, Clementine] CATIE, Program Sustainable Agr & Agroforestry, Turrialba, Costa Rica; [Avelino, Jacques] CIRAD, UR Bioagresseurs, TA A-106 Ave Agropolis, Montpellier, France; [Avelino, Jacques] IICA, AP 55, San Jose, Costa Rica; [Gary, Christian] INRA, UMR Syst, 2 Pl Pierre Viala, Montpellier, France; [Tixier, Philippe] CIRAD, UPR GECO, TA B-26,PS4 Blvd Lironde, Montpellier, France; [Lechevallier, Esther] ENSAT, Ave Agrobiopole, Auzeville Tolosane, France	CIRAD; CATIE - Centro Agronomico Tropical de Investigacion y Ensenanza; CIRAD; INRAE; CIRAD	Cerda, R (corresponding author), CIRAD, UMR Syst, 2 Pl Pierre Viala, Montpellier, France.; Cerda, R (corresponding author), CATIE, Program Sustainable Agr & Agroforestry, Turrialba, Costa Rica.	rcerda@catie.ac.cr	Avelino, Jacques/C-5624-2009; Tixier, Philippe/C-2119-2008	Avelino, Jacques/0000-0003-1983-9431; Tixier, Philippe/0000-0001-5147-9777; Allinne, Clementine/0000-0002-8147-5977; Gary, Christian/0000-0003-3267-5400	French National Institute for Agricultural Research (INRA); Tropical Agricultural Research and Higer Education Center (CATIE)	French National Institute for Agricultural Research (INRA); Tropical Agricultural Research and Higer Education Center (CATIE)	This work was supported by the French National Institute for Agricultural Research (INRA) http://institut.inra.fr/en and the Tropical Agricultural Research and Higer Education Center (CATIE) https://www.catie.ac.cr/. Authors who received the funding were CA and RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinne C, 2016, AGR ECOSYST ENVIRON, V222, P1, DOI 10.1016/j.agee.2016.02.001; [Anonymous], 1979, EPIDEMIOLOGY PLANT D; [Anonymous], 2014, COFFEE COCOA INT; Avelino J, 2006, ECOL MODEL, V197, P431, DOI 10.1016/j.ecolmodel.2006.03.013; AVELINO J, 1991, CAFE CACAO THE, V35, P21; Avelino J, 1999, DESAFIOS CAFICULTURA, P194; Avelino J, 1993, DEV ROUILLE ORANGEE, P293; Avelino J., 2011, ECOSYSTEMS SERVICES, P91; Avelino J, 2015, FOOD SECUR, V7, P303, DOI 10.1007/s12571-015-0446-9; Barbosa Dimmy H. S. G., 2004, Nematologia Brasileira, V28, P49; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Castella J-C, 2007, INT J TROPICAL INSEC, V25; Cheatham MR, 2009, PHYTOPATHOLOGY, V99, P1228, DOI 10.1094/PHYTO-99-11-1228; Cooke B. M., 2006, P43, DOI 10.1007/1-4020-4581-6_2; DaMatta Fábio M., 2007, Braz. J. Plant Physiol., V19, P485, DOI 10.1590/S1677-04202007000400014; DaMatta FM, 2004, FIELD CROP RES, V86, P99, DOI 10.1016/j.fcr.2003.09.001; de Ponti T, 2012, AGR SYST, V108, P1, DOI 10.1016/j.agsy.2011.12.004; Gutierrez Andrew P., 1998, Anais da Sociedade Entomologica do Brasil, V27, P357, DOI 10.1590/S0301-80591998000300005; Internarional Coffee Organization, 2016, TOT PROD CROP YEAR; Kropff MJ, 1995, AGR SYST, V49, P413, DOI 10.1016/0308-521X(95)00034-3; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Luo D., 2014, CALCULATE PREDICTED; McCook S, 2015, PHYTOPATHOLOGY, V105, P1164, DOI 10.1094/PHYTO-04-15-0085-RVW; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; NUTTER FW, 1993, PLANT DIS, V77, P211; Oerke E.C., 1994, CROP PRODUCTION CROP; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Pradhan P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129487; R Core Team, 2021, R LANGUAGE ENV STAT; Rakotonindraina T, 2012, PLANT DIS, V96, P935, DOI 10.1094/PDIS-09-11-0752; Robin MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075829; Rodriguez D, 2013, ECOL MODEL, V248, P203, DOI 10.1016/j.ecolmodel.2012.09.015; Sadras V. O., 2015, FAO WATER REPORTS, V41; Savary S, 2000, PLANT DIS, V84, P357, DOI 10.1094/PDIS.2000.84.3.357; Savary S, 2000, PLANT DIS, V84, P341, DOI 10.1094/PDIS.2000.84.3.341; Savary S., 2014, PLANT HLTH INSTRUCTO, V147; Savary S, 2006, EUR J PLANT PATHOL, V115, P123, DOI 10.1007/s10658-005-0651-z; Savary S, 2006, ANNU REV PHYTOPATHOL, V44, P89, DOI 10.1146/annurev.phyto.44.070505.143342; Schierhorn F, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/8/084017; Simko I, 2012, PHYTOPATHOLOGY, V102, P381, DOI 10.1094/PHYTO-07-11-0216; Smith HM, 2013, PLANT SCI, V207, P158, DOI 10.1016/j.plantsci.2013.02.014; van Ittersum MK, 2013, FIELD CROP RES, V143, P4, DOI 10.1016/j.fcr.2012.09.009; van Leeuwen GCM, 2000, EUR J PLANT PATHOL, V106, P519, DOI 10.1023/A:1008701315200; Wang N, 2015, EUR J AGRON, V63, P1, DOI 10.1016/j.eja.2014.11.003; Welham S, 2004, AUST NZ J STAT, V46, P325, DOI 10.1111/j.1467-842X.2004.00334.x; Zhang XY, 2006, CROP PROT, V25, P1013, DOI 10.1016/j.cropro.2006.01.013	47	67	74	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169133	10.1371/journal.pone.0169133	http://dx.doi.org/10.1371/journal.pone.0169133			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046054	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300125
J	Che, YL; Gui, SH; Lo, N; Ritchie, A; Wang, ZQ				Che, Yanli; Gui, Shunhua; Lo, Nathan; Ritchie, Andrew; Wang, Zongqing			Species Delimitation and Phylogenetic Relationships in Ectobiid Cockroaches (Dictyoptera, Blattodea) from China	PLOS ONE			English	Article							PARASITOID FLIES DIPTERA; DNA BARCODES; GENUS; EVOLUTION; INSECTA; CRYPTOCERCIDAE; MITOCHONDRIAL; COALESCENT; MORPHOLOGY; INVENTORY	We collected Ectobiidae cockroach specimens from 44 locations in the south of the Yangtze valley. We obtained 297 COI sequences specimens and carried out phylogenetic and divergence dating analyses, as well as species delimitation analysis using a General Mixed Yule Coalescent (GMYC) framework. The intraspecific and interspecific sequence divergence in Ectobiidae cockroaches ranged from 0.0 to 7.0% and 4.6 to 30.8%, respectively. GMYC analysis resulted in 53 (confidence interval: 37-65) entities (likelihood ratio = 103.63) including 14 downloaded species. The COI GMYC groups partly corresponded to the ectobiid species and 52 ectobiid species were delimited successfully based on the combination of GMYC result with morphological information. We used the molecular data and 6 cockroach fossil calibrations to obtain a preliminary estimate of the timescale of ectobiid evolution. The major subfamilies in the group were found to have diverged between similar to 125-110 Ma, and morphospecies pairs were found to have diverged similar to 10 or more Ma.	[Che, Yanli; Gui, Shunhua; Wang, Zongqing] Southwest Univ, Coll Plant Protect, Chongqing, Peoples R China; [Che, Yanli; Lo, Nathan; Ritchie, Andrew] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia	Southwest University - China; University of Sydney	Wang, ZQ (corresponding author), Southwest Univ, Coll Plant Protect, Chongqing, Peoples R China.	zqwang@swu.edu.cn	Gui, Shunhua/AAC-3070-2022; Lo, Nathan/E-6115-2010	Lo, Nathan/0000-0003-2176-2840; Shunhua, Gui/0000-0001-7612-2731	National Natural Sciences Foundation of China [31093430, 31493021, 31672329, 31472026]; Natural Science Foundation Project of Chongqing [cstc2014jcyjA80018]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing(Natural Science Foundation of Chongqing)	Funded by the National Natural Sciences Foundation of China (Nos. 31093430, 31493021, 31672329 to Wang ZQ and 31472026 to Che YL) http://www.nsfc.gov.cn and Natural Science Foundation Project of Chongqing No. cstc2014jcyjA80018 to Wang ZQ http://www.cstc.gov.cn.	[Anonymous], 2014, TAXONOMIC STUDY ECTO; Ashfaq M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097268; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barraclough TG, 2001, TRENDS ECOL EVOL, V16, P391, DOI 10.1016/S0169-5347(01)02161-9; Bello W, 2007, INT CORP RESPONS SER, V3, P1; BEY BIYENKO G. YA., 1957, ENT OBOZRENIE, V36, P895; Bey-Bienko GY, 1958, ENTOMOL OBOZR, V37, P670; Chao LI., FILE BLANK MAPS CHIN; Cho SY, 2013, ENTOMOL RES, V43, P253, DOI 10.1111/1748-5967.12034; Cochran DG, 1999, WHOCDSCPCWHOPES993; Cockerell TDA, 1920, ANN MAGAZINE NATURAL, V10, P273, DOI DOI 10.1080/00222932008632376; Cocuzza GEM, 2014, MOL ECOL RESOUR, V14, P447, DOI 10.1111/1755-0998.12199; Cognato AI, 2007, CLADISTICS, V23, P539, DOI 10.1111/j.1096-0031.2007.00159.x; Cotton MF, 2000, J HOSP INFECT, V44, P13, DOI 10.1053/jhin.1999.0650; Dai QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032544; Djernaes M, 2015, MOL PHYLOGENET EVOL, V84, P284, DOI 10.1016/j.ympev.2014.08.019; Djernaes M, 2012, SYST ENTOMOL, V37, P65, DOI 10.1111/j.1365-3113.2011.00598.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Evangelista D, 2013, J ECON ENTOMOL, V106, P2275, DOI 10.1603/EC13402; Evangelista DA, 2015, ZOOKEYS, P37, DOI 10.3897/zookeys.475.7877; Evangelista DA, 2014, SYST ENTOMOL, V39, P150, DOI 10.1111/syen.12043; Ezard T, 2009, PACKAGE SPLITS SPECI; Fisher BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001787; Fisk FW, 1983, T AM ENTOMOL SOC, V108, P479; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Grandcolas P, 1996, CAN J ZOOL, V74, P508, DOI 10.1139/z96-059; Greenstone MH, 2005, MOL ECOL, V14, P3247, DOI 10.1111/j.1365-294X.2005.02628.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebard M., 1920, Transactions of the American Entomological Society, V46; Hebard M., 1917, Memoirs of the American Entomological Society, V2; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Inward D, 2007, BIOL LETTERS, V3, P331, DOI 10.1098/rsbl.2007.0102; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klass KD, 2001, DEUT ENTOMOL Z, V48, P223; Klass KD, 2006, ENTOMOL ABH; Klass Klaus-Dieter, 1997, Bonner Zoologische Monographien, V42, P1; Knebelsberger Thomas, 2007, Zootaxa, V1522, P1; Legendre F, 2008, MOL PHYLOGENET EVOL, V48, P615, DOI 10.1016/j.ympev.2008.04.017; Legendre F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130127; Legendre F, 2014, BIOL J LINN SOC, V111, P58, DOI 10.1111/bij.12199; Lo N, 2003, MOL BIOL EVOL, V20, P907, DOI 10.1093/molbev/msg097; Lo N, 2007, BIOL LETTERS, V3, P327, DOI 10.1098/rsbl.2006.0614; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; McKittrick F. A., 1964, Memoirs Cornell Agric Expt Sta Ithaca, Vno. 389, P1; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Moriniere J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109719; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Mutanen M, 2015, MOL ECOL RESOUR, V15, P967, DOI 10.1111/1755-0998.12361; Pefura-Yone EW, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-22; Pellens R, 2007, MOL PHYLOGENET EVOL, V43, P616, DOI 10.1016/j.ympev.2006.12.017; Pongracz A., 1935, NOVA ACTA LEOPOLDINA, V2, P485; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pramual P, 2014, MOL ECOL RESOUR, V14, P262, DOI 10.1111/1755-0998.12174; Princis K, 1971, ORTHOPTERORUM CATALO, P1039; R Code Team, 2013, R LANG ENV STAT COMP; Rebijith KB, 2014, FLA ENTOMOL, V97, P1328, DOI 10.1653/024.097.0407; Rehn J. W. H., 1951, Memoirs of the American Entomological Society, Vno. 14; Rehn JAG, 1927, B AM MUS NAT HIST, V54, P1; Ritchie AM, 2016, ORG DIVERS EVOL, P1; Roth LM, 1996, ORIENT INSECTS, V30, P301; Roth LM, 2003, ORIENT INSECTS, V37, P1, DOI 10.1080/00305316.2003.10417344; ROTH LM, 1985, ENTOMOL SCAND, P1; Roth Louis M., 1995, Invertebrate Taxonomy, V9, P959, DOI 10.1071/IT9950959; Roth S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-50; Scudder SH, 1890, REPORT US GEOLOGICAL, V13, P1, DOI DOI 10.5962/BHL.TITLE.2507; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Sohn MH, 2012, ALLERGY ASTHMA IMMUN, V4, P264, DOI 10.4168/aair.2012.4.5.264; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Svenson GJ, 2009, CLADISTICS, V25, P468, DOI 10.1111/j.1096-0031.2009.00263.x; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang CQ, 2014, METHODS ECOL EVOL, V5, P1086, DOI 10.1111/2041-210X.12246; Trewick SA., 2007, CLADISTICS, V23, P1, DOI DOI 10.1111/J.1096-0031.2007.00174.X; Von BC, 2015, SCI REP, V5; Vrsansky Peter, 2005, Entomological Problems, V35, P163; Vrsansky Peter, 2002, AMBA Projekty, V6, P1; Vrsansky P, 2011, GEOL CARPATH, V62, P463, DOI 10.2478/v10096-011-0033-8; Vuataz L, 2013, MOL PHYLOGENET EVOL, V66, P979, DOI 10.1016/j.ympev.2012.12.003; Wang G, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039700, 10.1371/journal.pone.0051764, 10.1371/journal.pone.0047051]; Wang JJ, 2014, ZOOTAXA, V3827, P31, DOI 10.11646/zootaxa.3827.1.3; Wang ZQ, 2015, FLA ENTOMOL, V98, P260, DOI 10.1653/024.098.0143; Wang Zong-Qing, 2010, Acta Entomologica Sinica, V53, P908; Wang ZQ, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.337.5770; Ware JL, 2008, SYST ENTOMOL, V33, P429, DOI 10.1111/j.1365-3113.2008.00424.x; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Xiao B, 2012, CURR GENET, V58, P65, DOI 10.1007/s00294-012-0365-7; Yang ZF, 2012, SYST ENTOMOL, V37, P686, DOI 10.1111/j.1365-3113.2012.00637.x; Yue QY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106789; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zheng Y, 2016, ANN MAG NAT HIST, V50, P1; Zhou X, 2007, J N AM BENTHOL SOC, V26, P719, DOI 10.1899/06-089.1	102	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169006	10.1371/journal.pone.0169006	http://dx.doi.org/10.1371/journal.pone.0169006			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046038	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300086
J	Hoff, MLM; Fabrizius, A; Czech-Damal, NU; Folkow, LP; Burmester, T				Hoff, Mariana Leivas Mueller; Fabrizius, Andrej; Czech-Damal, Nicole U.; Folkow, Lars P.; Burmester, Thorsten			Transcriptome Analysis Identifies Key Metabolic Changes in the Hooded Seal (Cystophora cristata) Brain in Response to Hypoxia and Reoxygenation	PLOS ONE			English	Article							TRANSPORTER 4 EXPRESSION; DIVING SEALS; INTERMITTENT HYPOXIA; MICROARRAY ANALYSIS; GENE-EXPRESSION; MARINE MAMMALS; WEDDELL SEAL; TOLERANCE; ISCHEMIA; RAT	The brain of diving mammals tolerates low oxygen conditions better than the brain of most terrestrial mammals. Previously, it has been demonstrated that the neurons in brain slices of the hooded seal (Cystophora cristata) withstand hypoxia longer than those of mouse, and also tolerate reduced glucose supply and high lactate concentrations. This tolerance appears to be accompanied by a shift in the oxidative energy metabolism to the astrocytes in the seal while in terrestrial mammals the aerobic energy production mainly takes place in neurons. Here, we used RNA-Seq to compare the effect of hypoxia and reoxygenation in vitro on brain slices from the visual cortex of hooded seals. We saw no general reduction of gene expression, suggesting that the response to hypoxia and reoxygenation is an actively regulated process. The treatments caused the preferential upregulation of genes related to inflammation, as found before e.g. in stroke studies using mammalian models. Gene ontology and KEGG pathway analyses showed a downregulation of genes involved in ion transport and other neuronal processes, indicative for a neuronal shutdown in response to a shortage of O-2 supply. These differences may be interpreted in terms of an energy saving strategy in the seal's brain. We specifically analyzed the regulation of genes involved in energy metabolism. Hypoxia and reoxygenation caused a similar response, with upregulation of genes involved in glucose metabolism and downregulation of the components of the pyruvate dehydrogenase complex. We also observed upregulation of the monocarboxylate transporter Mct4, suggesting increased lactate efflux. Together, these data indicate that the seal brain responds to the hypoxic challenge by a relative increase in the anaerobic energy metabolism.	[Hoff, Mariana Leivas Mueller; Fabrizius, Andrej; Czech-Damal, Nicole U.; Burmester, Thorsten] Univ Hamburg, Inst Zool, Bioctr Grindel, Hamburg, Germany; [Folkow, Lars P.] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway	University of Hamburg; UiT The Arctic University of Tromso	Burmester, T (corresponding author), Univ Hamburg, Inst Zool, Bioctr Grindel, Hamburg, Germany.	thorsten.burmester@uni-hamburg.de	Burmester, Thorsten/I-7225-2013	Burmester, Thorsten/0000-0002-5772-7863	Deutsche Forschungsgemeinschaft [Bu956/12]; German Academic Exchange Service (DAAD); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/Brazil [5125/11-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study has been supported by the Deutsche Forschungsgemeinschaft (Bu956/12). MLMH is supported by a fellowship for Ph.D. by the German Academic Exchange Service (DAAD) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/Brazil (5125/11-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bano D, 2007, STROKE, V38, P674, DOI 10.1161/01.STR.0000256294.46009.29; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; Berg JM, 2012, BIOCHEMISTRY; Blix AS, 2010, J EXP BIOL, V213, P2610, DOI 10.1242/jeb.040345; BLIX AS, 1983, ACTA PHYSIOL SCAND, V118, P109, DOI 10.1111/j.1748-1716.1983.tb07250.x; Blix AS, 1983, HDB PHYSL CARDIOVASC, P917; Bonestroo HJC, 2013, DEV NEUROSCI-BASEL, V35, P197, DOI 10.1159/000346685; Buttner F, 2009, BRAIN RES, V1252, P1, DOI 10.1016/j.brainres.2008.10.045; Butler PJ, 1997, PHYSIOL REV, V77, P837, DOI 10.1152/physrev.1997.77.3.837; Butler PJ, 2004, RESP PHYSIOL NEUROBI, V141, P297, DOI 10.1016/j.resp.2004.01.010; Chamorro A, 2016, LANCET NEUR IN PRESS; Czech-Damal NU, 2014, NEUROSCIENCE, V275, P374, DOI 10.1016/j.neuroscience.2014.06.024; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Davis RW, 2014, J COMP PHYSIOL B, V184, P23, DOI 10.1007/s00360-013-0782-z; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Fabrizius A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2892-y; Folkow LP, 2008, NEUROSCI LETT, V446, P147, DOI 10.1016/j.neulet.2008.09.040; Folkow Lars P., 2010, P222; Folkow LP, 1999, POLAR BIOL, V22, P61, DOI 10.1007/s003000050391; Foote AD, 2015, NAT GENET, V47, P272, DOI 10.1038/ng.3198; Gao C, 2015, NEUROCHEM RES, V40, P818, DOI 10.1007/s11064-015-1532-2; Gao C, 2014, NEUROCHEM RES, V39, P2160, DOI 10.1007/s11064-014-1411-2; Geiseler SJ, 2016, NEUROSCIENCE, V334, P39, DOI 10.1016/j.neuroscience.2016.07.034; HADDAD GG, 1993, PROG NEUROBIOL, V40, P277, DOI 10.1016/0301-0082(93)90014-J; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hoff M, 2016, J COMP PHYSIOL B, V186, P373, DOI 10.1007/s00360-015-0956-y; Jin KL, 2001, ANN NEUROL, V50, P93, DOI 10.1002/ana.1073; KEREM D, 1973, RESP PHYSIOL, V19, P188, DOI 10.1016/0034-5687(73)90077-7; Kikuchi D, 2014, BIOCHEM BIOPH RES CO, V451, P288, DOI 10.1016/j.bbrc.2014.07.114; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Larson J, 2014, J EXP BIOL, V217, P1024, DOI 10.1242/jeb.085381; Liu B, 2014, MOL NEUROBIOL, V50, P327, DOI 10.1007/s12035-013-8619-z; Lonchamp Etienne, 2006, Critical Reviews in Neurobiology, V18, P179; Lukyanova LD, 1995, B EXP BIOL MED+, V120, P1189, DOI 10.1007/BF02445567; Lukyanova LD, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00320; Meir JU, 2009, AM J PHYSIOL-REG I, V297, pR927, DOI 10.1152/ajpregu.00247.2009; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mitz SA, 2009, NEUROSCIENCE, V163, P552, DOI 10.1016/j.neuroscience.2009.06.058; MURPHY B, 1980, J APPL PHYSIOL, V48, P596, DOI 10.1152/jappl.1980.48.4.596; MURPHY BJ, 1984, SCIENCE, V223, P707, DOI 10.1126/science.6320368; Nathaniel TI, 2015, BRAIN RES BULL, V114, P1, DOI 10.1016/j.brainresbull.2015.02.006; Odden A, 1999, ACTA PHYSIOL SCAND, V166, P77; Peng X, 2014, NAT BIOTECHNOL, V32, P1250, DOI 10.1038/nbt.3079; Ponganis PJ, 2011, COMPR PHYSIOL, V1, P447, DOI 10.1002/cphy.c091003; QVIST J, 1986, J APPL PHYSIOL, V61, P1560, DOI 10.1152/jappl.1986.61.4.1560; Ramirez JM, 2011, NEUROSCIENCE, V177, P35, DOI 10.1016/j.neuroscience.2010.12.032; Ramirez JM, 2007, ANNU REV PHYSIOL, V69, P113, DOI 10.1146/annurev.physiol.69.031905.163111; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Schmidt-Kastner R, 2002, MOL BRAIN RES, V108, P81, DOI 10.1016/S0169-328X(02)00516-8; Schneuer M, 2012, NEUROSCIENCE, V223, P35, DOI 10.1016/j.neuroscience.2012.07.052; Scholander P. F., 1940, Hvalradets Skrifter, Vno. 22, P1; Shibuya I, 2000, EXP PHYSIOL, V85, p145S, DOI 10.1111/j.1469-445X.2000.tb00018.x; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Therade-Matharan S, 2005, AM J PHYSIOL-REG I, V289, pR1756, DOI 10.1152/ajpregu.00480.2004; Williams TM, 2008, P R SOC B, V275, P751, DOI 10.1098/rspb.2007.1484; Yi JH, 2007, NEUROCHEM INT, V50, P1014, DOI 10.1016/j.neuint.2007.04.019; ZAPOL WM, 1979, J APPL PHYSIOL, V47, P968, DOI 10.1152/jappl.1979.47.5.968	57	20	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169366	10.1371/journal.pone.0169366	http://dx.doi.org/10.1371/journal.pone.0169366			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046118	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300174
J	Lang, S; Li, LB; Wang, XN; Sun, JP; Xue, XY; Xiao, YJ; Zhang, MY; Ao, T; Wang, JX				Lang, Shan; Li, Libing; Wang, Xuning; Sun, Junping; Xue, Xinying; Xiao, Yongjiu; Zhang, Mingyue; Ao, Ting; Wang, Jianxin			CXCL10/IP-10 Neutralization Can Ameliorate Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats	PLOS ONE			English	Article							ACUTE LUNG INJURY; NF-KAPPA-B; TNF-ALPHA; INFLAMMATION; CYTOKINE; BIOMARKERS; PATHOPHYSIOLOGY; PATHOGENESIS; ACTIVATION; EXPRESSION	The role of C-X-C motif chemokine 10 (CXCL10), a pro-inflammatory factor, in the development of acute respiratory distress syndrome (ARDS) remains unclear. In this study, we explored the role of CXCL10 and the effect of CXCL10 neutralization in lipopolysaccharide (LPS)-induced ARDS in rats. The expression of CXCL10 and its receptor chemokine receptor 3(CXCR3) increased after LPS induction. Moreover, neutralization of CXCL10 ameliorated the severity of ARDS by reducing pulmonary edema, inhibiting the release of inflammatory mediators (IFN-gamma, IL-6 and ICAM-1) and limiting inflammatory cells (neutro-phils, macrophages, CD8+ T cells) influx into the lung, with a reduction in CXCR3 expression in neutrophils and macrophages. Therefore, CXCL10 could be a potential therapeutic target in LPS-induced ARDS.	[Lang, Shan; Sun, Junping; Xue, Xinying; Xiao, Yongjiu; Zhang, Mingyue; Ao, Ting; Wang, Jianxin] Chinese Peoples Liberat Army Gen Hosp, Dept Resp Dis, Beijing, Peoples R China; [Li, Libing] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiovasc Surg, Beijing, Peoples R China; [Wang, Xuning] Chinese Peoples Liberat Army Gen Hosp, Dept Surg Oncol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Wang, JX (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Resp Dis, Beijing, Peoples R China.	wangjianxin301@yeah.net			National Science and Technology Major Project of China [2015ZX09J15105-004]	National Science and Technology Major Project of China	This work was supported by National Science and Technology Major Project of China (No.2015ZX09J15105-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista E, 2013, EXP MOL PATHOL, V94, P486, DOI 10.1016/j.yexmp.2013.03.007; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; Chen XP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/241983; Chi Y, 2013, J INFECT DIS, V208, P1962, DOI 10.1093/infdis/jit440; Clarke DL, 2010, J BIOL CHEM, V285, P29101, DOI 10.1074/jbc.M109.0999952; Cross LJM, 2011, CRIT CARE CLIN, V27, P355, DOI 10.1016/j.ccc.2010.12.005; Dhaliwal K, 2012, AM J RESP CRIT CARE, V186, P514, DOI 10.1164/rccm.201112-2132OC; Elsakkar MG, 2016, EUR J PHARMACOL, V786, P100, DOI 10.1016/j.ejphar.2016.06.002; Fujishima S, 2014, J INTENSIVE CARE, V2, DOI 10.1186/2052-0492-2-32; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; Gouwy M, 2004, J LEUKOCYTE BIOL, V76, P185, DOI 10.1189/jlb.1003479; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Han SH, 2015, J IMMUNOL, V194, P855, DOI 10.4049/jimmunol.1402513; Hart D, 2008, J IMMUNOL, V181, P8053, DOI 10.4049/jimmunol.181.11.8053; Hou SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087826; Ichikawa A, 2013, AM J RESP CRIT CARE, V187, P65, DOI 10.1164/rccm.201203-0508OC; Itoh T, 2007, AM J PHYSIOL-LUNG C, V293, pL446, DOI 10.1152/ajplung.00412.2005; Jeyaseelan S, 2004, INFECT IMMUN, V72, P7247, DOI 10.1128/IAI.72.12.7247-7256.2004; Kim J, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4583; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Long EO, 2011, J IMMUNOL, V186, P5021, DOI 10.4049/jimmunol.1100646; McClintock D, 2008, CRIT CARE, V12, DOI 10.1186/cc6846; Nick JA, 2002, J IMMUNOL, V169, P5260, DOI 10.4049/jimmunol.169.9.5260; Nie L, 2016, INFLAMMATION, V39, P526, DOI 10.1007/s10753-015-0276-0; Nieman GF, 2015, CHEST, V148, P1396, DOI 10.1378/chest.15-0990; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Papazian L, 2016, INTENS CARE MED, V42, P674, DOI 10.1007/s00134-016-4324-5; Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013; Pawankar R, 2015, CURR OPIN ALLERGY CL, V15, P41, DOI 10.1097/ACI.0000000000000129; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sasaki S, 2002, EUR J IMMUNOL, V32, P3197, DOI 10.1002/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1; Scolletta S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/876319; Singh UP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079751; Watkins TR, 2013, AM J RESP CRIT CARE, V188, P407, DOI 10.1164/rccm.201307-1208ED; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7; Williams AE, 2016, THORAX; Williams AE, 2014, AM J PHYSIOL-LUNG C, V306, pL217, DOI 10.1152/ajplung.00311.2013; Wu T, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0247-8; Wu WX, 2010, J GEN VIROL, V91, P1155, DOI 10.1099/vir.0.017905-0; Xiao M, 2014, INT J MOL SCI, V15, P19355, DOI 10.3390/ijms151119355; Zhang X, 2014, J HEPATOL, V61, P1365, DOI 10.1016/j.jhep.2014.07.006	43	40	44	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169100	10.1371/journal.pone.0169100	http://dx.doi.org/10.1371/journal.pone.0169100			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046003	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300114
J	Lukacs, A; Kemeny, F; Lum, JAG; Ullman, MT				Lukacs, Agnes; Kemeny, Ferenc; Lum, Jarrad A. G.; Ullman, Michael T.			Learning and Overnight Retention in Declarative Memory in Specific Language Impairment	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; PROCEDURAL MEMORY; WORKING-MEMORY; CHILDREN; CONSOLIDATION; SLEEP; NEUROSCIENCE; PERFORMANCE; VOCABULARY; IMPLICIT	We examined learning and retention in nonverbal and verbal declarative memory in Hungarian children with (n = 21) and without (n = 21) SLI. Recognition memory was tested both 10 minutes and one day after encoding. On nonverbal items, only the children with SLI improved overnight, with no resulting group differences in performance. In the verbal domain, the children with SLI consistently showed worse performance than the typically-developing children, but the two groups showed similar overnight changes. The findings suggest the possibility of spared or even enhanced declarative memory consolidation in SLI.	[Lukacs, Agnes; Kemeny, Ferenc] Budapest Univ Technol & Econ, Dept Cognit Sci, Budapest, Hungary; [Kemeny, Ferenc] Graz Univ, Inst Psychol, Graz, Austria; [Lum, Jarrad A. G.] Deakin Univ, Sch Psychol, Cognit Neurosci Unit, Melbourne, Vic, Australia; [Ullman, Michael T.] Georgetown Univ, Dept Neurosci, Brain & Language Lab, Washington, DC USA	Budapest University of Technology & Economics; University of Graz; Deakin University; Georgetown University	Lukacs, A (corresponding author), Budapest Univ Technol & Econ, Dept Cognit Sci, Budapest, Hungary.; Ullman, MT (corresponding author), Georgetown Univ, Dept Neurosci, Brain & Language Lab, Washington, DC USA.	alukacs@cogsci.bme.hu; michael@georgetown.edu	Lum, Jarrad A. G./K-3912-2016; Kemény, Ferenc/L-8685-2015	Lum, Jarrad A. G./0000-0003-2098-2403; Kemény, Ferenc/0000-0003-2961-3014	Hungarian National Science Foundation (OTKA) [OTKA K 83619]; National Institutes of Health [RO1 HD049347]; Mabel H. Flory Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD087088] Funding Source: NIH RePORTER	Hungarian National Science Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mabel H. Flory Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Hungarian National Science Foundation (OTKA) under OTKA K 83619 'Nonlinguistic abilities in Specific Language Impairment' to Agnes Lukacs, and by the National Institutes of Health under RO1 HD049347 and the Mabel H. Flory Trust to Michael Ullman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini CM, 2013, CURR BIOL, V23, pR746, DOI 10.1016/j.cub.2013.06.046; Baird G, 2010, DEV MED CHILD NEUROL, V52, P535, DOI 10.1111/j.1469-8749.2009.03494.x; BARRETT TR, 1972, J EXP PSYCHOL, V96, P321, DOI 10.1037/h0033625; Bishop D. V. M., 1983, TEST RECEPTION GRAMM; Bishop Dorothy V M, 2015, BMC Psychol, V3, P3, DOI 10.1186/s40359-015-0062-7; Boucher J, 2012, PSYCHOL BULL, V138, P458, DOI 10.1037/a0026869; Brown H, 2012, J EXP CHILD PSYCHOL, V112, P56, DOI 10.1016/j.jecp.2011.11.010; Cornelissen K, 2004, BRAIN LANG, V89, P617, DOI 10.1016/j.bandl.2003.12.007; Csanyi FY, 1974, PEABODY SZOKINCSTESZ; Dewey D, 1997, DEV NEUROPSYCHOL, V13, P507, DOI 10.1080/87565649709540692; Diekelmann S, 2010, NAT REV NEUROSCI; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Duinmeijer I, 2012, INT J LANG COMM DIS, V47, P542, DOI 10.1111/j.1460-6984.2012.00164.x; Dunn L.M, 1959, PEABODY PICTURE VOCA; EALS M, 1994, ETHOL SOCIOBIOL, V15, P95, DOI 10.1016/0162-3095(94)90020-5; Eichenbaum H., 2011, COGNITIVE NEUROSCIEN, V2, DOI [10.1093/acprof:oso/9780199778614.001.0001, DOI 10.1093/ACPROF:OSO/9780199778614.001.0001]; Ellenbogen JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004117; Fenn KM, 2009, LEARN MEMORY, V16, P509, DOI 10.1101/lm.1500808; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gabriel A, 2012, AM J SPEECH-LANG PAT, V21, P329, DOI 10.1044/1058-0360(2012/11-0044); Hedenius M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063998; Hedenius M, 2011, RES DEV DISABIL, V32, P2362, DOI 10.1016/j.ridd.2011.07.026; Henderson LM, 2012, DEVELOPMENTAL SCI, V15, P674, DOI 10.1111/j.1467-7687.2012.01172.x; Henke K, 2010, NAT REV NEUROSCI, V11, P523, DOI 10.1038/nrn2850; Holz J, 2012, J SLEEP RES, V21, P612, DOI 10.1111/j.1365-2869.2012.01017.x; Hull C.L., 1943, PRINCIPLES BEHAV INT, DOI DOI 10.2307/1416955; Karmiloff-Smith A, 1998, TRENDS COGN SCI, V2, P389, DOI 10.1016/S1364-6613(98)01230-3; Kas B, MAGYAR MONDATU UNPUB; Kemeny F, 2010, J CLIN EXP NEUROPSYC, V32, P249, DOI 10.1080/13803390902971131; Krishnan S, 2016, TRENDS COGN SCI, V20, P701, DOI 10.1016/j.tics.2016.06.012; Kuppuraj S, 2016, AUTISM DEV LANG IMPA, V1; Leonard LB, 2014, CHILDREN WITH SPECIFIC LANGUAGE IMPAIRMENT, 2ND EDITION, P1; Lukacs A, 2014, NEUROPSYCHOLOGY, V28, P472, DOI 10.1037/neu0000052; LukuYcs, 2012, TROG TEST RECEPTION, P47; Lum JAG, 2015, BRAIN LANG, V142, P76, DOI 10.1016/j.bandl.2015.01.008; Lum JAG, 2014, CORTEX, V51, P1, DOI 10.1016/j.cortex.2013.10.011; Lum JAG, 2013, TOP LANG DISORD, V33, P282, DOI 10.1097/01.TLD.0000437939.01237.6a; Lum JAG, 2012, CORTEX, V48, P1138, DOI 10.1016/j.cortex.2011.06.001; Lum JAG, 2010, INT J LANG COMM DIS, V45, P96, DOI 10.3109/13682820902752285; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Marton K, 2003, J SPEECH LANG HEAR R, V46, P1138, DOI 10.1044/1092-4388(2003/089); McGregor KK, 2013, J SPEECH LANG HEAR R, V56, P1845, DOI 10.1044/1092-4388(2013/12-0233); Mednick SC, 2011, TRENDS NEUROSCI, V34, P504, DOI 10.1016/j.tins.2011.06.003; Montgomery JW, 2010, AM J SPEECH-LANG PAT, V19, P78, DOI 10.1044/1058-0360(2009/09-0028); Morgan-Short K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032974; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nichols S, 2004, BRAIN LANG, V88, P180, DOI 10.1016/S0093-934X(03)00097-X; Payne JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033079; Racsmany Mihaly, 2005, MAGY PSZICHOL SZEML, V60, P479, DOI [10.1556/mpszle.60.2005.4.3, DOI 10.1556/MPSZLE.60.2005.4.3]; Raven J., 1987, RAVENS PROGR MATRICE; RECORDS NL, 1995, CLIN NEUROPSYCHOL, V9, P187, DOI 10.1080/13854049508401601; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Riccio CA, 2007, APPL NEUROPSYCHOL, V14, P255, DOI 10.1080/09084280701719203; Rice ML, 2015, J SPEECH LANG HEAR R, V58, P345, DOI 10.1044/2015_JSLHR-L-14-0150; Rice ML, 2013, INT J SPEECH-LANG PA, V15, P223, DOI 10.3109/17549507.2013.783113; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; SHEAR PK, 1992, NEUROPSYCHOLOGIA, V30, P451, DOI 10.1016/0028-3932(92)90092-Z; Sheth BR, 2012, SLEEP; Shimamura AP, 2010, HIPPOCAMPUS, V20, P1206, DOI 10.1002/hipo.20856; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; Tager-Flusberg H, 1999, J SPEECH LANG HEAR R, V42, P1275, DOI 10.1044/jslhr.4205.1275; Thomas M, 2002, BEHAV BRAIN SCI, V25, P727, DOI 10.1017/S0140525X02000134; Tomblin JB, 2007, LANG LEARN DEV, V3, P269, DOI 10.1080/15475440701377477; Tucker MA, 2008, SLEEP, V31, P197, DOI 10.1093/sleep/31.2.197; Ullman MT, 2015, NEUROSCI BIOBEHAV R, V51, P205, DOI 10.1016/j.neubiorev.2015.01.008; Ullman MT, 2005, CORTEX, V41, P399, DOI 10.1016/S0010-9452(08)70276-4; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Ullman MT., 2016, NEUROBIOLOGY LANGUAG; Ullman MT, ANN REV PSY IN PRESS; Walenski M, 2008, J AUTISM DEV DISORD, V38, P1395, DOI 10.1007/s10803-007-0513-y; Williams P, 1997, J EXP PSYCHOL LEARN, V23, P1344, DOI 10.1037/0278-7393.23.6.1344; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555	74	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169474	10.1371/journal.pone.0169474	http://dx.doi.org/10.1371/journal.pone.0169474			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2QJ	28046095	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300196
J	Berm, EJJ; Gout-Zwart, JJ; Luttjeboer, J; Wilffert, B; Postma, MJ				Berm, Elizabeth J. J.; Gout-Zwart, Judith J.; Luttjeboer, Jos; Wilffert, Bob; Postma, Maarten J.			A Model Based Cost-Effectiveness Analysis of Routine Genotyping for CYP2D6 among Older, Depressed Inpatients Starting Nortriptyline Pharmacotherapy	PLOS ONE			English	Article							CYTOCHROME-P450 2D6 CYP2D6; TRICYCLIC ANTIDEPRESSANTS; ECONOMIC-ANALYSIS; ASTERISK-D; DRUG; PSYCHIATRY; OUTCOMES; HOSPITALIZATION; POLYMORPHISMS; CONSEQUENCES	Objective Genotyping for CYP2D6 has the potential to predict differences in metabolism of nortriptyline. This information could optimize pharmacotherapy. We determined the costs and effects of routine genotyping for old aged Dutch depressed inpatients. Methods With a decision-tree, we modelled the first 12 weeks of nortriptyline therapy. Direct costs of genotyping, hospitalization, therapeutic drug monitoring and drugs were included. Based on genotype, patients could be correctly, sub-, or supratherapeutically dosed. Improvement from sub-or supratherapeutically dosed patients to correctly dosed patients was simulated, assuming that genotyping would prevent under-or overdosing of patients. In the base case, this improvement was assumed to be 35%. A probabilistic sensitivity analysis (PSA) was performed to determine uncertainty around the incremental cost-effectiveness ratio (ICER). Results In the base case analysis, costs for genotyping were assumed sic200 per test with a corresponding ICER at sic1 333 000 per QALY. To reach a sic50 000 per QALY cut-off, genotyping costs should be decreased towards sic40 per test. At genotyping test costs < sic35 per test, genotyping was dominant. At test costs of sic17 per test there was a 95% probability that genotyping was cost-effective at sic50 000 per QALY. Conclusions CYP2D6 genotyping was not cost-effective at current genotyping costs at a sic50 000 per QALY threshold, however at test costs below sic40, genotyping could be costs-effective.	[Berm, Elizabeth J. J.; Gout-Zwart, Judith J.; Luttjeboer, Jos; Wilffert, Bob; Postma, Maarten J.] Univ Groningen, Groningen Inst Pharm, Unit PharmacoTherapy Epidemiol & Econ PTE2, Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Inst Sci Hlth Aging & HealthcaRE SHARE, Groningen, Netherlands; Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Gout-Zwart, JJ (corresponding author), Univ Groningen, Groningen Inst Pharm, Unit PharmacoTherapy Epidemiol & Econ PTE2, Groningen, Netherlands.	judith@ascacademics.com	Gout, Judith/L-5201-2019	Gout, Judith/0000-0001-5876-8344; Postma, Maarten/0000-0002-6306-3653	The Netherlands Organization for Health Research and Development (ZonMw), "Priority Medicines in Elderly Program" [113102002]	The Netherlands Organization for Health Research and Development (ZonMw), "Priority Medicines in Elderly Program"	This study was funded by a grant from The Netherlands Organization for Health Research and Development (ZonMw, project number: 113102002) as a part of the "Priority Medicines in Elderly Program."	Altar CA, 2015, PHARMACOGENOMICS J, V15, P443, DOI 10.1038/tpj.2014.85; [Anonymous], 2008, DUTCH GUIDELINE DEPR; Biskupia JE, 2015, VALUE HEALTH, V18, pA747, DOI 10.1016/j.jval.2015.09.2883; Bradford LD, 2002, PHARMACOGENOMICS, V3, P229, DOI 10.1517/14622416.3.2.229; Breyer-Pfaff U, 2004, DRUG METAB REV, V36, P723, DOI 10.1081/DMR-200033482; Brixner D, 2015, J MED ECON, V19, P1; Caruso R, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-33; Chen SQ, 1996, CLIN PHARMACOL THER, V60, P522, DOI 10.1016/S0009-9236(96)90148-4; Chou WH, 2000, J CLIN PSYCHOPHARM, V20, P246, DOI 10.1097/00004714-200004000-00019; Dalen P, 1998, CLIN PHARMACOL THER, V63, P444, DOI 10.1016/S0009-9236(98)90040-6; Daly TM, 2007, CLIN CHEM, V53, P1222, DOI 10.1373/clinchem.2007.086348; Fleeman N, 2011, HEALTH TECHNOL ASSES, V15, pXIII, DOI 10.3310/hta15330; Gildengers AG, 2002, J AFFECT DISORDERS, V69, P177, DOI 10.1016/S0165-0327(01)00334-2; Greenhalgh J, 2005, HEALTH TECHNOL ASSES, V9, P1; Gressier F, 2015, J NEURAL TRANSM, V122, P35, DOI 10.1007/s00702-014-1273-4; Herbild L, 2013, BASIC CLIN PHARMACOL, V113, P266, DOI 10.1111/bcpt.12093; Hicks JK, 2013, CLIN PHARMACOL THER, V93, P402, DOI 10.1038/clpt.2013.2; Hiemke C, 2011, PHARMACOPSYCHIATRY, V44, P195, DOI 10.1055/s-0031-1286287; Higashi MK, 2003, AM J MANAG CARE, V9, P493; Hodgson K, 2015, PSYCHOPHARMACOLOGY B; Ingelman-Sundberg M, 2005, PHARMACOGENOMICS J, V5, P6, DOI 10.1038/sj.tpj.6500285; Jornil J, 2011, EUR J PHARM SCI, V44, P265, DOI 10.1016/j.ejps.2011.08.003; Kimmel SE, 2013, NEW ENGL J MED, V369, P2283, DOI 10.1056/NEJMoa1310669; Kin NMKNY, 1996, NEUROPSYCHOPHARMACOL, V15, P1; Kok RM, 2009, J AM GERIATR SOC, V57, P2112, DOI 10.1111/j.1532-5415.2009.02524.x; Kootstra-Ros JE, 2006, J CLIN PHARMACOL, V46, P1320, DOI 10.1177/0091270006293754; Kraus R P, 1996, Depress Anxiety, V4, P320, DOI 10.1002/(SICI)1520-6394(1996)4:6<320::AID-DA8>3.3.CO;2-6; Kropp S, 2006, CLIN LAB, V52, P237; Laika B, 2009, PHARMACOGENOMICS J, V9, P395, DOI 10.1038/tpj.2009.23; Lapid MI, 2011, INT PSYCHOGERIATR, V23, P485, DOI 10.1017/S104161021000133X; LLerena A, 2014, EXPERT OPIN DRUG MET, V10, P1569, DOI 10.1517/17425255.2014.964204; Matchar David B, 2007, Evid Rep Technol Assess (Full Rep), P1; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MONTGOMERY SA, 1977, BRIT MED J, V2, P166, DOI 10.1136/bmj.2.6080.166-a; Perlis RH, 2009, NEUROPSYCHOPHARMACOL, V34, P2227, DOI 10.1038/npp.2009.50; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; PRESKORN SH, 1988, CLIN CHEM, V34, P822; Rebsamen MC, 2009, PHARMACOGENOMICS J, V9, P34, DOI 10.1038/tpj.2008.7; Reuben D, 2014, DEPRESSION GERIATRIC; Revicki DA, 1998, J AFFECT DISORDERS, V48, P25, DOI 10.1016/S0165-0327(97)00117-1; Roberts RL, 2004, HUM PSYCHOPHARM CLIN, V19, P17, DOI 10.1002/hup.539; Rozenbaum MH, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2509; Ruano G, 2013, BIOMARK MED, V7, P429, DOI [10.2217/BMM.13.16, 10.2217/bmm.13.16]; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Sapin Christophe, 2004, Health Qual Life Outcomes, V2, P20, DOI 10.1186/1477-7525-2-20; Sobocki P, 2006, INT J CLIN PRACT, V60, P791, DOI 10.1111/j.1742-1241.2006.00997.x; Statistic Netherlands (CBS), 2014, HOSP GEND AG DIAGN I; Tan SS, 2012, INT J TECHNOL ASSESS, V28, P152, DOI 10.1017/S0266462312000062; Thompson AJ, 2014, VALUE HEALTH, V17, P22, DOI 10.1016/j.jval.2013.10.007; Unterecker S, 2013, J NEURAL TRANSM, V120, P1237, DOI 10.1007/s00702-012-0952-2; van Schaik RHN, 2006, NEDERLANDS TIJDSCHRI, V31, P234	51	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0169065	10.1371/journal.pone.0169065	http://dx.doi.org/10.1371/journal.pone.0169065			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7KQ	28033366	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900072
J	Zhou, RP; Lin, SJ; Wan, WB; Zuo, HL; Yao, FF; Ruan, HB; Xu, J; Song, W; Zhou, YC; Wen, SY; Dai, JH; Zhu, ML; Luo, J				Zhou, Rong Ping; Lin, Si Jian; Wan, Wen Bing; Zuo, Hui Ling; Yao, Fen Fen; Ruan, Hui Bing; Xu, Jin; Song, Wei; Zhou, Yi Cheng; Wen, Shi Yao; Dai, Jiang Hua; Zhu, Mei Lan; Luo, Jun			Chlorogenic Acid Prevents Osteoporosis by Shp2/PI3K/Akt Pathway in Ovariectomized Rats	PLOS ONE			English	Article							EUCOMMIA-ULMOIDES OLIV.; OVX-INDUCED OSTEOPOROSIS; BONE LOSS; ANTIOXIDANT ACTIVITY; POSTMENOPAUSAL OSTEOPOROSIS; PHENOLIC-COMPOUNDS; TISSUE METABOLISM; OXIDATIVE STRESS; CONTROLLED TRIAL; ESTROGEN	Cortex Eucommiae is used worldwide in traditional medicine, various constituents of Cortex Eucommiae, such as chlorogenic acid (CGA), has been reported to exert anti-osteoporosis activity in China, but the mechanism about their contribution to the overall activity is limited. The aims of this study were to determine whether chlorogenic acid can prevent estrogen deficiency-induced osteoporosis and to analyze the mechanism of CGA bioactivity. The effect of CGA on estrogen deficiency-induced osteoporosis was performed in vivo. Sixty female Sprague-Dawley rats were divided randomly among a sham-operated group and five ovariectomy (OVX) plus treatment subgroups: saline vehicle, 17 alpha-ethinylestradiol (E2), or CGA at 9, 27, or 45 mg/kg/d. The rats' femoral metaphyses were evaluated by microcomputed tomography (mu CT). The mechanism of CGA bioactivity was investigated in vitro. Bone mesenchymal stem cells (BMSCs) were treated with CGA, with or without phosphoinositide 3-kinase (PI3K) inhibitor LY294002. BMSCs proliferation and osteoblast differentiation were assessed with 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) and alkaline phosphatase, with or without Shp2 interfering RNA (RNAi). The results display that CGA at 27 and 45 mg/kg/day inhibited the decrease of bone mineral density (BMD) that induced by OVX in femur (p<0.01), significantly promoted the levels of bone turnover markers, and prevented bone volume fraction (BV/TV), connectivity density (CoonD), trabecular number (Tb. N), trabecular thickness (Tb. Th) (all p<0.01) to decrease and prevented the trabecular separation (Tb. Sp), structure model index (SMI)(both p<0.01) to increase. CGA at 1 or 10 mu M enhanced BMSC proliferation in a dose-dependent manner. CGA at 0.1 to 10 mu M increased phosphorylated Akt (p-Akt) and cyclin D1. These effects were reversed by LY294002. CGA at 1 or 10 mu M increased BMSC differentiation to osteoblasts (p<0.01), Shp2 RNAi suppressed CGA-induced osteoblast differentiation by decreasing Shp2, p-Akt, and cyclin D1. This study found that CGA improved the BMD and trabecular micro-architecture for the OVX-induced osteoporosis. Therefore, CGA might be an effective alternative treatment for postmenopausal osteoporosis. CGA promoted proliferation of osteoblast precursors and osteoblastic differentiation of BMSCs via the Shp2/PI3K/ Akt/cyclin D1 pathway.	[Zhou, Rong Ping; Wan, Wen Bing; Ruan, Hui Bing; Xu, Jin; Song, Wei; Zhou, Yi Cheng; Wen, Shi Yao] NanChang Univ, Affiliated Hosp 2, Dept Orthopaed, Nanchang, Jiangxi, Peoples R China; [Zhou, Rong Ping; Lin, Si Jian; Dai, Jiang Hua; Zhu, Mei Lan; Luo, Jun] Regenerat & Rehabil Engn Res Inst Bone & Nerve Ji, Nanchang, Jiangxi, Peoples R China; [Zhou, Rong Ping; Wan, Wen Bing; Ruan, Hui Bing; Xu, Jin; Song, Wei; Zhou, Yi Cheng; Wen, Shi Yao; Luo, Jun] NanChuang Univ, Orthopaed Res Inst Jiangxi, Nanchang, Jiangxi, Peoples R China; [Lin, Si Jian; Zuo, Hui Ling; Yao, Fen Fen; Dai, Jiang Hua; Zhu, Mei Lan; Luo, Jun] NanChang Univ, Affiliated Hosp 2, Rehabil Dept, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University	Zhou, RP (corresponding author), NanChang Univ, Affiliated Hosp 2, Dept Orthopaed, Nanchang, Jiangxi, Peoples R China.; Zhou, RP; Luo, J (corresponding author), Regenerat & Rehabil Engn Res Inst Bone & Nerve Ji, Nanchang, Jiangxi, Peoples R China.; Zhou, RP; Luo, J (corresponding author), NanChuang Univ, Orthopaed Res Inst Jiangxi, Nanchang, Jiangxi, Peoples R China.; Luo, J (corresponding author), NanChang Univ, Affiliated Hosp 2, Rehabil Dept, Nanchang, Jiangxi, Peoples R China.	rong8618241@126.com; Luojun1786@163.com			National Natural Science Foundation of China [81160508, 81260401, 81460342]; Natural Science Foundation of Jiangxi Province [GZY0170]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province)	This work was supported by National Natural Science Foundation of China (No: 81160508, 81260401, 81460342) and the Natural Science Foundation of Jiangxi Province (No: GZY0170).	Allen AJ, 2002, J CLIN PSYCHIAT, V63, P44; Andia DC, 2008, HISTOL HISTOPATHOL, V23, P1177, DOI 10.14670/HH-23.1177; Arjmandi BH, 1998, AM J CLIN NUTR, V68, p1364S, DOI 10.1093/ajcn/68.6.1364S; AVIOLI LV, 1965, J CLIN ENDOCR METAB, V25, P912, DOI 10.1210/jcem-25-7-912; Bai XC, 2004, BIOCHEM BIOPH RES CO, V314, P197, DOI 10.1016/j.bbrc.2003.12.073; Brezinski A., 1999, EUR J OBSTET GYN R B, V85, P47, DOI DOI 10.1016/S0301-2115(98)00281-4; Bunin DI, 2013, RADIAT RES, V179, P171, DOI 10.1667/RR3115.1; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Castelo-Branco C, 2013, GYNECOL ENDOCRINOL, V29, P735, DOI 10.3109/09513590.2013.801441; Chang KL, 2013, NUTRITION, V29, P250, DOI 10.1016/j.nut.2012.03.009; Cheng XG, 2007, J CLIN DENSITOM, V10, P276, DOI 10.1016/j.jocd.2007.05.004; Dang ZC, 2002, J BONE MINER RES, V17, P394, DOI 10.1359/jbmr.2002.17.3.394; Eklund PC, 2005, ORG BIOMOL CHEM, V3, P3336, DOI 10.1039/b506739a; FERRETTI JL, 1990, BONE MINER, V11, P111, DOI 10.1016/0169-6009(90)90020-G; Gatti D, 2011, J CLIN ENDOCR METAB, V96, P1555, DOI 10.1210/jc.2010-2552; Geng WX, 2013, BIOCHEM BIOPH RES CO, V434, P280, DOI 10.1016/j.bbrc.2013.02.116; Hassan HA, 2013, CYTOTECHNOLOGY, V65, P609, DOI 10.1007/s10616-012-9514-6; Ho SC, 2007, MENOPAUSE, V14, P905, DOI 10.1097/gme.0b013e318032b2d3; Horcajada-Molteni MN, 2000, J BONE MINER RES, V15, P2251, DOI 10.1359/jbmr.2000.15.11.2251; Hsieh CL, 2000, LIFE SCI, V66, P1387, DOI 10.1016/S0024-3205(00)00450-1; Huber Florian, 2003, Clin Lab, V49, P203; Hunyadi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050619; Hyeon S, 2013, FREE RADICAL BIO MED, V65, P789, DOI 10.1016/j.freeradbiomed.2013.08.005; Iolascon G, 2013, CLIN CASES MINER BON, V10, P47, DOI 10.11138/ccmbm/2013.10.1.047; Jilka RL, 1998, J CLIN INVEST, V101, P1942, DOI 10.1172/JCI1039; Alonso-Castro AJ, 2015, J ETHNOPHARMACOL, V175, P335, DOI 10.1016/j.jep.2015.09.029; Kahkonen MP, 1999, J AGR FOOD CHEM, V47, P3954, DOI 10.1021/jf990146l; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; Kamiyama M, 2015, J AGR FOOD CHEM, V63, P1996, DOI 10.1021/jf5060563; Khajuria DK, 2014, J ORTHOP SCI, V19, P646, DOI 10.1007/s00776-014-0557-8; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim MK, 2002, CLIN ENDOCRINOL, V56, P321, DOI 10.1046/j.1365-2265.2002.01470.x; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lee MK, 2007, BIOL PHARM BULL, V30, P814, DOI 10.1248/bpb.30.814; Lee MK, 2005, J MED FOOD, V8, P86, DOI 10.1089/jmf.2005.8.86; Li BJ, 2011, J CELL BIOCHEM, V112, P1229, DOI 10.1002/jcb.23049; LUFKIN EG, 1992, ANN INTERN MED, V117, P1, DOI 10.7326/0003-4819-117-1-1; Luo JY, 2009, J ENZYM INHIB MED CH, V24, P1280, DOI 10.3109/14756360902829741; Mattsson C, 2007, CURR MED CHEM, V14, P2918, DOI 10.2174/092986707782359972; Medical Advisory Secretariat, 2006, Ont Health Technol Assess Ser, V6, P1; MEYERSABELLEK W, 1988, J CHROMATOGR-BIOMED, V429, P419, DOI 10.1016/S0378-4347(00)83881-5; Omsland TK, 2014, OSTEOPOROSIS INT, V25, P2493, DOI 10.1007/s00198-014-2781-7; Rachidi Mouna, 2008, Journal de la Societe de Biologie, V202, P265, DOI 10.1051/jbio:2008035; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Rakshit S, 2010, BIOCHEM PHARMACOL, V80, P1662, DOI 10.1016/j.bcp.2010.08.013; Rendina E, 2012, J NUTR BIOCHEM, V23, P60, DOI 10.1016/j.jnutbio.2010.10.010; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Ro SC, 2007, MENOPAUSE, V14, P489, DOI 10.1097/gme.0b013e31802v4f4f; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rufus P, 2013, CURR DRUG TARGETS, V14, P1689, DOI 10.2174/1389450114666131220160357; Seidlova-Wuttke D, 2008, BONE, V43, P849, DOI 10.1016/j.bone.2008.07.237; Sontakke A, 2002, CLIN CHIM ACTA, V318, P145, DOI 10.1016/S0009-8981(01)00766-5; Tchernof A, 1998, OBES RES, V6, P246, DOI 10.1002/j.1550-8528.1998.tb00344.x; Teixeira S, 2005, FREE RADICAL BIO MED, V39, P1099, DOI 10.1016/j.freeradbiomed.2005.05.028; Tella SH, 2014, J STEROID BIOCHEM, V142, P155, DOI 10.1016/j.jsbmb.2013.09.008; WRONSKI TJ, 1989, ENDOCRINOLOGY, V125, P810, DOI 10.1210/endo-125-2-810; Wu CJ, 2001, ONCOGENE, V20, P6018, DOI 10.1038/sj.onc.1204699; Xu ZS, 2010, J AGR FOOD CHEM, V58, P7289, DOI 10.1021/jf100304t; Yang C., 2014, J BOT, V2014, P9, DOI [10.1155/2014/181727, DOI 10.1155/2014/181727]; Yin J, 2006, PHYTOMEDICINE, V13, P37, DOI 10.1016/j.phymed.2004.06.017; Zhang G, 2006, BONE, V38, P818, DOI 10.1016/j.bone.2005.11.019; Zhang R, 2009, BONE, V45, P553, DOI 10.1016/j.bone.2008.08.127; Zhao Q, 2013, CALCIFIED TISSUE INT, V93, P172, DOI 10.1007/s00223-013-9739-1; Zheng J, 2012, INDIAN J EXP BIOL, V50, P875; Zhu HM, 2012, MOLECULES, V17, P8001, DOI 10.3390/molecules17078001; Zito CI, 2004, J CELL PHYSIOL, V199, P227, DOI 10.1002/jcp.10446	66	46	51	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0166751	10.1371/journal.pone.0166751	http://dx.doi.org/10.1371/journal.pone.0166751			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033335	Green Published, Green Submitted, gold			2022-12-26	WOS:000391226900007
J	Gu, CM; Liu, Y; Mohamed, I; Zhang, RH; Wang, X; Nie, XX; Jiang, M; Brooks, M; Chen, F; Li, ZG				Gu, Chiming; Liu, Yi; Mohamed, Ibrahim; Zhang, Runhua; Wang, Xiao; Nie, Xinxin; Jiang, Min; Brooks, Margot; Chen, Fang; Li, Zhiguo			Dynamic Changes of Soil Surface Organic Carbon under Different Mulching Practices in Citrus Orchards on Sloping Land	PLOS ONE			English	Article							MATTER; FRACTIONS; PARTICULATE; NITROGEN; TILLAGE; SEQUESTRATION; MANAGEMENT; RUNOFF; POOLS; ASSOCIATIONS	Mulching management has been used in many places all over the world to improve agricultural sustainability. However, the cycling of carbon in the soil under applications of mulch on sloping arable land is not yet fully understood. A four-year field experiment was carried out in Xiaofuling watershed of Danjiangkou reservoir in China. The object was to evaluate the effects of the application of straw mulch (ST) and grass mulch (GT) on dynamic changes in soil organic carbon and its fractions. Results showed that mulch applied on the soil surface increased the contents of SOC and its active fractions in the soil. Compared to the control without cover (CK), ST and GT treatments increased the contents of SOC, LOC, DOC, POC and EOC by 14.73%, 16.5%, 22.5%, 41.5% and 21%, respectively, in the 0-40 cm soil layer, and by 17%, 14%, 19%, and 30%, respectively, in the 0-100 cm soil layer. The contents of organic carbon and its active fractions decreased with increasing soil depth in all of the treatments. SOC was accumulated in the period of December to the following March. The contents of soil DOC and LOC were high in January to March, while the contents of soil POC and EOC were high in June to September. The relative contents of soil organic carbon fractions were POC > EOC > LOC > DOC over the four years. Straw mulching had no significant effect on the changes in soil organic carbon active fractions during the different periods. Based on this long-term field experiment in Danjiangkou reservoir, we found that straw mulching had a significant effect on soil, increasing SOC content and stock in slopping arable land, and that live grass mulching was more effective than rice straw mulching. We discuss possible optimal periods for the implementation of mulching practices on sloping land.	[Gu, Chiming; Liu, Yi; Mohamed, Ibrahim; Wang, Xiao; Nie, Xinxin; Jiang, Min; Chen, Fang; Li, Zhiguo] Chinese Acad Sci China, Wuhan Bot Garden, Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China; [Gu, Chiming] Univ Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Gu, Chiming] Chinese Acad Agr Sci, Oil Crops Res Inst, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Wuhan, Peoples R China; [Zhang, Runhua] Wuhan Acad Agr Sci & Technol, Inst Vegetable, Wuhan, Peoples R China; [Brooks, Margot] Rhodes Univ, Dept Biochem & Microbiol, Grahamstown, South Africa; [Chen, Fang] China Program Int Plant Nutr Inst, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Rhodes University	Chen, F; Li, ZG (corresponding author), Chinese Acad Sci China, Wuhan Bot Garden, Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China.; Chen, F (corresponding author), China Program Int Plant Nutr Inst, Wuhan, Peoples R China.	fchen@ipni.ac.cn; lzg250@126.com	Gu, Chiming/K-5381-2019; Li, Xibing/ABD-5781-2021		Knowledge Innovative Program of the Chinese Academy of Sciences [Y455434102]; National Natural Science Foundation of China [41501313, 41471242, 31201618]; National Key Research and Development Plan [2016YFD0200108-4]	Knowledge Innovative Program of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Plan	This study was financially supported by the projects of the Knowledge Innovative Program of the Chinese Academy of Sciences (Y455434102), the National Natural Science Foundation of China (41501313; 41471242; 31201618), and the National Key Research and Development Plan (2016YFD0200108-4).; This study was financially supported by the projects of the Knowledge Innovative Program of the Chinese Academy of Sciences (Y455434102), the National Natural Science Foundation of China (41501313; 41471242; 31201618), and the National Key Research and Development Plan (2016YFD0200108-4). We gratefully acknowledge the comments of the subject editor and anonymous reviewers.	Adekalu KO, 2007, BIORESOURCE TECHNOL, V98, P912, DOI 10.1016/j.biortech.2006.02.044; Alvarez CR, 1998, SOIL BIOL BIOCHEM, V30, P767, DOI 10.1016/S0038-0717(97)00168-5; Alvarez R, 2000, SOIL SCI SOC AM J, V64, P184, DOI 10.2136/sssaj2000.641184x; Arneth A, 2015, NATURE, V524, P44, DOI 10.1038/524044a; Bai SH, 2014, BIOL FERT SOILS, V50, P37, DOI 10.1007/s00374-013-0829-z; Bao S.D, 2000, SOIL AGR CHEM ANAL; Bastian F, 2009, SOIL BIOL BIOCHEM, V41, P262, DOI 10.1016/j.soilbio.2008.10.024; BEARE MH, 1993, SOIL SCI SOC AM J, V57, P392, DOI 10.2136/sssaj1993.03615995005700020018x; Bernacchi CJ, 2005, GLOBAL CHANGE BIOL, V11, P1867, DOI 10.1111/j.1365-2486.01050.x; BIEDERBECK VO, 1994, SOIL BIOL BIOCHEM, V26, P1647, DOI 10.1016/0038-0717(94)90317-4; BLAIR GJ, 1995, AUST J AGR RES, V46, P1459, DOI 10.1071/AR9951459; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Chen FS, 2010, APPL SOIL ECOL, V44, P42, DOI 10.1016/j.apsoil.2009.09.003; Chen GS, 2004, PEDOSPHERE, V14, P297; Chen HQ, 2009, SOIL TILL RES, V106, P85, DOI 10.1016/j.still.2009.09.009; Chinese Academy of Sciences, 1978, SOIL PHYS PROP DET M; Conteh A., 1999, HUM SUBST ENV J, V1, P3; Diacono M, 2010, AGRON SUSTAIN DEV, V30, P401, DOI 10.1051/agro/2009040; Duiker SW, 1999, SOIL TILL RES, V52, P73, DOI 10.1016/S0167-1987(99)00059-8; Fallahzade J, 2012, LAND DEGRAD DEV, V23, P53, DOI 10.1002/ldr.1049; Franzluebbers AJ, 2003, SOIL SCI SOC AM J, V67, P132, DOI 10.2136/sssaj2003.0132; Gale WJ, 2000, SOIL SCI SOC AM J, V64, P201, DOI 10.2136/sssaj2000.641201x; GREGORICH EG, 1994, CAN J SOIL SCI, V74, P367, DOI 10.4141/cjss94-051; Gu CM, 2013, AGR RES ARID AREAS, V05, P48; Gu CM, 2013, AGR RES ARID AREAS, V05, P73; Jaillard B., 2003, Handbook of soil acidity, P231; JANZEN HH, 1992, SOIL SCI SOC AM J, V56, P1799, DOI 10.2136/sssaj1992.03615995005600060025x; JARDINE PM, 1989, SOIL SCI SOC AM J, V53, P1378, DOI 10.2136/sssaj1989.03615995005300050013x; Jastrow JD, 1996, SOIL BIOL BIOCHEM, V28, P665, DOI 10.1016/0038-0717(95)00159-X; Jiang PK, 2006, FOREST ECOL MANAG, V236, P30, DOI 10.1016/j.foreco.2006.06.010; Kuhn NJ, 2009, EARTH SURF PROC LAND, V34, P1033, DOI 10.1002/esp.1796; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; LARSON WE, 1972, AGRON J, V64, P204, DOI 10.2134/agronj1972.00021962006400020023x; Lei AL, 2013, CHINA SCI TECHNOLOGY, V12, P22; Lei AL, 2013, CHINA SCI TECHNOLOGY, V12, P20; Li CF, 2012, SOIL TILL RES, V119, P31, DOI 10.1016/j.still.2011.12.005; Liang Q, 2012, NUTR CYCL AGROECOSYS, V92, P21, DOI 10.1007/s10705-011-9469-6; Liu Y, 2012, AGR WATER MANAGE, V110, P34, DOI 10.1016/j.agwat.2012.03.011; Lou Y, 2011, SOIL USE MANAGE, V27, P163, DOI 10.1111/j.1475-2743.2010.00325.x; Luo SS, 2015, EUR J SOIL BIOL, V67, P35, DOI 10.1016/j.ejsobi.2015.01.004; Malhi SS, 2003, NUTR CYCL AGROECOSYS, V66, P33, DOI 10.1023/A:1023376905096; Mendham DS, 2004, SOIL BIOL BIOCHEM, V36, P1067, DOI 10.1016/j.soilbio.2004.02.018; Mi N, 2008, GLOBAL CHANGE BIOL, V14, P2380, DOI 10.1111/j.1365-2486.2008.01642.x; Mulumba LN, 2008, SOIL TILL RES, V98, P106, DOI 10.1016/j.still.2007.10.011; National Soil Survey Office, 1992, SOIL SURV TECHN CHIN, P42; Obalum SE, 2010, SOIL TILL RES, V108, P30, DOI 10.1016/j.still.2010.03.009; Polyakov VO, 2004, SOIL SCI, V169, P590, DOI 10.1097/01.ss.0000138414.84427.40; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Powlson DS, 2012, AGR ECOSYST ENVIRON, V146, P23, DOI 10.1016/j.agee.2011.10.004; Qiu Y, 2015, J ARID LAND, V7, P46, DOI 10.1007/s40333-014-0076-7; Quinton JN, 2001, J ENVIRON QUAL, V30, P538, DOI 10.2134/jeq2001.302538x; Saito M, 2009, GLOBAL CHANGE BIOL, V15, P221, DOI 10.1111/j.1365-2486.2008.01713.x; Six J, 2002, AGRONOMIE, V22, P755, DOI 10.1051/agro:2002043; [苏永中 Su Yongzhong], 2002, [中国沙漠, Journal of Desert Research], V22, P220; TURCHENEK LW, 1979, GEODERMA, V21, P311, DOI 10.1016/0016-7061(79)90005-3; Unger PW, 1998, SOIL TILL RES, V45, P39, DOI 10.1016/S0167-1987(97)00068-8; Wan ZM, 2011, 2011 5 INT C BIOINF; Wander MM, 2000, SOIL BIOL BIOCHEM, V32, P1151, DOI 10.1016/S0038-0717(00)00031-6; Wang Hu, 2014, Yingyong Shengtai Xuebao, V25, P3491; [王晶 Wang Jing], 2003, [生态学杂志, Chinese Journal of Ecology], V22, P109; Worrall F, 2008, J HYDROL, V358, P84, DOI 10.1016/j.jhydrol.2008.05.037; Yang Y, 2009, CHINA FRUIT IND INFO, V26, P36; YEOMANS JC, 1988, COMMUN SOIL SCI PLAN, V19, P1467, DOI 10.1080/00103628809368027; Zheng LC, 2006, J LIAONING TECHNOLOG, V6, P330; Zhong MF, 2006, P ANN M WAT SOIL CON; Zhu HongXun, 1997, Acta Pedologica Sinica, V34, P138; Zou XM, 2005, SOIL BIOL BIOCHEM, V37, P1923, DOI 10.1016/j.soilbio.2005.02.028	67	33	39	11	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168384	10.1371/journal.pone.0168384	http://dx.doi.org/10.1371/journal.pone.0168384			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030551	gold, Green Published, Green Submitted			2022-12-26	WOS:000391222000046
J	Lede, V; Franke, C; Meusel, A; Teupser, D; Ricken, A; Thiery, J; Schiller, J; Huster, D; Schoneberg, T; Schulz, A				Lede, Vera; Franke, Christin; Meusel, Andrej; Teupser, Daniel; Ricken, Albert; Thiery, Joachim; Schiller, Juergen; Huster, Daniel; Schoeneberg, Torsten; Schulz, Angela			Severe Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein Receptor	PLOS ONE			English	Article							E-DEFICIENT MICE; NONALCOHOLIC STEATOHEPATITIS; BRACHIOCEPHALIC ARTERY; FRAMESHIFT MUTATION; KNOCKOUT MICE; HUMAN OBESITY; MOUSE MODELS; AORTIC ROOT; LEPTIN; LIVER	Dysfunction of the melanocortin system can result in severe obesity accompanied with dyslipidemia and symptoms of the metabolic syndrome but the effect on vascular atherogenesis is not known. To study the impact of obesity and dyslipidemia on the cardiovascular system, we generated mice double-deficient for the melanocortin type 4 receptor (Mc4r(mut) mice) and the LDL receptor (Ldlr(-/-) mice). Mc4r(mut) mice develop obesity due to hyperphagia. Double-mutant mice (Mc4r(mut); Ldlr(-/-)) exhibited massive increases in body weight, plasma cholesterol and triacylglycerol levels and developed atherosclerosis. Atherosclerotic lesion size was affected throughout the aortic root and brachiocephalic artery not only under semisynthetic, cholesterol-containing diet but also under cholesterol-free standard chow. The Mc4r(mut) mice developed a hepatic steatosis which contributes to increased plasma cholesterol levels even under cholesterol-free standard chow. Transcripts of cholesterol biosynthesis components and liver cholesterol levels did not significantly differ between wild-type and all mutant mouse strains but RNA sequencing data and biochemical measurements point to an altered bile acid elimination in Mc4r(mut); Ldlr(-/-). Therefore, the unchanged endogenous cholesterol biosynthesis together with a reduced hepatic VLDL and LDL-cholesterol clearance most likely led to increased plasma lipid levels and consequently to atherosclerosis in this animal model. Our data indicate that dysfunction of the melanocortin-regulated food intake and the resulting obesity significantly add to the proatherogenic lipoprotein profile caused by LDL receptor deficiency and, therefore, can be regarded as relevant risk factor for atherosclerosis.	[Lede, Vera; Franke, Christin; Meusel, Andrej; Schoeneberg, Torsten; Schulz, Angela] Univ Leipzig, Rudolf Schonheimer Inst Biochem, Fac Med, Mol Biochem, Leipzig, Germany; [Meusel, Andrej; Schiller, Juergen; Huster, Daniel] Univ Leipzig, Inst Med Phys & Biophys, Fac Med, Leipzig, Germany; [Teupser, Daniel; Thiery, Joachim] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Fac Med, Leipzig, Germany; [Teupser, Daniel] Ludwig Maximilians Univ Munchen, Inst Lab Med, Munich, Germany; [Ricken, Albert] Univ Leipzig, Inst Anat, Fac Med, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; University of Munich; Leipzig University	Schoneberg, T; Schulz, A (corresponding author), Univ Leipzig, Rudolf Schonheimer Inst Biochem, Fac Med, Mol Biochem, Leipzig, Germany.	schoberg@medizin.uni-leipzig.de; angela.schulz@medizin.uni-leipzig.de	Lede, Vera/C-7258-2014	Lede, Vera/0000-0001-6045-2605	Deutsche Forschungsgemeinschaft [Sfb 1052]; Medical Faculty, University of Leipzig	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Faculty, University of Leipzig	This work was supported by the Deutsche Forschungsgemeinschaft (Sfb 1052, B6 and B7) and a student fellowship of the Medical Faculty, University of Leipzig, to C.M. http://www.sfb1052.de/index.php/en/.	Albarado DC, 2004, ENDOCRINOLOGY, V145, P243, DOI 10.1210/en.2003-0452; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Atkinson RD, 2008, AM J PHYSIOL-ENDOC M, V294, pE284, DOI 10.1152/ajpendo.00601.2007; Bamba V, 2007, GASTROENTEROLOGY, V132, P2181, DOI 10.1053/j.gastro.2007.03.056; Chiba T, 2008, ATHEROSCLEROSIS, V196, P68, DOI 10.1016/j.atherosclerosis.2007.01.040; Crowley VEF, 2008, ANN CLIN BIOCHEM, V45, P245, DOI 10.1258/acb.2007.007193; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fu SN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002902; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Grosse J, 2006, PHYSIOL GENOMICS, V26, P209, DOI 10.1152/physiolgenomics.00289.2005; Haskell-Luevano C, 2009, FASEB J, V23, P642, DOI 10.1096/fj.08-109686; Hasty AH, 2001, J BIOL CHEM, V276, P37402, DOI 10.1074/jbc.M010176200; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Itoh M, 2011, AM J PATHOL, V179, P2454, DOI 10.1016/j.ajpath.2011.07.014; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li SZ, 2009, CIRC RES, V105, P1072, DOI 10.1161/CIRCRESAHA.109.199570; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mueller MA, 2008, ATHEROSCLEROSIS, V198, P39, DOI 10.1016/j.atherosclerosis.2007.09.019; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Nojima K, 2013, ENDOCR J, V60, P261, DOI 10.1507/endocrj.EJ12-0258; Perfield JW, 2013, J OBES, V2013, DOI 10.1155/2013/296537; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Shimizu H, 2007, J ENDOCRINOL, V193, P1, DOI 10.1677/JOE-06-0144; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Staubert C, 2007, ENDOCRINOLOGY, V148, P4642, DOI 10.1210/en.2007-0138; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Sutton GM, 2006, ENDOCRINOLOGY, V147, P2183, DOI 10.1210/en.2005-1209; Taleb S, 2007, ARTERIOSCL THROM VAS, V27, P2691, DOI 10.1161/ATVBAHA.107.149567; Tallam LS, 2005, HYPERTENSION, V46, P326, DOI 10.1161/01.HYP.0000175474.99326.bf; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; VANREE JH, 1994, ATHEROSCLEROSIS, V111, P25, DOI 10.1016/0021-9150(94)90188-0; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Wu KK, 2005, ATHEROSCLEROSIS, V181, P251, DOI 10.1016/j.atherosclerosis.2005.01.029; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404	46	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167888	10.1371/journal.pone.0167888	http://dx.doi.org/10.1371/journal.pone.0167888			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030540	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000025
J	Nguyen, LDN; Deschaght, P; Merlin, S; Loywick, A; Audebert, C; Van Daele, S; Viscogliosi, E; Vaneechoutte, M; Delhaes, L				Linh Do Ngoc Nguyen; Deschaght, Pieter; Merlin, Sophie; Loywick, Alexandre; Audebert, Christophe; Van Daele, Sabine; Viscogliosi, Eric; Vaneechoutte, Mario; Delhaes, Laurence			Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; CANDIDA-ALBICANS; SAMPLES; MICROBIOME; CELLS; RARE; QUANTIFICATION; ASPERGILLOSIS; COMMUNITIES; DIVERSITY	Introduction and Purpose Propidium monoazide (PMA)-pretreatment has increasingly been applied to remove the bias from dead or damaged cell artefacts, which could impact the microbiota analysis by high-throughput sequencing. Our study aimed to determine whether a PMA-pretreatment coupled with high-throughput sequencing analysis provides a different picture of the airway mycobiome and bacteriome. Results and Discussion We compared deep-sequencing data of mycobiota and microbiota of 15 sputum samples from 5 cystic fibrosis (CF) patients with and without prior PMA-treatment of the DNA-extracts. PMA-pretreatment had no significant effect on the entire and abundant bacterial community (genera expressed as operational taxonomic units (OTUs) with a relative abundance greater than or equal to 1%), but caused a significant difference in the intermediate community (less than 1%) when analyzing the alpha biodiversity Simpson index (p = 0.03). Regarding PMA impact on the airway mycobiota evaluated for the first time here; no significant differences in alpha diversity indexes between PMA-treated and untreated samples were observed. Regarding beta diversity analysis, the intermediate communities also differed more dramatically than the total and abundant ones when studying both mycobiome and bacteriome. Our results showed that only the intermediate (or low abundance) population diversity is impacted by PMA-treatment, and therefore that abundant taxa are mostly viable during acute exacerbation in CF. Given such a cumbersome protocol (PMA-pretreatment coupled with high-throughput sequencing), we discuss its potential interest within the follow-up of CF patients. Further studies using PMA-pretreatment are warranted to improve our "omic" knowledge of the CF airways.	[Linh Do Ngoc Nguyen; Viscogliosi, Eric; Delhaes, Laurence] Univ Lille, Inst Pasteur Lille, Ctr Infect & Immun Lille, INSERM U1019,CNRS UMR 8204, Lille, France; [Deschaght, Pieter; Vaneechoutte, Mario] Univ Ghent, Lab Bacteriol Res, Fac Med & Hlth Sci, Ghent, Belgium; [Merlin, Sophie; Loywick, Alexandre; Audebert, Christophe] GenesDiffusion, Douai, France; [Merlin, Sophie; Loywick, Alexandre; Audebert, Christophe] Inst Pasteur, PEGASE, Biosci, Lille, France; [Van Daele, Sabine] Univ Ghent, Dept Pediat & Genet, Fac Med & Hlth Sci, Ghent, Belgium; [Delhaes, Laurence] Fac Med, Reg Hosp Ctr, Parasitol Med Mycol Dept, Lille, France; [Delhaes, Laurence] Reg Hosp Ctr, INSERM U1045, Parasitol Med Mycol Dept, Bordeaux, France; [Delhaes, Laurence] Fac Med Bordeaux, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Ghent University; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Ghent University; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Delhaes, L (corresponding author), Univ Lille, Inst Pasteur Lille, Ctr Infect & Immun Lille, INSERM U1019,CNRS UMR 8204, Lille, France.; Delhaes, L (corresponding author), Fac Med, Reg Hosp Ctr, Parasitol Med Mycol Dept, Lille, France.; Delhaes, L (corresponding author), Reg Hosp Ctr, INSERM U1045, Parasitol Med Mycol Dept, Bordeaux, France.; Delhaes, L (corresponding author), Fac Med Bordeaux, Bordeaux, France.	laurence.delhaes@chu-bordeaux.fr	Vaneechoutte, Mario/A-6189-2009; Delhaes, Laurence/AAD-6930-2020	Vaneechoutte, Mario/0000-0002-4586-203X; Delhaes, Laurence/0000-0001-7489-9205; Van daele, Sabine/0000-0002-6632-1240	French Ministry of Health and Research (PHRC) [2006/1902]; Lille Hospital; Lille 2 University [R7000]; Pasteur Institute of Lille	French Ministry of Health and Research (PHRC); Lille Hospital; Lille 2 University; Pasteur Institute of Lille	Laurence Delhaes has received research grants from the French Ministry of Health and Research (PHRC no. 2006/1902), Lille Hospital, Lille 2 University (Lille and Ghent Universities partnership: R7000), and Pasteur Institute of Lille. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GenesDiffusion's company provided support in the form of salaries for authors (SM, AL, AC) of GenesDiffusion's company, but did not have any additional role in the study design, data collection and analysis, or decision to publish. The specific roles of these authors are articulated in the 'author contributions' section.	Agusti G, 2013, APPL MICROBIOL BIOT, V97, P341, DOI 10.1007/s00253-012-4524-z; Baxter CG, 2013, J ALLERGY CLIN IMMUN, V132, P560, DOI 10.1016/j.jaci.2013.04.007; Cai YP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr349; Charlson ES, 2012, AM J RESP CRIT CARE, V186, P536, DOI 10.1164/rccm.201204-0693OC; Chiao TH, 2014, ENVIRON SCI TECHNOL, V48, P4038, DOI 10.1021/es4055725; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; Deschaght P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079010; Deschaght P, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-245; Dickson RP, 2015, ANN AM THORAC SOC, V12, P821, DOI 10.1513/AnnalsATS.201501-029OC; Exterkate RAM, 2015, CLIN ORAL INVEST, V19, P813, DOI 10.1007/s00784-014-1297-z; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Fittipaldi M, 2012, J MICROBIOL METH, V91, P276, DOI 10.1016/j.mimet.2012.08.007; Frealle E, 2009, EUR J CLIN MICROBIOL, V28, P223, DOI 10.1007/s10096-008-0616-1; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; Manavathu EK, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-53; Mangot JF, 2013, ENVIRON MICROBIOL, V15, P1745, DOI 10.1111/1462-2920.12065; Marsland BJ, 2014, NAT REV IMMUNOL, V14, P827, DOI 10.1038/nri3769; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; Mear JB, 2013, MED MALADIES INFECT, V43, P146, DOI 10.1016/j.medmal.2013.02.005; Nguyen LDN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00089; Nocker A, 2010, INT MICROBIOL, V13, P59, DOI 10.2436/20.1501.01.111; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quero GM, 2014, MAR GENOM, V17, P9, DOI 10.1016/j.margen.2014.04.002; Quinn RA, 2015, ISME J, V9, P1024, DOI 10.1038/ismej.2014.234; Ratjen F, 2012, AM J RESP CRIT CARE, V185, P933, DOI 10.1164/rccm.201202-0306UP; Rogers GB, 2013, ISME J, V7, P697, DOI 10.1038/ismej.2012.145; Roges GB, 2008, DIAGN MICR INFEC DIS, V62, P133, DOI 10.1016/j.diagmicrobio.2008.06.011; Roux D, 2009, CRIT CARE MED, V37, P1062, DOI 10.1097/CCM.0b013e31819629d2; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stenbit AE, 2011, CURR OPIN PULM MED, V17, P442, DOI 10.1097/MCP.0b013e32834b8c04; Surette Michael G, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS61, DOI 10.1513/AnnalsATS.201306-159MG; Tavernier S, 2015, PEERJ, V3, DOI 10.7717/peerj.787; Taylor Michael J, 2014, Microbiol Insights, V7, P15, DOI 10.4137/MBI.S17723; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Touati K, 2014, CURR FUNGAL INFECT R, V8, P302, DOI 10.1007/s12281-014-0197-7; Vaishampayan P, 2013, ISME J, V7, P312, DOI 10.1038/ismej.2012.114; van Woerden HC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-69; Venkataraman A, 2015, MBIO, V6, DOI 10.1128/mBio.02284-14; Venkateswaran K, 2014, APPL MICROBIOL BIOT, V98, P6453, DOI 10.1007/s00253-014-5650-6; Vesper S, 2008, J MICROBIOL METH, V72, P180, DOI 10.1016/j.mimet.2007.11.017; Waters VJ, 2015, J CYST FIBROS, V14, P755, DOI 10.1016/j.jcf.2015.01.007; Whiley RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115513; Whiteson KL, 2014, ISME J, V8, P1247, DOI 10.1038/ismej.2013.229; Willger SD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-40; Xu H, 2014, CELL MICROBIOL, V16, P214, DOI 10.1111/cmi.12216; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	53	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168860	10.1371/journal.pone.0168860	http://dx.doi.org/10.1371/journal.pone.0168860			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030619	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000081
J	Mier-Aguilar, CA; Cashman, KS; Raman, C; Soldevila, G				Mier-Aguilar, Carlos A.; Cashman, Kevin S.; Raman, Chander; Soldevila, Gloria			CD5-CK2 Signaling Modulates Erk Activation and Thymocyte Survival	PLOS ONE			English	Article							T-CELL DEVELOPMENT; CASEIN KINASE 2; NEGATIVE SELECTION; REGULATED KINASE; IN-VIVO; TRANSGENIC MICE; CD5; RECEPTOR; CK2; EXPRESSION	CD5 is well recognized for its importance in thymic selection. Although this property of CD5 has been attributed to its ITIM-domain dependent regulation of TCR-signal strength, the mechanism has not been established. A second major signaling domain within the cytoplasmic tail of CD5 is a CK2 binding/activation domain (CD5-CK2BD). Using a gene-targeted mouse in which the CD5-CK2BD is selectively ablated (CD5-ACK2BD), we determined that loss of function of CD5-CK2 signaling in a MHC-II selecting TCR transgenic (OT-11) mouse resulted in decrease in double positive (DP) thymocytes, which correlated with enhanced apoptosis. Remarkably, DP cells expressing high levels of CD5 and CD69 and single positive (CD4+SP) thymocytes were increased in CD5-ACK2BD mice indicating that CD5-CK2 signaling regulates positive selection and promotes survival. Consistent with this possibility, we determined that the activation and nuclear localization of ERK as well as apoptosis was greater in thymic populations from OTI1 CD5-ACK2BD mice than OTII CD5-WT mice following injection of OVA(323-339)-peptide. The mobilization of Ca2+, an early event of TCR activation, was not altered by the loss of CD5-CK2 signaling. Collectively, these data demonstrate that the CD5-CK2 signaling axis regulates positive selection by modulating activation of ERK and promoting survival independent of proximal TCR signals.	[Mier-Aguilar, Carlos A.; Soldevila, Gloria] Univ Nacl Autonoma Mexico, Dept Inmunol, Inst Invest Biomed, Mexico City, DF, Mexico; [Cashman, Kevin S.; Raman, Chander] Univ Alabama Birmingham, Dept Microbiol, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Raman, Chander] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Mier-Aguilar, Carlos A.] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico; [Cashman, Kevin S.] Emory Univ, Div Rheumatol, Lowance Ctr Human Immunol, 255 Whitehead Biomed Res Bldg, Atlanta, GA 30322 USA	Universidad Nacional Autonoma de Mexico; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University	Soldevila, G (corresponding author), Univ Nacl Autonoma Mexico, Dept Inmunol, Inst Invest Biomed, Mexico City, DF, Mexico.; Raman, C (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA.; Raman, C (corresponding author), Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA.	craman@uab.edu; soldevi@unam.mx		Soldevila, Gloria/0000-0003-1539-2548	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico [166024]; National Institutes of Health [AI 1076562]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [245318/303389]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR022807, G20RR025858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Work was supported by Grants from Consejo Nacional de Ciencia y Tecnologia (CONACYT #166024) (GS), Mexico (www.conacyt.gob.mx), and from National Institutes of Health AI 1076562 (CR) (https://www.nih.gov). CMA was supported by a doctoral fellowship from Consejo Nacional de Ciencia y Tecnologia (CONACYT#245318/303389).	Au-Yeung BB, 2014, NAT IMMUNOL, V15, P687, DOI 10.1038/ni.2918; Axtell RC, 2006, J IMMUNOL, V177, P8542, DOI 10.4049/jimmunol.177.12.8542; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Brewer JA, 2002, J IMMUNOL, V169, P1837, DOI 10.4049/jimmunol.169.4.1837; Castellanos MD, 1997, J IMMUNOL, V159, P5463; Chan S, 1999, EUR J IMMUNOL, V29, P2916, DOI 10.1002/(SICI)1521-4141(199909)29:09<2916::AID-IMMU2916>3.0.CO;2-I; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Fink PJ, 2013, ANNU REV IMMUNOL, V31, P31, DOI 10.1146/annurev-immunol-032712-100010; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Fu GP, 2010, J EXP MED, V207, P309, DOI 10.1084/jem.20090880; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Kishimoto H, 1998, J EXP MED, V187, P1427, DOI 10.1084/jem.187.9.1427; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Koonpaew S, 2006, J EXP MED, V203, P119, DOI 10.1084/jem.20050903; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Ludviksson BR, 1999, J IMMUNOL, V163, P4349; McGargill MA, 2000, NAT IMMUNOL, V1, P336, DOI 10.1038/79790; McGuire DJ, 2014, EUR J IMMUNOL, V44, P1137, DOI 10.1002/eji.201343998; McNeil LK, 2005, P NATL ACAD SCI USA, V102, P13574, DOI 10.1073/pnas.0505110102; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mier-Aguilar CA, 2015, BIOCHEM BIOPH RES CO, V466, P381, DOI 10.1016/j.bbrc.2015.09.033; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; Ordonez-Rueda D, 2009, EUR J IMMUNOL, V39, P2233, DOI 10.1002/eji.200839053; Plotnikov A, 2011, MOL CELL BIOL, V31, P3515, DOI 10.1128/MCB.05424-11; Raman C, 1998, J BIOL CHEM, V273, P19183, DOI 10.1074/jbc.273.30.19183; Roa NS, 2013, BIOCHEM BIOPH RES CO, V432, P52, DOI 10.1016/j.bbrc.2013.01.086; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Sestero CM, 2012, J IMMUNOL, V189, P2918, DOI 10.4049/jimmunol.1200065; Sinclair C, 2013, P NATL ACAD SCI USA, V110, pE2905, DOI 10.1073/pnas.1304859110; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Soldevila G, 2011, CURR OPIN IMMUNOL, V23, P310, DOI 10.1016/j.coi.2011.03.003; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Ulges A, 2015, NAT IMMUNOL, V16, P267, DOI 10.1038/ni.3083; Whitmarsh AJ, 2011, MOL CELL BIOL, V31, P3512, DOI 10.1128/MCB.05916-11; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhou XY, 2000, J IMMUNOL, V164, P1260, DOI 10.4049/jimmunol.164.3.1260; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	47	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168155	10.1371/journal.pone.0168155	http://dx.doi.org/10.1371/journal.pone.0168155			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030587	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000038
J	Butler, CT; Reynolds, AL; Tosetto, M; Dillon, ET; Guiry, PJ; Cagney, G; O'Sullivan, J; Kennedy, BN				Butler, Clare T.; Reynolds, Alison L.; Tosetto, Miriam; Dillon, Eugene T.; Guiry, Patrick J.; Cagney, Gerard; O'Sullivan, Jacintha; Kennedy, Breandan N.			A Quininib Analogue and Cysteinyl Leukotriene Receptor Antagonist Inhibits Vascular Endothelial Growth Factor (VEGF)-independent Angiogenesis and Exerts an Additive Antiangiogenic Response with Bevacizumab	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiogenesis; calpain; cell migration; colorectal cancer; drug development; endothelial cell; G protein-coupled receptor (GPCR); leukotriene; pharmacology; vascular endothelial growth factor (VEGF)	NF-KAPPA-B; CELL LUNG-CANCER; EXPRESSION; VEGF; MECHANISMS; IDENTIFICATION; DISCOVERY; SURVIVAL; THERAPY; PATHWAY	Excess blood vessel growth contributes to the pathology of metastatic cancers and age-related retinopathies. Despite development of improved treatments, these conditions are associated with high economic costs and drug resistance. Bevacizumab (Avastin (R)), a monoclonal antibody against vascular endothelial growth factor (VEGF), is used clinically to treat certain types of metastatic cancers. Unfortunately, many patients do not respond or inevitably become resistant to bevacizumab, highlighting the need for more effective antiangiogenic drugs with novel mechanisms of action. Previous studies discovered quininib, an antiangiogenic small molecule antagonist of cysteinyl leukotriene receptors 1 and 2 (CysLT(1) and CysLT(2)). Here, we screened a series of quininib analogues and identified a more potent antiangiogenic novel chemical entity (IUPAC name (E)-2-(2-quinolin-2-yl-vinyl)-benzene-1,4-diol HCl) hereafter designated Q8. Q8 inhibits developmental angiogenesis in Tg(fli1:EGFP) zebrafish and inhibits human microvascular endothelial cell (HMEC-1) proliferation, tubule formation, and migration. Q8 elicits antiangiogenic effects in a VEGF-independent in vitro model of angiogenesis and exerts an additive antiangiogenic response with the anti-VEGF biologic bevacizumab. Cell-based receptor binding assays confirm that Q8 is a CysLT(1) antagonist and is sufficient to reduce cellular levels of NF-B and calpain-2 and secreted levels of the proangiogenic proteins intercellular adhesion molecule-1, vascular cell adhesion protein-1, and VEGF. Distinct reductions of VEGF by bevacizumab explain the additive antiangiogenic effects observed in combination with Q8. In summary, Q8 is a more effective antiangiogenic drug compared with quininib. The VEGF-independent activity coupled with the additive antiangiogenic response observed in combination with bevacizumab demonstrates that Q8 offers an alternative therapeutic strategy to combat resistance associated with conventional anti-VEGF therapies.	[Butler, Clare T.; Reynolds, Alison L.; Dillon, Eugene T.; Cagney, Gerard; Kennedy, Breandan N.] Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Guiry, Patrick J.] Univ Coll Dublin, UCD Sch Chem, UCD Ctr Synth & Chem Biol, Dublin 4, Ireland; [Tosetto, Miriam] St Vincents Univ Hosp, Ctr Colorectal Dis, Dublin 4, Ireland; [O'Sullivan, Jacintha] Trinity Coll Dublin, St Jamess Hosp, Dept Surg, Trinity Translat Med Inst, Dublin 8, Ireland	University College Dublin; University College Dublin; University College Dublin; Saint Vincent's University Hospital; Trinity College Dublin	Kennedy, BN (corresponding author), Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, UCD Conway Inst F062, Dublin D04 V1W8, Ireland.	brendan.kennedy@ucd.ie	kennedy, Breandan/H-5643-2019	kennedy, Breandan/0000-0001-7991-4689; O'Sullivan, Jacintha/0000-0001-8622-9858; Cagney, Gerard/0000-0001-7189-9496; Reynolds, Alison/0000-0002-3147-0094	Irish Cancer Society Scholarship Grant [CRS13BUT]; Enterprise Ireland Grant [CF/20111319]	Irish Cancer Society Scholarship Grant; Enterprise Ireland Grant	This work was supported by Irish Cancer Society Scholarship Grant CRS13BUT and Enterprise Ireland Grant CF/20111319. J. O. and B. N. K. are inventors on United States Patent 8916586 B2, and A. L. R., J. O., and B. N. K. are inventors on United States Patent 9388138 B2.	Adair TH., 2010, C SERIES INTEGRATED, V2, P1, DOI DOI 10.4199/C00017ED1V01Y201009ISP010; Alswied A, 2015, J BIOL CHEM, V290, P29555, DOI 10.1074/jbc.M115.678292; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Bach PB, 2009, NEW ENGL J MED, V360, P626, DOI 10.1056/NEJMhpr0807774; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Behl T, 2016, PROSTAG OTH LIPID M, V122, P1, DOI 10.1016/j.prostaglandins.2015.12.001; Burke L, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00103; Calzado MA, 2007, CURR MED CHEM, V14, P367, DOI 10.2174/092986707779941113; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cernuda-Morollon E, 2006, CIRC RES, V98, P757, DOI 10.1161/01.RES.0000210579.35304.d3; Duah E, 2013, SCI REP-UK, V3, DOI 10.1038/srep03274; Edelman MJ, 2013, TRANSL LUNG CANCER R, V2, P304, DOI 10.3978/j.issn.2218-6751.2013.01.02; Fojo T, 2009, JNCI-J NATL CANCER I, V101, P1044, DOI 10.1093/jnci/djp177; FOLKMAN J, 1980, T OPHTHAL SOC UK, V100, P346; Galvin O, 2016, J CONTROL RELEASE, V233, P198, DOI 10.1016/j.jconrel.2016.04.004; Gunther JB, 2009, SURV OPHTHALMOL, V54, P372, DOI 10.1016/j.survophthal.2009.02.004; Han YS, 2009, GRAEF ARCH CLIN EXP, V247, P541, DOI 10.1007/s00417-008-0976-3; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jia ZL, 2007, CANCER RES, V67, P4878, DOI 10.1158/0008-5472.CAN-06-3494; Jung CH, 2012, INFLAMMATION, V35, P1041, DOI 10.1007/s10753-011-9409-2; Kanaoka Y, 2013, J BIOL CHEM, V288, P10967, DOI 10.1074/jbc.C113.453704; Kennedy B. N., 2014, Patent No. [WO 2014012889 A1, 2014012889]; Kotz J, 2012, SCIBX, V5, P1, DOI DOI 10.1038/SCIBX.2012.380; Kumler I, 2014, CANCER TREAT REV, V40, P960, DOI 10.1016/j.ctrv.2014.05.006; Lieu C, 2011, CLIN CANCER RES, V17, P6130, DOI 10.1158/1078-0432.CCR-11-0659; Lieu CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077117; Lin T. J., 2011, U.S. Patent, Patent No. [20110117106 A1, 20110117106]; Loges Sonja, 2010, Genes Cancer, V1, P12, DOI 10.1177/1947601909356574; Lynch TJ, 2014, J THORAC ONCOL, V9, P1332, DOI 10.1097/JTO.0000000000000257; Magnusson C, 2010, EUR J CANCER, V46, P826, DOI 10.1016/j.ejca.2009.12.022; Metheny-Barlow LJ, 2003, CELL RES, V13, P309, DOI 10.1038/sj.cr.7290176; Montero AJ, 2012, CURR ONCOL REP, V14, P1, DOI 10.1007/s11912-011-0202-z; Murphy AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep34523; MURPHY CS, 1991, MOL PHARMACOL, V39, P421; Ohd JF, 2003, GASTROENTEROLOGY, V124, P57, DOI 10.1053/gast.2003.50011; Otrock ZK, 2007, BLOOD CELL MOL DIS, V39, P212, DOI 10.1016/j.bcmd.2007.04.001; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Park MH, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020015; Reynolds AL, 2016, J BIOL CHEM, V291, P7242, DOI 10.1074/jbc.M115.710665; Riaz MK, 2016, J SURG ONCOL, V114, P323, DOI 10.1002/jso.24333; Salajegheh A., 2016, ANGIOGENESIS HLTH DI, P375; Savari S, 2014, WORLD J GASTROENTERO, V20, P968, DOI 10.3748/wjg.v20.i4.968; Schaecher K, 2004, NEUROCHEM RES, V29, P1443, DOI 10.1023/B:NERE.0000026410.56000.dd; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; Smith TJ, 2011, NEW ENGL J MED, V364, P2060, DOI 10.1056/NEJMsb1013826; Spirina LV, 2013, J CANCER RES CLIN, V139, P625, DOI 10.1007/s00432-012-1366-0; Su YC, 2006, FASEB J, V20, P1443, DOI 10.1096/fj.05-5354com; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; Tran TC, 2007, CANCER RES, V67, P11386, DOI 10.1158/0008-5472.CAN-07-3126; Tsai MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23979; Turtay MG, 2010, CLIN INVEST MED, V33, pE413; van Wetering S, 2003, AM J PHYSIOL-CELL PH, V285, pC343, DOI 10.1152/ajpcell.00048.2003; Wang ZW, 2015, SEMIN CANCER BIOL, V35, pS224, DOI 10.1016/j.semcancer.2015.01.001; World Health Organization, 2012, GLOBOCAN 2012 EST CA; Wu YJ, 2006, CIRC RES, V99, P315, DOI 10.1161/01.RES.0000235986.35957.a3; Xie TX, 2010, ONCOL REP, V23, P725, DOI 10.3892/or_00000690; Xu L, 2010, PHARMAZIE, V65, P750, DOI 10.1691/ph.2010.9810; ZAMBONI R, 1992, J MED CHEM, V35, P3832, DOI 10.1021/jm00099a011	62	14	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3552	3567		10.1074/jbc.M116.747766	http://dx.doi.org/10.1074/jbc.M116.747766			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28035003	Green Published, hybrid			2022-12-26	WOS:000395542500002
J	Jonak, CR; Lainez, NM; Roybal, LL; Williamson, AD; Coss, D				Jonak, Carrie R.; Lainez, Nancy M.; Roybal, Lacey L.; Williamson, Alexa D.; Coss, Djurdjica			c-JUN Dimerization Protein 2 (JDP2) Is a Transcriptional Repressor of Follicle-stimulating Hormone beta(FSH beta) and Is Required for Preventing Premature Reproductive Senescence in Female Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GONADOTROPIN-RELEASING-HORMONE; ANTI-MULLERIAN HORMONE; POLYCYSTIC-OVARY-SYNDROME; MESSENGER RIBONUCLEIC-ACIDS; RAT ESTROUS-CYCLE; N-TERMINAL KINASE; LUTEINIZING-HORMONE; BETA-GENE; FSH-BETA; HISTONE ACETYLATION	Follicle-stimulating hormone (FSH) regulates follicular growth and stimulates estrogen synthesis in the ovaries. FSH is a heterodimer consisting of an alpha subunit, also present in luteinizing hormone, and a unique beta subunit, which is transcriptionally regulated by gonadotropin-releasing hormone 1 (GNRH). Because most FSH is constitutively secreted, tight transcriptional regulation is critical for maintaining FSH levels within a narrow physiological range. Previously, we reported that GNRH induces FSH beta (Fshb) transcription via induction of the AP-1 transcription factor, a heterodimer of c-FOS and c-JUN. Herein, we identify c-JUN-dimerization protein 2 (JDP2) as a novel repressor of GNRH-mediated Fshb induction. JDP2 exhibited high basal expression and bound the Fshb promoter at an AP-1-binding site in a complex with c-JUN. GNRH treatment induced c-FOS to replace JDP2 as a c-JUN binding partner, forming transcriptionally active AP-1. Subsequently, rapid c-FOS degradation enabled reformation of the JDP2 complex. In vivo studies revealed that JDP2 null male mice have normal reproductive function, as expected from a negative regulator of the FSH hormone. Female JDP2 null mice, however, exhibited early puberty, observed as early vaginal opening, larger litters, and early reproductive senescence. JDP2 null females had increased levels of circulating FSH and higher expression of the Fshb subunit in the pituitary, resulting in elevated serum estrogen and higher numbers of large ovarian follicles. Disruption of JDP2 function therefore appears to cause early cessation of reproductive function, a condition that has been associated with elevated FSH in women.	[Jonak, Carrie R.; Lainez, Nancy M.; Roybal, Lacey L.; Williamson, Alexa D.; Coss, Djurdjica] Univ Calif Riverside, Sch Med, Div Biomed Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside	Coss, D (corresponding author), Univ Calif Riverside, Sch Med, Div Biomed Sci, Riverside, CA 92521 USA.	djurdjica.coss@ucr.edu		Coss, Djurdjica/0000-0003-0692-1612	Eunice Kennedy Shriver NICHD/National Institutes of Health (SCCPIR) Grant [U54-HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934, R01HD057549] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD/National Institutes of Health (SCCPIR) Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Dr. Aronheim for the JDP2 expression vector. We are especially grateful to Drs. Akira for JDP2 null mice and Mellon for L beta T2 cells. The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is a fee-for-service core facility and is supported in part by Eunice Kennedy Shriver NICHD/National Institutes of Health (SCCPIR) Grant U54-HD28934.	Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; BAARENDS WM, 1995, ENDOCRINOLOGY, V136, P4951, DOI 10.1210/en.136.11.4951; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Broekmans FJ, 2008, TRENDS ENDOCRIN MET, V19, P340, DOI 10.1016/j.tem.2008.08.002; BURRIN JM, 1989, MOL ENDOCRINOL, V3, P1643, DOI 10.1210/mend-3-10-1643; CESNJAJ M, 1994, ENDOCRINOLOGY, V135, P692, DOI 10.1210/en.135.2.692; Chand AL, 2010, HUM REPROD UPDATE, V16, P39, DOI 10.1093/humupd/dmp031; Chang RJ, 2007, NAT CLIN PRACT ENDOC, V3, P688, DOI 10.1038/ncpendmet0637; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Ciccone NA, 2010, MOL CELL BIOL, V30, P1028, DOI 10.1128/MCB.00848-09; Coss D, 2004, J BIOL CHEM, V279, P152, DOI 10.1074/jbc.M304697200; Coss D, 2007, MOL ENDOCRINOL, V21, P3071, DOI 10.1210/me.2007-0247; Darlyuk-Saadon I, 2012, BBA-GENE REGUL MECH, V1819, P1142, DOI 10.1016/j.bbagrm.2012.09.005; de Vet A, 2002, FERTIL STERIL, V77, P357, DOI 10.1016/S0015-0282(01)02993-4; Ely HA, 2011, MOL ENDOCRINOL, V25, P669, DOI 10.1210/me.2010-0437; GAY V L, 1970, Federation Proceedings, V29, P1880; Goswami D, 2007, HORM RES, V68, P196, DOI 10.1159/000102537; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; Haisenleder DJ, 2011, ENDOCRINOLOGY, V152, P4443, DOI 10.1210/en.2011-1501; Hall JE, 1998, J ENDOCRINOL INVEST, V21, P602, DOI 10.1007/BF03350785; He CY, 2010, HUM GENET, V128, P515, DOI 10.1007/s00439-010-0878-4; Howles CM, 2000, MOL CELL ENDOCRINOL, V161, P25, DOI 10.1016/S0303-7207(99)00219-1; Huhtaniemi I, 2006, MOL CELL ENDOCRINOL, V254, P84, DOI 10.1016/j.mce.2006.04.015; Huhtaniemi I, 2006, MOL CELL ENDOCRINOL, V252, P126, DOI 10.1016/j.mce.2006.03.026; Jin CY, 2006, NAT STRUCT MOL BIOL, V13, P331, DOI 10.1038/nsmb1063; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; Jin CY, 2001, FEBS LETT, V489, P34, DOI 10.1016/S0014-5793(00)02387-5; Katz S, 2001, FEBS LETT, V506, P196, DOI 10.1016/S0014-5793(01)02907-6; Kissell KA, 2014, HUM REPROD, V29, P1764, DOI 10.1093/humrep/deu142; Lamminen T, 2005, MOL HUM REPROD, V11, P601, DOI 10.1093/molehr/gah198; Lawson MA, 2007, MOL ENDOCRINOL, V21, P1175, DOI 10.1210/me.2006-0392; Layman LC, 2000, SEMIN REPROD MED, V18, P5, DOI 10.1055/s-2000-13470; Lim S, 2007, MOL CELL BIOL, V27, P4105, DOI 10.1128/MCB.00248-07; Lindaman LL, 2013, MOL CELL ENDOCRINOL, V365, P316, DOI 10.1016/j.mce.2012.11.012; Maruyama K, 2012, IMMUNITY, V37, P1024, DOI 10.1016/j.immuni.2012.08.022; Mbarek H, 2016, AM J HUM GENET, V98, P898, DOI 10.1016/j.ajhg.2016.03.008; McArdle CA, 1996, J BIOL CHEM, V271, P23711, DOI 10.1074/jbc.271.39.23711; McArdle CA, 2002, J ENDOCRINOL, V173, P1, DOI 10.1677/joe.0.1730001; McArdle CA, 1999, MOL CELL ENDOCRINOL, V151, P129, DOI 10.1016/S0303-7207(99)00024-6; Meduri G, 2007, HUM REPROD, V22, P117, DOI 10.1093/humrep/del346; Mistry DS, 2011, MOL ENDOCRINOL, V25, P1387, DOI 10.1210/me.2011-0032; Morales AJ, 1996, J CLIN ENDOCR METAB, V81, P2854, DOI 10.1210/jc.81.8.2854; Nakade K, 2007, CELL DEATH DIFFER, V14, P1398, DOI 10.1038/sj.cdd.4402129; Nicol L, 2004, J MOL ENDOCRINOL, V32, P467, DOI 10.1677/jme.0.0320467; ORTOLANO GA, 1988, ENDOCRINOLOGY, V123, P2946, DOI 10.1210/endo-123-6-2946; PADMANABHAN V, 1995, BIOL REPROD, V53, P263, DOI 10.1095/biolreprod53.2.263; Pan J., 2004, NUCL ACIDS S SER OXF, DOI [10.1093/nass/48.1.189, DOI 10.1093/NASS/48.1.189]; Park M, 2014, FERTIL STERIL, V102, P847, DOI 10.1016/j.fertnstert.2014.05.031; Reddy GR, 2013, MOL ENDOCRINOL, V27, P253, DOI 10.1210/me.2012-1168; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; SHUPNIK MA, 1990, MOL ENDOCRINOL, V4, P1444, DOI 10.1210/mend-4-10-1444; STOJILKOVIC SS, 1994, ENDOCR REV, V15, P462, DOI 10.1210/er.15.4.462; Taieb J, 2011, MOL ENDOCRINOL, V25, P645, DOI 10.1210/me.2010-0297; Visser JA, 2012, NAT REV ENDOCRINOL, V8, P331, DOI 10.1038/nrendo.2011.224; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wang HZ, 2014, P NATL ACAD SCI USA, V111, P5735, DOI 10.1073/pnas.1321404111; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; Weidenfeld-Baranboim K, 2011, BIOCHEM J, V436, P661, DOI 10.1042/BJ20101031; Wurmbach E, 2001, J BIOL CHEM, V276, P47195, DOI 10.1074/jbc.M108716200; Xie CC, 2015, MOL CELL ENDOCRINOL, V411, P223, DOI 10.1016/j.mce.2015.04.033; Xie JJ, 2005, MOL ENDOCRINOL, V19, P2624, DOI 10.1210/me.2005-0056; ZMEILI SM, 1986, ENDOCRINOLOGY, V119, P1867, DOI 10.1210/endo-119-4-1867	63	15	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2646	2659		10.1074/jbc.M116.771808	http://dx.doi.org/10.1074/jbc.M116.771808			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28007961	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000395535100008
J	Saleem, S; Biswas, SC				Saleem, Suraiya; Biswas, Subhas Chandra			Tribbles Pseudokinase 3 Induces Both Apoptosis and Autophagy in Amyloid-beta-induced Neuronal Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; ANTI-TUMORAL ACTION; ALZHEIMERS-DISEASE; CELL-DEATH; ER STRESS; TRANSCRIPTION FACTOR; SYMPATHETIC NEURONS; SIGNALING PATHWAY; MEDIATES DEATH; TRB3 LINKS	Amyloid-beta(A beta)-induced neuron death is considered central to the pathogenesis of Alzheimer's disease (AD). Among several death modalities, autophagy and apoptosis play important roles in A beta-induced neuron death suggesting that there may be regulatory mechanisms that initiate both cell death pathways. However, molecules that govern both pathways have not been identified. Here, we report that, upon A beta treatment, tribbles pseudokinase 3 (Trib3, an ortholog of Drosophila Tribbles) is up-regulated in neurons both in vivo and in vitro. Increased Trib3 levels inhibited the activity of the kinase Akt by interacting with it. As a result, forkhead box O1 (FoxO1), a transcription factor that is negatively regulated by Akt, was activated, translocated to the nucleus, and induced the pro-apoptotic gene BCL2-like 11 (Bim). Conversely, FoxO1 responded to A beta insult by binding to the Trib3 gene promoter, enhancing its expression. Our investigations further revealed that Trib3 also induces autophagy. Wefound that Trib3 indirectly activates unc-51-like autophagy-activating kinase1 (Ulk1) by impeding phosphorylation of, and thus inactivating, a negative regulator of Ulk1, mechanistic target of rapamycin. Ulk1 activation augmented autophagosome formation and reduced autophagy flux. Thus, Trib3 was required for formation of autophagosomes, which accumulated in neurons as autophagic flux was thwarted. Most importantly, silencing endogenous Trib3 strongly protected neurons from A beta insult. Our results suggest that a self-amplifying feed-forward loop among Trib3, Akt, and FoxO1 in A beta-treated neurons induces both apoptosis and autophagy, culminating in neuron death. Thus, Trib3 may serve as a potential therapeutic target for AD.	[Saleem, Suraiya; Biswas, Subhas Chandra] Indian Inst Chem Biol, Council Sci & Ind Res, Cell Biol & Physiol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Biswas, SC (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Cell Biol & Physiol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	biswassc@gmail.com			Council of Scientific and Industrial Research, Government of India [miND BSC0115]	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by one of the 12th Five Year Plan Projects, miND BSC0115, from the Council of Scientific and Industrial Research, Government of India. The authors declare that they have no conflicts of interest with the contents of this article.	Aime P, 2015, J NEUROSCI, V35, P10731, DOI 10.1523/JNEUROSCI.0614-15.2015; Akhter R, 2014, J BIOL CHEM, V289, P10812, DOI 10.1074/jbc.M113.519355; Biswas SC, 2005, J NEUROSCI, V25, P8349, DOI 10.1523/JNEUROSCI.1570-05.2005; Biswas SC, 2002, J BIOL CHEM, V277, P49511, DOI 10.1074/jbc.M208086200; Biswas SC, 2007, J BIOL CHEM, V282, P29368, DOI 10.1074/jbc.M702634200; Biswas SC, 2007, J NEUROSCI, V27, P893, DOI 10.1523/JNEUROSCI.3524-06.2007; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Cardinale A, 2012, J BIOL CHEM, V287, P2618, DOI 10.1074/jbc.M111.276550; Chen TJ, 2009, J NEUROSCI RES, V87, P2297, DOI 10.1002/jnr.22057; Corcoran CA, 2005, CANCER BIOL THER, V4, P1063, DOI 10.4161/cbt.4.10.2205; Cravero JD, 2009, ARTHRITIS RHEUM-US, V60, P492, DOI 10.1002/art.24225; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; Francois A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0139-x; FRAUTSCHY SA, 1991, P NATL ACAD SCI USA, V88, P8362, DOI 10.1073/pnas.88.19.8362; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Gilbert BJ, 2013, J CLIN PATHOL, V66, P362, DOI 10.1136/jclinpath-2013-201515; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; He L, 2006, J BIOL CHEM, V281, P11126, DOI 10.1074/jbc.M510724200; Hegde ML, 2004, J MOL NEUROSCI, V22, P19, DOI 10.1385/JMN:22:1-2:19; Hegedus Z, 2006, CELL MOL LIFE SCI, V63, P1632, DOI 10.1007/s00018-006-6007-9; Hua F, 2011, J CELL SCI, V124, P3235, DOI 10.1242/jcs.082875; Huang SB, 2013, J BIOL CHEM, V288, P33654, DOI 10.1074/jbc.M113.518134; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Hung SY, 2009, AUTOPHAGY, V5, P502, DOI 10.4161/auto.5.4.8096; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Kuusisto E, 2002, NEUROPATH APPL NEURO, V28, P228, DOI 10.1046/j.1365-2990.2002.00394.x; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lee HK, 2009, MOL BIOL CELL, V20, P1533, DOI 10.1091/mbc.E08-07-0777; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Liang JH, 2014, NEUROSCI BULL, V30, P308, DOI 10.1007/s12264-013-1418-8; Liew CW, 2010, J CLIN INVEST, V120, P2876, DOI 10.1172/JCI36849; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Liu Y, 2013, P NATL ACAD SCI USA, V110, P20364, DOI 10.1073/pnas.1319661110; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Moreira PI, 2010, EXPERT REV NEUROTHER, V10, P1209, DOI [10.1586/ern.10.84, 10.1586/ERN.10.84]; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Ni HM, 2013, AM J PATHOL, V183, P1815, DOI 10.1016/j.ajpath.2013.08.011; Nixon RA, 2001, J ALZHEIMERS DIS, V3, P97, DOI 10.3233/JAD-2001-3114; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Onoue S, 2002, PEPTIDES, V23, P1471, DOI 10.1016/S0196-9781(02)00085-2; Ord D, 2005, BIOCHEM BIOPH RES CO, V330, P210, DOI 10.1016/j.bbrc.2005.02.149; Pajak B, 2009, FOLIA NEUROPATHOL, V47, P252; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Sakai S, 2010, BIOL PHARM BULL, V33, P1112, DOI 10.1248/bpb.33.1112; Salazar M, 2009, AUTOPHAGY, V5, P1048, DOI 10.4161/auto.5.7.9508; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Salminen A, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-41; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sanphui P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.148; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shen HM, 2011, AUTOPHAGY, V7, P457, DOI 10.4161/auto.7.5.14226; Son JH, 2012, EXP MOL MED, V44, P89, DOI 10.3858/emm.2012.44.2.031; Song MS, 2011, NEUROSCIENCE, V178, P181, DOI 10.1016/j.neuroscience.2010.12.055; Takahashi Y, 2008, J LIPID RES, V49, P880, DOI 10.1194/jlr.M700545-JLR200; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Troy CM, 2000, J NEUROSCI, V20, P1386; Vara D, 2011, CELL DEATH DIFFER, V18, P1099, DOI 10.1038/cdd.2011.32; Wennemers M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2934; Wolfe DM, 2013, EUR J NEUROSCI, V37, P1949, DOI 10.1111/ejn.12169; Wu M, 2003, J BIOL CHEM, V278, P27072, DOI 10.1074/jbc.M209814200; Xuan ZY, 2005, MECH AGEING DEV, V126, P209, DOI 10.1016/j.mad.2004.09.021; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Yang DS, 2008, AM J PATHOL, V173, P665, DOI 10.2353/ajpath.2008.071176; Zareen N, 2013, CELL DEATH DIFFER, V20, P1719, DOI 10.1038/cdd.2013.128; Zhang J, 2011, ORAL ONCOL, V47, P934, DOI 10.1016/j.oraloncology.2011.06.512; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zheng L, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-19; Zou CG, 2009, ENDOCRINOLOGY, V150, P277, DOI 10.1210/en.2008-0794	84	45	47	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2571	2585		10.1074/jbc.M116.744730	http://dx.doi.org/10.1074/jbc.M116.744730			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28011637	hybrid, Green Published			2022-12-26	WOS:000395535100002
J	Feng, TC; Tammineni, P; Agrawal, C; Jeong, YY; Cai, Q				Feng, Tuancheng; Tammineni, Prasad; Agrawal, Chanchal; Jeong, Yu Young; Cai, Qian			Autophagy-mediated Regulation of BACE1 Protein Trafficking and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid precursor protein (APP); autophagy; beta-secretase 1 (BACE1); protein degradation; trafficking; transport; APP processing; autophagic stress; axonal transport; lysosomal degradation	AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE ACTIVITY; ALZHEIMERS-DISEASE; PRIMARY NEURONS; RETROGRADE TRANSPORT; HIPPOCAMPAL-NEURONS; HUNTINGTON-DISEASE; MAMMALIAN TARGET; AXONAL-TRANSPORT; CORTICAL-NEURONS	beta-Site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) is the major neuronal -secretase for amyloid- generation and is degraded in lysosomes. The autophagy-lysosomal system plays a key role in the maintenance of cellular homeostasis in neurons. Recent studies established that nascent autophagosomes in distal axons move predominantly in the retrograde direction toward the soma, where mature lysosomes are mainly located. However, it remains unknown whether autophagy plays a critical role in regulation of BACE1 trafficking and degradation. Here, we report that induction of neuronal autophagy enhances BACE1 turnover, which is suppressed by lysosomal inhibition. A significant portion of BACE1 is recruited to the autophagy pathway and co-migrates robustly with autophagic vacuoles along axons. Moreover, we reveal that autophagic vacuole-associated BACE1 is accumulated in the distal axon of Alzheimer's disease-related mutant human APP transgenic neurons and mouse brains. Inducing autophagy in mutant human APP neurons augments autophagic retention of BACE1 in distal axons, leading to enhanced beta-cleavage of APP. This phenotype can be reversed by Snapin-enhanced retrograde transport, which facilitates BACE1 trafficking to lysosomes for degradation. Therefore, our study provides new insights into autophagy-mediated regulation of BACE1 turnover and APP processing, thus building a foundation for future development of potential Alzheimer's disease therapeutic strategies.	[Feng, Tuancheng; Tammineni, Prasad; Agrawal, Chanchal; Jeong, Yu Young; Cai, Qian] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Cai, Q (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Nelson Labs, 604 Allison Rd, Piscataway, NJ 08854 USA.	cai@biology.rutgers.edu		Tammineni, Prasad/0000-0002-5030-7786	National Institutes of Health [R00AG033658, R01NS089737]; Alzheimer's Association [NIRG-14-321833]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG033658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health Grants R00AG033658 and R01NS089737 (to Q.C.) and Alzheimer's Association Grant NIRG-14-321833 (to Q.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; Caccamo A, 2014, J NEUROSCI, V34, P7988, DOI 10.1523/JNEUROSCI.0777-14.2014; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005; Cai QA, 2010, NEURON, V68, P73, DOI 10.1016/j.neuron.2010.09.022; Cheng XT, 2015, AUTOPHAGY, V11, P1434, DOI 10.1080/15548627.2015.1062203; Cheng XT, 2015, J CELL BIOL, V209, P377, DOI 10.1083/jcb.201412046; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Evin G, 2010, INT J BIOCHEM CELL B, V42, P1923, DOI 10.1016/j.biocel.2010.08.017; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; Funderburk SF, 2010, MT SINAI J MED, V77, P59, DOI 10.1002/msj.20161; Funmilayo E, 2016, J BIOL CHEM, V291, P15753, DOI 10.1074/jbc.M116.718023; Goslin K., 1998, CULTURING NERVE CELL, P339; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; Hung SY, 2009, AUTOPHAGY, V5, P502, DOI 10.4161/auto.5.4.8096; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Kang EL, 2012, J BIOL CHEM, V287, P42867, DOI 10.1074/jbc.M112.407072; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Kruger U, 2012, NEUROBIOL AGING, V33, P2291, DOI 10.1016/j.neurobiolaging.2011.11.009; Lafay-Chebassier C, 2006, J NEUROSCI RES, V84, P1323, DOI 10.1002/jnr.21039; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; Lefort R, 2012, J NEUROSCI, V32, P10674, DOI 10.1523/JNEUROSCI.6473-11.2012; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Maday S, 2016, J NEUROSCI, V36, P5933, DOI 10.1523/JNEUROSCI.4401-15.2016; Maday S, 2014, DEV CELL, V30, P71, DOI 10.1016/j.devcel.2014.06.001; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; Majumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025416; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nagahara AH, 2013, J NEUROSCI, V33, P15596, DOI 10.1523/JNEUROSCI.5195-12.2013; Nilsson P, 2013, CELL REP, V5, P61, DOI 10.1016/j.celrep.2013.08.042; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Overly CC, 1996, J NEUROSCI, V16, P6056; Prabhu Y, 2012, MOL BIOL CELL, V23, P2339, DOI 10.1091/mbc.E11-11-0944; Qing H, 2004, FASEB J, V18, P1571, DOI 10.1096/fj.04-1994fje; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sannerud R, 2011, P NATL ACAD SCI USA, V108, pE559, DOI 10.1073/pnas.1100745108; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Schneider JL, 2014, CURR OPIN GENET DEV, V26, P16, DOI 10.1016/j.gde.2014.04.003; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Su QN, 2004, NAT CELL BIOL, V6, P941, DOI 10.1038/ncb1169; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; SUZUKI K, 1967, ACTA NEUROPATHOL, V8, P276, DOI 10.1007/BF00688828; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Tsvetkov AS, 2010, P NATL ACAD SCI USA, V107, P16982, DOI 10.1073/pnas.1004498107; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Willem M, 2009, SEMIN CELL DEV BIOL, V20, P175, DOI 10.1016/j.semcdb.2009.01.003; Wong YC, 2015, J CELL SCI, V128, P1259, DOI 10.1242/jcs.161216; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036; Xie YX, 2015, NEURON, V87, P355, DOI 10.1016/j.neuron.2015.06.026; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Ye X, 2014, CELL REP, V6, P24, DOI 10.1016/j.celrep.2013.12.008; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010; Yue ZY, 2009, BBA-MOL CELL RES, V1793, P1496, DOI 10.1016/j.bbamcr.2009.01.016; Zhou B, 2012, CELL REPORTS, V2, P42, DOI 10.1016/j.celrep.2012.06.010	69	43	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1679	1690		10.1074/jbc.M116.766584	http://dx.doi.org/10.1074/jbc.M116.766584			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28028177	Green Published, hybrid			2022-12-26	WOS:000395515600012
J	Alkie, TN; Taha-Abdelaziz, K; Barjesteh, N; Bavananthasivam, J; Hodgins, DC; Sharif, S				Alkie, Tamiru N.; Taha-Abdelaziz, Khaled; Barjesteh, Neda; Bavananthasivam, Jegarubee; Hodgins, Douglas C.; Sharif, Shayan			Characterization of Innate Responses Induced by PLGA Encapsulated- and Soluble TLR Ligands In Vitro and In Vivo in Chickens	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; DOUBLE-STRANDED-RNA; NF-KAPPA-B; CPG OLIGODEOXYNUCLEOTIDES; INFLAMMASOME ACTIVATION; NLRP3 INFLAMMASOME; GENE-EXPRESSION; VACCINE; MICROPARTICLES; NANOPARTICLES	Natural or synthetic Toll-like receptor (TLR) ligands trigger innate responses by interacting with distinct TLRs. TLR ligands can thus serve as vaccine adjuvants or stand-alone antimicrobial agents. One of the limitations of TLR ligands for clinical application is their short half-life and rapid clearance from the body. In the current study, encapsulation of selected TLR ligands in biodegradable poly(D,L-lactide-co-glycolide) polymer nanoparticles (PLGA NPs) was examined in vitro and in vivo as a means to prolong innate responses. MQNCSU cells (a chicken macrophage cell line) were treated with encapsulated or soluble forms of TLR ligands and the resulting innate responses were evaluated. In most cases, encapsulated forms of TLR ligands (CpG ODN 2007, lipopolysaccharide and Pam3CSK4) induced comparable or higher levels of nitric oxide and cytokine gene expression in macrophages, compared to the soluble forms. Encapsulated CpG ODN, in particular the higher dose, induced significantly higher expression of interferon (IFN)-gamma and IFN-beta until at least 18 hr post-treatment. Cytokine expression by splenocytes was also examined in chickens receiving encapsulated or soluble forms of lipopolysaccharide (a potent inflammatory cytokine inducer in chickens) by intramuscular injection. Encapsulated LPS induced more sustained innate responses characterized by higher expression of IFN-gamma and IL-1 beta until up to 96 hr. The ability of TLR ligands encapsulated in polymeric nanoparticles to maintain prolonged innate responses indicates that this controlled-release system can extend the use of TLR ligands as vaccine adjuvants or as stand-alone prophylactic agents against pathogens.	[Alkie, Tamiru N.; Taha-Abdelaziz, Khaled; Barjesteh, Neda; Bavananthasivam, Jegarubee; Hodgins, Douglas C.; Sharif, Shayan] Univ Guelph, Dept Pathobiol, Guelph, ON, Canada; [Taha-Abdelaziz, Khaled] Beni Suef Univ, Dept Pathol, Bani Suwayf, Egypt	University of Guelph; Egyptian Knowledge Bank (EKB); Beni Suef University	Sharif, S (corresponding author), Univ Guelph, Dept Pathobiol, Guelph, ON, Canada.	shayan@uoguelph.ca	Bavananthasivam, Jegarubee/AFO-9233-2022	Bavananthasivam, Jegarubee/0000-0002-0332-4823	Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); Canadian Poultry Research Council (CPRC); Agriculture and Agri-Food Canada	Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); Canadian Poultry Research Council (CPRC); Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	This work was supported by the Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA), the Canadian Poultry Research Council (CPRC) and Agriculture and Agri-Food Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Careem MF, 2009, VIROLOGY, V393, P250, DOI 10.1016/j.virol.2009.08.001; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alkie TN, 2015, VET IMMUNOL IMMUNOP, V163, P157, DOI 10.1016/j.vetimm.2014.12.005; Anette PN, 2014, BIOMACROMOLECULES, V15, P2378, DOI 10.1021/bm5006728; Babu US, 2012, VET IMMUNOL IMMUNOP, V149, P92, DOI 10.1016/j.vetimm.2012.05.003; Barjesteh N, 2015, VACCINE, V33, P4843, DOI 10.1016/j.vaccine.2015.07.070; Barjesteh N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105713; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brisbin JT, 2010, CLIN VACCINE IMMUNOL, V17, P1337, DOI 10.1128/CVI.00143-10; Brownlie R, 2009, MOL IMMUNOL, V46, P3163, DOI 10.1016/j.molimm.2009.06.002; Chinnathambi S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00534; Chua BY, 2011, J IMMUNOL, V187, P1692, DOI 10.4049/jimmunol.1100486; de Titta A, 2013, P NATL ACAD SCI USA, V110, P19902, DOI 10.1073/pnas.1313152110; Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034; Diwan Manish, 2004, Current Drug Delivery, V1, P405, DOI 10.2174/1567201043334597; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Eigenbrod T, 2013, J IMMUNOL, V190, P6533, DOI 10.4049/jimmunol.1300324; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Engel Abbi L, 2011, Expert Rev Clin Pharmacol, V4, P275, DOI 10.1586/ecp.11.5; Hafner AM, 2013, ADV DRUG DELIVER REV, V65, P1386, DOI 10.1016/j.addr.2013.05.013; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Iqbal M, 2005, VET IMMUNOL IMMUNOP, V104, P117, DOI 10.1016/j.vetimm.2004.11.003; Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kazzaz J, 2006, J CONTROL RELEASE, V110, P566, DOI 10.1016/j.jconrel.2005.10.010; Klein DCG, 2010, ULTRAMICROSCOPY, V110, P689, DOI 10.1016/j.ultramic.2010.02.033; Klinman DM, 2010, VACCINE, V28, P1919, DOI 10.1016/j.vaccine.2009.10.094; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Malyala P, 2009, ADV DRUG DELIVER REV, V61, P218, DOI 10.1016/j.addr.2008.12.009; Man SM, 2015, IMMUNOL REV, V265, P6, DOI 10.1111/imr.12296; Manoharan Y, 2012, INT J NANOMED, V7, P3625, DOI 10.2147/IJN.S32592; Mathaes R, 2014, INT J PHARMACEUT, V465, P159, DOI 10.1016/j.ijpharm.2014.02.037; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Negash T, 2013, VACCINE, V31, P3656, DOI 10.1016/j.vaccine.2013.06.011; Neumann S, 2014, IMMUNOL CELL BIOL, V92, P535, DOI 10.1038/icb.2014.21; O'Hagan DT, 2006, METHODS, V40, P10, DOI 10.1016/j.ymeth.2006.05.017; Peine KJ, 2013, MOL PHARMACEUT, V10, P2849, DOI 10.1021/mp300643d; Rajapaksa TE, 2010, J BIOL CHEM, V285, P23739, DOI 10.1074/jbc.M110.126359; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Singh M, 2001, PHARM RES-DORDR, V18, P1476, DOI 10.1023/A:1012269226066; Singh M, 1997, J PHARM SCI-US, V86, P1229, DOI 10.1021/js970174n; St Paul M, 2011, VET IMMUNOL IMMUNOP, V144, P228, DOI 10.1016/j.vetimm.2011.09.004; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Toussi DN, 2014, VACCINES, V2, P323, DOI 10.3390/vaccines2020323; Villanueva AI, 2011, DEV COMP IMMUNOL, V35, P28, DOI 10.1016/j.dci.2010.08.001; Weilhammer DR, 2013, BIOMATERIALS, V34, P10305, DOI 10.1016/j.biomaterials.2013.09.038; Wheaton S, 2007, DNA SEQUENCE, V18, P478, DOI 10.1080/10425170701295856; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239	52	26	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169154	10.1371/journal.pone.0169154	http://dx.doi.org/10.1371/journal.pone.0169154			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045984	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300129
J	Derwish, R; Paterno, GD; Gillespie, LL				Derwish, Roya; Paterno, Gary D.; Gillespie, Laura L.			Differential HDAC1 and 2 Recruitment by Members of the MIER Family	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; SUBCELLULAR-LOCALIZATION; HUMAN INTERACTOME; BREAST; COMPLEXES; PROTEIN; CLONING; MI-ER1; CDNA; GENE	The mierfamily consists of three related genes encoding ELM2-SANT containing proteins. MIER1 has been well characterized and is known to function in transcriptional repression through its ability to recruit HDAC1 and 2. Little is known about MIER2 or MIER3 function and no study characterizing these two proteins has been published. In this report, we investigate MIER2 and MIER3 localization and function. Confocal analysis revealed that, while MIER2 and MIER3 are mainly nuclear proteins, a substantial proportion (32%) of MIER2 is localized in the cytoplasm. Co-immunoprecipitation experiments demonstrated that the MIER proteins do not dimerize; that MIER2, but not MIER3, can recruit HDACs; and that recruitment is cell line-dependent. MIER2 was associated with HDAC1 and HDAC2 in HEK293 cells, but only with HDAC1 in MCF7 and HeLa cells. Little or no MIER3 co-immunoprecipitated with either HDAC1 or 2 in any of the three cell lines tested. By contrast, HDAC1 and 2 were readily detected in MIER1 alpha complexes in all three cell lines. Histone deacetylase assays confirmed that MIER2, but not MIER3 complexes, have associated deacetylase activity, leading to the conclusion that MIER3 does not function in HDAC recruitment in these cell lines. In contrast to what has been reported for other ELM2-SANT associated HDACs, addition of D-myo-inosito1-1,4,5,6-tetrakisphosphate led to only a small increase in MIER1a associated deacetylase activity and no effect on that associated with MIER2. Deletion analysis revealed that HDAC recruitment occurs through the ELM2 domain. Finally, using site-directed mutagenesis, we show that, like MIER1, W-228 in the ELM2 domain is a critical residue for HDAC recruitment by MIER2.	[Derwish, Roya; Paterno, Gary D.; Gillespie, Laura L.] Mem Univ Newfoundland, Fac Med, Terry Fox Canc Res Labs, Div BioMed Sci, St John, NF, Canada	Memorial University Newfoundland	Gillespie, LL (corresponding author), Mem Univ Newfoundland, Fac Med, Terry Fox Canc Res Labs, Div BioMed Sci, St John, NF, Canada.	lgillesp@mun.ca			Canadian Institutes of Health Research [MOP 97938]; Canadian Breast Cancer Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This research was supported by the Canadian Institutes of Health Research (www.cihr.gc.ca) grant MOP 97938 to LLG and GDP and by funding from the Canadian Breast Cancer Foundation (www.cbcf.org/atlantic) to LLG and GDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Binder JX, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau012; Blackmore Tina M, 2008, BMC Res Notes, V1, P68, DOI 10.1186/1756-0500-1-68; Clements JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032499; denDekker AD, 2012, CANCER RES, V72, P6002, DOI 10.1158/0008-5472.CAN-12-0748; Ding ZH, 2004, J BIOL CHEM, V279, P28009, DOI 10.1074/jbc.M403793200; Ding ZH, 2003, MOL CELL BIOL, V23, P250, DOI 10.1128/MCB.23.1.250-258.2003; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Goldberg T, 2012, BIOINFORMATICS, V28, pI458, DOI 10.1093/bioinformatics/bts390; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Joshi P, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.26; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Li Shengnan, 2015, BMC Res Notes, V8, P356, DOI 10.1186/s13104-015-1336-0; Li SJ, 2013, SCOLIOSIS SPINAL DIS, V8, DOI 10.1186/1748-7161-8-1; Liu YC, 2010, BIOINFORMATICS, V26, P1958, DOI 10.1093/bioinformatics/btq338; Manavathi Bramanandam, 2007, Nucl Recept Signal, V5, pe010, DOI 10.1621/nrs.05010; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; McCarthy PL, 2008, BRIT J CANCER, V99, P639, DOI 10.1038/sj.bjc.6604518; Millard CJ, 2014, CANCER METAST REV, V33, P857, DOI 10.1007/s10555-014-9513-5; Millard CJ, 2013, MOL CELL, V51, P57, DOI 10.1016/j.molcel.2013.05.020; Paterno GD, 1997, J BIOL CHEM, V272, P25591, DOI 10.1074/jbc.272.41.25591; Paterno GD, 1998, GENE, V222, P77, DOI 10.1016/S0378-1119(98)00473-9; Paterno GD, 2002, GENE, V295, P79, DOI 10.1016/S0378-1119(02)00823-5; Ryan PJ, 1998, BIOCHEM BIOPH RES CO, V244, P763, DOI 10.1006/bbrc.1998.8326; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Thorne LB, 2005, DNA SEQUENCE, V16, P237, DOI 10.1080/10425170500069783	28	11	12	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169338	10.1371/journal.pone.0169338	http://dx.doi.org/10.1371/journal.pone.0169338			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046085	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300167
J	Jing, JY; Soegaard, K; Cong, WF; Eriksen, J				Jing, Jingying; Soegaard, Karen; Cong, Wen-Feng; Eriksen, Jorgen			Species Diversity Effects on Productivity, Persistence and Quality of Multispecies Swards in a Four-Year Experiment	PLOS ONE			English	Article							PLANT DIVERSITY; NUTRITIVE-VALUE; GRASSLAND COMMUNITIES; ECOSYSTEM STABILITY; FORAGE MIXTURES; BIODIVERSITY; CHICORY; PERFORMANCE; MANAGEMENT; PASTURES	Plant species diversity may benefit natural grassland productivity, but its effect in managed grassland systems is not well understood. A four-year multispecies grassland experiment was conducted to investigate the effect of species diversity-legumes and non-leguminous forbs-on productivity, persistence and sward quality under cutting or grazing regimes and with or without slurry application. Three mixtures were established -3-mix: grass, red and white clover, 10-mix: 3-mix plus birdsfoot trefoil and six non-leguminous forbs, and 12-mix: 10-mix plus lucerne and festulolium. Species diversity increased sward production and yield persistence under cutting regime. The 12-mix had the highest yield from the second year onwards and no statistically significant yield reduction over four years, while annual yields in the 3-mix and 10-mix decreased significantly with increasing grassland age. The higher yield in the 12-mix was mainly due to the inclusion of high-yielding lucerne. The 10-mix and 12-mix had lower proportions of unsown species than the 3-mix, the difference being dependent on grassland age. Generally, the 3-mix had higher concentrations of in-vitro organic matter digestibility (IVOMD), neutral detergent fiber (NDF) and crude protein (CP), and a lower concentration of ash than the 10-mix and 12-mix. Slurry application increased annual yield production by 10% and changed the botanical composition, increasing the proportion of grass and decreasing the proportion of legumes. Compared to cutting, grazing increased forage production by 9% per cut on average and lowered legume and forb proportions in the mixtures, but yields did not differ among the three mixtures. Overall, our results suggest that species diversity increases sward productivity and persistence only under an ungrazed cutting regime. We conclude that increasing species diversity by selecting appropriate species with compatible management is key to achieving both high yields and high persistence in managed grasslands.	[Jing, Jingying; Soegaard, Karen; Cong, Wen-Feng; Eriksen, Jorgen] Aarhus Univ, Dept Agroecol, Tjele, Denmark	Aarhus University	Eriksen, J (corresponding author), Aarhus Univ, Dept Agroecol, Tjele, Denmark.	jorgen-eriksen@agro.au.dk	Cong, Wen-Feng/F-5359-2015; Eriksen, Jørgen/E-9730-2016	Cong, Wen-Feng/0000-0002-6615-7241; Eriksen, Jørgen/0000-0002-4622-7660; , Jingying/0000-0002-8970-8579	International Centre for Research in Organic Food Systems (OrgGrass project)	International Centre for Research in Organic Food Systems (OrgGrass project)	This study was supported by the International Centre for Research in Organic Food Systems (OrgGrass project; hillp://www.icrof.org/Pages/Research/darcofIII_orggrass3.html); JE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The technical assistance of the staff at Foulumgaard Experimental Station is gratefully acknowledged. This study was financially supported by the International Centre for Research in Organic Food Systems (OrgGrass project).	Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Barry TN, 1998, J AGR SCI, V131, P251, DOI 10.1017/S002185969800584X; Belesky DP, 2002, AGRON J, V94, P575; BINNIE RC, 1991, GRASS FORAGE SCI, V46, P343, DOI 10.1111/j.1365-2494.1991.tb02393.x; Bruinenberg MH, 2002, GRASS FORAGE SCI, V57, P292, DOI 10.1046/j.1365-2494.2002.00327.x; Bullock JM, 2001, ECOL LETT, V4, P185, DOI 10.1046/j.1461-0248.2001.00215.x; Bultemeier, 2003, P AM FOR GRASSL C, V12, P172; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Clark E. Ann, 2001, P103, DOI 10.1079/9780851994413.0103; Creighton P, 2012, GRASS FORAGE SCI, V67, P526, DOI 10.1111/j.1365-2494.2012.00872.x; Daly M. J., 1996, Proceedings of the New Zealand Grassland Association, V58, P53; Deak A, 2007, AGRON J, V99, P814, DOI 10.2134/agronj2006.0166; DEAK A, 2004, P AM FORAGE GRASSL C, V13, P220; Dukes JS, 2002, ECOL APPL, V12, P602, DOI 10.1890/1051-0761(2002)012[0602:SCADAG]2.0.CO;2; Duru M, 2008, AGRON J, V100, P1622, DOI 10.2134/agronj2008.0003; Eriksen J, 2014, GRASS FORAGE SCI, V69, P241, DOI 10.1111/gfs.12025; Eriksen J, 2004, SOIL USE MANAGE, V20, P48, DOI 10.1079/SUM2003222; FOSTER L, 1988, BIOL AGRIC HORTIC, V5, P97, DOI 10.1080/01448765.1988.9755134; Hansen B, 1989, ACTA AGR SCAND, V39, P113, DOI DOI 10.1080/00015128909438504; Hunt R., 1990, ABRIDGED COMP PLANT; Huyghe C., 2008, Biodiversity and animal feed: future challenges for grassland production. Proceedings of the 22nd General Meeting of the European Grassland Federation, Uppsala, Sweden, 9-12 June 2008, P375; JACKSON MV, 1979, J AGR SCI-CAMBRIDGE, V92, P549, DOI 10.1017/S002185960005379X; Jung GA, 1996, AGRON J, V88, P104, DOI 10.2134/agronj1996.00021962008800010022x; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Labreveux M, 2004, AGRON J, V96, P710, DOI 10.2134/agronj2004.0710; Lantinga EA, 1999, NETH J AGR SCI, V47, P243; LODGE GM, 1991, AUST J EXP AGR, V31, P713, DOI 10.1071/EA9910713; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Mertens DR, 2002, J AOAC INT, V85, P1217; Muller-Stover D, 2012, BIOL FERT SOILS, V48, P371, DOI 10.1007/s00374-011-0633-6; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; R Core Team, 2012, R LANG ENV STAT COMP; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2008, ANN BOT-LONDON, V102, P113, DOI 10.1093/aob/mcn070; RUZJEREZ BE, 1991, P NZ GRASSLAND ASS, V53, P225; Sanderson MA, 2005, AGRON J, V97, P1465, DOI 10.2134/agronj2005.0032; Sanderson MA, 2004, CROP SCI, V44, P1132, DOI 10.2135/cropsci2004.1132; Sanderson M, 2010, AGRON J, V102, P728, DOI 10.2134/agronj2009.0374; Skinner RH, 2004, CROP SCI, V44, P1361, DOI 10.2135/cropsci2004.1361; SMITH A, 1971, J BRIT GRASSLAND SOC, V26, P157; Soder KJ, 2006, J DAIRY SCI, V89, P2158, DOI 10.3168/jds.S0022-0302(06)72286-X; TILLEY J. M. A., 1963, JOUR BRIT GRASSLAND SOC, V18, P104; Tilman D, 2001, ECOLOGY: ACHIEVEMENT AND CHALLENGE, P183; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Tracy BF, 2004, AGR ECOSYST ENVIRON, V102, P175, DOI 10.1016/j.agee.2003.08.002; Weigelt A, 2009, BIOGEOSCIENCES, V6, P1695, DOI 10.5194/bg-6-1695-2009; White TA, 2004, AGR ECOSYST ENVIRON, V101, P73, DOI 10.1016/S0167-8809(03)00169-5; Whitehead D.C, 2000, NUTR ELEMENTS GRASSL; Wood SA, 2015, TRENDS ECOL EVOL, V30, P531, DOI 10.1016/j.tree.2015.06.013; ZANNONE L, 1983, AGRONOMIE, V3, P451, DOI 10.1051/agro:19830508	52	17	18	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169208	10.1371/journal.pone.0169208	http://dx.doi.org/10.1371/journal.pone.0169208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046004	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300141
J	Mathieu, C; Macedo, JP; Hurlimann, D; Wirdnam, C; Haindrich, AC; Grotemeyer, MS; Gonzalez-Salgado, A; Schmidt, RS; Inbar, E; Maser, P; Butikofer, P; Zilberstein, D; Rentsch, D				Mathieu, Christoph; Macedo, Juan P.; Huerlimann, Daniel; Wirdnam, Corina; Haindrich, Alexander C.; Grotemeyer, Marianne Suter; Gonzalez-Salgado, Amaia; Schmidt, Remo S.; Inbar, Ehud; Maeser, Pascal; Buetikofer, Peter; Zilberstein, Dan; Rentsch, Doris			Arginine and Lysine Transporters Are Essential for Trypanosoma brucei	PLOS ONE			English	Article							MEMBRANE-PROTEINS; PERMEASE; LOCALIZATION; PROLINE; DIFLUOROMETHYLORNITHINE; IDENTIFICATION; METABOLISM; TOPOLOGY; FAMILIES; CLONING	For Trypanosoma brucei arginine and lysine are essential amino acids and therefore have to be imported from the host. Heterologous expression in Saccharomyces cerevisiae mutants identified cationic amino acid transporters among members of the T. brucei AAAP (amino acid/auxin permease) family. TbAAT5-3 showed high affinity arginine uptake (K-m 3.6 +/- 0.4 mu M) and high selectivity for L-arginine. L-arginine transport was reduced by a 10-times excess of L-arginine, homo-arginine, canavanine or arginine--naphthylamide, while lysine was inhibitory only at 100-times excess, and histidine or ornithine did not reduce arginine uptake rates significantly. TbAAT16-1 is a high affinity (Km 4.3 +/- 0.5 mu M) and highly selective L-lysine transporter and of the compounds tested, only L-lysine and thialysine were competing for L-lysine uptake. TbAAT5-3 and TbAAT16-1 are expressed in both procyclic and bloodstream form T. brucei and cMyc-tagged proteins indicate localization at the plasma membrane. RNAi-mediated down-regulation of TbAAT5 and TbAAT16 in bloodstream form trypanosomes resulted in growth arrest, demonstrating that TbAAT5-mediated arginine and TbAAT16-mediated lysine transport are essential for T. brucei. Growth of induced RNAi lines could partially be rescued by supplementing a surplus of arginine or lysine, respectively, while addition of both amino acids was less efficient. Single and double RNAi lines indicate that additional low affinity uptake systems for arginine and lysine are present in T. brucei.	[Mathieu, Christoph; Macedo, Juan P.; Huerlimann, Daniel; Wirdnam, Corina; Haindrich, Alexander C.; Grotemeyer, Marianne Suter; Rentsch, Doris] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Gonzalez-Salgado, Amaia; Buetikofer, Peter] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Schmidt, Remo S.; Maeser, Pascal] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Schmidt, Remo S.; Maeser, Pascal] Univ Basel, Basel, Switzerland; [Inbar, Ehud; Zilberstein, Dan] Technion Israel Inst Technol, Fac Biol, Haifa, Israel	University of Bern; University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Technion Israel Institute of Technology	Rentsch, D (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	doris.rentsch@ips.unibe.ch	; Macedo, Juan/B-4151-2017	Rentsch, Doris/0000-0003-4313-7683; Macedo, Juan/0000-0001-5759-1196; Schmidt, Remo S./0000-0002-6599-9201; Haindrich, Alexander C./0000-0001-6484-2846; Maser, Pascal/0000-0003-3122-1941	Swiss National Science Foundation [SNF SINERGIA CRSII3_127300, CRSII3_141913]; University of Bern	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Bern	This work was supported by grants from the Swiss National Science Foundation SNF SINERGIA CRSII3_127300 and CRSII3_141913 (PM, PB, DR), and the University of Bern (DR).	Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; BACCHI CJ, 1983, MOL BIOCHEM PARASIT, V7, P209, DOI 10.1016/0166-6851(83)90022-1; Baker N, 2011, MOL BIOCHEM PARASIT, V176, P55, DOI 10.1016/j.molbiopara.2010.11.010; Baukrowitz T, 1999, EMBO J, V18, P847, DOI 10.1093/emboj/18.4.847; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Brenndorfer M, 2010, MOL BIOCHEM PARASIT, V172, P52, DOI 10.1016/j.molbiopara.2010.03.007; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Burkard GS, 2011, MOL BIOCHEM PARASIT, V175, P91, DOI 10.1016/j.molbiopara.2010.09.002; Canepa GE, 2004, FEMS MICROBIOL LETT, V236, P79, DOI [10.1016/j.femsle.2004.05.021, 10.1111/j.1574-6968.2004.tb09630.x]; Carrillo C, 2010, FEMS MICROBIOL LETT, V306, P97, DOI 10.1111/j.1574-6968.2010.01936.x; Chaudhary K, 2005, NAT BIOTECHNOL, V23, P1089, DOI 10.1038/nbt0905-1089; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Colasante C, 2006, EUKARYOT CELL, V5, P1194, DOI 10.1128/EC.00096-06; Colasante Claudia, 2013, F1000Res, V2, P27, DOI 10.12688/f1000research.2-27.v1; Creek DJ, 2013, ANTIMICROB AGENTS CH, V57, P2768, DOI 10.1128/AAC.00044-13; Darlyuk I, 2009, J BIOL CHEM, V284, P19800, DOI 10.1074/jbc.M901066200; de Koning HP, 1998, J BIOL CHEM, V273, P9486, DOI 10.1074/jbc.273.16.9486; DOHMEN RJ, 1991, YEAST, V7, P691, DOI 10.1002/yea.320070704; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; EVANS DA, 1972, J PROTOZOOL, V19, P686, DOI 10.1111/j.1550-7408.1972.tb03561.x; FAIRLAMB AH, 1987, MOL BIOCHEM PARASIT, V24, P185, DOI 10.1016/0166-6851(87)90105-8; Fischer WN, 2002, PLANT J, V29, P717, DOI 10.1046/j.1365-313X.2002.01248.x; Fotiadis D, 2013, MOL ASPECTS MED, V34, P139, DOI 10.1016/j.mam.2012.10.007; Geerts S, 2001, TRENDS PARASITOL, V17, P25, DOI 10.1016/S1471-4922(00)01827-4; Goldman-Pinkovich A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005494; Gonzalez-Salgado A, 2012, J BIOL CHEM, V287, P13313, DOI 10.1074/jbc.M112.344812; Guther MLS, 2014, J PROTEOME RES, V13, P2796, DOI 10.1021/pr401209w; Hai Y, 2015, BIOCHEMISTRY-US, V54, P458, DOI 10.1021/bi501366a; Hammes UZ, 2010, J BIOL CHEM, V285, P39710, DOI 10.1074/jbc.M110.141457; Hatzoglou M, 2004, ANNU REV NUTR, V24, P377, DOI 10.1146/annurev.nutr.23.011702.073120; Henriques C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0950-y; Inbar E, 2012, AMINO ACIDS, V42, P347, DOI 10.1007/s00726-010-0812-z; Jackson AP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-26; JAUNIAUX JC, 1987, EUR J BIOCHEM, V164, P601, DOI 10.1111/j.1432-1033.1987.tb11169.x; Jones NG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003886; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; KANDPAL M, 1995, MOL BIOCHEM PARASIT, V71, P193, DOI 10.1016/0166-6851(95)00042-Y; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; Landfear SM, 2015, IUBMB LIFE, V67, P668, DOI 10.1002/iub.1411; Macedo JP, 2013, MOL BIOCHEM PARASIT, V190, P16, DOI 10.1016/j.molbiopara.2013.05.007; Mani J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7646; Mathieu C, 2014, BIOCH J; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Pereira CA, 1999, J EUKARYOT MICROBIOL, V46, P566, DOI 10.1111/j.1550-7408.1999.tb05132.x; Pereira CA, 2000, J BIOL CHEM, V275, P1495, DOI 10.1074/jbc.275.2.1495; Pereira CA, 2003, FEBS LETT, V554, P201, DOI 10.1016/S0014-5793(03)01171-2; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; Rentsch D, 1996, PLANT CELL, V8, P1437, DOI 10.1105/tpc.8.8.1437; Rentsch D, 2007, FEBS LETT, V581, P2281, DOI 10.1016/j.febslet.2007.04.013; Schioth HB, 2013, MOL ASPECTS MED, V34, P571, DOI 10.1016/j.mam.2012.07.012; Schluter A, 2010, NUCLEIC ACIDS RES, V38, pD800, DOI 10.1093/nar/gkp935; Serricchio M, 2013, MOL MICROBIOL, V87, P569, DOI 10.1111/mmi.12116; Shaked-Mishan P, 2006, MOL MICROBIOL, V60, P30, DOI 10.1111/j.1365-2958.2006.05060.x; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Subota I, 2014, MOL CELL PROTEOMICS, V13, P1769, DOI 10.1074/mcp.M113.033357; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TANAKA J, 1985, GENE, V38, P205, DOI 10.1016/0378-1119(85)90219-7; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Vincent IM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001618; Vincent IM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001204; Voncken F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065908; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xiao YJ, 2009, EUKARYOT CELL, V8, P747, DOI 10.1128/EC.00047-09; Young GB, 1999, BBA-BIOMEMBRANES, V1415, P306, DOI 10.1016/S0005-2736(98)00196-5	69	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168775	10.1371/journal.pone.0168775	http://dx.doi.org/10.1371/journal.pone.0168775			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045943	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000391612300052
J	Micallef, G; Cash, P; Fernandes, JMO; Rajan, B; Tinsley, JW; Bickerdike, R; Martin, SAM; Bowman, AS				Micallef, Giulia; Cash, Phillip; Fernandes, Jorge M. O.; Rajan, Binoy; Tinsley, John W.; Bickerdike, Ralph; Martin, Samuel A. M.; Bowman, Alan S.			Dietary Yeast Cell Wall Extract Alters the Proteome of the Skin Mucous Barrier in Atlantic Salmon (Salmo salar): Increased Abundance and Expression of a Calreticulin-Like Protein	PLOS ONE			English	Article							RAINBOW-TROUT; GROWTH-PERFORMANCE; IMMUNOLOGICAL PARAMETERS; INTESTINAL MICROBIOTA; ENDOPLASMIC-RETICULUM; DISEASE RESISTANCE; CHANNEL CATFISH; INNATE IMMUNITY; KERATIN CDNAS; CYCLOPHILIN D	In order to improve fish health and reduce use of chemotherapeutants in aquaculture production, the immunomodulatory effect of various nutritional ingredients has been explored. In salmon, there is evidence that functional feeds can reduce the abundance of sea lice. This study aimed to determine if there were consistent changes in the skin mucus proteome that could serve as a biomarker for dietary yeast cell wall extract. The effect of dietary yeast cell wall extract on the skin mucus proteome of Atlantic salmon was examined using two-dimensional gel electrophoresis. Forty-nine spots showed a statistically significant change in their normalised volumes between the control and yeast cell wall diets. Thirteen spots were successfully identified by peptide fragment fingerprinting and LC-MS/MS and these belonged to a variety of functions and pathways. To assess the validity of the results from the proteome approach, the gene expression of a selection of these proteins was studied in skin mRNA from two different independent feeding trials using yeast cell wall extracts. A calreticulin-like protein increased in abundance at both the protein and transcript level in response to dietary yeast cell wall extract. The calreticulin-like protein was identified as a possible biomarker for yeast-derived functional feeds since it showed the most consistent change in expression in both the mucus proteome and skin transcriptome. The discovery of such a biomarker is expected to quicken the pace of research in the application of yeast cell wall extracts.	[Micallef, Giulia; Martin, Samuel A. M.; Bowman, Alan S.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Cash, Phillip] Univ Aberdeen, Inst Med Sci, Div Appl Med, Aberdeen, Scotland; [Fernandes, Jorge M. O.; Rajan, Binoy] Nord Univ, Fac Biosci & Aquaculture, Bodo, Norway; [Tinsley, John W.; Bickerdike, Ralph] BioMar Ltd, Grangemouth Docks, Grangemouth, Scotland	University of Aberdeen; University of Aberdeen; Nord University	Bowman, AS (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.	a.bowman@abdn.ac.uk	Fernandes, Jorge MO/A-3526-2013; Fernandes, Jorge/AAC-4632-2022	Fernandes, Jorge MO/0000-0002-2550-1640; Fernandes, Jorge/0000-0002-2550-1640; Martin, Samuel/0000-0003-0289-6317; Micallef, Giulia/0000-0002-4350-4722; Bowman, Alan/0000-0002-0306-9033	BioMar Ltd.	BioMar Ltd.	This work was supported by a studentship from BioMar Ltd. to GM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akrami R, 2013, FISH SHELLFISH IMMUN, V35, P1235, DOI 10.1016/j.fsi.2013.07.039; Alvarez-Pellitero P, 2008, VET IMMUNOL IMMUNOP, V126, P171, DOI 10.1016/j.vetimm.2008.07.013; Bruemmer M, 2010, S AFR J ANIM SCI, V40, P14; Buentello JA, 2010, AQUAC RES, V41, P411, DOI 10.1111/j.1365-2109.2009.02178.x; Carmichael SN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-408; Casadei E, 2009, MOL IMMUNOL, V46, P3358, DOI 10.1016/j.molimm.2009.07.018; Cerezuela R, 2013, FISH SHELLFISH IMMUN, V34, P1063, DOI 10.1016/j.fsi.2013.01.015; Chong K, 2006, PROTEOMICS, V6, P2251, DOI 10.1002/pmic.200500591; Covello JM, 2012, AQUACULTURE, V366, P9, DOI 10.1016/j.aquaculture.2012.08.051; Davies Jr, 2000, METH MOL B, V125, P3; Donate C, 2010, MAR BIOTECHNOL, V12, P88, DOI 10.1007/s10126-009-9203-4; Dooley H, 2010, MOL IMMUNOL, V48, P147, DOI 10.1016/j.molimm.2010.08.015; Easy RH, 2009, COMP BIOCHEM PHYS D, V4, P159, DOI 10.1016/j.cbd.2009.02.001; Eliseev RA, 2009, J BIOL CHEM, V284, P9692, DOI 10.1074/jbc.M808750200; Elliott Diane G., 2000, P271, DOI 10.1016/B978-012529650-2/50023-8; Elrod JW, 2013, CIRC J, V77, P1111, DOI 10.1253/circj.CJ-13-0321; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Geraylou Z, 2012, FISH SHELLFISH IMMUN, V33, P718, DOI 10.1016/j.fsi.2012.06.010; Hirayama M, 2004, J EXP BIOL, V207, P1387, DOI 10.1242/jeb.00897; Hoseinifar SH, 2014, FISH SHELLFISH IMMUN, V39, P231, DOI 10.1016/j.fsi.2014.05.009; Jones S.R.M., 2009, NUTR NATURAL RESOURC, V4, P1; Kleessen B, 2005, BRIT J NUTR, V93, pS35, DOI 10.1079/BJN20041346; Kleessen B, 2003, BRIT J NUTR, V89, P597, DOI 10.1079/BJN2002827; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Li ZY, 2012, COMPUT ENG APPL, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0040132; Liu H, 2011, DEV COMP IMMUNOL, V35, P267, DOI 10.1016/j.dci.2010.11.009; Lokesh J, 2012, FISH SHELLFISH IMMUN, V33, P626, DOI 10.1016/j.fsi.2012.06.017; Marancik DP, 2013, FISH SHELLFISH IMMUN, V34, P1383, DOI 10.1016/j.fsi.2013.02.024; McCool DJ, 1999, BIOCHEM J, V341, P593, DOI 10.1042/0264-6021:3410593; Merrifield DL, 2010, AQUAC RES, V41, P1268, DOI 10.1111/j.1365-2109.2009.02397.x; Middlemas SJ, 2013, FISHERIES MANAG ECOL, V20, P68, DOI 10.1111/fme.12010; Miot S, 1996, DNA SEQUENCE, V6, P311, DOI 10.3109/10425179609047569; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Ortiz LT, 2013, AQUACULT NUTR, V19, P475, DOI 10.1111/j.1365-2095.2012.00981.x; Padhi BK, 2006, GENE, V368, P37, DOI 10.1016/j.gene.2005.09.016; Pagh R, 2008, FEBS J, V275, P515, DOI 10.1111/j.1742-4658.2007.06218.x; Peredo AM, 2015, J WORLD AQUACULT SOC, V46, P92, DOI 10.1111/jwas.12170; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Provan F, 2013, JAMA NEUROL, P1, DOI DOI 10.1001/JAMANEUROL; Rajan B, 2011, FISH SHELLFISH IMMUN, V31, P224, DOI 10.1016/j.fsi.2011.05.006; Refstie S, 2010, AQUACULTURE, V305, P109, DOI 10.1016/j.aquaculture.2010.04.005; Schaffeld M, 2002, DIFFERENTIATION, V70, P282, DOI 10.1046/j.1432-0436.2002.700606.x; Schaffeld M, 2002, DIFFERENTIATION, V70, P292, DOI 10.1046/j.1432-0436.2002.700607.x; Selim KM, 2015, N AM J AQUACULT, V77, P22, DOI 10.1080/15222055.2014.951812; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith RW, 2007, PROTEOMICS, V7, P4171, DOI 10.1002/pmic.200700573; Somogyi E, 2003, MATRIX BIOL, V22, P179, DOI 10.1016/S0945-053X(02)00117-8; Steino A, 2004, SCAND J IMMUNOL, V59, P485, DOI 10.1111/j.0300-9475.2004.01425.x; Tacchi L, 2011, FISH SHELLFISH IMMUN, V31, P704, DOI 10.1016/j.fsi.2011.02.023; Talpur AD, 2014, AQUACULTURE, V426, P14, DOI 10.1016/j.aquaculture.2014.01.013; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson M, 2015, ANIMAL, V9, P1113, DOI 10.1017/S1751731115000300; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Tian L, 2011, AQUAT TOXICOL, V104, P211, DOI 10.1016/j.aquatox.2011.04.019; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; Torrecillas S, 2011, FISH SHELLFISH IMMUN, V30, P674, DOI 10.1016/j.fsi.2010.12.020; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Trombetta ES, 2003, GLYCOBIOLOGY, V13, p77R, DOI 10.1093/glycob/cwg075; van der Marel M, 2012, FISH SHELLFISH IMMUN, V32, P494, DOI 10.1016/j.fsi.2011.12.008; Vasanth G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00409; von Schalburg KR, 2008, J FISH BIOL, V72, P2051, DOI 10.1111/j.1095-8649.2008.01910.x; Wang J, 2014, SIGCOMM'14: PROCEEDINGS OF THE 2014 ACM CONFERENCE ON SPECIAL INTEREST GROUP ON DATA COMMUNICATION, P235, DOI [10.1145/2619239.2626330, 10.1145/2740070.2626330]; Wulff T, 2012, J PROTEOMICS, V75, P2342, DOI 10.1016/j.jprot.2012.02.010; Zhang CN, 2013, FISH SHELLFISH IMMUN, V35, P1380, DOI 10.1016/j.fsi.2013.07.047; Zhou QC, 2010, AQUACULTURE, V309, P253, DOI 10.1016/j.aquaculture.2010.09.003; Zhu HL, 2012, FISH PHYSIOL BIOCHEM, V38, P1441, DOI 10.1007/s10695-012-9631-3	66	26	28	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169075	10.1371/journal.pone.0169075	http://dx.doi.org/10.1371/journal.pone.0169075			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046109	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000391612300110
J	Oladele, EA; Khamofu, H; Asala, S; Saleh, M; Ralph-Opara, U; Nwosisi, C; Anyaike, C; Gana, C; Adedokun, O; Dirks, R; Adebayo, O; Oduwole, M; Mandala, J; Torpey, K				Oladele, Edward Adekola; Khamofu, Hadiza; Asala, Seun; Saleh, Mariya; Ralph-Opara, Uche; Nwosisi, Charles; Anyaike, Chukwuma; Gana, Catherine; Adedokun, Oluwasanmi; Dirks, Rebecca; Adebayo, Olufunsho; Oduwole, Modupe; Mandala, Justin; Torpey, Kwasi			Playing the Catch-Up Game: Accelerating the Scale-Up of Prevention of Mother-To-Child Transmission of HIV (PMTCT) Services to Eliminate New Pediatric HIV Infection in Nigeria	PLOS ONE			English	Article							COUNTRIES; INFANTS; AFRICA	Introduction As the world is making progress towards elimination of mother-to-child transmission of HIV, poor coverage of PMTCT services in Nigeria remains a major challenge. In order to address this, scale-up was planned with activities organized into 3 phases. This paper describes the process undertaken in eight high burden Nigerian states to rapidly close PMTCT coverage gaps at facility and population levels between February 2013 and March 2014. Methods Activities were grouped into three phases pre-assessment phase (engagement of a wide range of stakeholders), assessment (rapid health facility assessment, a cross sectional survey using mixed methods conducted in the various states between Feb and May 2013 and impact modelling), and post-assessment (drawing up costed state operational plans to achieve eMTCT by 2015, data-driven smart scale-up). Results Over a period of 10 months starting June 2013, 2044 facilities were supported to begin provision of PMTCT services. This increased facility coverage from 8% to 50%. A 246% increase was also recorded in the number of pregnant women and their families who have access to HIV testing and counselling in the context of PMTCT. Similarly, access to antiretrovirals for PMTCT has witnessed a 152% increase in these eight states between October 2013 and October 2014. Conclusion A data-driven and participatory approach can be used to rapidly scale-up PMTCT services at community and facility levels in this region. These results present us with hope for real progress in Nigeria. We are confident that the efforts described here will contribute significantly to eliminating new pediatric HIV infection in Nigeria.	[Oladele, Edward Adekola; Khamofu, Hadiza; Asala, Seun; Saleh, Mariya; Ralph-Opara, Uche; Nwosisi, Charles; Gana, Catherine; Adedokun, Oluwasanmi; Adebayo, Olufunsho; Torpey, Kwasi] FHI360, Abuja, Nigeria; [Anyaike, Chukwuma] Fed Minist Hlth, Natl AIDS & STI Control Programme, Abuja, Nigeria; [Dirks, Rebecca; Mandala, Justin] FHI 360, Washington, DC USA; [Oduwole, Modupe] UNAIDS Country Off, Abuja, Nigeria; [Torpey, Kwasi] Univ Ghana, Coll Hlth Sci, Accra, Ghana	University of Ghana	Oladele, EA (corresponding author), FHI360, Abuja, Nigeria.	edward.a.oladele@gmail.com		Torpey, Kwasi/0000-0003-1628-2922; Adedokun, Oluwasanmi/0000-0002-4678-9735; Oladele, Edward Adekola/0000-0003-4999-1397; Nwosisi, Charles/0000-0002-9771-6659	President's Emergency Plan for AIDS Relief (PEPFAR) through United States Agency for International Development (USAID) [AID-620-A-00002]	President's Emergency Plan for AIDS Relief (PEPFAR) through United States Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This paper is based on work supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through United States Agency for International Development (USAID) under the terms of cooperative agreement AID-620-A-00002 of the Strengthening Integrated Delivery of HIV/AIDS Services (SIDHAS) project managed by FHI 360 and other partners. All the authors except CA and MO work with FHI 360.	[Anonymous], 2020, HIGH POSS COST COVID; Audureau E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-286; Bhardwaj S, 2014, SAMJ S AFR MED J, V104, P239, DOI [10.7196/samj.7605, 10.7196/SAMJ.7605]; Doherty Tanya M, 2005, Afr Health Sci, V5, P213; du Plessis E, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-S1-S10; FHI 360, 2014, RAP HLTH FAC ASS 8 N; FHI 360, 2014, STAT LEV OP PLANS EL; FMOH, 2009, HLTH NIG 2008 ANN RE; FMOH, 2013, PRES NAT PMTCT TASK; FMOH, 2012, PMTCT SERV PACK ACC; FMOH, 2010, NAT GUID PREV MOTH T; FMOH NASCP, 2010, NAT SCAL PLAN EL MOT; Geelhoed D, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-207; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Gulaid LA, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17390; HIarlaithe MO, 2014, AIDS BEHAV, V18, pS516, DOI 10.1007/s10461-014-0756-5; Luo C, 2007, REPROD HEALTH MATTER, V15, P179, DOI 10.1016/S0968-8080(07)30327-3; Lyons C, 2012, JAIDS-J ACQ IMM DEF, V60, pS35, DOI 10.1097/QAI.0b013e3182598684; NACA, 2014, PMTCT DEM CREAT ACCL; Nakakeeto ON, 2009, AIDS, V23, P987, DOI 10.1097/QAD.0b013e32832a17e9; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; Torpey K, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-29; UNAIDS, 2014, GEN JOINT UN PROGR H; WHO, 2013, GLOB UPD HIV TREATM; World Health Organization, 2010, UN ACC SCAL PRIOR HI	25	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169342	10.1371/journal.pone.0169342	http://dx.doi.org/10.1371/journal.pone.0169342			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046045	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300168
J	Dangor, Z; Cutland, CL; Izu, A; Kwatra, G; Trenor, S; Lala, SG; Madhi, SA				Dangor, Ziyaad; Cutland, Clare L.; Izu, Alane; Kwatra, Gaurav; Trenor, Siobhan; Lala, Sanjay G.; Madhi, Shabir A.			Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development	PLOS ONE			English	Article							ONSET NEONATAL SEPSIS; YOUNG INFANTS; UNITED-STATES; RISK-FACTORS; DISEASE; PREVENTION; AFRICA; BURDEN; SOWETO; WOMEN	Introduction There is a paucity of longitudinal data on the serotype-specific burden of invasive group B Streptococcus (GBS) disease from low-middle income countries, which could inform selection of vaccine epitopes. Methods From 2005 to 2014, infants less than 90 days of age with invasive GBS disease were identified through sentinel laboratory and hospital admission surveillance at Chris Hani Baragwanath Academic Hospital in Soweto, South Africa. Results We identified 820 cases of invasive GBS disease, including 55% among newborns <7 days age (i.e. early-onset disease; EOD). The overall incidence (per 1,000 live births) of invasive GBS disease was 2.59 (95% CI: 2.42-2.77), including 1.41 (95% CI: 1.28-1.55) for EOD and 1.18 (95% CI: 1.06-1.30) in infants 7-89 days age (late-onset disease). Year-on-year, from 2005 to 2014, we observed a 9.4% increase in incidence of serotype Ia invasive disease (RR: 1.09; 95% CI: 1.04-1.15; p<0.001), and a 7.4% decline in serotype III invasive disease (RR: 0.93; 95% CI: 0.90-0.96; p<0.001). Overall, serotypes Ia (28.2%), III (55.4%) and V (7.9%) were the commonest disease causing serotypes. Conclusions The incidence of invasive GBS disease has remained persistently high in our setting, with some changes in serotype distribution, albeit mainly involving the same group of dominant serotypes.	[Dangor, Ziyaad; Cutland, Clare L.; Izu, Alane; Kwatra, Gaurav; Trenor, Siobhan; Madhi, Shabir A.] Univ Witwatersrand, Fac Hlth Sci, Resp & Meningeal Pathogens Res Unit, MRC, Johannesburg, South Africa; [Dangor, Ziyaad; Cutland, Clare L.; Izu, Alane; Kwatra, Gaurav; Trenor, Siobhan; Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Fac Hlth Sci, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa; [Dangor, Ziyaad; Lala, Sanjay G.] Univ Witwatersrand, Dept Paediat & Child Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Madhi, Shabir A.] Natl Inst Communicable Dis, Johannesburg, South Africa	University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; University of Witwatersrand; National Institute for Communicable Diseases (NICD)	Dangor, Z (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Resp & Meningeal Pathogens Res Unit, MRC, Johannesburg, South Africa.; Dangor, Z (corresponding author), Univ Witwatersrand, Dept Sci & Technol, Fac Hlth Sci, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa.; Dangor, Z (corresponding author), Univ Witwatersrand, Dept Paediat & Child Hlth, Fac Hlth Sci, Johannesburg, South Africa.	ziyaad.dangor@wits.ac.za	Cutland, Clare L./GXE-9967-2022	Cutland, Clare L./0000-0001-8250-8307; Dangor, Ziyaad/0000-0003-4089-147X	National Research Foundation/Department of Science and Technology: South African Research Chair Initiative in Vaccine Preventable Diseases; Medical Research Council of South Africa	National Research Foundation/Department of Science and Technology: South African Research Chair Initiative in Vaccine Preventable Diseases; Medical Research Council of South Africa(South African Medical Research Council)	SAM is funded in part by National Research Foundation/Department of Science and Technology: South African Research Chair Initiative in Vaccine Preventable Diseases and Medical Research Council of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar B, 2011, J CLIN MICROBIOL, V49, P1475, DOI 10.1128/JCM.02365-10; Christou V, 2014, J TIME SER ANAL, V35, P55, DOI 10.1111/jtsa.12050; Cutland CL, 2015, EMERG INFECT DIS, V21, P638, DOI 10.3201/eid2104.141562; Dagnew AF, 2012, CLIN INFECT DIS, V55, P91, DOI 10.1093/cid/cis395; Dangor Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123014; [Department of Economic Development Department of Economic Development], 2012, 5 YEAR SOW EC DEV PL; District Research Committee, 2014, BIRTH STAT; Downie L, 2013, ARCH DIS CHILD, V98, P146, DOI 10.1136/archdischild-2012-302033; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; Ferrieri P, 2013, EMERG INFECT DIS, V19, P551, DOI 10.3201/eid1904.121572; HAFFEJEE IE, 1991, J INFECTION, V22, P225, DOI 10.1016/S0163-4453(05)80003-9; Heyderman RS, 2016, LANCET INFECT DIS, V16, P546, DOI 10.1016/S1473-3099(15)00484-3; Islam MS, 2016, PEDIAT INFECT DIS J; Kwatra G, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.01.030; Madhi SA, 2003, ANN TROP PAEDIATR, V23, P15, DOI 10.1179/000349803125002814; Madhi SA, 2016, LANCET INFECT DIS, V16, P923, DOI 10.1016/S1473-3099(16)00152-3; Madzivhandila M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017861; Mayosi BM, 2014, NEW ENGL J MED, V371, P1344, DOI 10.1056/NEJMsr1405012; Motsohi T., 2015, MAIL GUARDIAN; National Department of Health, 2010, CLIN GUID PMTCT PREV; National Department of Health, 2013, S AFR ANT TREATM GUI, P8; National Department of Health, 2012, NAT ANT SENT HIV SYP; Okike IO, 2014, CLIN INFECT DIS, V59, pE150, DOI 10.1093/cid/ciu514; Poyart C, 2007, J CLIN MICROBIOL, V45, P1985, DOI 10.1128/JCM.00159-07; Quan V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152524; Schrag SJ, 2013, VACCINE, V31, pD20, DOI 10.1016/j.vaccine.2012.11.056; Schrag SJ, 2012, PEDIATR INFECT DIS J, V31, P821, DOI 10.1097/INF.0b013e31825c4b5a; Schuchat A, 2000, PEDIATRICS, V105, P21, DOI 10.1542/peds.105.1.21; Slotved HC, 2003, J CLIN MICROBIOL, V41, P4445, DOI 10.1128/JCM.41.9.4445-4447.2003; Thigpen MC, 2007, NEW ENGL J MED, V364, P2016, DOI DOI 10.1056/NEJMoa1005384; UNICEF, 2008, STAT WORLD CHILDR 20; Weston EJ, 2011, PEDIATR INFECT DIS J, V30, P937, DOI 10.1097/INF.0b013e318223bad2; Zaidi AKM, 2009, PEDIATR INFECT DIS J, V28, pS10, DOI 10.1097/INF.0b013e3181958769	33	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169101	10.1371/journal.pone.0169101	http://dx.doi.org/10.1371/journal.pone.0169101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036363	Green Published, gold, Green Submitted			2022-12-26	WOS:000391229300054
J	Wu, ZY; Sun, XY; Chu, YH; Sun, JY; Qin, GY; Yang, L; Qin, JN; Xiao, Z; Ren, J; Qin, D; Wang, XL; Zheng, XY				Wu, Zhenyu; Sun, Xiaoyu; Chu, Yanhui; Sun, Jingyi; Qin, Guoyou; Yang, Lin; Qin, Jingning; Xiao, Zheng; Ren, Jian; Din, Di; Wang, Xiling; Zheng, Xueying			Coherence of Influenza Surveillance Data across Different Sources and Age Groups, Beijing, China, 2008-2015	PLOS ONE			English	Article							SEASONALITY	Influenza is active during the winter and spring in the city of Beijing, which has a typical temperate climate with four clear distinct seasons. The clinical and laboratory surveillance data for influenza have been used to construct critical indicators for influenza activities in the community, and previous studies have reported varying degrees of association between laboratory-confirmed influenza specimens and outpatient consultation rates of influenza-like illness in subtropical cities. However, few studies have reported on this issue for cities in temperate regions, especially in developing countries. Furthermore, the mechanism behind age-specific seasonal epidemics remains unresolved, although it has been widely discussed. We utilized a wavelet analysis method to monitor the coherence of weekly percentage of laboratory-confirmed influenza specimens with the weekly outpatient consultation rates of influenza-like illness in Beijing, China. We first examined the seasonal pattern of laboratory- confirmed cases of influenza A (subtyped into seasonal A(H1N1) and A(H3N2) and pandemic virus A(H1N1) pdm09) and influenza B separately within the period from 2008- 2015; then, we detected the coherence of clinical and laboratory surveillance data in this district, specially examining weekly time series of age-specific epidemics of influenza-like illnesses in the whole study period for three age categories (age 0-5, 5-15 and 25-60). We found that influenza A and B were both active in winter but were not always seasonally synchronous in Beijing. Synchronization between age ranges was found in most epidemic peaks from 2008-2015. Our findings suggested that peaks of influenza-like illness in individuals aged 0-5 and 5-15 years consistently appeared ahead of those of adults, implying the possibility that schoolchildren may lead epidemic fluctuations.	[Wu, Zhenyu; Qin, Guoyou; Wang, Xiling; Zheng, Xueying] Fudan Univ, Key Lab Publ Hlth Safety, Sch Publ Hlth, Dept Biostat, Shanghai, Peoples R China; [Wu, Zhenyu; Qin, Guoyou; Wang, Xiling; Zheng, Xueying] Fudan Univ, Collaborat Innovat Ctr Social Risks Governance Hl, Shanghai, Peoples R China; [Sun, Xiaoyu; Chu, Yanhui; Sun, Jingyi; Qin, Jingning; Xiao, Zheng; Ren, Jian; Din, Di] Xicheng Dist Ctr Dis Control & Prevent, Beijing, Peoples R China; [Yang, Lin] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	Fudan University; Fudan University; Hong Kong Polytechnic University	Wang, XL; Zheng, XY (corresponding author), Fudan Univ, Key Lab Publ Hlth Safety, Sch Publ Hlth, Dept Biostat, Shanghai, Peoples R China.; Wang, XL; Zheng, XY (corresponding author), Fudan Univ, Collaborat Innovat Ctr Social Risks Governance Hl, Shanghai, Peoples R China.	erinwang@fudan.edu.cn; xyzheng@fudan.edu.cn	YANG, Lin/F-9601-2014	YANG, Lin/0000-0002-5964-3233	National Nature and Science Foundation of China [11371100]; National Youth Nature and Science Foundation of China [11501124]	National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Youth Nature and Science Foundation of China	This work was supported by National Nature and Science Foundation of China [11371100] and National Youth Nature and Science Foundation of China [11501124]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; Brammer L, 2009, INFLUENZA OTHER RESP, V3, P51, DOI 10.1111/j.1750-2659.2009.00077.x; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; Khiabanian H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006832; Liu YG, 2007, J ATMOS OCEAN TECH, V24, P2093, DOI 10.1175/2007JTECHO511.1; Maraun D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016707; Maraun D, 2004, NONLINEAR PROC GEOPH, V11, P505, DOI 10.5194/npg-11-505-2004; Navarro-Mari JM, 2005, J CLIN EPIDEMIOL, V58, P275, DOI 10.1016/j.jclinepi.2004.08.014; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Schanzer D, 2011, AM J EPIDEMIOL, V174, P109, DOI 10.1093/aje/kwr037; Schanzer DL, 2010, INFLUENZA OTHER RESP, V4, P295, DOI 10.1111/j.1750-2659.2010.00154.x; Shih SR, 2005, J CLIN MICROBIOL, V43, P1651, DOI 10.1128/JCM.43.4.1651-1661.2005; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Tan Y, 2014, J GEN VIROL, V95, P531, DOI 10.1099/vir.0.059998-0; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Turbelin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065919; Viboud C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102429; Wang Jin-feng, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P164; Yang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125447; Yang L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001399; Yang P, 2009, EMERG INFECT DIS, V15, P1603, DOI 10.3201/eid1510.081040; Yang YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045807; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	29	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169199	10.1371/journal.pone.0169199	http://dx.doi.org/10.1371/journal.pone.0169199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036373	Green Published, Green Submitted, gold			2022-12-26	WOS:000391229300065
J	Sindet-Pedersen, C; Oestergaard, LB; Gundlund, A; Fosbol, EL; Aasbjerg, K; Pallisgaard, JL; Gislason, G; Torp-Pedersen, C; Olesen, JB				Sindet-Pedersen, Caroline; Oestergaard, Louise Bruun; Gundlund, Anna; Fosbol, Emil Loldrup; Aasbjerg, Kristian; Pallisgaard, Jannik Langtved; Gislason, Gunnar; Torp-Pedersen, Christian; Olesen, Jonas Bjerring			Familial Clustering of Venous Thromboembolism - A Danish Nationwide Cohort Study	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; RISK-FACTORS; 1ST-DEGREE RELATIVES; HISTORY; DEFICIENCY; POPULATION; VTE; EPIDEMIOLOGY; REGISTER	Background Identification of risk factors for venous thromboembolism (VTE) is of utmost importance to improve current prophylactic regimes and treatment guidelines. The extent to which a family history contributes to the risk of VTE needs further exploration. Objectives To examine the relative rate of VTE in first-degree relatives compared with the general population. Methods By crosslinking Danish nationwide registries we identified patients with VTE between 1978 and 2012, and their familial relations. The first member in a family to acquire VTE was defined as the proband. All first-degree relatives to probands were followed from the VTE date of the proband and until an event (VTE), death, emigration, 100 year birthday or end of study: 31 st of December 2012, whichever came first. The relative rate of VTE was estimated by standardized incidence ratios (SIR) using time-dependent Poisson regression models, with the general population as a fixed reference. Results We identified 70,767 children of maternal probands, 66,065 children of paternal probands, and 29,183 siblings to sibling probands. Having a maternal proband or a paternal proband were associated with a significantly increased VTE rate of 2.15 (CI: 2.00 - 2.30) and 2.06 (CI: 1.92 - 2.21), respectively. The highest estimate of VTE was observed among siblings (adjusted SIR of 2.60 [CI: 2.38 - 2.83]). Noteworthy, the rate of VTE increased for all first-degree relatives when the proband was diagnosed with VTE in a young age (<= 50 years). Conclusion A family history of VTE was associated with a significantly increased rate of VTE among first-degree relatives compared with the general population.	[Sindet-Pedersen, Caroline; Oestergaard, Louise Bruun; Gundlund, Anna; Pallisgaard, Jannik Langtved; Gislason, Gunnar; Torp-Pedersen, Christian; Olesen, Jonas Bjerring] Copenhagen Univ Hosp Herlev & Gentofte, Dept Cardiol, Hellerup, Denmark; [Sindet-Pedersen, Caroline; Pallisgaard, Jannik Langtved; Gislason, Gunnar] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen N, Denmark; [Oestergaard, Louise Bruun; Aasbjerg, Kristian; Torp-Pedersen, Christian] Aalborg Univ, Inst Hlth Sci & Technol, Aalborg, Denmark; [Fosbol, Emil Loldrup; Gislason, Gunnar] Danish Heart Fdn, Copenhagen K, Denmark; [Fosbol, Emil Loldrup] Rigshosp, Copenhagen Univ Hosp, Dept Cardiol, Copenhagen O, Denmark; [Aasbjerg, Kristian] Aalborg Univ Hosp, Dept Ophthalmol, Aalborg, Denmark; [Gislason, Gunnar] Univ Southern Denmark, Natl Inst Publ Hlth, Odense, Denmark	University of Copenhagen; Aalborg University; Rigshospitalet; University of Copenhagen; Aalborg University; Aalborg University Hospital; University of Southern Denmark	Sindet-Pedersen, C (corresponding author), Copenhagen Univ Hosp Herlev & Gentofte, Dept Cardiol, Hellerup, Denmark.; Sindet-Pedersen, C (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen N, Denmark.	carolinesindet@gmail.com	Gislason, Gunnar/B-7561-2009	Gislason, Gunnar/0000-0002-0548-402X; Fosbol, Emil/0000-0002-2048-4167	Danish Council of Independent Research [4183-00008]; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF12OC1015957] Funding Source: researchfish	Danish Council of Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was funded by a grant from the Danish Council of Independent Research (grant no. 4183-00008). Dr. Gislason is supported by an unrestricted clinical research scholarship from the Novo Nordisk Foundation. The funders had no role in the design and the conduct of the study; the collection, management, analyses, and interpretation of the data; the preparation or approval of this manuscript; or in the decision to submit the manuscript for publication.	Bezemer ID, 2009, ARCH INTERN MED, V169, P610, DOI 10.1001/archinternmed.2008.589; Bosson JL, 2006, J INTERN MED, V260, P168, DOI 10.1111/j.1365-2796.2006.01678.x; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; COMP PC, 1984, NEW ENGL J MED, V311, P1525, DOI 10.1056/NEJM198412133112401; Couturaud F, 2014, BLOOD, V124, P2124, DOI 10.1182/blood-2014-03-559757; Cushman Mary, 2005, Hematology Am Soc Hematol Educ Program, P452; Dowling NF, 2003, J THROMB HAEMOST, V1, P80, DOI 10.1046/j.1538-7836.2003.00031.x; EGEBERG O, 1965, THROMB DIATH HAEMOST, V13, P516, DOI 10.1055/s-0038-1656297; Germain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025581; Goldhaber SZ, 2012, LANCET, V379, P1835, DOI 10.1016/S0140-6736(11)61904-1; Goldhaber SZ, 2004, LANCET, V363, P1295, DOI 10.1016/S0140-6736(04)16004-2; GRIFFIN JH, 1981, J CLIN INVEST, V68, P1370, DOI 10.1172/JCI110385; Gundlund A, 2016, EUROPACE, V18, P658, DOI 10.1093/europace/euv274; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Martinelli I, 2014, NAT REV CARDIOL, V11, P140, DOI 10.1038/nrcardio.2013.211; Mili FD, 2011, THROMB RES, V127, P309, DOI 10.1016/j.thromres.2010.12.012; Morange PE, 2015, THROMB HAEMOSTASIS, V114, P910, DOI 10.1160/TH15-05-0410; Nielsen M, 2013, EUR HEART J, V34, P1198, DOI 10.1093/eurheartj/ehs475; Noboa S, 2008, THROMB RES, V122, P624, DOI 10.1016/j.thromres.2007.12.026; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Raskob GE, 2014, ARTERIOSCL THROM VAS, V34, P2363, DOI 10.1161/ATVBAHA.114.304488; Rojnuckarin P, 2011, THROMB HAEMOSTASIS, V106, P1103, DOI 10.1160/TH11-08-0555; SCHWARZ HP, 1984, BLOOD, V64, P1297; Severinsen MT, 2010, J CLIN EPIDEMIOL, V63, P223, DOI 10.1016/j.jclinepi.2009.03.018; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Sonnevi K, 2013, THROMB RES, V132, P164, DOI 10.1016/j.thromres.2013.06.003; Sorensen HT, 2011, J THROMB HAEMOST, V9, P320, DOI 10.1111/j.1538-7836.2010.04129.x; Spannagl M, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-8; Tang WH, 2013, GENET EPIDEMIOL, V37, P512, DOI 10.1002/gepi.21731; Thygesen LC, 2014, EUR J EPIDEMIOL, V29, P551, DOI 10.1007/s10654-013-9873-0; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; Tosetto A, 2003, J THROMB HAEMOST, V1, P1724, DOI 10.1046/j.1538-7836.2003.00313.x; Zoller B, 2011, J THROMB HAEMOST, V9, P64, DOI 10.1111/j.1538-7836.2010.04107.x; Zoller B, 2014, CIRC-CARDIOVASC GENE, V7, P296, DOI 10.1161/CIRCGENETICS.113.000341; Zoller B, 2015, THROMB HAEMOST, V114; Zoller B, 2016, SEMIN THROMB HEMOST; Zoller B, 2013, THROMB HAEMOSTASIS, V109, P458, DOI 10.1160/TH12-10-0743; Zoller B, 2012, THROMB RES, V130, P178, DOI 10.1016/j.thromres.2012.02.002; Zoller B, 2011, CIRCULATION, V124, P1012, DOI 10.1161/CIRCULATIONAHA.110.965020	43	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0169055	10.1371/journal.pone.0169055	http://dx.doi.org/10.1371/journal.pone.0169055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033406	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900071
J	Vogler, RE; Beltramino, AA; Strong, EE; Rumi, A; Peso, JG				Vogler, Roberto E.; Beltramino, Ariel A.; Strong, Ellen E.; Rumi, Alejandra; Peso, Juana G.			Insights into the Evolutionary History of an Extinct South American Freshwater Snail Based on Historical DNA	PLOS ONE			English	Article							EX-SITU CONSERVATION; LSU RIBOSOMAL-RNA; SECONDARY STRUCTURE; RIVER-BASIN; GASTROPODA; ARGENTINA; PHYLOGEOGRAPHY; BIOGEOGRAPHY; DIVERSITY; EXTRACTION	Highly oxygenated freshwater habitats in the High Parana River (Argentina Paraguay) were home to highly endemic snails of the genus Aylacostoma, which face extinction owing to the impoundment of the Yacyreta Reservoir in the 1990s. Two species, A. chloroticum and A. brunneum, are currently included in an ongoing ex situ conservation programme, whereas A. guaraniticum and A. stigmaticum are presumed extinct. Consequently, the validity and affinities of the latter two have remained enigmatic. Here, we provide the first molecular data on the extinct A. stigmaticum by means of historical DNA analysis. We describe patterns of molecular evolution based on partial sequences of the mitochondrial 12S ribosomal RNA gene from the extinct species and from those being bred within the ex situ programme. We further use this gene to derive a secondary structure model, to examine the specific status of A. stigmaticum and to explore the evolutionary history of these snails. The secondary structure model based on A. stigmaticum revealed that most polymorphic sites are located in unpaired regions. Our results support the view that the mitochondrial 12S region is an efficient marker for the discrimination of species, and the extinct A. stigmaticum is recognized here as a distinct evolutionary genetic species. Molecular phylogenetic analyses revealed a sister group relationship between A. chloroticum and A. brunneum, and estimated divergence times suggest that diversification of Aylacostoma in the High Parana River might have started in the late Miocene via intra-basin speciation due to a past marine transgression. Finally, our findings reveal that DNA may be obtained from dried specimens at least 80 years after their collection, and confirms the feasibility of extracting historical DNA from museum collections for elucidating evolutionary patterns and processes in gastropods.	[Vogler, Roberto E.; Peso, Juana G.] Univ Nacl Misiones, CONICET, Inst Biol Subtrop, Posadas, Misiones, Argentina; [Vogler, Roberto E.; Beltramino, Ariel A.; Rumi, Alejandra] Univ Nacl La Plata, Fac Ciencias Nat & Museo, Div Zool Invertebrados, CONICET, La Plata, Buenos Aires, Argentina; [Beltramino, Ariel A.] Univ Nacl Misiones, Dept Biol, Fac Ciencias Exactas Quim & Nat, CONICET, Posadas, Misiones, Argentina; [Strong, Ellen E.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Smithsonian Institution; Smithsonian National Museum of Natural History	Vogler, RE (corresponding author), Univ Nacl Misiones, CONICET, Inst Biol Subtrop, Posadas, Misiones, Argentina.; Vogler, RE (corresponding author), Univ Nacl La Plata, Fac Ciencias Nat & Museo, Div Zool Invertebrados, CONICET, La Plata, Buenos Aires, Argentina.	robertovogler@fceqyn.unam.edu.ar	Beltramino, Ariel/ABD-8068-2020; Vogler, Roberto/H-6101-2019	Beltramino, Ariel/0000-0002-0052-6710; Vogler, Roberto/0000-0001-9660-552X; Strong, Ellen/0000-0001-7181-4114				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andree KB, 2013, MOLLUSCAN RES, V33, P1, DOI 10.1080/13235818.2012.754141; Arzamendia V, 2012, DIVERS DISTRIB, V18, P168, DOI 10.1111/j.1472-4642.2011.00829.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Birky CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052544; Birky CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010609; Bonetto A.A., 1986, Monographiae Biologicae, V60, P541; Brea M, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P69; Brunhoff C, 2003, MOL ECOL, V12, P957, DOI 10.1046/j.1365-294X.2003.01796.x; Caldeira RL, 2004, MEM I OSWALDO CRUZ, V99, P499, DOI 10.1590/S0074-02762004000500007; Candela AM, 2012, GEOBIOS-LYON, V45, P515, DOI 10.1016/j.geobios.2012.05.003; Cardoso YP, 2012, ZOOTAXA, P69; Collado GA, 2016, SYST BIODIVERS, V14, P417, DOI 10.1080/14772000.2016.1153526; Collado GA, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-50; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davidson H, 1882, INFORM ESPEDICION AL; desCastellanos ZJA, 1981, FAUNA AGUA DULCE REP, P7; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Evangelisti F, 2016, J MOLLUS STUD, V82, P292, DOI 10.1093/mollus/eyv066; Facon B, 2003, MOL ECOL, V12, P3027, DOI 10.1046/j.1365-294X.2003.01972.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fontaneto D, 2015, MAR BIODIVERS, V45, P433, DOI 10.1007/s12526-015-0319-7; Fuchs J, 2011, MOL PHYLOGENET EVOL, V60, P398, DOI 10.1016/j.ympev.2011.05.008; Geist J, 2010, HYDROBIOLOGIA, V644, P69, DOI 10.1007/s10750-010-0190-2; Glaubrecht M, 2011, AM MALACOL BULL, V29, P187, DOI 10.4003/006.029.0211; Greve C, 2010, MOL PHYLOGENET EVOL, V57, P572, DOI 10.1016/j.ympev.2010.08.021; Gubili C, 2015, ENDANGER SPECIES RES, V27, P233, DOI 10.3354/esr00665; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gregoric DEG, 2016, PEERJ, V4, DOI 10.7717/peerj.2138; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Herbst R., 2000, INSUGEO SERIE CORREL, V14, P181; Hernandez RM, 2005, J S AM EARTH SCI, V19, P495, DOI 10.1016/j.jsames.2005.06.007; Hickson RE, 1996, MOL BIOL EVOL, V13, P150, DOI 10.1093/oxfordjournals.molbev.a025552; Holznagel WE, 1998, AM MALACOL BULL, V14, P181; Hubert N, 2007, MOL ECOL, V16, P2115, DOI 10.1111/j.1365-294X.2007.03267.x; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Hylton Scott MI., 1953, PHYSIS, V20, P438; Hylton Scott MI, 1954, NEOTROPICA, V1, P45; Jaksch Katharina, 2016, BMC Research Notes, V9, P348, DOI 10.1186/s13104-016-2147-7; Jorger KM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-245; Johnson PD, 2013, FISHERIES, V38, P247, DOI 10.1080/03632415.2013.785396; Ketmaier V, 2006, MOL PHYLOGENET EVOL, V39, P439, DOI 10.1016/j.ympev.2005.12.008; Ketmaier V, 2010, MALACOLOGIA, V52, P81, DOI 10.4002/040.052.0106; Lydeard C, 2000, MOL PHYLOGENET EVOL, V15, P83, DOI 10.1006/mpev.1999.0719; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; Lydeard C, 2002, MALACOLOGIA, V44, P349; Machida RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035887; Matteucci SD, 2004, ALTO PARANA ENCAJONA; Medina M, 2000, MOL PHYLOGENET EVOL, V15, P41, DOI 10.1006/mpev.1999.0736; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Nei M., 1987, MOL EVOLUTIONARY GEN; Neiff J. J., 1986, REV ASS CIENCIAS NAT, V17, P7; Peso JG., 2013, AMICI MOLLUSCARUM, V21, P43; Peso JG., 2013, AMICI MOLLUSCARUM, V21, P39; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Quintana MG, 1997, TENTACLE, V7, P17; Quintana MG, 1997, CIENCIA HOY, V7, P22; Rambaut A., 2014, TRACER V1 6; Ramirez Jorge, 2010, Rev. peru biol., V17, P53; Regnier C, 2015, CONSERV BIOL, V29, P1715, DOI 10.1111/cobi.12565; Regnier C, 2009, CONSERV BIOL, V23, P1214, DOI 10.1111/j.1523-1739.2009.01245.x; RUMBAK E, 1994, NAUTILUS, V108, P91; Rumi A, 2006, MALACOLOGIA, V49, P189, DOI 10.4002/1543-8120-49.1.189; Russello MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008683; Sanchez R, 2011, NUCLEIC ACIDS RES, V39, pW470, DOI 10.1093/nar/gkr408; Schon I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039844; Shrestha Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137325; Simone LRL., 2006, LAND FRESHWATER MOLL; Simone Luiz Ricardo L., 2001, Arquivos de Zoologia (Sao Paulo), V36, P147; Smith C, 2010, NUCLEIC ACIDS RES, V38, pW373, DOI 10.1093/nar/gkq316; Strayer DL, 2006, J N AM BENTHOL SOC, V25, P271, DOI 10.1899/0887-3593(2006)25[271:CFFIC]2.0.CO;2; Strong EE, 2008, HYDROBIOLOGIA, V595, P149, DOI 10.1007/s10750-007-9012-6; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1993, GENETICS, V135, P599; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Villanea FA, 2016, J MOLLUS STUD, V82, P449, DOI 10.1093/mollus/eyw011; Vogler RE., 2012, AMICI MOLLUSCARUM, V20, P43; Vogler RE, 2015, ZOOL J LINN SOC-LOND, V174, P487, DOI 10.1111/zoj.12250; Vogler RE, 2014, ZOOL J LINN SOC-LOND, V172, P501, DOI 10.1111/zoj.12179; Vogler RE, 2013, MALACOLOGIA, V56, P329, DOI 10.4002/040.056.0221; Vogler RE, 2012, REV MEX BIODIVERS, V83, P1045, DOI 10.7550/rmb.26165; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Whelan NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042499; Whelan NV, 2015, AM MALACOL B, V33, P1; Will S, 2012, RNA, V18, P900, DOI 10.1261/rna.029041.111	85	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0169191	10.1371/journal.pone.0169191	http://dx.doi.org/10.1371/journal.pone.0169191			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033407	Green Published, gold			2022-12-26	WOS:000391226900082
J	Flitcroft, RL; Lewis, SL; Arismendi, I; LovellFord, R; Santelmann, MV; Safeeq, M; Grant, G				Flitcroft, Rebecca L.; Lewis, Sarah L.; Arismendi, Ivan; LovellFord, Rachel; Santelmann, Mary V.; Safeeq, Mohammad; Grant, Gordon			Linking Hydroclimate to Fish Phenology and Habitat Use with Ichthyographs	PLoS One			English	Article							PACIFIC-NORTHWEST; BRITISH-COLUMBIA; SOCKEYE-SALMON; LIFE-HISTORIES; CHINOOK SALMON; MIGRATION; PATTERN; KISUTCH; COHO	Streamflow and water temperature (hydroclimate) influence the life histories of aquatic biota. The relationship between streamflow and temperature varies with climate, hydrogeomorphic setting, and season. Life histories of native fishes reflect, in part, their adaptation to regional hydroclimate (flow and water temperature), local habitats, and natural disturbance regimes, all of which may be affected by water management. Alterations to natural hydroclimates, such as those caused by river regulation or climate change, can modify the suitability and variety of in-stream habitat for fishes throughout the year. Here, we present the ichthyograph, a new empirically-based graphical tool to help visualize relationships between hydroclimate and fish phenology. Generally, this graphical tool can be used to display a variety of phenotypic traits. We used long-term data sets of daily fish passage to examine linkages between hydroclimate and the expression of life-history phenology by native fishes. The ichthyograph may be used to characterize the environmental phenology for fishes across multiple spatio-temporal domains. We illustrate the ichthyograph in two applications to visualize: 1) river use for the community of fishes at a specific location; and 2) stream conditions at multiple locations within the river network for one species at different life-history stages. The novel, yet simple, ichthyograph offers a flexible framework to enable transformations in thinking regarding relationships between hydroclimate and aquatic species across space and time. The potential broad application of this innovative tool promotes synergism between assessments of physical characteristics and the biological needs of aquatic species.	[Flitcroft, Rebecca L.; Grant, Gordon] USDA Forest Serv, Pacific Northwest Res Stn, Corvallis, OR 97331 USA; [Lewis, Sarah L.; Santelmann, Mary V.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR USA; [Arismendi, Ivan] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [LovellFord, Rachel] Water Resources Dept State Oregon, Salem, OR USA; [Safeeq, Mohammad] Univ Calif Merced, Geosci Dept, Merced, CA USA	United States Department of Agriculture (USDA); United States Forest Service; Oregon State University; Oregon State University; University of California System; University of California Merced	Flitcroft, RL (corresponding author), USDA Forest Serv, Pacific Northwest Res Stn, Corvallis, OR 97331 USA.	rflitcroft@fs.fed.us	Arismendi, Ivan/B-3144-2010	Arismendi, Ivan/0000-0002-8774-9350; Lewis, Sarah/0000-0002-1824-8739; Santelmann, Mary/0000-0002-1074-8237	USDA Forest Service; PNW Research Lab	USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); PNW Research Lab	Research funds to support data analysis and writing were provided by the USDA Forest Service, PNW Research Lab, through joint venture agreements at Oregon State University.	Arismendi I, 2013, HYDROBIOLOGIA, V712, P61, DOI 10.1007/s10750-012-1327-2; Brandon R.N., 1990, ADAPTATION ENV; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Groot C., 1991, PACIFIC SALMON LIFE; Healey MC, 2009, ECOL SOC, V14; Hinch SG, 2000, T AM FISH SOC, V129, P598, DOI 10.1577/1548-8659(2000)129<0598:EOSSAA>2.0.CO;2; Jones KK, 2014, J FISH BIOL, V85, P52, DOI 10.1111/jfb.12380; Lee CG, 2003, J EXP BIOL, V206, P3239, DOI 10.1242/jeb.00547; LovellFord R. M., 2013, THESIS; NMFS (National Marine Fisheries Service), 1998, FED REGISTER, V63, P42587; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; POFF NL, 1990, ENVIRON MANAGE, V14, P629, DOI 10.1007/BF02394714; Quinn TP, 2002, T AM FISH SOC, V131, P591, DOI 10.1577/1548-8659(2002)131&lt;0591:ASAECC&gt;2.0.CO;2; QUINN TP, 1993, CAN J FISH AQUAT SCI, V50, P1414, DOI 10.1139/f93-162; Reeves GH, 1995, AM FISH S S, V17, P334; Reimers P.E., 1971, THESIS; Safeeq M, 2014, HYDROL EARTH SYST SC, V18, P1; Safeeq M, 2015, HYDROL PROCESS, V29, P5337, DOI 10.1002/hyp.10553; Taylor G.H., 1999, CLIMATE OREGON RAIN; USGS (United States Geological Survey), 2016, NAT WAT INF SYST WEB; Waples RS, 2008, EVOL APPL, V1, P189, DOI 10.1111/j.1752-4571.2008.00023.x; Ward EJ, 2015, GLOBAL CHANGE BIOL, V21, P2500, DOI 10.1111/gcb.12847	23	24	25	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168831	10.1371/journal.pone.0168831	http://dx.doi.org/10.1371/journal.pone.0168831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006825	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200100
J	Fujimoto, D; Kato, R; Morimoto, T; Shimizu, R; Sato, Y; Kogo, M; Ito, J; Teraoka, S; Nagata, K; Nakagawa, A; Otsuka, K; Tomii, K				Fujimoto, Daichi; Kato, Ryoji; Morimoto, Takeshi; Shimizu, Ryoko; Sato, Yuki; Kogo, Mariko; Ito, Jiro; Teraoka, Shunsuke; Nagata, Kazuma; Nakagawa, Atsushi; Otsuka, Kojiro; Tomii, Keisuke			Characteristics and Prognostic Impact of Pneumonitis during Systemic Anti-Cancer Therapy in Patients with Advanced Non-Small Cell Lung Cancer	PLOS ONE			English	Article							PULMONARY-FIBROSIS; INTENSIVE-CARE; RADIATION PNEUMONITIS; PERFORMANCE STATUS; JAPANESE PATIENTS; DECISION-MAKING; SINGLE-AGENT; RISK-FACTORS; CHEMOTHERAPY; DISEASE	Background Data on characteristics, outcomes, and prognosis of advanced non-small-cell lung cancer (NSCLC) patients who develop pneumonitis during systemic anti-cancer therapy (pneumonitis) are currently lacking. Methods We conducted a retrospective cohort study of 910 consecutive patients diagnosed with advanced NSCLC between January 2004 and January 2014. Of these, 140 patients were excluded because they did not receive systemic anti-cancer therapy at this hospital. Results A total of 770 patients were included in the study, of whom 44 (6%) were diagnosed with pneumonitis. The mortality rate of pneumonitis was 36%. The incidence of pneumonitis was independently associated with pre-existing ILD (adjusted odds ratio, 2.99, P = 0.008), and survivors were significantly associated with younger age (P = 0.003) and radiographic non-acute interstitial pneumonia pattern (P = 0.004). In all patients, pneumonitis was identified as an independent predictor of overall survival (OS) (adjusted hazard ratio 1.53, 95% Cl, 1.09-2.09, P = 0.015). Performance status was poor in 82% of survivors of pneumonitis; in 62% of survivors, the PS worsened after the pneumonitis improved. Additionally, 54% of survivors received no further systemic anti-cancer therapy after pneumonitis. The median survival time of survivors after pneumonitis was 3.5 months (95% Cl, 2.3-7.2 months). Conclusions Our study indicated that 6% of patients with advanced NSCLC developed pneumonitis during systemic anti-cancer therapy. The early mortality rate of pneumonitis is high, and the survival and PS after pneumonitis is extremely poor. Additionally, pneumonitis has an adverse impact on the survival of patients with advanced NSCLC. These data should be considered for the management of pneumonitis, and we recommend that future work focuses on pneumonitis particularly to improve the survival of patients with advanced NSCLC.	[Fujimoto, Daichi; Kato, Ryoji; Shimizu, Ryoko; Sato, Yuki; Kogo, Mariko; Ito, Jiro; Teraoka, Shunsuke; Nagata, Kazuma; Nakagawa, Atsushi; Otsuka, Kojiro; Tomii, Keisuke] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan; [Morimoto, Takeshi] Kobe City Med Ctr Gen Hosp, Clin Res Ctr, Kobe, Hyogo, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Dept Clin Epidemiol, Nishinomiya, Hyogo, Japan	Kobe City Medical Center General Hospital; Kobe City Medical Center General Hospital; Hyogo College of Medicine	Fujimoto, D (corresponding author), Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan.	daichianzen@yahoo.co.jp	Ito, Jiro/M-1811-2019	Ito, Jiro/0000-0003-4836-9379; Fujimoto, Daichi/0000-0003-0615-3000	Ethics Committee of Kobe City Medical Center General Hospital	Ethics Committee of Kobe City Medical Center General Hospital	This study was supported by internal funding and the Ethics Committee of Kobe City Medical Center General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, N Engl J Med, V373, P782, DOI 10.1056/NEJMx150012; Aubry MC, 2002, MAYO CLIN PROC, V77, P763, DOI 10.4065/77.8.763; Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Bonomi MR, 2012, LUNG CANCER, V77, P600, DOI 10.1016/j.lungcan.2012.05.103; Camus P, 2001, EUR RESPIR J, V18, p93S; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Cushley MJ, 1999, THORAX, V54, pS1; Dhokarh R, 2012, CHEST, V142, P845, DOI 10.1378/chest.11-2103; Enomoto Y, 2016, LUNG CANCER, V96, P63, DOI 10.1016/j.lungcan.2016.03.017; Fujimoto D, 2015, EUR RESPIR J, V45, P1098, DOI 10.1183/09031936.00068114; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Isobe K, 2010, RESPIROLOGY, V15, P88, DOI 10.1111/j.1440-1843.2009.01666.x; Kane HL, 2014, CA-CANCER J CLIN, V64, P377, DOI 10.3322/caac.21245; Katz SJ, 2013, JAMA-J AM MED ASSOC, V310, P1559, DOI 10.1001/jama.2013.278944; Kenmotsu H, 2015, CANCER CHEMOTH PHARM, V75, P521, DOI 10.1007/s00280-014-2670-y; Kenmotsu H, 2011, J THORAC ONCOL, V6, P1242, DOI 10.1097/JTO.0b013e318216ee6b; Kim JY, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-59; Kinoshita T, 2012, ONCOL LETT, V4, P477, DOI 10.3892/ol.2012.753; Kubo K, 2013, RESPIR INVESTIG, V51, P260, DOI 10.1016/j.resinv.2013.09.001; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Lilenbaum RC, 2004, ONCOLOGY-NY, V18, P1321; Minami-Shimmyo Y, 2012, J THORAC ONCOL, V7, P177, DOI 10.1097/JTO.0b013e31823c4c07; Minegishi Y, 2014, LUNG CANCER, V85, P258, DOI 10.1016/j.lungcan.2014.05.016; Morth C, 2014, LUNG CANCER, V84, P209, DOI 10.1016/j.lungcan.2014.03.015; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Nishino M, 2016, CLIN CANC RES OFFICI; Nishino M, 2015, EUR J RADIOL, V84, P1259, DOI 10.1016/j.ejrad.2015.03.017; Niu XM, 2012, J THORAC ONCOL, V7, P1668, DOI 10.1097/JTO.0b013e318267cf5b; Ozawa Y, 2016, CANCER CHEMOTH PHARM, V77, P1031, DOI 10.1007/s00280-016-3025-7; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Rodrigues G, 2004, RADIOTHER ONCOL, V71, P127, DOI 10.1016/j.radonc.2004.02.015; Sakurada T, 2015, ANN PHARMACOTHER, V49, P398, DOI 10.1177/1060028014566446; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Slatore CG, 2012, J CLIN ONCOL, V30, P1686, DOI 10.1200/JCO.2011.40.0846; Soares M, 2014, ANN ONCOL, V25, P1829, DOI 10.1093/annonc/mdu234; Soares M, 2007, CHEST, V131, P840, DOI 10.1378/chest.06-2244; Takeda M, 2015, LUNG CANCER, V88, P74, DOI 10.1016/j.lungcan.2015.01.026; Togashi Y, 2012, CLIN LUNG CANCER, V13, P304, DOI 10.1016/j.cllc.2011.11.001; Tomassetti S, 2015, CHEST, V147, P157, DOI 10.1378/chest.14-0359; Usui K, 2011, RESPIROLOGY, V16, P326, DOI 10.1111/j.1440-1843.2010.01907.x; Vahid B, 2008, CHEST, V133, P528, DOI 10.1378/chest.07-0851; Yagihashi K, 2016, EUR RESPIR J, V47, P1189, DOI 10.1183/13993003.01680-2015; Zukin M, 2013, J CLIN ONCOL, V31, P2849, DOI 10.1200/JCO.2012.48.1911	44	32	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168465	10.1371/journal.pone.0168465	http://dx.doi.org/10.1371/journal.pone.0168465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006019	Green Published, gold, Green Submitted			2022-12-26	WOS:000392843200056
J	Li, XY; Yu, CX; Huang, X; Sun, SJ				Li, Xiuyun; Yu, Cuixiang; Huang, Xin; Sun, Shujuan			Synergistic Effects and Mechanisms of Budesonide in Combination with Fluconazole against Resistant Candida albicans	PLOS ONE			English	Article							IATROGENIC CUSHING SYNDROME; IN-VITRO; GALLERIA-MELLONELLA; DRUG-RESISTANCE; INFECTION MODEL; VIRULENCE; APOPTOSIS; BIOFILM; EFFLUX; EPIDEMIOLOGY	Candida albicans is an important opportunistic pathogen, causing both superficial mucosal infections and life-threatening systemic diseases in the clinic. The emergence of drug resistance in Candida albicans has become a noteworthy phenomenon due to the extensive use of antifungal agents and the development of biofilms. This study showed that budesonide potentiates the antifungal effect of fluconazole against fluconazole-resistant Candida albicans strains both in vitro and in vivo. In addition, our results demonstrated, for the first time, that the combination of fluconazole and budesonide can reverse the resistance of Candida albicans by inhibiting the function of drug transporters, reducing the formation of biofilms, promoting apoptosis and inhibiting the activity of extracellular phospholipases. This is the first study implicating the effects and mechanisms of budesonide against Candida albicans alone or in combination with fluconazole, which may ultimately lead to the identification of new potential antifungal targets.	[Li, Xiuyun] Shandong Univ, Sch Pharmaceut Sci, Jinan, Shandong, Peoples R China; [Yu, Cuixiang] Shandong Univ, Qianfoshan Hosp, Respirat Med, Jinan, Shandong, Peoples R China; [Huang, Xin; Sun, Shujuan] Shandong Univ, Qianfoshan Hosp, Dept Pharmaceut, Jinan, Shandong, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Sun, SJ (corresponding author), Shandong Univ, Qianfoshan Hosp, Dept Pharmaceut, Jinan, Shandong, Peoples R China.	sunshujuan888@163.com			Finance Department of Shandong Province of China [2015GSF118022, 2016GSF201187]	Finance Department of Shandong Province of China	This work was supported by 2015GSF118022 from Finance Department of Shandong Province of China (http://www.sdcz.gov.cn/) and 2016GSF201187 from Finance Department of Shandong Province of China (http://www.sdcz.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari F, 2015, PATHOGENS, V4, P457, DOI 10.3390/pathogens4030457; Albertson GD, 1996, ANTIMICROB AGENTS CH, V40, P2835, DOI 10.1128/AAC.40.12.2835; Angiolella L, 2008, ANTIMICROB AGENTS CH, V52, P927, DOI 10.1128/AAC.01223-07; [Anonymous], 2012, INT J MICROBIOL, DOI DOI 10.1155/2012/528521; Bink A, 2012, J MED MICROBIOL, V61, P813, DOI 10.1099/jmm.0.041020-0; Blondin MC, 2013, ENDOCR PRACT, V19, pE138, DOI 10.4158/EP13122.CR; Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236; Calabrese D, 2000, MICROBIOL-UK, V146, P2743, DOI 10.1099/00221287-146-11-2743; Cannon RD, 2007, MICROBIOL-SGM, V153, P3211, DOI 10.1099/mic.0.2007/010405-0; Mesa-Arango AC, 2013, MED MYCOL, V51, P461, DOI 10.3109/13693786.2012.737031; Clark TA, 2002, CURR OPIN INFECT DIS, V15, P569, DOI 10.1097/00001432-200212000-00003; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Cowen LE, 2006, EUKARYOT CELL, V5, P2184, DOI 10.1128/EC.00274-06; Dai BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045109; Dominic R M, 2007, Kathmandu Univ Med J (KUMJ), V5, P431; Epp E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000753; Fiori A, 2012, ANTIMICROB AGENTS CH, V56, P3785, DOI 10.1128/AAC.06017-11; Fukushima C, 2003, ANN ALLERG ASTHMA IM, V90, P646, DOI 10.1016/S1081-1206(10)61870-4; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; Golabek K, 2015, ACTA BIOCHIM POL, V62, P247, DOI 10.18388/abp.2014_940; Gourlay CW, 2006, MOL MICROBIOL, V62, P1515, DOI 10.1111/j.1365-2958.2006.05486.x; Gu W, 2016, ANTIMICROB AGENTS CH, V8; Guo QiongJie, 2015, China Tropical Medicine, V15, P920; Han S, 2013, ANTIMICROB AGENTS CH, V57, P1006, DOI 10.1128/AAC.01372-12; IBRAHIM AS, 1995, INFECT IMMUN, V63, P1993, DOI 10.1128/IAI.63.5.1993-1998.1995; Jones W, 2014, PHARMACOTHERAPY, V34, pE116, DOI 10.1002/phar.1432; Khan MAS, 2005, P NATL ACAD SCI USA, V102, P17326, DOI 10.1073/pnas.0508120102; Lee J, 2015, CURR MICROBIOL, V70, P383, DOI 10.1007/s00284-014-0734-1; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Li DD, 2013, BIOL PHARM BULL, V36, P1482, DOI 10.1248/bpb.b13-00270; Li H, 2015, J MED MICROBIOL, V64, P44, DOI 10.1099/jmm.0.081760-0; Li R, 2013, ANTIMICROB AGENTS CH, V57, P1832, DOI 10.1128/AAC.02295-12; Li XS, 2015, APPL ENVIRON MICROB, V81, P5048, DOI 10.1128/AEM.01313-15; Liu RH, 2015, J AM CHEM SOC, V137, P2183, DOI 10.1021/ja512567y; Liu SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150859; Madeo F, 2004, CURR OPIN MICROBIOL, V7, P655, DOI 10.1016/j.mib.2004.10.012; Mathe L, 2013, CURR GENET, V59, P251, DOI 10.1007/s00294-013-0400-3; Sardi JDO, 2014, REV IBEROAM MICOL, V31, P22, DOI 10.1016/j.riam.2013.09.014; Orsi CF, 2014, MICROB PATHOGENESIS, V69-70, P20, DOI 10.1016/j.micpath.2014.03.003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips AJ, 2006, P NATL ACAD SCI USA, V103, P726, DOI 10.1073/pnas.0506405103; Phillips AJ, 2003, P NATL ACAD SCI USA, V100, P14327, DOI 10.1073/pnas.2332326100; POLAK A, 1992, MYCOSES, V35, P9; PRICE MF, 1982, SABOURAUDIA, V20, P7; Ramage G, 2005, METH MOLEC MED, V118, P71; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; Sariguzel FM, 2015, J INFECT DEV COUNTR, V9, P857, DOI 10.3855/jidc.5359; Sarkar S, 2014, ANTIMICROB AGENTS CH, V58, P1183, DOI 10.1128/AAC.01745-13; Sprynski N, 2014, METHODS MOL BIOL, V1197, P3, DOI 10.1007/978-1-4939-1261-2_1; Sun S, 2008, ANTIMICROB AGENTS CH, V52, P409, DOI 10.1128/AAC.01070-07; Tortorano AM, 2006, INT J ANTIMICROB AG, V27, P359, DOI 10.1016/j.ijantimicag.2006.01.002; Wang TM, 2015, MICROB PATHOGENESIS, V87, P21, DOI 10.1016/j.micpath.2015.07.006; Youngsaye W, 2013, BEILSTEIN J ORG CHEM, V9, P1501, DOI 10.3762/bjoc.9.171; Yu LH, 2012, ANTIMICROB AGENTS CH, V56, P770, DOI 10.1128/AAC.05290-11; Zhang L, 2013, INT J NANOMED, V8, P4453, DOI 10.2147/IJN.S50312	56	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168936	10.1371/journal.pone.0168936	http://dx.doi.org/10.1371/journal.pone.0168936			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006028	Green Published, gold, Green Submitted			2022-12-26	WOS:000392843200111
J	Ho, O; Rogne, P; Edgren, T; Wolf-Watz, H; Login, FH; Wolf-Watz, M				Ho, Oanh; Rogne, Per; Edgren, Tomas; Wolf-Watz, Hans; Login, Frederic H.; Wolf-Watz, Magnus			Characterization of the Ruler Protein Interaction Interface on the Substrate Specificity Switch Protein in the Yersinia Type III Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gram-negative bacteria; nuclear magnetic resonance (NMR); protein conformation; secretion; type III secretion system (T3SS); YscI; YscP; YscU	NEEDLE LENGTH; BACTERIAL INJECTISOMES; SALMONELLA-TYPHIMURIUM; EXPORT APPARATUS; FLAGELLAR HOOK; YSCU; ENTEROCOLITICA; EXPRESSION; MECHANISM; COMPONENT	Many pathogenic Gram-negative bacteria use the type III secretion system (T3SS) to deliver effector proteins into eukaryotic host cells. In Yersinia, the switch to secretion of effector proteins is induced first after intimate contact between the bacterium and its eukaryotic target cell has been established, and the T3SS proteins YscP and YscU play a central role in this process. Here we identify the molecular details of the YscP binding site on YscU by means of nuclear magnetic resonance (NMR) spectroscopy. The binding interface is centered on the C-terminal domain of YscU. Disrupting the YscU-YscP interaction by introducing point mutations at the interaction interface significantly reduced the secretion of effector proteins and HeLa cell cytotoxicity. Interestingly, the binding of YscP to the slowly self-cleaving YscU variant P264A conferred significant protection against autoproteolysis. The YscP-mediated inhibition of YscU autoproteolysis suggests that the cleavage event may act as a timing switch in the regulation of early versus late T3SS substrates. We also show that YscU(C) binds to the inner rod protein YscI with a dissociation constant (K-d) of 3.8 m and with 1:1 stoichiometry. The significant similarity among different members of the YscU, YscP, and YscI families suggests that the protein-protein interactions discussed in this study are also relevant for other T3SS-containing Gram-negative bacteria.	[Ho, Oanh; Rogne, Per; Wolf-Watz, Magnus] Umea Univ, Chem Biol Ctr, Dept Chem, S-90187 Umea, Sweden; [Edgren, Tomas; Wolf-Watz, Hans; Login, Frederic H.] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Edgren, Tomas; Wolf-Watz, Hans; Login, Frederic H.] Umea Univ, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden	Umea University; Umea University; Umea University	Login, FH (corresponding author), Aarhus Univ, Dept Clin Med, Bartholins Alle 6,Bldg 1245, DK-8000 Aarhus C, Denmark.; Wolf-Watz, M (corresponding author), Umea Univ, Dept Chem, Bldg KBC,A3 Linnaeus Vag 10, S-90187 Umea, Sweden.	frederic.login@clin.au.dk; magnus.wolf-watz@umu.se		Rogne, Per/0000-0002-3687-9200	Swedish Research Council [2013-5954, 2015-02874]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Swedish Research Council Grants 2013-5954 (to M. W.-W.) and 2015-02874 (to H. W.-W). The authors declare that they have no conflicts of interest with the contents of this article.	Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x; Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x; Akopyan K, 2011, P NATL ACAD SCI USA, V108, P1639, DOI 10.1073/pnas.1013888108; Bergeron JRC, 2016, J BIOL CHEM, V291, P1676, DOI 10.1074/jbc.M115.684423; Bjornfot AC, 2009, J BACTERIOL, V191, P4259, DOI 10.1128/JB.01730-08; Botteaux A, 2008, MOL MICROBIOL, V70, P1515, DOI 10.1111/j.1365-2958.2008.06499.x; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diepold A, 2012, MOL MICROBIOL, V85, P878, DOI 10.1111/j.1365-2958.2012.08146.x; Diepold A, 2011, MOL MICROBIOL, V82, P502, DOI 10.1111/j.1365-2958.2011.07830.x; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Feria JVM, 2015, MBIO, V6, DOI 10.1128/mBio.01459-15; Ferris HU, 2005, J BIOL CHEM, V280, P41236, DOI 10.1074/jbc.M509438200; Frost S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049349; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Helgstrand M, 2000, J BIOMOL NMR, V18, P329, DOI 10.1023/A:1026729404698; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; KUTSUKAKE K, 1994, J BACTERIOL, V176, P7625, DOI 10.1128/JB.176.24.7625-7629.1994; Lefebre MD, 2014, P NATL ACAD SCI USA, V111, P817, DOI 10.1073/pnas.1319698111; Login FH, 2015, J BIOL CHEM, V290, P26282, DOI 10.1074/jbc.M114.633677; Lountos GT, 2009, PROTEIN SCI, V18, P467, DOI 10.1002/pro.56; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Makishima S, 2001, SCIENCE, V291, P2411, DOI 10.1126/science.1058366; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Mizuno S, 2011, J MOL BIOL, V409, P558, DOI 10.1016/j.jmb.2011.04.008; Mota LJ, 2005, SCIENCE, V307, P1278, DOI 10.1126/science.1107679; PORTNOY DA, 1984, INFECT IMMUN, V43, P108, DOI 10.1128/IAI.43.1.108-114.1984; Radics J, 2014, NAT STRUCT MOL BIOL, V21, P82, DOI 10.1038/nsmb.2722; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; ROSQVIST R, 1990, MOL MICROBIOL, V4, P657, DOI 10.1111/j.1365-2958.1990.tb00635.x; Sal-Man N, 2012, BIOCHEM J, V442, P119, DOI 10.1042/BJ20111620; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sorg I, 2007, EMBO J, V26, P3015, DOI 10.1038/sj.emboj.7601731; Stainier I, 2000, MOL MICROBIOL, V37, P1005, DOI 10.1046/j.1365-2958.2000.02026.x; Sukhan A, 2003, J BACTERIOL, V185, P3480, DOI 10.1128/JB.185.11.3480-3483.2003; Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x; Weise CF, 2014, BIOPHYS J, V107, P1950, DOI 10.1016/j.bpj.2014.09.005; Wiesand U, 2009, J MOL BIOL, V385, P854, DOI 10.1016/j.jmb.2008.10.034; Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08; Yip CK, 2006, TRENDS BIOCHEM SCI, V31, P223, DOI 10.1016/j.tibs.2006.02.005; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554; Zhong DL, 2012, J BIOL CHEM, V287, P25303, DOI 10.1074/jbc.M112.381574	48	19	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3299	3311		10.1074/jbc.M116.770255	http://dx.doi.org/10.1074/jbc.M116.770255			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28039361	Green Published, hybrid			2022-12-26	WOS:000395538800021
J	Goldberg, AA; Nkengfac, B; Sanchez, AMJ; Moroz, N; Qureshi, ST; Koromilas, AE; Wang, S; Burelle, Y; Hussain, SN; Kristof, AS				Goldberg, Alexander A.; Nkengfac, Bernard; Sanchez, Anthony M. J.; Moroz, Nikolay; Qureshi, Salman T.; Koromilas, Antonis E.; Wang, Shuo; Burelle, Yan; Hussain, Sabah N.; Kristof, Arnold S.			Regulation of ULK1 Expression and Autophagy by STAT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; autophagy; mammalian target of rapamycin (mTOR); proteolysis; signal transducers and activators of transcription 1 (STAT1)	TRANSCRIPTION FACTORS; DEACETYLASE ACTIVITY; SIGNAL-TRANSDUCTION; MAMMALIAN TARGET; GENE-EXPRESSION; INTERFERON; MTOR; PATHWAYS; GAMMA; ACETYLATION	Autophagy involves the lysosomal degradation of cytoplasmic contents for regeneration of anabolic substrates during nutritional or inflammatory stress. Its initiation occurs rapidly after inactivation of the protein kinase mammalian target of rapamycin (mTOR) (or mechanistic target of rapamycin), leading to dephosphorylation of Unc-51-like kinase 1 (ULK1) and autophagosome formation. Recent studies indicate that mTOR can, in parallel, regulate the activity of stress transcription factors, including signal transducer and activator of transcription-1 (STAT1). The current study addresses the role of STAT1 as a transcriptional suppressor of autophagy genes and autophagic activity. We show that STAT1-deficient human fibrosarcoma cells exhibited enhanced autophagic flux as well as its induction by pharmacological inhibition of mTOR. Consistent with enhanced autophagy initiation, ULK1 mRNA and protein levels were increased in STAT1-deficient cells. By chromatin immunoprecipitation, STAT1 bound a putative regulatory sequence in the ULK1 5-flanking region, the mutation of which increased ULK1 promoter activity, and rendered it unresponsive to mTOR inhibition. Consistent with an anti-apoptotic effect of autophagy, rapamycin-induced apoptosis and cytotoxicity were blocked in STAT1-deficient cells but restored in cells simultaneously exposed to the autophagy inhibitor ammonium chloride. In vivo, skeletal muscle ULK1 mRNA and protein levels as well as autophagic flux were significantly enhanced in STAT1-deficient mice. These results demonstrate a novel mechanism by which STAT1 negatively regulates ULK1 expression and autophagy.	[Goldberg, Alexander A.; Nkengfac, Bernard; Sanchez, Anthony M. J.; Moroz, Nikolay; Qureshi, Salman T.; Hussain, Sabah N.; Kristof, Arnold S.] McGill Univ, Ctr Hlth, Dept Crit Care, Montreal, PQ H4A 3J1, Canada; [Goldberg, Alexander A.; Nkengfac, Bernard; Sanchez, Anthony M. J.; Moroz, Nikolay; Qureshi, Salman T.; Hussain, Sabah N.; Kristof, Arnold S.] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H4A 3J1, Canada; [Goldberg, Alexander A.; Nkengfac, Bernard; Sanchez, Anthony M. J.; Moroz, Nikolay; Qureshi, Salman T.; Hussain, Sabah N.; Kristof, Arnold S.] McGill Univ, Meakins Christie Labs, Montreal, PQ H4A 3J1, Canada; [Koromilas, Antonis E.; Wang, Shuo] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Burelle, Yan] Univ Montreal, Fac Pharm, Montreal, PQ H3T 1J4, Canada	McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; Universite de Montreal	Kristof, AS (corresponding author), McGill Univ, Ctr Hlth, Res Inst, 1001 Decarie Blvd,EM3-2219, Montreal, PQ H4A 3J1, Canada.	arnold.kristof@mcgill.ca	Burelle, Yan/AAF-8104-2021; Hussain, Sabah/ABC-5315-2021; Sanchez, Anthony MJ/N-8092-2019	Burelle, Yan/0000-0001-9379-146X; Sanchez, Anthony MJ/0000-0003-3054-6349; , Alexander/0000-0002-7471-8598	NCI; National Institutes of Health Grant [R01CA125436-01A1]; Canada Research Chairs [950-213853]; Fonds de Recherche du Quebec-Sante [31052]; Canadian Institutes of Health Research; Meakins Christie Post-doctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA125436] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chairs(Canada Research ChairsCGIAR); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Meakins Christie Post-doctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grant R01CA125436-01A1 (to A. S. K.). This work was also supported by Canada Research Chairs (950-213853; to A. S. K.), Fonds de Recherche du Quebec-Sante (31052; to A. S. K.), Canadian Institutes of Health Research (to S. N. H., S. T. Q., and Y. B.), and a Meakins Christie Post-doctoral Fellowship (to B. N. and A. M. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Bin L, 2008, TRENDS PHARMACOL SCI, V29, P505, DOI 10.1016/j.tips.2008.07.008; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Copetti T, 2009, MOL CELL BIOL, V29, P2594, DOI 10.1128/MCB.01396-08; Culig Zoran, 2013, Front Biosci (Schol Ed), V5, P277; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Fielhaber J. A., 2010, AM J RESP CRIT CARE, V181, pA3542; Fielhaber JA, 2012, J BIOL CHEM, V287, P14325, DOI 10.1074/jbc.M111.246785; Fielhaber JA, 2009, J BIOL CHEM, V284, P24341, DOI 10.1074/jbc.M109.033530; Hoefer J, 2012, AM J PATHOL, V180, P2097, DOI 10.1016/j.ajpath.2012.01.026; Hussain SNA, 2010, AM J RESP CRIT CARE, V182, P1377, DOI 10.1164/rccm.201002-0234OC; Ilangumaran S, 2004, SEMIN IMMUNOL, V16, P351, DOI 10.1016/j.smim.2004.08.015; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klampfer L, 2004, J BIOL CHEM, V279, P30358, DOI 10.1074/jbc.M401359200; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Kramer OH, 2006, GENE DEV, V20, P473, DOI 10.1101/gad.364306; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Kusama Y, 2009, APOPTOSIS, V14, P1165, DOI 10.1007/s10495-009-0390-2; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu B, 2001, P NATL ACAD SCI USA, V98, P3203, DOI 10.1073/pnas.051489598; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; McCormick J, 2012, J CELL MOL MED, V16, P386, DOI 10.1111/j.1582-4934.2011.01323.x; Meier JA, 2014, SEMIN IMMUNOL, V26, P20, DOI 10.1016/j.smim.2013.12.005; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mofarrahi M, 2013, AUTOPHAGY, V9, P1604, DOI 10.4161/auto.25955; Mofarrahi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047265; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Pietrocola F, 2013, SEMIN CANCER BIOL, V23, P310, DOI 10.1016/j.semcancer.2013.05.008; Pitroda SP, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-68; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Saleiro D, 2015, CELL REP, V11, P605, DOI 10.1016/j.celrep.2015.03.056; Sanchez AMJ, 2014, CELL MOL LIFE SCI, V71, P1657, DOI 10.1007/s00018-013-1513-z; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Seo YK, 2011, CELL METAB, V13, P367, DOI 10.1016/j.cmet.2011.03.005; Settembre C, 2011, AUTOPHAGY, V7, P1379, DOI 10.4161/auto.7.11.17166; Sibinga NES, 1999, J BIOL CHEM, V274, P12139, DOI 10.1074/jbc.274.17.12139; Srinivasan P, 2011, IMMUNOLOGY, V132, P209, DOI 10.1111/j.1365-2567.2010.03355.x; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhu S, 2013, AUTOPHAGY, V9, P317, DOI 10.4161/auto.22923; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	55	17	19	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1899	1909		10.1074/jbc.M116.771584	http://dx.doi.org/10.1074/jbc.M116.771584			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28011640	hybrid, Green Published			2022-12-26	WOS:000395515600029
J	Angeles-Martinez, J; Posadas-Sanchez, R; Llorente, L; Alvarez-Leon, E; Ramirez-Bello, J; Villarreal-Molina, T; Lima, G; Cardoso-Saldana, G; Rodriguez-Perez, JM; Perez-Hernandez, N; Fragoso, JM; Posadas-Romero, C; Vargas-Alarcon, G				Angeles-Martinez, Javier; Posadas-Sanchez, Rosalinda; Llorente, Luis; Alvarez-Leon, Edith; Ramirez-Bello, Julian; Villarreal-Molina, Teresa; Lima, Guadalupe; Cardoso-Saldana, Guillermo; Manuel Rodriguez-Perez, Jose; Perez-Hernandez, Nonanzit; Manuel Fragoso, Jose; Posadas-Romero, Carlos; Vargas-Alarcon, Gilberto			The rs7044343 Polymorphism of the Interleukin 33 Gene Is Associated with Decreased Risk of Developing Premature Coronary Artery Disease and Central Obesity, and Could Be Involved in Regulating the Production of IL-33	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ATHEROSCLEROSIS; MICE; PATHWAY; MEXICO; INFLAMMATION; POPULATIONS; FREQUENCIES; DEFICIENCY; DIVERSITY	Aim The effect of interleukin 33 (IL-33) in the inflammatory process generates significant interest in the potential significance of IL-33 as a biomarker for coronary artery disease (CAD). Here, our objective was to analyze whether IL-33 gene polymorphisms are associated with premature CAD in a case-control association study. Methods Four IL-33 polymorphisms (rs7848215, rs16924144, rs16924159 and rs7044343) were genotyped by 5' exonuclease TaqMan assays in 1095 patients with premature CAD and 1118 controls. Results The rs7044343 T allele was significantly associated with a diminished risk of premature CAD (OR = 0.81, 95% CI: 0.69-0.97, P-dom = 0.020; OR = 0.85, 95% CI: 0.75-0.96, P-add = 0.019) and central obesity (OR = 0.74, 95% CI: 0.58-0.93, P-dom = 0.0007), respectively. When patients were divided into groups with and without type 2 diabetes mellitus (T2DM), the rs7044343 T allele was associated with a reduced risk of premature CAD in patients without ( OR = 0.85, 95% CI: 0.73-0.99, P-add = 0.038) and with T2DM ( OR = 0.61, 95% CI: 0.38-0.97, P-dom = 0.039; OR = 0.69, 95% CI: 0.49-0.97, P-add = 0.035). In order to establish the functional effect of the rs7044343 polymorphism, the production of IL-33 was determined in monocytes of selected individuals. Monocytes from individuals with rs7044343 CC genotype produced higher levels of IL-33 than monocytes from individuals with other genotypes. Conclusion The results suggest that the IL-33 rs7044343 T allele could be a susceptibility marker for premature CAD and central obesity. The rs7044343 polymorphism could be involved in regulating the production of IL-33.	[Angeles-Martinez, Javier; Alvarez-Leon, Edith; Manuel Rodriguez-Perez, Jose; Perez-Hernandez, Nonanzit; Manuel Fragoso, Jose; Vargas-Alarcon, Gilberto] Inst Nacl Cardiol Ignacio Chavez, Dept Mol Biol, Mexico City, DF, Mexico; [Posadas-Sanchez, Rosalinda; Cardoso-Saldana, Guillermo; Posadas-Romero, Carlos] Inst Nacl Cardiol Ignacio Chavez, Dept Endocrinol, Mexico City, DF, Mexico; [Llorente, Luis; Lima, Guadalupe] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico; [Ramirez-Bello, Julian] Hosp Juarez Mexico, Histocompatibil Lab, Res Unit, Mexico City, DF, Mexico; [Villarreal-Molina, Teresa] INMEGEN, Inst Nacl Med Genom, Cardiovasc Genom Lab, Mexico City, DF, Mexico	National Institute of Cardiology - Mexico; National Institute of Cardiology - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Medicina Genomica	Vargas-Alarcon, G (corresponding author), Inst Nacl Cardiol Ignacio Chavez, Dept Mol Biol, Mexico City, DF, Mexico.	gvargas63@yahoo.com	Llorente, Luis/GQP-7202-2022; Ramírez-Bello, Julian/AAR-1308-2020	Llorente, Luis/0000-0002-3464-3747; Ramírez-Bello, Julian/0000-0002-4153-9315; Vargas-Alarcon, Gilberto/0000-0001-7916-5163; Angeles Martinez, Javier/0000-0001-5405-0482; Cardoso, Guillermo/0000-0001-9525-1731; VILLARREAL MOLINA, TERESA/0000-0003-4450-7690	Consejo Nacional de Ciencia y Tecnologia [156911]; Fundacion Gonzalo Rio Arronte, Mexico City, Mexico; Consejo Nacional de Ciencia y Tecnologia (CONACyT)	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Gonzalo Rio Arronte, Mexico City, Mexico; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants from the Consejo Nacional de Ciencia y Tecnologia (projects 156911) and Fundacion Gonzalo Rio Arronte, Mexico City, Mexico. Javier Angeles-Martinez was supported by a fellowship from the Consejo Nacional de Ciencia y Tecnologia (CONACyT). All of the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CIRCULATION, V106, P3134; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Buono C, 2005, P NATL ACAD SCI USA, V102, P1596, DOI 10.1073/pnas.0409015102; Chinetti-Gbaguidi G, 2011, CURR OPIN LIPIDOL, V22, P365, DOI 10.1097/MOL.0b013e32834a77b4; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Davenport P, 2003, AM J PATHOL, V163, P1117, DOI 10.1016/S0002-9440(10)63471-2; Garcia-Moll X, 2005, REV ESP CARDIOL, V58, P615, DOI 10.1157/13076412; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Juarez-Cedillo T, 2008, FORENSIC SCI INT-GEN, V2, pE37, DOI 10.1016/j.fsigen.2007.08.017; Koca SS, 2016, RHEUMATOL INT, V36, P579, DOI 10.1007/s00296-015-3417-8; KVIST H, 1988, AM J CLIN NUTR, V48, P1351, DOI 10.1093/ajcn/48.6.1351; Latiano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062144; Li C, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4554; LISKER R, 1988, AM J PHYS ANTHROPOL, V76, P331, DOI 10.1002/ajpa.1330760307; LISKER R, 1986, AM J PHYS ANTHROPOL, V71, P203, DOI 10.1002/ajpa.1330710207; LISKER R, 1990, HUM BIOL, V62, P791; LONGO R, 1993, INVEST RADIOL, V28, P297, DOI 10.1097/00004424-199304000-00006; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MAUTNER GC, 1994, RADIOLOGY, V192, P619, DOI 10.1148/radiology.192.3.8058924; McLaren JE, 2010, J IMMUNOL, V185, P1222, DOI 10.4049/jimmunol.1000520; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Savenije OE, 2014, J ALLERGY CLIN IMMUN, V134, P170, DOI 10.1016/j.jaci.2013.12.1080; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785; Tu X, 2013, AM J HUM GENET, V93, P652, DOI 10.1016/j.ajhg.2013.08.009; Villarreal-Molina T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049285; Westerterp M, 2013, CIRC RES, V112, P1456, DOI 10.1161/CIRCRESAHA.113.301086; Whitman SC, 2002, CIRC RES, V90, pE34, DOI 10.1161/hh0202.105292; Wu FQ, 2014, INT J MOL SCI, V15, P23227, DOI 10.3390/ijms151223227; Yu JT, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.003; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhou XH, 2000, CIRCULATION, V102, P2919	35	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168828	10.1371/journal.pone.0168828	http://dx.doi.org/10.1371/journal.pone.0168828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045954	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300055
J	Dotti, S; Lombardo, T; Villa, R; Cacciamali, A; Zanotti, C; Andreani, NA; Cinotti, S; Ferrari, M				Dotti, Silvia; Lombardo, Tina; Villa, Riccardo; Cacciamali, Andrea; Zanotti, Cinzia; Andreani, Nadia Andrea; Cinotti, Stefano; Ferrari, Maura			Transformation and Tumorigenicity Testing of Simian Cell Lines and Evaluation of Poliovirus Replication	PLOS ONE			English	Article							SERUM-FREE MEDIUM; VERO CELLS; GROWTH CHARACTERISTICS; CULTURE; VIRUS; VACCINE; STRAINS; AGAR	The key role of cell cultures in different scientific fields is worldwide recognized, both as in vitro research models alternative to laboratory animals and substrates for biological production. However, many safety concerns rise from the use of animal/human cell lines that may be tumorigenic, leading to potential adverse contaminations in cell-derived biologicals. In order to evaluate the suitability of 13 different cell lines for Poliovirus vaccine production, safety and quality, in vitro/in vivo tumorigenicity and Poliovirus propagation properties were evaluated. Our results revealed that non-human primate cell lines CYNOM-K1, FRhK-4, 4MBr-5 and 4647 are free of tumorigenic features and represent highly susceptible substrates for attenuated Sabin Poliovirus strains. In particular, FRhK-4 and 4647 cell lines are characterized by a higher in vitro replication, resulting indicated for the use in large-scale production field.	[Dotti, Silvia; Lombardo, Tina; Villa, Riccardo; Cacciamali, Andrea; Zanotti, Cinzia; Andreani, Nadia Andrea; Cinotti, Stefano; Ferrari, Maura] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy	IZS Lombardia e Emilia	Dotti, S (corresponding author), Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy.	silvia.dotti@izsler.it	CACCIAMALI, ANDREA/AAE-1297-2021; cacciamali, andrea/AAB-7575-2019	Dotti, Silvia/0000-0002-2303-2027; Villa, Riccardo/0000-0001-8385-800X; cacciamali, andrea/0000-0002-3854-8085; Andreani, Nadia Andrea/0000-0003-0330-9874	Ministry of Health project, MINSALPOLIOVIRUS	Ministry of Health project, MINSALPOLIOVIRUS	This work was supported by the Ministry of Health project, MINSALPOLIOVIRUS.	[Anonymous], 1998, CPMPICH29495 EMA; [Anonymous], 2014, EUROPEAN PHARMACOPOE, P582; BODIAN D, 1949, AM J HYG, V49, P234, DOI 10.1093/oxfordjournals.aje.a119273; Butler M, 2000, BIOTECHNOL PROGR, V16, P854, DOI 10.1021/bp000110+; CAPUTO JL, 1979, IN VITRO CELL DEV B, V15, P222; CONTRERAS G, 1985, IN VITRO CELL DEV B, V21, P649, DOI 10.1007/BF02623298; DAHLING DR, 1986, APPL ENVIRON MICROB, V51, P790, DOI 10.1128/AEM.51.4.790-812.1986; ENDERS JF, 1949, SCIENCE, V109, P85, DOI 10.1126/science.109.2822.85; Ferrari M, 2003, J VIROL METHODS, V107, P205, DOI 10.1016/S0166-0934(02)00236-7; Food and Drug Administration (FDA), 2010, GUID IND IND; Frazzati-Gallina NM, 2001, J BIOTECHNOL, V92, P67, DOI 10.1016/S0168-1656(01)00362-5; Furesz J, 1989, Dev Biol Stand, V70, P233; Huber I, 2011, EUROSURVEILLANCE, V16, P17; HULL RN, 1962, J EXP MED, V115, P903, DOI 10.1084/jem.115.5.903; JOHNSON JB, 1982, DEV BIOL STAND, V50, P27; KANDA Y, 1959, J EXP MED, V109, P9, DOI 10.1084/jem.109.1.9; Landsteiner K, 1908, WEIN KLIN WSCHR, V21, P1930; LEVENBOOK IS, 1984, J BIOL STAND, V12, P391, DOI 10.1016/S0092-1157(84)80063-3; Li WY, 2016, MAT SCI ENG C-MATER, V58, P863, DOI 10.1016/j.msec.2015.09.045; MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0; Manohar M, 2008, BIOLOGICALS, V36, P65, DOI 10.1016/j.biologicals.2007.06.002; Melnick JL, 1996, CLIN MICROBIOL REV, V9, P293, DOI 10.1128/CMR.9.3.293; Milanesi E, 2003, IN VITRO CELL DEV-AN, V39, P124; MONTAGNON BJ, 1981, DEV BIOL STAND, V47, P55; MONTAGNON BJ, 1984, REV INFECT DIS, V6, pS341; Paillet C, 2009, VACCINE, V27, P6464, DOI 10.1016/j.vaccine.2009.06.020; Pearce JMS, 2004, J NEUROL NEUROSUR PS, V75, P1552, DOI 10.1136/jnnp.2003.028530; RACANIELLO VR, 1981, P NATL ACAD SCI-BIOL, V78, P4887, DOI 10.1073/pnas.78.8.4887; REED L. J., 1938, AMER JOUR HYG, V27, P493; van den Brand JMA, 2010, EMERG INFECT DIS, V16, P1745, DOI 10.3201/eid1611.100845; VANWEZEL AL, 1967, NATURE, V216, P64, DOI 10.1038/216064a0; Wallace RE, IN VITRO, V8, P333; World Health Organization, WHO TECHN REP SER, V878; Zhang DL, 2001, CELL BIOL INT, V25, P997, DOI 10.1006/cbir.2001.0745	34	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169391	10.1371/journal.pone.0169391	http://dx.doi.org/10.1371/journal.pone.0169391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046048	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000391612300180
J	Goldberg, S; Ollila, HM; Lin, L; Sharifi, H; Rico, T; Andlauer, O; Aran, A; Bloomrosen, E; Faraco, J; Fang, H; Mignot, E				Goldberg, Shmuel; Ollila, Hanna Maria; Lin, Ling; Sharifi, Husham; Rico, Tom; Andlauer, Olivier; Aran, Adi; Bloomrosen, Efrat; Faraco, Juliette; Fang, Han; Mignot, Emmanuel			Analysis of Hypoxic and Hypercapnic Ventilatory Response in Healthy Volunteers	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; CENTRAL HYPOVENTILATION SYNDROME; LONG-TERM FACILITATION; INTERMITTENT HYPOXIA; GENDER-DIFFERENCES; OXYGEN-TRANSPORT; NEURAL-CONTROL; LOOP GAIN; SEX; RATS	Introduction A previous study has suggested that the Human Leukocyte Antigen (HLA) allele DQB1*06:02 affects hypoxic ventilatory response (HVR) but not hypercapnic ventilatory response (HCVR) in an Asian population. The current study evaluated the relationship in Caucasians and Asians. In addition we assessed whether gender or polymorphisms in genes participating in the control of breathing affect HVR and HCVR. Methods Are-breathing system was used to measure HVR and HCVR in 551 young adults (56.8% Caucasians, 30% Asians). HLA-DQB1*06:02 and tagged polymorphisms and coding variants in genes participating in breathing (PHOX2B, GPR4 and TASK2/KCNK5) were analyzed. The associations between HVR/HCVR and HLA-DQB1*06:02, genetic polymorphisms, and gender were evaluated using ANOVA or frequentist association testing with SNPTEST. Results HVR and gender are strongly correlated. HCVR and gender are not. Mean HVR in women was 0.276 +/- 0.168 (liter/minute/%SpO2) compared to 0.429 +/- 0.266 (liter/minute/%Sp02) in men, p<0.001 (55.4% higher HVR in men). Women had lower baseline minute ventilation (8.08 +/- 2.36 l/m vs. 10.00 +/- 3.43I/m, p<0.001), higher Sp02 (98.0 +/- 1.3% vs. 96.6 +/- 1.7%, p<0.001), and lower EtCO2 (4.65 +/- 0.68% vs. 4.82 +/- 1.02%, p = 0.025). One hundred and two (18.5%) of the participants had HLA-DQB1 *06:02. No association was seen between HLA-DQB1 *06:02 and HVR or HCVR. Genetic analysis revealed point wise, uncorrected significant associations between two TASK2/KCNK5 variants (rs2815118 and rs150380 866) and HCVR. Conclusions This is the largest study to date reporting the relationship between gender and HVR/HCVR and the first study assessing the association between genetic polymorphisms in humans and HVR/HCVR. The data suggest that gender has a large effect on hypoxic breathing response.	[Goldberg, Shmuel] Hebrew Univ Jerusalem, Shaare Zedek Med Ctr, Sch Med, Pediat Pulmonol Unit, Jerusalem, Israel; [Ollila, Hanna Maria; Lin, Ling; Sharifi, Husham; Rico, Tom; Faraco, Juliette; Mignot, Emmanuel] Stanford Univ, Ctr Sleep Sci, Palo Alto, CA 94304 USA; [Andlauer, Olivier] Newham Ctr Mental Hlth, East London NHS Fdn Trust, London, England; [Aran, Adi] Hebrew Univ Jerusalem, Shaare Zedek Med Ctr, Sch Med, Neuropediatr Unit, Jerusalem, Israel; [Bloomrosen, Efrat] Hebrew Univ & Clalit Hlth Serv, Dept Family Med, Jerusalem, Israel; [Fang, Han] Peking Univ, Peoples Hosp, Dept Pulm Med, Beijing, Peoples R China	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Stanford University; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Clalit Health Services; Peking University	Mignot, E (corresponding author), Stanford Univ, Ctr Sleep Sci, Palo Alto, CA 94304 USA.	mignot@stanford.edu	Ollila, Hanna M/I-8552-2017; Ollila, Hanna M/GQA-6308-2022; fang, han/GSN-6404-2022	Ollila, Hanna M/0000-0002-5302-6429; Ollila, Hanna M/0000-0002-5302-6429; Sharifi, Husham/0000-0002-2331-3961; Aran, Adi/0000-0001-9460-4689	Feldman Family foundation; Sigrid Juselius Foundation; Paivikki and Sakari Sohlberg Foundation; Orion Farmos Research Foundation; Finnish Cultural Foundation; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Feldman Family foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Paivikki and Sakari Sohlberg Foundation; Orion Farmos Research Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The study was primarily funded by gifts to the Stanford Sleep Center and by grants from the Feldman Family foundation to Efrat Bloomrosen and Shmuel Goldberg. Sigrid Juselius Foundation, Paivikki and Sakari Sohlberg Foundation, Orion Farmos Research Foundation and the Finnish Cultural Foundation for HMO also contributed funding. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN ML, 1986, J APPL PHYSIOL, V60, P1894, DOI 10.1152/jappl.1986.60.6.1894; Baekey DM, 2009, ILAR J, V50, P248, DOI 10.1093/ilar.50.3.248; Bairam A, 2009, RESP PHYSIOL NEUROBI, V165, P261, DOI 10.1016/j.resp.2008.11.002; Behan M, 2003, RESP PHYSIOL NEUROBI, V136, P249, DOI 10.1016/S1569-9048(03)00086-7; CHAPMAN KR, 1987, J GERONTOL, V42, P202, DOI 10.1093/geronj/42.2.202; Deacon NL, 2015, SLEEP MED REV, V22, P3, DOI 10.1016/j.smrv.2014.10.003; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Edge D, 2015, ADV EXP MED BIOL, V860, P335, DOI 10.1007/978-3-319-18440-1_38; Edwards BA, 2014, J PHYSIOL-LONDON, V592, P4523, DOI 10.1113/jphysiol.2014.277210; Edwards BA, 2012, J PHYSIOL-LONDON, V590, P1199, DOI 10.1113/jphysiol.2011.223925; Fournier S, 2007, J PHYSIOL-LONDON, V584, P951, DOI 10.1113/jphysiol.2007.141655; Guyenet PG, 2015, NEURON, V87, P946, DOI 10.1016/j.neuron.2015.08.001; Han F, 2010, EUR RESPIR J, V36, P577, DOI 10.1183/09031936.00174609; HIRSHMAN CA, 1975, J APPL PHYSIOL, V38, P1095, DOI 10.1152/jappl.1975.38.6.1095; Hodges MR, 2002, J APPL PHYSIOL, V93, P974, DOI 10.1152/japplphysiol.00019.2002; HORNBEIN TF, 1961, J NEUROPHYSIOL, V24, P561, DOI 10.1152/jn.1961.24.6.561; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; HUMPELER E, 1989, MECH AGEING DEV, V47, P229, DOI 10.1016/0047-6374(89)90035-3; Jordan AS, 2000, J APPL PHYSIOL, V88, P3, DOI 10.1152/jappl.2000.88.1.3; Kumar NN, 2015, SCIENCE, V348, P1255, DOI 10.1126/science.aaa0922; LAHIRI S, 1975, RESP PHYSIOL, V24, P249, DOI 10.1016/0034-5687(75)90017-1; MacNutt M. J., 1985, J APPL PHYSIOL, V112, P2012; MATSUKI K, 1992, LANCET, V339, P1052, DOI 10.1016/0140-6736(92)90571-J; Moss M, 2002, CRIT CARE MED, V30, P1679, DOI 10.1097/00003246-200208000-00001; ORENSTEIN A, 1988, ANN PLAS SURG, V20, P419, DOI 10.1097/00000637-198805000-00004; PATRICK JM, 1972, RESP PHYSIOL, V16, P337, DOI 10.1016/0034-5687(72)90063-1; Ramanantsoa N, 2011, J NEUROSCI, V31, P12880, DOI 10.1523/JNEUROSCI.1721-11.2011; READ DJC, 1967, J APPL PHYSIOL, V23, P53, DOI 10.1152/jappl.1967.23.1.53; REBUCK AS, 1973, J APPL PHYSIOL, V35, P173, DOI 10.1152/jappl.1973.35.2.173; Reybrouck T, 1999, CHEST, V115, P788, DOI 10.1378/chest.115.3.788; Ricart A, 2008, BRIT J SPORT MED, V42, P620, DOI 10.1136/bjsm.2007.038653; Ruffault PL, 2015, ELIFE, V4, DOI 10.7554/eLife.07051; Sajkov D, 1997, J APPL PHYSIOL, V83, P599, DOI 10.1152/jappl.1997.83.2.599; SCHLENKER EH, 1992, J APPL PHYSIOL, V72, P2255, DOI 10.1152/jappl.1992.72.6.2255; SCHOENE RB, 1981, J APPL PHYSIOL, V50, P1300, DOI 10.1152/jappl.1981.50.6.1300; Sin DD, 2000, CHEST, V117, P454, DOI 10.1378/chest.117.2.454; SKATRUD JB, 1978, J APPL PHYSIOL, V44, P939, DOI 10.1152/jappl.1978.44.6.939; Soliz J, 2009, AM J PHYSIOL-REG I, V296, pR1837, DOI 10.1152/ajpregu.90967.2008; SUTTON FD, 1975, ANN INTERN MED, V83, P476, DOI 10.7326/0003-4819-83-4-476; Syed Z, 2013, J APPL PHYSIOL, V114, P52, DOI 10.1152/japplphysiol.00985.2012; Terblanche J, 2004, PHYSIOL MEAS, V25, P1189, DOI 10.1088/0967-3334/25/5/009; van Klaveren RJ, 1998, RESP PHYSIOL, V113, P157, DOI 10.1016/S0034-5687(98)00057-7; Weese-Mayer DE, 2003, AM J MED GENET A, V123A, P267, DOI 10.1002/ajmg.a.20527; Weese-Mayer DE, 2010, AM J RESP CRIT CARE, V181, P626, DOI 10.1164/rccm.200807-1069ST; Weil JV, 2003, RESP PHYSIOL NEUROBI, V135, P239, DOI 10.1016/S1569-9048(03)00048-X; WHITE DP, 1983, J APPL PHYSIOL, V54, P874, DOI 10.1152/jappl.1983.54.4.874	46	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168930	10.1371/journal.pone.0168930	http://dx.doi.org/10.1371/journal.pone.0168930			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045995	Green Submitted, gold, Green Published			2022-12-26	WOS:000391612300073
J	Tewahido, D; Berhane, Y				Tewahido, Dagmawit; Berhane, Yemane			Self-Care Practices among Diabetes Patients in Addis Ababa: A Qualitative Study	PLOS ONE			English	Article							MANAGEMENT; MELLITUS	Background Self-care practices that include self-monitoring of blood sugar level, diet management, physical exercise, adherence to medications, and foot care are the cornerstones of diabetes management. However, very little is known about self-care in developing countries where the prevalence of diabetes is increasing. Objective The objective of this study was to describe self-care practices among individuals with type II diabetes in Addis Ababa, Ethiopia. Methods A qualitative method was used to gather data from type II diabetes patients. Patients were recruited from the outpatient diabetes clinics of two public hospitals in Addis Ababa. Data were collected using a semi structured interview guide. A thematic analysis approach was used to process the data. Results Overall self-care practices were not adequate. Most patients reported irregular self-monitoring of blood sugar. Dietary and physical exercise recommendations were inadequately practiced by most of the participants. Most patients better adhered to medication prescriptions. Patients generally lack proper information/knowledge regarding the importance of self-care and how it should be implemented. Based on reported behavior we identified three main categories of patients; which are those 'endeavor to be compliant', 'confused' and 'negligent'. Conclusion Diabetes patients largely depend on prescribed medications to control their blood sugar level. The importance of proper self-care practices for effective management of diabetes is not adequately emphasized in diabetes care centers and patients lack sufficient knowledge for proper self-care.	[Tewahido, Dagmawit; Berhane, Yemane] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia	Addis Continental Institute of Public Health	Tewahido, D (corresponding author), Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia.	dagmawit.tewahido@gmail.com	Berhane, Yemane/ABB-8154-2020	Berhane, Yemane/0000-0002-2527-1339				Abebe SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060081; Ahmad NS, 2013, PATIENT PREFER ADHER, V7, P525, DOI 10.2147/PPA.S44698; Al-Maskari F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052857; [Anonymous], 2013, IDF DIABETES ATLAS; [Anonymous], 2014, UN GEN ASSEMBLY NONC; Ayele K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035515; Bains SS, 2010, DIABETES TECHNOLOGY, V12; Berhe KK, 2012, INT J PHARM SCI RES, V3, P4219, DOI 10.13040/IJPSR.0975-8232.3(11).4421-24; Beverly EA, 2012, DIABETES CARE, V35, P1466, DOI [10.2337/dc11-2422, 10.2337/dc12-0661]; Collins MM, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-6; Ganiyu AB, AFR J PRM HLTH CARE, V5, P457; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Kulzer B, 2013, HLTH QUALITY LIFE OU, V11; Lekoubou A, 2010, INT J ENV RES PUB HE, V7, P353, DOI 10.3390/ijerph7020353; Mathew R, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-122; Mshunqane N, 2012, AFR J PRIM HEALTH CA, V4, DOI 10.4102/phcfm.v4i1.392; Nshisso LD, 2012, DIABETES METAB SYND, V6, P36, DOI 10.1016/j.dsx.2012.05.005; Osborn CY, 2010, DIABETES TECHNOLOGY, V12; Paul GM, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-45; Ritholz Marilyn D, BARRIERS FACILITATOR; Shrivastava SR, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-14; Solomon Tamiru, 2010, ETHIOP J HLTH SCI, V20	22	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169062	10.1371/journal.pone.0169062	http://dx.doi.org/10.1371/journal.pone.0169062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045992	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300104
J	Jancic, S; Frisvad, JC; Kocev, D; Gostincar, C; Dzeroski, S; Gunde-Cimerman, N				Jancic, Saso; Frisvad, Jens C.; Kocev, Dragi; Gostincar, Cene; Dzeroski, Saso; Gunde-Cimerman, Nina			Production of Secondary Metabolites in Extreme Environments: Food- and Airborne Wallemia spp. Produce Toxic Metabolites at Hypersaline Conditions	PLOS ONE			English	Article							HORTAEA-WERNECKII; GENUS WALLEMIA; WATER ACTIVITY; BIOSYNTHESIS; FUNGUS; SEBI; GENOME; GROWTH; LIFE; DEREPLICATION	The food- and airborne fungal genus Wallemia comprises seven xerophilic and halophilic species: W. sebi, W. mellicola, W. canadensis, W. tropicalis, W. muriae, W. hederae and W. ichthyophaga. All listed species are adapted to low water activity and can contaminate food preserved with high amounts of salt or sugar. In relation to food safety, the effect of high salt and sugar concentrations on the production of secondary metabolites by this toxigenic fungus was investigated. The secondary metabolite profiles of 30 strains of the listed species were examined using general growth media, known to support the production of secondary metabolites, supplemented with different concentrations of NaCl, glucose and MgCl2. In more than two hundred extracts approximately one hundred different compounds were detected using high-performance liquid chromatography-diode array detection (HPLC-DAD). Although the genome data analysis of W. mellicola (previously W. sebi sensu lato) and W. ichthyophaga revealed a low number of secondary metabolites clusters, a substantial number of secondary metabolites were detected at different conditions. Machine learning analysis of the obtained dataset showed that NaCl has higher influence on the production of secondary metabolites than other tested solutes. Mass spectrometric analysis of selected extracts revealed that NaCl in the medium affects the production of some compounds with substantial biological activities (wallimidione, walleminol, walleminone, UCA 1064-A and UCA 1064-B). In particular an increase in NaCl concentration from 5% to 15% in the growth media increased the production of the toxic metabolites wallimidione, walleminol and walleminone.	[Jancic, Saso; Gostincar, Cene; Gunde-Cimerman, Nina] Univ Ljubljana, Biotech Fac, Dept Biol, Jamnikarjeva 101, Ljubljana, Slovenia; [Frisvad, Jens C.] Tech Univ Denmark, Dept Syst Biol, Bldg 221, Lyngby, Denmark; [Kocev, Dragi; Dzeroski, Saso] Jozef Stefan Inst, Dept Knowledge Technol, Jamova Cesta 39, Ljubljana, Slovenia; [Gunde-Cimerman, Nina] Ctr Excellence Integrated Approaches Chem & Biol, Jamova 39, Ljubljana, Slovenia	University of Ljubljana; Technical University of Denmark; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Gunde-Cimerman, N (corresponding author), Univ Ljubljana, Biotech Fac, Dept Biol, Jamnikarjeva 101, Ljubljana, Slovenia.; Gunde-Cimerman, N (corresponding author), Ctr Excellence Integrated Approaches Chem & Biol, Jamova 39, Ljubljana, Slovenia.	nina.gunde-cimerman@bf.uni-lj.si	Frisvad, Jens C/K-2818-2017; Dzeroski, Saso/ABH-2758-2021	Frisvad, Jens C/0000-0002-0573-4340; Dzeroski, Saso/0000-0003-2363-712X; Gostincar, Cene/0000-0002-0149-3674; Kocev, Dragi/0000-0003-0687-0878; Gunde-Cimerman, Nina/0000-0002-9464-3263	Slovenian Research Agency; Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (Cipkebip) [OP13.1.1.2.02.0005]; European Regional Development Fund; Slovenian Ministry of Higher Education, Science and Technology; European Commission through the project MAESTRA Learning from Massive, Incompletely annotated, and Structured Data [ICT-2013-612944]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (Cipkebip); European Regional Development Fund(European Commission); Slovenian Ministry of Higher Education, Science and Technology; European Commission through the project MAESTRA Learning from Massive, Incompletely annotated, and Structured Data	The authors acknowledge the financial support from the Slovenian Research Agency to the Infrastructural Centre Mycosmo and for providing a Young Researcher Grant to SJ. The study was partly financed through the Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (Cipkebip, OP13.1.1.2.02.0005), which is financed by a European Regional Development Fund (85% share of financing) and by the Slovenian Ministry of Higher Education, Science and Technology (15% share of financing). The authors would like to acknowledge the support of the European Commission through the project MAESTRA Learning from Massive, Incompletely annotated, and Structured Data (Grant number ICT-2013-612944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the financial support from the Slovenian Research Agency to the Infrastructural Centre Mycosmo and for providing a Young Researcher Grant to S. J. The study was partly financed through the Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (Cipkebip, OP13.1.1.2.02.0005), which is financed by a European Regional Development Fund (85% share of financing) and by the Slovenian Ministry of Higher Education, Science and Technology (15% share of financing). The authors would like to acknowledge the support of the European Commission through the project MAESTRA-Learning from Massive, Incompletely annotated, and Structured Data (Grant number ICT-2013-612944). Special thanks go to Kristian F. Nielsen for critically reading the manuscript and performing amss spectroscopy analyses and to Ellen Kirstine Lyhne for technical support.	Adrio JL, 2003, INT MICROBIOL, V6, P191, DOI 10.1007/s10123-003-0133-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BADAR Y, 1973, J CHEM SOC PERK T 1, P1416, DOI 10.1039/p19730001416; BELL AA, 1986, ANNU REV PHYTOPATHOL, V24, P411, DOI 10.1146/annurev.py.24.090186.002211; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Botic T, 2012, FEMS MICROBIOL LETT, V326, P40, DOI 10.1111/j.1574-6968.2011.02428.x; Brakhage AA, 2013, NAT REV MICROBIOL, V11, P21, DOI 10.1038/nrmicro2916; Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Cannon P.F., 2004, BIODIVERSITY FUNGI I, P217, DOI DOI 10.1016/B978-012509551-8/50014-3; CHAMBERLIN JW, 1974, J ANTIBIOT, V27, P992, DOI 10.7164/antibiotics.27.992; Chen H, 2006, GENE DEV, V20, P1150, DOI 10.1101/gad.1411806; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; De Hoog S, 2005, CELL ORIG LIFE EXTRE, V9, P371; Desroches TC, 2014, INDOOR AIR, V24, P533, DOI 10.1111/ina.12100; Frank M, 1999, TETRAHEDRON LETT, V40, P133, DOI 10.1016/S0040-4039(98)80039-7; Frisvad JC, 2005, CELL ORIG LIFE EXTRE, V9, P425; Frisvad JC, 2004, STUD MYCOL, P201; Frisvad JC, 2008, MYCOL RES, V112, P231, DOI 10.1016/j.mycres.2007.08.018; Frisvad Jens C, 2012, Methods Mol Biol, V944, P47, DOI 10.1007/978-1-62703-122-6_3; Gallo A, 2013, TOXINS, V5, P717, DOI 10.3390/toxins5040717; Gostincar C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00390; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gunde-Cimerman N, 2000, FEMS MICROBIOL ECOL, V32, P235; Hallsworth JE, 2007, ENVIRON MICROBIOL, V9, P801, DOI 10.1111/j.1462-2920.2006.01212.x; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Hong SB, 2005, MYCOLOGIA, V97, P1316, DOI 10.3852/mycologia.97.6.1316; Inglis DO, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-91; ITO M, 1981, J CHEM SOC PERK T 1, P3255, DOI 10.1039/p19810003255; Jancic S, 2016, FUNGAL DIVERS, V76, P97, DOI 10.1007/s13225-015-0333-x; Jancic S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125933; JAVOR BJ, 1984, APPL ENVIRON MICROB, V48, P352, DOI 10.1128/AEM.48.2.352-360.1984; Kejzar A, 2013, FUNGAL BIOL-UK, V117, P368, DOI 10.1016/j.funbio.2013.03.006; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Kildgaard S, 2014, MAR DRUGS, V12, P3681, DOI 10.3390/md12063681; Klitgaard A, 2014, ANAL BIOANAL CHEM, V406, P1933, DOI 10.1007/s00216-013-7582-x; Kocev D, 2013, ECOL INFORM, V18, P79, DOI 10.1016/j.ecoinf.2013.06.003; Kocev D, 2013, PATTERN RECOGN, V46, P817, DOI 10.1016/j.patcog.2012.09.023; Kocev D, 2009, ECOL MODEL, V220, P1159, DOI 10.1016/j.ecolmodel.2009.01.037; Kogej T, 2007, MICROBIOL-SGM, V153, P4261, DOI 10.1099/mic.0.2007/010751-0; Kogej T, 2006, ENVIRON CHEM, V3, P105, DOI 10.1071/EN06012; Kralj Kuncic M, 2013, FUNGAL BIOL-UK, V117, P466, DOI 10.1016/j.funbio.2013.04.003; Kuncic MK, 2010, APPL ENVIRON MICROB, V76, P329, DOI 10.1128/AEM.02318-09; Leong SLL, 2015, ENVIRON MICROBIOL, V17, P496, DOI 10.1111/1462-2920.12596; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Moss MO, 1998, J APPL MICROBIOL, V84, p62S, DOI 10.1046/j.1365-2672.1998.0840s162S.x; Nguyen HDT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120894; Nielsen KF, 2009, ANAL BIOANAL CHEM, V395, P1225, DOI 10.1007/s00216-009-3081-5; O'Callaghan J, 2013, INT J FOOD MICROBIOL, V161, P172, DOI 10.1016/j.ijfoodmicro.2012.12.014; Oren A, 2002, FEMS MICROBIOL ECOL, V39, P1, DOI 10.1111/j.1574-6941.2002.tb00900.x; Oren Aharon, 2005, Saline Syst, V1, P2, DOI 10.1186/1746-1448-1-2; Padamsee M, 2012, FUNGAL GENET BIOL, V49, P217, DOI 10.1016/j.fgb.2012.01.007; Patlewicz G, 2008, SAR QSAR ENVIRON RES, V19, P495, DOI 10.1080/10629360802083871; Peng XP, 2011, ARCH PHARM RES, V34, P907, DOI 10.1007/s12272-011-0607-0; Pitt JI, 2009, FUNGI AND FOOD SPOILAGE, THIRD EDITION, P3, DOI 10.1007/978-0-387-92207-2_2; Plemenitas A, 2008, STUD MYCOL, P67, DOI 10.3114/sim.2008.61.06; Raper KB, 1949, MANUAL PENICILLIA; Roncal T, 2002, EUKARYOT CELL, V1, P823, DOI 10.1128/EC.1.5.823-829.2002; Roncal T, 2002, TETRAHEDRON LETT, V43, P6799, DOI 10.1016/S0040-4039(02)01493-4; Samson R., 2004, INTRO FOOD AIRBORNE; Schmidt-Heydt M, 2015, INT J FOOD MICROBIOL, V192, P1, DOI 10.1016/j.ijfoodmicro.2014.09.008; Schmidt-Heydt M, 2011, TRENDS FOOD SCI TECH, V22, pS39, DOI 10.1016/j.tifs.2011.02.010; Sepcic K, 2011, MAR DRUGS, V9, P43, DOI 10.3390/md9010043; Smedsgaard J, 1997, J CHROMATOGR A, V760, P264, DOI 10.1016/S0021-9673(96)00803-5; Sonjak S, 2005, FEMS MICROBIOL ECOL, V53, P51, DOI 10.1016/j.femsec.2004.10.014; Struyf J, 2006, LECT NOTES COMPUT SC, V3933, P222; TAKAHASHI I, 1993, J ANTIBIOT, V46, P1312, DOI 10.7164/antibiotics.46.1312; Turner WB., 1971, FUNGAL METABOLITES; WHEELER KA, 1988, T BRIT MYCOL SOC, V90, P365, DOI 10.1016/S0007-1536(88)80144-X; Williams JP, 2009, ENVIRON MICROBIOL, V11, P3292, DOI 10.1111/j.1462-2920.2009.02079.x; WOOD GM, 1990, FOOD ADDIT CONTAM, V7, P69, DOI 10.1080/02652039009373822; Zajc J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00708; Zajc J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-617; Zak J. C., 2004, BIODIVERSITY FUNGI I, P303, DOI DOI 10.1016/B978-012509551-8/50017-9; Zalar P, 2005, ANTON LEEUW INT J G, V87, P311, DOI 10.1007/s10482-004-6783-x	75	23	26	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169116	10.1371/journal.pone.0169116	http://dx.doi.org/10.1371/journal.pone.0169116			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036382	Green Submitted, Green Published, gold			2022-12-26	WOS:000391229300057
J	Li, CM; Miao, YA; Lingeman, RG; Hickey, RJ; Malkas, LH				Li, Caroline M.; Miao, Yunan; Lingeman, Robert G.; Hickey, Robert J.; Malkas, Linda H.			Partial Purification of a Megadalton DNA Replication Complex by Free Flow Electrophoresis	PLOS ONE			English	Article							PROTEIN COMPLEXES; ENZYME COMPLEX; IDENTIFICATION; SYNTHESOME; SEPARATION; RESOLUTION; FACTORIES; PURINOSOME; KINASES; ANTIGEN	We describe a gentle and rapid method to purify the intact multiprotein DNA replication complex using free flow electrophoresis (FFE). In particular, we applied FFE to purify the human cell DNA synthesome, which is a multiprotein complex that is fully competent to carry-out all phases of the DNA replication process in vitro using a plasmid containing the simian virus 40 (SV40) origin of DNA replication and the viral large tumor antigen (T-antigen) protein. The isolated native DNA synthesome can be of use in studying the mechanism by which mammalian DNA replication is carried-out and how anti-cancer drugs disrupt the DNA replication or repair process. Partially purified extracts from HeLa cells were fractionated in a native, liquid based separation by FFE. Dot blot analysis showed co-elution of many proteins identified as part of the DNA synthesome, including proliferating cell nuclear antigen (PCNA), DNA topoisomerase I (topo I), DNA polymerase delta (Pol delta), DNA polymerase epsilon (Pol e), replication protein A (RPA) and replication factor C (RFC). Previously identified DNA synthesome proteins co-eluted with T-antigen dependent and SV40 origin-specific DNA polymerase activity at the same FFE fractions. Native gels show a multiprotein PCNA containing complex migrating with an apparent relative mobility in the megadalton range. When PCNA containing bands were excised from the native gel, mass spectrometric sequencing analysis identified 23 known DNA synthesome associated proteins or protein subunits.	[Li, Caroline M.; Lingeman, Robert G.; Malkas, Linda H.] City Hope Natl Med Ctr, Dept Mol & Cellular Biol, Beckman Res Inst, Duarte, CA USA; [Miao, Yunan; Hickey, Robert J.] City Hope Natl Med Ctr, Dept Mol Med, Beckman Res Inst, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Li, CM (corresponding author), City Hope Natl Med Ctr, Dept Mol & Cellular Biol, Beckman Res Inst, Duarte, CA USA.	cali@coh.org			National Cancer Institute of the National Institutes of Health [RO1 CA121289]; St. Baldrick's Foundation; ANNA fund; Beckman Research Institute; Harvey L. Miller Family Foundation; Knight Owl Foundation; Cancer Center support grant from the National Cancer Institute of the National Institutes of Health [P30CA033572]	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); St. Baldrick's Foundation; ANNA fund; Beckman Research Institute; Harvey L. Miller Family Foundation; Knight Owl Foundation; Cancer Center support grant from the National Cancer Institute of the National Institutes of Health	This work was supported by grants from the National Cancer Institute of the National Institutes of Health (RO1 CA121289), St. Baldrick's Foundation (www.stbaldricks.org) and the ANNA fund (www.annafund.com) to LHM as well as institutional start-up funds from the Beckman Research Institute to RJH, and an award from the Harvey L. Miller Family Foundation and the Knight Owl Foundation to RJH to help defray part of the cost of the instrumentation used for this project. Research reported in this publication also included work performed in the Translational Biomarker Discovery Core and instrumentation from the Mass Spectrometry and Proteomics Core that was supported by a Cancer Center support grant from the National Cancer Institute of the National Institutes of Health made to the City of Hope under award number P30CA033572. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; APPLEGREN N, 1995, J CELL BIOCHEM, V59, P91, DOI 10.1002/jcb.240590111; Bauer J, 1998, J DISPER SCI TECHNOL, V19, P937, DOI 10.1080/01932699808913224; Bulutoglu B, 2016, ACS CHEM BIOL, V11, P2847, DOI 10.1021/acschembio.6b00523; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Coll JM, 1996, ONCOL RES, V8, P435; Coll JM, 1996, CANCER CHEMOTH PHARM, V39, P97, DOI 10.1007/s002800050543; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Cseresnyes Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-88; de Michele R, 2016, J PROTEOME RES, V15, P900, DOI 10.1021/acs.jproteome.5b00876; Eichacker LA, 2015, METHODS MOL BIOL, V1295, P415, DOI 10.1007/978-1-4939-2550-6_29; Frouin I, 2003, EMBO REP, V4, P666, DOI 10.1038/sj.embor.embor886; Henneke G, 2003, EMBO REP, V4, P252, DOI 10.1038/sj.embor.embor774; HOZAK P, 1994, J CELL SCI, V107, P2191; HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I; Jiang HY, 2002, J CELL BIOCHEM, V85, P762, DOI 10.1002/jcb.10182; Kohlheyer D, 2008, ELECTROPHORESIS, V29, P977, DOI 10.1002/elps.200700725; Kyoung M, 2015, BIOCHEMISTRY-US, V54, P870, DOI 10.1021/bi501480d; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Lin SK, 1997, LEUKEMIA RES, V21, P501, DOI 10.1016/S0145-2126(96)00103-8; MALKAS LH, 1990, BIOCHEMISTRY-US, V29, P6362, DOI 10.1021/bi00479a004; Malkas LH, 1996, METHOD ENZYMOL, V275, P133; Malkas LH, 1998, J CELL BIOCHEM, P18; Malkas LH, 1996, SV40 REPLICON MODEL, P149; Malmstrom J, 2006, J PROTEOME RES, V5, P2241, DOI 10.1021/pr0600632; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Parsons HT, 2014, METHODS MOL BIOL, V1072, P527, DOI 10.1007/978-1-62703-631-3_35; Philimonenko AA, 2006, HISTOCHEM CELL BIOL, V125, P103, DOI 10.1007/s00418-005-0090-0; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; RUDOLPH J, 1995, BIOCHEMISTRY-US, V34, P2241, DOI 10.1021/bi00007a019; Sandoval JA, 2006, J PEDIATR SURG, V41, P266, DOI 10.1016/j.jpedsurg.2005.10.046; Sandoval JA, 2005, J PEDIATR SURG, V40, P1070, DOI 10.1016/j.jpedsurg.2005.03.054; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Shao J, 2012, ELECTROPHORESIS, V33, P2065, DOI 10.1002/elps.201200169; Simbulan-Rosenthal CM, 2011, METHODS MOL BIOL, V780, P165, DOI 10.1007/978-1-61779-270-0_11; Smith S, 2014, DNA REPLICATION MAMM; Smith S.J., 2016, ENCY CELL BIOL, VVolume 3, P458; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Symeonidou IE, 2012, FEBS LETT, V586, P2803, DOI 10.1016/j.febslet.2012.07.042; Tom TD, 1996, J CELL BIOCHEM, V63, P259, DOI 10.1002/(SICI)1097-4644(19961201)63:3<259::AID-JCB1>3.0.CO;2-W; TUBO RA, 1987, J BIOL CHEM, V262, P5857; Velot C, 1997, BIOCHEMISTRY-US, V36, P14271, DOI 10.1021/bi972011j; Vertino PM, 2002, CELL CYCLE, V1, P416, DOI 10.4161/cc.1.6.270; Weber G, 1998, ELECTROPHORESIS, V19, P1104, DOI 10.1002/elps.1150190709; Wildgruber R, 2014, PROTEOMICS, V14, P629, DOI 10.1002/pmic.201300253; Williamson MP, 2010, BIOCHEM SOC T, V38, P875, DOI 10.1042/BST0380875; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Woo RA, 2003, CELL CYCLE, V2, P316, DOI 10.4161/cc.2.4.468; WU Y, 1994, J CELL BIOCHEM, V54, P32, DOI 10.1002/jcb.240540105; Zhao H, 2013, CHEM COMMUN, V49, P4444, DOI 10.1039/c3cc41437j	53	2	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169259	10.1371/journal.pone.0169259	http://dx.doi.org/10.1371/journal.pone.0169259			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036377	gold, Green Published, Green Submitted			2022-12-26	WOS:000391229300068
J	Sun, Y; Wu, LH; Li, XY				Sun, Yan; Wu, Liang-huan; Li, Xiao-yan			Experimental Determination of Silicon Isotope Fractionation in Rice	PLOS ONE			English	Article							GAS MASS-SPECTROMETRY; HIGHER-PLANTS; TRANSPORTER; DIATOMS; RATIOS; GROWTH; CYCLE; RESPIRATION; ADSORPTION; PHYTOLITHS	Analyzing variations in silicon (Si) isotopes can help elucidate the biogeochemical Si cycle and Si accumulation processes of higher plants. Importantly, the composition of Si isotopes in higher plants has yet to be studied comprehensively and our knowledge of the distribution of Si isotopes in higher plants lags behind that of Si isotopes in marine organisms, such as diatoms. In the present study, we investigated the isotope fractionation that occurs during the uptake and transport of Si in rice, using a series of hydroponic experiments with different external concentrations of Si. We found that an active mechanism was responsible for the majority of Si uptake and transport at lower Si levels and that the uptake of Si by rice roots was significantly suppressed by both low temperature and metabolic inhibitors. In addition, light Si isotopes (Si-28) entered roots more readily than heavy Si isotopes (Si-30) when the active mechanism was inhibited. Therefore, we conclude that biologically mediated isotope fractionation occurs during the uptake of Si by rice roots. In addition, both active and passive Si uptake components co-exist in rice, and the fractionation effect is enhanced when more Si is absorbed by plants.	[Sun, Yan; Wu, Liang-huan; Li, Xiao-yan] Zhejiang Univ, Coll Environm & Resource Sci, Minist Educ, Key Lab Environm Remediat & Ecosyst Hlth, Hangzhou, Zhejiang, Peoples R China; [Sun, Yan; Wu, Liang-huan; Li, Xiao-yan] Zhejiang Univ, Coll Environm & Resource Sci, Zhejiang Prov Key Lab Subtrop Soil & Plant Nutr, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wu, LH (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Minist Educ, Key Lab Environm Remediat & Ecosyst Hlth, Hangzhou, Zhejiang, Peoples R China.; Wu, LH (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Zhejiang Prov Key Lab Subtrop Soil & Plant Nutr, Hangzhou, Zhejiang, Peoples R China.	finm@zju.edu.cn	li, xiaofeng/GXF-9442-2022; li, xiao/GSN-6181-2022		National Natural Science Foundation of China [31071850, 31172032, 31572194]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grants: 31071850, 31172032, and 31572194). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre A, 1997, GEOCHIM COSMOCHIM AC, V61, P677, DOI 10.1016/S0016-7037(97)00001-X; Alleman LY, 2005, J GREAT LAKES RES, V31, P509, DOI 10.1016/S0380-1330(05)70280-X; Bolou-Bi EB, 2010, GEOCHIM COSMOCHIM AC, V74, P2523, DOI 10.1016/j.gca.2010.02.010; Cardinal D, 2007, MAR CHEM, V106, P46, DOI 10.1016/j.marchem.2006.04.006; Conley DJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001894; Conrad CF, 2007, GEOCHIM COSMOCHIM AC, V71, P531, DOI 10.1016/j.gca.2006.10.001; COPLEN TB, 1973, GEOCHIM COSMOCHIM AC, V37, P2295, DOI 10.1016/0016-7037(73)90105-1; DANSGAARD W, 1964, TELLUS, V16, P436; De La Rocha CL, 1998, NATURE, V395, P680, DOI 10.1038/27174; De La Rocha CL, 1997, GEOCHIM COSMOCHIM AC, V61, P5051, DOI 10.1016/S0016-7037(97)00300-1; Ding T., 1996, SILICON ISOTOPE GEOC, P125; Ding TP, 2008, GEOCHIM COSMOCHIM AC, V72, P5600, DOI 10.1016/j.gca.2008.09.006; Ding TP, 2008, GEOCHIM COSMOCHIM AC, V72, P1381, DOI 10.1016/j.gca.2008.01.008; Ding TP, 2005, GEOCHIM COSMOCHIM AC, V69, pA551; Ding TP, 2003, GEOCHIM COSMOCHIM AC, V67, pA79; Ding TP, 2005, CHEM GEOL, V218, P41, DOI 10.1016/j.chemgeo.2005.01.018; Doering K, 2016, GEOCHIM COSMOCHIM AC, V177, P30, DOI 10.1016/j.gca.2015.12.029; DOUTHITT CB, 1982, GEOCHIM COSMOCHIM AC, V46, P1449, DOI 10.1016/0016-7037(82)90278-2; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Gonfiantini R, 1997, INT J MASS SPECTROM, V163, P207, DOI 10.1016/S0168-1176(97)00018-9; Gonfiantini R, 1997, INT J MASS SPECTROM, V171, P231, DOI 10.1016/S0168-1176(97)00129-8; Guo FS, 2015, SCI BULL, V60, P591, DOI 10.1007/s11434-015-0729-8; INANAGA S, 1995, SOIL SCI PLANT NUTR, V41, P111, DOI 10.1080/00380768.1995.10419564; Jasinski M, 2003, PLANT PHYSIOL, V131, P1169, DOI 10.1104/pp.102.014720; Jill N. S., 2013, GEOCHIM COSMOCHIM AC, V104, P300; KENNEDY RA, 1983, PLANT PHYSIOL, V72, P787, DOI 10.1104/pp.72.3.787; Koster JR, 2009, RAPID COMMUN MASS SP, V23, P2398, DOI 10.1002/rcm.3971; Li ZM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00529; Li ZM, 2013, PLANT SOIL, V370, P615, DOI 10.1007/s11104-013-1661-9; Liang YC, 2005, NEW PHYTOL, V167, P797, DOI 10.1111/j.1469-8137.2005.01463.x; Liang YC, 2006, NEW PHYTOL, V172, P63, DOI 10.1111/j.1469-8137.2006.01797.x; Liu JZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19711; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Ma JF, 2007, NATURE, V448, P209, DOI 10.1038/nature05964; Marschner H., 1995, MINERAL NUTR HIGHER, P7; Martin J. H., 2008, J QUATERNARY SCI, V23, P331; Nie XZ, 1997, PLANT PHYSIOL, V114, P835, DOI 10.1104/pp.114.3.835; Opfergelt S, 2006, PLANT SOIL, V285, P333, DOI 10.1007/s11104-006-9019-1; Opfergelt S, 2006, J GEOCHEM EXPLOR, V88, P224, DOI 10.1016/j.gexplo.2005.08.044; Pajchel L, 2011, J PHARMACEUT BIOMED, V56, P846, DOI 10.1016/j.jpba.2011.06.024; Patwardhan SV, 2005, CHEM COMMUN, P1113, DOI 10.1039/b416926c; Proost J, 2008, MICROCHEM J, V89, P48, DOI 10.1016/j.microc.2007.11.004; Raven JA, 2003, NEW PHYTOL, V158, P419, DOI 10.1046/j.1469-8137.2003.00778.x; Sun L, 2008, PLANT SOIL, V304, P291, DOI 10.1007/s11104-008-9552-1; Tilburey GE, 2007, J PHYS CHEM B, V111, P4630, DOI 10.1021/jp068539s; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; van den Boorn SHJM, 2006, J ANAL ATOM SPECTROM, V21, P734, DOI 10.1039/b600933f; Varela DE, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002140; Weiss DJ, 2005, NEW PHYTOL, V165, P703, DOI 10.1111/j.1469-8137.2004.01307.x; Wetzel F, 2014, GEOCHIM COSMOCHIM AC, V131, P128, DOI 10.1016/j.gca.2014.01.028; Xiong ZF, 2015, PALEOCEANOGRAPHY, V30, P803, DOI 10.1002/2015PA002793; Yamaji N, 2008, PLANT CELL, V20, P1381, DOI 10.1105/tpc.108.059311; Yamaji N, 2015, P NATL ACAD SCI USA, V112, P11401, DOI 10.1073/pnas.1508987112; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; Ziegler K, 2005, GEOCHIM COSMOCHIM AC, V69, P4597, DOI 10.1016/j.gca.2005.05.008	55	12	12	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168970	10.1371/journal.pone.0168970	http://dx.doi.org/10.1371/journal.pone.0168970			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036355	Green Published, Green Submitted, gold			2022-12-26	WOS:000391229300042
J	Suzuki, A; Saeki, T; Ikuji, H; Uchida, C; Uchida, T				Suzuki, Atsuko; Saeki, Toshiyuki; Ikuji, Hiroko; Uchida, Chiyoko; Uchida, Takafumi			Brown Algae Polyphenol, a Prolyl Isomerase Pin1 Inhibitor, Prevents Obesity by Inhibiting the Differentiation of Stem Cells into Adipocytes	PLOS ONE			English	Article							NATURAL-PRODUCTS; ADIPOSE-CELL; TRANSLOCATION; PATHOGENESIS; PROTEIN	Background While screening for an inhibitor of the peptidyl prolyl cis/trans isomerase, Pin1, we came across a brown algae polyphenol that blocks the differentiation of fibroblasts into adipocytes. However, its effectiveness on the accumulation of fat in the body has never been studied. Methodology/Principal Findings Oral administration of brown algae polyphenol to mice fed with a high fat diet, suppressed the increase in fat volume to a level observed in mice fed with a normal diet. We speculate that Pin1 might be required for the differentiation of stem cell to adipocytes. We established wild type (WT) and Pin1(-/-) ( Pin1-KO) adipose-derived mesenchymal stem cell (ASC) lines and found that WT ASCs differentiate to adipocytes but Pin1-KO ASCs do not. Conclusion and Significance Oral administration of brown algae polyphenol, a Pin1 inhibitor, reduced fat buildup in mice. We showed that Pin1 is required for the differentiation of stem cells into adipocytes. We propose that oral intake of brown algae polyphenol is useful for the treatment of obesity.	[Suzuki, Atsuko; Saeki, Toshiyuki; Ikuji, Hiroko; Uchida, Takafumi] Tohoku Univ, Dept Mol Cell Sci, Grad Sch Agr Sci, Mol Enzymol,Aoba Ku, 1-1 Amamiya, Sendai, Miyagi, Japan; [Uchida, Chiyoko] Fukushima Univ, Dept Human Dev & Culture, Kanayagawa 1, Fukushima, Fukushima, Japan	Tohoku University; Fukushima University	Uchida, T (corresponding author), Tohoku Univ, Dept Mol Cell Sci, Grad Sch Agr Sci, Mol Enzymol,Aoba Ku, 1-1 Amamiya, Sendai, Miyagi, Japan.	takafumi.uchida.c8@tohoku.ac.jp		Uchida, Takafumi/0000-0003-3665-4906	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26252064, 26660287]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry [25028A]; Grants-in-Aid for Scientific Research [26252064] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research Kiban (A) 26252064, Grant-in-aid for Challenging Exploratory Research 26660287 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry Grant 25028A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Komine A, 2012, BIOCHEM BIOPH RES CO, V426, P468, DOI 10.1016/j.bbrc.2012.08.094; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Mori T., 2010, CURR ENZYME INHIB, V6, P46; Mori T, 2014, BIOSCI BIOTECH BIOCH, V78, P832, DOI 10.1080/09168451.2014.905189; Mori T, 2011, BIOCHEM BIOPH RES CO, V406, P439, DOI 10.1016/j.bbrc.2011.02.066; Mori T, 2009, J BIOMOL SCREEN, V14, P419, DOI 10.1177/1087057109333979; Nakatsu Y, 2015, J BIOL CHEM, V290, P24255, DOI 10.1074/jbc.M115.658559; Nakatsu Y, 2012, J BIOL CHEM, V287, P44526, DOI 10.1074/jbc.M112.397133; Nakatsu Y, 2011, J BIOL CHEM, V286, P20812, DOI 10.1074/jbc.M110.206904; Nakatsu Y, 2010, J BIOL CHEM, V285, P33018, DOI 10.1074/jbc.M110.137836; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nishi M, 2011, J BIOL CHEM, V286, P11593, DOI 10.1074/jbc.M110.187989; Peng XH, 2015, BIOCHEM BIOPH RES CO, V462, P245, DOI 10.1016/j.bbrc.2015.04.124; Takahashi K, 2008, CELL MOL LIFE SCI, V65, P359, DOI 10.1007/s00018-007-7270-0; Takahashi K, 2014, CURR DRUG TARGETS, V15, P973, DOI 10.2174/1389450115666140903110724; Uchida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031823; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Yamashita-Yotsu M, 2013, MAR DRUGS, V11, P165, DOI [10.3390/md11010165, DOI 10.3390/MD11010165]	22	6	6	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168830	10.1371/journal.pone.0168830	http://dx.doi.org/10.1371/journal.pone.0168830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036348	gold, Green Submitted, Green Published			2022-12-26	WOS:000391229300033
J	Sand, H; Eklund, A; Zimmermann, B; Wikenros, C; Wabakken, P				Sand, Hakan; Eklund, Ann; Zimmermann, Barbara; Wikenros, Camilla; Wabakken, Petter			Prey Selection of Scandinavian Wolves: Single Large or Several Small?	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; GLACIER NATIONAL-PARK; WHITE-TAILED DEER; CANIS-LUPUS; KILL RATES; FUNCTIONAL-RESPONSE; WOLF PREDATION; SNOW DEPTH; ROE DEER; GROUP-SIZE	Research on large predator-prey interactions are often limited to the predators' primary prey, with the potential for prey switching in systems with multiple ungulate species rarely investigated. We evaluated wolf (Canis lupus) prey selection at two different spatial scales, i.e., inter- and intra-territorial, using data from 409 ungulate wolf-kills in an expanding wolf population in Scandinavia. This expansion includes a change from a one-prey into a two prey system with variable densities of one large-sized ungulate; moose (Aloes aloes) and one small-sized ungulate; roe deer (Capreolus capreolus). Among wolf territories, the proportion of roe deer in wolf kills was related to both pack size and roe deer density, but not to moose density. Pairs of wolves killed a higher proportion of roe deer than did packs, and wolves switched to kill more roe deer as their density increased above a 1:1 ratio in relation to the availability of the two species. At the intra-territorial level, wolves again responded to changes in roe deer density in their prey selection whereas we found no effect of snow depth, time during winter, or other predator-related factors on the wolves' choice to kill moose or roe deer. Moose population density was only weakly related to intra-territorial prey selection. Our results show that the functional response of wolves on moose, the species hitherto considered as the main prey, was strongly dependent on the density of a smaller, alternative, ungulate prey. The impact of wolf predation on the prey species community is therefore likely to change with the composition of the multi-prey species community along with the geographical expansion of the wolf population.	[Sand, Hakan; Eklund, Ann; Wikenros, Camilla] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden; [Zimmermann, Barbara; Wabakken, Petter] Hedmark Univ Appl Sci, Fac Appl Ecol & Agr Sci, Evenstad, Koppang, Norway	Swedish University of Agricultural Sciences	Sand, H (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden.	hakan.sand@slu.se	Zimmermann, Barbara/AAA-2631-2019	Zimmermann, Barbara/0000-0001-5133-9379; Sand, Hakan/0000-0002-2646-022X	Swedish Environmental Protection Agency; Norwegian Environment Agency; Norwegian Research Council; Norwegian Institute for Nature Research; Hedmark University of Applied Sciences; Office of Environmental Affairs in Hedmark County; Swedish Association for Hunting and Wildlife Management; Worldwide Fund for Nature (Sweden); Swedish University of Agricultural Sciences; Carl Tryggers Foundation; Marie-Claires Cronstedts Foundation; Swedish Carnivore Association	Swedish Environmental Protection Agency; Norwegian Environment Agency; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Institute for Nature Research(Bioforsk); Hedmark University of Applied Sciences; Office of Environmental Affairs in Hedmark County; Swedish Association for Hunting and Wildlife Management; Worldwide Fund for Nature (Sweden); Swedish University of Agricultural Sciences; Carl Tryggers Foundation; Marie-Claires Cronstedts Foundation; Swedish Carnivore Association	The Scandinavian wolf projects (SKANDULV) have been primarily funded by the Swedish Environmental Protection Agency the Norwegian Environment Agency, the Norwegian Research Council, the Norwegian Institute for Nature Research, Hedmark University of Applied Sciences, the Office of Environmental Affairs in Hedmark County, the Swedish Association for Hunting and Wildlife Management, the Worldwide Fund for Nature (Sweden), and the Swedish University of Agricultural Sciences, Carl Tryggers Foundation, Marie-Claires Cronstedts Foundation, and the Swedish Carnivore Association.	Arnemo J. M., 2012, BIOMEDICAL PROTOCOLS; Aronson A, 2001, WOLF SCANDINAVIA STA; Becker MS, ECOLOGY MAMMALS CENT, P305; Bergman EJ, 2006, ECOL APPL, V16, P273, DOI 10.1890/04-1532; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cederlund G, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P337; CEDERLUND GN, 1991, J WILDLIFE MANAGE, V55, P675, DOI 10.2307/3809517; Creel S., 2002, AFRICAN WILD DOG BEH; Cromhout M., 2006, THESIS; Dale B. W., 1995, ECOLOGY CONSERVATION, P223; DALE BW, 1994, J ANIM ECOL, V63, P644, DOI 10.2307/5230; ESRI (Environmental Systems Resource Institute), 2009, ARCMAP 9 3 1; FRYXELL JM, 1993, EVOL ECOL, V7, P379, DOI 10.1007/BF01237869; FULLER TK, 1991, CAN J ZOOL, V69, P283, DOI 10.1139/z91-044; Fuller Todd K., 2003, P161; Garrott RA, 2007, ECOL APPL, V17, P1588, DOI 10.1890/06-1439.1; Gervasi V, 2013, ECOL APPL, V23, P1722, DOI 10.1890/12-1615.1; Gervasi V, 2012, J ANIM ECOL, V81, P443, DOI 10.1111/j.1365-2656.2011.01928.x; Giraldeau L.-A., 2008, BEHAV ECOLOGY; Hegel TM, 2010, OIKOS, V119, P1453, DOI 10.1111/j.1600-0706.2010.18358.x; Holand O, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P117; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; HUGGARD DJ, 1993, CAN J ZOOL, V71, P140, DOI 10.1139/z93-020; HUGGARD DJ, 1993, CAN J ZOOL, V71, P130, DOI 10.1139/z93-019; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; JEDRZEJEWSKI W, 1992, OECOLOGIA, V90, P27, DOI 10.1007/BF00317805; Jedrzejewski W, 2002, ECOLOGY, V83, P1341, DOI 10.2307/3071948; Jedrzejewski W, 2000, J MAMMAL, V81, P197, DOI 10.1644/1545-1542(2000)081&lt;0197:PSAPBW&gt;2.0.CO;2; Keech MA, 2011, J WILDLIFE MANAGE, V75, P1361, DOI 10.1002/jwmg.188; Kjellander P, 2004, OECOLOGIA, V139, P478, DOI 10.1007/s00442-004-1529-z; Koper Nicola, 2012, Rangifer, V32, P195; Krebs JR, 1978, BEHAV ECOLOGY EVOLUT; Kunkel K, 2001, J WILDLIFE MANAGE, V65, P520, DOI 10.2307/3803105; Kunkel KE, 2004, J WILDLIFE MANAGE, V68, P167, DOI 10.2193/0022-541X(2004)068[0167:FCWFBO]2.0.CO;2; Latham ADM, 2013, ECOGRAPHY, V36, P1276, DOI 10.1111/j.1600-0587.2013.00035.x; Liberg O, 2012, HYSTRIX, V23, P29, DOI 10.4404/hystrix-23.1-4670; Lone K, 2014, OIKOS, V123, P641, DOI 10.1111/j.1600-0706.2013.00938.x; MacNulty DR, 2012, BEHAV ECOL, V23, P75, DOI 10.1093/beheco/arr159; MacNulty DR, 2009, ECOL LETT, V12, P1347, DOI 10.1111/j.1461-0248.2009.01385.x; Mansson J, 2011, EUR J WILDLIFE RES, V57, P1017, DOI 10.1007/s10344-011-0512-3; Mattioli L, 2011, EUR J WILDLIFE RES, V57, P909, DOI 10.1007/s10344-011-0503-4; Mattisson J, 2013, OECOLOGIA, V173, P813, DOI 10.1007/s00442-013-2668-x; MESSIER F, 1994, ECOLOGY, V75, P478, DOI 10.2307/1939551; Messier Francois, 1995, Canadian Circumpolar Institute Occasional Publication, V35, P187; Metz MC, 2012, J ANIM ECOL, V81, P553, DOI 10.1111/j.1365-2656.2011.01945.x; Milanesi P, 2012, ETHOL ECOL EVOL, V24, P81, DOI 10.1080/03949370.2011.592220; MURDOCH WW, 1975, ECOLOGY, V56, P1094, DOI 10.2307/1936149; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; NEFF DJ, 1968, J WILDLIFE MANAGE, V32, P597, DOI 10.2307/3798941; NELSON ME, 1986, J WILDLIFE MANAGE, V50, P471, DOI 10.2307/3801108; Nicholson KL, 2008, CAN FIELD NAT, V122, P253, DOI 10.22621/cfn.v122i3.608; Nowak S, 2005, ACTA THERIOL, V50, P263, DOI 10.1007/BF03194489; Nowak S, 2011, MAMM BIOL, V76, P709, DOI 10.1016/j.mambio.2011.06.007; OATEN A, 1975, AM NAT, V109, P299, DOI 10.1086/282999; Ordiz A, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00243.1; Peterson Rolf O., 2003, P104; Renecker Lyle A., 1998, P403; Ronnegard L, 2008, WILDLIFE BIOL, V14, P358, DOI 10.2981/0909-6396(2008)14[358:EOFMUT]2.0.CO;2; Sand H, 2005, WILDLIFE SOC B, V33, P914, DOI 10.2193/0091-7648(2005)33[914:UGTAGC]2.0.CO;2; Sand H, 2012, CAN J ZOOL, V90, P403, DOI 10.1139/Z2012-007; Sand H, 2008, OECOLOGIA, V156, P53, DOI 10.1007/s00442-008-0969-2; Sand H, 2006, ANIM BEHAV, V72, P781, DOI 10.1016/j.anbehav.2005.11.030; Sand H, 2012, OIKOS, V121, P1454, DOI 10.1111/j.1600-0706.2012.20082.x; Schwartz Charles C., 1998, P441; Shultz S, 2010, BEHAV ECOL, V21, P1073, DOI 10.1093/beheco/arq108; Smith DW, 2004, J WILDLIFE MANAGE, V68, P153, DOI 10.2193/0022-541X(2004)068[0153:WPSAEO]2.0.CO;2; Stephens D.W., 1986, pi; Svensson L, WOLF SCANDINAVIA FIN; Taylor R.J., 1984, PREDATION; Vedin H., 1995, KLIMAT SJOAR VATTEND, P44; VINCENT JP, 1995, J ZOOL, V236, P371, DOI 10.1111/j.1469-7998.1995.tb02719.x; Vucetich JA, 2004, ANIM BEHAV, V67, P1117, DOI 10.1016/j.anbehav.2003.06.018; Vucetich JA, 2002, ECOLOGY, V83, P3003; Wabakken P, 2001, CAN J ZOOL, V79, P710, DOI 10.1139/cjz-79-4-710; Wagner C, 2012, MAMM BIOL, V77, P196, DOI 10.1016/j.mambio.2011.12.004; Wikenros C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119957; Wikenros C, 2009, ACTA THERIOL, V54, P207, DOI 10.4098/j.at.0001-7051.082.2008; Zimmermann B, 2014, THESIS; Zimmermann B, 2007, J WILDLIFE MANAGE, V71, P1177, DOI 10.2193/2006-306; Zimmermann B, 2015, J ANIM ECOL, V84, P102, DOI 10.1111/1365-2656.12280	80	26	27	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168062	10.1371/journal.pone.0168062	http://dx.doi.org/10.1371/journal.pone.0168062			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030549	Green Submitted, Green Published, gold			2022-12-26	WOS:000391222000032
J	Witek, MA; Kuiper, EG; Minten, E; Crispell, EK; Conn, GL				Witek, Marta A.; Kuiper, Emily G.; Minten, Elizabeth; Crispell, Emily K.; Conn, Graeme L.			A Novel Motif for S-Adenosyl-L-methionine Binding by the Ribosomal RNA Methyltransferase TlyA from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; isothermal titration calorimetry (ITC); Mycobacterium tuberculosis; protein motif; proteolysis; RNA methylation; RNA methyltransferase; S-adenosylmethionine (SAM); site-directed mutagenesis; X-ray crystallography	CATALYTIC-ACTIVITY; RESISTANCE; CAPREOMYCIN; 16S; PURIFICATION; EXPRESSION; HEMOLYSIN; HOMOLOGY; VIOMYCIN; FAMILY	Capreomycin is a potent ribosome-targeting antibiotic that is an essential component of current antituberculosis treatments, particularly in the case of multidrug-resistant Mycobacterium tuberculosis (Mtb). Optimal capreomycin binding and Mtb ribosome inhibition requires ribosomal RNA methylation in both ribosome subunits by TlyA (Rv1694), an enzyme with dual 2'-O-methytransferase and putative hemolytic activities. Despite the important role of TlyA in capreomycin sensitivity and identification of inactivating mutations in the corresponding Mtb gene tlyA, which cause resistance to capreomycin, our current structural and mechanistic understanding of TlyA action remains limited. Here, we present structural and functional analyses of Mtb TlyA interaction with its obligatory co-substrate for methyltransferase activity, S-adenosyl-l-methionine (SAM). Despite adopting a complete class I methyltransferase fold containing conserved SAM-binding and catalytic motifs, the isolated TlyA carboxyl-terminal domain exhibits no detectable affinity for SAM. Further analyses identify a tetrapeptide motif (RXWV) in the TlyA interdomain linker as indispensable for co-substrate binding. Our results also suggest that structural plasticity of the RXWV motif could contribute to TlyA domain interactions, as well as specific recognition of its two structurally distinct ribosomal RNA targets. Our findings thus reveal a novel motif requirement for SAM binding by TlyA and set the stage for future mechanistic studies of TlyA substrate recognition and modification that underpin Mtb sensitivity to capreomycin.	[Witek, Marta A.; Kuiper, Emily G.; Conn, Graeme L.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Kuiper, Emily G.; Minten, Elizabeth] Emory Univ, Sch Med, Biochem Cell & Dev Biol Program, Atlanta, GA 30322 USA; [Crispell, Emily K.] Emory Univ, Sch Med, Microbiol & Mol Genet Program, Grad Div Biol & Biomed Sci, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Conn, GL (corresponding author), Dept Biochem, 4135 O Wayne Rollins Res Ctr,1510 Clifton Rd. NE, Atlanta, GA 30322 USA.	gconn@emory.edu		Conn, Graeme/0000-0002-2419-380X	National Science Foundation Major Research Instrumentation Program [104177]; Winship Cancer Institute's shared resource program; Biochemistry Department of Emory University; U.S. Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088025] Funding Source: NIH RePORTER	National Science Foundation Major Research Instrumentation Program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Winship Cancer Institute's shared resource program; Biochemistry Department of Emory University; U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Auto-iTC<INF>200</INF> instrument was purchased with support from the National Science Foundation Major Research Instrumentation Program Grant 104177, the Winship Cancer Institute's shared resource program, and the Biochemistry Department of Emory University. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Argonne National Laboratory, was supported by the U.S. Department of Energy under Contract DE-AC02-06CH11357. We are grateful to Dr. Christine M. Dunham and her group, as well as other members of the Conn lab for useful discussions during this work and the preparation of the manuscript. We also thank Drs. Haian Fu, Eric A. Ortlund, Daniel Reines, and Keith D. Wilkinson for comments on the final manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arenas NE, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-16; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Avent ML, 2011, INTERN MED J, V41, P441, DOI 10.1111/j.1445-5994.2011.02452.x; Bugl H, 2000, MOL CELL, V6, P349, DOI 10.1016/S1097-2765(00)00035-6; Conn G. L., 2009, DNA RNA MODIFICATION, P524; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CUNDLIFFE E, 1989, ANNU REV MICROBIOL, V43, P207, DOI 10.1146/annurev.micro.43.1.207; Dorman SE, 2007, NAT MED, V13, P295, DOI 10.1038/nm0307-295; DRAPEAU GR, 1972, J BIOL CHEM, V247, P6720; Dunkle JA, 2014, P NATL ACAD SCI USA, V111, P6275, DOI 10.1073/pnas.1402789111; Feder M, 2003, GENE, V302, P129, DOI 10.1016/S0378-1119(02)01097-1; Ito T, 2015, P NATL ACAD SCI USA, V112, pE4197, DOI 10.1073/pnas.1422981112; Johansen SK, 2006, MOL CELL, V23, P173, DOI 10.1016/j.molcel.2006.05.044; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Long K. S., 2009, DNA RNA MODIFICATION, P537; Maus CE, 2005, ANTIMICROB AGENTS CH, V49, P3192, DOI 10.1128/AAC.49.8.3192-3197.2005; Maus CE, 2005, ANTIMICROB AGENTS CH, V49, P571, DOI 10.1128/AAC.49.2.571-577.2005; Miyazaki K, 2011, METHOD ENZYMOL, V498, P399, DOI 10.1016/B978-0-12-385120-8.00017-6; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; Monshupanee T, 2012, MOL MICROBIOL, V85, P1194, DOI 10.1111/j.1365-2958.2012.08168.x; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Noeske J, 2015, NAT STRUCT MOL BIOL, V22, P336, DOI 10.1038/nsmb.2994; O'Gara M, 1999, J MOL BIOL, V287, P201, DOI 10.1006/jmbi.1999.2608; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Punekar AS, 2012, NUCLEIC ACIDS RES, V40, P10507, DOI 10.1093/nar/gks727; Rahman A, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-35; Savic M, 2008, J BACTERIOL, V190, P5855, DOI 10.1128/JB.00076-08; Stanley RE, 2010, NAT STRUCT MOL BIOL, V17, P289, DOI 10.1038/nsmb.1755; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Witek MA, 2016, NUCLEIC ACIDS RES, V44, P342, DOI 10.1093/nar/gkv1306; Witek MA, 2014, BBA-PROTEINS PROTEOM, V1844, P1648, DOI 10.1016/j.bbapap.2014.06.012; World Health Organization, 2015, GLOB TUB REP 2015; Wren BW, 1998, MICROBIOL-SGM, V144, P1205, DOI 10.1099/00221287-144-5-1205; Zelinskaya N, 2011, PROTEIN EXPRES PURIF, V75, P89, DOI 10.1016/j.pep.2010.07.005	37	13	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1977	1987		10.1074/jbc.M116.752659	http://dx.doi.org/10.1074/jbc.M116.752659			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28031456	Green Published, hybrid			2022-12-26	WOS:000395515600035
J	Ji, ZX; Huang, YB; Sun, QS; Cao, G; Zheng, YH				Ji, Zexuan; Huang, Yubo; Sun, Quansen; Cao, Guo; Zheng, Yuhui			A Rough Set Bounded Spatially Constrained Asymmetric Gaussian Mixture Model for Image Segmentation	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; ALGORITHM	Accurate image segmentation is an important issue in image processing, where Gaussian mixture models play an important part and have been proven effective. However, most Gaussian mixture model (GMM) based methods suffer from one or more limitations, such as limited noise robustness, over-smoothness for segmentations, and lack of flexibility to fit data. In order to address these issues, in this paper, we propose a rough set bounded asymmetric Gaussian mixture model with spatial constraint for image segmentation. First, based on our previous work where each cluster is characterized by three automatically determined rough-fuzzy regions, we partition the target image into three rough regions with two adaptively computed thresholds. Second, a new bounded indicator function is proposed to determine the bounded support regions of the observed data. The bounded indicator and posterior probability of a pixel that belongs to each sub-region is estimated with respect to the rough region where the pixel lies. Third, to further reduce over-smoothness for segmentations, two novel prior factors are proposed that incorporate the spatial information among neighborhood pixels, which are constructed based on the prior and posterior probabilities of the within-and between-clusters, and considers the spatial direction. We compare our algorithm to state-of-the-art segmentation approaches in both synthetic and real images to demonstrate the superior performance of the proposed algorithm.	[Ji, Zexuan; Huang, Yubo; Sun, Quansen; Cao, Guo] Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Zheng, Yuhui] Nanjing Univ Informat Sci & Technol, Sch Comp & Software, Nanjing, Jiangsu, Peoples R China	Nanjing University of Science & Technology; Nanjing University of Information Science & Technology	Ji, ZX (corresponding author), Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China.	jizexuan@njust.edu.cn	, Guo/AAC-1388-2022; Zheng, Yuhui/AAF-2420-2019	, Guo/0000-0002-2689-0932; 	National Science Foundation of China [61401209]; Natural Science Foundation of Jiangsu Province, China [BK20140790]; Fundamental Research Funds for the Central Universities [30916011324]; China Postdoctoral Science Foundation [2014T70525, 2013M531364]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported in part by the National Science Foundation of China under Grant 61401209, in part by the Natural Science Foundation of Jiangsu Province, China under Grant BK20140790, in part by Fundamental Research Funds for the Central Universities under grant 30916011324, and in part by China Postdoctoral Science Foundation under Grants 2014T70525 and 2013M531364. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the National Science Foundation of China under Grant 61401209, in part by the Natural Science Foundation of Jiangsu Province, China under Grant BK20140790, in part by Fundamental Research Funds for the Central Universities under grant 30916011324, and in part by China Postdoctoral Science Foundation under Grants 2014T70525 and 2013M531364.	Allili MS, 2010, IEEE T CIRC SYST VID, V20, P1373, DOI 10.1109/TCSVT.2010.2077483; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bishop Christopher M., 2006, PATTERN RECOGNITION; Blekas K, 2005, IEEE T NEURAL NETWOR, V16, P494, DOI 10.1109/TNN.2004.841773; Browne RP, 2012, IEEE T PATTERN ANAL, V34, P814, DOI 10.1109/TPAMI.2011.199; Celeux G, 2003, PATTERN RECOGN, V36, P131, DOI 10.1016/S0031-3203(02)00027-4; Clifford P., 1990, DISORDER PHYS SYSTEM, P19; Cremers D, 2007, INT J COMPUT VISION, V72, P195, DOI 10.1007/s11263-006-8711-1; Diplaros A, 2007, IEEE T NEURAL NETWOR, V18, P798, DOI 10.1109/TNN.2007.891190; Elguebaly T, 2011, SIGNAL PROCESS, V91, P801, DOI 10.1016/j.sigpro.2010.08.014; Figueiredo MAT, 2002, IEEE T PATTERN ANAL, V24, P381, DOI 10.1109/34.990138; Forbes F, 2003, IEEE T PATTERN ANAL, V25, P1089, DOI 10.1109/TPAMI.2003.1227985; Franczak BC, 2014, IEEE T PATTERN ANAL, V36, P1149, DOI 10.1109/TPAMI.2013.216; Grady L, 2006, IEEE T PATTERN ANAL, V28, P1768, DOI 10.1109/TPAMI.2006.233; Gu B, 2016, IEEE T NEUR NET LEAR, DOI [DOI 10.1109/TNNLS.2016.2527796, 10.1109/TNNLS.2016.2527796]; Gu B, 2017, IEEE T NEUR NET LEAR, V28, P1646, DOI 10.1109/TNNLS.2016.2544779; Gu B, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P3532; Gu B, 2015, NEURAL NETWORKS, V67, P140, DOI 10.1016/j.neunet.2015.03.013; Hirano S, 2005, INT J APPROX REASON, V40, P23, DOI 10.1016/j.ijar.2004.11.008; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Ji ZX, 2012, COMPUT METH PROG BIO, V108, P644, DOI 10.1016/j.cmpb.2011.10.010; Kwan RKS, 1999, IEEE T MED IMAGING, V18, P1085, DOI 10.1109/42.816072; Li CM, 2014, MAGN RESON IMAGING, V32, P913, DOI 10.1016/j.mri.2014.03.010; Li J, 2015, IEEE T INF FOREN SEC, V10, P507, DOI 10.1109/TIFS.2014.2381872; Li L, 2010, IEEE T IMAGE PROCESS, V19, P1, DOI 10.1109/TIP.2009.2032341; Lindblom J, 2003, IEEE T SPEECH AUDI P, V11, P88, DOI 10.1109/TSA.2002.805639; Martin D., 2001, P ICCV, P416, DOI DOI 10.1109/ICCV.2001.937655; McLachlan G., 2000, WILEY SER PROB STAT; MCLACHLAN G, 1997, WILEY SERIES PROBABI; Nikou C, 2007, IEEE T IMAGE PROCESS, V16, P1121, DOI 10.1109/TIP.2007.891771; Pawlak Z., 2012, ROUGH SETS THEORETIC, DOI [10.1007/978-94-011-3534-4_7, DOI 10.1007/978-94-011-3534-4]; Peel D, 2000, STAT COMPUT, V10, P339, DOI 10.1023/A:1008981510081; REDNER RA, 1984, SIAM REV, V26, P195, DOI 10.1137/1026034; Rohlfing T, 2012, IEEE T MED IMAGING, V31, P153, DOI 10.1109/TMI.2011.2163944; Sanjay-Gopel S, 1998, IEEE T IMAGE PROCESS, V7, P1014, DOI 10.1109/83.701161; SCALLAN AJ, 1992, J ROY STAT SOC D-STA, V41, P227; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Nguyen TM, 2014, PATTERN RECOGN, V47, P3132, DOI 10.1016/j.patcog.2014.03.030; Nguyen TM, 2014, IEEE T CYBERNETICS, V44, P857, DOI 10.1109/TCYB.2013.2273714; Nguyen TM, 2014, IEEE J BIOMED HEALTH, V18, P109, DOI 10.1109/JBHI.2013.2264749; Nguyen TM, 2013, IEEE T CYBERNETICS, V43, P751, DOI 10.1109/TSMCB.2012.2215849; Nguyen TM, 2013, IEEE T CIRC SYST VID, V23, P621, DOI 10.1109/TCSVT.2012.2211176; Titterington D. M., 1985, STAT ANAL FINITE MIX; Unnikrishnan R., 2005, P IEEE COMP SOC C CO, P34, DOI DOI 10.1109/CVPR.2005.390; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270; Wei X, 2012, PATTERN RECOGN, V45, P4346, DOI 10.1016/j.patcog.2012.05.003; Wen XZ, 2015, INFORM SCIENCES, V295, P395, DOI 10.1016/j.ins.2014.10.040; Zhang H, 2013, INT CONF ACOUST SPEE, P1478, DOI 10.1109/ICASSP.2013.6637897; Zheng YH, 2015, J INTELL FUZZY SYST, V28, P961, DOI 10.3233/IFS-141378	49	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168449	10.1371/journal.pone.0168449	http://dx.doi.org/10.1371/journal.pone.0168449			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045950	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300025
J	Rocha-Brischiliari, SC; de Oliveira, RR; Andrade, L; Brischiliari, A; Gravena, AAF; Carvalho, MDD; Pelloso, SM				Rocha-Brischiliari, Sheila Cristina; de Oliveira, Rosana Rosseto; Andrade, Luciano; Brischiliari, Adriano; Franca Gravena, Angela Andreia; de Barros Carvalho, Maria Dalva; Pelloso, Sandra Marisa			The Rise in Mortality from Breast Cancer in Young Women: Trend Analysis in Brazil	PLOS ONE			English	Article							LATIN-AMERICA; FEMALE; EPIDEMIOLOGY; DISPARITIES; OUTCOMES; SYSTEM; IRAN	Introduction Breast cancer is the most common cause of cancer death among women. Objective The objective of this study was to analyze time trends in overall mortality from breast cancer in Brazil, Brazilian regions and States. Methods This is an exploratory study, of the time series of deaths from breast cancer contained in the Mortality Information System (SIM), of women living in Brazil, Brazilian regions and States, from 1996 to 2013. For the trend analysis, the polynomial regression model was used, and a significant trend was considered when the estimated model obtained a p value <0.05. Results There was a tendency of increased mortality from breast cancer in Brazilian women (average increase of 0.18 per year; p <0.001), with regional differences, particularly in the age group 20-49 years (0.07 per year; p <0.001). The age group 50-69 years remained constant but had high average rates (37.14). Conclusion More effective planning is needed to focus on the different scenarios of the Brazilian regions. Screening strategies for the incidence and mortality from breast cancer must also be rethought according to age group in the country.	[Rocha-Brischiliari, Sheila Cristina; Franca Gravena, Angela Andreia] Univ Estadual Maringa, Hlth Sci Ctr, Maringa, Parana, Brazil; [de Oliveira, Rosana Rosseto; Brischiliari, Adriano] Univ Estadual Maringa, Dept Nursing, Maringa, Parana, Brazil; [Andrade, Luciano] Univ Estadual Maringa, Dept Med, Maringa, Parana, Brazil; [de Barros Carvalho, Maria Dalva] Univ Estadual Maringa, Dept Post Grad Hlth Sci, Maringa, Parana, Brazil; [Pelloso, Sandra Marisa] Univ Estadual Maringa, Dept Post Grad Hlth Sci & Nursing, Maringa, Parana, Brazil; [Rocha-Brischiliari, Sheila Cristina; Andrade, Luciano; Franca Gravena, Angela Andreia; de Barros Carvalho, Maria Dalva; Pelloso, Sandra Marisa] Univ Estadual Maringa, Dept Hlth Sci, Maringa, Parana, Brazil; [de Oliveira, Rosana Rosseto; Brischiliari, Adriano; Pelloso, Sandra Marisa] Univ Estadual Maringa, Dept Nursing, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Rocha-Brischiliari, SC (corresponding author), Univ Estadual Maringa, Hlth Sci Ctr, Maringa, Parana, Brazil.; Rocha-Brischiliari, SC (corresponding author), Univ Estadual Maringa, Dept Hlth Sci, Maringa, Parana, Brazil.	sheila.brischiliari@gmail.com	Carvalho, Maria Dalva/AAK-8411-2021; Oliveira, Rosana Rosseto/E-6193-2017	Carvalho, Maria Dalva/0000-0002-1377-3331; Oliveira, Rosana Rosseto/0000-0003-3373-1654				Abu-Rmeileh NME, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2715-8; Adams P, 2013, B WORLD HEALTH ORGAN, V91, P626, DOI 10.2471/BLT.13.020913; Afsharfard A, 2013, ASIAN PAC J CANCER P, V14, P6905, DOI 10.7314/APJCP.2013.14.11.6905; Albrecht Cristina Arthmar Mentz, 2013, Rev. bras. epidemiol., V16, P582, DOI 10.1590/S1415-790X2013000300003; Almasi Zeinab, 2015, Asian Pac J Cancer Prev, V16, P2757; Arab M, 2014, IRAN J PUBLIC HEALTH, V43, P1372; Silva Gulnar Azevedo e, 2011, Rev. Saúde Pública, V45, P1009, DOI 10.1590/S0034-89102011005000076; Silva GAE, 2014, CAD SAUDE PUBLICA, V30, P1537, DOI 10.1590/0102-311X00156513; Barbosa IR, 2015, REV CIENCIA PLURAL, V1, P4; Brasil. Instituto Nacional de Cancer Jose Alencar Gomes da Silva (INCA) / Ministerio da Saude, 2015, MON AC CONTR CANC MA; Brasil. Ministerio da Saude. Instituto Nacional de Cancer Jose Alencar Gomes da Silva (INCA), 2015, EST 2016 INC CANC BR; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Informatica do SUS (Datasus), SIST INF MORT SIM; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Cecilio AP, 2015, BREAST CANCER-TARGET, V7, P43, DOI 10.2147/BCTT.S50361; Felix JD, 2012, CIENC SAUDE COLETIVA, V17, P945, DOI 10.1590/S1413-81232012000400016; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Gravena AAF, 2014, ASIAN PAC J CANCER P, V15, P10313, DOI 10.7314/APJCP.2014.15.23.10313; Gravena AAF, 2012, REV ESC ENFERM USP, V46, P15, DOI 10.1590/S0080-62342012000100002; Freitas R, 2012, CLINICS, V67, P731, DOI 10.6061/clinics/2012(07)05; Kluthcovsky ACGC, 2014, REV ASSOC MED BRAS, V60, P387, DOI 10.1590/1806-9282.60.04.019; Girianelli VR, 2014, REV SAUDE PUBL, V48, P459, DOI 10.1590/S0034-8910.2014048005214; Gravena AAF, 2014, EPIDEMIOL RES INT, P1, DOI DOI 10.1155/2014/261625; Guo P, 2012, ANN ONCOL, V23, P2755, DOI 10.1093/annonc/mds069; IBGE. Instituto Brasileiro de Geografia e Estatistica, SER EST SER HIST; International Agency for Research on Cancer, 2012, GLOBOCAN 2012 EST CA; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Latasa P, 2015, AN SIST SANIT NAVAR, V38, P21; Li CH, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0211-x; Liedke PER, 2014, CANCER EPIDEM BIOMAR, V23, P126, DOI 10.1158/1055-9965.EPI-13-0693; Liu LH, 2012, INT J CANCER, V130, P395, DOI 10.1002/ijc.26004; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; QGIS Development Team, 2018, QGIS GEOGR INF SYST; Gonzaga CMR, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1445-7; Rohani-Rasaf M, 2013, ASIAN PAC J CANCER P, V14, P1669, DOI 10.7314/APJCP.2013.14.3.1669; Si W, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000820; Strasser-Weippl K, 2015, LANCET ONCOL, V16, P1405, DOI 10.1016/S1470-2045(15)00218-1; Suh M, 2016, CANCER RES TREAT, V48, P1, DOI 10.4143/crt.2014.204; Tumas N, 2015, REV PANAM SALUD PUBL, V37, P330; Unger-Saldana K, 2014, WORLD J CLIN ONCOL, V5, P465, DOI 10.5306/wjco.v5.i3.465; Villarreal-Garza C, 2013, ONCOLOGIST, V18, P1298, DOI 10.1634/theoncologist.2013-0321; Warner WA, 2015, CANCER MED-US, V4, P1742, DOI 10.1002/cam4.503; Youlden Danny R., 2014, Cancer Biology Medicine, V11, P101, DOI 10.7497/j.issn.2095-3941.2014.02.005	42	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168950	10.1371/journal.pone.0168950	http://dx.doi.org/10.1371/journal.pone.0168950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046087	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300078
J	Yasuda, M; Nagata, S; Yamane, S; Kunikata, C; Kida, Y; Kuwano, K; Suezawa, C; Okuda, J				Yasuda, Masashi; Nagata, Syouya; Yamane, Satoshi; Kunikata, Chinami; Kida, Yutaka; Kuwano, Koichi; Suezawa, Chigusa; Okuda, Jun			Pseudomonas aeruginosa serA Gene Is Required for Bacterial Translocation through Caco-2 Cell Monolayers	PLOS ONE			English	Article							ESCHERICHIA-COLI; D-3-PHOSPHOGLYCERATE DEHYDROGENASE; 3-PHOSPHOGLYCERATE DEHYDROGENASE; BACTEREMIA; HOST; PENETRATION; SEPTICEMIA; EXPRESSION; MORTALITY; PATHOGEN	To specify critical factors responsible for Pseudomonas aeruginosa penetration through the Caco-2 cell epithelial barrier, we analyzed transposon insertion mutants that demonstrated a dramatic reduction in penetration activity relative to P. aeruginosa PAO1 strain. From these strains, mutations could be grouped into five classes, specifically flagellin-associated genes, pili-associated genes, heat-shock protein genes, genes related to the glycolytic pathway, and biosynthesis-related genes. Of these mutants, we here focused on the serA mutant, as the association between this gene and penetration activity is yet unknown. Inactivation of the serA gene caused significant repression of bacterial penetration through Caco-2 cell monolayers with decreased swimming and swarming motilities, bacterial adherence, and fly mortality rate, as well as repression of ExoS secretion; however, twitching motility was not affected. Furthermore, L-serine, which is known to inhibit the D-3-phosphoglycerate dehydrogenase activity of the SerA protein, caused significant reductions in penetration through Caco-2 cell monolayers, swarming and swimming motilities, bacterial adherence to Caco-2 cells, and virulence in flies in the wild-type P. aeruginosa PAO1 strain. Together, these results suggest that serA is associated with bacterial motility and adherence, which are mediated by flagella that play a key role in the penetration of P. aeruginosa through Caco-2 cell monolayers. Oral administration of cserine to compromised hosts might have the potential to interfere with bacterial translocation and prevent septicemia caused by P. aeruginosa through inhibition of serA function.	[Yasuda, Masashi; Nagata, Syouya; Yamane, Satoshi; Kunikata, Chinami; Suezawa, Chigusa; Okuda, Jun] Kagawa Prefectural Univ Hlth Sci, Div Microbiol, Dept Med Technol, Takamatsu, Kagawa, Japan; [Kida, Yutaka; Kuwano, Koichi] Kurume Univ, Div Microbiol, Dept Infect Med, Sch Med, Fukuoka, Japan	Kurume University	Okuda, J (corresponding author), Kagawa Prefectural Univ Hlth Sci, Div Microbiol, Dept Med Technol, Takamatsu, Kagawa, Japan.	okuda@chs.pref.kagawa.jp						Alverdy J, 2000, ANN SURG, V232, P480, DOI 10.1097/00000658-200010000-00003; Blum JE, 2013, MBIO, V4, DOI 10.1128/mBio.00860-13; Cisz M, 2008, J BACTERIOL, V190, P2726, DOI 10.1128/JB.01553-07; Dey S, 2005, J BIOL CHEM, V280, P14884, DOI 10.1074/jbc.M414488200; DICK JD, 1988, EUR J CANCER CLIN ON, V24, pS47; Espinosa-Urgel M, 2000, J BACTERIOL, V182, P2363, DOI 10.1128/JB.182.9.2363-2369.2000; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; FINLAY BB, 1990, J INFECT DIS, V162, P1096, DOI 10.1093/infdis/162.5.1096; FURUYA N, 1993, J MED MICROBIOL, V39, P141, DOI 10.1099/00222615-39-2-141; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Gallagher LA, 2011, MBIO, V2, DOI 10.1128/mBio.00315-10; Gehring K, 1994, 94 GEN M AM SOC MICR; GILLARD BK, 1977, CLIN CHEM, V23, P2279; Grant GA, 2002, J BIOL CHEM, V277, P39548, DOI 10.1074/jbc.M208019200; Heiniger RW, 2010, CELL MICROBIOL, V12, P1158, DOI 10.1111/j.1462-5822.2010.01461.x; Hinz A, 2011, J BACTERIOL, V193, P4790, DOI 10.1128/JB.05133-11; HIRAKATA Y, 1993, INFECT IMMUN, V61, P2468, DOI 10.1128/IAI.61.6.2468-2473.1993; Hirakata Y, 2002, J EXP MED, V196, P109, DOI 10.1084/jem.20020005; HIRAKATA Y, 1991, INFECT IMMUN, V59, P289, DOI 10.1128/IAI.59.1.289-294.1991; Hirakata Y, 1998, INFECT IMMUN, V66, P1748, DOI 10.1128/IAI.66.4.1748-1751.1998; HIRAKATA Y, 1992, ANTIMICROB AGENTS CH, V36, P1198, DOI 10.1128/AAC.36.6.1198; HIRAKATA Y, 1995, J MED MICROBIOL, V43, P141, DOI 10.1099/00222615-43-2-141; INTERNATIONAL UNION OF BIOCHEMISTRY NOMENCLATURE COMMITTEE., 1979, European Journal of Biochemistry, V97, P319, DOI 10.1111/j.1432-1033.1979.tb13116.x; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kida Y, 2008, CELL MICROBIOL, V10, P1491, DOI 10.1111/j.1462-5822.2008.01142.x; Kruczek C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149229; Kuchma SL, 2010, J BACTERIOL, V192, P2950, DOI 10.1128/JB.01642-09; LEIFSON E, 1951, J BACTERIOL, V62, P377, DOI 10.1128/JB.62.4.377-389.1951; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; MARSH P, 1986, NUCLEIC ACIDS RES, V14, P3603, DOI 10.1093/nar/14.8.3603; MARSHALL JC, 1993, ANN SURG, V218, P111, DOI 10.1097/00000658-199308000-00001; Miyauchi E, 2008, LETT APPL MICROBIOL, V46, P469, DOI 10.1111/j.1472-765X.2008.02332.x; Moyano AJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004163; Okuda J, 2014, J INFECT CHEMOTHER, V20, P121, DOI 10.1016/j.jiac.2013.09.001; Osmon S, 2004, CHEST, V125, P607, DOI 10.1378/chest.125.2.607; Peters-Wendisch P, 2002, APPL MICROBIOL BIOT, V60, P437, DOI 10.1007/s00253-002-1161-y; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Suezawa C, 2016, MICROB PATHOGENESIS, V95, P148, DOI 10.1016/j.micpath.2016.04.007; Zaborina Olga, 2006, Ann Clin Microbiol Antimicrob, V5, P14, DOI 10.1186/1476-0711-5-14; Zhang SP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000564; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996	43	13	13	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169367	10.1371/journal.pone.0169367	http://dx.doi.org/10.1371/journal.pone.0169367			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046014	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300175
J	Zhang, Y; Li, ZJ; Zhang, J; Li, HS; Qiao, YM; Huang, CS; Li, BS				Zhang, Yang; Li, Zongjuan; Zhang, Jian; Li, Hongsheng; Qiao, Yumei; Huang, Chengsuo; Li, Baosheng			Genetic Variants in MTHFR Gene Predict >= 2 Radiation Pneumonitis in Esophageal Squamous Cell Carcinoma Patients Treated with Thoracic Radiotherapy	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE MTHFR; MANGANESE SUPEROXIDE-DISMUTASE; DEFINITIVE RADIOTHERAPY; PARKINSONS-DISEASE; OXIDATIVE STRESS; POLYMORPHISMS; ASSOCIATION; THERAPY; REPAIR; FOLATE	Reactive oxygen species (ROS), formed as an indirect production of radiotherapy (RT), could cause DNA damage of normal tissues. Meanwhile, our body possesses the ability to restore the damage by DNA repair pathways. The imbalance between the two systems could finally result in radiation injury. Therefore, in this prospective cohort study, we explored the association of genetic variants in ROS metabolism and DNA repair pathway-related genes with radiation pneumonitis (RP). A total of 265 locally advanced esophageal squamous cell carcinoma (ESCC) patients receiving RT in Chinese Han population were enrolled. Five functional single nucleotide polymorphisms (SNPs) (rs1695 in GSTP1; rs4880 in SOD2-, rs3957356 in GSTA1; and rs1801131, rs1801133 in MTHFR) were genotyped using the MassArray system, and rs1801131 was found to be a predictor of >= 2 RP. Our results showed that, compared with TT genotype, patients with GG/GT genotypes of rs1801131 had a notably lower risk of developing >= 2 RP (HR = 0.339, 95% CI = 0.137-0.839, P = 0.019). Further independent studies are required to confirm this findings.	[Zhang, Yang] Univ Jinan, Sch Med & Life Sci, Shandong Acad Med Sci, Jinan, Shandong, Peoples R China; [Zhang, Yang; Zhang, Jian; Li, Hongsheng; Li, Baosheng] Shandong Univ, Shandong Acad Med Sci, Dept Radiat Oncol, Shandong Canc Hosp, Jinan, Shandong, Peoples R China; [Li, Zongjuan] Dalian Med Univ, Hosp 2, Dept Radiat Oncol, Dalian, Liaoning Provin, Peoples R China; [Qiao, Yumei] Sixth Peoples Hosp Jinan, Dept Ophthalmol & Otorhinolaryngol, Jinan, Shandong, Peoples R China; [Huang, Chengsuo] Shandong Univ, Shandong Acad Med Sci, Dept Internal Med, Shandong Canc Hosp, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Jinan; Dalian Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Jinan	Li, BS (corresponding author), Shandong Univ, Shandong Acad Med Sci, Dept Radiat Oncol, Shandong Canc Hosp, Jinan, Shandong, Peoples R China.	baoshli1963@163.com			National Nature Science Foundation of China [81530060]; Taishan Scholars Program of Shandong Province, China [Ts20120505]; Shandong Province Natural Science Foundation [ZR2012HL33, ZR2013HL049]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholars Program of Shandong Province, China; Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province)	This work was supported by National Nature Science Foundation of China, grant No. 81530060, and Taishan Scholars Program of Shandong Province, China, grant No. Ts20120505 (to B.L.). This work was also supported by Shandong Province Natural Science Foundation ZR2012HL33 (H.L.) and ZR2013HL049 (to C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrani H, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0337-7; Andreassen CN, 2012, RADIOTHER ONCOL, V105, P337, DOI 10.1016/j.radonc.2012.11.004; Andreassen CN, 2010, RADIOTHER ONCOL, V97, P1, DOI 10.1016/j.radonc.2010.07.018; Andreassen CN, 2002, RADIOTHER ONCOL, V64, P131, DOI 10.1016/S0167-8140(02)00154-8; Bahari Gholamreza, 2016, Int J Hematol Oncol Stem Cell Res, V10, P130; Batra V, 2004, J RADIAT RES, V45, P527, DOI 10.1269/jrr.45.527; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; Das SK, 2007, INT J RADIAT ONCOL, V68, P1212, DOI 10.1016/j.ijrobp.2007.03.064; Cordoba EE, 2016, CANCER RES TREAT, V48, P948, DOI 10.4143/crt.2015.360; Funke S., 2009, Journal of Cancer Epidemiology, V2009, P302047, DOI 10.1155/2009/302047; Gaughan DJ, 2000, GENE, V257, P279, DOI 10.1016/S0378-1119(00)00392-9; Goyette P, 1998, MAMM GENOME, V9, P652, DOI 10.1007/s003359900838; Hildebrandt MAT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012402; Hmimech W, 2016, BIOMED REP, V5, P361, DOI 10.3892/br.2016.717; Huang WQ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003857; Kerns SL, 2014, RADIOTHER ONCOL, V110, P182, DOI 10.1016/j.radonc.2013.07.011; Kim JH, 2014, RADIAT ONCOL J, V32, P103, DOI 10.3857/roj.2014.32.3.103; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Luo S, 2016, INT J ENV RES PUBLIC, V13; MacMillan-Crow LA, 2001, FREE RADICAL RES, V34, P325, DOI 10.1080/10715760100300281; Mak RH, 2012, CANCER-AM CANCER SOC, V118, P3654, DOI 10.1002/cncr.26667; Mitra S, 2001, ENVIRON MOL MUTAGEN, V38, P180, DOI 10.1002/em.1070; Napoli C, 2001, J CELL BIOCHEM, V82, P674, DOI 10.1002/jcb.1198; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Schallenkamp JM, 2007, INT J RADIAT ONCOL, V67, P410, DOI 10.1016/j.ijrobp.2006.09.030; Sutton A, 2003, PHARMACOGENETICS, V13, P145, DOI 10.1097/00008571-200303000-00004; Tsoutsou PG, 2006, INT J RADIAT ONCOL, V66, P1281, DOI 10.1016/j.ijrobp.2006.08.058; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Wu YL, 2013, J NEUROL SCI, V335, P14, DOI 10.1016/j.jns.2013.09.006; Yin M, 2012, CANCER SCI, V103, P945, DOI 10.1111/j.1349-7006.2012.02229.x; Yin M, 2012, CANCER-AM CANCER SOC, V118, P528, DOI 10.1002/cncr.26214; Yin M, 2011, INT J RADIAT ONCOL, V81, pE67, DOI 10.1016/j.ijrobp.2010.11.079; Yuan LM, 2016, NEUROSCI LETT, V616, P26, DOI 10.1016/j.neulet.2016.01.031	34	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169147	10.1371/journal.pone.0169147	http://dx.doi.org/10.1371/journal.pone.0169147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046029	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300127
J	Wu, ZH; Lin, C; Liu, MM; Zhang, J; Tao, ZH; Hu, XC				Wu, Zhen-Hua; Lin, Chen; Liu, Ming-Ming; Zhang, Jian; Tao, Zhong-Hua; Hu, Xi-Chun			Src Inhibition Can Synergize with Gemcitabine and Reverse Resistance in Triple Negative Breast Cancer Cells via the AKT/c-Jun Pathway	PLOS ONE			English	Article							STEM-CELLS; C-JUN; PROLIFERATION; DASATINIB; THERAPY; COMBINATION; METASTASIS; CISPLATIN; TRIAL	Purpose Gemcitabine-based chemotherapy remains one of the standards in management of metastatic breast cancer. However, intrinsic and acquired resistance to gemcitabine inevitably occurs. The aims of this study were to assess the efficacy of the combination of src inhibition and gemcitabine in gemcitabine-resistant breast cancer cells. Methods and Results By using colony formation, sphere forming, flow cytometry, cell counting kit-8 and transwell assays, 231/GEM-res (gemcitabine-resistant) cell line, which was 10 times more resistant, was shown to have elevated drug tolerance, enhanced proliferative and self-renewal abilities, compared with its parental cells. Inhibition of src by both saracatinib (AZD0530) and siRNA could partially reverse gemcitabine resistance and attenuate resistance-associated anti-apoptosis, migration and stem cell capacities. In addition, the combination of src inhibition and gemcitabine had synergistic antitumor effects. Western blot analysis revealed upregulation of pro-apoptotic protein BAX, along with the down-regulation of anti-apoptotic proteins (BCL-XL, Survivin), migration associated proteins (p-FAK, MMP-3) and cancer stem cell (CSC) markers (CD44, Oct-4), which was probably mediated by AKT/c-Jun pathway. Conclusion In highly gemcitabine-resistant 231 cells, src inhibition can synergize with gemcitabine, reverse drug resistance, inhibit tumor growth/metastasis/stemness of cancer stem cells, possibly via the AKT/c-Jun pathway.	[Wu, Zhen-Hua; Lin, Chen; Zhang, Jian; Tao, Zhong-Hua; Hu, Xi-Chun] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai, Peoples R China; [Wu, Zhen-Hua; Lin, Chen; Zhang, Jian; Tao, Zhong-Hua; Hu, Xi-Chun] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China; [Liu, Ming-Ming] Fudan Univ, Sch Pharm, Dept Med Chem, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Hu, XC (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai, Peoples R China.; Hu, XC (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.	xchu2009@hotmail.com			AstraZeneca	AstraZeneca(AstraZeneca)	Xi-Chun Hu received the support from "an Investigator Sponsored Study Programme" of AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, CANCER DISCOV, V4, pOF19, DOI [10.1158/2159-8290.CD-RW2014-015, DOI 10.1158/2159-8290.CD-RW2014-015]; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Boyer B, 2002, ONCOGENE, V21, P2347, DOI 10.1038/sj.onc.1205298; Chen K, 2013, ACTA PHARMACOL SIN, V34, P732, DOI 10.1038/aps.2013.27; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Clark AS, 2002, MOL CANCER THER, V1, P707; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; DeGraffenried LA, 2004, CLIN CANCER RES, V10, P8059, DOI 10.1158/1078-0432.CCR-04-0035; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Duxbury MS, 2004, CLIN CANCER RES, V10, P2307, DOI 10.1158/1078-0432.CCR-1183-3; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Green TP, 2009, MOL ONCOL, V3, P248, DOI 10.1016/j.molonc.2009.01.002; Gucalp A, 2011, CLIN BREAST CANCER, V11, P306, DOI 10.1016/j.clbc.2011.03.021; Duong HQ, 2014, INT J ONCOL, V44, P2132, DOI 10.3892/ijo.2014.2357; Hu XC, 2015, LANCET ONCOL, V16, P436, DOI 10.1016/S1470-2045(15)70064-1; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Park BJ, 2012, CANCER LETT, V320, P104, DOI 10.1016/j.canlet.2012.01.039; Saini KS, 2013, CANCER TREAT REV, V39, P935, DOI 10.1016/j.ctrv.2013.03.009; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Silvestris N, 2008, BREAST, V17, P220, DOI 10.1016/j.breast.2007.10.009; Somlo G, 2013, CLIN CANCER RES, V19, P1884, DOI 10.1158/1078-0432.CCR-12-0652; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Vleugel MM, 2006, HUM PATHOL, V37, P668, DOI 10.1016/j.humpath.2006.01.022; West KA, 2011, MOL CANCER THER, V10, P2031, DOI 10.1158/1535-7163.MCT-11-0712; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wu ZH, 2016, TUMOR BIOL, V37, P7245, DOI 10.1007/s13277-015-4604-7; Ye FG, 2015, CANCER RES, V75, P1504, DOI 10.1158/0008-5472.CAN-14-2341; Zhang J, 2015, INT J CANCER, V136, P204, DOI 10.1002/ijc.28966; Zhang Y, 2007, ONCOL REP, V18, P1207	32	17	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169230	10.1371/journal.pone.0169230	http://dx.doi.org/10.1371/journal.pone.0169230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036386	Green Published, Green Submitted, gold			2022-12-26	WOS:000391229300066
J	Hsiao, JF; Chung, CM; Chu, CM; Lin, YS; Pan, KL; Chang, ST; Hsu, JT				Hsiao, Ju-Feng; Chung, Chang-Min; Chu, Chi-Ming; Lin, Yu-Shen; Pan, Kuo-Li; Chang, Shih-Tai; Hsu, Jen-Te			Two-Dimensional Speckle Tracking Echocardiography Predict Left Ventricular Remodeling after Acute Myocardial Infarction in Patients with Preserved Ejection Fraction	PLOS ONE			English	Article							GLOBAL LONGITUDINAL STRAIN; MOTION SCORE INDEX; CIRCUMFERENTIAL STRAIN; CORONARY ANGIOPLASTY; STANDARDS COMMITTEE; OF-ECHOCARDIOGRAPHY; RISK STRATIFICATION; PROGNOSTIC VALUE; TISSUE DOPPLER; SIZE	Objectives Left ventricular remodeling after acute myocardial infarction increases cardiovascular events and mortality. But few study was done in patients with preserved ejection fraction (EF > 40%). We investigate whether the strain and strain rate by 2D speckle tracking echocardiography could predict left ventricular remodeling after acute myocardial infarction in this cohort. Methods The 83 patients (average age 60.7 +/- 12.3 y, 75 [90.4%] male) with new-onset acute myocardial infarction receiving echocardiography immediately, and 6 months after admission were grouped by the presence or absence of left ventricular remodeling. Strain and strain rate including longitudinal, circumferential, and radial direction were calculated. The average of strain and strain rate of which segmental longitudinal strains > - 15% were defined as the injury longitudinal strain (InjLS). Results Left ventricular remodeling occurred in 24 of 83 patients (28.9%). In univariate logistic regression analyses, gender, peak CK-MB, log BNP, use of statin before discharge, wall motion score index, and InjLS were significantly associated with left ventricular remodeling (p < 0.05). In multivariate analysis using the forward stepwise method, gender, CK-MB, and InjLS were independent predictors. The hazard ratio for InjLS was 1.48 (p = 0.04). Receiver operating characteristic curve (ROC) analyses showed the area under the curve (AUC) of InjLS was largest (AUC = 0.75, cut-off value = -11.7%, sensitivity = 81%, specificity = 71%, p < 0.01). In ST-segment elevation myocardial infarction subgroup, InjLS was the only predictor according to ROC analysis (AUC = 0.79, p < 0.01, cut-off value = -11.4%, sensitivity = 88%, specificity = 77%) and multivariate logistic regression analysis (hazard ratio = 1.88, 95% CI: 1.22-2.88, p < 0.01). Conclusions InjLS was an excellent predictor for left ventricular remodeling after acute myocardial infarction in patient with preserved ejection fraction.	[Hsiao, Ju-Feng; Chung, Chang-Min; Lin, Yu-Shen; Pan, Kuo-Li; Chang, Shih-Tai; Hsu, Jen-Te] Chang Gung Univ, Coll Med, Chiayi Chang Gung Mem Hosp, Dept Cardiol, Pu Tz City, Chai Yi Hsien, Taiwan; [Chu, Chi-Ming] Natl Def Med Ctr, Sect Hlth Informat, Inst Publ Hlth, Taipei, Taiwan; [Chu, Chi-Ming] Univ Taipei, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Defense Medical Center; University of Taipei	Hsu, JT (corresponding author), Chang Gung Univ, Coll Med, Chiayi Chang Gung Mem Hosp, Dept Cardiol, Pu Tz City, Chai Yi Hsien, Taiwan.	hsujente@gmail.com			Chang Gung Memorial hospital [CMRPG6B0141similar to43]	Chang Gung Memorial hospital(Chang Gung Memorial Hospital)	JFH received the funding from Chang Gung Memorial hospital (CMRPG6B0141 similar to 43). URL:https://www.cgmh.org.tw. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate E, 2014, J AM SOC ECHOCARDIOG, V27, P239, DOI 10.1016/j.echo.2013.12.009; Altiok E, 2014, J AM SOC ECHOCARDIOG, V27, P249, DOI 10.1016/j.echo.2013.11.014; Bochenek T, 2011, J AM SOC ECHOCARDIOG, V24, P1342, DOI 10.1016/j.echo.2011.09.003; Bolognese L, 2002, CIRCULATION, V106, P2351, DOI 10.1161/01.CIR.0000036014.90197.FA; Bonios MJ, 2014, HELL J CARDIOL, V55, P305; D'Andrea A, 2011, INT J CARDIOL, V153, P185, DOI 10.1016/j.ijcard.2010.08.025; Eek C, 2010, CIRC-CARDIOVASC IMAG, V3, P187, DOI 10.1161/CIRCIMAGING.109.910521; Ferrari R, 2006, ARCH INTERN MED, V166, P659; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; Gjesdal O, 2007, CLIN SCI, V113, P287, DOI 10.1042/CS20070066; Gjesdal O, 2008, CIRC-CARDIOVASC IMAG, V1, P189, DOI 10.1161/CIRCIMAGING.108.784900; Grabka M, 2013, CORONARY ARTERY DIS, V24, P127, DOI 10.1097/MCA.0b013e32835b6798; Hung CL, 2010, J AM COLL CARDIOL, V56, P1812, DOI 10.1016/j.jacc.2010.06.044; Ingul CB, 2010, J AM SOC ECHOCARDIOG, V23, P432, DOI 10.1016/j.echo.2010.01.018; Joyce E, 2014, CIRC-CARDIOVASC IMAG, V7, P74, DOI 10.1161/CIRCIMAGING.113.000982; KINNEY EL, 1990, ANGIOLOGY, V41, P112, DOI 10.1177/000331979004100204; Kober L, 1997, PACE, V20, P2553, DOI 10.1111/j.1540-8159.1997.tb06104.x; Lacalzada J, 2015, INT J CARDIOVASC IMA; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Moller JE, 2006, AM HEART J, V151, P419, DOI 10.1016/j.ahj.2005.03.042; Munk K, 2011, EUR J ECHOCARDIOGR, V12, DOI 10.1093/ejechocard/jeq168; Nicolosi GL, 2009, EUR HEART J, V30, P1656, DOI 10.1093/eurheartj/ehp139; Park YH, 2008, J AM SOC ECHOCARDIOG, V21, P262, DOI 10.1016/j.echo.2007.08.026; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Savoye C, 2006, AM J CARDIOL, V98, P1144, DOI 10.1016/j.amjcard.2006.06.011; Sjoli B, 2009, J AM SOC ECHOCARDIOG, V22, P1232, DOI 10.1016/j.echo.2009.07.027; Tsai WC, 2010, J AM SOC ECHOCARDIOG, V23, P1183, DOI 10.1016/j.echo.2010.08.011; Yoon HJ, 2011, KOREAN CIRC J, V41, P124, DOI 10.4070/kcj.2011.41.3.124; Zaliaduonyte-Peksiene D, 2012, ECHOCARDIOGR-J CARD, V29, P419, DOI 10.1111/j.1540-8175.2011.01597.x	30	3	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168109	10.1371/journal.pone.0168109	http://dx.doi.org/10.1371/journal.pone.0168109			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033331	Green Published, Green Submitted, gold			2022-12-26	WOS:000391226900014
J	Lopez-Sobaler, AM; Rodriguez-Rodriguez, E; Aranceta-Bartrina, J; Gil, A; Gonzalez-Gross, M; Serra-Majem, L; Varela-Moreiras, G; Ortega, RM				Lopez-Sobaler, Ana M.; Rodriguez-Rodriguez, Elena; Aranceta-Bartrina, Javier; Gil, Angel; Gonzalez-Gross, Marcela; Serra-Majem, Lluis; Varela-Moreiras, Gregorio; Ortega, Rosa M.			General and Abdominal Obesity Is Related to Physical Activity, Smoking and Sleeping Behaviours and Mediated by the Educational Level: Findings from the ANIBES Study in Spain	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; RISK-FACTORS; WEIGHT; TELEVISION; OVERWEIGHT; ASSOCIATION; POPULATION; DURATION; ADULTS; HEALTH	The aim of the present study was to analyze the association of socioeconomic (SES) and lifestyle factors, with the conditions of overweight (OW), general (OB) and abdominal obesity (AO) in Spanish adults. A representative sample of 1655 Spanish adults (18 to 65 years) from the ANIBES Study was investigated. Collected data included measured anthropometry (weight, height and waist circumference), demographic and SES data (region and habitant population size, educational level, family income, unemployment rate), physical activity (PA) and other lifestyle factors (sleeping time and frequency of viewing television). OW, OB and AO were determined in each participant. Being male, older than 40 years, and watching television more frequently were associated with higher risk of OB and AO, whereas those with a higher level of education, smokers, and more time in sleeping and in vigorous PA, but not in moderate-vigorous PA, were associated with a lower risk. Living in the Atlantic region and stating no answer to the question regarding family income were also associated with lower risk of AO. Strategies for preventing and reducing OB and AO should consider improving sleeping habits and PA. They should also pay more attention to the most vulnerable groups such as those less educated.	[Lopez-Sobaler, Ana M.; Ortega, Rosa M.] Univ Complutense Madrid, Fac Pharm, Dept Nutr, VALORNUT Res Grp, Madrid, Spain; [Rodriguez-Rodriguez, Elena] Univ Complutense Madrid, Fac Pharm, Dept Sect Analyt Chem, VALORNUT Res Grp, Madrid, Spain; [Aranceta-Bartrina, Javier] Univ Navarra, Dept Prevent Med & Publ Hlth, Pamplona, Spain; [Aranceta-Bartrina, Javier; Gil, Angel; Gonzalez-Gross, Marcela; Serra-Majem, Lluis] Carlos III Hlth Inst, Ctr Physiopathol Obes & Nutr, CIBEROBN, Biomed Res Networking, Madrid, Spain; [Gil, Angel] Univ Granada, Dept Biochem & Mol Biol 2, Campus Salud, Granada, Spain; [Gil, Angel] Univ Granada, Inst Nutr & Food Sci, Campus Salud, Granada, Spain; [Gonzalez-Gross, Marcela] Tech Univ Madrid, Dept Hlth & Human Performance, ImFINE Res Grp, Madrid, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Res Inst Biomed & Hlth Sci, Edificio Dept & Invest, Las Palmas Gran Canaria, Las Palmas, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Sch Med, Edificio Dept & Invest, Las Palmas Gran Canaria, Las Palmas, Spain; [Varela-Moreiras, Gregorio] CEU San Pablo Univ, Fac Pharm, Dept Pharmaceut & Hlth Sci, Madrid, Spain; [Varela-Moreiras, Gregorio] Spanish Nutr Fdn FEN, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Granada; University of Granada; Universidad Politecnica de Madrid; Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria; San Pablo CEU University	Ortega, RM (corresponding author), Univ Complutense Madrid, Fac Pharm, Dept Nutr, VALORNUT Res Grp, Madrid, Spain.	rortega@ucm.es	Gil, Angel/ABA-7621-2020; López-Sobaler, Ana M/I-3589-2016; Rodriguez, Elena Rodriguez/I-1836-2017; Ortega, Rosa M/S-5760-2016; Serra-Majem, Lluis/I-6708-2019; Gonzalez-Gross, Marcela/W-8000-2018; Jimenez, Ana Isabel/I-2750-2017	Gil, Angel/0000-0001-7663-0939; López-Sobaler, Ana M/0000-0002-4133-1450; Rodriguez, Elena Rodriguez/0000-0003-3513-4642; Ortega, Rosa M/0000-0003-3837-9450; Serra-Majem, Lluis/0000-0002-9658-9061; Gonzalez-Gross, Marcela/0000-0001-7757-3235; Jimenez, Ana Isabel/0000-0002-9868-1013; VARELA-MOREIRAS, GREGORIO/0000-0001-5158-4999	Coca Cola Iberia; Spanish Nutrition Foundation (FEN)	Coca Cola Iberia; Spanish Nutrition Foundation (FEN)	ANIBES Study was financially supported by Coca Cola Iberia through an agreement with the Spanish Nutrition Foundation (FEN). The funding sponsors had no role in the study design, data collection, analysis or interpretation of the data; the writing of the manuscript; or the decision to publish the results.; The authors would like to thank Coca Cola Iberia for its support and technical advice, particularly Rafael Urrialde and Isabel de Julian.	Ashwell Margaret, 2009, Nurs Stand, V23, P49; Audrain-McGovern J, 2011, CLIN PHARMACOL THER, V90, P164, DOI 10.1038/clpt.2011.105; Cohen AK, 2013, OBES REV, V14, P989, DOI 10.1111/obr.12062; Coll JL, 2015, OBESITY FACTS, V8, P220, DOI 10.1159/000435826; Comitato R, 2015, CRIT REV FOOD SCI, V55, P227, DOI 10.1080/10408398.2011.651177; Cortes-Franch Imma, 2014, Gac Sanit, V28 Suppl 1, P1, DOI 10.1016/j.gaceta.2014.03.011; Cummings DE, 2003, GASTROENTEROLOGY, V124, P1532, DOI 10.1016/S0016-5085(03)00350-0; Czernichow S, 2004, DIABETES METAB, V30, P153, DOI 10.1016/S1262-3636(07)70101-5; Filippidis FT, 2014, EUR J PUBLIC HEALTH, V24, P974, DOI 10.1093/eurpub/cku028; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Grandner MA, 2015, OBESITY, V23, P2491, DOI 10.1002/oby.21247; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Gutierrez-Fisac JL, 2012, OBES REV, V13, P388, DOI 10.1111/j.1467-789X.2011.00964.x; Healy GN, 2008, MED SCI SPORT EXER, V40, P639, DOI 10.1249/MSS.0b013e3181607421; Heinonen I, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002901; Hou XH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149234; Lallukka T, 2012, SLEEP MED, V13, P680, DOI 10.1016/j.sleep.2011.10.036; Leon-Munoz LM, 2014, CLIN NUTR, V33, P836, DOI 10.1016/j.clnu.2013.10.013; Liao Y, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-131; Lopez-Sobaler AM, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8341487; Luostarinen M, 2013, NICOTINE TOB RES, V15, P1696, DOI 10.1093/ntr/ntt043; Lv JT, 2015, MICRO NANO LETT, V10, P5, DOI 10.1049/mnl.2014.0525; Mansoubi M, 2014, PREV MED, V69, P28, DOI 10.1016/j.ypmed.2014.08.028; Marfell-Jones M, 2006, INT STANDARDS ANTHRO; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mekary RA, 2010, OBESITY, V18, P167, DOI 10.1038/oby.2009.170; Mielgo-Ayuso J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149969; Moholdt T, 2014, BRIT J SPORT MED, V48, P1489, DOI 10.1136/bjsports-2014-093416; Ogna A, 2014, EUR J NUTR, V53, P1281, DOI 10.1007/s00394-013-0643-2; Perez-Farinos N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/163687; Roman-Vinas B, 2010, EUR J SPORT SCI, V10, P297, DOI 10.1080/17461390903426667; Rosiek A, 2015, INT J ENV RES PUB HE, V12, P9408, DOI 10.3390/ijerph120809408; Ruiz E, 2015, NUTRIENTS, V7, P970, DOI 10.3390/nu7020970; Sayon-Orea C, 2013, OBESITY FACTS, V6, P337, DOI 10.1159/000354746; Serra-Majem L, 2013, NUTR HOSP, V28, P32, DOI 10.3305/nh.2013.28.sup5.6916; Sperry SD, 2015, SLEEP, V38, P1269, DOI 10.5665/sleep.4906; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Turrell G, 2003, PUBLIC HEALTH NUTR, V6, P191, DOI 10.1079/PHN2002416; Vernay M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-215; WHO, 2000, OB PREV MAN GLOB EP; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	41	23	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0169027	10.1371/journal.pone.0169027	http://dx.doi.org/10.1371/journal.pone.0169027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033380	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900069
J	Wangroongsarb, P; Hwang, J; Thwing, J; Karuchit, S; Kumpetch, S; Rand, A; Drakeley, C; MacArthur, JR; Kachur, SP; Satimail, W; Meele, S; Sintasath, DM				Wangroongsarb, Piyaporn; Hwang, Jimee; Thwing, Julie; Karuchit, Samart; Kumpetch, Suthon; Rand, Alison; Drakeley, Chris; MacArthur, John R.; Kachur, S. Patrick; Satimail, Wichai; Meele, Sylvia; Sintasath, David M.			Using Respondent Driven Sampling to Identify Malaria Risks and Occupational Networks among Migrant Workers in Ranong, Thailand	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; HIDDEN POPULATIONS; RESISTANT MALARIA; TRANSMISSION; CAMBODIA; BORDER	Background Ranong Province in southern Thailand is one of the primary entry points for migrants entering Thailand from Myanmar, and borders Kawthaung Township in Myanmar where artemisinin resistance in malaria parasites has been detected. Areas of high population movement could increase the risk of spread of artemisinin resistance in this region and beyond. Methods A respondent-driven sampling (RDS) methodology was used to compare migrant populations coming from Myanmar in urban (Site 1) vs. rural (Site 2) settings in Ranong, Thailand. The RDS methodology collected information on knowledge, attitudes, and practices for malaria, travel and occupational histories, as well as social network size and structure. Individuals enrolled were screened for malaria by microscopy, Real Time-PCR, and serology. Results A total of 619 participants were recruited in Ranong City and 623 participants in Kraburi, a rural sub-district. By PCR, a total of 14 (1.1%) samples were positive (2 P. falciparum in Site 1; 10 P. vivax, 1 Pf, and 1 P. malariae in Site 2). PCR analysis demonstrated an overall weighted prevalence of 0.5% (95% CI, 0-1.3%) in the urban site and 1.0% (95% CI, 0.5-1.7%) in the rural site for all parasite species. PCR positivity did not correlate with serological positivity; however, as expected there was a strong association between antibody prevalence and both age and exposure. Access to long-lasting insecticidal treated nets remains low despite relatively high reported traditional net use among these populations. Conclusions The low malaria prevalence, relatively smaller networks among migrants in rural settings, and limited frequency of travel to and from other areas of malaria transmission in Myanmar, suggest that the risk for the spread of artemisinin resistance from this area may be limited in these networks currently but may have implications for regional malaria elimination efforts.	[Wangroongsarb, Piyaporn; Satimail, Wichai] Minist Publ Hlth, Dept Dis Control, Bur Vector Borne Dis, Nonathaburi, Thailand; [Hwang, Jimee] Ctr Dis Control & Prevent, US Presidents Malaria Initiat, Malaria Branch, Div Parasit Dis & Malaria, Atlanta, GA USA; [Hwang, Jimee] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Thwing, Julie; Kachur, S. Patrick] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Atlanta, GA USA; [Karuchit, Samart; MacArthur, John R.] Thailand MOPH US CDC Collaborat, Nonathaburi, Thailand; [Kumpetch, Suthon] Minist Publ Hlth, Ranong Prov Hlth Off, Ranong, Thailand; [Rand, Alison; Drakeley, Chris] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England; [Meele, Sylvia] Malaria Consortium, London, England; [Sintasath, David M.] USAID RDMA, US Presidents Malaria Initiat, Bangkok, Thailand	Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine	Sintasath, DM (corresponding author), USAID RDMA, US Presidents Malaria Initiat, Bangkok, Thailand.	dsintasath@usaid.gov	Kachur, Patrick/ABE-7220-2021		USAID; CDC; Malaria Consortium [5U01CK000112-05]	USAID(United States Agency for International Development (USAID)); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Malaria Consortium	This study was funded by USAID through an Interagency Agreement with CDC through a cooperative agreement with Malaria Consortium (5U01CK000112-05). USAID and CDC contributed to the design, analysis, and preparation of the manuscript.	Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DSS, 2002, AIDS BEHAV, P1; Johnston LG, 2006, J URBAN HEALTH, V83, pI16, DOI 10.1007/s11524-006-9099-5; Khamsiriwatchara A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-120; Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Perez AO, 2012, EUR ADDICT RES, V18, P184, DOI 10.1159/000336118; Reisner SL, 2010, J URBAN HEALTH, V87, P467, DOI 10.1007/s11524-010-9439-3; Richards AK, 2009, TROP MED INT HEALTH, V14, P512, DOI 10.1111/j.1365-3156.2009.02258.x; Richards Adam K, 2007, Confl Health, V1, P9, DOI 10.1186/1752-1505-1-9; Rogawski ET, 2012, AM J TROP MED HYG, V86, P789, DOI 10.4269/ajtmh.2012.11-0617; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Tatem AJ, 2010, P NATL ACAD SCI USA, V107, P12222, DOI 10.1073/pnas.1002971107; VERDRAGER J, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P111; Volz E., 2012, RESPONDENT DRIVEN SA; Wangroongsarb P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-117; White RG, 2012, SEX TRANSM INFECT, V88, P397, DOI 10.1136/sextrans-2012-050703; Wiwanitkit V, 2002, SCAND J INFECT DIS, V34, P236, DOI 10.1080/00365540110077272; World Health Organization, 2011, GLOB PLAN ART RECO	27	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168371	10.1371/journal.pone.0168371	http://dx.doi.org/10.1371/journal.pone.0168371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7KQ	28033322	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000391226900022
J	Park, MS; Kim, YD; Kim, BM; Kim, YJ; Kim, JK; Rhee, JS				Park, Mi Seon; Kim, Young Dae; Kim, Bo-Mi; Kim, Youn-Jung; Kim, Jang Kyun; Rhee, Jae-Sung			Effects of Antifouling Biocides on Molecular and Biochemical Defense System in the Gill of the Pacific Oyster Crassostrea gigas	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; COPEPOD TIGRIOPUS-JAPONICUS; ROTIFER BRACHIONUS-KOREANUS; OXIDATIVE STRESS; MONOGONONT ROTIFER; PESTICIDE EXPOSURE; ACETYLCHOLINESTERASE ACTIVITY; ANTIOXIDANT ENZYMES; ORGANOTIN COMPOUNDS; MARINE-ENVIRONMENT	Antifouling biocides such as organotin compounds and their alternatives are potent toxicants in marine ecosystems. In this study, we employed several molecular and biochemical response systems of the Pacific oyster Crassostrea gigas to understand a potential mode of action of antifouling biocides (i.e. tributyltin (TBT), diuron and irgarol) after exposure to different concentrations (0.01, 0.1, and 1 mu g L-1) for 96 h. As a result, all the three antifouling biocides strongly induced the antioxidant defense system. TBT reduced both enzymatic activity and mRNA expression of Na+/K+-ATPase and acetylcholinesterase (AChE). Lower levels of both Na+/K+-ATPase activity and AChE mRNA expression were observed in the diuron-exposed oysters compared to the control, while the irgarol treatment reduced only the transcriptional expression of AChE gene. We also analyzed transcript profile of heat shock protein (Hsp) superfamily in same experimental conditions. All antifouling biocides tested in this study significantly modulated mRNA expression of Hsp superfamily with strong induction of Hsp70 family. Taken together, overall results indicate that representative organotin TBT and alternatives have potential hazardous effects on the gill of C. gigas within relatively short time period. Our results also suggest that analyzing a series of molecular and biochemical parameters can be a way of understanding and uncovering the mode of action of emerging antifouling biocides. In particular, it was revealed that Pacific oysters have different sensitivities depend on the antifouling biocides.	[Park, Mi Seon; Kim, Young Dae] Natl Inst Fisheries Sci, Southeast Sea Fisheries Res Inst, Tongyeong, South Korea; [Kim, Bo-Mi] Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea; [Kim, Youn-Jung; Kim, Jang Kyun; Rhee, Jae-Sung] Incheon Natl Univ, Dept Marine Sci, Coll Nat Sci, Incheon, South Korea; [Kim, Jang Kyun; Rhee, Jae-Sung] Incheon Natl Univ, Res Inst Basic Sci, Incheon, South Korea; [Rhee, Jae-Sung] Inst Green Environm Res Ctr, 169 Gaetbeol Ro, Incheon, South Korea	National Institute of Fisheries Science; Korea Polar Research Institute (KOPRI); Incheon National University; Incheon National University	Kim, JK; Rhee, JS (corresponding author), Incheon Natl Univ, Dept Marine Sci, Coll Nat Sci, Incheon, South Korea.; Kim, JK; Rhee, JS (corresponding author), Incheon Natl Univ, Res Inst Basic Sci, Incheon, South Korea.; Rhee, JS (corresponding author), Inst Green Environm Res Ctr, 169 Gaetbeol Ro, Incheon, South Korea.	jang.kim@inu.ac.kr; jsrhee@inu.ac.kr		Rhee, Jae-Sung/0000-0003-3313-8850	National Institute of Fisheries Science, Republic of Korea [R2016015]	National Institute of Fisheries Science, Republic of Korea	This work was supported by a grant from the National Institute of Fisheries Science (R2016015), http://www.nifs.go.kr/en/, Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcha F, 2016, ENVIRON SCI POLLUT R, V23, P8008, DOI 10.1007/s11356-015-5969-2; Akcha F, 2012, AQUAT TOXICOL, V106, P104, DOI 10.1016/j.aquatox.2011.10.018; ALDRIDGE WN, 1977, BIOCHEM PHARMACOL, V26, P1997, DOI 10.1016/0006-2952(77)90008-9; ALZIEU C, 1986, MAR POLLUT BULL, V17, P494, DOI 10.1016/0025-326X(86)90636-3; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Antizar-Ladislao B, 2008, ENVIRON INT, V34, P292, DOI 10.1016/j.envint.2007.09.005; Guardiola FA, 2012, INT J MOL SCI, V13, P1541, DOI 10.3390/ijms13021541; Baek Inseon, 2015, Toxicology and Environmental Health Sciences, V7, P303, DOI 10.1007/s13530-015-0253-x; Barranger A, 2016, COMP BIOCHEM PHYS C, V180, P23, DOI 10.1016/j.cbpc.2015.11.002; Beguel JP, 2013, COMP BIOCHEM PHYS C, V157, P63, DOI 10.1016/j.cbpc.2012.10.004; Bianchini A, 2003, ENVIRON TOXICOL CHEM, V22, P1361, DOI [10.1002/etc.5620220624, 10.1897/1551-5028(2003)022&lt;1361:MOASTI&gt;2.0.CO;2]; Bouilly K, 2007, ARCH ENVIRON CON TOX, V52, P58, DOI 10.1007/s00244-005-0256-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Callow ME, 1995, BIOFOULING, V9, P153, DOI 10.1080/08927019509378299; Clayton ME, 2000, AQUAT TOXICOL, V47, P213, DOI 10.1016/S0166-445X(99)00022-3; Collin H, 2010, J EXP BIOL, V213, P4010, DOI 10.1242/jeb.048033; Cruz-Rodriguez LA, 2002, AQUAT TOXICOL, V60, P157, DOI 10.1016/S0166-445X(02)00008-5; Dafforn KA, 2011, MAR POLLUT BULL, V62, P453, DOI 10.1016/j.marpolbul.2011.01.012; Downs C, 2007, ARCH ENVIRON CON TOX, V52, P47, DOI 10.1007/s00244-005-0213-6; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Elsabbagh HS, 2002, PHARMACOL RES, V45, P201, DOI 10.1006/phrs.2001.0909; Fabbri E, 2008, INVERTEBRATE SURVIV, V5, pe161; Farcy E, 2009, CELL STRESS CHAPERON, V14, P371, DOI 10.1007/s12192-008-0091-8; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FISH RH, 1977, TETRAHEDRON LETT, P3515; Gagnaire B, 2007, AQUAT TOXICOL, V84, P92, DOI 10.1016/j.aquatox.2007.06.002; Geret F, 2002, AQUAT LIVING RESOUR, V15, P61, DOI 10.1016/S0990-7440(01)01147-0; Giacomin M, 2013, AQUAT TOXICOL, V144, P105, DOI 10.1016/j.aquatox.2013.09.028; Guo SH, 2007, CELL STRESS CHAPERON, V12, P245, DOI 10.1379/CSC-265.1; Hamdoun AM, 2003, BIOL BULL-US, V205, P160, DOI 10.2307/1543236; Hartl MGJ, 2001, AQUAT TOXICOL, V55, P125, DOI 10.1016/S0166-445X(01)00184-9; Horiguchi T, 1997, APPL ORGANOMET CHEM, V11, P451, DOI 10.1002/(SICI)1099-0739(199705)11:5<451::AID-AOC598>3.0.CO;2-#; Horiguchi Toshihiro, 2006, Environmental Sciences, V13, P77; Jo PG, 2008, COMP BIOCHEM PHYS C, V147, P460, DOI 10.1016/j.cbpc.2008.02.001; Kalmar B, 2009, ADV DRUG DELIVER REV, V61, P310, DOI 10.1016/j.addr.2009.02.003; Kim BM, 2011, CHEMOSPHERE, V84, P1467, DOI 10.1016/j.chemosphere.2011.04.043; Kim RO, 2016, ENVIRON TOXICOL CHEM, V35, P1449, DOI 10.1002/etc.3288; Kim RO, 2013, ENVIRON SCI TECHNOL, V47, P13804, DOI 10.1021/es403269v; Konstantinou IK, 2004, ENVIRON INT, V30, P235, DOI 10.1016/S0160-4120(03)00176-4; Kotake Y, 2012, BIOL PHARM BULL, V35, P1876, DOI 10.1248/bpb.b212017; La Terza A, 2004, ANTARCT SCI, V16, P23, DOI 10.1017/S0954102004001774; Lee JW, 2015, COMP BIOCHEM PHYS C, V167, P147, DOI 10.1016/j.cbpc.2014.10.005; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lewis JA, 1998, MARINE BIOFOULING IT; Li ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123091; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano P, 2014, ECOTOX ENVIRON SAFE, V104, P294, DOI 10.1016/j.ecoenv.2014.03.021; Lucu C, 1999, AM J PHYSIOL-REG I, V276, pR490, DOI 10.1152/ajpregu.1999.276.2.R490; Mai H, 2013, MAR ENVIRON RES, V89, P1, DOI [10.1016/j.marenvres.2013.04.003, 10.1016/j.envres.2013.02.006]; Matthiessen P, 1998, ENVIRON TOXICOL CHEM, V17, P37, DOI 10.1002/etc.5620170106; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; Metzger DC, 2012, J SHELLFISH RES, V31, P627, DOI 10.2983/035.031.0305; Morcillo Y, 1997, ARCH ENVIRON CON TOX, V32, P198, DOI 10.1007/s002449900175; Nakatsu Y, 2007, TOXICOL SCI, V97, P438, DOI 10.1093/toxsci/kfm039; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Niyogi S, 2001, SCI TOTAL ENVIRON, V281, P237, DOI 10.1016/S0048-9697(01)00850-6; Oberdorster E, 1998, AQUAT TOXICOL, V41, P83, DOI 10.1016/S0166-445X(97)00067-2; Rainbow PS, 1995, MAR POLLUT BULL, V31, P183, DOI 10.1016/0025-326X(95)00116-5; Rhee JS, 2007, AQUAT TOXICOL, V83, P104, DOI 10.1016/j.aquatox.2007.03.015; Rhee JS, 2013, COMP BIOCHEM PHYS C, V158, P216, DOI 10.1016/j.cbpc.2013.08.005; Rondon R, 2016, AQUAT TOXICOL, V175, P47, DOI 10.1016/j.aquatox.2016.03.007; ROSENBERG DW, 1983, BIOCHEM PHARMACOL, V32, P3823, DOI 10.1016/0006-2952(83)90155-7; Samuel PM, 1998, J APPL TOXICOL, V18, P383, DOI 10.1002/(SICI)1099-1263(1998090)18:5<383::AID-JAT523>3.3.CO;2-S; Serrano MAS, 2015, ENVIRON SCI POLLUT R, V22, P17375, DOI 10.1007/s11356-014-4023-0; Slaninova A, 2009, NEUROENDOCRINOL LETT, V30, P2; Sole M, 2000, B ENVIRON CONTAM TOX, V64, P852; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; STEGEMAN JJ, 1973, MAR BIOL, V22, P37, DOI 10.1007/BF00388908; STEINERT SA, 1993, MAR ENVIRON RES, V35, P89, DOI 10.1016/0141-1136(93)90019-V; Tanguy A, 2005, FEBS J, V272, P390, DOI 10.1111/j.1742-4658.2004.04479.x; Thomas KV, 2010, BIOFOULING, V26, P73, DOI 10.1080/08927010903216564; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Wang L, 2013, TOXICOL IN VITRO, V27, P1771, DOI 10.1016/j.tiv.2013.05.006; Wang Y, 2012, B ENVIRON CONTAM TOX, V89, P704, DOI 10.1007/s00128-012-0760-2; Wu YQ, 2007, J ENVIRON SCI-CHINA, V19, P1129, DOI 10.1016/S1001-0742(07)60184-3; Zhang GF, 2016, ANNU REV ANIM BIOSCI, V4, P357, DOI 10.1146/annurev-animal-022114-110903; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang JL, 2008, CHEMOSPHERE, V73, P337, DOI 10.1016/j.chemosphere.2008.05.072; Zhu QH, 2016, MAR BIOTECHNOL, V18, P176, DOI 10.1007/s10126-015-9678-0	81	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168978	10.1371/journal.pone.0168978	http://dx.doi.org/10.1371/journal.pone.0168978			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006823	Green Submitted, gold, Green Published			2022-12-26	WOS:000392843200120
J	Zhang, GW; Wang, Z; Ling, X; Zou, P; Yang, H; Chen, Q; Zhou, NY; Sun, L; Gao, JF; Zhou, ZY; Cao, J; Ao, L				Zhang, Guowei; Wang, Zhi; Ling, Xi; Zou, Peng; Yang, Huan; Chen, Qing; Zhou, Niya; Sun, Lei; Gao, Jianfang; Zhou, Ziyuan; Cao, Jia; Ao, Lin			Mitochondrial Biomarkers Reflect Semen Quality: Results from the MARCHS Study in Chongqing, China	PLOS ONE			English	Article							URINARY PHTHALATE METABOLITES; MALE REPRODUCTIVE HEALTH; SPERM DNA FRAGMENTATION; MALE-INFERTILITY; HUMAN SPERMATOZOA; CIGARETTE-SMOKING; MEN; FUNCTIONALITY; PARAMETERS; DAMAGE	Unexplained infertility requires that more sensitive and mechanism-based biomarkers should be developed and used independently of or in addition to conventional semen parameters for an infertility diagnosis. In the present study, semen samples were collected from young men participating in the Male Reproductive Health in Chongqing College students (MARCHS) cohort study in the follow-up stage in 2014. Conventional semen parameters were measured in all 656 participants, whereas sperm mitochondrial membrane potential (MMP), mitochondrial DNA copy number (mtDNAcn), mtDNA integrity and apoptotic parameters were measured among 627, 386, 362, and 628 participants, respectively. We found that sperm MMP was significantly positively correlated with all of conventional semen parameters including semen volume (r = 0.090, p = 0.025), sperm concentration (r = 0.301, p<0.01), total sperm count (r = 0.324, p<0.01), and progressive motility (r = 0.399, p<0.01); sperm MMP was also negatively correlated with Annexin V+ sperm (r = -0.553, p<0.01); mtDNAcn was significantly negatively correlated with sperm concentration (r = -0.214, p<0.01), total sperm count (r = -0.232, p<0.01), and progressive motility (r = -0.164, p = 0.01); mtDNA integrity was also significantly positively correlated with sperm concentration (r = 0.195, p<0.01), total sperm count (r = 0.185, p<0.01), and progressive motility (r = 0.106, p = 0.043). After adjusting for potential confounders, these relationships remained significant. Furthermore, we explored the potential effects of lifestyles on such mitochondrial biomarkers and found that the current drinkers displayed a higher level of sperm MMP; additionally, mt DNAcn was increased with age. The results indicated that certain mitochondrial biomarkers could serve as predictors of semen quality in a general population, and the study provides a baseline for the effects of population characteristics and lifestyles on such mitochondrial markers.	[Zhang, Guowei; Zhou, Ziyuan] Third Mil Med Univ, Dept Environm Hlth, Coll Prevent Med, Chongqing, Peoples R China; [Wang, Zhi; Ling, Xi; Zou, Peng; Yang, Huan; Chen, Qing; Zhou, Niya; Sun, Lei; Gao, Jianfang; Cao, Jia; Ao, Lin] Third Mil Med Univ, Inst Toxicol, Coll Prevent Med, Chongqing, Peoples R China	Army Medical University; Army Medical University	Cao, J; Ao, L (corresponding author), Third Mil Med Univ, Inst Toxicol, Coll Prevent Med, Chongqing, Peoples R China.	tmmuwsdlcaojia@126.com; tmmuwsdlaolin@126.com	陈, 卿/Q-5601-2019	陈, 卿/0000-0003-4108-7977	National Natural Science Foundation of China [81130051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study is funded by the National Natural Science Foundation of China (grant number 81130051), http://www.nsfc.gov.cn/, to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, FERTIL STERIL, V84, P850, DOI 10.1016/j.fertnstert.2005.03.080; Aitken RJ, 2013, INT J DEV BIOL, V57, P265, DOI 10.1387/ijdb.130146ja; Amaral A, 2013, REPRODUCTION, V146, pR163, DOI 10.1530/REP-13-0178; Anifandis G, 2014, ARCH GYNECOL OBSTET, V290, P777, DOI 10.1007/s00404-014-3281-x; Barazani Y, 2014, UROL CLIN N AM, V41, P55, DOI 10.1016/j.ucl.2013.08.017; Chandra Anjani, 2014, Natl Health Stat Report, P1; Cummins JM, 1998, INT J ANDROL, V21, P47; de Jong AME, 2014, ANDROLOGIA, V46, P112, DOI 10.1111/and.12054; Diez-Sanchez C, 2003, BIOL REPROD, V68, P180, DOI 10.1095/biolreprod.102.005140; Dodaran HV, 2015, CRYOBIOLOGY, V71, P12, DOI 10.1016/j.cryobiol.2015.06.008; Eskenazi B, 2003, HUM REPROD, V18, P447, DOI 10.1093/humrep/deg107; Espinoza JA, 2009, HUM REPROD, V24, P2079, DOI 10.1093/humrep/dep120; Gallon F, 2006, FERTIL STERIL, V86, P1526, DOI 10.1016/j.fertnstert.2006.03.055; Grobner S, 2015, J BIOL REG HOMEOS AG, V29, P317; Han X, 2014, INT J HYG ENVIR HEAL, V217, P271, DOI 10.1016/j.ijheh.2013.06.006; Han X, 2011, ENVIRON HEALTH PERSP, V119, P652, DOI 10.1289/ehp.1002340; Huang HFS, 2004, J SPINAL CORD MED, V27, P55, DOI 10.1080/10790268.2004.11753731; Ieremiadou Fotini, 2009, BMC Res Notes, V2, P18, DOI 10.1186/1756-0500-2-18; Jensen TK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005462; Jensen TK, 2014, HUM REPROD, V29, P1801, DOI 10.1093/humrep/deu118; Jurewicz J, 2013, REPROD TOXICOL, V42, P232, DOI 10.1016/j.reprotox.2013.10.001; KAO SH, 1995, BIOL REPROD, V52, P729, DOI 10.1095/biolreprod52.4.729; Kidd SA, 2001, FERTIL STERIL, V75, P237, DOI 10.1016/S0015-0282(00)01679-4; Ko EY, 2014, FERTIL STERIL, V102, P1518, DOI 10.1016/j.fertnstert.2014.10.020; Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6; Lee HC, 2000, J BIOMED SCI, V7, P2, DOI 10.1007/BF02255913; Marchetti P, 2012, ANDROLOGIA, V44, P136, DOI 10.1111/j.1439-0272.2010.01117.x; May-Panloup P, 2003, HUM REPROD, V18, P550, DOI 10.1093/humrep/deg096; Pant N, 2008, TOXICOL APPL PHARM, V231, P112, DOI 10.1016/j.taap.2008.04.001; Paoli D, 2011, FERTIL STERIL, V95, P2315, DOI 10.1016/j.fertnstert.2011.03.059; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2; Rajender S, 2010, MITOCHONDRION, V10, P419, DOI 10.1016/j.mito.2010.05.015; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Rashki Ghaleno L, 2015, GYNECOL OBSTET INVES; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sawyer DE, 2003, MUTAT RES-FUND MOL M, V529, P21, DOI 10.1016/S0027-5107(03)00101-5; Shafik A, 2006, ARCH ANDROLOGY, V52, P197, DOI 10.1080/01485010500503561; Sharlip ID, 2002, FERTIL STERIL, V77, P873, DOI 10.1016/S0015-0282(02)03105-9; Smith RP, 2014, UROL CLIN N AM, V41, P19, DOI 10.1016/j.ucl.2013.08.002; Song GJ, 2008, FERTIL STERIL, V90, P2238, DOI 10.1016/j.fertnstert.2007.10.059; St John JC, 2001, MOL HUM REPROD, V7, P103, DOI 10.1093/molehr/7.1.103; Stepanov I, 2009, CHEM RES TOXICOL, V22, P406, DOI 10.1021/tx800398x; THONNEAU P, 1991, HUM REPROD, V6, P811, DOI 10.1093/oxfordjournals.humrep.a137433; Troiano L, 1998, EXP CELL RES, V241, P384, DOI 10.1006/excr.1998.4064; Wang MJ, 2012, ANTIOXID REDOX SIGN, V17, P513, DOI 10.1089/ars.2012.4514; Yang H, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001166; Zorn B, 2012, J ASSIST REPROD GEN, V29, P357, DOI 10.1007/s10815-012-9718-x	49	35	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168823	10.1371/journal.pone.0168823	http://dx.doi.org/10.1371/journal.pone.0168823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006017	Green Submitted, Green Published, gold			2022-12-26	WOS:000392843200099
J	Zhao, LJ; Ni, Y; Yu, HY; Zhang, P; Zhao, AH; Bao, YQ; Liu, JJ; Chen, TL; Xie, GX; Panee, J; Chen, WL; Rajani, C; Wei, RM; Su, MM; Jia, WP; Jia, W				Zhao, Linjing; Ni, Yan; Yu, Haoyong; Zhang, Pin; Zhao, Aihua; Bao, Yuqian; Liu, Jiajian; Chen, Tianlu; Xie, Guoxiang; Panee, Jun; Chen, Wenlian; Rajani, Cynthia; Wei, Runmin; Su, Mingming; Jia, Weiping; Jia, Wei			Serum stearic acid/palmitic acid ratio as a potential predictor of diabetes remission after Roux-en-Y gastric bypass in obesity	FASEB JOURNAL			English	Article						bariatric surgery; fatty acid metabolism; elovl6; UPLC/QTOFMS; targeted metabolomics	POLYUNSATURATED FATTY-ACIDS; HUMAN ADIPOSE-TISSUE; BODY-MASS INDEX; INSULIN SENSITIVITY; DESATURASE ACTIVITY; BARIATRIC SURGERY; DELTA-6 DESATURASE; WEIGHT-LOSS; RISK; ASSOCIATION	Endogenous fatty acid metabolism that results in elongation and desaturation lipid products is thought to play a role in the development of type 2 diabetes mellitus (T2DM). In this study, we evaluated the potential of estimated elongase and desaturase activities for use as predictive markers for T2DM remission after Roux-en-Y gastric bypass (RYGB). The results of a targeted metabolomics approach from 2 independent studies were used to calculate 24 serum FA concentration ratios (product/precursor). Gene expression data from an open public data set was also analyzed. In a longitudinal study of 38 obese diabetic patients with RYGB, we found higher baseline stearic acid/palmitic acid(S/P) ratio. This ratio reflects anelovl6-encoded elongase enzyme activity that has been found to be associated with greater possibility for diabetes remission after RYGB [ odds ratio, 2.16 (95% CI 1.10-4.26)], after adjustment for age, gender, body mass index, diabetes duration, glycosylated hemoglobin A1c, and fasting C-peptide. Our results were validated by examination of postsurgical elovl6 gene expression in morbidly obese patients. The association of S/P with the metabolic status of obese individuals was further validated in a crosssectional cohort of 381 participants. In summary, higher baseline S/P was associated with greater probability of diabetes remission after RYGB and may serve as a diagnostic marker in preoperative patient assessment.-Zhao, L., Ni, Y., Yu, H., Zhang, P., Zhao, A., Bao, Y., Liu, J., Chen, T., Xie, G., Panee, J., Chen, W., Rajani, C., Wei, R., Su, M., Jia, W., Jia, W. Serum stearic acid/palmitic acid ratio as a potential predictor of diabetes remission after Roux-en-Y gastric bypass in obesity. FASEB J. 31, 1449-1460 (2017). www.fasebj.org	[Zhao, Linjing; Ni, Yan; Zhao, Aihua; Bao, Yuqian; Liu, Jiajian; Chen, Tianlu; Jia, Weiping; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, Shanghai, Peoples R China; [Zhao, Linjing; Ni, Yan; Zhao, Aihua; Bao, Yuqian; Liu, Jiajian; Chen, Tianlu; Jia, Weiping; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Translat Med, Shanghai, Peoples R China; [Zhao, Linjing] Shanghai Univ Engn Sci, Coll Chem & Chem Engn, Shanghai, Peoples R China; [Ni, Yan; Xie, Guoxiang; Chen, Wenlian; Rajani, Cynthia; Wei, Runmin; Su, Mingming; Jia, Wei] Univ Hawaii, Canc Ctr, 701 Ilalo St, Honolulu, HI 96813 USA; [Yu, Haoyong; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Zhang, Pin] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Gen Surg, Shanghai, Peoples R China; [Panee, Jun] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai University of Engineering Science; Cancer Research Center of Hawaii; University of Hawaii System; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Hawaii System; University of Hawaii Manoa	Jia, W (corresponding author), Univ Hawaii, Canc Ctr, 701 Ilalo St, Honolulu, HI 96813 USA.; Jia, WP (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China.	wpjia@sjtu.edu.cn; wjia@cc.hawaii.edu	Xie, Guoxiang/F-3022-2016; Wei, Runmin/J-6128-2019; Jia, Wei/AAN-5102-2020	Xie, Guoxiang/0000-0002-0951-4150; Wei, Runmin/0000-0001-7707-0160; Jia, Wei/0000-0002-3739-8994	International Science and Technology Cooperation Program of China [2014DFA31870]; China Scholarship Council [201408310049]; GEO [GSE53376]; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	International Science and Technology Cooperation Program of China; China Scholarship Council(China Scholarship Council); GEO; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by grants from International Science and Technology Cooperation Program of China (2014DFA31870) and China Scholarship Council (201408310049). The authors thank Dr. F. J. Ortega and Dr. J. M. Fernandez-Real for sharing the clinical data of microarray datasets, GEO GSE53376. The authors declare no conflicts of interest.	Aarts EO, 2013, OBES SURG, V23, P867, DOI 10.1007/s11695-013-0872-8; Arora T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126401; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Campos GM, 2014, SURG OBES RELAT DIS, V10, P1, DOI 10.1016/j.soard.2013.07.010; Chen WL, 2014, BLOOD, V124, P1645, DOI 10.1182/blood-2014-02-554204; Courcoulas AP, 2013, JAMA-J AM MED ASSOC, V310, P2416, DOI 10.1001/jama.2013.280928; Curry TB, 2011, AM J PHYSIOL-ENDOC M, V300, pE746, DOI 10.1152/ajpendo.00596.2010; de Antueno RJ, 2001, FEBS LETT, V509, P77, DOI 10.1016/S0014-5793(01)03135-0; Dixon JB, 2013, DIABETES CARE, V36, P20, DOI 10.2337/dc12-0779; EVANS DJ, 1984, J CLIN INVEST, V74, P1515, DOI 10.1172/JCI111565; Ferrannini E, 2013, DIABETES, V62, P1730, DOI 10.2337/db12-0707; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9; Gonzalez-Plaza JJ, 2016, SURG OBES RELAT DIS, V12, P257, DOI 10.1016/j.soard.2015.07.007; Halliwell KJ, 1996, J LIPID RES, V37, P1842; Hayes MT, 2011, OBES SURG, V21, P910, DOI 10.1007/s11695-011-0370-9; Hellerstein MK, 1996, ANNU REV NUTR, V16, P523, DOI 10.1146/annurev.nu.16.070196.002515; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Huang CK, 2011, OBES SURG, V21, P1344, DOI 10.1007/s11695-011-0408-z; Hudgins LC, 1996, J CLIN INVEST, V97, P2081, DOI 10.1172/JCI118645; Jacobs S, 2015, AM J CLIN NUTR, V102, P155, DOI 10.3945/ajcn.114.102707; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Johansson LE, 2012, AM J CLIN NUTR, V96, P196, DOI 10.3945/ajcn.111.020578; Kegg Pathway Database, BIOS UNS FATT AC; Kim MK, 2011, OBESITY, V19, P1835, DOI 10.1038/oby.2011.205; Kroger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447; Lankinen MA, 2015, DIABETOLOGIA, V58, P2533, DOI 10.1007/s00125-015-3730-5; Lee WJ, 2015, SURG OBES RELAT DIS, V11, P991, DOI 10.1016/j.soard.2014.12.027; Li SW, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0834-8; Liang ZW, 2013, DIABETES RES CLIN PR, V101, P50, DOI 10.1016/j.diabres.2013.04.005; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Luo P, 2016, J PROTEOME RES, V15, P1288, DOI 10.1021/acs.jproteome.6b00022; Mahendran Y, 2014, AM J CLIN NUTR, V99, P79, DOI 10.3945/ajcn.113.069740; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Mor A, 2014, SURG ENDOSC, V28, P1489, DOI 10.1007/s00464-013-3338-0; Ni Y, 2015, EBIOMEDICINE, V2, P1513, DOI 10.1016/j.ebiom.2015.09.004; Ortega F.J., 2014, ADIPOSE TRANSCRIPTOM; PUTTMANN M, 1993, CLIN CHEM, V39, P825; Reynoso R, 2003, MOL CELL BIOCHEM, V246, P155, DOI 10.1023/A:1023423005187; Robert M, 2013, OBES SURG, V23, P770, DOI 10.1007/s11695-013-0868-4; Rubino F, 2006, CURR OPIN CLIN NUTR, V9, P497, DOI 10.1097/01.mco.0000232914.14978.c5; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Sieber J, 2010, AM J PHYSIOL-RENAL, V299, pF821, DOI 10.1152/ajprenal.00196.2010; Still CD, 2014, LANCET DIABETES ENDO, V2, P38, DOI 10.1016/S2213-8587(13)70070-6; Thyfault JP, 2004, AM J PHYSIOL-ENDOC M, V287, pE1076, DOI 10.1152/ajpendo.00177.2004; Vaittinen M, 2016, J LIPID RES, V57, P56, DOI 10.1194/jlr.M059113; van den Berg SAA, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-24; VANDERVUSSE GJ, 1985, J MOL CELL CARDIOL, V17, P527, DOI 10.1016/S0022-2828(85)80059-6; VESSBY B, 1994, DIABETES, V43, P1353, DOI 10.2337/diabetes.43.11.1353; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Yary T, 2016, AM J CLIN NUTR, V103, P1337, DOI 10.3945/ajcn.115.128629; Yu HY, 2015, J CLIN ENDOCR METAB, V100, P4222, DOI 10.1210/jc.2015-2884; Yu HY, 2015, SURG OBES RELAT DIS, V11, P6, DOI 10.1016/j.soard.2014.06.019; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	58	25	27	4	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1449	1460		10.1096/fj.201600927R	http://dx.doi.org/10.1096/fj.201600927R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28007782	Green Published			2022-12-26	WOS:000398504300015
J	Waz, S; Nakamura, T; Hirata, K; Koga-Ogawa, Y; Chirifu, M; Arimori, T; Tamada, T; Ikemizu, S; Nakabeppu, Y; Yamagata, Y				Waz, Shaimaa; Nakamura, Teruya; Hirata, Keisuke; Koga-Ogawa, Yukari; Chirifu, Mami; Arimori, Takao; Tamada, Taro; Ikemizu, Shinji; Nakabeppu, Yusaku; Yamagata, Yuriko			Structural and Kinetic Studies of the Human Nudix Hydrolase MTH1 Reveal the Mechanism for Its Broad Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE DNA-DAMAGE; HUMAN MUTT HOMOLOG; X-RAY ANALYSIS; CRYSTAL-STRUCTURE; PROTEIN; CANCER; EXPRESSION; CRYSTALLIZATION; NUCLEOTIDES; RECOGNITION	The human MutT homolog 1 (hMTH1, human NUDT1) hydrolyzes oxidatively damaged nucleoside triphosphates and is the main enzyme responsible for nucleotide sanitization. hMTH1 recently has received attention as an anticancer target because hMTH1 blockade leads to accumulation of oxidized nucleotides in the cell, resulting in mutations and death of cancer cells. Unlike Escherichia coli MutT, which shows high substrate specificity for 8-oxoguanine nucleotides, hMTH1 has broad substrate specificity for oxidized nucleotides, including 8-oxo-dGTP and 2-oxo-dATP. However, the reason for this broad substrate specificity remains unclear. Here, we determined crystal structures of hMTH1 in complex with 8-oxodGTP or 2-oxo-dATP at neutral pH. These structures based on high quality data showed that the base moieties of two substrates are located on the similar but not the same position in the substrate binding pocket and adopt a different hydrogen-bonding pattern, and both triphosphate moieties bind to the hMTH1 Nudix motif (i.e. the hydrolase motif) similarly and align for the hydrolysis reaction. We also performed kinetic assays on the substrate-binding Asp-120 mutants (D120N and D120A), and determined their crystal structures in complex with the substrates. Analyses of bond lengths with high-resolution X-ray data and the relationship between the structure and enzymatic nucleotides via an exchange of the protonation state at two neighboring aspartate residues (Asp-119 and Asp-120) in its substrate binding pocket. To our knowledge, this mechanism of broad substrate recognition by enzymes has not been reported previously and may have relevance for anticancer drug development strategies targeting hMTH1.	[Waz, Shaimaa; Nakamura, Teruya; Hirata, Keisuke; Koga-Ogawa, Yukari; Chirifu, Mami; Ikemizu, Shinji; Yamagata, Yuriko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan; [Nakamura, Teruya] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto 8620973, Japan; [Arimori, Takao; Tamada, Taro] Natl Inst Quantum & Radiol Sci & Technol, Quantum Beam Sci Res Directorate, Tokai, Ibaraki 3191106, Japan; [Nakabeppu, Yusaku] Kyushu Univ, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Koga-Ogawa, Yukari] Nihon Inst Med Sci, Iruma, Saitama 3500435, Japan; [Arimori, Takao] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Kumamoto University; Kumamoto University; National Institutes for Quantum Science & Technology; Kyushu University; Osaka University	Yamagata, Y (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	yamagata@gpo.kumamoto-u.ac.jp	Nakabeppu, Yusaku/A-8902-2011	Nakabeppu, Yusaku/0000-0002-6739-242X; Arimori, Takao/0000-0002-6063-5572; Tamada, Taro/0000-0003-1419-8022; Nakamura, Teruya/0000-0003-2013-3057; Waz, Shaimaa/0000-0002-1665-4864	Ministry of Education Culture, Sports, Sciences and Technology of Japan; Egyptian Ministry of Higher Education	Ministry of Education Culture, Sports, Sciences and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Egyptian Ministry of Higher Education(Science and Technology Development Fund (STDF))	This work was supported in part by Grants-in-aid for Scientific Research and the Photon and Quantum Basic Research Coordinated Development Program from the Ministry of Education, Culture, Sports, Sciences and Technology of Japan and the Egyptian Ministry of Higher Education (to S. W.). The authors declare that they have no conflicts of interest with the contents of this article	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmed HU, 2007, ACTA CRYSTALLOGR D, V63, P906, DOI 10.1107/S0907444907029976; [Anonymous], PYMOL MOL GRAPHICS S; Arimori T, 2011, NUCLEIC ACIDS RES, V39, P8972, DOI 10.1093/nar/gkr575; Blakeley MP, 2008, CURR OPIN STRUC BIOL, V18, P593, DOI 10.1016/j.sbi.2008.06.009; Bridge G, 2014, CANCERS, V6, P1597, DOI 10.3390/cancers6031597; Cai JP, 1997, NUCLEIC ACIDS RES, V25, P1170, DOI 10.1093/nar/25.6.1170; Carter M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8871; Chatake T, 2003, PROTEINS, V50, P516, DOI 10.1002/prot.10303; Coskun E, 2015, DNA REPAIR, V33, P101, DOI 10.1016/j.dnarep.2015.05.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher SJ, 2012, ACTA CRYSTALLOGR D, V68, P800, DOI 10.1107/S0907444912012589; Forsyth WR, 2002, PROTEINS, V48, P388, DOI 10.1002/prot.10174; Fujii Y, 1999, J BIOL CHEM, V274, P38251, DOI 10.1074/jbc.274.53.38251; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; Fujikawa K, 2001, NUCLEIC ACIDS RES, V29, P449, DOI 10.1093/nar/29.2.449; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Hori M, 2010, FREE RADICAL BIO MED, V48, P1197, DOI 10.1016/j.freeradbiomed.2010.02.002; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Iida T, 2001, NEURO-ONCOLOGY, V3, P73, DOI 10.1093/neuonc/3.2.73; Inoue M, 1998, J BIOL CHEM, V273, P11069, DOI 10.1074/jbc.273.18.11069; Ishibashi T, 2005, NUCLEIC ACIDS RES, V33, P3779, DOI 10.1093/nar/gki682; KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659; Kettle JG, 2016, J MED CHEM, V59, P2346, DOI 10.1021/acs.jmedchem.5b01760; Koga Y, 2013, ACTA CRYSTALLOGR F, V69, P45, DOI 10.1107/S1744309112048002; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Mishima M, 2004, J BIOL CHEM, V279, P33806, DOI 10.1074/jbc.M402393200; MO JY, 1992, P NATL ACAD SCI USA, V89, P11021, DOI 10.1073/pnas.89.22.11021; Nakabeppu Y, 2014, INT J MOL SCI, V15, P12543, DOI 10.3390/ijms150712543; Nakamura T, 2006, ACTA CRYSTALLOGR F, V62, P1283, DOI 10.1107/S1744309106049529; Nakamura T, 2010, J BIOL CHEM, V285, P444, DOI 10.1074/jbc.M109.066373; Nissink JWM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151154; Okamoto K, 1996, INT J CANCER, V65, P437, DOI 10.1002/(SICI)1097-0215(19960208)65:4<437::AID-IJC7>3.0.CO;2-Y; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel A, 2015, ONCOGENE, V34, P2586, DOI 10.1038/onc.2014.195; Rai P, 2010, MUTAT RES-GEN TOX EN, V703, P71, DOI 10.1016/j.mrgentox.2010.07.010; Sakai Y, 2002, J BIOL CHEM, V277, P8579, DOI 10.1074/jbc.M110566200; SEPIOL J, 1976, Z NATURFORSCH C, V31, P361; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Streib M, 2014, ANGEW CHEM INT EDIT, V53, P305, DOI 10.1002/anie.201307849; Svensson LM, 2011, FEBS LETT, V585, P2617, DOI 10.1016/j.febslet.2011.07.017; TOPAL MD, 1982, P NATL ACAD SCI-BIOL, V79, P2211, DOI 10.1073/pnas.79.7.2211; Tsuzuki T, 2001, MUTAT RES-FUND MOL M, V477, P71, DOI 10.1016/S0027-5107(01)00108-7; Tsuzuki T, 2007, CANCER SCI, V98, P465, DOI 10.1111/j.1349-7006.2007.00409.x; Ventura I, 2013, NEUROBIOL DIS, V49, P148, DOI 10.1016/j.nbd.2012.09.002; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200	47	19	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2785	2794		10.1074/jbc.M116.749713	http://dx.doi.org/10.1074/jbc.M116.749713			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28035004	Green Published, hybrid			2022-12-26	WOS:000395535100019
J	Noguchi, K; Hongama, K; Hariki, S; Nonomiya, Y; Katayama, K; Sugimoto, Y				Noguchi, Kohji; Hongama, Keita; Hariki, Shiori; Nonomiya, Yuma; Katayama, Kazuhiro; Sugimoto, Yoshikazu			Functional Effects of AKT3 on Aurora Kinase Inhibitor-induced Aneuploidy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AKT PKB; cancer; cancer biology; cell division; drug resistance; mitosis	CANCER RESISTANCE PROTEIN; CELL-CYCLE ARREST; B KINASE; PLK1 PHOSPHORYLATION; CENTRAL SPINDLE; GROWTH; ACTIVATION; MUTATION; REVEALS; MK-2206	The suppression of mitotic Aurora kinases (AURKs) by AURK inhibitors frequently causes cytokinetic failure, leading to polyploidy or aneuploidy, indicating the critical role of AURK-mediated phosphorylation during cytokinesis. We demonstrate the deregulated expression of AKT3 in Aurora kinase inhibitor (AURKi)-resistant cells, which we established from human colorectal cancer HCT 116 cells. The AKT family, which includes AKT1, -2, and -3, plays multiple roles in antiapoptotic functions and drug resistance and is involved in cell growth and survival pathways. We found that an AKT inhibitor, AZD5363, showed synergistic effect with an AURKi, VX-680, on two AKT3-expressing AURKi-resistant cell lines, and AKT3 knockdown sensitized cells to VX-680. Consistent with these activities, AKT3 expression suppressed AURKi-induced apoptosis and conferred resistance to AURKi. Thus, AKT3 expression affects cell sensitivity to AURKi. Moreover, we found that AKT3 expression suppressed AURKi-induced aneuploidy, and inversely AKT3 knockdown enhanced it. In addition, partial co-localization of AKT3 with AURKB was observed during anaphase. Overall, this study suggests that AKT3 could repress the antiproliferative effects of AURKi, with a novel activity particularly suppressing the aneuploidy induction.	[Noguchi, Kohji; Hongama, Keita; Hariki, Shiori; Nonomiya, Yuma; Katayama, Kazuhiro; Sugimoto, Yoshikazu] Keio Univ, Fac Pharm, Div Chemotherapy, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan	Keio University	Noguchi, K (corresponding author), Keio Univ, Fac Pharm, Div Chemotherapy, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	noguchi-kj@pha.keio.ac.jp	Katayama, Kazuhiro/AAH-2914-2019	Katayama, Kazuhiro/0000-0003-4232-7661	Japan Society for the Promotion of Science KAKENHI [S1411004, 15K14409, 26460076]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants-in-Aid S1411004, 15K14409, and 26460076. The authors declare that they have no conflicts of interest with the contents of this article	Bastos RN, 2013, J CELL BIOL, V202, P605, DOI 10.1083/jcb.201301094; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Carmena M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001250; Chen L, 2015, BIOCHEMISTRY-US, V54, P2473, DOI 10.1021/acs.biochem.5b00016; Choi BH, 2014, J BIOL CHEM, V289, P14066, DOI 10.1074/jbc.M114.558155; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies BR, 2012, MOL CANCER THER, V11, P873, DOI 10.1158/1535-7163.MCT-11-0824-T; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; Dominguez-Brauer C, 2015, MOL CELL, V60, P524, DOI 10.1016/j.molcel.2015.11.006; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Girdler F, 2008, CHEM BIOL, V15, P552, DOI 10.1016/j.chembiol.2008.04.013; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Goldenson B, 2015, ONCOGENE, V34, P537, DOI 10.1038/onc.2014.14; Grundy M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-254; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hilton JF, 2014, J CLIN ONCOL, V32, P57, DOI 10.1200/JCO.2013.50.7988; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Kasahara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2879; Katayama K, 2005, MOL CELL BIOL, V25, P5725, DOI 10.1128/MCB.25.13.5725-5737.2005; Katayama K, 2009, ANTICANCER RES, V29, P1059; Kawahara H, 2010, CANCER SCI, V101, P1493, DOI 10.1111/j.1349-7006.2010.01539.x; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Kumari G, 2014, J BIOL CHEM, V289, P16072, DOI 10.1074/jbc.M114.555060; Li ZG, 2014, MOL CELL BIOL, V34, P3642, DOI 10.1128/MCB.00814-14; Lin J, 2013, CLIN CANCER RES, V19, P1760, DOI 10.1158/1078-0432.CCR-12-3072; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mende I, 2001, ONCOGENE, V20, P4419, DOI 10.1038/sj.onc.1204486; Mitsuhashi J, 2007, HUM GENE THER, V18, P895, DOI 10.1089/hum.2007.075; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nikonova AS, 2013, CELL MOL LIFE SCI, V70, P661, DOI 10.1007/s00018-012-1073-7; Noguchi K, 1996, ONCOGENE, V13, P39; Noguchi K, 2004, J BIOL CHEM, V279, P32716, DOI 10.1074/jbc.M404104200; Noguchi K, 2006, EMBO J, V25, P5372, DOI 10.1038/sj.emboj.7601396; Onishi K, 2007, GENES CELLS, V12, P535, DOI 10.1111/j.1365-2443.2007.01071.x; Rines DR, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r44; Sangai T, 2012, CLIN CANCER RES, V18, P5816, DOI 10.1158/1078-0432.CCR-12-1141; SATO W, 1995, CANCER CHEMOTH PHARM, V35, P271, DOI 10.1007/BF00689444; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Siegel JJ, 2012, ANNU REV CELL DEV BI, V28, P189, DOI 10.1146/annurev-cellbio-101011-155807; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Toi M, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.08.1646; Uehara R, 2013, J CELL BIOL, V202, P623, DOI 10.1083/jcb.201302123; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	55	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1910	1924		10.1074/jbc.M116.747048	http://dx.doi.org/10.1074/jbc.M116.747048			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28028179	Green Published, hybrid			2022-12-26	WOS:000395515600030
J	Coulombe-Huntington, J; Xia, Y				Coulombe-Huntington, Jasmin; Xia, Yu			Network Centrality Analysis in Fungi Reveals Complex Regulation of Lost and Gained Genes	PLOS ONE			English	Article							WHOLE-GENOME DUPLICATION; SACCHAROMYCES-CEREVISIAE; PHYLOGENETIC ANALYSIS; EVOLUTIONARY RATES; YEAST; EXPRESSION; PATTERNS; DATABASE; NEOFUNCTIONALIZATION; INTEGRATION	Gene gain and loss shape both proteomes and the networks they form. The increasing availability of closely related sequenced genomes and of genome-wide network data should enable a better understanding of the evolutionary forces driving gene gain, gene loss and evolutionary network rewiring. Using orthology mappings across 23 ascomycete fungi genomes, we identified proteins that were lost, gained or universally conserved across the tree, enabling us to compare genes across all stages of their life-cycle. Based on a collection of genome-wide network and gene expression datasets from baker's yeast, as well as a few from fission yeast, we found that gene loss is more strongly associated with network and expression features of closely related species than that of distant species, consistent with the evolutionary modulation of gene loss propensity through network rewiring. We also discovered that lost and gained genes, as compared to universally conserved "core" genes, have more regulators, more complex expression patterns and are much more likely to encode for transcription factors. Finally, we found that the relative rate of network integration of new genes into the different types of networks agrees with experimentally measured rates of network rewiring. This systems-level view of the life-cycle of eukaryotic genes suggests that the gain and loss of genes is tightly coupled to the gain and loss of network interactions, that lineage-specific adaptations drive regulatory complexity and that the relative rates of integration of new genes are consistent with network rewiring rates.	[Coulombe-Huntington, Jasmin] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Xia, Yu] McGill Univ, Fac Engn, Dept Bioengn, Montreal, PQ, Canada	Universite de Montreal; McGill University	Xia, Y (corresponding author), McGill Univ, Fac Engn, Dept Bioengn, Montreal, PQ, Canada.	brandon.xia@mcgill.ca	Xia, Yu/W-6150-2019	Xia, Yu/0000-0002-5596-5518	National Science Foundation [CCF-1219007]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-03892]; Canada Research Chairs program	National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs program(Canada Research Chairs)	This work was supported by the National Science Foundation [grant number CCF-1219007], the Natural Sciences and Engineering Research Council of Canada [grant number RGPIN-2014-03892], and the Canada Research Chairs program (to YX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Byrne KP, 2007, GENETICS, V175, P1341, DOI 10.1534/genetics.106.066951; Capra JA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r127; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Coulombe-Huntington J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002734; Dong D, 2011, NUCLEIC ACIDS RES, V39, P837, DOI 10.1093/nar/gkq874; FARRIS JS, 1977, SYST ZOOL, V26, P77, DOI 10.2307/2412867; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Ha M, 2009, P NATL ACAD SCI USA, V106, P2295, DOI 10.1073/pnas.0807350106; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jovelin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r35; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Lee S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-168; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Lercher MJ, 2008, MOL BIOL EVOL, V25, P559, DOI 10.1093/molbev/msm283; Nash R, 2007, NUCLEIC ACIDS RES, V35, pD468, DOI 10.1093/nar/gkl931; Ohno S., 1970, EVOLUTION GENE DUPLI; Planas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011476; Prachumwat A, 2006, MOL BIOL EVOL, V23, P30, DOI 10.1093/molbev/msi249; Ptitsyn A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S15-S5; Qian WF, 2010, TRENDS GENET, V26, P425, DOI 10.1016/j.tig.2010.07.002; Ryan CJ, 2012, MOL CELL, V46, P691, DOI 10.1016/j.molcel.2012.05.028; Semon M, 2007, TRENDS GENET, V23, P108, DOI 10.1016/j.tig.2007.01.003; Shou C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001050; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; VanderSluis B, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.82; Vo TV, 2016, CELL, V164, P310, DOI 10.1016/j.cell.2015.11.037; Wang Y, 2010, NUCLEIC ACIDS RES, V38, P5959, DOI 10.1093/nar/gkq353; Wapinski I, 2007, BIOINFORMATICS, V23, pI549, DOI 10.1093/bioinformatics/btm193; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang P, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r56; Zhou LQ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-54; Zhu Y, 2013, G3-GENES GENOM GENET, V3, P2049, DOI 10.1534/g3.113.008458	49	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169459	10.1371/journal.pone.0169459	http://dx.doi.org/10.1371/journal.pone.0169459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046110	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300191
J	Grant, LR; O'Brien, KL; Weatherholtz, RC; Reid, R; Goklish, N; Santosham, M; Parashar, U; Vinje, J				Grant, Lindsay R.; O'Brien, Katherine L.; Weatherholtz, Robert C.; Reid, Raymond; Goklish, Novalene; Santosham, Mathuram; Parashar, Umesh; Vinje, Jan			Norovirus and Sapovirus Epidemiology and Strain Characteristics among Navajo and Apache Infants	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; UNITED-STATES; HOSPITALIZED CHILDREN; ROTAVIRUS VACCINE; INFECTIONS; OUTBREAKS; CALICIVIRUSES; ASSOCIATION; GENOTYPES; ETIOLOGY	Norovirus and sapovirus are important causes of acute gastroenteritis (AGE) among American Indian infants. We investigated the prevalence and molecular epidemiology of norovirus and sapovirus in American Indian infants who have historically experienced a high burden of AGE compared to other US populations. Stool samples were collected from 241 children with AGE (cases) and from 343 infants without AGE (controls) <= 9 months of age from 2002-2004. Cases experienced forceful vomiting and/or 3 or more watery or looser-than normal stools in 24 hours. Stools were tested by real-time RT-PCR for norovirus GI, GII and GIV and sapovirus GI, GII, GIV and GV. Positive samples were genotyped after sequencing conventional RT-PCR products. Norovirus was identified in 76 (31.5%) of the cases and 70 (20.4%) of the controls (p<0.001). GII.3 and GII.4 Farmington Hills were the most frequently identified genotypes in 14.5% and 30.3% of cases and 17.1% and 27.1% of controls, respectively. Sapovirus GI and GII genotypes were identified in 8 (3.3%) of cases and 8 (2.3%) of controls and a single GIV virus was detected in a control. The same norovirus and sapovirus genotypes were circulating in the general U.S. population in the same time period. The high detection rate of norovirus in healthy controls suggests significant asymptomatic transmission in young infants in these communities.	[Grant, Lindsay R.; O'Brien, Katherine L.; Weatherholtz, Robert C.; Reid, Raymond; Goklish, Novalene; Santosham, Mathuram] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Amer Indian Hlth, Baltimore, MD 21205 USA; [Parashar, Umesh; Vinje, Jan] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA	Grant, LR (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Amer Indian Hlth, Baltimore, MD 21205 USA.	lgrant10@jhu.edu	Vinje, Jan/ABE-6336-2020	Vinje, Jan/0000-0002-1530-3675; O'Brien, Katherine/0000-0002-0164-4030	CDC Foundation	CDC Foundation(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was partially supported by a grant from the CDC Foundation (http://www.cdcfoundation.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Becker-Dreps S, 2014, PEDIATR INFECT DIS J, V33, P1156, DOI 10.1097/INF.0000000000000427; Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; Bucardo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098201; Bucardo F, 2010, PEDIATR INFECT DIS J, V29, P934, DOI 10.1097/INF.0b013e3181ed9f2f; Chhabra P, 2013, J INFECT DIS, V208, P790, DOI 10.1093/infdis/jit254; Dove W, 2005, J MED VIROL, V77, P522, DOI 10.1002/jmv.20488; Gonzalez MD, 2016, J CLIN MICROBIOL, V54, P142, DOI 10.1128/JCM.02361-15; Grant L, 2012, J PEDIATR-US, V161, P110, DOI 10.1016/j.jpeds.2011.12.046; Grant LR, 2012, PEDIATR INFECT DIS J, V31, P184, DOI 10.1097/INF.0b013e3182435afe; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hassine-Zaafrane M, 2013, J MED VIROL, V85, P1100, DOI 10.1002/jmv.23552; Holman RC, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.1.e11; Johnsen CK, 2009, J CLIN VIROL, V46, P265, DOI 10.1016/j.jcv.2009.07.008; Kirkwood CD, 2005, J MED VIROL, V77, P96, DOI 10.1002/jmv.20419; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Lee LE, 2012, EMERG INFECT DIS, V18, P873, DOI 10.3201/eid1805.111843; Lopman BA, 2015, J INFECT DIS, V211, P1813, DOI 10.1093/infdis/jiu672; Oka T, 2015, CLIN MICROBIOL REV, V28, P32, DOI 10.1128/CMR.00011-14; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Platts-Mills JA, 2015, LANCET GLOB HLTH; Svraka S, 2010, J CLIN MICROBIOL, V48, P2191, DOI 10.1128/JCM.02427-09; Tran TNH, 2013, J CLIN VIROL, V56, P185, DOI 10.1016/j.jcv.2012.11.011; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; Widdowson MA, 2004, J INFECT DIS, V190, P27, DOI 10.1086/420888; Yan HN, 2003, J VIROL METHODS, V114, P37, DOI 10.1016/j.jviromet.2003.08.009; Yassin MA, 2012, PAEDIATR INT CHILD H, V32, P51, DOI 10.1179/1465328111Y.0000000047; Zhang SW, 2011, J MED VIROL, V83, P1476, DOI 10.1002/jmv.22108	30	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169491	10.1371/journal.pone.0169491	http://dx.doi.org/10.1371/journal.pone.0169491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046108	gold, Green Submitted, Green Published			2022-12-26	WOS:000391612300199
J	Inacio, V; Barros, PM; Costa, A; Roussado, C; Goncalves, E; Costa, R; Graca, J; Oliveira, MM; Morais-Cecilio, L				Inacio, Vera; Barros, Pedro M.; Costa, Augusta; Roussado, Cristovao; Goncalves, Elsa; Costa, Rita; Graca, Jose; Margarida Oliveira, M.; Morais-Cecilio, Leonor			Differential DNA Methylation Patterns Are Related to Phellogen Origin and Quality of Quercus suber Cork	PLOS ONE			English	Article							NATURAL-POPULATIONS; PINUS-RADIATA; AFLP MARKERS; L.; ARABIDOPSIS; PLANTS; GROWTH; TISSUE; AMPLIFICATION; ASSOCIATION	DNA methylation is thought to influence Quercus suber cork quality, which is the main constraint for its economic valorisation. However, a deep knowledge of the cytosine methylation patterns disclosing the epigenetic variability of trees with different cork quality types is totally missing. This study investigates the hypothesis that variations in DNA methylation contribute to differences in cork cellular characteristics directly related to original or traumatic phellogen activity. We used MSAPs (Methylation Sensitive Amplified Polymorphism) to assess DNA methylation patterns of cork and leaf tissues of Q. suber adu It trees growing in three cork oak stands. The relationship between the detected polymorphisms and the diversity of cork quality traits was explored by a marker-trait analysis focusing on the most relevant quality characteristics. Populations differed widely in cork quality, but only slightly in degree of epigenetic differentiation. Four MSAP markers (1.3% of the total) were significantly associated with the most noteworthy quality traits: wood inclusions (nails) and porosity. This evidence supports the potential role of cytosine methylation in the modulation of differential phellogen activity either involved in localized cell death or in pore production, resulting in different cork qualities. Although, the underlying basis of the methylation polymorphism of loci affecting cork quality traits remain unclear, the disclosure of markers statistically associated with cork quality strengthens the potential role of DNA methylation in the regulation of these traits, namely at the phellogen level.	[Inacio, Vera; Roussado, Cristovao; Goncalves, Elsa; Morais-Cecilio, Leonor] Univ Lisbon, Inst Agron, Linking Landscape Environm Agr & Food LEAF, Lisbon, Portugal; [Barros, Pedro M.; Margarida Oliveira, M.] Univ Nova Lisboa, ITQB NOVA Inst Tecnol Quim & Biol Antonio Xavier, Genom Plant Stress Unit, Oeiras, Portugal; [Costa, Augusta; Costa, Rita] Inst Nacl Invest Agraria & Vet, IP, Oeiras, Portugal; [Costa, Augusta] NOVA Univ Lisbon, Fac Sci & Technol, Dept Environm Sci & Engn, Ctr Environm & Sustainabil Res CENSE, Caparica, Portugal; [Graca, Jose] Univ Lisbon, Inst Agron, Forest Res Ctr, Lisbon, Portugal	Universidade de Lisboa; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Universidade de Lisboa; Forest Research Centre	Morais-Cecilio, L (corresponding author), Univ Lisbon, Inst Agron, Linking Landscape Environm Agr & Food LEAF, Lisbon, Portugal.; Oliveira, MM (corresponding author), Univ Nova Lisboa, ITQB NOVA Inst Tecnol Quim & Biol Antonio Xavier, Genom Plant Stress Unit, Oeiras, Portugal.	mmolive@itqb.unl.pt; lmorais@isa.ulisboa.pt	Costa, Rita Lourenco/Q-4564-2019; Inacio, Vera/AAY-2356-2020; Morais-Cecilio, Leonor/AAH-5920-2019; Barros, PM/J-3613-2013; Graça, José/AAD-1845-2019; Costa, Augusta/J-3644-2013; Costa, Rita L/B-5190-2016; Oliveira, M. Margarida/H-9318-2012; Graca, Jose/H-9996-2012	Costa, Rita Lourenco/0000-0001-9503-6126; Barros, PM/0000-0001-5626-0619; Costa, Augusta/0000-0002-0400-8523; Costa, Rita L/0000-0001-9503-6126; Felix Goncalves, Elsa Maria/0000-0003-0216-436X; Oliveira, M. Margarida/0000-0002-0095-1952; Graca, Jose/0000-0003-0019-0847; Inacio, Vera/0000-0002-5652-2540; Morais-Cecilio, Leonor/0000-0001-9313-2253	Portuguese Foundation for Science and Technology (FCT) [PTDC/AGR-CFL/104197/2008, PTDC/AGR-GPL 101785/2008, PTDC/AGR-FOR/3356/2014]; FCT [SFRH/BD/85879/2012, SFRH/BPD/86742/2012, SFRH/BDP/97166/2013]; Cost Action [FP1202];  [UID/Multi/04551/2013];  [UID/AGR/04129/2013]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Cost Action(European Cooperation in Science and Technology (COST)); ; 	This work was supported by the Portuguese Foundation for Science and Technology (FCT, http://www.fct.pt/) through the projects PTDC/AGR-CFL/104197/2008, PTDC/AGR-GPL 101785/2008, and PTDC/AGR-FOR/3356/2014. Also through funding to the Research unit GREEN-it "Bioresources for Sustainability" (UID/Multi/04551/2013), and LEAF Unit UID/AGR/04129/2013. VI PhD grant SFRH/BD/85879/2012; PMB Post-doc grant SFRH/BPD/86742/2012 and AC Postdoctoral Fellow SFRH/BDP/97166/2013 were also supported by FCT. PMB also acknowledges the STSM financed by Cost Action FP1202 MaPFGR.	[Anonymous], 1950, DIRECAO GERAL SERVIC; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Brautigam K, 2013, ECOL EVOL, V3, P399, DOI 10.1002/ece3.461; Candaele J, 2014, PLANT PHYSIOL, V164, P1350, DOI 10.1104/pp.113.233312; Coelho AC, 2006, SILVAE GENET, V55, P105, DOI 10.1515/sg-2006-0016; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Correia B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053543; Costa A, 2016, DENDROCHRONOLOGIA, V38, P72, DOI 10.1016/j.dendro.2016.03.007; Costa A, 2007, J SCI FOOD AGR, V87, P2222, DOI 10.1002/jsfa.2947; Costa A, 2006, AM J ENOL VITICULT, V57, P210; Costa A, 2015, ECON BOT, V69, P171, DOI 10.1007/s12231-015-9305-z; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Eichten SR, 2014, PLANT PHYSIOL, V165, P933, DOI 10.1104/pp.113.234211; Santamaria ME, 2009, J PLANT PHYSIOL, V166, P1360, DOI 10.1016/j.jplph.2009.02.014; Evert RF., 2006, ESAUS PLANT ANATOMY, DOI [10.1002/0470047380, DOI 10.1002/0470047380]; EXCOFFIER L, 1992, GENETICS, V131, P479; Felsenfeld G, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018200; Fortes MA, 2004, A CORTICA, V1st; Fraga MF, 2002, TREE PHYSIOL, V22, P813, DOI 10.1093/treephys/22.11.813; Fraga MF, 2002, PLANTA, V215, P672, DOI 10.1007/s00425-002-0795-4; Fulnecek J, 2002, MOL GENET GENOMICS, V268, P510, DOI 10.1007/s00438-002-0761-7; Fulnecek J, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-2; Gonzalez-Adrados JR, 2000, HOLZ ROH WERKST, V58, P39, DOI 10.1007/s001070050383; Graca J, 2004, IAWA J, V25, P325, DOI 10.1163/22941932-90000369; Gugger PF, 2016, MOL ECOL, V25, P1665, DOI 10.1111/mec.13563; Herrera CM, 2011, MOL ECOL, V20, P1675, DOI 10.1111/j.1365-294X.2011.05026.x; Herrera CM, 2013, BOT J LINN SOC, V171, P441, DOI 10.1111/boj.12007; Lauria M, 2004, PLANT CELL, V16, P510, DOI 10.1105/tpc.017780; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lendzian KJ, 2006, J EXP BOT, V57, P2535, DOI 10.1093/jxb/erl014; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Long Y, 2011, GENETICS, V189, P1093, DOI 10.1534/genetics.111.131615; Medrano M, 2014, MOL ECOL, V23, P4926, DOI 10.1111/mec.12911; Negishi M, 2009, GENES CELLS, V14, P1347, DOI 10.1111/j.1365-2443.2009.01352.x; Oliveira G, 2012, FOREST ECOL MANAG, V270, P257, DOI 10.1016/j.foreco.2012.01.025; Papini A, 2009, CARYOLOGIA, V62, P236; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Peraza-Echeverria S, 2001, PLANT SCI, V161, P359, DOI 10.1016/S0168-9452(01)00421-6; Pereira H, 1996, HOLZFORSCHUNG, V50, P111, DOI 10.1515/hfsg.1996.50.2.111; PEREIRA H, 1992, IAWA BULL, V13, P389, DOI 10.1163/22941932-90001294; Pereira H., 2011, CORK BIOL PRODUCTION; Platt A, 2015, MOL ECOL, V24, P3823, DOI 10.1111/mec.13230; Plomion C, 2016, MOL ECOL RESOUR, V16, P254, DOI 10.1111/1755-0998.12425; Prislan P, 2013, IAWA J, V34, P391, DOI 10.1163/22941932-00000032; Ramos M, 2013, TREE GENET GENOMES, V9, P1481, DOI 10.1007/s11295-013-0652-6; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Ribeiro T, 2009, SEX PLANT REPROD, V22, P1, DOI 10.1007/s00497-008-0083-y; Riggs A. D., 1996, TORRENTS SPRING, P1; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Schulz B, 2013, MOL ECOL RESOUR, V13, P642, DOI 10.1111/1755-0998.12100; Sen A, 2011, IND CROP PROD, V34, P929, DOI 10.1016/j.indcrop.2011.02.015; Shin JH, 2010, BIOCHEM BIOPH RES CO, V402, P110, DOI 10.1016/j.bbrc.2010.09.126; Silva SP, 2005, INT MATER REV, V50, P345, DOI 10.1179/174328005X41168; Soler M, 2008, TREE PHYSIOL, V28, P743, DOI 10.1093/treephys/28.5.743; Soler M, 2007, PLANT PHYSIOL, V144, P419, DOI 10.1104/pp.106.094227; Sork VL, 2016, G3-GENES GENOM GENET, V6; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Teixeira RT, 2014, J EXP BOT, V65, P4887, DOI 10.1093/jxb/eru252; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Trucchi E, 2016, MOL ECOL, V25, P1697, DOI 10.1111/mec.13550; van der Graaf A, 2015, P NATL ACAD SCI USA, V112, P6676, DOI 10.1073/pnas.1424254112; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Wilschut RA, 2016, MOL ECOL, V25, P1759, DOI 10.1111/mec.13502; Zhang J, 2011, NEW PHYTOL, V192, P869, DOI 10.1111/j.1469-8137.2011.03855.x; Zhang MS, 2011, PLANT PHYSIOL, V156, P1955, DOI 10.1104/pp.111.176842; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	70	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169018	10.1371/journal.pone.0169018	http://dx.doi.org/10.1371/journal.pone.0169018			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045988	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300092
J	Magalhaes, LP; dos Reis, LM; Graciolli, FG; Pereira, BJ; de Oliveira, RB; de Souza, AAL; Moyses, RM; Elias, RM; Jorgetti, V				Magalhaes, Luciene P.; dos Reis, Luciene M.; Graciolli, Fabiana G.; Pereira, Benedito J.; de Oliveira, Rodrigo B.; de Souza, Altay A. L.; Moyses, Rosa M.; Elias, Rosilene M.; Jorgetti, Vanda			Predictive Factors of One-Year Mortality in a Cohort of Patients Undergoing Urgent-Start Hemodialysis	PLOS ONE			English	Article							GROWTH-FACTOR 23; DISEASE; INFLAMMATION; OUTCOMES	Background Chronic kidney disease (CKD) affects 10-15% of adult population worldwide. Incident patients on hemodialysis, mainly those on urgent-start dialysis at the emergency room, have a high mortality risk, which may reflect the absence of nephrology care. A lack of data exists regarding the influence of baseline factors on the mortality of these patients. The aim of this study was to evaluate the clinical and laboratory characteristics of this population and identify risk factors that contribute to their mortality. Patients and methods We studied 424 patients who were admitted to our service between 01/2006 and 12/2012 and were followed for 1 year. We analyzed vascular access, risk factors linked to cardiovascular disease (CVD) and mineral and bone disease associated with CKD (CKD-MBD), and clinical events that occurred during the follow-up period. Factors that influenced patient survival were evaluated by Cox regression analysis. Results The patient mean age was 50 18 years, and 58.7% of them were male. Hypertension was the main cause of primary CKD (31.8%). Major risk factors were smoking (19.6%), dyslipidemia (48.8%), and CVD (41%). Upon admission, most patients had no vascular access for hemodialysis (89.4%). Biochemical results showed that most patients were anemic with high C-reactive protein levels, hypocalcemia, hyperphosphatemia, elevated parathyroid hormone and decreased 25-hydroxy vitamin D. At the end of one year, 60 patients died (14.1%). These patients were significantly older, had a lower percentage of arteriovenous fistula in one year, and low levels of 25-hydroxy vitamin D. Conclusions The combined evaluation of clinical and biochemical parameters and risk factors revealed that the mortality in urgent-start dialysis is associated with older age and low levels of vitamin D deficiency. A lack of a permanent hemodialysis access after one year was also a risk factor for mortality in this population.	[Magalhaes, Luciene P.; dos Reis, Luciene M.; Graciolli, Fabiana G.; Pereira, Benedito J.; Moyses, Rosa M.; Elias, Rosilene M.; Jorgetti, Vanda] Univ Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil; [Pereira, Benedito J.; Moyses, Rosa M.] Univ Nove Julho UNINOVE, Med Master Degree Program, Sao Paulo, Brazil; [de Oliveira, Rodrigo B.] Univ Estadual Campinas, Sch Med Sci, Div Nephrol, UNICAMP, Campinas, SP, Brazil; [de Souza, Altay A. L.] Fed Univ Sao Paulo UNIFESP, Dept Psychobiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Nove de Julho; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP)	Jorgetti, V (corresponding author), Univ Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil.	vandajor@usp.br	dos Reis, Luciene M/C-7143-2013; de Oliveira, Rodrigo Bueno/I-2186-2015; Elias, Rosilene M/J-1099-2012; JORGETTI, VANDA/C-9470-2012; Moyses, Rosa M A/F-8268-2012	dos Reis, Luciene M/0000-0001-8476-6780; de Oliveira, Rodrigo Bueno/0000-0002-8273-6200; Elias, Rosilene M/0000-0003-2212-041X; JORGETTI, VANDA/0000-0002-4824-8879; Moyses, Rosa M A/0000-0002-7902-2127	Sao Paulo Research Foundation (FAPESP) [2010/03867-7]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation (FAPESP) - Grant number: 2010/03867-7 to VJ.	Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Jimenez ZNC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042290; Carrero JJ, 2010, SEMIN DIALYSIS, V23, P498, DOI 10.1111/j.1525-139X.2010.00784.x; Charytan DM, 2015, AM J KIDNEY DIS, V66, P196, DOI 10.1053/j.ajkd.2014.12.016; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Diegoli Henrique, 2015, Braz. J. Nephrol., V37, P32, DOI 10.5935/0101-2800.20150006; Drueke TB, 2010, NAT REV NEPHROL, V6, P723, DOI 10.1038/nrneph.2010.143; Foley RN, 2014, KIDNEY INT, V86, P392, DOI 10.1038/ki.2014.15; Fouque D, 2011, KIDNEY INT, V80, P348, DOI 10.1038/ki.2011.118; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Hayashi T, 2000, AM J KIDNEY DIS, V35, P250, DOI 10.1016/S0272-6386(00)70334-9; Honda H, 2006, AM J KIDNEY DIS, V47, P139, DOI 10.1053/j.ajkd.2005.09.014; Isakova T, 2012, CURR OPIN NEPHROL HY, V21, P334, DOI 10.1097/MNH.0b013e328351a391; Kim SM, 2014, J RENAL NUTR, V24, P20, DOI 10.1053/j.jrn.2013.07.003; Kosa SD, 2013, SEMIN DIALYSIS, V26, P482, DOI 10.1111/sdi.12115; Levin A, 2013, KIDNEY INT S, V3, P1, DOI [DOI 10.1038/KISUP.2012.73, 10.1038/kisup.2012.73]; LINK CL, 1984, BIOMETRICS, V40, P601, DOI 10.2307/2530904; Longenecker JC, 2002, J AM SOC NEPHROL, V13, P1918, DOI 10.1097/01.ASN.0000019641.41496.1E; Machowska A, 2016, TRANSL RES, V167, P204, DOI 10.1016/j.trsl.2015.06.012; Malas MB, 2015, JAMA SURG, V150, P441, DOI 10.1001/jamasurg.2014.3484; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Pisoni RL, 2009, AM J KIDNEY DIS, V53, P475, DOI 10.1053/j.ajkd.2008.10.043; Rastogi Anjay, 2013, Ther Adv Cardiovasc Dis, V7, P322, DOI 10.1177/1753944713513061; Robinson BM, 2014, KIDNEY INT, V85, P158, DOI 10.1038/ki.2013.252; Scott MC, 2015, EMERG MED CLIN N AM, V33, P553, DOI 10.1016/j.emc.2015.04.006; Smart NA, 2014, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD007333:PUB2; Smart NA, 2011, AM J MED, V124, P1073, DOI 10.1016/j.amjmed.2011.04.026; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Unger MD, 2010, CLIN NUTR, V29, P784, DOI 10.1016/j.clnu.2010.06.009; United States Renal Data System, 2015, 2015 USRDS ANN DAT R; Wang AYM, 2008, J AM SOC NEPHROL, V19, P1643, DOI 10.1681/ASN.2008010012	31	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0167895	10.1371/journal.pone.0167895	http://dx.doi.org/10.1371/journal.pone.0167895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045952	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300010
J	Neubauer, V; Djurdjevic, T; Griesmaier, E; Biermayr, M; Gizewski, ER; Kiechl-Kohlendorfer, U				Neubauer, Vera; Djurdjevic, Tanja; Griesmaier, Elke; Biermayr, Marlene; Gizewski, Elke Ruth; Kiechl-Kohlendorfer, Ursula			Routine Magnetic Resonance Imaging at Term-Equivalent Age Detects Brain Injury in 25% of a Contemporary Cohort of Very Preterm Infants	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; DEVELOPMENTAL-DISABILITY; PREMATURE NEWBORNS; MRI; LESIONS; OUTCOMES	Introduction In recent years, significant investigation has been undertaken by means of magnetic resonance imaging (MRI) in an attempt to identify preterm infants at risk for adverse outcome. The primary objective is to provide a comprehensive characterization of cerebral injury detected by conventional MRI at term-equivalent age in an unselected, consecutive, contemporary cohort of preterm infants born <32 gestational weeks. Secondly, this study aims to identify risk factors for the different injury types in this population. Methods Data for all preterm infants born <32 gestational weeks and admitted to Innsbruck Medical University Hospital were prospectively collected (October 2010 to December 2015). Cerebral MRI was evaluated retrospectively using a validated scoring system that incorporates intraventricular haemorrhage (IVH), white matter disease (WMD) and cerebellar haemorrhage (CBH). Results 300 infants were included in the study. MRI showed 24.7% of all infants to have some form of brain injury. The most common injury type was IVH (16.0%). WMD and CBH were seen in 10.0% and 8.0%. The prevalence of common neonatal risk factors was greater within the group of infants with CBH. In particular indicators for respiratory disease were observed more often: longer ventilation duration, more frequent need for supplemental oxygen at day 28, higher rates of hydrocortisone treatment. Catecholamine treatment was the only neonatal risk factor that was overrepresented in infants with WMD Discussion Cerebral MRI at term-equivalent age, as addition to cranial ultrasound, detected brain injury in 25% of preterm survivors. The diagnosis of IVH was already made by neonatal ultrasound in most cases. In contrast, only a minority of the CBH and none of the non-cystic WMD have been detected prior to MRI. Decreasing gestational age and neonatal complications involved with immaturity have been identified as risk factors for CBH, whereas WMD was found in relatively mature infants with circulatory disturbances.	[Neubauer, Vera; Griesmaier, Elke; Biermayr, Marlene; Kiechl-Kohlendorfer, Ursula] Med Univ Innsbruck, Dept Paediat 2, Neonatol, Innsbruck, Austria; [Djurdjevic, Tanja; Gizewski, Elke Ruth] Med Univ Innsbruck, Dept Neuroradiol, Innsbruck, Austria; [Gizewski, Elke Ruth] Med Univ Innsbruck, Neuroimaging Core Facil, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Neubauer, V (corresponding author), Med Univ Innsbruck, Dept Paediat 2, Neonatol, Innsbruck, Austria.	Vera.Neubauer@i-med.ac.at		Hammerl, Marlene/0000-0002-7588-0431; Gizewski, Elke Ruth/0000-0001-6859-8377				Alderliesten T, 2014, J PEDIATR-US, V164, P986, DOI 10.1016/j.jpeds.2013.12.042; Allin MPG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024525; Buitendijk S, 2003, EUR J OBSTET GYN R B, V111, pS66, DOI 10.1016/j.ejogrb.2003.09.007; Cornette LG, 2002, ARCH DIS CHILD-FETAL, V86, P171, DOI 10.1136/fn.86.3.F171; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; Inder TE, 2003, J PEDIATR-US, V143, P171, DOI 10.1067/S0022-3476(03)00357-3; Kidokoro H, 2014, PEDIATRICS, V134, pE444, DOI 10.1542/peds.2013-2336; Kinney HC, 2005, ACTA NEUROPATHOL, V110, P563, DOI 10.1007/s00401-005-1077-6; Leijser LM, 2009, EARLY HUM DEV, V85, P101, DOI 10.1016/j.earlhumdev.2008.11.010; Limperopoulos C, 2005, PEDIATRICS, V116, P717, DOI 10.1542/peds.2005-0556; Maalouf EF, 1999, J PEDIATR-US, V135, P351, DOI 10.1016/S0022-3476(99)70133-2; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Miller SP, 2003, AM J NEURORADIOL, V24, P1661; Munro MJ, 2004, PEDIATRICS, V114, P1591, DOI 10.1542/peds.2004-1073; Neubauer V, 2011, ACTA PAEDIATR, V100, P1544, DOI 10.1111/j.1651-2227.2011.02388.x; Neubauer V, 2015, NEONATOLOGY, V107, P179, DOI 10.1159/000369199; Niwa T, 2011, NEURORADIOLOGY, V53, P669, DOI 10.1007/s00234-011-0872-0; Rutherford MA, 2010, NEURORADIOLOGY, V52, P505, DOI 10.1007/s00234-010-0700-y; Slaughter LA, 2016, NEONATOLOGY, V110, P47, DOI 10.1159/000444179; Steggerda SJ, 2009, RADIOLOGY, V252, P190, DOI 10.1148/radiol.2521081525; Tam EWY, 2011, J PEDIATR-US, V158, P245, DOI 10.1016/j.jpeds.2010.07.049; Volpe J.J., 2008, NEUROLOGY NEWBORN; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792	25	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169442	10.1371/journal.pone.0169442	http://dx.doi.org/10.1371/journal.pone.0169442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046071	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300190
J	Rashidi, MM; Yang, Z; Awais, M; Nawaz, M; Hayat, T				Rashidi, M. M.; Yang, Z.; Awais, Muhammad; Nawaz, Maria; Hayat, Tasawar			Generalized Magnetic Field Effects in Burgers' Nanofluid Model	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; STRETCHING SHEET; HEAT-TRANSFER; FLUID	Analysis has been conducted to present the generalized magnetic field effects on the flow of a Burgers' nanofluid over an inclined wall. Mathematical modelling for hydro-magnetics reveals that the term "sigma B(0)(2)u/p" is for the Newtonian model whereas the generalized magnetic field term (as mentioned in Eq 4) is for the Burgers' model which is incorporated in the current analysis to get the real insight of the problem for hydro-magnetics. Brownian motion and thermophoresis phenomenon are presented to analyze the nanofluidics for the non Newtonian fluid. Mathematical analysis is completed in the presence of non-uniform heat generation/absorption. The constructed set of partial differential system is converted into coupled nonlinear ordinary differential system by employing the suitable transformations. Homotopy approach is employed to construct the analytical solutions which are shown graphically for sundr5y parameters including Deborah numbers, magnetic field, thermophoresis, Brownian motion and non-uniform heat generation/absorption. A comparative study is also presented showing the comparison of present results with an already published data.	[Rashidi, M. M.; Yang, Z.] Tongji Univ, Shanghai Key Lab Vehicle Aerodynam & Vehicle Ther, Shanghai, Peoples R China; [Awais, Muhammad; Nawaz, Maria] COMSATS Inst Informat Technol, Dept Math, Attock, Pakistan; [Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan	Tongji University; COMSATS University Islamabad (CUI); Quaid I Azam University	Awais, M (corresponding author), COMSATS Inst Informat Technol, Dept Math, Attock, Pakistan.	awais_mm@yahoo.com	Hayat, Tasawar/Y-2524-2019; Awais, Muhammad/AAZ-3455-2020; Awais, Muhammad/HCI-3725-2022; Rashidi, Mohammad Mehdi/P-2692-2014	Rashidi, Mohammad Mehdi/0000-0002-6309-8688				Abbasbandy S, 2013, NUMER ALGORITHMS, V64, P593, DOI 10.1007/s11075-012-9680-9; Abbasbandy S, 2011, INT J COMPUT MATH, V88, P1763, DOI 10.1080/00207160.2010.526706; Awais M, 2015, BRAZ J CHEM ENG, V32, P555, DOI 10.1590/0104-6632.20150322s00001918; Awais M., 2015, J EGYP MATH SOC, V23, P410, DOI [10.1016/j.joems.2014.04.004, DOI 10.1016/J.JOEMS.2014.04.004, DOI 10.1016/j.joems.2014.04.004]; Awais M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129814; Choi S. U. S., 1995, 231MD ASME FED, V66, P99; Fetecau C, 2010, J NON-NEWTON FLUID, V165, P350, DOI 10.1016/j.jnnfm.2010.01.009; Hamad MAA, 2012, COMMUN NONLINEAR SCI, V17, P132, DOI 10.1016/j.cnsns.2011.02.024; Hassan H, 2014, INT J NUMER METHOD H, V24, P419, DOI 10.1108/HFF-08-2011-0158; Hayat T, 2016, J MOL LIQ, V215, P749, DOI 10.1016/j.molliq.2015.12.109; Jamil M, 2010, J NON-NEWTON FLUID, V165, P1700, DOI 10.1016/j.jnnfm.2010.08.004; Javed M, 2014, APPL MATH COMPUT, V244, P654, DOI 10.1016/j.amc.2014.07.009; Khan M, 2010, MATH COMPUT MODEL, V51, P682, DOI 10.1016/j.mcm.2009.10.040; Khan M, 2016, J MOL LIQ, V218, P1, DOI 10.1016/j.molliq.2016.02.024; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Liao SJ, 2009, COMMUN NONLINEAR SCI, V14, P983, DOI 10.1016/j.cnsns.2008.04.013; Liu YQ, 2011, COMPUT MATH APPL, V62, P3123, DOI 10.1016/j.camwa.2011.08.025; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Rana P, 2012, COMMUN NONLINEAR SCI, V17, P212, DOI 10.1016/j.cnsns.2011.05.009; Rashidi MM, 2014, MECCANICA, V49, P469, DOI 10.1007/s11012-013-9805-9; Rashidi MM, 2012, COMPUT STRUCT, V106, P46, DOI 10.1016/j.compstruc.2012.04.004; Rashidi MM, 2012, J APPL MATH, DOI 10.1155/2012/780415; Rashidi MM, 2012, COMPUT FLUIDS, V54, P1, DOI 10.1016/j.compfluid.2011.08.001; Tsai R, 2008, INT COMMUN HEAT MASS, V35, P1340, DOI 10.1016/j.icheatmasstransfer.2008.07.001; Xue CF, 2008, NONLINEAR ANAL-THEOR, V69, P2086, DOI 10.1016/j.na.2007.07.047	25	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168923	10.1371/journal.pone.0168923	http://dx.doi.org/10.1371/journal.pone.0168923			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045965	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300072
J	Rass, S; Konig, S; Schauer, S				Rass, Stefan; Koenig, Sandra; Schauer, Stefan			Defending Against Advanced Persistent Threats Using Game-Theory	PLOS ONE			English	Article							ADVERSARIAL RISK ANALYSIS; PUBLIC-GOODS GAME; IMPACT	Advanced persistent threats (APT) combine a variety of different attack forms ranging from social engineering to technical exploits. The diversity and usual stealthiness of APT turns them into a central problem of contemporary practical system security, since information on attacks, the current system status or the attacker's incentives is often vague, uncertain and in many cases even unavailable. Game theory is a natural approach to model the conflict between the attacker and the defender, and this work investigates a generalized class of matrix games as a risk mitigation tool for an advanced persistent threat (APT) defense. Unlike standard game and decision theory, our model is tailored to capture and handle the full uncertainty that is immanent to APTs, such as disagreement among qualitative expert risk assessments, unknown adversarial incentives and uncertainty about the current system state (in terms of how deeply the attacker may have penetrated into the system's protective shells already). Practically, game-theoretic APT models can be derived straightforwardly from topological vulnerability analysis, together with risk assessments as they are done in common risk management standards like the ISO 31000 family. Theoretically, these models come with different properties than classical game theoretic models, whose technical solution presented in this work may be of independent interest.	[Rass, Stefan] Univ Klagenfurt, Inst Appl Informat, Klagenfurt, Austria; [Koenig, Sandra; Schauer, Stefan] Austrian Inst Technol, Safety & Secur Dept, Klagenfurt, Austria	University of Klagenfurt	Rass, S (corresponding author), Univ Klagenfurt, Inst Appl Informat, Klagenfurt, Austria.	stefan.rass@aau.at	König, Sandra/AAM-3315-2021	König, Sandra/0000-0003-2881-4519; Rass, Stefan/0000-0003-2821-2489	European Commission [608090]; HyRiM (Hybrid Risk Management for Utility Networks) under the 7th Framework Programme [FP7-SEC-2013-1]	European Commission(European CommissionEuropean Commission Joint Research Centre); HyRiM (Hybrid Risk Management for Utility Networks) under the 7th Framework Programme	This work was supported by the European Commission's Project No. 608090, HyRiM (Hybrid Risk Management for Utility Networks) under the 7th Framework Programme (FP7-SEC-2013-1) http://cordis.europa.eu/project/rcn/185511_en.html.	Berger U, 2007, J ECON THEORY, V135, P572, DOI 10.1016/j.jet.2005.12.010; Busby JS, 2016, EUR J OPER RES, V251, P1029, DOI 10.1016/j.ejor.2015.12.034; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Chandola V, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1541880.1541882; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Chen MH, 2015, APPL MATH COMPUT, V251, P192, DOI 10.1016/j.amc.2014.11.052; Chien E, 2011, W32 STUXNET DOSSIER; Coleman TW, 2014, CYBERSECURITY THREAT; Dehmer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094985; Deutscher Bundestag, 2014, UNT DURCH BUND BER R; Elstrodt J., 2002, MASS INTEGRATIONSTHE; Embrechts P, 2001, HDB HEAVY TAILED DIS; Emmert-Streib F, 2016, INFORM SCIENCES, V346, P180, DOI 10.1016/j.ins.2016.01.074; Friedberg I, 2015, SYMMETRY, V6, P997; Fudenberg D., 1991, GAME THEORY; Garcia-Teodoro P, 2009, COMPUT SECUR, V28, P18, DOI 10.1016/j.cose.2008.08.003; Gibbons R., 1992, PRIMER GAME THEORY; Hamilton SN, 2002, INF SURV WORKSH, P167; Hassanzadeh A, 2009, 2009 FIRST INTERNATIONAL CONFERENCE ON FUTURE INFORMATION NETWORKS, P242, DOI 10.1109/ICFIN.2009.5339579; Hohl M, 2013, METHODE RISIKOANALYS; Innerhofer-Oberperfler F, 2009, 2009 INTERNATIONAL CONFERENCE ON AVAILABILITY, RELIABILITY, AND SECURITY (ARES), VOLS 1 AND 2, P66, DOI 10.1109/ARES.2009.85; International Standards Organisation (ISO), 2011, 27005 ISOIEC; International Standards Organisation (ISO), 2013, 27001 ISOIEC; International Standards Organisation (ISO), 2009, 31000 ISOIEC; ISO/IEC, 270002018 ISOIEC; Jajodia S, 2005, MASSIVE COMP, V5, P247, DOI 10.1007/0-387-24230-9_9; Karnouskos S, 2011, IEEE IND ELEC, P4490; Konig S., 2016, ARXIV160403558; Konigsberger K., 2004, ANALYSIS, V2; Krugel C., 2002, Information Security and Cryptology - ICISC 2001. 4th International Conference. Proceedings (Lecture Notes in Computer Science Vol.2288), P114; Kushner D, 2013, IEEE SPECTRUM, V50, P48, DOI 10.1109/MSPEC.2013.6471059; Levin D. A., 2008, MARKOV CHAINS MIXING; Lozovanu D., 2005, B ACAD STIINTE REPUB, V3, P115; MacKenzie CA, 2014, RISK ANAL, V34, P2143, DOI 10.1111/risa.12220; Mandiant Intelligence Center, 2013, APT1 EXP ON CHIN CYB; Mell P.M., 2007, PUBLISHED 1 FORUM IN; Meng XK, 2015, PHYS LETT A, V379, P767, DOI 10.1016/j.physleta.2014.12.051; Moon D, 2014, COMPUT SECUR, V6, P35; Moore T, 2010, NEW SECURITY PARADIGMS WORKSHOP 2010, P85; Nguyen KC, 2009, IEEE ICC, P714; Noel S, 2010, INT J NEXT-GENER COM, V1, P113; Pavlovic D, 2011, PROCEEDINGS OF THE 2011 NEW SECURITY PARADIGMS WORKSHOP (NSPW'11), P125; R Core Team, 2021, R LANGUAGE ENV STAT; Rass S., 2015, ARXIV E PRINTS; Rass S., 2015, ARXIV151108591; Rass S., 2015, GAME THEORETIC RIS 1; Rass S, 2015, LECT NOTES COMPUT SC, V9406, P346, DOI 10.1007/978-3-319-25594-1_20; Rass S, 2014, LECT NOTES COMPUT SC, V8840, P118, DOI 10.1007/978-3-319-12601-2_7; Rass S, 2013, J NETW SYST MANAG, V21, P47, DOI 10.1007/s10922-012-9229-1; Insua IR, 2009, J AM STAT ASSOC, V104, P841, DOI 10.1198/jasa.2009.0155; Rios J, 2012, RISK ANAL, V32, P894, DOI 10.1111/j.1539-6924.2011.01713.x; ROBERT CP, 2001, BAYESIAN CHOICE; Robinson A., 1966, STUDIES LOGIC FDN MA; Rothschild C, 2012, RISK ANAL, V32, P1219, DOI 10.1111/j.1539-6924.2011.01701.x; SANS Institute, 2000, CRIT SEC CONTR GUID; Shaked M, 2007, SPRINGER SER STAT, P3; SHAPLEY LS, 1953, P NATL ACAD SCI USA, V39, P1095, DOI 10.1073/pnas.39.10.1095; Silverman BW., 1986, DENSITY ESTIMATION S, DOI 10.1201/9781315140919; Singhal A., 2011, SECURITY RISK ANAL E; Skopik F, 2013, 43 JAHR GES FUER INF, P2240; Skopik F, 2014, 2014 IEEE PES INNOVATIVE SMART GRID TECHNOLOGIES CONFERENCE (ISGT); Tankard Colin, 2011, Network Security, V2011, P16, DOI 10.1016/S1353-4858(11)70086-1; van Dijk M, 2013, J CRYPTOL, V26, P655, DOI 10.1007/s00145-012-9134-5; Voorneveld M, 1999, J OPTIMIZ THEORY APP, V102, P203, DOI 10.1023/A:1021854814980; Wand MP., 1994, KERNEL SMOOTHING; Wang LY, 2014, IEEE T DEPEND SECURE, V11, P30, DOI 10.1109/TDSC.2013.24; Washburn A., 2001, NEW KIND FICTITIOUS; Wellman MP, 2014, LECT NOTES COMPUT SC, V8840, P43, DOI 10.1007/978-3-319-12601-2_3; Winehav M, 2012, SWEDISH NATL RISK AS; Xia CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129542; Zhang M, 2015, ELIFE, V4, DOI 10.7554/eLife.11205; Zhu Q., 2013, INT C DECISION GAME, P246, DOI DOI 10.1007/978-3-319-02786-9_15	74	39	42	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168675	10.1371/journal.pone.0168675	http://dx.doi.org/10.1371/journal.pone.0168675			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2QJ	28045922	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300041
J	Benkisser-Petersen, M; Buchner, M; Dorffel, A; Duhren-von-Minden, M; Claus, R; Klasener, K; Leberecht, K; Burger, M; Dierks, C; Jumaa, H; Malavasi, F; Reth, M; Veelken, H; Duyster, J; Zirlik, K				Benkisser-Petersen, Marco; Buchner, Maike; Doerffel, Arlette; Duehren-von-Minden, Marcus; Claus, Rainer; Klaesener, Kathrin; Leberecht, Kerstin; Burger, Meike; Dierks, Christine; Jumaa, Hassan; Malavasi, Fabio; Reth, Michael; Veelken, Hendrik; Duyster, Justus; Zirlik, Katja			Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							CYCLIC ADP-RIBOSE; B-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; MULTIPLE-MYELOMA; EXPRESSION; PHOSPHORYLATION; SYK; COMPLEX; LYN; STIMULATION	The survival and proliferation of CLL cells depends on microenvironmental contacts in lymphoid organs. CD38 is a cell surface receptor that plays an important role in survival and proliferation signaling in CLL. In this study we demonstrate SYK's direct involvement in the CD38 signaling pathway in primary CLL samples. CD38 stimulation of CLL cells revealed SYK activation. SYK downstream target AKT was subsequently induced and MCL-1 expression was increased. Concomitant inhibition of SYK by the SYK inhibitor R406 resulted in reduced activation of AKT and prevented upregulation of MCL-1. Moreover, short-term CD38 stimulation enhanced BCR-signaling, as indicated by increased ERK phosphorylation. CXCL12-dependent migration was increased after CD38 stimulation. Treating CLL cells with R406 inhibited CD38-mediated migration. In addition, we observed marked down-regulation of CD38 expression for CLL cells treated with R406 compared to vehicle control. Finally, we observed a clear correlation between CD38 expression on CLL cells and SYK-inhibitor efficacy. In conclusion, our study provides deeper mechanistic insight into the effect of SYK inhibition in CLL.	[Benkisser-Petersen, Marco; Claus, Rainer; Burger, Meike; Dierks, Christine; Duyster, Justus; Zirlik, Katja] Univ Freiburg, Univ Med Ctr, Dept Hematol Oncol & Stem Cell Transplantat, Fac Med, Freiburg, Germany; [Benkisser-Petersen, Marco] Univ Freiburg, Fac Biol, Freiburg, Germany; [Buchner, Maike] Tech Univ Munich, Inst Clin Chem & Pathobiochem, Munich, Germany; [Doerffel, Arlette] Univ Heidelberg Hosp, Dept Internal Med 5, Heidelberg, Germany; [Duehren-von-Minden, Marcus; Jumaa, Hassan] Univ Med Ctr, Dept Immunol, Ulm, Germany; [Klaesener, Kathrin; Leberecht, Kerstin; Reth, Michael] Univ Freiburg, Dept Mol Immunol, BIOSS Ctr Biol Signalling Studies, Biol 3, Freiburg, Germany; [Klaesener, Kathrin; Leberecht, Kerstin; Reth, Michael] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Malavasi, Fabio] Univ Torino, Immunogenet Lab, Dept Med Sci, Turin, Italy; [Malavasi, Fabio] Univ Torino, CeRMS, Turin, Italy; [Malavasi, Fabio] Transplant Immunol, Turin, Italy; [Veelken, Hendrik] Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands	University of Freiburg; University of Freiburg; Technical University of Munich; Ruprecht Karls University Heidelberg; Ulm University; University of Freiburg; Max Planck Society; University of Turin; University of Turin; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Zirlik, K (corresponding author), Univ Freiburg, Univ Med Ctr, Dept Hematol Oncol & Stem Cell Transplantat, Fac Med, Freiburg, Germany.	katja.zirlik@uniklinik-freiburg.de	Claus, Rainer/AAZ-5606-2020	Claus, Rainer/0000-0003-2617-8766; Klasener, Kathrin/0000-0002-5969-2553; Veelken, Hendrik/0000-0002-9108-3125	Deutsche Krebshilfe [DKH 110461]; German Cancer Consortium (DKTK) [L664]; Forschungskommission Medizinische Fakultat Freiburg [ZIR1032/15]; Excellence Initiative of the German Federal and State Governments [EXC 294]; Deutsche Forschungsgemeinschaft [TRR130, SFB 746]; European Research Council [32297]; German Cancer Foundation [111026]	Deutsche Krebshilfe(Deutsche Krebshilfe); German Cancer Consortium (DKTK); Forschungskommission Medizinische Fakultat Freiburg; Excellence Initiative of the German Federal and State Governments; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); German Cancer Foundation	This work was funded by the Deutsche Krebshilfe (Grant: DKH 110461) to RC, the German Cancer Consortium (DKTK, Grant: L664) to KZ, the Forschungskommission Medizinische Fakultat Freiburg (Grant: ZIR1032/15) to KZ, the Excellence Initiative of the German Federal and State Governments (Grant: EXC 294) to MR, the Deutsche Forschungsgemeinschaft (Grants: TRR130, SFB 746) to MR, the European Research Council (Grant: 32297) to MR, and the German Cancer Foundation (Grant: 111026) to MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin S, 2008, BLOOD, V111, P5646, DOI 10.1182/blood-2008-01-129726; Buchner M, 2010, BLOOD, V115, P4497, DOI 10.1182/blood-2009-07-233692; Buchner M, 2009, CANCER RES, V69, P5424, DOI 10.1158/0008-5472.CAN-08-4252; Buggins AGS, 2011, BRIT J HAEMATOL, V154, P216, DOI 10.1111/j.1365-2141.2011.08725.x; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Congleton J, 2014, CELL SIGNAL, V26, P1589, DOI 10.1016/j.cellsig.2014.03.021; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; Deaglio S, 2005, BLOOD, V105, P3042, DOI 10.1182/blood-2004-10-3873; Deaglio S, 2003, BLOOD, V102, P2146, DOI 10.1182/blood-2003-03-0989; Deaglio S, 2001, FASEB J, V15, P580; Deaglio S, 2007, BLOOD, V110, P4012, DOI 10.1182/blood-2007-06-094029; Deaglio S, 2007, BLOOD, V109, P5390, DOI 10.1182/blood-2006-12-061812; Deaglio S, 2010, MOL MED, V16, P87, DOI 10.2119/molmed.2009.00146; Deckert J, 2014, CLIN CANCER RES, V20, P4574, DOI 10.1158/1078-0432.CCR-14-0695; Del Poeta G, 2001, BLOOD, V98, P2633, DOI 10.1182/blood.V98.9.2633; Duhren-von Minden M, 2012, NATURE, V489, P309, DOI 10.1038/nature11309; FARIS M, 1994, J EXP MED, V179, P1923, DOI 10.1084/jem.179.6.1923; Fields PE, 2000, METH MOL B, V134, P307; FRANCIS DA, 1995, INT IMMUNOL, V7, P151, DOI 10.1093/intimm/7.2.151; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Ghia P, 2002, EUR J IMMUNOL, V32, P1403, DOI 10.1002/1521-4141(200205)32:5<1403::AID-IMMU1403>3.0.CO;2-Y; Granziero L, 2001, BLOOD, V97, P2777, DOI 10.1182/blood.V97.9.2777; Hoellenriegel J, 2012, LEUKEMIA, V26, P1576, DOI 10.1038/leu.2012.24; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; KIKUCHI Y, 1995, P NATL ACAD SCI USA, V92, P11814, DOI 10.1073/pnas.92.25.11814; Kitanaka A, 1997, J IMMUNOL, V159, P184; Lee HC, 1996, RECENT PROG HORM RES, V51, P355; Lee HC, 1996, RECENT PROG HORM RES, V51, P389; Lokhorst HM, 2015, NEW ENGL J MED, V373, P1207, DOI 10.1056/NEJMoa1506348; Lund FE, 1996, J IMMUNOL, V157, P1455; Lund FE, 2006, INT IMMUNOL, V18, P1029, DOI 10.1093/intimm/dxl037; Patten PEM, 2008, BLOOD, V111, P5173, DOI 10.1182/blood-2007-08-108605; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Rodriguez-Alba JC, 2008, BLOOD, V111, P3644, DOI 10.1182/blood-2007-08-107714; Saborit-Villarroya I, 2011, LEUKEMIA, V25, P479, DOI 10.1038/leu.2010.291; SANTOSARGUMEDO L, 1995, INT IMMUNOL, V7, P163, DOI 10.1093/intimm/7.2.163; Sharman J, 2015, BLOOD, V125, P2336, DOI 10.1182/blood-2014-08-595934; Silvennoinen O, 1996, J IMMUNOL, V156, P100; Vaisitti T, 2010, LEUKEMIA, V24, P958, DOI 10.1038/leu.2010.36; Wendt ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119532; Willimott S, 2007, HAEMATOLOGICA, V92, P1359, DOI 10.3324/haematol.11340; Yasue T, 1997, P NATL ACAD SCI USA, V94, P10307, DOI 10.1073/pnas.94.19.10307; Zubiaur M, 2002, J BIOL CHEM, V277, P13, DOI 10.1074/jbc.M107474200; Zucchetto A, 2012, LEUKEMIA, V26, P1301, DOI 10.1038/leu.2011.369	47	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169159	10.1371/journal.pone.0169159	http://dx.doi.org/10.1371/journal.pone.0169159			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036404	Green Published, gold, Green Submitted			2022-12-26	WOS:000391229300059
J	Coskun, A; Baykal, AT; Kazan, D; Akgoz, M; Senal, MO; Berber, I; Titiz, I; Bilsel, G; Kilercik, H; Karaosmanoglu, K; Cicek, M; Yurtsever, I; Yazici, C				Coskun, Abdurrahman; Baykal, Ahmet Tarik; Kazan, Dilek; Akgoz, Muslum; Senal, Merve Oztug; Berber, Ibrahim; Titiz, Izzet; Bilsel, Gokhan; Kilercik, Hakan; Karaosmanoglu, Kubra; Cicek, Muslum; Yurtsever, Ilknur; Yazici, Cevat			Proteomic Analysis of Kidney Preservation Solutions Prior to Renal Transplantation	PLOS ONE			English	Article							ISCHEMIA; PROTEINS; EXPRESSION; ACTIN; APOPTOSIS; INJURY; BETA	One of the main issues in kidney transplantation is the optimal functional preservation of the organ until its transplantation into the appropriate recipient. Despite intensive efforts, the functional preservation period remains limited to hours. During this time, as a result of cellular injury, various proteins, peptides, and other molecules are released by the organ into the preservation medium. In this study, we used proteomic techniques to analyze the protein profiles of preservation solutions in which organs had been preserved prior to their transplantation. Samples were obtained from the preservation solutions of 25 deceased donor kidneys scheduled for transplantation. The protein profiles of the solutions were analyzed using 2D gel electrophoresis/MALDI-TOF and LC-MS/MS. We identified and quantified 206 proteins and peptides belonging to 139 different groups. Of these, 111 proteins groups were belonging to kidney tissues. This study used proteomic techniques to analyze the protein profiles of organ preservation solutions. These findings will contribute to the development of improved preservation solutions to effectively protect organs for transplantation.	[Coskun, Abdurrahman; Baykal, Ahmet Tarik] Acibadem Univ, Sch Med, Dept Med Biochem, Istanbul, Turkey; [Kazan, Dilek; Karaosmanoglu, Kubra] Marmara Univ, Fac Engn, Dept Bioengn, Istanbul, Turkey; [Akgoz, Muslum; Senal, Merve Oztug; Bilsel, Gokhan] Natl Metrol Inst, Gebze, Turkey; [Berber, Ibrahim] Acibadem Univ, Sch Med, Dept Gen Surg, Istanbul, Turkey; [Titiz, Izzet] Haydarpasa Numune Res & Training Hosp, Dept Gen Surg, Istanbul, Turkey; [Kilercik, Hakan; Cicek, Muslum] Yeni Yuzyil Univ, Gaziosmanpasa Hosp, Dept Anesthesiol, Istanbul, Turkey; [Yurtsever, Ilknur] Istanbul Medipol Univ, Regenerat & Restorat Med Res Ctr, Beykoz Istanbul, Turkey; [Yazici, Cevat] Erciyes Univ, Sch Med, Dept Med Biochem, Kayseri, Turkey	Acibadem University; Marmara University; National Metrology Institute of Turkey; Acibadem University; Istanbul Haydarpasa Numune Training & Research Hospital; Gaziosmanpasa University; Yeni Yuzyil University; Istanbul Medipol University; Erciyes University	Coskun, A (corresponding author), Acibadem Univ, Sch Med, Dept Med Biochem, Istanbul, Turkey.	Coskun2002@gmail.com	YAZICI, Cevat/AAE-2558-2019; Akgoz, Muslum/AAG-4598-2019; Baykal, Ahmet T/C-3948-2013; Coskun, Abdurrahman/C-3906-2015; Berber, Ibrahim/C-2852-2019; cicek, muslum/P-5252-2019; Oztug, Merve/ABC-4768-2021; cicek, muslum/AGX-0585-2022; yurtsever, ilknur/G-2560-2019; Oztug, Merve/AAH-6132-2021; Berber, ibrahim/E-2583-2016	YAZICI, Cevat/0000-0003-0625-9542; Akgoz, Muslum/0000-0001-5065-8087; Baykal, Ahmet T/0000-0002-8814-7351; Coskun, Abdurrahman/0000-0002-1273-0604; cicek, muslum/0000-0001-9187-8342; Oztug, Merve/0000-0002-6287-2774; Berber, ibrahim/0000-0002-6618-8347	Scientific and Technological Research Council of Turkey (TUBITAK) [110S103]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This study was financed by The Scientific and Technological Research Council of Turkey (TUBITAK), project number 110S103, http://www.tubitak.gov.tr/en. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON P, 1994, ANN NY ACAD SCI, V723, P401, DOI 10.1111/j.1749-6632.1994.tb36758.x; Baykal AT, 2013, TURK J BIOL, V37, P414, DOI 10.3906/biy-1208-14; Caron A, 2004, ARCH BIOCHEM BIOPHYS, V431, P31, DOI 10.1016/j.abb.2004.07.009; Chatauret N, 2011, CURR OPIN ORGAN TRAN, V16, P180, DOI 10.1097/MOT.0b013e3283446b1d; Desai MM, 2005, BJU INT, V95, P377, DOI 10.1111/j.1464-410X.2005.05304.x; Ebert T, 2014, NUTR METAB CARDIOVAS, V24, P1027, DOI 10.1016/j.numecd.2014.03.006; Fox C, 2016, SCI REP-UK, V6, DOI 10.1038/srep20101; Genesca M, 2006, APOPTOSIS, V11, P563, DOI 10.1007/s10495-006-4937-1; GOLIGORSKY MS, 1993, AM J PHYSIOL, V264, pF1, DOI 10.1152/ajprenal.1993.264.1.F1; Gottmann U, 2007, TRANSPLANTATION, V84, P755, DOI 10.1097/01.tp.0000281410.85659.48; GRONE HJ, 1987, AM J PATHOL, V129, P1; Gunal O, 2010, TURK J MED SCI, V40, P465, DOI 10.3906/sag-0811-26; Hauet T, 2008, KIDNEY INT, V74, P998, DOI 10.1038/ki.2008.336; Joosten SA, 2002, AM J PATHOL, V160, P1301, DOI 10.1016/S0002-9440(10)62557-6; Kaga E, 2013, J PROTEOMICS, V92, P260, DOI 10.1016/j.jprot.2013.06.015; Kelly KJ, 2005, CONTRIB NEPHROL, V148, P86, DOI 10.1159/000086054; Kepka Alina, 2008, Pol Merkur Lekarski, V24, P125; Kruidering M, 1998, CELL DEATH DIFFER, V5, P601, DOI 10.1038/sj.cdd.4400392; Lefaucheur C, 2014, CLIN EXP IMMUNOL, V178, P57, DOI 10.1111/cei.12511; MOLITORIS BA, 1989, J CLIN INVEST, V84, P1334, DOI 10.1172/JCI114302; MOLITORIS BA, 1992, AM J PHYSIOL, V263, pF488, DOI 10.1152/ajprenal.1992.263.3.F488; Nanda N, 2009, BIOMARK INSIGHTS, V4, P111; Noris M, 2012, CLIN KIDNEY J, V5, P94, DOI 10.1093/ckj/sfs032; O'Neill S, 2014, NEPHRON EXP NEPHROL, V126, P167, DOI 10.1159/000363323; PFALLER W, 1994, KIDNEY INT, pS68; Rienstra H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009095; Serhatli M, 2014, J PROTEOME RES, V13, P5071, DOI 10.1021/pr5006586; Smith MPW, 2013, KIDNEY INT, V84, P1214, DOI 10.1038/ki.2013.200; Spiegel HU, 2001, SPR SP SURG SER, P265; Tamura M, 1996, BIOCHEM BIOPH RES CO, V222, P683, DOI 10.1006/bbrc.1996.0804; Tang Z, 2014, J PROTEOME RES, V13, P2433, DOI 10.1021/pr500192g; Thelen S, 2015, AM J PHYSIOL-RENAL, V309, pF501, DOI 10.1152/ajprenal.00220.2014; Tian X, 2014, J CLIN INVEST, V124, P1098, DOI 10.1172/JCI69778; Wang F, 2015, KIDNEY INT, V88, P796, DOI 10.1038/ki.2015.176; Whitaker RM, 2015, TOXICOL SCI, V145, P108, DOI 10.1093/toxsci/kfv038; Yamauchi A, 2002, J PHARM PHARMACOL, V54, P205, DOI 10.1211/0022357021778394; Zager RA, 2012, AM J PHYSIOL-RENAL, V303, pF1460, DOI 10.1152/ajprenal.00426.2012; Zager RA, 2009, AM J PHYSIOL-RENAL, V296, pF1032, DOI 10.1152/ajprenal.00061.2009	38	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168755	10.1371/journal.pone.0168755	http://dx.doi.org/10.1371/journal.pone.0168755			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036361	Green Published, gold, Green Submitted			2022-12-26	WOS:000391229300025
J	Wang, DB; Huang, W; Liang, RW; Li, FS				Wang, Daobo; Huang, Wei; Liang, Ruwen; Li, Fusheng			Effects of Spartina alterniflora Invasion on Soil Quality in Coastal Wetland of Beibu Gulf of South China	PLOS ONE			English	Article							MICROBIAL BIOMASS; ECOSYSTEM; CARBON; DYNAMICS; NITROGEN; FUMIGATION; EXTRACTION	Background Since Spartina alterniflora (simplified as Spartina) has strong ecological competitiveness and rapid growth, it has been introduced and living in the coastal wetland regions of China for more than 30 years. Taking coastal wetland in the Beibu Gulf of south China as an example, the effects of Spartina invasion on soil quality were investigated to provide scientific basis for soil management. Methodology The soil quality of six different coastal wetlands, i.e. mangrove (vegetation coverage is above 95%), mangrove-Spartina ecotones (vegetation coverage is above 95%), sparse mangrove (vegetation coverage is 10%-20%), sparse mangrove-Spartina ecotones (vegetation coverage is about 80%), Spartina (vegetation coverage is about 80%) and bare beach (no plants), were analyzed using the following indicators: pH, cation exchange capacity, contents of total nitrogen, total phosphorus and organic carbon, microbial biomass carbon, microbial biomass nitrogen, microbial carbon / organic carbon, and activities of urease, acid phosphatase, invertase, polyphenol oxidase and catalase. Principal Findings The results showed that compared to mangrove wetland, most indicators in the mangrove-Spartina wetland showed a decline tendency except pH value, and the contents of total phosphorus and organic carbon, microbial biomass carbon and soil microbial biomass nitrogen, and the activities of acid phosphatase and invertase were significantly reduced (P<0.05). Compared to sparse mangrove wetland and bare beach, the Spartina invasion wetland (sparse mangrove-Spartina wetland and Spartina wetland) had higher contents of total nitrogen, total phosphorus and organic carbon, microbial biomass carbon, microbial biomass nitrogen, cation exchange capacity and the activities of urease and acid phosphatase, so soil quality in the sparse mangrove wetland and bare beach was significantly improved. Factor Analysis and PCA also showed that: the quality of mangrove wetland soil is better than that of mangrove-Spartina ecotones wetland soil; the quality of sparse mangrove-Spartina ecotones wetland soil is better than that of sparse mangrove wetland soil; the quality of Spartina wetland soil is better than that of bare beach wetland soil. Conclusions/Significance Therefore, in the invaded Beibu Gulf wetland ecosystems of south China, for the mangrove wetlands where the productivity of native plant was higher than that of Spartina, the Spartina invasion can cause soil degradation significantly and it must be strictly controlled, while for sparse mangrove wetland and bare beach where the productivity of native plant was lower than that of Spartina, Spartina invasion can improve the soil quality. Thus our study may help to better understand the effect of plant invasion.	[Wang, Daobo; Liang, Ruwen] Qinzhou Univ, Guangxi Key Lab Beibu Gulf Marine Biodivers Conse, Guangxi Coll & Univ Key Lab Exploitat & Protect B, Coll Resources & Environm, Guangxi, Peoples R China; [Huang, Wei; Li, Fusheng] Guangxi Univ, Coll Agr, Guangxi, Peoples R China	Beibu Gulf University; Guangxi University	Li, FS (corresponding author), Guangxi Univ, Coll Agr, Guangxi, Peoples R China.	zhenz@gxu.edu.cn	王, 道波/AAD-7962-2020; Li, Fusheng/E-4914-2011; Li, Fusheng/AGG-1317-2022	Li, Fusheng/0000-0003-4189-3354; Li, Fusheng/0000-0003-4189-3354; Wang, Daobo/0000-0002-6512-6662	Guangxi Key Laboratory of Beibu Gulf Marine Biodiversity Conservation, Guangxi colleges and universities Key Laboratory of Exploitation and Protection of Beibu Gulf Marine Biological Resources [2015ZB09, 2015KA02]; Guangxi Key Research & Development Program [GXS-AB16380164]	Guangxi Key Laboratory of Beibu Gulf Marine Biodiversity Conservation, Guangxi colleges and universities Key Laboratory of Exploitation and Protection of Beibu Gulf Marine Biological Resources; Guangxi Key Research & Development Program	This work was supported by Guangxi Key Laboratory of Beibu Gulf Marine Biodiversity Conservation, Guangxi colleges and universities Key Laboratory of Exploitation and Protection of Beibu Gulf Marine Biological Resources (2015ZB09, 2015KA02), Guangxi Key Research & Development Program (GXS-AB16380164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SQ, 2007, WEED RES, V47, P183, DOI 10.1111/j.1365-3180.2007.00559.x; Bao S., 2013, SOIL AGR CHEM ANAL; Batten KM, 2006, BIOL INVASIONS, V8, P217, DOI 10.1007/s10530-004-3856-8; Bernik BM, 2016, BIOL INVASIONS, V18, P1485, DOI 10.1007/s10530-016-1096-3; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Bu NS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121571; Chen Lu-Zhen, 2010, Chinese Journal of Plant Ecology, V34, P186, DOI 10.3773/j.issn.1005-264x.2010.02.010; Chmura GL, 2004, ESTUARIES, V27, P70, DOI 10.1007/BF02803561; Chung CH, 2006, ECOL ENG, V27, P49, DOI 10.1016/j.ecoleng.2005.09.012; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; [高建华 GAO Jianhua], 2007, [地理研究, Geographical Research], V26, P799; Guan S., 1987, SOIL ENZYME ITS RES, P123; Hart P. B. S., 1989, Land Degradation & Rehabilitation, V1, P77, DOI 10.1002/ldr.3400010202; Hong Rong-biao, 2005, Journal of Oceanography in Taiwan Strait, V24, P189; Hou D., 2015, WETL SCI MANAG, V11, P67, DOI 10.3969/j.issn.1673; [黄利东 Huang Lidong], 2015, [土壤通报, Chinese Journal of Soil Science], V46, P1447; Kourtev PS, 1998, WATER AIR SOIL POLL, V105, P493, DOI 10.1023/A:1005037105499; Li B, 2009, ECOL ENG, V35, P511, DOI 10.1016/j.ecoleng.2008.05.013; Li HP, 2008, ECOL ENG, V32, P11, DOI 10.1016/j.ecoleng.2007.08.005; Li WH, 2006, PLANT SOIL, V281, P309, DOI 10.1007/s11104-005-9641-3; Li XW, 2011, WETLAND SCI MANAGE, V7, P44; Liao CZ, 2007, ECOSYSTEMS, V10, P1351, DOI 10.1007/s10021-007-9103-2; Liao ChengZhang, 2010, Biodiversity Science, V18, P631, DOI 10.3724/SP.J.1003.2010.631; Liu Chun-yue, 2009, Yingyong Shengtai Xuebao, V20, P901; [毛子龙 Mao Zilong], 2011, [生态环境学报, Ecology and Environmental Sciences], V20, P1813; MCGILL WB, 1986, CAN J SOIL SCI, V66, P1, DOI 10.4141/cjss86-001; Mendelssohn IA, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P59; Pan Xiao-cui, 2016, Yingyong Shengtai Xuebao, V27, P1145, DOI 10.13287/j.1001-9332.201604.026; POWLSON DS, 1987, SOIL BIOL BIOCHEM, V19, P159, DOI 10.1016/0038-0717(87)90076-9; SPARLING GP, 1992, AUST J SOIL RES, V30, P195, DOI 10.1071/SR9920195; Sundareshwar PV, 2003, SCIENCE, V299, P563, DOI 10.1126/science.1079100; Tyler AC, 2007, ECOL APPL, V17, P1886, DOI 10.1890/06-0822.1; Vasu D, 2016, GEODERMA, V282, P70, DOI 10.1016/j.geoderma.2016.07.010; von Lutzow M, 2002, GEODERMA, V105, P243, DOI 10.1016/S0016-7061(01)00106-9; Wang BX, 2010, SCI SOIL WATER CONSE, V8, P114; [王刚 Wang Gang], 2013, [生态学报, Acta Ecologica Sinica], V33, P2474; Wang HongLi, 2010, Environmental Science & Technology (China), V33, P1; Wang M, 2007, PEDOSPHERE, V17, P545, DOI 10.1016/S1002-0160(07)60065-4; Wei T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120994; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Xiong HF, 2005, CHIN J SOIL SCI, V36, P240; [许振 Xu Zhen], 2014, [海洋通报, Marine Science Bulletin], V33, P444; Yang SG, 2009, BIOMASS BIOENERG, V33, P597, DOI 10.1016/j.biombioe.2008.09.007; Zeng Yan, 2011, Shengtaixue Zazhi, V30, P2080; Zhang CB, 2009, APPL SOIL ECOL, V43, P163, DOI 10.1016/j.apsoil.2009.07.001; Zhang Li, 2013, Yingyong Shengtai Xuebao, V24, P1153; [张琪 Zhang Qi], 2005, 土壤, V37, P679; Zhang QF, 2011, J SOIL SEDIMENT, V11, P1020, DOI 10.1007/s11368-011-0369-9; Zhang WenMin, 2014, Acta Pedologica Sinica, V51, P1351; [张祥霖 ZHANG Xianglin], 2008, [地球科学进展, Advance in Earth Sciences], V23, P974; [张耀鸿 Zhang Yaohong], 2012, [土壤通报, Journal of Soil Science], V43, P102; Zhang YH, 2010, SOIL BIOL BIOCHEM, V42, P1712, DOI 10.1016/j.soilbio.2010.06.006; Zhao Qing, 2007, Research of Environmental Sciences, V20, P44; Zhao YJ, 2010, HYDROBIOLOGIA, V637, P143, DOI 10.1007/s10750-009-9992-5; Zhen YY, 2014, THESIS; Zhou HX, 2008, PEDOSPHERE, V18, P77, DOI 10.1016/S1002-0160(07)60105-2; [周虹霞 Zhou Hongxia], 2005, [生态学报, Acta Ecologica Sinica], V25, P2304; [周军 Zhou Jun], 2007, [南京大学学报. 自然科学版, Journal of Nanjing University], V43, P494	58	17	17	17	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168951	10.1371/journal.pone.0168951	http://dx.doi.org/10.1371/journal.pone.0168951			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036358	Green Submitted, Green Published, gold			2022-12-26	WOS:000391229300040
J	Calvo, P; Bowen, J; Bulbena, A; Tobena, A; Fatjo, J				Calvo, Paula; Bowen, Jonathan; Bulbena, Antoni; Tobena, Adolf; Fatjo, Jaume			Highly Educated Men Establish Strong Emotional Links with Their Dogs: A Study with Monash Dog Owner Relationship Scale (MDORS) in Committed Spanish Dog Owners	PLOS ONE			English	Article							PET OWNERSHIP; HEALTH; BEHAVIORS; IMPACT; INCOME; RISK; BOND	The characteristics of the human-animal bond may be influenced by both owner-related and dog-related factors. A study was designed to explore the existence of different dog ownership patterns and their related factors. We created an on line questionnaire that included demographic questions about the dog and the owner, a Spanish version of the Monash Dog Owner Relationship Scale (MDORS) and a validated measure of satisfaction with life (Cantril's ladder). We collected 1140 valid responses from adult dog owners, who were recruited using the client databases of Spanish veterinary practices. We explored the presence of groups within the population using Principal Components Analysis (PCA) of the MDORS variables combined with Hierarchical Cluster Analysis (HCA). Two groups were found; Group I having a higher level of emotional involvement with their dogs compared with Group II. Binary logistic regression was used to explore demographic factors that influenced group membership. Four variables were significantly associated with membership of Group I (p<0.0001); male gender of the owner (OR = 32.36), high school level of maximum educational attainment (OR = 0.052), university level of maximum educational attainment (OR = 8.652), and owner Cantril's score (OR = 0.807). The results obtained from this convenience sample demonstrate that different patterns of dog-ownership may be present within a population of owner-dog dyads, and that certain owner characteristics are associated with the type of owner-dog relationship. Future research could apply a similar approach to different types of sample population in order to identify specific patterns of dog-ownership.	[Calvo, Paula; Bowen, Jonathan; Bulbena, Antoni; Tobena, Adolf; Fatjo, Jaume] Univ Autonoma Barcelona, Dept Psychiat & Legal Med, Chair Affin Fdn Anim & Hlth, Bellaterra, Catalunya, Spain; [Calvo, Paula; Bulbena, Antoni; Fatjo, Jaume] Hosp del Mar Med Res Inst IMIM, Parc Recerca Biomed Barcelona, Barcelona, Catalunya, Spain; [Bowen, Jonathan] Royal Vet Coll, Hawkshead Lane, North Mimms, Herts, England; [Bulbena, Antoni] Parc Salut Mar, INAD Inst Neuropsiquiatria & Addicc, Barcelona, Catalunya, Spain	Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of London; University of London Royal Veterinary College; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Calvo, P (corresponding author), Univ Autonoma Barcelona, Dept Psychiat & Legal Med, Chair Affin Fdn Anim & Hlth, Bellaterra, Catalunya, Spain.; Calvo, P (corresponding author), Hosp del Mar Med Res Inst IMIM, Parc Recerca Biomed Barcelona, Barcelona, Catalunya, Spain.	pcalvoetologia@gmail.com	CALVO, PAULA/AAI-4860-2020; tobena, adolf/G-1032-2010; Bulbena, Antonio/AAG-5411-2019	CALVO, PAULA/0000-0002-1013-6521; Bulbena, Antonio/0000-0003-2404-2478; Fatjo, Jaume/0000-0001-6806-2097; Bowen, Jonathan/0000-0002-8047-7225; Tobena, Adolf/0000-0001-6137-0660	Affinity Foundation	Affinity Foundation	This research was developed by the Chair Affinity Foundation Animals and Health form the Universitat Autonoma de Barcelona, which is sponsored by a non-profit Foundation (Affinity Foundation, http://www.fundacion-affinity.org). This sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAHA-American Animal Hospital Association, 2004, PET OWN SURV; Anderson LS, 2010, J SPEC PEDIATR NURS, V15, P111, DOI 10.1111/j.1744-6155.2009.00223.x; ANFAAC-Asociacion Nacional de Fabricantes de Alimentos para Animales de nitudes del sector, 2013, CENS DE MASC; AVMA, 2012, US PET OWN STAT; AVMA, 2012, US PET OWN DEM SOURC; Bennett PC, 2007, APPL ANIM BEHAV SCI, V102, P65, DOI 10.1016/j.applanim.2006.03.009; Bonas S, 2000, COMPANION ANIMALS AND US, P209; Bosnjak M, 2010, SOC SCI COMPUT REV, V28, P350, DOI 10.1177/0894439309353395; Bryan JL, 2014, PERS INDIV DIFFER, V68, P23, DOI 10.1016/j.paid.2014.04.003; Bueker C.S., 2013, J SOCIOL SOCIAL WELF, V40, P211; Cantril H., 1965, PATTERN HUMAN CONCER; Diener E, 2013, J PERS SOC PSYCHOL, V104, P267, DOI 10.1037/a0030487; DiGiacomo N, 1998, ANTHROZOOS, V11, P41, DOI 10.2752/089279398787000878; Diverio S, 2016, J VET BEHAV, V12, P27, DOI 10.1016/j.jveb.2016.02.004; Downes M, 2009, PREV VET MED, V92, P140, DOI 10.1016/j.prevetmed.2009.07.005; Duggan M, 2013, DEMOGRAPHICS SOCIAL; Dwyer F, 2006, ANTHROZOOS, V19, P243, DOI 10.2752/089279306785415592; EMERSON RM, 1976, ANNU REV SOCIOL, V2, P335, DOI 10.1146/annurev.so.02.080176.002003; Freiwald A, 2014, PREV VET MED, V115, P198, DOI 10.1016/j.prevetmed.2014.03.025; Garcia AG, 2014, PSICOTHEMA, V26, P314, DOI 10.7334/psicothema2013.215; Handlin L, 2012, ANTHROZOOS, V25, P215, DOI 10.2752/175303712X13316289505468; Helliwell JF., 2020, WORLD HAPPINESS REPO; INE, 2020, ENC EQ US TECN INF C; INE (Instituto Nacional de Estadistica), 2013, DEM POBL CIFR POBL C; Joinson AN, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1027; Julius H., 2013, ATTACHMENT PETS AN I; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; King T, 2009, APPL ANIM BEHAV SCI, V120, P84, DOI 10.1016/j.applanim.2009.04.011; Kotila LE, 2013, FAM RELAT, V62, P795, DOI 10.1111/fare.12037; Levine GN, 2013, CIRCULATION, V127, P2353, DOI 10.1161/CIR.0b013e31829201e1; Lewis A., 2009, ELECT J APPL PSYCHOL, V5, P96, DOI [DOI 10.7790/ejap.v5i1.138, 10.7790/ejap.v5i1.138, DOI 10.7790/EJAP.V5I1.138]; Marinelli L, 2007, APPL ANIM BEHAV SCI, V108, P143, DOI 10.1016/j.applanim.2006.11.018; Marston LC, 2003, APPL ANIM BEHAV SCI, V83, P227, DOI 10.1016/S0168-1591(03)00135-7; Martins CM, 2013, PREV VET MED, V109, P213, DOI 10.1016/j.prevetmed.2012.10.006; McConnell AR, 2011, J PERS SOC PSYCHOL, V101, P1239, DOI 10.1037/a0024506; Meyer I, 2014, J VET BEHAV, V9, P143, DOI 10.1016/j.jveb.2014.03.002; Ministerio de Agricultura, GOB ESP AN CAR SECT; Mullersdorf M, 2010, SCAND J PUBLIC HEALT, V38, P53, DOI 10.1177/1403494809344358; Murray JK, 2010, VET REC, V166, P163, DOI 10.1136/vr.b4712; NETTING FE, 1987, SOC WORK, V32, P60, DOI 10.1093/sw/32.1.60; Patronek GJ, 1996, J AM VET MED ASSOC, V209, P572; Pierce GR, 1990, PERS RELATIONSHIP, P173; Prato-Previde E, 2006, ETHOLOGY, V112, P64, DOI 10.1111/j.1439-0310.2006.01123.x; Raina P, 1999, J AM GERIATR SOC, V47, P323, DOI 10.1111/j.1532-5415.1999.tb02996.x; Rehn T, 2014, APPL ANIM BEHAV SCI, V150, P65, DOI 10.1016/j.applanim.2013.10.008; Rohlf VI, 2010, ANTHROZOOS, V23, P143, DOI 10.2752/175303710X12682332909972; Siniscalchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078455; Slater MR, 2008, PREV VET MED, V85, P267, DOI 10.1016/j.prevetmed.2008.02.001; Smith G., 2008, 501717 ED; Thorn P, 2015, ANTHROZOOS, V28, P569, DOI 10.1080/08927936.2015.1069992; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; Toukhsati SR, 2007, ANTHROZOOS, V20, P131, DOI 10.2752/175303707X207927; Vazquez C, 2012, ESCALA SATISFACCION; Westgarth Carri, 2007, BMC Vet Res, V3, P5, DOI 10.1186/1746-6148-3-5; Westgarth C, 2010, INT J ENV RES PUB HE, V7, P3704, DOI 10.3390/ijerph7103704	55	13	13	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168748	10.1371/journal.pone.0168748	http://dx.doi.org/10.1371/journal.pone.0168748			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7KQ	28033397	Green Published, Green Submitted, gold			2022-12-26	WOS:000391226900043
J	Cokcetin, NN; Pappalardo, M; Campbell, LT; Brooks, P; Carter, DA; Blair, SE; Harry, EJ				Cokcetin, Nural N.; Pappalardo, Matthew; Campbell, Leona T.; Brooks, Peter; Carter, Dee A.; Blair, Shona E.; Harry, Elizabeth J.			The Antibacterial Activity of Australian Leptospermum Honey Correlates with Methylglyoxal Levels	PLOS ONE			English	Article							APIS-MELLIFERA COLONIES; MANUKA HONEY; DIHYDROXYACETONE; EXPRESSION	Most commercially available therapeutic honey is derived from flowering Leptospermum scoparium (manuka) plants from New Zealand. Australia has more than 80 Leptospermum species, and limited research to date has found at least some produce honey with high non-peroxide antibacterial activity (NPA) similar to New Zealand manuka, suggesting Australia may have a ready supply of medical-grade honey. The activity of manuka honey is largely due to the presence of methylglyoxal (MGO), which is produced non-enzymatically from dihydroxyacetone (DHA) present in manuka nectar. The aims of the current study were to chemically quantify the compounds contributing to antibacterial activity in a collection of Australian Leptospermum honeys, to assess the relationship between MGO and NPA in these samples, and to determine whether NPA changes during honey storage. Eighty different Leptospermum honey samples were analysed, and therapeutically useful NPA was seen in samples derived from species including L. liversidgei and L. polygalifolium. Exceptionally high levels of up to 1100 mg/kg MGO were present in L. polygalifolium honey samples sourced from the Northern Rivers region in NSW and Byfield, QLD, with considerable diversity among samples. There was a strong positive relationship between NPA and MGO concentration, and DHA was present in all of the active honey samples, indicating a potential for ongoing conversion to MGO. NPA was stable, with most samples showing little change following seven years of storage in the dark at 4 degrees C. This study demonstrates the potential for Australian Leptospermum honey as a wound care product, and argues for an extension of this analysis to other Leptospermum species.	[Cokcetin, Nural N.; Pappalardo, Matthew; Blair, Shona E.; Harry, Elizabeth J.] Univ Technol Sydney, Ithree Inst, Sydney, NSW, Australia; [Pappalardo, Matthew; Brooks, Peter] Univ Sunshine Coast, Maroochydore, Qld, Australia; [Campbell, Leona T.; Carter, Dee A.] Univ Sydney, Sydney, NSW, Australia	University of Technology Sydney; University of the Sunshine Coast; University of Sydney	Harry, EJ (corresponding author), Univ Technol Sydney, Ithree Inst, Sydney, NSW, Australia.	liz.harry@uts.edu.au	Carter, Dee/C-1331-2010; Harry, Elizabeth/G-8123-2017; Harry, Liz/AAT-9396-2020; Cokcetin, Nural/AAV-6974-2021; Cokcetin, Nural N/Q-2068-2016	Carter, Dee/0000-0002-4638-0059; Cokcetin, Nural/0000-0002-3874-2873; Cokcetin, Nural N/0000-0002-3874-2873; Harry, Elizabeth/0000-0003-0858-9473; Brooks, Peter/0000-0003-4915-4986	Rural Industries Research and Development Corporation, Australia; Comvita NZ Ltd.; Capilano Honey Pty Ltd. Australia; Rural Industries Research & Development Corporation; Capilano Honey Pty Ltd	Rural Industries Research and Development Corporation, Australia; Comvita NZ Ltd.; Capilano Honey Pty Ltd. Australia; Rural Industries Research & Development Corporation; Capilano Honey Pty Ltd	This work was supported by the Rural Industries Research and Development Corporation, Australia http://www.rirdc.gov.au/, and partially funded by Comvita NZ Ltd. http://www.comvita.co.nz/ and Capilano Honey Pty Ltd. Australia http://capilano.com.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the many beekeepers who supplied honey samples for the survey, Comvita New Zealand for the supply of Medihoney (TM) and active 18+ manuka honey, and Ralf Schlothauer for his manuka honey expertise. This research was supported in part by a Rural Industries Research & Development Corporation grant, as well as Comvita NZ Ltd. and Capilano Honey Pty Ltd.	Adams CJ, 2008, CARBOHYD RES, V343, P651, DOI 10.1016/j.carres.2007.12.011; Adams CJ, 2009, CARBOHYD RES, V344, P1050, DOI 10.1016/j.carres.2009.03.020; Allen K.L., 1991, APIACTA, V26, P114, DOI [10.1080/ 0005772X.1992.11099118, DOI 10.1080/0005772X.1992.11099118]; ALLEN KL, 1991, J PHARM PHARMACOL, V43, P817, DOI 10.1111/j.2042-7158.1991.tb03186.x; Atrott J, 2009, CZECH J FOOD SCI, V27, pS163, DOI 10.17221/911-CJFS; Atrott J, 2012, CARBOHYD RES, V361, P7, DOI 10.1016/j.carres.2012.07.025; Blair SE, 2009, EUR J CLIN MICROBIOL, V28, P1199, DOI 10.1007/s10096-009-0763-z; Brady N, 2004, J APICULT RES, V43, P47, DOI 10.1080/00218839.2004.11101109; Cabrera L, 2006, REV CIENT-FAC CIEN V, V16, P556; Carter DA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00569; Cooper RA, 2010, EUR J CLIN MICROBIOL, V29, P1237, DOI 10.1007/s10096-010-0992-1; Cooper RA, 2009, HONEY MODERN WOUND M; Cooper R, 2012, EXPERT REV ANTI-INFE, V10, P623, DOI [10.1586/ERI.12.46, 10.1586/eri.12.46]; Forst J, 2013, LEPTOSPERMUM; Grainger MNC, 2014, FOOD CHEM, V153, P134, DOI 10.1016/j.foodchem.2013.12.017; Henriques A, 2005, J APICULT RES, V44, P119, DOI 10.1080/00218839.2005.11101161; Irish J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018229; Janmaat AF, 2000, BEHAV ECOL SOCIOBIOL, V47, P171, DOI 10.1007/s002650050008; Khalil MI, 2010, FOOD CHEM TOXICOL, V48, P2388, DOI 10.1016/j.fct.2010.05.076; Kwakman PHS, 2011, EUR J CLIN MICROBIOL, V30, P251, DOI 10.1007/s10096-010-1077-x; Lu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055898; Maddocks SE, 2012, MICROBIOL-SGM, V158, P781, DOI 10.1099/mic.0.053959-0; Mattila HR, 2006, ENVIRON ENTOMOL, V35, P708, DOI 10.1603/0046-225X-35.3.708; Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282; Ministry for Primary Industries, 2012, FARM MON REP 2012, P9; MOAR NT, 1985, NEW ZEAL J AGR RES, V28, P39, DOI 10.1080/00288233.1985.10426997; MOLAN PC, 1988, J APICULT RES, V27, P62, DOI 10.1080/00218839.1988.11100783; Molan PC, 1996, J PHARM PHARMACOL, V48, P1206, DOI 10.1111/j.2042-7158.1996.tb03922.x; MOLAN PC, 1992, BEE WORLD, V73, P5, DOI 10.1080/0005772X.1992.11099109; Mundo MA, 2004, INT J FOOD MICROBIOL, V97, P1, DOI 10.1016/j.ijfoodmicro.2004.03.025; Norton AM, 2015, J AGR FOOD CHEM, V63, P6513, DOI 10.1021/acs.jafc.5b01930; Ohashi K, 1999, EUR J BIOCHEM, V265, P127, DOI 10.1046/j.1432-1327.1999.00696.x; Price JN, 2006, ECOGRAPHY, V29, P623, DOI 10.1111/j.0906-7590.2006.04645.x; Shaban, 2013, NATL SURVEILLANCE RE; Staveley JP, 2014, HUM ECOL RISK ASSESS, V20, P566, DOI 10.1080/10807039.2013.831263; Stephens JM, 2010, FOOD CHEM, V120, P78, DOI 10.1016/j.foodchem.2009.09.074; Todd JH, 2007, APIDOLOGIE, V38, P354, DOI 10.1051/apido:2007021; Truchado P, 2009, FOOD CHEM, V115, P1337, DOI 10.1016/j.foodchem.2009.01.065; Windsor S, 2012, J PHARMACOGNOSY PHYT, V4; Windsor S., 2013, J PHARMACOGN PHYTOTH, V5, P21; Wrigley J, 1996, AUSTR NATIVE PLANTS; Yao LH, 2003, FOOD CHEM, V81, P159, DOI 10.1016/S0308-8146(02)00388-6	42	43	44	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167780	10.1371/journal.pone.0167780	http://dx.doi.org/10.1371/journal.pone.0167780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030589	Green Published, Green Submitted, gold			2022-12-26	WOS:000391222000021
J	Kim, JH; Lee, HS; Choi, HK; Kim, JA; Chu, IS; Leem, SH; Oh, IH				Kim, Jung-Ho; Lee, Ho-Sun; Choi, Hyun-Kyung; Kim, Jin-A; Chu, In-Sun; Leem, Sun-Hee; Oh, Il-Hoan			Heterogeneous Niche Activity of Ex-Vivo Expanded MSCs as Factor for Variable Outcomes in Hematopoietic Recovery	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; UMBILICAL-CORD BLOOD; STROMAL CELLS; BONE-MARROW; SELF-RENEWAL; REGENERATIVE MEDICINE; PROMOTE ENGRAFTMENT; UNRELATED DONORS; GRAFT FAILURE; FREE MEDIA	Ex-vivo expanded mesenchymal stromal cells (MSCs) are increasingly used for paracrine support of hematopoietic stem cell (HSC) regeneration, but inconsistent outcomes have hindered ongoing clinical trials. Here, we show that significant heterogeneity in the niche activity of MSCs is created during their culture in various serum-supplemented media. The MSCs cultured under stimulatory or non-stimulatory culture conditions exhibited differences in colony forming unit-fibroblast contents, expression levels of cross-talk molecules (Jagged-1 and CXCL-12) and their support for HSC self-renewal. Accordingly, the enhancing effects of MSCs on hematopoietic engraftment were only visible when HSCs were co-transplanted with MSCs under stimulatory conditions. Of note, these differences in MSCs and their effects on HSCs were readily reversed by switching the cultures, indicating that the difference in niche activity can be caused by distinct functional state, rather than by clonal heterogeneity. Supporting the findings, transcriptomic analysis showed distinct upstream signaling pathways such as inhibition of P53 and activation of ER-stress response gene ATF4 for MSCs under stimulatory conditions. Taken together, our study shows that the niche activity of MSCs can vary rapidly by the extrinsic cues during culture causing variable outcomes in hematopoietic recoveries, and point to the possibility that MSCs can be prescreened for more predictable efficacy in various cell therapy trials.	[Kim, Jung-Ho; Lee, Ho-Sun; Choi, Hyun-Kyung; Kim, Jin-A; Oh, Il-Hoan] Catholic Univ Korea, Catholic High Performance Cell Therapy Ctr, Seoul, South Korea; [Kim, Jung-Ho; Lee, Ho-Sun; Choi, Hyun-Kyung; Kim, Jin-A; Oh, Il-Hoan] Catholic Univ Korea, Dept Med Life Sci, Seoul, South Korea; [Chu, In-Sun] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Daejeon, South Korea; [Leem, Sun-Hee] Dong A Univ, Dept Biol Sci, Busan, South Korea	Catholic University of Korea; Catholic University of Korea; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Dong A University	Oh, IH (corresponding author), Catholic Univ Korea, Catholic High Performance Cell Therapy Ctr, Seoul, South Korea.; Oh, IH (corresponding author), Catholic Univ Korea, Dept Med Life Sci, Seoul, South Korea.	iho@catholic.ac.kr			Ministry of Science, ICT, & Future Planning [2011-0019352]; NRF [2012R1A5A2047939]; Ministry of Food and Drug Safety [14172MFDS974]	Ministry of Science, ICT, & Future Planning; NRF; Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This study was funded by the Ministry of Science, ICT, & Future Planning (No. 2011-0019352), a grant from NRF (2012R1A5A2047939) and a grant from Ministry of Food and Drug Safety (14172MFDS974).	Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Balboni AL, 2015, MOL CANCER RES, V13, P732, DOI 10.1158/1541-7786.MCR-14-0152-T; Ball LM, 2007, BLOOD, V110, P2764, DOI 10.1182/blood-2007-04-087056; Bernardo ME, 2012, BONE MARROW TRANSPL, V47, P323, DOI 10.1038/bmt.2011.102; Bernardo ME, 2011, BONE MARROW TRANSPL, V46, P200, DOI 10.1038/bmt.2010.87; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Chung YJ, 2006, BLOOD, V108, P1208, DOI 10.1182/blood-2006-01-010199; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Drake LE, 2014, J PATHOL, V232, P283, DOI 10.1002/path.4298; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Galipeau J, 2013, CYTOTHERAPY, V15, P2, DOI 10.1016/j.jcyt.2012.10.002; Gonzalo-Daganzo R, 2009, CYTOTHERAPY, V11, P278, DOI 10.1080/14653240902807018; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hagen J, 2014, CANCER RES, V74, P6661, DOI 10.1158/0008-5472.CAN-13-3742; Ho AD, 2008, CYTOTHERAPY, V10, P320, DOI 10.1080/14653240802217011; Horwitz ME, 2015, CURRENT HEMATOLOGIC; Huang GP, 2007, CELL TRANSPLANT, V16, P579, DOI 10.3727/000000007783465073; Jeong Hyunsuk, 2014, International Journal of Stem Cells, V7, P63, DOI 10.15283/ijsc.2014.7.2.63; Jeong H, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt233; KANG YJ, 2007, STEM CELLS; Keating A, 2006, CURR OPIN HEMATOL, V13, P419, DOI 10.1097/01.moh.0000245697.54887.6f; Kim DW, 2004, BLOOD, V103, P1941, DOI 10.1182/blood-2003-05-1601; Kim JA, 2015, CANCER RES, V75, P2222, DOI 10.1158/0008-5472.CAN-14-3379; Kim JA, 2015, STEM CELL RES, V14, P356, DOI 10.1016/j.scr.2015.02.007; Kim JA, 2009, STEM CELLS, V27, P1318, DOI 10.1002/stem.52; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; Kristt D, 2010, BONE MARROW TRANSPL, V45, P137, DOI 10.1038/bmt.2009.120; Kwon KR, 2010, STEM CELLS, V28, P268, DOI 10.1002/stem.285; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001; Liu Min, 2013, Methods Mol Biol, V946, P241, DOI 10.1007/978-1-62703-128-8_15; Lui K, 2013, J CELL SCI, V126, P2436, DOI 10.1242/jcs.118117; MacMillan ML, 2009, BONE MARROW TRANSPL, V43, P447, DOI 10.1038/bmt.2008.348; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mishima S, 2010, EUR J HAEMATOL, V84, P538, DOI 10.1111/j.1600-0609.2010.01419.x; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Montalbano J, 2009, J BIOL CHEM, V284, P18129, DOI 10.1074/jbc.M109.009597; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; NISHIZAWA M, 1992, FEBS LETT, V299, P36, DOI 10.1016/0014-5793(92)80094-W; Noort WA, 2002, EXP HEMATOL, V30, P870, DOI 10.1016/S0301-472X(02)00820-2; Oh Il-Hoan, 2012, Korean J Hematol, V47, P87, DOI 10.5045/kjh.2012.47.2.87; Oh IH, 2010, STEM CELLS, V28, P1243, DOI 10.1002/stem.453; Oikonomopoulos A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16570; Park IH, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.87; Park JY, 2004, BIOCHEM BIOPH RES CO, V325, P1346, DOI 10.1016/j.bbrc.2004.10.151; PEAULT B, 1993, NOUV REV FR HEMATOL, V35, P91; Pereira ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012521; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Riordan NH, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0561-6; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Rodgers JT, 2014, NATURE, V510, P393, DOI 10.1038/nature13255; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Smith JR, 2004, STEM CELLS, V22, P823, DOI 10.1634/stemcells.22-5-823; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Wermann K, 1996, J Hematother, V5, P379, DOI 10.1089/scd.1.1996.5.379; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Ye JB, 2009, CURR MOL MED, V9, P411, DOI 10.2174/156652409788167096; Yu SB, 2013, INT J BIOL SCI, V9, P256, DOI 10.7150/ijbs.5898; Zhang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021397; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhao YZ, 2015, BLOOD, V126, P2383, DOI 10.1182/blood-2015-03-633354	66	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168036	10.1371/journal.pone.0168036	http://dx.doi.org/10.1371/journal.pone.0168036			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030562	gold, Green Published, Green Submitted			2022-12-26	WOS:000391222000031
J	Krauel, JJ; LeBuhn, G				Krauel, Jennifer J.; LeBuhn, Gretchen			Patterns of Bat Distribution and Foraging Activity in a Highly Urbanized Temperate Environment	PLOS ONE			English	Article							HABITAT USE; COMMUNITY STRUCTURE; INSECTIVOROUS BATS; EUCALYPTUS PLANTATIONS; FOREST FRAGMENTS; BIRD DIVERSITY; PREY SELECTION; ECOLOGY; ABUNDANCE; INSECTS	Understanding how to manage biodiversity in urban areas will become increasingly important as density of humans residing in urban centers increases and urban areas expand. While considerable research has documented the shifts in biodiversity along urbanization gradients, much less work has focused on how characteristics of dense urban centers, effectively novel environments, influence behavior and biodiversity. Urban bats in San Francisco provide an opportunity to document changes in behavior and biodiversity to very high-density development. We studied (1) the distribution and abundance of bat foraging activity in natural areas; and (2) characteristics of natural areas that influence the observed patterns of distribution and foraging activity. We conducted acoustic surveys of twenty-two parks during 2008-2009. We confirmed the presence of four species of bats (Tadarida brasiliensis, Myotis yumanensis, Lasiurus blossevillii, and M. lucifugus). T. brasiliensis were found in all parks, while M. yumanensis occurred in 36% of parks. Results indicate that proximity to water, park size, and amount of forest edge best explained overall foraging activity. Proximity to water best explained species richness. M. yumanensis activity was best explained by reduced proportion of native vegetation as well as proximity to water. Activity was year round but diminished in December. We show that although bats are present even in very densely populated urban centers, there is a large reduction in species richness compared to that of outlying areas, and that most habitat factors explaining their community composition and activity patterns are similar to those documented in less urbanized environments.	[Krauel, Jennifer J.; LeBuhn, Gretchen] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Krauel, Jennifer J.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA	California State University System; San Francisco State University; University of Tennessee System; University of Tennessee Knoxville	Krauel, JJ (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.; Krauel, JJ (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	jkrauel@vols.utk.edu	Krauel, Jennifer/AAD-1949-2019	Krauel, Jennifer/0000-0003-2207-8952; lebuhn, gretchen/0000-0001-5030-3366	San Francisco Natural Areas program; Bat Conservation International; Presidio Trust; Wildlife Society; San Francisco State University	San Francisco Natural Areas program; Bat Conservation International; Presidio Trust; Wildlife Society; San Francisco State University	Funding for this study was provided by the San Francisco Natural Areas program, http://sfrecpark.org/parks-open-spaces/natural-areas-program/, Bat Conservation International, http://www.batcon.org/, the Presidio Trust, http://www.presidio.gov/, the Wildlife Society, http://tws-west.org/, and San Francisco State University, http://www.sfsu.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlen I, 2009, J MAMMAL, V90, P1318, DOI 10.1644/09-MAMM-S-223R.1; [Anonymous], 2016, ESTIMATES STAT ESTIM; [Anonymous], 2010, POPULATION HOUSING U; [Anonymous], 2021, LANG ENV STAT COMP; Avila-Flores R, 2005, J MAMMAL, V86, P1193, DOI 10.1644/04-MAMM-A-085R1.1; Banks PB, 2007, BIOLOGY LETT, V3, P611, DOI 10.1098/rsbl.2007.0374; Barbosa A.M., 2016, MODEVA MODEL EVALUAT; BARCLAY RMR, 1991, J ANIM ECOL, V60, P165, DOI 10.2307/5452; Barton K., 2016, MUMIN MULTIMODEL INF; BELL GP, 1980, CAN J ZOOL, V58, P1876, DOI 10.1139/z80-256; Beninde J, 2015, ECOL LETT, V18, P581, DOI 10.1111/ele.12427; Bennett VJ, 2013, J WILDLIFE MANAGE, V77, P93, DOI 10.1002/jwmg.467; Berthinussen A, 2011, J APPL ECOL; Beyer HL., HAWTHS ANAL TOOLS AR; Bolger DT, 2000, ECOL APPL, V10, P1230, DOI 10.1890/1051-0761(2000)010[1230:AIUHFI]2.0.CO;2; BRIGHAM RM, 1992, J MAMMAL, V73, P640, DOI 10.2307/1382036; Burnham KP, 2002, MODEL SELECTION MULT, VXXVI; Chamberlain DE, 2009, IBIS, V151, P1, DOI 10.1111/j.1474-919X.2008.00899.x; Christensen R.H.B., 2012, ORDINAL REGRESSION M; Ciechanowski M, 2007, CAN J ZOOL, V85, P1249, DOI 10.1139/Z07-090; Clarke Kevin M., 2008, Urban Ecosystems, V11, P317, DOI 10.1007/s11252-008-0065-8; Clergeau P, 2001, J APPL ECOL, V38, P1122, DOI 10.1046/j.1365-2664.2001.00666.x; Clergeau P, 1998, CONDOR, V100, P413, DOI 10.2307/1369707; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; Coleman JL, 2013, J MAMMAL, V94, P1111, DOI 10.1644/12-MAMM-A-217.1; Coleman JL, 2012, URBAN ECOSYST, V15, P87, DOI 10.1007/s11252-011-0181-8; Coleman JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020483; Connor EF, 2002, J INSECT CONSERV, V6, P247, DOI 10.1023/A:1024426727504; Cryan PM, 2007, BIOL CONSERV, V139, P1, DOI 10.1016/j.biocon.2007.05.019; Dallimer M, 2011, BIOL LETTERS, V7, P763, DOI 10.1098/rsbl.2011.0025; Derkzen ML, 2015, J APPL ECOL, V52, P1020, DOI 10.1111/1365-2664.12469; Dixon MD, 2012, URBAN ECOSYST, V15, P683, DOI 10.1007/s11252-011-0219-y; Duchamp JE, 2004, CAN J ZOOL, V82, P1157, DOI [10.1139/z04-095, 10.1139/Z04-095]; Duchamp JE, 2008, LANDSCAPE ECOL, V23, P849, DOI 10.1007/s10980-008-9241-8; EIP Associates, 2005, SIGN NAT RES AR MAN; Evans KL, 2011, GLOBAL CHANGE BIOL, V17, P32, DOI 10.1111/j.1365-2486.2010.02247.x; Evelyn MJ, 2004, BIOL CONSERV, V115, P463, DOI 10.1016/S0006-3207(03)00163-0; Everette AL, 2001, WILDLIFE SOC B, V29, P967; Fabianek F, 2011, ECOSCIENCE, V18, P9, DOI 10.2980/18-1-3373; FAETH SH, 1978, OECOLOGIA, V32, P127, DOI 10.1007/BF00344697; Fellers GM, 2005, ACOUSTIC INVENTORY M; FENTON MB, 1970, CAN J ZOOLOG, V48, P847, DOI 10.1139/z70-148; FENTON MB, 1990, CAN J ZOOL, V68, P411, DOI 10.1139/z90-061; Forman RTT, 1995, LAND MOSAICS ECOLOGY, Vxx; Frank KD, 2006, EFFECTS ARTIFICIAL N; FRANKIE GW, 1978, ANNU REV ENTOMOL, V23, P367, DOI 10.1146/annurev.en.23.010178.002055; Fried JH, 2005, OECOLOGIA, V143, P645, DOI 10.1007/s00442-005-0023-6; Fukui D, 2006, J ANIM ECOL, V75, P1252, DOI 10.1111/j.1365-2656.2006.01146.x; FURLONGER CL, 1987, CAN J ZOOL, V65, P284, DOI 10.1139/z87-044; Gaisler J, 1998, J ZOOL, V244, P439, DOI 10.1111/j.1469-7998.1998.tb00048.x; GAVARESKI CA, 1976, CONDOR, V78, P375, DOI 10.2307/1367699; Gehrt SD, 2003, ECOL APPL, V13, P939, DOI 10.1890/02-5188; Gehrt SD, 2004, ECOL APPL, V14, P625, DOI 10.1890/03-5013; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Haase D, 2014, AMBIO, V43, P407, DOI 10.1007/s13280-014-0503-1; Hale JD, 2015, GLOBAL CHANGE BIOL, V21, P2467, DOI 10.1111/gcb.12884; Hale JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033300; Heady PA, 2000, BAT INVENTORY SURVEY; Hilbe J.M., 2014, MODELING COUNT DATA; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hourigan C. L., 2006, Urban Ecosystems, V9, P67, DOI 10.1007/s11252-006-7902-4; Hourigan CL, 2010, AUSTRAL ECOL, V35, P849, DOI 10.1111/j.1442-9993.2009.02086.x; Jameson JW, 2014, ANIM BEHAV, V97, P145, DOI 10.1016/j.anbehav.2014.09.003; Johnson JS, 2007, J MAMMAL, V88, P1261, DOI 10.1644/06-MAMM-A-254R1.1; Johnson Joshua B., 2008, Urban Ecosystems, V11, P227, DOI 10.1007/s11252-008-0055-x; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; JONES RC, 1987, WATER RESOUR BULL, V23, P1047; Jung Kirsten, 2016, P13; Jung K, 2011, DIVERS DISTRIB, V17, P262, DOI 10.1111/j.1472-4642.2010.00738.x; Kalcounis-Rueppell MC, 2007, BIOL CONSERV, V138, P120, DOI 10.1016/j.biocon.2007.04.009; Kervyn T, 2008, BELG J ZOOL, V138, P41; Krauel Jennifer J., 2013, P293; KRUTZSCH PHILIP H., 1955, JOUR MAMMAL, V36, P236, DOI 10.2307/1375882; KURTA A, 1992, ECOGRAPHY, V15, P257, DOI 10.1111/j.1600-0587.1992.tb00032.x; Lane DJW, 2006, BIOL CONSERV, V131, P584, DOI 10.1016/j.biocon.2006.03.005; Lesinski G, 2000, Z SAUGETIERKD, V65, P129; Lesnoff, 2012, AOD ANAL OVERDISPERS; LEWIS T, 1969, J APPL ECOL, V6, P443, DOI 10.2307/2401510; Li H, 2014, URBAN ECOSYST, V17, P1013, DOI 10.1007/s11252-014-0369-9; Lidicker WZ, 1999, LANDSCAPE ECOL, V14, P333, DOI 10.1023/A:1008056817939; Lintott PR, 2016, ECOL EVOL; Loeb Susan C., 2009, Urban Ecosystems, V12, P197, DOI 10.1007/s11252-008-0075-6; Lookingbill TR, 2010, BIOL CONSERV, V143, P974, DOI 10.1016/j.biocon.2010.01.011; Marsden SJ, 2001, BIODIVERS CONSERV, V10, P737, DOI 10.1023/A:1016669118956; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Mendes ES, 2014, EUR J WILDLIFE RES, V60, P651, DOI 10.1007/s10344-014-0832-1; Morris AD, 2010, J WILDLIFE MANAGE, V74, P26, DOI 10.2193/2008-471; Mudd T, 2007, ASSESSMENT STATUS BA; NUCKOLS MS, 1995, ECOL ENTOMOL, V20, P253, DOI 10.1111/j.1365-2311.1995.tb00455.x; Null J, 1999, CLIMATOLOGY SAN FRAN; Nupp TE, 2000, J MAMMAL, V81, P512, DOI 10.1644/1545-1542(2000)081&lt;0512:LLCOSM&gt;2.0.CO;2; O'Farrell MJ, 1999, J MAMMAL, V80, P11, DOI 10.2307/1383203; O'Shea TJ, 2011, URBAN ECOSYST, V14, P665, DOI 10.1007/s11252-011-0182-7; Ober HK, 2008, J MAMMAL, V89, P1191, DOI 10.1644/08-MAMM-A-025.1; Perre P, 2011, URBAN ECOSYST, V14, P711, DOI 10.1007/s11252-011-0179-2; Pickett STA, 2011, J ENVIRON MANAGE, V92, P331, DOI 10.1016/j.jenvman.2010.08.022; Pierson ED, 2004, DISTRIBUTION STATUS; Pierson ED, 1995, BAT SURVEYS PRESIDIO; PYE JD, 1971, NATURE, V229, P572, DOI 10.1038/229572b0; Rainey WE, 2006, TEMPORAL SPATIAL VAR; Rainho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019227; Ritter M. E., 2006, PHYS ENV INTRO PHYS; Russo D, 2003, ECOGRAPHY, V26, P197, DOI 10.1034/j.1600-0587.2003.03422.x; Russo D, 2015, MAMM BIOL, V80, P205, DOI 10.1016/j.mambio.2014.10.003; Russo D, 2015, MAMM BIOL, V80, P157, DOI 10.1016/j.mambio.2015.03.005; RYDELL J, 1989, OECOLOGIA, V80, P562, DOI 10.1007/BF00380082; Schaub A, 2008, J EXP BIOL, V211, P3174, DOI 10.1242/jeb.022863; Sherwin RE, 2000, ACTA CHIROPTEROL, V2, P145; Skalak S.L., 2012, METHODS ECOL EVOL; SOULE M E, 1988, Conservation Biology, V2, P75, DOI 10.1111/j.1523-1739.1988.tb00337.x; Sparks DW, 2005, J MAMMAL, V86, P713, DOI 10.1644/1545-1542(2005)086[0713:FHOTIB]2.0.CO;2; Stahlschmidt P, 2012, METHODS ECOL EVOL, V3, P503, DOI 10.1111/j.2041-210X.2012.00188.x; Stanley MC, 2015, FRONT ECOL ENVIRON, V13, P553, DOI 10.1890/150229; Stone EL, 2015, MAMM BIOL, V80, P213, DOI 10.1016/j.mambio.2015.02.004; Sumasgutner P, 2014, FRONT ZOOL, V11, P13, DOI [10.1186/1742-9994-11-13, DOI 10.1186/1742-9994-11-13]; Szewczak JM, 2004, BAT ECHOLOCATION RES; Szewczak JM, 2006, ECHOLOCATION CALL CH; Threlfall C, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1144; Threlfall C, 2011, ECOGRAPHY, V34, P814, DOI 10.1111/j.1600-0587.2010.06939.x; Threlfall CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038800; Tratalos J, 2007, LANDSCAPE URBAN PLAN, V83, P308, DOI 10.1016/j.landurbplan.2007.05.003; Vaughan N, 1997, J APPL ECOL, V34, P716, DOI 10.2307/2404918; Vindigni MA, 2009, FOREST ECOL MANAG, V258, P2056, DOI 10.1016/j.foreco.2009.07.058; Walsh AL, 1996, J APPL ECOL, V33, P508, DOI 10.2307/2404980; Weller TJ, 2001, J WILDLIFE MANAGE, V65, P489, DOI 10.2307/3803102; Whitaker John O. Jr, 2003, Proceedings of the Indiana Academy of Science, V112, P55; WILKINS K T, 1989, Mammalian Species, P1, DOI 10.2307/3504148; WILLIAMS TC, 1973, J MAMMAL, V54, P807, DOI 10.2307/1379076; Zahn A, 2009, APPL ECOL ENV RES, V7, P297, DOI 10.15666/aeer/0704_297301	132	22	25	2	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168927	10.1371/journal.pone.0168927	http://dx.doi.org/10.1371/journal.pone.0168927			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030640	Green Submitted, Green Published, gold			2022-12-26	WOS:000391222000085
J	Kriegisch, N; Reeves, S; Johnson, CR; Ling, SD				Kriegisch, Nina; Reeves, Simon; Johnson, Craig R.; Ling, Scott D.			Phase-Shift Dynamics of Sea Urchin Overgrazing on Nutrified Reefs	PLOS ONE			English	Article							SHALLOW SUBTIDAL REEFS; CENTROSTEPHANUS-RODGERSII; NUTRIENT ENRICHMENT; REGIME SHIFTS; STABLE STATES; TOP-DOWN; KELP; COMMUNITY; DENSITY; FOREST	Shifts from productive kelp beds to impoverished sea urchin barrens occur globally and represent a wholesale change to the ecology of sub-tidal temperate reefs. Although the theory of shifts between alternative stable states is well advanced, there are few field studies detailing the dynamics of these kinds of transitions. In this study, sea urchin herbivory (a 'top-down' driver of ecosystems) was manipulated over 12 months to estimate (1) the sea urchin density at which kelp beds collapse to sea urchin barrens, and (2) the minimum sea urchin density required to maintain urchin barrens on experimental reefs in the urbanised Port Phillip Bay, Australia. In parallel, the role of one of the 'bottom-up' drivers of ecosystem structure was examined by (3) manipulating local nutrient levels and thus attempting to alter primary production on the experimental reefs. It was found that densities of 8 or more urchins m(-2) (>= 427 g m(-2) biomass) lead to complete overgrazing of kelp beds while kelp bed recovery occurred when densities were reduced to <= 4 urchins m(-2) (<= 213 g m(-2) biomass). This experiment provided further insight into the dynamics of transition between urchin barrens and kelp beds by exploring possible tipping-points which in this system can be found between 4 and 8 urchins m(-2) (213 and 427 g m(-2) respectively). Local enhancement of nutrient loading did not change the urchin density required for overgrazing or kelp bed recovery, as algal growth was not affected by nutrient enhancement.	[Kriegisch, Nina; Reeves, Simon; Johnson, Craig R.; Ling, Scott D.] Univ Tasmania, Inst Marine & Antarctic Studies, Battery Point, Tas, Australia	University of Tasmania	Kriegisch, N (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Battery Point, Tas, Australia.	nina.kriegisch@utas.edu.au	Johnson, Craig R/E-1788-2013; Reeves, Simon E/AAJ-3379-2021; Ling, Scott/J-7161-2014	Johnson, Craig R/0000-0002-9511-905X; Reeves, Simon/0000-0001-6715-466X; Ling, Scott/0000-0002-5544-8174	Victorian Department of Environment, Land, Water and Planning	Victorian Department of Environment, Land, Water and Planning	Funding was provided by the Victorian Department of Environment, Land, Water and Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW NL, 1993, ECOLOGY, V74, P292, DOI 10.2307/1939293; ANDREW NL, 1993, MAR ECOL PROG SER, V99, P89, DOI 10.3354/meps099089; Beaugrand G, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0272; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.2307/3868190; Benedetti-Cecchi L, 1998, MAR ECOL PROG SER, V163, P203, DOI 10.3354/meps163203; Blamey LK, 2012, J EXP MAR BIOL ECOL, V420, P33, DOI 10.1016/j.jembe.2012.03.022; Bonaviri C, 2011, MAR BIOL, V158, P2505, DOI 10.1007/s00227-011-1751-2; Brandt M, 2012, ECOLOGY, V93, P868, DOI 10.1890/10-1785.1; Bulleri F, 2013, MAR BIOL, V160, P2493, DOI 10.1007/s00227-013-2244-2; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Carnell PE, 2014, OECOLOGIA, V175, P409, DOI 10.1007/s00442-014-2907-9; CHAPMAN ARO, 1981, MAR BIOL, V62, P307, DOI 10.1007/BF00397697; CHAPMAN ARO, 1990, HYDROBIOLOGIA, V192, P77, DOI 10.1007/BF00006228; CHAPMAN ARO, 1977, MAR BIOL, V40, P197, DOI 10.1007/BF00390875; Collie JS, 2004, PROG OCEANOGR, V60, P281, DOI 10.1016/j.pocean.2004.02.013; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Constable AJ, 1846, INVESTIGATION RESOUR; DAYTON PK, 1984, SCIENCE, V224, P283, DOI 10.1126/science.224.4646.283; Dong Q, 2002, THEOR POPUL BIOL, V61, P1, DOI 10.1006/tpbi.2001.1554; Fauchald P, 2010, ECOLOGY, V91, P2191, DOI 10.1890/09-1500.1; Feehan C, 2012, MAR ECOL PROG SER, V444, P69, DOI 10.3354/meps09441; Filbee-Dexter K, 2014, MAR ECOL PROG SER, V495, P1, DOI 10.3354/meps10573; Flukes EB, 2014, MAR ECOL PROG SER, V514, P57, DOI 10.3354/meps10964; Fung T, 2011, ECOLOGY, V92, P967, DOI 10.1890/10-0378.1; Gagnon P, 2004, MAR BIOL, V144, P1191, DOI 10.1007/s00227-003-1270-x; Guarnieri G, 2014, OECOLOGIA, V175, P959, DOI 10.1007/s00442-014-2944-4; Harris G., 1996, PORT PHILLIP BAY ENV; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; Heggie DT, 1999, MAR FRESHWATER RES, V50, P589, DOI 10.1071/MF98054; Hill NA, 2003, MAR FRESHWATER RES, V54, P691, DOI 10.1071/MF03052; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; JOHNSON CR, 1988, ECOL MONOGR, V58, P129, DOI 10.2307/1942464; Jung CA, 2011, OCEAN COAST MANAGE, V54, P93, DOI 10.1016/j.ocecoaman.2010.10.035; KENNELLY SJ, 1987, MAR ECOL PROG SER, V40, P145, DOI 10.3354/meps040145; KENNELLY SJ, 1989, MAR ECOL PROG SER, V50, P215, DOI 10.3354/meps050215; Korpinen S, 2007, ECOLOGY, V88, P839, DOI 10.1890/05-0144; Korpinen S, 2008, ESTUAR COAST SHELF S, V78, P437, DOI 10.1016/j.ecss.2008.01.005; Kraufvelin P, 2010, MAR BIOL, V157, P29, DOI 10.1007/s00227-009-1293-z; Lawrence J.M., 1975, Oceanography mar Biol, V13, P213; Lindenmayer DB, 2011, P NATL ACAD SCI USA, V108, P15887, DOI 10.1073/pnas.1110245108; Ling SD, 2008, OECOLOGIA, V156, P883, DOI 10.1007/s00442-008-1043-9; Ling SD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0269; Ling SD, 2010, J EXP MAR BIOL ECOL, V395, P135, DOI 10.1016/j.jembe.2010.08.027; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; MENGE BA, 1976, AM NAT, V110, P351, DOI 10.1086/283073; North W, 1984, INFLUENCES MACRONUTR, P419; Ortega-Borges L, 2009, J SHELLFISH RES, V28, P947, DOI 10.2983/035.028.0426; Osman RW, 2010, MAR ECOL PROG SER, V413, P185, DOI 10.3354/meps08765; Pfister CA, 2003, J PHYCOL, V39, P285, DOI 10.1046/j.1529-8817.2003.01229.x; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Posey MH, 2002, ESTUARIES, V25, P999, DOI 10.1007/BF02691347; Russell BD, 2007, MAR FRESHWATER RES, V58, P657, DOI 10.1071/MF06194; Russell BD, 2005, MAR BIOL, V147, P551, DOI 10.1007/s00227-005-1571-3; Russell BD, 2005, MAR ECOL PROG SER, V289, P5, DOI 10.3354/meps289005; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; Sternberg LDL, 2001, GLOBAL ECOL BIOGEOGR, V10, P369, DOI 10.1046/j.1466-822X.2001.00243.x; Valentine JP, 2003, J EXP MAR BIOL ECOL, V295, P63, DOI 10.1016/S0022-0981(03)00272-7; Worm B, 2000, INT REV HYDROBIOL, V85, P359; Wright JT, 2005, MAR ECOL PROG SER, V298, P143, DOI 10.3354/meps298143	62	24	24	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168333	10.1371/journal.pone.0168333	http://dx.doi.org/10.1371/journal.pone.0168333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030596	Green Published, Green Submitted, gold			2022-12-26	WOS:000391222000044
J	Marzluff, JM; DeLap, JH; Oleyar, MD; Whittaker, KA; Gardner, B				Marzluff, John M.; DeLap, Jack H.; Oleyar, M. David; Whittaker, Kara A.; Gardner, Beth			Breeding Dispersal by Birds in a Dynamic Urban Ecosystem	PLOS ONE			English	Article							BIASED DISPERSAL; TROPHIC DYNAMICS; LAND-USE; MATE; URBANIZATION; SURVIVAL; CONSEQUENCES; BIODIVERSITY; RESPONSES; PATTERNS	Changes in land cover during urbanization profoundly affect the diversity of bird communities, but the demographic mechanisms affecting diversity are poorly known. We advance such understanding by documenting how urbanization influences breeding dispersal-the annual movement of territorial adults-of six songbird species in the Seattle, WA, USA metropolitan area. We color-banded adults and mapped the centers of their annual breeding activities from 2000-2010 to obtain 504 consecutive movements by 337 adults. By comparing movements, annual reproduction, and mate fidelity among 10 developed, 5 reserved, and 11 changing (areas cleared and developed during our study) landscapes, we determined that adaptive breeding dispersal of sensitive forest species (Swainson's Thrush and Pacific wren), which involves shifting territory and mate after reproductive failure, was constrained by development. In changing lands, sensitive forest specialists dispersed from active development to nearby forested areas, but in so doing suffered low annual reproduction. Species tolerant of suburban lands (song sparrow, spotted towhee, dark-eyed junco, and Bewick's wren) dispersed adaptively in changing landscapes. Site fidelity ranged from 0% (Pacific wren in changing landscape) to 83% (Bewick's wren in forest reserve). Mate fidelity ranged from 25% (dark-eyed junco) to 100% (Bewick's wren). Variation in fidelity to mate and territory was consistent with theories positing an influence of territory quality, asynchronous return from migration, prior productivity, and reproductive benefits of retaining a familiar territory. Costly breeding dispersal, as well as reduced reproductive success and lowered survival cause some birds to decline in the face of urbanization. In contrast, the ability of species that utilize edges and early successional habitats to breed successfully, disperse to improve reproductive success after failure, and survive throughout the urban ecosystem enables them to maintain or increase population size.	[Marzluff, John M.; DeLap, Jack H.; Oleyar, M. David; Whittaker, Kara A.; Gardner, Beth] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Marzluff, JM (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	corvid@uw.edu		Marzluff, John/0000-0002-6266-4975	U.S. National Science Foundation [DEB-9875041, IGERT-0114351, BCS 0120024, BCS 0508002]; University of Washington	U.S. National Science Foundation(National Science Foundation (NSF)); University of Washington(University of Washington)	Funding was provided by the U.S. National Science Foundation (DEB-9875041, IGERT-0114351, BCS 0120024, and BCS 0508002) and the University of Washington (Rachel Wood's Endowed Graduate Program, James W. Ridgeway Professorship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti M, 2003, BIOSCIENCE, V53, P1169, DOI 10.1641/0006-3568(2003)053[1169:IHIEOA]2.0.CO;2; ALDRICH J W, 1980, American Birds, V34, P3; Angel S, 2011, PROG PLANN, V75, P53, DOI 10.1016/j.progress.2011.04.001; [Anonymous], 2021, LANG ENV STAT COMP; Arcese P., 2020, BIRDS OF THE WORLD, DOI [10.2173/bow.sonspa.01, DOI 10.2173/BOW.SONSPA.01]; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Bartos Smith S, 2015, BIRDS N AM ONLINE; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Blewett CM, 2005, CONDOR, V107, P678, DOI 10.1650/0010-5422(2005)107[0678:EOUSOS]2.0.CO;2; Boggie MA, 2015, J RAPTOR RES, V49, P458, DOI 10.3356/rapt-49-04-458-470.1; Breton AR, 2014, IBIS, V156, P534, DOI 10.1111/ibi.12161; Camara G, 1996, COMPUT GRAPH, V20, P395, DOI 10.1016/0097-8493(96)00008-8; Chamberlain DE, 2009, IBIS, V151, P1, DOI 10.1111/j.1474-919X.2008.00899.x; Christoferson LL, 2001, WILDLIFE SOC B, V29, P688; Cline MH, 2013, AUK, V130, P742, DOI 10.1525/auk.2013.12244; Clucas B, 2012, AUK, V129, P8, DOI 10.1525/auk.2011.11121; Cramp S., 1980, Acta Congressus Internationalis Ornithologici, V2, P1316; DAVIES NB, 1989, ANIM BEHAV, V38, P226, DOI 10.1016/S0003-3472(89)80085-5; Dhondt AA, 2002, TRENDS ECOL EVOL, V17, P55, DOI 10.1016/S0169-5347(01)02407-7; DHONDT AA, 1994, J ANIM ECOL, V63, P979, DOI 10.2307/5274; Donnelly R, 2004, CONSERV BIOL, V18, P733, DOI 10.1111/j.1523-1739.2004.00032.x; Donnelly Roarke, 2006, Urban Ecosystems, V9, P99, DOI 10.1007/s11252-006-7904-2; Dubois F, 2002, BEHAV ECOL SOCIOBIOL, V52, P357, DOI 10.1007/s00265-002-0521-z; Ens Bruno J., 1996, Oxford Ornithology Series, V6, P344; ESRI, 2011, ARCGIS DESKT REL 10; Evans BS, 2015, ECOLOGY, V96, P1631, DOI 10.1890/14-0171.1; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; Farwell LS, 2013, BIOL CONSERV, V161, P128, DOI 10.1016/j.biocon.2013.03.017; Fischer JD, 2012, BIOSCIENCE, V62, P809, DOI 10.1525/bio.2012.62.9.6; Fisher RA, 1925, P CAMB PHILOS SOC, V22, P700, DOI 10.1017/S0305004100009580; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; Friedrich MJ, 2015, AUK, V132, P265, DOI 10.1642/AUK-14-100.1; Fuller RA, 2012, STUD AVIAN BIOL, V45, P249; Gehlbach Frederick R., 2005, Bulletin of the Texas Ornithological Society, V38, P35; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; Grimm NB, 2000, BIOSCIENCE, V50, P571, DOI 10.1641/0006-3568(2000)050[0571:IATLTO]2.0.CO;2; Gutierrez RJ, 2011, IBIS, V153, P592, DOI 10.1111/j.1474-919X.2011.01140.x; Halabisky M, 2011, J APPL REMOTE SENS, V5, DOI 10.1117/1.3563569; Handel CM, 2000, ANIM BEHAV, V60, P471, DOI 10.1006/anbe.2000.1505; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; Hepinstall JA, 2008, LANDSCAPE ECOL, V23, P1257, DOI 10.1007/s10980-008-9296-6; IBM Corporation, 2010, IBM SPSS STAT, V19; Kath J, 2009, LANDSCAPE URBAN PLAN, V92, P72, DOI 10.1016/j.landurbplan.2009.02.007; Kaye JP, 2006, TRENDS ECOL EVOL, V21, P192, DOI 10.1016/j.tree.2005.12.006; Kennedy ED, 2013, BIRDS N AM ONLINE; Kight CR, 2007, BIOL CONSERV, V138, P189, DOI 10.1016/j.biocon.2007.04.014; Liebgold EB, 2013, MOL ECOL, V22, P5548, DOI 10.1111/mec.12508; Longcore T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034025; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Loss SR, 2014, CONDOR, V116, P8, DOI 10.1650/CONDOR-13-090.1; Mack D. E, 2000, BIRDS N AM ONLINE; Magle SB, 2012, BIOL CONSERV, V155, P23, DOI 10.1016/j.biocon.2012.06.018; Marzluff J.M., 2005, URBAN ECOSYST, V8, P155; MARZLUFF JM, 1989, ECOLOGY, V70, P316, DOI 10.2307/1937536; Marzluff JM, 2015, URBAN ECOSYSTEMS; Marzluff JM, 2012, STUD AVIAN BIOL, V45, P287; Natuhara Y, 2009, ECOLOGY OF CITIES AND TOWNS: A COMPARATIVE APPROACH, P197, DOI 10.1017/CBO9780511609763.013; Newton I., 1996, Oxford Ornithology Series, V6, P249; Nichols J., 2001, DISPERSAL; Nolan V., 2002, BIRDS N AM; Pickett STA, 2001, ANNU REV ECOL SYST, V32, P127, DOI 10.1146/annurev.ecolsys.32.081501.114012; Pyle P, 1997, IDENTIFICATION GUIDE; Ralph C.J., 1993, PSWGTR144WWW USDA; RECHER HF, 1991, CONSERV BIOL, V5, P90, DOI 10.1111/j.1523-1739.1991.tb00391.x; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Robinson DH, 2002, J WILDLIFE MANAGE, V66, P263, DOI 10.2307/3803158; Robinson L, 2005, LANDSCAPE URBAN PLAN, V71, P51, DOI 10.1016/j.landurbplan.2004.02.005; Rodewald AD, 2014, URBAN WILDLIFE CONSE, p117 147, DOI DOI 10.1007/978-1-4899-7500-3_8; Rodewald AD, 2008, J ANIM ECOL, V77, P83, DOI 10.1111/j.1365-2656.2007.01313.x; Rodewald AD, 2011, ECOL APPL, V21, P936, DOI 10.1890/10-0863.1; Rodewald AD, 2010, BIOL INVASIONS, V12, P33, DOI 10.1007/s10530-009-9426-3; Ryder TB, 2010, ECOL APPL, V20, P419, DOI 10.1890/09-0040.1; Sattler T, 2010, ECOLOGY, V91, P3343, DOI 10.1890/09-1810.1; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Shochat E, 2010, BIOSCIENCE, V60, P199, DOI 10.1525/bio.2010.60.3.6; Sol D, 2013, ANIM BEHAV, V85, P1101, DOI 10.1016/j.anbehav.2013.01.023; Stamps Judy A., 2001, P230; Svensson S., 1970, Audubon Fld Notes, V24, P722; Terraube J, 2015, OIKOS, V124, P762, DOI 10.1111/oik.01974; Toews D. P. L., 2012, BIRDS N AM ONLINE; Van Coillie FMB, 2014, INT J REMOTE SENS, V35, P754, DOI 10.1080/01431161.2013.873152; VICKERY PD, 1992, AUK, V109, P697, DOI 10.2307/4088145; Whittaker K, 2012, STUD AVIAN BIOL, V45, P183; Whittaker KA, 2009, AUK, V126, P288, DOI 10.1525/auk.2009.07136; Wlodarczyk R, 2013, ACTA ORNITHOL, V48, P237, DOI 10.3161/000164513X678874	85	14	15	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167829	10.1371/journal.pone.0167829	http://dx.doi.org/10.1371/journal.pone.0167829			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030559	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000022
J	Alkooranee, JT; Aledan, TR; Ali, AK; Lu, GY; Zhang, XK; Wu, JS; Fu, CH; Li, MT				Alkooranee, Jawadayn Talib; Aledan, Tamarah Raad; Ali, Ali Kadhim; Lu, Guangyuan; Zhang, Xuekun; Wu, Jiangsheng; Fu, Chunhua; Li, Maoteng			Detecting the Hormonal Pathways in Oilseed Rape behind Induced Systemic Resistance by Trichoderma harzianum TH12 to Sclerotinia sclerotiorum	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; BRASSICA-NAPUS; BOTRYTIS-CINEREA; SALICYLIC-ACID; STEM ROT; PLANT; DEFENSE; ISR; BIOCONTROL; INDUCTION	Plants have the ability to resist pathogen attack after infection or treatment with biotic and abiotic elicitors. In oilseed rape plant Brassica napus AACC and in the artificially synthesized Raphanus alboglabra RRCC, the root-colonizing Trichoderma harzianum TH12 fungus triggers induced systemic resistance (ISR), and its culture filtrate (CF) triggers a systemic acquired resistance (SAR) response against infection by the Sclerotinia sclerotiorum. Salicylic acid (SA) and jasmonic acid/ethylene (JA/ET) are plant hormone signals that play important roles in the regulation of ISR and SAR. In this study, at six different time points (1, 2, 4, 6, 8 and 10 days post-infection [ dpi]), six resistance genes were used as markers of signaling pathways: JA/ET signaling used AOC3, PDF1.2 and ERF2 genes, while PR-1, TGA5 and TGA6 genes were used as markers of SA signaling. The results of quantitative real-time polymerase chain reaction (qRT-PCR) showed that AOC3, PDF1.2 and ERF2 expression levels in infected leaves of AACC and RRCC increase at 1 and 2 dpi with S. sclerotiorum or inoculation with TH12. PR-1, TGA5 and TGA6 expression levels increased at 8 and 10 dpi in infected leaves. PR-1, TGA5 and TGA6 expression levels increased early in plants treated with CF in both of the healthy genotypes. Furthermore, induction of SA-and JA/ET-dependent defense decreased disease symptoms in infected leaves at different times. The results suggest that the RRCC genotype exhibits resistance to disease and that the ability of TH12 and its CF to induce systemic resistance in susceptible and resistant oilseed rape genotypes exists. In addition, the results indicate for the first time that in RRCC the SA signaling pathway is involved in resistance to necrotrophic pathogens.	[Alkooranee, Jawadayn Talib; Aledan, Tamarah Raad; Ali, Ali Kadhim; Fu, Chunhua; Li, Maoteng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biotechnol, Wuhan, Peoples R China; [Alkooranee, Jawadayn Talib] Univ Basrah, Coll Agr, Plant Protect, Basrah, Iraq; [Alkooranee, Jawadayn Talib; Li, Maoteng] Huanggang Normal Univ, Hubei Collaborat Innovat Ctr Characterist Resourc, Huanggang, Peoples R China; [Lu, Guangyuan; Zhang, Xuekun] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China; [Wu, Jiangsheng] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Huazhong University of Science & Technology; University of Basrah; Huanggang Normal University; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Huazhong Agricultural University	Fu, CH; Li, MT (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biotechnol, Wuhan, Peoples R China.; Li, MT (corresponding author), Huanggang Normal Univ, Hubei Collaborat Innovat Ctr Characterist Resourc, Huanggang, Peoples R China.	fuch2003@126.com; limaoteng426@mail.hust.edu.cn	Alkooranee, Jawadayn Talib/ABG-4193-2020	Alkooranee, Jawadayn Talib/0000-0003-2997-4637	National Key Research and Development Program [2016YFD0100200]; scientific research project of Hubei Collaborative Innovation Centre for the Characteristic Resources Exploitation of Dabie Mountains [2015TD03]; New Century Talents Support Program by the Ministry of Education of China [NCET110172]	National Key Research and Development Program; scientific research project of Hubei Collaborative Innovation Centre for the Characteristic Resources Exploitation of Dabie Mountains; New Century Talents Support Program by the Ministry of Education of China	This work was supported by the National Key Research and Development Program (2016YFD0100200), the scientific research project of Hubei Collaborative Innovation Centre for the Characteristic Resources Exploitation of Dabie Mountains (2015TD03) and the New Century Talents Support Program by the Ministry of Education of China (NCET110172).	Abd El-Rahman AA, 2014, ASIAN PAC J CANCER P, V15, P7229, DOI 10.7314/APJCP.2014.15.17.7229; Aghajani MA, 2010, J AGR SCI TECH-IRAN, V12, P471; Alizadeh H, 2013, BIOL CONTROL, V65, P14, DOI 10.1016/j.biocontrol.2013.01.009; Alkooranee J. T., 2015, American Journal of Plant Sciences, V6, P1662, DOI 10.4236/ajps.2015.610166; Alkooranee JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142177; Almquist C, 2015, PLANT PATHOL, V64, P109, DOI 10.1111/ppa.12230; Bhowmik TP., 2003, OILSEDD BRASSICAS CO; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Brotman Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003221; Choudhary Devendra K., 2007, Indian Journal of Microbiology, V47, P289, DOI 10.1007/s12088-007-0054-2; Chowdappa P, 2013, BIOL CONTROL, V65, P109, DOI 10.1016/j.biocontrol.2012.11.009; De Meyer G, 1998, EUR J PLANT PATHOL, V104, P279, DOI 10.1023/A:1008628806616; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Ellinger D, 2013, PLANT PHYSIOL, V161, P1433, DOI 10.1104/pp.112.211011; Elsharkawy MM, 2013, PLANT PATHOLOGY J, V29, P193, DOI [10.5423/PPJ.SI.07.2012.0117, 10.5423/PPJ.SI.07.2012.01]; Ferrigo D, 2014, J PLANT PATHOL, V96, P133; Garg H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065205; Garg H, 2010, ANN BOT-LONDON, V106, P897, DOI 10.1093/aob/mcq196; GHISALBERTI EL, 1991, SOIL BIOL BIOCHEM, V23, P1011, DOI 10.1016/0038-0717(91)90036-J; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gomez K.A., 1984, STAT PROCEDURES AGR, P13; Grant M, 2006, CURR OPIN PLANT BIOL, V9, P414, DOI 10.1016/j.pbi.2006.05.013; Hafez YM, 2011, EGYPTIAN J PHYTOPATH, V39, P180; Hardham AR, 2007, CURR OPIN PLANT BIOL, V10, P342, DOI 10.1016/j.pbi.2007.05.001; Heil M, 2002, ANN BOT-LONDON, V89, P503, DOI 10.1093/aob/mcf076; Hermosa R, 2012, MICROBIOL-SGM, V158, P17, DOI 10.1099/mic.0.052274-0; Hoitink HAJ, 2006, PHYTOPATHOLOGY, V96, P186, DOI 10.1094/PHYTO-96-0186; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Korolev N, 2008, BIOCONTROL, V53, P667, DOI 10.1007/s10526-007-9103-3; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Lee B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048744; Li CX, 2008, AUSTRALAS PLANT PATH, V37, P162, DOI 10.1071/AP08005; Li XL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-207; Long H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117198; Martinez-Medina A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00206; Mathys J, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00108; Mei JQ, 2015, THEOR APPL GENET, V128, P639, DOI 10.1007/s00122-015-2459-3; Mei JQ, 2013, THEOR APPL GENET, V126, P549, DOI 10.1007/s00122-012-2000-x; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Nawrocka J, 2013, BIOL CONTROL, V67, P149, DOI 10.1016/j.biocontrol.2013.07.005; Naznin HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086882; Novakova M, 2014, PLANT PHYSIOL BIOCH, V80, P308, DOI 10.1016/j.plaphy.2014.04.019; Oliver RP, 2010, CURR OPIN PLANT BIOL, V13, P415, DOI 10.1016/j.pbi.2010.05.003; Sanchez-Vallet A, 2012, PLANT PHYSIOL, V160, P2109, DOI 10.1104/pp.112.200154; Sharma Pratibha, 2004, Journal of Biological Control, V18, P21; Singh R., 2014, INT J ADV RES, V2, P210; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Sticher L, 1997, ANNU REV PHYTOPATHOL, V35, P235, DOI 10.1146/annurev.phyto.35.1.235; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; Vinale F, 2008, PHYSIOL MOL PLANT P, V72, P80, DOI 10.1016/j.pmpp.2008.05.005; Viterbo A, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P676; Wang Z, 2012, PLANT SCI, V184, P75, DOI 10.1016/j.plantsci.2011.12.013; Wu J.J., 2013, INT J MIN SCI TECHNO, V5, P6, DOI DOI 10.1371/J0URNAL.P0NE.0067740; Yang B, 2010, PLANT MOL BIOL REP, V28, P253, DOI 10.1007/s11105-009-0149-5; Yoshioka Y, 2012, PEST MANAG SCI, V68, P60, DOI 10.1002/ps.2220; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894; Zhao J, 2004, PLANT DIS, V88, P1033, DOI 10.1094/PDIS.2004.88.9.1033; Zhu WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053901	60	27	32	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168850	10.1371/journal.pone.0168850	http://dx.doi.org/10.1371/journal.pone.0168850			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045929	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300059
J	Gavidia-Bovadilla, G; Kanaan-Izquierdo, S; Mataro-Serrat, M; Perera-Lluna, A				Gavidia-Bovadilla, Giovana; Kanaan-Izquierdo, Samir; Mataro-Serrat, Maria; Perera-Lluna, Alexandre		Alzheimer's Dis Neuroimaging Initi	Early Prediction of Alzheimer's Disease Using Null Longitudinal Model-Based Classifiers	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; NEUROIMAGING INITIATIVE ADNI; BIOMARKER SIGNATURE; CEREBRAL-CORTEX; STRUCTURAL MRI; BRAIN ATROPHY; DIAGNOSIS; SCANS; CLASSIFICATION; SEVERITY	Incipient Alzheimer's Disease (AD) is characterized by a slow onset of clinical symptoms, with pathological brain changes starting several years earlier. Consequently, it is necessary to first understand and differentiate age-related changes in brain regions in the absence of disease, and then to support early and accurate AD diagnosis. However, there is poor understanding of the initial stage of AD; seemingly healthy elderly brains lose matter in regions related to AD, but similar changes can also be found in non-demented subjects having mild cognitive impairment (MCI). By using a Linear Mixed Effects approach, we modelled the change of 166 Magnetic Resonance Imaging (MRI)-based biomarkers available at a 5-year follow up on healthy elderly control (HC, n = 46) subjects. We hypothesized that, by identifying their significant variant (vr) and quasi-variant (qvr) brain regions over time, it would be possible to obtain an age-based null model, which would characterize their normal atrophy and growth patterns as well as the correlation between these two regions. By using the null model on those subjects who had been clinically diagnosed as HC (n = 161), MCI (n = 209) and AD (n = 331), normal age-related changes were estimated and deviation scores (residuals) from the observed MRI-based biomarkers were computed. Subject classification, as well as the early prediction of conversion to MCI and AD, were addressed through residual-based Support Vector Machines (SVM) modelling. We found reductions in most cortical volumes and thicknesses (with evident gender differences) as well as in sub-cortical regions, including greater atrophy in the hippocampus. The average accuracies (ACC) recorded for men and women were: AD-HC: 94.11%, MCI-HC: 83.77% and MCI converted to AD (cAD)-MCI non-converter (sMCI): 76.72%. Likewise, as compared to standard clinical diagnosis methods, SVM classifiers predicted the conversion of cAD to be 1.9 years earlier for females (ACC:72.5%) and 1.4 years earlier for males (ACC:69.0%).	[Gavidia-Bovadilla, Giovana; Kanaan-Izquierdo, Samir; Perera-Lluna, Alexandre] Univ Politecn Cataluna, Dept ESAII, Barcelona, Catalonia, Spain; [Kanaan-Izquierdo, Samir] Univ Politecn Cataluna, Dept ESAII, Ctr Biomed Engn Res CREB, Barcelona, Catalonia, Spain; [Mataro-Serrat, Maria] Univ Barcelona, Dept Clin Psychol & Psychobiol, Barcelona, Catalonia, Spain; [Mataro-Serrat, Maria] Univ Barcelona, Inst Neurosci, Barcelona, Catalonia, Spain; [Perera-Lluna, Alexandre] CIBER Bioengn Biomat & Nanomed, Barcelona, Catalonia, Spain	Universitat Politecnica de Catalunya; Universitat Politecnica de Catalunya; University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Perera-Lluna, A (corresponding author), Univ Politecn Cataluna, Dept ESAII, Barcelona, Catalonia, Spain.; Perera-Lluna, A (corresponding author), CIBER Bioengn Biomat & Nanomed, Barcelona, Catalonia, Spain.	alexandre.perera@upc.edu	Perera Lluna, Alexandre/CAG-2156-2022; Mataro, Maria/B-4524-2011; Lluna, Alexandre Perera/R-8546-2018	Perera Lluna, Alexandre/0000-0001-6427-851X; Mataro, Maria/0000-0002-9946-2656; Lluna, Alexandre Perera/0000-0001-6427-851X; Kanaan-Izquierdo, Samir/0000-0002-6564-0557; Gavidia, Giovana/0000-0002-5743-1800	Ministerio de Economia y Competitividad (MINECO) [TEC2014-60337-R, PSI2013-47724-P]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie, Alzheimer's Association(AbbVie); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Cogstate(CogState Limited); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by TEC2014-60337-R and PSI2013-47724-P grants from the Ministerio de Economia y Competitividad (MINECO). GIBER of Bioengineering, Biomaterials and Nanomedicine is an initiative of ISCIII. Authors are part of the 2014SGR-1063 consolidated research group of the Generalitat de Catalunya, Spain. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). Data used in preparation of this article were obtained from the ADNI (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how-to-apply/ADNI_ -Acknowledgement_List.pdf. ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.	Aguilar Carlos, 2014, Front Aging Neurosci, V6, P145, DOI 10.3389/fnagi.2014.00145; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Cho Y, 2012, NEUROIMAGE, V59, P2217, DOI 10.1016/j.neuroimage.2011.09.085; Chupin M, 2009, HIPPOCAMPUS, V19, P579, DOI 10.1002/hipo.20626; Coffey CE, 1998, ARCH NEUROL-CHICAGO, V55, P169, DOI 10.1001/archneur.55.2.169; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Das SR, 2012, NEUROIMAGE, V60, P1266, DOI 10.1016/j.neuroimage.2012.01.098; Dayal BS, 1997, J CHEMOMETR, V11, P73, DOI 10.1002/(SICI)1099-128X(199701)11:1<73::AID-CEM435>3.0.CO;2-#; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Desikan RS, 2010, NEUROBIOL AGING, V31, P1364, DOI 10.1016/j.neurobiolaging.2010.04.023; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Dubois B, 2016, ALZHEIMERS DEMENT, V12, P292, DOI 10.1016/j.jalz.2016.02.002; Esiri MM, 2007, J PATHOL, V211, P181, DOI 10.1002/path.2089; Fischl B., 2012, NEUROIMAGE; Fjell AM, 2013, J NEUROSCI, V33, P8237, DOI 10.1523/JNEUROSCI.5506-12.2013; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Franke K, 2012, GEROPSYCH, V25, P235, DOI 10.1024/1662-9647/a000074; Franke K, 2010, NEUROIMAGE, V50, P883, DOI 10.1016/j.neuroimage.2010.01.005; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Gaser C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067346; H?skuldsson A., 1988, J CHEMOMETR, V2, P211, DOI DOI 10.1002/CEM.1180020306; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jiang JY, 2014, NEUROIMAGE, V86, P203, DOI 10.1016/j.neuroimage.2013.08.022; Jie B, 2013, LECT NOTES COMPUT SC, V8149, P275, DOI 10.1007/978-3-642-40811-3_35; Kiraly A, 2015, BRAIN IMAGING BEHAV, P1; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Liu F, 2014, NEUROIMAGE, V84, P466, DOI 10.1016/j.neuroimage.2013.09.015; Liu YW, 2012, NEURORADIOLOGY, V54, P929, DOI 10.1007/s00234-012-1005-0; Mevik B.-H., 2013, PLS PARTIAL LEAST SQ; Morris GP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0135-5; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Saykin AJ, 2010, ALZHEIMERS DEMENT, V6, P265, DOI 10.1016/j.jalz.2010.03.013; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Spulber G, 2013, J INTERN MED, V273, P396, DOI 10.1111/joim.12028; Suk HI, 2013, LECT NOTES COMPUT SC, V8150, P583, DOI 10.1007/978-3-642-40763-5_72; Suk HI, 2014, NEUROIMAGE, V101, P569, DOI 10.1016/j.neuroimage.2014.06.077; Toledo JB, 2013, ACTA NEUROPATHOL, V126, P659, DOI 10.1007/s00401-013-1151-4; Tosun D, 2010, NEUROBIOL AGING, V31, P1340, DOI 10.1016/j.neurobiolaging.2010.04.030; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wolfe MS, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/796024; Xu J, 2000, AM J NEURORADIOL, V21, P112; Zhang DQ, 2012, NEUROIMAGE, V59, P895, DOI 10.1016/j.neuroimage.2011.09.069	54	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168011	10.1371/journal.pone.0168011	http://dx.doi.org/10.1371/journal.pone.0168011			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045907	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300011
J	Leung, TW; Li, RWH; Kee, CS				Leung, Tsz Wing; Li, Roger Wing-hong; Kee, Chea-su			Blue-Light Filtering Spectacle Lenses: Optical and Clinical Performances	PLOS ONE			English	Article							AGE-RELATED MACULOPATHY; INTRAOCULAR LENSES; CONTRAST SENSITIVITY; VISUAL FUNCTION; COLOR-VISION; SCOTOPIC SENSITIVITY; MACULAR DEGENERATION; SUNLIGHT EXPOSURE; RADIATION-DAMAGE; RISK-FACTORS	Purposes To evaluate the optical performance of blue-light filtering spectacle lenses and investigate whether a reduction in blue light transmission affects visual performance and sleep quality. Methods Experiment 1: The relative changes in phototoxicity, scotopic sensitivity, and melatonin suppression of five blue-light filtering plano spectacle lenses were calculated based on their spectral transmittances measured by a spectrophotometer. Experiment 2: A pseudo-randomized controlled study was conducted to evaluate the clinical performance of two bluelight filtering spectacle lenses (BF:blue-filtering anti-reflection coating; BT: brown-tinted) with a regular clear lens (AR) serving as a control. A total of eighty computer users were recruited from two age cohorts (young adults: 18 - 30 yrs, middle-aged adults: 40 - 55 yrs). Contrast sensitivity under standard and glare conditions, and colour discrimination were measured using standard clinical tests. After one month of lens wear, subjective ratings of lens performance were collected by questionnaire. Results All tested blue-light filtering spectacle lenses theoretically reduced the calculated phototoxicity by 10.6% to 23.6%. Although use of the blue-light filters also decreased scotopic sensitivity by 2.4% to 9.6%, and melatonin suppression by 5.8% to 15.0%, over 70% of the participants could not detect these optical changes. Our clinical tests revealed no significant decrease in contrast sensitivity either with (95% confidence intervals [CI]: AR - BT [- 0.05, 0.05]; AR - BF [ 0.05, 0.06]; BT - BF [- 0.06, 0.06]) or without glare (95% CI: AR - BT [- 0.01, 0.03]; AR - BF [- 0.01, 0.03]; BT - BF [- 0.02, 0.02]) and colour discrimination (95% CI: AR - BT [- 9.07, 1.02]; AR - BF [- 7.06, 4.46]; BT - BF [- 3.12, 8.57]). Conclusion Blue-light filtering spectacle lenses can partially filter high-energy short-wavelength light without substantially degrading visual performance and sleep quality. These lenses may serve as a supplementary option for protecting the retina from potential blue-light hazard.	[Leung, Tsz Wing; Kee, Chea-su] Hong Kong Polytech Univ, Sch Optometry, Kowloon, Hong Kong, Peoples R China; [Li, Roger Wing-hong] Univ Calif Berkeley, Sch Optometry, Berkeley, CA USA	Hong Kong Polytechnic University; University of California System; University of California Berkeley	Leung, TW (corresponding author), Hong Kong Polytech Univ, Sch Optometry, Kowloon, Hong Kong, Peoples R China.	jeffrey.TW.leung@polyu.edu.hk		Li, Roger/0000-0002-1666-0543; Kee, Chea-Su/0000-0002-5177-129X; Leung, Tsz Wing/0000-0001-9588-2891	Swiss lens laboratory Ltd.	Swiss lens laboratory Ltd.	This work was supported by Swiss lens laboratory Ltd. http://www.swisscoat.com. The second part of this study (clinical trial) was supported by Swiss lens laboratory Ltd. The sponsor provided the blue-light filtering spectacle lenses for the clinical trial and funding for hiring a research assistant. Funder (for the second part of the study): Swiss lens laboratory Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Arditi A, 2005, INVEST OPHTH VIS SCI, V46, P2225, DOI 10.1167/iovs.04-1198; Cruickshanks KJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P246; Cuthbertson FM, 2009, J CATARACT REFR SURG, V35, P1281, DOI 10.1016/j.jcrs.2009.04.017; Davison James A., 2005, International Ophthalmology Clinics, V45, P55; Davison JA, 2011, GRAEF ARCH CLIN EXP, V249, P957, DOI 10.1007/s00417-011-1697-6; Delcourt C, 2001, ARCH OPHTHALMOL-CHIC, V119, P1463; DIN, 2009, V5031100200906 DIN; Dougherty BE, 2005, OPTOMETRY VISION SCI, V82, P970, DOI 10.1097/01.opx.0000187844.27025.ea; Downie LE, 2015, BLUE LIGHT FILTERING; Falkner-Radler CI, 2008, AM J OPHTHALMOL, V145, P499, DOI 10.1016/j.ajo.2007.10.021; Farnsworth D., 1957, FARNSWORTH MUNSELL 1; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fletcher AE, 2008, ARCH OPHTHALMOL-CHIC, V126, P1396, DOI 10.1001/archopht.126.10.1396; Greenstein VC, 2007, J CATARACT REFR SURG, V33, P667, DOI 10.1016/j.jcrs.2006.12.012; GRISWOLD MS, 1992, VISION RES, V32, P1739, DOI 10.1016/0042-6989(92)90166-G; Grosvenor T., 2007, PRIMARY CARE OPTOMET, P209; Grosvenor T, 2007, PRIMARY CARE OPTOMET, P251; HAM WT, 1979, PHOTOCHEM PHOTOBIOL, V29, P735, DOI 10.1111/j.1751-1097.1979.tb07759.x; HAM WT, 1980, VISION RES, V20, P1105, DOI 10.1016/0042-6989(80)90047-4; HAM WT, 1976, NATURE, V260, P153, DOI 10.1038/260153a0; HAM WT, 1978, INVEST OPHTH VIS SCI, V17, P1029; Hammond BR, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/607635; Hayashi K, 2006, BRIT J OPHTHALMOL, V90, P1019, DOI 10.1136/bjo.2006.090712; Hunt RWG, 2004, REPROD COLOUR; ISO, 2013, 898032013 ISO; Jackson GR, 2000, VISION RES, V40, P2467, DOI 10.1016/S0042-6989(00)00108-5; Kara N, 2011, J CATARACT REFR SURG, V37, P2115, DOI 10.1016/j.jcrs.2011.06.024; Kinnear PR, 2002, BRIT J OPHTHALMOL, V86, P1408, DOI 10.1136/bjo.86.12.1408; Kiser AK, 2008, CLIN EXP OPHTHALMOL, V36, P514, DOI 10.1111/j.1442-9071.2008.01824.x; Klein BEK, 2014, INVEST OPHTH VIS SCI, V55, P5855, DOI 10.1167/iovs.14-14602; Klein R, 1998, ARCH OPHTHALMOL-CHIC, V116, P506, DOI 10.1001/archopht.116.4.506; Landers J, 2007, CLIN EXP OPHTHALMOL, V35, P152, DOI 10.1111/j.1442-9071.2006.01434.x; Landers JA, 2009, J CATARACT REFR SURG, V35, P83, DOI 10.1016/j.jcrs.2008.10.015; Leibovitch I, 2006, ACTA OPHTHALMOL SCAN, V84, P95, DOI 10.1111/j.1600-0420.2005.00607.x; Lix LM, 1996, REV EDUC RES, V66, P579, DOI 10.3102/00346543066004579; Mainster MA, 2005, ARCH OPHTHALMOL-CHIC, V123, P550, DOI 10.1001/archopht.123.4.550; Mainster MA, 2003, BRIT J OPHTHALMOL, V87, P1523, DOI 10.1136/bjo.87.12.1523; Mainster MA, 2010, SURV OPHTHALMOL, V55, P272, DOI 10.1016/j.survophthal.2009.07.006; McCarty CA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1455; Muftuoglu O, 2007, J CATARACT REFR SURG, V33, P658, DOI 10.1016/j.jcrs.2006.12.018; Noell W K, 1966, Invest Ophthalmol, V5, P450; O'Hagan JB, 2016, EYE, V30, P230, DOI 10.1038/eye.2015.261; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Schutt F, 2002, GRAEF ARCH CLIN EXP, V240, P983, DOI 10.1007/s00417-002-0558-8; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Sparrow JR, 2004, J CATARACT REFR SURG, V30, P873, DOI 10.1016/j.jcrs.2004.01.031; Sparrow JR, 2003, J BIOL CHEM, V278, P18207, DOI 10.1074/jbc.M300457200; Sparrow JR, 2001, INVEST OPHTH VIS SCI, V42, P1356; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Tomany SC, 2004, ARCH OPHTHALMOL-CHIC, V122, P750, DOI 10.1001/archopht.122.5.750; Viola AU, 2008, SCAND J WORK ENV HEA, V34, P297, DOI 10.5271/sjweh.1268; Vuori ML, 2006, ACTA OPHTHALMOL SCAN, V84, P92, DOI 10.1111/j.1600-0420.2005.00579.x; Ziegelberger G, 2013, HEALTH PHYS, V105, P74, DOI 10.1097/HP.0b013e318289a611	55	59	63	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169114	10.1371/journal.pone.0169114	http://dx.doi.org/10.1371/journal.pone.0169114			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045969	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300117
J	Liu, JL; Stone, VN; Ge, XC; Tang, M; Elrami, F; Xu, P				Liu, Jinlin; Stone, Victoria N.; Ge, Xiuchun; Tang, Madison; Elrami, Fadi; Xu, Ping			TetR Family Regulator brpT Modulates Biofilm Formation in Streptococcus sanguinis	PLOS ONE			English	Article							MUTANS; EXPRESSION; IDENTIFICATION; GENOME; MATRIX; GENES; GLUCOSYLTRANSFERASES; TRANSCRIPTION; SUCROSE; SYSTEM	Biofilms are a key component in bacterial communities providing protection and contributing to infectious diseases. However, mechanisms involved in S. sanguinis biofilm formation have not been clearly elucidated. Here, we report the identification of a novel S. sanguinis TetR repressor, brpT (Biofilm Regulatory Protein TetR), involved in biofilm formation. Deletion of brpTresulted in a significant increase in biofilm formation. Interestingly, the mutant accumulated more water soluble and water insoluble glucans in its biofilm compared to the wild-type and the complemented mutant. The brpT mutation led to an altered biofilm morphology and structure exhibiting a rougher appearance, uneven distribution with more filaments bound to the chains. RNA-sequencing revealed that gtfP, the only glucosyltransferase present in S. sanguinis, was significantly up-regulated. In agreement with these findings, we independently observed that deletion of gtfP in S. sanguinis led to reduced biofilm and low levels of water soluble and insoluble glucans. These results suggest that brpTis involved in the regulation of the gtfP-mediated exopolysaccharide synthesis and controls S. sanguinis biofilm formation. The deletion of brpT may have a potential therapeutic application in regulating S. sanguinis colonization in the oral cavity and the prevention of dental caries.	[Liu, Jinlin; Stone, Victoria N.; Ge, Xiuchun; Tang, Madison; Elrami, Fadi; Xu, Ping] Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Richmond, VA 23284 USA; [Elrami, Fadi; Xu, Ping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Xu, Ping] Virginia Commonwealth Univ, Ctr Study Biol Complex Virginia, Richmond, VA 23284 USA; [Liu, Jinlin] Cent China Normal Univ, Coll Life Sci, Wuhan, Hunan, Peoples R China; [Tang, Madison] Univ Virginia, Sch Engn & Appl Sci, Charlottesville, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Central China Normal University; University of Virginia	Xu, P (corresponding author), Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Richmond, VA 23284 USA.; Xu, P (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA.; Xu, P (corresponding author), Virginia Commonwealth Univ, Ctr Study Biol Complex Virginia, Richmond, VA 23284 USA.	pxu@vcu.edu			NIH [R01DE023078]; VCU Center for Clinical and Translational Research Fund [2-92120]; NIH-NCI Cancer Center Support Grant [P30 CA016059]; NIH-NCI Cancer Center Grant [P30 CA016059]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023078] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VCU Center for Clinical and Translational Research Fund; NIH-NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-NCI Cancer Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH grant R01DE023078 and by VCU Center for Clinical and Translational Research Fund 2-92120 to Professor Ping Xu. RNA sequencing was performed at the Nucleic Acids Research Core Facility, Virginia Commonwealth University, supported, in part, by funding from the NIH-NCI Cancer Center Support Grant (P30 CA016059). Microscopy was performed at the VCU Microscopy Facility, supported, in part, by funding from NIH-NCI Cancer Center Grant (P30 CA016059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banas JA, 2003, CRIT REV ORAL BIOL M, V14, P89, DOI 10.1177/154411130301400203; Bernal P, 2012, MICROB BIOTECHNOL, V5, P670, DOI 10.1111/j.1751-7915.2012.00359.x; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Bowen WH, 2002, CRIT REV ORAL BIOL M, V13, P126, DOI 10.1177/154411130201300203; Chattoraj P, 2011, J BACTERIOL, V193, P6605, DOI 10.1128/JB.06122-11; Chen LH, 2012, J NANOMATER, V2012, DOI 10.1155/2012/491051; Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Decker EM, 2011, INT J DENT, V2011, DOI 10.1155/2011/435830; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Ge XC, 2008, INFECT IMMUN, V76, P2551, DOI 10.1128/IAI.00338-08; Hojo K, 2009, J DENT RES, V88, P982, DOI 10.1177/0022034509346811; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jefferson KK, 2004, J BACTERIOL, V186, P2449, DOI 10.1128/JB.186.8.2449-2456.2004; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; KILIAN M, 1981, INFECT IMMUN, V31, P868, DOI 10.1128/IAI.31.3.868-873.1981; Kloosterman TG, 2007, MOL MICROBIOL, V65, P1049, DOI 10.1111/j.1365-2958.2007.05849.x; Koo H, 2006, ANTIMICROB AGENTS CH, V50, P542, DOI 10.1128/AAC.50.2.542-546.2006; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Koo H, 2009, INT J ORAL SCI, V1, P229, DOI 10.4248/IJOS.09086; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Lei L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01432; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Li YH, 2001, MICROBIOL-SGM, V147, P2841, DOI 10.1099/00221287-147-10-2841; Liu C, 2011, ANTIMICROB AGENTS CH, V55, P2679, DOI 10.1128/AAC.01496-10; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; MACRINA FL, 1982, GENE, V19, P345, DOI 10.1016/0378-1119(82)90025-7; Marsh Philip D, 2006, BMC Oral Health, V6 Suppl 1, pS14, DOI 10.1186/1472-6831-6-S1-S14; Martinez-Bueno M, 2004, BIOINFORMATICS, V20, P2787, DOI 10.1093/bioinformatics/bth330; McClure R, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt444; Merritt JH, 2007, J BACTERIOL, V189, P8154, DOI 10.1128/JB.00585-07; Moraes JJ, 2014, INFECT IMMUN, V82, P4941, DOI 10.1128/IAI.01850-14; Murillo LA, 2005, EUKARYOT CELL, V4, P1562, DOI 10.1128/EC.4.9.1562-1573.2005; NYVAD B, 1987, SCAND J DENT RES, V95, P369; Ooshima T, 2001, J DENT RES, V80, P1672, DOI 10.1177/00220345010800071401; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Redanz S, 2012, J BIOL CHEM, V287, P36111, DOI 10.1074/jbc.M112.379230; Ren Z, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.31095; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Venkitaraman AR, 1995, J DENT RES, V74, P1695, DOI 10.1177/00220345950740101101; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Wang B, 2006, INFECT IMMUN, V74, P4581, DOI 10.1128/IAI.00001-06; Wang S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00384; Xiao J, 2010, J APPL MICROBIOL, V108, P2103, DOI 10.1111/j.1365-2672.2009.04616.x; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125; Yoshida A, 2005, APPL ENVIRON MICROB, V71, P2372, DOI 10.1128/AEM.71.5.2372-2380.2005; Yoshida Y, 2014, APMIS, V122, P951, DOI 10.1111/apm.12238	53	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169301	10.1371/journal.pone.0169301	http://dx.doi.org/10.1371/journal.pone.0169301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046010	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300162
J	Liu, T; Lee, M; Bane, JJ; Im, W; Mook-Jung, I; Kim, M				Liu, Tian; Lee, Mijung; Bane, Jae-Jun; Im, Wooseok; Mook-Jung, Inhee; Kim, Manho			Cytosolic Extract of Human Adipose Stem Cells Reverses the Amyloid Beta-Induced Mitochondrial Apoptosis via P53/Foxo3a Pathway	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; STROMAL CELLS; DYSFUNCTION; NEURONS; PROTEIN; NEURODEGENERATION; THERAPY; STRESS; MODELS; DEATH	Human adipose stem cells (hASC) have therapeutic potential for the treatment of neurodegenerative disorders. Mitochondrial dysfunction is frequently observed in most neurodegenerative disorders, including Alzheimer's disease. We explored the therapeutic potential of hASC cytosolic extracts to attenuate neuronal death induced by mitochondrial dysfunction in an Alzheimer's disease (AD) in vitro models. Amyloid beta (A beta) was used to induce cytotoxity in an immortal hippocampal cell line (HT22) and neuronal stem cells from the brain of TG2576 transgenic mice were also used to test the protective role of hASC cytosolic extracts. Cell viability and flow cytometry results demonstrated that the hASC extract prevents the toxicity and apoptosis in AD in vitro models. Moreover, JC-1 and MitoSoxRed staining followed by fluorescence microscopy and flow cytometry results showed that the hASC extract ameliorated the effect of A beta-induced mitochondrial oxidative stress and reduced the mitochondrial membrane potential. Western blot result showed that hASC extract modulated mitochondriaassociated proteins, such as Bax and Bcl2, and down-regulated cleaved caspase-3. In addition, hASC extract decreased A beta generation and reversed up-regulated p53 and foxo3a protein level in AD in vitro model cell derived from TG2576 mice. Taken together, these findings implicate a protective role of the hASC extract in the A beta-induced mitochondrial apoptosis via regulation of P53/foxo3a pathway, providing insight into the molecular mechanisms of hASC extract and a therapeutic strategy to ameliorate neuronal death induced by A beta.	[Liu, Tian] Univ S Florida, Coll Med, Alzheimers Byrd Inst, Dept Mol Med, Tampa, FL USA; [Lee, Mijung; Bane, Jae-Jun; Im, Wooseok; Kim, Manho] Seoul Natl Univ Hosp, Coll Med, Biomed Res Inst, Dept Neurol, Seoul, South Korea; [Im, Wooseok] Seoul Natl Univ, Coll Med, Neurosci Res Inst, Seoul, South Korea; [Mook-Jung, Inhee] Seoul Natl Univ, Coll Med, Dept Biochem, Seoul, South Korea; [Mook-Jung, Inhee] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Kim, Manho] Seoul Natl Univ Hosp, Coll Med, Prot Metab Med Res Ctr, Seoul, South Korea	State University System of Florida; University of South Florida; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Im, W; Kim, M (corresponding author), Seoul Natl Univ Hosp, Coll Med, Biomed Res Inst, Dept Neurol, Seoul, South Korea.; Im, W (corresponding author), Seoul Natl Univ, Coll Med, Neurosci Res Inst, Seoul, South Korea.; Kim, M (corresponding author), Seoul Natl Univ Hosp, Coll Med, Prot Metab Med Res Ctr, Seoul, South Korea.	imwooseok@gmail.com; kimmanho@snu.ac.kr	Liu, Tian/M-8684-2016	Liu, Tian/0000-0003-3639-7321; Liu, Tian/0000-0002-6437-8892	National Research Foundation of Korea (NRF) [2014R1A2A1A11051520]; Korea Health 21 R&D Project by the Ministry of Health & Welfare, Republic of Korea [HI14C2348]; Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2016M3C7A1914002]; SNUH research fund [03-2016-0340]; National Research Foundation of Korea [2015R1D1A1A01060056]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea Health 21 R&D Project by the Ministry of Health & Welfare, Republic of Korea; Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; SNUH research fund; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) (2014R1A2A1A11051520), Korea Health 21 R&D Project (HI14C2348) by the Ministry of Health & Welfare, Republic of Korea, the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2016M3C7A1914002), SNUH research fund (03-2016-0340) and National Research Foundation of Korea (2015R1D1A1A01060056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter R, 2015, J NEUROCHEMISTRY; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Ban JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148691; Cha MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034929; de Girolamo L, 2011, J ORTHOP RES, V29, P100, DOI 10.1002/jor.21184; Ebrahimian TG, 2009, ARTERIOSCL THROM VAS, V29, P503, DOI 10.1161/ATVBAHA.108.178962; Eckert A, 2003, BIOCHEM PHARMACOL, V66, P1627, DOI 10.1016/S0006-2952(03)00534-3; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Im W, 2015, SCI REP-UK, V5, DOI 10.1038/srep16887; Im W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059438; Jeon D, 2013, NEUROBIOL DIS, V54, P414, DOI 10.1016/j.nbd.2013.01.015; Jeon GS, 2016, NEUROCHEM RES, V41, P913, DOI 10.1007/s11064-015-1774-z; Kajkowski EM, 2001, J BIOL CHEM, V276, P18748, DOI 10.1074/jbc.M011161200; Kar S, 2004, J PSYCHIATR NEUROSCI, V29, P427; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045757; Lee M, 2016, EUROPEAN J NEUROSCIE; Lee ST, 2009, ANN NEUROL, V66, P671, DOI 10.1002/ana.21788; Li YP, 1996, BRAIN RES, V738, P196, DOI 10.1016/S0006-8993(96)00733-0; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.203; Liu T, 2014, BIOCHEM BIOPH RES CO, V448, P403, DOI 10.1016/j.bbrc.2014.04.129; Marchi Saverio, 2012, J Signal Transduct, V2012, P329635, DOI 10.1155/2012/329635; Mayer B, 2003, NEWS PHYSIOL SCI, V18, P89, DOI 10.1152/nips.01433.2002; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; Nelson TJ, 2007, J BIOL CHEM, V282, P31238, DOI 10.1074/jbc.M705558200; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; Qiao HJ, 2005, NEUROBIOL AGING, V26, P849, DOI 10.1016/j.neurobiolaging.2004.08.003; Renault VM, 2011, ONCOGENE, V30, P3207, DOI 10.1038/onc.2011.35; Resende R, 2008, NEUROSCIENCE, V155, P725, DOI 10.1016/j.neuroscience.2008.06.036; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Shahani N, 2006, J NEUROSCI, V26, P6103, DOI 10.1523/JNEUROSCI.4245-05.2006; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Takuma K, 2005, J PHARMACOL SCI, V97, P312, DOI 10.1254/jphs.CPJ04006X; Todd K, 2014, BBA-MOL BASIS DIS, V1842, P2457, DOI 10.1016/j.bbadis.2014.09.010	35	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168859	10.1371/journal.pone.0168859	http://dx.doi.org/10.1371/journal.pone.0168859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046000	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300061
J	Macanas-Pirard, P; Quezada, T; Navarrete, L; Broekhuizen, R; Leisewitz, A; Nervi, B; Ramirez, PA				Macanas-Pirard, Patricia; Quezada, Thomas; Navarrete, Leonardo; Broekhuizen, Richard; Leisewitz, Andrea; Nervi, Bruno; Ramirez, Pablo A.			The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CC-CHEMOKINE; KAPPA-B; CXCR4; EXPRESSION; CANCER; ACTIVATION; CHEMOSENSITIZATION; MICROENVIRONMENT; MODULATION	Acute myeloid leukemia (AML) has a high mortality rate despite chemotherapy and transplantation. Both CXCR4/SDF-1 and VLA-4/VCAM1 axes are involved in leukemia protection but little is known about the role of CCL2/CCR2 in AML biology and protection against chemotherapy. We measured CCR2 expression in AML cell lines and primary AML cells by flow cytometry (FCM), real time PCR (RT-PCR) and western blot (WB). CCL2 production was quantified by solid phase ELISA in peripheral blood (PB) and bone marrow (BM) serum. We measured chemotaxis in a transwell system with different concentrations of CCL2/CCR2 blockers; cell cycle with BrDU and propidium iodide and proliferation with yellow tetrazolium MTT. We determined synergy in in vitro cell apoptosis combining chemotherapy and CCL2/CCR2 blockade. Finally, we performed chemoprotection studies in an in vivo mouse model. Of 35 patients, 23 (65%) expressed CCR2 by FCM in PB. Two cell lines expressed high levels of CCR2 (THP-1 and murine AML). RT-PCR and WB confirmed CCR2 production. CCL2 solid phase ELISA showed significantly lower levels of CCL2 in PB and BM compared to normal controls. Chemotaxis experiments confirmed a dose-dependent migration in AML primary cells expressing CCR2 and THP-1 cells. A significant inhibition of transmigration was seen after CCL2/CCR2 blockade. Proliferation of CCR2+ AML cell lines was slightly increased (1.4-fold) after axis stimulation. We observed a non-significant increase in phase S THP-1 cells exposed to CCL2 and a concomitant decrease of cells in G1. The chemotherapy studies did not show a protective effect of CCL2 on cytarabine-induced apoptosis or synergy with chemotherapy after CCL2/CCR2 blockade both in vitro and in vivo. In conclusion, CCL2/CCR2 axis is expressed in the majority of monocytoid AML blasts. The axis is involved in cell trafficking and proliferation but no in vitro and in vivo chemotherapy protective effect was seen.	[Macanas-Pirard, Patricia; Quezada, Thomas; Navarrete, Leonardo; Broekhuizen, Richard; Leisewitz, Andrea; Nervi, Bruno] Pontificia Univ Catolica Chile, Sch Med, Dept Hematol Oncol, Santiago, Chile; [Ramirez, Pablo A.] Univ Austral Chile, Fac Med, Inst Med, Valdivia, Region De Los R, Chile	Pontificia Universidad Catolica de Chile; Universidad Austral de Chile	Ramirez, PA (corresponding author), Univ Austral Chile, Fac Med, Inst Med, Valdivia, Region De Los R, Chile.	pablo.ramirez01@uach.cl	Nervi, Bruno/L-7470-2014; Macanas-Pirard, Patricia/HCI-9651-2022	Nervi, Bruno/0000-0002-3016-7261; Macanas-Pirard, Patricia/0000-0003-2631-8618	Chilean National Commission for Scientific Research and Technology CONICYT (FONDECYT) [1110319]	Chilean National Commission for Scientific Research and Technology CONICYT (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by grants from the Chilean National Commission for Scientific Research and Technology CONICYT (FONDECYT #1110319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assem MM, 2012, EXPRESSION CHEMOKINE; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Brenner AK, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00205; Bruserud O, 2007, HAEMATOLOGICA, V92, P332, DOI 10.3324/haematol.10148; Burger JA, 2009, LEUKEMIA, V23, P43, DOI 10.1038/leu.2008.299; Cignetti A, 2003, EXP HEMATOL, V31, P495, DOI 10.1016/S0301-472X(03)00066-3; Fujita K, 2010, PROSTATE, V70, P473, DOI 10.1002/pros.21081; Gupta SK, 1999, J LEUKOCYTE BIOL, V66, P135, DOI 10.1002/jlb.66.1.135; Hinojosa AE, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-77; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Jacamo RO, 2015, BLOOD, V126, P1348, DOI DOI 10.1182/BLOOD.V126.23.1348.1348; Jacamo R, 2014, BLOOD, V123, P2691, DOI 10.1182/blood-2013-06-511527; Konopleva M, 2009, DRUG RESIST UPDATE, V12, P103, DOI 10.1016/j.drup.2009.06.001; Kumar SN, 2000, MOL IMMUNOL, V37, P623, DOI 10.1016/S0161-5890(00)00097-3; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; Lee JS, 2009, CYTOKINE, V48, P186, DOI 10.1016/j.cyto.2009.07.008; Loberg RD, 2006, NEOPLASIA, V8, P578, DOI 10.1593/neo.06280; Macanas-Pirard P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037203; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; Mazur G, 2007, NEOPLASMA, V54, P285; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Miller Cindy L, 2005, Methods Mol Biol, V290, P71; Monti P, 2003, CANCER RES, V63, P7451; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; O'Hayre M, 2008, CHEMOKINES CANC MIGR, P635; Rowe Jacob M, 2009, Hematology Am Soc Hematol Educ Program, P396, DOI 10.1182/asheducation-2009.1.396; Ryerson AB, 2016, CANCER-AM CANCER SOC, V122, P1312, DOI 10.1002/cncr.29936; Schaniel C, 1998, J EXP MED, V188, P451, DOI 10.1084/jem.188.3.451; Tavor S, 2008, LEUKEMIA, V22, P2151, DOI 10.1038/leu.2008.238; Uy GL, 2012, BLOOD, V119, P3917, DOI 10.1182/blood-2011-10-383406; Van Coillie E, 1999, CYTOKINE GROWTH F R, V10, P61, DOI 10.1016/S1359-6101(99)00005-2; Viedt C, 2002, ARTERIOSCL THROM VAS, V22, P914, DOI 10.1161/01.ATV.0000019009.73586.7F; Volpe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037208; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; Wong TN, 2015, NATURE, V518, P552, DOI 10.1038/nature13968; WU VY, 1977, PREP BIOCHEM, V7, P479, DOI 10.1080/00327487708065515; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311	38	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168888	10.1371/journal.pone.0168888	http://dx.doi.org/10.1371/journal.pone.0168888			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045930	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300066
J	Song, Y; Wan, XM; Bai, SX; Guo, D; Ren, C; Zeng, Y; Li, YR; Li, XW				Song, Yang; Wan, Xiaoming; Bai, Shuoxin; Guo, Dong; Ren, Ci; Zeng, Yu; Li, Yirui; Li, Xuewen			The Characteristics of Air Pollutants during Two Distinct Episodes of Fireworks Burning in a Valley City of North China	PLOS ONE			English	Article							LANTERN FESTIVAL; AEROSOL; PARTICLES; POLLUTION; HAZE; VISIBILITY; GUANGZHOU; IMPACTS; WEATHER; QUALITY	Background The elevation and dissipation of pollutants after the ignition of fireworks in different functional areas of a valley city were investigated. Methods The Air Quality Index (AQI) as well as inter-day and intra-day concentrations of various air pollutants (PM10, PM2.5, SO2, NO2, CO, O-3) were measured during two episodes that took place during Chinese New Year festivities. Results For the special terrain of Jinan, the mean concentrations of pollutants increased sharply within 2-4 h of the firework displays, and concentrations were 4-6 times higher than the usual levels. It took 2-3 d for the pollutants to dissipate to background levels. Compared to Preliminary Eve (more fireworks are ignited on New Year's Eve, but the amounts of other human activities are also lesser), the primary pollutants PM2.5, PM10, and CO reached higher concentrations on New Year's Eve, and the highest concentrations of these pollutants were detected in living quarters. All areas suffered from serious pollution problems on New Year's Eve (rural = urban for PM10, but rural > urban for PM2.5). However, SO2 and NO2 levels were 20%-60% lower in living quarters and industrial areas compared to the levels in these same areas on Preliminary Eve. In contrast to the other pollutants, O-3 concentrations fell instead of rising with the firework displays. Conclusion Interactions between firework displays and other human activities caused different change trends of pollutants. PM2.5 and PM10 were the main pollutants, and the rural living quarter had some of the highest pollution levels.	[Song, Yang; Bai, Shuoxin; Guo, Dong; Ren, Ci; Zeng, Yu; Li, Yirui; Li, Xuewen] Shandong Univ, Sch Publ Hlth, Dept Environm & Hlth, Jinan, Peoples R China; [Wan, Xiaoming] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Shandong University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Li, XW (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Environm & Hlth, Jinan, Peoples R China.	lxw@sdu.edu.cn		Li, Xuewen/0000-0003-0841-8658	National Basic Research Program of China (973 Program) [2012CB955500-955503]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by the National Basic Research Program of China (973 Program) (2012CB955500-955503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annesi-Maesano I, 2007, RESP MED, V101, P1721, DOI 10.1016/j.rmed.2007.02.022; Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752; Cheng Y, 2014, ENVIRON POLLUT, V185, P149, DOI 10.1016/j.envpol.2013.10.037; Godri KJ, 2010, ENVIRON SCI TECHNOL, V44, P8295, DOI 10.1021/es1016284; Guo S, 2010, ATMOS CHEM PHYS, V10, P947, DOI 10.5194/acp-10-947-2010; Jie P, 2015, ASIAN PACIFIC J CANC, V16; Joly A, 2010, ATMOS ENVIRON, V44, P4325, DOI 10.1016/j.atmosenv.2009.12.010; Lai HK, 2011, 23 ISEE ANN C 201120; Laumbach RJ, 2010, AM FAM PHYSICIAN, V81, P175; Lin CC, 2016, AEROSOL AIR QUAL RES, V16, P373, DOI 10.4209/aaqr.2015.09.0569; Lippmann M, 2005, INHAL TOXICOL, V17, P255, DOI 10.1080/08958370590912941; Liu XG, 2013, ATMOS CHEM PHYS, V13, P4501, DOI 10.5194/acp-13-4501-2013; Manigrasso M, 2010, J CHROMATOGR SCI, V48, P549, DOI 10.1093/chromsci/48.7.549; Moreno T, 2010, J HAZARD MATER, V183, P945, DOI 10.1016/j.jhazmat.2010.07.082; Nishanth T, 2012, ATMOS ENVIRON, V47, P295, DOI 10.1016/j.atmosenv.2011.10.062; Petroeschevsky A, 2001, ARCH ENVIRON HEALTH, V56, P37, DOI 10.1080/00039890109604053; Ravindra K, 2003, J ENVIRON MONITOR, V5, P260, DOI 10.1039/b211943a; ROSSI OVJ, 1993, THORAX, V48, P244, DOI 10.1136/thx.48.3.244; Rouse RL, 2008, AM J RESP CELL MOL, V39, P198, DOI 10.1165/rcmb.2008-0057OC; SEATON A, 1995, LANCET, V345, P176, DOI 10.1016/S0140-6736(95)90173-6; Singh DP, 2010, ENVIRON MONIT ASSESS, V169, P1, DOI 10.1007/s10661-009-1145-9; Sun YL, 2006, ENVIRON SCI TECHNOL, V40, P3148, DOI 10.1021/es051533g; Tao J, 2015, SCI TOTAL ENVIRON, V508, P57, DOI 10.1016/j.scitotenv.2014.11.074; Tie XX, 2009, ATMOS ENVIRON, V43, P2375, DOI 10.1016/j.atmosenv.2009.01.036; Vecchi R, 2008, ATMOS ENVIRON, V42, P1121, DOI 10.1016/j.atmosenv.2007.10.047; Wang Y, 2007, ATMOS ENVIRON, V41, P417, DOI 10.1016/j.atmosenv.2006.07.043; Wang Y, 2006, ATMOS ENVIRON, V40, P6579, DOI 10.1016/j.atmosenv.2006.05.066; Wu D, 2005, ATMOS ENVIRON, V39, P6568, DOI 10.1016/j.atmosenv.2005.07.061; Yadav AK, 2003, PURE APPL GEOPHYS, V160, P265, DOI 10.1007/s00024-003-8777-4; Yang LX, 2014, SCI TOTAL ENVIRON, V476, P57, DOI 10.1016/j.scitotenv.2013.12.110; Ye XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151119; Zhang M, 2010, ATMOS ENVIRON, V44, P5191, DOI 10.1016/j.atmosenv.2010.08.048	32	8	8	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168297	10.1371/journal.pone.0168297	http://dx.doi.org/10.1371/journal.pone.0168297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045925	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300018
J	Wang, XS; Deng, Z; Zhang, WZ; Meng, ZJ; Chang, X; Lv, MC				Wang, Xiaosen; Deng, Zhong; Zhang, Wenzheng; Meng, Zhaojiang; Chang, Xiao; Lv, Mouchao			Effect of Waterlogging Duration at Different Growth Stages on the Growth, Yield and Quality of Cotton	PLOS ONE			English	Article							GOSSYPIUM-HIRSUTUM L.; CRACKING GREY CLAY; FURROW IRRIGATION; NUTRITION; STRESS; LEAVES; FIELD; BOLL	In this study, a soil culture experiment was set up in barrels to investigate the effect of water-logging duration at different growth stages on the growth, yield, and quality of cotton in the Huang-Huai Region of China during summer. The experiment was conducted at four growth stages of cotton (seedling, squaring, flowering, and boll opening), and the waterlogging duration at each stage was set to five levels (2, 4, 6, 8, and 10 d) and the waterlogging depth was 5cm. Twenty different treatment combinations were established, and one group without waterlogging throughout the whole growth period was used as the control (CK). The results showed that the waterlogging treatments at the different growth stages reduced the morphological and yield parameters of the cotton plants as well as the physiological parameters of the cotton leaves, and the extent of the reduction in these parameters increased with the extension of the waterlogging duration. The effect of waterlogging at different growth stages on the cotton decreased in the order of the flowering, squaring, seedling, and boll-opening stages, and the highest yield reduction rates for the four stages were 38.8%, 27.9%, 18.3%, and 7.6% respectively. Additionally, waterlogging decreased the quality parameters of cotton such as the upper-half mean length, uniformity index, micronaire value, elongation, yellowness, and lint percentage at the squaring, flowering, and boll-opening stages. Furthermore, at the seedling stage waterlogging for no more than 6 d allowed the morphological and yield parameters to recover in the boll-opening stage upon timely drainage, and these parameters showed no significant decreases compared with the CK level. The critical duration of waterlogging at the squaring stage was 4 d. However, at the flowering stage, even 2 d of waterlogging could lead to the stagnation of morphological development and prevent the recovery of the cotton yield to the CK level. Therefore, when waterlogging disasters occur in cotton fields, the implementation of appropriate surface and subsurface drainage schemes for the different growth stages is needed as soon as possible to mitigate the damage.	[Wang, Xiaosen; Deng, Zhong; Zhang, Wenzheng; Meng, Zhaojiang; Chang, Xiao; Lv, Mouchao] Chinese Acad Agr Sci, Farmland Irrigat Res Inst, Xinxiang City, Henan Province, Peoples R China; [Wang, Xiaosen; Deng, Zhong; Zhang, Wenzheng; Lv, Mouchao] Key Lab Water Saving Agr Henan Prov, Xinxiang City, Henan Province, Peoples R China; [Wang, Xiaosen; Deng, Zhong; Zhang, Wenzheng; Lv, Mouchao] CAAS, Ctr Efficient Irrigat Engn & Technol Res, Xinxiang City, Henan Province, Peoples R China	Chinese Academy of Agricultural Sciences; Farmland Irrigation Research Institute, CAAS; Chinese Academy of Agricultural Sciences	Lv, MC (corresponding author), Chinese Acad Agr Sci, Farmland Irrigat Res Inst, Xinxiang City, Henan Province, Peoples R China.; Lv, MC (corresponding author), Key Lab Water Saving Agr Henan Prov, Xinxiang City, Henan Province, Peoples R China.; Lv, MC (corresponding author), CAAS, Ctr Efficient Irrigat Engn & Technol Res, Xinxiang City, Henan Province, Peoples R China.	13937381585@163.com			National Natural Science Foundation of China [U1504530]; Science and Technology Innovation Project of The Chinese Academy of Agricultural Sciences; National High Technology Research and Development Program 863 of China [2011M100509]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Project of The Chinese Academy of Agricultural Sciences; National High Technology Research and Development Program 863 of China(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (U1504530), http://www.nsfc.gov.cn/; Science and Technology Innovation Project of The Chinese Academy of Agricultural Sciences, http://www.caas.net.cn/; National High Technology Research and Development Program 863 of China (2011M100509), http://www.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2006, ENVIRON EXP BOT, V57, P278, DOI 10.1016/j.envexpbot.2005.06.006; Ashraf MA, 2011, CROP PASTURE SCI, V62, P25, DOI 10.1071/CP09225; Bange MP, 2004, FIELD CROP RES, V88, P129, DOI 10.1016/j.fcr.2003.12.002; Cao G, 2012, PROCEDIA ENGINEER, V28, P202, DOI 10.1016/j.proeng.2012.01.706; Christianson JA, 2010, PLANT CELL PHYSIOL, V51, P21, DOI 10.1093/pcp/pcp163; Dodd K, 2013, CROP PASTURE SCI, V64, P816, DOI 10.1071/CP13093; Guang C., 2012, PROCEDIA ENG, V28, P202; HOCKING PJ, 1987, PLANT SOIL, V101, P211, DOI 10.1007/BF02370647; HODGSON AS, 1982, AUST J AGR RES, V33, P109, DOI 10.1071/AR9820109; HODGSON AS, 1982, AUST J AGR RES, V33, P1019, DOI 10.1071/AR9821019; Jackson M. B., 1984, FLOODING PLANT GROWT; Jiang ZH, 2013, 2013 THIRD INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEM DESIGN AND ENGINEERING APPLICATIONS (ISDEA), P692, DOI 10.1109/ISDEA.2012.164; Kuai J, 2015, EUR J AGRON, V67, P61, DOI 10.1016/j.eja.2015.03.005; Kuai J, 2014, PLANT SCI, V223, P79, DOI 10.1016/j.plantsci.2014.03.010; LIPE JA, 1973, PLANTA, V115, P93, DOI 10.1007/BF00388610; Liu RX, 2015, AGRON J, V107, P2038, DOI 10.2134/agronj14.0567; McLeod IG., 2001, THESIS; Milroy SP, 2013, FIELD CROP RES, V140, P51, DOI 10.1016/j.fcr.2012.10.016; Milroy SP, 2009, FIELD CROP RES, V113, P246, DOI 10.1016/j.fcr.2009.05.012; Najeeb U, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv080; Najeeb U, 2015, PLANT GROWTH REGUL, V76, P83, DOI 10.1007/s10725-015-0037-y; REICOSKY DC, 1985, AGR WATER MANAGE, V10, P127, DOI 10.1016/0378-3774(85)90002-2; Teakle NL, 2007, J EXP BOT, V58, P2169, DOI 10.1093/jxb/erm102; Wu Q., 2012, ADV J FOOD SCI TECHN, V4, P398; Yang Yun, 2011, Jiangsu Journal of Agricultural Sciences, V27, P475; Zhang YJ, 2015, FIELD CROP RES, V179, P164, DOI 10.1016/j.fcr.2015.05.001; [张艳军 Zhang Yanjun], 2015, [棉花学报, Cotton Science], V27, P80; Zhu JianQiang, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P13	28	32	34	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169029	10.1371/journal.pone.0169029	http://dx.doi.org/10.1371/journal.pone.0169029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045994	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300094
J	Wei, JJ; Li, YG				Wei, Jianjian; Li, Yuguo			Human Cough as a Two-Stage Jet and Its Role in Particle Transport	PLOS ONE			English	Article							INDOOR ENVIRONMENT; DROPLET NUCLEI; STARTING JETS; FLOW; AIR; SURROUNDINGS; DISPERSION; INFECTION; AEROSOLS; SPREAD	The human cough is a significant vector in the transmission of respiratory diseases in indoor environments. The cough flow is characterized as a two-stage jet; specifically, the starting jet (when the cough starts and flow is released) and interrupted jet (after the source supply is terminated). During the starting-jet stage, the flow rate is a function of time; three temporal profiles of the exit velocity (pulsation, sinusoidal and real-cough) were investigated in this study, and our results showed that the cough flow's maximum penetration distance was in the range of a 50.6-85.5 opening diameter (D) under our experimental conditions. The real cough and sinusoidal cases exhibited greater penetration ability than the pulsation cases under the same characteristic Reynolds number (Re-c) and normalized cough expired volume (Q/AD, with Q as the cough expired volume and A as the opening area). However, the effects of Re-c and QIAD on the maximum penetration distances proved to be more significant; larger values of Re-c and QIAD reflected cough flows with greater penetration distances. A protocol was developed to scale the particle experiments between the prototype in air, and the model in water. The water tank experiments revealed that although medium and large particles deposit readily, their maximum spread distance is similar to that of small particles. Moreover, the leading vortex plays an important role in enhancing particle transport.	[Wei, Jianjian; Li, Yuguo] Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China; [Wei, Jianjian; Li, Yuguo] Shenzhen Inst Res & Innovat, Shenzhen, Peoples R China	University of Hong Kong	Wei, JJ (corresponding author), Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China.; Wei, JJ (corresponding author), Shenzhen Inst Res & Innovat, Shenzhen, Peoples R China.	wei.jianjian.88@gmail.com	Wei, Jianjian/AAW-4145-2021; Li, Yuguo/A-9469-2010; Wei, Jianjian/F-7788-2011	Li, Yuguo/0000-0002-2281-4529; Wei, Jianjian/0000-0001-8859-8462	National Natural Science Foundation of China [51278440]; Research Grants Council [17205014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Grants Council(Hong Kong Research Grants Council)	This study received financial support from National Natural Science Foundation of China (http://www.nsfc.gov.cn/, 51278440, YL) and The Research Grants Council (http//www.ugc.edu.hk/eng/rgc/, 17205014, YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JJ, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1823532; Bourouiba L, 2014, J FLUID MECH, V745, P537, DOI 10.1017/jfm.2014.88; Chan SN, 2014, ENVIRON FLUID MECH, V14, P173, DOI 10.1007/s10652-013-9287-2; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; Chen C, 2013, BUILD ENVIRON, V62, P45, DOI 10.1016/j.buildenv.2012.12.020; Diez FJ, 2003, J HEAT TRANS-T ASME, V125, P1046, DOI 10.1115/1.1622720; DUGUID JP, 1946, J HYG-CAMBRIDGE, V44, P471, DOI 10.1017/S0022172400019288; Ghaem-Maghami E, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3504378; Glauser MN, 2004, P ROOMVENT 2004 9 IN, P6; Gupta JK, 2009, INDOOR AIR, V19, P517, DOI 10.1111/j.1600-0668.2009.00619.x; Hill PG, 1999, J FLUID ENG-T ASME, V121, P93, DOI 10.1115/1.2822018; Hunt JCR, 2007, FLOW TURBUL COMBUST, V79, P207, DOI 10.1007/s10494-007-9096-0; Kwon SB, 2012, CHEMOSPHERE, V87, P1260, DOI 10.1016/j.chemosphere.2012.01.032; Li A. C. Y., 2006, THESIS; Lindsley WG, 2012, J OCCUP ENVIRON HYG, V9, P443, DOI 10.1080/15459624.2012.684582; Liu L, 2016, INDOOR AIR; Liu SC, 2014, AEROSOL SCI TECH, V48, P1183, DOI 10.1080/02786826.2014.968655; LONGMIRE EK, 1992, J FLUID MECH, V236, P217, DOI 10.1017/S002211209200140X; Mazumdar S, 2011, ATMOS ENVIRON, V45, P6019, DOI 10.1016/j.atmosenv.2011.07.049; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; MORTON BR, 1956, PROC R SOC LON SER-A, V234, P1, DOI 10.1098/rspa.1956.0011; Nielsen PV, 2009, J R SOC INTERFACE, V6, pS747, DOI 10.1098/rsif.2009.0228.focus; Papineni RS, 1996, J AEROSOL MED, V10, P105, DOI 10.1089/jam.1997.10.105; Qian H, 2006, INDOOR AIR, V16, P111, DOI 10.1111/j.1600-0668.2005.00407.x; RICHARDS JM, 1965, J FLUID MECH, V21, P97, DOI 10.1017/S002211206500006X; Rim D, 2008, ASHRAE TRAN, V114, P130; Sangras R, 2002, J HEAT TRANS-T ASME, V124, P460, DOI 10.1115/1.1421047; Tang JW, 2008, NEW ENGL J MED, V359, pE19, DOI 10.1056/NEJMicm072576; Tang JW, 2009, J R SOC INTERFACE, V6, pS727, DOI 10.1098/rsif.2009.0295.focus; TURNER JS, 1962, J FLUID MECH, V13, P356, DOI 10.1017/S0022112062000762; VanSciver M, 2011, AEROSOL SCI TECH, V45, P415, DOI 10.1080/02786826.2010.542785; Villafruela JM, 2013, BUILD ENVIRON, V62, P191, DOI 10.1016/j.buildenv.2013.01.022; Wan MP, 2009, AEROSOL SCI TECH, V43, P322, DOI 10.1080/02786820802641461; Wei JJ, 2016, AM J INFECT CONTROL, V44, pS102, DOI 10.1016/j.ajic.2016.06.003; Wei JJ, 2015, BUILD ENVIRON, V93, P86, DOI 10.1016/j.buildenv.2015.06.018; Wells WF, 1934, AM J HYG, V20, P611, DOI 10.1093/oxfordjournals.aje.a118097; WITZE PO, 1983, AIAA J, V21, P308, DOI 10.2514/3.8071; Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2007.00469.x; Zhang L, 2012, BUILD ENVIRON, V47, P58, DOI 10.1016/j.buildenv.2011.03.015; Zhu SW, 2006, BUILD ENVIRON, V41, P1691, DOI 10.1016/j.buildenv.2005.06.024	40	66	66	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169235	10.1371/journal.pone.0169235	http://dx.doi.org/10.1371/journal.pone.0169235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046084	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300151
J	Hai, JJ; Chan, PH; Chan, YH; Fong, CHY; Huang, D; Li, WH; Yin, LX; Lau, CP; Tse, HF; Siu, CW				Hai, Jo-Jo; Chan, Pak-Hei; Chan, Yap-Hang; Fong, Carol-Ho-Yi; Huang, Duo; Li, Wen-Hua; Yin, Li-Xue; Lau, Chu-Pak; Tse, Hung-Fat; Siu, Chung-Wah			Prediction of Thromboembolic Events in Heart Failure Patients in Sinus Rhythm: The Hong Kong Heart Failure Registry	PLOS ONE			English	Article							RISK STRATIFICATION SCHEMES; ATRIAL-FIBRILLATION; ANTITHROMBOTIC THERAPY; RANDOMIZED-TRIAL; ISCHEMIC-STROKE; ASSOCIATION; WARFARIN; ASPIRIN; STATE	Aim Heart failure (HF) increases the risk of thromboembolic events (TE). Study in a Caucasian population has shown that the CHA(2)DS(2)-VASc score predicts TE among HF patients without atrial fibrillation. We sought to assess the usefulness of the CHA(2)DS(2)-VASc score in predicting TE in an Asian population and refine the scoring system to improve its predictability of TE among HF patients in sinus rhythm. Methods A total of 1,202 consecutive patients who were admitted to our institution for new-onset HF from 2005 to 2012 and without atrial fibrillation or anticoagulation were retrospectively reviewed. Results The mean age was 77.6 +/- 12.2 years and 51.7% were female. After 36.2 +/- 30.1 months, 113 (9.4%) developed TE. The annual incidence was 0.54%, 1.54%, 2.98% and 5.04% per year in those who had a CHA(2)DS(2)-VASc score of 1, 2-3, 4-5 and >= 6, respectively. In multivariate analysis, age >= 75 years [Hazard ratio (HR) 2.59, 95% confidence interval (CI) 1.23-5.46, p = 0.012), chronic ischemic heart disease (HR 1.54, 95% CI 1.02-2.31, p = 0.040) and chronic kidney disease (HR 1.66, 95% CI 1.09-2.53, p = 0.018) independently predicted TE. Incorporation of chronic ischemic heart disease and chronic kidney disease into the CHA(2)DS(2)-VASc score significantly increased the area under the Receiver Operating Curve from 0.57 (95% CI 0.54-0.59) to 0.61 (95% CI 0.55-0.66; p = 0.022). Conclusion The CHA(2)DS(2)-VASc score is useful for stratification of the risk of TE among HF patients in sinus rhythm. Incorporation of chronic ischemic heart disease and chronic kidney disease into the score modestly improves its predictive value.	[Hai, Jo-Jo; Chan, Pak-Hei; Chan, Yap-Hang; Huang, Duo; Lau, Chu-Pak; Tse, Hung-Fat; Siu, Chung-Wah] Univ Hong Kong, Div Cardiol, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Fong, Carol-Ho-Yi] Univ Hong Kong, Endocrinol & Metab Div, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Li, Wen-Hua; Yin, Li-Xue] Sichuan Acad Med Sci, Dept Echocardiog, Chengdu, Peoples R China; [Li, Wen-Hua; Yin, Li-Xue] Sichuan Acad Med Sci, Noninvas Cardiol Lab, Chengdu, Peoples R China; [Li, Wen-Hua; Yin, Li-Xue] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China	University of Hong Kong; University of Hong Kong; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Siu, CW (corresponding author), Univ Hong Kong, Div Cardiol, Dept Med, Hong Kong, Hong Kong, Peoples R China.	cwdsiu@hku.hk	Tse, Hung-Fat/C-4426-2009; Siu, Chung Wah/C-6947-2011	Tse, Hung-Fat/0000-0002-9578-7808; Tse, Hung Fat/0000-0003-4665-7887				Abdul-Rahim AH, 2016, EUROPEAN HEART J; Abdul-Rahim AH, 2015, CIRCULATION, V131, P1486, DOI 10.1161/CIRCULATIONAHA.114.013760; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Boriani G, 2011, STROKE, V42, P1768, DOI 10.1161/STROKEAHA.110.609297; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Camm AJ, 2012, EUR HEART J, V33; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleland JGF, 2004, AM HEART J, V148, P157, DOI 10.1016/j.ahj.2004.03.010; Cokkinos DV, 2006, EUR J HEART FAIL, V8, P428, DOI 10.1016/j.ejheart.2006.02.012; de Peuter OR, 2009, SEMIN THROMB HEMOST, V35, P497, DOI 10.1055/s-0029-1234145; Freudenberger RS, 2007, CIRCULATION, V115, P2637, DOI 10.1161/CIRCULATIONAHA.106.661397; Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488; Guo YT, 2013, INT J CARDIOL, V168, P904, DOI 10.1016/j.ijcard.2012.10.052; Hai JJ, 2016, J CARDIAC FAILURE; Homma S, 2012, NEW ENGL J MED, V366, P1859, DOI 10.1056/NEJMoa1202299; Ito H, 2012, J DIABETES COMPLICAT, V26, P286, DOI 10.1016/j.jdiacomp.2012.04.011; January CT., 2014, J AM COLL CARDIOL, V64, P76, DOI [DOI 10.1016/J.JACC.2014.03.022, 10.1016/j.jacc.2014.03.022, 10.1016/j.jacc]; Jug B, 2009, INT HEART J, V50, P591, DOI 10.1536/ihj.50.591; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Lip GYH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000975; Lip GYH, 2012, EUR J HEART FAIL, V14, P681, DOI 10.1093/eurjhf/hfs073; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lip GYH, 1999, J AM COLL CARDIOL, V33, P1424; Loh E, 1997, NEW ENGL J MED, V336, P251, DOI 10.1056/NEJM199701233360403; Massie BM, 2009, CIRCULATION, V119, P1616, DOI 10.1161/CIRCULATIONAHA.108.801753; Melgaard L, 2015, JAMA-J AM MED ASSOC, P1; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Pullicino P, 2010, J STROKE CEREBROVASC, V19, P1, DOI 10.1016/j.jstrokecerebrovasdis.2009.09.002; Siu CW, 2007, HEART, V93, P483, DOI 10.1136/hrt.2006.100628; Solomon SD, 2004, CIRCULATION, V110, P2180, DOI 10.1161/01.CIR.0000144474.65922.AA; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Uchiyama S, 2014, FRONT NEUROL NEUROSC, V33, P11, DOI 10.1159/000351888; Witt BJ, 2007, J CARD FAIL, V13, P489, DOI 10.1016/j.cardfail.2007.01.009; Wolsk E, 2015, EUR J HEART FAIL, V17, P828, DOI 10.1002/ejhf.309; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	36	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169095	10.1371/journal.pone.0169095	http://dx.doi.org/10.1371/journal.pone.0169095			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036365	gold, Green Published, Green Submitted			2022-12-26	WOS:000391229300053
J	Fernandes, JM; Felix-Silva, J; da Cunha, LM; Gomes, JAD; Siqueira, EMD; Gimenes, LP; Lopes, NP; Soares, LAL; Fernandes-Pedrosa, MD; Zucolotte, SM				Fernandes, Julia Morais; Felix-Silva, Juliana; da Cunha, Lorena Medeiros; dos Santos Gomes, Jacyra Antunes; da Silva Siqueira, Emerson Michell; Gimenes, Luisa Possamai; Lopes, Norberto Peporine; Lira Soares, Luiz Alberto; Fernandes-Pedrosa, Matheus de Freitas; Zucolotte, Silvana Maria			Inhibitory Effects of Hydroethanolic Leaf Extracts of Kalanchoe brasiliensis and Kalanchoe pinnata (Crassulaceae) against Local Effects Induced by Bothrops jararaca Snake Venom	PLOS ONE			English	Article							PHOSPHOLIPASES A(2); MASS-SPECTROMETRY; NATURAL-PRODUCTS; ASPER VENOM; FRAGMENTATION; ENVENOMINGS; NEWBORN; PROTEIN; BITE; NEED	The species Kalanchoe brasiliensis and Kalanchoe pinnata, both known popularly as "Saiao," are used interchangeably in traditional medicine for their antiophidic properties. Studies evaluating the anti-venom activity of these species are scarce. This study aims to characterize the chemical constituents and evaluate the inhibitory effects of hydroethanolic leaf extracts of K. brasiliensis and K. pinnata against local effects induced by Bothrops jararaca snake venom. Thin Layer Chromatography (TLC) and High Performance Liquid Chromatography coupled with Diode Array Detection and Electrospray Mass Spectrometry (HPLC-DAD-MS/MS) were performed for characterization of chemical markers of the extracts from these species. For antiophidic activity evaluation, B. jararaca venom-induced paw edema and skin hemorrhage in mice were evaluated. In both models, hydroethanolic extracts (125-500 mg/kg) were administered intraperitoneally in different protocols. Inhibition of phospholipase enzymatic activity of B. jararaca was evaluated. The HPLC-DAD-MS/MS chromatographic profile of extracts showed some particularities in the chemical profile of the two species. K. brasileinsis exhibited major peaks that have UV spectra similar to flavonoid glycosides derived from patuletin and eupafolin, while K. pinnata showed UV spectra similar to flavonoids glycosides derived from quercetin and kaempferol. Both extracts significantly reduced the hemorrhagic activity of B. jararaca venom in pre-treatment protocol, reaching about 40% of inhibition, while only K. pinnata was active in post-treatment protocol (about 30% of inhibition). In the antiedematogenic activity, only K. pinnata was active, inhibiting about 66% and 30% in pre and post-treatment protocols, respectively. Both extracts inhibited phospholipase activity; however, K. pinnata was more active. In conclusion, the results indicate the potential antiophidic activity of Kalanchoe species against local effects induced by B. jararaca snake venom, suggesting their potential use as a new source of bioactive molecules against bothropic venom.	[Fernandes, Julia Morais; da Cunha, Lorena Medeiros; da Silva Siqueira, Emerson Michell; Zucolotte, Silvana Maria] Univ Fed Rio Grande Norte UFRN, Dept Farm, Lab Farmacognosia, Grp Pesquisa Prod Nat Bioat PNBio, Natal, RN, Brazil; [Felix-Silva, Juliana; dos Santos Gomes, Jacyra Antunes; Fernandes-Pedrosa, Matheus de Freitas] Univ Fed Rio Grande Norte UFRN, PPgCF, Lab Tecnol & Biotecnol Farmaceut TecBioFar, Natal, RN, Brazil; [Gimenes, Luisa Possamai; Lopes, Norberto Peporine] Fac Ciencias Farmaceut, Dept Quim & Fis, NPPNS, Ribeirao Preto, SP, Brazil; [Lira Soares, Luiz Alberto] Univ Fed Pernambuco UFPE, Lab Farmacognosia, Recife, PE, Brazil; [Zucolotte, Silvana Maria] Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Dept Farm, Lab Farmacognosia, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal de Pernambuco; Universidade Federal do Rio Grande do Norte	Zucolotte, SM (corresponding author), Univ Fed Rio Grande Norte UFRN, Dept Farm, Lab Farmacognosia, Grp Pesquisa Prod Nat Bioat PNBio, Natal, RN, Brazil.; Zucolotte, SM (corresponding author), Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Dept Farm, Lab Farmacognosia, Natal, RN, Brazil.	szucolotto@hotmail.com	Soares, Luiz Alberto/AAS-3050-2020; Fernandes, Júlia Morais/AAM-2962-2020; Fapesp, Biota/F-8655-2017; Félix-Silva, Juliana/AAA-1737-2019; Fernandes-Pedrosa, Matheus/C-6398-2014; Zucolotto, Silvana Maria/A-8557-2014; Lopes, Norberto P/C-7148-2012; Soares, Luiz/R-3373-2016; Félix-Silva, Juliana/K-7066-2012	Fernandes, Júlia Morais/0000-0001-9769-5352; Fapesp, Biota/0000-0002-9887-8449; Félix-Silva, Juliana/0000-0003-3131-9025; Fernandes-Pedrosa, Matheus/0000-0003-4221-9580; Zucolotto, Silvana Maria/0000-0002-2768-0793; Lopes, Norberto P/0000-0002-8159-3658; Félix-Silva, Juliana/0000-0003-3131-9025; Soares, Luiz/0000-0002-3142-6173	CNPq [447857/2014-2]; Master Degree Scholarship from Capes of Julia Morais Fernandes	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Master Degree Scholarship from Capes of Julia Morais Fernandes	This work was supported by CNPq (447857/2014-2) and Master Degree Scholarship from Capes of Julia Morais Fernandes.	Afzal M, 2012, FITOTERAPIA, V83, P853, DOI 10.1016/j.fitote.2012.03.013; AKIHISA T, 1991, LIPIDS, V26, P660, DOI 10.1007/BF02536432; Amaral A.C.F., 2005, COLETANEA CIENTIFICA; Pereanez JA, 2014, CHEM-BIOL INTERACT, V220, P94, DOI 10.1016/j.cbi.2014.06.015; Antunes TC, 2010, TOXICON, V56, P1443, DOI 10.1016/j.toxicon.2010.08.011; Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Patino AC, 2015, TOXINS, V7, P1532, DOI 10.3390/toxins7051532; Cardozo KHM, 2008, INT J MASS SPECTROM, V273, P11, DOI 10.1016/j.ijms.2008.02.014; Carvalho BMA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/153045; Chibli LA, 2014, J ETHNOPHARMACOL, V154, P330, DOI 10.1016/j.jep.2014.03.035; Costa ACO, 2013, J LIQ CHROMATOGR R T, V38, P795; COSTA SS, 1994, J NAT PRODUCTS, V57, P1503, DOI 10.1021/np50113a005; Cotrim CA, 2011, CHEM-BIOL INTERACT, V189, P9, DOI 10.1016/j.cbi.2010.10.016; Cruz EA, 2012, PHYTOMEDICINE, V19, P115, DOI 10.1016/j.phymed.2011.06.030; de Moura VM, 2015, J ETHNOPHARMACOL, V161, P224, DOI 10.1016/j.jep.2014.12.020; de Paula RC, 2009, PROTEIN PEPTIDE LETT, V16, P899, DOI 10.2174/092986609788923365; de Roodt AR, 2000, TOXICON, V38, P865, DOI 10.1016/S0041-0101(99)00205-6; Demarque DP, 2016, NAT PROD REP, V33, P432, DOI 10.1039/c5np00073d; Felix-Silva J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104952; Fonseca F. V., 2004, Rev. bras. farmacogn., V14, P26; Garcia-Mediavilla V, 2007, EUR J PHARMACOL, V557, P221, DOI 10.1016/j.ejphar.2006.11.014; Gehrig H, 2001, PLANT SCI, V160, P827, DOI 10.1016/S0168-9452(00)00447-7; Gomes A, 2010, INDIAN J EXP BIOL, V48, P865; GUTIERREZ J M, 1989, Memorias do Instituto Butantan (Sao Paulo), V51, P211; Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; Gutierrez JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002162; HOUGHTON PJ, 1993, J ETHNOPHARMACOL, V39, P1, DOI 10.1016/0378-8741(93)90047-9; Ibrahim T, 2002, INT IMMUNOPHARMACOL, V2, P875, DOI 10.1016/S1567-5769(02)00020-6; Kang TS, 2011, FEBS J, V278, P4544, DOI 10.1111/j.1742-4658.2011.08115.x; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kothari N, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.09.001; Lomonte B, 2011, ACTA CHIM SLOV, V58, P647; Lomonte B, 2009, TOXICON, V54, P1012, DOI 10.1016/j.toxicon.2009.03.015; Lorenzi H., 2000, PLANTAS MED BRASIL N; LOURENCO WR, 1996, BIOGEOGRAPHIE MADAGA; Gutierrez JM, 2007, CURR PHARM DESIGN, V13, P2935, DOI 10.2174/138161207782023784; Gutierrez JM, 2013, TOXICON, V62, P27, DOI 10.1016/j.toxicon.2012.09.006; Gutierrez JM, 2011, BIOLOGICALS, V39, P129, DOI 10.1016/j.biologicals.2011.02.005; Markham KR, FLAVONOIDS, DOI 10.1016/0022-2860(71)87109-0; Mendes MM, 2013, PHYTOCHEMISTRY, V86, P72, DOI 10.1016/j.phytochem.2012.10.007; Ministerio da Saude, 2009, GUIA VIGILANCIA EPID, V7; Mors WB, 2000, PHYTOCHEMISTRY, V55, P627, DOI 10.1016/S0031-9422(00)00229-6; Mourao RHV, 1999, PHYTOTHER RES, V13, P352, DOI 10.1002/(SICI)1099-1573(199906)13:4&lt;352::AID-PTR452&gt;3.0.CO;2-T; Muzitano MF, 2006, PLANTA MED, V72, P81, DOI 10.1055/s-2005-873183; Muzitano MF, 2006, PHYTOCHEMISTRY, V67, P2071, DOI 10.1016/j.phytochem.2006.06.027; Nagpure, 2012, MINTAGE J PHARM MED, V1, P1; Paiva LS, 2008, J LEUKOCYTE BIOL, V83, P1; Patrao-Neto FC, 2013, TOXICON, V69, P55, DOI 10.1016/j.toxicon.2013.01.023; Pinho F M, 2001, Rev Assoc Med Bras (1992), V47, P24, DOI 10.1590/S0104-42302001000100026; Santhosh MS, 2013, MINI-REV MED CHEM, V13, P106; Sarkhel Sumana, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P416, DOI 10.12980/APJTB.4.2014C1120; Domingos TFS, 2015, MOLECULES, V20, P3515, DOI 10.3390/molecules20033515; Srinivasa V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106364; Strauch MA, 2013, J ETHNOPHARMACOL, V145, P50, DOI 10.1016/j.jep.2012.10.033; Supratman U, 2000, BIOSCI BIOTECH BIOCH, V64, P1310, DOI 10.1271/bbb.64.1310; Supratman U, 2001, BIOSCI BIOTECH BIOCH, V65, P947, DOI 10.1271/bbb.65.947; Vasquez J, 2013, J ETHNOPHARMACOL, V146, P449, DOI 10.1016/j.jep.2012.12.043; Vessecchi R, 2011, RAPID COMMUN MASS SP, V25, P2020, DOI 10.1002/rcm.5075; Wagner H., 2001, PLANT DRUGS ANAL THI; Zelanis A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001554	63	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168658	10.1371/journal.pone.0168658	http://dx.doi.org/10.1371/journal.pone.0168658			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033347	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900034
J	Talebi, M; Azadegan, A; Sadeghi, J; Ahmadi, A; Ghanei, M; Katouli, M; Owlia, P; Pourshafie, MR				Talebi, Malihe; Azadegan, Azadeh; Sadeghi, Javad; Ahmadi, Ali; Ghanei, Mostafa; Katouli, Mohammad; Owlia, Parviz; Pourshafie, Mohammad R.			Determination of Characteristics of Erythromycin Resistant Streptococcus pneumoniae with Preferred PCV Usage in Iran	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; INVASIVE PNEUMOCOCCI; MECHANISMS; SEROTYPES; GENOTYPE; PHENOTYPES; TRANSPOSON; EMERGENCE; EVOLUTION; ELEMENTS	Amongst 100 Streptococcus pneumoniae isolated from clinical cases and nasopharynx of healthy individuals, 60 erythromycin resistant strains were isolated and characterized using MLST, PFGE, transposon analysis and Quellung reaction. Most of the S. pneumoniae erythromycin resistant (80%) were found to be attributable to the ermB-edncoded ribosome methylase activity which differs from the dominant mechanism of macrolide resistance seen in North America. The most predominant transposons were; Tn1545/6003 (27%), Tn6002 (22%), Tn2009 (20%), Tn2010 (17%). Number of the clinical isolates carrying Tn2010 was more significant than the normal flora. The serotypes found were; 14 (33%), 3 (22%), 23F (15%), 19F (15%), 19A (7%), 6A (3%), 9V (3%) and 6B (2%). The most prevalent serotypes among the clinical (n = 28) and normal flora (n = 32) isolates were serotypes 14 (46%) and 3 (31%), respectively. The most prevalent vaccine serotypes amongst the clinical isolates and the healthy individuals were pneumococcal conjugate vaccines (PCV) 13 and PCV10, respectively. PFGE revealed 34 pulsotypes with 9 common and 25 single types. Significant number of the normal isolates belonged to CT5 and CT6. On the other hand, significant number of clinical isolates belonged to CT8 as compared to the normal flora isolates. MLST showed 2 dominant sequence types. ST3130 (23%) and ST180 (22%) were the most predominant sequence types in the clinical and normal isolates, respectively. There was no significant difference in other sequence types between clinical and normal flora isolates. Three polyclonal complexes including Sweden(15A) -25, Spain(23F) -1 and Spain(9V) -3 constituted 58% of the isolates. Our results suggest that the genetic diversity and transposon distribution were high among S. pneumoniae, particularly in the isolates containing erm(B) and double antibiotic resistant genes (erm/mef). The results presented here could influence the change in the current vaccination practices in Iran which currently calls for vaccination with PCV7 or PCV10.	[Talebi, Malihe; Ahmadi, Ali] Iran Univ Med Sci, Sch Med, Dept Microbiol, Tehran, Iran; [Azadegan, Azadeh; Sadeghi, Javad] Univ Tehran Med Sci, Sch Med, Dept Microbiol, Tehran, Iran; [Ghanei, Mostafa] Pasteur Inst Iran, TB Dept, Tehran, Iran; [Katouli, Mohammad] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol Res Ctr, Maroochydore, Qld, Australia; [Owlia, Parviz] Shahed Univ, Mol Microbiol Res Ctr, Tehran, Iran; [Pourshafie, Mohammad R.] Pasteur Inst Iran, Dept Microbiol, Tehran, Iran	Iran University of Medical Sciences; Tehran University of Medical Sciences; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; University of the Sunshine Coast; Shahed University; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Pourshafie, MR (corresponding author), Pasteur Inst Iran, Dept Microbiol, Tehran, Iran.	m_pour@pasteur.ac.ir	sadeghi, Javad/AAW-9467-2020; Pourshafie, Mohammad R/GQH-4798-2022; Ghanei, Mostafa/V-1975-2019; Ahmadi, Ali/O-6293-2015; Owlia, Parviz/S-4800-2017	Ghanei, Mostafa/0000-0001-9372-0928; Owlia, Parviz/0000-0002-5981-3781	Deputy of Research, Iran National Science Foundation [P1394]	Deputy of Research, Iran National Science Foundation	This work was supported by the by a grant from the Deputy of Research, Iran National Science (P1394) Foundation. The funder had no role in study design, data collection and explanation, or the decision to submit the work for publication.	Adamiak P, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-143; Azadegan A, 2015, ANN LAB MED, V35, P57, DOI 10.3343/alm.2015.35.1.57; Bae S, 2009, DIAGN MICR INFEC DIS, V63, P213, DOI 10.1016/j.diagmicrobio.2008.10.002; Bley C, 2011, INT J ANTIMICROB AG, V37, P425, DOI 10.1016/j.ijantimicag.2011.01.019; Calatayud L, 2007, ANTIMICROB AGENTS CH, V51, P3240, DOI 10.1128/AAC.00157-07; Calatayud L, 2010, J CLIN MICROBIOL, V48, P1310, DOI 10.1128/JCM.01868-09; Chancey ST, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00026; Clinical Laboratory Standards Institute (CLSI), M100S20 CLSI, V30; Cochetti I, 2008, ANTIMICROB AGENTS CH, V52, P1285, DOI 10.1128/AAC.01457-07; Cornick JE, 2012, MICROBES INFECT, V14, P573, DOI 10.1016/j.micinf.2012.01.012; Farrell DJ, 2005, EMERG INFECT DIS, V11, P851, DOI 10.3201/eid1106.050222; Gay K, 2000, J INFECT DIS, V182, P1417, DOI 10.1086/315853; Geng Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093752; Hawkins PA, 2015, MICROB DRUG RESIST, V21, P121, DOI 10.1089/mdr.2014.0086; Jefferies JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097912; Kim SH, 2012, ANTIMICROB AGENTS CH, V56, P1418, DOI 10.1128/AAC.05658-11; Korona-Glowniak I, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/836496; Marzouk M, 2014, MED MALADIES INFECT, V44, P478, DOI 10.1016/j.medmal.2014.07.016; Mayanskiy N, 2014, INT J INFECT DIS, V20, P58, DOI 10.1016/j.ijid.2013.11.005; Montanari MP, 2003, J CLIN MICROBIOL, V41, P428, DOI 10.1128/JCM.41.1.428-431.2003; Palmieri C, 2012, ANTIMICROB AGENTS CH, V56, P5994, DOI 10.1128/AAC.01487-12; Raddaoui A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140390; Sadeghi J, 2015, CURR MICROBIOL, V70, P206, DOI 10.1007/s00284-014-0704-7; Telli M, 2011, J INFECT CHEMOTHER, V17, P658, DOI 10.1007/s10156-011-0238-x; Wierzbowski AK, 2014, J ANTIMICROB CHEMOTH, V69, P59, DOI 10.1093/jac/dkt332; Zhou L, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-228	26	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0167803	10.1371/journal.pone.0167803	http://dx.doi.org/10.1371/journal.pone.0167803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033345	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900011
J	Dales, RE; Cakmak, S				Dales, Robert E.; Cakmak, Sabit			Does Mental Health Status Influence Susceptibility to the Physiologic Effects of Air Pollution? A Population Based Study of Canadian Children	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE; DEPRESSION; RISK; STRENGTHS; DISORDER; DISEASE; ANXIETY; SDQ	Background Both air pollution exposure and the presence of mental illness are associated with an increased risk of physical illness. Objective To determine whether or not children with less favourable mental health are more susceptible to pulmonary and cardiovascular effects of ambient air pollution, compared to those who are mentally healthy. Methods We carried out a cross-sectional study of 1,883 children between the ages of 6 and 17 years of age who participated in the Canadian Health Measures population survey between 2007 and 2009. Subjects were assigned the air pollution values obtained from the National Air Pollution monitor closest to their neighborhood. Lung function, heart rate and blood pressure were stratified by indicators of mental health. The latter were ascertained by questions about feelings of happiness, a diagnosed mood disorder, and the emotional symptom sub-scale of the Strengths and Difficulties Questionnaire. Results Among those who reported a mood disorder, an interquartile increase in ozone was associated with increases in systolic and diastolic pressures of 3.8 mmHg (95% CI 1.6, 5.9) and 3.0mmHg (95% CI 0.9, 5.2) respectively, and a decreases in FVC of 7.6% (95% CI 2.9, 12.3). No significant changes in these variables were observed in those who did not report a mood disorder. Among those with unfavourable emotional symptoms, ozone was associated with a 6.4% (95% CI 1.7, 11.3) increase in heart rate, a 4.1% (95% CI 1.2, 7.1) increase in systolic blood pressure, and a 6.0% (95% CI 1.4, 10.6) decrease in FEVl. No significant effect was seen in these variables among those with no emotional symptoms. Conclusions In the Canadian population, children who report mood disorders or unfavourable emotional symptoms appear to be more vulnerable to the adverse physiologic effects of air pollution.	[Dales, Robert E.; Cakmak, Sabit] Hlth Canada, Populat Studies Div, Ottawa, ON, Canada; [Dales, Robert E.] Univ Ottawa, Sch Med, Ottawa, ON, Canada	Health Canada; University of Ottawa	Cakmak, S (corresponding author), Hlth Canada, Populat Studies Div, Ottawa, ON, Canada.	sabit.cakmak@canada.ca			Government of Canada, Clean Air Regulatory Agenda	Government of Canada, Clean Air Regulatory Agenda	The work was supported by Government of Canada, Clean Air Regulatory Agenda.	Cakmak S, 2016, INT J SUS DEV PLANN, V11, P537; Cakmak S, 2011, ENVIRON RES, V111, P1309, DOI 10.1016/j.envres.2011.09.016; Campbell NRC, 2005, CAN J PUBLIC HEALTH, V96, P217, DOI 10.1007/BF03403694; Committee on Research Priorities for Airborne Particulate Matter National Research Council, 1998, RES PRIOR AIRB PART; Copeland WE, 2012, BIOL PSYCHIAT, V71, P15, DOI 10.1016/j.biopsych.2011.09.023; DALES RE, 1989, AM REV RESPIR DIS, V139, P1459, DOI 10.1164/ajrccm/139.6.1459; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Goodman A, 2011, J CHILD PSYCHOL PSYC, V52, P100, DOI 10.1111/j.1469-7610.2010.02278.x; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hicken MT, 2013, ENVIRON HEALTH PERSP, V121, P205, DOI 10.1289/ehp.1104517; Kawakami N, 1999, DIABETES CARE, V22, P1071, DOI 10.2337/diacare.22.7.1071; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; Lasalvia A, 2013, LANCET, V381, P55, DOI 10.1016/S0140-6736(12)61379-8; Lawrence D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2539; Levy JL, 2002, ENVIRON HEALTH PERSP, V110, P1253, DOI 10.1289/ehp.021101253; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; National Institute of Mental Health, 2019, MENT ILLN; Penninx BWJH, 2003, BIOL PSYCHIAT, V54, P566, DOI 10.1016/S0006-3223(02)01811-5; Rao J. N. K., 1992, SURV METHODOL, V18, P209; Richter J, 2011, J CHILD PSYCHOL PSYC, V52, P1002, DOI 10.1111/j.1469-7610.2011.02372.x; Rugulies R, 2002, AM J PREV MED, V23, P51, DOI 10.1016/S0749-3797(02)00439-7; Sacks JD, 2011, ENVIRON HEALTH PERSP, V119, P446, DOI 10.1289/ehp.1002255; Shanahan L, 2013, J PEDIATR-US, V163, P1443, DOI 10.1016/j.jpeds.2013.06.046; Stieb DM, 2008, J AIR WASTE MANAGE, V58, P435, DOI 10.3155/1047-3289.58.3.435; US EPA, NAT AMB AIR QUAL STA; Xu WN, 2008, AM J RESP CRIT CARE, V178, P913, DOI 10.1164/rccm.200804-619OC; Zanobetti A, 2000, Biostatistics, V1, P279, DOI 10.1093/biostatistics/1.3.279	29	13	13	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168931	10.1371/journal.pone.0168931	http://dx.doi.org/10.1371/journal.pone.0168931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030615	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000086
J	Son, GY; Bak, EJ; Kim, JH; Lee, DE; Kang, SM; Lee, SY; Choi, L; Sun, JS; Kim, SK; Park, W; Kim, BI; Yoo, YJ; Chang, I; Shin, DM				Son, Ga-Yeon; Bak, Eun-Jung; Kim, Ji-Hye; Lee, Dong Eun; Kang, Si-Mook; Lee, So Yun; Choi, Lin; Sun, Ji Su; Kim, Seul Ki; Park, Wonse; Kim, Baek Il; Yoo, Yun-Jung; Chang, Inik; Shin, Dong Min			Endothelin Regulates Porphyromonas gingivalis-Induced Production of Inflammatory Cytokines	PLOS ONE			English	Article							EPITHELIAL-CELLS; ADULT PERIODONTITIS; BONE LOSS; RECEPTOR ANTAGONIST; CONVERTING ENZYME; EXPRESSION; DISEASE; GENE; SYSTEM; MACROPHAGES	Periodontitis is a very common oral inflammatory disease that results in the destruction of supporting connective and osseous tissues of the teeth. Although the exact etiology is still unclear, Gram-negative bacteria, especially Porphyromonas gingivalis in subgingival pockets are thought to be one of the major etiologic agents of periodontitis. Endothelin (ET) is a family of three 21-amino acid peptides, ET-1, -2, and -3, that activate G protein-coupled receptors, ETA and ETB. Endothelin is involved in the occurrence and progression of various inflammatory diseases. Previous reports have shown that ET-1 and its receptors, ETA and ETB are expressed in the periodontal tissues and, that ET-1 levels in gingival crevicular fluid are increased in periodontitis patients. Moreover, P. gingivalis infection has been shown to induce the production of ET-1 along with other inflammatory cytokines. Despite these studies, however, the functional significance of endothelin in periodontitis is still largely unknown. In this study, we explored the cellular and molecular mechanisms of ET-1 action in periodontitis using human gingival epithelial cells (HGECs). ET-1 and ETA, but not ETB, were abundantly expressed in HGECs. Stimulation of HGECs with P. gingivalis or P. gingivalis lipopolysaccharide increased the expression of ET-1 and ETA suggesting the activation of the endothelin signaling pathway. Production of inflammatory cytokines, IL-1 beta, TNF alpha, and IL-6, was significantly enhanced by exogenous ET-1 treatment, and this effect depended on the mitogen-activated protein kinases via intracellular Ca2+ increase, which resulted from the activation of the phospholipase C/inositol 1,4,5-trisphosphate pathway. The inhibition of the endothelin receptor-mediated signaling pathway with the dual receptor inhibitor, bosentan, partially ameliorated alveolar bone loss and immune cell infiltration. These results suggest that endothelin plays an important role in P. gingivalis-mediated periodontitis. Thus, endothelin antagonism may be a potential therapeutic approach for periodontitis treatment.	[Son, Ga-Yeon; Bak, Eun-Jung; Lee, Dong Eun; Lee, So Yun; Choi, Lin; Sun, Ji Su; Kim, Seul Ki; Yoo, Yun-Jung; Chang, Inik; Shin, Dong Min] Yonsei Univ, Coll Dent, Dept Oral Biol, Seoul, South Korea; [Son, Ga-Yeon; Lee, Dong Eun; Kang, Si-Mook; Lee, So Yun; Sun, Ji Su; Kim, Seul Ki; Kim, Baek Il; Shin, Dong Min] Yonsei Univ, Coll Dent, PLUS Project BK21, Seoul, South Korea; [Kim, Ji-Hye] Jeonju Kijeon Coll, Dept Dent Hyg, Jeonju, South Korea; [Kang, Si-Mook; Kim, Baek Il] Yonsei Univ, Coll Dent, Dept Prevent Dent & Publ Oral Hlth, Seoul, South Korea; [Park, Wonse] Yonsei Univ, Coll Dent, Dept Adv Gen Dent, Seoul, South Korea; [Son, Ga-Yeon] NIDCR, Secretory Physiol Sect, Mol Physiol & Therapeut Branch, Bethesda, MD USA; [Son, Ga-Yeon] NIH, Secretory Physiol Sect, Mol Physiol & Therapeut Branch, Bldg 10, Bethesda, MD 20892 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA	Chang, I; Shin, DM (corresponding author), Yonsei Univ, Coll Dent, Dept Oral Biol, Seoul, South Korea.; Shin, DM (corresponding author), Yonsei Univ, Coll Dent, PLUS Project BK21, Seoul, South Korea.	ichang@yuhs.ac; dmshin@yuhs.ac	Yoo, Yun-Jung/HDN-0946-2022	Park, Wonse/0000-0002-2081-1156; Kang, Si-Mook/0000-0003-2341-3636; Shin, Dong Min/0000-0001-6042-0435; Kim, Baek Il/0000-0001-8234-2327; Kim, Seul Ki/0000-0002-2926-5972; Yoo, Yun-Jung/0000-0002-0045-9597	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2061305]; Ministry of Science, ICT and future Planning [2015R1A2A1A15054157, 2016R1A5A2008630]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea); Ministry of Science, ICT and future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2061305 for Inik Chang) and the Ministry of Science, ICT and future Planning (2015R1A2A1A15054157 for Dong Min Shin and 2016R1A5A2008630 for Inik Chang and Dong Min Shin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Ansai T, 2003, ORAL MICROBIOL IMMUN, V18, P398, DOI 10.1046/j.0902-0055.2003.00080.x; Ansai T, 2002, CLIN SCI, V103, p327S, DOI 10.1042/CS103S327S; Anthoni C, 2006, INT J COLORECTAL DIS, V21, P409, DOI 10.1007/s00384-005-0015-3; Awano S, 1999, FEBS LETT, V460, P139, DOI 10.1016/S0014-5793(99)01326-5; Bohm F, 2007, CARDIOVASC RES, V76, P8, DOI 10.1016/j.cardiores.2007.06.004; Chen SZ, 2000, CHINESE MED J-PEKING, V113, P844; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Donate PB, 2012, INFLAMM RES, V61, P337, DOI 10.1007/s00011-011-0415-5; Finsnes F, 1997, AM J RESP CRIT CARE, V155, P1404, DOI 10.1164/ajrccm.155.4.9105086; Fujioka D, 2003, J PERIODONTAL RES, V38, P269, DOI 10.1034/j.1600-0765.2003.00653.x; Graves DT, 2011, J DENT RES, V90, P143, DOI 10.1177/0022034510385236; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Holla LI, 2001, J PERIODONTOL, V72, P85, DOI 10.1902/jop.2001.72.1.85; Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851; Kim JH, 2014, J PERIODONTAL RES, V49, P792, DOI 10.1111/jre.12165; Kirikae T, 1999, INFECT IMMUN, V67, P1736; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Liang L, 2014, J PERIODONTOL, V85, P618, DOI 10.1902/jop.2013.130195; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; NAKANO J, 1994, CLIN EXP ALLERGY, V24, P330, DOI 10.1111/j.1365-2222.1994.tb00243.x; Ogawa T, 2007, FRONT BIOSCI-LANDMRK, V12, P3795, DOI 10.2741/2353; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prabhu A, 1996, J PERIODONTOL, V67, P515, DOI 10.1902/jop.1996.67.5.515; Rikimaru T, 2009, BIOMED RES-TOKYO, V30, P349, DOI 10.2220/biomedres.30.349; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766; Sprogar S, 2008, BONE, V43, P740, DOI 10.1016/j.bone.2008.06.012; Yamamoto E, 2003, J PERIODONTAL RES, V38, P417, DOI 10.1034/j.1600-0765.2003.00668.x; Yamazaki K, 1997, ORAL MICROBIOL IMMUN, V12, P281, DOI 10.1111/j.1399-302X.1997.tb00392.x; Zhang H, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00023	33	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167713	10.1371/journal.pone.0167713	http://dx.doi.org/10.1371/journal.pone.0167713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030574	gold, Green Published, Green Submitted			2022-12-26	WOS:000391222000018
J	Yeonan-Kim, J; Bertalmio, M				Yeonan-Kim, Jihyun; Bertalmio, Marcelo			Retinal Lateral Inhibition Provides the Biological Basis of Long-Range Spatial Induction	PLOS ONE			English	Article							SIMULTANEOUS BRIGHTNESS CONTRAST; GANGLION-CELLS; RECEPTIVE-FIELD; AMACRINE CELLS; LIGHT ADAPTATION; EDGE INTEGRATION; PRIMATE; MODEL; ASSIMILATION; SENSITIVITY	Retinal lateral inhibition is one of the conventional efficient coding mechanisms in the visual system that is produced by interneurons that pool signals over a neighborhood of presynaptic feedforward cells and send inhibitory signals back to them. Thus, the receptive-field (RF) of a retinal ganglion cell has a center-surround receptive-field (RF) profile that is classically represented as a difference-of-Gaussian (DOG) adequate for efficient spatial contrast coding. The DOG RF profile has been attributed to produce the psychophysical phenomena of brightness induction, in which the perceived brightness of an object is affected by that of its vicinity, either shifting away from it (brightness contrast) or becoming more similar to it (brightness assimilation) depending on the size of the surfaces surrounding the object. While brightness contrast can be modeled using a DOG with a narrow surround, brightness assimilation requires a wide suppressive surround. Early retinal studies determined that the suppressive surround of a retinal ganglion cell is narrow (< 100-300 mu m; 'classic RF'), which led researchers to postulate that brightness assimilation must originate at some post-retinal, possibly cortical, stage where long-range interactions are feasible. However, more recent studies have reported that the retinal interneurons also exhibit a spatially wide component (> 500-1000 mu m). In the current study, we examine the effect of this wide interneuron RF component in two biophysical retinal models and show that for both of the retinal models it explains the long-range effect evidenced in simultaneous brightness induction phenomena and that the spatial extent of this long-range effect of the retinal model responses matches that of perceptual data. These results suggest that the retinal lateral inhibition mechanism alone can regulate local as well as long-range spatial induction through the narrow and wide RF components of retinal interneurons, arguing against the existing view that spatial induction is operated by two separate local vs. long-range mechanisms.	[Yeonan-Kim, Jihyun; Bertalmio, Marcelo] Univ Pompeu Fabra, Dept Tecnol Informacio & Comunicac, Barcelona, Spain	Pompeu Fabra University	Yeonan-Kim, J (corresponding author), Univ Pompeu Fabra, Dept Tecnol Informacio & Comunicac, Barcelona, Spain.	yeonankim@phototrophique.com	Bertalmío, Marcelo/A-4341-2012; Kim, Jihyun/H-5154-2015	Kim, Jihyun/0000-0002-0066-534X; Bertalmio, Marcelo/0000-0002-1023-8325	European Research Council [306337]; Spanish government; FEDER Fund [TIN2015-71537-P(MINECO/FEDER,UE]; Icrea Academia Award	European Research Council(European Research Council (ERC)European Commission); Spanish government(Spanish GovernmentEuropean Commission); FEDER Fund; Icrea Academia Award(ICREA)	This work was supported by the European Research Council, Starting Grant ref. 306337, by the Spanish government and FEDER Fund, grant ref. TIN2015-71537-P(MINECO/FEDER,UE), and by the Icrea Academia Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitto HJ, 2015, J NEUROPHYSIOL, V113, P2605, DOI 10.1152/jn.00480.2014; ANSTIS SM, 2005, SEEING SPATIAL FORM, P91; AREND LE, 1971, PERCEPT PSYCHOPHYS, V9, P367, DOI 10.3758/BF03212669; Barlow H. B., 1961, P331; Barlow H. B., 1961, SENS COMMUN, P782; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Benardete EA, 1999, J PHYSIOL-LONDON, V519, P775, DOI 10.1111/j.1469-7793.1999.0775n.x; Benardete EA, 1999, VISUAL NEUROSCI, V16, P355, DOI 10.1017/S0952523899162151; Bertalmio M, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00071; Bertalmio M, 2009, J PHYSIOL-PARIS, V103, P69, DOI 10.1016/j.jphysparis.2009.05.001; Bertalmio M, 2009, INT J COMPUT VISION, V83, P101, DOI 10.1007/s11263-009-0221-5; Lin B, 2006, J COMP NEUROL, V499, P797, DOI 10.1002/cne.21126; Blakeslee B, 2005, VISION RES, V45, P607, DOI 10.1016/j.visres.2004.09.027; Blakeslee B, 2004, VISION RES, V44, P2483, DOI 10.1016/j.visres.2004.05.015; Blakeslee B, 1999, VISION RES, V39, P4361, DOI 10.1016/S0042-6989(99)00119-4; Blakeslee B, 1997, VISION RES, V37, P2849, DOI 10.1016/S0042-6989(97)00086-2; Blakeslee B, 2013, VISION RES, V78, P39, DOI 10.1016/j.visres.2012.12.007; DeBonet JS, 1997, VISION RES, V37, P1141, DOI 10.1016/S0042-6989(96)00250-7; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; FACH C, 1986, PERCEPT PSYCHOPHYS, V40, P412, DOI 10.3758/BF03208201; FESTINGER L, 1970, AM J PSYCHOL, V83, P189, DOI 10.2307/1421323; Fiorentini A, 1972, HDB SENSORY PHYSL, VVII/4, P188; FRY GA, 1953, J OPT SOC AM, V43, P189, DOI 10.1364/JOSA.43.000189; Goldstein E.Bruce., 2013, SENSATION PERCEPTION; HEINEMANN EG, 1995, VISION RES, V35, P2007, DOI 10.1016/0042-6989(94)00281-P; HELSON H, 1963, J OPT SOC AM, V53, P179, DOI 10.1364/JOSA.53.000179; Hennig MH, 2002, J NEUROSCI, V22, P8726; Hong SW, 2004, VISION RES, V44, P35, DOI 10.1016/j.visres.2003.07.010; Jameson D., 1985, CENTRAL PERIPHERAL M, P83; Kamermans M, 1998, VISUAL NEUROSCI, V15, P787, DOI 10.1017/S0952523898154172; Kaplan E, 2001, PROG BRAIN RES, V134, P17; Kingdom FAA, 2011, VISION RES, V51, P652, DOI 10.1016/j.visres.2010.09.012; Kolb H, 1997, EYE, V11, P904, DOI 10.1038/eye.1997.230; LAND EH, 1971, J OPT SOC AM, V61, P1, DOI 10.1364/JOSA.61.000001; LAND EH, 1983, P NATL ACAD SCI USA, V80, P5163, DOI 10.1073/pnas.80.16.5163; LAND EH, 1977, SCI AM, V237, P108, DOI 10.1038/scientificamerican1277-108; Lee BB, 2011, J PHYSIOL-LONDON, V589, P59, DOI 10.1113/jphysiol.2010.188862; Lee BB, 2010, PROG RETIN EYE RES, V29, P622, DOI 10.1016/j.preteyeres.2010.08.004; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; LEIBOWITZ H, 1953, J EXP PSYCHOL, V46, P453, DOI 10.1037/h0062595; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Manookin MB, 2015, J NEUROPHYSIOL, V114, P1606, DOI 10.1152/jn.00484.2015; McMahon MJ, 2004, J NEUROSCI, V24, P3736, DOI 10.1523/JNEUROSCI.5252-03.2004; Packer OS, 2002, J VISION, V2, DOI 10.1167/2.4.1; Packer OS, 2005, J VISION, V5, P1038, DOI 10.1167/5.11.9; Passaglia CL, 2001, J NEUROSCI, V21, P5794, DOI 10.1523/JNEUROSCI.21-15-05794.2001; Perlman I, 1998, PROG RETIN EYE RES, V17, P523, DOI 10.1016/S1350-9462(98)00005-6; Provenzi E, 2007, IEEE T IMAGE PROCESS, V16, P162, DOI 10.1109/TIP.2006.884946; RATLIFF F, 1971, P AM PHILOS SOC, V115, P150; Ratliff F., 1965, MACH BANDS QUANTITAT; REID RC, 1988, VISION RES, V28, P115, DOI 10.1016/0042-6989(88)90013-2; Rizzi A, 2003, PATTERN RECOGN LETT, V24, P1663, DOI 10.1016/S0167-8655(02)00323-9; RODIECK RW, 1965, J NEUROPHYSIOL, V28, P833, DOI 10.1152/jn.1965.28.5.833; Rudd M., 2014, FRONT HUM NEUROSCI, V8, P1, DOI DOI 10.3389/FNHUM.2014.00640; Rudd ME, 2005, J VISION, V5, P983, DOI 10.1167/5.11.5; Rudd ME, 2004, VISION RES, V44, P971, DOI 10.1016/j.visres.2003.12.004; Rudd ME, 2007, J OPT SOC AM A, V24, P2134, DOI 10.1364/JOSAA.24.002134; Rudd ME, 2013, J VISION, V13, DOI 10.1167/13.14.18; Rudd ME, 2010, J VISION, V10, DOI 10.1167/10.14.40; Shah S, 1996, IEEE T SYST MAN CY B, V26, P275, DOI 10.1109/3477.485878; SHAPLEY R, 1985, P NATL ACAD SCI USA, V82, P5983, DOI 10.1073/pnas.82.17.5983; Shapley R.M., 1984, PROG RETIN RES, V3, P263, DOI [DOI 10.1016/0278-4327(84)90011-7, 10.1016/0278-4327(84)90011-7]; SHEVELL SK, 1992, VISION RES, V32, P2331, DOI 10.1016/0042-6989(92)90096-2; Smith VC, 2001, J NEUROPHYSIOL, V85, P545, DOI 10.1152/jn.2001.85.2.545; Solomon SG, 2006, J NEUROSCI, V26, P8715, DOI 10.1523/JNEUROSCI.0821-06.2006; Solomon SG, 2002, J NEUROSCI, V22, P338, DOI 10.1523/JNEUROSCI.22-01-00338.2002; SUGITA Y, 1995, VISION RES, V35, P881, DOI 10.1016/0042-6989(94)00217-A; Thoreson WB, 2012, PROG RETIN EYE RES, V31, P407, DOI 10.1016/j.preteyeres.2012.04.003; van Hateren H, 2005, J VISION, V5, P331, DOI 10.1167/5.4.5; van Hateren JH, 2007, J VISION, V7, DOI 10.1167/7.4.1; van Hateren JH, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-34; Vanleeuwen MT, 2007, VISUAL NEUROSCI, V24, P277, DOI 10.1017/S0952523807070058; WHITE M, 1979, PERCEPTION, V8, P413, DOI 10.1068/p080413; WHITE M, 1981, PERCEPTION, V10, P215, DOI 10.1068/p100215; Wilson HR, 1997, VISUAL NEUROSCI, V14, P403, DOI 10.1017/S0952523800012098; Wohrer A, 2009, J COMPUT NEUROSCI, V26, P219, DOI 10.1007/s10827-008-0108-4; ZAIDI Q, 1992, VISION RES, V32, P1695, DOI 10.1016/0042-6989(92)90162-C	78	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168963	10.1371/journal.pone.0168963	http://dx.doi.org/10.1371/journal.pone.0168963			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030651	Green Submitted, Green Published, gold			2022-12-26	WOS:000391222000091
J	Zheng, XH; Kuang, YY; Lv, WH; Cao, DC; Sun, ZP; Sun, XW				Zheng, Xianhu; Kuang, Youyi; Lv, Weihua; Cao, Dingchen; Sun, Zhipeng; Sun, Xiaowen			Genome-Wide Association Study for Muscle Fat Content and Abdominal Fat Traits in Common Carp (Cyprinus carpio)	PLOS ONE			English	Article							GENETIC-PARAMETERS; BODY-COMPOSITION; QUALITY TRAITS; LIPID-CONTENT; LINKAGE MAP; METABOLISM; SELECTION; SEQUENCE; CHOLINE; WEIGHT	Muscle fat content is an important phenotypic trait in fish, as it affects the nutritional, technical and sensory qualities of flesh. To identify loci and candidate genes associated with muscle fat content and abdominal fat traits, we performed a genome-wide association study (GWAS) using the common carp 250 K SNP assay in a common carp F2 resource population. A total of 18 loci surpassing the genome-wide suggestive significance level were detected for 4 traits: fat content in dorsal muscle (MFdo), fat content in abdominal muscle (MFab), abdominal fat weight (AbFW), and AbFW as a percentage of eviscerated weight (AbFP). Among them, one SNP (carp089419) affecting both AbFW and AbFP reached the genome-wide significance level. Ten of those loci were harbored in or near known genes. Furthermore, relative expressions of 5 genes related to MFdo were compared using dorsal muscle samples with high and low phenotypic values. The results showed that 4 genes were differentially expressed between the high and low phenotypic groups. These genes are, therefore, prospective candidate genes for muscle fat content: ankyrin repeat domain 10a (ankrd10a), tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 (tanc2), and four jointed box 1 (fjx1) and choline kinase alpha (chka). These results offer valuable insights into the complex genetic basis of fat metabolism and deposition.	[Zheng, Xianhu; Kuang, Youyi; Lv, Weihua; Cao, Dingchen; Sun, Zhipeng; Sun, Xiaowen] Chinese Acad Fishery Sci, Heilongjiang River Fisheries Res Inst, Natl & Local United Engn Lab Freshwater Fish Bree, Harbin, Heilongjiang, Peoples R China; [Lv, Weihua] Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China	Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS; Northeast Agricultural University - China	Sun, XW (corresponding author), Chinese Acad Fishery Sci, Heilongjiang River Fisheries Res Inst, Natl & Local United Engn Lab Freshwater Fish Bree, Harbin, Heilongjiang, Peoples R China.	sunxw2002@163.com	Kuang, Youyi/AFO-8327-2022	Kuang, Youyi/0000-0003-4053-9353	National Natural Science Foundation of China [31302174]; Central-Level Non-profit Scientific Research Institutes Special Funds [HSY201303]; China Ministry of Agriculture "948" Program [2016-X15]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central-Level Non-profit Scientific Research Institutes Special Funds; China Ministry of Agriculture "948" Program	This research was supported in part by the National Natural Science Foundation of China (31302174), the Central-Level Non-profit Scientific Research Institutes Special Funds (HSY201303) and the China Ministry of Agriculture 948 Program (2016-X15).	Ankra-Badu GA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-107; Baranski M, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-17; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Corbin KD, 2013, FASEB J, V27, P1674, DOI 10.1096/fj.12-219097; Derayat A, 2007, AQUACULTURE, V272, pS250, DOI 10.1016/j.aquaculture.2007.07.046; Dolley G, 2011, MOL GENET METAB, V102, P448, DOI 10.1016/j.ymgme.2010.12.011; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gallego-Ortega D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007819; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gjedrem T, 2009, REV-METHODS TECHNOL, V10, P1, DOI 10.1007/978-90-481-2773-3_1; Grant RW, 2013, ANIM GENET, V44, P560, DOI 10.1111/age.12035; Haghighi F, 2002, AM J HUM GENET, V70, P142, DOI 10.1086/324709; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Ionita-Laza I, 2013, EUR J HUM GENET, V21, P1158, DOI 10.1038/ejhg.2012.308; Ishii A, 2013, ANIM SCI J, V84, P675, DOI 10.1111/asj.12063; Jeff JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086931; Johansson L, 2000, FOOD QUAL PREFER, V11, P247, DOI 10.1016/S0950-3293(99)00073-7; Kocour M, 2007, AQUACULTURE, V270, P43, DOI 10.1016/j.aquaculture.2007.03.001; Kuang YY, 2015, AQUACULTURE, V435, P100, DOI 10.1016/j.aquaculture.2014.09.020; Lee J, 2015, MOL GENET GENOMICS, V290, P1673, DOI 10.1007/s00438-015-1025-7; Li Y, 2011, MAR BIOTECHNOL, V13, P706, DOI 10.1007/s10126-010-9332-9; Liu JS, 2009, J AGR FOOD CHEM, V57, P3808, DOI 10.1021/jf8033144; Liu ZJ, 2007, AQUACULTURE GENOME T; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; Peng WZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26693; Powell J, 2008, AQUACULTURE, V274, P225, DOI 10.1016/j.aquaculture.2007.11.036; Quillet E, 2005, AQUACULTURE, V245, P49, DOI 10.1016/j.aquaculture.2004.12.014; Quinton CD, 2005, AQUACULTURE, V247, P211, DOI 10.1016/j.aquaculture.2005.02.030; Rye M., 1996, Aquaculture Research, V27, P121; Santana MHA, 2015, GENET MOL RES, V14, P5229, DOI 10.4238/2015.May.18.14; Sharma A, 2015, ASIAN AUSTRAL J ANIM, V28, P1371, DOI 10.5713/ajas.14.0715; Sodeland M, AQUACULTURE; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Tobin D, 2006, AQUACULTURE, V261, P510, DOI 10.1016/j.aquaculture.2006.07.023; Ulrich V, 2014, P NATL ACAD SCI USA, V111, P13493, DOI 10.1073/pnas.1402106111; Vicira VLA, 2007, AQUACULTURE, V272, pS100, DOI 10.1016/j.aquaculture.2007.08.028; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang L, 2006, AM J HUM GENET, V78, P770, DOI 10.1086/503712; Wijsman EM, 2016, BMC GENET, V17, DOI 10.1186/s12863-015-0318-5; [吴景 Wu Jing], 2015, [中国水产科学, Journal of Fishery Sciences of China], V22, P9; Xia JH, 2014, MAR BIOTECHNOL, V16, P1, DOI 10.1007/s10126-013-9524-1; Xu J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-307; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-537; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-188; Yang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065554; Yao JF, 2010, POULTRY SCI, V89, P883, DOI 10.3382/ps.2009-00613; Zhang H, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002718; Zhang XF, 2013, MAR BIOTECHNOL, V15, P275, DOI 10.1007/s10126-012-9485-9; Zhang Y, 2011, MAR BIOTECHNOL, V13, P376, DOI 10.1007/s10126-010-9307-x; Zheng XH, 2011, MOL GENET GENOMICS, V286, P261, DOI 10.1007/s00438-011-0644-x; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	53	19	26	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0169127	10.1371/journal.pone.0169127	http://dx.doi.org/10.1371/journal.pone.0169127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030623	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000105
J	Mazzaferro, S; Bermudez, I; Sine, SM				Mazzaferro, Simone; Bermudez, Isabel; Sine, Steven M.			alpha 4 beta 2 Nicotinic Acetylcholine Receptors RELATIONSHIPS BETWEEN SUBUNIT STOICHIOMETRY AND FUNCTION AT THE SINGLE CHANNEL LEVEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYS-LOOP RECEPTORS; ACH BINDING-SITE; ALTERNATE STOICHIOMETRIES; SELECTIVE AGONIST; INTERFACE; SENSITIVITY; RESOLUTION; KINETICS; MICE; (ALPHA-4)(2)(BETA-2)(3)	Acetylcholine receptors comprising alpha 4 and beta 2 subunits are the most abundant class of nicotinic acetylcholine receptor in the brain. They contribute to cognition, reward, mood, and nociception and are implicated in a range of neurological disorders. Previous measurements of whole-cell macroscopic currents showed that alpha 4 and beta 2 subunits assemble in two predominant pentameric stoichiometries, which differ in their sensitivity to agonists, antagonists, and allosteric modulators. Here we compare agonist-elicited single channel currents from receptors assembled with an excess of either the alpha 4 or beta 2 subunit, forming receptor populations biased toward one or the other stoichiometry, with currents from receptors composed of five concatemeric subunits in which the subunit stoichiometry is predetermined. Our results associate each subunit stoichiometry with a unique single channel conductance, mean open channel lifetime, and sensitivity to the allosteric potentiator 3-[3-(3-pyridinyl)-1,2,4-oxadiazol-5-yl] benzonitrile (NS-9283). Receptors with the composition (alpha 4 beta 2)(2)alpha 4 exhibit high single channel conductance, brief mean open lifetime, and strong potentiation by NS-9283, whereas receptors with the composition (alpha 4 beta 2)(2)beta 2 exhibit low single channel conductance and long mean open lifetime and are not potentiated by NS-9283. Thus single channel current measurements reveal bases for the distinct functional and pharmacological properties endowed by different stoichiometries of alpha 4 and beta 2 subunits and establish pentameric concatemers as a means to delineate interactions between subunits that confer these properties.	[Mazzaferro, Simone; Sine, Steven M.] Mayo Clin, Coll Med, Receptor Biol Lab, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Sine, Steven M.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA; [Sine, Steven M.] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Bermudez, Isabel] Oxford Brookes Univ, Sch Life Sci, Oxford OX3 OBP, England	Mayo Clinic; Mayo Clinic; Mayo Clinic; Oxford Brookes University	Sine, SM (corresponding author), Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.	sine@mayo.edu		Mazzaferro, Simone/0000-0003-4402-5325	National Institutes of Health [NS031744]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031744, R01NS031744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant NS031744 (to S.M.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Benallegue N, 2013, BRIT J PHARMACOL, V170, P304, DOI 10.1111/bph.12268; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Carignano C, 2016, BBA-BIOMEMBRANES, V1858, P1964, DOI 10.1016/j.bbamem.2016.05.019; Chen Y, 2003, NEUROPHARMACOLOGY, V45, P334, DOI 10.1016/S0028-3908(03)00189-8; Colquhoun D., 1983, SINGLE CHANNEL RECOR, P483, DOI 10.1007/978-1-4615-7858-1_11; Cooper ST, 1999, J BIOL CHEM, V274, P27145, DOI 10.1074/jbc.274.38.27145; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Marubio LM, 1999, NATURE, V398, P805, DOI 10.1038/19756; Mazzaferro S, 2014, J BIOL CHEM, V289, P21795, DOI 10.1074/jbc.M114.555136; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Mukhtasimova N, 2016, J GEN PHYSIOL, V148, P43, DOI 10.1085/jgp.201611584; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Olsen JA, 2013, J BIOL CHEM, V288, P35997, DOI 10.1074/jbc.M113.498618; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Ragozzino D, 1997, EUR J NEUROSCI, V9, P480, DOI 10.1111/j.1460-9568.1997.tb01625.x; Rayes D, 2005, MOL PHARMACOL, V68, P1475, DOI 10.1124/mol.105.015438; Ross SA, 2000, J NEUROSCI, V20, P6431, DOI 10.1523/JNEUROSCI.20-17-06431.2000; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; SINE SM, 1994, J BIOL CHEM, V269, P8808; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; SINE SM, 1990, J GEN PHYSIOL, V96, P395, DOI 10.1085/jgp.96.2.395; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Zoli M, 1998, J NEUROSCI, V18, P4461; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124; Zwart R, 2008, MOL PHARMACOL, V73, P1838, DOI 10.1124/mol.108.045104	43	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2729	2740		10.1074/jbc.M116.764183	http://dx.doi.org/10.1074/jbc.M116.764183			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28031459	Green Published, hybrid			2022-12-26	WOS:000395535100015
J	Espejo, AB; Gao, GZ; Black, K; Gayatri, S; Veland, N; Kim, J; Chen, TP; Sudol, M; Walker, C; Bedford, MT				Espejo, Alexsandra B.; Gao, Guozhen; Black, Karynne; Gayatri, Sitaram; Veland, Nicolas; Kim, Jeesun; Chen, Taiping; Sudol, Marius; Walker, Cheryl; Bedford, Mark T.			PRMT5 C-terminal Phosphorylation Modulates a 14-3-3/PDZ Interaction Switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PAPILLOMAVIRUS E6; ARGININE METHYLTRANSFERASE PRMT5; FORKHEAD TRANSCRIPTION FACTOR; PROTEIN-KINASE; PDZ DOMAINS; MESSENGER-RNA; BINDING; METHYLATION; RECOGNITION; ONCOPROTEINS	PRMT5 is the primary enzyme responsible for the deposition of the symmetric dimethylarginine in mammalian cells. In an effort to understand how PRMT5 is regulated, we identified a threonine phosphorylation site within a C-terminal tail motif, which is targeted by the Akt/serum-and glucocorticoid-inducible kinases. While investigating the function of this post-translational modification, we serendipitously discovered that its free C-terminal tail binds PDZ domains (when unphosphorylated) and 14-3-3 proteins (when phosphorylated). In essence, a phosphorylation event within the last few residues of the C-terminal tail generates a posttranslational modification-dependent PDZ/14-3-3 interaction "switch." The C-terminal motif of PRMT5 is required for plasma membrane association, and loss of this switching capacity is not compatible with life. This signaling phenomenon was recently reported for theHPVE6 oncoprotein but has not yet been observed for mammalian proteins. To investigate the prevalence of PDZ/14-3-3 switching in signal transduction, we built a protein domain microarray that harbors PDZ domains and 14-3-3 proteins. We have used this microarray to interrogate the C-terminal tails of a small group of candidate proteins and identified ERBB4, PGHS2, and IRK1 (as well as E6 and PRMT5) as conforming to this signaling mode, suggesting that PDZ/14-3-3 switching may be a broad biological paradigm.	[Espejo, Alexsandra B.; Gao, Guozhen; Black, Karynne; Gayatri, Sitaram; Veland, Nicolas; Kim, Jeesun; Chen, Taiping; Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA; [Espejo, Alexsandra B.; Gayatri, Sitaram; Veland, Nicolas] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Sudol, Marius] Natl Univ Singapore, Dept Physiol, Mechanobiol Inst, Singapore 117597, Singapore; [Sudol, Marius] ASTAR, IMCB, Singapore 117597, Singapore; [Walker, Cheryl] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Bedford, MT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA.	mtbedford@mdanderson.org	Gayatri, Sitaram/GLT-7340-2022; Gao, Guozhen/U-1554-2019	Gao, Guozhen/0000-0002-9510-1474; Espejo, Alexsandra/0000-0002-8841-7219; Walker, Cheryl/0000-0003-4854-9695; Sudol, Marius/0000-0003-3051-6406; bedford, mark/0000-0002-8899-1050; Veland, Nicolas/0000-0002-3096-7867	National Institutes of Health MPI Grant [ES023206]; CPRIT Grant [RP130432]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health MPI Grant; CPRIT Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by National Institutes of Health MPI Grant ES023206.; Supported by CPRIT Grant RP130432 for the protein array analysis.	Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Beltran-Alvarez P, 2013, FEBS LETT, V587, P3159, DOI 10.1016/j.febslet.2013.07.043; Bezzi M, 2013, GENE DEV, V27, P1903, DOI 10.1101/gad.219899.113; Boon SS, 2013, J VIROL, V87, P1586, DOI 10.1128/JVI.02074-12; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Butler JS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202416; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cheng DH, 2012, METHOD ENZYMOL, V512, P71, DOI 10.1016/B978-0-12-391940-3.00004-4; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Czechanski A, 2014, NAT PROTOC, V9, P559, DOI 10.1038/nprot.2014.030; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Espejo A, 2002, BIOCHEM J, V367, P697, DOI 10.1042/BJ20020860; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Fern RJ, 1995, AM J PHYSIOL-RENAL, V269, pF751, DOI 10.1152/ajprenal.1995.269.6.F751; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Ganguly N, 2009, J BIOSCIENCES, V34, P113, DOI 10.1007/s12038-009-0013-7; Gayatri S, 2014, BBA-GENE REGUL MECH, V1839, P702, DOI 10.1016/j.bbagrm.2014.02.015; Guo SS, 2010, J BIOL CHEM, V285, P35133, DOI 10.1074/jbc.M110.153429; Hadjikyriacou A, 2015, J BIOL CHEM, V290, P16723, DOI 10.1074/jbc.M115.659433; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Ivarsson Y, 2012, FEBS LETT, V586, P2638, DOI 10.1016/j.febslet.2012.04.015; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; JORGENSEN PL, 1988, METHOD ENZYMOL, V156, P29; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Kuhne C, 2000, ONCOGENE, V19, P5884, DOI 10.1038/sj.onc.1203988; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Li ZW, 2015, EMBO J, V34, P748, DOI 10.15252/embj.201489319; Likhite N, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aad0872; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Smith AJ, 2011, PHYSIOLOGY, V26, P181, DOI 10.1152/physiol.00042.2010; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Stopa N, 2015, CELL MOL LIFE SCI, V72, P2041, DOI 10.1007/s00018-015-1847-9; Sulka B, 2009, J BIOL CHEM, V284, P10659, DOI 10.1074/jbc.M807643200; Tanaka H, 2009, MOL CANCER RES, V7, P557, DOI 10.1158/1541-7786.MCR-08-0197; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Tommasino M, 2014, SEMIN CANCER BIOL, V26, P13, DOI 10.1016/j.semcancer.2013.11.002; WEBSTER MK, 1993, J BIOL CHEM, V268, P11482; Weimann M, 2013, NAT METHODS, V10, P339, DOI [10.1038/NMETH.2397, 10.1038/nmeth.2397]; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783; Yoo BK, 2012, AM J PHYSIOL-GASTR L, V303, pG180, DOI 10.1152/ajpgi.00069.2012; ZHANG HY, 1993, P NATL ACAD SCI USA, V90, P3880, DOI 10.1073/pnas.90.9.3880; Zhang T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8140	51	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2255	2265		10.1074/jbc.M116.760330	http://dx.doi.org/10.1074/jbc.M116.760330			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28031468	Green Published, hybrid			2022-12-26	WOS:000395530300018
J	Patra, AP; Sharma, S; Ainavarapu, RK				Patra, Aditya Prasad; Sharma, Shobhona; Ainavarapu, Rama Koti			Force Spectroscopy of the Plasmodium falciparum Vaccine Candidate Circumsporozoite Protein Suggests a Mechanically Pliable Repeat Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDING PATHWAYS; BINDING-PROTEIN; MALARIA; GENE; SPOROZOITES; MOLECULE; EXPRESSION; ANTIGEN; CLONING; TRAP	The most effective vaccine candidate of malaria is based on the Plasmodium falciparum circumsporozoite protein (CSP), a major surface protein implicated in the structural strength, motility, and immune evasion properties of the infective sporozoites. It is suspected that reversible conformational changes of CSP are required for infection of the mammalian host, but the detailed structure and dynamic properties of CSP remain incompletely understood, limiting our understanding of its function in the infection. Here, we report the structural and mechanical properties of the CSP studied using singlemolecule force spectroscopy on several constructs, one including the central region of CSP, which is rich in NANP amino acid repeats (CSPrep), and a second consisting of a near full length sequence without the signal and anchor hydrophobic domains (CSP Delta HP). Our results show that the CSPrep is heterogeneous, with 40% of molecules requiring virtually no mechanical force to unfold (< 10 piconewtons (pN)), suggesting that these molecules are mechanically compliant and perhaps act as entropic springs, whereas the remaining 60% are partially structured with low mechanical resistance (similar to 70 pN). CSP Delta HP having multiple force peaks suggests specifically folded domains, with two major populations possibly indicating the open and collapsed forms. Our findings suggest that the overall low mechanical resistance of the repeat region, exposed on the outer surface of the sporozoites, combined with the flexible full length conformations of CSP, may provide the sporozoites not only with immune evasion properties, but also with lubricating capacity required during its navigation through the mosquito and vertebrate host tissues. We anticipate that these findings would further assist in the design and development of future malarial vaccines.	[Patra, Aditya Prasad; Sharma, Shobhona] Tata Inst Fundamental Res, Dept Biol Sci, Dr Homi Bhabha Rd, Bombay 400005, Maharashtra, India; [Ainavarapu, Rama Koti] Tata Inst Fundamental Res, Dept Chem Sci, Dr Homi Bhabha Rd, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR)	Sharma, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Dr Homi Bhabha Rd, Bombay 400005, Maharashtra, India.; Ainavarapu, RK (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, Dr Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	sharma@tifr.res.in; koti@tifr.res.in	Ainavarapu, Sri Rama Koti/D-1231-2011	Ainavarapu, Sri Rama Koti/0000-0002-1646-2731	Department of Atomic Energy (DAE); Tata Institute of Fundamental Research (TIFR)	Department of Atomic Energy (DAE)(Department of Atomic Energy (DAE)); Tata Institute of Fundamental Research (TIFR)(Tata Institute of Fundamental Research (TIFR))	This work was supported by the Department of Atomic Energy (DAE) and Tata Institute of Fundamental Research (TIFR). The authors declare that they have no conflicts of interest with the contents of this article.	Adzhubei AA, 2013, J MOL BIOL, V425, P2100, DOI 10.1016/j.jmb.2013.03.018; Aggarwal V, 2011, J BIOL CHEM, V286, P28056, DOI 10.1074/jbc.M111.249045; Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034; ARNOT DE, 1985, SCIENCE, V230, P815, DOI 10.1126/science.2414847; BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6; BISANG C, 1995, J AM CHEM SOC, V117, P7904, DOI 10.1021/ja00135a008; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Coppi A, 2011, J EXP MED, V208, P341, DOI 10.1084/jem.20101488; Das S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002858; Doud MB, 2012, P NATL ACAD SCI USA, V109, P7817, DOI 10.1073/pnas.1205737109; ELLIS J, 1983, NATURE, V302, P536, DOI 10.1038/302536a0; ENEA V, 1984, P NATL ACAD SCI-BIOL, V81, P7520, DOI 10.1073/pnas.81.23.7520; Ferguson DJP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113923; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; GALINSKI MR, 1987, CELL, V48, P311, DOI 10.1016/0092-8674(87)90434-X; Ghasparian A, 2006, CHEM COMMUN, P174, DOI 10.1039/b510812h; Herrera R, 2015, INFECT IMMUN, V83, P3771, DOI 10.1128/IAI.02676-14; Kaslow DC, 2015, VACCINE, V33, P7425, DOI 10.1016/j.vaccine.2015.09.061; Kotamarthi HC, 2014, J PHYS CHEM B, V118, P11449, DOI 10.1021/jp507463q; Kotamarthi HC, 2013, J AM CHEM SOC, V135, P14768, DOI 10.1021/ja406238q; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Li HB, 2001, P NATL ACAD SCI USA, V98, P10682, DOI 10.1073/pnas.191189098; LOCKYER MJ, 1987, MOL BIOCHEM PARASIT, V22, P101, DOI 10.1016/0166-6851(87)90073-9; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Mishra S, 2012, J IMMUNOL METHODS, V377, P47, DOI 10.1016/j.jim.2012.01.009; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; MULLER HM, 1993, EMBO J, V12, P2881, DOI 10.1002/j.1460-2075.1993.tb05950.x; NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20; NARDIN EH, 1993, ANNU REV IMMUNOL, V11, P687, DOI 10.1146/annurev.iy.11.040193.003351; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Rathore D, 2000, P NATL ACAD SCI USA, V97, P8530, DOI 10.1073/pnas.140224597; ROBSON KJH, 1995, EMBO J, V14, P3883, DOI 10.1002/j.1460-2075.1995.tb00060.x; Sarkar A, 2005, J BIOL CHEM, V280, P6261, DOI 10.1074/jbc.C400573200; SCHOFIELD L, 1990, J IMMUNOL, V144, P2781; SHARMA S, 1986, J IMMUNOL, V137, P357; SHARMA S, 1985, SCIENCE, V229, P779, DOI 10.1126/science.4023712; Sinnis P, 2007, PARASITOL INT, V56, P171, DOI 10.1016/j.parint.2007.04.002; Tewari R, 2002, J BIOL CHEM, V277, P47613, DOI 10.1074/jbc.M208453200; Tossavainen H, 2006, PROTEIN SCI, V15, P1760, DOI 10.1110/ps.052068506; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; WHO, 2015, WORLD MAL REP 2015; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249	48	9	9	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2110	2119		10.1074/jbc.M116.754796	http://dx.doi.org/10.1074/jbc.M116.754796			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28031457	hybrid, Green Published			2022-12-26	WOS:000395530300006
J	Gulia, R; Sharma, R; Bhattacharyya, S				Gulia, Ravinder; Sharma, Rohan; Bhattacharyya, Samarjit			Critical Role for Ubiquitination in the Endocytosis of Glutamate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; PROTEIN-COUPLED RECEPTOR; FRAGILE-X-SYNDROME; PROTEASOME SYSTEM; AMPA RECEPTORS; SYNAPTIC PLASTICITY; CANCER THERAPEUTICS; MEMBRANE-PROTEIN; MECHANISMS; PHOSPHORYLATION	Group I metabotropic glutamate receptors (mGluRs) play important roles in various neuronal processes and elicit changes in synaptic efficacy through AMPA receptor (AMPAR) endocytosis. Trafficking of mGluRs plays an important role in controlling the precise localization of these receptors at specific region of the cell; it also regulates the activity of these receptors. Despite this obvious significance, we know very little about the cellular mechanisms that control the trafficking of group I mGluRs. We show here that ligand-mediated internalization of group I mGluRs is ubiquitination-dependent. A lysine residue (Lys(1112)) at the C-terminal tail of mGluR1 (a member of the group I mGluR family) plays crucial role in this process. Our data suggest that Lys(63)-linked polyubiquitination is involved in the ligand-mediated endocytosis of mGluR1. Wealso show here that the mGluR1 internalization is dependent on a specific E3 ubiquitin ligase, Siah-1A. Furthermore, acute knockdown of Siah-1A enhances the mGluR-mediated AMPAR endocytosis. These studies reveal a novel function of ubiquitination in the regulation of group I mGluRs, as well as its role in mGluR-dependent AMPAR endocytosis.	[Gulia, Ravinder; Sharma, Rohan; Bhattacharyya, Samarjit] Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Sect 81, Sas Nagar 140306, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali	Bhattacharyya, S (corresponding author), Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Sect 81, Sas Nagar 140306, Punjab, India.	samarjit@iisermohali.ac.in	Gulia, Ravinder/AAD-3983-2021	Bhattacharyya, Samarjit/0000-0002-7055-7555	Indian Institute of Science Education and Research Mohali; University Grants Commission, India	Indian Institute of Science Education and Research Mohali; University Grants Commission, India(University Grants Commission, India)	This work was supported by Indian Institute of Science Education and Research Mohali and University Grants Commission, India fellowships (to R. G. and R. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alonso V, 2013, MOL ENDOCRINOL, V27, P558, DOI 10.1210/me.2012-1404; Anwyl R, 2006, PROG NEUROBIOL, V78, P17, DOI 10.1016/j.pneurobio.2005.12.001; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Bhattacharyya S, 2016, INT J BIOCHEM CELL B, V77, P205, DOI 10.1016/j.biocel.2016.03.003; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Biou V, 2008, P NATL ACAD SCI USA, V105, P1038, DOI 10.1073/pnas.0711412105; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; Citri A, 2009, EUR J NEUROSCI, V30, P1443, DOI 10.1111/j.1460-9568.2009.06950.x; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; DELLA NG, 1993, DEVELOPMENT, V117, P1333; Dey A, 2008, NAT REV DRUG DISCOV, V7, P1031, DOI 10.1038/nrd2759; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Francesconi A, 2000, P NATL ACAD SCI USA, V97, P6185, DOI 10.1073/pnas.97.11.6185; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Gladding CM, 2009, PHARMACOL REV, V61, P395, DOI 10.1124/pr.109.001735; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hislop JN, 2011, TRAFFIC, V12, P137, DOI 10.1111/j.1600-0854.2010.01121.x; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Ishikawa K, 1999, GENES CELLS, V4, P381, DOI 10.1046/j.1365-2443.1999.00269.x; Kammermeier PJ, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-15; Kim CH, 2008, J NEUROSCI RES, V86, P1, DOI 10.1002/jnr.21437; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Mahato PK, 2015, NEUROSCIENCE, V306, P138, DOI 10.1016/j.neuroscience.2015.08.031; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Moriyoshi K, 2004, P NATL ACAD SCI USA, V101, P8614, DOI 10.1073/pnas.0403042101; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Pandey S, 2014, J NEUROCHEM, V131, P602, DOI 10.1111/jnc.12930; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Regalado MP, 2006, J NEUROSCI, V26, P2343, DOI 10.1523/JNEUROSCI.5247-05.2006; Satheshkumar PS, 2009, J VIROL, V83, P2469, DOI 10.1128/JVI.01986-08; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; SHIGEMOTO R, 1993, NEUROSCI LETT, V163, P53, DOI 10.1016/0304-3940(93)90227-C; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Trivedi RR, 2012, BIOCHEM BIOPH RES CO, V427, P185, DOI 10.1016/j.bbrc.2012.09.040; Widagdo J, 2015, CELL REP; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Zaarur N, 2008, J BIOL CHEM, V283, P27575, DOI 10.1074/jbc.M802216200	48	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1426	1437		10.1074/jbc.M116.752105	http://dx.doi.org/10.1074/jbc.M116.752105			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	28011638	hybrid, Green Published			2022-12-26	WOS:000393339800024
J	Avuvika, E; Masese, LN; Wanje, G; Wanyonyi, J; Nyaribo, B; Omoni, G; Baghazal, A; McClelland, RS				Avuvika, Ethel; Masese, Linnet N.; Wanje, George; Wanyonyi, Juliet; Nyaribo, Benard; Omoni, Grace; Baghazal, Anisa; McClelland, R. Scott			Barriers and Facilitators of Screening for Sexually Transmitted Infections in Adolescent Girls and Young Women in Mombasa, Kenya: A Qualitative Study	PLOS ONE			English	Article							SEX-EDUCATION; BEHAVIOR; COMMUNICATION; URBAN; RISK; PREVALENCE; CHLAMYDIA; GONORRHEA; YOUTH; AGE	Objective Young women bear the greatest burden of sexually transmitted infections (STIs), so it is important to identify and address barriers to STI screening in this population. We conducted a qualitative study to explore the feasibility of STI screening among adolescent girls and young women in Mombasa, Kenya. Methods We conducted 17 in-depth interviews (IDIs) (8 with adolescent girls and 9 with young women) and 6 focus group discussions (FGDs) (4 with adolescent girls and 2 with young women, total 55 participants). The audio recordings for the IDIs and FGDs were translated and transcribed into English. Transcripts were independently reviewed by two researchers, and a set of codes was designed to help analyze the data using the content analysis approach. Data content was then analyzed manually and digitally using ATLAS. ti, and consensus was reached on central and specific emergent themes discussed by the research team. Results Adolescent girls and young women in Mombasa, Kenya expressed willingness to participate in STI screening. A major incentive for screening was participants' desire to know their STI status, especially following perceived high-risk sexual behavior. Lack of symptoms and fear of positive test results were identified as barriers to STI screening at the individual level, while parental notification and stigmatization from parents, family members and the community were identified as barriers at the community level. Uncomfortable or embarrassing methods of specimen collection were an additional barrier. Thus, urine based screening was felt to be the most acceptable. Conclusion Kenyan adolescent girls and young women seem willing to participate in screening for STIs using urine testing. Addressing stigmatization by parents, health care workers and the community could further facilitate STI screening in this population.	[Avuvika, Ethel; Wanje, George; McClelland, R. Scott] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya; [Masese, Linnet N.; McClelland, R. Scott] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Wanyonyi, Juliet] Tech Univ Mombasa, Student Serv, Mombasa, Kenya; [Nyaribo, Benard; Baghazal, Anisa] Mombasa Cty Dept Hlth, Mombasa, Kenya; [Omoni, Grace] Univ Nairobi, Sch Nursing Sci, Nairobi, Kenya; [McClelland, R. Scott] Univ Washington, Dept Med, Seattle, WA USA; [McClelland, R. Scott] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	University of Nairobi; University of Washington; University of Washington Seattle; Technical University of Mombasa; University of Nairobi; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Masese, LN (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	linnet@uw.edu		Masese, Linnet/0000-0003-4704-9154	University of Washington Global Center for Integrated Health of Women, Adolescents, and Children (Global WACh); Fogarty International Center (NIH) [5D43-TW000007]; University of Washington & Fred Hutchinson Cancer Research Center's Center for AIDS Research [P30-AI-27757]	University of Washington Global Center for Integrated Health of Women, Adolescents, and Children (Global WACh); Fogarty International Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); University of Washington & Fred Hutchinson Cancer Research Center's Center for AIDS Research	This research was funded by a 2011 developmental grant from the University of Washington Global Center for Integrated Health of Women, Adolescents, and Children (Global WACh). One of the authors received training support from the Fogarty International Center (NIH 5D43-TW000007 to LM). Infrastructure and logistical support for the Mombasa Field Site were received from the University of Washington & Fred Hutchinson Cancer Research Center's Center for AIDS Research (grant number P30-AI-27757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, STAT WORLDS CHILDR; Aspy CB, 2007, J ADOLESCENCE, V30, P449, DOI 10.1016/j.adolescence.2006.04.007; Bastien S, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-25; Brahmbhatt H, 2014, J ADOLESCENT HEALTH, V55, pS48, DOI 10.1016/j.jadohealth.2014.07.023; Cherie A BY, 2012, J AIDS CLIN RES; Da Ros CT, 2008, ASIAN J ANDROL, V10, P110, DOI 10.1111/j.1745-7262.2008.00367.x; Darj E, 2010, SEX REPROD HEALTHC, V1, P111, DOI 10.1016/j.srhc.2010.03.001; Datta SD, 2007, ANN INTERN MED, V147, P89, DOI 10.7326/0003-4819-147-2-200707170-00007; Davis AN, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-55; Dehne KaR G, SEXUALLY TRANSMITTED; DiClemente RJ, J ACQUIR IMMUNE D S1, V54, pS12; Giorgio MM, 2013, J MED INTERNET RES, V15, P69, DOI 10.2196/jmir.2619; Greif MJ, 2011, URBAN STUD, V48, P947, DOI 10.1177/0042098010368575; Halcomb EJ, 2007, J CLIN NURS, V16, P1000, DOI 10.1111/j.1365-2702.2006.01760.x; Jones K, 2014, SEX TRANSM DIS, V41, P413, DOI 10.1097/OLQ.0000000000000146; Kenya MoH, 2011, KEN SERV PROV ASS 20; Kohler PK, 2008, J ADOLESCENT HEALTH, V42, P344, DOI 10.1016/j.jadohealth.2007.08.026; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Markham CM, 2010, J ADOLESCENT HEALTH, V46, pS23, DOI 10.1016/j.jadohealth.2009.11.214; Mbugua N, 2007, SOC SCI MED, V64, P1079, DOI 10.1016/j.socscimed.2006.10.008; McClelland L, 2011, AIDS EDUC PREV, V23, P299, DOI 10.1521/aeap.2011.23.4.299; McManus Alexandra, 2008, BMC Womens Health, V8, P12, DOI 10.1186/1472-6874-8-12; MILLSTEIN SG, 1995, J ADOLESCENT HEALTH, V17, P83, DOI 10.1016/1054-139X(95)00065-Z; Molla M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-9; Navarro Christine, 2002, Can J Infect Dis, V13, P195; Russell BH, 2010, ANAL QUALITATIVE DAT; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Schenk KD, 2014, J ADOLESCENT HEALTH, V54, P654, DOI 10.1016/j.jadohealth.2014.01.014; SHAFER MA, 1991, J PEDIATR-US, V119, P826, DOI 10.1016/S0022-3476(05)80312-9; Strauss A, 2008, BASICS QUALITATIVE R; Tilson EC, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-21; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x; Yadeta TA, 2014, J ENVIRON PUBLIC HEA, V2014, DOI 10.1155/2014/102579; Zaba B, 2004, SEX TRANSM INFECT, V80, P28, DOI 10.1136/sti.2004.012674	34	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169388	10.1371/journal.pone.0169388	http://dx.doi.org/10.1371/journal.pone.0169388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2QJ	28046104	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300179
J	Forred, BJ; Daugaard, DR; Titus, BK; Wood, RR; Floen, MJ; Booze, ML; Vitiello, PF				Forred, Benjamin J.; Daugaard, Darwin R.; Titus, Brianna K.; Wood, Ryan R.; Floen, Miranda J.; Booze, Michelle L.; Vitiello, Peter F.			Detoxification of Mitochondrial Oxidants and Apoptotic Signaling Are Facilitated by Thioredoxin-2 and Peroxiredoxin-3 during Hyperoxic Injury	PLOS ONE			English	Article							PULMONARY VASCULAR-DISEASE; OXYGEN SPECIES GENERATION; INDUCED LUNG INJURY; BCL-X-L; REACTIVE OXYGEN; OXIDATIVE STRESS; CELL-DEATH; PERMEABILITY TRANSITION; PRETERM INFANTS; THIOL SWITCHES	Mitochondria play a fundamental role in the regulation of cell death during accumulation of oxidants. High concentrations of atmospheric oxygen (hyperoxia), used clinically to treat tissue hypoxia in premature newborns, is known to elicit oxidative stress and mitochondrial injury to pulmonary epithelial cells. A consequence of oxidative stress in mitochondria is the accumulation of peroxides which are detoxified by the dedicated mitochondrial thioredoxin system. This system is comprised of the oxidoreductase activities of peroxiredoxin-3 (Prx3), thioredoxin-2 (Trx2), and thioredoxin reductase-2 (TrxR2). The goal of this study was to understand the role of the mitochondrial thioredoxin system and mitochondrial injuries during hyperoxic exposure. Flow analysis of the redox-sensitive, mitochondrial-specific fluorophore, MitoSOX, indicated increased levels of mitochondrial oxidant formation in human adenocarcinoma cells cultured in 95% oxygen. Increased expression of Trx2 and TrxR2 in response to hyperoxia were not attributable to changes in mitochondrial mass, suggesting that hyperoxic upregulation of mitochondrial thioredoxins prevents accumulation of oxidized Prx3. Mitochondrial oxidoreductase activities were modulated through pharmacological inhibition of TrxR2 with auranofin and genetically through shRNA knockdown of Trx2 and Prx3. Diminished Trx2 and Prx3 expression was associated with accumulation of mitochondrial superoxide; however, only shRNA knockdown of Trx2 increased susceptibility to hyperoxic cell death and increased phosphorylation of apoptosis signal-regulating kinase-1 (ASK1). In conclusion, the mitochondrial thioredoxin system regulates hyperoxic-mediated death of pulmonary epithelial cells through detoxification of oxidants and regulation of redox-dependent apoptotic signaling.	[Forred, Benjamin J.; Daugaard, Darwin R.; Titus, Brianna K.; Wood, Ryan R.; Floen, Miranda J.; Booze, Michelle L.; Vitiello, Peter F.] Sanford Res, Childrens Hlth Res Ctr, Sioux Falls, SD 57104 USA; [Vitiello, Peter F.] Univ South Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD 57105 USA	Sanford Health; University of South Dakota	Vitiello, PF (corresponding author), Sanford Res, Childrens Hlth Res Ctr, Sioux Falls, SD 57104 USA.; Vitiello, PF (corresponding author), Univ South Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD 57105 USA.	peter.vitiello@sanfordhealth.org	Booze, Michelle/AFV-2351-2022	Booze, Michelle/0000-0001-9581-0652; Vitiello, Peter/0000-0001-5344-9192	National Institutes of Health [P20GM103620, R25HD072596, P20GM103548]; National Science Foundation [1262744]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD072596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103620, P20GM103548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Institutes of Health P20GM103620 (PFV) and R25HD072596 (sponsorship of DRD) and the National Science Foundation 1262744 (sponsorship of RRW). We would also like to thank the Imaging and Flow Cytometry Cores at Sanford Research supported by the National Institutes of Health (P20GM103620, P20GM103548).	Asikainen TM, 2004, ANTIOXID REDOX SIGN, V6, P155, DOI 10.1089/152308604771978462; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Berger J, 2014, AM J PHYSIOL-LUNG C, V307, pL936, DOI 10.1152/ajplung.00159.2014; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brown KK, 2010, FEBS LETT, V584, P1257, DOI 10.1016/j.febslet.2010.02.042; Buccellato LJ, 2004, J BIOL CHEM, V279, P6753, DOI 10.1074/jbc.M310145200; Budinger GRS, 2011, AM J RESP CRIT CARE, V183, P1043, DOI 10.1164/rccm.201002-0181OC; Budinger GRS, 2002, J BIOL CHEM, V277, P15654, DOI 10.1074/jbc.M109317200; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Castillo R L, 2015, Open Respir Med J, V9, P83, DOI 10.2174/1874306401509010083; Chen FQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061999; Chen Y, 2002, J BIOL CHEM, V277, P33242, DOI 10.1074/jbc.M202026200; Chow CW, 2003, AM J RESP CELL MOL, V29, P427, DOI 10.1165/rcmb.F278; Cox AG, 2010, METHOD ENZYMOL, V474, P51, DOI 10.1016/S0076-6879(10)74004-0; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Cox AG, 2009, BIOCHEMISTRY-US, V48, P6495, DOI 10.1021/bi900558g; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Damdimopoulos AE, 2002, J BIOL CHEM, V277, P33249, DOI 10.1074/jbc.M203036200; Das KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073358; Del Riccio V, 2004, PEDIATR RES, V55, P183, DOI 10.1203/01.PDR.0000103930.93849.B2; Deponte M, 2015, BIOL CHEM, V396, P401, DOI 10.1515/hsz-2014-0280; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Eriksson SE, 2009, FREE RADICAL BIO MED, V47, P1661, DOI 10.1016/j.freeradbiomed.2009.09.016; Floen MJ, 2014, FREE RADICAL BIO MED, V75, P167, DOI 10.1016/j.freeradbiomed.2014.07.023; Flynn JM, 2013, FREE RADICAL BIO MED, V62, P4, DOI 10.1016/j.freeradbiomed.2013.05.027; GIACCONE G, 1992, CANCER RES, V52, pS2732; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Go Y. M., 2009, CURR PROTOC TOXICOL, V17, P12, DOI DOI 10.1002/0471140856.TX1712S41; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Halvey PJ, 2005, BIOCHEM J, V386, P215, DOI 10.1042/BJ20041829; Hansen JM, 2006, TOXICOL SCI, V91, P643, DOI 10.1093/toxsci/kfj175; Hattori F, 2003, J NEUROCHEM, V86, P860, DOI 10.1046/j.1471-4159.2003.01918.x; He M, 2008, TOXICOL SCI, V105, P44, DOI 10.1093/toxsci/kfn116; Ho YS, 1997, J BIOL CHEM, V272, P16644, DOI 10.1074/jbc.272.26.16644; Ho YS, 2002, AM J RESP CRIT CARE, V166, pS51, DOI 10.1164/rccm.2206017; Huang QH, 2015, CIRCULATION, V131, P1082, DOI 10.1161/CIRCULATIONAHA.114.012725; Hutten Matthias C, 2016, Mol Cell Pediatr, V3, P15, DOI 10.1186/s40348-016-0043-9; Jorgenson TC, 2013, CANCER RES, V73, P6118, DOI 10.1158/0008-5472.CAN-13-1117; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Karlenius Therese Christina, 2010, Cancers (Basel), V2, P209, DOI 10.3390/cancers2020209; Kipp AP, 2012, BBA-GEN SUBJECTS, V1820, P1588, DOI 10.1016/j.bbagen.2012.05.016; Li J, 2004, FREE RADICAL BIO MED, V36, P1460, DOI 10.1016/j.freeradbiomed.2004.03.005; Li LF, 2007, CRIT CARE, V11, DOI 10.1186/cc5704; Li Z, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-54; Lim PLK, 2008, TOXICOL SCI, V101, P341, DOI 10.1093/toxsci/kfm273; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Makena PS, 2012, AM J RESP CELL MOL, V46, P461, DOI 10.1165/rcmb.2011-0234OC; McGrath-Morrow SA, 2001, AM J RESP CELL MOL, V25, P150, DOI 10.1165/ajrcmb.25.2.4362; Mirza H, 2014, J PEDIATR-US, V165, P909, DOI 10.1016/j.jpeds.2014.07.040; Mourani PM, 2015, AM J RESP CRIT CARE, V191, P87, DOI 10.1164/rccm.201409-1594OC; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Petrache I, 1999, AM J PHYSIOL-LUNG C, V277, pL589, DOI 10.1152/ajplung.1999.277.3.L589; Phillips NR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03887; Rasola A, 2014, CELL CALCIUM, V56, P437, DOI 10.1016/j.ceca.2014.10.003; Resseguie EA, 2015, REDOX BIOL, V5, P176, DOI 10.1016/j.redox.2015.04.012; Riemer J, 2015, BIOL CHEM, V396, P465, DOI 10.1515/hsz-2014-0293; Rigobello MP, 2002, BRIT J PHARMACOL, V136, P1162, DOI 10.1038/sj.bjp.0704823; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Staversky RJ, 2010, AM J RESP CELL MOL, V43, P376, DOI 10.1165/rcmb.2009-0165OC; Sun HY, 2015, FEBS J, V282, P2758, DOI 10.1111/febs.13324; Tipple TE, 2009, AM J RESP CELL MOL, V41, P612, DOI 10.1165/rcmb.2008-0224OC; Tolle LB, 2013, J PATHOL, V229, P145, DOI 10.1002/path.4124; Tomanek L, 2015, J EXP BIOL, V218, P1867, DOI 10.1242/jeb.116475; Tsan MF, 1998, AM J RESP CELL MOL, V19, P114, DOI 10.1165/ajrcmb.19.1.3066; Vitiello PF, 2008, FREE RADICAL BIO MED, V44, P367, DOI 10.1016/j.freeradbiomed.2007.09.021; Vitiello PF, 2006, AM J PATHOL, V168, P1838, DOI 10.2353/ajpath.2006.051162; Vitiello PF, 2009, FREE RADICAL BIO MED, V46, P33, DOI 10.1016/j.freeradbiomed.2008.09.022; Wang DM, 2006, J BIOL CHEM, V281, P7384, DOI 10.1074/jbc.M509876200; Ward PA, 2010, ANN NY ACAD SCI, V1203, P53, DOI 10.1111/j.1749-6632.2010.05552.x; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yee M, 2006, AM J PHYSIOL-LUNG C, V291, pL1101, DOI 10.1152/ajplung.00126.2006; Yee M, 2014, AM J RESP CELL MOL, V50, P757, DOI 10.1165/rcmb.2013-0207OC; Yee M, 2011, AM J PATHOL, V178, P2601, DOI 10.1016/j.ajpath.2011.02.010; Yee M, 2009, AM J PHYSIOL-LUNG C, V297, pL641, DOI 10.1152/ajplung.00023.2009; Zhang H, 2007, ARCH BIOCHEM BIOPHYS, V465, P119, DOI 10.1016/j.abb.2007.05.001; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7	81	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168777	10.1371/journal.pone.0168777	http://dx.doi.org/10.1371/journal.pone.0168777			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045936	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300053
J	Lange, D; Calixto, ES; Del-Claro, K				Lange, Denise; Calixto, Eduardo Soares; Del-Claro, Kleber			Variation in Extrafloral Nectary Productivity Influences the Ant Foraging	PLOS ONE			English	Article							SECRETION; HERBIVORE; COMMUNITY; PATTERNS; ECOLOGY; PLANTS; MEMBRACIDAE; HYMENOPTERA; VEGETATION; POPULATION	Extrafloral nectar is the main food source offered by plants to predatory ants in most land environments. Although many studies have demonstrated the importance of extrafloral nectaries (EFNs) to plant defense against herbivores, the influence of EFNs secretory activity pattern on predatory ants remains yet not fully understood. Here, we verified the relation between the extrafloral nectar production of a plant community in Cerrado in different times of the day, and its attractiveness to ants. The extrafloral nectaries (EFNs) of seven plant species showed higher productivity overnight. Ant abundance was higher in times of large extrafloral nectar production, however, there was no positive relation between ant richness on plants and EFNs productivity. There was temporal resource partitioning among ant species, and it indicates strong resource competition. The nectar productivity varied among plant species and time of the day, and it influenced the visitation patterns of ants. Therefore, EFNs are a key ant-plant interaction driver in the studied system.	[Lange, Denise] Univ Tecnol Fed Parana, Campus Santa Helena, Santa Helena, PR, Brazil; [Calixto, Eduardo Soares] Univ Sao Paulo, Fac Filosofia Ciencias & Letras, Posgrad Entomol, Ribeirao Preto, SP, Brazil; [Del-Claro, Kleber] Univ Fed Uberlandia, Inst Biol, LECI, Uberlandia, MG, Brazil	Universidade Tecnologica Federal do Parana; Universidade de Sao Paulo; Universidade Federal de Uberlandia	Del-Claro, K (corresponding author), Univ Fed Uberlandia, Inst Biol, LECI, Uberlandia, MG, Brazil.	delclaro@ufu.br	Soares, Eduardo C/A-2728-2019; Soares, Eduardo Calixto/O-2528-2019; Del-Claro, K/C-5570-2013; Del-Claro, Kleber/N-3700-2019	Soares, Eduardo C/0000-0003-3617-2464; Soares, Eduardo Calixto/0000-0003-3617-2464; Del-Claro, K/0000-0001-8886-9568; 				Aguirre A, 2013, FLORA, V208, P147, DOI 10.1016/j.flora.2013.02.008; Albrecht M, 2001, OECOLOGIA, V126, P134, DOI 10.1007/s004420000494; Alves-Silva E, 2016, SOCIOBIOLOGY, V63, P705, DOI 10.13102/sociobiology.v63i1.908; Appolinario V., 2002, Boletim do Herbario Ezechias Paulo Heringer, V10, P57; Bachtold A, 2014, ENTOMOL SCI, V17, P66, DOI 10.1111/ens.12038; Belchior C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158283; BENTLEY BL, 1977, J ECOL, V65, P27, DOI 10.2307/2259060; Bixenmann RJ, 2011, OECOLOGIA, V165, P417, DOI 10.1007/s00442-010-1787-x; Bluthgen N, 2000, OECOLOGIA, V125, P229, DOI 10.1007/s004420000449; Bluthgen N, 2004, AUSTRAL ECOL, V29, P418, DOI 10.1111/j.1442-9993.2004.01380.x; Bluthgen N, 2004, ECOLOGY, V85, P1479, DOI 10.1890/03-0430; BOLTEN AB, 1979, OECOLOGIA, V41, P301, DOI 10.1007/BF00377434; Bonser R, 1998, ECOL ENTOMOL, V23, P15, DOI 10.1046/j.1365-2311.1998.00103.x; Breed MD, 1996, J INSECT BEHAV, V9, P659, DOI 10.1007/BF02213547; BREED MD, 1987, BEHAV ECOL SOCIOBIOL, V20, P407, DOI 10.1007/BF00302983; Byk J, 2011, POPUL ECOL, V53, P327, DOI 10.1007/s10144-010-0240-7; Calixto ES, 2015, FLORA, V212, P19, DOI 10.1016/j.flora.2015.02.001; Cerda X, 1998, FUNCT ECOL, V12, P45, DOI 10.1046/j.1365-2435.1998.00160.x; Choate BA, 2013, BIOCONTROL, V58, P359, DOI 10.1007/s10526-012-9501-z; Dafni A, 2005, PRACTICAL POLLINATIO, P503; Dattilo W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099838; Davidson Diane W., 1993, Journal of Hymenoptera Research, V2, P13; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; Dejean A, 1997, ECOSCIENCE, V4, P446, DOI 10.1080/11956860.1997.11682422; Del-Claro K, 1999, BIOTROPICA, V31, P135, DOI 10.2307/2663967; Del-Claro K, 2016, INSECT SOC, V63, P207, DOI 10.1007/s00040-016-0466-2; Del-Claro K, 2015, BIOTROPICA, V47, P459, DOI 10.1111/btp.12227; Eichhorn SE, 2014, BIOL VEGETAL; Elias T. S., 1983, The biology of nectaries, P174; Fagundes R, 2013, SOCIOBIOLOGY, V60, P11; Floren A, 2000, OECOLOGIA, V123, P129, DOI 10.1007/s004420050998; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Heil M, 2000, FUNCT ECOL, V14, P749, DOI 10.1046/j.1365-2435.2000.00480.x; Heil M, 2015, ANNU REV ENTOMOL, V60, P213, DOI 10.1146/annurev-ento-010814-020753; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; Holland JN, 2010, ECOLOGY, V91, P1286, DOI 10.1890/09-1163.1; Holldobler B., 1990, pi; Hossaert-McKey M, 2001, ECOSCIENCE, V8, P325, DOI 10.1080/11956860.2001.11682660; Jones IM, 2015, AM J BOT, V102, P58, DOI 10.3732/ajb.1400381; KOPTUR S, 1994, BIOTROPICA, V26, P276, DOI 10.2307/2388848; Koptur Suzanne, 1992, P81; Korndorfer AP, 2006, BIOTROPICA, V38, P786, DOI 10.1111/j.1744-7429.2006.00200.x; Lange D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105574; Lange D, 2013, ECOL ENTOMOL, V38, P463, DOI 10.1111/een.12036; Leiss KA, 2005, BASIC APPL ECOL, V6, P317, DOI 10.1016/j.baae.2005.02.006; LEVINGS SC, 1983, ECOL MONOGR, V53, P435, DOI 10.2307/1942647; Machado SR, 2008, PLANT BIOLOGY, V10, P660, DOI 10.1111/j.1438-8677.2008.00068.x; Marazzi B, 2013, ANN BOT-LONDON, V111, P1243, DOI 10.1093/aob/mct109; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; Mitchell RJ, 2004, ECOLOGY, V85, P1527, DOI 10.1890/03-0388; Nahas L, 2012, BIOTROPICA, V44, P498, DOI 10.1111/j.1744-7429.2011.00850.x; Ness JH, 2009, ECOLOGY, V90, P2823, DOI 10.1890/08-1580.1; Nicolson S.W., 2007, NECTARIES NECTAR; Nicolson SW, 2005, INT J PLANT SCI, V166, P227, DOI 10.1086/427616; ODOWD DJ, 1979, OECOLOGIA, V43, P233, DOI 10.1007/BF00344773; OLIVEIRA PS, 1987, BIOTROPICA, V19, P140, DOI 10.2307/2388736; Pereira MF, 2013, ACTA OECOL, V51, P49, DOI 10.1016/j.actao.2013.05.012; Petanidou Theodora, 2007, P343, DOI 10.1007/978-1-4020-5937-7_8; Reu WF, 2005, NEOTROP ENTOMOL, V34, P357, DOI 10.1590/S1519-566X2005000300001; Rhoades DF, 1979, HERBIVORES THEIR INT, P4; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; RISSING SW, 1984, BEHAV ECOL SOCIOBIOL, V15, P121, DOI 10.1007/BF00299379; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Schoereder Jose H., 2010, Terrestrial Arthropod Reviews, V3, P3, DOI 10.1163/187498310X487785; Stefani V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131843; SUDD JH, 1985, ECOL ENTOMOL, V10, P89, DOI 10.1111/j.1365-2311.1985.tb00538.x; Wackers FL, 2001, ANN BOT-LONDON, V87, P365, DOI 10.1006/anbo.2000.1342; Weber MG, 2013, ANN BOT-LONDON, V111, P1251, DOI 10.1093/aob/mcs225; Xu FF, 2014, ARTHROPOD-PLANT INTE, V8, P513, DOI 10.1007/s11829-014-9331-2; Zhang S, 2015, SCI REP	70	42	43	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169492	10.1371/journal.pone.0169492	http://dx.doi.org/10.1371/journal.pone.0169492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046069	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300200
J	Yang, L; Xu, JF; Kang, Q; Li, AQ; Jin, P; Wang, X; He, YQ; Li, N; Cheng, T; Sheng, JQ				Yang, Lang; Xu, Jun-Feng; Kang, Qian; Li, Ai-Qin; Jin, Peng; Wang, Xin; He, Yu-Qi; Li, Na; Cheng, Tao; Sheng, Jian-Qiu			Predictive Value of Sternness Factor Sox2 in Gastric Cancer Is Associated with Tumor Location and Stage	PLOS ONE			English	Article							STEM-LIKE CELLS; ALDEHYDE DEHYDROGENASE 1; ESOPHAGOGASTRIC JUNCTION; PROGNOSTIC VALUE; SOLID TUMORS; EXPRESSION; ADENOCARCINOMA; METASTASIS; MARKER; PROGRESSION	Cancer stem cells (CSCs) are thought to be the "root" of cancer. Although stemness-related factors ALDH1 A1 and Sox2 have been used as markers to identify gastric CSCs, the expression pattern and significance of these factors in gastric cancer have not been sufficiently demonstrated. In this study, the expressions of ALDH1 A1 and Sox2 were detected by immunohistochemistry in 122 gastric cancer specimens. And the correlation between Sox2 or ALDH1 A1 expression and clinicopathological parameters and overall survival data were analyzed. The positive rate of ALDH1 A1 expression was 60%, but there was no significant difference between survival rates of ALDH1 A1-positive and ALDH1 A1-negative patients. Sox2 was expressed in 42% of specimens and was associated with poor prognosis of patients (P= 0.015). Stratified analysis showed that Sox2 expression correlated with shorter lifespan only in patients with cardiac gastric cancers (P= 0.002) or stage I or II gastric cancers (P= 0.002); but not in patients with non-cardiac cancers (P= 0.556) or stage III or IV gastric cancers (P= 0.121). Analysis on a database cohort validated the correlation between Sox2 expression and poor prognosis in stage II cancer. Also, expression of Sox2 was associated with lymphnode metastasis in patients with cardiac gastric cancer (P= 0.037). A multivariate analysis revealed that Sox2 was an independent prognostic factor in cardiac gastric cancer. Our results indicate that predictive value of Sox2 in gastric cancer is associated with cardiac cancer location and with early cancer stages (I and II).	[Yang, Lang; Xu, Jun-Feng; Kang, Qian; Li, Ai-Qin; Jin, Peng; Wang, Xin; He, Yu-Qi; Li, Na; Cheng, Tao; Sheng, Jian-Qiu] PLA Army Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Xu, Jun-Feng] Peoples Liberat Army Gen Hosp, GraduateColl, Beijing, Peoples R China; [Cheng, Tao] PLA Army Gen Hosp, Dept Pathol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Yang, L; Sheng, JQ (corresponding author), PLA Army Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China.	yanglang2009@126.com; jianqiu@263.net	Yang, Lang/AAL-3025-2020; yang, lang/ABA-2517-2021; Xu, Junfeng/GXF-1288-2022	Yang, Lang/0000-0002-5234-7394; Jin, Peng/0000-0001-6685-1906	National Natural Science Foundation of China [81402460]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (No. 81402460).	Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Brungs D, 2016, J GASTROENTEROL, V51, P313, DOI 10.1007/s00535-015-1125-5; Camilo V, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-753; Carrasco-Garcia E, 2016, AM J CANCER RES, V6, P701; Chen YS, 2016, J CANCER RES CLIN, V142, P1221, DOI 10.1007/s00432-016-2125-4; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Dechaphunkul A, 2012, CURR ONCOL, V19, P302, DOI 10.3747/co.19.1081; Du XM, 2016, J HUAZHONG U SCI-MED, V36, P305, DOI 10.1007/s11596-016-1584-9; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hasegawa S, 2010, GASTRIC CANCER, V13, P63, DOI 10.1007/s10120-010-0555-2; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Huang Q, 2011, MODERN PATHOL, V24, P138, DOI 10.1038/modpathol.2010.183; Hutz K, 2014, CARCINOGENESIS, V35, P942, DOI 10.1093/carcin/bgt410; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Katsuno Y, 2012, J PATHOL, V228, P391, DOI 10.1002/path.4020; Kunju LP, 2011, MODERN PATHOL, V24, P786, DOI 10.1038/modpathol.2011.8; Li K, 2014, WORLD J GASTROENTERO, V20, P5420, DOI 10.3748/wjg.v20.i18.5420; Li N, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0433-6; Li XS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-705; Lin SC, 2014, HEPATO-GASTROENTEROL, V61, P1274, DOI 10.5754/hge14079; Liu K, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001386; Martin-Richard M, 2015, CLIN TRANSL ONCOL, V17, P996, DOI 10.1007/s12094-015-1456-y; Matsuoka J, 2012, J SURG RES, V174, P130, DOI 10.1016/j.jss.2010.11.903; Nguyen PH, 2016, ONCOGENE, V35, P5619, DOI 10.1038/onc.2016.87; Nishii T, 2009, CANCER SCI, V100, P1397, DOI 10.1111/j.1349-7006.2009.01211.x; Nishikawa S, 2013, INT J ONCOL, V42, P1437, DOI 10.3892/ijo.2013.1837; Otsubo T, 2008, BRIT J CANCER, V98, P824, DOI 10.1038/sj.bjc.6604193; Patel Purvi, 2012, Front Endocrinol (Lausanne), V3, P125, DOI 10.3389/fendo.2012.00125; Shen JX, 2016, ONCOTARGET; Shiraishi N, 2007, J SURG ONCOL, V96, P14, DOI 10.1002/jso.20631; Siewert JR, 2005, J SURG ONCOL, V90, P139, DOI 10.1002/jso.20218; Singh SR, 2013, CANCER LETT, V338, P110, DOI 10.1016/j.canlet.2013.03.035; Stojnev S, 2014, GASTRIC CANCER, V17, P13, DOI 10.1007/s10120-013-0254-x; Tian T, 2012, J BIOMED RES, V26, P336, DOI 10.7555/JBR.26.20120045; Tirino V, 2013, FASEB J, V27, P13, DOI 10.1096/fj.12-218222; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001; Vasiliou V, 2000, CHEM-BIOL INTERACT, V129, P1, DOI 10.1016/S0009-2797(00)00211-8; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wakamatsu Y, 2012, PATHOL INT, V62, P112, DOI 10.1111/j.1440-1827.2011.02760.x; Wang SM, 2015, CANCER LETT, V358, P210, DOI 10.1016/j.canlet.2014.12.045; Weina K, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-19; Xue ZF, 2012, J CELL BIOCHEM, V113, P302, DOI 10.1002/jcb.23356; Yang L, 2014, MODERN PATHOL, V27, P775, DOI 10.1038/modpathol.2013.189; Yang L, 2011, CANCER LETT, V310, P46, DOI 10.1016/j.canlet.2011.06.003; Zhang GF, 2016, EUR REV MED PHARMACO, V20, P2045; Zhi QM, 2011, BIOMED PHARMACOTHER, V65, P509, DOI 10.1016/j.biopha.2011.06.006; Zhou YN, 2008, CANCER LETT, V269, P18, DOI 10.1016/j.canlet.2008.04.013	48	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169124	10.1371/journal.pone.0169124	http://dx.doi.org/10.1371/journal.pone.0169124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046028	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300121
J	Finetti, F; Terzuoli, E; Donnini, S; Uva, M; Ziche, M; Morbidelli, L				Finetti, Federica; Terzuoli, Erika; Donnini, Sandra; Uva, Marianna; Ziche, Marina; Morbidelli, Lucia			Monitoring Endothelial and Tissue Responses to Cobalt Ferrite Nanoparticles and Hybrid Hydrogels	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; POLYSACCHARIDE-BASED HYDROGELS; MAGNETIC NANOPARTICLES; SYSTEM	Iron oxide nanoparticles (NPs) have been proposed for many biomedical applications as in vivo imaging and drug delivery in cancer treatment, but their toxicity is an ongoing concern. When NPs are intravenously administered, the endothelium represents the first barrier to tissue diffusion/penetration. However, there is little information about the biological effects of NPs on endothelial cells. In this work we showed that cobalt-ferrite (CoFe2O4) NPs affect endothelial cell integrity by increasing permeability, oxidative stress, inflammatory profile and by inducing cytoskeletal modifications. To overcome these problems, NPs have be loaded into biocompatible gels to form nanocomposite hybrid material (polysaccharide hydrogels containing magnetic NPs) that can be further conjugated with anticancer drugs to allow their release close to the target. The organic part of hybrid biomaterials is a carboxymethylcellulose (CMC) polymer, while the inorganic part consists of CoFe2O4 NPs coated with (3-aminopropyl) trimethoxysilane. The biological activity of these hybrid hydrogels was evaluated in vitro and in vivo. Our findings showed that hybrid hydrogels, instead of NPs alone, were not toxic on endothelial, stromal and epithelial cells, safe and biodegradable in vivo. In conclusion, biohydrogels with paramagnetic NPs as cross-linkers can be further exploited for antitumor drug loading and delivery systems.	[Finetti, Federica; Terzuoli, Erika; Donnini, Sandra; Ziche, Marina; Morbidelli, Lucia] Univ Siena, Dept Life Sci, Siena, Italy; [Uva, Marianna] Univ Siena, Dept Biotechnol Chem & Pharm, Siena, Italy	University of Siena; University of Siena	Finetti, F (corresponding author), Univ Siena, Dept Life Sci, Siena, Italy.	finetti2@unisi.it	Morbidelli, Lucia/AAC-7858-2020; Donnini, Sandra/K-9252-2019; Finetti, Federica/J-9089-2016; Terzuoli, Erika/M-7346-2016	Donnini, Sandra/0000-0001-6617-1644; Finetti, Federica/0000-0003-1144-3360; Ziche, Marina/0000-0002-9564-214X; Terzuoli, Erika/0000-0001-9248-4505	M.I.U.R. (Ministero Istruzione, Universita e Ricerca)	M.I.U.R. (Ministero Istruzione, Universita e Ricerca)(Ministry of Education, Universities and Research (MIUR))	The authors thank the M.I.U.R. (Ministero Istruzione, Universita e Ricerca) for financial support for the project "Strategies for engineering ferromagnetic nanoparticles as cross-linkers of polymer chains: application as a targeted drug delivery system in primary and secondary bone tumors", (F.I.R.B. project RBAP11ZJFA, 2010) and Istituto Toscano Tumori (ITT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri S, 2013, Mater Sci Eng C Mater Biol Appl, V33, P1, DOI 10.1016/j.msec.2012.09.003; Astanina K, 2014, ACTA BIOMATER, V10, P4896, DOI 10.1016/j.actbio.2014.07.027; Baldi G, 2007, J MAGN MAGN MATER, V311, P10, DOI 10.1016/j.jmmm.2006.11.157; Barbucci R, 2012, ACTA BIOMATER, V8, P4244, DOI 10.1016/j.actbio.2012.09.006; Barbucci R, 2011, SOFT MATTER, V7, P5558, DOI 10.1039/c1sm05174a; Barrefelt A, 2013, INT J NANOMED, V8, P3241, DOI 10.2147/IJN.S49948; De Jong WH, 2008, INT J NANOMED, V3, P133, DOI 10.2147/ijn.s596; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Donnini S, 2007, FASEB J, V21, P2418, DOI 10.1096/fj.06-7581com; Giani G, 2012, POLYMERS-BASEL, V4, P1157, DOI 10.3390/polym4021157; Gobbo OL, 2015, THERANOSTICS, V5, P1249, DOI 10.7150/thno.11544; Grabbe S, 2016, NANOMEDICINE-UK, V11, P2621, DOI 10.2217/nnm-2016-0281; Hong SC, 2011, INT J NANOMED, V6, P3219, DOI 10.2147/IJN.S26355; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Liang YY, 2007, CHEMPHYSCHEM, V8, P2367, DOI 10.1002/cphc.200700359; Liu HX, 2009, INT J PHARMACEUT, V376, P92, DOI 10.1016/j.ijpharm.2009.04.031; Mahmoudi M, 2009, J PHYS CHEM C, V113, P8124, DOI 10.1021/jp900798r; Monti M, 2014, J PHARMACOL EXP THER, V351, P500, DOI 10.1124/jpet.114.218404; Monti M, 2010, J MOL CELL CARDIOL, V48, P746, DOI 10.1016/j.yjmcc.2009.11.002; Morbidelli Lucia, 2016, Cardiooncology, V2, P3, DOI 10.1186/s40959-016-0010-6; Pasqui D, 2012, POLYMERS-BASEL, V4, P1517, DOI 10.3390/polym4031517; Pasqui D, 2011, MATER LETT, V65, P392, DOI 10.1016/j.matlet.2010.10.053; Schexnailder P, 2009, COLLOID POLYM SCI, V287, P1, DOI 10.1007/s00396-008-1949-0; Sivakumar B, 2013, LANGMUIR, V29, P3453, DOI 10.1021/la305048m; Uva M., 2014, J BIOMATER NANOBIOTE, V05, P116, DOI [10.4236/jbnb.2014.52014, DOI 10.4236/JBNB.2014.52014]; Uva M, 2015, GELS-BASEL, V1, P24, DOI 10.3390/gels1010024; Weng LH, 2013, ACTA BIOMATER, V9, P6823, DOI 10.1016/j.actbio.2013.02.017; Wu XY, 2010, INT J NANOMED, V5, P385	28	20	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168727	10.1371/journal.pone.0168727	http://dx.doi.org/10.1371/journal.pone.0168727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036325	Green Published, gold, Green Submitted			2022-12-26	WOS:000391229300023
J	Owen, J; McEwan, C; Nesbitt, H; Bovornchutichai, P; Averre, R; Borden, M; McHale, AP; Callan, JF; Stride, E				Owen, Joshua; McEwan, Conor; Nesbitt, Heather; Bovornchutichai, Phurit; Averre, Raymond; Borden, Mark; McHale, Anthony P.; Callan, John F.; Stride, Eleanor			Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles	PLOS ONE			English	Article							THERAPY; MICROBUBBLES; CANCER; HEAD; CELL	Hypoxia has been shown to be a key factor inhibiting the successful treatment of solid tumours. Existing strategies for reducing hypoxia, however, have shown limited efficacy and/or adverse side effects. The aim of this study was to investigate the potential for reducing tumour hypoxia using an orally delivered suspension of surfactant-stabilised oxygen nanobubbles. Experiments were carried out in a mouse xenograft tumour model for human pancreatic cancer (BxPc-3 cells in male SCID mice). A single dose of 100 mu L of oxygen saturated water, oxygen nanobubbles or argon nanobubbles was administered via gavage. Animals were sacrificed 30 minutes post-treatment (3 per group) and expression of hypoxia-inducible-factor-1 alpha (H1F1 alpha) protein measured by real time quantitative polymerase chain reaction and Western blot analysis of the excised tumour tissue. Neither the oxygen saturated water nor argon nanobubbles produced a statistically significant change in H1F1 alpha expression at the transcriptional level. In contrast, a reduction of 75% and 25% in the transcriptional and translational expression of H1F1 alpha respectively (p<0.001) was found for the animals receiving the oxygen nanobubbles. This magnitude of reduction has been shown in previous studies to be commensurate with an improvement in outcome with both radiation and drug-based treatments. In addition, there was a significant reduction in the expression of vascular endothelial growth factor (VEGF) in this group and corresponding increase in the expression of arrest-defective protein 1 homolog A (ARD1A).	[Owen, Joshua; Bovornchutichai, Phurit; Stride, Eleanor] Univ Oxford, Oxford Inst Biomed Engn, Oxford, England; [McEwan, Conor; Nesbitt, Heather; McHale, Anthony P.; Callan, John F.] Univ Ulster, Biomed Sci Res Inst, Coleraine, Londonderry, North Ireland; [Averre, Raymond] Avrox Technol Ltd Copgrove, Harrogate, N Yorkshire, England; [Borden, Mark] Univ Colorado, Dept Mech Engn, 1111 Engn Dr, Boulder, CO 80309 USA	University of Oxford; Ulster University; University of Colorado System; University of Colorado Boulder	Stride, E (corresponding author), Univ Oxford, Oxford Inst Biomed Engn, Oxford, England.	eleanor.stride@eng.ox.ac.uk	McHale, Anthony/M-4729-2019	McHale, Anthony/0000-0003-2397-648X; Stride, Eleanor/0000-0003-3371-5929	Engineering and Physical Sciences Research Council [EP/I021795/1]; EPSRC [EP/I021795/1] Funding Source: UKRI; Cancer Research UK [21892] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK)	The authors thank the Engineering and Physical Sciences Research Council for supporting this work through EP/I021795/1 and the Impact Acceleration Scheme (https://www.epsrc.acuk). John Callan thanks Norbrook Laboratories Ltd. for an endowed chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Raymond Averre is a director of Avrox Technologies Ltd. but neither he nor any other associate of Avrox Technologies Ltd. had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Brown JM, 2000, MOL MED TODAY, V6, P157, DOI 10.1016/S1357-4310(00)01677-4; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; DUBROVSKII V I, 1982, Voprosy Pitaniya, P29; Feshitan JA, 2014, BIOMATERIALS, V35, P2600, DOI 10.1016/j.biomaterials.2013.12.070; Hampson NP N, 2003, J AM MED ASS, V290; Henk JM, 2003, RADIOTHER ONCOL, V66, P65, DOI 10.1016/S0167-8140(02)00284-0; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Kheir JN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003679; Lee MN, 2010, J NATL CANCER I, V102, P426, DOI 10.1093/jnci/djq026; Martin DS, 2013, CRIT CARE MED, V41, P423, DOI 10.1097/CCM.0b013e31826a44f6; Matsutani N, 2010, SURG TODAY, V40, P451, DOI 10.1007/s00595-009-4104-8; McEwan C, 2015, J CONTROL RELEASE, V203, P51, DOI 10.1016/j.jconrel.2015.02.004; Nordsmark M, 1996, RADIOTHER ONCOL, V41, P31, DOI 10.1016/S0167-8140(96)91811-3; Ogawa Y, 2011, INT J ONCOL, V39, P553, DOI 10.3892/ijo.2011.1069; Owen J, 2015, ULTRASOUND MED BIOL, V41, P3253, DOI 10.1016/j.ultrasmedbio.2015.07.024; Rockwell S, 2009, CURR MOL MED, V9, P442, DOI 10.2174/156652409788167087; Sastry, 2000, Pharm Sci Technol Today, V3, P138; Sennoga CA, 2012, ULTRASOUND MED BIOL, V38, P834, DOI 10.1016/j.ultrasmedbio.2012.01.012; Stetsenko G S, 1975, Vrach Delo, P63; TEICHER BA, 1994, CANCER METAST REV, V13, P139, DOI 10.1007/BF00689633; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; VAUPEL P, 1989, CANCER RES, V49, P6449; Yarin YM, 2005, HEARING RES, V201, P1, DOI 10.1016/j.heares.2004.09.015; Yoshimura M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685308; ZANOZDRA N S, 1978, Vrachebnoe Delo, P25	26	33	34	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168088	10.1371/journal.pone.0168088	http://dx.doi.org/10.1371/journal.pone.0168088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036332	gold, Green Published, Green Submitted			2022-12-26	WOS:000391229300011
J	Broxton, CN; Culotta, VC				Broxton, Chynna N.; Culotta, Valeria C.			An Adaptation to Low Copper in Candida albicans Involving SOD Enzymes and the Alternative Oxidase	PLOS ONE			English	Article							CONTAINING SUPEROXIDE-DISMUTASE; BOVINE HEART-MITOCHONDRIA; TRANSCRIPTIONAL REGULATION; SACCHAROMYCES-CEREVISIAE; INTERMEMBRANE SPACE; RESPIRATORY PATHWAYS; PHYSIOLOGICAL-ROLE; TRANSGENIC MICE; CHAPERONE CCS; GENE	In eukaryotes, the Cu/Zn superoxide dismutase (SOD1) is a major cytosolic cuproprotein with a small fraction residing in the mitochondrial intermembrane space (IMS) to protect against respiratory superoxide. Curiously, the opportunistic human fungal pathogen Candida albicans is predicted to express two cytosolic SODs including Cu/Zn containing SOD1 and manganese containing SOD3. As part of a copper starvation response, C. albicans represses SOD1 and induces the non-copper alternative SOD3. While both SOD1 and SOD3 are predicted to exist in the same cytosolic compartment, their potential role in mitochondrial oxidative stress had yet to be investigated. We show here that under copper replete conditions, a fraction of the Cu/Zn containing SOD1 localizes to the mitochondrial IMS to guard against mitochondrial superoxide. However in copper starved cells, localization of the manganese containing SOD3 is restricted to the cytosol leaving the mitochondrial IMS devoid of SOD. We observe that during copper starvation, an alternative oxidase (AOX) form of respiration is induced that is not coupled to ATP synthesis but maintains mitochondrial superoxide at low levels even in the absence of IMS SOD. Surprisingly, the copper-dependent cytochrome c oxidase (COX) form of respiration remains high with copper starvation. We provide evidence that repression of SOD1 during copper limitation serves to spare copper for COX and maintain COX respiration. Overall, the complex copper starvation response of C. albicans involving SOD1, SOD3 and AOX minimizes mitochondrial oxidative damage whilst maximizing COX respiration essential for fungal pathogenesis.	[Broxton, Chynna N.; Culotta, Valeria C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Culotta, VC (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA.	vculott1@jhu.edu			NIH [R01 AI119949, T32 CA009110, F31 GM1136]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI119949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM113637] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01 AI119949, T32 CA009110, and F31 GM1136. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abreu IA, 2010, BBA-PROTEINS PROTEOM, V1804, P263, DOI 10.1016/j.bbapap.2009.11.005; Allen MD, 2007, PLANT PHYSIOL, V143, P263, DOI 10.1104/pp.106.088609; Becker JM, 2010, P NATL ACAD SCI USA, V107, P22044, DOI 10.1073/pnas.1009845107; BENOV L, 1995, ARCH BIOCHEM BIOPHYS, V319, P508, DOI 10.1006/abbi.1995.1324; Broxton CN, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005295; Chaudhuri M, 2006, TRENDS PARASITOL, V22, P484, DOI 10.1016/j.pt.2006.08.007; CULOTTA VC, 1995, J BIOL CHEM, V270, P29991; Cvetkovska M, 2012, NEW PHYTOL, V195, P32, DOI 10.1111/j.1469-8137.2012.04166.x; Dupont CL, 2008, ENVIRON MICROBIOL, V10, P1831, DOI 10.1111/j.1462-2920.2008.01604.x; Enriquez Rolando P. Hong, 2012, Life-Basel, V2, P274, DOI 10.3390/life2040274; Feng HQ, 2010, MOL PLANT PATHOL, V11, P429, DOI [10.1111/J.1364-3703.2010.00615.X, 10.1111/j.1364-3703.2010.00615.x]; Field LS, 2003, IMPACT COPPER ZINC S; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; Gleason JE, 2014, J BIOL INORG CHEM; Gleason JE GA, 2014, CANDIDA ALBICANS SOD; Goldsteins G, 2008, J BIOL CHEM; Grahl N, 2012, MOL MICROBIOL, V84, P383, DOI 10.1111/j.1365-2958.2012.08034.x; Helmerhorst EJ, 2005, MITOCHONDRION, V5, P200, DOI 10.1016/j.mito.2005.04.001; Helmerhorst EJ, 2002, BBA-BIOENERGETICS, V1556, P73, DOI 10.1016/S0005-2728(02)00308-0; Higgins CMJ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-16; Higgins CMJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-06-j0001.2002; Huh WK, 1999, J BACTERIOL, V181, P4098, DOI 10.1128/JB.181.13.4098-4102.1999; Huh WK, 2001, BIOCHEM J, V356, P595, DOI 10.1042/0264-6021:3560595; Hwang CS, 2003, YEAST, V20, P929, DOI 10.1002/yea.1004; Hwang CS, 2002, MICROBIOL-SGM, V148, P3705, DOI 10.1099/00221287-148-11-3705; Hwang CS, 1999, BBA-GEN SUBJECTS, V1427, P245, DOI 10.1016/S0304-4165(99)00020-3; Inarrea P, 2004, BIOCH J; Inarrea P, 2007, BIOCHEM J, V405, P173, DOI 10.1042/BJ20061809; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200; Joseph-Horne T, 2001, BBA-BIOENERGETICS, V1504, P179, DOI 10.1016/S0005-2728(00)00251-6; Kawamata H, 2010, ANTIOXID REDOX SIGN, V13, P1375, DOI 10.1089/ars.2010.3212; Kloppel C, 2011, MOL BIOL CELL, V22, P3749, DOI 10.1091/mbc.E11-04-0293; KRAB K, 1995, J BIOENERG BIOMEMBR, V27, P387, DOI 10.1007/BF02110001; Kropat J, 2015, P NATL ACAD SCI USA, V112, P2644, DOI 10.1073/pnas.1422492112; Lamarre C, 2001, J BIOL CHEM, V276, P43784, DOI 10.1074/jbc.M108095200; Li CX, 2015, P NATL ACAD SCI USA, V112, pE5336, DOI 10.1073/pnas.1513447112; Li DM, 2011, EUKARYOT CELL, V10, P672, DOI 10.1128/EC.00303-10; Li QH, 1996, GENETICS, V142, P129; Liao YWK, 2012, PLANTA, V235, P225, DOI 10.1007/s00425-011-1483-z; Luk E, 2005, J BIOL CHEM, V280, P22715, DOI 10.1074/jbc.M504257200; Martchenko M, 2004, MOL BIOL CELL, V15, P456, DOI 10.1091/mbc.E03-03-0179; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MERCHANT S, 1986, MOL CELL BIOL, V6, P462, DOI 10.1128/MCB.6.2.462; MERCHANT S, 1991, EMBO J, V10, P1383, DOI 10.1002/j.1460-2075.1991.tb07658.x; MINAGAWA N, 1992, FEBS LETT, V302, P217, DOI 10.1016/0014-5793(92)80444-L; MOORE AL, 1995, J BIOENERG BIOMEMBR, V27, P367, DOI 10.1007/BF02109999; Muller F.L, 2004, J BIOL CHEM; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Peterson RL, 2016, J BIOL CHEM; Reddehase S, 2009, J MOL BIOL, V385, P331, DOI 10.1016/j.jmb.2008.10.088; Reddi AR, 2013, CELL, V152, P224, DOI 10.1016/j.cell.2012.11.046; Sluse FE, 1998, BRAZ J MED BIOL RES, V31, P733, DOI 10.1590/S0100-879X1998000600003; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Tsang CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4446; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Vanlerberghe GC, 1997, ANNU REV PLANT PHYS, V48, P703, DOI 10.1146/annurev.arplant.48.1.703; Vemuri GN, 2007, P NATL ACAD SCI USA, V104, P2402, DOI 10.1073/pnas.0607469104; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; Wood LK, 2009, J BIOL CHEM, V284, P404, DOI 10.1074/jbc.M807027200; Woodacre A, 2008, MICROBIOL-SGM, V154, P1502, DOI 10.1099/mic.0.2007/013441-0; Yan L, 2009, J ANTIMICROB CHEMOTH, V64, P764, DOI 10.1093/jac/dkp273; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972	67	26	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168400	10.1371/journal.pone.0168400	http://dx.doi.org/10.1371/journal.pone.0168400			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033429	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900023
J	Domert, J; Sackmann, C; Severinsson, E; Agholme, L; Bergstrom, J; Ingelsson, M; Hallbeck, M				Domert, Jakob; Sackmann, Christopher; Severinsson, Emelie; Agholme, Lotta; Bergstrom, Joakim; Ingelsson, Martin; Hallbeck, Martin			Aggregated Alpha-Synuclein Transfer Efficiently between Cultured Human Neuron-Like Cells and Localize to Lysosomes	PLOS ONE			English	Article							AMYLOID-BETA PEPTIDE; PARKINSONS-DISEASE; CEREBROSPINAL-FLUID; IN-VIVO; PATHOLOGY; OLIGOMERS; MITOCHONDRIA; TRANSMISSION; AUTOPHAGY; PATHWAY	Parkinson's disease and other alpha-synucleinopathies are progressive neurodegenerative diseases characterized by aggregates of misfolded alpha-synuclein spreading throughout the brain. Recent evidence suggests that the pathological progression is likely due to neuron-to-neuron transfer of these aggregates between neuroanatomically connected areas of the brain. As the impact of this pathological spreading mechanism is currently debated, we aimed to investigate the transfer and subcellular location of alpha-synuclein species in a novel 3D co-culture human cell model based on highly differentiated SH-SY5Y cells. Fluorescently-labeled monomeric, oligomeric and fibrillar species of alpha-synuclein were introduced into a donor cell population and co-cultured with an EGFP-expressing acceptor-cell population of differentiated neuron-like cells. Subsequent transfer and colocalization of the different species were determined with confocal microscopy. We could confirm cell-to-cell transfer of all three alpha-synuclein species investigated. Interestingly the level of transferred oligomers and fibrils and oligomers were significantly higher than monomers, which could affect the probability of seeding and pathology in the recipient cells. Most alpha-synuclein colocalized with the lysosomal/endosomal system, both pre- and postsynaptically, suggesting its importance in the processing and spreading of alpha-synuclein.	[Domert, Jakob; Sackmann, Christopher; Severinsson, Emelie; Agholme, Lotta; Hallbeck, Martin] Linkoping Univ, Dept Clin Pathol, Linkoping, Sweden; [Domert, Jakob; Sackmann, Christopher; Severinsson, Emelie; Agholme, Lotta; Hallbeck, Martin] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Bergstrom, Joakim; Ingelsson, Martin] Uppsala Univ, Rudbeck Lab, Dept Publ Hlth Geriatr, Uppsala, Sweden; [Agholme, Lotta] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden	Linkoping University; Linkoping University; Uppsala University; University of Gothenburg	Hallbeck, M (corresponding author), Linkoping Univ, Dept Clin Pathol, Linkoping, Sweden.; Hallbeck, M (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	Martin.Hallbeck@liu.se		Agholme, Lotta/0000-0003-3816-7474; Hallbeck, Martin/0000-0001-6716-0314; Sackmann, Christopher/0000-0002-1273-6731	Swedish Research Council [MH: 523-2013-2735]; Swedish Brain Power Program; Research Foundation of the Swedish Parkinson's Disease Association; Ostergotland Research Foundation for Parkinson's Disease; Parkinson Research Foundation; Hans-Gabriel and Alice Trolle-Wachtmeister Foundation for Medical Research; Gustav V and Queen Victoria's Foundation; Swedish Dementia Foundation; Linkoping University Neurobiology Centre; County Council of Ostergotland; Marianne and Marcus Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Power Program; Research Foundation of the Swedish Parkinson's Disease Association; Ostergotland Research Foundation for Parkinson's Disease; Parkinson Research Foundation; Hans-Gabriel and Alice Trolle-Wachtmeister Foundation for Medical Research; Gustav V and Queen Victoria's Foundation; Swedish Dementia Foundation; Linkoping University Neurobiology Centre; County Council of Ostergotland; Marianne and Marcus Wallenberg Foundation	This research was made possible by funding from the Swedish Research Council (MH: 523-2013-2735), The Swedish Brain Power Program, The Research Foundation of the Swedish Parkinson's Disease Association, Ostergotland Research Foundation for Parkinson's Disease, Parkinson Research Foundation, the Hans-Gabriel and Alice Trolle-Wachtmeister Foundation for Medical Research, Gustav V and Queen Victoria's Foundation, Swedish Dementia Foundation, the Linkoping University Neurobiology Centre and the County Council of Ostergotland, Marianne and Marcus Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme L, 2014, MOL CELL NEUROSCI, V58, P29, DOI 10.1016/j.mcn.2013.11.001; Agholme L, 2012, J ALZHEIMERS DIS, V31, P343, DOI 10.3233/JAD-2012-120001; Agholme L, 2010, J ALZHEIMERS DIS, V20, P1069, DOI 10.3233/JAD-2010-091363; Alafuzoff I, 2009, ACTA NEUROPATHOL, V117, P635, DOI 10.1007/s00401-009-0523-2; Blanz J., 2016, J NEUROCHEM; Boassa D, 2013, J NEUROSCI, V33, P2605, DOI 10.1523/JNEUROSCI.2898-12.2013; Braak H, 1995, J NEURAL TRANSM-SUPP, P15; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chiasserini D, 2014, J PROTEOMICS, V106, P191, DOI 10.1016/j.jprot.2014.04.028; Choi BK, 2013, P NATL ACAD SCI USA, V110, P4087, DOI 10.1073/pnas.1218424110; Colla E, 2012, J NEUROSCI, V32, P3301, DOI 10.1523/JNEUROSCI.5368-11.2012; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Danzer KM, 2009, J NEUROCHEM, V111, P192, DOI 10.1111/j.1471-4159.2009.06324.x; DeWitt DC, 2013, BIOCHEMISTRY-US, V52, P2385, DOI 10.1021/bi4002369; Dhungel N, 2015, NEURON, V85, P76, DOI 10.1016/j.neuron.2014.11.027; Dimant Hemi, 2013, Acta Neuropathol Commun, V1, P6, DOI 10.1186/2051-5960-1-6; Domert J, 2014, NEUROBIOL DIS; Gan-Or Z, 2015, AUTOPHAGY, V11, P1443, DOI 10.1080/15548627.2015.1067364; Guardia-Laguarta C, 2014, J NEUROSCI, V34, P249, DOI 10.1523/JNEUROSCI.2507-13.2014; Holmqvist S, 2014, ACTA NEUROPATHOL, V128, P805, DOI 10.1007/s00401-014-1343-6; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Lebouvier T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012728; Lee HJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.45; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li WW, 2007, NEUROREPORT, V18, P1543, DOI 10.1097/WNR.0b013e3282f03db4; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Lindstrom V, 2014, IMMUNOTHERAPY-UK, V6, P141, DOI [10.2217/imt.13.162, 10.2217/IMT.13.162]; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Luth ES, 2014, J BIOL CHEM, V289, P21490, DOI 10.1074/jbc.M113.545749; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Miners JS, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0164-0; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Nasstrom T, 2011, FREE RADICAL BIO MED, V50, P428, DOI 10.1016/j.freeradbiomed.2010.11.027; Nath S, 2012, J NEUROSCI, V32, P8767, DOI 10.1523/JNEUROSCI.0615-12.2012; Perrett RM, 2015, MOL CELL NEUROSCI, V66, P21, DOI 10.1016/j.mcn.2015.02.009; Poehler AM, 2014, AUTOPHAGY, V10, P2171, DOI 10.4161/auto.36436; Raiss CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23116; Ravi M, 2015, J CELL PHYSIOL, V230, P16, DOI 10.1002/jcp.24683; Saido T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006379; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Small SA, 2015, NAT REV NEUROSCI, V16, P126, DOI 10.1038/nrn3896; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Zheng L, 2013, J ALZHEIMERS DIS, V37, P713, DOI 10.3233/JAD-122455	51	38	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168700	10.1371/journal.pone.0168700	http://dx.doi.org/10.1371/journal.pone.0168700			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030591	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000063
J	Bustamante, AE; Jaime-Perez, JC; Cordero-Perez, P; Galindo-Rodriguez, G; Munoz-Espinosa, LE; Villarreal-Villarreal, CD; Mercado-Longoria, R				Ester Bustamante, Adriana; Carlos Jaime-Perez, Jose; Cordero-Perez, Paula; Galindo-Rodriguez, Gabriela; Elsa Munoz-Espinosa, Linda; Daniel Villarreal-Villarreal, Cesar; Mercado-Longoria, Roberto			A High Level of Soluble CD40L Is Associated with P. aeruginosa Infection in Patients with Cystic Fibrosis	PLOS ONE			English	Article							MUCOID PSEUDOMONAS-AERUGINOSA; LUNG-DISEASE; SCORING SYSTEM; LIGAND LEVELS; CHILDREN; ACIDIFICATION; INFLAMMATION; MACROPHAGES; PROGRESSION; DIAGNOSIS	Objective The aim of this study was to evaluate whether the concentration of sCD40L, a product of platelet activation, correlates with the presence of Pseudomonas aeruginosa in the airway of patients with cystic fibrosis (CF) and to determine its possible clinical association. Methods Sixty patients with CF, ranging in age from 2 months to 36 years, were studied. The demographics, cystic fibrosis transmembrane conductance regulator (CFTR) genotype, spirometry measurements, radiographic and tomographic scans, platelet count in peripheral blood, sCD40L, IL-6, TNF-alpha and ICAM1 data were collected. Infection-colonization of the airway was evaluated using sputum and throat swab cultures; the levels of anti-Pseudomonas aeruginosa antibodies (Anti-PaAb) were evaluated. Results Patients with CF and chronic colonization had anti-PaAb values of 11.6 +/- 2.1 ELISA units (EU) and sCD40L in plasma of 1530.9 +/- 1162.3 pg/mL; those with intermittent infection had 5.7 +/- 2.7 EU and 2243.6 +/- 1475.9 pg/mL; and those who were never infected had 3.46 +/- 1.8 EU (p <= 0.001) and 1008.1 +/- 746.8 pg/ mL (p <= 0.01), respectively. The cutoff value of sCD40L of 1255 pg/ mL was associated with an area under the ROC (receiver operating characteristic curve) of 0.84 (95% CI, 0.71 to 0.97), reflecting P. aeruginosa infection with a sensitivity of 73% and a specificity of 89%. Lung damage was determined using the Brasfield Score, the Bhalla Score, and spirometry (FVC%, FEV1%) and found to be significantly different among the groups (p <= 0.001). Conclusion Circulating sCD40L levels are increased in patients with cystic fibrosis and P. aeruginosa infection. Soluble CD40L appears to reflect infection and provides a tool for monitoring the evolution of lung deterioration.	[Ester Bustamante, Adriana; Mercado-Longoria, Roberto] Univ Autonoma Nuevo Leon, Clin Fibrosis Quist, Hosp Univ Dr Jose E Gonzalez, Serv Neumol,Fac Med, Monterrey Nuevo Leon, Mexico; [Carlos Jaime-Perez, Jose; Daniel Villarreal-Villarreal, Cesar] Univ Autonoma Nuevo Leon, Dept Hematol, Hosp Univ Dr Jose E Gonzalez, Fac Med, Monterrey Nuevo Leon, Mexico; [Cordero-Perez, Paula; Elsa Munoz-Espinosa, Linda] Univ Autonoma Nuevo Leon, Unidad Higado, Hosp Univ Dr Jose E Gonzalez, Fac Med, Monterrey Nuevo Leon, Mexico; [Galindo-Rodriguez, Gabriela] Univ Autonoma Nuevo Leon, Serv Alergia & Inmunol, Hosp Univ Dr Jose E Gonzalez, Fac Med, Monterrey Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon	Bustamante, AE (corresponding author), Univ Autonoma Nuevo Leon, Clin Fibrosis Quist, Hosp Univ Dr Jose E Gonzalez, Serv Neumol,Fac Med, Monterrey Nuevo Leon, Mexico.	abustamante@ceprep.edu.mx	Cordero, Paula/AAF-6961-2020; Bustamante, Adriana Ester/AAR-2816-2021	Bustamante, Adriana Ester/0000-0002-8245-6671; Munoz, Linda/0000-0002-0455-9325; Villarreal-Villarreal, Cesar D/0000-0003-2432-2517; Cordero-Perez, Paula/0000-0001-7747-8895				BHALLA M, 1991, RADIOLOGY, V179, P783, DOI 10.1148/radiology.179.3.2027992; Blumberg N, 2009, IMMUNOL RES, V45, P251, DOI 10.1007/s12026-009-8106-9; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; BRASFIELD D, 1979, PEDIATRICS, V63, P24; Brodlie M, 2012, AM J RESP CRIT CARE, V185, P108, DOI 10.1164/ajrccm.185.1.108a; Brodlie M, 2011, AM J RESP CRIT CARE, V183, P133, DOI 10.1164/ajrccm.183.1.133; Brodlie M, 2010, AM J RESP CRIT CARE, V182, P369, DOI 10.1164/rccm.200905-0799OC; Cohen-Cymberknoh M, 2013, THORAX, V68, P1157, DOI 10.1136/thoraxjnl-2013-203204; COUTINHO IR, 1988, THROMB RES, V51, P495, DOI 10.1016/0049-3848(88)90115-6; Cystic Fibrosis Foundation, 2013, CYST FIBR FDN REG AN; Cystic Fibrosis Foundation, 2016, CLIN FUNCT TRASL CFT; da Silva LVF, 2007, PEDIATR PULM, V42, P938, DOI 10.1002/ppul.20686; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Douglas TA, 2009, EUR RESPIR J, V33, P305, DOI 10.1183/09031936.00043108; Falco A, 2004, J THROMB HAEMOST, V2, P557, DOI 10.1111/j.1538-7836.2004.00683.x; Farrell PM, 2009, RADIOLOGY, V252, P534, DOI 10.1148/radiol.2522081882; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Heijerman Harry, 2005, J Cyst Fibros, V4 Suppl 2, P3, DOI 10.1016/j.jcf.2005.05.005; HENRY RL, 1992, PEDIATR PULM, V12, P158, DOI 10.1002/ppul.1950120306; Hur YG, 2015, J INFECTION, V70, P346, DOI 10.1016/j.jinf.2014.10.019; Husson MO, 2005, J ANTIMICROB CHEMOTH, V56, P247, DOI 10.1093/jac/dki179; Koch C, 2002, PEDIATR PULM, V34, P232, DOI 10.1002/ppul.10135; KONIG B, 1994, INT ARCH ALLERGY IMM, V104, P33, DOI 10.1159/000236706; Kushwah R, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-138; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lamothe J, 2008, MICROBIOL-SGM, V154, P3825, DOI 10.1099/mic.0.2008/023200-0; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Li ZH, 2005, JAMA-J AM MED ASSOC, V293, P581, DOI 10.1001/jama.293.5.581; Lorente L, 2011, CRIT CARE, V15, DOI 10.1186/cc10104; Mauch RM, 2014, J CYST FIBROS, V13, P499, DOI 10.1016/j.jcf.2014.01.005; Metwalley Kotb Abbass, 2013, Indian J Endocrinol Metab, V17, P1024, DOI 10.4103/2230-8210.122617; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; O'Sullivan BP, 2005, BLOOD, V105, P4635, DOI 10.1182/blood-2004-06-2098; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Pittman JE, 2011, PEDIATR PULM, V46, P497, DOI 10.1002/ppul.21397; Regamey N, 2012, THORAX, V67, P170, DOI 10.1136/thoraxjnl-2011-200585; ROUM JH, 1993, J APPL PHYSIOL, V75, P2419, DOI 10.1152/jappl.1993.75.6.2419; Segal E, 2004, BUENOS AIRES EDICION, P5; Subauste CS, 2009, SEMIN IMMUNOL, V21, P273, DOI 10.1016/j.smim.2009.06.003; The Hospital for Sick Children, 2011, CYSTIC FIBROSIS MUTA; Tirouvanziam R, 2002, AM J PHYSIOL-LUNG C, V283, pL445, DOI 10.1152/ajplung.00419.2001	43	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168819	10.1371/journal.pone.0168819	http://dx.doi.org/10.1371/journal.pone.0168819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030642	Green Submitted, Green Published, gold			2022-12-26	WOS:000391222000079
J	Feng, XB; Pan, WY; Liu, L; Wu, M; Ding, FW; Hu, HX; Ding, X; Wei, H; Zou, YH; Qian, X; Wang, MM; Wu, J; Tao, J; Tan, J; Da, ZY; Zhang, MJ; Li, J; Sun, LY				Feng, Xuebing; Pan, Wenyou; Liu, Lin; Wu, Min; Ding, Fuwan; Hu, Huaixia; Ding, Xiang; Wei, Hua; Zou, Yaohong; Qian, Xian; Wang, Meimei; Wu, Jian; Tao, Juan; Tan, Jun; Da, Zhanyun; Zhang, Miaojia; Li, Jing; Sun, Lingyun		Jiangsu Lupus Collaborative Grp	Prognosis for Hospitalized Patients with Systemic Lupus Erythematosus in China: 5-Year Update of the Jiangsu Cohort	PLOS ONE			English	Article							REVISED CRITERIA; DISEASE-ACTIVITY; MORTALITY; NEPHRITIS; CLASSIFICATION; PREDICTORS; SURVIVAL; FEATURES; DAMAGE; INDEX	Objective To identify early signs associated with poor prognosis in Chinese patients with systemic lupus erythematosus (SLE) through a large population-based follow-up study. Methods Medical records of > 2,500 SLE patients that first hospitalized between 1999-2009 were collected from 26 centers across Jiangsu province, China, and entered into a database. These patients were followed-up for 5 to 15 years, and those remained contact and had known survival status in 2015 were assessed for the association of factors presented at the initial hospitalization with mortality at two time points (<= 1year and >1year). The independency of mortality factors was evaluated using multivariate Cox regression analysis. Results Among 1,372 patients we assessed, 92.3% were women and 17.2% were deceased in 2015. The main causes of death were infection (30.1%), neuropsychiatric impairment (14.8%), renal failure (14.4%) and cardiopulmonary involvement (8.5%). Hazard ratios (HR) of independent predictors for mortality (<= 1year and >1year, respectively) included hospital presentation of neuropsychiatric involvement (2.03 and 1.91), cardiopulmonary involvement (1.94 and 1.61) and increased serum creatinine (2.52 and 2.58). Patients older than 45 years and with disease durations more than 2 years at admission had unfavorable short-term outcome (HR 1.76 and 1.79), while the presence of anti-dsDNA and anti-Sm antibodies indicated diverse prognosis after 1 year (HR 1.60 and 0.45). Treatment with cyclophosphamide was beneficial for patient's first-year outcome (HR 0.50), and anti-malarial drugs significantly reduced the risk of mortality over different time points (HR 0.48 and 0.54). SLEDAI score, proteinuria or hypocomplementemia was not independently associated with the outcome in this cohort. Conclusion SLE patients presented with vital organ damages rather than active disease at initial hospitalization are likely to have a poor outcome, especially for those with neuropsychiatric, cardiopulmonary involvements and renal insufficiency. Early and effective intervention with the use of anti-malarial drugs may decrease mortality.	[Feng, Xuebing; Sun, Lingyun] Nanjing Univ Med Sch, Dept Rheumatol & Immunol, Affiliated Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; [Pan, Wenyou] Huaian First Peoples Hosp, Dept Rheumatol, Huaian, Peoples R China; [Liu, Lin] Xuzhou Cent Hosp, Dept Rheumatol, Xuzhou, Peoples R China; [Wu, Min] Soochow Univ, Dept Rheumatol, Affiliated Hosp 3, Changzhou, Peoples R China; [Ding, Fuwan] Yancheng Third Peoples Hosp, Dept Endocrinol, Yancheng, Peoples R China; [Hu, Huaixia] Lianyungang Second Peoples Hosp, Dept Rheumatol, Lianyungang, Peoples R China; [Ding, Xiang] Lianyungang First Peoples Hosp, Dept Rheumatol, Lianyungang, Peoples R China; [Wei, Hua] Northern Jiangsu Peoples Hosp, Dept Rheumatol, Yangzhou, Jiangsu, Peoples R China; [Zou, Yaohong] Wuxi Peoples Hosp, Dept Rheumatol, Wuxi, Peoples R China; [Qian, Xian] TCM, Dept Rheumatol, Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Meimei] Southeast Univ, Zhongda Hosp, Dept Rheumatol, Nanjing, Jiangsu, Peoples R China; [Wu, Jian] Soochow Univ, Dept Rheumatol, Affiliated Hosp 1, Suzhou, Peoples R China; [Tao, Juan] Wuxi TCM Hosp, Dept Rheumatol, Wuxi, Peoples R China; [Tan, Jun] Zhenjiang First Peoples Hosp, Dept Rheumatol, Zhenjiang, Peoples R China; [Da, Zhanyun] Nantong Univ, Dept Rheumatol, Affiliated Hosp, Nantong, Peoples R China; [Zhang, Miaojia] Jiangsu Prov Hosp, Dept Rheumatol, Nanjing, Jiangsu, Peoples R China; [Li, Jing] Jiangsu Univ, Dept Rheumatol, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China	Nanjing University; Soochow University - China; Jiangnan University; Nanjing Medical University; Southeast University - China; Soochow University - China; Nantong University; Nanjing Medical University; Jiangsu University	Feng, XB; Sun, LY (corresponding author), Nanjing Univ Med Sch, Dept Rheumatol & Immunol, Affiliated Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China.	fengxuebing@hotmail.com; lingyunsun@nju.edu.cn		Feng, Xuebing/0000-0002-9837-9690	National Natural Science Foundation of China [81373198]; Jiangsu Provincial Special Program of Medical Science [13E2015602]; Cinkate Corp	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Special Program of Medical Science; Cinkate Corp	This study was supported by National Natural Science Foundation of China (grant number 81373198 to XF), Jiangsu Provincial Special Program of Medical Science (13E2015602 to LS), and from Cinkate Corp (LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon GS, 2007, ANN RHEUM DIS, V66, P1168, DOI 10.1136/ard.2006.068676; Ayodele OE, 2010, NEPHROLOGY, V15, P482, DOI 10.1111/j.1440-1797.2010.01290.x; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Borchers AT, 2004, AUTOIMMUN REV, V3, P423, DOI 10.1016/j.autrev.2004.04.002; Cartella S, 2013, AUTOIMMUNITY, V46, P363, DOI 10.3109/08916934.2013.794793; Elfving P, 2014, LUPUS, V23, P1430, DOI 10.1177/0961203314543919; Feng XB, 2011, J RHEUMATOL, V38, P1289, DOI 10.3899/jrheum.101088; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hoi A, 2015, INT J RHEUM DIS, V18, P113, DOI 10.1111/1756-185X.12497; Jakes RW, 2012, ARTHRIT CARE RES, V64, P159, DOI 10.1002/acr.20683; Lerang K, 2014, LUPUS, V23, P1546, DOI 10.1177/0961203314551083; Moroni G, 2013, LUPUS, V22, P810, DOI 10.1177/0961203313492576; Nieves CEF, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0571-2; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P4021, DOI 10.1002/art.34672; Rees F, 2016, RHEUMATOLOGY, V55, P854, DOI 10.1093/rheumatology/kev424; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tektonidou MG, 2016, ARTHRITIS RHEUMATOL, V68, P1432, DOI 10.1002/art.39594; Thomas G, 2014, ARTHRITIS RHEUMATOL, V66, P2503, DOI 10.1002/art.38731; Yee CS, 2015, RHEUMATOLOGY, V54, P836, DOI 10.1093/rheumatology/keu412	20	14	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168619	10.1371/journal.pone.0168619	http://dx.doi.org/10.1371/journal.pone.0168619			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030595	Green Published, Green Submitted, gold			2022-12-26	WOS:000391222000062
J	Jha, MK; Minhajuddin, A; Greer, TL; Carmody, T; Rush, AJ; Trivedi, MH				Jha, Manish K.; Minhajuddin, Abu; Greer, Tracy L.; Carmody, Thomas; Rush, Augustus John; Trivedi, Madhukar H.			Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; MEASUREMENT-BASED CARE; STAR-ASTERISK-D; SEQUENCED TREATMENT ALTERNATIVES; SOCIAL-ADJUSTMENT SCALE; REPORT QIDS-SR; COGNITIVE THERAPY; QUICK INVENTORY; MAJOR DEPRESSION; SAS PROCEDURE	The goal of this study was to evaluate the relationship between early change in psychosocial function independent of depression severity and longer-term symptomatic remission. Participants of Combining Medications to Enhance Depression Outcomes trial were randomly selected for model selection (n = 334) and validation (n = 331). Changes in psychosocial function (Work and Social Adjustment Scale, WSAS) from baseline to week 6 were assessed and two data-driven sub-groups of WSAS change were identified in the randomly selected model selection half. Results of analyses to predict symptomatic remission at 3 and 7 months were validated for these sub-groups in the second half (validation sample). From baseline to week 6, psychosocial function improved significantly even after adjusting for depression severity at each visit and select baseline variables (age, gender, race, ethnicity, education, income, employment, depression onset before age 18, anxious features, and suicidal ideation), treatment-arm, and WSAS score. The WSAS change patterns identified two (early improvement and gradual change) subgroups. After adjusting for baseline variables and remission status at week 6, participants with early improvement in the second half (validation sample) had greater remission rates than those with gradual change at both 3 (3.3 times) and 7 months (2.3 times) following acute treatment initiation. In conclusion, early improvement in psychosocial function provides a clinically meaningful prediction of longer-term symptomatic remission, independent of depression symptom severity.	[Jha, Manish K.; Greer, Tracy L.; Carmody, Thomas; Trivedi, Madhukar H.] UT Southwestern Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; [Minhajuddin, Abu] UT Southwestern Med Ctr, Dept Clin Sci, Dallas, TX USA; [Rush, Augustus John] Duke Natl Univ Singapore, Dept Psychiat & Behav Sci, Singapore, Singapore	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National University of Singapore	Trivedi, MH (corresponding author), UT Southwestern Med Ctr, Dept Psychiat, Dallas, TX 75390 USA.	madhukar.trivedi@utsouthwestern.edu	Jha, Manish Kumar/ABI-3594-2020; Trivedi, Madhukar/A-9029-2013	Jha, Manish Kumar/0000-0002-2764-2391; Trivedi, Madhukar/0000-0002-2983-1110	National Institute of Mental Health [N01 MH-90003]; Center for Depression Research and Clinical Care; Hersh Foundation	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Center for Depression Research and Clinical Care; Hersh Foundation	This work was funded by the National Institute of Mental Health under contract N01 MH-90003 to the University of Texas Southwestern Medical Center at Dallas (MHT and AJR). Forest Pharmaceuticals, GlaxoSmithKline, Organon, and Wyeth Pharmaceuticals provided medications for this trial at no cost. This work was also supported in part through the Center for Depression Research and Clinical Care (MHT) and the Hersh Foundation (MHT). The content of this publication does not necessarily reflect the views or policies of the U.S. Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government. National Institute of Mental Health had no role in the drafting or review of the manuscript or in the collection or analysis of the data.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Arrandale VH, 2009, INT ARCH OCC ENV HEA, V82, P1097, DOI 10.1007/s00420-009-0412-y; BLAND JM, 1994, BRIT MED J, V308, P896, DOI 10.1136/bmj.308.6933.896; Cabello M, 2012, J AFFECT DISORDERS, V141, P22, DOI 10.1016/j.jad.2011.12.009; Carter MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047065; Cohen RM, 2013, JAMA PSYCHIAT, V70, P343, DOI 10.1001/jamapsychiatry.2013.286; Daly EJ, 2010, ANN CLIN PSYCHIATRY, V22, P43; Denninger JW, 2011, J NERV MENT DIS, V199, P807, DOI 10.1097/NMD.0b013e31822fcbe2; Dunn TW, 2012, PSYCHOL MED, V42, P317, DOI 10.1017/S0033291711001279; Gilmour H, 2013, HEALTH REP, V24, P14; Greenberg T, 2015, AM J PSYCHIAT, V172, P881, DOI 10.1176/appi.ajp.2015.14050594; Greer TL, 2016, DEPRESS ANXIETY, V33, P870, DOI 10.1002/da.22521; Greer TL, 2010, CNS DRUGS, V24, P267, DOI 10.2165/11530230-000000000-00000; Guo T, 2015, AM J PSYCHIAT, V172, P1004, DOI 10.1176/appi.ajp.2015.14050652; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hamlett A, P STAT DAT AN SAS US; Hirschfeld RMA, 2002, BIOL PSYCHIAT, V51, P123, DOI 10.1016/S0006-3223(01)01291-4; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jha M, 2016, AM J PSYCHIAT; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Liang J, 2011, PSYCHOL AGING, V26, P761, DOI 10.1037/a0023945; Lin CH, 2015, J AFFECT DISORDERS, V182, P115, DOI 10.1016/j.jad.2015.04.022; McKnight PE, 2009, CLIN PSYCHOL REV, V29, P243, DOI 10.1016/j.cpr.2009.01.005; Melchior M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114526; Miller IW, 1998, J CLIN PSYCHIAT, V59, P608, DOI 10.4088/JCP.v59n1108; Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461; Ram N, 2009, INT J BEHAV DEV, V33, P565, DOI 10.1177/0165025409343765; Rush AJ, 2015, J CLIN PSYCHIAT, V76, pE832, DOI 10.4088/JCP.15com09859; Rush AJ, 2011, AM J PSYCHIAT, V168, P689, DOI 10.1176/appi.ajp.2011.10111645; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Rush AJ, 2006, BIOL PSYCHIAT, V59, P493, DOI 10.1016/j.biopsych.2005.08.022; Sheehan D.V., 1998, J CLIN PSYCHIAT; Shelton RC, 2006, J CLIN PSYCHIAT, V67, P1674, DOI 10.4088/JCP.v67n1102; Solomon DA, 2004, COMPR PSYCHIAT, V45, P423, DOI 10.1016/j.comppsych.2004.07.002; Trivedi MH, 2007, DRUG ALCOHOL DEPEN, V88, pS61, DOI 10.1016/j.drugalcdep.2007.01.007; Trivedi MH, 2010, J AFFECT DISORDERS, V126, P420, DOI 10.1016/j.jad.2010.04.011; Trivedi MH, 2009, J CLIN PSYCHIAT, V70, P26, DOI 10.4088/JCP.8133su1c.04; Trivedi MH, 2009, INT CLIN PSYCHOPHARM, V24, P133, DOI 10.1097/YIC.0b013e3283277614; Trivedi MH, 2006, J CLIN PSYCHIAT, V67, P185, DOI 10.4088/JCP.v67n0203; Trivedi MH, 2004, J CLIN PSYCHIAT, V65, P1356, DOI 10.4088/JCP.v65n1010; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Uher R, 2010, PSYCHOL MED, V40, P1367, DOI 10.1017/S0033291709991528; Uher R, 2011, J CLIN PSYCHIAT, V72, P1478, DOI 10.4088/JCP.10m06419; Vittengl JR, 2007, J CONSULT CLIN PSYCH, V75, P475, DOI 10.1037/0022-006X.75.3.475; Vittengl JR, 2009, J AFFECT DISORDERS, V112, P135, DOI 10.1016/j.jad.2008.04.004; Vittengl JR, 2004, PSYCHOL MED, V34, P643, DOI 10.1017/S0033291703001478; Wardenaar KJ, 2014, DEPRESS ANXIETY, V31, P778, DOI 10.1002/da.22228; Wisniewski Stephen R, 2006, J Psychiatr Pract, V12, P71, DOI 10.1097/00131746-200603000-00002; Zahra D, 2014, INT J PSYCHIAT CLIN, V18, P131, DOI 10.3109/13651501.2014.894072; Zimmerman M, 2006, AM J PSYCHIAT, V163, P148, DOI 10.1176/appi.ajp.163.1.148	53	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167901	10.1371/journal.pone.0167901	http://dx.doi.org/10.1371/journal.pone.0167901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030546	Green Published, Green Submitted, gold			2022-12-26	WOS:000391222000026
J	Kingry, LC; Batra, D; Replogle, A; Rowe, LA; Pritt, BS; Petersen, JM				Kingry, Luke C.; Batra, Dhwani; Replogle, Adam; Rowe, Lori A.; Pritt, Bobbi S.; Petersen, Jeannine M.			Whole Genome Sequence and Comparative Genomics of the Novel Lyme Borreliosis Causing Pathogen, Borrelia mayonii	PLOS ONE			English	Article							IMMUNODOMINANT CONSERVED REGION; REGULATORS FACTOR-H; DISEASE SPIROCHETE; CLINICAL-MANIFESTATIONS; SP-NOV; BURGDORFERI; PROTEIN; BINDING; REPLICATION; EXPRESSION	Borrelia mayonii, a Borrelia burgdorferi sensu lato (Bbsl) genospecies, was recently identified as a cause of Lyme borreliosis (LB) among patients from the upper midwestern United States. By microscopy and PCR, spirochete/genome loads in infected patients were estimated at 10(5) to 10(6) per milliliter of blood. Here, we present the full chromosome and plasmid sequences of two B. mayonii isolates, MN14-1420 and MN14-1539, cultured from blood of two of these patients. Whole genome sequencing and assembly was conducted using Pac-Bio long read sequencing (Pacific Biosciences RSII instrument) followed by hierarchical genome-assembly process (HGAP). The B. mayonii genome is similar to 1.31 Mbp in size (26.9% average GC content) and is comprised of a linear chromosome, 8 linear and 7 circular plasmids. Consistent with its taxonomic designation as a new Bbsl genospecies, the B. mayonii linear chromosome shares only 93.83% average nucleotide identity with other genospecies. Both B. mayonii genomes contain plasmids similar to B. burgdorferi sensu stricto lp54, lp36, lp28-3, lp28-4, lp25, lp17, lp5, 5 cp32s, cp26, and cp9. The vls locus present on lp28-10 of B. mayonii MN14-1420 is remarkably long, being comprised of 24 silent vls cassettes. Genetic differences between the two B. mayonii genomes are limited and include 15 single nucleotide variations as well as 7 fewer silent vls cassettes and a lack of the lp5 plasmid in MN14-1539. Notably, 68 homologs to proteins present in B. burgdorferi sensu stricto appear to be lacking from the B. mayonii genomes. These include the complement inhibitor, CspZ (BB_H06), the fibronectin binding protein, BB_K32, as well as multiple lipoproteins and proteins of unknown function. This study shows the utility of long read sequencing for full genome assembly of Bbsl genomes, identifies putative genome regions of B. mayonii that may be linked to clinical manifestation or tissue tropism, and provides a valuable resource for pathogenicity, diagnostic and vaccine studies.	[Kingry, Luke C.; Replogle, Adam; Petersen, Jeannine M.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Bacterial Dis Branch, Ft Collins, CO 80521 USA; [Batra, Dhwani; Rowe, Lori A.] Ctr Dis Control & Prevent, Div Sci Resources, Biotechnol Core Facil Branch, Atlanta, GA USA; [Pritt, Bobbi S.] Mayo Clin, Div Clin Microbiol, Dept Lab Med & Pathol, Rochester, MN USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Mayo Clinic	Petersen, JM (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Bacterial Dis Branch, Ft Collins, CO 80521 USA.	nzp0@cdc.gov		Kingry, Luke/0000-0002-5724-2575	Advanced Molecular Detection (AMD) initiative at the Centers for Disease Control and Prevention	Advanced Molecular Detection (AMD) initiative at the Centers for Disease Control and Prevention	This work was made possible through support from the Advanced Molecular Detection (AMD) initiative at the Centers for Disease Control and Prevention. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeolu M, 2014, ANTON LEEUW INT J G, V105, P1049, DOI 10.1007/s10482-014-0164-x; Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; ANDERSON JF, 1988, ANN NY ACAD SCI, V539, P180, DOI 10.1111/j.1749-6632.1988.tb31852.x; BARANTON G, 1992, INT J SYST BACTERIOL, V42, P378, DOI 10.1099/00207713-42-3-378; Bil-Lula I, 2015, ADV CLIN EXP MED, V24, P663, DOI 10.17219/acem/28625; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cannon Ethalinda K S, 2011, Int J Plant Genomics, V2011, P373875, DOI 10.1155/2011/373875; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Casjens S, 2010, BORRELIA MOL BIOL HO; Casjens SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033280; Casjens SR, 2011, J BACTERIOL, V193, P6995, DOI 10.1128/JB.05951-11; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Coutte L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000293; Cutler SJ, 2016, MOL CELL PROBES; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Di L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-233; Eggers CH, 2002, MOL MICROBIOL, V43, P281, DOI 10.1046/j.1365-2958.2002.02758.x; Fingerle V, 2002, J CLIN MICROBIOL, V40, P1456, DOI 10.1128/JCM.40.4.1456-1463.2002; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gern L, 1998, ZBL BAKT-INT J MED M, V287, P196; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Hammerschmidt C, 2016, MOL MICROBIOL, V99, P407, DOI 10.1111/mmi.13239; Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x; Hyde JA, 2011, MOL MICROBIOL, V82, P99, DOI 10.1111/j.1365-2958.2011.07801.x; JOHNSON RC, 1984, INT J SYST BACTERIOL, V34, P496, DOI 10.1099/00207713-34-4-496; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Kraiczy P, 2013, TICKS TICK-BORNE DIS, V4, P26, DOI 10.1016/j.ttbdis.2012.10.039; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Liang FT, 1999, J IMMUNOL, V163, P5566; Liang FT, 1999, J CLIN MICROBIOL, V37, P3990, DOI 10.1128/JCM.37.12.3990-3996.1999; Lin YP, 2015, CELL MICROBIOL, V17, P860, DOI 10.1111/cmi.12407; Lin YP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004238; Liveris D, 2012, EUR J CLIN MICROBIOL, V31, P791, DOI 10.1007/s10096-011-1376-x; Mongodin EF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-693; Moriarty TJ, 2012, MOL MICROBIOL, V86, P1116, DOI 10.1111/mmi.12045; Norris SJ, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0038-2014; Norris SJ, 2011, APPL ENVIRON MICROB, V77, P1483, DOI 10.1128/AEM.01877-10; Pettersson J, 2007, INFECT IMMUN, V75, P3877, DOI 10.1128/IAI.00199-07; Pritt BS, 2016, LANCET INFECT DIS, V16, P556, DOI 10.1016/S1473-3099(15)00464-8; Pritt BS R-K L. B., 2016, INT J SYST UNPUB JUL; Qiu WG, 2014, INFECT GENET EVOL, V27, P576, DOI 10.1016/j.meegid.2014.03.025; Revel AT, 2005, P NATL ACAD SCI USA, V102, P6972, DOI 10.1073/pnas.0502565102; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schuler W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120548; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; Siegel C, 2008, J BIOL CHEM, V283, P34855, DOI 10.1074/jbc.M805844200; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stanek G, 2003, LANCET, V362, P1639, DOI 10.1016/S0140-6736(03)14798-8; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; STEERE AC, 1983, ANN INTERN MED, V99, P76, DOI 10.7326/0003-4819-99-1-76; Stevenson B, 2000, J MOL MICROB BIOTECH, V2, P411; Stewart PE, 2001, MOL MICROBIOL, V39, P714, DOI 10.1046/j.1365-2958.2001.02256.x; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatusova T, 2016, NUCL ACIDS RES; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; VANDAM AP, 1993, CLIN INFECT DIS, V17, P708, DOI 10.1093/clinids/17.4.708; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960; Zhang JR, 1998, INFECT IMMUN, V66, P3698, DOI 10.1128/IAI.66.8.3698-3704.1998	61	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168994	10.1371/journal.pone.0168994	http://dx.doi.org/10.1371/journal.pone.0168994			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030649	gold, Green Published			2022-12-26	WOS:000391222000097
J	Liu, L; Kalter, HD; Chu, Y; Kazmi, N; Koffi, AK; Amouzou, A; Joos, O; Munos, M; Black, RE				Liu, Li; Kalter, Henry D.; Chu, Yue; Kazmi, Narjis; Koffi, Alain K.; Amouzou, Agbessi; Joos, Olga; Munos, Melinda; Black, Robert E.			Understanding Misclassification between Neonatal Deaths and Stillbirths: Empirical Evidence from Malawi	PLOS ONE			English	Article							VERBAL AUTOPSY; PRETERM BIRTH; PREGNANCY; COUNTRIES; VALIDITY; AFRICA	Improving the counting of stillbirths and neonatal deaths is important to tracking Sustainable Development Goal 3.2 and improving vital statistics in low-and middle-income countries (LMICs). However, the validity of self-reported stillbirths and neonatal deaths in surveys is often threatened by misclassification errors between the two birth outcomes. We assessed the extent and correlates of stillbirths being misclassified as neonatal deaths by comparing two recent and linked population surveys conducted in Malawi, one being a full birth history (FBH) survey, and the other a follow-up verbal/social autopsy (VASA) survey. We found that one-fifth of 365 neonatal deaths identified in the FBH survey were classified as stillbirths in the VASA survey. Neonatal deaths with signs of movements in the last few days before delivery reported were less likely to be misclassified stillbirths (OR = 0.08, p<0.05). Having signs of birth injury was found to be associated with higher odds of misclassification (OR = 6.17, p<0.05). We recommend replicating our study with larger sample size in other settings. Additionally, we recommend conducting validation studies to confirm accuracy and completeness of live births and neonatal deaths reported in household surveys with events reported in a full birth history and the extent of underestimation of neonatal mortality resulting from misclassifications. Questions on fetal movement, signs of life at delivery and improved probing among older mother may be useful to improve accuracy of reported events.	[Liu, Li] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA; [Liu, Li; Chu, Yue; Kazmi, Narjis; Koffi, Alain K.; Amouzou, Agbessi; Joos, Olga; Munos, Melinda; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Dept Int Hlth, Baltimore, MD 21205 USA; [Kalter, Henry D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Hlth Syst Program, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Liu, L (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.; Liu, L (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Dept Int Hlth, Baltimore, MD 21205 USA.	lliu26@jhu.edu	liu, li/HGC-0900-2022	Munos, Melinda/0000-0002-1349-8026; Kalter, Henry/0000-0002-4165-2393; Amouzou, Agbessi/0000-0002-6262-3866; Joos, Olga/0000-0003-0335-4982; Koffi, Alain/0000-0003-3499-0949	Foreign Affairs, Trade and Development Canada [7056791]	Foreign Affairs, Trade and Development Canada	The project was funded by Foreign Affairs, Trade and Development Canada (http://www.international.gc.ca/international/index.aspx?lang=eng) through the Real-Time Results Tracking grant (#7056791) under the Catalytic Initiative to Save a Million Lives. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal AK, 2011, B WORLD HEALTH ORGAN, V89, P31, DOI 10.2471/BLT.10.076828; Amouzou A, 2013, TROP MED INT HEALTH, V18, P1231, DOI 10.1111/tmi.12167; Barrett Anna M, 2003, Cogn Behav Neurol, V16, P160, DOI 10.1097/00146965-200309000-00003; Blencowe H, 2016, LANCET GLOBAL HLTH; Bradford S, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0694-4; Bryce Jennifer, 2016, PLoS Med, V13, pe1001912, DOI 10.1371/journal.pmed.1001912; Engmann C, 2009, INT J GYNECOL OBSTET, V105, P112, DOI 10.1016/j.ijgo.2008.12.012; Haws RA, 2010, SOC SCI MED, V71, P1764, DOI 10.1016/j.socscimed.2010.03.051; Helleringer S, 2015, TROP MED INT HEALTH, V20, P1415, DOI 10.1111/tmi.12583; Kalter HD, 2015, J GLOB HEALTH, V5, P196, DOI 10.7189/jogh.05.010415; Koffi AK, 2015, J GLOBAL HLTH, V5; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Leisher SH, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1071-0; Liu L, 2016, LANCET; McTavish S, 2010, SOC SCI MED, V71, P1958, DOI 10.1016/j.socscimed.2010.09.007; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; Pullum T. W., 2006, ASSESSMENT AGE DATE; RMM working group, 2014, RMM IN MAL; Rutstein S.O., 2014, MAKING DEMOGRAPHIC H; Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x; Stacey T, 2011, BIRTH-ISS PERINAT C, V38, P311, DOI 10.1111/j.1523-536X.2011.00490.x; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; The World Bank, 2014, GLOB CIV REG VIT STA; Tolhurst R, 2008, MIDWIFERY, V24, P83, DOI 10.1016/j.midw.2006.09.003; Tveit JVH, 2009, ACTA OBSTET GYN SCAN, V88, P1345, DOI 10.3109/00016340903348375; United Nations, 2015, 2030 AG SUST DEV	30	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168743	10.1371/journal.pone.0168743	http://dx.doi.org/10.1371/journal.pone.0168743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030594	Green Submitted, Green Published, gold			2022-12-26	WOS:000391222000073
J	Lu, JC; Chiang, YT; Lin, YC; Chang, YT; Lu, CY; Chen, TY; Yeh, CS				Lu, Juu-Chin; Chiang, Yu-Ting; Lin, Yu-Chun; Chang, Yu-Tzu; Lu, Chia-Yun; Chen, Tzu-Yu; Yeh, Chia-Shan			Disruption of Lipid Raft Function Increases Expression and Secretion of Monocyte Chemoattractant Protein-1 in 3T3-L1 Adipocytes	PLOS ONE			English	Article							NF-KAPPA-B; STIMULATED GLUCOSE-TRANSPORT; INSULIN-RESISTANCE; CHOLESTEROL ACCUMULATION; MOLECULAR-MECHANISMS; GLUT4 TRANSLOCATION; SCAVENGER RECEPTOR; ACTIVATION; PATHWAYS; CELLS	The adipocyte is unique in its capacity to store lipids. In addition to triglycerides, the adipocyte stores a significant amount of cholesterol. Moreover, obese adipocytes are characterized by a redistribution of cholesterol with depleted cholesterol in the plasma membrane, suggesting that cholesterol perturbation may play a role in adipocyte dysfunction. We used methyl-beta-cyclodextrin (M beta CD), a molecule with high affinity for cholesterol, to rapidly deplete cholesterol level in differentiated 3T3-L1 adipocytes. We tested whether this perturbation altered adipocyte secretion of monocyte chemoattractant protein-1 (MCP-1), a chemokine that is elevated in obesity and is linked to obesity-associated chronic diseases. Depletion of cholesterol by M beta CD increased MCP-1 secretion as well as the mRNA and protein levels, suggesting perturbation at biosynthesis and secretion. Pharmacological inhibition revealed that NF-kappa B, but not MEK, p38 and JNK, was involved in M beta CD-stimulated MCP-1 biosynthesis and secretion in adipocytes. Finally, another cholesterol-binding drug, filipin, also induced MCP-1 secretion without altering membrane cholesterol level. Interestingly, both M beta CD and filipin disturbed the integrity of lipid rafts, the membrane microdomains enriched in cholesterol. Thus, the depletion of membrane cholesterol in obese adipocytes may result in dysfunction of lipid rafts, leading to the elevation of proinflammatory signaling and MCP-1 secretion in adipocytes.	[Lu, Juu-Chin; Lin, Yu-Chun; Chang, Yu-Tzu; Lu, Chia-Yun] Chang Gung Univ, Dept Physiol & Pharmacol, Taoyuan, Taiwan; [Lu, Juu-Chin; Chiang, Yu-Ting; Lin, Yu-Chun; Lu, Chia-Yun; Yeh, Chia-Shan] Chang Gung Univ, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Lu, Juu-Chin] Chang Gung Mem Hosp, Div Endocrinol & Metab, Dept Internal Med, Linkou, Taiwan; [Chen, Tzu-Yu] Chang Gung Univ, Dept Biomed Sci, Coll Med, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lu, JC (corresponding author), Chang Gung Univ, Dept Physiol & Pharmacol, Taoyuan, Taiwan.; Lu, JC (corresponding author), Chang Gung Univ, Grad Inst Biomed Sci, Taoyuan, Taiwan.; Lu, JC (corresponding author), Chang Gung Mem Hosp, Div Endocrinol & Metab, Dept Internal Med, Linkou, Taiwan.	juuchin@mail.cgu.edu.tw	Lu, Juu-Chin/ABB-3198-2020	Lu, Juu-Chin/0000-0001-8523-6992	Ministry of Science and Technology [NSC101-2320-B-182-007, NSC102-2320-B-182-022-MY3]; Chang Gung Medical Research Project [CMRPD1C0591similar to3, CMRPD180513, BMRPC03]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chang Gung Medical Research Project	This study was supported by the Ministry of Science and Technology Grant NSC101-2320-B-182-007 and NSC102-2320-B-182-022-MY3, and Chang Gung Medical Research Project CMRPD1C0591 similar to 3, CMRPD180513, and BMRPC03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar D, 2014, ADV NUTR, V5, P497, DOI 10.3945/an.114.005934; Ahmed RAM, 2009, ENDOCRINE, V35, P184, DOI 10.1007/s12020-008-9136-0; Aksamitiene E, 2010, CELL SIGNAL, V22, P1369, DOI 10.1016/j.cellsig.2010.05.006; Awasthi-Kalia M, 2001, BIOCHEM BIOPH RES CO, V287, P77, DOI 10.1006/bbrc.2001.5536; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Bickel PE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1, DOI 10.1152/ajpendo.2002.282.1.E1; Bogan JS, 2012, TRAFFIC, V13, P1466, DOI 10.1111/j.1600-0854.2012.01407.x; Breen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034516; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chamberlain LH, 2002, J BIOL CHEM, V277, P49750, DOI 10.1074/jbc.M206936200; Cheng AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033917; Chiang SH, 2006, METHOD ENZYMOL, V406, P701, DOI 10.1016/S0076-6879(06)06055-1; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Christian AE, 1997, J LIPID RES, V38, P2264; Cuddy LK, 2014, J NEUROCHEM, V128, P725, DOI 10.1111/jnc.12490; Dugail I, 2003, HORM METAB RES, V35, P204, DOI 10.1055/s-2003-39475; Ehehalt R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-45; FARKAS J, 1973, J LIPID RES, V14, P344; Flemming JA, 2004, CELL IMMUNOL, V229, P68, DOI 10.1016/j.cellimm.2004.06.004; Gonzalez-Munoz E, 2009, ENDOCRINOLOGY, V150, P3493, DOI 10.1210/en.2008-1520; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; GUERREMILLO M, 1994, LIPIDS, V29, P205, DOI 10.1007/BF02536730; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; Han JH, 1999, J LIPID RES, V40, P830; Ikonen Elina, 2005, Sci STKE, V2005, ppe3; Ito A, 2007, J BIOL CHEM, V282, P25445, DOI 10.1074/jbc.M701549200; Jiao P, 2009, DIABETES, V58, P104, DOI 10.2337/db07-1344; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kimura A, 2002, J BIOL CHEM, V277, P30153, DOI 10.1074/jbc.M203375200; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Le Lay S, 2001, J BIOL CHEM, V276, P16904, DOI 10.1074/jbc.M010955200; Lemaire-Ewing S, 2012, ATHEROSCLEROSIS, V221, P303, DOI 10.1016/j.atherosclerosis.2011.10.016; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Loftsson Thorsteinn, 2005, Expert Opin Drug Deliv, V2, P335, DOI 10.1517/17425247.2.1.335; Lu JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071517; Marwali MR, 2003, BLOOD, V102, P215, DOI 10.1182/blood-2002-10-3195; Niu JL, 2009, CLIN SCI, V117, P95, DOI 10.1042/CS20080581; Olsson S, 2006, MOL IMMUNOL, V43, P607, DOI 10.1016/j.molimm.2005.04.011; Ottinger EA, 2014, CURR TOP MED CHEM, V14, P330, DOI 10.2174/1568026613666131127160118; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Salaun C, 2004, TRAFFIC, V5, P255, DOI 10.1111/j.1600-0854.2004.0162.x; SCHREIBMAN PH, 1975, J CLIN INVEST, V55, P986, DOI 10.1172/JCI108028; Sell H, 2007, CURR OPIN LIPIDOL, V18, P258, DOI 10.1097/MOL.0b013e3281338546; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sultana A, 2016, FASEB J; Surma MA, 2012, BBA-MOL CELL BIOL L, V1821, P1059, DOI 10.1016/j.bbalip.2011.12.008; Takahashi K, 2008, AM J PHYSIOL-ENDOC M, V294, pE898, DOI 10.1152/ajpendo.00131.2007; Takahashi K, 2013, OBESITY, V21, P1625, DOI 10.1002/oby.20206; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Triantafilou M, 2002, J CELL SCI, V115, P2603; Tsuchiya K, 2006, AM J PHYSIOL-ENDOC M, V291, pE771, DOI 10.1152/ajpendo.00560.2005; UEDA A, 1994, J IMMUNOL, V153, P2052; Umemoto T, 2013, CIRC RES, V112, P1345, DOI 10.1161/CIRCRESAHA.111.300581; Watson RT, 2001, J CELL BIOL, V154, P829, DOI 10.1083/jcb.200102078; Wuyts WA, 2003, RESP MED, V97, P811, DOI 10.1016/S0954-6111(03)00036-2; Yang X., 2011, INT J OPT, V2011, P1, DOI [DOI 10.5402/2011/389872, DOI 10.1155/2011/754610]; Yao HH, 2010, BLOOD, V115, P4951, DOI 10.1182/blood-2010-01-266221; Yao Y, 2009, CELL RES, V19, P497, DOI 10.1038/cr.2009.27; Yoshida T, 2012, ONCOTARGET, V3, P1533; Yu BL, 2010, OBES REV, V11, P560, DOI 10.1111/j.1467-789X.2009.00699.x	63	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0169005	10.1371/journal.pone.0169005	http://dx.doi.org/10.1371/journal.pone.0169005			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030645	Green Published, Green Submitted, gold			2022-12-26	WOS:000391222000099
J	Andrich, K; Hegenbart, U; Kimmich, C; Kedia, N; Bergen, HR; Schonland, S; Wanker, E; Bieschke, J				Andrich, Kathrin; Hegenbart, Ute; Kimmich, Christoph; Kedia, Niraja; Bergen, H. Robert, III; Schoenland, Stefan; Wanker, Erich; Bieschke, Jan			Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEROZOITE SURFACE PROTEIN-2; BENCE-JONES PROTEINS; FIBRIL FORMATION; 3-DIMENSIONAL STRUCTURE; VARIABLE DOMAINS; GREEN TEA; IN-VITRO; MOLECULAR-INTERACTIONS; THERMODYNAMIC ANALYSIS; THERMAL-STABILITY	Intervention into amyloid deposition with anti-amyloid agents like the polyphenol epigallocatechin-3-gallate (EGCG) is emerging as an experimental secondary treatment strategy in systemic light chain amyloidosis (AL). In both AL and multiple myeloma (MM), soluble immunoglobulin light chains (LC) are produced by clonal plasma cells, but only in AL do they form amyloid deposits in vivo. Weinvestigated the amyloid formation of patient-derived LC and their susceptibility to EGCG in vitro to probe commonalities and systematic differences in their assembly mechanisms. Weisolated nine LC from the urine of AL and MM patients. We quantified their thermodynamic stabilities and monitored their aggregation under physiological conditions by thioflavin T fluorescence, light scattering, SDS stability, and atomic force microscopy. LC from all patients formed amyloid-like aggregates, albeit with individually different kinetics. LC existed as dimers, similar to 50% of which were linked by disulfide bridges. Our results suggest that cleavage into LC monomers is required for efficient amyloid formation. The kinetics of AL LC displayed a transition point in concentration dependence, which MM LC lacked. The lack of concentration dependence of MM LC aggregation kinetics suggests that conformational change of the light chain is rate-limiting for these proteins. Aggregation kinetics displayed two distinct phases, which corresponded to the formation of oligomers and amyloid fibrils, respectively. EGCG specifically inhibited the second aggregation phase and induced the formation of SDS-stable, non-amyloid LC aggregates. Our data suggest that EGCG intervention does not depend on the individual LC sequence and is similar to the mechanism observed for amyloid-beta and alpha-synuclein.	[Andrich, Kathrin; Kedia, Niraja; Bieschke, Jan] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Andrich, Kathrin; Wanker, Erich] Max Delbruck Ctr Mol Med Helmholtz Assoc, D-13125 Berlin, Germany; [Hegenbart, Ute; Kimmich, Christoph; Schoenland, Stefan] Univ Heidelberg Hosp, Dept Internal Med 5, Hematol Amyloidosis Ctr, D-69120 Heidelberg, Germany; [Bergen, H. Robert, III] Mayo Clin, Translat PKD Ctr, Rochester, MN 55905 USA	Washington University (WUSTL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Ruprecht Karls University Heidelberg; Mayo Clinic	Bieschke, J (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.	bieschke@wustl.edu	Schönland, Stefan/AAV-5607-2020; Bieschke, Jan/AAG-2705-2019	Schönland, Stefan/0000-0002-4853-5579; Bieschke, Jan/0000-0002-3485-9767; Wanker, Erich/0000-0001-8072-1630	German Ministry for Science and Education (BMBF GERAMY) [01GM1107C, 01GM1107A]; Diabetes Research Center at Washington University (National Institutes of Health) [P30 DK020579]; German Science Foundation (DFG) [BI 1409/1-1]; MRC [MC_UU_00024/6] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA015083, P50CA186781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	German Ministry for Science and Education (BMBF GERAMY)(Federal Ministry of Education & Research (BMBF)); Diabetes Research Center at Washington University (National Institutes of Health); German Science Foundation (DFG)(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by German Ministry for Science and Education (BMBF GERAMY) Grants 01GM1107C and 01GM1107A, by the Diabetes Research Center at Washington University (National Institutes of Health Grant No. 5, P30 DK020579), and by German Science Foundation (DFG) Grant BI 1409/1-1. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe M, 2013, PROTEIN SCI, V22, P467, DOI 10.1002/pro.2228; AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; Andrich K, 2015, ADV EXP MED BIOL, V863, P139, DOI 10.1007/978-3-319-18365-7_7; Arosio P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033372; Baden EM, 2008, J BIOL CHEM, V283, P30950, DOI 10.1074/jbc.M804822200; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BAUMSTARK JS, 1983, PREP BIOCHEM, V13, P315, DOI 10.1080/00327488308068176; Bergen HR, 2016, CLIN CHEM, V62, P243, DOI 10.1373/clinchem.2015.242651; Bergen HR, 2004, BIOMED CHROMATOGR, V18, P191, DOI 10.1002/bmc.323; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Blancas-Mejia LM, 2016, BIOCHEMISTRY-US, V55, P2967, DOI 10.1021/acs.biochem.6b00090; Blancas-Mejia LM, 2015, BIOPHYS CHEM, V207, P13, DOI 10.1016/j.bpc.2015.07.005; Blancas-Mejia LM, 2014, J MOL BIOL, V426, P347, DOI 10.1016/j.jmb.2013.10.016; Blancas-Mejia LM, 2009, J MOL BIOL, V386, P1153, DOI 10.1016/j.jmb.2008.12.069; Brumshtein B, 2015, ELIFE, V4, DOI 10.7554/eLife.10935; Caruana M, 2011, FEBS LETT, V585, P1113, DOI 10.1016/j.febslet.2011.03.046; Chandrashekaran IR, 2011, ARCH BIOCHEM BIOPHYS, V513, P153, DOI 10.1016/j.abb.2011.07.008; Chandrashekaran IR, 2010, BIOCHEMISTRY-US, V49, P5899, DOI 10.1021/bi902197x; Chung CM, 2005, BIOPHYS J, V88, P4232, DOI 10.1529/biophysj.105.061317; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; COHN JR, 1978, ANN CLIN LAB SCI, V8, P270; Davern S, 2011, BBA-MOL BASIS DIS, V1812, P32, DOI 10.1016/j.bbadis.2010.07.022; DAVIES DR, 1975, ANNU REV BIOCHEM, V44, P639, DOI 10.1146/annurev.bi.44.070175.003231; Desport E, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-54; DiCostanzo AC, 2012, J BIOL CHEM, V287, P27997, DOI 10.1074/jbc.M112.362921; Ehrenmann F, 2010, NUCLEIC ACIDS RES, V38, pD301, DOI 10.1093/nar/gkp946; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Feige MJ, 2007, J MOL BIOL, V365, P1232, DOI 10.1016/j.jmb.2006.10.049; Garai K, 2013, P NATL ACAD SCI USA, V110, P3321, DOI 10.1073/pnas.1222478110; Gauci AJ, 2011, J ALZHEIMERS DIS, V27, P767, DOI 10.3233/JAD-2011-111061; GLENNER GG, 1971, SCIENCE, V174, P712, DOI 10.1126/science.174.4010.712; GOTO Y, 1979, J BIOCHEM-TOKYO, V86, P1433, DOI 10.1093/oxfordjournals.jbchem.a132661; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Grelle G, 2011, BIOCHEMISTRY-US, V50, P10624, DOI 10.1021/bi2012383; Gupta P, 2015, RSC ADV, V5, P95717, DOI 10.1039/c5ra17794d; HOPKINS TR, 1967, BIOCHEM BIOPH RES CO, V28, P480, DOI 10.1016/0006-291X(67)90337-3; Hunstein W, 2007, BLOOD, V110, P2216, DOI 10.1182/blood-2007-05-089243; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Kaas Quentin, 2007, Briefings in Functional Genomics & Proteomics, V6, P253, DOI 10.1093/bfgp/elm032; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; KLATSKIN G, 1969, AM J PATHOL, V56, P1; KLAUSNER RD, 1983, BIOCHEM J, V212, P801, DOI 10.1042/bj2120801; Klimtchuk ES, 2010, BIOCHEMISTRY-US, V49, P9848, DOI 10.1021/bi101351c; KRATZIN HD, 1989, BIOL CHEM H-S, V370, P263, DOI 10.1515/bchm3.1989.370.1.263; KYLE RA, 1992, BLOOD, V79, P1817; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Lee YK, 2009, BRAIN RES, V1250, P164, DOI 10.1016/j.brainres.2008.10.012; Lefranc M.-P., 2001, IMMUNOGLOBULIN FACTS, P17; Lefranc MP, 2005, DEV COMP IMMUNOL, V29, P185, DOI 10.1016/j.dci.2004.07.003; Lefranc MP, 2004, MOL IMMUNOL, V40, P647, DOI 10.1016/j.molimm.2003.09.006; Lefranc MP, 2003, LEUKEMIA, V17, P260, DOI 10.1038/sj.leu.2402637; Lefranc MP, 2003, NUCLEIC ACIDS RES, V31, P307, DOI 10.1093/nar/gkg085; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Li CX, 2013, ADV MATER, V25, P3694, DOI 10.1002/adma.201300904; Li CX, 2013, NANOSCALE, V5, P6207, DOI 10.1039/c3nr01644g; Liao RL, 2001, CIRCULATION, V104, P1594, DOI 10.1161/circ.104.14.1594; Lopez del Amo JM, 2012, J MOL BIOL, V421, P517, DOI 10.1016/j.jmb.2012.01.013; MANTULIN WW, 1980, J BIOL CHEM, V255, P8185; Marin-Argany M, 2015, PROTEIN SCI, V24, P1829, DOI 10.1002/pro.2790; Martin DJ, 2011, BIOPHYS CHEM, V158, P81, DOI 10.1016/j.bpc.2011.05.011; Martin DJ, 2010, AMYLOID, V17, P129, DOI 10.3109/13506129.2010.530081; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; Mereles D, 2008, CLIN RES CARDIOL, V97, P341, DOI 10.1007/s00392-008-0649-6; Mereles D, 2010, CLIN RES CARDIOL, V99, P483, DOI 10.1007/s00392-010-0142-x; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Pelaez-Aguilar AE, 2015, BIOCHEMISTRY-US, V54, P4978, DOI 10.1021/acs.biochem.5b00288; POLJAK RJ, 1975, NATURE, V256, P373, DOI 10.1038/256373a0; Poshusta TL, 2013, INT J MOL SCI, V14, P22604, DOI 10.3390/ijms141122604; ROBINSON EL, 1982, CLIN CHEM, V28, P2254; Ruiz M, 2002, IMMUNOGENETICS, V53, P857, DOI 10.1007/s00251-001-0408-6; SAEED SM, 1967, AM J CLIN PATHOL, V47, P588, DOI 10.1093/ajcp/47.5.588; SCHIFFER M, 1985, J MOL BIOL, V186, P475, DOI 10.1016/0022-2836(85)90120-2; Sengupta S, 2001, J BIOL CHEM, V276, P30111, DOI 10.1074/jbc.M104324200; Shinagawa A, 2001, INT J HEMATOL, V73, P526, DOI 10.1007/BF02994017; Sikkink LA, 2008, AMYLOID, V15, P29, DOI 10.1080/13506120701815324; SILVERTON EW, 1977, P NATL ACAD SCI USA, V74, P5140, DOI 10.1073/pnas.74.11.5140; Sinha S, 2012, ACS CHEM NEUROSCI, V3, P451, DOI 10.1021/cn200133x; SOLLING K, 1976, SCAND J CLIN LAB INV, V36, P447, DOI 10.3109/00365517609054462; SOLOMON A, 1969, J BIOL CHEM, V244, P3393; STEVENS PW, 1995, PROTEIN SCI, V4, P421; SUN T, 1979, AM J CLIN PATHOL, V72, P5; TEPPO AM, 1985, DIABETES, V34, P589, DOI 10.2337/diabetes.34.6.589; TSUNENAGA M, 1987, BIOCHEMISTRY-US, V26, P6044, DOI 10.1021/bi00393a015; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wang SH, 2012, J PHYS CHEM B, V116, P5803, DOI 10.1021/jp209406t; Wang SH, 2010, J PHYS CHEM B, V114, P11576, DOI 10.1021/jp1001435; Wobst HJ, 2015, FEBS LETT, V589, P77, DOI 10.1016/j.febslet.2014.11.026	91	27	27	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2328	2344		10.1074/jbc.M116.750323	http://dx.doi.org/10.1074/jbc.M116.750323			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28031465	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000395530300024
J	Verhelst, J; Van Hoecke, L; Spitaels, J; De Vlieger, D; Kolpe, A; Saelens, X				Verhelst, Judith; Van Hoecke, Lien; Spitaels, Jan; De Vlieger, Dorien; Kolpe, Annasaheb; Saelens, Xavier			Chemical-controlled Activation of Antiviral Myxovirus Resistance Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-VIRUS; MX-PROTEINS; OLIGOMERIZATION; OVEREXPRESSION; REQUIREMENTS; SENSITIVITY; POLYMERASE; RAPAMYCIN; REVEALS; TARGET	The antiviral myxovirus resistance protein 1 (MX1) is an interferon-induced GTPase that plays an important role in the defense of mammalian cells against influenza A viruses. Mouse MX1 interacts with the influenza ribonucleoprotein complexes (vRNPs) and can prevent the interaction between polymerase basic 2 (PB2) and the nucleoprotein (NP) of influenza A viruses. However, it is unclear whether mouse MX1 disrupts the PB2-NP interaction in the context of pre-existing vRNPs or prevents the assembly of new vRNP components. Here, we describe a conditionally active mouse MX1 variant that only exerts antiviral activity in the presence of a small molecule drug. Once activated, this MX1 construct phenocopies the antiviral and NP binding activity of wild type MX1. The interaction between PB2 and NP is disrupted within minutes after the addition of the small molecule activator. These findings support a model in which mouse MX1 interacts with the incoming influenza A vRNPs and inhibits their activity by disrupting the PB2-NP interaction.	[Verhelst, Judith; Van Hoecke, Lien; Spitaels, Jan; De Vlieger, Dorien; Kolpe, Annasaheb; Saelens, Xavier] VIB, Ctr Med Biotechnol, Technol Pk 927, B-9052 Ghent, Belgium; [Verhelst, Judith; Van Hoecke, Lien; Spitaels, Jan; De Vlieger, Dorien; Kolpe, Annasaheb; Saelens, Xavier] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Saelens, X (corresponding author), VIB, Ctr Med Biotechnol, Technol Pk 927, B-9052 Ghent, Belgium.	xavier.saelens@vib-ugent.be	Saelens, Xavier/N-5728-2015	Kolpe, Annasaheb/0000-0002-1255-1593; Van Hoecke, Lien/0000-0001-8602-4211; , Xavier/0000-0002-3861-6965	Ghent University Special Research Fund [BOF12/GOA/014]; IWT-Vlaanderen; FP7 ITN UniVacFlu	Ghent University Special Research Fund(Ghent University); IWT-Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); FP7 ITN UniVacFlu	This work was supported by Ghent University Special Research Fund (Project BOF12/GOA/014) (to X.S. and J.V.) This work was also supported by grants from IWT-Vlaanderen (to J.S. and D.D.V.) and FP7 ITN UniVacFlu (to A.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017; Dittmann J, 2008, J VIROL, V82, P3624, DOI 10.1128/JVI.01753-07; Edwards SR, 2007, J BIOL CHEM, V282, P13395, DOI 10.1074/jbc.M700498200; Engelhardt OG, 2006, REV MED VIROL, V16, P329, DOI 10.1002/rmv.512; Gao S, 2011, IMMUNITY, V35, P514, DOI 10.1016/j.immuni.2011.07.012; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; HUANG T, 1992, J VIROL, V66, P4154, DOI 10.1128/JVI.66.7.4154-4160.1992; Manz B, 2013, J VIROL, V87, P7200, DOI 10.1128/JVI.00980-13; Mitchell PS, 2012, CELL HOST MICROBE, V12, P598, DOI 10.1016/j.chom.2012.09.005; Nigg PE, 2015, J BIOL CHEM, V290, P29893, DOI 10.1074/jbc.M115.681494; Patzina C, 2014, J BIOL CHEM, V289, P6020, DOI 10.1074/jbc.M113.543892; PAVLOVIC J, 1992, J VIROL, V66, P2564, DOI 10.1128/JVI.66.4.2564-2569.1992; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Stankunas K, 2007, CHEMBIOCHEM, V8, P1162, DOI 10.1002/cbic.200700087; STRANDEN AM, 1993, VIROLOGY, V197, P642, DOI 10.1006/viro.1993.1639; Verhelst J, 2015, JOVE-J VIS EXP, DOI 10.3791/52871; Verhelst J, 2015, J VIROL, V89, P10879, DOI 10.1128/JVI.01744-15; Verhelst J, 2013, MICROBIOL MOL BIOL R, V77, P551, DOI 10.1128/MMBR.00024-13; Verhelst J, 2012, J VIROL, V86, P13445, DOI 10.1128/JVI.01682-12; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11	23	4	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2226	2236		10.1074/jbc.M116.748806	http://dx.doi.org/10.1074/jbc.M116.748806			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28011636	hybrid, Green Published			2022-12-26	WOS:000395530300016
J	Bezerra, DCD; de Barcelos, RO; de Castro, EC; Duarte, CCJ; Oliveira, RDC; Torraca, TSS; de Araujo-Melo, MH; Braga, FPB; Terceiro, BRF; Paesl, LRDB; Schubach, AD; Valete-Rosalino, CM				de Oliveira Bezerra, Debora Cristina; de Barcelos, Renata Oliveira; de Castro, Ellen Carvalho; Jardim Duarte, Claudia Cristina; Carvalhaes Oliveira, Raquel de Vasconcellos; de Sousa Torraca, Tania Salgado; de Araujo-Melo, Maria Helena; Born Braga, Frederico Pereira; Ferreira Terceiro, Benivaldo Ramos; do Nascimento Brahim Paesl, Lucia Regina; Schubach, Armando de Oliveira; Valete-Rosalino, Claudia Maria			Alterations in Evoked Otoacoustic Emissions by the Use of Meglumine Antimoniate in American Tegumentary Leishmaniasis Patients	PLOS ONE			English	Article							PENTAVALENT ANTIMONY; OTOTOXICITY	Introduction Tegumentary Leishmaniasis (TL) is a neglected, non-contagious, infectious disease, caused by different protozoa species of the Leishmania genus that affects skin and mucous membranes. Meglumine Antimoniate (MA), the first drug of choice for TL treatment in Brazil, has already been associated with cochlear toxicity, which is defined as damages of the cochlea caused by exposure to chemical substances, resulting in reversible or irreversible hearing loss. Auditory monitoring for cochlear toxicity aims at the early detection of auditory disorders, enabling, when possible, hearing to be preserved or an early auditory rehabilitation. Although otoacoustic emissions (OAEs) are used in this monitoring, there is no consensus on the criteria that define cochlear toxicity by this examination. The objective of this study was to describe the characteristics of the OAEs in cochlear toxicity monitoring in TL patients using MA. Methods Prospective and longitudinal study of auditory monitoring of 35 patients with parasitological diagnosis of TL, with liminal tonal audiometry, high frequency audiometry, immitanciometry, distortion product evoked otoacoustic emissions (DPEOAEs) and transient evoked otoacoustic emissions (TEOAEs) before treatment, at the end of treatment, one month after the end of treatment and two months after the end of treatment. Results 80% male, with median age of 44 years (IIQ: 22-59). In the pre-treatment evaluation: 11.4% complained of hearing loss and 20% of tinnitus, 48.6% presented auditory alterations in liminal tonal audiometry (LTA, 65.2% in high frequency audiometry (HFA), 26.6% in DPEOAE and 51.4% in TEOAE. No association was verified between genre and alterations in the EOAE examinations. We observed that patients that presented disorders in DPEOAE examinations were 17 years older than those without alterations and that patients that showed disorders in TEOAEO examinations were 34 years older than those without disorders. The presence of alterations in DPEOAE and TEOAE before beginning treatment was associated with each other and with the presence of alterations in LTA and HFA, and only DPEOAE was associated with hearing loss. We observed a significantly higher number of alterations of DPEOAE at the end of treatment than during pre-treatment and values of the ratio signal/noise significantly smaller at the end of treatment than during pre-treatment in the frequencies of 2 kHz (difference of 1.7dB; p = 0.016) and 4 kHz (difference of 2.45dB; p = 0.016) in DPEOAE and in the range 1.75/2.5 kHz in TEOAE (difference of 2.9dB; p = 0.039). Conclusion The ototoxic signals observed in our study using EOAE indicated that both, DPEOAE and TEOAE are adequate and sensitive techniques for clinical monitoring of ototoxicity by MA. Their application is very simple, and their results help the physician to take the most adequate steps for each patient, thus avoiding permanent hearing damage.	[de Oliveira Bezerra, Debora Cristina; de Castro, Ellen Carvalho; Carvalhaes Oliveira, Raquel de Vasconcellos; Born Braga, Frederico Pereira; Ferreira Terceiro, Benivaldo Ramos; do Nascimento Brahim Paesl, Lucia Regina; Schubach, Armando de Oliveira; Valete-Rosalino, Claudia Maria] Oswaldo Cruz Fdn INI FIOCRUZ, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil; [de Barcelos, Renata Oliveira; Jardim Duarte, Claudia Cristina; de Sousa Torraca, Tania Salgado; Valete-Rosalino, Claudia Maria] Univ Fed Rio de Janeiro, Fac Med, Dept Otorhinolaryngol & Ophthalmol, Rio De Janeiro, Brazil; [de Araujo-Melo, Maria Helena] Fed Univ State Rio de Janeiro, Dept Otorhinolaryngol, Fac Med, UNIRIO, Rio De Janeiro, Brazil; [Schubach, Armando de Oliveira] Brazilian Natl Council Sci & Technol Dev CNPq, Brasilia, DF, Brazil; [Schubach, Armando de Oliveira; Valete-Rosalino, Claudia Maria] Carlos Chagas Filho Fdn Res Support State Rio de, Rio De Janeiro, Brazil; [Valete-Rosalino, Claudia Maria] New Univ Lisbon UNL, Hyg & Trop Med Inst IHMT, Lisbon, Portugal	Universidade Federal do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro; Universidade Nova de Lisboa	Valete-Rosalino, CM (corresponding author), Oswaldo Cruz Fdn INI FIOCRUZ, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.; Valete-Rosalino, CM (corresponding author), Univ Fed Rio de Janeiro, Fac Med, Dept Otorhinolaryngol & Ophthalmol, Rio De Janeiro, Brazil.; Valete-Rosalino, CM (corresponding author), Carlos Chagas Filho Fdn Res Support State Rio de, Rio De Janeiro, Brazil.; Valete-Rosalino, CM (corresponding author), New Univ Lisbon UNL, Hyg & Trop Med Inst IHMT, Lisbon, Portugal.	claudia.valete@ini.fiocruz.br	Valete-Rosalino, Cláudia Maria/AAR-4293-2021; Oliveira, Raquel de V C de/S-7443-2016	Oliveira, Raquel de V C de/0000-0001-9387-8645	Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ), Brazil [E-26/102.183/2013, E-26/111.717/2012]; "Grant Apoio Emergencial - BBP/PPG FAPERJ [E- 26/203.563/2015]; CNPq, Brazil; FAPERJ, Brazil; FAPERJ	Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ), Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); "Grant Apoio Emergencial - BBP/PPG FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ, Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by the Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ) (E-26/102.183/2013; E-26/111.717/2012), Brazil, and "Grant Apoio Emergencial - BBP/PPG FAPERJ, processo E- 26/203.563/2015". AOS is the recipient of fellowships from CNPq and FAPERJ, Brazil. CMVR is the recipient of fellowships from FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparing the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; American Academy of Audiology, 2005, POS STAT CLIN PRACT; American Speech-Language-Hearing Association, 2004, SCOP PRACT AUD; Azeredo-Coutinho RB, 2014, LEISHMANIOSES CONTIN, P311; Azevedo MF., 2003, CONHECIMENTOS ESSENC, P35; Bezerra D. M., 2011, THESIS; Bom Braga FP, 2012, THESIS; Brasil MdS Secretaria de Vigilancia em Saude, 2013, NORM MAN TECHN MAN V; CHULAY JD, 1985, AM J TROP MED HYG, V34, P702, DOI 10.4269/ajtmh.1985.34.702; Crepaldi de Almeida Elizabeth Oliveira, 2008, Braz J Otorhinolaryngol, V74, P382; Jacob Lilian Cassia Bornia, 2006, Rev. Bras. Otorrinolaringol., V72, P836, DOI 10.1590/S0034-72992006000600017; Konrad-Martin D, 2014, J REHABIL RES DEV, V51, P81, DOI 10.1682/JRRD.2013.04.0092; Lopes AC, 2009, INT ARCH OTORHINOLAR, V13, P293; Miekeley N, 2002, ANAL BIOANAL CHEM, V372, P495, DOI 10.1007/s00216-001-1213-7; Obasikene G, 2012, NIGER J CLIN PRACT, V15, P453, DOI 10.4103/1119-3077.104527; Oliveira LF, 2011, ACTA TROP, V118, P87, DOI 10.1016/j.actatropica.2011.02.007; Reavis KM, 2015, EAR HEARING, V36, pE251, DOI 10.1097/AUD.0000000000000176; Reavis KM, 2011, EAR HEARING, V32, P61, DOI 10.1097/AUD.0b013e3181e8b6a7; Russo IP, 2009, PRATICA AUDIOLOGIA C; Santos Andreza Ferreira dos, 2009, Rev. soc. bras. fonoaudiol., V14, P521, DOI 10.1590/S1516-80342009000400016; Saude P., 2015, CASOS LEISHMANIOSE T; Schubach AD, 2005, REV SOC BRAS MED TRO, V38, P213, DOI 10.1590/S0037-86822005000300001; Schubach AO, 2002, REV SOC BRASILEIRA M, V35, P102; Sheppard A, 2014, ACTA OTORHINOLARYNGO, V34, P79; Sockalingam R, 2000, AM J OTOL, V21, P521; Valete-Rosalino CM, 2014, REV INST MED TROP SP, V56, P439, DOI 10.1590/S0036-46652014000500012; Valete-Rosalino Cláudia Maria, 2005, Rev. Bras. Otorrinolaringol., V71, P193, DOI 10.1590/S0034-72992005000200013; Vasquez L, 2006, CURR THER RES CLIN E, V67, P193, DOI 10.1016/j.curtheres.2006.06.005; WHO, 2015, LEISHM SIT TRENDS; ZOROWKA PG, 1993, INT J PEDIATR OTORHI, V25, P73, DOI 10.1016/0165-5876(93)90011-Q	30	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168492	10.1371/journal.pone.0168492	http://dx.doi.org/10.1371/journal.pone.0168492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045920	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300026
J	Pietrzak, R; Werner, B				Pietrzak, Radoslaw; Werner, Bozena			Postsystolic Shortening Is Associated with Altered Right Ventricular Function in Children after Tetralogy of Fallot Surgical Repair	PLOS ONE			English	Article							SYSTOLIC FUNCTION; DOPPLER-ECHOCARDIOGRAPHY; PULMONARY REGURGITATION; FILLING PRESSURES; DYSSYNCHRONY; MECHANISMS; ADULTS; HYPERTENSION; ADOLESCENTS; DYSFUNCTION	The aim of the study was to determine whether segmental interactions, as expressed by postsystolic shortening (PSS), affects RV mechanics and are connected with impaired systolic and diastolic function in rTOF children. Patients and Methods: 55 rTOF adolescent (study group), and 34 healthy volunteers (control group) were examined using classical Doppler flow (Doppler), Tissue Doppler Imaging (TDI) and Speckle Tracking Echocardiography (STE). PSS was found to occur when time to peak (TTP) was longer than pulmonary valve closure time (PVCT). TTP and strain were derived from RV lateral segments basal (BL), medial (ML) and apical (AL) in STE. PVCT was measured from the beginning of QRS complex in the ECG to the termination of Doppler flow at the pulmonary valve. TDI was obtained at the lateral tricuspid annulus site and the systolic (S'), early (E') and late diastolic (A') peak velocities were measured along with isovolumic contraction (IVCT), and relaxation (IVRT) time. PW was used to measure early tricuspid inflow velocity (E) for calculating the E/E' ratio. The TDI data in patients with PSS presence (TTP>PVCT) and those in whom it did not occur (TTP<PVCT) were compared. Results: PSS in BL, ML and AL were observed respectively in: 27(51,9%), 9 (18%), and 8 (16,7%) patients. Mean values of TTP in BL, ML, and AL were respectively: 420.6 +/- 55.5ms, 389.8 +/- 50.Oms and 366.7 +/- 59.Oms. PVCT mean value was 396.6 +/- 33.5ms. In the study group, the mean E' in TTP>PVCT was significantly lower (4.8 1.8 cm/s) compared to mean E' in TTP<PVCT (8.4 +/- 2.6 cm/s), p<0.01. The average E/E' was significantly higher in TTP>PCVT than in TTP<PVCT, respectively 21.6 +/- 7.3 vs 12.2 +/- 5.1, p<0.05. IVRT was significantly prolonged in TTP>PVCT compared to IVRT in TTP<PVCT, respectively 95.9 +/- 38.7 vs 77.0 +/- 35.1, p<0.05. Furthermore, in TTP>PVCT, significantly higher strain in BL (-28.8 +/- 8.7%) was observed when compared to that parameter in TTP<PVCT (-35.3 +/- 13.1%), p <0.05. Conclusions: Tissue Doppler Echocardiography and Speckle Tracking Echocardiography are useful techniques for detecting regional systolic and diastolic dysfunction in children after Tetralogy of Fallot surgical repair. Postsystolic shortening in the basal lateral segment is commonly seen in children after the Tetralogy of Fallot surgical repair, and is associated with altered right ventricular systolic and diastolic function.	[Pietrzak, Radoslaw; Werner, Bozena] Med Univ Warsaw Zwirki & Wigury, Dept Pediat Cardiol & Gen Pediat, Warsaw, Poland		Werner, B (corresponding author), Med Univ Warsaw Zwirki & Wigury, Dept Pediat Cardiol & Gen Pediat, Warsaw, Poland.	bozena.werner@wum.edu.pl	Pietrzak, Radoslaw/V-2693-2018; Werner, Bożena/V-4573-2018	Pietrzak, Radoslaw/0000-0003-3810-2822; Werner, Bożena/0000-0002-6416-4106				Baltabaeva A, 2008, EUR J ECHOCARDIOGR, V9, P501, DOI 10.1016/j.euje.2007.08.004; Bordachar P, 2008, EUROPACE, V10, P967, DOI 10.1093/europace/eun178; Bouzas B, 2005, EUR HEART J, V26, P433, DOI 10.1093/eurheartj/ehi091; Claus P, 2007, ULTRASOUND MED BIOL, V33, P1963, DOI 10.1016/j.ultrasmedbio.2007.06.003; Coetzee A, 1991, J Cardiothorac Vasc Anesth, V5, P546, DOI 10.1016/1053-0770(91)90003-C; D'Andrea A, 2004, INT J CARDIOL, V94, P213, DOI 10.1016/j.ijcard.2003.04.033; Eek C, 2011, EUR J ECHOCARDIOGR, V12, P483, DOI 10.1093/ejechocard/jer055; Friedberg MK, 2012, EUR HEART J-CARD IMG, V13, P905, DOI 10.1093/ehjci/jes067; Gatzoulis MA, 2000, AM J CARDIOL, V86, P1352, DOI 10.1016/S0002-9149(00)01241-8; GATZOULIS MA, 1995, CIRCULATION, V91, P1775, DOI 10.1161/01.CIR.91.6.1775; Hui W, 2014, CIRC-CARDIOVASC IMAG, V7, P610, DOI 10.1161/CIRCIMAGING.113.001483; Ito T, 2009, AM J CARDIOL, V104, P1568, DOI 10.1016/j.amjcard.2009.07.028; Kjaergaard J, 2006, EUR J ECHOCARDIOGR, V7, P430, DOI 10.1016/j.euje.2005.10.009; Kjaergaard J, 2012, DAN MED J, V59; Li SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078826; Li W, 2004, AM HEART J, V147, P165, DOI 10.1016/S0002-8703(03)00527-1; Lim P, 2008, J AM SOC ECHOCARDIOG, V21, P452, DOI 10.1016/j.echo.2007.09.004; Mercer-Rosa L, 2013, J AM SOC ECHOCARDIOG, V26, P1322, DOI 10.1016/j.echo.2013.06.022; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Ommen SR, 2000, CIRCULATION, V102, P1788; Parsai C, 2009, EUR HEART J, V30, P940, DOI 10.1093/eurheartj/ehn481; Scherptong RWC, 2010, J AM COLL CARDIOL, V56, P1486, DOI 10.1016/j.jacc.2010.04.058; Utsunomiya H, 2009, J AM SOC ECHOCARDIOG, V22, P1368, DOI 10.1016/j.echo.2009.08.023	23	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169178	10.1371/journal.pone.0169178	http://dx.doi.org/10.1371/journal.pone.0169178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046050	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300137
J	Slike, BM; Creegan, M; Marovich, M; Ngauy, V				Slike, Bonnie M.; Creegan, Matthew; Marovich, Mary; Ngauy, Viseth			Humoral Immunity to Primary Smallpox Vaccination: Impact of Childhood versus Adult Immunization on Vaccinia Vector Vaccine Development in Military Populations	PLOS ONE			English	Article							PREEXISTING POXVIRUS IMMUNITY; HIV-1 NEUTRALIZING ANTIBODIES; IMMUNOLOGICAL RESPONSE; HVTN 503/PHAMBILI; DENDRITIC CELLS; SOUTH-AFRICA; PHASE 2H; MVA-B; VIRUS; HIV/AIDS	Modified Vaccinia virus has been shown to be a safe and immunogenic vector platform for delivery of HIV vaccines. Use of this vector is of particular importance to the military, with the implementation of a large scale smallpox vaccination campaign in 2002 in active duty and key civilian personnel in response to potential bioterrorist activities. Humoral immunity to smallpox vaccination was previously shown to be long lasting (up to 75 years) and protective. However, using vaccinia-vectored vaccine delivery for other diseases on a background of anti-vector antibodies (i.e. pre-existing immunity) may limit their use as a vaccine platform, especially in the military. In this pilot study, we examined the durability of vaccinia antibody responses in adult primary vaccinees in a healthy military population using a standard ELISA assay and a novel dendritic cell neutralization assay. We found binding and neutralizing antibody (NAb) responses to vaccinia waned after 5-10 years in a group of 475 active duty military, born after 1972, who were vaccinated as adults with Dryvax (R). These responses decreased from a geometric mean titer (GMT) of 250 to baseline (<20) after 1020 years post vaccination. This contrasted with a comparator group of adults, ages 35-49, who were vaccinated with Dryvax (R) as children. In the childhood vaccinees, titers persisted for >30 years with a GMT of 210 (range 112-3234). This data suggests limited durability of antibody responses in adult vaccinees compared to those vaccinated in childhood and further that adult vaccinia recipients may benefit similarly from receipt of a vaccinia based vaccine as those who are vaccinia na ve. Our findings may have implications for the smallpox vaccination schedule and support the ongoing development of this promising viral vector in a military vaccination program.	[Slike, Bonnie M.; Creegan, Matthew] US Mil HIV Res Program, Silver Spring, MD USA; [Slike, Bonnie M.; Creegan, Matthew] Henry M Jackson Adv Mil Med, Bethesda, MD USA; [Marovich, Mary] NIAID, Div Aids, Bethesda, MD USA; [Ngauy, Viseth] Tripler Army Med Ctr, Honolulu, HI 96859 USA	Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Defense; United States Army	Ngauy, V (corresponding author), Tripler Army Med Ctr, Honolulu, HI 96859 USA.	Viseth.ngauy.mil@mail.mil			Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense [W81XWH-07-2-0067]; Infectious Disease Clinical Research Program (IDCRP); Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [Y1-AI-5072]; Military Vaccine Program (MILVAX)	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense(United States Department of Defense); Infectious Disease Clinical Research Program (IDCRP); Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); Military Vaccine Program (MILVAX)	This work was supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and the U.S. Department of Defense, the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement Y1-AI-5072, and the Military Vaccine Program (MILVAX). The views expressed are those of the authors and should not be construed to represent the positions of the U.S. Army or DoD.	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; [Anonymous], 1994, DRYV PACK INS; [Anonymous], 2007, ACAM2000PACKINS AC I; Bakari M, 2011, VACCINE, V29, P8417, DOI 10.1016/j.vaccine.2011.08.001; Barouch DH, 2014, NAT REV MICROBIOL, V12, P765, DOI 10.1038/nrmicro3360; Belyakov IM, 1999, P NATL ACAD SCI USA, V96, P4512, DOI 10.1073/pnas.96.8.4512; Carr JK, 1996, J VIROL, V70, P5935, DOI 10.1128/JVI.70.9.5935-5943.1996; Climent N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019644; COONEY EL, 1991, LANCET, V337, P567, DOI 10.1016/0140-6736(91)91636-9; Cosma A, 2004, CLIN DIAGN LAB IMMUN, V11, P406, DOI 10.1128/CDLI.11.2.406-410.2004; Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983; de Barra E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115161; Defense Health Agency IB Public Health Division, 2016, SMALLPOX; Gomez CE, 2011, J VIROL, V85, P11468, DOI 10.1128/JVI.05165-11; Esteban M, 2009, HUM VACCINES, V5, P867, DOI 10.4161/hv.9693; Fisman DN, 2002, CLIN INFECT DIS, V35, P1368, DOI 10.1086/344271; Frey SE, 2003, JAMA-J AM MED ASSOC, V289, P3295, DOI 10.1001/jama.289.24.3295; Garcia F, 2011, VACCINE, V29, P8309, DOI 10.1016/j.vaccine.2011.08.098; Giuliano AR, 2007, J INFECT DIS, V196, P1153, DOI 10.1086/521679; Goepfert PA, 2014, J INFECT DIS, V210, P99, DOI 10.1093/infdis/jiu003; Gray GE, 2014, LANCET INFECT DIS, V14, P388, DOI 10.1016/S1473-3099(14)70020-9; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Gudmundsdotter L, 2009, VACCINE, V27, P4468, DOI 10.1016/j.vaccine.2009.05.018; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Lee H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-60; Marovich MA, 2002, J INFECT DIS, V186, P1242, DOI 10.1086/344302; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mastrangeli A, 1996, HUM GENE THER, V7, P79, DOI 10.1089/hum.1996.7.1-79; Naito T, 2007, J GEN VIROL, V88, P61, DOI 10.1099/vir.0.82216-0; OCONNELL CJ, 1964, ANN INTERN MED, V60, P282, DOI 10.7326/0003-4819-60-2-282; ROONEY JF, 1988, J VIROL, V62, P1530, DOI 10.1128/JVI.62.5.1530-1534.1988; Simonich CA, 2016, CELL, V166, P77, DOI 10.1016/j.cell.2016.05.055; Taub DD, 2008, AM J MED, V121, P1058, DOI 10.1016/j.amjmed.2008.08.019; Thiele F, 2015, J VIROL, V89, P2698, DOI 10.1128/JVI.03244-14	34	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169247	10.1371/journal.pone.0169247	http://dx.doi.org/10.1371/journal.pone.0169247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046039	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300152
J	Vyas, M; Raza, A; Ali, MY; Ashraf, MA; Mansoor, S; Shahid, AA; Brown, JK				Vyas, Meenal; Raza, Amir; Ali, Muhammad Yousaf; Ashraf, Muhammad Aleem; Mansoor, Shahid; Shahid, Ahmad Ali; Brown, Judith K.			Knock down of Whitefly Gut Gene Expression and Mortality by Orally Delivered Gut Gene-Specific dsRNAs	PLOS ONE			English	Article							BEMISIA-TABACI HOMOPTERA; DOUBLE-STRANDED-RNA; MEMBRANE-BOUND TREHALASE; SWEET-POTATO; CROP PROTECTION; INSECT PEST; INTERFERENCE; RESISTANCE; HEMIPTERA; ALEYRODIDAE	Control of the whitefly Bemisia tabaci (Genn.) agricultural pest and plant virus vector relies on the use of chemical insecticides. RNA-interference (RNAi) is a homology-dependent innate immune response in eukaryotes, including insects, which results in degradation of the corresponding transcript following its recognition by a double-stranded RNA (dsRNA) that shares 100% sequence homology. In this study, six whitefly `gut' genes were selected from an in silico-annotated transcriptome library constructed from the whitefly alimentary canal or 'gut' of the B biotype of B. tabaci, and tested for knock down efficacy, post-ingestion of dsRNAs that share 100% sequence homology to each respective gene target. Candidate genes were: Acetylcholine receptor subunit a, Alpha glucosidase 1, Aquaporin 1, Heat shock protein 70, Trehalasel, and Trehalose transported. The efficacy of RNAi knock down was further tested in a gene-specific functional bioassay, and mortality was recorded in 24 hr intervals, six days, post-treatment. Based on qPCR analysis, all six genes tested showed significantly reduced gene expression. Moderate-to-high whitefly mortality was associated with the down-regulation of osmoregulation, sugar metabolism and sugar transport -associated genes, demonstrating that whitefly survivability was linked with RNAi results. Silenced Acetylcholine receptor subunit a and Heat shock protein 70 genes showed an initial low whitefly mortality, however, following insecticide or high temperature treatments, respectively, significantly increased knockdown efficacy and death was observed, indicating enhanced post-knockdown sensitivity perhaps related to systemic silencing. The oral delivery of gut-specific dsRNAs, when combined with qPCR analysis of gene expression and a corresponding gene-specific bioassay that relates knockdown and mortality, offers a viable approach for functional genomics analysis and the discovery of prospective dsRNA biopesticide targets. The approach can be applied to functional genomics analyses to facilitate, species-specific dsRNA-mediated control of other non-model hemipterans.	[Vyas, Meenal; Raza, Amir; Ali, Muhammad Yousaf; Brown, Judith K.] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [Raza, Amir; Ali, Muhammad Yousaf; Mansoor, Shahid] NIBGE, Faisalabad, Pakistan; [Ashraf, Muhammad Aleem; Shahid, Ahmad Ali] Univ Punjab, Ctr Excellence Mol Biol CEMB, Lahore, Pakistan	University of Arizona; Pakistan Institute of Engineering & Applied Science; University of Punjab	Brown, JK (corresponding author), Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA.	jbrown@ag.arizona.edu	ali, muhammad/GYR-3505-2022; Ashraf, Muhammad Aleem/AAO-9243-2021; Shahid, Ahmad/AAE-8961-2019; Ali, Muhammad/GXH-4405-2022; Ali, Muhammad Yousaf/AAG-7650-2019	Ashraf, Muhammad Aleem/0000-0001-5503-8223; Ali, Muhammad/0000-0002-1444-7888; Vyas, Meenal/0000-0002-8513-2381; Mansoor, Shahid/0000-0001-7418-1826	USDA [6402-21310-003-10S]; Higher Education Commission of Pakistan-International Research Support Initiative Program	USDA(United States Department of Agriculture (USDA)); Higher Education Commission of Pakistan-International Research Support Initiative Program	MV was a Post-Doctoral Associate funded in part on the whitefly component of the USDA-funded Project 6402-21310-003-10S, Development of Cotton leaf curl virus diagnostic tools and monitoring of CLCuV in Pakistan. AR, MYA, and MAA were visiting scholars supported by funding received from the Higher Education Commission of Pakistan-International Research Support Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Benga G, 2009, IUBMB LIFE, V61, P112, DOI 10.1002/iub.156; Borgio JF, 2011, J BIOSCIENCE, V36, P153; Boutla A, 2001, CURR BIOL, V11, P1776, DOI 10.1016/S0960-9822(01)00541-3; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; Brown JK, 2002, PLANT VIRUSES AS MOLECULAR PATHOGENS, P279; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Brown JK, 2002, ADV BOT RES, V36, P65, DOI 10.1016/S0065-2296(02)36059-2; Brown Judith K., 2010, P31; BYRNE DN, 1989, ENVIRON ENTOMOL, V18, P429, DOI 10.1093/ee/18.3.429; BYRNE DN, 1991, ANNU REV ENTOMOL, V36, P431, DOI 10.1146/annurev.en.36.010191.002243; Campbell EM, 2008, J COMP PHYSIOL B, V178, P935, DOI 10.1007/s00360-008-0288-2; Chen J, 2010, STOMATOLOGY, V2010, P5, DOI DOI 10.1371/J0URNAL.P0NE.0010133; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; CLEGG JS, 1961, SCIENCE, V134, P54, DOI 10.1126/science.134.3471.54; COLACO C, 1995, SCIENCE, V268, P788, DOI 10.1126/science.7754360; COSTA HS, 1993, INSECT SCI APPL, V14, P255, DOI 10.1017/S1742758400014703; COUDRIET DL, 1985, ENVIRON ENTOMOL, V14, P516, DOI 10.1093/ee/14.4.516; Cristofoletti PT, 2003, J INSECT PHYSIOL, V49, P11, DOI 10.1016/S0022-1910(02)00222-6; DENHOLM I, 1992, ANNU REV ENTOMOL, V37, P91, DOI 10.1146/annurev.en.37.010192.000515; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Elbein A D, 1974, Adv Carbohydr Chem Biochem, V30, P227, DOI 10.1016/S0065-2318(08)60266-8; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Gauthier M, 2010, ADV EXP MED BIOL, V683, P97; Ghanim M, 2007, INSECT BIOCHEM MOLEC, V37, P732, DOI 10.1016/j.ibmb.2007.04.006; Gill Raymond J., 2010, P5; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; HOFFMAN CJ, 1986, ENTOMOL EXP APPL, V42, P139, DOI 10.1007/BF00343540; Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jaubert-Possamai S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-63; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Kang ZW, INSECT SCI; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104; Killiny N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110536; Li HC, 2015, PLANT CELL ENVIRON, V38, P2277, DOI 10.1111/pce.12546; Liu ZW, 2005, P NATL ACAD SCI USA, V102, P8420, DOI 10.1073/pnas.0502901102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu ZC, 2011, J EXP BIOL, V214, P764, DOI 10.1242/jeb.047415; Lu ZC, 2008, COMP BIOCHEM PHYS D, V3, P257, DOI 10.1016/j.cbd.2008.06.003; Mao JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048718; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Millar Neil S., 2007, Invertebrate Neuroscience, V7, P53, DOI 10.1007/s10158-006-0040-0; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Prabhaker N, 2006, J ECON ENTOMOL, V99, P141, DOI 10.1603/0022-0493(2006)099[0141:EOBSDT]2.0.CO;2; Prentice K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115336; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Quintero Constanza, 2001, Revista Colombiana de Entomologia, V27, P27; Rauch N, 2003, ARCH INSECT BIOCHEM, V54, P165, DOI 10.1002/arch.10114; Roh JY, 2007, J MICROBIOL BIOTECHN, V17, P547; Rosa C, 2012, PEST MANAG SCI, V68, P995, DOI 10.1002/ps.3253; Rosell RC, 1997, ANN ENTOMOL SOC AM, V90, P575, DOI 10.1093/aesa/90.5.575; Rosell RC, 2003, ANN ENTOMOL SOC AM, V96, P544, DOI 10.1603/0013-8746(2003)096[0544:SLITFC]2.0.CO;2; ROWLAND M, 1991, B ENTOMOL RES, V81, P189, DOI 10.1017/S0007485300051270; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Salvucci ME, 2000, J THERM BIOL, V25, P363, DOI 10.1016/S0306-4565(99)00108-4; Salvucci ME, 2000, J INSECT PHYSIOL, V46, P1461, DOI 10.1016/S0022-1910(00)00070-6; San Miguel K., 2015, PEST MANAG SCI; Shakesby AJ, 2009, INSECT BIOCHEM MOLEC, V39, P1, DOI 10.1016/j.ibmb.2008.08.008; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Tang B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-51; Tatun N, 2008, INSECT BIOCHEM MOLEC, V38, P788, DOI 10.1016/j.ibmb.2008.05.003; Thakur N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087235; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Upadhyay SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083692; Whangbo JS, 2008, TRENDS GENET, V24, P297, DOI 10.1016/j.tig.2008.03.007; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Yu H, 2012, BIOL INVASIONS, V14, P1587, DOI 10.1007/s10530-012-0171-7; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang J, 2015, SCIENCE, V347, P991, DOI 10.1126/science.1261680; Zhang YX, 2015, J NEUROCHEM, V135, P686, DOI 10.1111/jnc.13281	81	35	35	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168921	10.1371/journal.pone.0168921	http://dx.doi.org/10.1371/journal.pone.0168921			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045942	gold, Green Submitted, Green Published			2022-12-26	WOS:000391612300071
J	Babcock, RC; Dambacher, JM; Morello, EB; Plaganyi, EE; Hayes, KR; Sweatman, HPA; Pratchett, MS				Babcock, Russell C.; Dambacher, Jeffrey M.; Morello, Elisabetta B.; Plaganyi, Eva E.; Hayes, Keith R.; Sweatman, Hugh P. A.; Pratchett, Morgan S.			Assessing Different Causes of Crown-of-Thorns Starfish Outbreaks and Appropriate Responses for Management on the Great Barrier Reef	PLOS ONE			English	Article							ACANTHASTER-PLANCI L; FOOD-LIMITED GROWTH; LARVAL DEVELOPMENT; QUALITATIVE-ANALYSIS; POPULATION-DYNAMICS; RECURRING OUTBREAKS; GEOLOGICAL EVIDENCE; TERRESTRIAL RUNOFF; PREDATOR REMOVAL; CORAL-REEFS	The crown-of-thorns starfish Acanthaster planci (COTS) has contributed greatly to declines in coral cover on Australia's Great Barrier Reef, and remains one of the major acute disturbances on Indo-Pacific coral reefs. Despite uncertainty about the underlying causes of outbreaks and the management responses that might address them, few studies have critically and directly compared competing hypotheses. This study uses qualitative modelling to compare hypotheses relating to outbreak initiation, explicitly considering the potential role of positive feedbacks, elevated nutrients, and removal of starfish predators by fishing. When nutrients and fishing are considered in isolation, the models indicate that a range of alternative hypotheses are capable of explaining outbreak initiation with similar levels of certainty. The models also suggest that outbreaks may be caused by multiple factors operating simultaneously, rather than by single proximal causes. As the complexity and realism of the models increased, the certainty of outcomes decreased, but key areas that require further research to improve the structure of the models were identified. Nutrient additions were likely to result in outbreaks only when COTS larvae alone benefitted from nutrients. Similarly, the effects of fishing on the decline of corals depended on the complexity of interactions among several categories of fishes. Our work suggests that management approaches which seek to be robust to model structure uncertainty should allow for multiple potential causes of outbreaks. Monitoring programs can provide tests of alternative potential causes of outbreaks if they specifically monitor all key taxa at reefs that are exposed to appropriate combinations of potential causal factors.	[Babcock, Russell C.; Morello, Elisabetta B.; Plaganyi, Eva E.] CSIRO Oceans & Atmosphere, Brisbane, Qld, Australia; [Babcock, Russell C.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Dambacher, Jeffrey M.; Hayes, Keith R.] CSIRO Computat Informat, Hobart, Tas, Australia; [Sweatman, Hugh P. A.] Australian Inst Marine Sci, PMB 3, Townsville, Qld, Australia; [Pratchett, Morgan S.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian Institute of Marine Science; James Cook University	Babcock, RC (corresponding author), CSIRO Oceans & Atmosphere, Brisbane, Qld, Australia.; Babcock, RC (corresponding author), Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia.	Russ.Baboock@csiro.au	Pratchett, Morgan/AAW-5179-2020; Hayes, Keith R/A-4550-2009; Babcock, Russell C/A-3794-2012; Plaganyi, Eva E/C-5130-2011	Pratchett, Morgan/0000-0002-1862-8459; Hayes, Keith R/0000-0003-4094-3575; Babcock, Russell C/0000-0002-7756-1290; Plaganyi, Eva E/0000-0002-4740-4200	CSIRO Oceans and Atmosphere; Australian Department of the Environment	CSIRO Oceans and Atmosphere; Australian Department of the Environment(Australian Government)	This work was financially supported by the CSIRO Oceans and Atmosphere and the Australian Department of the Environment.	ANTONELLI PL, 1984, J THEOR BIOL, V107, P667, DOI 10.1016/S0022-5193(84)80138-1; Babcock R., 1992, MARINE FRESHWATER RE, V43, P525; BABCOCK RC, 1994, BIOL BULL-US, V186, P17, DOI 10.2307/1542033; Babcock RC, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-3009-5; Belliveau SA, 2002, MAR ECOL PROG SER, V232, P105, DOI 10.3354/meps232105; BENZIE JAH, 1992, MAR BIOL, V112, P119, DOI 10.1007/BF00349735; BENZIE JAH, 1992, AUST J MAR FRESH RES, V43, P597, DOI 10.1071/MF9920597; BIRKELAND C, 1982, MAR BIOL, V69, P175, DOI 10.1007/BF00396897; BIRKELAND C, 1989, AM SCI, V77, P154; BIRKELAND C, 1990, MAJOR MANAGEMENT PRO; BLACK KP, 1991, MAR ECOL PROG SER, V69, P55, DOI 10.3354/meps069055; Bradbury R, 1990, WHAT CONTROLS OUTBRE, P278; BRADBURY RH, 1990, MATH COMPUT MODEL, V13, P61, DOI 10.1016/0895-7177(90)90009-C; Brodie J, 2005, MAR POLLUT BULL, V51, P266, DOI 10.1016/j.marpolbul.2004.10.035; Brodie J, 1999, MANAGEMENT GREAT BAR, P428; BRODIE JE, 1992, AUST J MAR FRESH RES, V43, P539; Brodie J, 2012, ESTUAR COAST SHELF S, V104, P1, DOI 10.1016/j.ecss.2012.03.012; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; CAMPBELL A C, 1970, Biological Conservation, V2, P246, DOI 10.1016/0006-3207(70)90004-2; Chakroborty S, 2016, J MAR BIOL ASSOC UK, P1; COLGAN MW, 1987, ECOLOGY, V68, P1592, DOI 10.2307/1939851; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Dambacher JM, 2007, Q REV BIOL, V82, P227, DOI 10.1086/519966; Dambacher JM, 2015, ECOL APPL, V25, P278, DOI 10.1890/13-2030.1; Dambacher JM, 2005, MATH BIOSCI, V197, P1, DOI 10.1016/j.mbs.2005.06.001; Dambacher JM, 2003, ECOL MODEL, V161, P79, DOI 10.1016/S0304-3800(02)00295-8; DANA TF, 1972, PAC SCI, V26, P355; DAWIRS RR, 1984, J EXP MAR BIOL ECOL, V80, P47, DOI 10.1016/0022-0981(84)90093-5; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DOHERTY P, 1994, SCIENCE, V263, P935, DOI 10.1126/science.263.5149.935; DONE TJ, 1987, CORAL REEFS, V6, P75, DOI 10.1007/BF00301377; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Endean R, 1969, REPORT INVESTIGATION; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; FENAUX L, 1994, LIMNOL OCEANOGR, V39, P84, DOI 10.4319/lo.1994.39.1.0084; Ganter R, 1987, ORAL HIST HUMAN USE; Hayes K, 2012, ECOLOGICAL INDICATOR; Hosack GR, 2008, ECOL APPL, V18, P1070, DOI 10.1890/07-0482.1; JAMES MK, 1992, AUST J MAR FRESH RES, V43, P569; JOHNSON CR, 1991, MAR ECOL PROG SER, V71, P143, DOI 10.3354/meps071143; Jones G.P., 1991, P156; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; KEESING JK, 1992, CORAL REEFS, V11, P79, DOI 10.1007/BF00357425; KEESING JK, 1992, AUST J MAR FRESH RES, V43, P635; KEESING JK, 1992, MAR ECOL PROG SER, V85, P107, DOI 10.3354/meps085107; KENCHINGTON RA, 1977, BIOL CONSERV, V11, P103, DOI 10.1016/0006-3207(77)90032-5; Kroon FJ, 2012, MAR POLLUT BULL, V65, P261, DOI 10.1016/j.marpolbul.2011.10.030; Lane DJW, 2012, J MAR BIOL ASSOC UK, V92, P803, DOI 10.1017/S0025315411000890; Lucas J.S., 1975, P109; LUCAS JS, 1982, J EXP MAR BIOL ECOL, V65, P173, DOI 10.1016/0022-0981(82)90043-0; McCallum H, 1989, P 6 INT COR REEF S, P101; McCallum H.I., 1990, Lecture Notes in Biomathematics, V88, P208; MCCALLUM HI, 1987, J THEOR BIOL, V127, P207, DOI 10.1016/S0022-5193(87)80131-5; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Mendonca VM, 2010, ZOOL STUD, V49, P108; MORAN PJ, 1986, OCEANOGR MAR BIOL, V24, P379; Morello EB, 2014, MAR ECOL PROG SER, V512, P167, DOI 10.3354/meps10858; Nakamura M, 2014, MAR BIOL, V161, P2521, DOI 10.1007/s00227-014-2524-5; Nishihira M., 1974, Proceedings int Coral Reef Symp, V2, P577; OLSON RR, 1989, ANNU REV ECOL SYST, V20, P225; Ormond R., 1990, Lecture Notes in Biomathematics, V88, P189; Owens D, 1971, FIJI AGR J, V33, P3; PANDOLFI JM, 1992, CORAL REEFS, V11, P87, DOI 10.1007/BF00357427; PAULAY G, 1985, J EXP MAR BIOL ECOL, V93, P1, DOI 10.1016/0022-0981(85)90145-5; PEARSON RG, 1981, MAR ECOL PROG SER, V4, P105, DOI 10.3354/meps004105; Peason R., 1969, PRELIMINARY STUDY CO, V3, P27; Pratchett MS, 2014, OCEANOGR MAR BIOL, V52, P133; Pratchett MS, 2005, CORAL REEFS, V24, P453, DOI 10.1007/s00338-005-0006-4; Puccia C.J., 1991, QUALITATIVE SIMULATI, P119, DOI [10.1007/978-1-4613-9072-5_6, DOI 10.1007/978-1-4613-9072-5_6]; QIAN PY, 1993, J EXP MAR BIOL ECOL, V166, P93, DOI 10.1016/0022-0981(93)90080-8; REICHELT RE, 1990, CORAL REEFS, V9, P97, DOI 10.1007/BF00258219; REICHELT RE, 1990, ECOL MODEL, V49, P153, DOI 10.1016/0304-3800(90)90026-D; Rivera-posada Jairo, 2014, Journal of Coastal Life Medicine, V2, P187; Roche RC, 2015, MAR BIOL, V162, P1695, DOI 10.1007/s00227-015-2708-7; Seymour RM, 1999, MAR ECOL PROG SER, V176, P1, DOI 10.3354/meps176001; SWEATMAN HPA, 1995, CORAL REEFS, V14, P47, DOI 10.1007/BF00304071; Sweatman H, 2008, CURR BIOL, V18, pR598, DOI 10.1016/j.cub.2008.05.033; Taylor S., 2012, 2010 STATEWIDE RECRE; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; VANDERLAAN JD, 1990, MATH COMPUT MODEL, V14, P705, DOI 10.1016/0895-7177(90)90273-P; Vanhatalo J., 2016, J APPL ECOL; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014312; Vine P.J., 1973, Atoll Res Bull, VNo. 166, P1; YAMAGUCHI M, 1986, CORAL REEFS, V5, P23, DOI 10.1007/BF00302168	85	40	41	3	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169048	10.1371/journal.pone.0169048	http://dx.doi.org/10.1371/journal.pone.0169048			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036360	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000391229300049
J	Berchtold, L; Ponte, B; Moll, S; Hadaya, K; Seyde, O; Bachtler, M; Vallee, JP; Martine, PY; Pasch, A; de Seigneux, S				Berchtold, Lena; Ponte, Belen; Moll, Solange; Hadaya, Karine; Seyde, Olivia; Bachtler, Matthias; Vallee, Jean-Paul; Martine, Pierre-Yves; Pasch, Andreas; de Seigneux, Sophie			Phosphocalcic Markers and Calcification Propensity for Assessment of Interstitial Fibrosis and Vascular Lesions in Kidney Allograft Recipients	PLOS ONE			English	Article							GROWTH-FACTOR 23; ALL-CAUSE MORTALITY; TRANSPLANT RECIPIENTS; VITAMIN-D; OBSTRUCTIVE NEPHROPATHY; CARDIOVASCULAR-DISEASE; RENAL-TRANSPLANTATION; PARATHYROID-HORMONE; MINERAL METABOLISM; KLOTHO LEVELS	Renal interstitial fibrosis and arterial lesions predict loss of function in chronic kidney disease. Noninvasive estimation of interstitial fibrosis and vascular lesions is currently not available. The aim of the study was to determine whether phosphocalcic markers are associated with, and can predict, renal chronic histological changes. We included 129 kidney allograft recipients with an available transplant biopsy in a retrospective study. We analyzed the associations and predictive values of phosphocalcic markers and serum calcification propensity (T-50) for chronic histological changes (interstitial fibrosis and vascular lesions). PTH, T-50 and vitamin D levels were independently associated to interstitial fibrosis. PTH elevation was associated with increasing interstitial fibrosis severity (r = 0.29, p = 0.001), while T-50 and vitamin D were protective (r = -0.20, p = 0.025 and r = -0.23, p = 0.009 respectively). On the contrary, fibroblast growth factor 23 (FGF23) and Klotho correlated only modestly with interstitial fibrosis (p = 0.045) whereas calcium and phosphate did not. PTH, vitamin D and T-50 were predictors of extensive fibrosis (AUC: 0.73, 0.72 and 0.68 respectively), but did not add to renal function prediction. PTH, FGF23 and T-50 were modestly predictive of low fibrosis (AUC: 0.63, 0.63 and 0.61) but did not add to renal function prediction. T-50 decreased with increasing arterial lesions (r = -0.21, p = 0.038). The discriminative performance of T-50 in predicting significant vascular lesions was modest (AUC 0.61). In summary, we demonstrated that PTH, vitamin D and T-50 are associated to interstitial fibrosis and vascular lesions in kidney allograft recipients independently of renal function. Despite these associations, mineral metabolism indices do not show superiority or additive value to fibrosis prediction by eGFR and proteinuria in kidney allograft recipients, except for vascular lesions where T-50 could be of relevance.	[Berchtold, Lena] Univ Hosp Geneva, Dept Internal Med, Serv Internal Med, Geneva, Switzerland; [Berchtold, Lena; Ponte, Belen; Hadaya, Karine; Martine, Pierre-Yves; de Seigneux, Sophie] Univ Hosp Geneva, Dept Internal Med Special, Serv Nephrol, Geneva, Switzerland; [Moll, Solange; Seyde, Olivia] Univ Hosp Geneva, Inst Clin Pathol, Dept Clin Pathol, Geneva, Switzerland; [Bachtler, Matthias; Pasch, Andreas] Univ Bern, Dept Clin Res, Serv Clin Res, Bern, Switzerland; [Vallee, Jean-Paul] Univ Hosp Geneva, Dept Radiol & Med Informat, Serv Radiol, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Bern; University of Geneva	de Seigneux, S (corresponding author), Univ Hosp Geneva, Dept Internal Med Special, Serv Nephrol, Geneva, Switzerland.	Sophie.deseigneux@hcuge.ch		Vallee, Jean-Paul/0000-0001-7546-2013; Berchtold, Lena/0000-0001-8815-4263	NCCR kidney.ch; Swiss National Foundation	NCCR kidney.ch; Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was funded by grants from NCCR kidney.ch to SdS and AP and Swiss National Foundation to SdS.	Baia LC, 2015, NAT REV NEPHROL, V11, P656, DOI 10.1038/nrneph.2015.153; BANFI G, 1991, AM J KIDNEY DIS, V18, P240, DOI 10.1016/S0272-6386(12)80885-7; Bleskestad IH, 2015, EUR J ENDOCRINOL, V172, P343, DOI 10.1530/EJE-14-0457; Bleskestad IH, 2014, CLIN TRANSPLANT, V28, P479, DOI 10.1111/ctr.12341; Bosworth CR, 2012, KIDNEY INT, V82, P693, DOI 10.1038/ki.2012.193; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Cosio FG, 2005, AM J TRANSPLANT, V5, P1130, DOI 10.1111/j.1600-6143.2005.00811.x; Cosio FG, 2005, AM J TRANSPLANT, V5, P2464, DOI 10.1111/j.1600-6143.2005.01050.x; Courbebaisse M, 2011, TRANSPLANTATION, V91, P207, DOI 10.1097/TP.0b013e318200ba37; Dahle DO, 2015, AM J TRANSPLANTATION; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Doorenbos CRC, 2009, NAT REV NEPHROL, V5, P691, DOI 10.1038/nrneph.2009.185; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Grimm P C, 1999, Pediatr Transplant, V3, P257, DOI 10.1034/j.1399-3046.1999.00044.x; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Heijboer AC, 2009, ANN CLIN BIOCHEM, V46, P338, DOI 10.1258/acb.2009.009066; Hernandez D, 2005, KIDNEY INT, V67, P2015, DOI 10.1111/j.1523-1755.2005.00303.x; Hiemstra TF, 2013, AM J NEPHROL, V37, P339, DOI 10.1159/000348376; Hu MC, 2013, SEMIN NEPHROL, V33, P118, DOI 10.1016/j.semnephrol.2012.12.013; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Keyzer CA, 2015, J AM SOC NEPHROLOGY; Kim HR, 2013, AM J KIDNEY DIS, V61, P899, DOI 10.1053/j.ajkd.2013.01.024; Kitagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056695; Kovesdy CP, 2008, KIDNEY INT, V73, P1296, DOI 10.1038/ki.2008.64; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lucisano S, 2013, KIDNEY BLOOD PRESS R, V37, P667, DOI 10.1159/000355747; Malyszko J, 2014, TRANSPL P, V46, P2647, DOI 10.1016/j.transproceed.2014.09.015; Marques Igor Denizarde Bacelar, 2014, J Bras Nefrol, V36, P54; Mehta R, 2015, NEPHROL DIAL TRANSPL, V30, P1534, DOI 10.1093/ndt/gfv123; Mirkovic K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055887; Mirza MAI, 2009, NEPHROL DIAL TRANSPL, V24, P3125, DOI 10.1093/ndt/gfp205; Park WD, 2010, J AM SOC NEPHROL, V21, P1987, DOI 10.1681/ASN.2010010049; Pasch A, 2012, J AM SOC NEPHROL, V23, P1744, DOI 10.1681/ASN.2012030240; Pavik I, 2013, NEPHROL DIAL TRANSPL, V28, P352, DOI 10.1093/ndt/gfs460; Pedersen L, 2013, CLIN BIOCHEM, V46, P1079, DOI 10.1016/j.clinbiochem.2013.05.046; Pihlstrom H, 2015, TRANSPLANTATION, V99, P351, DOI 10.1097/TP.0000000000000583; RISDON RA, 1968, LANCET, V2, P363; Fructuoso AIS, 2012, NEPHROL DIAL TRANSPL, V27, P4227, DOI 10.1093/ndt/gfs409; Schainuck L I, 1970, Hum Pathol, V1, P631, DOI 10.1016/S0046-8177(70)80061-2; Seiler S, 2010, NEPHROL DIAL TRANSPL, V25, P3983, DOI 10.1093/ndt/gfq309; Semba RD, 2011, J AM GERIATR SOC, V59, P1596, DOI 10.1111/j.1532-5415.2011.03558.x; Smith ER, 2014, J AM SOC NEPHROL, V25, P339, DOI 10.1681/ASN.2013060635; Stevens Kathryn K, 2015, Lancet, V385 Suppl 1, pS10, DOI 10.1016/S0140-6736(15)60325-7; Tan XY, 2006, J AM SOC NEPHROL, V17, P3382, DOI 10.1681/ASN.2006050520; Tan XY, 2009, KIDNEY INT, V76, P1248, DOI 10.1038/ki.2009.346; Tseng PY, 2015, KIDNEY BLOOD PRESS R, V40, P386, DOI 10.1159/000368514; Whittier WL, 2004, J AM SOC NEPHROL, V15, P142, DOI 10.1097/01.ASN.0000102472.37947.14; Wolf M, 2011, J AM SOC NEPHROL, V22, P956, DOI 10.1681/ASN.2010080894; Yilmaz MI, 2013, AM J NEPHROL, V37, P126, DOI 10.1159/000346711; Zhang Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147347; Zhang ZL, 2008, PROCEEDINGS OF FIRST INTERNATIONAL CONFERENCE OF MODELLING AND SIMULATION, VOL III, P105; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865	56	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0167929	10.1371/journal.pone.0167929	http://dx.doi.org/10.1371/journal.pone.0167929			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036331	Green Published, gold, Green Submitted			2022-12-26	WOS:000391229300010
J	Errarte, P; Guarch, R; Pulido, R; Blanco, L; Nunes-Xavier, CE; Beitia, M; Gil, J; Angulo, JC; Lopez, JI; Larrinaga, G				Errarte, Peio; Guarch, Rosa; Pulido, Rafael; Blanco, Lorena; Nunes-Xavier, Caroline E.; Beitia, Maider; Gil, Javier; Angulo, Javier C.; Lopez, Jose I.; Larrinaga, Gorka			The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases	PLOS ONE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; MESENCHYMAL TRANSITION; PROGNOSTIC-FACTORS; PROGRESSION; SURVIVAL; MICROENVIRONMENT; IMMUNOTHERAPY; IMPACT; STROMA; ALPHA	Clear cell renal cell carcinoma (CCRCC) is a heterogeneous and complex disease that frequently develops distant metastases. Fibroblast activation protein (FAP) is a serine peptidase the expression of which in cancer-associated fibroblasts has been associated with higher risk of metastases and poor survival. The objective of this study was to evaluate the role of FAP in metastatic CCRCC (mCCRCC). A series of 59 mCCRCC retrospectively collected was included in the study. Metastases developed either synchronous (n = 14) or metachronous to renal disease (n = 45). Tumor specimens were obtained from both primary lesion (n = 59) and metastases (n = 54) and FAP expression was immunohistochemically analyzed. FAP expression in fibroblasts from primary tumors correlated with FAP expression in the corresponding metastatic lesions. Also, primary and metastatic FAP expression was correlated with large tumor diameter (>7cm), high grade (G3/4), high stage (pT3/4), tumor necrosis and sarcomatoid transformation. The expression of FAP in primary tumors and in their metastases was associated both with synchronous metastases and also with metastases to the lymph nodes. FAP expression in the primary tumor was correlated with worse 10-year overall survival. Immunohistochemical detection of FAP in the stromal tumor fibroblasts could be a biomarker of early lymph node metastatic status and therefore could account for the poor prognosis of FAP positive CCRCC.	[Errarte, Peio; Beitia, Maider; Gil, Javier; Larrinaga, Gorka] Univ Basque Country UPV EHU, Dept Physiol, Leioa, Spain; [Errarte, Peio; Beitia, Maider; Larrinaga, Gorka] Univ Basque Country UPV EHU, Sch Nursing, Dept Nursing 1, Leioa, Spain; [Errarte, Peio; Pulido, Rafael; Blanco, Lorena; Nunes-Xavier, Caroline E.; Beitia, Maider; Gil, Javier; Lopez, Jose I.; Larrinaga, Gorka] BioCruces Hlth Res Inst, Canc Biomarkers Grp, Baracaldo, Bizkaia, Spain; [Guarch, Rosa] Complejo Hosp B Navarra, Dept Pathol, Navarra, Spain; [Pulido, Rafael] Basque Fdn Sci, Ikerbasque, Bilbao, Bizkaia, Spain; [Nunes-Xavier, Caroline E.] Radiumhospitalet, Oslo Univ Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Angulo, Javier C.] Univ Europea Madrid, Hosp Getafe, Dept Urol, Madrid, Spain; [Lopez, Jose I.] Univ Basque Country UPV EHU, Cruces Univ Hosp, Dept Pathol, Baracaldo, Bizkaia, Spain	University of Basque Country; University of Basque Country; Servicio Navarro de Salud - Osasunbidea; Basque Foundation for Science; University of Oslo; European University of Madrid; Hospital Universitario de Getafe; Hospital Universitario Cruces; University of Basque Country	Larrinaga, G (corresponding author), Univ Basque Country UPV EHU, Dept Physiol, Leioa, Spain.; Larrinaga, G (corresponding author), Univ Basque Country UPV EHU, Sch Nursing, Dept Nursing 1, Leioa, Spain.; Larrinaga, G (corresponding author), BioCruces Hlth Res Inst, Canc Biomarkers Grp, Baracaldo, Bizkaia, Spain.	gorka.larrinaga@ehu.eus	Lopez, Jose Ignacio/L-3884-2019; Errarte, Peio/AAD-4169-2020; Beitia, Maider/AAD-1618-2020; Nunes-Xavier, Caroline E./R-5893-2018	Lopez, Jose Ignacio/0000-0003-0842-5348; Errarte, Peio/0000-0002-1581-5152; Nunes-Xavier, Caroline E./0000-0002-1875-6645; Pulido, Rafael/0000-0001-9100-248X; Angulo, Javier/0000-0002-1735-8792	Ministerio de Economia y Competitividad (Spain) [SAF2013-48812-R]; de Basque Government [IT 8-11/13]; University of the Basque Country (UPV/EHU) [EHUA14/25]; Basque Government [PRE_2013_1_762, PRE_2015_2_0148]	Ministerio de Economia y Competitividad (Spain)(Spanish Government); de Basque Government(Basque Government); University of the Basque Country (UPV/EHU); Basque Government(Basque Government)	This work was partially funded by Grant SAF2013-48812-R from Ministerio de Economia y Competitividad (Spain), IT 8-11/13 from de Basque Government and EHUA14/25 from de University of the Basque Country (UPV/EHU). The current work has been developed as PhD project of PE and MB, who are recipients of a Predoctoral Fellowship from the Basque Government (Exp no PRE_2013_1_762 and PRE_2015_2_0148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augoff K, 2014, ONCOL REP, V31, P2820, DOI 10.3892/or.2014.3162; Baird SK, 2015, CLIN EXP METASTAS, V32, P507, DOI 10.1007/s10585-015-9723-4; Bostrom AK, 2012, HUM PATHOL, V43, P708, DOI 10.1016/j.humpath.2011.06.019; Brennen WN, 2016, PROSTATE, V76, P552, DOI 10.1002/pros.23145; Brennen WN, 2014, PROSTATE, V74, P1308, DOI 10.1002/pros.22847; Brennen WN, 2012, JNCI-J NATL CANCER I, V104, P1320, DOI 10.1093/jnci/djs336; Dabestani S, 2016, WORLD J UROL; Edge S.B., 2010, AJCC CANC STAGING MA, V7th ed., P143; ELSON PJ, 1988, CANCER RES, V48, P7310; Escudier B, 2014, ANN ONCOL, V25, P49, DOI 10.1093/annonc/mdu259; Escudier B, 2007, J UROLOGY, V178, P1901, DOI 10.1016/j.juro.2007.07.035; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Incorvaia L, 2016, ONCOTARGET, V7, P21259, DOI 10.18632/oncotarget.7267; Kelly T, 2012, INT REV CEL MOL BIO, V297, P83, DOI 10.1016/B978-0-12-394308-8.00003-0; Kroeger N, 2015, EUR UROL, V68, P506, DOI 10.1016/j.eururo.2014.11.054; Kwak C, 2007, TUMORI J, V93, P68; Larrinaga G, 2012, AM J PHYSIOL-RENAL, V303, pF1584, DOI 10.1152/ajprenal.00477.2012; Leibovich BC, 2005, J UROLOGY, V174, P1759, DOI 10.1097/01.ju.0000177487.64651.3a; Li ZJ, 2016, ONCOTARGET, V7, P16172, DOI 10.18632/oncotarget.7473; Liu F, 2015, PLOS ONE; Ljungberg B, 2015, EUR UROL, V67, P913, DOI 10.1016/j.eururo.2015.01.005; Lopez JI, 2016, HUM PATHOL; MacLennan GT, 2014, UROLOGIC SURG PATHOL, P76; Marx J, 2008, SCIENCE, V320, P38, DOI 10.1126/science.320.5872.38; Montel V, 2006, INT J CANCER, V119, P251, DOI 10.1002/ijc.21757; Mourad WF, 2014, AM J CLIN ONCOL-CANC, V37, P498, DOI 10.1097/COC.0b013e31825d5522; Mundim FGL, 2016, APPL IMMUNOHISTOCHEM; Piva F, 2016, MOL DIAGN THER, V20, P111, DOI 10.1007/s40291-016-0192-5; Ruger R, 2014, J CONTROL RELEASE, V186, P1, DOI 10.1016/j.jconrel.2014.04.050; Santoni M, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0122-0; Semeniuk-Wojtas A, 2016, UROL ONCOL-SEMIN ORI, V34, P215, DOI 10.1016/j.urolonc.2015.12.013; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Tansi FL, 2016, BIOMATERIALS, V88, P70, DOI 10.1016/j.biomaterials.2016.02.028; Teichgraber V, 2015, ADV MED SCI-POLAND, V60, P264, DOI 10.1016/j.advms.2015.04.006; Varona A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-193; Volpe A, 2010, WORLD J UROL, V28, P319, DOI 10.1007/s00345-010-0540-8; Xu YZ, 2015, TUMOR BIOL, V36, P3483, DOI 10.1007/s13277-014-2984-8; Zhou B, 2014, J ORAL PATHOL MED, V43, P585, DOI 10.1111/jop.12172; Zi FM, 2015, MOL MED REP, V11, P3203, DOI 10.3892/mmr.2015.3197	40	27	27	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0169105	10.1371/journal.pone.0169105	http://dx.doi.org/10.1371/journal.pone.0169105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033421	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900076
J	Sepehri, Z; Masoumi, M; Ebrahimi, N; Kiani, Z; Nasiri, AA; Kohan, F; Fathollahi, MS; Arababadi, MK; Asadikaram, G				Sepehri, Zahra; Masoumi, Mohammad; Ebrahimi, Nazanin; Kiani, Zohre; Nasiri, Ali Akbar; Kohan, Farhad; Fathollahi, Mahmood Sheikh; Arababadi, Mohammad Kazemi; Asadikaram, Gholamreza			Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-beta, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension	PLOS ONE			English	Article							ACTIVATION; CYTOKINES; STATINS; CELLS; MODEL; BIOMARKERS; RISK; RATS	Introduction Coronary artery disease (CAD) and hypertension are the main reasons of ischemic heart diseases (IHDs). Cytokines as the small glycoproteins are the main arm of immune system and manipulate all of the cardiovascular diseases. The aim of the current study was to examine the effects of treatment of hypertension and CAD on serum levels of IL-6, IL-8, TGF-beta and TNF-alpha. Material and Methods This interventional study was performed on the patients with hypertension without CAD (group 1), hypertension and CAD (group 2), CAD but not hypertension (group 3) and without hypertension and CAD as controls (group 4). The patients received routine treatment for hypertension and CAD. Serum levels of IL-6, IL-8, TGF-beta and TNF-alpha were analyzed in the groups treated with various drugs, using ELISA technique. Results With regard to the medications, Atorvastatin, Losartan and Captopril were administered more in patients (groups 1, 2 and 3) than the patients without hypertension and CAD. The results revealed that serum levels of TGF-beta and IL-6 were significantly increased and decreased, respectively, in the groups 1, 2 and 3 when compared to group 4. Serum levels of TGF-beta were also increased in females in comparison to males in the group 4. Discussion According to the results it seems that Atorvastatin, Losartan and Captopril have reduced inflammation in in vivo conditions via downregulation of IL-6 and upregulation of TGF-beta.	[Sepehri, Zahra] Zabol Univ Med Sci, Dept Internal Med, Fac Med, Zabol, Iran; [Masoumi, Mohammad] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Cardiovasc Res Ctr, Kerman, Iran; [Ebrahimi, Nazanin] Kerman Univ Med Sci, Dept Biochem, Fac Med, Kerman, Iran; [Kiani, Zohre; Kohan, Farhad] Zabol Univ Med Sci, Student Res Comm, Zabol, Iran; [Kiani, Zohre] Kerman Univ Med Sci, Dept Internal Med, Fac Med, Kerman, Iran; [Nasiri, Ali Akbar] Zabol Univ Med Sci, Dept Anesthesiol, Zabol, Iran; [Fathollahi, Mahmood Sheikh; Arababadi, Mohammad Kazemi] Rafsanjan Univ Med Sci, Immunol Infect Dis Res Ctr, Rafsanjan, Iran; [Fathollahi, Mahmood Sheikh] Rafsanjan Univ Med Sci, Dept Social Med, Fac Med, Rafsanjan, Iran; [Arababadi, Mohammad Kazemi] Rafsanjan Univ Med Sci, Fac Paramed, Dept Lab Sci, Rafsanjan, Iran; [Asadikaram, Gholamreza] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Kerman, Iran	Kerman University of Medical Sciences; Kerman University of Medical Sciences; Kerman University of Medical Sciences; Kerman University of Medical Sciences	Masoumi, M (corresponding author), Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Cardiovasc Res Ctr, Kerman, Iran.	masoomi@kmu.ac.ir	Asadikaram, Gholamreza/AAG-4437-2021; Kazemi Arababadi, Mohammad/H-5282-2017	Asadikaram, Gholamreza/0000-0002-9100-0756; Kazemi Arababadi, Mohammad/0000-0002-4829-1586; Asadi karam, Gholamreza/0000-0002-6417-5200; Kazemi Arababadi, Mohammad/0000-0002-4315-8153	Zabol University of Medical Sciences	Zabol University of Medical Sciences	This project has been funded by Zabol University of Medical Sciences.	Agarwal I, 2014, CIRC-ARRHYTHMIA ELEC, V7, P583, DOI 10.1161/CIRCEP.114.001610; Aktas O, 2003, J EXP MED, V197, P725, DOI 10.1084/jem.20021425; Albuquerque D, 2010, CELL IMMUNOL, V260, P92, DOI 10.1016/j.cellimm.2009.09.006; Ariel A, 2003, J IMMUN; Baybutt RC, 2007, CURR PHARM DESIGN, V13, P1327, DOI 10.2174/138161207780618803; Blankier S, 2011, CLIN EXP IMMUNOL, V164, P193, DOI 10.1111/j.1365-2249.2011.04331.x; Brzustewicz E, 2015, CYTOKINE, V76, P527, DOI 10.1016/j.cyto.2015.08.260; Choi M, 2003, KIDNEY INT, V63, P96, DOI 10.1046/j.1523-1755.2003.00718.x; Coimbra LS, 2011, J PERIODONTOL, V82, P767, DOI 10.1902/jop.2010.100555; Correa CR, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-23; De Albuquerque DA, 2004, KIDNEY INT, V65, P846, DOI 10.1111/j.1523-1755.2004.00462.x; Djousse L, 2007, CIRCULATION, V115, P34, DOI 10.1161/CIRCULATIONAHA.106.661868; Ebrahim M, 2014, FUTURE VIROL, V9, P431, DOI 10.2217/fvl.14.21; Guimaraes DA, 2015, REDOX BIOL, V6, P386, DOI 10.1016/j.redox.2015.08.017; Hillyard DZ, 2004, ATHEROSCLEROSIS, V175, P305, DOI 10.1016/j.atherosclerosis.2004.03.018; Ioannidou E, 2006, CURR PHARM DESIGN, V12, P2397, DOI 10.2174/138161206777699007; Karimi-Googheri M, 2014, J MED VIROL, V86, P102, DOI 10.1002/jmv.23727; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Ma J, 2014, PROTEIN CELL, V5, P307, DOI 10.1007/s13238-014-0029-0; Meroni PL, 2001, ARTHRITIS RHEUM-US, V44, P2870, DOI 10.1002/1529-0131(200112)44:12<2870::AID-ART475>3.0.CO;2-Y; Miguel-Carrasco JL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-21; Neurauter G, 2003, CLIN EXP IMMUNOL, V131, P264, DOI 10.1046/j.1365-2249.2003.02021.x; Nilsson PM, 2014, BLOOD PRESSURE, V23, P17, DOI 10.3109/08037051.2013.796142; Ortego M, 1999, ATHEROSCLEROSIS, V147, P253, DOI 10.1016/S0021-9150(99)00193-8; Rajman I, 1996, ATHEROSCLEROSIS, V125, P231; Stevens DL, 1996, J INFECT DIS, V173, P619, DOI 10.1093/infdis/173.3.619; Vidal F, 2015, INT ENDOD J IN PRESS; WHITE WB, 1993, HYPERTENSION, V21, P504, DOI 10.1161/01.HYP.21.4.504; Xie SS, 2015, INT J CLIN EXP MED, V8, P5129; Ye HH, 2014, J CARDIOVASC PHARM T, V19, P290, DOI 10.1177/1074248413513500; Zhang JD, 2015, CURR OPIN PHARMACOL, V21, P14, DOI 10.1016/j.coph.2014.12.003	31	22	22	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168312	10.1371/journal.pone.0168312	http://dx.doi.org/10.1371/journal.pone.0168312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033321	Green Published, Green Submitted, gold			2022-12-26	WOS:000391226900020
J	Yang, J; Sharma, S; Watzinger, P; Hartmann, JD; Kotter, P; Entian, KD				Yang, Jun; Sharma, Sunny; Watzinger, Peter; Hartmann, Johannes David; Koetter, Peter; Entian, Karl-Dieter			Mapping of Complete Set of Ribose and Base Modifications of Yeast rRNA by RP-HPLC and Mung Bean Nuclease Assay	PLOS ONE			English	Article							COMPLETE CHEMICAL-STRUCTURE; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; PRERIBOSOMAL RNA; BOX C/D; METHYLATION; BIOGENESIS; TRANSLATION; IDENTIFICATION; MECHANISM	Ribosomes are large ribonucleoprotein complexes that are fundamental for protein synthesis. Ribosomes are ribozymes because their catalytic functions such as peptidyl transferase and peptidyl-tRNA hydrolysis depend on the rRNA. rRNA is a heterogeneous biopolymer comprising of at least 112 chemically modified residues that are believed to expand its topological potential. In the present study, we established a comprehensive modification profile of Saccharomyces cerevisiae's 18S and 25S rRNA using a high resolution Reversed-Phase High Performance Liquid Chromatography (RP-HPLC). A combination of mung bean nuclease assay, rDNA point mutants and snoRNA deletions allowed us to systematically map all ribose and base modifications on both rRNAs to a single nucleotide resolution. We also calculated approximate molar levels for each modification using their UV (254nm) molar response factors, showing sub-stoichiometric amount of modifications at certain residues. The chemical nature, their precise location and identification of partial modification will facilitate understanding the precise role of these chemical modifications, and provide further evidence for ribosome heterogeneity in eukaryotes.	[Yang, Jun; Sharma, Sunny; Watzinger, Peter; Hartmann, Johannes David; Koetter, Peter; Entian, Karl-Dieter] Goethe Univ, Inst Mol & Cellular Microbiol, Frankfurt, Germany; [Sharma, Sunny] Univ Libre Bruxelles, RNA Mol Biol, Rue Profs Jeener & Brachet, Gosselies, Belgium	Goethe University Frankfurt; Universite Libre de Bruxelles	Sharma, S; Entian, KD (corresponding author), Goethe Univ, Inst Mol & Cellular Microbiol, Frankfurt, Germany.	sunnysharma@daad-alumni.de; entian@bio.uni-frankfurt.de	Sharma, Sunny/S-9454-2017; Sharma, Sunny/N-2341-2019	Sharma, Sunny/0000-0001-8896-9016; Sharma, Sunny/0000-0001-8896-9016; Yang, Jun/0000-0002-3965-8171	EMBO [ALTF 644-2014]; European Commission (EMBOCOFUND) from Marie Curie Action [GA-2012-600394]; DFG (AOBJ) [620220 EN 134/12-1]	EMBO(European Molecular Biology Organization (EMBO)); European Commission (EMBOCOFUND) from Marie Curie Action; DFG (AOBJ)(German Research Foundation (DFG))	SS would like to acknowledge EMBO for Long-term fellowship (ALTF 644-2014) and European Commission (EMBOCOFUND2012, GA-2012-600394) support from Marie Curie Action. This work was supported by DFG (AOBJ) 620220 EN 134/12-1 to KDE.; SS would like to acknowledge EMBO for Long-term fellowship (ALTF 644-2014) and European Commission (EMBOCOFUND2012, GA-2012-600394) support from Marie Curie Action. This work was supported by DFG (AOBJ) 620220 EN 134/12-1 to KDE. Authors would like to thank Dr. Virginie Marchand, and Prof. Yuri Motorin for sharing RiboMethSeq values.	BAKIN A, 1995, NUCLEIC ACIDS RES, V23, P3290, DOI 10.1093/nar/23.16.3290; Baxter-Roshek JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000174; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Beringer M, 2007, MOL CELL, V26, P311, DOI 10.1016/j.molcel.2007.03.015; Birkedal U, 2015, ANGEW CHEM INT EDIT, V54, P451, DOI 10.1002/anie.201408362; Buchhaupt M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089640; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Dinman JD, 2016, J MOL BIOL, V428, P2186, DOI 10.1016/j.jmb.2015.12.021; Figaro S, 2012, MOL CELL BIOL, V32, P2254, DOI 10.1128/MCB.06623-11; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Gehrke CW, 1990, RIBONUCLEOSIDE ANAL, pA3; Giessing AMB, 2012, J PROTEOMICS, V75, P3434, DOI 10.1016/j.jprot.2012.01.032; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Higa-Nakamine S, 2012, NUCLEIC ACIDS RES, V40, P391, DOI 10.1093/nar/gkr700; Jenner L, 2012, CURRENT OPINION STRU; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Klootwijk J, 1973, EUROPEAN J BIOCH; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Lafontaine DLJ, 2015, NAT STRUCT MOL BIOL, V22, P11, DOI 10.1038/nsmb.2939; Li L, 2006, NATURE, V443, P302, DOI 10.1038/nature05151; Liang XH, 2007, MOL CELL, V28, P965, DOI 10.1016/j.molcel.2007.10.012; Liang XH, 2009, RNA, V15, P1716, DOI 10.1261/rna.1724409; Lin JZ, 2011, NATURE, V469, P559, DOI 10.1038/nature09688; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Marchand V, 2016, NAR; Meyer B, 2016, NUCLEIC ACIDS RES, V44, P4304, DOI 10.1093/nar/gkw244; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Noon KR, 2003, J BACTERIOL, V185, P5483, DOI 10.1128/JB.185.18.5483-5490.2003; Noon KR, 1998, J BACTERIOL, V180, P2883, DOI 10.1128/JB.180.11.2883-2888.1998; Ogle JM, 2003, TRENDS BIOCH SCI; Peifer C, 2013, NUCLEIC ACIDS RES, V41, P1151, DOI 10.1093/nar/gks1102; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Schosserer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7158; Sharma S, 2015, TRENDS BIOCHEM SCI, V40, P560, DOI 10.1016/j.tibs.2015.07.008; Sharma S, 2015, NUCLEIC ACIDS RES, V43, P2242, DOI 10.1093/nar/gkv075; Sharma S, 2014, NUCLEIC ACIDS RES, V42, P3246, DOI 10.1093/nar/gkt1281; Strunk BS, 2012, CELL, V150, P111, DOI 10.1016/j.cell.2012.04.044; Taoka M, 2016, NUCLEIC ACIDS RES, V44, P8951, DOI 10.1093/nar/gkw564; Taoka M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv560; Watkins NJ, 2012, WIRES RNA, V3, P397, DOI 10.1002/wrna.117; Wilson DN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011536; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Yang J, 2015, NUCLEIC ACIDS RES, V43, P2342, DOI 10.1093/nar/gkv058	44	31	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168873	10.1371/journal.pone.0168873	http://dx.doi.org/10.1371/journal.pone.0168873			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033325	Green Submitted, gold, Green Published			2022-12-26	WOS:000391226900053
J	Herrmann, V; McMahon, SM; Detto, M; Lutz, JA; Davies, SJ; Chang-Yang, CH; Anderson-Teixeira, KJ				Herrmann, Valentine; McMahon, Sean M.; Detto, Matteo; Lutz, James A.; Davies, Stuart J.; Chang-Yang, Chia-Hao; Anderson-Teixeira, Kristina J.			Tree Circumference Dynamics in Four Forests Characterized Using Automated Dendrometer Bands	PLOS ONE			English	Article							STEM RADIUS CHANGES; DIAMETER VARIATIONS; WATER RELATIONS; GROWTH; XYLEM; WOOD; PATTERNS; DROUGHT; NETWORK	Stem diameter is one of the most commonly measured attributes of trees, forming the foundation of forest censuses and monitoring. Changes in tree stem circumference include both irreversible woody stem growth and reversible circumference changes related to water status, yet these fine-scale dynamics are rarely leveraged to understand forest ecophysiology and typically ignored in plot-or stand-scale estimates of tree growth and forest productivity. Here, we deployed automated dendrometer bands on 12-40 trees at four different forested sites-two temperate broadleaf deciduous, one temperate conifer, and one tropical broadleaf semi-deciduous-to understand how tree circumference varies on time scales of hours to months, how these dynamics relate to environmental conditions, and whether the structure of these variations might introduce substantive error into estimates of woody growth. Diurnal stem circumference dynamics measured over the bark commonly-but not consistently-exhibited daytime shrinkage attributable to transpiration-driven changes in stem water storage. The amplitude of this shrinkage was significantly correlated with climatic variables (daily temperature range, vapor pressure deficit, and radiation), sap flow and evapo-transpiration. Diurnal variations were typically <0.5 mm circumference in amplitude and unlikely to be of concern to most studies of tree growth. Over time scales of multiple days, the bands captured circumference increases in response to rain events, likely driven by combinations of increased stem water storage and bark hydration. Particularly at the tropical site, these rain responses could be quite substantial, ranging up to 1.5 mm circumference expansion within 48 hours following a rain event. We conclude that over-bark measurements of stem circumference change sometimes correlate with but have limited potential for directly estimating daily transpiration, but that they can be valuable on time scales of days to weeks for characterizing changes in stem growth and hydration.	[Herrmann, Valentine; Anderson-Teixeira, Kristina J.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Front Royal, VA 22630 USA; [McMahon, Sean M.; Chang-Yang, Chia-Hao] Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA; [McMahon, Sean M.; Detto, Matteo; Davies, Stuart J.; Anderson-Teixeira, Kristina J.] Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Forest Global Earth Observ, Panama City, Panama; [Detto, Matteo] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Lutz, James A.] Utah State Univ, Wildland Resources Dept, Logan, UT 84322 USA; [Davies, Stuart J.] Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA; [Chang-Yang, Chia-Hao] Natl Dong Hwa Univ, Dept Nat Resources & Environm Studies, Hualien, Taiwan	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian Environmental Research Center; Smithsonian Institution; Smithsonian Tropical Research Institute; Princeton University; Utah System of Higher Education; Utah State University; Smithsonian Institution; Smithsonian National Museum of Natural History; National Dong Hwa University	Anderson-Teixeira, KJ (corresponding author), Natl Zool Pk, Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Front Royal, VA 22630 USA.; Anderson-Teixeira, KJ (corresponding author), Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Forest Global Earth Observ, Panama City, Panama.	teixeirak@si.edu	Herrmann, Valentine/AAY-4643-2021; Chang-Yang, Chia-Hao/I-9273-2019; Anderson-Teixeira, Kristina J./U-6075-2019; Lutz, James/AAA-9574-2019	Herrmann, Valentine/0000-0002-4519-481X; Chang-Yang, Chia-Hao/0000-0003-3635-4946; Lutz, James/0000-0002-2560-0710; Teixeira, Kristina/0000-0001-8461-9713	internal Smithsonian Institution funds from the Consortium for Understanding and Sustaining a Biodiverse Planet; Smithsonian Competitive Grants Program for Science grant; Smithsonian Institution Center for Tropical Forest Science - Forest Global Earth Observatory (CTFS-ForestGEO); Next Generation Ecosystem Experiment (NGEE) Tropics project; Division Of Environmental Biology [1545761] Funding Source: National Science Foundation	internal Smithsonian Institution funds from the Consortium for Understanding and Sustaining a Biodiverse Planet; Smithsonian Competitive Grants Program for Science grant; Smithsonian Institution Center for Tropical Forest Science - Forest Global Earth Observatory (CTFS-ForestGEO); Next Generation Ecosystem Experiment (NGEE) Tropics project; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by internal Smithsonian Institution funds from the Consortium for Understanding and Sustaining a Biodiverse Planet and a Smithsonian Competitive Grants Program for Science grant to KAT and by the Smithsonian Institution Center for Tropical Forest Science - Forest Global Earth Observatory (CTFS-ForestGEO). SJD received support from the Next Generation Ecosystem Experiment (NGEE) Tropics project.	Anderson-Teixeira KJ, 2015, FUNCT ECOL; Anderson-Teixeira KJ, 2015, GLOBAL CHANGE BIOL, V21, P528, DOI 10.1111/gcb.12712; Angi Roesch HS, 2014, WAVELETCOMP COMPUTAT; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Biondi F, 2005, ARCT ANTARCT ALP RES, V37, P16, DOI 10.1657/1523-0430(2005)037[0016:DWATGA]2.0.CO;2; Bourg N. A., 2013, Ecology, V94, P2111, DOI 10.1890/13-0010.1; Bouriaud O, 2005, TREE PHYSIOL, V25, P651, DOI 10.1093/treephys/25.6.651; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chitra-Tarak R, 2015, FOREST ECOL MANAG, V336, P129, DOI 10.1016/j.foreco.2014.10.007; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; Cuny HE, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.160, 10.1038/nplants.2015.160]; de la Rosa JM, 2013, AGR WATER MANAGE, V126, P133, DOI 10.1016/j.agwat.2013.05.009; Devine WD, 2011, AGR FOREST METEOROL, V151, P414, DOI 10.1016/j.agrformet.2010.11.004; Doughty CE, 2015, NATURE, V519, P78, DOI 10.1038/nature14213; Drew DM, 2009, DENDROCHRONOLOGIA, V27, P159, DOI 10.1016/j.dendro.2009.06.008; Fereres E, 2008, CALIF AGR, V53, P21; GARNIER E, 1986, J APPL ECOL, V23, P193, DOI 10.2307/2403091; Genard M, 2001, PLANT PHYSIOL, V126, P188, DOI 10.1104/pp.126.1.188; Goldstein G, 1998, PLANT CELL ENVIRON, V21, P397, DOI 10.1046/j.1365-3040.1998.00273.x; GRANIER A., 1985, EDP SCI, V42, P193; HINCKLEY TM, 1975, CAN J BOT, V53, P62, DOI 10.1139/b75-009; Hubbell S.P., 2010, BARRO COLORADO FORES; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Jenkins JC, 2003, FOREST SCI, V49, P12; Leigh EG, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P451; Lutz JA, 2014, ECOLOGY, V95, P2047, DOI 10.1890/14-0157.1; Lutz JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082784; Malhi Y, 2002, J VEG SCI, V13, P439, DOI 10.1111/j.1654-1103.2002.tb02068.x; Mantgem PJ van, 2003, GROWTH RATE PREDICTS; McLaughlin SB, 2003, TREE PHYSIOL, V23, P1125, DOI 10.1093/treephys/23.16.1125; McMahon SM, 2015, ECOL EVOL, V5, P243, DOI 10.1002/ece3.1117; Mencuccini M, 2013, NEW PHYTOL, V198, P1143, DOI 10.1111/nph.12224; Muller B, 2011, J EXP BOT; Offenthaler I, 2001, TREES-STRUCT FUNCT, V15, P215, DOI 10.1007/s004680100090; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Peramaki M, 2001, TREE PHYSIOL, V21, P889, DOI 10.1093/treephys/21.12-13.889; R Core Team, 2021, R LANGUAGE ENV STAT; Sevanto S, 2005, BOREAL ENVIRON RES, V10, P447; Sevanto S, 2005, BOREAL ENVIRON RES, V10, P437; Sevanto S, 2008, PLANT SOIL, V305, P77, DOI 10.1007/s11104-008-9566-8; Sheil D, 2003, CAN J FOREST RES, V33, P2027, DOI 10.1139/X03-121; Stahl C, 2010, J TROP ECOL, V26, P393, DOI 10.1017/S0266467410000155; Steppe K, 2015, TRENDS PLANT SCI; Urrutia-Jalabert R, 2015, AGR FOREST METEOROL, V200, P209, DOI 10.1016/j.agrformet.2014.10.001; Wagner F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092337; Wagner FH, 2016, BIOGEOSCIENCES, V13, P2537, DOI 10.5194/bg-13-2537-2016; Woudenberg S.W., 2010, RMRSGTR245 USDA FOR, V245, P336, DOI DOI 10.2737/RMRS-GTR-245; Zweifel R, 2006, J EXP BOT, V57, P1445, DOI 10.1093/jxb/erj125; Zweifel R, 2001, TREE PHYSIOL, V21, P869, DOI 10.1093/treephys/21.12-13.869; Zweifel R, 2000, TREES-STRUCT FUNCT, V15, P50, DOI 10.1007/s004680000072; Zweifel R, 2014, FUNCT PLANT BIOL, V41, P520, DOI 10.1071/FP13240	51	12	13	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0169020	10.1371/journal.pone.0169020	http://dx.doi.org/10.1371/journal.pone.0169020			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030646	Green Published, Green Submitted, gold			2022-12-26	WOS:000391222000100
J	Jenny, FH; Basler, K				Jenny, Fabian H.; Basler, Konrad			Drosophila DDX3/Belle Exerts Its Function Outside of the Wnt/Wingless Signaling Pathway	PLOS ONE			English	Article							RNA HELICASE; OVERGROWN PROMOTES; WINGLESS; CATENIN; DDX3; EXPRESSION; FAMILY; CELLS	The helicases human DDX3 and Drosophila Belle (Bel) are part of a well-defined subfamily of the DEAD-box helicases. Individual subfamily-members perform a myriad of functions in nuclear and cytosolic RNA metabolism. It has also been reported that DDX3X is involved in cell signaling, including IFN-alpha and IFN-beta inducing pathways upon viral infection as well as in Wnt signaling. Here we used a collection of EMS-induced bel alleles recovered from a Wingless (Wg) suppressor screen to analyze the role of the Drosophila homolog of DDX3 in Wg/Wnt signaling. These EMS alleles, as well as a P-element induced null allele and RNAimediated knock down of bel, all suppressed the phenotype of ectopic Wg signaling in the eye. However, they did not affect the expression of known Wg target genes like senseless, Distalless or wingful/Notum. Ectopic Wg signaling in eye imaginal discs induces apoptosis by increasing grim expression. Mutations in bel revert grim expression to wild-type levels. Together, these results indicate that Bel does not function as a core component in the Drosophila Wg pathway, and that mutations affecting its helicase function suppress the effects of ectopic Wg signaling downstream of the canonical pathway.	[Jenny, Fabian H.; Basler, Konrad] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Zurich	Basler, K (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	konrad.basler@imls.uzh.ch		Basler, Konrad/0000-0003-3534-1529	Swiss National Science Foundation; University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich	This work was financially supported by the Swiss National Science Foundation and the University of Zurich.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S, 2011, BABRAHAM BIOINFORMAT; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Brunner E, 1999, DEV BIOL, V206, P178, DOI 10.1006/dbio.1998.9136; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; DeVorkin Lindsay, 2014, Cold Spring Harb Protoc, V2014, P951, DOI 10.1101/pdb.prot080325; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fogel JL, 2012, JOVE-J VIS EXP, V68, P1; Franca R, 2007, PROTEINS, V67, P1128, DOI 10.1002/prot.21433; Garbelli A, 2011, CURR MED CHEM, V18, P3015, DOI 10.2174/092986711796391688; Guan J, 2007, DEV BIOL, V303, P16, DOI 10.1016/j.ydbio.2006.10.028; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Poulton JS, 2011, DEVELOPMENT, V138, P1737, DOI 10.1242/dev.059352; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sharma D, 2014, CRIT REV BIOCHEM MOL, V49, P343, DOI 10.3109/10409238.2014.931339; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120	22	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0166862	10.1371/journal.pone.0166862	http://dx.doi.org/10.1371/journal.pone.0166862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030561	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000391222000004
J	Morato, RG; Stabach, JA; Fleming, CH; Calabrese, JM; De Paula, RC; Ferraz, KMPM; Kantek, DLZ; Miyazaki, SS; Pereira, TDC; Araujo, GR; Paviolo, A; De Angelo, C; Di Bitetti, MS; Cruz, P; Lima, F; Cullen, L; Sana, DA; Ramalho, EE; Carvalho, MM; Soares, FHS; Zimbres, B; Silva, MX; Moraes, MDF; Vogliotti, A; May, JA; Haberfeld, M; Rampim, L; Sartorello, L; Ribeiro, MC; Leimgruber, P				Morato, Ronaldo G.; Stabach, Jared A.; Fleming, Chris H.; Calabrese, Justin M.; De Paula, Rogerio C.; Ferraz, Katia M. P. M.; Kantek, Daniel L. Z.; Miyazaki, Selma S.; Pereira, Thadeu D. C.; Araujo, Gediendson R.; Paviolo, Agustin; De Angelo, Carlos; Di Bitetti, Mario S.; Cruz, Paula; Lima, Fernando; Cullen, Laury; Sana, Denis A.; Ramalho, Emiliano E.; Carvalho, Marina M.; Soares, Fabio H. S.; Zimbres, Barbara; Silva, Marina X.; Moraes, Marcela D. F.; Vogliotti, Alexandre; May, Joares A., Jr.; Haberfeld, Mario; Rampim, Lilian; Sartorello, Leonardo; Ribeiro, Milton C.; Leimgruber, Peter			Space Use and Movement of a Neotropical Top Predator: The Endangered Jaguar	PLOS ONE			English	Article							PANTHERA-ONCA; HABITAT; ECOLOGY; STRATEGIES; CARNIVORES; LANDSCAPE; MODEL; RISK	Accurately estimating home range and understanding movement behavior can provide important information on ecological processes. Advances in data collection and analysis have improved our ability to estimate home range and movement parameters, both of which have the potential to impact species conservation. Fitting continuous-time movement model to data and incorporating the autocorrelated kernel density estimator (AKDE), we investigated range residency of forty-four jaguars fit with GPS collars across five biomes in Brazil and Argentina. We assessed home range and movement parameters of range resident animals and compared AKDE estimates with kernel density estimates (KDE). We accounted for differential space use and movement among individuals, sex, region, and habitat quality. Thirty-three (80%) of collared jaguars were range resident. Home range estimates using AKDE were 1.02 to 4.80 times larger than KDE estimates that did not consider autocorrelation. Males exhibited larger home ranges, more directional movement paths, and a trend towards larger distances traveled per day. Jaguars with the largest home ranges occupied the Atlantic Forest, a biome with high levels of deforestation and high human population density. Our results fill a gap in the knowledge of the species' ecology with an aim towards better conservation of this endangered/critically endangered carnivore the top predator in the Neotropics.	[Morato, Ronaldo G.; De Paula, Rogerio C.] Inst Chico Mendes Conservacao Biodiversidade, Ctr Nacl Pesquisa & Conservacao Mamiferos Carnivo, Sao Paulo, Brazil; [Morato, Ronaldo G.; Stabach, Jared A.; Fleming, Chris H.; Calabrese, Justin M.; Leimgruber, Peter] Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Natl Zool Pk, Front Royal, VA 22630 USA; [Morato, Ronaldo G.; De Paula, Rogerio C.; Ferraz, Katia M. P. M.; Sana, Denis A.; Ramalho, Emiliano E.] Inst Procarnivoros, Sao Paulo, Brazil; [Ferraz, Katia M. P. M.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Kantek, Daniel L. Z.; Miyazaki, Selma S.; Pereira, Thadeu D. C.] Inst Chico Mendes Conservacao Biodiversidade, Estacao Ecol Taiama, Caceres, Mato Grosso, Brazil; [Araujo, Gediendson R.] Univ Fed Vicosa, Dept Med Vet, Vicosa, MG, Brazil; [Paviolo, Agustin; De Angelo, Carlos; Di Bitetti, Mario S.; Cruz, Paula] Univ Nacl Misiones, Inst Biol Subtrop, Puerto Iguazu, Argentina; [Paviolo, Agustin; De Angelo, Carlos; Di Bitetti, Mario S.; Cruz, Paula] Consejo Nacl Invest Cient & Tecn, Puerto Iguazu, Argentina; [Lima, Fernando; Cullen, Laury] IPE, Sao Paulo, Brazil; [Lima, Fernando; Ribeiro, Milton C.] Univ Estadual Sao Paulo, Inst Biociencias, Lab Ecol Espacial & Conservacao, Sao Paulo, Brazil; [Sana, Denis A.] Univ Fed Rio Grande do Sul, Programa Posgrad Ecol, Porto Alegre, RS, Brazil; [Ramalho, Emiliano E.] Inst Desenvolvimento Sustentavel Mamiraua, Tefe, Amazonas, Brazil; [Carvalho, Marina M.; Soares, Fabio H. S.] Inst Def & Preservacao Felideos Brasileiros, Corumba De Goias, Go, Brazil; [Zimbres, Barbara] Univ Brasilia, Inst Ciencias Biol, Programa Posgrad Zool, Brasilia, DF, Brazil; [Silva, Marina X.; Moraes, Marcela D. F.] Inst Chico Mendes Conservacao Biodiversidade, Projeto Carnivoros Iguacu, Parque Nacl Iguacu, Foz Do Iguacu, Parana, Brazil; [Vogliotti, Alexandre] Univ Fed Integracao Latino Amer, Foz Do Iguacu, Parana, Brazil; [May, Joares A., Jr.; Haberfeld, Mario; Rampim, Lilian; Sartorello, Leonardo] Projeto Oncafari Miranda, Miranda, MS, Brazil	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Universidade de Sao Paulo; Universidade Federal de Vicosa; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Federal do Rio Grande do Sul; Universidade de Brasilia; Universidade Federal da Integracao Latino-Americana	Morato, RG (corresponding author), Inst Chico Mendes Conservacao Biodiversidade, Ctr Nacl Pesquisa & Conservacao Mamiferos Carnivo, Sao Paulo, Brazil.; Morato, RG (corresponding author), Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Natl Zool Pk, Front Royal, VA 22630 USA.; Morato, RG (corresponding author), Inst Procarnivoros, Sao Paulo, Brazil.	ronaldo.morato@icmbio.gov.br; paviolo4@gmail.com; pardalismitis@gmail.com; eeramalho@gmail.com; mmaribio@gmail.com; haberfeldm@gmail.com	Stabach, Jared/AEX-9187-2022; Kantek, Daniel/AAJ-4781-2021; Ferraz, Katia Maria P. M. B./D-7244-2012; Lima, Fernando/E-8023-2016; May-Junior, Joares Adenilson/AAC-3220-2019; Leimgruber, Peter/O-1304-2015; Sana, Denis/AAE-1570-2019; Calabrese, Justin/B-9131-2012; DE PAULA, ROGERIO/S-2182-2017	Stabach, Jared/0000-0002-7896-1237; Ferraz, Katia Maria P. M. B./0000-0002-7870-8696; Lima, Fernando/0000-0002-8644-9647; May-Junior, Joares Adenilson/0000-0002-0007-9690; Leimgruber, Peter/0000-0002-3682-0153; Calabrese, Justin/0000-0003-0575-6408; Di Bitetti, Mario/0000-0001-9704-8649; DE PAULA, ROGERIO/0000-0003-1943-8320; Morato, Ronaldo/0000-0002-8304-9779	FAPESP [2013-10029-6, 2014-24921-0]; Cat Heaven Endangered Species-Project Survival; Dallas World Aquarium; Orient Express Hotels do Brasil; WWF Switzerland-Fundacion Vida Silvestre Argentina; Panthera Foundation; Rufford Small Grant Foundation; CNPq [312045/2013-1]; National Science Foundation [ABI 1458748]; National Foundation Grant	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Cat Heaven Endangered Species-Project Survival; Dallas World Aquarium; Orient Express Hotels do Brasil; WWF Switzerland-Fundacion Vida Silvestre Argentina; Panthera Foundation; Rufford Small Grant Foundation; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Science Foundation(National Science Foundation (NSF)); National Foundation Grant	This work was supported by FAPESP (2013-10029-6) to RGM, Cat Heaven Endangered Species-Project Survival to RGM, Dallas World Aquarium to RGM, Orient Express Hotels do Brasil to MSX, WWF Switzerland-Fundacion Vida Silvestre Argentina to AP, Panthera Foundation to EER, Rufford Small Grant Foundation to EER, FAPESP (2014-24921-0) to RGM, CNPq (312045/2013-1) to MCR, National Science Foundation Grant (ABI 1458748) to JMC, and National Foundation Grant to CHF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], [No title captured]; [Anonymous], 2012, LIBRO ROJO MAMIFEROS; ASTETE S., 2007, CAT NEWS, V4, P9; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Blackwell PG, 2016, METHODS ECOL EVOL, V7, P184, DOI 10.1111/2041-210X.12460; Boone RB, 2006, ECOLOGY, V87, P1987, DOI 10.1890/0012-9658(2006)87[1987:SWMPMF]2.0.CO;2; Bright EA, 2012, LANDSCAN 2011 DIGIT; Calabrese JM, 2016, METHODS ECOL EVOL; Cardillo M, 2004, PLOS BIOL; Carvalho EAR, 2015, BASIC APPL ECOL, V16, P413, DOI 10.1016/j.baae.2015.03.005; de Azevedo FCC, 2007, BIOL CONSERV, V137, P391, DOI 10.1016/j.biocon.2007.02.022; Caso A., 2008, IUCN RED LIST THREAT; Cavalcanti SMC, 2009, J MAMMAL, V90, P935, DOI 10.1644/08-MAMM-A-188.1; Chapman BB, 2014, ANIMAL MOVEMENT ACROSS SCALES, P11; Chetkiewicz CLB, 2009, J APPL ECOL, V46, P1036, DOI 10.1111/j.1365-2664.2009.01686.x; Colchero F, 2011, ANIM CONSERV, V14, P158, DOI 10.1111/j.1469-1795.2010.00406.x; Conde DA, 2010, BIOL CONSERV, V143, P1980, DOI 10.1016/j.biocon.2010.04.049; Crawshaw, 1995, COMP ECOLOGY OCELOT; CRAWSHAW PG, 1991, J ZOOL, V223, P357, DOI 10.1111/j.1469-7998.1991.tb04770.x; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cullen Junior L., 2005, Natureza & Conservacao, V3, P43; De Angelo C, 2013, BIOL CONSERV, V159, P422, DOI 10.1016/j.biocon.2012.12.021; De Angelo C, 2011, DIVERS DISTRIB, V17, P422, DOI 10.1111/j.1472-4642.2011.00746.x; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Fleming CH, 2015, ECOLOGY, V96, P1182, DOI 10.1890/14-2010.1; Fleming C.H., 2015, CTMM CONTINUOUS TIME; Fleming CH, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.032107; Fleming CH, 2014, AM NAT, V183, pE154, DOI 10.1086/675504; Fleming CH, 2014, METHODS ECOL EVOL, V5, P462, DOI 10.1111/2041-210X.12176; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.2277/0521867061; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Horne JS, 2006, ECOLOGY, V87, P1146, DOI 10.1890/0012-9658(2006)87[1146:STBHRM]2.0.CO;2; Kanda Z, 2015, ECOLOGIA MOVIMENTO D; Kery M., 2010, INTRO WINBUGS ECOLOG; Kittle AM, 2015, J ANIM ECOL, V84, P1177, DOI 10.1111/1365-2656.12366; Leal I.R., 2005, MEGADIVERSIDADE, V1, P139; Liu JG, 1999, CONSERV BIOL, V13, P1360, DOI 10.1046/j.1523-1739.1999.98418.x; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Mauritzen M, 2001, CAN J ZOOL, V79, P1704, DOI 10.1139/z01-126; May R, 2010, ECOL MODEL, V221, P936, DOI 10.1016/j.ecolmodel.2009.12.024; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1; Morato RG, 2001, REPRODUCTION, V122, P745, DOI 10.1530/reprod/122.5.745; Morato Ronaldo Goncalves, 2013, Biodiversidade Brasileira, V3, P122; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19050, DOI 10.1073/pnas.0808918105; Nowell K, 1996, WILD CATS STATUS SUR, P110; Plummer M., 2015, PACKAGE CODA; Powell RA, 2012, J MAMMAL, V93, P948, DOI 10.1644/11-MAMM-S-177.1; R Core Team, 2016, R FDN STAT COMP; RABINOWITZ AR, 1986, J ZOOL, V210, P149, DOI 10.1111/j.1469-7998.1986.tb03627.x; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Rodriguez-Soto C, 2011, DIVERS DISTRIB, V17, P350, DOI 10.1111/j.1472-4642.2010.00740.x; ROYSTON JP, 1982, J R STAT SOC C-APPL, V31, P176; Sandell M., 1989, P164; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; Schaller G, 1976, SERENGETI LION STUDY; SCHALLER GB, 1980, BIOTROPICA, V12, P161, DOI 10.2307/2387967; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Silveira L, 2004, ECOLOGIA COMP CONSER; Singh NJ, 2012, ECOL APPL, V22, P2007, DOI 10.1890/12-0245.1; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Stabach JA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1428	64	63	68	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168176	10.1371/journal.pone.0168176	http://dx.doi.org/10.1371/journal.pone.0168176			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030568	Green Published, Green Submitted, gold			2022-12-26	WOS:000391222000039
J	Gunera, J; Kindinger, F; Li, SM; Kolb, P				Gunera, Jakub; Kindinger, Florian; Li, Shu-Ming; Kolb, Peter			PrenDB, a Substrate Prediction Database to Enable Biocatalytic Use of Prenyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPERGILLUS-FUMIGATUS; OVERPRODUCTION; PURIFICATION; GENERATION; DOCKING	Prenyltransferases of the dimethylallyltryptophan synthase (DMATS) superfamily catalyze the attachment of prenyl or prenyl-like moieties to diverse acceptor compounds. These acceptor molecules are generally aromatic in nature and mostly indole or indole-like. Their catalytic transformation represents a major skeletal diversification step in the biosynthesis of secondary metabolites, including the indole alkaloids. DMATS enzymes thus contribute significantly to the biological and pharmacological diversity of small molecule metabolites. Understanding the substrate specificity of these enzymes could create opportunities for their biocatalytic use in preparing complex synthetic scaffolds. However, there has been no framework to achieve this in a rational way. Here, we report a chemoinformatic pipeline to enable prenyltransferase substrate prediction. We systematically catalogued 32 unique prenyltransferases and 167 unique substrates to create possible reaction matrices and compiled these data into a browsable database named PrenDB. We then used a newly developed algorithm based on molecular fragmentation to automatically extract reactive chemical epitopes. The analysis of the collected data sheds light on the thus far explored substrate space of DMATS enzymes. To assess the predictive performance of our virtual reaction extraction tool, 38 potential substrates were tested as prenyl acceptors in assays with three prenyltransferases, and we were able to detect turnover in > 55% of the cases. The database, PrenDB (www. kolblab. org/prendb. php), enables the prediction of potential substrates for chemoenzymatic synthesis through substructure similarity and virtual chemical transformation techniques. It aims at making prenyltransferases and their highly regio-and stereoselective reactions accessible to the research community for integration in synthetic work flows.	[Gunera, Jakub; Kolb, Peter] Philipps Univ, Dept Pharmaceut Chem, D-35032 Marburg, Hesse, Germany; [Kindinger, Florian; Li, Shu-Ming] Philipps Univ, Inst Pharmaceut Biol & Biotechnol, D-35032 Marburg, Hesse, Germany; [Gunera, Jakub; Li, Shu-Ming; Kolb, Peter] Philipps Univ, LOEWE Ctr Synthet Microbiol, Synmikro, D-35043 Marburg, Hesse, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg	Kolb, P (corresponding author), Philipps Univ, Dept Pharmaceut Chem, D-35032 Marburg, Hesse, Germany.; Li, SM (corresponding author), Philipps Univ, Inst Pharmaceut Biol & Biotechnol, D-35032 Marburg, Hesse, Germany.; Li, SM; Kolb, P (corresponding author), Philipps Univ, LOEWE Ctr Synthet Microbiol, Synmikro, D-35043 Marburg, Hesse, Germany.	shuming.li@staff.uni-marburg.de; peter.kolb@uni-marburg.de	Kolb, Peter/A-3782-2008	Kolb, Peter/0000-0003-4089-614X	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Frank Balzer for help with making PrenDB available online and Christian Raab for data processing during the implementation. S.-M.L. acknowledges the Deutsche Forschungsgemeinschaft for funding the Bruker micrOTOF-Q III mass spectrometer.	Botta B, 2005, CURR MED CHEM, V12, P713, DOI 10.2174/0929867053202241; Fan AL, 2015, APPL MICROBIOL BIOT, V99, P7399, DOI 10.1007/s00253-015-6813-9; Grundmann A, 2005, MICROBIOL-SGM, V151, P2199, DOI 10.1099/mic.0.27962-0; Gunera J, 2015, J COMPUT CHEM, V36, P1597, DOI 10.1002/jcc.23974; Hawkins PCD, 2007, J MED CHEM, V50, P74, DOI 10.1021/jm0603365; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Li SM, 2010, NAT PROD REP, V27, P57, DOI 10.1039/b909987p; Liu AH, 2013, BIOORG MED CHEM LETT, V23, P2491, DOI 10.1016/j.bmcl.2013.03.038; Mai P, 2016, ADV SYNTH CATAL, V358, P1639, DOI 10.1002/adsc.201600064; McGann M, 2012, J COMPUT AID MOL DES, V26, P897, DOI 10.1007/s10822-012-9584-8; Oya A, 2015, J NAT PROD, V78, P258, DOI 10.1021/np500827h; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Schomburg K, 2010, J CHEM INF MODEL, V50, P1529, DOI 10.1021/ci100209a; Sunassee SN, 2012, NAT PROD REP, V29, P513, DOI 10.1039/c2np00086e; Unsold IA, 2005, MICROBIOL-SGM, V151, P1499, DOI 10.1099/mic.0.27759-0; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Winkelblech J, 2015, APPL MICROBIOL BIOT, V99, P7379, DOI 10.1007/s00253-015-6811-y; Wollinsky B, 2012, BIOORG MED CHEM LETT, V22, P3866, DOI 10.1016/j.bmcl.2012.04.119; WOODSIDE AB, 1988, ORG SYNTH, V66, P211; Yin WB, 2007, CHEMBIOCHEM, V8, P1154, DOI 10.1002/cbic.200700079	22	4	4	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4003	4021		10.1074/jbc.M116.759118	http://dx.doi.org/10.1074/jbc.M116.759118			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28007960	Green Published, hybrid			2022-12-26	WOS:000395837100005
J	Kaburagi, T; Kizuka, Y; Kitazume, S; Taniguchi, N				Kaburagi, Tomoko; Kizuka, Yasuhiko; Kitazume, Shinobu; Taniguchi, Naoyuki			The Inhibitory Role of alpha 2,6-Sialylation in Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; EPIGENETIC REGULATION; GANGLIOSIDE GM3; DNA METHYLATION; GENE-EXPRESSION; N-GLYCOSYLATION; CELL-MIGRATION; VISCERAL FAT; ADIPOCYTE; DIFFERENTIATION	Adipose tissue plays critical roles in obesity and related diseases such as diabetes and cardiovascular diseases. Previous reports suggest that glycans, the most common posttranslational modifications, are involved in obesity-related diseases, but what type of glycan regulates adipogenesis during obesity remains unclear. In this study, we first quantified the mRNA levels of 167 genes (encoding 144 glycosyltransferases and 23 related enzymes) in visceral adipose tissues (VATs) from control mice and high-fat diet (HFD)-induced obese mice. We found that a gene encoding beta-galactoside alpha 2,6-sialyltransferase-1 (St6gal1), a key enzyme responsible for the biosynthesis of alpha 2,6-linked sialic acid in N-linked glycans, was most down-regulated in VATs from obese mice. We confirmed the reduction in alpha 2,6-sialic acid in VATs from obese mice and differentiated adipocyte model 3T3-L1 cells. Using proteomic analysis, integrin- beta 1 was identified as one of the target alpha 2,6-sialylated proteins in adipose tissues, and phosphorylation of its downstream molecule focal adhesion kinase was found to be decreased after HFD feeding. St6gal1 overexpression in differentiating 3T3-L1 cells inhibited adipogenesis with increased phosphorylation of focal adhesion kinase. Furthermore, St6gal1 knockout mice exhibited increased bodyweight and VAT weight after HFDfeeding. The down-regulation of St6gal1 during adipogenesis was canceled by treatment with a DNA methyltransferase inhibitor, suggesting an involvement of epigenetic DNA methylation in St6gal1 silencing. Our findings suggest that ST6GAL1 has an inhibitory role in adipogenesis through integrin-beta 1 activation, providing new insights into the roles and regulation mechanisms of glycans in adipocytes during obesity.	[Kaburagi, Tomoko] Daito Bunka Univ, Fac Sports & Hlth Sci, Dept Hlth Sci, 560 Iwadono, Higashi Matsuyama, Saitama 3558681, Japan; [Kaburagi, Tomoko; Kizuka, Yasuhiko; Kitazume, Shinobu; Taniguchi, Naoyuki] RIKEN, Max Planck Joint Res Ctr Syst Chem Biol, Syst Glycobiol Res Grp, Dis Glyc Team,Global Res Cluster, 2-1 Hirosawa, Wako, Saitama 3510198, Japan	RIKEN	Kaburagi, T (corresponding author), Daito Bunka Univ, Fac Sports & Hlth Sci, Dept Hlth Sci, 560 Iwadono, Higashi Matsuyama, Saitama 3558681, Japan.; Kaburagi, T; Taniguchi, N (corresponding author), RIKEN, Max Planck Joint Res Ctr Syst Chem Biol, Syst Glycobiol Res Grp, Dis Glyc Team,Global Res Cluster, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	t-kabu@ic.daito.ac.jp; dglycotani@riken.jp	Taniguchi, Naoyuki/I-4182-2014	Taniguchi, Naoyuki/0000-0001-5889-5968; Kizuka, Yasuhiko/0000-0002-3181-9743	RIKEN (the Systems Glycobiology Research Project); Japan Society for the Promotion of Science [15K14481, 15H04700, 15K00885]; Grants-in-Aid for Scientific Research [15K00885] Funding Source: KAKEN	RIKEN (the Systems Glycobiology Research Project); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by RIKEN (the Systems Glycobiology Research Project) (to N. T.) and by Japan Society for the Promotion of Science Grant-in-Aid for Challenging Exploratory Research 15K14481 (to N. T.), Grant-in-Aid for Scientific Research (B) 15H04700 (to N. T.), and Grant-in-Aid for Scientific Research (C) 15K00885 (to T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Antony P, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-901; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Boque N, 2013, MOL NUTR FOOD RES, V57, P1473, DOI 10.1002/mnfr.201200686; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Farnier C, 2003, INT J OBESITY, V27, P1178, DOI 10.1038/sj.ijo.0802399; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Fuentes P, 2010, J ENDOCRINOL, V206, P75, DOI 10.1677/JOE-10-0049; Gentile TL, 2013, MOL CELL BIOL, V33, P3864, DOI 10.1128/MCB.01495-12; Geurts L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7495; Haga Y, 2011, J BIOL CHEM, V286, P31320, DOI 10.1074/jbc.M111.253955; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hoffmann LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8235; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699; Kawamura YI, 2008, GASTROENTEROLOGY, V135, P142, DOI 10.1053/j.gastro.2008.03.031; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Kitazume S, 2009, GLYCOBIOLOGY, V19, P479, DOI 10.1093/glycob/cwp003; Kizuka Y, 2016, PROTEOMICS, V16, P2854, DOI 10.1002/pmic.201600053; Kizuka Y, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020025; Kizuka Y, 2014, J BIOL CHEM, V289, P11253, DOI 10.1074/jbc.M114.554311; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kroes RA, 2016, GLYCOBIOLOGY, V26, P1271, DOI 10.1093/glycob/cww058; Lauc G, 2014, BBA-GEN SUBJECTS, V1840, P65, DOI 10.1016/j.bbagen.2013.08.017; Lefebvre T, 2010, BBA-GEN SUBJECTS, V1800, P67, DOI 10.1016/j.bbagen.2009.08.008; Li X, 2009, J BIOL CHEM, V284, P19248, DOI 10.1074/jbc.M109.005678; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Lin TH, 1997, J CELL BIOL, V136, P1385, DOI 10.1083/jcb.136.6.1385; Lipina C, 2015, FEBS LETT, V589, P3221, DOI 10.1016/j.febslet.2015.09.018; LISSNER L, 1995, EUR J CLIN NUTR, V49, P79; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Lu JS, 2016, J BIOL CHEM, V291, P5708, DOI 10.1074/jbc.M115.712836; Lu JS, 2015, MOLECULES, V20, P7509, DOI 10.3390/molecules20057509; Marino JH, 2008, GLYCOBIOLOGY, V18, P719, DOI 10.1093/glycob/cwn051; Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652; Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x; Minami A, 2013, J BIOL CHEM, V288, P11845, DOI 10.1074/jbc.M112.405993; Mito N, 2004, J ENDOCRINOL, V180, P167, DOI 10.1677/joe.0.1800167; Mito N, 2000, METABOLISM, V49, P1295, DOI 10.1053/meta.2000.9523; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Patrick CW, 2003, ANN BIOMED ENG, V31, P505, DOI 10.1114/1.1566446; Rellier N, 1999, LIFE SCI, V64, P1571, DOI 10.1016/S0024-3205(99)00094-6; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; SCOTT RE, 1982, P NATL ACAD SCI-BIOL, V79, P845, DOI 10.1073/pnas.79.3.845; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Shabana, 2016, EUR J HUM GENET, V24, P903, DOI 10.1038/ejhg.2015.212; SHIBUYA N, 1989, J BIOCHEM-TOKYO, V106, P1098, DOI 10.1093/oxfordjournals.jbchem.a122972; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; Taniguchi N., 2014, HDB GLYCOSYLTRANSFER; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang Y, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1089; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zaarour N, 2012, BIOCHEM J, V445, P265, DOI 10.1042/BJ20120232; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101	68	18	19	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2278	2286		10.1074/jbc.M116.747667	http://dx.doi.org/10.1074/jbc.M116.747667			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28031460	Green Published, hybrid			2022-12-26	WOS:000395530300020
J	Shiraishi, A; Uruno, T; Sanematsu, F; Ushijima, M; Sakata, D; Hara, T; Fukui, Y				Shiraishi, Akira; Uruno, Takehito; Sanematsu, Fumiyuki; Ushijima, Miho; Sakata, Daiji; Hara, Toshiro; Fukui, Yoshinori			DOCK8 Protein Regulates Macrophage Migration through Cdc42 Protein Activation and LRAP35a Protein Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELL-MIGRATION; RETROGRADE FLOW; RHO-GTPASES; MYOSIN-II; ACTIN; MUTATIONS; LOCALIZATION; POLARIZATION; DEDICATOR; MONOCYTES	DOCK8 is an atypical guanine nucleotide exchange factor for Cdc42, and its mutations cause combined immunodeficiency in humans. Accumulating evidence indicates that DOCK8 regulates the migration and activation of various subsets of leukocytes, but its regulatory mechanism is poorly understood. We here report that DOCK8-deficient macrophages exhibit a migration defect in a 2D setting. Although DOCK8 deficiency in macrophages did not affect the global Cdc42 activation induced by chemokine stimulation, rescue experiments revealed that the guanine nucleotide exchange factor activity of DOCK8 was required for macrophage migration. We found that DOCK8 associated with LRAP35a, an adaptor molecule that binds to the Cdc42 effector myotonic dystrophy kinase-related Cdc42-binding kinase, and facilitated its activity to phosphorylate myosin II regulatory light chain. When this interaction was disrupted in WT macrophages, they showed a migration defect, as seen in DOCK8-deficient macrophages. These results suggest that, during macrophage migration, DOCK8 links Cdc42 activation to actomyosin dynamics through the association with LRAP35a.	[Shiraishi, Akira; Uruno, Takehito; Sanematsu, Fumiyuki; Ushijima, Miho; Sakata, Daiji; Fukui, Yoshinori] Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Immunogenet, Fukuoka 8128582, Japan; [Shiraishi, Akira] Kyushu Univ, Dept Pediat, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Uruno, Takehito; Sanematsu, Fumiyuki; Fukui, Yoshinori] Kyushu Univ, Res Ctr Adv Immunol, Fukuoka 8128582, Japan; [Hara, Toshiro] Fukuoka Childrens Hosp, Fukuoka 8130017, Japan	Kyushu University; Kyushu University; Kyushu University	Fukui, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neuroscience, Div Immunogenet,Higashi Ku, Fukuoka 8128582, Japan.	fukui@bioreg.kyushu-u.ac.jp	Shiraishi, Akira/AAM-8444-2021; Uruno, Takehito/AAF-7998-2019	Uruno, Takehito/0000-0002-2812-9645; Fukui, Yoshinori/0000-0003-2335-8745	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Leading Advanced Projects for Medical Innovation; Research on Development of New Drugs from Japan Agency for Medical Research and Development	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Leading Advanced Projects for Medical Innovation; Research on Development of New Drugs from Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by a grant-in-aid for scientific research on innovative areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; grants-in-aid for scientific research from the Japan Society for the Promotion of Science; the Leading Advanced Projects for Medical Innovation; and the Research on Development of New Drugs from Japan Agency for Medical Research and Development. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson TW, 2008, MOL BIOL CELL, V19, P5006, DOI 10.1091/mbc.E08-01-0034; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Crawford G, 2013, BLOOD, V122, P2052, DOI 10.1182/blood-2013-02-482331; Engelhardt KR, 2009, J ALLERGY CLIN IMMUN, V124, P1289, DOI 10.1016/j.jaci.2009.10.038; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Gotoh K, 2008, BLOOD, V111, P2973, DOI 10.1182/blood-2007-09-112169; Harada Y, 2012, BLOOD, V119, P4451, DOI 10.1182/blood-2012-01-407098; Jacobelli J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075151; Krishnaswamy JK, 2015, P NATL ACAD SCI USA, V112, P3056, DOI 10.1073/pnas.1501554112; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; Lambe T, 2011, EUR J IMMUNOL, V41, P3423, DOI 10.1002/eji.201141759; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Maus UA, 2005, AM J PHYSIOL-LUNG C, V288, pL350, DOI 10.1152/ajplung.00061.2004; Maus UA, 2006, AM J RESP CELL MOL, V35, P227, DOI 10.1165/rcmb.2005-0241OC; Mizesko MC, 2013, J ALLERGY CLIN IMMUN, V131, P840, DOI 10.1016/j.jaci.2012.12.1568; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; Randall KL, 2011, J EXP MED, V208, P2305, DOI 10.1084/jem.20110345; Randall KL, 2009, NAT IMMUNOL, V10, P1283, DOI 10.1038/ni.1820; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ruusala A, 2004, FEBS LETT, V572, P159, DOI 10.1016/j.febslet.2004.06.095; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Zhang Q, 2014, J EXP MED, V211, P2549, DOI 10.1084/jem.20141307; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506; Zhou YY, 2013, BIOCHEMISTRY-US, V52, P4354, DOI 10.1021/bi301688g	33	16	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2191	2202		10.1074/jbc.M116.736306	http://dx.doi.org/10.1074/jbc.M116.736306			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28028174	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000395530300013
J	van Lis, R; Popek, M; Coute, Y; Kosta, A; Drapier, D; Nitschke, W; Atteia, A				van Lis, Robert; Popek, Marion; Coute, Yohann; Kosta, Artemis; Drapier, Dominique; Nitschke, Wolfgang; Atteia, Ariane			Concerted Up-regulation of Aldehyde/Alcohol Dehydrogenase (ADHE) and Starch in Chlamydomonas reinhardtii Increases Survival under Dark Anoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-FORMATE-LYASE; ANAEROBIC ENERGY-METABOLISM; ALCOHOL-DEHYDROGENASE; ESCHERICHIA-COLI; FERREDOXIN OXIDOREDUCTASE; FERMENTATIVE METABOLISM; CONCENTRATING MECHANISM; HYDROGEN-PRODUCTION; GENE-EXPRESSION; PROTEIN	Aldehyde/alcohol dehydrogenases (ADHEs) are bifunctional enzymes that commonly produce ethanol from acetyl-CoA with acetaldehyde as intermediate and play a key role in anaerobic redox balance in many fermenting bacteria. ADHEs are also present in photosynthetic unicellular eukaryotes, where their physiological role and regulation are, however, largely unknown. Herein we provide the first molecular and enzymatic characterization of the ADHE from the photosynthetic microalga Chlamydomonas reinhardtii. Purified recombinant ADHE catalyzed the reversible NADH-mediated interconversions of acetyl-CoA, acetaldehyde, and ethanol but seemed to be poised toward the production of ethanol from acetaldehyde. Phylogenetic analysis of the algal fermentative enzyme supports a vertical inheritance from a cyanobacterial-related ancestor. ADHE was located in the chloroplast, where it associated in dimers and higher order oligomers. Electron microscopy analysis of ADHE-enriched stromal fractions revealed fine spiral structures, similar to bacterial ADHE spirosomes. Protein blots showed that ADHE is regulated under oxic conditions. Up-regulation is observed in cells exposed to diverse physiological stresses, including zinc deficiency, nitrogen starvation, and inhibition of carbon concentration/fixation capacity. Analyses of the overall proteome and fermentation profiles revealed that cells with increased ADHE abundance exhibit better survival under dark anoxia. This likely relates to the fact that greater ADHE abundance appeared to coincide with enhanced starch accumulation, which might reflect ADHE-mediated anticipation of anaerobic survival.	[van Lis, Robert; Popek, Marion; Nitschke, Wolfgang; Atteia, Ariane] Aix Marseille Univ, CNRS, BIP UMR 7281, F-13402 Marseille, France; [van Lis, Robert] INRA, LBE, F-11100 Narbonne, France; [Coute, Yohann] Univ Grenoble Alpes, BIG BGE, F-38000 Grenoble, France; [Coute, Yohann] Commissariat Energie Atom, BIG BGE, F-38000 Grenoble, France; [Coute, Yohann] INSERM, BGE, F-38000 Grenoble, France; [Kosta, Artemis] FR3479 Inst Microbiol Mediterranee, Microscopy Core Facil, F-13402 Marseille 20, France; [Drapier, Dominique] UPMC, Inst Biol Phys Chim, CNRS UMR7141, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Atteia, A (corresponding author), Aix Marseille Univ, CNRS, Unite Bioenerget & Ingn Prot UMR 7281, 31 Chemin Joseph Aiguier, F-13402 Marseille, France.	ariane.atteia@imm.cnrs.fr	Couté, Yohann/G-2695-2015; Nitschke, Wolfgang/C-4812-2012	Couté, Yohann/0000-0003-3896-6196; Kosta, Artemis/0000-0001-7115-4566; Nitschke, Wolfgang/0000-0003-2084-3032	Centre National de la Recherche Scientifique; Agence Nationale pour la Recherche [ANR-10-BIOE-0004]; ProFi Infrastructure [ANR-10-INBS-08-01]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); ProFi Infrastructure	This work was supported by the Centre National de la Recherche Scientifique and partly supported by Agence Nationale pour la Recherche Grant ANR-10-BIOE-0004 (to A. A., R.V.L., and M.P.), and ProFi Infrastructure Grant ANR-10-INBS-08-01 (to Y.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Atteia A, 2006, J BIOL CHEM, V281, P9909, DOI 10.1074/jbc.M507862200; Atteia A, 2003, PLANT MOL BIOL, V53, P175, DOI 10.1023/B:PLAN.0000009274.19340.36; Atteia A, 2013, BBA-BIOENERGETICS, V1827, P210, DOI 10.1016/j.bbabio.2012.08.002; BALL SG, 1990, PLANT SCI, V66, P1, DOI 10.1016/0168-9452(90)90162-H; Beckham KSH, 2014, MOL MICROBIOL, V93, P199, DOI 10.1111/mmi.12651; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Boxma B, 2004, MOL MICROBIOL, V51, P1389, DOI 10.1046/j.1365-2958.2003.03912.x; BRUCHHAUS I, 1994, BIOCHEM J, V303, P743, DOI 10.1042/bj3030743; Burgess SJ, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv167; CABISCOL E, 1994, J BIOL CHEM, V269, P6592; Catalanotti C, 2012, PLANT CELL, V24, P692, DOI 10.1105/tpc.111.093146; Dagan T, 2013, GENOME BIOL EVOL, V5, P31, DOI 10.1093/gbe/evs117; DRON M, 1983, PLASMID, V9, P321, DOI 10.1016/0147-619X(83)90009-4; Dubini A, 2009, J BIOL CHEM, V284, P7201, DOI 10.1074/jbc.M803917200; Dupierris V, 2009, BIOINFORMATICS, V25, P1980, DOI 10.1093/bioinformatics/btp301; DURRANT I, 1990, NATURE, V346, P297, DOI 10.1038/346297a0; Fukuzawa H, 2001, P NATL ACAD SCI USA, V98, P5347, DOI 10.1073/pnas.081593498; GFELLER RP, 1984, PLANT PHYSIOL, V75, P212, DOI 10.1104/pp.75.1.212; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; Hemschemeier A, 2008, EUKARYOT CELL, V7, P518, DOI 10.1128/EC.00368-07; Hoffmeister M, 2004, J BIOL CHEM, V279, P22422, DOI 10.1074/jbc.M400913200; Hsieh SI, 2013, MOL CELL PROTEOMICS, V12, P65, DOI 10.1074/mcp.M112.021840; Johnson X, 2014, PLANT PHYSIOL, V165, P438, DOI 10.1104/pp.113.233593; Johnson X, 2010, PLANT CELL, V22, P234, DOI 10.1105/tpc.109.066266; Karlsson J, 1998, EMBO J, V17, P1208, DOI 10.1093/emboj/17.5.1208; KAWATA T, 1975, JPN J MICROBIOL, V19, P225, DOI 10.1111/j.1348-0421.1975.tb00872.x; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; KESSLER D, 1991, FEBS LETT, V281, P59, DOI 10.1016/0014-5793(91)80358-A; KREUZBERG K, 1984, PHYSIOL PLANTARUM, V61, P87, DOI 10.1111/j.1399-3054.1984.tb06105.x; KREUZBERG K, 1987, PHYSIOL PLANTARUM, V69, P481, DOI 10.1111/j.1399-3054.1987.tb09229.x; Kucho K, 2003, PLANT PHYSIOL, V133, P783, DOI 10.1104/pp.103.026492; Laurenceau R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004835; LEONARDO MR, 1993, J BACTERIOL, V175, P870, DOI 10.1128/JB.175.3.870-878.1993; Magneschi L, 2012, PLANT PHYSIOL, V158, P1293, DOI 10.1104/pp.111.191569; MAIONE TE, 1986, PLANT PHYSIOL, V80, P360, DOI 10.1104/pp.80.2.360; Malasarn D, 2013, J BIOL CHEM, V288, P10672, DOI 10.1074/jbc.M113.455105; McDonald KL, 2014, MICROSC MICROANAL, V20, P152, DOI 10.1017/S1431927613013846; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Moezelaar R, 1996, APPL ENVIRON MICROB, V62, P1752, DOI 10.1128/AEM.62.5.1752-1758.1996; Montella C, 2005, J BACTERIOL, V187, P4957, DOI 10.1128/JB.187.14.4957-4966.2005; MORONEY JV, 1989, PLANT PHYSIOL, V89, P897, DOI 10.1104/pp.89.3.897; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; Noth J, 2013, J BIOL CHEM, V288, P4368, DOI 10.1074/jbc.M112.429985; O'Toole ET, 2010, METHOD CELL BIOL, V96, P71, DOI 10.1016/S0091-679X(10)96004-4; OREN A, 1979, ARCH MICROBIOL, V122, P77, DOI 10.1007/BF00408049; Pagels M, 2010, MOL MICROBIOL, V76, P1142, DOI 10.1111/j.1365-2958.2010.07105.x; Philipps G, 2011, PLANT J, V66, P330, DOI 10.1111/j.1365-313X.2011.04494.x; Sanchez LB, 1998, ARCH BIOCHEM BIOPHYS, V354, P57, DOI 10.1006/abbi.1998.0664; Schmollinger S, 2014, PLANT CELL, V26, P1410, DOI 10.1105/tpc.113.122523; Shasmal M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19936; Silakov A, 2009, BIOCHEMISTRY-US, V48, P7780, DOI 10.1021/bi9009105; SPREITZER RJ, 1980, NATURE, V285, P114, DOI 10.1038/285114a0; Stal LJ, 1997, FEMS MICROBIOL REV, V21, P179, DOI 10.1016/S0168-6445(97)00056-9; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terashima M, 2010, MOL CELL PROTEOMICS, V9, P1514, DOI 10.1074/mcp.M900421-MCP200; Valledor L, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0171-1; van Lis R, 2005, PLANT PHYSIOL, V139, P1946, DOI 10.1104/pp.105.069732; van Lis R, 2013, PLANT PHYSIOL, V161, P57, DOI 10.1104/pp.112.208181; Wang YJ, 2011, PHOTOSYNTH RES, V109, P115, DOI 10.1007/s11120-011-9643-3; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yang WQ, 2014, PLANT CELL, V26, P4499, DOI 10.1105/tpc.114.129965; YANG WG, 1994, MOL BIOCHEM PARASIT, V64, P253, DOI 10.1016/0166-6851(93)00020-A; Zabawinski C, 2001, J BACTERIOL, V183, P1069, DOI 10.1128/JB.183.3.1069-1077.2001; Zheng TY, 2015, J BACTERIOL, V197, P2610, DOI 10.1128/JB.00232-15	70	19	19	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2395	2410		10.1074/jbc.M116.766048	http://dx.doi.org/10.1074/jbc.M116.766048			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28007962	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000395530300029
J	Choi, HW; Berwick, ZC; Sulking, MS; Owens, CD; Kassab, GS				Choi, Hyo Won; Berwick, Zachary C.; Sulking, Matthew S.; Owens, Christopher D.; Kassab, Ghassan S.			Optimization of Peripheral Vascular Sizing with Conductance Guidewire: Theory and Experiment	PLOS ONE			English	Article							FINITE-ELEMENT MODEL; LUMEN AREA; ELECTRICAL-CONDUCTIVITY; CATHETER MEASUREMENTS; DIELECTRIC-PROPERTIES; IMPEDANCE CATHETER; CORONARY-ARTERIES; SKELETAL-MUSCLE; IN-VITRO; VALIDATION	Although the clinical range of interventions for coronary arteries is about 2 to 5 mm, the range of diameters of peripheral vasculature is significantly larger (about 10 mm for human iliac artery). When the vessel diameter is increased, the spacing between excitation electrodes on a conductance sizing device must also increase to accommodate the greater range of vessel diameters. The increase in the excitation electrodes distance, however, causes higher parallel conductance or current losses outside of artery lumen. We have previously shown that the conductance catheter/guidewire excitation electrode distances affects the measurement accuracy for the peripheral artery lumen sizing. Here, we propose a simple solution that varies the detection electrode distances to compensate for parallel conductance losses. Computational models were constructed to simulate the conductance guidewire with various electrodes spacing combinations over a range of peripheral artery lumen diameters and surrounding tissue electrical conductivities. The results demonstrate that the measurement accuracy may be significantly improved by increased detection spacing. Specifically, an optimally configured detection/ excitation spacing (i.e., 5-5-5 or an equidistant electrode interval with a detection-to-excitation spacing ratio of 0.3) was shown to accurately predict the lumen diameter (i.e., -10% < error < 10%) over a broad range of peripheral artery dimensions (4 mm < diameter < 10 mm). The computational results were substantiated with both ex-vivo and in-vivo measurements of peripheral arteries. The present results support the accuracy of the conductance technique for measurement of peripheral reference vessel diameter.	[Choi, Hyo Won; Kassab, Ghassan S.] Calif Med Innovat Inst Inc, San Diego, CA 92121 USA; [Berwick, Zachary C.; Sulking, Matthew S.] 3DT Holdings LLC, San Diego, CA USA; [Owens, Christopher D.] UCSF, Dept Vasc Surg, San Francisco, CA USA	University of California System; University of California San Francisco	Kassab, GS (corresponding author), Calif Med Innovat Inst Inc, San Diego, CA 92121 USA.	gkassab@calmi2.org			IDS; 3DT Holdings	IDS; 3DT Holdings	This research was funded by IDS and 3DT Holdings. The funder provided support in the form of salary for Dr. Berwick, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Choi HW, 2013, J APPL PHYSIOL, V114, P656, DOI 10.1152/japplphysiol.00987.2012; Choi HW, 2012, J R SOC INTERFACE, V9, P2971, DOI 10.1098/rsif.2012.0188; Choi HW, 2011, J APPL PHYSIOL, V111, P758, DOI 10.1152/japplphysiol.00304.2011; Cooke J P, 1997, Vasc Med, V2, P227; EPSTEIN BR, 1983, MED BIOL ENG COMPUT, V21, P51, DOI 10.1007/BF02446406; Faes TJC, 1999, PHYSIOL MEAS, V20, pR1, DOI 10.1088/0967-3334/20/4/201; FOSTER KR, 1989, CRIT REV BIOMED ENG, V17, P25; Gabriel C, 2009, PHYS MED BIOL, V54, P4863, DOI 10.1088/0031-9155/54/16/002; GIELEN FLH, 1984, MED BIOL ENG COMPUT, V22, P569, DOI 10.1007/BF02443872; Hermiller J, 2011, CATHETER CARDIO INTE, V78, P202, DOI 10.1002/ccd.22842; Hettrick DA, 1996, ANN BIOMED ENG, V24, P675, DOI 10.1007/BF02684180; Hettrick DA, 1997, ANN BIOMED ENG, V25, P126, DOI 10.1007/BF02738544; Hettrick DA, 1999, ANN BIOMED ENG, V27, P151, DOI 10.1114/1.215; Kassab GS, 2009, AM J PHYSIOL-HEART C, V297, pH485, DOI 10.1152/ajpheart.01224.2008; Kassab GS, 2005, AM J PHYSIOL-HEART C, V288, pH2014, DOI 10.1152/ajpheart.00508.2004; Kassab GS, 2004, ANN BIOMED ENG, V32, P1642, DOI 10.1007/s10439-004-7817-2; Klepfer RN, 1997, IEEE T BIO-MED ENG, V44, P706, DOI 10.1109/10.605427; RUSH S, 1963, CIRC RES, V12, P40, DOI 10.1161/01.RES.12.1.40; Svendsen MC, 2015, CATHETER CARDIO INTE, V86, P136, DOI 10.1002/ccd.25774	19	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168886	10.1371/journal.pone.0168886	http://dx.doi.org/10.1371/journal.pone.0168886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045933	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300065
J	Handelzalts, JE; Peyser, AW; Krissi, H; Levy, S; Wiznitzer, A; Peled, Y				Handelzalts, Jonathan E.; Peyser, Avigail Waldman; Krissi, Haim; Levy, Sigal; Wiznitzer, Arnon; Peled, Yoav			Indications for Emergency Intervention, Mode of Delivery, and the Childbirth Experience	PLOS ONE			English	Article							STRESS FOLLOWING CHILDBIRTH; WOMENS SATISFACTION; BIRTH EXPERIENCE; RISK-FACTORS; PREVALENCE; EVENTS; TRAUMA; IMPACT	Background Although the impact of emergency procedures on the childbirth experience has been studied extensively, a possible association of childbirth experience with indications for emergency interventions has not been reported. Objectives To compare the impacts on childbirth experience of 'planned' delivery (elective cesarean section and vaginal delivery) versus 'unplanned' delivery (vacuum extraction or emergency cesarean section); the intervention itself (vacuum extraction versus emergency cesarean section); and indications for intervention (arrest of labor versus risk to the mother or fetus). Study design A total of 469 women, up to 72 hours post-partum, in the maternity ward of one tertiary health care institute completed the Subjective Childbirth Experience Questionnaire (score: 0-4, a higher score indicated a more negative experience) and a Personal Information Questionnaire. Intra-partum information was retrieved from the medical records. One-way analysis of variance and two-way analysis of variance, followed by analysis of covariance, to test the unique contribution of variables, were used to examine differences between groups in outcome. Tukey's Post-Hoc analysis was used when appropriate. Results Planned delivery, either vaginal or elective cesarean section, was associated with a more positive experience than unplanned delivery, either vacuum or emergency cesarean section (mean respective Subjective Childbirth Experience scores: 1.58 and 1.49 vs. 2.02 and 2.07, P <0.01). The difference in mean Subjective Childbirth Experience scores following elective cesarean section and vaginal delivery was not significant; nor was the difference following vacuum extraction and emergency cesarean section. Interventions due to immediate risk to mother or fetus resulted in a more positive birth experience than interventions due to arrest of labor (Subjective Childbirth Experience: 1.9 vs. 2.2, P <0.01). Conclusions Compared to planned interventions, unplanned interventions were shown to be associated with a more negative maternal childbirth experience. However, the indication for unplanned intervention appears to have a greater effect than the nature of the intervention on the birth experience. Women who underwent emergency interventions due to delay of birth (arrest of labor) perceived their birth experience more negatively than those who underwent interventions due to risk for the mother or fetus, regardless of the nature of the intervention (vacuum or emergency cesarean section). The results indicate the importance of follow-up after unexpected emergency interventions, especially following arrest of labor, as negative birth experience may have repercussions in a woman's psychosocial life and well-being.	[Handelzalts, Jonathan E.; Peyser, Avigail Waldman; Levy, Sigal] Acad Coll Tel Aviv Yaffo, Sch Behav Sci, Tel Aviv, Israel; [Krissi, Haim; Wiznitzer, Arnon; Peled, Yoav] Helen Schneider Hosp Women, Rabin Med Ctr, Petah Tiqwa, Israel; [Krissi, Haim; Wiznitzer, Arnon; Peled, Yoav] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Handelzalts, JE (corresponding author), Acad Coll Tel Aviv Yaffo, Sch Behav Sci, Tel Aviv, Israel.	jonathanh@013.net; dr.peled@gmail.com		Handelzalts, Jonathan/0000-0002-9045-6057				Ayers S, 2016, PSYCHOL MED, V46, P1121, DOI 10.1017/S0033291715002706; Bar-On S, 2014, J PERINAT MED, V42, P435, DOI 10.1515/jpm-2013-0236; Blomquist JL, 2011, AM J PERINAT, V28, P383, DOI 10.1055/s-0031-1274508; Callister LC, 2004, JOGNN-J OBST GYN NEO, V33, P508, DOI 10.1177/0884217504266898; Creedy DK, 2000, BIRTH-ISS PERINAT C, V27, P104, DOI 10.1046/j.1523-536x.2000.00104.x; Fenwick Jennifer, 2003, Int J Nurs Pract, V9, P10, DOI 10.1046/j.1440-172X.2003.00397.x; Figley C. R., 1986, TRAUMA ITS WAKE, P39; Ford E, 2009, J ANXIETY DISORD, V23, P260, DOI 10.1016/j.janxdis.2008.07.009; Goodman P, 2004, J ADV NURS, V46, P212, DOI 10.1111/j.1365-2648.2003.02981.x; Gottvall K, 2002, BJOG-INT J OBSTET GY, V109, P254, DOI 10.1111/j.1471-0528.2002.01200.x; Handelzalts JE, 2015, ARCH GYNECOL OBSTET, V291, P1055, DOI 10.1007/s00404-014-3532-x; Hodnett ED, 2002, AM J OBSTET GYNECOL, V186, pS160, DOI 10.1067/mob.2002.121141; Lev-Wiesel R, 2009, J WOMENS HEALTH, V18, P119, DOI 10.1089/jwh.2008.0774; Olde E, 2006, CLIN PSYCHOL REV, V26, P1, DOI 10.1016/j.cpr.2005.07.002; Pang MW, 2008, BIRTH-ISS PERINAT C, V35, P121, DOI 10.1111/j.1523-536X.2008.00225.x; Righetti-Veltema M, 1998, J AFFECT DISORDERS, V49, P167, DOI 10.1016/S0165-0327(97)00110-9; Ryding EL, 1998, BIRTH-ISS PERINAT C, V2, P246; SALMON P, 1992, J PSYCHOSOM RES, V36, P317, DOI 10.1016/0022-3999(92)90068-D; Schindl M, 2003, ACTA OBSTET GYN SCAN, V82, P834, DOI 10.1034/j.1600-0412.2003.00194.x; Shorten A, 2012, J MIDWIFERY WOM HEAL, V57, P126, DOI 10.1111/j.1542-2011.2011.00106.x; Soet JE, 2003, BIRTH-ISS PERINAT C, V30, P36, DOI 10.1046/j.1523-536X.2003.00215.x; Spaich S, 2013, EUR J OBSTET GYN R B, V170, P401, DOI 10.1016/j.ejogrb.2013.07.040; Waldenstrom U, 2004, BIRTH-ISS PERINAT C, V31, P17, DOI 10.1111/j.0730-7659.2004.0270.x; Waldenstrom U, 1996, BIRTH-ISS PERINAT C, V23, P144, DOI 10.1111/j.1523-536X.1996.tb00475.x	24	33	34	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169132	10.1371/journal.pone.0169132	http://dx.doi.org/10.1371/journal.pone.0169132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2QJ	28046019	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300124
J	Lu, DH; Sepulveda, C; Dillman, AR				Lu, Dihong; Sepulveda, Claudia; Dillman, Adler R.			Infective Juveniles of the Entomopathogenic Nematode Steinernema scapterisci Are Preferentially Activated by Cricket Tissue	PLOS ONE			English	Article							BACTERIAL SYMBIONTS; XENORHABDUS; GRYLLOTALPIDAE; PATHOGENICITY; RHABDITIDA; ORTHOPTERA; REPRODUCTION; CARPOCAPSAE	Entomopathogenic nematodes are a subgroup of insect-parasitic nematodes that are used in biological control as alternatives or supplements to chemical pesticides. Steinernema scapterisci is an unusual member of the entomopathogenic nematode guild for many reasons including that it is promiscuous in its association with bacteria, it can reproduce in the absence of its described bacterial symbiont, and it is known to have a narrow host range. It is a powerful comparative model within the species and could be used to elucidate parasite specialization. Here we describe a new method of efficiently producing large numbers of S. scapterisci infective juveniles (IJs) in house crickets and for quantifying parasitic activation of the IJs upon exposure to host tissue using morphological features. We found that parasite activation is a temporal process with more IJs activating over time. Furthermore, we found that activated IJs secrete a complex mixture of proteins and that S. scapterisci IJs preferentially activate upon exposure to cricket tissue, reaffirming the description of S. scapterisci as a cricket specialist.	[Lu, Dihong; Sepulveda, Claudia; Dillman, Adler R.] Univ Calif Riverside, Dept Nematol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Dillman, AR (corresponding author), Univ Calif Riverside, Dept Nematol, Riverside, CA 92521 USA.	adlerd@ucr.edu	Dillman, Adler/H-6737-2019	Dillman, Adler/0000-0001-7171-4332	National Institutes of Health, National Institute of Allergy and Infectious Diseases; K22 Career Transition Award [Al119155]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI119155] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); K22 Career Transition Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health, National Institute of Allergy and Infectious Diseases. K22 Career Transition Award Al119155 to ARD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BJ, 2007, NEMATOL MONOGR PERSP, V5, P693; AGUILLERA MM, 1993, J INVERTEBR PATHOL, V62, P289, DOI 10.1006/jipa.1993.1115; AGUILLERA MM, 1993, J INVERTEBR PATHOL, V62, P68, DOI 10.1006/jipa.1993.1076; Balasubramanian N, 2009, INT J PARASITOL, V39, P975, DOI 10.1016/j.ijpara.2009.01.012; BEDDING RA, 1981, NEMATOLOGICA, V27, P109, DOI 10.1163/187529281X00115; Bonifassi E, 1999, J INVERTEBR PATHOL, V74, P164, DOI 10.1006/jipa.1999.4866; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Castelletto ML, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004305; Dillman AR, 2014, ENVIRON ENTOMOL, V43, P146, DOI 10.1603/EN13152; Dillman AR, 2012, P NATL ACAD SCI USA, V109, pE2324, DOI 10.1073/pnas.1211436109; Dillman AR, 2012, CURR BIOL, V22, pR430, DOI 10.1016/j.cub.2012.03.047; Dillman AR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002527; Emelianoff V, 2007, PARASITOL RES, V100, P657, DOI 10.1007/s00436-006-0284-y; Frank J. H., 2006, American Entomologist, V52, P138; Frank J. Howard, 2009, V6, P115; Gang SS, 2016, MOL BIOCHEM PARASIT, V208, P23, DOI 10.1016/j.molbiopara.2016.05.007; Hallem EA, 2011, CURR BIOL, V21, P377, DOI 10.1016/j.cub.2011.01.048; Han RC, 2000, J INVERTEBR PATHOL, V75, P55, DOI 10.1006/jipa.1999.4900; KAYA HK, 1993, ANNU REV ENTOMOL, V38, P181, DOI 10.1146/annurev.en.38.010193.001145; Kaya HK, 1997, MANUAL TECHNIQUES IN; Lee JH, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0259-0; Lee MM, 2010, J INVERTEBR PATHOL, V104, P67, DOI 10.1016/j.jip.2010.01.005; Lewis EE, 2012, INSECT PATHOLOGY, 2ND EDITION, P395, DOI 10.1016/B978-0-12-384984-7.00011-7; LEWIS EE, 1995, PARASITOLOGY, V110, P207, DOI 10.1017/S0031182000063976; Lewis EE, 1996, PARASITOLOGY, V113, P573, DOI 10.1017/S0031182000067627; McMullen JG, 2014, JOVE-J VIS EXP, DOI 10.3791/52096; Morran LT, 2016, EVOLUTION, V70, P687, DOI 10.1111/evo.12878; Murfin KE, 2012, BIOL BULL-US, V223, P85, DOI 10.1086/BBLv223n1p85; Nadler SA, 2006, SYST PARASITOL, V63, P161, DOI 10.1007/s11230-005-9009-3; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; NGUYEN KB, 1990, J NEMATOL, V22, P187; NGUYEN KB, 1991, J NEMATOL, V23, P7; NGUYEN KB, 1992, J NEMATOL, V24, P160; Nguyen KB., 1988, NEW NEMATODE PARASIT; Nguyen KB, 2007, NEMATOL MONOGR PERSP, V5, P121; PARKMAN JP, 1994, ENVIRON ENTOMOL, V23, P1331, DOI 10.1093/ee/23.5.1331; Poinar G. O., 1979, NEMATODES BIOL CONTR; Price P. W., 1980, EVOLUTIONARY BIOL PA; Sicard M, 2005, NATURWISSENSCHAFTEN, V92, P472, DOI 10.1007/s00114-005-0021-x; Sicard M, 2003, PARASITOL RES, V91, P520, DOI 10.1007/s00436-003-0998-z; Thompson J.N, 2009, COEVOLUTIONARY PROCE; Toubarro D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075691; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a	43	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169410	10.1371/journal.pone.0169410	http://dx.doi.org/10.1371/journal.pone.0169410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046065	Green Submitted, gold, Green Published			2022-12-26	WOS:000391612300184
J	Majer, A; Caligiuri, KA; Gale, KK; Niu, YL; Phillipson, CS; Booth, TF; Booth, SA				Majer, Anna; Caligiuri, Kyle A.; Gale, Kamilla K.; Niu, Yulian; Phillipson, Clark S.; Booth, Timothy F.; Booth, Stephanie A.			Induction of Multiple miR-200/182 Members in the Brains of Mice Are Associated with Acute Herpes Simplex Virus 1 Encephalitis	PLOS ONE			English	Article							T-CELL RESPONSES; 3-O-SULFATED HEPARAN-SULFATE; MICRORNA EXPRESSION; IMMUNE-RESPONSE; INFECTION; TYPE-1; HOST; RNA; MIR-155; REPLICATION	Important roles of microRNAs (miRNAs) in regulating the host response during viral infection have begun to be defined. However, little is known about the functional roles of miRNAs within an in vivo acute viral encephalitis model. We therefore identified global changes in miRNA expression during acute herpes simplex virus type 1 (HSV-1) encephalitis (HSVE) in mice. We found that many of the highly upregulated miRNAs (miR-155, miR-146a and miR-15b) detected in HSV-1 infected brain tissue are known regulators of inflammation and innate immunity. We also observed upregulation of 7 members belonging to the related group of miRNAs, the miR-200 family and miR-182 cluster (miR-200/182). Using in situ hybridization, we found that these miRNAs co-localized to regions of the brain with severe HSVE-related pathology and were upregulated in various cell types including neurons. Induction was apparent but not limited to cells in which HSV-1 was detected by immunohistochemistry, suggesting possible roles of these miRNAs in the host response to viral-induced tissue damage. Bioinformatic prediction combined with gene expression profiling revealed that the induced miR-200/182 members could regulate the biosynthesis of heparan sulfate proteoglycans. Using luciferase assays, we found that miR-96, miR-141, miR-183 and miR-200c all potentially targeted the syndecan-2 gene (Sdc2), which codes for a cell surface heparan sulfate proteoglycan involved in HSV-1 cellular attachment and entry.	[Majer, Anna; Caligiuri, Kyle A.; Booth, Timothy F.; Booth, Stephanie A.] Univ Manitoba, Coll Med, Fac Hlth Sci, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Majer, Anna; Caligiuri, Kyle A.; Gale, Kamilla K.; Niu, Yulian; Phillipson, Clark S.; Booth, Stephanie A.] Publ Hlth Agcy Canada, Canadian Sci Ctr Human & Anim Hlth, Natl Microbiol Lab, Mol PathoBiol, Winnipeg, MB, Canada; [Booth, Timothy F.] Publ Hlth Agcy Canada, Canadian Sci Ctr Human & Anim Hlth, Natl Microbiol Lab, Viral Dis, Winnipeg, MB, Canada	University of Manitoba; Canadian Science Centre for Human & Animal Health; Public Health Agency of Canada; Canadian Science Centre for Human & Animal Health; Public Health Agency of Canada	Booth, SA (corresponding author), Univ Manitoba, Coll Med, Fac Hlth Sci, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada.; Booth, SA (corresponding author), Publ Hlth Agcy Canada, Canadian Sci Ctr Human & Anim Hlth, Natl Microbiol Lab, Mol PathoBiol, Winnipeg, MB, Canada.	Stephanie.Booth@phac-aspc.gc.ca	Booth, Stephanie/AAX-6671-2020	Booth, Stephanie/0000-0001-8108-5955	Public Health Agency of Canada; Natural Science and Engineering Council of Canada	Public Health Agency of Canada; Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by the Public Health Agency of Canada and a Natural Science and Engineering Council of Canada graduate studentship to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacsa S, 2011, J GEN VIROL, V92, P733, DOI 10.1099/vir.0.027052-0; Baringer JR, 2008, NEUROL CLIN, V26, P657, DOI 10.1016/j.ncl.2008.03.005; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhela S, 2014, J IMMUNOL, V192, P2734, DOI 10.4049/jimmunol.1302326; Buggele WA, 2012, J BIOL CHEM, V287, P31027, DOI 10.1074/jbc.M112.387670; CAI WZ, 1992, J VIROL, V66, P2904, DOI 10.1128/JVI.66.5.2904-2915.1992; Cardoso AL, 2012, IMMUNOLOGY, V135, P73, DOI 10.1111/j.1365-2567.2011.03514.x; Cheng YQ, 2015, IMMUNOLOGY, V145, P485, DOI 10.1111/imm.12463; Contreras J, 2012, LEUKEMIA, V26, P404, DOI 10.1038/leu.2011.356; Cui C, 2006, J VIROL, V80, P5499, DOI 10.1128/JVI.00200-06; Cullen BR, 2011, GENE DEV, V25, P1881, DOI 10.1101/gad.17352611; Dudda JC, 2013, IMMUNITY, V38, P742, DOI 10.1016/j.immuni.2012.12.006; Enquist LW, 1999, ADV VIRUS RES, V51, P237; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Grigoryev YA, 2011, J IMMUNOL, V187, P2233, DOI 10.4049/jimmunol.1101233; Gupta P, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-64; Hill JM, 2009, NEUROREPORT, V20, P1500, DOI 10.1097/WNR.0b013e3283329c05; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kamakura M, 2008, MICROBES INFECT, V10, P405, DOI 10.1016/j.micinf.2007.12.019; Kong HM, 2015, J MOL NEUROSCI, V57, P28, DOI 10.1007/s12031-015-0574-x; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kumar M, 2014, VIROLOGY, V452, P143, DOI 10.1016/j.virol.2014.01.004; KWONG AD, 1987, P NATL ACAD SCI USA, V84, P1926, DOI 10.1073/pnas.84.7.1926; Lam WY, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-104; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2010, J VIROL, V84, P3023, DOI 10.1128/JVI.02203-09; Lind EF, 2013, J IMMUNOL, V190, P1210, DOI 10.4049/jimmunol.1202700; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Ramirez MA, 2014, FASEB J, V28, P2551, DOI 10.1096/fj.13-248880; Lundberg P, 2008, J VIROL, V82, P7078, DOI 10.1128/JVI.00619-08; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Majer A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003002; Marques CP, 2008, J IMMUNOL, V181, P6417, DOI 10.4049/jimmunol.181.9.6417; Marques CP, 2006, VIRUS RES, V121, P1, DOI 10.1016/j.virusres.2006.03.009; Maudet C, 2014, FEBS LETT, V588, P4140, DOI 10.1016/j.febslet.2014.08.002; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Miyazaki D, 2011, INVEST OPHTH VIS SCI, V52, P4282, DOI 10.1167/iovs.10-6911; Mulik S, 2012, AM J PATHOL, V181, P525, DOI 10.1016/j.ajpath.2012.04.014; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connor CM, 2014, J VIROL, V88, P5524, DOI 10.1128/JVI.00481-14; Pan DL, 2014, CELL HOST MICROBE, V15, P446, DOI 10.1016/j.chom.2014.03.004; Pareek S, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-97; Pasieka TJ, 2011, J VIROL, V85, P12972, DOI 10.1128/JVI.06032-11; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Peng T, 2016, AM J TRANSL RES, V8, P3513; Reske A, 2007, REV MED VIROL, V17, P205, DOI 10.1002/rmv.531; Rozenberg Flore, 2011, Infectious Disorders - Drug Targets, V11, P235; Ru J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114021; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Selvamani SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103624; Sharma N, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0249-0; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Spillmann D, 2001, BIOCHIMIE, V83, P811, DOI 10.1016/S0300-9084(01)01290-1; Stark TJ, 2012, J VIROL, V86, P226, DOI 10.1128/JVI.05903-11; Sung TL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000263; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Terrier O, 2013, J GEN VIROL, V94, P985, DOI 10.1099/vir.0.049528-0; Tiwari V, 2006, J VIROL, V80, P8970, DOI 10.1128/JVI.00296-06; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Wang FZ, 2008, J VIROL, V82, P9065, DOI 10.1128/JVI.00961-08; Wendlandt EB, 2012, INNATE IMMUN-LONDON, V18, P846, DOI 10.1177/1753425912443903; Whitley R, 2006, Herpes, V13, P53; Wu SY, 2013, J INFECTION, V67, P329, DOI 10.1016/j.jinf.2013.05.003; Wu ZT, 2009, J VIROL, V83, P6652, DOI 10.1128/JVI.00260-09; Zhao PS, 2012, MICROB PATHOGENESIS, V52, P47, DOI 10.1016/j.micpath.2011.10.001; Zheng SQ, 2011, ANTIVIR RES, V89, P219, DOI 10.1016/j.antiviral.2011.01.008; Zhu B, 2015, J IMMUNOL, V195, P2251, DOI 10.4049/jimmunol.1500370	74	21	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169081	10.1371/journal.pone.0169081	http://dx.doi.org/10.1371/journal.pone.0169081			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045967	gold, Green Published			2022-12-26	WOS:000391612300111
J	Pitt, A; Bendavid, E				Pitt, Allison; Bendavid, Eran			Effect of Meat Price on Race and Gender Disparities in Obesity, Mortality and Quality of Life in the US: A Model-Based Analysis	PLOS ONE			English	Article							FOOD-PRICES; HEALTH; CARE	Introduction There are large differences in the burden and health implications of obesity by race and gender in the US. It is unclear to what extent policies modifying caloric consumption change the distribution of the burden of obesity and related health outcomes. Meat is a large component of the American diet. We investigate how changing meat prices (that may result from policies or from exogenous factors that reduce supply) might impact the burden of obesity by race and gender. Methods We construct a microsimulation model that evaluates the 15-year body-mass index (BMI) and mortality impact of changes in meat price (5, 10, 25, and 50% increase) in the US adult population stratified by age, gender, race, and BMI. Results Under each price change evaluated, relative to the status quo, white males, black males, and black females are expected to realize more dramatic reduction in 2030 obesity prevalence than white females. Life expectancy gains are also projected to differ by subpopulation, with black males far less likely to benefit from an increase in meat prices than other groups. Conclusions Changing meat prices has considerable potential to affect population health differently by race and gender. In designing interventions that alter the price of foods to consumers, it is not sufficient to assess health effects based solely on the population as a whole, since differential effects across subpopulations may be substantial.	[Pitt, Allison] Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Div Gen Med Disciplines, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Pitt, A (corresponding author), Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA.	alpitt@stanford.edu			NIA NIH HHS [P30 AG017253] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG017253] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; Arias Elizabeth, 2014, Natl Vital Stat Rep, V63, P1; Basu S, 2014, HEALTH AFFAIR, V33, P1032, DOI 10.1377/hlthaff.2013.1246; Bentley TGK, 2011, QUAL LIFE RES, V20, P665, DOI 10.1007/s11136-011-9878-7; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Cruz-Flores S, 2011, STROKE, V42, P2091, DOI 10.1161/STR.0b013e3182213e24; Deswal A, 2004, J AM COLL CARDIOL, V43, P778, DOI 10.1016/j.jacc.2003.10.033; Duru O Kenrik, 2009, Med Care, V47, P700; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; National Center for Health Statistics, 2018, NAT HLTH NUTR EX SUR; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Patel AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109153; Powell LM, 2009, MILBANK Q, V87, P229, DOI 10.1111/j.1468-0009.2009.00554.x; Sturm R, 2008, PUBLIC HEALTH, V122, P1140, DOI 10.1016/j.puhe.2008.04.001; Trust for America's Health, 2013, F FAT OB THREAT AM F; U.S. Census Bureau, 2014, ANN EST RES POP SEX; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Zhen C, 2014, AM J AGR ECON	24	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168710	10.1371/journal.pone.0168710	http://dx.doi.org/10.1371/journal.pone.0168710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2QJ	28045931	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300047
J	Scribner, E; Fathallah-Shaykh, HM				Scribner, Elizabeth; Fathallah-Shaykh, Hassan M.			Single Cell Mathematical Model Successfully Replicates Key Features of GBM: Go-Or-Grow Is Not Necessary	PLOS ONE			English	Article							ANTIANGIOGENIC THERAPY; TUMOR PROGRESSION; GLIOMA GROWTH; INVASION	Glioblastoma (GBM) is a malignant brain tumor that continues to be associated with neurological morbidity and poor survival times. Brain invasion is a fundamental property of malignant glioma cells. The Go-or-Grow (GoG) phenotype proposes that cancer cell motility and proliferation are mutually exclusive. Here, we construct and apply a single glioma cell mathematical model that includes motility and angiogenesis and lacks the GoG phenotype. Simulations replicate key features of GBM including its multilayer structure (i.e.edema, enhancement, and necrosis), its progression patterns associated with bevacizumab treatment, and replicate the survival times of GBM treated or untreated with bevacizumab. These results suggest that the GoG phenotype is not a necessary property for the formation of the multilayer structure, recurrence patterns, and the poor survival times of patients diagnosed with GBM.	[Scribner, Elizabeth; Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Math, Birmingham, AL 35294 USA; [Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Fathallah-Shaykh, HM (corresponding author), Univ Alabama Birmingham, Dept Math, Birmingham, AL 35294 USA.; Fathallah-Shaykh, HM (corresponding author), Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA.	hfshaykh@uabms.edu		Fathallah-Shaykh, Hassan/0000-0002-2690-7685				Baker GJ, 2014, NEOPLASIA, V16, P543, DOI 10.1016/j.neo.2014.06.003; Dhruv HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072134; Giese A, 1996, INT J CANCER, V67, P275, DOI 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9; Hatzikirou H, 2012, MATH MED BIOL, V29, P49, DOI 10.1093/imammb/dqq011; Nowosielski M, 2014, NEUROLOGY, V82, P1684, DOI 10.1212/WNL.0000000000000402; Raman F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146617; Scribner E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115018; Swanson KR, 2003, J NEUROL SCI, V216, P1, DOI 10.1016/j.jns.2003.06.001; Swanson KR, 2011, CANCER RES, V71, P7366, DOI 10.1158/0008-5472.CAN-11-1399	9	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169434	10.1371/journal.pone.0169434	http://dx.doi.org/10.1371/journal.pone.0169434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046101	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300189
J	Venturelli, C; Righi, E; Borsari, L; Aggazzotti, G; Busani, S; Mussini, C; Rumpianesi, F; Rossolini, GM; Girardis, M				Venturelli, Claudia; Righi, Elena; Borsari, Lucia; Aggazzotti, Gabriella; Busani, Stefano; Mussini, Cristina; Rumpianesi, Fabio; Rossolini, Gian Maria; Girardis, Massimo			Impact of Pre-Analytical Time on the Recovery of Pathogens from Blood Cultures: Results from a Large Retrospective Survey	PLOS ONE			English	Article							BACT/ALERT FA-MEDIUM; STREAM INFECTIONS; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-TREATMENT; TRANSPORT TIME; DELAYED-ENTRY; BOTTLES; DIAGNOSIS; BACTERIAL; MICROORGANISMS	Background Prompt identification of bloodstream pathogens is essential for optimal management of patients. Significant changes in analytical methods have improved the turnaround time for laboratory diagnosis. Less attention has been paid to the time elapsing from blood collection to incubation and to its potential effect on recovery of pathogens. We evaluated the performance of blood cultures collected under typical hospital conditions in relation to the length of their pre-analytical time. Methods We carried out a large retrospective study including 50,955 blood cultures collected, over a 30-month period, from 7,035 adult septic patients. Cultures were accepted by the laboratory only during opening time (Mon-Fri: 8am-4pm; Sat: 8am-2pm). Samples collected outside laboratory hours were stored at room temperature at clinical wards. All cultures were processed by automated culture systems. Day and time of blood collection and of culture incubation were known for all samples. Results A maximum pre-analytical interval of 2 hours is recommended by guidelines. When the laboratory was open, 57% of cultures were processed within 2 h. When the laboratory was closed, 4.9% of cultures were processed within 2 h (P<0.001). Samples collected when the laboratory was closed showed pre-analytical times significantly longer than those collected when laboratory was open (median time: 13 h and 1 h, respectively, P<0.001). The prevalence of positive cultures was significantly lower for samples collected when the laboratory was closed compared to open (11% vs 13%, P<0.001). The probability of a positive result decreased of 16% when the laboratory was closed (OR:0.84; 95%CI:0.80-0.89, P<0.001). Further, each hour elapsed from blood collection to incubation resulted associated with a decrease of 0.3% (OR:0.997; 95%C1:0.994-0.999, P<0.001) in the probability of a positive result. Discussion Delayed insertions of cultures into automated systems was associated with lower detection rates, with potentially important consequences for patients. In each hospital setting the logistic factors able to shorten pre-analytical time should be carefully investigated and specifically targeted.	[Venturelli, Claudia; Rumpianesi, Fabio] Univ Hosp Modena, Microbiol & Virol Lab, Modena, Italy; [Righi, Elena; Borsari, Lucia; Aggazzotti, Gabriella] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy; [Busani, Stefano; Girardis, Massimo] Univ Hosp Modena, Anesthesia & Intens Care Unit, Modena, Italy; [Busani, Stefano; Girardis, Massimo] Univ Modena & Reggio Emilia, Modena, Italy; [Mussini, Cristina] Univ Modena & Reggio Emilia, Clin Infect Dis, Modena, Italy; [Rossolini, Gian Maria] Univ Firenze, Dept Expt & Clin Med, Florence, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; University of Florence	Righi, E (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy.	elena.righi@unimore.it	Mussini, Cristina/K-8672-2016; Busani, Stefano/AAC-1588-2019; Girardis, Massimo/K-8974-2016; Righi, Elena/B-8345-2013; Aggazzotti, Gabriella/P-5046-2015	Mussini, Cristina/0000-0002-6615-4198; Busani, Stefano/0000-0003-0150-4967; Girardis, Massimo/0000-0002-2453-0829; Righi, Elena/0000-0002-3469-7446; Aggazzotti, Gabriella/0000-0002-2497-9941				Akan OA, 2006, DIAGN MICR INFEC DIS, V54, P193, DOI 10.1016/j.diagmicrobio.2005.09.016; Barenfanger J, 1999, J CLIN MICROBIOL, V37, P1415, DOI 10.1128/JCM.37.5.1415-1418.1999; Bengtsson Jonas, 1998, Clin Microbiol Infect, V4, P33, DOI 10.1111/j.1469-0691.1998.tb00331.x; Berild D, 2006, J ANTIMICROB CHEMOTH, V57, P326, DOI 10.1093/jac/dki463; Buehler SS, 2016, CLIN MICROBIOL REV, V29, P59, DOI 10.1128/CMR.00053-14; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; Clinical and Laboratory Standards Institute, 2007, M47A CLSI; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Ferrer R, 2014, CRIT CARE MED, V42, P1749, DOI 10.1097/CCM.0000000000000330; Fitzpatrick F, 2004, CLIN MICROBIOL INFEC, V10, P917, DOI 10.1111/j.1469-0691.2004.00914.x; Garcia LS, 2010, CLIN MICROBIOLOGY PR; Goglio A, 2011, MICROBIOLOGIA MED, V26, P156; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Janapatla RP, 2010, J MICROBIOL IMMUNOL, V43, P126, DOI 10.1016/S1684-1182(10)60020-5; Jorgensen JH, 2015, MANUAL CLIN MICROBIO, V1; Kerremans JJ, 2008, J ANTIMICROB CHEMOTH, V61, P428, DOI 10.1093/jac/dkm497; Kerremans JJ, 2009, J CLIN MICROBIOL, V47, P3520, DOI 10.1128/JCM.01092-09; Kerremans JJ, 2009, J CLIN MICROBIOL, V47, P819, DOI 10.1128/JCM.01829-08; Klaerner HG, 2000, J CLIN MICROBIOL, V38, P1036, DOI 10.1128/JCM.38.3.1036-1041.2000; Koh EH, 2014, ANN CLIN MICROB ANTI, V17, P14; Lamy B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00697; Lee DH, 2013, ANN LAB MED, V33, P406, DOI 10.3343/alm.2013.33.6.406; Lemming L, 2004, CLIN MICROBIOL INFEC, V10, P1089, DOI 10.1111/j.1469-0691.2004.00969.x; Liesenfeld O, 2014, EUR J MICROBIOL IMMU, V4, P1, DOI 10.1556/EuJMI.4.2014.1.1; Mirrett S, 2001, J CLIN MICROBIOL, V39, P2098, DOI 10.1128/JCM.39.6.2098-2101.2001; Morton B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141361; Murray PR, 2012, CRIT CARE MED, V40, P3277, DOI 10.1097/CCM.0b013e318270e771; Public Health England, 2014, BACTERIOLOGY, V8, P1; Reinhart K, 2010, Ger Med Sci, V8, pDoc14, DOI 10.3205/000103; Riedel S, 2010, J INFECT CHEMOTHER, V16, P301, DOI 10.1007/s10156-010-0069-1; Riest Gunther, 1997, Clin Microbiol Infect, V3, P345, DOI 10.1111/j.1469-0691.1997.tb00624.x; Ronnberg C, 2013, DIAGN MICR INFEC DIS, V76, P286, DOI 10.1016/j.diagmicrobio.2013.03.031; Saito T, 2009, J INFECT CHEMOTHER, V15, P49, DOI 10.1007/s10156-008-0664-6; Sautter RL, 2006, J CLIN MICROBIOL, V44, P1245, DOI 10.1128/JCM.44.4.1245-1249.2006; Schmitz RPH, 2013, CRIT CARE, V17, DOI 10.1186/cc13074; Seegmuller I, 2004, J MED MICROBIOL, V53, P869, DOI 10.1099/jmm.0.45533-0; van der Velden LB, 2011, J CLIN MICROBIOL, V49, P275, DOI 10.1128/JCM.00552-10; Willems E, 2012, DIAGN MICR INFEC DIS, V73, P1, DOI 10.1016/j.diagmicrobio.2012.01.009	38	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169466	10.1371/journal.pone.0169466	http://dx.doi.org/10.1371/journal.pone.0169466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046040	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300194
J	Yu, N; Fang, X; Zhao, DD; Mu, QQ; Zuo, JC; Ma, Y; Zhang, Y; Mo, FF; Zhang, DW; Jiang, GJ; Wu, R; Gao, SH				Yu, Na; Fang, Xin; Zhao, Dandan; Mu, Qianqian; Zuo, Jiacheng; Ma, Yue; Zhang, Yi; Mo, Fangfang; Zhang, Dongwei; Jiang, Guangjian; Wu, Rui; Gao, Sihua			Anti-Diabetic Effects of Jiang Tang Xiao Ke Granule via PI3K/Akt Signalling Pathway in Type 2 Diabetes KKAy Mice	PLOS ONE			English	Article							MUSCLE INSULIN-RESISTANCE; TRADITIONAL CHINESE MEDICINE; BETA-CELL DYSFUNCTION; GLUCOSE-UPTAKE; 3T3-L1 ADIPOCYTES; FATTY-ACIDS; PPAR-GAMMA; TRANSLOCATION; OBESITY; EXPRESSION	Jiang Tang Xiao Ke (JTXK) granule, a Chinese herbal formula, has been used clinically to treat type 2 diabetes (T2DM) for decades. Our previous studies showed that JTXK granule exhibited anti-diabetic and anti-oxidative functions in experimental diabetic rats induced by a high fat diet and streptozotocin. However, the underlying mechanisms remain poorly understood. Herein, we aimed to investigate the therapeutic effect of JTXK granule on T2DM KKAy mice and the possible associations with skeletal muscle in the current study. Our results showed that JTXK granule significantly reduced food intake and body weight in T2DM KKAy mice. JTXK granule treatment also decreased the blood glucose and HbA1c levels and increased the insulin sensitivity in a time-dependent manner. Additionally, it ameliorated hyperlipidaemia and induced a lower free fatty acid level, displaying an effect on disorders of lipid metabolism. JTXK granule significantly increased the expression of insulin receptor substrate-1 (IRS-1), phosphoinositide 3-kinase (PI3K), protein kinase B (PKB/Akt) and glucose transporter 4 (Glut4) and decreased the expression of glycogen synthase kinase 3 beta (GSK3 beta). We concluded that JTXK granule is an effective drug for T2DM through regulating the PI3K/Akt signalling pathway in skeletal muscle.	[Yu, Na; Mu, Qianqian; Zuo, Jiacheng; Ma, Yue; Zhang, Yi] Beijing Univ Chinese Med, Preclin Med Sch, Beijing, Peoples R China; [Fang, Xin] Beijing Univ Chinese Med, Dept Endocrinol, Affiliated Hosp 3, Beijing, Peoples R China; [Zhao, Dandan; Mo, Fangfang; Zhang, Dongwei; Jiang, Guangjian; Gao, Sihua] Beijing Univ Chinese Med, Diabet Res Ctr, Beijing, Peoples R China; [Wu, Rui] China Acad Chinese Med Sci, South Area Guanganmen Hosp, Dept Endocrinol, Beijing, Peoples R China	Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; China Academy of Chinese Medical Sciences	Gao, SH (corresponding author), Beijing Univ Chinese Med, Diabet Res Ctr, Beijing, Peoples R China.	gaosihua1216@163.com	Zhang, Dongwei/AAS-8384-2020	Zhang, Dongwei/0000-0002-7793-1482	key drug development Programme of MOST [20122X09103201- 005]; National Natural Science Foundation of China [NSFC81274041, NSFC81503540]; International Cooperation Projects of MOE [2011DFA30920]	key drug development Programme of MOST; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Projects of MOE	This work is supported by grants from the key drug development Programme of MOST (20122X09103201- 005), the National Natural Science Foundation of China (NSFC81274041 and NSFC81503540) and the International Cooperation Projects of MOE (2011DFA30920).	Altaf QA, 2015, DIABETES OBES METAB, V17, P319, DOI 10.1111/dom.12400; Arner P, 2015, OBESITY FACTS, V8, P147, DOI 10.1159/000381224; Bhupathiraju SN, 2016, CIRC RES, V118, P1723, DOI 10.1161/CIRCRESAHA.115.306825; Boden G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4765; Chan Chung-Hung, 2012, Pharmacogn Rev, V6, P22, DOI 10.4103/0973-7847.95854; Chen KK, 2014, APOPTOSIS, V19, P946, DOI 10.1007/s10495-014-0977-0; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Fang X, 2015, CHINESE J INTEGRATIV; Favaretto F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109540; Federation ID, 2014, IDF DIABETES ATLAS; Gandhi GR, 2013, BBA-GEN SUBJECTS, V1830, P2243, DOI 10.1016/j.bbagen.2012.10.016; Gao J, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-198; Gu JY, 2011, COMPUT BIOL CHEM, V35, P293, DOI 10.1016/j.compbiolchem.2011.07.003; Guo YB, 2016, LIFE SCI, V148, P24, DOI 10.1016/j.lfs.2016.02.056; Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006; Higaki Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE889, DOI 10.1152/ajpendo.00150.2007; Kahn S E, 2000, Postgrad Med, V107, P11, DOI 10.3810/pgm.5.15.2000.suppl4.22; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; KANAI F, 1993, BIOCHEM BIOPH RES CO, V195, P762, DOI 10.1006/bbrc.1993.2111; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lee OH, 2011, PHYTOTHER RES, V25, P768, DOI 10.1002/ptr.3322; Li XH, 2015, 2ND INTERNATIONAL CONFERENCE ON ADVANCED EDUCATION TECHNOLOGY AND MANAGEMENT SCIENCE (AETMS 2014), P31; Lian FM, 2014, J CLIN ENDOCR METAB, V99, P648, DOI 10.1210/jc.2013-3276; Magnoni LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031219; Mu QQ, 2015, BIOCHEM BIOPH RES CO, V466, P530, DOI 10.1016/j.bbrc.2015.09.064; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Peng J, 2014, PPAR RES, V2014, DOI 10.1155/2014/538183; [秦培洁 Qin Peijie], 2014, [北京中医药大学学报, Journal of Beijing University of Traditional Chinese Medicine], V37, P236; Rachek LI, 2014, PROG MOL BIOL TRANSL, V121, P267, DOI 10.1016/B978-0-12-800101-1.00008-9; Raymond KL, 2016, J DIABETES COMPLICAT, V30, P651, DOI 10.1016/j.jdiacomp.2016.01.020; Raymond KL, 2015, APPETITE, V95, P383, DOI 10.1016/j.appet.2015.07.030; Sharma BR, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0412-5; Stein SA, 2013, EXPERT OPIN DRUG SAF, V12, P153, DOI 10.1517/14740338.2013.752813; Steinberg GR, 2009, DIABETES, V58, P829, DOI 10.2337/db08-0659; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Yan XF, 2014, CHIN J INTEGR MED, V20, P633, DOI 10.1007/s11655-013-1462-2; Zhang JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100918; Zhang XX, 2015, J DIABETES INVEST, V6, P708, DOI 10.1111/jdi.12352; Zhao DD, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/475192; [赵丹丹 Zhao Dandan], 2014, [中医杂志, Journal of Traditional Chinese Medicine], V55, P205; Zhao XY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002522; 2006, NATURE, V444, P840, DOI DOI 10.1038/NATURE05482	44	25	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168980	10.1371/journal.pone.0168980	http://dx.doi.org/10.1371/journal.pone.0168980			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045971	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300082
J	Zeyner, A; Romanowski, K; Vernunft, A; Herne, P; Muller, AM; Wolf, C; Kienzle, E				Zeyner, Annette; Romanowski, Kristin; Vernunft, Andreas; Herne, Patricia; Mueller, Ann-Marie; Wolf, Carole; Kienzle, Ellen			Effects of Different Oral Doses of Sodium Chloride on the Basal Acid-Base and Mineral Status of Exercising Horses Fed Low Amounts of Hay	PLOS ONE			English	Article							AMMONIUM-CHLORIDE; INDEX MATERIAL; INSOLUBLE ASH; SALT; SWEAT; BALANCE; FLUID; DIGESTIBILITY; SENSITIVITY; EXCRETION	The provision of NaCl, according to current recommendations, to horses in moderate work has been shown to induce immediate postprandial acidosis. The present study aimed to clarify whether this NaCl induced acidosis i) persists beyond the immediate postprandial period, and ii) is still present after a 2 week adaptation period. Six adult warmblood mares in moderate work received daily 1.00 kg hay per 100 kg body weight (bwt) only together with 0.64 kg unprocessed cereal grains/100 kg bwt. d as fed basis. Using a 3x3 Latin Square, either 0 (NaCl-0), 50 (NaCl-50) or 100 (NaCl-100) g NaCl/d were fed together with the concentrates in two equal doses for 3 weeks. During the final week, a mineral digestibility trial was undertaken. The middle sodium and chloride intake (NaCl-50) at least met the most common recommendations for moderate work. Morning (7: 00 AM) urine and venous blood samples were collected on days 0, 1-4, 8, and 15, and analysed for pH, acid-base status, creatinine and electrolyte concentrations. Fractional electrolyte clearances (FC) were determined. Mean apparent sodium digestibility ranged between 60-62% whereas chloride digestibility was consistently above 94%. Supplementing 100 g but not 50 g of NaCl resulted in significant reduction of blood pH and base excess as well as urinary pH and urine acid excretion. Both 50 g and 100 g NaCl supplementation caused a significant reduction in base and net acid-base excretion, urine density and potassium concentration, but increased urine sodium concentration and the FC of sodium and chloride (P < 0.05). This suggests that a high proportion of the recommended salt doses is excreted renally. The above effects of NaCl supplementation persisted over the 2 week measurement period. Results suggest that feeding 100 g NaCl to moderately exercising horses results in mild metabolic acidosis, whereas feeding 50 g according to current recommendations resulted in compensated acidosis.	[Zeyner, Annette] Martin Luther Univ Halle Wittenberg, Grp Anim Nutr, Inst Agr & Nutr Sci, Halle, Saale, Germany; [Romanowski, Kristin; Mueller, Ann-Marie] Univ Rostock, Chair Nutr Physiol & Anim Nutr, Rostock, Germany; [Vernunft, Andreas] Leibniz Inst Farm Anim Biol, Dummerstorf, Germany; [Herne, Patricia] Waltham Ctr Pet Nutr, Equine Studies Grp, Waltham On The Worlds, England; [Wolf, Carole] State Off Agr, Food Safety & Fishery Mecklenburg Western Pomeran, Rostock, Germany; [Kienzle, Ellen] Ludwig Maximilian Univ Munich, Inst Physiol & Anim Nutr, Munich, Germany	Martin Luther University Halle Wittenberg; University of Rostock; Forschungsinstitut fur Nutztierbiologie (FBN); Mars; WALTHAM Petcare Science Institute; University of Munich	Zeyner, A (corresponding author), Martin Luther Univ Halle Wittenberg, Grp Anim Nutr, Inst Agr & Nutr Sci, Halle, Saale, Germany.	annette.zeyner@landw.uni-halle.de			WALTHAM Centre for Pat Nutrition	WALTHAM Centre for Pat Nutrition	"Consumables from the research were funded by WALTHAM Centre for Pat Nutrition. The funders (with exception of Patricia Harris, co-author and collaborator) had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The experiment is in no way linked to any core activity, employment, consultancy, patents, products in develop-ment or marketed products associated with WALTHAM Centre for Pet Nutrition."; We are grateful to the WALTHAM Centre for Pat Nutrition for the partial financial support of the study. We also thank the involved laboratory stuff for their excellent help in laboratory work.	Ausschuss fur Bedarfsnormen der Gesellschaft fur Ernahrungsphysiologie, 2014, EN UND NAHRST LANDW; Beker S., 1999, THESIS; Berchtold L, 2009, THESIS; Brunner J, 2012, J ANIM PHYSIOL AN N, V96, P878, DOI 10.1111/j.1439-0396.2012.01324.x; Coenen M, 1991, CHLORIDHAUSHALT CHLO; Cooper SR, 2000, J EQUINE VET SCI, V20, P39, DOI 10.1016/S0737-0806(00)80318-4; Denton D., 1982, CONSUMMATORY ACT SAT, P278; DONOVAN DS, 1993, AM J PHYSIOL, V264, pE730, DOI 10.1152/ajpendo.1993.264.5.E730; Frings-Meuthen P, 2008, J BONE MINER RES, V23, P517, DOI [10.1359/jbmr.071118, 10.1359/JBMR.071118]; FUCHS R, 1987, ARCH TIERERNAHR, V37, P235, DOI 10.1080/17450398709428239; Furll M., 1981, KLIN LABORDIAGNOSTIK; Gerzer R, 2005, CURR PHARM BIOTECHNO, V6, P299, DOI 10.2174/1389201054553662; [GfE Ausschuss fur Bedarfsnormen der Gesellschaft fur Erna E hrungsphysiologie], 1994, EN UND NAHRST LANDW, V2; Goren G, 2014, J ANIM PHYSIOL AN N, V98, P239, DOI 10.1111/jpn.12071; Harris P., 1992, EQUINE VET EDUC, V4, P162, DOI [10.1111/j.2042-3292.1992.tb01605.x, DOI 10.1111/J.2042-3292.1992.TB01605.X]; Harris PA, 2013, NUTR MANAGEMENT ELIT, P261; Holbrook TC, 2005, EQUINE VET J, V37, P501, DOI 10.2746/042516405775314880; Jansson A, 1999, J APPL PHYSIOL, V86, P1610, DOI 10.1152/jappl.1999.86.5.1610; Jose-Cunilleras E., 2004, Equine sports medicine and surgery: basic and clinical sciences of the equine athlete, P898, DOI 10.1016/B978-0-7020-2671-3.50044-1; Kennedy MAP, 1998, ADVANCES IN EQUINE NUTRITION, P73; KERR MG, 1983, AM J VET RES, V44, P1571; Kienzle E, 1998, J ANIM PHYSIOL AN N, V80, P130, DOI 10.1111/j.1439-0396.1998.tb00514.x; Kienzle E, 2006, J NUTR, V136, p2048S, DOI 10.1093/jn/136.7.2048S; Kienzle E., 2011, Ubersichten zur Tierernahrung, V39, P67; Kienzle E., 2010, Ubersichten zur Tierernahrung, V38, P33; Kienzle E, 2010, J ANIM PHYSIOL AN N, V94, pE231, DOI 10.1111/j.1439-0396.2010.01015.x; Lindner A., 1983, EQUINE EXERCISE PHYS, P310; LUCAS PA, 1988, KIDNEY INT, V34, pS19; MacLeay JM, 2006, P 7 INT C EQ EX PHYS, P210; MCCARTHY JF, 1974, CAN J ANIM SCI, V54, P107, DOI 10.4141/cjas74-016; McCutcheon L J, 1995, Equine Vet J Suppl, P153; McCutcheon L.J., 1995, EQUINE VET J, V27, P279, DOI 10.1111/j.2042-3306.1995.tb04937.x; McCutcheon LJ, 1998, VET CLIN N AM-EQUINE, V14, P75, DOI 10.1016/S0749-0739(17)30213-4; McCutcheon LJ, 1999, J APPL PHYSIOL, V87, P1843, DOI 10.1152/jappl.1999.87.5.1843; Meyer H., 1990, Advances in Animal Physiology and Animal Nutrition, P86; Meyer H, 1987, NUTR EQUINE ATHLETE, P644; NACHMAN M, 1966, J COMP PHYSIOL PSYCH, V62, P280, DOI 10.1037/h0023667; Nehring K, 1972, FUTTERMITTELTABELLEN; NRC, 2007, NUTR REQUIREMENTS HO; SCHURG WA, 1977, J ANIM SCI, V45, P1317, DOI 10.2527/jas1977.4561317x; Schwarzer U, 1997, THESIS; SHARMA AM, 1990, HYPERTENSION, V16, P407, DOI 10.1161/01.HYP.16.4.407; SHARMA AM, 1994, AM J MED SCI, V307, pS112; SHARMA AM, 1991, KLIN WOCHENSCHR, V69, P41; Smith F, 1890, J Physiol, V11, P497; SNOW DH, 1982, VET REC, V110, P377, DOI 10.1136/vr.110.16.377; Spooner HS, 2010, EQUINE VET J, V42, P382, DOI 10.1111/j.2042-3306.2010.00208.x; Sturmer K, 2005, UNTERSUCHUNGEN ZUM E; SUTTON EI, 1977, CAN J ANIM SCI, V57, P543, DOI 10.4141/cjas77-070; Tsugane S, 2005, CANCER SCI, V96, P1, DOI 10.1111/j.1349-7006.2005.00006.x; [VDLUFA Verband Deutscher Landwirtschaftlicher Untersuchungs-und Forschungsanstalten], 1976, HDB LANDW VERS UND U, VIII; WALL DL, 1992, J EQUINE VET SCI, V12, P168, DOI 10.1016/S0737-0806(06)81475-9; Williams EL, 1999, ANESTH ANALG, V88, P999, DOI 10.1097/00000539-199905000-00006; Zeyner A, 2014, J ANIM PHYSIOL AN N, V98, P246, DOI 10.1111/jpn.12073; Zeyner A, 2004, J ANIM PHYSIOL AN N, V88, P7, DOI 10.1111/j.1439-0396.2004.00447.x; Zeyner A, 2002, EQUINE VET J, V34, P85; Zeyner A, 2005, P 9 C ESVCN GRUGL IT, P124; Zeyner A., 2011, LANDBAUFORSCHUNG, V353, P164	58	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							0168325	10.1371/journal.pone.0168325	http://dx.doi.org/10.1371/journal.pone.0168325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045916	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300020
J	Hong, SY; Ng, LT; Ng, LF; Inoue, T; Tolwinski, NS; Hagen, T; Gruber, J				Hong, Shin Yee; Ng, Li Theng; Ng, Li Fang; Inoue, Takao; Tolwinski, Nicholas S.; Hagen, Thilo; Gruber, Jan			The Role of Mitochondrial Non-Enzymatic Protein Acylation in Ageing	PLOS ONE			English	Article							LIFE-SPAN; CAENORHABDITIS-ELEGANS; HISTONE ACETYLATION; SIRT3 GENE; AGE; DNA; MUTANTS; OXYGEN; STRESS; COA	In recent years, various large-scale proteomic studies have demonstrated that mitochondrial proteins are highly acylated, most commonly by addition of acetyl and succinyl groups. These acyl modifications may be enzyme catalysed but can also be driven non-enzymatically. The latter mechanism is promoted in mitochondria due to the nature of the mitochondrial microenvironment, which is alkaline and contains high concentrations of acyl-CoA species. Protein acylation may modify enzyme activity, typically inhibiting it. We posited that organismal ageing might be accompanied by an accumulation of acylated proteins, especially in mitochondria, and that this might compromise mitochondrial function and contribute to ageing. In this study, we used R. norvegicus, C. elegans and D. melanogasterto compare the acylation status of mitochondrial proteins between young and old animals. We observed a specific age-dependent increase in protein succinylation in worms and flies but not in rat. Rats have two substrate-specific mitochondrial deacylases, SIRT3 and SIRT5 while both flies and worms lack these enzymes. We propose that accumulation of mitochondrial protein acylation contributes to age-dependent mitochondrial functional decline and that SIRT3 and SIRT5 enzymes may promote longevity through regulation of mitochondrial protein acylation during ageing.	[Hong, Shin Yee; Inoue, Takao; Hagen, Thilo; Gruber, Jan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Ng, Li Theng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore, Singapore; [Ng, Li Fang; Tolwinski, Nicholas S.; Gruber, Jan] Yale NUS Coll, Dept Sci, Singapore, Singapore; [Tolwinski, Nicholas S.] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Hagen, Thilo] Block MD 7,8 Med Dr, Singapore, Singapore	National University of Singapore; National University of Singapore; Yale NUS College; National University of Singapore	Hagen, T; Gruber, J (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.; Gruber, J (corresponding author), Yale NUS Coll, Dept Sci, Singapore, Singapore.; Hagen, T (corresponding author), Block MD 7,8 Med Dr, Singapore, Singapore.	bchth@nus.edu.sg; yncjg@nus.edu.sg	Tolwinski, Nicholas/Q-5782-2019	Tolwinski, Nicholas/0000-0002-8507-2737	MOE Academic Research Fund [MOE2014-T2-2-120, MOE2014-T2-2-039]	MOE Academic Research Fund	The authors would also like to gratefully acknowledge the Singapore Ministry of Education (MOE). Work in the authors' laboratory is supported by MOE Academic Research Fund to JG and NT (MOE2014-T2-2-120 to JG, MOE2014-T2-2-039 to NT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 1998, J GERONTOL A-BIOL, V53, pB240, DOI 10.1093/gerona/53A.4.B240; Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Ayyadevara S, 2008, AGING CELL, V7, P13, DOI 10.1111/j.1474-9726.2007.00348.x; Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; Bayne ACV, 2005, BIOCHEM J, V391, P277, DOI 10.1042/BJ20041872; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Eisenberg T, 2014, CELL METAB, V19, P431, DOI 10.1016/j.cmet.2014.02.010; FRIEDMAN DB, 1988, GENETICS, V118, P75; Greiss S, 2013, EUROPE PMC FUNDERS G, V28, P407, DOI DOI 10.1007/S10059-009-0169-X.SIRTUIN/SIR2; Gruber J, 2015, ANTIOXID REDOX SIGN, V23, P256, DOI 10.1089/ars.2014.6210; Gruber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019444; Gruber J, 2009, FEBS LETT, V583, P3377, DOI 10.1016/j.febslet.2009.09.051; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; HAGEN T, 1993, ARCH BIOCHEM BIOPHYS, V303, P195, DOI 10.1006/abbi.1993.1273; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hartmann N, 2011, AGING CELL, V10, P824, DOI 10.1111/j.1474-9726.2011.00723.x; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8; HONDA S, 1993, J GERONTOL, V48, pB57, DOI 10.1093/geronj/48.2.B57; HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lane RK, 2015, BIOCH BIOPHYS ACTA; Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8; Li F, 2015, MOL CELL, V60, P661, DOI 10.1016/j.molcel.2015.10.017; Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011; Luz AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130940; Madsen AS, 2016, J BIOL CHEM, V291, P7128, DOI 10.1074/jbc.M115.668699; Martin LJ, 2010, J ALZHEIMERS DIS, V20, pS335, DOI 10.3233/JAD-2010-100348; MASSIE HR, 1991, EXP GERONTOL, V26, P487, DOI 10.1016/0531-5565(91)90037-M; Mathias RA, 2014, CELL, V159, P1615, DOI 10.1016/j.cell.2014.11.046; MELOV S, 1995, NUCLEIC ACIDS RES, V23, P1419, DOI 10.1093/nar/23.8.1419; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Ng LF, 2014, FREE RADICAL BIO MED, V71, P390, DOI 10.1016/j.freeradbiomed.2014.03.003; Nishida Y, 2015, MOL CELL; PAIK WK, 1970, BIOCHIM BIOPHYS ACTA, V213, P513, DOI 10.1016/0005-2787(70)90058-4; Peleg S, 2016, EMBO REP, V17, P455, DOI 10.15252/embr.201541132; Perez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x; Pougovkina O, 2014, HUM MOL GENET, V23, P3513, DOI 10.1093/hmg/ddu059; Rardin MJ, 2013, CELL METAB, V18, P920, DOI 10.1016/j.cmet.2013.11.013; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Sanz A, 2010, AGING-US, V2, P200, DOI 10.18632/aging.100137; Schaffer S, 2011, BIOGERONTOLOGY, V12, P195, DOI 10.1007/s10522-010-9310-7; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Stiernagle Theresa, 2006, WormBook, P1; STOCCO DM, 1978, J GERONTOL, V33, P802, DOI 10.1093/geronj/33.6.802; Tan WZ, 2014, BBA-MOL BASIS DIS, V1842, P1295, DOI 10.1016/j.bbadis.2014.02.009; TAUCHI H, 1968, J GERONTOL, V23, P454, DOI 10.1093/geronj/23.4.454; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tsai P-H, 2015, STEM CELLS DEV; Velazquez E., 2011, THESIS; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Weinert BT, 2015, EMBO J, V34, P2620, DOI 10.15252/embj.201591271; Weinert BT, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134766; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Westphal CH, 2007, TRENDS BIOCHEM SCI, V32, P555, DOI 10.1016/j.tibs.2007.09.008; Yanase S, 2008, J RADIAT RES, V49, P211, DOI 10.1269/jrr.07043; Yasuda K, 1999, J GERONTOL A-BIOL, V54, pB47, DOI 10.1093/gerona/54.2.B47; Yasuda K, 2006, MECH AGEING DEV, V127, P763, DOI 10.1016/j.mad.2006.07.002; YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	75	14	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168752	10.1371/journal.pone.0168752	http://dx.doi.org/10.1371/journal.pone.0168752			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7KQ	28033361	Green Submitted, Green Published, gold			2022-12-26	WOS:000391226900044
J	Nath, M; Chandra, P; Halder, N; Singh, B; Deorari, AK; Kumar, A; Azad, R; Velpandian, T				Nath, Madhu; Chandra, Parijat; Halder, Nabanita; Singh, Baskar; Deorari, Ashok Kumar; Kumar, Atul; Azad, Rajvardhan; Velpandian, Thirumurthy			Involvement of Renin-Angiotensin System in Retinopathy of Prematurity - A Possible Target for Therapeutic Intervention	PLOS ONE			English	Article							OXYGEN-INDUCED RETINOPATHY; RAT MODEL; TYPE-1 RECEPTOR; INHIBITION; RETINA	Objective Examining the Retinal Renin Angiotensin System (RRAS) in the ROP neonates and analyzing the possibility of modulating the RRAS to prevent the progression in Oxygen Induced Retinopathy (OIR) model. Method Vitreous of ROP patients (n = 44, median age 5.5 months) was quantified for RRAS components, VEGF, HIF-1 alpha and compared with age matched control. The involvement of RRAS in ROP was tested in the rat model of OIR and compared with normoxia. Expressions of RAS components, VEGF and HIF-1 alpha in retina were analyzed using qPCR and retinal structure and function was also analyzed. Effect of Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin Receptor Blocker (ARB) was evaluated and compared with Bevacizumab which served as a positive control. Drug penetration into retina was confirmed by liquid chromatography coupled ESI-tandem mass spectroscopy (LC-MS/MS). Results Multifold increase in the expression of RAS components in human vitreous and rat retina showed their involvement in ROP. ERG & fundus studies in OIR revealed the altered function of retina and were successfully prevented by ARB (telmisartan), ACEI (lisinopril) and bevacizumab. Retinal analysis revealed the presence of ACEI and ARB in their therapeutic levels. Conclusion This study for the first time demonstrates the upregulated level of RAS components in human ROP vitreous and further that the pharmacological intervention in RRAS can functionally and structurally preserve retina against the progression of ROP in the OIR model.	[Nath, Madhu; Chandra, Parijat; Kumar, Atul; Azad, Rajvardhan] All India Inst Med Sci, Dept Ophthalmol, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India; [Halder, Nabanita; Velpandian, Thirumurthy] All India Inst Med Sci, Dept Ocular Pharmacol, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India; [Singh, Baskar] All India Inst Med Sci, Dept Biophys, New Delhi, India; [Deorari, Ashok Kumar] All India Inst Med Sci, Dept NICU, Pediat, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences; All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Velpandian, T (corresponding author), All India Inst Med Sci, Dept Ocular Pharmacol, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India.	tvelpandian@hotmail.com	Velpandian, Thirumurthy/ABE-7016-2021; Chandra, Parijat/I-2929-2013	Chandra, Parijat/0000-0002-7516-1410	Department of Science and Technology (DST/SSTP/New Delhi)	Department of Science and Technology (DST/SSTP/New Delhi)(Department of Science & Technology (India))	Department of Science and Technology for the funding to carry out this research work (DST/SSTP/New Delhi/2012-13/12th Plan/149(c).	Autrata R, 2012, Cesk Slov Oftalmol, V68, P29; Chaturvedi N, 1998, LANCET, V351, P28, DOI 10.1016/S0140-6736(97)06209-0; DANSER AHJ, 1994, INVEST OPHTH VIS SCI, V35, P1008; Downie LE, 2010, J COMP NEUROL, V518, P41, DOI 10.1002/cne.22205; Favazza TL, 2013, DOC OPHTHALMOL, V127, P3, DOI 10.1007/s10633-013-9392-z; Gilbert RE, 2000, DIABETOLOGIA, V43, P1360, DOI 10.1007/s001250051539; Hancock HA, 2004, INVEST OPHTH VIS SCI, V45, P1002, DOI 10.1167/iovs.03-1080; Hernandez C, 2012, ENDOCRINE, V41, P220, DOI 10.1007/s12020-011-9579-6; Liu K, 2005, INVEST OPHTH VIS SCI, V47, P5447; Liu K, 2006, INVEST OPHTH VIS SCI, V47, P2639, DOI 10.1167/iovs.06-0016; Lonchampt M, 2002, INVEST OPHTH VIS SCI, V42, P429; McColm JR, 2004, PEDIATR RES, V55, P107, DOI 10.1203/01.PDR.0000099772.66376.02; Michael W. Pfaffl, 2002, NUCL ACIDS RES, V30; Moravski CJ, 2003, AM J PATHOL, V162, P151, DOI 10.1016/S0002-9440(10)63806-0; Moravski CJ, 2000, HYPERTENSION, V36, P1099, DOI 10.1161/01.HYP.36.6.1099; Nakamura H, 2009, OPHTHALMIC RES, V41, P210, DOI 10.1159/000217725; Patten DA, 2010, MOL BIOL CELL, V21, P3247, DOI 10.1091/mbc.E10-01-0025; Ramirez M, 1996, J OCUL PHARMACOL TH, V12, P299, DOI 10.1089/jop.1996.12.299; RE RN, 1984, ARCH INTERN MED, V144, P2037, DOI 10.1001/archinte.144.10.2037; RICCI B, 1995, GRAEF ARCH CLIN EXP, V233, P226, DOI 10.1007/BF00183596; Roberto KA, 1996, CURR EYE RES, V15, P932, DOI 10.3109/02713689609017637; Sarlos S, 2005, INVEST OPHTH VIS SCI, V46, P1069, DOI 10.1167/iovs.04-0885; Senanayake PD, 2007, INVEST OPHTH VIS SCI, V48, P3301, DOI 10.1167/iovs.06-1024; Shapiro MJ, 2001, MALHOTRA ENTERPRISES, P23; Sramek SJ, 2002, INVEST OPHTH VIS SCI, V29, P1749; Sramek SJ, 2002, INVEST OPHTH VIS SCI, V29, P1198; Wagner J, 1996, BRIT J OPHTHALMOL, V80, P159, DOI 10.1136/bjo.80.2.159; Wu LH, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2005	28	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168809	10.1371/journal.pone.0168809	http://dx.doi.org/10.1371/journal.pone.0168809			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033392	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900050
J	Abera, SF; Adane, K				Abera, Semaw Ferede; Adane, Kelemework			Burden and Determinants of Smoking among Prisoners with Respiratory Tract Infection: A Cross-Sectional Study of Nine Major Prison Setups in Northern Ethiopia	PLOS ONE			English	Article							CIGARETTE-SMOKING; SUBSTANCE USE; YOUNG-ADULTS; RISK-FACTOR; TOBACCO USE; MORTALITY; INCARCERATION; POPULATION; PREVALENCE; CESSATION	Background Morbidity, mortality and a wide range of associated risk factors are disproportionately clustered among prisoners compared to the general population. Smoking is one of the risk factors for the increased burden of unfavorable health outcomes particularly among prisoners. However, little is known about the level and determinants of smoking among the incarcerated population in Ethiopia. Methods We collected data from 738 prisoners in nine major prison setups in Tigray region by nurses and clinical officers. Data were entered in to Epi Data 3.1 and exported to stata 13.0 for cleaning and further analysis. Multivariable logistic regression model was fitted to identify determinants of smoking at p value of less than 5%. Result The prevalence of smoking was 21 per cent (95% CI = 18.2%, 24.1). Urban residence (AOR = 2.15; 95% CI = 1.20, 3.84), previous history of incarceration (AOR = 1.91; 95% CI = 1.08, 3.40) and alcohol use before incarcerated (AOR = 4.20; 95% CI = 2.57, 6.87) were significantly associated with risk of smoking. In contrast, risk of smoking was significantly lower for farmers (AOR = 0.20; 95% CI = 0.08, 0.49), prisoners with family support (AOR = 0.52; 95% CI = 0.32, 0.87) and for those who were jailed in Shire prison site (AOR = 0.43; 95% CI = 0.20, 0.95). Conclusion Our work clearly indicates that the observed smoking prevalence calls for the need of comprehensive and interdisciplinary interventions targeting prisoners.	[Abera, Semaw Ferede] Mekelle Univ, Sch Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia; [Abera, Semaw Ferede] Kilte Awlaelo Hlth & Demog Surveillance Site, Mekelle, Ethiopia; [Adane, Kelemework] Mekelle Univ, Dept Med Microbiol & Immunol, Coll Hlth Sci, Mekelle, Ethiopia	Mekelle University; Mekelle University	Abera, SF (corresponding author), Mekelle Univ, Sch Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia.; Abera, SF (corresponding author), Kilte Awlaelo Hlth & Demog Surveillance Site, Mekelle, Ethiopia.	semawfer@yahoo.com			Mekelle University	Mekelle University	We are grateful to Mekelle University for funding the research project and we are also thankful to Commander Tsegay Uqubay, Head of the Regional Prison Health Office, for facilitating the research process in all the nine prison sites. Last but not least, we are extremely grateful to our research participants, all staffs of the prison sites, staffs of the nearby health centers and clinical officers for all their tremendous support and time.	Alcaide J, 1996, TUBERCLE LUNG DIS, V77, P112, DOI 10.1016/S0962-8479(96)90024-6; Awofeso N, 2001, TOB CONTROL, V10, P84; Bailey ZD, 2015, AM J PUBLIC HEALTH, V105, P2275, DOI 10.2105/AJPH.2015.302772; BARRERA M, 1992, J ABNORM CHILD PSYCH, V20, P1, DOI 10.1007/BF00927113; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Binswanger IA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4542; Dearden KA, 2007, REV PANAM SALUD PUBL, V22, P160, DOI 10.1590/S1020-49892007000800002; den Velde WO, 2011, PSYCHOL REP, V108, P437, DOI 10.2466/02.10.16.PR0.108.2.437-448; Deressa W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-660; Dickert J, 2015, PSYCHIAT SERV, V66, P975, DOI 10.1176/appi.ps.201400429; DIFRANZA JR, 1990, J STUD ALCOHOL, V51, P130, DOI 10.15288/jsa.1990.51.130; Donahue J, 2014, J CORRECT HEALTH CAR, V20, P302, DOI 10.1177/1078345814541534; Graham L, 2015, EUR J PUBLIC HEALTH, V25, P879, DOI 10.1093/eurpub/cku252; Howell BA, 2015, ADDICT BEHAV, V50, P157, DOI 10.1016/j.addbeh.2015.06.017; Jama-Alol KA, 2015, INT J PRISON HEALTH, V11, P108, DOI 10.1108/IJPH-10-2013-0046; Kauffman RM, 2011, NICOTINE TOB RES, V13, P449, DOI 10.1093/ntr/ntr024; Mdodo R, 2015, ANN INTERN MED, V162, P335, DOI 10.7326/M14-0954; Olsen MH, 2015, INT J CANCER, V136, P2476, DOI 10.1002/ijc.29288; Papadodima SA, 2010, EUR J PUBLIC HEALTH, V20, P470, DOI 10.1093/eurpub/ckp209; Ramaswamy M, 2013, SUBST ABUSE TREAT PR, V8, DOI 10.1186/1747-597X-8-37; Sieminska A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-181; Tiwari RV, 2014, ASIAN PAC J CANCER P, V15, P413, DOI 10.7314/APJCP.2014.15.1.413; Turan O, 2015, J ADDICT MED, V9, P118, DOI 10.1097/ADM.0000000000000103; Wang EA, 2009, ARCH INTERN MED, V169, P687, DOI 10.1001/archinternmed.2009.26; WILLS TA, 1992, AM J COMMUN PSYCHOL, V20, P349, DOI 10.1007/BF00937914; Zlodre Jakov, 2012, Am J Public Health, V102, pe67, DOI 10.2105/AJPH.2012.300764	26	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168941	10.1371/journal.pone.0168941	http://dx.doi.org/10.1371/journal.pone.0168941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030604	gold, Green Published, Green Submitted			2022-12-26	WOS:000391222000087
J	Ahrazem, O; Argandona, J; Castillo, R; Rubio-Moraga, A; Gomez-Gomez, L				Ahrazem, Oussama; Argandona, Javier; Castillo, Raquel; Rubio-Moraga, Angela; Gomez-Gomez, Lourdes			Identification and Cloning of Differentially Expressed SOUL and ELIP Genes in Saffron Stigmas Using a Subtractive Hybridization Approach	PLOS ONE			English	Article							LIGHT-INDUCED-PROTEIN; CHLAMYDOMONAS-REINHARDTII; CROCUS-SATIVUS; CHROMOPLAST DIFFERENTIATION; CAROTENOID BIOSYNTHESIS; INDUCIBLE PROTEINS; PROTEOMIC ANALYSIS; ARABIDOPSIS; BINDING; STRESS	Using a subtractive hybridization approach, differentially expressed genes involved in the light response in saffron stigmas were identified. Twenty-two differentially expressed transcript-derived fragments were cloned and sequenced. Two of them were highly induced by light and had sequence similarity to early inducible proteins (ELIP) and SOUL heme-binding proteins. Using these sequences, we searched for other family members expressed in saffron stigma. ELIP and SOUL are represented by small gene families in saffron, with four and five members, respectively. The expression of these genes was analyzed during the development of the stigma and in light and dark conditions. ELIP transcripts were detected in all the developmental stages showing much higher expression levels in the developed stigmas of saffron and all were up-regulated by light but at different levels. By contrast, only one SOUL gene was up-regulated by light and was highly expressed in the stigma at anthesis. Both the ELIP and SOUL genes induced by light in saffron stigmas might be associated with the structural changes affecting the chromoplast of the stigma, as a result of light exposure, which promotes the development and increases the number of plastoglobules, specialized in the recruitment of specific proteins, which enables them to act in metabolite synthesis and disposal under changing environmental conditions and developmental stages.	[Ahrazem, Oussama; Argandona, Javier; Rubio-Moraga, Angela; Gomez-Gomez, Lourdes] Univ Castilla La Mancha, Dept Ciencia & Tecnol Agroforestal & Genet, Inst Bot, Fac Farm, Albacete, Spain; [Ahrazem, Oussama] Univ Castilla La Mancha, Fac Ciencias Ambientales & Bioquim, Toledo, Spain; [Castillo, Raquel] VITAB Labs, La Gineta, Albacete, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha	Gomez-Gomez, L (corresponding author), Univ Castilla La Mancha, Dept Ciencia & Tecnol Agroforestal & Genet, Inst Bot, Fac Farm, Albacete, Spain.	Marialourdes.gomez@uclm.es	Ahrazem, oussama/AAV-1392-2021; Ahrazem, Oussama/E-5602-2016; Gomez-Gomez, Lourdes/AAF-2371-2020	Ahrazem, oussama/0000-0001-9183-9319; Ahrazem, Oussama/0000-0001-9183-9319; Gomez-Gomez, Lourdes/0000-0003-2586-4457; Rubio-Moraga, Angela/0000-0002-2162-2314	Spanish Ministerio de Economia y Competitividad [BIO2013-44239-R]	Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by the Spanish Ministerio de Economia y Competitividad (BIO2013-44239-R).	ADAMSKA I, 1993, J BIOL CHEM, V268, P5438; Adamska I, 2001, J BIOL CHEM, V276, P8582, DOI 10.1074/jbc.M010447200; Adamska I, 1999, EUR J BIOCHEM, V260, P453, DOI 10.1046/j.1432-1327.1999.00178.x; Ahrazem O, 2016, PLANT MOL BIOL; Ahrazem O, 2015, J AGR FOOD CHEM, V63, P8751, DOI 10.1021/acs.jafc.5b03194; Ahrazem O, 2012, J EXP BOT, V63, P681, DOI 10.1093/jxb/err293; Ahrazem O, 2010, J EXP BOT, V61, P105, DOI 10.1093/jxb/erp283; Alos E, 2008, PLANT PHYSIOL, V147, P1300, DOI 10.1104/pp.108.119917; Ambrosi E, 2011, BIOCHEM J, V438, P291, DOI 10.1042/BJ20110257; Beltran J, 2015, NAT CHEM BIOL, V11, P598, DOI [10.1038/NCHEMBIO.1840, 10.1038/nchembio.1840]; Berti M, 2012, CHIL J AGR RES, V72, P371, DOI 10.4067/S0718-58392012000300011; Binyamin L, 2001, PLANTA, V212, P591, DOI 10.1007/s004250000423; Boyd Joseph S, 2011, Bioarchitecture, V1, P196; Brehelin C, 2007, TRENDS PLANT SCI, V12, P260, DOI 10.1016/j.tplants.2007.04.003; Bruno AK, 2004, J EXP BOT, V55, P2541, DOI 10.1093/jxb/erh273; Caiola MG, 2004, PLANT BIOSYST, V138, P43, DOI 10.1080/11263500410001684116; Castillo R, 2005, PLANT PHYSIOL, V139, P674, DOI 10.1104/pp.105.067827; Champagne A, 2010, J FOOD COMPOS ANAL, V23, P8; CHEUNG AY, 1993, PLANT PHYSIOL, V101, P1223, DOI 10.1104/pp.101.4.1223; Cluis CP, 2004, PLANT J, V38, P332, DOI 10.1111/j.1365-313X.2004.02052.x; Davidi L, 2015, PLANT PHYSIOL, V167, P60, DOI 10.1104/pp.114.248450; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Eitzinger N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01085; Ferreira CF, 2008, CROP BREED APPL BIOT, V8, P23, DOI 10.12702/1984-7033.v08n01a04; Fortunato AE, 2016, J MOL EVOL, V82, P279, DOI 10.1007/s00239-016-9745-9; GREEN BR, 1995, PHOTOSYNTH RES, V44, P139, DOI 10.1007/BF00018304; GRIMM B, 1987, EUR J BIOCHEM, V167, P493, DOI 10.1111/j.1432-1033.1987.tb13364.x; Harari-Steinberg O, 2001, PLANT PHYSIOL, V127, P986, DOI 10.1104/pp.010270; Hardtke CS, 2000, EMBO J, V19, P4997, DOI 10.1093/emboj/19.18.4997; Hayami N, 2015, PLANT PHYSIOL, V169, P840, DOI 10.1104/pp.15.00398; Heddad M, 2006, PLANT PHYSIOL, V142, P75, DOI 10.1104/pp.106.081489; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; KATZ A, 1995, PLANT PHYSIOL, V108, P1657, DOI 10.1104/pp.108.4.1657; Khanna R, 2006, PLANT CELL, V18, P2157, DOI 10.1105/tpc.106.042200; Kreimer G, 2009, CURR GENET, V55, P19, DOI 10.1007/s00294-008-0224-8; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lado J, 2015, PHYSIOL PLANTARUM, V154, P469, DOI 10.1111/ppl.12332; Lee HJ, 2012, J EXP BOT, V63, P5967, DOI 10.1093/jxb/ers242; Lee JH, 2014, J NANOMATER, V2014, DOI 10.1155/2014/567827; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; LERS A, 1991, J BIOL CHEM, V266, P13698; Liu LH, 2015, MOL PLANT, V8, P28, DOI 10.1016/j.molp.2014.11.006; Llorente B, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00263; Llorente B, 2016, PLANT J, V85, P107, DOI 10.1111/tpj.13094; Lundquist PK, 2012, PLANT PHYSIOL, V158, P1172, DOI 10.1104/pp.111.193144; McCollum JP, 1954, J FOOD SCI, V19, P7; Noordally ZB, 2013, SCIENCE, V339, P1316, DOI 10.1126/science.1230397; Noren H, 2003, PLANT CELL ENVIRON, V26, P245, DOI 10.1046/j.1365-3040.2003.00954.x; Page D, 2008, POSTHARVEST BIOL TEC, V50, P117, DOI 10.1016/j.postharvbio.2008.05.017; Peng YH, 2008, PHYSIOL PLANTARUM, V132, P44, DOI 10.1111/j.1399-3054.2007.00988.x; Pera EM, 2005, INT J DEV BIOL, V49, P781, DOI 10.1387/ijdb.052003ep; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rodriguez-Concepcion M, 2013, ARCH BIOCHEM BIOPHYS, V539, P110, DOI 10.1016/j.abb.2013.07.009; Rubio A, 2008, J BIOL CHEM, V283, P24816, DOI 10.1074/jbc.M804000200; Moraga AR, 2009, PHYTOCHEMISTRY, V70, P1009, DOI 10.1016/j.phytochem.2009.04.022; Rubio-Moraga A, 2010, PHYTOCHEMISTRY, V71, P1506, DOI 10.1016/j.phytochem.2010.05.026; Ruiz-Sola M Aguila, 2012, Arabidopsis Book, V10, pe0158, DOI 10.1199/tab.0158; Schmidt M, 2006, PLANT CELL, V18, P1908, DOI 10.1105/tpc.106.041749; Schulze T, 2013, MOL PLANT, V6, P931, DOI 10.1093/mp/sss137; Singh DK, 2011, TRENDS PLANT SCI, V16, P432, DOI 10.1016/j.tplants.2011.03.014; Takahashi S, 2008, PHOTOCH PHOTOBIO SCI, V7, P1216, DOI 10.1039/b802588f; Tian L, 2004, ARCH BIOCHEM BIOPHYS, V430, P22, DOI 10.1016/j.abb.2004.02.003; Vanhee C, 2011, PLANT SIGNAL BEHAV, V6, P1383, DOI 10.4161/psb.6.9.16477; Wagner V, 2008, PLANT PHYSIOL, V146, P772, DOI 10.1104/pp.107.109645; Wang H, 2015, ACTA PHYSL PLANTARUM, V37; Waters MT, 2009, PLANT CELL, V21, P1109, DOI 10.1105/tpc.108.065250; Xiao LH, 2015, P NATL ACAD SCI USA, V112, P5833, DOI 10.1073/pnas.1505811112; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083; Zeng Qin, 2002, Journal of Experimental Botany, V53, P1197, DOI 10.1093/jexbot/53.371.1197; Zylka MJ, 1999, MOL BRAIN RES, V74, P175, DOI 10.1016/S0169-328X(99)00277-6	72	2	3	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168736	10.1371/journal.pone.0168736	http://dx.doi.org/10.1371/journal.pone.0168736			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030614	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000070
J	Savage, A; Thomas, L; Feilen, KL; Kidney, D; Soto, LH; Pearson, M; Medina, FS; Emeris, G; Guillen, RR				Savage, Anne; Thomas, Len; Feilen, Katie L.; Kidney, Darren; Soto, Luis H.; Pearson, Mackenzie; Medina, Felix S.; Emeris, German; Guillen, Rosamira R.			An Assessment of the Population of Cotton-Top Tamarins (Saguinus oedipus) and Their Habitat in Colombia	PLOS ONE			English	Article							CONSERVATION; BIODIVERSITY; DEFORESTATION	Numerous animals have declining populations due to habitat loss, illegal wildlife trade, and climate change. The cotton-top tamarin (Saguinus oedipus) is a Critically Endangered primate species, endemic to northwest Colombia, threatened by deforestation and illegal trade. In order to assess the current state of this species, we analyzed changes in the population of cotton-top tamarins and its habitat from 2005 to 2012. We used a tailor-made "lure strip transect" method to survey 43 accessible forest parcels that represent 30% of the species' range. Estimated population size in the surveyed region was approximately 2,050 in 2005 and 1,900 in 2012, with a coefficient of variation of approximately 10%. The estimated population change between surveys was -7% (a decline of approximately 1.3% per year) suggesting a relatively stable population. If densities of inaccessible forest parcels are similar to those of surveyed samples, the estimated population of cotton-top tamarins in the wild in 2012 was 6,946 individuals. We also recorded little change in the amount of suitable habitat for cotton-top tamarins between sample periods: in 2005, 18% of surveyed forest was preferred habitat for cotton-top tamarins, while in 2012, 17% percent was preferred. We attribute the relatively stable population of this Critically Endangered species to increased conservation efforts of Proyecto Titi, conservation NGOs, and the Colombian government. Due to continued threats to cotton-top tamarins and their habitat such as agriculture and urban expansion, ongoing conservation efforts are needed to ensure the long-term survival of cotton-top tamarins in Colombia.	[Savage, Anne; Feilen, Katie L.; Pearson, Mackenzie] Disneys Anim Sci & Environm, Conservat Dept, Lake Buena Vista, FL USA; [Thomas, Len; Kidney, Darren] Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Scotland; [Thomas, Len; Kidney, Darren] Univ St Andrews, Sch Math & Stat, St Andrews, Scotland; [Soto, Luis H.; Medina, Felix S.; Emeris, German; Guillen, Rosamira R.] Fdn Proyecto Titi, Barranquilla, Colombia	University of St Andrews; University of St Andrews	Savage, A (corresponding author), Disneys Anim Sci & Environm, Conservat Dept, Lake Buena Vista, FL USA.	Anne.Savage@disney.com		Thomas, Len/0000-0002-7436-067X	Disney's Animal, Science and Environment; SeaWorld & Busch Gardens Conservation Fund; Mohammed bin Zayed Species Conservation Fund; Wildlife Conservation Network; Phoenix Zoo	Disney's Animal, Science and Environment; SeaWorld & Busch Gardens Conservation Fund; Mohammed bin Zayed Species Conservation Fund; Wildlife Conservation Network; Phoenix Zoo	Disney's Animal, Science and Environment provided support in the form of salaries for authors AS, KLF, and MP. They also covered a proportion of research expenses (field equipment, transportation to survey areas) for these studies. These authors participated in the study design, data collection and analysis, decision to publish, and preparation of the manuscript, but the funder, itself, did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The study was also funded by The SeaWorld & Busch Gardens Conservation Fund, Mohammed bin Zayed Species Conservation Fund, Wildlife Conservation Network, and Phoenix Zoo.	Brawn JD, 1996, ECOLOGY, V77, P3, DOI 10.2307/2265649; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Calix M., 2018, EUROPEAN RED LIST SA; CDB, 2002, CONTRIBUTION 6 NATL; Davalos LM, 2011, ENVIRON SCI TECHNOL, V45, P1219, DOI 10.1021/es102373d; DUNBAR RIM, 1987, INT J PRIMATOL, V8, P299, DOI 10.1007/BF02737386; Etter A, 2006, AGR ECOSYST ENVIRON, V114, P369, DOI 10.1016/j.agee.2005.11.013; Fearnside PM, 2001, ENVIRON MANAGE, V27, P377, DOI 10.1007/s002670010156; Fewster RM, 2009, BIOMETRICS, V65, P225, DOI 10.1111/j.1541-0420.2008.01018.x; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Hernandez-Camacho J., 1976, P35; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Kierulff M. C. M., 2012, International Zoo Yearbook, V46, P36, DOI 10.1111/j.1748-1090.2012.00170.x; Kleiman D.G., 1986, P959; McNeilage A, 2006, ORYX, V40, P419, DOI 10.1017/S0030605306001311; Miller L, 2004, AM J PRIMATOL, V64, P451, DOI 10.1002/ajp.20091; Perez-Barrios, 2013, MEDIO CUAL SE DECLAR; ProAves, 2015, PROAVES RES 2015; R Development Core Team, 2016, R LANG ENV STAT COMP; Rico L, 2010, AEROPUERTO BICENTENA; Sanchez-Cuervo AM, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00207.1; Sanchez-Cuervo AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043943; Savage A., 2012, International Zoo Yearbook, V46, P56, DOI 10.1111/j.1748-1090.2011.00159.x; Savage A, 2010, AM J PRIMATOL, V72, P379, DOI 10.1002/ajp.20770; Savage A, 1996, AM J PRIMATOL, V38, P85, DOI 10.1002/(SICI)1098-2345(1996)38:1<85::AID-AJP7>3.0.CO;2-P; Savage A, 2009, AM J PRIMATOL, V71, P707, DOI 10.1002/ajp.20696; Savage A, 1997, AM J PRIMATOL, V43, P329, DOI 10.1002/(SICI)1098-2345(1997)43:4<329::AID-AJP4>3.0.CO;2-Z; Savage A, 2009, PRIMATES PERIL WORLD, P1; Savage A, 2014, IUCN RED LIST THREAT; Savage A., 1990, THESIS; Savage A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1030; Swenson JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018875; Thompson S.K., 2012, SAMPLING, V3rd; Trust WL, 2014, COLOMBIAS COTTON TOP; UNEP-WCMC (Comps.), 2015, CHECKL CITES SPEC WE; UNEP-WCMC IUCN, 2021, PROT PLAN INS NAM CO; United Nations Development Program, 2012, POW LOC ACT COMM FRO; United Nations Development Programme, 2013, EQ IN CAS STUD SER; Verano de la Rosa E, 2011, 00015 CORP AUT REG A; World Bank Global Poverty Working Group, 2016, POV HEADC RAT NAT PO	41	7	7	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168324	10.1371/journal.pone.0168324	http://dx.doi.org/10.1371/journal.pone.0168324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030570	gold, Green Published			2022-12-26	WOS:000391222000043
J	Turgeon, N; Michel, K; Ha, TL; Robine, E; Moineau, S; Duchaine, C				Turgeon, Nathalie; Michel, Kevin; Ha, Thi-Lan; Robine, Enric; Moineau, Sylvain; Duchaine, Caroline			Resistance of Aerosolized Bacterial Viruses to Four Germicidal Products	PLOS ONE			English	Article							AIRBORNE INFLUENZA-VIRUS; RELATIVE-HUMIDITY; INACTIVATION; SURVIVAL; QUANTIFICATION; SUSCEPTIBILITY; FILTERS; AIR	Viral diseases can spread through a variety of routes including aerosols. Yet, limited data are available on the efficacy of aerosolized chemicals to reduce viral loads in the air. Bacteriophages (phages) are often used as surrogates for hazardous viruses in aerosol studies because they are inexpensive, easy to handle, and safe for laboratory workers. Moreover, several of these bacterial viruses display physical characteristics similar to pathogenic human and animal viruses, like morphological size, type of nucleic acids, capsid morphology, and the presence of an envelope. In this study, the efficacy of four chemicals was evaluated on four airborne phages at two different relative humidity levels. Non-tailed bacteriophages MS2 (single-stranded RNA), phi 6 (double-stranded RNA, enveloped), PR772 (double-stranded DNA), and phi X174 (single-stranded DNA) were first aerosolized in a 55L rotative environmental chamber at 19 degrees C with 25% and 50% relative humidity. Then, hydrogen peroxide, Eugenol (phenylpropene used in commercial perfumes and flavorings), Mist (R) (automobile disinfectant containing Triethylene glycol), and Pledge (R) (multisurface disinfectant containing Isopropanol, n-Alkyl Dimethyl Benzyl Amonium Chlorides, and n-Alkyl Dimethyl Ethylbenzyl Ammonium Chloride) were nebulized with the phages using a separate nebulizer. Aerosols were maintained in suspension during 10 minutes, 1 hour, and 2 hours. Viral aerosols were sampled using an SKC BioSampler and samples were analyzed using qPCR and plaque assays. The resistance levels of the four phages varied depending on the relative humidity (RH) and germicidal products tested. Phage MS2 was the most stable airborne virus under the environmental conditions tested while phage PR772 was the least stable. Pledge (R) and Eugenol reduced the infectivity of all airborne phages tested. At 25% RH, Pledge (R) and Eugenol were more effective at reducing infectivity of RNA phages phi 6 and MS2. At 50% RH, Pledge (R) was the most effective agent against phage MS2. These findings illustrate that various airborne viruses should be tested to demonstrate the effectiveness of germicidal treatments. This research also provides a set of parameters for testing germicidal products in large-scale settings to reduce the risk of virus transmission.	[Turgeon, Nathalie; Michel, Kevin; Duchaine, Caroline] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Turgeon, Nathalie; Michel, Kevin; Moineau, Sylvain; Duchaine, Caroline] Univ Laval, Dept Biochim Microbiol & Bioinformat, Fac Sci & Genie, Quebec City, PQ, Canada; [Ha, Thi-Lan; Robine, Enric] Ctr Sci & Tech Batiment, Champs Sur Marne, Marne La Vallee, France; [Moineau, Sylvain] Univ Laval, Felix Herelle Reference Ctr Bacterial Viruses, Fac Med Dent, Quebec City, PQ, Canada; [Moineau, Sylvain] Univ Laval, GREB, Fac Med Dent, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University	Duchaine, C (corresponding author), Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.; Duchaine, C (corresponding author), Univ Laval, Dept Biochim Microbiol & Bioinformat, Fac Sci & Genie, Quebec City, PQ, Canada.	Caroline.Duchaine@bcm.ulaval.ca	Moineau, Sylvain/I-7231-2019	Moineau, Sylvain/0000-0002-2832-5101	Ministere du developpement durable et de l'energie-France	Ministere du developpement durable et de l'energie-France	This work was funded by the Ministere du developpement durable et de l'energie-France and was conducted within the framework of the French research program PRIMEQUAL. Convention no12-MRES-Primequal-5-CVS-37. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibby K, 2013, ENVIRON SCI-PROC IMP, V15, P336, DOI 10.1039/c2em30831b; Bibby K, 2013, ENVIRON SCI TECHNOL, V47, P1945, DOI 10.1021/es305181x; Bischoff WE, 2013, J INFECT DIS, V207, P1037, DOI 10.1093/infdis/jis773; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Bonifait L, 2015, CLIN INFECT DIS, V61, P299, DOI 10.1093/cid/civ321; Cutler TD, 2012, VET MICROBIOL, V159, P47, DOI 10.1016/j.vetmic.2012.03.044; Dee S, 2005, CAN J VET RES, V69, P64; ELAZHARY MASY, 1979, CAN J COMP MED, V43, P305; Gendron L, 2010, AEROSOL SCI TECH, V44, P893, DOI 10.1080/02786826.2010.501351; Gregersen JP, 2012, BIOLOGICALS, V40, P282, DOI 10.1016/j.biologicals.2012.02.004; Grinshpun SA, 2007, ENVIRON SCI TECHNOL, V41, P606, DOI 10.1021/es061373o; Hsu CS, 2014, ENVIRON MONIT ASSESS, V186, P2941, DOI 10.1007/s10661-013-3591-7; Hsu CS, 2013, J AIR WASTE MANAGE, V63, P796, DOI 10.1080/10962247.2012.735212; IJAZ MK, 1985, J GEN VIROL, V66, P2743, DOI 10.1099/0022-1317-66-12-2743; KARIM YG, 1985, CAN J MICROBIOL, V31, P1058, DOI 10.1139/m85-199; La Rosa G, 2013, ANN I SUPER SANITA, V49, P124, DOI 10.4415/ANN_13_02_03; Longest PW, 2012, J AEROSOL SCI, V51, P66, DOI 10.1016/j.jaerosci.2012.04.002; LORENZ D, 1980, LAB ANIM SCI, V30, P661; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lute S, 2004, APPL ENVIRON MICROB, V70, P4864, DOI 10.1128/AEM.70.8.4864-4871.2004; McDevitt JJ, 2012, APPL ENVIRON MICROB, V78, P1666, DOI 10.1128/AEM.06960-11; Milton DK, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00150; Moss OR, 2011, AEROSOL MEASUREMENT, P785; Panec M, 2010, PLAQUE ASSAY PROTOCO; Phillpotts RJ, 2010, AEROBIOLOGIA, V26, P301, DOI 10.1007/s10453-010-9166-y; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; Steel J, 2011, J VIROL, V85, P1400, DOI 10.1128/JVI.02186-10; Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus; Tseng CC, 2005, AEROSOL SCI TECH, V39, P1136, DOI 10.1080/02786820500428575; Tseng CC, 2006, AEROSOL SCI TECH, V40, P683, DOI 10.1080/02786820600796590; Turgeon N, 2016, CAN J MICROBIOL; Turgeon N, 2014, APPL ENVIRON MICROB, V80, P4242, DOI 10.1128/AEM.00767-14; Verreault D, 2008, MICROBIOL MOL BIOL R, V72, P413, DOI 10.1128/MMBR.00002-08; Verreault D, 2015, APPL ENVIRON MICROB, V81, P7305, DOI 10.1128/AEM.02484-15; Verreault D, 2014, INHAL TOXICOL, V26, P554, DOI 10.3109/08958378.2014.928763; Verreault D, 2010, AEROSOL SCI TECH, V44, P197, DOI 10.1080/02786820903518899; Walker CM, 2007, ENVIRON SCI TECHNOL, V41, P5460, DOI 10.1021/es070056u; Yu L, 2010, AEROBIOLOGIA, V26, P75, DOI 10.1007/s10453-009-9144-4	38	16	16	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168815	10.1371/journal.pone.0168815	http://dx.doi.org/10.1371/journal.pone.0168815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030577	Green Published, Green Submitted, gold			2022-12-26	WOS:000391222000078
J	Shin, B; Koh, WJ; Shin, SW; Jeong, BH; Park, HY; Suh, GY; Jeon, K				Shin, Beomsu; Koh, Won-Jung; Shin, Sung Wook; Jeong, Byeong-Ho; Park, Hye Yun; Suh, Gee Young; Jeon, Kyeongman			Outcomes of Bronchial Artery Embolization for Life-Threatening Hemoptysis in Patients with Chronic Pulmonary Aspergillosis	PLoS One			English	Article							INFECTIOUS-DISEASES SOCIETY; CLINICAL CHARACTERISTICS; PRACTICE GUIDELINES; CHRONIC CAVITARY; MANAGEMENT; DIAGNOSIS; TUBERCULOSIS; VORICONAZOLE; PROGNOSIS; SPECTRUM	Background Bronchial artery embolization (BAE) is an important treatment option for short-term control of hemoptysis in patients with simple aspergilloma (SA). However, there are no data on the outcomes of BAE in patients with chronic pulmonary aspergillosis (CPA). In this study, the clinical characteristics and outcomes of BAE were investigated and compared in patients with CPA and SA. Methods We retrospectively analyzed the clinical data of 64 patients (55 [86%] with CPA and 9 [14%] with SA) who underwent BAE for life-threatening hemoptysis. The clinical characteristics and outcomes of BAE in CPA patients were compared to those of patients with SA. Results The most common angiographic abnormality was hypervascularity (n = 60, 94%), followed by contrast extravasation (n = 50, 78%) and systemic-pulmonary shunt (n = 48, 75%), with similar incidence rates in both groups. Immediate success was achieved in 41 (64%) BAE procedures, but it was incomplete in 23 (36%) cases due to difficulty with the approach and/or overuse of contrast medium. Clinical failure of BAE was observed in only one (2%) patient. Complications following BAE were observed in four (6%) patients. Recurrence of hemoptysis was seen in a total of 33 patients (52%) within a median of 2.0 (0.3-10.0) months, and repeat BAE was performed in 25 (76%) of these cases. In comparing the outcomes of patients with CPA and SA, there were no differences in the rates of success of initial BAE, incomplete embolization, or clinical failure in the two groups. However, recurrence of hemoptysis tended to be higher in patients with CPA (55%) than in those with SA (33%). In addition, antifungal medications following BAE were more commonly prescribed in the CPA group (56%) compared to the SA group (0%). Conclusions BAE was a safe and effective procedure for the management of life-threatening hemoptysis in patients with CPA. However, recurrence of hemoptysis was common, especially in patients with CPA. Therefore, definitive treatment for CPA following successful BAE should be considered to ensure the long-term success of the embolization in these patients.	[Shin, Beomsu; Koh, Won-Jung; Jeong, Byeong-Ho; Park, Hye Yun; Suh, Gee Young; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea; [Shin, Sung Wook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Suh, Gee Young; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, K (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea.; Jeon, K (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea.	kjeon@skku.edu	shin, sw/O-6248-2014; Koh, Won-Jung/D-9586-2018; Jeon, Kyeongman/F-5963-2019; park, hy/O-5934-2014; Koh, Won Jung/C-9595-2011; Suh, Gee Young/O-3676-2019; Shin, Beomsu/AAP-3328-2020	Koh, Won-Jung/0000-0002-4756-3527; Jeon, Kyeongman/0000-0002-4822-1772; Suh, Gee Young/0000-0001-5473-1712; Jeong, Byeong-Ho/0000-0002-3124-1718				Abdulmalak C, 2015, EUR RESPIR J, V46, P503, DOI 10.1183/09031936.00218214; Agarwal R, 2013, MYCOSES, V56, P559, DOI 10.1111/myc.12075; Brinson GM, 1998, AM J RESP CRIT CARE, V157, P1951, DOI 10.1164/ajrccm.157.6.9708067; Cadranel J, 2012, EUR J CLIN MICROBIOL, V31, P3231, DOI 10.1007/s10096-012-1690-y; Camuset J, 2007, CHEST, V131, P1435, DOI 10.1378/chest.06-2441; Chan VL, 2009, INT J TUBERC LUNG D, V13, P1167; Chun JY, 2010, CARDIOVASC INTER RAD, V33, P240, DOI 10.1007/s00270-009-9788-z; Chun JY, 2010, EUR RADIOL, V20, P558, DOI 10.1007/s00330-009-1591-3; Corr P, 2006, CARDIOVASC INTER RAD, V29, P807, DOI 10.1007/s00270-005-0329-0; Denning DW, 2016, EUR RESPIR J, V47, P45, DOI 10.1183/13993003.00583-2015; Denning DW, 2003, CLIN INFECT DIS, V37, pS265, DOI 10.1086/376526; Izumikawa K, 2016, RESPIR INVESTIG, V54, P85, DOI 10.1016/j.resinv.2015.10.003; Jhun BW, 2013, MED MYCOL, V51, P811, DOI 10.3109/13693786.2013.806826; Kim SW, 2015, LUNG, V193, P575, DOI 10.1007/s00408-015-9728-4; Kosmidis C, 2015, THORAX, V70, P270, DOI 10.1136/thoraxjnl-2014-206291; Lee JH, 2007, INT J TUBERC LUNG D, V11, P781; McDonald DM, 2001, AM J RESP CRIT CARE, V164, pS39, DOI 10.1164/ajrccm.164.supplement_2.2106065; Nam HS, 2010, INT J INFECT DIS, V14, pE479, DOI 10.1016/j.ijid.2009.07.011; Ohba H, 2012, RESP MED, V106, P724, DOI 10.1016/j.rmed.2012.01.014; Otani Y, 1997, SURG TODAY, V27, P812, DOI 10.1007/BF02385271; Patterson KC, 2014, CHEST, V146, P1358, DOI 10.1378/chest.14-0917; Patterson TF, 2016, CLIN INFECT DIS, V63, pE1, DOI 10.1093/cid/ciw326; Pei RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115956; Shin BS, 2011, INT J TUBERC LUNG D, V15, P1093, DOI 10.5588/ijtld.10.0659; Shin B, 2014, J INFECTION, V68, P494, DOI 10.1016/j.jinf.2014.01.005; Sopko David R, 2011, Semin Intervent Radiol, V28, P48, DOI 10.1055/s-0031-1273940; Soubani AO, 2002, CHEST, V121, P1988, DOI 10.1378/chest.121.6.1988; UFLACKER R, 1985, RADIOLOGY, V157, P637, DOI 10.1148/radiology.157.3.4059552; van den Heuvel MM, 2007, INT J TUBERC LUNG D, V11, P909; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258	30	20	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168373	10.1371/journal.pone.0168373	http://dx.doi.org/10.1371/journal.pone.0168373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006828	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200047
J	Choi, S; Chung, H; Hong, H; Kim, SY; Kim, SE; Seoh, JY; Moon, CM; Yang, EG; Oh, ES				Choi, Sojoong; Chung, Heesung; Hong, Heejeong; Kim, So Yeon; Kim, Seong-Eun; Seoh, Ju-Young; Moon, Chang Mo; Yang, Eun Gyeong; Oh, Eok-Soo			Inflammatory hypoxia induces syndecan-2 expression through IL-1 beta-mediated FOXO3a activation in colonic epithelia	FASEB JOURNAL			English	Article						colon cancer; FOXO3a; IL-1 beta	INTESTINAL INFLAMMATION; CYTOKINE REGULATION; COLORECTAL-CANCER; CELL-MIGRATION; COLITIS; PROMOTES; PHOSPHORYLATION; CARCINOGENESIS; PROLIFERATION; STRESS	Chronic inflammation is known to be a key causative factor in tumor progression, but we do not yet fully understand the molecular mechanism through which inflammation leads to cancer. Here, we report that the dextran sulfate sodium (DSS)-induced mouse model of chronic colitis is associated with increases in the serum level of IL-1 beta and the colonic epithelial expression of the cell-surface heparan sulfate proteoglycan, syndecan-2. We further show that IL-1b stimulated the transcription of syndecan-2 via NF-kappa B-dependent FOXO3a activation in CCD841CoN normal colonic epithelial cells and early-stage HT29 colon cancer cells. Inflammatory hypoxia was observed in the colonic epithelia of mice with chronic colitis, suggesting that hypoxic stress is involved in the regulation of syndecan-2 expression. Consistently, experimental inflammatory hypoxia induced hypoxia inducible factor-1 alpha-dependent FOXO3a expression and the p38 MAPK-mediated nuclear localization of FOXO3a. FOXO3a directly mediated syndecan-2 expression in both cell lines and the colonic epithelia of mice with DSS-induced colitis. Moreover, syndecan-2 expression was detected in azoxymethane/ DSS-induced colon tumors. Together, these data demonstrate that inflammatory hypoxia upregulates syndecan-2 via the IL-1 beta-NF-kappa B-FOXO3a pathway. These findings provide new mechanistic insights into inflammatory hypoxia-mediated syndecan-2 expression to connect chronic inflammation and the development of colon cancer.-Choi, S., Chung, H., Hong, H., Kim, S. Y., Kim, S.-E., Seoh, J.-Y., Moon, C. M., Yang, E. G., Oh, E.-S. Inflammatory hypoxia induces syndecan-2 expression through IL-1b-mediated FOXO3a activation in colonic epithelia. FASEB J. 31, 1516-1530 (2017). www.fasebj.org	[Choi, Sojoong; Kim, So Yeon; Yang, Eun Gyeong] Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Hwarangno 14 Gil 5, Seoul 02792, South Korea; [Chung, Heesung; Hong, Heejeong; Oh, Eok-Soo] Ewha Womans Univ, Sch Med, Dept Life Sci, Seoul, South Korea; [Chung, Heesung; Hong, Heejeong; Oh, Eok-Soo] Ewha Womans Univ, Sch Med, Res Ctr Cellular Homeostasis, Seoul, South Korea; [Kim, Seong-Eun; Moon, Chang Mo] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Seoh, Ju-Young] Ewha Womans Univ, Grad Sch Med, Dept Microbiol, Seoul, South Korea	Korea Institute of Science & Technology (KIST); Ewha Womans University; Ewha Womans University; Ewha Womans University; Ewha Womans University	Yang, EG (corresponding author), Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Hwarangno 14 Gil 5, Seoul 02792, South Korea.; Oh, ES (corresponding author), Ewha Womans Univ, Dept Life Sci, 52 Ewhayeodae Gil, Seoul 03760, South Korea.	eunyang@kist.re.kr; ohes@ewha.ac.kr		Kim, So Yeon/0000-0001-9167-5182	National Research Foundation of Korea [2012R1A5A1048236, 2014K1A3A7A03075056, 2012M3A9B9028156]; Korean Ministry of Science, Information and Communications Technology (ICT) and Future Planning [NRF2012M3A9C4048761]; Korea Institute of Science and Technology grant	National Research Foundation of Korea(National Research Foundation of Korea); Korean Ministry of Science, Information and Communications Technology (ICT) and Future Planning; Korea Institute of Science and Technology grant	The authors thank the National Research Foundation of Korea for Grants 2012R1A5A1048236 and 2014K1A3A7A03075056 (to E.-S.O.), and Grant 2012M3A9B9028156 (to E.G.Y.), Korean Ministry of Science, Information and Communications Technology (ICT) and Future Planning Grant NRF2012M3A9C4048761 (to E.-S.O.), and a Korea Institute of Science and Technology grant. The construct of dominant negative p38 was kindly provided by Dr. Y.J. Oh (Yonsei University, Seoul, South Korea). The syndecan-2 promoter constructs, wild p3.62kb-LUC, and mutant p3.62kb-LUC (in which FOXO3a binding was abolished) were kindly provided by Dr. D. Modrowski (Laboratory of Osteoblast Biology and Pathology, INSERM U606, Paris, France). The authors declare no competing financial interests.	Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Bamba S, 2006, J PATHOL, V209, P265, DOI 10.1002/path.1967; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Chen LG, 2004, J BIOL CHEM, V279, P15715, DOI 10.1074/jbc.C300430200; Choi WS, 2004, J BIOL CHEM, V279, P20451, DOI 10.1074/jbc.M311164200; Choi Y, 2010, BIOCHEM BIOPH RES CO, V391, P921, DOI 10.1016/j.bbrc.2009.11.165; Chou CC, 2014, CANCER RES, V74, P4783, DOI 10.1158/0008-5472.CAN-14-0135; Chung H, 2012, J BIOL CHEM, V287, P19326, DOI 10.1074/jbc.M111.334730; Clasper S, 1999, J BIOL CHEM, V274, P24113, DOI 10.1074/jbc.274.34.24113; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; Couchman JR, 2015, INT J EXP PATHOL, V96, P1, DOI 10.1111/iep.12112; De Francesco MA, 2011, J BIOL CHEM, V286, P19541, DOI 10.1074/jbc.M110.191270; Dieudonne FX, 2012, J BONE MINER RES, V27, P2118, DOI 10.1002/jbmr.1650; Du C, 2014, SCI REP-UK, V4, DOI 10.1038/srep06096; Dyson JK, 2012, WORLD J GASTROENTERO, V18, P3839, DOI 10.3748/wjg.v18.i29.3839; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Essner JJ, 2006, INT J BIOCHEM CELL B, V38, P152, DOI 10.1016/j.biocel.2005.08.012; Foersch S, 2014, CELL MOL LIFE SCI, V71, P3523, DOI 10.1007/s00018-014-1636-x; Francescone R, 2015, INFLAMM BOWEL DIS, V21, P409, DOI 10.1097/MIB.0000000000000236; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Hagland HR, 2015, CANCER LETT, V356, P273, DOI 10.1016/j.canlet.2014.02.026; Halden Y, 2004, BIOCHEM J, V377, P533, DOI 10.1042/BJ20030729; Ho KK, 2012, J BIOL CHEM, V287, P1545, DOI 10.1074/jbc.M111.284224; Hoshi N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2113; Kabat AM, 2014, TRENDS IMMUNOL, V35, P507, DOI 10.1016/j.it.2014.07.010; Kaur C, 2009, GLIA, V57, P336, DOI 10.1002/glia.20764; Kennedy RJ, 2000, BRIT J SURG, V87, P1346, DOI 10.1046/j.1365-2168.2000.01615.x; Lee H, 2011, BIOCHEM BIOPH RES CO, V409, P148, DOI 10.1016/j.bbrc.2011.04.135; Lee JH, 2009, J BIOL CHEM, V284, P27167, DOI 10.1074/jbc.M109.034678; Lin YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079299; Link W, 2009, J BIOL CHEM, V284, P28392, DOI 10.1074/jbc.M109.038984; Lopez-Bojorquez LN, 2004, INFLAMM RES, V53, P567, DOI 10.1007/s00011-004-1297-6; Ning C, 2015, MUCOSAL IMMUNOL, V8, P1275, DOI 10.1038/mi.2015.18; Noguer O, 2009, EXP CELL RES, V315, P795, DOI 10.1016/j.yexcr.2008.11.016; Nowacki TM, 2015, DIGEST DIS SCI, V60, P492, DOI 10.1007/s10620-014-3373-2; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Park H, 2002, J BIOL CHEM, V277, P29730, DOI 10.1074/jbc.M202435200; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Ryu HY, 2009, J BIOL CHEM, V284, P35692, DOI 10.1074/jbc.M109.054254; Sebestyen A, 2000, CYTOKINE, V12, P1557, DOI 10.1006/cyto.2000.0754; Shouval DS, 2016, GASTROENTEROLOGY, V151, P1100, DOI 10.1053/j.gastro.2016.08.055; Teixe T, 2008, MOL IMMUNOL, V45, P2905, DOI 10.1016/j.molimm.2008.01.033; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Vela JM, 2002, MOL CELL NEUROSCI, V20, P489, DOI 10.1006/mcne.2002.1127; Worapamorn W, 2002, J PERIODONTAL RES, V37, P273, DOI 10.1034/j.1600-0765.2002.01610.x; Zhou X., 2016, INT J AUDIOL, V1, P1, DOI DOI 10.18632/0NC0TARGET.6418; Zoratto F, 2014, TUMOR BIOL, V35, P6195, DOI 10.1007/s13277-014-1845-9	50	23	24	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1516	1530		10.1096/fj.201601098R	http://dx.doi.org/10.1096/fj.201601098R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28031321				2022-12-26	WOS:000398504300020
J	Aryal, M; Fischer, K; Gentile, C; Gitto, S; Zhang, YZ; McDannold, N				Aryal, Muna; Fischer, Krisztina; Gentile, Caroline; Gitto, Salvatore; Zhang, Yong-Zhi; McDannold, Nathan			Effects on P-Glycoprotein Expression after Blood-Brain Barrier Disruption Using Focused Ultrasound and Microbubbles	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; LIPOSOMAL DOXORUBICIN; GENE-EXPRESSION; SOLID TUMORS; DELIVERY; MODEL; CANCER; CELLS; PERMEABILITY; SYSTEM	Many blood-borne substances attempting to pass through the luminal membrane of brain endothelial cells are acted upon by a variety of metabolizing enzymes or are actively expelled back into the capillary lumen by embedded efflux transporters, such as Permeability-glycoprotein (Pgp). Overexpression of this protein has also been linked to multidrug resistance in cancer cells. Previous studies have shown that focused ultrasound (FUS), when combined with a microbubble agent, has ability to temporarily disrupt blood-brain barrier (BBBD). In this work, we investigated whether modulation of Pgp expression is part of the FUS-induced effects. We found that ultrasound can temporarily suppress Pgp expression. When BBBD was produced at 0.55 MPa, Pgp was suppressed up to 48 hours and restored by 72 hours. At 0.81 MPa, suppression can last 72 hours or longer. These findings support the idea that microbubble-enhanced FUS disrupts the functional components of the BBB through suppression of drug efflux.	[Aryal, Muna; Fischer, Krisztina; Gentile, Caroline; Zhang, Yong-Zhi; McDannold, Nathan] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Gentile, Caroline] Harvard Univ, Dept Neurobiol, Cambridge, MA USA; [Gitto, Salvatore] Univ Pavia, Dept Radiol, Pavia, Italy	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; University of Pavia	Aryal, M (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA.	muna01@stanford.edu		Aryal, Muna/0000-0002-7997-5614	NIH [P01CA17464501]; NATIONAL CANCER INSTITUTE [P01CA174645] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH with grant P01CA17464501. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins CE, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00136; Alkins R, 2013, CANCER RES, V73, P1892, DOI 10.1158/0008-5472.CAN-12-2609; Arvanitis CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045783; Aryal M, 2015, POSSIBLE EFFECTS P G; Aryal M, 2015, J CONTROL RELEASE, V204, P60, DOI 10.1016/j.jconrel.2015.02.033; Aryal M, 2013, J CONTROL RELEASE, V169, P103, DOI 10.1016/j.jconrel.2013.04.007; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Chai WY, 2014, J CONTROL RELEASE, V192, P1, DOI 10.1016/j.jconrel.2014.06.023; Cho H., 2016, CORRELATION REGULATI; Chopra R, 2010, ACS CHEM NEUROSCI, V1, P391, DOI 10.1021/cn9000445; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Fan CH, 2013, BIOMATERIALS, V34, P2142, DOI 10.1016/j.biomaterials.2012.11.048; Ferry DR, 1996, EUR J CANCER, V32A, P1070, DOI 10.1016/0959-8049(96)00091-3; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; He Y, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-104; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Jordao JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010549; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kinoshita M, 2006, P NATL ACAD SCI USA, V103, P11719, DOI 10.1073/pnas.0604318103; Konofagou EE, 2012, THERANOSTICS, V2, P1223, DOI 10.7150/thno.5576; Lin JH, 2003, CLIN PHARMACOKINET, V42, P59, DOI 10.2165/00003088-200342010-00003; Liu HL, 2008, IEEE T BIO-MED ENG, V55, P2407, DOI 10.1109/TBME.2008.925697; Liu HL, 2010, P NATL ACAD SCI USA, V107, P15205, DOI 10.1073/pnas.1003388107; Loscher W, 2011, SEIZURE-EUR J EPILEP, V20, P359, DOI 10.1016/j.seizure.2011.01.003; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Marty B, 2012, J CEREBR BLOOD F MET, V32, P1948, DOI 10.1038/jcbfm.2012.100; McDannold N, 2006, PHYS MED BIOL, V51, P793, DOI 10.1088/0031-9155/51/4/003; McDannold N, 2012, CANCER RES, V72, P3652, DOI 10.1158/0008-5472.CAN-12-0128; Milane A, 2010, NEUROSCI LETT, V472, P166, DOI 10.1016/j.neulet.2010.01.078; Nance E, 2014, J CONTROL RELEASE, V189, P123, DOI 10.1016/j.jconrel.2014.06.031; O'Reilly MA, 2012, RADIOLOGY, V263, P96, DOI 10.1148/radiol.11111417; O'Reilly MA, 2011, ULTRASOUND MED BIOL, V37, P1930, DOI 10.1016/j.ultrasmedbio.2011.08.001; Oda Y, 1997, VIRCHOWS ARCH, V430, P99, DOI 10.1007/BF01008030; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Park EJ, 2012, J CONTROL RELEASE, V163, P277, DOI 10.1016/j.jconrel.2012.09.007; Park J, 2012, J CONTROL RELEASE, V162, P134, DOI 10.1016/j.jconrel.2012.06.012; Pilatou M, 2008, BLOOD BRAIN BARRIER; Samiotaki G, 2012, MAGN RESON MED, V67, P769, DOI 10.1002/mrm.23063; Schinkel AH, 1999, ADV DRUG DELIVER REV, V36, P179, DOI 10.1016/S0169-409X(98)00085-4; Seegers U, 2002, EPILEPSY RES, V51, P257, DOI 10.1016/S0920-1211(02)00156-0; Seegers U, 2002, EPILEPSIA, V43, P675, DOI 10.1046/j.1528-1157.2002.33101.x; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; Sheikov N, 2008, ULTRASOUND MED BIOL, V34, P1093, DOI 10.1016/j.ultrasmedbio.2007.12.015; Sun T, 2015, PHYS MED BIOL, V60, P9079, DOI 10.1088/0031-9155/60/23/9079; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; TISHLER DM, 1995, EPILEPSIA, V36, P1, DOI 10.1111/j.1528-1157.1995.tb01657.x; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; Wan CPL, 2012, ULTRASOUND MED BIOL, V38, P736, DOI 10.1016/j.ultrasmedbio.2012.01.023; Wu F, 2011, ULTRASOUND MED BIOL, V37, P151, DOI 10.1016/j.ultrasmedbio.2010.10.009; Yu M, 2013, CANCER METAST REV, V32, P211, DOI 10.1007/s10555-012-9402-8; Zhai Bao-Jin, 2003, Ai Zheng, V22, P1284; Zhang ZH, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/408012	52	72	75	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0166061	10.1371/journal.pone.0166061	http://dx.doi.org/10.1371/journal.pone.0166061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045902	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300002
J	EI-Shenawy, AK; ElSaharty, MA; Zakzouk, EE				EI-Shenawy, Ahmed K.; ElSaharty, M. A.; Zakzouk, Ezz Eldin			Neuro-Analogical Gate Tuning of Trajectory Data Fusion for a Mecanum-Wheeled Special Needs Chair	PLOS ONE			English	Article								Trajectory tracking of mobile wheeled chairs using internal shaft encoder and inertia measurement unit(IMU), exhibits several complications and accumulated errors in the tracking process due to wheel slippage, offset drift and integration approximations. These errors can be realized when comparing localization results from such sensors with a camera tracking system. In long trajectory tracking, such errors can accumulate and result in significant deviations which make data from these sensors unreliable for tracking. Meanwhile the utilization of an external camera tracking system is not always a feasible solution depending on the implementation environment. This paper presents a novel sensor fusion method that combines the measurements of internal sensors to accurately predict the location of the wheeled chair in an environment. The method introduces a new analogical OR gate structured with tuned parameters using multi-layer feedforward neural network denoted as "Neuro-Analogical Gate" (NAG). The resulting system minimize any deviation error caused by the sensors, thus accurately tracking the wheeled chair location without the requirement of an external camera tracking system. The fusion methodology has been tested with a prototype Mecanum wheel-based chair, and significant improvement over tracking response, error and performance has been observed.	[EI-Shenawy, Ahmed K.; ElSaharty, M. A.; Zakzouk, Ezz Eldin] Arab Acad Sci Technol & Maritime Transport, Elect & Control Dept, Coll Engn & Technol, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Arab Academy for Science, Technology & Maritime Transport	EI-Shenawy, AK (corresponding author), Arab Acad Sci Technol & Maritime Transport, Elect & Control Dept, Coll Engn & Technol, Alexandria, Egypt.	ahmed.elshenawy@aast.edu		El-Shenawy, Ahmed/0000-0003-1333-3659; Elsaharty, Mohamed Atef Abbas/0000-0001-9425-0032	Arab Academy for Science, Technology and Maritime transport	Arab Academy for Science, Technology and Maritime transport(Arab Academy for Science, Technology & Maritime Transport)	The Arab Academy for Science, Technology and Maritime transport is supporting this project.	Abd El-Kader S., 2014, INT J APPL ENG MANAG, V3, P11; Ahmadi A, 2014, J SUPERCOMPUT, V68, P599, DOI 10.1007/s11227-013-1054-0; Aznar F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112507; Badreddin E., 2007, P IEEE INT C SYST MA, P1584; Badreddin E, 1994, P IEEE C ROB AUT SAN, P8; Boger Z, 1997, IEEE SYS MAN CYBERN, P3030; Diegel O, 2002, P 2002 AUSTR C ROB A, P27; El-Shenawy A, 2006, 6 WORLD C INT CONTR, P8270; El-Shenawy A, 2014, INT REV MECH ENG I R, V8, P872; Featherstone R., 2000, Proceedings 2000 ICRA. Millennium Conference. IEEE International Conference on Robotics and Automation. Symposia Proceedings (Cat. No.00CH37065), P826, DOI 10.1109/ROBOT.2000.844153; Habert O, 1997, ROBOT AUTON SYST, V21, P341, DOI 10.1016/S0921-8890(96)00050-4; Holmberg R, 2000, INT J ROBOT RES, V19, P1066, DOI 10.1177/02783640022067977; Jun Woochun, 2015, [Asia-pacific Journal of Multimedia Services Convergent with Art, Humanities, and Sociology, 예술인문사회 융합 멀티미디어 논문지], V5, P47, DOI 10.14257/AJMAHS.2015.10.46; Karsoliya S., 2012, INT J ENG TRENDS TEC, V3, P714; Koestler A., 2004, INT C AUT ROB AG ICA, P46; Leishman F, 2010, ROBOT AUTON SYST, V58, P1149, DOI 10.1016/j.robot.2010.06.007; Ling Chen, 2012, 2012 UKACC International Conference on Control (CONTROL), P339, DOI 10.1109/CONTROL.2012.6334653; Longhi S., 2005, J ZHEJIANG U SCI A, V6, P110, DOI DOI 10.1631/JZUS.2005.A0110; Morales Y, 2012, SEMIAUTONOMOUS WHEEL; Naranjo PGV, 2017, J SUPERCOMPUT, V73, P733, DOI 10.1007/s11227-016-1785-9; Panchal F, 2014, INT J COMPUTER SCI M, V3, P455, DOI DOI 10.1155/2013/425740; Panchal G, 2011, INT J COMPUT THEORY, V3, P332, DOI DOI 10.7763/IJCTE.2011.V3.328; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; Shiomi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128031; Sun ZY, 2017, WIREL NETW, V23, P1201, DOI 10.1007/s11276-016-1213-3; Tabar A. M., 2006, P 4 ACM INT WORKSHOP, P145, DOI DOI 10.1145/1178782.1178804; Vanhooydonck D, 2010, ROBOT AUTON SYST, V58, P963, DOI 10.1016/j.robot.2010.04.002; Xu P, 2005, CUTTING EDGE ROBOTIC; Yang JC, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16030421	29	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169036	10.1371/journal.pone.0169036	http://dx.doi.org/10.1371/journal.pone.0169036			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045973	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300096
J	Singhania, A; Rupani, H; Jayasekera, N; Lumb, S; Hales, P; Gozzard, N; Davies, DE; Woelk, CH; Howarth, PH				Singhania, Akul; Rupani, Hitasha; Jayasekera, Nivenka; Lumb, Simon; Hales, Paul; Gozzard, Neil; Davies, Donna E.; Woelk, Christopher H.; Howarth, Peter H.			Altered Epithelial Gene Expression in Peripheral Airways of Severe Asthma	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; MAST-CELLS; INFLAMMATION; TISSUE; DYSFUNCTION; DEPOSITION; RESPONSES; SYMPTOMS	Management of severe asthma remains a challenge despite treatment with glucocorticosteroid therapy. The majority of studies investigating disease mechanisms in treatment resistant severe asthma have previously focused on the large central airways, with very few utilizing transcriptomic approaches. The small peripheral airways, which comprise the majority of the airway surface area, remain an unexplored area in severe asthma and were targeted for global epithelial gene expression profiling in this study. Differences between central and peripheral airways were evaluated using transcriptomic analysis (Affymetrix HG U133 plus 2.0 GeneChips) of epithelial brushings obtained from severe asthma patients (N = 17) and healthy volunteers (N = 23). Results were validated in an independent cohort (N = 10) by real-time quantitative PCR. The IL-13 disease signature that is associated with an asthmatic phenotype was upregulated in severe asthmatics compared to healthy controls but was predominantly evident within the peripheral airways, as were genes related to mast cell presence. The gene expression response associated with glucocorticosteroid therapy (i.e. FKBP5) was also upregulated in severe asthmatics compared to healthy controls but, in contrast, was more pronounced in central airways. Moreover, an altered epithelial repair response (e.g. FGFBP1) was evident across both airway sites reflecting a significant aspect of disease in severe asthma unadressed by current therapies. A transcriptomic approach to understand epithelial activation in severe asthma has thus highlighted the need for better-targeted therapy to the peripheral airways in severe asthma, where the IL-13 disease signature persists despite treatment with currently available therapy.	[Singhania, Akul; Rupani, Hitasha; Jayasekera, Nivenka; Davies, Donna E.; Woelk, Christopher H.; Howarth, Peter H.] Univ Southampton, Fac Med, Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Lumb, Simon; Hales, Paul; Gozzard, Neil] UCB Celltech, Slough, Berks, England; [Davies, Donna E.; Howarth, Peter H.] Univ Hosp Southampton NHS Fdn Trust, Southampton Ctr Biomed Res, Southampton NIHR Resp Biomed Res Unit, Southampton, Hants, England	University of Southampton; Celltech Group Ltd; University of Southampton; University Hospital Southampton NHS Foundation Trust	Woelk, CH; Howarth, PH (corresponding author), Univ Southampton, Fac Med, Clin & Expt Sci, Southampton SO9 5NH, Hants, England.; Howarth, PH (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Southampton Ctr Biomed Res, Southampton NIHR Resp Biomed Res Unit, Southampton, Hants, England.	c.h.woelk@soton.ac.uk; p.h.howarth@soton.ac.uk	Singhania, Akul/I-4633-2019	Singhania, Akul/0000-0002-6941-3618; Woelk, Christopher/0000-0002-1977-0502; Howarth, Peter/0000-0003-0619-7927	Medical Research Council UK [G0800649, G0900453]; Faculty of Medicine, University of Southampton; UCB Celtech; University of Southampton; MRC [G0900453, G0800649, G0800753] Funding Source: UKRI; Medical Research Council [G0800649, G0900453, G0800753] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Faculty of Medicine, University of Southampton; UCB Celtech; University of Southampton; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by the Medical Research Council UK grants G0800649 and G0900453. AS was funded by the Faculty of Medicine, University of Southampton. Gene array analysis was funded by UCB Celtech as part of an academic collaboration with The University of Southampton. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section in the online submission form.	Andersson CK, 2011, J ALLERGY CLIN IMMUN, V127, P905, DOI 10.1016/j.jaci.2011.01.022; [Anonymous], MORPHOMETRY HUMAN LU; Balzar S, 2005, AM J RESP CRIT CARE, V171, P431, DOI 10.1164/rccm.200407-949OC; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Beer HD, 2005, ONCOGENE, V24, P5269, DOI 10.1038/sj.onc.1208560; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRADDING P, 1995, AM J RESP CRIT CARE, V151, P1900, DOI 10.1164/ajrccm.151.6.7767538; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cho JH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-117; Djukanovic R, 1997, AM J RESP CRIT CARE, V155, P826, DOI 10.1164/ajrccm.155.3.9117012; Fajt ML, 2013, J ALLERGY CLIN IMMUN, V131, P1504, DOI 10.1016/j.jaci.2013.01.035; Gibson PG, 2000, J ALLERGY CLIN IMMUN, V105, P752, DOI 10.1067/mai.2000.105319; Hamid Q, 1997, J ALLERGY CLIN IMMUN, V100, P44, DOI 10.1016/S0091-6749(97)70193-3; Holgate Stephen T, 2004, Proc Am Thorac Soc, V1, P93, DOI 10.1513/pats.2306034; Howarth P, 1998, INT J CLIN PRACT, P15; LAUBE BL, 1986, AM REV RESPIR DIS, V133, P740; Leach CL, 2006, J AEROSOL MED, V19, P117, DOI 10.1089/jam.2006.19.117; Leek JT, 2013, R PACKAGE VERSION, V3; Li H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-209; Loxham M, 2014, CLIN EXP ALLERGY, V44, P1299, DOI 10.1111/cea.12309; Marone G, 2005, ADV IMMUNOL, V88, P97, DOI 10.1016/S0065-2776(05)88004-6; Massanella M, 2013, ANTIVIR RES, V100, P420, DOI 10.1016/j.antiviral.2013.07.017; Minshall EM, 1998, J ALLERGY CLIN IMMUN, V101, P386, DOI 10.1016/S0091-6749(98)70252-0; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Riley CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145476; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Schmitz N, 2003, EUR J IMMUNOL, V33, P991, DOI 10.1002/eji.200323801; Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P571, DOI 10.1016/j.coi.2013.09.015; Shute JK, 2004, THORAX, V59, P557, DOI 10.1136/thx.2002.002626; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Taha RA, 1999, J ALLERGY CLIN IMMUN, V103, P476, DOI 10.1016/S0091-6749(99)70474-4; Traister RS, 2015, J ALLERGY CLIN IMMUN, V135, P92, DOI 10.1016/j.jaci.2014.06.023; Tulic MK, 2001, RESP RES, V2, P333, DOI 10.1186/rr83; van der Wiel E, 2013, J ALLERGY CLIN IMMUN, V131, P646, DOI 10.1016/j.jaci.2012.12.1567; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wilson SJ, 2016, EUR RESPIR J, V48, P1307, DOI 10.1183/13993003.01129-2016; Woelk CH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-218; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	41	37	39	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168680	10.1371/journal.pone.0168680	http://dx.doi.org/10.1371/journal.pone.0168680			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045928	Green Submitted, gold, Green Published			2022-12-26	WOS:000391612300043
J	Thomason, MJS; Rice, KJ				Thomason, Meghan J. Skaer; Rice, Kevin J.			Spatial Pattern and Scale Influence Invader Demographic Response to Simulated Precipitation Change in an Annual Grassland Community	PLOS ONE			English	Article							EXPERIMENTAL PLANT-COMMUNITIES; BIOLOGICAL INVASIONS; CLIMATE-CHANGE; CALIFORNIA; IMPACTS; POPULATIONS; COMPETITION; PLASTICITY; RAINFALL; DENSITY	It is important to predict which invasive species will benefit from future changes in climate, and thereby identify those invaders that need particular attention and prioritization of management efforts. Because establishment, persistence, and spread determine invasion success, this prediction requires detailed demographic information. Explicit study of the impact of pattern on demographic response is particularly important for species that are naturally patchy, such as the invasive grass, Aegilops triuncialis. In the northern California Coast Range, where climate change may increase or decrease mean annual rainfall, we conducted a field experiment to understand the interaction of climate change and local-scale patterning on the demography of A. triuncialis. We manipulated precipitation (reduced, ambient, or augmented), seed density, and seeding pattern. Demographic and environmental data were collected for three years following initial seeding. Pattern and scale figure prominently in the demographic response of A. triuncialis to precipitation manipulation. Pattern interacts with precipitation and seeding density in its influence on per-plant seed output. Although per-plot seed production was highest when seeds were not aggregated, per-plant seed output was higher in aggregated patches. Results suggest aggregation of invasive A. triuncialis reduces the detrimental impact of interspecific competition in its invaded community, and that interspecific competition per se has a stronger impact than intraspecific competition.	[Thomason, Meghan J. Skaer; Rice, Kevin J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Thomason, Meghan J. Skaer] Univ Calif Davis, USDA ARS, Exot & Invas Weeds Res Unit, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis; United States Department of Agriculture (USDA); University of California System; University of California Davis	Thomason, MJS (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.; Thomason, MJS (corresponding author), Univ Calif Davis, USDA ARS, Exot & Invas Weeds Res Unit, Dept Plant Sci, Davis, CA 95616 USA.	mjskaer@ucdavis.edu		Skaer Thomason, Meghan/0000-0001-9485-9729	Henry A. Jastro Research Fellowship; US Department of Agriculture - Agricultural Research Service	Henry A. Jastro Research Fellowship; US Department of Agriculture - Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported in part by the Henry A. Jastro Research Fellowship to MJST and the US Department of Agriculture - Agricultural Research Service.	[Anonymous], 2011, WEATH PHYS BIOL DAT; Baldwin B.G., 2012, JEPSON MANUAL VASCUL, V2nd ed.; Barnard RL, 2013, ISME J, V7, P2229, DOI 10.1038/ismej.2013.104; Bartolome J.W., 1986, MADRONO, V33, P217; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clauss MJ, 2000, AM NAT, V155, P168, DOI 10.1086/303314; CLIFFORD P, 1973, BIOMETRIKA, V60, P581, DOI 10.2307/2335008; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davy J., 2007, BARB GOATGRASS IMPAC; Davy JS, 2008, U CALIF DIV AGR NAT, V8315, P1; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Dech JP, 2004, INT J BIOMETEOROL, V49, P26, DOI 10.1007/s00484-004-0210-x; Dietz Hansjorg, 2002, Biological Invasions, V4, P211, DOI 10.1023/A:1020971509871; DiTomaso JM, 2000, WEED SCI, V48, P255, DOI 10.1614/0043-1745(2000)048[0255:IWIRSI]2.0.CO;2; DiVittorio CT, 2007, ECOL APPL, V17, P311, DOI 10.1890/06-0610; Espeland EK, 2012, AM J BOT, V99, P2058, DOI 10.3732/ajb.1200372; Gardner RH, 2008, PERSPECT PLANT ECOL, V9, P211, DOI 10.1016/j.ppees.2007.08.003; Gerlach JD, 2004, J ARID ENVIRON, V57, P365, DOI 10.1016/S0140-1963(03)00102-2; Griffin D, 2014, GEOPHYS RES LETT, V41, P9017, DOI 10.1002/2014GL062433; Groffman P.M., 1999, STANDARD SOIL METHOD, P272; Hansen TF, 2003, J EVOLUTION BIOL, V16, P754, DOI 10.1046/j.1420-9101.2003.00556.x; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; Heady H.F., 1977, TERRESTRIAL VEGETATI, P491; HEYWOOD JS, 1986, AM NAT, V127, P851, DOI 10.1086/284529; Konings AG, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001748; Levin Simon A., 1997, V30, P271; Lloret F, 2005, J ECOL, V93, P512, DOI 10.1111/j.1365-2745.2005.00979.x; Mack R. N., 1989, BIOL INVASIONS GLOBA, P155; Meimberg H, 2006, BIOL INVASIONS, V8, P1355, DOI 10.1007/s10530-005-2463-7; Moloney KA, 2008, PERSPECT PLANT ECOL, V9, P119, DOI 10.1016/j.ppees.2007.12.002; Monzeglio U, 2005, OECOLOGIA, V145, P619, DOI 10.1007/s00442-005-0168-3; Monzeglio U, 2008, EVOL ECOL, V22, P723, DOI 10.1007/s10682-007-9197-1; National Cooperative Soil Survey, 2014, NAT COOP SOIL SURV; Pacala Stephen W., 1997, V30, P204; RICE KJ, 1990, ECOLOGY, V71, P1316, DOI 10.2307/1938269; Schiener S. M., 2001, DESIGN ANAL ECOLOGIC, P94; SILVERTOWN J, 1992, J ECOL, V80, P527, DOI 10.2307/2260696; Stoll P, 2001, ECOLOGY, V82, P319, DOI 10.1890/0012-9658(2001)082[0319:IAACII]2.0.CO;2; Stoll P, 2005, J ECOL, V93, P395, DOI 10.1111/j.0022-0477.2005.00989.x; Taylor CM, 2004, J APPL ECOL, V41, P1049, DOI 10.1111/j.0021-8901.2004.00979.x; Thomson DM, 2007, ECOLOGY, V88, P3126, DOI 10.1890/06-1463.1; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vitousek PM, 1996, AM SCI, V84, P468; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; Wilson JB, 2011, J VEG SCI, V22, P184, DOI 10.1111/j.1654-1103.2010.01226.x; Yahdjian L, 2002, OECOLOGIA, V133, P95, DOI 10.1007/s00442-002-1024-3; Zotz G, 2000, PLANT BIOLOGY, V2, P653, DOI 10.1055/s-2000-16639	48	5	5	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169328	10.1371/journal.pone.0169328	http://dx.doi.org/10.1371/journal.pone.0169328			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046090	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300166
J	Young-Xu, Y; van Aalst, R; Russo, E; Lee, JKH; Chit, A				Young-Xu, Yinong; van Aalst, Robertus; Russo, Ellyn; Lee, Jason K. H.; Chit, Ayman			The Annual Burden of Seasonal Influenza in the US Veterans Affairs Population	PLOS ONE			English	Article							COST-EFFECTIVENESS; VA; HOSPITALIZATIONS; VALUES; IMPACT; CARE	Seasonal influenza epidemics have a substantial public health and economic burden in the United States (US). On average, over 200,000 people are hospitalized and an estimated 23,000 people die from respiratory and circulatory complications associated with seasonal influenza virus infections each year. Annual direct medical costs and indirect productivity costs across the US have been found to average respectively at $10.4 billion and $16.3 billion. The objective of this study was to estimate the economic impact of severe influenza induced illness on the US Veterans Affairs population. The five-year study period included 2010 through 2014. Influenza-attributed outcomes were estimated with a statistical regression model using observed emergency department (ED) visits, hospitalizations, and deaths from the Veterans Health Administration of the Department of Veterans Affairs (VA) electronic medical records and respiratory viral surveillance data from the Centers for Disease Control and Prevention (CDC). Data from VA's Managerial Cost Accounting system were used to estimate the costs of the emergency department and hospital visits. Data from the Bureau of Labor Statistics were used to estimate the costs of lost productivity; data on age at death, life expectancy and economic valuations for a statistical life year were used to estimate the costs of a premature death. An estimated 10,674 (95% CI 8,661-12,687) VA ED visits, 2,538 (95% CI 2,112-2,964) VA hospitalizations, 5,522 (95% CI 4,834-6,210) all cause deaths, and 3,793 (95% CI 3,375-4,211) underlying respiratory or circulatory deaths (inside and outside VA) among adult Veterans were attributable to influenza each year from 2010 through 2014. The annual value of lost productivity amounted to $27 (95% CI $24-31) million and the annual costs for ED visits were $6.2 (95% CI $5.1-7.4) million. Ninety-six percent of VA hospitalizations resulted in either death or a discharge to home, with annual costs totaling $36 (95% CI $30-43) million. The remaining 4% of hospitalizations were followed by extended care at rehabilitation and skilled nursing facilities with annual costs totaling $5.5 (95% CI $4.4-6.8) million. The annual monetary value of quality-adjusted life years (QALYs) lost amounted to $1.1 (95% CI $1.0-1.2) billion. In total, the estimated annual economic burden was $1.2 (95% CI $1.0-1.3) billion, indicating the substantial burden of seasonal influenza epidemics on the US Veterans Affairs population. Premature death was found to be the largest driver of these costs, followed by hospitalization.	[Young-Xu, Yinong; van Aalst, Robertus; Russo, Ellyn] Vet Affairs Med Ctr, Clin Epidemiol Program, White River Jct, VT 05009 USA; [Young-Xu, Yinong] Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH USA; [Lee, Jason K. H.; Chit, Ayman] Sanofi Pasteur, Hlth Outcomes & Econ, Swiftwater, PA USA; [Lee, Jason K. H.; Chit, Ayman] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada	US Department of Veterans Affairs; Veterans Health Administration (VHA); Dartmouth College; Sanofi-Aventis; University of Toronto	van Aalst, R (corresponding author), Vet Affairs Med Ctr, Clin Epidemiol Program, White River Jct, VT 05009 USA.	robertus.vanaalst@va.gov	van Aalst, Robertus/F-8207-2016	van Aalst, Robertus/0000-0003-3025-7811; Lee, Jason/0000-0001-8875-607X	Sanofi-Pasteur, Swiftwater, PA, USA	Sanofi-Pasteur, Swiftwater, PA, USA	This research was supported by an unrestricted research grant from Sanofi-Pasteur (http://www.sanofipasteur.us), Swiftwater, PA, USA and received by YYX. AC and JL are employees of Sanofi Pasteur. AC and JL contributed to the study design and writing of the manuscript; AC contributed to the data analysis.	Arias E, 2014, NAT VITAL STAT REP, V63, P1; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Chit A, 2015, VACCINE, V33, P734, DOI 10.1016/j.vaccine.2014.10.079; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; Lakdawalla DN, 2009, HEALTH AFFAIR, V28, pW138, DOI 10.1377/hlthaff.28.1.w138; Marder E, 2013, MMWR-MORBID MORTAL W, V62, P1; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Nugent G, 2003, MED CARE, V41, P2; Nugent GN, 2004, MED CARE RES REV, V61, P495, DOI 10.1177/1077558704269795; Rogers William H, 2004, J Ambul Care Manage, V27, P249; Sales MM, 2005, AM J MANAG CARE, V11, P104; Schanzer DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080481; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; West AN, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1069-8; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	22	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169344	10.1371/journal.pone.0169344	http://dx.doi.org/10.1371/journal.pone.0169344			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046080	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300169
J	Ambe, PC; Orth, V; Godde, D; Zirngibl, H				Ambe, Peter C.; Orth, Valerie; Goedde, Daniel; Zirngibl, Hubert			Improving the Preoperative Diagnostic Accuracy of Acute Appendicitis. Can Fecal Calprotectin Be Helpful?	PLOS ONE			English	Article							SUSPECTED ACUTE APPENDICITIS; LAPAROSCOPIC SURGERY; DISEASE; MARKER; PSEUDOAPPENDICITIS; INFLAMMATION; LACTOFERRIN; PROTEIN	Background Is the patient really suffering from acute appendicitis? Right lower quadrant pain is the most common sign of acute appendicitis. However, many other bowels pathologies might mimic acute appendicitis. Due to fear of the consequences of delayed or missed diagnosis, the indication for emergency appendectomy is liberally made. This has been shown to be associated with high rates of negative appendectomy with risk of potentially serious or lethal complications. Thus there is need for a better preoperative screening of patients with suspected appendicitis. Methods This prospective single center single-blinded pilot study was conducted in the Department of surgery at the HELIOS Universitatsklinikum Wuppertal, Germany. Calprotectin was measured in pre-therapeutic stool samples of patients presenting in the emergency department with pain to the right lower quadrant. Fecal calprotectin (FC) values were analyzed using commercially available ELISA kits. Cut-off values for FC were studied using the receiver-operator characteristic (ROC) curve. The Area under the curve (AUC) was reported for each ROC curve. Results The mean FC value was 51.4 +/- 118.8 mu g/g in patients with AA, 320.9 +/- 416.6 mu g/g in patients with infectious enteritis and 24.8 +/- 27.4 mu g/g in the control group. ROC curve showed a close to 80% specificity and sensitivity of FC for AA at a cut-off value of 51 mu g/g, AUC = 0.7. The sensitivity of FC at this cut-off value is zero for enteritis with a specificity of 35%. Conclusion Fecal calprotectin could be helpful in screening patients with pain to the right lower quadrant for the presence of acute appendicitis or infectious enteritis with the aim of facilitating clinical decision-making and reducing the rate of negative appendectomy.	[Ambe, Peter C.; Orth, Valerie; Zirngibl, Hubert] Witten Herdecke Univ, HELIOS Univ Klinikum Wuppertal, Dept Surg, Heusnerstr, Wuppertal, Germany; [Goedde, Daniel] Witten Herdecke Univ, HELIOS Univ Klinikum Wuppertal, Inst Pathol & Mol Pathol, Heusnerstr, Wuppertal, Germany		Ambe, PC (corresponding author), Witten Herdecke Univ, HELIOS Univ Klinikum Wuppertal, Dept Surg, Heusnerstr, Wuppertal, Germany.	Peter.ambe@uni-wh.de	Ambe, Peter C./H-7050-2019	Ambe, Peter C./0000-0002-6614-3480	Helios Research Grant [064479]; HELIOS Kliniken GmbH	Helios Research Grant; HELIOS Kliniken GmbH	This work was funded by a Helios Research Grant (ID 064479), HELIOS Kliniken GmbH (http://www.helios-kliniken.de/servicenavigation/suche.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadland E, 2002, EUR J GASTROEN HEPAT, V14, P823, DOI 10.1097/00042737-200208000-00002; Abraham BP, 2012, GASTROENTEROL CLIN N, V41, P483, DOI 10.1016/j.gtc.2012.01.007; Ambe PC, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0863-3; Andersson M, 2014, WORLD J SURG, V38, P2777, DOI 10.1007/s00268-014-2708-7; Bhangu A, 2015, LANCET, V386, P1278, DOI 10.1016/S0140-6736(15)00275-5; Bressler B, 2015, CAN J GASTROENTEROL, V29, P369, DOI 10.1155/2015/852723; Burri E, 2014, EXPERT REV GASTROENT, V8, P197, DOI 10.1586/17474124.2014.869476; Cikot M, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0062-9; Costa F, 2003, DIGEST LIVER DIS, V35, P642, DOI 10.1016/S1590-8658(03)00381-5; DALE I, 1983, EUR J BIOCHEM, V134, P1, DOI 10.1111/j.1432-1033.1983.tb07522.x; Damms A, 2008, INT J COLORECTAL DIS, V23, P985, DOI 10.1007/s00384-008-0506-0; FISCHER K, 1988, J CLIN MICROBIOL, V26, P2675, DOI 10.1128/JCM.26.12.2675-2677.1988; Guller U, 2011, BRIT J SURG, V98, P589, DOI 10.1002/bjs.7395; Johnson MW, 2008, EUR J GASTROEN HEPAT, V20, P174, DOI 10.1097/MEG.0b013e3282f1c9a7; Jones K, 2004, AM J SURG, V188, P748, DOI 10.1016/j.amjsurg.2004.08.044; Lasson Anders, 2010, Lakartidningen, V107, P2645; Otten CMT, 2008, CLIN CHEM LAB MED, V46, P1275, DOI 10.1515/CCLM.2008.246; STOCKLEY RA, 1984, SCAND J CLIN LAB INV, V44, P629, DOI 10.3109/00365518409083622; Tauxe RV, 2004, J INFECT DIS, V189, P761, DOI 10.1086/381806; van Rossem CC, 2016, BRIT J SURG, V103, P144, DOI 10.1002/bjs.9964; Wagner JM, 1996, JAMA-J AM MED ASSOC, V276, P1589, DOI 10.1001/jama.276.19.1589; Wiesing U, 2009, HAUTARZT, V60, P409, DOI 10.1007/s00105-009-1715-3; Wu AHB, 2016, ANN TRANSL MED, V4, DOI 10.3978/j.issn.2305-5839.2015.12.41; Yu CW, 2013, BRIT J SURG, V100, P322, DOI 10.1002/bjs.9008; Yu JS, 2016, CHINESE MED J-PEKING, V129, P1625, DOI 10.4103/0366-6999.184469	25	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168769	10.1371/journal.pone.0168769	http://dx.doi.org/10.1371/journal.pone.0168769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033410	gold, Green Published, Green Submitted			2022-12-26	WOS:000391226900045
J	Moss, HE; Samelson, M; Mohan, G; Jiang, QL				Moss, Heather E.; Samelson, Monica; Mohan, Girish; Jiang, Qin Li			High and Low Contrast Visual Acuity Are Not Affected in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MULTIPLE-SCLEROSIS; INVOLVEMENT; ABNORMALITIES; DIAGNOSIS; CRITERIA; VISION; CHARTS	The afferent visual system may be affected by neuro-degeneration in amyotrophic lateral sclerosis (ALS) based on observations of visual function impairment and retinal inclusions on histopathology in ALS patients. To test the hypothesis that visual acuity is impaired in ALS, we compared three measures of visual acuity in ALS patients (n = 25) attending a multidisciplinary ALS clinic and age matched control subjects (n = 25). Bilateral monocular and binocular visual acuities were assessed using high contrast (black letters on white background) and low contrast (2.5%, 1.25% grey letters on white background) visual acuity charts under controlled lighting conditions following refraction. Binocular summation was calculated as the difference between binocular and best monocular acuity scores. There were no associations between binocular or monocular high contrast visual acuity or low contrast visual acuity and amyotrophic lateral sclerosis diagnosis (generalized estimating equation models accounting for age). Binocular summation was similar in both amyotrophic lateral sclerosis and control subjects. There was a small magnitude association between increased duration of ALS symptoms and reduced 1.25% low contrast visual acuity. This study does not confirm prior observations of impaired visual acuity in patients with amyotrophic lateral sclerosis and does not support this particular measure of visual function for use in broad scale assessment of visual pathway involvement in ALS patients.	[Moss, Heather E.; Samelson, Monica; Mohan, Girish] Univ Illinois, Dept Ophthalmol & Visual Sci, Div Neuroophthalmol, Chicago, IL 60607 USA; [Moss, Heather E.; Jiang, Qin Li] Univ Illinois, Dept Neurol & Rehabil, Chicago, IL 60607 USA; [Moss, Heather E.] Stanford Univ, Dept Ophthalmol, Palo Alto, CA 94304 USA; [Samelson, Monica] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [Mohan, Girish] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Stanford University; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital	Moss, HE (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Div Neuroophthalmol, Chicago, IL 60607 USA.; Moss, HE (corresponding author), Univ Illinois, Dept Neurol & Rehabil, Chicago, IL 60607 USA.; Moss, HE (corresponding author), Stanford Univ, Dept Ophthalmol, Palo Alto, CA 94304 USA.	hemoss@stanford.edu		Moss, Heather/0000-0003-4373-447X	US National Institute of Health [K12 EY02147, K23 EY 024345, UL1TR000050]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [K12EY021475, K23EY024345] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the US National Institute of Health (nih.gov) grants numbered K12 EY02147, K23 EY 024345 and UL1TR000050; Research to Prevent Blindness (www.rpbusa.org) unrestricted grant to the UIC Department of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcer LJ, 2000, MULT SCLER J, V6, P163, DOI 10.1191/135245800701566025; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; CHAUDHURI KR, 1995, J NEUROL SCI, V129, P11; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; ESTEBAN A, 1978, J NEUROL NEUROSUR PS, V41, P690, DOI 10.1136/jnnp.41.8.690; Fawzi AA, 2014, AMYOTROPH LAT SCL FR, V15, P569, DOI 10.3109/21678421.2014.951941; Hubers A, 2016, J NEURAL TRANSM, V123, P281, DOI 10.1007/s00702-015-1483-4; JACOBS L, 1981, NEUROLOGY, V31, P1282, DOI 10.1212/WNL.31.10.1282; Lakes A Great, 2003, NEUROLOGY, V61, P1503; LEGGE GE, 1984, VISION RES, V24, P373, DOI 10.1016/0042-6989(84)90063-4; Moss HE, 2012, J NEUROL SCI, V314, P97, DOI 10.1016/j.jns.2011.10.016; Munte TF, 1998, J NEUROL, V245, P206, DOI 10.1007/s004150050206; Munte TF, 1999, AMYOTROPH LATERAL SC, V1, P21; REGAN D, 1983, OPHTHALMOLOGY, V90, P1192; Ringelstein M, 2014, ANN CLIN TRANSL NEUR, V1, P290, DOI 10.1002/acn3.46; Roth NM, 2013, EUR J NEUROL, V20, P1170, DOI 10.1111/ene.12146; Simonett JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29187; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; van der Graaff MM, 2009, NEUROMUSCULAR DISORD, V19, P53, DOI 10.1016/j.nmd.2008.10.002; Volpe NJ, 2015, T AM OPHTHAL SOC, V113, pT121	21	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168714	10.1371/journal.pone.0168714	http://dx.doi.org/10.1371/journal.pone.0168714			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033389	Green Submitted, gold, Green Published			2022-12-26	WOS:000391226900038
J	Zhu, YP; Guan, LN; Mu, YM				Zhu, Yanping; Guan, Lina; Mu, Yuming			Combined Low-Frequency Ultrasound and Urokinase-Containing Microbubbles in Treatment of Femoral Artery Thrombosis in a Rabbit Model	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; TRANSCRANIAL ULTRASOUND; POTENTIATED ULTRASOUND; TARGETED MICROBUBBLES; ENHANCED THROMBOLYSIS; LIPID MICROBUBBLES; 2-MHZ ULTRASOUND; CLOT LYSIS; SONOTHROMBOLYSIS; STROKE	This paper aims to study the thrombolytic effect of low-frequency ultrasound combined with targeted urokinase-containing microbubble contrast agents on treatment of thrombosis in rabbit femoral artery; and to determine the optimal combination of parameters for achieving thrombolysis in this model. A biotinylated-avidin method was used to prepare microbubble contrast agents carrying urokinase and Arg-Gly-Asp-Ser (RGDS) peptides. Following femoral artery thrombosis in New Zealand white rabbits, microbubble contrast agents were injected intravenously, and ultrasonic exposure was applied. A 3 x 2 x 2 factorial table was applied to categorize the experimental animals based on different levels of combination of ultrasonic frequencies (Factor A: 1.6 MHz, 2.2 MHz, 2.8 MHz), doses of urokinase (Factor B: 90,000 IU/Kg, 180,000 IU/Kg) and ultrasound exposure time (Factor C: 30 min, 60 min). A total of 72 experimental animals were randomly divided into 12 groups (n = 6/group). Doppler techniques were used to assess blood flow in the distal end of the thrombotic femoral artery during the 120 minutes thrombolysis experiment. The rate of recanalization following thrombolysis was calculated, and thrombolytic efficacy was evaluated and compared. The thrombolytic recanalization rate for all experimental subjects after thrombolytic therapy was 68.1%. The optimal parameters for thrombolysis were determined to be 1) an ultrasound frequency of 2.2 MHz and 2) a 90,000 IU/kg dose of urokinase. Ultrasound exposure time (30 min vs. 60 min) had no significant effect on the thrombolytic effects. The combination of local low-frequency ultrasound radiation, targeted microbubbles, and thrombolytic urokinase induced thrombolysis of femoral artery thrombosis in a rabbit model. The ultrasonic frequency of 2.2 MHz and urokinase dose of 90,000 IU/kg induced optimal thrombolytic effects, while the application of either 30 min or 60 min of ultrasound exposure had similar effects.	[Zhu, Yanping; Guan, Lina; Mu, Yuming] Xinjiang Med Univ, Dept Echocardiog, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University	Mu, YM (corresponding author), Xinjiang Med Univ, Dept Echocardiog, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China.	yumingmu120@sina.com	Mu, Yuming/AAO-9354-2020		National Natural Science Foundation of China [81301230]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (No.81301230) https://isisn.nsfc.gov.cn/egrantweb/. The funder is Lina Guan, who has done the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Acconcia C, 2014, ULTRASOUND MED BIOL, V40, P2134, DOI 10.1016/j.ultrasmedbio.2014.03.008; Alexandrov AV, 2008, STROKE, V39, P1464, DOI 10.1161/STROKEAHA.107.505727; Alonso A, 2009, THROMB RES, V124, P70, DOI 10.1016/j.thromres.2008.11.019; Behrens S, 2001, ULTRASOUND MED BIOL, V27, P1683, DOI 10.1016/S0301-5629(01)00481-1; Behrens S, 1999, ULTRASOUND MED BIOL, V25, P269, DOI 10.1016/S0301-5629(98)00158-6; Birnbaum Y, 1998, CIRCULATION, V97, P130, DOI 10.1161/01.CIR.97.2.130; Cintas P, 2004, J THROMB HAEMOST, V2, P1163, DOI 10.1111/j.1538-7836.2004.00746.x; Cooperation Group for Major scientific and Technological Issues of The National 9th Five-Year Plan, 2002, CHIN J NEUROL, V25, P210; Culp WC, 2004, STROKE, V35, P2407, DOI 10.1161/01.STR.0000140890.86779.79; Culp WC, 2003, J VASC INTERV RADIOL, V14, P1433, DOI 10.1097/01.RVI.0000096767.47047.FA; Culp WC, 2001, CARDIOVASC INTER RAD, V24, P407, DOI 10.1007/s00270-001-0052-4; Culp WC, 2011, STROKE, V42, P2280, DOI 10.1161/STROKEAHA.110.607150; Datta S, 2008, ULTRASOUND MED BIOL, V34, P1421, DOI 10.1016/j.ultrasmedbio.2008.01.016; de St Victor M, 2014, EXPERT OPIN DRUG DEL, V11, P187, DOI 10.1517/17425247.2014.868434; Graham GD, 2003, STROKE, V34, P2847, DOI 10.1161/01.STR.0000101752.23813.C3; Hua X, 2014, J THROMB THROMBOLYS, V38, P57, DOI 10.1007/s11239-014-1071-8; Laing ST, 2012, THROMB RES, V130, P629, DOI 10.1016/j.thromres.2011.11.010; Leeman JE, 2012, ULTRASOUND MED BIOL, V38, P1589, DOI 10.1016/j.ultrasmedbio.2012.05.020; Lentacker I, 2014, ADV DRUG DELIVER REV, V72, P49, DOI 10.1016/j.addr.2013.11.008; Liu WS, 2012, THROMB RES, V130, P547, DOI 10.1016/j.thromres.2012.06.020; Meairs S, 2015, FRONT NEUROL NEUROSC, V36, P83, DOI 10.1159/000366239; Molina CA, 2006, STROKE, V37, P425, DOI 10.1161/01.STR.0000199064.94588.39; Molina CA, 2009, ANN NEUROL, V66, P28, DOI 10.1002/ana.21723; Mu YM, 2009, ULTRASONICS, V49, P676, DOI 10.1016/j.ultras.2009.05.003; Perren F, 2008, J THROMB THROMBOLYS, V25, P219, DOI 10.1007/s11239-007-0044-6; Porter TR, 2001, J ULTRAS MED, V20, P1313, DOI 10.7863/jum.2001.20.12.1313; Ren ST, 2014, J THROMB THROMBOLYS, V37, P303, DOI 10.1007/s11239-013-0950-8; Ren ST, 2012, J THROMB THROMBOLYS, V33, P74, DOI 10.1007/s11239-011-0644-z; Tsivgoulis G, 2010, STROKE, V41, P280, DOI 10.1161/STROKEAHA.109.563304; Wang B, 2008, THROMB HAEMOSTASIS, V100, P356, DOI 10.1160/TH07-09-0583; Wang Chong-Bao, 2012, Sichuan Da Xue Xue Bao Yi Xue Ban, V43, P864; Xie F, 2005, ULTRASOUND MED BIOL, V31, P979, DOI 10.1016/j.ultrasmedbio.2005.03.008; Yamashita A, 2003, ARTERIOSCL THROM VAS, V23, P1105, DOI 10.1161/01.ATV.0000077206.35631.B2; Zhang Y, 2013, INT J NANOMED, V8, P3745, DOI 10.2147/IJN.S49835	34	9	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168909	10.1371/journal.pone.0168909	http://dx.doi.org/10.1371/journal.pone.0168909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033371	Green Submitted, gold, Green Published			2022-12-26	WOS:000391226900058
J	Christensen, S; Groftehauge, MK; Byriel, K; Huston, WM; Furlong, E; Heras, B; Martin, JL; McMahon, RM				Christensen, Signe; Groftehauge, Morten K.; Byriel, Karl; Huston, Wilhelmina M.; Furlong, Emily; Heras, Begona; Martin, Jennifer L.; McMahon, Roisin M.			Structural and Biochemical Characterization of Chlamydia trachomatis DsbA Reveals a Cysteine-Rich and Weakly Oxidising Oxidoreductase	PLOS ONE			English	Article							PROTEIN DISULFIDE-ISOMERASE; CRYSTAL-STRUCTURE; BOND FORMATION; FUNCTIONAL-CHARACTERIZATION; DESTABILIZING DISULFIDE; REDOX PROPERTIES; CXXC-MOTIF; THIOREDOXIN; IONIZATION; DEPENDENCE	The Gram negative bacteria Chlamydia trachomatis is an obligate intracellular human pathogen that can cause pelvic inflammatory disease, infertility and blinding trachoma. C. trachomatis encodes a homolog of the dithiol oxidoreductase DsbA. Bacterial DsbA proteins introduce disulfide bonds to folding proteins providing structural bracing for secreted virulence factors, consequently these proteins are potential targets for antimicrobial drugs. Despite sharing functional and structural characteristics, the DsbA enzymes studied to date vary widely in their redox character. In this study we show that the truncated soluble form of the predicted membrane anchored protein C. trachomatis DsbA (CtDsbA) has oxidase activity and redox properties broadly similar to other characterized DsbA proteins. However CtDsbA is distinguished from other DsbAs by having six cysteines, including a second disulfide bond, and an unusual dipeptide sequence in its catalytic motif (Cys-Ser-Ala-Cys). We report the 2.7 A crystal structure of CtDsbA revealing a typical DsbA fold,which is most similar to that of DsbA-II type proteins. Consistent with this, the catalytic surface of CtDsbA is negatively charged and lacks the hydrophobic groove found in EcDsbA and DsbAs from other enterobacteriaceae. Biochemical characterization of CtDsbA reveals it to be weakly oxidizing compared to other DsbAs and with only a mildly destabilizing active site disulfide bond. Analysis of the crystal structure suggests that this redox character is consistent with a lack of contributing factors to stabilize the active site nucleophilic thiolate relative to more oxidizing DsbA proteins.	[Christensen, Signe; Groftehauge, Morten K.; Byriel, Karl; Furlong, Emily; Heras, Begona; Martin, Jennifer L.; McMahon, Roisin M.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld, Australia; [Huston, Wilhelmina M.] Univ Technol Sydney, Sch Life Sci, Broadway, NSW, Australia; [Groftehauge, Morten K.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Heras, Begona] La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic, Australia; [Martin, Jennifer L.] Griffith Univ, Eskitis Inst Drug Discovery, Nathan, Qld, Australia	University of Queensland; University of Technology Sydney; Durham University; La Trobe University; Griffith University	Martin, JL; McMahon, RM (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld, Australia.; Martin, JL (corresponding author), Griffith Univ, Eskitis Inst Drug Discovery, Nathan, Qld, Australia.	jlm@griffith.edu.au; r.mcmahon@imb.uq.edu.au	Furlong, Emily J/S-5044-2016; McMahon, Roisin/A-9823-2014; Christensen, Signe/C-7989-2017; Heras, Begona/H-8686-2014; Christensen, Signe/AAF-3443-2019; Christensen, Signe/GQP-7049-2022; Huston, Wilhelmina/S-7269-2019; Byriel, Karl/Y-4155-2019; Huston, Wilhelmina/B-9984-2008	Furlong, Emily J/0000-0002-9086-2979; McMahon, Roisin/0000-0001-5437-0355; Christensen, Signe/0000-0001-9556-1545; Heras, Begona/0000-0003-3469-7988; Christensen, Signe/0000-0001-9556-1545; Byriel, Karl/0000-0003-1615-1551; Huston, Wilhelmina/0000-0002-0879-1287; Groftehauge, Morten/0000-0002-1823-3713	Australian Research Council [FL0992138]; NHMRC [1061241]; Australian Postgraduate Award; Institute for Molecular Bioscience Research Advancement Award	Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Institute for Molecular Bioscience Research Advancement Award	This work was supported by an Australian Research Council (www.arc.gov.au) Australian Laureate Fellowship (FL0992138) to JLM; RMM, MKG, BH and SC were also supported by this award. RMM is also supported by an NHMRC (www.nhmrc.gov.au) Project Grant (1061241) awarded to JLM. SC holds a UQI Tuition Fee Award (www.scholarships.uq.edu.au/). EF is supported by an Australian Postgraduate Award and an Institute for Molecular Bioscience Research Advancement Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Adams LA, 2015, ANGEW CHEM INT EDIT, V54, P2179, DOI 10.1002/anie.201410341; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arts IS, 2013, MBIO, V4, DOI 10.1128/mBio.00912-13; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Cho SH, 2012, MBIO, V3, DOI 10.1128/mBio.00291-11; Crow A, 2009, J BIOL CHEM, V284, P23719, DOI 10.1074/jbc.M109.005785; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; Duprez W, 2015, J MED CHEM, V58, P577, DOI 10.1021/jm500955s; Emsley P, 2004, ACTA CRYSTALLOGRAP D; EVANS JC, 1959, BIOCHIM BIOPHYS ACTA, V33, P574, DOI 10.1016/0006-3002(59)90157-X; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Guddat LW, 1997, PROTEIN SCI, V6, P1893, DOI 10.1002/pro.5560060910; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Ireland PM, 2014, ANTIOXID REDOX SIGN, V20, P606, DOI 10.1089/ars.2013.5375; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Kurth F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080210; Kurz M, 2009, ANTIOXID REDOX SIGN, V11, P1485, DOI [10.1089/ars.2008.2420, 10.1089/ARS.2008.2420]; Lafaye C, 2009, J MOL BIOL, V392, P952, DOI 10.1016/j.jmb.2009.07.056; Lee K, 2004, J AM CHEM SOC, V126, P13616, DOI 10.1021/ja047300r; LIN TY, 1989, BIOCHEMISTRY-US, V28, P5282, DOI 10.1021/bi00438a054; Mac TT, 2008, J BIOL CHEM, V283, P824, DOI 10.1074/jbc.M707863200; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; McMahon RM, 2014, BBA-PROTEINS PROTEOM, V1844, P1391, DOI 10.1016/j.bbapap.2014.01.013; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Premkumar L, 2013, ACTA CRYSTALLOGR D, V69, P1981, DOI 10.1107/S0907444913017800; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ruddock LW, 1996, BIOCHEM J, V315, P1001, DOI 10.1042/bj3151001; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Vivian JP, 2009, J MOL BIOL, V394, P931, DOI 10.1016/j.jmb.2009.09.065; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Walden PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081440; Walden PM, 2012, ACTA CRYSTALLOGR D, V68, P1290, DOI 10.1107/S0907444912026388; WUNDERLICH M, 1993, J BIOL CHEM, V268, P24547; WUNDERLICH M, 1993, J MOL BIOL, V233, P559, DOI 10.1006/jmbi.1993.1535; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	53	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168485	10.1371/journal.pone.0168485	http://dx.doi.org/10.1371/journal.pone.0168485			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030602	gold, Green Published, Green Submitted			2022-12-26	WOS:000391222000050
J	Lorenz, K; Beck, S; Keilani, MM; Wasielica-Poslednik, J; Pfeiffer, N; Grus, FH				Lorenz, Katrin; Beck, Sabine; Keilani, Munir M.; Wasielica-Poslednik, Joanna; Pfeiffer, Norbert; Grus, Franz H.			Longitudinal Analysis of Serum Autoantibody-Reactivities in Patients with Primary Open Angle Glaucoma and Optic Disc Hemorrhage	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; OCULAR HYPERTENSION; OXIDATIVE STRESS; PROGRESSION; COMPLEX; NEUROPROTECTION; PROTEIN; TRIAL; PATHOGENESIS; DEGRADATION	Background The aim of our current investigation was to analyze the autoantibody-reactivities of primary open angle glaucoma patients with optic disc hemorrhage as possibly correlated to disease progression by means of a protein microarray approach. Methods Sera of patients with primary open angle glaucoma and optic disc hemorrhage (n = 16) were collected directly after study inclusion (0 weeks) and after 2 weeks, 4 weeks and 12 weeks. As a control group patients with primary open angle glaucoma (n = 18) were used (0 weeks and 12 weeks). Microarrays were incubated and occurring antibody-antigen-reactions were visualized with fluorescence labeled anti-human-IgG secondary antibodies. To detect changes in autoantibodies spot intensities were digitized and compared. Results With respect to the immunoreactivity at 0 weeks level increment of anti-adaptor protein 1 complex subunit mu-1 antibodies and anti-SPRY domain-containing SOCS box protein 3 antibodies in sera of primary open angle patients with optic disc hemorrhage was detected. Linear trend analysis revealed a positive correlation with r >= 0.8 between antibody-level and time course. Control group show no relevant changes in the same period. Significant changes were found in time point 4 comparison between patient groups in anti-adaptor protein 1 complex subunit mu-1-level (p = 0.01). No significant changes in visual acuity were found. Conclusion With this approach we were able to detect autoimmune reactivities in sera of patients with primary open angle glaucoma and optic disc hemorrhage compared to patients without optic disc hemorrhage. These antibodies could give further insights into the pathogenesis and the autoimmune component of glaucomatous optic neuropathy.	[Lorenz, Katrin; Beck, Sabine; Keilani, Munir M.; Wasielica-Poslednik, Joanna; Pfeiffer, Norbert; Grus, Franz H.] Johannes Gutenberg Univ Mainz, Dept Expt Ophthalmol, Univ Med Ctr, Mainz, Germany; [Beck, Sabine] Johannes Gutenberg Univ Mainz, Dept Biochem & Pharm, Mainz, Germany; [Keilani, Munir M.] Vis 100 Augenarzte, Gemeinschaftspraxis Monchengladbach, Monchengladbach, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Grus, FH (corresponding author), Johannes Gutenberg Univ Mainz, Dept Expt Ophthalmol, Univ Med Ctr, Mainz, Germany.	grus@eye-research.org	Pfeiffer, Norbert/AAO-7586-2020					Aghagolzadeh P, 2016, WORLD J GASTROENTERO, V22, P5678, DOI 10.3748/wjg.v22.i25.5678; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bell K, 2013, PROG RETIN EYE RES, V36, P199, DOI 10.1016/j.preteyeres.2013.02.003; Bengtsson B, 2008, OPHTHALMOLOGY, V115, P2044, DOI 10.1016/j.ophtha.2008.05.031; Boehm N, 2010, ANAL IMMUNOLOGISCHER; Boehm N, 2012, BRAIN BEHAV IMMUN, V26, P96, DOI 10.1016/j.bbi.2011.07.241; Bonifacino JS, 2014, J CELL BIOL, V204, P7, DOI 10.1083/jcb.201310021; Budenz DL, 2006, OPHTHALMOLOGY, V113, P2137, DOI 10.1016/j.ophtha.2006.06.022; Canagarajah BJ, 2013, PROTEIN SCI, V22, P517, DOI 10.1002/pro.2235; Casson RJ, 2012, CLIN EXP OPHTHALMOL, V40, P341, DOI 10.1111/j.1442-9071.2012.02773.x; Cavet ME, 2014, INVEST OPHTH VIS SCI, V55, P5005, DOI 10.1167/iovs.14-14515; Chang EE, 2012, OPHTHALMOLOGY, V119, P979, DOI 10.1016/j.ophtha.2011.11.003; Chrysostomou V, 2013, CURR OPIN PHARMACOL, V13, P12, DOI 10.1016/j.coph.2012.09.008; Chung E, 2015, BRIT J OPHTHALMOL, V99, P21, DOI 10.1136/bjophthalmol-2014-305349; Cretich M, 2014, ANALYST, V139, P528, DOI 10.1039/c3an01619f; De Moraes CG, 2013, ACTA OPHTHALMOL, V91, pe86, DOI 10.1111/j.1755-3768.2012.02577.x; Diekmann H, 2013, CELL TISSUE RES, V353, P327, DOI 10.1007/s00441-013-1596-8; Farias GG, 2012, NEURON, V75, P810, DOI 10.1016/j.neuron.2012.07.007; Gramlich OW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057557; Grus FH, 2004, MOL VIS, V10, P132; Guo L, 2008, PROG BRAIN RES, V173, P437, DOI 10.1016/S0079-6123(08)01130-8; Hecker M, 2012, AUTOIMMUN REV, V11, P180, DOI 10.1016/j.autrev.2011.05.010; Hoyne GF, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/294968; Huang Y, 2007, EXP EYE RES, V85, P684, DOI 10.1016/j.exer.2007.08.003; Hwang YH, 2014, J GLAUCOMA, V23, P547, DOI 10.1097/IJG.0000000000000083; Icking A, 2007, TRAFFIC, V8, P285, DOI 10.1111/j.1600-0854.2006.00526.x; Jeong Daun, 2015, Korean J Ophthalmol, V29, P40, DOI 10.3341/kjo.2015.29.1.40; Jindal V, 2013, MOL NEUROBIOL, V48, P186, DOI 10.1007/s12035-013-8416-8; Joachim SC, 2008, GRAEF ARCH CLIN EXP, V246, P573, DOI 10.1007/s00417-007-0737-8; Joachim SC, 2014, J MOL NEUROSCI, V52, P216, DOI 10.1007/s12031-013-0125-2; Joachim SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040616; Keller KE, 2013, MOL VIS, V19, P1639; Kim JM, 2014, BRIT J OPHTHALMOL, V98, P1555, DOI 10.1136/bjophthalmol-2013-304584; Landers JA, 2002, CLIN EXP OPHTHALMOL, V30, P338, DOI 10.1046/j.1442-9071.2002.00552.x; Laspas P, 2011, INVEST OPHTH VIS SCI, V52, P8835, DOI 10.1167/iovs.10-6889; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Linossi EM, 2012, IUBMB LIFE, V64, P316, DOI 10.1002/iub.1011; Maruyama I, 2000, INVEST OPHTH VIS SCI, V41, P1657; Medeiros FA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1250, DOI 10.1001/archophthalmol.2009.276; Moore D, 2008, CLIN OPHTHALMOL, V2, P849; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nakatsu F, 2014, MEMBRANES, V4, P747, DOI 10.3390/membranes4040747; Nishiya T, 2011, J BIOL CHEM, V286, P9009, DOI 10.1074/jbc.M110.190678; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Park SY, 2014, BIOSCIENCE REPORTS, V34; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; Ren XF, 2013, CELL, V152, P755, DOI 10.1016/j.cell.2012.12.042; Resnikoff S, 2002, B WORLD HEALTH ORGAN, V82, P844; Schulzer M, 1998, AM J OPHTHALMOL, V126, P487; Sharts-Hopko NC, 2009, AM J NURS, V109, P40, DOI 10.1097/01.NAJ.0000345434.37734.ee; Suh MH, 2014, SURV OPHTHALMOL, V59, P19, DOI 10.1016/j.survophthal.2013.03.005; Tamm ER, 2013, CELL TISSUE RES, V353, P201, DOI 10.1007/s00441-013-1672-0; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Tham YC, 2014, OPHTHALMOLOGY; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Wilding C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090737; Yang JJ, 2001, INVEST OPHTH VIS SCI, V42, P1273	63	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0166813	10.1371/journal.pone.0166813	http://dx.doi.org/10.1371/journal.pone.0166813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030545	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000002
J	Maceda-Veiga, A; Green, AJ; Poulin, R; Lagrue, C				Maceda-Veiga, Alberto; Green, Andy J.; Poulin, Robert; Lagrue, Clement			Body Condition Peaks at Intermediate Parasite Loads in the Common Bully Gobiomorphus cotidianus	PLOS ONE			English	Article							BARBUS-HAASI; FISH; INFECTION; GROWTH; WINTER; TEMPERATURE; PERFORMANCE; BIOMARKERS; RESIDUALS; ABUNDANCE	Most ecologists and conservationists perceive parasitic infections as deleterious for the hosts. Their effects, however, depend on many factors including host body condition, parasite load and the life cycle of the parasite. More research into how multiple parasite taxa affect host body condition is required and will help us to better understand host-parasite coevolution. We used body condition indices, based on mass-length relationships, to test the effects that abundances and biomasses of six parasite taxa (five trematodes, Apatemon sp., Tylodelphys sp., Stegodexamene anguillae, Telogaster opisthorchis, Coitocaecum parvum, and the nematode Eustrongylides sp.) with different modes of transmission have on the body condition of their intermediate or final fish host, the common bully Gobiomorphus cotidianus in New Zealand. We used two alternative body condition methods, the Scaled Mass Index (SMI) and Fulton's condition factor. General linear and hierarchical partitioning models consistently showed that fish body condition varied strongly across three lakes and seasons, and that most parasites did not have an effect on the two body condition indices. However, fish body condition showed a highly significant humpbacked relationship with the total abundance of all six parasite taxa, mostly driven by Apatemon sp. and S. anguillae, indicating that the effects of these parasites can range from positive to negative as abundance increases. Such a response was also evident in models including total parasite biomass. Our methodological comparison supports the SMI as the most robust mass-length method to examine the effects of parasitic infections on fish body condition, and suggests that linear, negative relationships between host condition and parasite load should not be assumed.	[Maceda-Veiga, Alberto] CSIC, Dept Integrat Ecol, Estn Biol Donana, Seville, Spain; [Maceda-Veiga, Alberto] Univ Barcelona, Fac Biol, Inst Res Biodivers IRBio, Barcelona, Spain; [Green, Andy J.] CSIC, Dept Wetland Ecol, Estn Biol Donana, Seville, Spain; [Poulin, Robert; Lagrue, Clement] Univ Otago, Dept Zool, Dunedin, New Zealand	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Otago	Maceda-Veiga, A (corresponding author), CSIC, Dept Integrat Ecol, Estn Biol Donana, Seville, Spain.; Maceda-Veiga, A (corresponding author), Univ Barcelona, Fac Biol, Inst Res Biodivers IRBio, Barcelona, Spain.	albertomaceda@gmail.com	Poulin, Robert/C-3117-2008; Poulin, Robert/GQO-8936-2022; Green, Andy J/A-5189-2008; Maceda-Veiga, Alberto/F-1185-2010	Poulin, Robert/0000-0003-1390-1206; Poulin, Robert/0000-0003-1390-1206; Green, Andy J/0000-0002-1268-4951; Lagrue, Clement/0000-0003-3347-6497; Maceda-Veiga, Alberto/0000-0002-1736-4631	Marsden Fund (Royal Society of New Zealand); Severo Ochoa Program for Centres of Excellence in R+D+I [SEV-2012-0262]; Ajuda de la Fundacio Barcelona Zoo i l'Ajuntament de Barcelona'	Marsden Fund (Royal Society of New Zealand)(Royal Society of New ZealandMarsden Fund (NZ)); Severo Ochoa Program for Centres of Excellence in R+D+I; Ajuda de la Fundacio Barcelona Zoo i l'Ajuntament de Barcelona'	The project was funded by a grant from the Marsden Fund (Royal Society of New Zealand) to RP. AMV was funded by the Severo Ochoa Program for Centres of Excellence in R+D+I (Ref: SEV-2012-0262) and the grant Ajuda de la Fundacio Barcelona Zoo i l'Ajuntament de Barcelona'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], IMODEL2 MODEL 2 REGR; Bakke TA, 2007, ADV PARASIT, V64, P161, DOI 10.1016/S0065-308X(06)64003-7; Bearhop S, 2004, P ROY SOC B-BIOL SCI, V271, pS215, DOI 10.1098/rsbl.2003.0129; Bentley KT, 2013, T AM FISH SOC, V142, P747, DOI 10.1080/00028487.2013.769899; BRETT JR, 1969, J FISH RES BOARD CAN, V26, P2363, DOI 10.1139/f69-230; Capela R, 2016, SCI TOTAL ENVIRON, V539, P85, DOI 10.1016/j.scitotenv.2015.08.113; Colin N, 2016, SCI TOTAL ENVIRON, V540, P307, DOI 10.1016/j.scitotenv.2015.06.099; Cornet S, 2010, P ROY SOC B-BIOL SCI, V277, P1929, DOI 10.1098/rspb.2010.0138; Cressler CE, 2014, ECOL LETT, V17, P284, DOI 10.1111/ele.12229; Faltynkova A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-85; Figuerola B, 2012, HYDROBIOLOGIA, V694, P75, DOI 10.1007/s10750-012-1132-y; Fox J., R COMPANION APPL REG, V3; Freckleton RP, 2011, BEHAV ECOL SOCIOBIOL, V65, P91, DOI 10.1007/s00265-010-1045-6; Garcia-Berthou E, 2001, J ANIM ECOL, V70, P708, DOI 10.1046/j.1365-2656.2001.00524.x; Gislason H, 2010, FISH FISH, V11, P149, DOI 10.1111/j.1467-2979.2009.00350.x; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Guillemain M, 2013, J ORNITHOL, V154, P1007, DOI 10.1007/s10336-013-0968-x; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Karvonen A, 2004, PARASITOLOGY, V129, P473, DOI 10.1017/S0031182004006006; Kelly CD, 2014, ECOL EVOL, V4, P4476, DOI 10.1002/ece3.1257; Kelly DW, 2010, J ANIM ECOL, V79, P445, DOI 10.1111/j.1365-2656.2009.01636.x; Koops MA, 2004, FISH FISH, V5, P120, DOI 10.1111/j.1467-2979.2004.00149.x; Labocha MK, 2014, OIKOS, V123, P111, DOI 10.1111/j.1600-0706.2013.00755.x; Lagrue C, 2015, J FISH BIOL, V87, P836, DOI 10.1111/jfb.12749; Lagrue C, 2015, PARASITOL RES, V114, P3637, DOI 10.1007/s00436-015-4590-0; Lagrue C, 2011, J FISH BIOL, V79, P466, DOI 10.1111/j.1095-8649.2011.03041.x; Lambertucci J. R., 1993, Human schistosomiasis., P195; LECREN ED, 1951, J ANIM ECOL, V20, P201, DOI 10.2307/1540; LEMLY AD, 1984, J PARASITOL, V70, P475, DOI 10.2307/3281395; Lom J., 1992, DEV AQUACULTURE FISH; Lyndon AR, 2001, BULL EUR ASSN FISH P, V21, P263; Mac Nally R, 2004, BIODIVERS CONSERV, V13, P659; MacCracken JG, 2012, J HERPETOL, V46, P346, DOI 10.1670/10-292; Maceda-Veiga A, 2013, B EUR ASSOC FISH PAT, V33, P187; Maceda-Veiga A, 2009, J AQUAT ANIM HEALTH, V21, P189, DOI 10.1577/H08-054.1; Maceda-Veiga A, 2015, SCI TOTAL ENVIRON, V514, P322, DOI 10.1016/j.scitotenv.2015.02.004; Maceda-Veiga A, 2014, FRESHWATER BIOL, V59, P1145, DOI 10.1111/fwb.12336; Marcogliese DJ, 2011, TRENDS PARASITOL, V27, P123, DOI 10.1016/j.pt.2010.11.002; Marshall CT, 1998, CAN J FISH AQUAT SCI, V55, P1766, DOI 10.1139/cjfas-55-7-1766; MCDOWALL RM, 1990, NZ FRESHWATER FISHES; Olstad K., NOBANIS INVASIVE ALI; Omar WA, 2015, J TOXICOL-US, V2015, DOI 10.1155/2015/167319; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Poulin R, 1999, ECOGRAPHY, V22, P246, DOI 10.1111/j.1600-0587.1999.tb00499.x; Poulin R, 2013, J EXP BIOL, V216, P18, DOI 10.1242/jeb.073353; R Core Team, 2013, R LANG ENV STAT COMP; Redon S, 2015, PEERJ, V3, DOI 10.7717/peerj.1073; Rowe DK, 1998, NEW ZEAL J MAR FRESH, V32, P21, DOI 10.1080/00288330.1998.9516803; Roznik EA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0694; Sanchez MI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161478; Sanchez MI, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005459; Santoro M, 2013, DIS AQUAT ORGAN, V105, P139, DOI 10.3354/dao02626; Seppanen E, 2009, J FISH BIOL, V74, P553, DOI 10.1111/j.1095-8649.2008.02144.x; Solomon NU, 2015, ANN RES REV BIOL, P5; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1169, DOI 10.1093/icb/icl052; TAYLOR EB, 1991, AQUACULTURE, V98, P185, DOI 10.1016/0044-8486(91)90383-I; Vinyoles D, 2010, J FISH BIOL, V77, P20, DOI 10.1111/j.1095-8649.2010.02653.x; Walsh C, PACKAGE HIER PART; Walsh ML, 2015, J WORLD AQUACULT SOC, V46, P61, DOI 10.1111/jwas.12171; Zamora L, 2009, CONCEPTOS TECNICAS E, P271	61	15	15	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168992	10.1371/journal.pone.0168992	http://dx.doi.org/10.1371/journal.pone.0168992			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030606	Green Published, Green Submitted, gold			2022-12-26	WOS:000391222000096
J	Urman, NM; Mirza, A; Atwood, SX; Whitson, RJ; Sarin, KY; Tang, JY; Oro, AE				Urman, Nicole M.; Mirza, Amar; Atwood, Scott X.; Whitson, Ramon J.; Sarin, Kavita Y.; Tang, Jean Y.; Oro, Anthony E.			Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions	PLOS ONE			English	Article							BASAL-CELL CARCINOMA	The Hedgehog pathway is a potent regulator of cellular growth and plays a central role in the development of many cancers including basal cell carcinoma (BCC). The majority of BCCs arise from mutations in the Patched receptor resulting in constitutive activation of the Hedgehog pathway. Secondary driver mutations promote BCC oncogenesis and occur frequently due to the high mutational burden resulting from sun exposure of the skin. Here, we uncover novel secondary mutations in Suppressor of Fused (SUFU), the major negative regulator of the Hedgehog pathway. SUFU normally binds to a Hedgehog transcriptional activator, GLI1, in order to prevent it from initiating transcription of Hedgehog target genes. We sequenced tumor-normal pairs from patients with early sporadic BCCs. This resulted in the discovery of nine mutations in SUFU, which were functionally investigated to determine whether they help drive BCC formation. Our results show that four of the SUFU mutations inappropriately activate the Hedgehog pathway, suggesting they may act as driver mutations for BCC development. Indeed, all four of the loss of function SUFU variants were found to disrupt its binding to GLI, leading to constitutive pathway activation. Our results from functional characterization of these mutations shed light on SUFU's role in Hedgehog signaling, tumor progression, and highlight a way in which BCCs can arise.	[Urman, Nicole M.; Mirza, Amar; Atwood, Scott X.; Whitson, Ramon J.; Sarin, Kavita Y.; Tang, Jean Y.; Oro, Anthony E.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Urman, Nicole M.; Mirza, Amar; Atwood, Scott X.; Whitson, Ramon J.; Sarin, Kavita Y.; Tang, Jean Y.; Oro, Anthony E.] Stanford Univ, Sch Med, Dept Dermatol, Stanford, CA 94305 USA; [Atwood, Scott X.] Univ Calif Irvine, Dept Dev & Cell Biol, Chao Family Comprehens Canc Ctr, Irvine, CA 92717 USA	Stanford University; Stanford University; University of California System; University of California Irvine	Oro, AE (corresponding author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA.; Oro, AE (corresponding author), Stanford Univ, Sch Med, Dept Dermatol, Stanford, CA 94305 USA.	oro@stanford.edu		Tang, Jean/0000-0002-5510-6502; Atwood, Scott/0000-0001-7407-9792; Oro, Anthony/0000-0002-6261-138X; Sarin, Kavita/0000-0001-5363-3053	Stanford University Undergraduate Advising and Research Major Grant; Stanford Bio-X Undergraduate Summer Research Grant award; V Foundation Translational Award; NIAMS [5AR054780, 2AR046786, 5ARO54780]; NIH [5R00CA176847]; Damon Runyon Clinical Investigator Award; Stanford Cancer Institute Grant; Dermatology Foundation Career Development Award; NATIONAL CANCER INSTITUTE [R00CA176847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054780, R01AR046786] Funding Source: NIH RePORTER	Stanford University Undergraduate Advising and Research Major Grant; Stanford Bio-X Undergraduate Summer Research Grant award; V Foundation Translational Award; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Clinical Investigator Award; Stanford Cancer Institute Grant; Dermatology Foundation Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by the Stanford University Undergraduate Advising and Research Major Grant (Nicole Urman), the Stanford Bio-X Undergraduate Summer Research Grant award (Nicole Urman), the V Foundation Translational Award and the NIAMS 5AR054780, 2AR046786 (Anthony Oro), the NIH Pathway to Independence Award 5R00CA176847 (Scott Atwood), the Damon Runyon Clinical Investigator Award (Jean Tang), the Stanford Cancer Institute Grant, and by the Dermatology Foundation Career Development Award (Kavita Sarin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to thank all the members of the A.E.O. lab and the Stanford Dermatology Department for their guidance. This work was funded by the Stanford University Undergraduate Advising and Research Major Grant (Nicole Urman), the Stanford Bio-X Undergraduate Summer Research Grant award (Nicole Urman), the V Foundation Translational Award and the NIAMS 5ARO54780, 2AR046786 (Anthony Oro), the NIH Pathway to Independence Award 5R00CA176847 (Scott Atwood), the Damon Runyon Clinical Investigator Award (Jean Tang), the Stanford Cancer Institute Grant, and by the Dermatology Foundation Career Development Award (Kavita Sarin).	Aavikko M, 2012, AM J HUM GENET, V91, P520, DOI 10.1016/j.ajhg.2012.07.015; Atwood SX, 2015, J INVEST DERMATOL, V135, P2138, DOI 10.1038/jid.2015.115; Atwood SX, 2015, CANCER CELL, V27, P342, DOI 10.1016/j.ccell.2015.02.002; Bonilla X, 2016, NAT GENET, V48, P398, DOI 10.1038/ng.3525; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Cherry AL, 2013, ACTA CRYSTALLOGR D, V69, P2563, DOI 10.1107/S0907444913028473; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Merchant M, 2004, MOL CELL BIOL, V24, P8627, DOI 10.1128/MCB.24.19.8627-8641.2004; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; So PL, 2006, EXP DERMATOL, V15, P742, DOI 10.1111/j.1600-0625.2006.00465.x; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Zhang Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3608	14	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							0168031	10.1371/journal.pone.0168031	http://dx.doi.org/10.1371/journal.pone.0168031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030567	Green Published, gold			2022-12-26	WOS:000391222000030
J	Zirbel, SA; Tolman, KA; Trease, BP; Howell, LL				Zirbel, Shannon A.; Tolman, Kyler A.; Trease, Brian P.; Howell, Larry L.			Bistable Mechanisms for Space Applications	PLOS ONE			English	Article							BULK METALLIC-GLASS; COMPLIANT MECHANISMS; DESIGN; COMPOSITES; MICROMECHANISMS; OPTIMIZATION; BISTABILITY; FREEDOM	Compliant bistable mechanisms are monolithic devices with two stable equilibrium positions separated by an unstable equilibrium position. They show promise in space applications as nonexplosive release mechanisms in deployment systems, thereby eliminating friction and improving the reliability and precision of those mechanical devices. This paper presents both analytical and numerical models that are used to predict bistable behavior and can be used to create bistable mechanisms in materials not previously feasible for compliant mechanisms. Materials compatible with space applications are evaluated for use as bistable mechanisms and prototypes are fabricated in three different materials. Pin -puller and cutter release mechanisms are proposed as potential space applications.	[Zirbel, Shannon A.] Aerosp Corp, Vehicle Syst Div, El Segundo, CA 90245 USA; [Trease, Brian P.] Univ Toledo, Dept Mech Ind & Mfg Engn, 2801 W Bancroft St, Toledo, OH 43606 USA; [Tolman, Kyler A.; Howell, Larry L.] Brigham Young Univ, Dept Mech Engn, Provo, UT 84602 USA	Aerospace Corporation - USA; University System of Ohio; University of Toledo; Brigham Young University	Howell, LL (corresponding author), Brigham Young Univ, Dept Mech Engn, Provo, UT 84602 USA.	lhowell@byu.edu	Howell, Larry L/A-6828-2008	Howell, Larry L/0000-0001-8132-8822	NASA Office of the Chief Technologist's Space Technology Research Fellowship	NASA Office of the Chief Technologist's Space Technology Research Fellowship	This work was supported by a NASA Office of the Chief Technologist's Space Technology Research Fellowship. A portion of this work was carried out at the NASA Jet Propulsion Laboratory in Pasadena, California.	Betts DN, 2012, AIAA J, V50, P2211, DOI 10.2514/1.J051535; Chen GM, 2015, J MECH DESIGN, V137, DOI 10.1115/1.4029024; Chen GM, 2011, J MECH DESIGN, V133, DOI 10.1115/1.4004543; Chen GM, 2010, J MECH ROBOT, V2, DOI 10.1115/1.4000529; Conley P, 1998, SPACE VEHICLE MECH E; Daynes S, 2010, J AIRCRAFT, V47, P334, DOI 10.2514/1.45389; Demetriou MD, 2011, NAT MATER, V10, P123, DOI [10.1038/nmat2930, 10.1038/NMAT2930]; Demetriou MD, 2010, JOM-US, V62, P83, DOI 10.1007/s11837-010-0038-2; Emam SA, 2015, APPL MECH REV, V67, DOI 10.1115/1.4032037; Follador M, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4898142; Follador M, 2015, MECCANICA, V50, P2741, DOI 10.1007/s11012-015-0212-2; Fowler RM, 2011, MECH SCI, V2, P205, DOI 10.5194/ms-2-205-2011; Fowler RM, 2014, MECH MACH THEORY, V82, P203, DOI 10.1016/j.mechmachtheory.2014.08.008; Hofmann DC, 2008, NATURE, V451, P1085, DOI 10.1038/nature06598; Hofmann DC, 2010, SCIENCE, V329, P1294, DOI 10.1126/science.1193522; Homer ER, 2014, ADV ENG MATER, V16, P850, DOI 10.1002/adem.201300566; Howell LL, 2001, 21 CENTURY KINEMATIC; Huang HW, 2013, J MICROELECTROMECH S, V22, P7, DOI 10.1109/JMEMS.2012.2228165; Jensen BD, 1999, J MECH DESIGN, V121, P416, DOI 10.1115/1.2829477; Kim HA, 2010, AIAA J, V48, P1265, DOI 10.2514/1.J050100; Kim SW, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/3/036004; Launey ME, 2009, P NATL ACAD SCI USA, V106, P4986, DOI 10.1073/pnas.0900740106; Lewis S, 2006, P 38 AER MECH S; Lewis SD, 2009, P 13 EUR SPAC MECH T; Lichter MD, 2001, LECT NOTES CONTR INF, V271, P219; Lusk CP, 2008, J MECH DESIGN, V130, DOI 10.1115/1.2885079; Mallikarachchi H, 2014, J SPACECRAFT ROCKETS, P1; Ohsaki M, 2013, ENG STRUCT, V56, P910, DOI 10.1016/j.engstruct.2013.06.019; Pirrera A, 2012, INT J SOLIDS STRUCT, V49, P685, DOI 10.1016/j.ijsolstr.2011.11.011; Pollard LW, 1987, P 6 INT C APPL LAS E, V563, P109; Purdy WE, 1994, P 28 AER MECH S; Qiu J, 2004, J MICROELECTROMECH S, V13, P137, DOI 10.1109/JMEMS.2004.825308; Robinson A, 1995, P 29 AER MECH S; Safsten C, 2016, J APPL MECH-T ASME, V83, DOI 10.1115/1.4032572; Santer M, 2008, INT J SOLIDS STRUCT, V45, P6190, DOI 10.1016/j.ijsolstr.2008.07.014; Schioler T, 2007, AIAA J, V45, P1740, DOI 10.2514/1.16825; Silverberg JL, 2015, NAT MATER, V14, P389, DOI [10.1038/NMAT4232, 10.1038/nmat4232]; Tibbitts S., 1988, P 22 AER MECH S; Wilcox DL, 2005, J MICROELECTROMECH S, V14, P1223, DOI 10.1109/JMEMS.2005.859089; Wingert A, 2006, IEEE-ASME T MECH, V11, P448, DOI 10.1109/TMECH.2006.878542; Zhang Z, 2016, COMPOS STRUCT, V135, P17, DOI 10.1016/j.compstruct.2015.09.015; Zhou ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097086; Zirbel SA, 2013, J MECH DESIGN, V135, DOI 10.1115/1.4025372	43	47	52	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168218	10.1371/journal.pone.0168218	http://dx.doi.org/10.1371/journal.pone.0168218			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030588	Green Submitted, Green Published, gold			2022-12-26	WOS:000391222000040
J	Dammers, C; Yolcu, D; Kukuk, L; Willbold, D; Pickhardt, M; Mandelkow, E; Horn, AHC; Sticht, H; Malhis, MN; Will, N; Schuster, J; Funke, SA				Dammers, Christina; Yolcu, Deniz; Kukuk, Laura; Willbold, Dieter; Pickhardt, Marcus; Mandelkow, Eckhard; Horn, Anselm H. C.; Sticht, Heinrich; Malhis, Marwa Nidal; Will, Nadja; Schuster, Judith; Funke, Susanne Aileen			Selection and Characterization of Tau Binding D-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; IMAGE PHAGE DISPLAY; IN-VITRO; TRANSGENIC MICE; BETA-STRUCTURE; AGGREGATION INHIBITORS; FIBRIL FORMATION; AMYLOID PEPTIDE; PROTEIN-TAU; SEQUENCE	A variety of neurodegenerative disorders, including Alzheimer disease (AD), are associated with neurofibrillary tangles composed of the tau protein, as well as toxic tau oligomers. Inhibitors of pathological tau aggregation, interrupting tau self-assembly, might be useful for the development of therapeutics. Employing mirror image phage display with a large peptide library (over 109 different peptides), we have identified tau fibril binding peptides consisting of D-enantiomeric amino acids. D-enantiomeric peptides are extremely protease stable and not or less immunogenic than L-peptides, and the suitability of D-peptides for in vivo applications have already been demonstrated. Phage display selections were performed using fibrils of the D-enantiomeric hexapeptide VQIVYK, representing residues 306 to 311 of the tau protein, as a target. VQIVYK has been demonstrated to be important for fibril formation of the full lengths protein and forms fibrils by itself. Here, we report on D-enantiomeric peptides, which bind to VQIVYK, tau isoforms like tau3RD (K19) as well as to full lengths tau fibrils, and modulate the aggregation of the respective tau form. The peptides are able to penetrate cells and might be interesting for therapeutic and diagnostic applications in AD research.	[Dammers, Christina; Yolcu, Deniz; Kukuk, Laura; Willbold, Dieter] Forschungszentrum Julich, ICS 6, Julich, Germany; [Willbold, Dieter] Heinrich Heine Univ, Inst Phys Biol, Dusseldorf, Germany; [Pickhardt, Marcus; Mandelkow, Eckhard] DZNE, Bonn, Germany; [Pickhardt, Marcus; Mandelkow, Eckhard] CAESAR Res Ctr, Bonn, Germany; [Mandelkow, Eckhard] Max Planck Inst Metab Res, Cologne, Germany; [Horn, Anselm H. C.; Sticht, Heinrich] Friedrich Alexander Univ Erlangen Nurnberg, Inst Biochem, Erlangen, Germany; [Malhis, Marwa Nidal; Will, Nadja; Schuster, Judith; Funke, Susanne Aileen] Hsch Angew Wissensch, Bioanalyt, Coburg, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR); University of Erlangen Nuremberg	Funke, SA (corresponding author), Hsch Angew Wissensch, Bioanalyt, Coburg, Germany.	aileen.funke@hs-coburg.de	Willbold, Dieter/A-6280-2013	Willbold, Dieter/0000-0002-0065-7366; Sticht, Heinrich/0000-0001-5644-045X; Horn, Anselm/0000-0003-3539-8103	DZNE; MPG; Welcome Trust; Emerging Fields Initiative from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU); grant of Deutsche Hirnliga e.V.; TechnologieAllianzOberfranken - TAO; TAO; grant of "Landeskonferenz der Frauenbeauftragten an bayrischen HAW"	DZNE(Helmholtz Association); MPG(Max Planck Society); Welcome Trust(Wellcome Trust); Emerging Fields Initiative from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU); grant of Deutsche Hirnliga e.V.; TechnologieAllianzOberfranken - TAO; TAO; grant of "Landeskonferenz der Frauenbeauftragten an bayrischen HAW"	MP and EM were supported in part by DZNE, MPG, and Welcome Trust. AHCH and HS acknowledge support by the Emerging Fields Initiative from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU). SAF was supported by a grant of Deutsche Hirnliga e.V. and by TechnologieAllianzOberfranken - TAO. JS was fully supported by TAO. MNM was supported by a grant of "Landeskonferenz der Frauenbeauftragten an bayrischen HAW", and TAO.	Adessi C, 2002, CURR MED CHEM, V9, P963, DOI 10.2174/0929867024606731; Alzheimer A, 1995, Clin Anat, V8, P429; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Bartnik D, 2010, REJUV RES, V13, P202, DOI 10.1089/rej.2009.0924; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bulic B, 2013, J MED CHEM, V56, P4135, DOI 10.1021/jm3017317; Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0; Chalifour RJ, 2003, J BIOL CHEM, V278, P34874, DOI 10.1074/jbc.M212694200; Danho W, 2009, ADV EXP MED BIOL, V611, P467, DOI 10.1007/978-0-387-73657-0_201; de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Fauchere J.L., 1992, ADV DRUG RES, V23, P127; Frederix PWJM, 2015, NAT CHEM, V7, P30, DOI [10.1038/NCHEM.2122, 10.1038/nchem.2122]; Frenkel-Pinter M, 2016, J ALZHEIMERS DIS, V51, P165, DOI 10.3233/JAD-150927; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Funke SA, 2012, CURR PHARM DESIGN, V18, P755; Funke SA, 2010, ACS CHEM NEUROSCI, V1, P639, DOI 10.1021/cn100057j; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; Godyn J, 2016, PHARMACOL REP, V68, P127, DOI 10.1016/j.pharep.2015.07.006; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gotz J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00072; Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Haas C, 2012, J ALZHEIMERS DIS, V28, P241, DOI 10.3233/JAD-2011-110986; Holmes BB, 2014, J BIOL CHEM, V289, P19855, DOI 10.1074/jbc.R114.549295; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Lien S, 2003, TRENDS BIOTECHNOL, V21, P556, DOI 10.1016/j.tibtech.2003.10.005; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Matsuoka Y, 2008, J PHARMACOL EXP THER, V325, P146, DOI 10.1124/jpet.107.130526; Mohamed T, 2013, ACS CHEM NEUROSCI, V4, P1559, DOI 10.1021/cn400151a; Morimoto BH, 2013, DEMENT GERIATR COGN, V35, P325, DOI 10.1159/000348347; Nisbet RM, 2015, ACTA NEUROPATHOL, V129, P207, DOI 10.1007/s00401-014-1371-2; Pappenheimer JR, 1997, J PHARMACOL EXP THER, V280, P292; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickhardt M, 2005, J BIOL CHEM, V280, P3628, DOI 10.1074/jbc.M410984200; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Rudolph S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147470; Sadowski M, 2004, AM J PATHOL, V165, P937, DOI 10.1016/S0002-9440(10)63355-X; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schumacher TNM, 1996, SCIENCE, V271, P1854, DOI 10.1126/science.271.5257.1854; Shiryaev N, 2009, NEUROBIOL DIS, V34, P381, DOI 10.1016/j.nbd.2009.02.011; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Streets AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054541; van Groen T, 2013, J ALZHEIMERS DIS, V34, P609, DOI 10.3233/JAD-121792; van Groen T, 2008, CHEMMEDCHEM, V3, P1848, DOI 10.1002/cmdc.200800273; van Groen T, 2009, CHEMMEDCHEM, V4, P276, DOI 10.1002/cmdc.200800289; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wadia JS, 2005, ADV DRUG DELIVER REV, V57, P579, DOI 10.1016/j.addr.2004.10.005; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wegmann S, 2013, P NATL ACAD SCI USA, V110, pE313, DOI 10.1073/pnas.1212100110; Wiesehan K, 2003, CHEMBIOCHEM, V4, P748, DOI 10.1002/cbic.200300631; Wilson DM, 1997, AM J PATHOL, V150, P2181; Zheng J, 2011, J AM CHEM SOC, V133, P3144, DOI 10.1021/ja110545h	61	27	28	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167432	10.1371/journal.pone.0167432	http://dx.doi.org/10.1371/journal.pone.0167432			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006031	Green Published, gold			2022-12-26	WOS:000392843200017
J	Trumble, BC; Stieglitz, J; Blackwell, AD; Allayee, H; Beheim, B; Finch, CE; Gurven, M; Kaplan, H				Trumble, Benjamin C.; Stieglitz, Jonathan; Blackwell, Aaron D.; Allayee, Hooman; Beheim, Bret; Finch, Caleb E.; Gurven, Michael; Kaplan, Hillard			Apolipoprotein E4 is associated with improved cognitive function in Amazonian forager-horticulturalists with a high parasite burden	FASEB JOURNAL			English	Article						antagonistic pleiotropy; mismatch; cognitive decline; Tsimane; Alzheimer's disease	CARDIOVASCULAR-DISEASE; ALLELE FREQUENCIES; E GENOTYPES; E GENE; APOE; EVOLUTIONARY; INFECTION; CHILDREN; TSIMANE; RISK	The apolipoprotein E4 (E4) allele is present worldwide, despite its associations with higher risk of cardiovascular morbidity, accelerated cognitive decline during aging, and Alzheimer's disease (AD). The E4 allele is especially prevalent in some tropical regions with a high parasite burden. Equatorial populations also face a potential dual burden of high E4 prevalence combined with parasitic infections that can also reduce cognitive performance. We examined the interactions of E4, parasite burden, and cognitive performance in a traditional, nonindustrialized population of Amazonian forager-horticulturalists (N = 372) to test whether E4 protects against cognitive decline in environments with a heavy pathogen burden. Contrary to observations in industrial populations, older adult E4 carriers with high parasite burdens either maintained or showed slight improvements in cognitive performance, whereas non-E4 carriers with a high parasite burden showed reduced cognitive performance. Being an E4 carrier is the strongest risk factor to date of AD and cognitive decline in industrial populations; it is associated with greater cognitive performance in individuals facing a high parasite and pathogen load, suggesting advantages to the E4 allele under certain environmental conditions. The current mismatch between postindustrial hygienic lifestyles and active parasite-rich environs may be critical for understanding genetic risk for cognitive aging.-Trumble, B. C., Stieglitz, J., Blackwell, A. D., Allayee, H., Beheim, B., Finch, C. E., Gurven, M., Kaplan, H. Apolipoprotein E4 is associated with improved cognitive function in Amazonian forager-horticulturalists with a high parasite burden. FASEB J. 31, 1508-1515 (2017). www.fasebj.org	[Trumble, Benjamin C.] Arizona State Univ, Sch Human Evolut & Social Change, 900 Cady Mall, Tempe, AZ 85287 USA; [Trumble, Benjamin C.] Arizona State Univ, Ctr Evolut & Med, Tempe, AZ USA; [Stieglitz, Jonathan] Inst Adv Study Toulouse, Toulouse, France; [Stieglitz, Jonathan; Kaplan, Hillard] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Blackwell, Aaron D.; Gurven, Michael] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; [Allayee, Hooman] Univ Southern Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA USA; [Allayee, Hooman] Univ Southern Calif, Inst Med Genet, Keck Sch Med, Los Angeles, CA USA; [Finch, Caleb E.] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA USA; [Finch, Caleb E.] Univ Southern Calif, Dornsife Coll, Los Angeles, CA USA; [Beheim, Bret] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of New Mexico; University of California System; University of California Santa Barbara; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Max Planck Society	Trumble, BC (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, 900 Cady Mall, Tempe, AZ 85287 USA.	trumble@asu.edu	Blackwell, Aaron/B-5258-2008; Finch, Caleb/AAA-7250-2022	Blackwell, Aaron/0000-0002-5871-9865; Trumble, Benjamin/0000-0003-3201-0628; Gurven, Michael/0000-0002-5661-527X; Kaplan, Hillard/0000-0002-7398-7358	U.S. National Institutes of Health (NIH)/National Institute on Aging (NIA) [R01AG024119, R56AG024119]; National Science Foundation (NSF) [BCS-0422690]; Agence Nationale de la Recherche (ANR)-Labex IAST; NATIONAL INSTITUTE ON AGING [R01AG024119, RF1AG054442, R56AG024119, P50AG005142] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Institute on Aging (NIA); National Science Foundation (NSF)(National Science Foundation (NSF)); Agence Nationale de la Recherche (ANR)-Labex IAST(French National Research Agency (ANR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank the U.S. National Institutes of Health (NIH)/National Institute on Aging (NIA) for Grants R01AG024119 and R56AG024119, and the National Science Foundation (NSF) for Grant BCS-0422690. J.S. also thanks the Agence Nationale de la Recherche (ANR)-Labex IAST for financial support. The authors declare no conflicts of interest.	Altmann A, 2014, ANN NEUROL, V75, P563, DOI 10.1002/ana.24135; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Azevedo OGR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089562; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Blackwell AD, 2016, ANN HUM BIOL, V43, P382, DOI 10.1080/03014460.2016.1189963; Blackwell AD, 2015, SCIENCE, V350, P970, DOI 10.1126/science.aac7902; Bowles S, 2001, AM ECON REV, V91, P155, DOI 10.1257/aer.91.2.155; Cacciottolo M, 2016, NEUROBIOL AGING, V37, P47, DOI 10.1016/j.neurobiolaging.2015.10.010; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; Eisenberg DTA, 2010, AM J PHYS ANTHROPOL, V143, P100, DOI 10.1002/ajpa.21298; Ewbank DC, 2004, J GERONTOL A-BIOL, V59, P16; Finch CE, 2009, NEUROBIOL AGING, V30, P515, DOI 10.1016/j.neurobiolaging.2008.11.011; Finch CE, 2004, Q REV BIOL, V79, P3, DOI 10.1086/381662; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Gale SD, 2016, BRAIN BEHAV IMMUN, V52, P161, DOI 10.1016/j.bbi.2015.10.014; Gale SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116874; Ghasemian R. F., 2005, IRAN J PUBLIC HEALTH, V34, P62; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gurven M, 2007, AM J HUM BIOL, V19, P376, DOI 10.1002/ajhb.20600; Gurven M, 2006, J HUM EVOL, V51, P454, DOI 10.1016/j.jhevol.2006.05.003; Gurven M, 2017, DEV PSYCHOL, V53, P160, DOI 10.1037/dev0000175; Gurven M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006590; Hagberg JM, 2000, PHYSIOL GENOMICS, V4, P101, DOI 10.1152/physiolgenomics.2000.4.2.101; Hall A, 2008, MATERN CHILD NUTR, V4, P118, DOI 10.1111/j.1740-8709.2007.00127.x; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; Hooper PL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2808; Kaplan HS, 2009, PHILOS T R SOC B, V364, P3289, DOI 10.1098/rstb.2009.0115; Katan M, 2013, NEUROLOGY, V80, P1209, DOI 10.1212/WNL.0b013e3182896e79; Kulminski AM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004141; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Kuzawa CW, 2014, P NATL ACAD SCI USA, V111, P13010, DOI 10.1073/pnas.1323099111; Maheshwari P, 2015, J ALZHEIMERS DIS, V43, P957, DOI 10.3233/JAD-140621; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mitter SS, 2012, CLINICS, V67, P11, DOI 10.6061/clinics/2012(01)03; Mueller T, 2016, LIVER INT, V36, P1267, DOI 10.1111/liv.13094; Nair MG, 2016, IMMUNOLOGY, V148, P115, DOI 10.1111/imm.12601; Nichol K, 2009, ALZHEIMERS DEMENT, V5, P287, DOI 10.1016/j.jalz.2009.02.006; O'Connell EM, 2015, IMMUNOL ALLERGY CLIN, V35, P493, DOI 10.1016/j.iac.2015.05.003; Oria RB, 2010, BRAZ J MED BIOL RES, V43, P249, DOI 10.1590/S0100-879X2010007500003; Oria RB, 2005, PEDIATR RES, V57, P310, DOI 10.1203/01.PDR.0000148719.82468.CA; Oria RB, 2007, MED HYPOTHESES, V68, P1099, DOI 10.1016/j.mehy.2006.09.036; Panizzon MS, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.025; Prieto Ricardo, 2013, Curr Gastroenterol Rep, V15, P324, DOI 10.1007/s11894-013-0324-6; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Rocha MOC, 1996, TROP MED INT HEALTH, V1, P213; Singh PP, 2006, ANN HUM BIOL, V33, P279, DOI 10.1080/03014460600594513; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; Soerensen M, 2013, AGE, V35, P487, DOI 10.1007/s11357-011-9373-7; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; Trumble BC, 2015, AM J HUM BIOL, V27, P582, DOI 10.1002/ajhb.22665; van Exel E, 2009, ARCH GEN PSYCHIAT, V66, P1263, DOI 10.1001/archgenpsychiatry.2009.146; Vasunilashorn S, 2011, BIODEMOGR SOC BIOL, V57, P33, DOI 10.1080/19485565.2011.564475; Weiner Michael W, 2015, Alzheimers Dement, V11, pe1, DOI 10.1016/j.jalz.2014.11.001; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williamson LL, 2016, BRAIN BEHAV IMMUN, V51, P14, DOI 10.1016/j.bbi.2015.07.006; Wright RO, 2003, PEDIATR RES, V54, P819, DOI 10.1203/01.PDR.0000090927.53818.DE; Yaffe K, 2000, NEUROLOGY, V54, P1949, DOI 10.1212/WNL.54.10.1949	60	56	56	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1508	1515		10.1096/fj.201601084R	http://dx.doi.org/10.1096/fj.201601084R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28031319	Green Published			2022-12-26	WOS:000398504300019
J	Levdikov, VM; Blagova, E; Young, VL; Belitsky, BR; Lebedev, A; Sonenshein, AL; Wilkinson, AJ				Levdikov, Vladimir M.; Blagova, Elena; Young, Vicki L.; Belitsky, Boris R.; Lebedev, Andrey; Sonenshein, Abraham L.; Wilkinson, Anthony J.			Structure of the Branched-chain Amino Acid and GTP-sensing Global Regulator, CodY, from Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRULENCE GENE-EXPRESSION; GRAM-POSITIVE BACTERIA; STATIONARY-PHASE; BINDING-SITES; MACROMOLECULAR STRUCTURES; STAPHYLOCOCCUS-AUREUS; DEPENDENT REGULATION; LACTOCOCCUS-LACTIS; TRANSCRIPTION; IDENTIFICATION	CodY is a branched-chain amino acid (BCAA) and GTP sensor and a global regulator of transcription in low G + C Grampositive bacteria. It controls the expression of over 100 genes and operons, principally by repressing during growth genes whose products are required for adaptations to nutrient limitation. However, the mechanism by which BCAA binding regulates transcriptional changes is not clear. It is known that CodY consists of a GAF (c (G) under bar MP-stimulated phosphodiesterases, (a) under bar denylate cyclases, (F) under bar hlA) domain that binds BCAAs and a winged helix-turn-helix (wHTH) domain that binds to DNA, but the way in which these domains interact and the structural basis of the BCAA dependence of this interaction are unknown. To gain new insights, we determined the crystal structure of unliganded CodY from Bacillus subtilis revealing a 10-turn alpha-helix linking otherwise discrete GAF and wHTH domains. The structure of CodY in complex with isoleucine revealed a reorganized GAF domain. In both complexes CodY was tetrameric. Size exclusion chromatography with multiangle laser light scattering (SEC-MALLS) experiments showed that CodY is a dimer at concentrations found in bacterial cells. Comparison of structures of dimers of unliganded CodY and CodYIle derived from the tetramers showed a splaying of the wHTH domains when Ile was bound; splaying is likely to account for the increased affinity of Ile-bound CodY for DNA. Electrophoretic mobility shift and SEC-MALLS analyses of CodY binding to 19-36-bp operator fragments are consistent with isoleucine dependent binding of two CodY dimers per duplex. The implications of these observations for effector control of CodY activity are discussed.	[Levdikov, Vladimir M.; Blagova, Elena; Young, Vicki L.; Wilkinson, Anthony J.] Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Belitsky, Boris R.; Sonenshein, Abraham L.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Lebedev, Andrey] STFC Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England	University of York - UK; Tufts University; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Wilkinson, AJ (corresponding author), Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England.	tony.wilkinson@york.ac.uk	Levdikov, Vladimir/AAA-6139-2022	Levdikov, Vladimir/0000-0003-3041-1049; Wilkinson, Anthony/0000-0003-4577-9479; Young, Vicki/0000-0002-9816-7858	National Institutes of Health [GM042219]; Biotechnology and Biological Sciences Research Council [BBS/B1213X]; Wellcome Trust [082829/Z/07/Z]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042219] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/B/1213X] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Institutes of Health Grant GM042219 from NIGMS, Biotechnology and Biological Sciences Research Council Grant BBS/B1213X, and Wellcome Trust Grant 082829/Z/07/Z. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; ATKINSON MR, 1990, J BACTERIOL, V172, P4758, DOI 10.1128/jb.172.9.4758-4765.1990; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Belitsky BR, 2008, J BACTERIOL, V190, P1224, DOI 10.1128/JB.01780-07; Belitsky BR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005600; Belitsky BR, 2015, J BACTERIOL, V197, P1330, DOI 10.1128/JB.02563-14; Belitsky BR, 2013, P NATL ACAD SCI USA, V110, P7026, DOI 10.1073/pnas.1300428110; Belitsky BR, 2011, J MOL BIOL, V413, P321, DOI 10.1016/j.jmb.2011.08.003; Belitsky BR, 2011, J MOL BIOL, V411, P729, DOI 10.1016/j.jmb.2011.06.012; Belitsky BR, 2011, J BACTERIOL, V193, P473, DOI 10.1128/JB.01151-10; Belitsky BR, 1998, J BACTERIOL, V180, P6298; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; Blagova EV, 2003, ACTA CRYSTALLOGR D, V59, P155, DOI 10.1107/S0907444902018358; Brinsmade SR, 2014, P NATL ACAD SCI USA, V111, P8227, DOI 10.1073/pnas.1321308111; den Hengst CD, 2005, J BIOL CHEM, V280, P34332, DOI 10.1074/jbc.M502349200; Dineen SS, 2010, J BACTERIOL, V192, P5350, DOI 10.1128/JB.00341-10; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fogg MJ, 2008, BIOCHEM SOC T, V36, P771, DOI 10.1042/BST0360771; FOUET A, 1990, J BACTERIOL, V172, P835, DOI 10.1128/jb.172.2.835-844.1990; Guedon E, 2005, MICROBIOL-SGM, V151, P3895, DOI 10.1099/mic.0.28186-0; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Han AR, 2016, NUCLEIC ACIDS RES, V44, P9483, DOI 10.1093/nar/gkw775; Hendriksen WT, 2008, J BACTERIOL, V190, P590, DOI 10.1128/JB.00917-07; Ji QJ, 2013, P NATL ACAD SCI USA, V110, P5010, DOI 10.1073/pnas.1219446110; Lebedev AA, 2014, ACTA CRYSTALLOGR D, V70, P2430, DOI 10.1107/S1399004714014795; Levdikov VM, 2012, J MOL BIOL, V415, P343, DOI 10.1016/j.jmb.2011.11.017; Levdikov VM, 2009, J MOL BIOL, V390, P1007, DOI 10.1016/j.jmb.2009.05.077; Levdikov VM, 2006, J BIOL CHEM, V281, P11366, DOI 10.1074/jbc.M513015200; Lewis RJ, 2000, J MOL BIOL, V297, P757, DOI 10.1006/jmbi.2000.3598; Lobel L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002887; Maass S, 2014, MOL CELL PROTEOMICS, V13, P2260, DOI 10.1074/mcp.M113.035741; Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07; Malke H, 2006, INT J MED MICROBIOL, V296, P259, DOI 10.1016/j.ijmm.2005.11.008; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Miller J. H., 1972, EXPT MOL GENETICS, P433; Molle V, 2003, J BACTERIOL, V185, P1911, DOI 10.1128/JB.185.6.1911-1922.2003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICOLAI T, 1987, J CHROMATOGR, V389, P286, DOI 10.1016/S0021-9673(01)94436-X; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Preis H, 2009, J BACTERIOL, V191, P5446, DOI 10.1128/JB.00602-09; Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568; Ratnayake-Lecamwasam M, 2001, GENE DEV, V15, P1093, DOI 10.1101/gad.874201; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos JA, 2014, P NATL ACAD SCI USA, V111, pE2251, DOI 10.1073/pnas.1322728111; Shivers RP, 2006, MOL MICROBIOL, V62, P811, DOI 10.1111/j.1365-2958.2006.05410.x; Shivers RP, 2004, MOL MICROBIOL, V53, P599, DOI 10.1111/j.1365-2958.2004.04135.x; SLACK FJ, 1995, MOL MICROBIOL, V15, P689, DOI 10.1111/j.1365-2958.1995.tb02378.x; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; TRAVERS AA, 1987, PHILOS T ROY SOC B, V317, P537, DOI 10.1098/rstb.1987.0080; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; van Schaik W, 2009, INFECT IMMUN, V77, P4437, DOI 10.1128/IAI.00716-09; Villapakkam AC, 2009, J BACTERIOL, V191, P6865, DOI 10.1128/JB.00818-09; Wen J, 2000, ANAL BIOCHEM, V280, P327, DOI 10.1006/abio.2000.4524; Wilkinson AJ, 1996, CHEM BIOL, V3, P519, DOI 10.1016/S1074-5521(96)90141-6; Wray LV, 2011, J BACTERIOL, V193, P4841, DOI 10.1128/JB.05258-11; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zeigler DR, 2008, J BACTERIOL, V190, P6983, DOI 10.1128/JB.00722-08	61	21	21	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2714	2728		10.1074/jbc.M116.754309	http://dx.doi.org/10.1074/jbc.M116.754309			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28011634	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000395535100014
J	Liu, MY; Pile, LA				Liu, Mengying; Pile, Lori A.			The Transcriptional Corepressor SIN3 Directly Regulates Genes Involved in Methionine Catabolism and Affects Histone Methylation, Linking Epigenetics and Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; gene transcription; histone acetylation; histone methylation; methionine; S-adenosylmethionine (SAM); SIN3	DROSOPHILA-MELANOGASTER; DEACETYLASE COMPLEX; S-ADENOSYLMETHIONINE; EXPRESSION; CELLS; DIFFERENTIATION; LOCALIZATION; RESISTANCE; VIABILITY; PROTEINS	Chromatin modification and cellular metabolism are tightly connected. Chromatin modifiers regulate the expression of genes involved in metabolism and, in turn, the levels of metabolites. The generated metabolites are utilized by chromatin modifiers to affect epigenetic modification. The mechanism for this cross-talk, however, remains incompletely understood. The corepressor SIN3 controls histone acetylation through association with the histone deacetylase RPD3. The SIN3 complex is known to regulate genes involved in a number of metabolic processes. Here, we find that Drosophila SIN3 binds to the promoter region of genes involved in methionine catabolism and that this binding affects histone modification, which in turn influences gene expression. Specifically, we observe that reduced expression of SIN3 leads to an increase in S-adenosylmethionine (SAM), which is the major cellular donor of methyl groups for protein modification. Additionally, Sin3A knockdown results in an increase in global histone H3K4me3 levels. Furthermore, decreased H3K4me3 caused by knockdown of either SAM synthetase (Sam-S) or the histone methyltransferase Set1 is restored to near normal levels when SIN3 is also reduced. Taken together, these results indicate that knockdown of Sin3A directly alters the expression of methionine metabolic genes to increase SAM, which in turn leads to an increase in global H3K4me3. Our study reveals that SIN3 is an important epigenetic regulator directly connecting methionine metabolism and histone modification.	[Liu, Mengying; Pile, Lori A.] Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall,Biological Sci Bldg, Detroit, MI 48202 USA	Wayne State University	Pile, LA (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall,Biological Sci Bldg, Detroit, MI 48202 USA.	loripile@wayne.edu			Wayne State University; NIGMS, National Institutes of Health [R01GM088886-01A2]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088886] Funding Source: NIH RePORTER	Wayne State University; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Grants Plus Award from Wayne State University and NIGMS, National Institutes of Health Grant R01GM088886-01A2 (to L.A.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ardehali MB, 2011, EMBO J, V30, P2817, DOI 10.1038/emboj.2011.194; Barnes VL, 2014, AGING-US, V6, P645, DOI 10.18632/aging.100684; Barnes VL, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-26; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Black JC, 2011, EPIGENETICS-US, V6, P13, DOI 10.4161/epi.6.1.13331; Caggese C, 1997, MOL GEN GENET, V253, P492, DOI 10.1007/s004380050348; Cheng P. G., 2011, J HUAZHONG AGR U SOC, V3, P6, DOI DOI 10.1371/J0URNAL.P0NE.0022018; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; Gajan A, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0053-9; Gan QA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r42; Gonneaud A, 2015, FEBS LETT, V589, P2776, DOI 10.1016/j.febslet.2015.08.009; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Hallson G, 2012, GENETICS, V190, P91, DOI 10.1534/genetics.111.135863; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; LARSSON J, 1994, FEBS LETT, V342, P329, DOI 10.1016/0014-5793(94)80526-1; Li SS, 2015, MOL CELL, V60, P408, DOI 10.1016/j.molcel.2015.09.024; Liu MY, 2016, G3-GENES GENOM GENET, V6, P121, DOI 10.1534/g3.115.024273; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Mentch SJ, 2015, CELL METAB, V22, P861, DOI 10.1016/j.cmet.2015.08.024; Mohan M, 2011, MOL CELL BIOL, V31, P4310, DOI 10.1128/MCB.06092-11; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Neufeld TP, 1998, GENETICS, V148, P277; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Pennetta G, 1998, DEV GENES EVOL, V208, P531, DOI 10.1007/s004270050212; Pile LA, 2000, EMBO J, V19, P6131, DOI 10.1093/emboj/19.22.6131; Pile LA, 2003, J BIOL CHEM, V278, P37840, DOI 10.1074/jbc.M305996200; Pile LA, 2002, MOL CELL BIOL, V22, P4965, DOI 10.1128/MCB.22.14.4965-4976.2002; Sadhu MJ, 2013, GENETICS, V195, P831, DOI 10.1534/genetics.113.153981; Saha N, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2428-5; Sassone-Corsi P, 2013, SCIENCE, V339, P148, DOI 10.1126/science.1233423; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Shiraki N, 2014, CELL METAB, V19, P780, DOI 10.1016/j.cmet.2014.03.017; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Spain MM, 2010, J BIOL CHEM, V285, P27457, DOI 10.1074/jbc.M110.130245; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Swaminathan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049563; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	42	15	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1970	1976		10.1074/jbc.M116.749754	http://dx.doi.org/10.1074/jbc.M116.749754			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28028175	hybrid, Green Published			2022-12-26	WOS:000395515600034
J	Dunislawska, A; Slawinska, A; Stadnicka, K; Bednarczyk, M; Gulewicz, P; Jozefiak, D; Siwek, M				Dunislawska, Aleksandra; Slawinska, Anna; Stadnicka, Katarzyna; Bednarczyk, Marek; Gulewicz, Piotr; Jozefiak, Damian; Siwek, Maria			Synbiotics for Broiler Chickens-In Vitro Design and Evaluation of the Influence on Host and Selected Microbiota Populations following In Ovo Delivery	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; GROWTH-PERFORMANCE; GENE-EXPRESSION; LACTOBACILLUS-ACIDOPHILUS; DIETARY MODULATION; ALPHA-GALACTOSIDES; SITU HYBRIDIZATION; SMALL-INTESTINE; GUT MICROFLORA; IMMUNE-SYSTEM	Synbiotics are synergistic combinations of prebiotics and probiotics. In chickens, synbiotics can be delivered in ovo to expedite colonization of the gut by beneficial bacteria. We therefore aimed to design synbiotics in vitro and validate them in broiler chickens upon in ovo delivery. The probiotic components of the synbiotics were Lactobacillus salivarius and Lactobacillus plantarum. Their growth was assessed in MRS medium supplemented with different prebiotics. Based on in vitro results (hatchability and growth curve), two synbiotics were designed: S1-Lactobacillus salivarius with galactooligosaccarides (GOS) and S2-Lactobacillus plantarum with raffinose family oligosaccharides (RFO). These synbiotics were delivered to Cobb broiler chicken embryos on day 12 of incubation at optimized doses (10(5) cfu egg(-1) of probiotic, 2 mg egg(-1) of prebiotic). Post hatching, 2,400 roosters were reared (600 individuals group-1 divided into eight replicate pens). Microbial communities were analyzed in ileal and cecal digesta on day 21 using FISH. Gene expression analysis (IL1 beta, IL4, IL6, IL8, IL12, IL18, IFN beta, and IFN gamma) was performed on days 7, 14, 21, and 42 for the spleen and cecal tonsils with RT-qPCR. Body weight and feed intake of the roosters did not differ by the treatments. Microbial populations of Lactobacillus spp. and Enterococcus spp. in the ileum were higher in S1 and S2 than in the control. In the cecum, the control had the highest bacterial counts. S1 caused significant up-regulation of IL6, IL18, IL1 beta, IFN., and IFN beta in the spleen on day 21 and IL1 beta on day 7 (P < 0.05). In cecal tonsils, S1 caused significant down-regulation of IL12, IL8, and IL1 beta on day 42 and IFN beta on day 14 (P < 0.05). S2 did not elicit such patterns in any tissues investigated. Thus, we demonstrate that divergent effects of synbiotics in broiler chickens were reflected in in vitro tests.	[Dunislawska, Aleksandra; Slawinska, Anna; Stadnicka, Katarzyna; Bednarczyk, Marek; Siwek, Maria] UTP Univ Sci & Technol, Dept Anim Biochem & Biotechnol, Bydgoszcz, Poland; [Gulewicz, Piotr] Poznan Sci & Technol Pk AMU Fdn, Poznan, Poland; [Jozefiak, Damian] Poznan Univ Life Sci, Dept Anim Nutr & Feed Management, Poznan, Poland	Bydgoszcz University of Science & Technology; Poznan University of Life Sciences	Siwek, M (corresponding author), UTP Univ Sci & Technol, Dept Anim Biochem & Biotechnol, Bydgoszcz, Poland.	siwek@utp.edu.pl	Siwek, Maria/AAG-8929-2019; Slawinska, Anna/B-3781-2016; Dunisławska, Aleksandra/AAN-5182-2020	Siwek, Maria/0000-0003-4148-5174; Slawinska, Anna/0000-0002-5706-6145; Gulewicz, Piotr/0000-0001-8479-2153; Dunislawska, Aleksandra/0000-0001-6608-0013; Jozefiak, Damian/0000-0002-6606-7975	European Union's Seventh Framework Programme for research, technological development and demonstration [311794]	European Union's Seventh Framework Programme for research, technological development and demonstration	This project (ECO-FCE) has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement No. 311794.	Alloui MN, 2013, ANN ANIM SCI, V13, P17, DOI 10.2478/v10220-012-0055-x; Aminov RI, 2006, APPL ENVIRON MICROB, V72, P6371, DOI 10.1128/AEM.00701-06; Andreesen J.R., 1992, PROKARYOTES, P1914; Awad WA, 2009, POULTRY SCI, V88, P49, DOI 10.3382/ps.2008-00244; Ayed L, 2002, BIOTECHNOL LETT, V24, P1762; Bar-Shira E, 2003, DEV COMP IMMUNOL, V27, P147, DOI 10.1016/S0145-305X(02)00076-9; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Bednarczyk M, 2016, ANIMAL, V10, P1271, DOI 10.1017/S1751731116000173; Bednarczyk M, 2011, B VET I PULAWY, V55, P465; Bodera P, 2008, RECENT PATENTS INFLA, V2, P149, DOI 10.2174/187221308784543656; Bogucka J, 2016, FOLIA BIOL-KRAKOW, V64, P131, DOI 10.3409/fb64_3.131; Brisbin JT, 2010, CLIN VACCINE IMMUNOL, V17, P1337, DOI 10.1128/CVI.00143-10; Brisbin Jennifer T., 2008, Animal Health Research Reviews, V9, P101, DOI 10.1017/S146625230800145X; Chiang HI, 2009, GENET MOL BIOL, V32, P507, DOI 10.1590/S1415-47572009000300013; Chlebowska-Smigiel A, 2013, ZASTOSOWANIA PULLULA, V3, P111; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Cummings JH, 2001, AM J CLIN NUTR, V73, p415S, DOI 10.1093/ajcn/73.2.415s; De Boever S, 2008, VET IMMUNOL IMMUNOP, V122, P312, DOI 10.1016/j.vetimm.2007.12.002; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; de Vrese M, 2008, ADV BIOCHEM ENG BIOT, V111, P1, DOI 10.1007/10_2008_097; Engberg RM, 2000, POULTRY SCI, V79, P1311, DOI 10.1093/ps/79.9.1311; Engberg RM, 2004, POULTRY SCI, V83, P925, DOI 10.1093/ps/83.6.925; Falagas ME, 2000, INT J ANTIMICROB AG, V15, P1, DOI 10.1016/S0924-8579(99)00164-8; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; FULLER R, 1989, J APPL BACTERIOL, V66, P365; FURUSE M, 1985, BRIT POULTRY SCI, V26, P97, DOI 10.1080/00071668508416791; Galdeano CM, 2007, CLIN VACCINE IMMUNOL, V14, P485, DOI 10.1128/CVI.00406-06; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; GILLILAND SE, 1975, APPL MICROBIOL, V30, P541, DOI 10.1128/AEM.30.4.541-545.1975; Goderska K, 2008, ACTA SCI POLON-TECHN, V7, P5; Guban J, 2006, POULTRY SCI, V85, P2186, DOI 10.1093/ps/85.12.2186; Gulewicz P, 2002, J AGR FOOD CHEM, V50, P384, DOI 10.1021/jf010973y; Gulewicz P, 2000, J AGR FOOD CHEM, V48, P3120, DOI 10.1021/jf000210v; Hajati H., 2010, INT J POULT SCI, V9, P298, DOI [10.3923/ijps.2010.298.304, DOI 10.3923/IJPS.2010.298.304]; Harmsen Hermie J.M., 1999, Microbial Ecology in Health and Disease, V11, P3, DOI 10.1080/089106099435862; Jozefiak D, 2012, POULTRY SCI, V91, P1899, DOI 10.3382/ps.2012-02151; Jozefiak D, 2013, ANN ANIM SCI, V13, P449, DOI 10.2478/aoas-2013-0031; Knarreborg A, 2002, APPL ENVIRON MICROB, V68, P6425, DOI 10.1128/AEM.68.12.6425-6428.2002; Kneifel Wolfgang, 2000, Microbial Ecology in Health and Disease, V12, P27, DOI 10.1080/089106000435563; Kobayashi A, 2013, APPL MICROBIOL BIOT, V97, P7427, DOI 10.1007/s00253-012-4469-2; Koenen ME, 2004, FEMS IMMUNOL MED MIC, V40, P119, DOI 10.1016/S0928-8244(03)00306-7; KRUMHOLZ LR, 1986, ARCH MICROBIOL, V143, P313, DOI 10.1007/BF00412795; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Madej JP, 2016, POULTRY SCI, V95, P19, DOI 10.3382/ps/pev291; Madej JP, 2015, POULTRY SCI, V94, P1209, DOI 10.3382/ps/pev076; Maiorano G, 2012, POULTRY SCI, V91, P2963, DOI 10.3382/ps.2012-02208; MANZ W, 1993, APPL ENVIRON MICROB, V59, P2293, DOI 10.1128/AEM.59.7.2293-2298.1993; Mirzapour Rezaei SS, 2015, BR POULT SCI; Mista D., 2016, ANIM PROD SCI; Mookiah S, 2014, J SCI FOOD AGR, V94, P341, DOI 10.1002/jsfa.6365; Mountzouris KC, 2010, POULTRY SCI, V89, P58, DOI 10.3382/ps.2009-00308; Mousavi SMAA, 2015, EUROP POULT SCI; Murshed MA, 2015, BRAZ J POULTRY SCI, V17, P99, DOI [10.1590/1516-635XSPECIALISSUENutrition-PoultryFeedingAdditives099-104, 10.1590/1516-635xSpecialIssueNutrition-PoultryFeedingAdditives099-104]; Naidu AS, 1999, CRIT REV FOOD SCI, V39, P13, DOI 10.1080/10408699991279187; Nazef L, 2008, POULTRY SCI, V87, P329, DOI 10.3382/ps.2007-00282; Pan D, 2014, GUT MICROBES, V5, P108, DOI 10.4161/gmic.26945; Patterson JA, 2003, POULTRY SCI, V82, P627, DOI 10.1093/ps/82.4.627; Pilarski R, 2005, FOLIA BIOL-KRAKOW, V53, P13, DOI 10.3409/1734916054663474; Plowiec A, 2015, AM J VET RES, V76, P975, DOI 10.2460/ajvr.76.11.975; Pruszynska-Oszmalek E, 2015, POULTRY SCI, V94, P1909, DOI 10.3382/ps/pev162; Ptak A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119770; Rawski M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147859; Roberfroid M, 2007, J NUTR, V137, p830S, DOI 10.1093/jn/137.3.830S; SALANITRO JP, 1978, APPL ENVIRON MICROB, V35, P782, DOI 10.1128/AEM.35.4.782-790.1978; Salih N. K. M., 2009, Proceedings 25th Southern Biomedical Engineering Conference (IFMBE 2009), P175, DOI 10.1007/978-3-642-01697-4_64; Sansonetti PJ, 2007, IMMUNITY, V26, P149, DOI 10.1016/j.immuni.2007.02.004; Schrezenmeir J, 2001, AM J CLIN NUTR, V73, p361S, DOI 10.1093/ajcn/73.2.361s; Sevane N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098942; Sghir A, 1998, SYST APPL MICROBIOL, V21, P291, DOI 10.1016/S0723-2020(98)80036-2; Slawinska A, 2016, ANIM SCI PAP REP, V34, P81; Slawinska A, 2014, AM J VET RES, V75, P997, DOI 10.2460/ajvr.75.11.997; Slawinska A, 2014, FOLIA BIOL-KRAKOW, V62, P277, DOI 10.3409/fb62_3.277; Sornplang P, 2015, ASIAN AUSTRAL J ANIM, V28, P1657, DOI 10.5713/ajas.15.0359; Yang Y, 2009, WORLD POULTRY SCI J, V65, P97, DOI 10.1017/S0043933909000008; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	76	54	59	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168587	10.1371/journal.pone.0168587	http://dx.doi.org/10.1371/journal.pone.0168587			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045927	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300035
J	Poras, I; Yaghi, L; Martelli-Palomino, G; Mendes, CT; Muniz, YCN; Cagnin, NF; de Almeida, BS; Castelli, EC; Carosella, ED; Donadi, EA; Moreau, P				Poras, Isabelle; Yaghi, Layale; Martelli-Palomino, Gustavo; Mendes-Junior, Celso T.; Netto Muniz, Yara Costa; Cagnin, Natalia F.; de Almeida, Bibiana Sgorla; Castelli, Erick C.; Carosella, Edgardo D.; Donadi, Eduardo A.; Moreau, Philippe			Haplotypes of the HLA-G 3 ' Untranslated Region Respond to Endogenous Factors of HLA-G plus and HLA-G- Cell Lines Differentially	PLOS ONE			English	Article							G MESSENGER-RNA; LEUKOCYTE ANTIGEN-G; CLASS-I; G MOLECULE; INHIBITORY RECEPTOR; BALANCING SELECTION; G GENOTYPE; GENE; EXPRESSION; POLYMORPHISMS	The immune checkpoint HLA-G prevents maternal rejection of the fetus and contributes in cancer invasion and acceptance of allografts. The 5' and 3' regulatory regions of the HLA-G gene are polymorphic and balancing selection probably maintains this variability. It is proposed that nucleotide variations may affect the level of HLA-G expression. To investigate this issue we aimed to analyze how haplotypes of the 3' untranslated region (3'UTR) with highest worldwide frequencies, namely UTR-1, UTR-2, UTR-3, UTR-4, UTR-5, UTR-18 and UTR-7, impact the expression of a luciferase reporter gene in vitro. Experiments performed with the HLA-G positive cell lines JEG-3 (choricarcinoma) and FON (melanoma), and with the HLA-G negative cell lines M8 (melanoma) and U251 MG (glioblastoma) showed that the HLA-G 3'UTR polymorphism influences the response to endogenous cellular factors and may vary according to the cell type. UTR-5 and UTR-7 impact the activity of luciferase the most whereas UTR-2, UTR-3, UTR-4, and UTR-18 have intermediate impact, and UTR-1 has the lowest impact. These results corroborate the previous associations between amounts of plasma sHLA-G levels and 3'UTR haplotypes in healthy individuals and reinforce that 3'UTR typing may be a predictor of the genetic predisposition of an individual to express different levels of HLA-G.	[Poras, Isabelle; Yaghi, Layale; Martelli-Palomino, Gustavo; Netto Muniz, Yara Costa; Cagnin, Natalia F.; de Almeida, Bibiana Sgorla; Carosella, Edgardo D.; Moreau, Philippe] Hop St Louis, Commissariat Energie Atom & Energies Alternat, Inst Malad Emergentes & Therapies Innovantes, Serv Rech Hematoimmunol, Paris, France; [Poras, Isabelle; Yaghi, Layale; Martelli-Palomino, Gustavo; Netto Muniz, Yara Costa; Cagnin, Natalia F.; de Almeida, Bibiana Sgorla; Carosella, Edgardo D.; Moreau, Philippe] Univ Paris Diderot, Hop St Louis, Inst Univ Hematol, Sorbonne Paris Cite,UMR E5, Paris, France; [Yaghi, Layale] Lebanese Univ, Sch Med, Hadath, Lebanon; [Martelli-Palomino, Gustavo] Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Programa Posgrad Ciencias Saude, Natal, RN, Brazil; [Mendes-Junior, Celso T.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, Ribeirao Preto, SP, Brazil; [Netto Muniz, Yara Costa; de Almeida, Bibiana Sgorla] Univ Fed Santa Catarina, Dept Biol Celular Embriol & Genet, Ctr Ciencias Biol, Florianopolis, SC, Brazil; [Cagnin, Natalia F.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Ribeirao Preto, SP, Brazil; [de Almeida, Bibiana Sgorla] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Div Imunol Clin, Ribeirao Preto, SP, Brazil; [Castelli, Erick C.] Univ Estadual Paulista, Sch Med, Dept Pathol, UNESP, Botucatu, SP, Brazil	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; CEA; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Lebanese University; Universidade Federal do Rio Grande do Norte; Universidade de Sao Paulo; Universidade Federal de Santa Catarina (UFSC); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista	Moreau, P (corresponding author), Hop St Louis, Commissariat Energie Atom & Energies Alternat, Inst Malad Emergentes & Therapies Innovantes, Serv Rech Hematoimmunol, Paris, France.; Moreau, P (corresponding author), Univ Paris Diderot, Hop St Louis, Inst Univ Hematol, Sorbonne Paris Cite,UMR E5, Paris, France.	Philippe.moreau@cea.fr	Mendes-Junior, Celso Teixeira/B-1994-2010; donadi, eduardo A/H-7080-2013; Castelli, Erick C./B-4250-2010; de Almeida, Bibiana Sgorla/AAE-8128-2020	Mendes-Junior, Celso Teixeira/0000-0002-7337-1203; donadi, eduardo A/0000-0002-9457-9601; Castelli, Erick C./0000-0003-2142-7196; Yaghi, Layale/0000-0001-6022-1890; Muniz, Yara Costa Netto/0000-0001-9526-8306; Moreau, Philippe/0000-0002-2868-7401	Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA); CAPES/Brazil-COFECUB/France [653/09]; Programa Ciencia sem Fronteiras Pesq uisador Visitante Especial (CNPq) [406594/2013-9]; Universite Sorbonne Paris Cite' Mobilite Internationale Bresil, FAPESP [2014/18730-9]; CAPES Doutorado Sanduiche N.F.C [014747/2013-8]	Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)(French Atomic Energy Commission); CAPES/Brazil-COFECUB/France(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa Ciencia sem Fronteiras Pesq uisador Visitante Especial (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universite Sorbonne Paris Cite' Mobilite Internationale Bresil, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES Doutorado Sanduiche N.F.C(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA), the binational research cooperation programs CAPES/Brazil-COFECUB/France (project Me 653/09), Programa Ciencia sem Fronteiras Pesq uisador Visitante Especial (CNPq grant 406594/2013-9), Universite Sorbonne Paris Cite Mobilite Internationale Bresil 2015, FAPESP (grant 2014/18730-9) and CAPES Doutorado Sanduiche N.F.C. (grant 014747/2013-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio G, 2016, HUM IMMUNOL, V77, P886, DOI 10.1016/j.humimm.2016.06.020; Berger DS, 2010, REPROD SCI, V17, P331, DOI 10.1177/1933719109356802; Carlini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082517; Carosella ED, 2015, ADV IMMUNOL, V127, P33, DOI 10.1016/bs.ai.2015.04.001; Castelli EC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00476; Castelli EC, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/734068; Chen XY, 2008, TISSUE ANTIGENS, V72, P335, DOI 10.1111/j.1399-0039.2008.01107.x; Alves DCC, 2012, HUM IMMUNOL, V73, P52, DOI 10.1016/j.humimm.2011.10.007; Colonna M, 1998, J IMMUNOL, V160, P3096; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Courtin D, 2013, INFECT GENET EVOL, V17, P1, DOI 10.1016/j.meegid.2013.03.004; Dahl M, 2014, AM J REPROD IMMUNOL, V72, P89, DOI 10.1111/aji.12251; Deschaseaux F, 2013, FASEB J, V27, P2977, DOI 10.1096/fj.13-227264; Di Cristofaro J, 2013, HUM IMMUNOL, V74, P203, DOI 10.1016/j.humimm.2012.10.027; Dias FC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00009; Djurisic S, 2015, MOL HUM REPROD, V21, P281, DOI 10.1093/molehr/gau108; Donadi EA, 2011, CELL MOL LIFE SCI, V68, P369, DOI 10.1007/s00018-010-0580-7; Flajollet S, 2009, J IMMUNOL, V183, P6948, DOI 10.4049/jimmunol.0902053; FUJII T, 1994, J IMMUNOL, V153, P5516; Garcia A, 2013, INFECT GENET EVOL, V16, P263, DOI 10.1016/j.meegid.2013.02.021; Garziera M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144000; Gineau L, 2015, GENES IMMUN, V16, P57, DOI 10.1038/gene.2014.63; Hiby SE, 1999, TISSUE ANTIGENS, V53, P1, DOI 10.1034/j.1399-0039.1999.530101.x; Hviid TVF, 2003, IMMUNOGENETICS, V55, P63, DOI 10.1007/s00251-003-0547-z; Hviid TVF, 2004, IMMUNOGENETICS, V56, P135, DOI 10.1007/s00251-004-0673-2; ISHITANI A, 1992, P NATL ACAD SCI USA, V89, P3947, DOI 10.1073/pnas.89.9.3947; Jasinski-Bergner S, 2016, ONCOTARGET; KIRSZENBAUM M, 1994, P NATL ACAD SCI USA, V91, P4209, DOI 10.1073/pnas.91.10.4209; Lucena-Silva N, 2013, J RHEUMATOL, V40, P1104, DOI 10.3899/jrheum.120814; Manaster I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033395; Martelli-Palomino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071742; Martinez-Laso J, 2013, HUM IMMUNOL, V74, P383, DOI 10.1016/j.humimm.2012.11.016; Michita RT, 2016, HUM IMMUNOL, V77, P892, DOI 10.1016/j.humimm.2016.07.004; Moreau P, 2003, P NATL ACAD SCI USA, V100, P1191, DOI 10.1073/pnas.0337539100; MOREAU P, 1995, HUM IMMUNOL, V43, P231, DOI 10.1016/0198-8859(95)00009-S; Moreau P, 2009, J CELL MOL MED, V13, P2973, DOI 10.1111/j.1582-4934.2009.00800.x; Mouillot G, 2005, INT J CANCER, V113, P928, DOI 10.1002/ijc.20682; Ober C, 2006, HUM REPROD, V21, P1743, DOI 10.1093/humrep/del036; Paul P, 2000, HUM IMMUNOL, V61, P1138, DOI 10.1016/S0198-8859(00)00197-X; Porto IOP, 2015, MOL IMMUNOL, V65, P230, DOI 10.1016/j.molimm.2015.01.030; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Reches A, 2016, J IMMUNOL; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Rousseau P, 2003, HUM IMMUNOL, V64, P1005, DOI 10.1016/j.humimm.2003.08.347; Sabbagh A, 2014, GENES IMMUN, V15, P95, DOI 10.1038/gene.2013.67; Santos KE, 2013, MOL BIOL EVOL, V30, P2423, DOI 10.1093/molbev/mst142; SCHMIDT CM, 1993, J IMMUNOL, V151, P2633; Schwerk J, 2015, J IMMUNOL, V195, P2963, DOI 10.4049/jimmunol.1500756; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Svendsen SG, 2013, HUM IMMUNOL, V74, P818, DOI 10.1016/j.humimm.2013.03.003; Tan Z, 2005, HUM MOL GENET, V14, P3619, DOI 10.1093/hmg/ddi389; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; Wang XH, 2012, REPROD BIOMED ONLINE, V25, P415, DOI 10.1016/j.rbmo.2012.06.022; Wastowski IJ, 2013, AM J PATHOL, V182, P540, DOI 10.1016/j.ajpath.2012.10.021; Yaghi L, 2016, ONCOTARGET; Yie SM, 2008, MOL HUM REPROD, V14, P649, DOI 10.1093/molehr/gan059	56	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169032	10.1371/journal.pone.0169032	http://dx.doi.org/10.1371/journal.pone.0169032			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045999	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300095
J	Tebbett, SB; Goatley, CHR; Bellwood, DR				Tebbett, Sterling B.; Goatley, Christopher H. R.; Bellwood, David R.			The Effects of Algal Turf Sediments and Organic Loads on Feeding by Coral Reef Surgeonfishes	PLOS ONE			English	Article							GREAT-BARRIER-REEF; PARROTFISHES FAMILY SCARIDAE; HERBIVOROUS GRAZING FISHES; PHASE-SHIFTS; FUNCTIONAL-ANALYSIS; EPILITHIC ALGAL; TROPHIC STATUS; MID-SHELF; RESILIENCE; COMMUNITIES	Herbivorous and detritivorous fishes interact closely with the epilithic algal matrix (EAM) on coral reefs. While sediment and organic detrital loads within the EAM might influence this interaction, the responses of functionally distinct fishes to changing sediment and organic loads have not been investigated. Aquarium based feeding trials were performed to assess how different sediment and organic loads affected feeding by the highly abundant surgeon fishes, Ctenochaetus striatus, a detritivore, and Acanthurus nigrofuscus, a herbivore. C. striatus were highly sensitive to even small increases in sediment loads (of just 75 g m(-2)), displaying a significant decline in feeding rates as sediment loads increased. Although C. striatus is a specialised detritivore, changing organic loads had no effect and suggests that selection of feeding surfaces is primarily mediated by total sediment loads rather than organic loads. By contrast, A. nigrofuscus displayed no changes to its feeding behaviour regardless of sediment or organic load. These findings highlight the complex, species-specific way that sediments may mediate key ecological processes on coral reefs.	[Tebbett, Sterling B.] James Cook Univ, Coll Sci & Engn, Townsville, Qld 4811, Australia; James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Tebbett, SB (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld 4811, Australia.	sterling.tebbett@my.jcu.edu.au	Goatley, Christopher/C-1492-2016; Tebbett, Sterling B./J-9420-2019	Goatley, Christopher/0000-0002-2930-5591; Tebbett, Sterling B./0000-0002-9372-7617	Australian Research Council [DP140100122, CE140100020]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council (DRB: grant numbers DP140100122 and CE140100020, URL: http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SN, 2010, MAR ECOL PROG SER, V414, P91, DOI 10.3354/meps08724; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bellwood DR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3046; Bellwood DR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4144; Bellwood DR, 2008, LIMNOL OCEANOGR, V53, P2695, DOI 10.4319/lo.2008.53.6.2695; BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035; Bellwood DR, 1996, MAR BIOL, V125, P795, DOI 10.1007/BF00349262; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Bonaldo RM, 2011, CORAL REEFS, V30, P381, DOI 10.1007/s00338-010-0704-4; Bonaldo RM, 2014, OCEANOGR MAR BIOL, V52, P81; Brandl SJ, 2016, OECOLOGIA, V182, P203, DOI 10.1007/s00442-016-3643-0; Brandl SJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1147; Brodie JE, 2016, ESTUAR COAST SHELF S; Bruggemann JH, 1996, MAR ECOL PROG SER, V134, P59, DOI 10.3354/meps134059; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Cheal A, 2012, MAR BIOL, V159, P1143, DOI 10.1007/s00227-012-1893-x; Cheal AJ, 2013, ECOL APPL, V23, P174, DOI 10.1890/11-2253.1; Choat J.H., 1991, P120; CHOAT JH, 1985, MAR BIOL, V89, P221, DOI 10.1007/BF00393655; Choat JH, 2004, MAR BIOL, V145, P445, DOI 10.1007/s00227-004-1341-7; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; Clausing RJ, 2014, MAR ECOL PROG SER, V517, P121, DOI 10.3354/meps11029; Cleary DFR, 2016, MAR POLLUT BULL, V110, P701, DOI 10.1016/j.marpolbul.2016.04.042; Crawley M. J., 2013, R BOOK; Crossman DJ, 2005, MAR ECOL PROG SER, V296, P129, DOI 10.3354/meps296129; Crossman DJ, 2001, LIMNOL OCEANOGR, V46, P1596, DOI 10.4319/lo.2001.46.7.1596; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Goatley CHR, 2016, ECOL SOC, V21, DOI 10.5751/ES-08334-210129; Goatley CHR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077737; Goatley CHR, 2012, BIOL LETTERS, V8, P1016, DOI 10.1098/rsbl.2012.0770; Goatley CHR, 2010, MAR ECOL PROG SER, V415, P237, DOI 10.3354/meps08761; Gordon SE, 2016, MAR POLLUT BULL, V111, P178, DOI 10.1016/j.marpolbul.2016.07.013; Gordon SE, 2016, CORAL REEFS, V35, P285, DOI 10.1007/s00338-015-1374-z; Gowan JC, 2014, CORAL REEFS, V33, P651, DOI 10.1007/s00338-014-1154-1; Graham NAJ, 2013, FRONT ECOL ENVIRON, V11, P541, DOI 10.1890/120305; Harrison XA, 2015, PEERJ, V3, DOI 10.7717/peerj.1114; Hess S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10561; Hoey J, 2007, CORAL REEFS, V26, P603, DOI 10.1007/s00338-007-0246-6; Hughes TP, 2015, NAT CLIM CHANGE, V5, P508, DOI 10.1038/nclimate2604; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Johansson CL, 2013, CORAL REEFS, V32, P963, DOI 10.1007/s00338-013-1044-y; Krone R, 2011, FACIES, V57, P215, DOI 10.1007/s10347-010-0239-8; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Mazerolle MJ, 2015, AICCMODAVG MODEL SEL; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Neil DT, 2002, MAR FRESHWATER RES, V53, P733, DOI 10.1071/MF00151; Nugues MM, 2003, CORAL REEFS, V22, P507, DOI 10.1007/s00338-003-0338-x; O'Connor JJ, 2016, OECOLOGIA, V180, P11, DOI 10.1007/s00442-015-3367-6; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pinheiro J, 2020, R PACKAGE VERSION 31; Plass-Johnson JG, 2015, LIMNOL OCEANOGR, V60, P1382, DOI 10.1002/lno.10105; Purcell SW, 2001, CORAL REEFS, V20, P117, DOI 10.1007/s003380100150; Purcell SW, 2000, B MAR SCI, V66, P199; PURCELL SW, 1993, ENVIRON BIOL FISH, V37, P139, DOI 10.1007/BF00000589; R Core Team, 2021, R LANGUAGE ENV STAT; Randall J. E., 2005, REEF SHORE FISHES S; Randall JE, 1955, THESIS; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; RUSS G, 1984, MAR ECOL PROG SER, V20, P23, DOI 10.3354/meps020023; RUSS G, 1984, MAR ECOL PROG SER, V20, P35, DOI 10.3354/meps020035; Tebbett SB, 2016, MAR POLLUT B; TENORE KR, 1981, ESTUAR COAST SHELF S, V12, P39, DOI 10.1016/S0302-3524(81)80116-8; Thompson A., 2013, REEF RESCUE MARINE M; Trip EL, 2008, MAR ECOL PROG SER, V373, P97, DOI 10.3354/meps07755; Wenger AS, 2014, J EXP BIOL, V217, P1122, DOI 10.1242/jeb.094409; Wenger AS, 2011, CORAL REEFS, V30, P879, DOI 10.1007/s00338-011-0773-z; WILLIAMS DM, 1983, MAR ECOL PROG SER, V10, P239, DOI 10.3354/meps010239; Wilson S, 1997, MAR ECOL PROG SER, V153, P299, DOI 10.3354/meps153299; Wilson SK, 2003, OCEANOGR MAR BIOL, V41, P279; Zaneveld JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11833	73	44	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169479	10.1371/journal.pone.0169479	http://dx.doi.org/10.1371/journal.pone.0169479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046102	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000391612300197
J	Venters, M; Carlson, RP; Gedeon, T; Heys, JJ				Venters, Michael; Carlson, Ross P.; Gedeon, Tomas; Heys, Jeffrey J.			Effects of Spatial Localization on Microbial Consortia Growth	PLOS ONE			English	Article							DIFFUSION-COEFFICIENTS; STABLE COEXISTENCE; EVOLUTION; BIOFILMS	Microbial consortia are commonly observed in natural and synthetic systems, and these consortia frequently result in higher biomass production relative to monocultures. The focus here is on the impact of initial spatial localization and substrate diffusivity on the growth of a model microbial consortium consisting of a producer strain that consumes glucose and produces acetate and a scavenger strain that consumes the acetate. The mathematical model is based on an individual cell model where growth is described by Monod kinetics, and substrate transport is described by a continuum-based, non-equilibrium reaction-diffusion model where convective transport is negligible (e.g., in a biofilm). The first set of results focus on a single producer cell at the center of the domain and surrounded by an initial population of scavenger cells. The impact of the initial population density and substrate diffusivity is examined. A transition is observed from the highest initial density resulting in the greatest cell growth to cell growth being independent of initial density. A high initial density minimizes diffusive transport time and is typically expected to result in the highest growth, but this expected behavior is not predicted in environments with lower diffusivity or larger length scales. When the producer cells are placed on the bottom of the domain with the scavenger cells above in a layered biofilm arrangement, a similar critical transition is observed. For the highest diffusivity values examined, a thin, dense initial scavenger layer is optimal for cell growth. However, for smaller diffusivity values, a thicker, less dense initial scavenger layer provides maximal growth. The overall conclusion is that high density clustering of members of a food chain is optimal under most common transport conditions, but under some slow transport conditions, high density clustering may not be optimal for microbial growth.	[Venters, Michael; Carlson, Ross P.; Heys, Jeffrey J.] Montana State Univ, Chem & Biol Engn Dept, Bozeman, MT 59717 USA; [Gedeon, Tomas] Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Heys, JJ (corresponding author), Montana State Univ, Chem & Biol Engn Dept, Bozeman, MT 59717 USA.	jeff.heys@gmail.com			U.S. National Science Foundation [DMS 1361240]; NSF [DMS 1361240]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB019416] Funding Source: NIH RePORTER	U.S. National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the U.S. National Science Foundation grant DMS 1361240.; This work was supported by NSF grant DMS 1361240.	Alpkvist E, 2006, BIOTECHNOL BIOENG, V94, P961, DOI 10.1002/bit.20917; Bernstein HC, 2014, METHODS MOL BIOL, V1151, P49, DOI 10.1007/978-1-4939-0554-6_4; Bernstein HC, 2012, J BIOTECHNOL, V157, P159, DOI 10.1016/j.jbiotec.2011.10.001; BROWN PN, 1989, SIAM J SCI STAT COMP, V10, P1038, DOI 10.1137/0910062; Buchner A, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4823504; Buchner A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.208104; CHARACKLIS WG, 1973, WATER RES, V7, P1113, DOI 10.1016/0043-1354(73)90066-3; Christner Brent C., 2008, P51, DOI 10.1007/978-3-540-74335-4_4; Cole JA, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0155-1; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Escalante AE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00143; Estrela S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003398; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Haange SB, 2012, J PROTEOME RES, V11, P5406, DOI 10.1021/pr3006364; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Harvey E, 2014, J THEOR BIOL, V360, P222, DOI 10.1016/j.jtbi.2014.07.011; Head DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105012; Hellweger FL, 2009, ECOL MODEL, V220, P8, DOI 10.1016/j.ecolmodel.2008.09.004; Kinnersley M, 2011, EVOLUTIONARY BIOLOGY: CONCEPTS, BIODIVERSITY, MACROEVOLUTION AND GENOME EVOLUTION, P107, DOI 10.1007/978-3-642-20763-1_7; Klapper I, 2010, SIAM REV, V52, P221, DOI 10.1137/080739720; Kreft JU, 2001, MICROBIOL-SGM, V147, P2897, DOI 10.1099/00221287-147-11-2897; Lardon LA, 2011, ENVIRON MICROBIOL, V13, P2416, DOI 10.1111/j.1462-2920.2011.02414.x; Mitri S, 2011, P NATL ACAD SCI USA, V108, P10839, DOI 10.1073/pnas.1100292108; Momeni B, 2013, ELIFE, V2, DOI 10.7554/eLife.00960; Nadell CD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000716; Pfeiffer T, 2004, AM NAT, V163, pE126, DOI 10.1086/383593; Picioreanu C, 2004, APPL ENVIRON MICROB, V70, P3024, DOI 10.1128/AEM.70.5.3024-3040.2004; POWELL GE, 1985, J CHEM TECH BIOT B, V35, P46, DOI 10.1002/jctb.280350109; POWELL GE, 1986, THEOR POPUL BIOL, V30, P17, DOI 10.1016/0040-5809(86)90022-5; Rani SA, 2005, ANTIMICROB AGENTS CH, V49, P728, DOI 10.1128/AAC.49.2.728-732.2005; ROSENZWEIG RF, 1994, GENETICS, V137, P903; Schillinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037583; Schink B, 2002, ANTON LEEUW INT J G, V81, P257, DOI 10.1023/A:1020579004534; Smith HL, 1995, THEORY CHEMOSTAT DYN, pxvi; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; STEWART PS, 1995, CHEM ENG SCI, V50, P3099, DOI 10.1016/0009-2509(95)00143-S; Stewart PS, 1998, BIOTECHNOL BIOENG, V59, P261, DOI 10.1002/(SICI)1097-0290(19980805)59:3<261::AID-BIT1>3.0.CO;2-9; WANNER O, 1985, WATER SCI TECHNOL, V17, P27; WILKE CR, 1955, AICHE J, V1, P264, DOI 10.1002/aic.690010222; Wintermute EH, 2010, GENE DEV, V24, P2603, DOI 10.1101/gad.1985210; Wintermute EH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.66; Wu JH, 2001, MICROBIOL-UK, V147, P373, DOI 10.1099/00221287-147-2-373	43	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168592	10.1371/journal.pone.0168592	http://dx.doi.org/10.1371/journal.pone.0168592			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045924	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300036
J	Dively, GP; Venugopal, PD; Finkenbinder, C				Dively, Galen P.; Venugopal, P. Dilip; Finkenbinder, Chad			Field-Evolved Resistance in Corn Earworm to Cry Proteins Expressed by Transgenic Sweet Corn	PLOS ONE			English	Article							HELICOVERPA-ZEA LEPIDOPTERA; BACILLUS-THURINGIENSIS TOXINS; FALL ARMYWORM LEPIDOPTERA; BASE-LINE SUSCEPTIBILITY; INSECT RESISTANCE; SPODOPTERA-FRUGIPERDA; BT MAIZE; CROSS-RESISTANCE; BORER LEPIDOPTERA; FITNESS COSTS	Background Transgenic corn engineered with genes expressing insecticidal toxins from the bacterium Bacillus thuringiensis (Berliner) (Bt) are now a major tool in insect pest management. With its widespread use, insect resistance is a major threat to the sustainability of the Bt transgenic technology. For all Bt corn expressing Cry toxins, the high dose requirement for resistance management is not achieved for corn earworm, Helicoverpa zea (Boddie), which is more tolerant to the Bt toxins. Methodology/Major Findings We present field monitoring data using Cry1Ab (1996-2016) and Cry1A.105+Cry2Ab2 (2010-2016) expressing sweet corn hybrids as in-field screens to measure changes in field efficacy and Cry toxin susceptibility to H. zea. Larvae successfully damaged an increasing proportion of ears, consumed more kernel area, and reached later developmental stages (4th - 6th instars) in both types of Bt hybrids (Cry1Ab-event Bt11, and Cry1A.105+Cry2Ab2-event MON89034) since their commercial introduction. Yearly patterns of H. zea population abundance were unrelated to reductions in control efficacy. There was no evidence of field efficacy or tissue toxicity differences among different Cry1Ab hybrids that could contribute to the decline in control efficacy. Supportive data from laboratory bioassays demonstrate significant differences in weight gain and fitness characteristics between the Maryland H. zea strain and a susceptible strain. In bioassays with Cry1Ab expressing green leaf tissue, Maryland H. zea strain gained more weight than the susceptible strain at all concentrations tested. Fitness of the Maryland H. zea strain was significantly lower than that of the susceptible strain as indicated by lower hatch rate, longer time to adult eclosion, lower pupal weight, and reduced survival to adulthood. Conclusions/Significance After ruling out possible contributing factors, the rapid change in field efficacy in recent years and decreased susceptibility of H. zea to Bt sweet corn provide strong evidence of field-evolved resistance in H. zea populations to multiple Cry toxins. The high adoption rate of Bt field corn and cotton, along with the moderate dose expression of Cry1Ab and related Cry toxins in these crops, and decreasing refuge compliance probably contributed to the evolution of resistance. Our results have important implications for resistance monitoring, refuge requirements and other regulatory policies, cross-resistance issues, and the sustainability of the pyramided Bt technology.	[Dively, Galen P.; Venugopal, P. Dilip] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Venugopal, P. Dilip] US EPA, Amer Assoc Adv Sci, Sci & Technol Policy Fellowship Program, Transportat & Climate Div,Off Transportat & Air Q, Washington, DC USA; [Finkenbinder, Chad] Benzon Res Inc, Carlisle, PA USA	University System of Maryland; University of Maryland College Park; United States Environmental Protection Agency	Venugopal, PD (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.; Venugopal, PD (corresponding author), US EPA, Amer Assoc Adv Sci, Sci & Technol Policy Fellowship Program, Transportat & Climate Div,Off Transportat & Air Q, Washington, DC USA.	venugopal.dilip@gmail.com		Venugopal, Dilip/0000-0001-6339-5087	Maryland Agricultural Experiment Station [MD-ENTO-8732]; Maryland Extension Integrated Pest Management Project; United States Environmental Protection Agency (U.S. EPA) [X3-83588701]	Maryland Agricultural Experiment Station; Maryland Extension Integrated Pest Management Project; United States Environmental Protection Agency (U.S. EPA)(United States Environmental Protection Agency)	This work was supported by the Maryland Agricultural Experiment Station, #MD-ENTO-8732 (GPD) and the Maryland Extension Integrated Pest Management Project (GPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This publication was developed under Assistance Agreement No. X3-83588701 awarded by the United States Environmental Protection Agency (U.S. EPA) to the American Association for the Advancement of Science (AAAS). It has not been formally reviewed by the U.S. EPA. The views expressed in this document are solely those of the authors, and do not reflect those of either U.S. EPA or AAAS. Products or commercial services mentioned in this publication are solely for reference purposes only, and do not represent endorsement by the authors, the U.S. EPA, or AAAS.	Anilkumar KJ, 2008, APPL ENVIRON MICROB, V74, P462, DOI 10.1128/AEM.01612-07; Bernardi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140130; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brevault T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09807; Brevault T, 2013, P NATL ACAD SCI USA, V110, P5806, DOI 10.1073/pnas.1216719110; Burkness EC, 2012, J ECON ENTOMOL, V105, P1773, DOI 10.1603/EC12128; Burkness Eric C, 2010, GM Crops, V1, P337, DOI 10.4161/gmcr.1.5.14765; Carriere Y, 2015, NAT BIOTECHNOL, V33, P161, DOI 10.1038/nbt.3099; Chilcutt CF, 2004, P NATL ACAD SCI USA, V101, P7526, DOI 10.1073/pnas.0400546101; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Diffenbaugh NS, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/044007; DITMAN L. P., 1931, Bulletin of the Maryland Agricultural Experiment Station, P443; Dively GP, 1993, VEGETABLE PEST MANAG, P10; DULMAGE HT, 1971, J INVERTEBR PATHOL, V18, P240, DOI 10.1016/0022-2011(71)90151-0; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; Gassmann AJ, 2012, J INVERTEBR PATHOL, V110, P287, DOI 10.1016/j.jip.2012.04.006; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Horner TA, 2003, J ECON ENTOMOL, V96, P914, DOI 10.1603/0022-0493-96.3.914; Horner TA, 2003, J ECON ENTOMOL, V96, P925, DOI 10.1603/0022-0493-96.3.925; Horner TA, 2003, J ECON ENTOMOL, V96, P931, DOI 10.1603/0022-0493-96.3.931; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Huang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112958; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Jacobson A, 2009, J ECON ENTOMOL, V102, P2289, DOI 10.1603/029.102.0634; Jaffe G, 2009, COMPLACENCY FARM SIG, P19; Jakka SRK, 2014, J ECON ENTOMOL, V107, P342, DOI 10.1603/EC13326; James C., 2014, GLOBAL STATUS COMMER; Kathage J, 2012, P NATL ACAD SCI USA, V109, P11652, DOI 10.1073/pnas.1203647109; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Kuhn M., 2013, CONTRAST COLLECTION; Kurtz RW, 2007, J INVERTEBR PATHOL, V95, P227, DOI 10.1016/j.jip.2007.03.014; Lynch RE, 1999, J ECON ENTOMOL, V92, P246, DOI 10.1093/jee/92.1.246; Lynch RE, 1999, J ECON ENTOMOL, V92, P1217, DOI 10.1093/jee/92.5.1217; Marcon PCRG, 1999, J ECON ENTOMOL, V92, P279, DOI 10.1093/jee/92.2.279; Matten, 2012, REGULATION AGR BIOTE, P1752267; McCaffery AR, 1998, PHILOS T R SOC B, V353, P1735, DOI 10.1098/rstb.1998.0326; Moar W, 2008, NAT BIOTECHNOL, V26, P1072, DOI 10.1038/nbt1008-1072; Monnerat R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119544; National Academies of Sciences Engineering and Medicine, 2016, GEN ENG CROPS EXP PR; National Research Council, 2010, IMP GEN ENG CROPS FA; Olmstead DL, 2016, J ECON ENTOMOL; Omoto C, 2016, PEST MANAG SCI, V72, P1727, DOI 10.1002/ps.4201; Onstad DW, 1998, J ECON ENTOMOL, V91, P585, DOI 10.1093/jee/91.3.585; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pray CE, 2002, PLANT J, V31, P423, DOI 10.1046/j.1365-313X.2002.01401.x; Qaim M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064879; R Development Core Team, 2014, R LANG ENV STAT COMP; Reisig D, 2016, EARWORMS BOLLWORMS B; Reisig DD, 2015, ENVIRON ENTOMOL, V44, P1275, DOI 10.1093/ee/nvv076; Sandstrom M.A., 2007, PLANT HLTH PROG, V8, P63, DOI [10.1094/PHP-2007-0719-08-RV, DOI 10.1094/PHP-2007-0719-08-RV]; Santos-Amaya OF, 2015, SCI REP-UK, V5, DOI 10.1038/srep18243; Hernandez-Rodriguez CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068164; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Shelton AM, 2013, J ECON ENTOMOL, V106, P2151, DOI 10.1603/EC13146; Siegfried BD, 2000, J ECON ENTOMOL, V93, P1265, DOI 10.1603/0022-0493-93.4.1265; Siegfried Blair D., 2007, American Entomologist, V53, P208; STADELBACHER EA, 1990, J ECON ENTOMOL, V83, P1207, DOI 10.1093/jee/83.4.1207; Storer NP, 2012, J INVERTEBR PATHOL, V110, P294, DOI 10.1016/j.jip.2012.04.007; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Storer NP, 2003, J ECON ENTOMOL, V96, P156, DOI 10.1603/0022-0493-96.1.156; Storer NP, 2001, J ECON ENTOMOL, V94, P1268, DOI 10.1603/0022-0493-94.5.1268; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P1074, DOI 10.1038/nbt1008-1074; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005646; Tabashnik BE, 2014, J ECON ENTOMOL, V107, P496, DOI 10.1603/EC13458; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; U.S. Department of Agriculture D Economic Research Service, 2015, REC TRENDS GE AD; U.S. Department of Agriculture-National Agricultural Statistics Service, 2015, USDA NASS QUICKSTATS; University of Delaware College of Agriculture and Natural Resources, DEL HIST TRAP CATCH; US EPA, 2014, INS RES MAN FACT SHE; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Venette RC, 2000, J ECON ENTOMOL, V93, P1055, DOI 10.1603/0022-0493-93.4.1055; Wei JZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07714; Welch KL, 2015, J INVERTEBR PATHOL, V132, P149, DOI 10.1016/j.jip.2015.10.003; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Yang F, 2016, SCI REP-UK, V6, DOI 10.1038/srep28059; Yang FL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100031, 10.1371/journal.pone.0076458]	83	103	106	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169115	10.1371/journal.pone.0169115	http://dx.doi.org/10.1371/journal.pone.0169115			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036388	Green Published, gold, Green Submitted			2022-12-26	WOS:000391229300056
J	Grasso, C; Zugna, D; Fiano, V; Rodriguez, NR; Maule, M; Gillio-Tos, A; Ciuffreda, L; Lista, P; Segnan, N; Merletti, F; Richiardi, L				Grasso, Chiara; Zugna, Daniela; Fiano, Valentina; Rodriguez, Nena Robles; Maule, Milena; Gillio-Tos, Anna; Ciuffreda, Libero; Lista, Patrizia; Segnan, Nereo; Merletti, Franco; Richiardi, Lorenzo			Subfertility and Risk of Testicular Cancer in the EPSAM Case-Control Study	PLOS ONE			English	Article							GERM-CELL CANCER; SUSCEPTIBILITY LOCI; TYROSINE KINASE; KITLG GENES; MEN; FERTILITY; MUTATIONS; ASSOCIATION; VARIANTS; TRENDS	Background/objectives It has been suggested that subfertility and testicular cancer share genetic and environmental risk factors. We studied both subfertility and the strongest known testicular cancer susceptibility gene, the c-KIT ligand (KITLG), whose pathway is involved in spermatogenesis. Methods The EPSAM case-control study is comprised of testicular cancer patients from the Province of Turin, Italy, diagnosed between 1997 and 2008. The present analysis included 245 cases and 436 controls from EPSAM, who were aged 20 years or older at diagnosis/recruitment. The EPSAM questionnaire collected information on factors such as number of children, age at first attempt to conceive, duration of attempt to conceive, use of assisted reproduction techniques, physician-assigned diagnosis of infertility, number of siblings, and self-reported cryptorchidism. Genotyping of the KITLG single nucleotide polymorphism (SNP) rs995030 was performed on the saliva samples of 202 cases and 329 controls. Results Testicular cancer was associated with the number of children fathered 5 years before diagnosis (odds ratio (OR) per additional child: 0.78, 95% confidence interval (CI): 0.58-1.04) and sibship size (OR per additional sibling: 0.76, 95% CI: 0.66-0.88). When considering the reproductive history until 1 year before diagnosis, attempting to conceive for at least 12 months or fathering a child using assisted reproduction techniques was not associated with the risk of testicular cancer, nor was age at first attempt to conceive or physician-assigned diagnosis of infertility. The SNP rs995030 was strongly associated with risk of testicular cancer (per allele OR: 1.83; 95% CI: 1.26-2.64), but it did not modify the association between number of children and the risk of testicular cancer. Conclusion This study supports the repeatedly reported inverse association between number of children and risk of testicular cancer, but it does not find evidence of an association for other indicators of subfertility.	[Grasso, Chiara; Zugna, Daniela; Fiano, Valentina; Rodriguez, Nena Robles; Maule, Milena; Gillio-Tos, Anna; Merletti, Franco; Richiardi, Lorenzo] Univ Turin, Dept Med Sci, Canc Epidemiol Unit CeRMS, Turin, Italy; [Grasso, Chiara; Zugna, Daniela; Fiano, Valentina; Rodriguez, Nena Robles; Maule, Milena; Gillio-Tos, Anna; Merletti, Franco; Richiardi, Lorenzo] CPO Piedmont, Turin, Italy; [Ciuffreda, Libero; Lista, Patrizia] Univ Hosp Citta Salute & Sci, Med Oncol Div 1, Turin, Italy; [Segnan, Nereo] CPO Piedmont, Dept Canc Screening, Turin, Italy; [Segnan, Nereo] CPO Piedmont, Canc Epidemiol Unit, WHO Collaborat Ctr Canc Early Diag & Screening, Turin, Italy; [Segnan, Nereo] Univ Hosp Citta Salute & Sci, Turin, Italy	University of Turin; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; A.O.U. Citta della Salute e della Scienza di Torino; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; A.O.U. Citta della Salute e della Scienza di Torino	Grasso, C (corresponding author), Univ Turin, Dept Med Sci, Canc Epidemiol Unit CeRMS, Turin, Italy.; Grasso, C (corresponding author), CPO Piedmont, Turin, Italy.	chgrasso@unito.it	Maule, Milena M/K-3858-2018; , Robles-Rodriguez ,N/G-8271-2019	Maule, Milena M/0000-0003-2142-1288; Gillio-Tos, Anna/0000-0001-6553-5362; , Robles-Rodriguez ,N/0000-0001-8764-8704	Piedmont Region; scolarship Erasmus Columbus project	Piedmont Region(Regione Piemonte); scolarship Erasmus Columbus project	This work was partially supported by the Piedmont Region (www.regione.piemonte.it/). NRR was funded by a scolarship Erasmus Columbus project for academic mobility scholarships in the thematic fields related to health and public health (ERACOL) (http://nihes.com/eracol). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen KE, 2013, HUM REPROD, V28, P1995, DOI 10.1093/humrep/det127; Aschim EL, 2008, INT J ANDROL, V31, P588, DOI 10.1111/j.1365-2605.2007.00813.x; Baker JA, 2005, CANCER CAUSE CONTROL, V16, P295, DOI 10.1007/s10552-004-4024-2; Banz-Jansen C, 2012, ARCH GYNECOL OBSTET, V285, P247, DOI 10.1007/s00404-011-1938-2; Bialas M, 2010, ANDROLOGIA, V42, P83, DOI 10.1111/j.1439-0272.2009.00960.x; Boldajipour Bijan, 2007, Sci STKE, V2007, ppe16, DOI 10.1126/stke.3832007pe16; Bray F, 2006, INT J CANCER, V118, P3099, DOI 10.1002/ijc.21747; BROWN LM, 1987, J EPIDEMIOL COMMUN H, V41, P349, DOI 10.1136/jech.41.4.349; Cheng P, 2013, BIOMARKERS, V18, P650, DOI 10.3109/1354750X.2013.838307; Chung CC, 2013, NAT GENET, V45, P680, DOI 10.1038/ng.2634; Coffey J, 2008, GENE CHROMOSOME CANC, V47, P34, DOI 10.1002/gcc.20503; Cook MB, 2009, INT J EPIDEMIOL, V38, P1532, DOI 10.1093/ije/dyp287; de Llanos M, 2005, HUM REPROD, V20, P216, DOI 10.1093/humrep/deh582; Dong SM, 2002, CANCER EPIDEM BIOMAR, V11, P3; Doria-Rose VP, 2005, CANCER CAUSE CONTROL, V16, P651, DOI 10.1007/s10552-005-0169-x; Eisenberg ML, 2015, J UROLOGY, V193, P1596, DOI 10.1016/j.juro.2014.11.080; Feng HL, 1999, FERTIL STERIL, V71, P85, DOI 10.1016/S0015-0282(98)00401-4; Ferlin A, 2005, J MED GENET, V42, P209, DOI 10.1136/jmg.2004.025833; Ferlin A, 2012, ENDOCR-RELAT CANCER, V19, P101, DOI 10.1530/ERC-11-0340; FORMAN D, 1994, BRIT MED J, V308, P1393, DOI 10.1136/bmj.308.6941.1393; Fujisawa M, 1998, UROLOGY, V51, P460, DOI 10.1016/S0090-4295(97)00627-4; Galan JJ, 2006, HUM REPROD, V21, P3185, DOI 10.1093/humrep/del313; Ghazarian AA, 2015, ANDROLOGY-US, V3, P13, DOI 10.1111/andr.288; Guerif F, 2002, INT J ANDROL, V25, P358, DOI 10.1046/j.1365-2605.2002.00382.x; Hanson HA, 2016, FERTIL STERIL, V105, P322, DOI 10.1016/j.fertnstert.2015.10.027; HAUGHEY BP, 1989, AM J EPIDEMIOL, V130, P25, DOI 10.1093/oxfordjournals.aje.a115319; Jacobsen R, 2000, BMJ-BRIT MED J, V321, P789, DOI 10.1136/bmj.321.7264.789; Jacobsen R, 2000, HUM REPROD, V15, P1958, DOI 10.1093/humrep/15.9.1958; Kanatsu-Shinohara M, 2005, HUM REPROD, V20, P2376, DOI 10.1093/humrep/dei096; Kanetsky PA, 2011, HUM MOL GENET, V20, P3109, DOI 10.1093/hmg/ddr207; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kissel H, 2000, EMBO J, V19, P1312, DOI 10.1093/emboj/19.6.1312; Kratz CP, 2011, INT J ANDROL, V34, pE98, DOI 10.1111/j.1365-2605.2011.01156.x; Lessel D, 2012, CARCINOGENESIS, V33, P1548, DOI 10.1093/carcin/bgs218; Looijenga LHJ, 2003, CANCER RES, V63, P7674; Lynch M, 2005, MOL HUM REPROD, V11, P507, DOI 10.1093/molehr/gah191; Mauduit C, 1999, HUM REPROD UPDATE, V5, P535, DOI 10.1093/humupd/5.5.535; McGlynn KA, 2012, NAT REV UROL, V9, P339, DOI 10.1038/nrurol.2012.61; Mirabello L, 2012, INT J MOL EPIDEMIOL, V3, P213; Moirano G, 2016, ANDROLOGY-US, V4, P251, DOI 10.1111/andr.12148; Moller H, 1999, BMJ-BRIT MED J, V318, P559, DOI 10.1136/bmj.318.7183.559; Nathanson KL, 2005, AM J HUM GENET, V77, P1034, DOI 10.1086/498455; Raman JD, 2005, J UROLOGY, V174, P1819, DOI 10.1097/01.ju.0000177491.98461.aa; Rapley EA, 2004, BRIT J CANCER, V90, P2397, DOI 10.1038/sj.bjc.6601880; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Richiardi L, 2004, EPIDEMIOLOGY, V15, P323, DOI 10.1097/01.ede.0000120043.45185.7e; Richiardi L, 2004, J NATL CANCER I, V96, P145, DOI 10.1093/jnci/djh012; Richiardi L, 2014, INT J CANCER, V135, P695, DOI 10.1002/ijc.28688; Rosen A, 2011, EUR UROL, V60, P374, DOI 10.1016/j.eururo.2011.05.004; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Ruark E, 2013, NAT GENET, V45, P686, DOI 10.1038/ng.2635; Schumacher FR, 2013, HUM MOL GENET, V22, P2748, DOI 10.1093/hmg/ddt109; SWERDLOW AJ, 1989, INT J CANCER, V43, P549, DOI 10.1002/ijc.2910430403; Tian QS, 1999, AM J PATHOL, V154, P1643, DOI 10.1016/S0002-9440(10)65419-3; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Walsh TJ, 2009, ARCH INTERN MED, V169, P351, DOI 10.1001/archinternmed.2008.562	56	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169174	10.1371/journal.pone.0169174	http://dx.doi.org/10.1371/journal.pone.0169174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036409	Green Published, Green Submitted, gold			2022-12-26	WOS:000391229300062
J	Kalita, B; Ranjan, R; Singh, A; Yashavarddhan, MH; Bajaj, S; Gupta, ML				Kalita, Bhargab; Ranjan, Rajiv; Singh, Abhinav; Yashavarddhan, M. H.; Bajaj, Sania; Gupta, Manju Lata			A Combination of Podophyllotoxin and Rutin Attenuates Radiation Induced Gastrointestinal Injury by Negatively Regulating NF-kappa B/p53 Signaling in Lethally Irradiated Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; IONIZING-RADIATION; ACTIVE PRINCIPLES; IN-VITRO; KAPPA-B; HEXANDRUM; ACTIVATION; PROTECTION; DAMAGE; MOUSE	Development of an effective radio protector to minimise radiation-inflicted damages have largely failed owing to inherent toxicity of most of the agents examined so far. This study is centred towards delivering protection to lethally irradiated mice by pre-administration of a safe formulation G-003M (combination of podophyllotoxin and rutin) majorly through regulation of inflammatory and cell death pathways in mice. Single intramuscular dose of G-003M injected 60 min prior to 9 Gy exposure rescued 89% of whole body lethally irradiated C57BL/6J mice. Studies have revealed reduction in radiation induced reactive oxygen species (ROS), nitric oxide (NO) generation, prostaglandin E2 (PGE2) levels and intestinal apoptosis in G-003M pre-treated mice intestine. Restricted nuclear translocation of redox-sensitive Nuclear factor-kappa B (NF-kappa B) and subsequent downregulation of cyclo-oxygenase 2 (COX-2), inducible nitric oxide synthase (iNOS; EC 1.14.13.39) and tumor necrosis factor (TNF-alpha) levels demonstrated the anti-inflammatory effect that G-003M exerts. Support to early hematopoietic recovery was exhibited through G-003M mediated induction of granulocyte colony stimulating factor (G-CSF) and interleukin (IL-6) levels in lethally irradiated mice. Considerable attenuation in radiation induced morphological damage to the intestinal villi, crypts and mucosal layers was observed in G-003M pre-treated mice. Additionally, our formulation did not reduce the sensitivity of tumor tissue to radiation. Altogether, these results suggest that G-003M ameliorates the deleterious effects of radiation exposure by minimising ROS and NO generation and effectively regulating inflammatory and cell death pathways. Mechanism of protection elucidated in the current study demonstrates that G-003M can be used as a safe and effective radio protective agent in radiotherapy for human application.	[Kalita, Bhargab; Ranjan, Rajiv; Singh, Abhinav; Yashavarddhan, M. H.; Bajaj, Sania; Gupta, Manju Lata] Inst Nucl Med & Allied Sci, Div Radioprotect Drug Dev & Res, Brig SK Mazumdar Marg, Delhi, India	Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS)	Gupta, ML (corresponding author), Inst Nucl Med & Allied Sci, Div Radioprotect Drug Dev & Res, Brig SK Mazumdar Marg, Delhi, India.	manjuinmas@gmail.com		Yashavarddhan, M. H./0000-0002-3520-4287	Defence Research & Development Organization (DRDO), Ministry of Defence, Govt. of India [INM-311]; University Grants Commission (UGC), Government of India	Defence Research & Development Organization (DRDO), Ministry of Defence, Govt. of India; University Grants Commission (UGC), Government of India(University Grants Commission, India)	This work was funded by the grant INM-311 from Defence Research & Development Organization (DRDO), Ministry of Defence, Govt. of India. BK, RR, AS, SB acknowledges University Grants Commission (UGC), Government of India for the award of senior research fellowship. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; Brush J, 2007, SEMIN RADIAT ONCOL, V17, P121, DOI 10.1016/j.semradonc.2006.11.008; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Chiu FL, 2008, FEBS LETT, V582, P2407, DOI 10.1016/j.febslet.2008.05.049; Circu ML, 2011, FREE RADICAL RES, V45, P1245, DOI 10.3109/10715762.2011.611509; Cohn SM, 1997, J CLIN INVEST, V99, P1367, DOI 10.1172/JCI119296; Datta K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042224; Dutta A, 2015, FREE RADICAL RES, V49, P317, DOI 10.3109/10715762.2015.1004328; Dutta S, 2014, MUTAGENESIS, V29, P139, DOI 10.1093/mutage/get071; Goel A, 2010, NUTR CANCER, V62, P919, DOI 10.1080/01635581.2010.509835; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Gupta ML, 2008, J MED FOOD, V11, P486, DOI 10.1089/jmf.2006.0216; Hosseinimehr SJ, 2007, DRUG DISCOV TODAY, V12, P794, DOI 10.1016/j.drudis.2007.07.017; Huang EY, 2009, INT J RADIAT ONCOL, V74, P237, DOI 10.1016/j.ijrobp.2009.01.017; Jagetia GC, 2007, J CLIN BIOCHEM NUTR, V40, P74, DOI 10.3164/jcbn.40.74; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; Kouvaris JR, 2007, ONCOLOGIST, V12, P738, DOI 10.1634/theoncologist.12-6-738; Kulkarni SS, 2012, INT IMMUNOPHARMACOL, V14, P495, DOI 10.1016/j.intimp.2012.09.001; Lata M, 2009, PHYTOMEDICINE, V16, P47, DOI 10.1016/j.phymed.2007.04.010; Lu XY, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-36; Macartney KK, 2000, J VIROL, V74, P5597, DOI 10.1128/JVI.74.12.5597-5603.2000; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MacNaughton WK, 1998, INT J RADIAT BIOL, V74, P255; Ong ZY, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-22; Polistena Andrea, 2008, BMC Surg, V8, P1, DOI 10.1186/1471-2482-8-1; Qiu W, 2010, ONCOGENE, V29, P1622, DOI 10.1038/onc.2009.451; RACHMILEWITZ D, 1995, GUT, V36, P718, DOI 10.1136/gut.36.5.718; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Saini R, 2013, CELLBIO; Sankhwar S, 2011, EVIDENCE BASED COMPL; Schreiber S, 1998, ACTIVATION NUCL FACT, V42, P477; Singer II, 1996, GASTROENTEROLOGY, V111, P871, DOI 10.1016/S0016-5085(96)70055-0; Somosy Z, 2002, MICRON, V33, P167, DOI 10.1016/S0968-4328(01)00013-0; Srivastava NN, 2014, ENVIRON MOL MUTAGEN, V55, P436, DOI 10.1002/em.21853; Tessner TG, 2004, J CLIN INVEST, V114, P1676, DOI 10.1172/JCI200422218; Thotala D, 2009, FREE RADICAL BIO MED, V47, P779, DOI 10.1016/j.freeradbiomed.2009.06.020; Verma S., 2014, OXID ANTIOXID MED SC, V3, P51; YUHAS JM, 1980, CANCER RES, V40, P1519; YUHAS JM, 1979, CANCER TREAT REP, V63, P971; Zhang H, 2011, J RADIAT RES, V52, P717, DOI 10.1269/jrr.11054; Zhou DH, 1999, RADIAT RES, V151, P703, DOI 10.2307/3580209	44	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168525	10.1371/journal.pone.0168525	http://dx.doi.org/10.1371/journal.pone.0168525			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036347	gold, Green Submitted, Green Published			2022-12-26	WOS:000391229300016
J	Farre, D; Engel, P; Angulo, A				Farre, Domenec; Engel, Pablo; Angulo, Ana			Novel Role of 3'UTR-Embedded Alu Elements as Facilitators of Processed Pseudogene Genesis and Host Gene Capture by Viral Genomes	PLOS ONE			English	Article							LINE-1 RETROTRANSPOSITION; L1 RETROTRANSPOSITION; REVERSE-TRANSCRIPTASE; MESSENGER-RNA; DIHYDROFOLATE-REDUCTASE; TRANSPOSABLE ELEMENTS; HERPESVIRUS SAIMIRI; RETROPOSED GENE; SRP9/14 SUBUNIT; EVOLUTION	Since the discovery of the high abundance of Alu elements in the human genome, the interest for the functional significance of these retrotransposons has been increasing. Primate Alu and rodent Alu-like elements are retrotransposed by a mechanism driven by the LINE1 (LI) encoded proteins, the same machinery that generates the L1 repeats, the processed pseudogenes (PPs), and other retroelements. Apart from free Alu RNAs, Alus are also transcribed and retrotranscribed as part of cellular gene transcripts, generally embedded inside 3' untranslated regions (UTRs). Despite different proposed hypotheses, the functional implication of the presence of Alus inside 3'UTRs remains elusive. In this study we hypothesized that Alu elements in 3'UTRs could be involved in the genesis of PPs. By analyzing human genome data we discovered that the existence of 3'UTR-embedded Alu elements is over-represented in genes source of PPs. In contrast, the presence of other retrotransposable elements in 3'UTRs does not show this PP linked overrepresentation. This research was extended to mouse and rat genomes and the results accordingly reveal overrepresentation of 3'UTR-embedded B1 (Alu-like) elements in PP parent genes. Interestingly, we also demonstrated that the overrepresentation of 3'UTR-embedded Alus is particularly significant in PP parent genes with low germline gene expression level. Finally, we provide data that support the hypothesis that the L1 machinery is also the system that herpesviruses, and possibly other large DNA viruses, use to capture host genes expressed in germline or somatic cells. Altogether our results suggest a novel role for Alu or Alu-like elements inside 3'UTRs as facilitators of the genesis of PPs, particularly in lowly expressed genes. Moreover, we propose that this L1-driven mechanism, aided by the presence of 3'UTR-embedded Alus, may also be exploited by DNA viruses to incorporate host genes to their viral genomes.	[Farre, Domenec; Engel, Pablo; Angulo, Ana] Univ Barcelona, Immunol Unit, Dept Biomed Sci, Sch Med, Barcelona, Spain; [Farre, Domenec; Engel, Pablo; Angulo, Ana] Inst Invest Biomed August Pi I Sunyer, Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Farre, D (corresponding author), Univ Barcelona, Immunol Unit, Dept Biomed Sci, Sch Med, Barcelona, Spain.; Farre, D (corresponding author), Inst Invest Biomed August Pi I Sunyer, Barcelona, Spain.	domenecfarre@ub.edu	Engel, Pablo/R-5907-2019; Farre, Domenec/K-8010-2014	Engel, Pablo/0000-0001-8410-252X; Farre, Domenec/0000-0001-8553-1983; Angulo, Ana/0000-0002-5792-1164	Ministerio de Ciencia e Innovacion (MICINN, Spain) [SAF2011-25155, SAF2015-69829]; Ministerio de Educacion y Ciencia [SAF2012-39536]; National Institutes of Health [P01 AI065687]; Juan de la Cierva postdoctoral contract from the MICINN [JCI-2011-10313]	Ministerio de Ciencia e Innovacion (MICINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Educacion y Ciencia(Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juan de la Cierva postdoctoral contract from the MICINN	This work was supported by grants from the Ministerio de Ciencia e Innovacion (MICINN, Spain; grant numbers SAF2011-25155 to AA and SAF2015-69829 to PE); the Ministerio de Educacion y Ciencia (grant number SAF2012-39536 to PE); and the National Institutes of Health (grant number P01 AI065687 to PE). DF was supported by a Juan de la Cierva postdoctoral contract (JCI-2011-10313) from the MICINN.	ALBRECHT JC, 1992, VIROLOGY, V190, P527, DOI 10.1016/0042-6822(92)91247-R; An HJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-97; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Balasubramanian S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r2; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Belancio VP, 2010, NUCLEIC ACIDS RES, V38, P3909, DOI 10.1093/nar/gkq132; Boeke JD, 1997, NAT GENET, V16, P6, DOI 10.1038/ng0597-6; Bovia F, 1997, NUCLEIC ACIDS RES, V25, P318, DOI 10.1093/nar/25.2.318; BOVIA F, 1995, MOL BIOL CELL, V6, P471, DOI 10.1091/mbc.6.4.471; Brunet TDP, 2015, GENOME BIOL EVOL, V7, P2445, DOI 10.1093/gbe/evv152; Brunovskis P, 1995, VIRUS GENES, V11, P259, DOI 10.1007/BF01728664; Chang DY, 1996, NUCLEIC ACIDS RES, V24, P4165, DOI 10.1093/nar/24.21.4165; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Ciomborowska J, 2013, MOL BIOL EVOL, V30, P384, DOI 10.1093/molbev/mss235; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cuconati A, 2002, GENE DEV, V16, P2465, DOI 10.1101/gad.1012702; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; de Boer M, 2014, HUM MUTAT, V35, P486, DOI 10.1002/humu.22519; DEININGER PL, 1992, TRENDS GENET, V8, P307, DOI 10.1016/0168-9525(92)90262-3; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Dewannieux M, 2005, CYTOGENET GENOME RES, V110, P35, DOI 10.1159/000084936; Dewannieux M, 2005, J MOL BIOL, V349, P241, DOI 10.1016/j.jmb.2005.03.068; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Dhellin O, 1997, EMBO J, V16, P6590, DOI 10.1093/emboj/16.21.6590; Doucet AJ, 2015, MOL BIOL EVOL, V32, P1815, DOI 10.1093/molbev/msv062; Doucet AJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001150; Engel P, 2012, ADV EXP MED BIOL, V738, P256, DOI 10.1007/978-1-4614-1680-7_15; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Farkash EA, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/37285; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Firth C, 2010, MOL BIOL EVOL, V27, P2038, DOI 10.1093/molbev/msq088; Fitzpatrick T, 2012, NUCLEUS-PHILA, V3, P359, DOI 10.4161/nucl.20827; Frankish A, 2014, METHODS MOL BIOL, V1167, P129, DOI 10.1007/978-1-4939-0835-6_10; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hasler J, 2007, CELL MOL LIFE SCI, V64, P1793, DOI 10.1007/s00018-007-7084-0; Hoffman Y, 2013, BIOINFORMATICS, V29, P894, DOI 10.1093/bioinformatics/btt044; Holzerlandt R, 2002, GENOME RES, V12, P1739, DOI 10.1101/gr.334302; HSU DH, 1990, SCIENCE, V250, P830, DOI 10.1126/science.2173142; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jayawardane G, 2008, J GEN VIROL, V89, P2447, DOI 10.1099/vir.0.2008/001743-0; Ji Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.69; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Jurka J, 1996, J MOL EVOL, V43, P685, DOI 10.1007/BF02202117; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Karro JE, 2007, NUCLEIC ACIDS RES, V35, pD55, DOI 10.1093/nar/gkl851; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kazazian HH, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-20; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kramerov DA, 2011, HEREDITY, V107, P487, DOI 10.1038/hdy.2011.43; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy A, 2008, NUCLEIC ACIDS RES, V36, pD47, DOI 10.1093/nar/gkm949; Li TH, 2001, GENE, V276, P135, DOI 10.1016/S0378-1119(01)00637-0; LIU WM, 1995, NUCLEIC ACIDS RES, V23, P1758, DOI 10.1093/nar/23.10.1758; Makalowski W, 2000, GENE, V259, P61, DOI 10.1016/S0378-1119(00)00436-4; Mandal PK, 2013, HUM MOL GENET, V22, P3730, DOI 10.1093/hmg/ddt225; Marques AC, 2005, PLOS BIOL, V3, P1970, DOI 10.1371/journal.pbio.0030357; Martin SL, 2005, J MOL BIOL, V348, P549, DOI 10.1016/j.jmb.2005.03.003; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; McEntee G, 2011, P NATL ACAD SCI USA, V108, P15157, DOI 10.1073/pnas.1103605108; McFadden G, 2000, CURR OPIN MICROBIOL, V3, P371, DOI 10.1016/S1369-5274(00)00107-7; McVicker G, 2010, GENOME RES, V20, P1503, DOI 10.1101/gr.106666.110; Michelson S, 2004, HUM IMMUNOL, V65, P465, DOI 10.1016/j.humimm.2004.02.002; Miller-Kittrell M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-4; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; Muotri AR, 2007, HUM MOL GENET, V16, pR159, DOI 10.1093/hmg/ddm196; Navarro FCP, 2015, GENOME BIOL EVOL, V7, P2265, DOI 10.1093/gbe/evv142; Odom MR, 2009, VIRUS RES, V144, P233, DOI 10.1016/j.virusres.2009.05.006; Ohshima K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r74; Okamura K, 2008, MOL BIOL EVOL, V25, P1231, DOI 10.1093/molbev/msn071; Oliver KR, 2012, ECOL EVOL, V2, P2912, DOI 10.1002/ece3.400; Oliver KR, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-8; Ouyang P, 2014, J GEN VIROL, V95, P245, DOI 10.1099/vir.0.058966-0; PANNING B, 1995, J MOL BIOL, V248, P513, DOI 10.1006/jmbi.1995.0239; PAULSON KE, 1986, NUCLEIC ACIDS RES, V14, P6145, DOI 10.1093/nar/14.15.6145; Pavlicek A, 2006, TRENDS GENET, V22, P69, DOI 10.1016/j.tig.2005.11.005; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Perez-Carmona N, 2015, J VIROL, V89, P11323, DOI 10.1128/JVI.01296-15; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Prak ETL, 2003, P NATL ACAD SCI USA, V100, P1832, DOI 10.1073/pnas.0337627100; Prokesch A, 2011, NUCLEIC ACIDS RES, V39, P3224, DOI 10.1093/nar/gkq1289; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; QUENTIN Y, 1994, NUCLEIC ACIDS RES, V22, P2222, DOI 10.1093/nar/22.12.2222; QUENTIN Y, 1992, NUCLEIC ACIDS RES, V20, P3397, DOI 10.1093/nar/20.13.3397; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schmid CW, 1998, NUCLEIC ACIDS RES, V26, P4541, DOI 10.1093/nar/26.20.4541; Sciamanna I, 2014, ONCOTARGET, V5, P8039, DOI 10.18632/oncotarget.2504; Sela N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010907; Shackelton LA, 2004, TRENDS MICROBIOL, V12, P458, DOI 10.1016/j.tim.2004.08.005; Shen SH, 2011, P NATL ACAD SCI USA, V108, P2837, DOI 10.1073/pnas.1012834108; Smalheiser NR, 2006, TRENDS GENET, V22, P532, DOI 10.1016/j.tig.2006.08.007; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Tajnik M, 2015, NUCLEIC ACIDS RES, V43, P10492, DOI 10.1093/nar/gkv956; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; TRIMBLE JJ, 1988, SCIENCE, V239, P1145, DOI 10.1126/science.2830673; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; Vassetzky NS, 2003, GENE, V319, P149, DOI 10.1016/S0378-1119(03)00805-9; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Walters RD, 2009, IUBMB LIFE, V61, P831, DOI 10.1002/iub.227; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weber MJ, 2006, PLOS GENET, V2, P1984, DOI 10.1371/journal.pgen.0020205; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Weichenrieder O, 2000, NATURE, V408, P167, DOI 10.1038/35041507; Wilson GM, 1998, J LIPID RES, V39, P1025; Worley KC, 2014, NAT GENET, V46, P850, DOI 10.1038/ng.3042; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Zhang ZL, 2004, TRENDS GENET, V20, P62, DOI 10.1016/j.tig.2003.12.005; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zheng DY, 2007, TRENDS GENET, V23, P219, DOI 10.1016/j.tig.2007.03.003	123	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0169196	10.1371/journal.pone.0169196	http://dx.doi.org/10.1371/journal.pone.0169196			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033411	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900084
J	Haber, YO; Chandler, HK; Serrador, JM				Haber, Yaa O.; Chandler, Helena K.; Serrador, Jorge M.			Symptoms Associated with Vestibular Impairment in Veterans with Posttraumatic Stress Disorder	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ANXIETY DISORDERS; PTSD CHECKLIST; PRIMARY-CARE; HEAD-INJURY; PSYCHOMETRIC PROPERTIES; MOBILITY INVENTORY; CIVILIAN VERSION; BALANCE CONTROL; DIZZY PATIENTS	Posttraumatic stress disorder (PTSD) is a chronic and disabling, anxiety disorder resulting from exposure to life threatening events such as a serious accident, abuse or combat (DSM IV definition). Among veterans with PTSD, a common complaint is dizziness, disorientation and/or postural imbalance in environments such as grocery stores and shopping malls. The etiology of these symptoms in PTSD is poorly understood and some attribute them to anxiety or traumatic brain injury. There is a possibility that an impaired vestibular system may contribute to these symptoms since, symptoms of an impaired vestibular system include dizziness, disorientation and postural imbalance. To our knowledge, this is the first report to describe the nature of vestibular related symptoms in veterans with and without PTSD. We measured PTSD symptoms using the Posttraumatic Stress Disorder Checklist (PCL-C) and compared it to responses on vestibular function scales including the Dizziness Handicap Inventory (DHI), the Vertigo Symptom Scale Short Form (VSS-SF), the Chambless Mobility Inventory (CMI), and the Neurobehavioral Scale Inventory (NSI) in order to identify vestibular-related symptoms. Our findings indicate that veterans with worse PTSD symptoms report increased vestibular related symptoms. Additionally veterans with PTSD reported 3 times more dizziness related handicap than veterans without PTSD. Veterans with increased avoidance reported more vertigo and dizziness related handicap than those with PTSD and reduced avoidance. We describe possible contributing factors to increased reports of vestibular symptoms in PTSD, namely, anxiety, a vestibular component as well as an interactive effect of anxiety and vestibular impairment. We also present some preliminary analyses regarding the contribution of TBI. This data suggests possible evidence for vestibular symptom reporting in veterans with PTSD, which may be explained by possible underlying vestibular impairment, worthy of further exploration.	[Haber, Yaa O.; Serrador, Jorge M.] Rutgers Biomed Hlth Sci, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA; [Haber, Yaa O.; Chandler, Helena K.; Serrador, Jorge M.] Vet Affairs New Jersey Healthcare Syst, War Related Illness & Injury Study Ctr, E Orange, NJ USA; [Serrador, Jorge M.] Natl Univ Ireland Galway, Cardiovasc Elect, Galway, Ireland	Rutgers State University New Brunswick; Rutgers State University Medical Center; Ollscoil na Gaillimhe-University of Galway	Chandler, HK (corresponding author), Vet Affairs New Jersey Healthcare Syst, War Related Illness & Injury Study Ctr, E Orange, NJ USA.	Helena.chandler@va.gov		Serrador, Jorge Manuel/0000-0003-1830-4398	War Related Illness and Injury Study Center (WRIISC); Office of Public Health within the Department of Veteran Affairs	War Related Illness and Injury Study Center (WRIISC); Office of Public Health within the Department of Veteran Affairs	This work was supported by the War Related Illness and Injury Study Center (WRIISC) and the Office of Public Health within the Department of Veteran Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Andersson G, 2000, SCAND J PSYCHOL, V41, P49, DOI 10.1111/1467-9450.00170; AZZENA GB, 1993, ARCH ITAL BIOL, V131, P127; Baker DG, 1997, ARCH INTERN MED, V157, P2076, DOI 10.1001/archinte.157.18.2076; Balaban CD, 2002, PHYSIOL BEHAV, V77, P469, DOI 10.1016/S0031-9384(02)00935-6; Balaban CD, 2001, J ANXIETY DISORD, V15, P27, DOI 10.1016/S0887-6185(00)00041-4; Balabann CD, 2011, EXPERT REV NEUROTHER, V11, P379, DOI [10.1586/ern.11.19, 10.1586/ERN.11.19]; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; CHAMBLESS DL, 1985, BEHAV RES THER, V23, P35, DOI 10.1016/0005-7967(85)90140-8; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Cohen JT, 2002, ISRAEL MED ASSOC J, V4, P559; Cominski TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00273; COX BJ, 1993, BEHAV RES THER, V31, P427, DOI 10.1016/0005-7967(93)90102-Z; Dobie DJ, 2006, J GEN INTERN MED, V21, pS58, DOI 10.1111/j.1525-1497.2006.00376.x; Dutia MB, 2010, CURR OPIN OTOLARYNGO, V18, P420, DOI 10.1097/MOO.0b013e32833de71f; Furman JM, 2006, J VESTIBUL RES-EQUIL, V16, P209; Gore KL, 2008, GEN HOSP PSYCHIAT, V30, P391, DOI 10.1016/j.genhosppsych.2008.05.002; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Jacob RG, 2009, J NEUROL NEUROSUR PS, V80, P74, DOI 10.1136/jnnp.2007.136432; Jacob RG, 1996, AM J PSYCHIAT, V153, P503; JOHANSSON R, 1991, ACTA OTO-LARYNGOL, P585; Karstoft KI, 2014, PSYCHOL ASSESSMENT, V26, P321, DOI 10.1037/a0034889; Karstoft KI, 2013, PSYCHOL ASSESSMENT, DOI [10.1186/1472-6815-8-2, DOI 10.1186/1472-6815-8-2]; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kisilevski V, 2001, Int Tinnitus J, V7, P118; Lang AJ, 2003, J TRAUMA STRESS, V16, P257, DOI 10.1023/A:1023796007788; Ma FR, 2007, CHINESE MED J-PEKING, V120, P120, DOI 10.1097/00029330-200701020-00009; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; Murray K, 2001, Physiother Res Int, V6, P251, DOI 10.1002/pri.232; Pogoda TK, 2012, MULTISENSORY IMPAIRM, P971; Radziej K, 2015, J PSYCHOSOM RES, V79, P123, DOI 10.1016/j.jpsychores.2015.05.005; Ragsdale KA, 2013, J ANXIETY DISORD, V27, P420, DOI 10.1016/j.janxdis.2013.04.003; Rogers C, 2011, S AFR J COMMUN DISOR, V58, P6; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Saman Yougan, 2012, Front Neurol, V3, P116, DOI 10.3389/fneur.2012.00116; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Scherer MR, 2009, PHYS THERAPY, V89, P980, DOI 10.2522/ptj.20080353; Schlund MW, 2010, NEUROIMAGE, V53, P769, DOI 10.1016/j.neuroimage.2010.06.058; Schubert MC, 2004, PHYS THER, V84, P373, DOI 10.1093/ptj/84.4.373; Serrador JM BM, ASS RES OTOLARYNGOLO; Surget A, 2008, EUR J PHARMACOL, V583, P340, DOI 10.1016/j.ejphar.2007.11.065; Tamber AL, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-101; Teggi R, 2010, J LARYNGOL OTOL, V124, P285, DOI 10.1017/S0022215109991976; WALL C, 1983, ACTA OTO-LARYNGOL, V95, P235, DOI 10.3109/00016488309130940; Wilhelmsen K, 2008, BMC EAR NOSE THROAT, V8, DOI 10.1186/1472-6815-8-2; YARDLEY L, 1992, J PSYCHOSOM RES, V36, P731, DOI 10.1016/0022-3999(92)90131-K; YARDLEY L, 1994, SOC SCI MED, V39, P573, DOI 10.1016/0277-9536(94)90100-7; YARDLEY L, 1995, BEHAV RES THER, V33, P435, DOI 10.1016/0005-7967(94)00060-W; Yeager DE, 2007, GEN HOSP PSYCHIAT, V29, P294, DOI 10.1016/j.genhosppsych.2007.03.004; Yeh JR, 2014, GAIT POSTURE, V40, P581, DOI 10.1016/j.gaitpost.2014.06.016	54	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168803	10.1371/journal.pone.0168803	http://dx.doi.org/10.1371/journal.pone.0168803			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7KQ	28033352	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900049
J	Javaid, A; Kulesz, MM; Schluter, A; Ghosh, A; Jiddawi, NS				Javaid, Aneeque; Kulesz, Micaela M.; Schlueter, Achim; Ghosh, Alexandra; Jiddawi, Narriman S.			Time Preferences and Natural Resource Extraction Behavior: An Experimental Study from Artisanal Fisheries in Zanzibar	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; CORAL-REEF FISHERIES; RISK PREFERENCES; ECONOMICS; ILLEGAL; COMMONS; COOPERATION; MANAGEMENT; REWARDS; SYSTEMS	Natural resource users face a trade-off between present and future consumption. Using harmful methods or extracting unsustainably, lowers future consumption. Therefore, it is reasonable to posit that people with higher time preferences extract more as compared to people with lower time preferences. The present study combines experimental methods and questionnaire data in order to understand the relationship between individual time preferences and fishers' extraction behavior. We elicit individual time preferences using an incentivized experiment, linking the resulting time preference measures to extraction data from a questionnaire, as well as data collected from a framed Common Pool Resource (CPR) experiment. Both the experiments and questionnaire were conducted with artisanal fishers in Zanzibar. Our findings suggest that the relationship between time preferences and CPR extraction is not as straightforward as predicted by classical economic theory. In contrast to earlier studies, we find that fishers' time preferences are negatively correlated to their extraction rates. Our surprising findings can partly be explained by the fact that higher time preferences are associated with lower investment in extraction capability (the disinvestment effect of time preferences), and by fishers A cognitive abilities.	[Javaid, Aneeque] Univ Osnabruck, Inst Umweltsyst Forsch, Osnabruck, Germany; [Javaid, Aneeque; Schlueter, Achim; Ghosh, Alexandra] Jacobs Univ, Bremen, Germany; [Javaid, Aneeque; Kulesz, Micaela M.; Schlueter, Achim; Ghosh, Alexandra] Leibniz Ctr Trop Marine Ecol Zmt, Bremen, Germany; [Kulesz, Micaela M.] Swedish Univ Agr Sci, Uppsala, Sweden; [Jiddawi, Narriman S.] Dar Es Salaam Univ, Inst Marine Sci, Zanzibar, Tanzania	University Osnabruck; Jacobs University; Leibniz Zentrum fur Marine Tropenforschung (ZMT); Swedish University of Agricultural Sciences; University of Dar es Salaam	Javaid, A (corresponding author), Univ Osnabruck, Inst Umweltsyst Forsch, Osnabruck, Germany.; Javaid, A (corresponding author), Jacobs Univ, Bremen, Germany.; Javaid, A (corresponding author), Leibniz Ctr Trop Marine Ecol Zmt, Bremen, Germany.	aneeque.javaid@uni-osnabrueck.de		Javaid, Aneeque/0000-0003-0453-2701	Leibniz Center for Tropical Marine Ecology; Leibniz Association	Leibniz Center for Tropical Marine Ecology; Leibniz Association	Financial support from the Leibniz Center for Tropical Marine Ecology, the Leibniz Association and the graduate school SUTAS is gratefully acknowledged. For more details about SUTAS visit: http://www.zmt-bremen.de/en/SUTAS.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The field work was conducted with the excellent assistance provided by Ramadhan Rashid Hassan, Mwanamrishu Gora Haji, Ali Mkanga, Mohammed S.Yusuf, Fatma Mhina, Said Juma. We thank Marty Anderies, Joshua Abbott, the members of the Department of Social Sciences at the Leibniz Center for Tropical Marine Ecology, the SUTAS PhD students, and the participants at the WIOMSA 2015 conference for valuable comments. Caroline van Bers provided scientific editorial help. We thank the anonymous reviewers, whose comments and suggestions improved the manuscript considerably. Finally, we would like to express our gratitude to the participants in our experiments for taking part in the study and providing detailed information about their fishing activities. Financial support from the Leibniz Center for Tropical Marine Ecology the Leibniz Association and the graduate school SUTAS is gratefully acknowledged.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Al-Ubaydli O, 2013, J NEUROSCI PSYCHOL E, V6, P71, DOI 10.1037/npe0000005; Andreoni J, 2012, AM ECON REV, V102, P3357, DOI 10.1257/aer.102.7.3357; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Burks S, 2012, J ECON BEHAV ORGAN, V84, P308, DOI 10.1016/j.jebo.2012.03.012; Chabris C. F., 2008, MEASURING INTERTEMPO; Chakravorty U, 2000, FOREST RESOURCE EXTR; Chuang Y, 2014, STABILITY EXPT SURVE; Cinner JE, 2009, CURR BIOL, V19, P206, DOI 10.1016/j.cub.2008.11.055; CLARK CW, 1973, SCIENCE, V181, P630, DOI 10.1126/science.181.4100.630; Coller M., 1999, Experimental Economics, V2, P107, DOI 10.1007/BF01673482; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Cox JC, 2013, SOUTH ECON J, V79, P496, DOI 10.4284/0038-4038-2012.186; Curtis JA, 2002, APPL ECON LETT, V9, P775, DOI 10.1080/13504850210128802; Dasgupta P., 1979, EC THEORY EXHAUSTIBL; Eggert H, 2007, MAR RESOUR ECON, V22, P49, DOI 10.1086/mre.22.1.42629535; FARZIN YH, 1984, J POLIT ECON, V92, P841, DOI 10.1086/261261; Fehr E, 2011, J PUBLIC ECON, V95, P1144, DOI 10.1016/j.jpubeco.2011.05.013; Gardner R, 1990, RATION SOC, V2, P335, DOI DOI 10.1177/1043463190002003005; Gill D, 2014, J POLITICAL IN PRESS; Hotelling H, 1931, J POLIT ECON, V39, P137, DOI 10.1086/254195; Johnson AE, 2014, ECOL ECON, V100, P130, DOI 10.1016/j.ecolecon.2014.01.004; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kirby KN, 2009, PSYCHON B REV, V16, P457, DOI 10.3758/PBR.16.3.457; KOOPMANS TC, 1974, REV ECON STUD, P117; Maier J, 2010, NOTE MEASURING RISK; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Meier S, 2015, REV ECON STAT, V97, P273, DOI 10.1162/REST_a_00433; Pauly D, 2016, NATURE COMMUNICATION, P7; Pitcher TJ, 2002, FISH FISH, V3, P317, DOI 10.1046/j.1467-2979.2002.00093.x; Proto E, 2014, HIGHER INTELLIGENCE; Reuben E, 2010, ECON LETT, V106, P125, DOI 10.1016/j.econlet.2009.10.020; Rustagi D, 2010, SCIENCE, V330, P961, DOI 10.1126/science.1193649; Sumaila UR, 2006, MAR POLICY, V30, P696, DOI 10.1016/j.marpol.2005.11.001; Sumaila UR, 2005, ECOL ECON, V52, P135, DOI 10.1016/j.ecolecon.2003.11.012; Suss HM, 2002, INTELLIGENCE, V30, P261, DOI 10.1016/S0160-2896(01)00100-3; Tanaka T, 2010, AM ECON REV, V100, P557, DOI 10.1257/aer.100.1.557; Teh LSL, 2014, MAR POLICY, V44, P222, DOI 10.1016/j.marpol.2013.08.028; Vollan B, 2010, SCIENCE, V330, P923, DOI 10.1126/science.1198349; Wolbert E, 2013, MEASURING TIME RISK	41	11	11	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168898	10.1371/journal.pone.0168898	http://dx.doi.org/10.1371/journal.pone.0168898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7KQ	28033328	Green Published, gold			2022-12-26	WOS:000391226900055
J	Sun, LL; Liu, XJ; Fu, HA; Zhou, W; Zhong, DS				Sun, Linlin; Liu, Xiuju; Fu, Haian; Zhou, Wei; Zhong, Diansheng			2-Deoxyglucose Suppresses ERK Phosphorylation in LKB1 and Ras Wild-Type Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MTOR ACTIVITY; 2-DEOXY-D-GLUCOSE; METABOLISM; GLYCOLYSIS; GROWTH; RADIOTHERAPY; INHIBITION; EXPRESSION; MUTATIONS	Tumor cells rely on aerobic glycolysis to generate ATP, namely the "Warburg" effect. 2-deoxyglucose (2-DG) is well characterized as a glycolytic inhibitor, but its effect on cellular signaling pathways has not been fully elucidated. Herein, we sought to investigate the effect of 2-DG on ERK function in lung cancer cells. We found that 2-DG inhibits ERK phosphorylation in a time and dose-dependent manner in lung cancer cells. This inhibition requires functional LKB1. LKB1 knockdown in LKB1 wildtype cells correlated with an increase in the basal level of p-ERK. Restoration of LKB1 in LKB1-null cells significantly inhibits ERK activation. Blocking AMPK function with AMPK inhibitor, AMPK siRNA or DN-AMPK diminishes the inhibitory effect of 2-DG on ERK, suggesting that 2-DG induced ERK inhibition is mediated by LKB1/AMPK signaling. Moreover, IGF1-induced ERK phosphorylation is significantly decreased by 2-DG. Conversely, a subset of oncogenic mutants of K-Ras, the main upstream regulator of ERK, blocks 2-DG induced LKB1/AMPK signaling. These findings reveal the potential cross-talk between LKB1/AMPK and ERK signaling and help to better understand the mechanism of action of 2-DG.	[Sun, Linlin; Zhong, Diansheng] Tianjin Med Univ, Gen Hosp, Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China; [Liu, Xiuju; Zhou, Wei] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA; [Fu, Haian] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Fu, Haian] Emory Univ, Sch Med, Emory Chem Biol Discovery Ctr, Atlanta, GA USA; [Zhou, Wei] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Zhou, Wei] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Zhong, Diansheng] Tianjin Med Univ, Gen Hosp, Dept Med Oncol, Tianjin, Peoples R China	Tianjin Medical University; Emory University; Emory University; Emory University; Emory University; Emory University; Tianjin Medical University	Zhong, DS (corresponding author), Tianjin Med Univ, Gen Hosp, Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China.; Zhou, W (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA.; Zhou, W (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.; Zhou, W (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA.; Zhong, DS (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Med Oncol, Tianjin, Peoples R China.	wzhou2@emory.edu; Zhongdsh@hotmail.com			National Natural Science Foundation of China [81572268, 81071915, 31301160]; National Institutes of Health [R01-CA140571, P01 CA116676]; Natural Science Foundation of Tianjin City [16JCYBJC24400]; Winship Cancer Institute (NIH) [5P30CA138292]; Anise McDaniel Brock Scholar fund; China Scholarship Council; "New Century" Talent Foundation of Tianjin Medical University General Hospital; NATIONAL CANCER INSTITUTE [R01CA140571, P01CA116676] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of Tianjin City(Natural Science Foundation of Tianjin); Winship Cancer Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anise McDaniel Brock Scholar fund; China Scholarship Council(China Scholarship Council); "New Century" Talent Foundation of Tianjin Medical University General Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Natural Science Foundation of China (No. 81572268 and 81071915 to DZ and No. 31301160 to LS), National Institutes of Health (R01-CA140571 to WZ, P01 CA116676 to HF and WZ), Natural Science Foundation of Tianjin City (No. 16JCYBJC24400 to LS), Winship Cancer Institute (NIH 5P30CA138292 to HF), Anise McDaniel Brock Scholar fund to WZ, China Scholarship Council, and the New Century Talent Foundation of Tianjin Medical University General Hospital to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bost F, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.46; BROWN J, 1962, METABOLISM, V11, P1098; Calles A, 2015, CLIN CANCER RES, V21, P2851, DOI 10.1158/1078-0432.CCR-14-3112; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dong LX, 2013, ACTA PHARMACOL SIN, V34, P314, DOI 10.1038/aps.2012.143; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Green CJ, 2011, BIOCHEM J, V435, P463, DOI 10.1042/BJ20101517; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; KARCZMAR GS, 1992, CANCER RES, V52, P71; Keohavong P, 1996, CLIN CANCER RES, V2, P411; Kim J, 2001, J BIOL CHEM, V276, P19102, DOI 10.1074/jbc.M011579200; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Lee SW, 2015, MOL CELL, V57, P1022, DOI 10.1016/j.molcel.2015.01.015; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Martin MJ, 2012, CANCER DISCOV, V2, P344, DOI 10.1158/2159-8290.CD-11-0280; MCCOMB RB, 1964, CANCER RES, V24, P198; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Oh YT, 2012, J BIOL CHEM, V287, P257, DOI 10.1074/jbc.M111.304006; PARNIAK M, 1985, CAN J BIOCHEM CELL B, V63, P333, DOI 10.1139/o85-049; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Ralser M, 2008, P NATL ACAD SCI USA, V105, P17807, DOI 10.1073/pnas.0803090105; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Shen CH, 2013, MOL CELL, V52, P161, DOI 10.1016/j.molcel.2013.08.044; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Singh DH, 2005, STRAHLENTHER ONKOL, V181, P507, DOI 10.1007/s00066-005-1320-z; Sottnik JL, 2011, CLIN EXP METASTAS, V28, P865, DOI 10.1007/s10585-011-9417-5; Sun LL, 2011, CHINESE MED J-PEKING, V124, P2028, DOI 10.3760/cma.j.issn.0366-6999.2011.13.019; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zhang DS, 2014, CANCER LETT, V355, P176, DOI 10.1016/j.canlet.2014.09.003; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026; Zhong DS, 2008, MOL CANCER THER, V7, P809, DOI 10.1158/1535-7163.MCT-07-0559; Zhong DS, 2006, LUNG CANCER, V53, P285, DOI 10.1016/j.lungcan.2006.05.018; Zhong DS, 2009, J BIOL CHEM, V284, P23225, DOI 10.1074/jbc.M109.005280; Zhou W, 2013, CHIN J CANCER, V32, P427, DOI 10.5732/cjc.013.10086; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	44	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168793	10.1371/journal.pone.0168793	http://dx.doi.org/10.1371/journal.pone.0168793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033353	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900047
J	Treese, C; Sanchez, P; Grabowski, P; Berg, E; Blaker, H; Kruschewski, M; Haase, O; Hummel, M; Daum, S				Treese, Christoph; Sanchez, Pedro; Grabowski, Patricia; Berg, Erika; Blaeker, Hendrik; Kruschewski, Martin; Haase, Oliver; Hummel, Michael; Daum, Severin			Poorly Differentiated Medullary Phenotype Predicts Poor Survival in Early Lymph Node-Negative Gastro-Esophageal Adenocarcinomas	PLOS ONE			English	Article							EARLY GASTRIC-CANCER; PROGNOSTIC-FACTORS; REGRESSION-ANALYSIS; CURATIVE RESECTION; SEROSAL INVASION; EXPRESSION; CARCINOMA; P53; MARKER; RECURRENCE	Background 5-year survival rate in patients with early adenocarcinoma of the gastro-esophageal junction or stomach (AGE/S) in Caucasian patients is reported to be 60-80%. We aimed to identify prognostic markers for patients with UICC-I without lymph-node involvement (N0). Methods Clinical data and tissue specimen from patients with AGE/S stage UICC-I-N0, treated by surgery only, were collected retrospectively. Tumor size, lymphatic vessel or vein invasion, grading, classification systems (WHO, Lauren, Ming), expression of BAX, BCL-2, CDX2, Cyclin E, E-cadherin, Ki-67, TP53, TP21, SHH, Survivin, HIF1A, TROP2 and mismatch repair deficiency were analyzed using tissue microarrays and correlated with overall and tumor related survival. Results 129 patients (48 female) with a mean follow-up of 129.1 months were identified. 5-year overall survival was 83.9%, 5-year tumor related survival was 95.1%. Poorly differentiated medullary cancer subtypes (p<0.001) and positive vein invasion (p<0.001) were identified as risk factors for decreased overall-and tumor related survival. Ki-67 (p = 0.012) and TP53 mutation (p = 0.044) were the only immunohistochemical markers associated with worse overall survival but did not reach significance for decreased tumor related survival. Conclusion In the presented study patients with AGE/S in stage UICC-I-N0 had a better prognosis as previously reported for Caucasian patients. Poorly differentiated medullary subtype was associated with reduced survival and should be considered when studying prognosis in these patients.	[Treese, Christoph; Sanchez, Pedro; Grabowski, Patricia; Daum, Severin] Charite Univ Med Berlin, Dept Gastroenterol Infect Dis & Rheumatol, Campus Benjamin Franklin, Berlin, Germany; [Treese, Christoph] Berlin Inst Hlth, Berlin, Germany; [Grabowski, Patricia] Zent Klin Bad Berka GmbH, Dept Gastroenterol & Endocrinol, Bad Berka, Germany; [Berg, Erika; Blaeker, Hendrik; Hummel, Michael] Charite Univ Med Berlin, Inst Pathol, Campus Benjamin Franklin, Berlin, Germany; [Kruschewski, Martin] Stadt Klinikum Solingen GmbH, Dept Gen Visceral & Thorac Surg, Solingen, Germany; [Haase, Oliver] Charite Univ Med Berlin, Dept Gen Visceral Vasc & Thorac Surg, Campus Mitte, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Zentralklinik Bad Berka; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Treese, C (corresponding author), Charite Univ Med Berlin, Dept Gastroenterol Infect Dis & Rheumatol, Campus Benjamin Franklin, Berlin, Germany.; Treese, C (corresponding author), Berlin Inst Hlth, Berlin, Germany.	christoph.treese@charite.de	Haase, Oliver/W-9231-2019	Haase, Oliver/0000-0002-3220-6236; Hummel, Michael/0000-0001-6717-605X; Treese, Christoph/0000-0001-9120-6773; Daum, Severin/0000-0003-0060-6013	Berliner Krebsgesellschaft [DAFF201101]; Charite-University Medicine Berlin; Berlin Institute of Health	Berliner Krebsgesellschaft; Charite-University Medicine Berlin; Berlin Institute of Health	This study has been supported by a grant from Berliner Krebsgesellschaft (DAFF201101) (http://www.berliner-krebsgesellschaft.de). C. Treese is a participant in the Charite Clinical Scientist Program funded by the Charite-University Medicine Berlin and the Berlin Institute of Health (http://www.stiftung-charite.de/en/funding/private-excellence-initiative-johanna-quandt/bih-clinical-scientists.html).	ADACHI Y, 1992, CANCER, V70, P1462, DOI 10.1002/1097-0142(19920915)70:6<1462::AID-CNCR2820700603>3.0.CO;2-E; BABA H, 1989, ARCH SURG-CHICAGO, V124, P1061; Bai Z, 2007, APMIS, V115, P1383, DOI 10.1111/j.1600-0463.2007.00654.x; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Berlth F, 2014, WORLD J GASTROENTERO, V20, P5679, DOI 10.3748/wjg.v20.i19.5679; Borie F, 2004, WORLD J SURG, V28, P686, DOI 10.1007/s00268-004-7127-8; Busuttil RA, 2014, ONCOTARGET, V5, P12016, DOI 10.18632/oncotarget.2434; Cristescu R, 2015, NAT MED, P21; D'Angelica M, 2004, ANN SURG, V240, P808, DOI 10.1097/01.sla.0000143245.28656.15; Fassan M, 2014, GASTRIC CANCER, V17, P442, DOI 10.1007/s10120-013-0315-1; Fenoglio-Preiser CM, 2003, HUM MUTAT, V21, P258, DOI 10.1002/humu.10180; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Ferlay J, 2014, INT J CANC; Gamboa-Dominguez A, 2007, J CLIN PATHOL, V60, P756, DOI 10.1136/jcp.2006.038976; Gemmill EH, 2015, ANN ROY COLL SURG, V97, P173, DOI 10.1308/003588414X14055925061630; Grabowski P, 2003, BRIT J CANCER, V88, P115, DOI 10.1038/sj.bjc.6600696; Hamilton SR., 2000, WORLD HLTH ORG CLASS; Holscher AH, 2009, ANN SURG, V250, P791, DOI 10.1097/SLA.0b013e3181bdd3e4; Huang BJ, 2011, EXP THER MED, V2, P1059, DOI 10.3892/etm.2011.323; Isozaki H, 1999, HEPATO-GASTROENTEROL, V46, P2669; Jiaqing Li, 1998, Gastric Cancer, V1, P160, DOI 10.1007/s101200050011; KAIBARA N, 1985, J SURG ONCOL, V28, P195, DOI 10.1002/jso.2930280310; Kim JH, 2008, J SURG ONCOL, V97, P125, DOI 10.1002/jso.20937; Kouraklis G, 2009, DIGEST DIS SCI, V54, P1015, DOI 10.1007/s10620-008-0464-y; Krieg A, 2013, MOL BIOL REP, V40, P5501, DOI 10.1007/s11033-013-2650-z; Lee KB, 2013, APMIS, V121, P926, DOI 10.1111/apm.12119; Li N, 2014, MED ONCOL, P32; Liarmakopoulos E, 2013, MOL MED REP, V7, P887, DOI 10.3892/mmr.2012.1247; Lin SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056675; Marrelli D, 2012, ANN SURG, V255, P486, DOI 10.1097/SLA.0b013e3182389b1a; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Mrozek A, 2003, CELL DEATH DIFFER, V10, P461, DOI 10.1038/sj.cdd.4401193; Muhlmann G, 2009, J CLIN PATHOL, V62, P152, DOI 10.1136/jcp.2008.060590; Okuyama T, 2002, ONCOLOGY-BASEL, V63, P353, DOI 10.1159/000066223; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Ren G, 2013, WORLD J GASTROENTERO, V19, P3096, DOI 10.3748/wjg.v19.i20.3096; Saragoni L, 2013, GASTRIC CANCER, V16, P549, DOI 10.1007/s10120-013-0233-2; Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Sumiyoshi Y, 2006, CLIN CANCER RES, V12, P5112, DOI 10.1158/1078-0432.CCR-05-2382; Vallbohmer D, 2008, PHARMACOGENOMICS, V9, P681, DOI 10.2217/14622416.9.6.681; Warneke VS, 2013, DIAGN MOL PATHOL, V22, P127, DOI 10.1097/PDM.0b013e318284188e; Wu JH, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-40; Xiao LJ, 2013, ONCOL LETT, V6, P1277, DOI 10.3892/ol.2013.1532; Yasui Wataru, 2005, Gastric Cancer, V8, P86, DOI 10.1007/s10120-005-0320-0; Yemelyanova A, 2011, MODERN PATHOL, V24, P1248, DOI 10.1038/modpathol.2011.85; Yildirim Mustafa, 2015, Asian Pac J Cancer Prev, V16, P327; Yoon HJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/576306; Youn HG, 2010, ANN SURG ONCOL, V17, P448, DOI 10.1245/s10434-009-0772-2; Zhu L, 2015, MOL CLIN ONCOL, V3, P699, DOI 10.3892/mco.2015.506	50	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168237	10.1371/journal.pone.0168237	http://dx.doi.org/10.1371/journal.pone.0168237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030564	gold, Green Published			2022-12-26	WOS:000391222000041
J	Tsuji, T; Kurokawa, Y; Chiche, J; Pouyssegur, J; Sato, H; Fukuzawa, H; Nagao, M; Kambe, T				Tsuji, Tokuji; Kurokawa, Yayoi; Chiche, Johanna; Pouyssegur, Jacques; Sato, Hiroshi; Fukuzawa, Hideya; Nagao, Masaya; Kambe, Taiho			Dissecting the Process of Activation of Cancer-promoting Zinc-requiring Ectoenzymes by Zinc Metalation Mediated by ZNT Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBONIC-ANHYDRASE-IX; TUMOR-CELL GROWTH; SECRETORY PATHWAY; BREAST-CANCER; ALKALINE-PHOSPHATASES; VERTEBRATE CELLS; SOLUBLE FORM; AUTOTAXIN; COMPLEXES; PROTEINS	Zinc-requiring ectoenzymes, including both secreted and membrane-bound enzymes, are considered to capture zinc in their active site for their activation in the early secretory pathway. This idea has been confirmed by our studies conducted using tissue-nonspecific alkaline phosphatase (TNAP), which is elaborately activated by means of a two-step mechanism by zinc transporter 5 (ZNT5)-ZNT6 heterodimers and ZNT7 homodimers, through protein stabilization followed by enzyme activation with zinc in the early secretory pathway. However, the molecular basis of the activation process in other zinc-requiring ectoenzymes remains largely unknown. In this study, we investigated this activation process by using three cancer- promoting zinc-requiring ectoenzymes, autotaxin (ATX), matrix metalloproteinase 9 (MMP9), and carbonic anhydrase IX (CAIX), and the chicken DT40 cell mutants that we generated; we specifically focused on clarifying whether the same or a similar activation mechanism operates in these ectoenzymes. ATX activation required ZNT5-ZNT6 heterodimers and ZNT7 homodimers in a manner similar to TNAP activation, although the protein stability of ATX was differently regulated from that of TNAP. MMP9 required ZNT5-ZNT6 heterodimers and ZNT7 homodimers for its activation as well as secretion; MMP9 was not secreted into the spent medium unless both zinc-transport complexes were present. Finally, CAIX activation by zinc was mediated not only by ZNT5-ZNT6 heterodimers and ZNT7 homodimers but also by ZNT4 homodimers; thus, these three zinc-transport complexes redundantly contribute to CAIX activation. Our results provide pivotal insights into the activation processes of zinc-requiring ectoenzymes, and furthermore, they offer novel insights for potential cancer therapy applications given the cancer-promoting potencies of ATX, MMP9, and CAIX.	[Tsuji, Tokuji; Kurokawa, Yayoi; Fukuzawa, Hideya; Nagao, Masaya; Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan; [Chiche, Johanna] INSERM, Equipe Controle Metab Morts Cellulaires, Ctr Mediterraneen Med Mol C3M, U1065,Equipe 3, F-06204 Nice, France; [Pouyssegur, Jacques] Univ Nice Sophia Antipolis, Ctr A Lacassagne, Inst Res Canc & Aging, F-06189 Nice, France; [Pouyssegur, Jacques] Ctr Sci Monaco, Dept Med Biol, MC-98000 Monaco, Monaco; [Sato, Hiroshi] Kanazawa Univ, Canc Res Inst, Dept Mol Virol & Oncol, Kanazawa, Ishikawa 9201192, Japan	Kyoto University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Kanazawa University	Kambe, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan.	kambe1@kais.kyoto-u.ac.jp	Chiche, Johanna/P-6382-2016; Fukuzawa, Hideya/I-5906-2018	Chiche, Johanna/0000-0001-5276-1125; Fukuzawa, Hideya/0000-0003-0963-5662; Kambe, Taiho/0000-0001-9757-063X	Japan Society for the Promotion of Science (KAKENHI) [26660086, 15H04501]; Fuji Foundation for Protein Research; Japan Foundation for Applied Enzymology; Foundation for the Promotion of Cancer Research in Japan; Suzuken Memorial Foundation; Salt Science Research Foundation	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Fuji Foundation for Protein Research(Fuji Foundation for Protein Research); Japan Foundation for Applied Enzymology; Foundation for the Promotion of Cancer Research in Japan; Suzuken Memorial Foundation; Salt Science Research Foundation	This work was supported in part by Grants-in-aid for Challenging Exploratory Research and Scientific Research (B) from the Japan Society for the Promotion of Science (KAKENHI) Grants 26660086 and 15H04501, the Fuji Foundation for Protein Research, the Japan Foundation for Applied Enzymology, the Foundation for the Promotion of Cancer Research in Japan, Suzuken Memorial Foundation, and the Salt Science Research Foundation (to T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Andreini C, 2012, J INORG BIOCHEM, V111, P150, DOI 10.1016/j.jinorgbio.2011.11.020; Benesch MGK, 2014, FEBS LETT, V588, P2712, DOI 10.1016/j.febslet.2014.02.009; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Franz MC, 2013, MOL ASPECTS MED, V34, P735, DOI 10.1016/j.mam.2012.11.007; Fujimoto S, 2016, BIOCHEM J, V473, P2611, DOI 10.1042/BCJ20160324; Fujimoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077445; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Henry R.P., 1991, CARBONIC ANHYDRASES, P119, DOI [10.1007/978-1-4899-0750-98, DOI 10.1007/978-1-4899-0750-9_8]; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Hogstrand C, 2013, BIOCHEM J, V455, P229, DOI 10.1042/BJ20130483; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Hyrsl L, 2009, NEOPLASMA, V56, P298, DOI 10.4149/neo_2009_04_29; IMAMURA S, 1978, J BIOCHEM-TOKYO, V83, P677, DOI 10.1093/oxfordjournals.jbchem.a131960; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Itsumura N, 2016, PEDIATR RES, V80, P586, DOI 10.1038/pr.2016.108; Kagara N, 2007, CANCER SCI, V98, P692, DOI 10.1111/j.1349-7006.2007.00446.x; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kambe T, 2016, ARCH BIOCHEM BIOPHYS, V611, P37, DOI 10.1016/j.abb.2016.03.035; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kambe T, 2014, METHOD ENZYMOL, V534, P77, DOI 10.1016/B978-0-12-397926-1.00005-6; Kambe T, 2011, BIOSCI BIOTECH BIOCH, V75, P1036, DOI 10.1271/bbb.110056; Kochanczyk T, 2015, METALLOMICS, V7, P244, DOI 10.1039/c4mt00094c; Kukic I, 2013, BIOCHEM J, V451, P155, DOI 10.1042/BJ20121506; Lee S, 2015, J BIOL CHEM, V290, P13064, DOI 10.1074/jbc.M115.637439; Li M, 2007, P NATL ACAD SCI USA, V104, P18636, DOI 10.1073/pnas.0709307104; Liao SY, 1997, CANCER RES, V57, P2827; MacDiarmid CW, 2002, J BIOL CHEM, V277, P39187, DOI 10.1074/jbc.M205052200; MAREN TH, 1960, J PHARMACOL EXP THER, V130, P26; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; Martin JE, 2016, J BACTERIOL, V198, P1066, DOI 10.1128/JB.00975-15; McCormick NH, 2012, AM J PHYSIOL-CELL PH, V303, pC291, DOI 10.1152/ajpcell.00443.2011; Miyai T, 2014, P NATL ACAD SCI USA, V111, P11780, DOI 10.1073/pnas.1323549111; Murgia C, 1999, AM J PHYSIOL-GASTR L, V277, pG1231, DOI 10.1152/ajpgi.1999.277.6.G1231; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Reich R, 2015, J ENZYM INHIB MED CH, V30, P767, DOI 10.3109/14756366.2014.968146; Reich R, 2012, J MED CHEM, V55, P7875, DOI 10.1021/jm300981b; Seo YA, 2010, PHYSIOL GENOMICS, V42A, P219, DOI 10.1152/physiolgenomics.00137.2010; Shin HJ, 2011, J CELL SCI, V124, P1077, DOI 10.1242/jcs.072207; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; TAMAOKU K, 1982, CHEM PHARM BULL, V30, P2492; Taylor KM, 2007, MOL MED, V13, P396, DOI 10.2119/2007-00040.Taylor; Taylor KM, 2016, BIOCHEM J, V473, P2531, DOI 10.1042/BCJ20160388; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; Weaver Benjamin P, 2010, PLoS One, V5, DOI 10.1371/journal.pone.0013158; Zavada J, 2003, BRIT J CANCER, V89, P1067, DOI 10.1038/sj.bjc.6601264; Zogzas CE, 2016, J BIOL CHEM, V291, P15940, DOI 10.1074/jbc.M116.726935	59	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2159	2173		10.1074/jbc.M116.763946	http://dx.doi.org/10.1074/jbc.M116.763946			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28028180	hybrid, Green Published			2022-12-26	WOS:000395530300010
J	Chung, DD; Frausto, RF; Cervantes, AE; Gee, KM; Zakharevich, M; Hanser, EM; Stone, EM; Heon, E; Aldave, AJ				Chung, Doug D.; Frausto, Ricardo F.; Cervantes, Aleck E.; Gee, Katherine M.; Zakharevich, Marina; Hanser, Evelyn M.; Stone, Edwin M.; Heon, Elise; Aldave, Anthony J.			Confirmation of the OVOL2 Promoter Mutation c.-307T > C in Posterior Polymorphous Corneal Dystrophy 1	PLOS ONE			English	Article							CANDIDATE GENES; ZEB1; EXCLUSION; LOCUS; IDENTIFICATION; CHROMOSOME-20; PHENOTYPE; LINKAGE; MAPS; VSX1	Purpose To identify the genetic basis of posterior polymorphous corneal dystrophy (PPCD) in families mapped to the PPCD1 locus and in affected individuals without ZEB1 coding region mutations. Methods The promoter, 5' UTR, and coding regions of OVOL2 was screened in the PPCD family in which linkage analysis established the PPCD1 locus and in 26 PPCD probands who did not harbor a ZEB1 mutation. Copy number variation (CNV) analysis in the PPCD1 and PPCD3 intervals was performed on DNA samples from eight probands using aCGH. Luciferase reporter assays were performed in human corneal endothelial cells to determine the impact of the identified potentially pathogenic variants on OVOL2 promoter activity. Results OVOL2 mutation analysis in the first PPCD1-linked family demonstrated segregation of the c.-307T>C variant with the affected phenotype. In the other 26 probands screened, one heterozygous coding region variant and five promoter region heterozygous variants were identified, though none are likely pathogenic based on allele frequency. Array CGH in the PPCD1 and PPCD3 loci excluded the presence of CNV involving either OVOL2 or ZEB1, respectively. The c.-307T>C variant demonstrated increased promoter activity in corneal endothelial cells when compared to the wild-type sequence as has been demonstrated previously in another cell type. Conclusions Previously identified as the cause of PPCD1, the OVOL2 promoter variant c.-307T>C was herein identified in the original family that established the PPCD1 locus. However, the failure to identify presumed pathogenic coding or non-coding OVOL2 or ZEB1 variants, or CNV involving the PPCD1 and PPCD3 loci in 26 other PPCD probands suggests that other genetic loci may be involved in the pathogenesis of PPCD.	[Chung, Doug D.; Frausto, Ricardo F.; Cervantes, Aleck E.; Gee, Katherine M.; Zakharevich, Marina; Hanser, Evelyn M.; Aldave, Anthony J.] Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA; [Stone, Edwin M.] Univ Iowa, Dept Ophthalmol, Carver Coll Med, Iowa City, IA 52242 USA; [Heon, Elise] Univ Toronto, Hosp Sick Children, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Iowa; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Aldave, AJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA.	aldave@jsei.ucla.edu	; Frausto, Ricardo/AAE-3146-2021	Chung, Doug/0000-0002-8505-9495; Stone, Edwin M./0000-0003-3343-4414; Frausto, Ricardo/0000-0003-3064-6745	National Eye Institute [1R01 EY022082, P30 EY000331]; Walton Li Chair in Cornea and Uveitis; Stotter Revocable Trust; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY022082, P30EY000331] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Walton Li Chair in Cornea and Uveitis; Stotter Revocable Trust; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Support provided by National Eye Institute Grants 1R01 EY022082 (AJA), P30 EY000331 (core grant), the Walton Li Chair in Cornea and Uveitis (AJA), the Stotter Revocable Trust and an unrestricted grant to Stein Eye Institute from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support provided by National Eye Institute Grants RO1 EY022082 (A.J.A.), P30 EY000331 (core grant), the Walton Li Chair in Cornea and Uveitis (A.J.A.), the Stotter Revocable Trust and an unrestricted grant to Stein Eye Institute from Research to Prevent Blindness.	Aldave AJ, 2005, CORNEA, V24, P151, DOI 10.1097/01.ico.0000141235.26096.1d; Aldave AJ, 2009, CORNEA, V28, P801, DOI 10.1097/ICO.0b013e31819672fb; Bakhtiari P, 2013, MOL VIS, V19, P575; Chung DWD, 2014, INVEST OPHTH VIS SCI, V55, P6159, DOI 10.1167/iovs.14-15247; Davidson AE, 2016, AM J HUM GENET, V98, P75, DOI 10.1016/j.ajhg.2015.11.018; Evans CJ, 2015, ANN HUM GENET, V79, P1, DOI 10.1111/ahg.12090; Gwilliam R, 2005, INVEST OPHTH VIS SCI, V46, P4480, DOI 10.1167/iovs.05-0269; HEON E, 1995, HUM MOL GENET, V4, P485, DOI 10.1093/hmg/4.3.485; Heon E, 2002, HUM MOL GENET, V11, P1029, DOI 10.1093/hmg/11.9.1029; Hosseini SM, 2008, MOL VIS, V14, P71; Kitazawa K, 2016, CELL REP, V15, P1359, DOI 10.1016/j.celrep.2016.04.020; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; Lai IN, 2010, MOL VIS, V16, P2829; Le DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158467; Lechner J, 2013, INVEST OPHTH VIS SCI, V54, P3215, DOI 10.1167/iovs.13-11781; Liskova P, 2015, EUR J HUM GENET; Liskova P, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9495; Liskova P, 2013, JAMA OPHTHALMOL, V131, P1296, DOI 10.1001/jamaophthalmol.2013.405; Liskova P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045495; Nguyen DQ, 2010, ACTA OPHTHALMOL, V88, P695, DOI 10.1111/j.1755-3768.2009.01511.x; Roca H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076773; Shen AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157577; Shen AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012213; Shimizu S, 2004, AM J MED GENET A, V130A, P372, DOI 10.1002/ajmg.a.30267; Vincent AL, 2009, MOL VIS, V15, P2544; Weiss JS, 2015, CORNEA, V34, P117, DOI 10.1097/ICO.0000000000000307; Yellore VS, 2007, GENET MED, V9, P228, DOI 10.1097/GIM.0b013e31803c4dc2; Yellore VS, 2005, INVEST OPHTH VIS SCI, V46, P1599, DOI 10.1167/iovs.04-1321	28	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169215	10.1371/journal.pone.0169215	http://dx.doi.org/10.1371/journal.pone.0169215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046031	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300146
J	Halpin, CG; Skelhorn, J; Rowe, C; Ruxton, GD; Higginson, AD				Halpin, Christina G.; Skelhorn, John; Rowe, Candy; Ruxton, Graeme D.; Higginson, Andrew D.			The Impact of Detoxification Costs and Predation Risk on Foraging: Implications for Mimicry Dynamics	PLOS ONE			English	Article							EAT DEFENDED PREY; BODY-MASS; TRADE-OFF; MONARCH BUTTERFLIES; STRATEGIC DECISIONS; EDUCATED PREDATORS; MULLERIAN MIMICRY; ALTERNATIVE PREY; FAT RESERVES; STARVATION	Prey often evolve defences to deter predators, such as noxious chemicals including toxins. Toxic species often advertise their defence to potential predators by distinctive sensory signals. Predators learn to associate toxicity with the signals of these so-called aposematic prey, and may avoid them in future. In turn, this selects for mildly toxic prey to mimic the appearance of more toxic prey. Empirical evidence shows that mimicry could be either beneficial ('Mullerian) or detrimental ('quasi-Batesian') to the highly toxic prey, but the factors determining which are unknown. Here, we use state-dependent models to explore how tritrophic interactions could influence the evolution of prey defences. We consider how predation risk affects predators' optimal foraging strategies on aposematic prey, and explore the resultant impact this has on mimicry dynamics between unequally defended species. In addition, we also investigate how the potential energetic cost of metabolising a toxin can alter the benefits to eating toxic prey and thus impact on predators' foraging decisions. Our model predicts that both how predators perceive their own predation risk, and the cost of detoxification, can have significant, sometimes counterintuitive, effects on the foraging decisions of predators. For example, in some conditions predators should: (i) avoid prey they know to be undefended, (ii) eat more mildly toxic prey as detoxification costs increase, (iii) increase their intake of highly toxic prey as the abundance of undefended prey increases. These effects mean that the relationship between a mimic and its model can qualitatively depend on the density of alternative prey and the cost of metabolising toxins. In addition, these effects are mediated by the predators' own predation risk, which demonstrates that, higher trophic levels than previously considered can have fundamental impacts on interactions among aposematic prey species.	[Halpin, Christina G.; Skelhorn, John; Rowe, Candy] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne, Tyne & Wear, England; [Ruxton, Graeme D.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland; [Higginson, Andrew D.] Univ Exeter, Coll Life & Environm Sci, Ctr Res Anim Behav, Exeter, Devon, England	Newcastle University - UK; University of St Andrews; University of Exeter	Halpin, CG (corresponding author), Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne, Tyne & Wear, England.	christina.halpin@ncl.ac.uk		Ruxton, Graeme/0000-0001-8943-6609; Rowe, Candy/0000-0001-5379-843X	European Research Council [250209]; Natural Environment Research Council Independent Research Fellowship [NE/L011921/1]; Biotechnology and Biological Sciences Research Council-Natural Environment Research Council project [BB/G00188X/1]; Wellcome Trust; BBSRC [BB/G00188X/1] Funding Source: UKRI; NERC [NE/L011921/1, NE/L011921/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G00188X/1] Funding Source: researchfish; Natural Environment Research Council [NE/L011921/1, NE/L011921/2] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council Independent Research Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council-Natural Environment Research Council project(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the European Research Council (Advanced Grant 250209 to Alasdair Houston), a Natural Environment Research Council Independent Research Fellowship (NE/L011921/1) awarded to A.D.H., a Biotechnology and Biological Sciences Research Council-Natural Environment Research Council project grant (BB/G00188X/1) awarded to J.S., C.R. and G.D.R. and a faculty fellowship awarded to C.G.H. (Medical Sciences, Newcastle University) with strategic support funding from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, CHEM DEFENSES ARTHRO; Barnett CA, 2007, BEHAV ECOL, V18, P645, DOI 10.1093/beheco/arm027; Barnett CA, 2012, BEHAV ECOL, V23, P418, DOI 10.1093/beheco/arr206; Beckerman AP, 1997, P NATL ACAD SCI USA, V94, P10735, DOI 10.1073/pnas.94.20.10735; Bezzerides AL, 2007, BEHAV ECOL SOCIOBIOL, V61, P1401, DOI 10.1007/s00265-007-0371-9; Bowers M.D., 1992, P216; BROWER LINCOLN PIERSON, 1963, ZOOLOGICA [NEW YORK], V48, P65; BROWER LP, 1985, EVOLUTION, V39, P852, DOI 10.1111/j.1558-5646.1985.tb00427.x; Carle T, 2014, ANIM BEHAV, V93, P97, DOI 10.1016/j.anbehav.2014.04.030; Casewell NR, 2013, TRENDS ECOL EVOL, V28, P219, DOI 10.1016/j.tree.2012.10.020; COHEN JA, 1985, J CHEM ECOL, V11, P85, DOI 10.1007/BF00987608; Cott H.B., 1940, ADAPTIVE COLORATION; Cuthill Innes C., 1997, P97; de Jong P.W., 1991, Chemoecology, V2, P15, DOI 10.1007/BF01240661; Duriez O, 2005, ANIM BEHAV, V69, P39, DOI 10.1016/j.anbehav.2004.04.009; Endler JA, 2004, AM NAT, V163, P532, DOI 10.1086/382662; Gentle LK, 2001, P ROY SOC B-BIOL SCI, V268, P487, DOI 10.1098/rspb.2000.1405; Glendinning J.I., 1990, Chemoecology, V1, P114, DOI 10.1007/BF01241652; GOSLER AG, 1995, NATURE, V377, P621, DOI 10.1038/377621a0; Halpin CG, 2013, ANIM BEHAV, V85, P1315, DOI 10.1016/j.anbehav.2013.03.021; Halpin CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044895; Higginson AD, 2011, J ANIM ECOL, V80, P384, DOI 10.1111/j.1365-2656.2010.01786.x; Holloway G.J., 1991, Chemoecology, V2, P7, DOI 10.1007/BF01240660; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; Kokko H, 2003, ECOL LETT, V6, P1068, DOI 10.1046/j.1461-0248.2003.00532.x; Kullberg C, 1996, P ROY SOC B-BIOL SCI, V263, P1671, DOI 10.1098/rspb.1996.0244; Lerch-Henning S, 2015, COMP BIOCHEM PHYS A, V190, P47, DOI 10.1016/j.cbpa.2015.08.015; Lerch-Henning S, 2013, J AVIAN BIOL, V44, P408, DOI 10.1111/j.1600-048X.2013.00079.x; Lilliendahl K, 1997, ANIM BEHAV, V53, P75, DOI 10.1006/anbe.1996.0279; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lindstrom L, 2001, P NATL ACAD SCI USA, V98, P9181, DOI 10.1073/pnas.161071598; Lindstrom L, 2004, EVOLUTION, V58, P1294, DOI 10.1554/03-271; Macleod R, 2005, J ANIM ECOL, V74, P292, DOI 10.1111/j.1365-2656.2005.00923.x; Macleod R, 2008, IBIS, V150, P199, DOI 10.1111/j.1474-919X.2008.00820.x; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Mallet J, 1999, EVOL ECOL, V13, P777, DOI 10.1023/A:1011060330515; Mappes J, 2005, TRENDS ECOL EVOL, V20, P598, DOI 10.1016/j.tree.2005.07.011; MARPLES NM, 1989, ECOL ENTOMOL, V14, P79, DOI 10.1111/j.1365-2311.1989.tb00756.x; Marsh KJ, 2005, ECOLOGY, V86, P2946, DOI 10.1890/05-0303; MCNAMARA JM, 1987, ECOLOGY, V68, P1515, DOI 10.2307/1939235; MCNAMARA JM, 1990, ACTA BIOTHEOR, V38, P37, DOI 10.1007/BF00047272; MULLER F., 1879, T ENTOMOL SOC LOND, V1879, pxx; NUR U, 1970, AM NAT, V104, P477, DOI 10.1086/282682; Oudman T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136144; PARADISE CJ, 1993, J INSECT BEHAV, V6, P155, DOI 10.1007/BF01051501; Pinheiro CEG, 1996, BIOL J LINN SOC, V59, P351, DOI 10.1111/j.1095-8312.1996.tb01471.x; Poulton EB, 1890, COLORS ANIMALS THEIR; Pravosudov VV, 1997, CURR ORNITHOL, V14, P189; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; ROUSH RT, 1978, ENVIRON ENTOMOL, V7, P287, DOI 10.1093/ee/7.2.287; Rowe C, 2013, BEHAV ECOL SOCIOBIOL, V67, P1425, DOI 10.1007/s00265-013-1515-8; Rowland HM, 2007, NATURE, V448, P64, DOI 10.1038/nature05899; Rowland HM, 2010, ECOL LETT, V13, P1494, DOI 10.1111/j.1461-0248.2010.01539.x; Ruxton GD, 2004, EVOLUTIONARY ECOLOGY; Sherratt TN, 2004, J THEOR BIOL, V228, P217, DOI 10.1016/j.jtbi.2003.12.009; Sherratt TN, 2003, OIKOS, V103, P93, DOI 10.1034/j.1600-0706.2003.12576.x; Skelhorn J, 2007, CURR BIOL, V17, P1479, DOI 10.1016/j.cub.2007.07.064; Skelhorn J, 2006, BIOL LETT-UK, V2, P348, DOI 10.1098/rsbl.2006.0483; Skelhorn J, 2016, BEHAV ECOL, V27, P955, DOI 10.1093/beheco/arw009; Skelhorn J, 2010, P ROY SOC B-BIOL SCI, V277, P1729, DOI 10.1098/rspb.2009.2092; Speed MP, 2014, ANIM BEHAV, V98, P53, DOI 10.1016/j.anbehav.2014.09.011; Speed MP, 2001, ANIM BEHAV, V61, P205, DOI 10.1006/anbe.2000.1558; SPEED MP, 1993, ANIM BEHAV, V45, P571, DOI 10.1006/anbe.1993.1067; Speed MP, 2000, P ROY SOC B-BIOL SCI, V267, P725, DOI 10.1098/rspb.2000.1063; Speed MP, 1999, EVOL ECOL, V13, P755, DOI 10.1023/A:1010871106763; Speed MP, 1999, BIOL J LINN SOC, V67, P281, DOI 10.1006/bijl.1998.0310; Turner JRG, 1999, EVOL ECOL, V13, P807, DOI 10.1023/A:1010856716448; Turner JT, 1997, LIMNOL OCEANOGR, V42, P1203, DOI 10.4319/lo.1997.42.5_part_2.1203; Vogler AP, 1998, EVOLUTION, V52, P529, DOI [10.2307/2411088, 10.1111/j.1558-5646.1998.tb01652.x]; Whitman D.W., 1990, P289; WITTER MS, 1994, ANIM BEHAV, V48, P201, DOI 10.1006/anbe.1994.1227	72	4	4	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169043	10.1371/journal.pone.0169043	http://dx.doi.org/10.1371/journal.pone.0169043			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045959	Green Published, gold			2022-12-26	WOS:000391612300097
J	Jamann, TM; Sood, S; Wisser, RJ; Holland, JB				Jamann, Tiffany M.; Sood, Shilpa; Wisser, Randall J.; Holland, James B.			High-Throughput Resequencing of Maize Landraces at Genomic Regions Associated with Flowering Time	PLOS ONE			English	Article							POSTDOMESTICATION SPREAD; READ ALIGNMENT; GENERATION; ENRICHMENT; DIVERSITY; FORMAT; RACES; ZMCCT	Despite the reduction in the price of sequencing, it remains expensive to sequence and assemble whole, complex genomes of multiple samples for population studies, particularly for large genomes like those of many crop species. Enrichment of target genome regions coupled with next generation sequencing is a cost-effective strategy to obtain sequence information for loci of interest across many individuals, providing a less expensive approach to evaluating sequence variation at the population scale. Here we evaluate amplicon-based enrichment coupled with semiconductor sequencing on a validation set consisting of three maize inbred lines, two hybrids and 19 landrace accessions. We report the use of a multiplexed panel of 319 PCR assays that target 20 candidate loci associated with photoperiod sensitivity in maize while requiring 25 ng or less of starting DNA per sample. Enriched regions had an average on-target sequence read depth of 105 with 98% of the sequence data mapping to the maize 'B73' reference and 80% of the reads mapping to the target interval. Sequence reads were aligned to B73 and 1,486 and 1,244 variants were called using SAMtools and GATK, respectively. Of the variants called by both SAMtools and GATK, 30% were not previously reported in maize. Due to the high sequence read depth, heterozygote genotypes could be called with at least 92.5% accuracy in hybrid materials using GATK. The genetic data are congruent with previous reports of high total genetic diversity and substantial population differentiation among maize landraces. In conclusion, semiconductor sequencing of highly multiplexed PCR reactions is a cost-effective strategy for resequencing targeted genomic loci in diverse maize materials.	[Jamann, Tiffany M.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Sood, Shilpa] Monsanto Co, 700 Chesterfield Pkwy West, Chesterfield, MI USA; [Wisser, Randall J.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE USA; [Holland, James B.] USDA ARS, Plant Sci Res Unit, Raleigh, NC 27695 USA; [Holland, James B.] North Carolina State Univ, Dept Crop & Soil Sci, Raleigh, NC 27695 USA	University of Illinois System; University of Illinois Urbana-Champaign; Monsanto; University of Delaware; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University	Jamann, TM (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	tjamann@illinois.edu	Jamann, Tiffany/S-7392-2019	Jamann, Tiffany/0000-0002-7288-0866; Holland, James/0000-0002-4341-9675	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture (Agriculture and Natural Resources Science for Climate Variability and Change Program) [2011-67003-30342]; United States National Science Foundation [IOS-1238014]; Direct For Biological Sciences [1238014] Funding Source: National Science Foundation	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture (Agriculture and Natural Resources Science for Climate Variability and Change Program); United States National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by Agriculture and Food Research Initiative Competitive Grant No. 2011-67003-30342 (RJW and JBH) from the USDA National Institute of Food and Agriculture (Agriculture and Natural Resources Science for Climate Variability and Change Program), and United States National Science Foundation grant IOS-1238014 (JBH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture.	Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Bukowski R., 2015, BIORXIV; Caboche S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-264; Cheng AY, 2014, BIOINFORMATICS, V30, P1707, DOI 10.1093/bioinformatics/btu067; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; DOEBLEY JF, 1985, AM J BOT, V72, P629, DOI 10.2307/2443674; Dong ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043450; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fu Y, 2010, PLANT J, V62, P898, DOI 10.1111/j.1365-313X.2010.04196.x; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gareth J, 2013, INTRO STAT LEARNING, Vxvi; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Hung HY, 2012, P NATL ACAD SCI USA, V109, pE1913, DOI 10.1073/pnas.1203189109; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Muraya MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132120; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Perkel J, 2008, NAT METHODS, V5, P447, DOI 10.1038/nmeth0508-447; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Ramirez E R, 1960, RACES MAIZE BOLIVIA, Vvii; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Sanchez JJ, 2000, ECON BOT, V54, P43, DOI 10.1007/BF02866599; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Singh RR, 2013, J MOL DIAGN, V15, P607, DOI 10.1016/j.jmoldx.2013.05.003; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; Swarts K, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.05.0023; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wu Y, 2016, THEOR APPL GENET; Yang Q, 2013, P NATL ACAD SCI USA, V110, P16969, DOI 10.1073/pnas.1310949110	43	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168910	10.1371/journal.pone.0168910	http://dx.doi.org/10.1371/journal.pone.0168910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045987	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300068
J	Sun, SS; Yu, XL; Liu, ZT; Chen, XP				Sun, Songsong; Yu, Xiaoli; Liu, Zhentao; Chen, Xiaoping			Component HCF Research Based on the Theory of Critical Distance and a Relative Stress Gradient Modification	PLOS ONE			English	Article							LIFE PREDICTION; FATIGUE; STRENGTH	For the critical engine parts such as the crankshaft, the fatigue limit load is one of the most important parameters involved the design and manufacture stage. In previous engineering applications, this parameter has always been obtained by experiment, which is expensive and time-consuming. This paper, based on the theory of critical distance (TCD), first analyzes the stress distribution of a crankshaft under its limit load. In this way, the length of the critical distance can be obtained. Then a certain load is applied to a new crankshaft made of the same material and the effective stress is calculated based on the critical distance above. Finally, the fatigue limit load of the new crankshaft can be obtained by comparing the effective stress and the fatigue limit of the material. Comparison between the prediction and the corresponding experimental data shows that the traditional TCD may result in bigger errors on some occasions, while the modified TCD proposed in this paper can provide a more satisfactory result in terms of the fatigue limit for a quick engineering prediction.	[Sun, Songsong; Yu, Xiaoli; Liu, Zhentao] Zhejiang Univ, Power Machinery & Vehicular Engn Inst, Hangzhou, Zhejiang, Peoples R China; [Chen, Xiaoping] Ningbo Univ Technol, Sch Mech Engn, Ningbo, Zhejiang, Peoples R China	Zhejiang University; Ningbo University of Technology	Liu, ZT (corresponding author), Zhejiang Univ, Power Machinery & Vehicular Engn Inst, Hangzhou, Zhejiang, Peoples R China.	11227004@zju.edu.cn			National Natural Science Foundation of China [51305215]; Science Fund of State Key Laboratory of Engine Reliability [skler-201602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund of State Key Laboratory of Engine Reliability	This study is finally supported by National Natural Science Foundation of China under the Grant Number of No. 51305215 and the Science Fund of State Key Laboratory of Engine Reliability (skler-201602).	Benedetti M, 2016, INT J FATIGUE, V93, P133, DOI 10.1016/j.ijfatigue.2016.08.015; Chen X.-p., 2010, 2010 INT C MEAS TECH, V3, P548; Chen XP, 2014, ENG FAIL ANAL, V42, P210, DOI 10.1016/j.engfailanal.2014.04.015; Clegg R.E, 2011, FATIGUE FRACT ENG M, V35, P81; Gao WJ, VEHICLE ENG, V6, P64; Gates N, 2016, INT J FATIGUE, V91, P337, DOI 10.1016/j.ijfatigue.2015.12.011; Kasiri S, 2008, J BIOMECH, V41, P603, DOI 10.1016/j.jbiomech.2007.10.003; Neuber H, 1958, THEORY NOTCH STRESSE, p2nd; Peterson R. E., 1959, NOTCH SENSITIVITY ME, P293; Spaggiari A, 2011, PROCEDIA ENGINEER, V10, DOI 10.1016/j.proeng.2011.04.459; Sun SS, 2016, ENG FAIL ANAL, V70, P31, DOI 10.1016/j.engfailanal.2016.07.005; Sun SS, 2016, ENG FAIL ANAL, V60, P199, DOI 10.1016/j.engfailanal.2015.11.053; Susmel L, 2010, ENG FRACT MECH, V77, P452, DOI 10.1016/j.engfracmech.2009.11.015; Taylor D, 2008, INT J MECH SCI, V50, P1075, DOI 10.1016/j.ijmecsci.2008.02.005; Taylor D, 2011, ENG FAIL ANAL, V18, P543, DOI 10.1016/j.engfailanal.2010.07.002; Taylor D, 2009, INT J FATIGUE, V31, P20, DOI 10.1016/j.ijfatigue.2008.01.011; Wang JK, 2012, INT J FATIGUE, V40, P97, DOI 10.1016/j.ijfatigue.2011.12.019; Yang XG, 2011, INT J FATIGUE, V33, P1470, DOI 10.1016/j.ijfatigue.2011.05.018; Zhou X, 2007, CHINESE INTERNAL COM, V5, P45; Zhou X, 2007, T CHINESE SOC AGR MA, V4, P35; Zhou X., 2006, THEORETICAL EXPT STU	21	8	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0167722	10.1371/journal.pone.0167722	http://dx.doi.org/10.1371/journal.pone.0167722			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036338	Green Published, Green Submitted, gold			2022-12-26	WOS:000391229300008
J	Casquere-Veiga, M; Hadar, R; Pascau, J; Winter, C; Desco, M; Sato-Montenegro, ML				Casquere-Veiga, Marta; Hadar, Ravit; Pascau, Javier; Winter, Christine; Desco, Manuel; Luisa Sato-Montenegro, Maria			Response to Deep Brain Stimulation in Three Brain Targets with Implications in Mental Disorders: A PET Study in Rats	PLOS ONE			English	Article							TREATMENT-RESISTANT DEPRESSION; CEREBRAL-BLOOD-FLOW; NUCLEUS-ACCUMBENS; PREFRONTAL CORTEX; CLINICAL-PRACTICE; C-FOS; CEREBELLUM; DIAGNOSIS; OBESITY; DBS	Objective To investigate metabolic changes in brain networks by deep brain stimulation (DBS) of the medial prefrontal cortex (mPFC), nucleus accumbens (NAcc) and dorsomedial thalamus (DM) using positron emission tomography (PET) in naive rats. Methods 43 male Wistar rats underwent stereotactic surgery and concentric bipolar platinum-iridium electrodes were bilaterally implanted into one of the three brain sites. [F-18]-fluoro-2-deoxyglucose-PET ((18)FDG-PET) and computed tomography (CT) scans were performed at the 7th (without DBS) and 9th day (with DBS) after surgery. Stimulation period matched tracer uptake period. Images were acquired with a small-animal PET-CT scanner. Differences in glucose uptake between groups were assessed with Statistical Parametric Mapping. Results DBS induced site-specific metabolic changes, although a common increased metabolic activity in the piriform cortex was found for the three brain targets. mPFC-DBS increased metabolic activity in the striatum, temporal and amygdala, and reduced it in the cerebellum, brainstem (BS) and periaqueductal gray matter (PAG). NAcc-DBS increased metabolic activity in the subiculum and olfactory bulb, and decreased it in the BS, PAG, septum and hypothalamus. DM-DBS increased metabolic activity in the striatum, NAcc and thalamus and decreased it in the temporal and cingulate cortex. Conclusions DBS induced significant changes in (18)FDG uptake in brain regions associated with the basal ganglia-thalamo-cortical circuitry. Stimulation of mPFC, NAcc and DM induced different patterns of (18)FDG uptake despite interacting with the same circuitries. This may have important implications to DBS research suggesting individualized target selection according to specific neural modulatory requirements.	[Casquere-Veiga, Marta; Pascau, Javier; Desco, Manuel; Luisa Sato-Montenegro, Maria] CIBER Salud Mental CIBERSAM, Madrid, Spain; [Casquere-Veiga, Marta; Desco, Manuel; Luisa Sato-Montenegro, Maria] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Hadar, Ravit; Winter, Christine] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Psychiat & Psychotherapy, Dresden, Germany; [Pascau, Javier; Desco, Manuel] Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Universidad Carlos III de Madrid	Desco, M (corresponding author), CIBER Salud Mental CIBERSAM, Madrid, Spain.; Desco, M (corresponding author), Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain.; Desco, M (corresponding author), Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Madrid, Spain.	desco@hggm.es	Pascau, Javier/B-5734-2013; Soto-Montenegro, María Luisa/AFS-1781-2022; Casquero-Veiga, Marta/T-6576-2019; Desco, Manuel/AAD-7137-2019	Pascau, Javier/0000-0003-1484-731X; Casquero-Veiga, Marta/0000-0003-0859-9495; Desco, Manuel/0000-0003-0989-3231; Soto Montenegro, Maria Luisa/0000-0003-4350-4789	Federal Ministry of Education and Research, Germany (BMBF) [01EW1103]; Ministry of Economy and Competitiveness ISCIII-FIS [PI14/00860, CPII/00005]; ERDF (FEDER) Funds from the European Commission, "A way of making Europe"; Fundacion Mapfre; Comunidad de Madrid [BRADE S2013/ICE-2958]	Federal Ministry of Education and Research, Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); Ministry of Economy and Competitiveness ISCIII-FIS; ERDF (FEDER) Funds from the European Commission, "A way of making Europe"; Fundacion Mapfre; Comunidad de Madrid(Comunidad de Madrid)	This research was conducted under the EraNet Neuron framework (DBS_F20rat) and supported by the Federal Ministry of Education and Research, Germany (BMBF 01EW1103), the Ministry of Economy and Competitiveness ISCIII-FIS grants (PI14/00860, CPII/00005) co-financed by ERDF (FEDER) Funds from the European Commission, "A way of making Europe", Fundacion Mapfre and Comunidad de Madrid (BRADE S2013/ICE-2958).	Aggleton JP, 2016, BRAIN, V139, P1877, DOI 10.1093/brain/aww083; Akdemir UO, 2014, CLIN NUCL MED, V39, pE220, DOI 10.1097/RLU.0000000000000315; Arnsten AFT, 2012, J AM ACAD CHILD PSY, V51, P356, DOI 10.1016/j.jaac.2012.01.008; Batra V, 2016, J NEUROSURG, P1; Bejjani BP, 1999, NEW ENGL J MED, V340, P1476, DOI 10.1056/NEJM199905133401905; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Berlim MT, 2014, J AFFECT DISORDERS, V159, P31, DOI 10.1016/j.jad.2014.02.016; BIKOVSKY L, 2016, EXP NEUROL, V283, P80594, DOI DOI 10.1016/J.EXPNEUR0L.2016.06.012; Boix-Trelis N, 2009, NEUROSCI LETT, V449, P137, DOI 10.1016/j.neulet.2008.10.105; Bostan AC, 2013, TRENDS COGN SCI, V17, P241, DOI 10.1016/j.tics.2013.03.003; Burns JK, 2014, INT J SOC PSYCHIATR, V60, P185, DOI 10.1177/0020764013481426; Covolan L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097618; Creed M, 2015, SCIENCE, V347, P659, DOI 10.1126/science.1260776; Dougherty DD, 2015, BIOL PSYCHIAT, V78, P240, DOI 10.1016/j.biopsych.2014.11.023; DREVETS WC, 1992, PSYCHOPHARMACOL BULL, V28, P261; Erro ME, 2002, NEUROSCI RES, V42, P45, DOI 10.1016/S0168-0102(01)00302-9; Ewing SG, 2013, J CHEM NEUROANAT, V52, P20, DOI 10.1016/j.jchemneu.2013.04.002; Gallivanone F, 2016, CURR ALZHEIMER RES, V13, P682, DOI 10.2174/1567205013666151116142039; Goozee R, 2014, NEUROSCI BIOBEHAV R, V43, P118, DOI 10.1016/j.neubiorev.2014.03.014; Grace AA, 2000, BRAIN RES REV, V31, P330, DOI 10.1016/S0165-0173(99)00049-1; Groenewegen HJ, 1999, J CHEM NEUROANAT, V16, P167, DOI 10.1016/S0891-0618(99)00009-5; Hadar R, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.100; Halpern CH, 2011, ACTA NEUROCHIR, V153, P2293, DOI 10.1007/s00701-011-1166-3; Hamani C, 2010, CLIN PHARMACOL THER, V88, P559, DOI 10.1038/clpt.2010.133; Hamani C, 2014, NEUROBIOL DIS, V71, P205, DOI 10.1016/j.nbd.2014.08.007; Hamani C, 2012, BIOL PSYCHIAT, V72, P916, DOI 10.1016/j.biopsych.2012.05.024; Hamani C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003722; Hamani C, 2010, EUR J NEUROSCI, V32, P1109, DOI 10.1111/j.1460-9568.2010.07414.x; Hamani C, 2010, BIOL PSYCHIAT, V67, P117, DOI 10.1016/j.biopsych.2009.08.025; Ishii K, 2014, AM J NEURORADIOL, V35, P2030, DOI 10.3174/ajnr.A3695; Kato T, 2016, AGEING RES REV; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kessler RM, 2009, BIOL PSYCHIAT, V65, P1024, DOI 10.1016/j.biopsych.2008.12.029; Klein JC, 2010, NEUROIMAGE, V51, P555, DOI 10.1016/j.neuroimage.2010.02.062; Klein J, 2013, BRAIN STIMUL, V6, P490, DOI 10.1016/j.brs.2012.09.004; Klein J, 2011, J PSYCHIATR RES, V45, P927, DOI 10.1016/j.jpsychires.2010.12.008; Konarski JZ, 2005, J PSYCHIATR NEUROSCI, V30, P178; Kuhn J, 2011, FORTSCHR NEUROL PSYC, V79, P632, DOI 10.1055/s-0031-1281733; Kuhn J, 2010, DTSCH ARZTEBL INT, V107, P105, DOI 10.3238/arztebl.2010.0105; Lapidus KAB, 2014, NEUROTHERAPEUTICS, V11, P485, DOI 10.1007/s13311-014-0287-9; Lehrer DS, 2005, AM J PSYCHIAT, V162, P931, DOI 10.1176/appi.ajp.162.5.931; Levesque J, 2003, BIOL PSYCHIAT, V53, P502, DOI 10.1016/S0006-3223(02)01817-6; Loscher W, 1996, BRAIN RES, V725, P252, DOI 10.1016/0006-8993(96)00341-1; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; Soto-Montenegro ML, 2014, MOL IMAGING BIOL, V16, P830, DOI 10.1007/s11307-014-0753-0; Lyons MK, 2011, MAYO CLIN PROC, V86, P662, DOI 10.4065/mcp.2011.0045; Ma JY, 2014, BEHAV BRAIN RES, V266, P174, DOI 10.1016/j.bbr.2014.03.010; Marenco S, 2012, NEUROPSYCHOPHARMACOL, V37, P499, DOI 10.1038/npp.2011.215; MATHEW RJ, 1982, ARCH GEN PSYCHIAT, V39, P1121; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Mikell CB, 2009, STEREOT FUNCT NEUROS, V87, P256, DOI 10.1159/000225979; Millet B, 2014, EUR NEUROPSYCHOPHARM, V24, P1229, DOI 10.1016/j.euroneuro.2014.05.006; Mitchell AS, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00037; Mittleman G, 2008, SYNAPSE, V62, P544, DOI 10.1002/syn.20525; Moghbel M, 2016, HAND CLINIC, V135, P229, DOI 10.1016/B978-0-444-53485-9.00012-X; Morishita T, 2014, NEUROTHERAPEUTICS, V11, P475, DOI 10.1007/s13311-014-0282-1; Mueller K, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.121; Muller UJ, 2016, PHARMACOPSYCHIATRY, V49, P170, DOI 10.1055/s-0042-104507; Muller UJ, 2013, ANN NY ACAD SCI, V1282, P119, DOI 10.1111/j.1749-6632.2012.06834.x; Panov F, 2014, NEUROTHERAPEUTICS, V11, P564, DOI 10.1007/s13311-014-0283-0; Pascau J, 2009, MOL IMAGING BIOL, V11, P107, DOI 10.1007/s11307-008-0166-z; Paxinos G, 2008, RAT BRAIN STEREOTAXI; Peled A, 2011, MED HYPOTHESES, V76, P914, DOI 10.1016/j.mehy.2011.03.009; Qiu XZ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00235; Rogers TD, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00015; Salgado-Lopez L, 2016, J NEUROSURG, V125, P229, DOI 10.3171/2015.12.JNS152874; Segobin S, 2015, NEUROPSYCHOL REV, V25, P326, DOI 10.1007/s11065-015-9297-6; Sekar S, 2011, PSYCHOPHARMACOLOGY, V213, P521, DOI 10.1007/s00213-010-2084-4; Shinohara RT, 2014, NEUROIMAGE-CLIN, V6, P9, DOI 10.1016/j.nicl.2014.08.008; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Song IU, 2016, ACTA RADIOL, V57, P90, DOI 10.1177/0284185114566088; Soto-Montenegro ML, 2014, MOL IMAGING BIOL; Spalletta G, 2013, PSYCHIAT RES-NEUROIM, V212, P54, DOI 10.1016/j.pscychresns.2012.04.015; Strutt AM, 2012, EUR J NEUROL, V19, P121, DOI 10.1111/j.1468-1331.2011.03447.x; Suzuki L, 2012, J NEUROSCI, V32, P10854, DOI 10.1523/JNEUROSCI.0857-12.2012; Tamminga CA, 2010, AM J PSYCHIAT, V167, P1178, DOI 10.1176/appi.ajp.2010.09081187; Trotta N, 2016, HUM BRAIN MAPP, V37, P3017, DOI 10.1002/hbm.23223; Van Den Berge N, 2015, MOL IMAGING BIOL, V17, P373, DOI 10.1007/s11307-014-0801-9; Van Weehaeghe D, 2016, J NUCL MED; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang S, 2010, NEUROSCI LETT, V481, P97, DOI 10.1016/j.neulet.2010.06.060; Watson TC, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00004; Widge AS, 2016, EXP NEUROL; Williams NR, 2016, NEUROCASE, V22, P201, DOI 10.1080/13554794.2015.1112019; Williams NR, 2014, WORLD J RADIOL, V6, P756, DOI 10.4329/wjr.v6.i10.756; Zhong XL, 2011, BRAIN RES BULL, V85, P81, DOI 10.1016/j.brainresbull.2011.03.020	86	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168689	10.1371/journal.pone.0168689	http://dx.doi.org/10.1371/journal.pone.0168689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033356	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900036
J	Kovacs, K; West, G				Kovacs, Kent; West, Grant			The Influence of Groundwater Depletion from Irrigated Agriculture on the Tradeoffs between Ecosystem Services and Economic Returns	PLOS ONE			English	Article							CONJUNCTIVE WATER MANAGEMENT; CONSERVATION; STATES	An irrigated agricultural landscape experiencing groundwater overdraft generates economic returns and a suite of ecosystem services (in particular, groundwater supply, greenhouse gases reduction, and surface water quality). Alternative land cover choices indicate tradeoffs among the value of ecosystem services created and the economic returns. These tradeoffs are explored using efficiency frontiers that determine the least value in ecosystem services that must be given up to generate additional economic returns. Agricultural producers may switch to irrigation with surface water using on-farm reservoirs and tail water recovery systems in response to groundwater overdraft, and this has consequences for the bundle of ecosystem service values and economic returns achievable from the landscape. Planning that accounts for both ecosystem service value and economic returns can achieve more value for society, as does the adoption of reservoirs though lowering the costs of irrigation, increasing groundwater levels, and reducing fuel combustion and associated GHG emissions from groundwater pumping. Sensitivity analyses of per unit value of ecosystem services, crop prices, and the groundwater and water purification model parameters indicate tradeoff among ecosystems service values, such as the use of a high-end social cost of carbon ultimately lowers groundwater supply and water purification value by more than 15%.	[Kovacs, Kent; West, Grant] Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville	Kovacs, K (corresponding author), Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA.	kkovacs@uark.edu		West, Grant/0000-0002-0066-8903	University of Arkansas Division of Agriculture; US Geologic Survey of the 104b research grant program, US Department of the Interior	University of Arkansas Division of Agriculture; US Geologic Survey of the 104b research grant program, US Department of the Interior	This project was supported by the University of Arkansas Division of Agriculture and the US Geologic Survey of the 104b research grant program, US Department of the Interior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Arkansas Land Information Board, 2006, SDE RAST DIG DAT; Arkansas Natural Resources Commission (ANRC), 2015, ARK WAT PLAN UPD 201; Barker JR, 1995, J BIOGEOGR, V22, P743, DOI 10.2307/2845976; Barlow PM., 2012, STREAMFLOW DEPLETION; Blomquist W, 2001, NAT RESOUR J, V41, P653; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Clark BR, 2013, 20135161 US GEOL SUR, V29; Cole A, 2003, ARKANSAS POPULATION; Egoh B, 2009, BIOL CONSERV, V142, P553, DOI 10.1016/j.biocon.2008.11.009; Egoh B, 2008, AGR ECOSYST ENVIRON, V127, P135, DOI 10.1016/j.agee.2008.03.013; European Commission Emission Trading Scheme, 2015, AUCT TRANS COMM AUCT; Flanders A, 2014, 2014 CROP PROD BUDG; Hite D, 2002, J AGR RESOUR ECON, V27, P433; Huffaker R. G., 1995, Choices. The Magazine of Food, Farm, and Resources Issues, P24; Jenkins CT, 1968, US GEOLOGICAL SURVEY, V4, P17; Johnson DM, 2010, PHOTOGRAMM ENG REM S, V76, P1201; Kovacs K., 2014, J AGR APPL EC, V46, P1; Kovacs K, 2015, J AGR RESOUR ECON, V40, P23; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Nalley L., 2011, Agricultural and Resource Economics Review, V40, P63; Nelson E, 2008, P NATL ACAD SCI USA, V105, P9471, DOI 10.1073/pnas.0706178105; NOAA, 2014, NAT CLIM DAT CTR CLI; NOEL JE, 1980, AM J AGR ECON, V62, P489, DOI 10.2307/1240203; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Popp J., 2003, J AGR APPL EC, V35, P69; Popp M, 2011, AGRON J, V103, P1132, DOI 10.2134/agronj2010.0517; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Reed TB, 2003, 2003034109 US GEOL S; Sharpley A., 2013, COMMUNICATION; Smartt JH, 2002, MARORA MODIFIED ARKA; Tol RSJ, 2009, J ECON PERSPECT, V23, P29, DOI 10.1257/jep.23.2.29; TSUR Y, 1990, WATER RESOUR RES, V26, P811, DOI 10.1029/89WR03301; U.S. Department of Agriculture (USDA)-Farm Service Agency (FSA), CONS RES PROGR STAT; U.S. Department of Agriculture (USDA)-National Agricultural Statistics Service (NASS) Arkansas Field Office, SOYB IRR NON; U.S. Department of Agriculture (USDA)-Natural Resources Conservation Service (NRCS) Arkansas, 2014, EQIP CONS PRACT PAYM; U.S. Department of the Treasury, INT RAT STAT; Vories E.D., 2010, P 5 NAT DEC IRR C AS, P1; Ward FA, 2008, P NATL ACAD SCI USA, V105, P18215, DOI 10.1073/pnas.0805554105; Wolny, 2011, INVEST 2 1 BETA USER; Young K.B., 2004, J ASFMRA, V2004, P119	40	8	8	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168681	10.1371/journal.pone.0168681	http://dx.doi.org/10.1371/journal.pone.0168681			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7KQ	28033405	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900035
J	Kunstner, A; Hoffmann, M; Fraser, BA; Kottler, VA; Sharma, E; Weigel, D; Dreyer, C				Kuenstner, Axel; Hoffmann, Margarete; Fraser, Bonnie A.; Kottler, Verena A.; Sharma, Eshita; Weigel, Detlef; Dreyer, Christine			The Genome of the Trinidadian Guppy, Poecilia reticulata, and Variation in the Guanapo Population	PLOS ONE			English	Article							SEX-CHROMOSOME EVOLUTION; GENETIC-LINKAGE MAP; READ ALIGNMENT; COLOR-VISION; FISH; SELECTION; MODEL; POLYMORPHISMS; DIVERGENCE; GENERATION	For over a century, the live bearing guppy, Poecilia reticulata, has been used to study sexual selection as well as local adaptation. Natural guppy populations differ in many traits that are of intuitively adaptive significance such as ornamentation, age at maturity, brood size and body shape. Water depth, light supply, food resources and predation regime shape these traits, and barrier waterfalls often separate contrasting environments in the same river. We have assembled and annotated the genome of an inbred single female from a high-predation site in the Guanapo drainage. The final assembly comprises 731.6 Mb with a scaffold N50 of 5.3 MB. Scaffolds were mapped to linkage groups, placing 95% of the genome assembly on the 22 autosomes and the X-chromosome. To investigate genetic variation in the population used for the genome assembly, we sequenced 10 wild caught male individuals. The identified 5 million SNPs correspond to an average nucleotide diversity (pi) of 0.0025. The genome assembly and SNP map provide a rich resource for investigating adaptation to different predation regimes. In addition, comparisons with the genomes of other Poeciliid species, which differ greatly in mechanisms of sex determination and maternal resource allocation, as well as comparisons to other teleost genera can begin to reveal how live bearing evolved in teleost fish.	[Kuenstner, Axel; Hoffmann, Margarete; Fraser, Bonnie A.; Kottler, Verena A.; Sharma, Eshita; Weigel, Detlef; Dreyer, Christine] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Kuenstner, Axel] Max Planck Inst Evolutionary Biol, Guest Grp Evolutionary Genom, Plon, Germany; [Kuenstner, Axel] Univ Lubeck, Lubeck Inst Expt Dermatol, Grp Med Syst Biol, Lubeck, Germany; [Fraser, Bonnie A.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Kottler, Verena A.] Univ Wurzburg, Dept Physiol Chem, Wurzburg, Germany; [Sharma, Eshita] Wellcome Trust Res Labs, Ctr Human Genet, Bioinformat & Stat Genet Core, Oxford, England	Max Planck Society; Max Planck Society; University of Lubeck; University of Sussex; University of Wurzburg; University of Oxford; Wellcome Centre for Human Genetics	Kunstner, A (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany.; Kunstner, A (corresponding author), Max Planck Inst Evolutionary Biol, Guest Grp Evolutionary Genom, Plon, Germany.; Kunstner, A (corresponding author), Univ Lubeck, Lubeck Inst Expt Dermatol, Grp Med Syst Biol, Lubeck, Germany.	axel.kuenstner@uni-luebeck.de	Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/GSJ-0799-2022	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Kunstner, Axel/0000-0003-0692-2105; Fraser, Bonnie/0000-0001-5905-9056	Deutsche Forschungsgemeinschaft; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by a Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 2006, BRAIN BEHAV EVOLUT, V68, P181, DOI 10.1159/000094087; Alexander HJ, 2006, EVOLUTION, V60, P2352, DOI 10.1111/j.0014-3820.2006.tb01870.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366; Bachtrog D, 2011, TRENDS GENET, V27, P350, DOI 10.1016/j.tig.2011.05.005; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Barson NJ, 2009, J EVOLUTION BIOL, V22, P485, DOI 10.1111/j.1420-9101.2008.01675.x; Bolger A, 2014, NAT GENET, P1; Braasch I, 2015, J EXP ZOOL PART B, V324, P316, DOI 10.1002/jez.b.22589; Brawand D, 2014, NATURE; Brooks R, 2001, EVOLUTION, V55, P1002, DOI 10.1554/0014-3820(2001)055[1002:DAISSA]2.0.CO;2; Burri R., 2015, GENOME RES; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Dreyer C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-269; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Ellegren H, 2011, NAT REV GENET, V12, P157, DOI 10.1038/nrg2948; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; Fischer C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067048; Fraser BA, 2015, MOL ECOL, V24, P389, DOI 10.1111/mec.13022; Fraser BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-202; Fukamachi S, 2004, GENETICS, V168, P1519, DOI 10.1534/genetics.104.030494; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Garrison E, 2012, HAPLOTYPE BASED VARI; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gordon SP, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1244; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Hoffmann M, 2007, P ROY SOC B-BIOL SCI, V274, P33, DOI 10.1098/rspb.2006.3707; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Houde AE, 1997, SEX COLOR MATE CHOIC, DOI [10.1098/rspb.2008.1930, DOI 10.1098/RSPB.2008.1930]; Hughes KA, 2005, J EVOLUTION BIOL, V18, P35, DOI 10.1111/j.1420-9101.2004.00806.x; Hughes KA, 2013, NATURE, P1; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Johnen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058751; Kawauchi H, 2004, PEPTIDES, V25, P1577, DOI 10.1016/j.peptides.2004.03.025; Kottler VA, 2015, PIGM CELL MELANOMA R, V28, P545, DOI 10.1111/pcmr.12386; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laver CRJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-81; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lindholm A, 2002, AM NAT, V160, pS214, DOI 10.1086/342898; Lisachov AP, 2015, ZEBRAFISH, V12, P174, DOI 10.1089/zeb.2014.1000; Loveland JL, 2014, J EXP BIOL, V217, P2680, DOI 10.1242/jeb.100685; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nanda I, 2014, CHROMOSOMA, V123, P373, DOI 10.1007/s00412-014-0455-z; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Negishi S, 2003, PIGM CELL RES, V16, P501, DOI 10.1034/j.1600-0749.2003.00079.x; Olendorf R, 2006, NATURE, V441, P633, DOI 10.1038/nature04646; Ossowski S, 2008, GENOME RES; Park JY, 2013, MOL ENDOCRINOL, V27, P1871, DOI 10.1210/me.2013-1097; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; R Development Core Team, 2014, R LANG ENV STAT COMP; Recknagel H, 2013, G3-GENES GENOM GENET, V3, P65, DOI 10.1534/g3.112.003897; Renaut S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2833; Reznick DN, 2008, MOL ECOL, V17, P97, DOI 10.1111/j.1365-294X.2007.03474.x; REZNICK DN, 1987, EVOLUTION, V41, P1370, DOI 10.1111/j.1558-5646.1987.tb02474.x; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Sandkam B, 2015, MOL ECOL, V24, P596, DOI 10.1111/mec.13058; Schartl M, 2013, NAT GENET; Sharma E, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-400; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Smit AFA, 2008, REPEATMODELER OPEN 1; Smit AFA, 2010, REPEATMASKER OPEN 3; Soria-Carrasco V, 2014, SCIENCE, V344, P738, DOI 10.1126/science.1252136; Thornton K, 2003, LIBSEQUENCE C CLASS, DOI [10.1101/gr.089532.108, DOI 10.1101/GR.089532.108]; Traut W, 2001, CHROMOSOME RES, V9, P659, DOI 10.1023/A:1012956324417; Tripathi N, 2009, GENETICS, V182, P365, DOI 10.1534/genetics.108.098541; Tripathi N, 2009, P ROY SOC B-BIOL SCI, V276, P2195, DOI 10.1098/rspb.2008.1930; Ward MN, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-210; Watson CT, 2011, J MOL EVOL, V72, P240, DOI 10.1007/s00239-010-9426-z; Watson CT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-87; Weadick CJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S11; Yang CT, 2007, PLOS GENET, V3, P886, DOI 10.1371/journal.pgen.0030088; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	90	47	47	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0169087	10.1371/journal.pone.0169087	http://dx.doi.org/10.1371/journal.pone.0169087			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033408	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000391226900073
J	Cobey, S; Baskerville, EB				Cobey, Sarah; Baskerville, Edward B.			Limits to Causal Inference with State-Space Reconstruction for Infectious Disease	PLOS ONE			English	Article							EMBEDDING DIMENSION; SEASONALITY; STOCHASTICITY; VACCINATION; DYNAMICS; DRIVERS; MEASLES	Infectious diseases are notorious for their complex dynamics, which make it difficult to fit models to test hypotheses. Methods based on state-space reconstruction have been proposed to infer causal interactions in noisy, nonlinear dynamical systems. These "model-free" methods are collectively known as convergent cross-mapping (CCM). Although CCM has theoretical support, natural systems routinely violate its assumptions. To identify the practical limits of causal inference under CCM, we simulated the dynamics of two pathogen strains with varying interaction strengths. The original method of CCM is extremely sensitive to periodic fluctuations, inferring interactions between independent strains that oscillate with similar frequencies. This sensitivity vanishes with alternative criteria for inferring causality. However, CCM remains sensitive to high levels of process noise and changes to the deterministic attractor. This sensitivity is problematic because it remains challenging to gauge noise and dynamical changes in natural systems, including the quality of reconstructed attractors that underlie cross-mapping. We illustrate these challenges by analyzing time series of reportable childhood infections in New York City and Chicago during the pre-vaccine era. We comment on the statistical and conceptual challenges that currently limit the use of state-space reconstruction in causal inference.	[Cobey, Sarah; Baskerville, Edward B.] Univ Chicago, Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Cobey, S (corresponding author), Univ Chicago, Ecol & Evolut, Chicago, IL 60637 USA.	cobey@uchicago.edu			University of Chicago's Big Ideas Generator	University of Chicago's Big Ideas Generator	This work was funded by a seed grant from the University of Chicagos Big Ideas Generator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2007, J R SOC INTERFACE, V4, P575, DOI 10.1098/rsif.2006.0192; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Anderson R.H, 1991, INFECT DIS HUMANS; ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; Boland RP, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051131; Burnham K P, 2003, MODEL SELECT MULTIMO; Cao LY, 1997, PHYSICA D, V110, P43, DOI 10.1016/S0167-2789(97)00118-8; CASDAGLI M, 1991, PHYSICA D, V51, P52, DOI 10.1016/0167-2789(91)90222-U; Clark AT, 2015, ECOLOGY, V96, P1174, DOI 10.1890/14-1479.1; Cobey S, 2014, ANN NY ACAD SCI, V1320, P1, DOI 10.1111/nyas.12493; Dalziel BD, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004655; de Celles MD, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2309; Deyle ER, 2016, P NATL ACAD SCI USA, V113, P13081, DOI 10.1073/pnas.1607747113; Deyle ER, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2258; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; ELLNER S, 1995, AM NAT, V145, P343, DOI 10.1086/285744; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Gog JR, 2002, J MATH BIOL, V44, P169, DOI 10.1007/s002850100120; Grad YH, 2012, EPIDEMIOLOGY, V23, P523, DOI 10.1097/EDE.0b013e3182572581; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GURNEY WSC, 1978, AM NAT, V112, P1075, DOI 10.1086/283347; Hastings A, 2004, TRENDS ECOL EVOL, V19, P39, DOI 10.1016/j.tree.2003.09.007; He DH, 2010, J R SOC INTERFACE, V7, P271, DOI 10.1098/rsif.2009.0151; Hilborn Ray, 1997, V28; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Keeling M.J., 2011, MODELING INFECT DIS, DOI 10.1111/j.1541-0420.2008.01082-_}7.x; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kocarev L, 1996, PHYS REV LETT, V76, P1816, DOI 10.1103/PhysRevLett.76.1816; Laneri K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000898; Lavine JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072086; McKane AJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.218102; Metcalf CJE, 2009, P ROY SOC B-BIOL SCI, V276, P4111, DOI 10.1098/rspb.2009.1058; Mina MJ, 2015, SCIENCE, V348, P694, DOI 10.1126/science.aaa3662; Mooij JM, 2016, J MACH LEARN RES, V17; Nguyen HTH, 2008, J R SOC INTERFACE, V5, P403, DOI 10.1098/rsif.2007.1168; Nichkawde C, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022905; Pecora LM, 2007, CHAOS, V17, DOI 10.1063/1.2430294; Plowright RK, 2008, FRONT ECOL ENVIRON, V6, P420, DOI 10.1890/070086; RAND DA, 1991, P ROY SOC B-BIOL SCI, V246, P179, DOI 10.1098/rspb.1991.0142; Rohani P, 2002, AM NAT, V159, P469, DOI 10.1086/339467; Rohani P, 2003, NATURE, V422, P885, DOI 10.1038/nature01542; Ross R., 1910, PREVENTION MALARIA; Schumacher J, 2015, NEURAL COMPUT, V27, P1555, DOI 10.1162/NECO_a_00756; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; SIMBERLOFF DS, 1969, ECOLOGY, V50, P278, DOI 10.2307/1934856; Small M, 2004, PHYSICA D, V194, P283, DOI 10.1016/j.physd.2004.03.006; Stegle O., 2010, ADV NEURAL INF PROCE, V23, P1687; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; SUGIHARA G, 1994, PHILOS T R SOC A, V348, P477, DOI 10.1098/rsta.1994.0106; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Tajima S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004537; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; TILMAN D, 1989, P136; Tsonis AA, 2015, P NATL ACAD SCI USA, V112, P3253, DOI 10.1073/pnas.1420291112; Turchin P., 2003, MONOGRAPHS POPULATIO; Uzal LC, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016223; van Panhuis WG, 2013, NEW ENGL J MED, V369, P2152, DOI 10.1056/NEJMms1215400; Wood SN, 1999, P ROY SOC B-BIOL SCI, V266, P565, DOI 10.1098/rspb.1999.0673; Ye H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14750; Ye H, 2015, P NATL ACAD SCI USA, V112, pE1569, DOI 10.1073/pnas.1417063112; YODZIS P, 1988, ECOLOGY, V69, P508, DOI 10.2307/1940449	64	26	26	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0169050	10.1371/journal.pone.0169050	http://dx.doi.org/10.1371/journal.pone.0169050			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030639	gold, Green Submitted, Green Published			2022-12-26	WOS:000391222000102
J	Kawase, T; Yahata, I; Kanno, A; Sakamoto, S; Takanashi, Y; Takata, S; Nakasato, N; Kawashima, R; Katori, Y				Kawase, Tetsuaki; Yahata, Izumi; Kanno, Akitake; Sakamoto, Shuichi; Takanashi, Yoshitaka; Takata, Shiho; Nakasato, Nobukazu; Kawashima, Ryuta; Katori, Yukio			Impact of Audio-Visual Asynchrony on Lip-Reading Effects -Neuromagnetic and Psychophysical Study-	PLOS ONE			English	Article							VISUAL SPEECH-PERCEPTION; EVOKED MAGNETIC-FIELDS; HUMAN AUDITORY-CORTEX; HUMAN-BRAIN; MULTISENSORY INTEGRATION; SEEING VOICES; SOUNDS; MEG; LOCALIZATION; MISMATCH	The effects of asynchrony between audio and visual (A/V) stimuli on the N100m responses of magnetoencephalography in the left hemisphere were compared with those on the psychophysical responses in 11 participants. The latency and amplitude of N100m were significantly shortened and reduced in the left hemisphere by the presentation of visual speech as long as the temporal asynchrony between A/V stimuli was within 100 ms, but were not significantly affected with audio lags of -500 and +500 ms. However, some small effects were still preserved on average with audio lags of 500 ms, suggesting similar asymmetry of the temporal window to that observed in psychophysical measurements, which tended to be more robust (wider) for audio lags; i.e., the pattern of visual-speech effects as a function of A/V lag observed in the N100m in the left hemisphere grossly resembled that in psychophysical measurements on average, although the individual responses were somewhat varied. The present results suggest that the basic configuration of the temporal window of visual effects on auditory-speech perception could be observed from the early auditory processing stage.	[Kawase, Tetsuaki; Yahata, Izumi; Takanashi, Yoshitaka; Takata, Shiho; Katori, Yukio] Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sendai, Miyagi, Japan; [Kawase, Tetsuaki] Tohoku Univ, Grad Sch Biomed Engn, Lab Rehabil Auditory Sci, Sendai, Miyagi, Japan; [Kawase, Tetsuaki] Tohoku Univ, Grad Sch Med, Dept Audiol, Sendai, Miyagi, Japan; [Kanno, Akitake; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi, Japan; [Sakamoto, Shuichi] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi, Japan; [Nakasato, Nobukazu] Tohoku Univ, Grad Sch Med, Dept Epileptol, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Kawase, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sendai, Miyagi, Japan.; Kawase, T (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Lab Rehabil Auditory Sci, Sendai, Miyagi, Japan.; Kawase, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Audiol, Sendai, Miyagi, Japan.	kawase@orl.med.tohoku.ac.jp	Nakasato, Nobukazu/AAC-3650-2019		Ministry of Education, Culture, Sports, Science and Technology-Japan [24390386, H1605478]; Grants-in-Aid for Scientific Research [16H05435] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology-Japan (Grant-in-Aid for Scientific Research (B), 24390386, H1605478). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal LH, 2009, J NEUROSCI, V29, P13445, DOI 10.1523/JNEUROSCI.3194-09.2009; Baum SH, 2012, NEUROIMAGE, V62, P1825, DOI 10.1016/j.neuroimage.2012.05.034; Besle J, 2004, EUR J NEUROSCI, V20, P2225, DOI 10.1111/j.1460-9568.2004.03670.x; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2003, J COGNITIVE NEUROSCI, V15, P57, DOI 10.1162/089892903321107828; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Cappe C, 2005, EUR J NEUROSCI, V22, P2886, DOI 10.1111/j.1460-9568.2005.04462.x; Davis C, 2008, BRAIN RES, V1242, P151, DOI 10.1016/j.brainres.2008.04.077; ERBER NP, 1971, J SPEECH HEAR RES, V14, P496, DOI 10.1044/jshr.1403.496; Falchier A, 2002, J NEUROSCI, V22, P5749; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; GREEN KP, 1991, PERCEPT PSYCHOPHYS, V50, P524, DOI 10.3758/BF03207536; HARI R, 1980, EXP BRAIN RES, V40, P237, DOI 10.1007/BF00237543; Helenius P, 2002, J NEUROSCI, V22, P2936, DOI 10.1523/JNEUROSCI.22-07-02936.2002; Kanno A, 2000, NEUROSCI LETT, V293, P187, DOI 10.1016/S0304-3940(00)01525-1; Kanno A, 1996, EEG CL N SU, P129; Kawase T, 2012, NEUROIMAGE, V59, P1037, DOI 10.1016/j.neuroimage.2011.08.108; Klucharev V, 2003, COGNITIVE BRAIN RES, V18, P65, DOI 10.1016/j.cogbrainres.2003.09.004; Kujala A, 2004, COGNITIVE BRAIN RES, V21, P106, DOI 10.1016/j.cogbrainres.2004.05.011; KURIKI S, 1989, EXP BRAIN RES, V77, P127; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Munhall KG, 1996, PERCEPT PSYCHOPHYS, V58, P351, DOI 10.3758/BF03206811; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Nakamura I, 2015, NEUROPSYCHOBIOLOGY, V71, P187, DOI 10.1159/000377680; Nakasato N, 1997, J NEUROSURG, V86, P610, DOI 10.3171/jns.1997.86.4.0610; NAKASATO N, 1995, ELECTROEN CLIN NEURO, V94, P183, DOI 10.1016/0013-4694(94)00280-X; Obleser J, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-24; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PANTEV C, 1986, AUDIOLOGY, V25, P54; Parviainen T, 2005, CEREB CORTEX, V15, P1054, DOI 10.1093/cercor/bhh206; Phillips C, 2000, J COGNITIVE NEUROSCI, V12, P1038, DOI 10.1162/08989290051137567; Poeppel D, 1996, COGNITIVE BRAIN RES, V4, P231, DOI 10.1016/S0926-6410(96)00643-X; Reale RA, 2007, NEUROSCIENCE, V145, P162, DOI 10.1016/j.neuroscience.2006.11.036; REITE M, 1994, COGNITIVE BRAIN RES, V2, P13, DOI 10.1016/0926-6410(94)90016-7; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Saint-Amour D, 2007, NEUROPSYCHOLOGIA, V45, P587, DOI 10.1016/j.neuropsychologia.2006.03.036; Salmelin R, 2007, CLIN NEUROPHYSIOL, V118, P237, DOI 10.1016/j.clinph.2006.07.316; Sasaki T, 2005, NEUROIMAGE, V25, P684, DOI 10.1016/j.neuroimage.2004.11.030; Sekiyama K, 2003, NEUROSCI RES, V47, P277, DOI 10.1016/S0168-0102(03)00214-1; Soto-Faraco S, 2009, J EXP PSYCHOL HUMAN, V35, P580, DOI 10.1037/a0013483; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; Stevenson RA, 2012, J EXP PSYCHOL HUMAN, V38, P1517, DOI 10.1037/a0027339; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Usubuchi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099457; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vihla M, 2000, P NATL ACAD SCI USA, V97, P10590, DOI 10.1073/pnas.180317297; Wright TM, 2003, CEREB CORTEX, V13, P1034, DOI 10.1093/cercor/13.10.1034	51	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168740	10.1371/journal.pone.0168740	http://dx.doi.org/10.1371/journal.pone.0168740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030631	gold, Green Submitted, Green Published			2022-12-26	WOS:000391222000072
J	Sokolowski, M; Wasserman, J; Wasserman, D				Sokolowski, Marcus; Wasserman, Jerzy; Wasserman, Danuta			Rare CNVs in Suicide Attempt include Schizophrenia-Associated Loci and Neurodevelopmental Genes: A Pilot GenomeWide and Family-Based Study	PLOS ONE			English	Article							COPY NUMBER VARIATION; WIDE ASSOCIATION; ENVIRONMENT INTERACTIONS; DISORDERS; BEHAVIORS; POLYMORPHISMS; VARIANTS; GUIDANCE; RISK	Suicidal behavior (SB) has a complex etiology involving genes and environment. One of the genetic components in SB could be copy number variations (CNVs), as CNVs are implicated in neurodevelopmental disorders. However, a recently published genome-wide and case control study did not observe any significant role of CNVs in SB. Here we complemented these initial observations by instead using a family-based trio-sample that is robust to control biases, having severe suicide attempt (SA) in offspring as main outcome (n = 660 trios). We first tested for CNV associations on the genome-wide Illumina 1M SNP-array by using FBAT-CNV methodology, which allows for evaluating CNVs without reliance on CNV calling algorithms, analogous to a common SNP-based GWAS. We observed association of certain T-cell receptor markers, but this likely reflected inter-individual variation in somatic rearrangements rather than association with SA outcome. Next, we used the PennCNV software to call 385 putative rare (<1%) and large (>100 kb) CNVs, observed in n = 225 SA offspring. Nine SA offspring had rare CNV calls in a set of previously schizophrenia-associated loci, indicating the importance of such CNVs in certain SA subjects. Several additional, very large (>1MB) sized CNV calls in 15 other SA offspring also spanned pathogenic regions or other neural genes of interest. Overall, 45 SA had CNVs enriched for 65 medically relevant genes previously shown to be affected by CNVs, which were characterized by a neurodevelopmental biology. A neurodevelopmental implication was partly congruent with our previous SNP-based GWAS, but follow-up analysis here indicated that carriers of rare CNVs had a decreased burden of common SNP risk-alleles compared to non-carriers. In conclusion, while CNVs did not show genome-wide association by the FBAT-CNV methodology, our preliminary observations indicate rare pathogenic CNVs affecting neurodevelopmental functions in a subset of SA, who were distinct from SA having increased SNP risk allele burden. These observations may open up new avenues in the genetic etiology of SB.	[Sokolowski, Marcus; Wasserman, Jerzy; Wasserman, Danuta] Karolinska Inst, Natl Ctr Suicide Res & Prevent Mental Hlth NASP 3, Stockholm, Sweden; [Wasserman, Danuta] KI, NASP, WHO Collaborating Ctr Res Methods Dev & Training, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Sokolowski, M (corresponding author), Karolinska Inst, Natl Ctr Suicide Res & Prevent Mental Hlth NASP 3, Stockholm, Sweden.	marcus.sokolowski@ki.se	farjad, farshad/AGC-9105-2022	Sokolowski, Marcus/0000-0003-3931-1810	Knut and Alice Wallenberg Foundation	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This GISS study was funded by the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; BECK AT, 1975, AM J PSYCHIAT, V132, P285; Ben-Efraim YJ, 2011, GENES BRAIN BEHAV, V10, P663, DOI 10.1111/j.1601-183X.2011.00703.x; Ben-Efraim YJ, 2013, NEUROPSYCHOPHARMACOL, V38, P1504, DOI 10.1038/npp.2013.49; Ben-Efraim Y, 2013, MOL PSYCHIATR, V18, P758, DOI 10.1038/mp.2012.86; Brent DA, 2008, PSYCHIAT CLIN N AM, V31, P157, DOI 10.1016/j.psc.2008.02.001; Chapman J, 2013, HUM MOL GENET, V22, P816, DOI 10.1093/hmg/dds476; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; COX DR, 1970, BIOMETRIKA, V57, P217, DOI 10.1093/biomet/57.1.217; Galfalvy H, 2011, WORLD J BIOL PSYCHIA, DOI http://dx.doi.org/10.3109/15622975.2011.597875; Galfalvy H, 2013, WORLD J BIOL PSYCHIA, V14, P574, DOI 10.3109/15622975.2011.597875; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; GEIJER T, 1994, EUR ARCH PSY CLIN N, V244, P26, DOI 10.1007/BF02279808; Georgieva L, 2014, HUM MOL GENET, V23, P6677, DOI 10.1093/hmg/ddu379; Grayton HM, 2012, PROG NEUROBIOL, V99, P81, DOI 10.1016/j.pneurobio.2012.07.005; Gross JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128369; GROTE SS, 1974, J NEUROCHEM, V23, P791, DOI 10.1111/j.1471-4159.1974.tb04405.x; Grozeva D, 2012, SCHIZOPHR RES, V135, P1, DOI 10.1016/j.schres.2011.11.004; Hoertel N, 2015, MOL PSYCHIATR, V20, P718, DOI 10.1038/mp.2015.19; Ionita-Laza I, 2008, GENET EPIDEMIOL, V32, P273, DOI 10.1002/gepi.20302; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Jonas RK, 2014, BIOL PSYCHIAT, V75, P351, DOI 10.1016/j.biopsych.2013.07.019; Lenz B, 2016, J NEURAL TRANSM VIEN; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Mann JJ, 2009, BIOL PSYCHIAT, V65, P556, DOI 10.1016/j.biopsych.2008.11.021; Mittendorfer-Rutz E, 2004, LANCET, V364, P1135, DOI 10.1016/S0140-6736(04)17099-2; Mullins N, 2014, AM J MED GENET B, V165, P428, DOI 10.1002/ajmg.b.32247; Oquendo MA, 2014, AM J PSYCHIAT, V171, P1259, DOI 10.1176/appi.ajp.2014.14020194; Perlis RH, 2010, AM J PSYCHIAT, V167, P1499, DOI 10.1176/appi.ajp.2010.10040541; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Rees E, 2014, BRIT J PSYCHIAT, V204, P108, DOI 10.1192/bjp.bp.113.131052; Schild AHE, 2013, PROG NEURO-PSYCHOPH, V46, P36, DOI 10.1016/j.pnpbp.2013.06.014; Schosser A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020690; Schwienbacher C, 2010, IMMUNOGENETICS, V62, P561, DOI 10.1007/s00251-010-0459-7; Sokolowski M, 2016, MOL PSYCHIATR, V21, P1381, DOI 10.1038/mp.2015.187; Sokolowski M, 2015, MOL PSYCHIATR, V20, P56, DOI 10.1038/mp.2014.101; Sokolowski M, 2013, MOL PSYCHIATR, V18, P985, DOI 10.1038/mp.2012.112; Sokolowski M, 2010, MOL PSYCHIATR, V15, P10, DOI 10.1038/mp.2009.70; Sokolowski M, 2014, EUR NEUROPSYCHOPHARM, V24, P1567, DOI 10.1016/j.euroneuro.2014.08.006; Szatkiewicz JP, 2014, MOL PSYCHIATR, V19, P762, DOI 10.1038/mp.2014.40; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tansey KE, 2015, MOL PSYCHIAT; Turecki G, 2012, TRENDS NEUROSCI, V35, P14, DOI 10.1016/j.tins.2011.11.008; Voracek M, 2007, WIEN KLIN WOCHENSCHR, V119, P463, DOI 10.1007/s00508-007-0823-2; Walsh KM, 2010, MUTAT RES-FUND MOL M, V690, P89, DOI 10.1016/j.mrfmmm.2010.05.005; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wasserman D, 2008, GENES BRAIN BEHAV, V7, P14, DOI 10.1111/j.1601-183X.2007.00310.x; Wasserman D, 2007, GENES BRAIN BEHAV, V6, P321, DOI 10.1111/j.1601-183X.2006.00259.x; Wasserman D, 2005, AM J MED GENET B, V133B, P116, DOI 10.1002/ajmg.b.30128; Wasserman D, 2012, EUR PSYCHIAT, V27, P129, DOI 10.1016/j.eurpsy.2011.06.003; Wasserman Danuta, 2006, Behav Brain Funct, V2, P14, DOI 10.1186/1744-9081-2-14; Wasserman D, 2007, EUR NEUROPSYCHOPHARM, V17, P230, DOI 10.1016/j.euroneuro.2006.08.006; Willour VL, 2012, MOL PSYCHIATR, V17, P433, DOI 10.1038/mp.2011.4; Zanda M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004367; Zanda M, 2012, GENET EPIDEMIOL, V36, P895, DOI 10.1002/gepi.21674; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871	57	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168531	10.1371/journal.pone.0168531	http://dx.doi.org/10.1371/journal.pone.0168531			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030616	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000053
J	Mehta-D'souza, P; Klopocki, AG; Oganesyan, V; Terzyan, S; Mather, T; Li, ZH; Panicker, SR; Zhu, C; McEver, RP				Mehta-D'souza, Padmaja; Klopocki, Arkadiusz G.; Oganesyan, Vaheh; Terzyan, Simon; Mather, Timothy; Li, Zhenhai; Panicker, Sumith R.; Zhu, Cheng; McEver, Rodger P.			Glycan Bound to the Selectin Low Affinity State Engages Glu-88 to Stabilize the High Affinity State under Force	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH ENDOTHELIAL VENULES; LIGAND BINDING-KINETICS; P-SELECTIN; GLYCOPROTEIN LIGAND-1; LECTIN DOMAIN; CELL-ADHESION; CONFORMATION; REPLACEMENT; NEUTROPHILS; SOFTWARE	Selectin interactions with fucosylated glycan ligands mediate leukocyte rolling in the vasculature under shear forces. Crystal structures of P-and E-selectin suggest a two-state model in which ligand binding to the lectin domain closes loop 83-89 around the Ca2+ coordination site, enabling Glu-88 to engage Ca2+ and fucose. This triggers further allostery that opens the lectin/EGF domain hinge. The model posits that force accelerates transition from the bent (low affinity) to the extended (high affinity) state. However, transition intermediates have not been described, and the role of Glu-88 in force-assisted allostery has not been examined. Here we report the structure of the lectin and EGF domains of L-selectin bound to a fucose mimetic; that is, a terminal mannose on an N-glycan attached to a symmetry-related molecule. The structure is a transition intermediate where loop 83-89 closes to engage Ca2+ and mannose without triggering allostery that opens the lectin/EGF domain hinge. We used three complementary assays to compare ligand binding to WT selectins and to E88D selectins that replaced Glu-88 with Asp. Soluble P-selectinE88D bound with an similar to 9-fold lower affinity to PSGL-1, a physiological ligand, due to faster dissociation. Adhesion frequency experiments with a biomembrane force probe could not detect interactions of P-selectinE88D with PSGL-1. Cells expressing transmembrane P-selectinE88D or L-selectinE88D detached from immobilized ligands immediately after initiating flow. Cells expressing E-selectinE88D rolled but detached faster. Our data support a two-state model for selectins in which Glu-88 must engage ligand to trigger allostery that stabilizes the high affinity state under force.	[Mehta-D'souza, Padmaja; Klopocki, Arkadiusz G.; Oganesyan, Vaheh; Mather, Timothy; Panicker, Sumith R.; McEver, Rodger P.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Terzyan, Simon] Oklahoma Med Res Fdn, Crystallog Res Program, Oklahoma City, OK 73104 USA; [McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Li, Zhenhai; Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Zhu, Cheng] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Zhu, Cheng] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA	Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	McEver, RP (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	rodger-mcever@omrf.org	Panicker, Sumith/X-8830-2019; Li, Zhenhai/B-2591-2018	Li, Zhenhai/0000-0002-0720-2807; Zhu, Cheng/0000-0002-1718-565X; Panicker, Sumith/0000-0001-8550-9436; McEver, Rodger/0000-0001-5343-2622	National Institutes of Health [HL034363, AI077343, HL085607]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL034363, R01HL034363, R01HL132019, P01HL085607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI077343, R01AI077343, R01AI044902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL034363, AI077343, and HL085607. R.P.M. is a co-founder of Selexys Pharmaceutical Corp., now part of Novartis, and of Tetherex Pharmaceutical Corp. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen W, 2008, CELL MOL BIOENG, V1, P276, DOI 10.1007/s12195-008-0024-8; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Diacovo TG, 1996, SCIENCE, V273, P252, DOI 10.1126/science.273.5272.252; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; GRAVES BJ, 1994, NATURE, V367, P532, DOI 10.1038/367532a0; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; KISHIMOTO TK, 1991, BLOOD, V78, P805; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu W, 1998, J BIOL CHEM, V273, P7078, DOI 10.1074/jbc.273.12.7078; Lou JZ, 2007, BIOPHYS J, V92, P1471, DOI 10.1529/biophysj.106.097048; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; McEver RP, 2015, CARDIOVASC RES, V107, P331, DOI 10.1093/cvr/cvv154; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Mehta P, 1997, BLOOD, V90, P2381, DOI 10.1182/blood.V90.6.2381.2381_2381_2389; Mehta P, 1998, J BIOL CHEM, V273, P32506, DOI 10.1074/jbc.273.49.32506; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATEL KD, 1995, J CLIN INVEST, V96, P1887, DOI 10.1172/JCI118234; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Preston RC, 2016, J MOL CELL BIOL, V8, P62, DOI 10.1093/jmcb/mjv046; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Springer TA, 2009, P NATL ACAD SCI USA, V106, P91, DOI 10.1073/pnas.0810784105; STEARNS DJ, 1988, J BIOL CHEM, V263, P826; STOOLMAN LM, 1984, J CELL BIOL, V99, P1535, DOI 10.1083/jcb.99.4.1535; Turk D, 2013, ACTA CRYSTALLOGR D, V69, P1342, DOI 10.1107/S0907444913008408; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Waldron TT, 2009, P NATL ACAD SCI USA, V106, P85, DOI 10.1073/pnas.0810620105; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Yago T, 2010, P NATL ACAD SCI USA, V107, P9204, DOI 10.1073/pnas.1003110107; Yakovenko O, 2015, P NATL ACAD SCI USA, V112, P9884, DOI 10.1073/pnas.1503160112	35	21	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2510	2518		10.1074/jbc.M116.767186	http://dx.doi.org/10.1074/jbc.M116.767186			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28011641	hybrid, Green Published			2022-12-26	WOS:000395530300037
J	Zhao, QJJ; Cai, WH; Zhang, X; Tian, S; Zhang, JW; Li, HB; Hou, CC; Ma, XL; Chen, H; Huang, BR; Chen, D				Zhao, Qiaojiajie; Cai, Weihua; Zhang, Xuan; Tian, Shuo; Zhang, Junwen; Li, Haibo; Hou, Congcong; Ma, Xiaoli; Chen, Hong; Huang, Bingren; Chen, Deng			RYBP Expression Is Regulated by KLF4 and Sp1 and Is Related to Hepatocellular Carcinoma Prognosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEATH EFFECTOR DOMAIN; TRANSCRIPTION FACTOR; SPECIFICITY PROTEIN-1; HEPATOBLASTOMA CELLS; POLYCOMB COMPLEX; APOPTOSIS; INTERACTS; ACTIVATION; SURVIVAL; TARGET	The expression of Ring1and YY1 binding protein (RYBP) is reduced in several human cancers, but the molecular mechanism( s) have remained elusive. In this study, we used human hepatocellular carcinoma (HCC) cell lines and tissue specimens to study the mechanism and herein report several new findings. First, we cloned and characterized the basal promoter region of the human RYBP gene. We found that the decreased RYBP expression in HCC tissues was not due to promoter sequence variation/polymorphisms orCpGdinucleotide methylation. Weidentified two transcription factors, KLF4 and Sp1, which directly bind the promoter region of RYBP to induce and suppress RYBP transcription, respectively. We mapped the binding sites of KLF4 and Sp1 on theRYBPpromoter. Studies in vitro showed that KLF4 suppresses whereas Sp1 promotesHCCcell growth through modulating RYBP expression. Deregulated KLF4 and Sp1 contributed to decreasedexpressionofRYBPinHCCtumortissues. Ourstudiesof human HCC tissues indicated that a diminished RYBP level in the tumor (in association with altered KLF4 and Sp1 expression) was statistically associated with a larger tumor size, poorer differentiation, and an increased susceptibility to distant metastasis. These findings help to clarifywhyRYBPis decreased inHCCand indicate that deregulated KLF4, Sp1, and RYBP may lead to a poorer prognosis. Our findings support the idea that RYBP may represent a target for cancer therapy and suggest that it may be useful as a prognostic biomarker for HCC, either alone or in combination with KLF4 and Sp1.	[Zhao, Qiaojiajie; Zhang, Xuan; Tian, Shuo; Zhang, Junwen; Hou, Congcong; Ma, Xiaoli; Chen, Hong; Huang, Bingren; Chen, Deng] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem & Mol Biol, State Key Lab Med Mol Biol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China; [Zhao, Qiaojiajie; Zhang, Xuan; Tian, Shuo; Zhang, Junwen; Hou, Congcong; Ma, Xiaoli; Chen, Hong; Huang, Bingren; Chen, Deng] Peking Union Med Coll, Sch Basic Med, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China; [Cai, Weihua] Nantong Univ, Nantong Hosp 3, Dept Hepatobiliary Surg, Nantong 226006, Jiangsu, Peoples R China; [Li, Haibo] Nantong Maternal & Child Hlth Hosp, Dept Clin Lab Med, Nantong 226018, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Nantong University	Huang, BR; Chen, D (corresponding author), Peking Union Med Coll, Sch Basic Med, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	hbr541@hotmail.com; chendeng2001@hotmail.com		Zhang, Junwen/0000-0003-3359-7213; Zhang, Xuan/0000-0002-1801-5855	Project of the National Natural Science Foundation of China [81272229]; State Key Laboratory of Medical Molecular Biology of China	Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Medical Molecular Biology of China	This work was supported by the Project of the National Natural Science Foundation of China (Grant 81272229) and the State Key Laboratory of Medical Molecular Biology of China. The authors declare that they have no conflicts of interest with the contents of this article.	Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148; Chen D, 2009, EMBO REP, V10, P166, DOI 10.1038/embor.2008.231; Cui JJ, 2013, CURR CANCER DRUG TAR, V13, P986, DOI 10.2174/15680096113136660104; Danen-van Oorschot AAAM, 2004, CELL DEATH DIFFER, V11, P564, DOI 10.1038/sj.cdd.4401391; Fowler CB, 2011, METHODS MOL BIOL, V724, P23, DOI 10.1007/978-1-61779-055-3_2; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Gonzalez I, 2009, CELL RES, V19, P747, DOI 10.1038/cr.2009.29; Hsiao CC, 2015, CANCER LETT, V368, P144, DOI 10.1016/j.canlet.2015.08.004; Hsu HT, 2014, INT J MOL SCI, V15, P9894, DOI 10.3390/ijms15069894; Kong LM, 2011, J CELL MOL MED, V15, P1415, DOI 10.1111/j.1582-4934.2010.01124.x; Lando M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000719; Li Q, 2012, GASTROENTEROLOGY, V143, P799, DOI 10.1053/j.gastro.2012.05.043; Ma W, 2016, CELL SIGNAL, V28, P779, DOI 10.1016/j.cellsig.2016.03.012; Majumdar G, 2003, AM J PHYSIOL-ENDOC M, V285, pE584, DOI 10.1152/ajpendo.00140.2003; Novak RL, 2008, CANCER GENE THER, V15, P713, DOI 10.1038/cgt.2008.25; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; Safe S, 2014, EXPERT OPIN THER TAR, V18, P759, DOI 10.1517/14728222.2014.914173; Sawa C, 2002, J BIOL CHEM, V277, P22484, DOI 10.1074/jbc.M203060200; Schickling O, 2001, CELL DEATH DIFFER, V8, P1157, DOI 10.1038/sj.cdd.4400928; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Stanton SE, 2007, APOPTOSIS, V12, P2197, DOI 10.1007/s10495-007-0131-3; Sun HC, 2016, CLIN CANCER RES, V22, P502, DOI 10.1158/1078-0432.CCR-15-0528; Sung MT, 2015, ONCOL REP, V34, P439, DOI 10.3892/or.2015.3964; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tischoff I, 2008, WORLD J GASTROENTERO, V14, P1741, DOI 10.3748/wjg.14.1741; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Voruganti S, 2015, CANCER LETT, V369, P386, DOI 10.1016/j.canlet.2015.09.003; Wang W, 2014, ONCOTARGET, V5, P11604, DOI 10.18632/oncotarget.2598; Wang YT, 2008, J MOL BIOL, V380, P869, DOI 10.1016/j.jmb.2008.05.043; Yang JL, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-56; Yin X, 2013, ONCOL LETT, V5, P1155, DOI 10.3892/ol.2013.1151; Yumnam S, 2016, J CELL PHYSIOL, V231, P1261, DOI 10.1002/jcp.25222; Zeng XY, 2011, THEOR APPL MECH LETT, V1, DOI 10.1063/2.1103301; Zheng LX, 2001, J BIOL CHEM, V276, P31945, DOI 10.1074/jbc.M102799200	37	24	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2143	2158		10.1074/jbc.M116.770727	http://dx.doi.org/10.1074/jbc.M116.770727			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28028181	Green Published, hybrid			2022-12-26	WOS:000395530300009
J	Alkhenizan, A; Mahmoud, A; Hussain, A; Gabr, A; Alsoghayer, S; Eldali, A				Alkhenizan, Abdullah; Mahmoud, Ahmed; Hussain, Aneela; Gabr, Alia; Alsoghayer, Suad; Eldali, Abdelmoneim			The Relationship between 25 (OH) D Levels (Vitamin D) and Bone Mineral Density (BMD) in a Saudi Population in a Community-Based Setting	PLOS ONE			English	Article							HIGH PREVALENCE; LIFE-STYLE; WOMEN; SERUM; OSTEOPOROSIS	Background Vitamin D deficiency has been linked to an increased risk of osteoporosis. Vitamin D deficiency has reached high levels in the Saudi population, but there is conflicting evidence both in the Saudi population, and worldwide, regarding the existence of a correlation between these low vitamin D levels and reduced BMD (bone mineral density), or osteoporosis. Objective The objective of this study was primarily to determine whether there was a correlation between vitamin D deficiency and osteoporosis in the Saudi population. We aimed to investigate whether the high levels of vitamin D deficiency and insufficiency would translate to higher prevalence of osteoporosis, and whether there is a correlation between vitamin D levels and bone mineral density. Materials and methods This was a community based cross sectional study conducted in the Family Medicine Clinics at King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia. Electronic records of 1723 patients were reviewed. Laboratory and radiology results were collected, including vitamin D levels, calcium levels, and bone mineral density scan results. Results Among the whole population, 61.5% had moderate to severe vitamin D deficiency with levels less than 50nmol/L. 9.1% of the population had osteoporosis, and 38.6% had osteopenia. Among the whole population, there was no significant correlation between spine or total femoral BMD and serum 25(OH) D. Conclusion Vitamin D deficiency is prevalent in the Saudi population. However, no correlation has been found between vitamin D deficiency and reduced bone mineral density in any age group, in males or females, Saudis or Non-Saudis, in our population in Riyadh, Saudi Arabia.	[Alkhenizan, Abdullah; Mahmoud, Ahmed; Hussain, Aneela; Gabr, Alia; Alsoghayer, Suad] King Faisal Specialist Hosp & Res Ctr, Dept Family Med, Riyadh, Saudi Arabia; [Eldali, Abdelmoneim] King Faisal Specialist Hosp & Res Ctr, Dept Biostat Epidemiol & Sci Comp, Riyadh, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center	Alkhenizan, A (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Family Med, Riyadh, Saudi Arabia.	akhenizan@kfshre.edu.sa	Alkhenizan, Abdullah/ABE-7878-2020	Hussain, Aneela/0000-0003-3446-7314				Allali F, 2009, SEMIN ARTHRITIS RHEU, V38, P444, DOI 10.1016/j.semarthrit.2008.01.009; [Anonymous], 2016, SAUDI ARABIAN POPULA; Ardawi MSM, 2012, OSTEOPOROSIS INT, V23, P675, DOI 10.1007/s00198-011-1606-1; Ardawi MS, 2010, BONE, V47, pS192; Bischoff-Ferrari HA, 2004, AM J MED, V116, P634, DOI 10.1016/j.amjmed.2003.12.029; Ebeling PR., 2014, BONEKEY REP, V3; Ghannam NN, 1999, CALCIFIED TISSUE INT, V65, P23, DOI 10.1007/s002239900652; Grant WB, 2005, ALTERN MED REV, V10, P94; Hannan MT, 2008, J CLIN ENDOCR METAB, V93, P40, DOI 10.1210/jc.2007-1217; Lips P, 2001, J CLIN ENDOCR METAB, V86, P1212, DOI 10.1210/jc.86.3.1212; Nakamura K, 2008, BONE, V42, P271, DOI 10.1016/j.bone.2007.09.056; Rassouli A, 2001, BONE, V29, P428, DOI 10.1016/S8756-3282(01)00591-9; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Zhen DH, 2015, BONE, V71, P1, DOI 10.1016/j.bone.2014.09.024	15	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169122	10.1371/journal.pone.0169122	http://dx.doi.org/10.1371/journal.pone.0169122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046015	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300120
J	Franaszczyk, M; Chmielewski, P; Truszkowska, G; Stawinski, P; Michalak, E; Rydzanicz, M; Sobieszczanska-Malek, M; Pollak, A; Szczygiel, J; Kosinska, J; Parulski, A; Stoklosa, T; Tarnowska, A; Machnicki, MM; Foss-Nieradko, B; Szperil, M; Sioma, A; Kusmierczyk, M; Grzybowski, J; Zielinski, T; Ploski, R; Bilinska, ZT				Franaszczyk, Maria; Chmielewski, Przemyslaw; Truszkowska, Grazyna; Stawinski, Piotr; Michalak, Ewa; Rydzanicz, Malgorzata; Sobieszczanska-Malek, Malgorzata; Pollak, Agnieszka; Szczygiel, Justyna; Kosinska, Joanna; Parulski, Adam; Stoklosa, Tomasz; Tarnowska, Agnieszka; Machnicki, Marcin M.; Foss-Nieradko, Bogna; Szperil, Malgorzata; Sioma, Agnieszka; Kusmierczyk, Mariusz; Grzybowski, Jacek; Zielinski, Tomasz; Ploski, Rafal; Bilinska, Zofia T.			Titin Truncating Variants in Dilated Cardiomyopathy - Prevalence and Genotype-Phenotype Correlations	PLOS ONE			English	Article							LAMIN A/C GENE; HYPERTROPHIC CARDIOMYOPATHY; PERICARDIAL DISEASES; POSITION STATEMENT; WORKING GROUP; MUTATIONS; AGE	TTN gene truncating variants are common in dilated cardiomyopathy (DCM), although data on their clinical significance is still limited. We sought to examine the frequency of truncating variants in TTN in patients with DCM, including familial DCM (FDCM), and to look for genotype-phenotype correlations. Clinical cardiovascular data, family histories and blood samples were collected from 72 DCM probands, mean age of 34 years, 45.8% FDCM. DNA samples were examined by next generation sequencing (NGS) with a focus on the TTN gene. Truncating mutations were followed up by segregation study among family members. We identified 16 TTN truncating variants (TTN trunc) in 17 probands (23.6% of all cases, 30.3% of FDCM, 17.9% of sporadic DCM). During mean 63 months from diagnosis, there was no difference in adverse cardiac events between probands with and without TTN truncating mutations. Among relatives 29 mutation carriers were identified, nine were definitely affected (31%), eight probably affected (27.6%) one possibly affected (3.4%) and eleven were not affected (37.9%). When relatives with all affected statuses were combined, disease penetrance was still incomplete (62.1%) even after exclusion of unaffected relatives under 40 (82%) and was higher in males versus females. In all mutation carriers, during follow-up, 17.4% had major adverse cardiac events, and prognosis was significantly worse in men than in women. In conclusion, TTN truncating variants were observed in nearly one fourth of young DCM patient population, in vast majority without conduction system disease. Incomplete penetrance suggests possible influence of other genetic and/or environmental factors on the course of cardiotitinopathy. Counseling should take into account sex and incomplete penetrance.	[Franaszczyk, Maria; Truszkowska, Grazyna; Szperil, Malgorzata] Inst Cardiol, Dept Med Biol, Mol Biol Lab, Warsaw, Poland; [Chmielewski, Przemyslaw; Michalak, Ewa; Foss-Nieradko, Bogna; Bilinska, Zofia T.] Inst Cardiol, Unit Screening Studies Inherited Cardiovasc Dis, Warsaw, Poland; [Stawinski, Piotr; Pollak, Agnieszka] Inst Physiol & Pathol Hearing, Dept Genet, Kajetany Warsaw, Poland; [Rydzanicz, Malgorzata; Kosinska, Joanna; Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Sobieszczanska-Malek, Malgorzata; Tarnowska, Agnieszka; Zielinski, Tomasz] Inst Cardiol, Dept Heart Failure & Transplantol, Warsaw, Poland; [Szczygiel, Justyna; Sioma, Agnieszka; Grzybowski, Jacek] Inst Cardiol, Dept Cardiomyopathies, Warsaw, Poland; [Parulski, Adam; Kusmierczyk, Mariusz] Inst Cardiol, Dept Cardiac Surg & Transplantol, Warsaw, Poland; [Stoklosa, Tomasz; Machnicki, Marcin M.] Med Univ Warsaw, Dept Immunol, Ctr Biostruct Res, Warsaw, Poland; [Machnicki, Marcin M.] Med Univ Warsaw, Postgrad Sch Mol Med, Warsaw, Poland	Institute of Cardiology - Poland; Institute of Cardiology - Poland; Institute of Physiology & Hearing Pathology; Medical University of Warsaw; Institute of Cardiology - Poland; Institute of Cardiology - Poland; Institute of Cardiology - Poland; Medical University of Warsaw; Medical University of Warsaw	Bilinska, ZT (corresponding author), Inst Cardiol, Unit Screening Studies Inherited Cardiovasc Dis, Warsaw, Poland.; Ploski, R (corresponding author), Med Univ Warsaw, Dept Med Genet, Warsaw, Poland.	rploski@wp.pl; zbilinska@ikard.pl	Zieliński, Tomasz/K-5949-2014; Stoklosa, Tomasz A/I-8825-2017; Chmielewski, Przemyslaw/GNP-6905-2022; Machnicki, Marcin/HGT-7769-2022; Michalak, Ewa/AAA-5741-2021; Zieliński, Tomasz/B-7807-2017; Chmielewski, Przemysław/ABG-1511-2021	Zieliński, Tomasz/0000-0001-9277-0552; Zieliński, Tomasz/0000-0001-9277-0552; Chmielewski, Przemysław/0000-0001-6655-0070; Pollak, Agnieszka/0000-0002-2847-1782; Truszkowska, Grazyna/0000-0002-9577-5145; Kosinska, Joanna/0000-0003-3767-6584; Stoklosa, Tomasz/0000-0001-6918-5056; GRZYBOWSKI, JACEK/0000-0002-5848-5579; Sobieszczanska-Malek, Malgorzata/0000-0002-6977-4173; Kusmierczyk, Mariusz/0000-0001-9851-9596; Ploski, Rafal/0000-0001-6286-5526; Rydzanicz, Malgorzata/0000-0002-6969-0535; Franaszczyk, Maria/0000-0002-0719-1933; Bilinska, Zofia/0000-0003-1451-2069; Machnicki, Marcin/0000-0001-8525-543X	Institute of Cardiology [2.56/II/2014]; National Science Centre Poland [2013/11/N/NZ2/02528, 2011/01/B/NZ4/03455]	Institute of Cardiology; National Science Centre Poland(National Science Centre, Poland)	Funded by Institute of Cardiology grant No 2.56/II/2014 GT (http://www.ikard.pi/home.html); National Science Centre Poland grants No 2013/11/N/NZ2/02528 MF and 2011/01/B/NZ4/03455 RP (https://www.ncn.gov.pl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinrinade O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145284; Akinrinade O, 2015, EUR HEART J, V36, P2327, DOI 10.1093/eurheartj/ehv253; Beckendorf L, 2015, J MUSCLE RES CELL M, V36, P25, DOI 10.1007/s10974-014-9392-y; Cheng WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038650; Cox MGPJ, 2011, CIRCULATION, V123, P2690, DOI 10.1161/CIRCULATIONAHA.110.988287; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Haas J, 2015, EUR HEART J, V36, P1123, DOI 10.1093/eurheartj/ehu301; HENRY WL, 1980, CIRCULATION, V62, P1054, DOI 10.1161/01.CIR.62.5.1054; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hershberger RE, 2008, CTS-CLIN TRANSL SCI, V1, P21, DOI 10.1111/j.1752-8062.2008.00017.x; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Itoh-Satoh M, 2002, BIOCHEM BIOPH RES CO, V291, P385, DOI 10.1006/bbrc.2002.6448; Jansweijer JA, 2016, EUR J HEART FAIL; Morales A, 2015, CAN J CARDIOL, V31, P1309, DOI 10.1016/j.cjca.2015.06.034; Page SP, 2012, CIRC-CARDIOVASC GENE, V5, P156, DOI 10.1161/CIRCGENETICS.111.960831; Pinto YM, 2016, EUR HEART J, V37, P1850, DOI 10.1093/eurheartj/ehv727; Ploski R, 2014, CIRC RES, V114, pE2, DOI 10.1161/CIRCRESAHA.114.302662; Pugh TJ, 2014, GENET MED, V16, P601, DOI 10.1038/gim.2013.204; Roberts AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010134; Taylor MRG, 2003, J AM COLL CARDIOL, V41, P771, DOI 10.1016/S0735-1097(02)02954-6; Vytopil M, 2002, NEUROMUSCULAR DISORD, V12, P958, DOI 10.1016/S0960-8966(02)00178-5	23	47	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169007	10.1371/journal.pone.0169007	http://dx.doi.org/10.1371/journal.pone.0169007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045975	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300087
J	Kashima, S; Inoue, K; Matsumoto, M				Kashima, Saori; Inoue, Kazuo; Matsumoto, Masatoshi			Characteristics of Physician Outflow from Disaster Areas following the Great East Japan Earthquake	PLOS ONE			English	Article							FUKUSHIMA	Objective The shortage of physicians after a major disaster is a crucial issue. We aimed to evaluate the characteristics of physicians who left affected areas following the accident at Fukushima Daiichi Nuclear Power Plant caused by the Great East Japan Earthquake on March 11, 2011. Methods Using data from a physician census conducted in 2010 (pre-disaster) and 2012 (post-disaster), we evaluated changes in the number of physicians in affected areas. We then calculated the odds ratios and 95% confidence intervals using a logistic regression model to evaluate the association between physician characteristics and outflow. We also conducted stratified analyses based on physician characteristics. Results The number of physicians decreased in Fukushima Prefecture (-5.3%) and increased in Miyagi Prefecture (2.8%). The decrease in Fukushima and increase in Miyagi were evident even after taking the prefecture's population change into account (change in physician to population ratios: -1.9% and 3.2%, respectively). Compared with physicians who lived in areas >100 km from the nuclear power plant, physicians living 20-50 km and 50-100 km were, respectively, 3.9 times (95% confidence interval, 2.6-5.7) and 2.6 times (95% confidence interval, 1.7-3.8) more likely to migrate to distant areas. In the stratified analysis, younger physicians and those earlier in their careers had higher odds ratios for outflow than other physicians (P for interaction = 0.02 and <0.01, respectively). Conclusions The risk of outflow was greater among younger and early-career physicians in areas around the power plant. Political support may be necessary to recruit and retain such physicians, who will be responsible for future community health in the disaster area.	[Kashima, Saori] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan; [Inoue, Kazuo] Teikyo Univ, Chiba Med Ctr, Dept Community Med, Sch Med, Chiba, Japan; [Matsumoto, Masatoshi] Hiroshima Univ, Dept Community Based Med Syst, Inst Biomed & Hlth Sci, Hiroshima 730, Japan	Hiroshima University; Teikyo University; Hiroshima University	Kashima, S (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan.	saori.ksm@gmail.com	Kashima, Saori/B-4524-2010	Kashima, Saori/0000-0002-3401-8191; Matsumoto, Masatoshi/0000-0002-8341-9303	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP25516015]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number JP25516015 (http://www.jsps.go.jp/english/e-grants/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fukushima prefectural government office, 2016, FUK PREF RAD MEAS MA; Fukushima prefectural government office, 2016, FUK REV; Fukushima prefectural government office, 2016, CURR STAT MED CAR FU; Geospatial Information Authority of Japan Ministry of Land Infrastructure Transport and Tourism, 2011, OV TSUN IN AR 1 1000; Hasegawa A, 2015, LANCET, V386, P479, DOI 10.1016/S0140-6736(15)61106-0; Hayakawa Y., 2013, RADIO CONTOUR MAP FU; Inoue K, 2009, RURAL REMOTE HEALTH, V9; Ishii M., 2012, J JAPAN MED ASS, V141, P32; Iwasaki K., 2015, RELAY MESSAGE 4 YEAR; Izumi M, 2011, MED TREATMENT NURSIN, V713; Japan Atomic Energy Agency, 2011, RES DEP RAD CES 4 AI; Koike S, 2010, MED EDUC, V44, P289, DOI 10.1111/j.1365-2923.2009.03582.x; Madamala K, 2007, DISASTER MED PUBLIC, V1, P21, DOI 10.1097/DMP.0b013e3180679118; Ministry of Education Culture Sports Science and Technology J, 2011, RES 4 AIRB MON SURV; Ministry of Health Labour and Welfare Japan, 2011, SURV PHYS DENT PHARM; Ministry of Health Labour and Welfare Japan, 2013, SURV PHYS DENT PHARM; Ministry of Health LaW, 2013, OUTL CLIN TRAIN SYST; Minitry of Land Infrastructure Transport and Tourism., 2011, WAT ENV SECT PERF RE, P1; Morioka N, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0067-6; National Police Agency of Japan, 2015, DAM SIT POL COUNT; Nikkei, 2016, NIKK ISH KIT FUK HE; Ohtsuru A, 2015, LANCET, V386, P489, DOI 10.1016/S0140-6736(15)60994-1; Support Team for Residents Affected by Nuclear Incidents Nuclear Emergency Response Headquarters Cabinet Office Japan, 2013, REV AR EV ORD; Torii T, 2013, HEALTH PHYS, V105, P192, DOI 10.1097/HP.0b013e318294444e; World Health Organization, 2012, PREL DOS EST NUCL AC; World Health Organization, 2013, HLTH RISK ASS NUCL A; World Nuclear Association, 2015, FUK ACC	27	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169220	10.1371/journal.pone.0169220	http://dx.doi.org/10.1371/journal.pone.0169220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046089	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300147
J	Lou, YH; Zhao, P; Wang, DL; Amombo, E; Sun, X; Wang, H; Zhuge, YP				Lou, Yanhong; Zhao, Peng; Wang, Deling; Amombo, Erick; Sun, Xin; Wang, Hui; Zhuge, Yuping			Germination, Physiological Responses and Gene Expression of Tall Fescue (Festuca arundinacea Schreb.) Growing under Pb and Cd	PLOS ONE			English	Article							OXIDATIVE STRESS; LIPID-PEROXIDATION; SALT STRESS; ANTIOXIDANT ENZYMES; KENTUCKY BLUEGRASS; METAL ACCUMULATION; LEAD STRESS; CADMIUM; GROWTH; RICE	Cadmium (Cd) and lead (Pb) are recognized as the most toxic metal ions due to their detrimental effects not only to plants, but also to humans. The objective of this study was to investigate the effects of Cd and Pb treatments on seed germination, plant growth, and physiological response in tall fescue (Festuca arundinacea Schreb.). We employed six treatments: CK (nutrient solution as control), T1 (1000 mg L-1 Pb), T2 (50 mg L-1 Cd), T3 (150 mg L-1 Cd), T4 (1000 mg L-1 Pb+50 mg L-1 Cd), T5 (1000 mg L-1 Pb+150 mg L-1 Cd). Antagonistic and synergistic actions were observed in tall fescue under Pb and Cd combined treatments. Under low Cd, plants exhibited higher relative germination rate, germ length, VSGR, catalase (CAT) and peroxidase (POD) activities. Additionally, in the shoots, the gene expression level of Cu/Zn SOD, FeSOD, POD, GPX, translocation factors, MDA, EL, and soluble protein contents were reduced under Pb stress. Conversely, under high Cd level, there was a decline in NRT, Pb content in shoots, Pb translocation factors, CAT activity; and an increase in VSGR, Pb content in roots, gene expression level of Cu/ZnSOD and POD in tall fescue exposed to Pb2+ regimes. On the other hand, tall fescue plants treated with low Cd exhibited lower relative germination rate, germination index, germ length, NRT, Cd content in roots. On the other hand there was higher Cd content, Cd translocation factor, CAT and POD activities, and gene expression level of Cu/Zn SOD, FeSOD, POD, GPX under Pb treatment compared with single Cd2+ treatment in the shoots. However, after high Cd exposure, plants displayed lower NRT, Cd content, CAT activity, and exhibited higher Cd contents, Cd translocation factor, MDA content, gene expression level of Cu/ZnSOD and GPX with the presence of Pb2+ relative to single Cd2+ treatment. These findings lead to a conclusion that the presence of low Cd level impacted positively towards tall fescue growth under Pb stress, while high level of Cd impacted negatively. In summary, antioxidant enzymes responded to Cd and Pb interaction at an early stage of exposure, and their gene expression profiles provided more details of the activation of those systems.	[Lou, Yanhong; Zhao, Peng; Wang, Deling; Amombo, Erick; Sun, Xin; Wang, Hui; Zhuge, Yuping] Shandong Agr Univ, Coll Resources & Environm, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Zhuge, YP (corresponding author), Shandong Agr Univ, Coll Resources & Environm, Tai An, Shandong, Peoples R China.	zhugeyp@sdau.edu.cn	Amombo, Erick/P-2440-2019; Zhao, Peng/HDO-7507-2022; lou, yanhong/AAE-8504-2020		project of independent innovation and achievement transformation project of Shandong Province [2014ZZCX07402]; National Natural Science Foundation of China [31502009]	project of independent innovation and achievement transformation project of Shandong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the project of independent innovation and achievement transformation project of Shandong Province (2014ZZCX07402) and the National Natural Science Foundation of China (No. 31502009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YJ, 2004, SCI TOTAL ENVIRON, V326, P85, DOI 10.1016/j.scitotenv.2004.01.002; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Baker AJM, 2002, NEW PHYTOL, V155, P1, DOI 10.1046/j.1469-8137.2002.00449_1.x; Begonia M T, 2005, Int J Environ Res Public Health, V2, P228, DOI 10.3390/ijerph2005020005; Bian SM, 2009, SCI HORTIC-AMSTERDAM, V120, P264, DOI 10.1016/j.scienta.2008.10.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunet J, 2009, CHEMOSPHERE, V77, P1113, DOI 10.1016/j.chemosphere.2009.07.058; Byrne SL, 2010, PLANTA, V231, P901, DOI 10.1007/s00425-009-1096-y; Chakravarty B, 1997, AGR ECOSYST ENVIRON, V61, P45, DOI 10.1016/S0167-8809(96)01078-X; Chaoui A, 1997, PLANT SCI, V127, P139, DOI 10.1016/S0168-9452(97)00115-5; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Dubey R. S., 2010, REACTIVE OXYGEN SPEC, V15, P177; Farooq MA, 2013, ECOTOX ENVIRON SAFE, V96, P242, DOI 10.1016/j.ecoenv.2013.07.006; Fu JM, 2004, HORTSCIENCE, V39, P1740, DOI 10.21273/HORTSCI.39.7.1740; Fu JM, 2001, ENVIRON EXP BOT, V45, P105, DOI 10.1016/S0098-8472(00)00084-8; Gajewska E, 2006, BIOL PLANTARUM, V50, P653, DOI 10.1007/s10535-006-0102-5; Gao Y, 2012, ENVIRON EARTH SCI, V65, P1923, DOI 10.1007/s12665-011-1174-x; Gill SS, 2012, PLANT SCI, V182, P112, DOI 10.1016/j.plantsci.2011.04.018; HALLIWELL B, 1987, CHEM PHYS LIPIDS, V44, P327, DOI 10.1016/0009-3084(87)90056-9; He J, 2016, ECOL ENG, V87, P102, DOI 10.1016/j.ecoleng.2015.11.004; He JY, 2014, ECOTOX ENVIRON SAFE, V108, P114, DOI 10.1016/j.ecoenv.2014.05.021; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hu LX, 2012, J AM SOC HORTIC SCI, V137, P38, DOI 10.21273/JASHS.137.1.38; Hu ZR, 2015, ECOTOXICOLOGY, V24, P563, DOI 10.1007/s10646-014-1404-6; HUANG B, 2009, INT TURFGRASS SOC RE, V11, P799; Israr M, 2011, J HAZARD MATER, V186, P1520, DOI 10.1016/j.jhazmat.2010.12.021; Kapoor D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/726070; Kim DW, 2007, MOL CELLS, V24, P45; Li HY, 2012, J AM SOC HORTIC SCI, V137, P80, DOI 10.21273/JASHS.137.2.80; Liu T, 2009, ENVIRON EXP BOT, V67, P377, DOI 10.1016/j.envexpbot.2009.03.016; Lou YH, 2015, ECOTOXICOLOGY, V24, P1330, DOI 10.1007/s10646-015-1508-7; Lou YH, 2013, ECOTOXICOLOGY, V22, P207, DOI 10.1007/s10646-012-1017-x; Malecka A, 2001, ACTA BIOCHIM POL, V48, P687; Malinowski DP, 1999, J PLANT NUTR, V22, P1335, DOI 10.1080/01904169909365716; Marichali A, 2014, IND CROP PROD, V55, P248, DOI 10.1016/j.indcrop.2014.02.033; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; MROZEK E, 1982, ENVIRON EXP BOT, V22, P23, DOI 10.1016/0098-8472(82)90005-3; Neugschwandtner RW, 2008, GEODERMA, V144, P446, DOI 10.1016/j.geoderma.2007.11.021; Pflugmacher S, 2004, AQUAT TOXICOL, V70, P169, DOI 10.1016/j.aquatox.2004.06.010; POLLE A, 1994, PLANT PHYSIOL, V106, P53, DOI 10.1104/pp.106.1.53; Puyang XH, 2015, ECOTOX ENVIRON SAFE, V117, P96, DOI 10.1016/j.ecoenv.2015.03.023; Rotkittikhun P, 2006, ENVIRON POLLUT, V144, P681, DOI 10.1016/j.envpol.2005.12.039; Schutzendubel A, 2001, PLANT PHYSIOL, V127, P887, DOI 10.1104/pp.010318; Srivastava AK, 2007, PLANTA, V225, P1353, DOI 10.1007/s00425-006-0445-3; Srivastava RK, 2014, PROTOPLASMA, V251, P1047, DOI 10.1007/s00709-014-0614-3; Tauqeer HM, 2016, ECOTOX ENVIRON SAFE, V126, P138, DOI 10.1016/j.ecoenv.2015.12.031; Tkalec M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087582; Tzure-Meng WU, 2009, BOT STUDIES, V50, P25; Xu PX, 2013, ENVIRON EXP BOT, V96, P35, DOI 10.1016/j.envexpbot.2013.09.001; Yourtchi M. S., 2013, International Journal of Agriculture and Crop Sciences (IJACS), V6, P1099; Yu XZ, 2008, ECOTOX ENVIRON SAFE, V71, P609, DOI 10.1016/j.ecoenv.2008.05.007; Yu XZ, 2007, INT J PHYTOREMEDIAT, V9, P243, DOI 10.1080/15226510701376141; Yu XZ, 2007, ECOTOXICOLOGY, V16, P299, DOI 10.1007/s10646-006-0129-6; Yu XZ, 2014, ENVIRON SCI POLLUT R, V21, P14014, DOI 10.1007/s11356-014-3306-9; Zhu ZJ, 2004, PLANT SCI, V167, P527, DOI 10.1016/j.plantsci.2004.04.020	55	45	45	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169495	10.1371/journal.pone.0169495	http://dx.doi.org/10.1371/journal.pone.0169495			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046098	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300201
J	Tong, YB; Udupa, JK; Torigian, DA; Odhner, D; Wu, CY; Pednekar, G; Palmer, S; Rozenshtein, A; Shirk, MA; Newell, JD; Porteous, M; Diamond, JM; Christie, JD; Lederer, DJ				Tong, Yubing; Udupa, Jayaram K.; Torigian, Drew A.; Odhner, Dewey; Wu, Caiyun; Pednekar, Gargi; Palmer, Scott; Rozenshtein, Anna; Shirk, Melissa A.; Newell, John D.; Porteous, Mary; Diamond, Joshua M.; Christie, Jason D.; Lederer, David J.			Chest Fat Quantification via CT Based on Standardized Anatomy Space in Adult Lung Transplant Candidates	PLOS ONE			English	Article							VISCERAL ADIPOSE-TISSUE; CORONARY-ARTERY-DISEASE; X-RAY ABSORPTIOMETRY; MIDDLE-AGED MEN; BODY-MASS INDEX; ABDOMINAL FAT; RISK-FACTORS; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; PERICARDIAL FAT	Purpose Overweight and underweight conditions are considered relative contraindications to lung transplantation due to their association with excess mortality. Yet, recent work suggests that body mass index (BMI) does not accurately reflect adipose tissue mass in adults with advanced lung diseases. Alternative and more accurate measures of adiposity are needed. Chest fat estimation by routine computed tomography (CT) imaging may therefore be important for identifying high-risk lung transplant candidates. In this paper, an approach to chest fat quantification and quality assessment based on a recently formulated concept of standardized anatomic space (SAS) is presented. The goal of the paper is to seek answers to several key questions related to chest fat quantity and quality assessment based on a single slice CT (whether in the chest, abdomen, or thigh) versus a volumetric CT, which have not been addressed in the literature. Methods Unenhanced chest CT image data sets from 40 adult lung transplant candidates (age 58 12 yrs and BMI 26.4 4.3 kg/m2), 16 with chronic obstructive pulmonary disease (COPD), 16 with idiopathic pulmonary fibrosis (IPF), and the remainder with other conditions were analyzed together with a single slice acquired for each patient at the L5 vertebral level and mid-thigh level. The thoracic body region and the interface between subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) in the chest were consistently defined in all patients and delineated using Live Wire tools. The SAT and VAT components of chest were then segmented guided by this interface. The SAS approach was used to identify the corresponding anatomic slices in each chest CT study, and SAT and VAT areas in each slice as well as their whole volumes were quantified. Similarly, the SAT and VAT components were segmented in the abdomen and thigh slices. Key parameters of the attenuation (Hounsfield unit (HU) distributions) were determined from each chest slice and from the whole chest volume separately for SAT and VAT components. The same parameters were also computed from the single abdominal and thigh slices. The ability of the slice at each anatomic location in the chest (and abdomen and thigh) to act as a marker of the measures derived from the whole chest volume was assessed via Pearson correlation coefficient (PCC) analysis. Results The SAS approach correctly identified slice locations in different subjects in terms of vertebral levels. PCC between chest fat volume and chest slice fat area was maximal at the T8 level for SAT (0.97) and at the T7 level for VAT (0.86), and was modest between chest fat volume and abdominal slice fat area for SAT and VAT (0.73 and 0.75, respectively). However, correlation was weak for chest fat volume and thigh slice fat area for SAT and VAT (0.52 and 0.37, respectively), and for chest fat volume for SAT and VAT and BMI (0.65 and 0.28, respectively). These same single slice locations with maximal PCC were found for SAT and VAT within both COPD and IPF groups. Most of the attenuation properties derived from the whole chest volume and single best chest slice for VAT (but not for SAT) were significantly different between COPD and IPF groups. Conclusions This study demonstrates a new way of optimally selecting slices whose measurements may be used as markers of similar measurements made on the whole chest volume. The results suggest that one or two slices imaged at T7 and T8 vertebral levels may be enough to estimate reliably the total SAT and VAT components of chest fat and the quality of chest fat as determined by attenuation distributions in the entire chest volume.	[Tong, Yubing; Udupa, Jayaram K.; Torigian, Drew A.; Odhner, Dewey; Wu, Caiyun; Pednekar, Gargi] Univ Penn, Dept Radiol, Med Image Proc Grp, Philadelphia, PA 19104 USA; [Palmer, Scott] Duke Univ, Dept Med, Durham, NC 27706 USA; [Rozenshtein, Anna] Columbia Univ, Dept Radiol, New York, NY 10027 USA; [Shirk, Melissa A.; Newell, John D.; Christie, Jason D.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [Porteous, Mary; Diamond, Joshua M.] Hosp Univ Penn, Div Pulm & Crit Care Med, Philadelphia, PA 19104 USA; [Porteous, Mary; Diamond, Joshua M.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Lederer, David J.] Columbia Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, New York, NY 10027 USA	University of Pennsylvania; Duke University; Columbia University; University of Iowa; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Columbia University	Udupa, JK (corresponding author), Univ Penn, Dept Radiol, Med Image Proc Grp, Philadelphia, PA 19104 USA.	jay@mail.med.upenn.edu	Lederer, David/W-7957-2018; Odhner, Dewey/ABD-3841-2020	Lederer, David/0000-0001-5258-0228; Pednekar, Gargi/0000-0002-4734-9598; Christie, Jason/0000-0003-0519-218X; Palmer, Scott/0000-0002-1370-3771	National Institutes of Health (NIH) DHHS [R01 HL114626, R01 HL087115, K24 HL115354, K24 HL131937]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL115354, K24HL131937, R01HL087115, R01HL114626] Funding Source: NIH RePORTER	National Institutes of Health (NIH) DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research is partly funded by the National Institutes of Health (NIH) DHHS grant R01 HL114626 (to Lederer and Christie), R01 HL087115 (to Christie), K24 HL115354 (to Christie), and K24 HL131937 (to Lederer) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzmon G, 2002, HORM METAB RES, V34, P622, DOI 10.1055/s-2002-38250; Bouchard C, 2007, INT J OBESITY, V31, P1552, DOI 10.1038/sj.ijo.0803653; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chan VO, 2012, CAN ASSOC RADIOL J, V63, P260, DOI 10.1016/j.carj.2011.02.006; Empana JP, 2004, CIRCULATION, V110, P2781, DOI 10.1161/01.CIR.0000146395.64065.BA; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; GRAUER WO, 1984, AM J CLIN NUTR, V39, P631, DOI 10.1093/ajcn/39.4.631; Grevera G, 2007, J DIGIT IMAGING, V20, P101, DOI 10.1007/s10278-007-9060-5; Iacobellis G, 2003, J CLIN ENDOCR METAB, V88, P5163, DOI 10.1210/jc.2003-030698; Irlbeck T, 2010, INT J OBESITY, V34, P781, DOI 10.1038/ijo.2009.279; Jeong JW, 2007, CIRC J, V71, P536, DOI 10.1253/circj.71.536; Jousilahti P, 1996, CIRCULATION, V93, P1372, DOI 10.1161/01.CIR.93.7.1372; Kim J, 2004, J APPL PHYSIOL, V97, P655, DOI 10.1152/japplphysiol.00260.2004; Kyle UG, 2013, J HEART LUNG TRANSPL, V32, P800, DOI 10.1016/j.healun.2013.06.002; Lederer DJ, 2011, AM J RESP CRIT CARE, V184, P1055, DOI 10.1164/rccm.201104-0728OC; Lederer DJ, 2009, AM J RESP CRIT CARE, V180, P887, DOI 10.1164/rccm.200903-0425OC; Manninen AH, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-9; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Nakazato R, 2011, J CARDIOVASC COMPUT, V5, P172, DOI 10.1016/j.jcct.2011.03.009; Nytroen K, 2014, EUR J PREV CARDIOL, V21, P21, DOI 10.1177/2047487312450540; Onat A, 2004, INT J OBESITY, V28, P1018, DOI 10.1038/sj.ijo.0802695; Peng Q, 2005, J MAGN RESON IMAGING, V21, P263, DOI 10.1002/jmri.20252; Poonawalla AH, 2013, J MAGN RESON IMAGING, V37, P707, DOI 10.1002/jmri.23846; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Scafoglieri A, 2013, EXP GERONTOL, V48, P985, DOI 10.1016/j.exger.2013.07.005; Schaudinn A, 2015, NMR BIOMED, V28, P583, DOI 10.1002/nbm.3286; Shah NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033308; Sicari R, 2011, J AM SOC ECHOCARDIOG, V24, P1156, DOI 10.1016/j.echo.2011.06.013; Singer JP, 2014, AM J RESP CRIT CARE, V190, P1012, DOI 10.1164/rccm.201405-0973OC; Sironi AM, 2012, DIABETIC MED, V29, P622, DOI 10.1111/j.1464-5491.2011.03503.x; So R, 2012, EUR J CLIN NUTR, V66, P1351, DOI 10.1038/ejcn.2012.147; So R, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-56; Sottier D, 2013, Diagn Interv Imaging, V94, P879, DOI 10.1016/j.diii.2013.04.006; St-Onge MP, 2004, J GERONTOL A-BIOL, V59, P796; Taguchi R, 2001, ATHEROSCLEROSIS, V157, P203, DOI 10.1016/S0021-9150(00)00709-7; Tong YB, 2014, MED PHYS, V41, DOI 10.1118/1.4876275; Tran T, 2014, EUR HEART J-CARD IMG, V15, P423, DOI 10.1093/ehjci/jet175; Udupa JK, 2006, COMPUT MED IMAG GRAP, V30, P75, DOI 10.1016/j.compmedimag.2005.12.001; Weill D, 2015, J HEART LUNG TRANSPL, V34, P1, DOI 10.1016/j.healun.2014.06.014; Yusen RD, 2014, J HEART LUNG TRANSPL, V33, P1009, DOI 10.1016/j.healun.2014.08.004; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714	44	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168932	10.1371/journal.pone.0168932	http://dx.doi.org/10.1371/journal.pone.0168932			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046024	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300074
J	Lai, SJ; Deng, YC; Lai, MC				Lai, Shu-Jung; Deng, Yu-Chen; Lai, Mei-Chin			Comparison of Enzymatic Traits between Native and Recombinant Glycine Sarcosine N-Methyltransferase from Methanohalophilus portucalensis FDF1(T)	PLOS ONE			English	Article							ACETYL-BETA-LYSINE; METHANOGENIC ARCHAEBACTERIA; PHOSPHOPROTEOMIC ANALYSIS; STRESS; PHOSPHORYLATION; OSMOADAPTATION; IDENTIFICATION; OSMOLYTES; ARCHAEA; SOLUTE	The halophilic methanoarchaeon Methanohalophilus portucalensis FDF1(T) possesses the ability to synthesize the osmolyte betaine from its precursor, glycine, in response to extracellular salt stress through a three-step transmethylation process. Analysis of recombinant glycine sarcosine N-methyltransferase (rGSMT) and recombinant sarcosine dimethylglycine N-methyltransferase (rSDMT) from Escherichia coli indicated that betaine synthesis is rate-limited by rGSMT and is constitutively activated by rSDMT. Therefore, it is of interest to purify native GSMT from Methanohalophilus portucalensis to further compare its enzymatic characteristics and kinetics with rGSMT. In this study, native GSMT was purified through DEAE ion exchange and gel filtration chromatography with 95% purity. The enzymatic characteristics of GSMT and rGSMT showed similar trends of activities that were activated by high concentrations of monovalent cations. Both were feedback-inhibited by the end product, betaine, and competitively inhibited by S-adenosylhomocysteine (SAH). Native GSMT was 2-fold more sensitive to SAH than rGSMT. Notably, comparison of the kinetic parameters illustrated that the turnover rate of glycine methylation of GSMT was promoted by potassium ions, whereas rGSMT was activated by increasing protein-glycine binding affinity. These results suggest that GSMT and rGSMT may have different levels of post translational modifications. Our preliminary mass spectrometry evidence indicated that there was no detectable phosphosite on GSMT after the complicated purification processes, whereas purified rGSMT still possessed 23.1% of its initial phosphorylation level. We believe that a phosphorylation-mediated modification may be involved in the regulation of this energy consuming betaine synthesis pathway during the stress response in halophilic methanoarchaea.	[Lai, Shu-Jung; Deng, Yu-Chen; Lai, Mei-Chin] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan; [Lai, Shu-Jung] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lai, Mei-Chin] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung, Taiwan	National Chung Hsing University; Academia Sinica - Taiwan; National Chung Hsing University	Lai, MC (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan.; Lai, MC (corresponding author), Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung, Taiwan.	mclai@dragon.nchu.edu.tw	Lai, Shu-Jung/G-8875-2019	Lai, Shu-Jung/0000-0001-7653-8147; Lai, Mei-Chin/0000-0002-1385-1686	Ministry of Education, Taiwan, R.O.C. under the ATU plan; Ministry of Science and Technology [MOST-103-2113-M-001-029-MY3]	Ministry of Education, Taiwan, R.O.C. under the ATU plan(Ministry of Education, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work is supported in part by the Ministry of Education, Taiwan, R.O.C. under the ATU plan to MCL. We thank the Ministry of Science and Technology (MOST-103-2113-M-001-029-MY3) for the postdoc fellowship to SJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; BOONE DR, 1993, INT J SYST BACTERIOL, V43, P430, DOI 10.1099/00207713-43-3-430; Chen SY, 2009, ARCH MICROBIOL, V191, P735, DOI 10.1007/s00203-009-0501-z; Chen THH, 2008, TRENDS PLANT SCI, V13, P499, DOI 10.1016/j.tplants.2008.06.007; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Hung CC, 2013, J MICROBIOL IMMUNOL, V46, P1, DOI 10.1016/j.jmii.2011.12.031; Kimura Y, 2010, J BACTERIOL, V192, P1467, DOI 10.1128/JB.01118-09; Lai MC, 1999, APPL ENVIRON MICROB, V65, P828; LAI MC, 1991, J BACTERIOL, V173, P5352, DOI 10.1128/jb.173.17.5352-5358.1991; Lai MC, 2000, J BACTERIOL, V182, P5020, DOI 10.1128/JB.182.17.5020-5024.2000; Lai MC, 2006, RES MICROBIOL, V157, P948, DOI 10.1016/j.resmic.2006.08.007; Lai SJ, 2014, PLANT MOL BIOL, V85, P429, DOI 10.1007/s11103-014-0195-8; Lai SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025090; Lu WD, 2006, ARCH MICROBIOL, V186, P495, DOI 10.1007/s00203-006-0167-8; Martin DD, 1999, APPL ENVIRON MICROB, V65, P1815; Muller V, 2005, CURR OPIN MICROBIOL, V8, P729, DOI 10.1016/j.mib.2005.10.011; Nyyssola A, 2000, J BIOL CHEM, V275, P22196, DOI 10.1074/jbc.M910111199; Nyyssola A, 2001, APPL ENVIRON MICROB, V67, P2044, DOI 10.1128/AEM.67.5.2044-2050.2001; ROBERTS MF, 1992, J BACTERIOL, V174, P6688, DOI 10.1128/JB.174.20.6688-6693.1992; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; SOWERS KR, 1990, P NATL ACAD SCI USA, V87, P9083, DOI 10.1073/pnas.87.23.9083; Waditee R, 2003, J BIOL CHEM, V278, P4932, DOI 10.1074/jbc.M210970200; Wu WL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29013; Wu WL, 2013, MOL CELL PROTEOMICS, V12, P2701, DOI 10.1074/mcp.M113.029330	25	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168666	10.1371/journal.pone.0168666	http://dx.doi.org/10.1371/journal.pone.0168666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036340	Green Published, Green Submitted, gold			2022-12-26	WOS:000391229300020
J	Tao, FF; Ruan, SM; Liu, WH; Wang, LB; Xiong, Y; Shen, MH				Tao, Fangfang; Ruan, Shanming; Liu, Wenhong; Wang, Libin; Xiong, Yang; Shen, Minhe			Fuling Granule, a Traditional Chinese Medicine Compound, Suppresses Cell Proliferation and TGF beta-Induced EMT in Ovarian Cancer	PLOS ONE			English	Article							SALMONELLA-TYPHIMURIUM A1-R; NUDE-MOUSE MODEL; ORTHOTOPIC IMPLANTATION; TUMOR-GROWTH; PATIENT; METASTASIS; CARCINOMA; EFFICACY; TRANSPLANTATION; ANGIOGENESIS	The compound fuling granule (CFG) is a traditional Chinese drug which has been used to treat ovarian cancer in China for over twenty years. Nevertheless, the underlying molecular mechanism of its anti-cancer effect remains unclear. In this study, microarray data analysis was performed to search differentially expressed genes in CFG-treated ovarian cancer cells. Several cell cycle and epithelial-mesenchymal transition (EMT) related genes were identified. The microarray analyses also revealed that CFG potentially regulates EMT in ovarian cancer. We also found that, functionally, CFG significantly suppresses ovarian cancer cell proliferation by cell cycle arrest, apoptosis and senescence and the AKT/GSK-3 beta pathway is possibly involved. Additionally, the invasion and migration ability of ovarian cancer induced by TGF beta is significantly suppressed by CFG. In conclusion, our results demonstrated that CFG suppresses ovarian cancer cell proliferation as well as TGF beta 1-induced EMT in vitro. Finally, we discovered that CFG suppresses tumor growth and distant metastasis in vivo. Overall, these findings provide helpful clues to design novel clinical treatments against cancer.	[Tao, Fangfang; Liu, Wenhong] Zhejiang Chinese Med Univ, Basic Med Coll, Dept Immunol & Microbiol, Hangzhou, Zhejiang, Peoples R China; [Ruan, Shanming; Shen, Minhe] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China; [Wang, Libin] Ningxia Med Univ, Gen Hosp, Inst Stem Cell Res, Ningxia, Peoples R China; [Xiong, Yang] Zhejiang Chinese Med Univ, Sch Pharm, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Ningxia Medical University; Zhejiang Chinese Medical University	Tao, FF (corresponding author), Zhejiang Chinese Med Univ, Basic Med Coll, Dept Immunol & Microbiol, Hangzhou, Zhejiang, Peoples R China.; Shen, MH (corresponding author), Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China.	taoff@zcmu.edu.cn; shenminhe@aliyun.com	Ruan, Shanming/S-3999-2018	Ruan, Shanming/0000-0003-1061-5255; tao, fang fang/0000-0002-2090-2701	National Natural Science Foundation of China [81302896, 81473434, 81202926]; Zhejiang Provincial Public Welfare Projects [2016C37056]; China Scholarship Council; Youth Talents Foundation of Zhejiang TCM Administration [2013ZQ008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Public Welfare Projects; China Scholarship Council(China Scholarship Council); Youth Talents Foundation of Zhejiang TCM Administration	This work is supported by National Natural Science Foundation of China (FT, No.81302896, http://isisn.nsfc.gov.cn/; YX, No.81473434, http://isisn.nsfc.gov.cn/; YX, No.81202926, http://isisn.nsfc.gov.cn/); Zhejiang Provincial Public Welfare Projects (FT, 2016C37056, http://xm.zjkjt.gov.cn/); China Scholarship Council and Youth Talents Foundation of Zhejiang TCM Administration (FT, 2013ZQ008, http://zgj.zjtcm.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTOUL P, 1993, ANTICANCER RES, V13, P1999; Chen NN, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-2; FU XY, 1993, ANTICANCER RES, V13, P283; Fu Y, 2014, INT J GYNECOL CANCER, V21, P439; Gao F, 2015, ONCOTARGET, V6, P5947, DOI 10.18632/oncotarget.3335; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Hahn HS, 2014, J GYNECOL ONCOL, V25, P130, DOI 10.3802/jgo.2014.25.2.130; Hiroshima Y, 2014, ONCOTARGET, V5, P12346, DOI 10.18632/oncotarget.2641; Hu C, 2014, CLIMACTERIC, V17, P410, DOI 10.3109/13697137.2013.876618; Kiguchi K, 1998, CLIN EXP METASTAS, V16, P751, DOI 10.1023/A:1006537013317; Kong Sai, 2014, Evid Based Complement Alternat Med, V2014, P146383, DOI 10.1155/2014/146383; Lee SE, 2014, PHARM DEV TECHNOL, V19, P438, DOI 10.3109/10837450.2013.789911; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083037, 10.1371/journal.pone.0067928, 10.1371/journal.pone.0057604]; Liu HO, 2012, CANCER SCI, V103, P2072, DOI 10.1111/cas.12017; Liu LL, 2014, HEPATOLOGY, V59, P531, DOI 10.1002/hep.26677; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Makris N, 2013, INT J ONCOL, V42, P2019, DOI 10.3892/ijo.2013.1888; Matsumoto Y, 2015, ONCOTARGET, V6, P11369, DOI 10.18632/oncotarget.3607; Matsumoto Y, 2014, J CELL BIOCHEM, V115, P1996, DOI 10.1002/jcb.24871; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Murakami T, 2015, ONCOTARGET, V6, P31368, DOI 10.18632/oncotarget.5187; Park B, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/316872; Park JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109055; Patil MA, 2009, CANCER RES, V69, P253, DOI 10.1158/0008-5472.CAN-08-2514; Saiprasad G, 2014, EUR J CANCER, V50, P2489, DOI 10.1016/j.ejca.2014.06.013; Shirakawa H, 2008, TRANSPL P, V40, P1741, DOI 10.1016/j.transproceed.2008.02.089; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sun BG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/752850; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; [陶方方 Tao Fangfang], 2015, [中华中医药杂志, China Journal of Traditional Chinese Medicine and Pharmacy], V30, P235; Tao FF, 2013, CHINESE ARCH TRADITI, V31, P559; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Vergara D, 2012, MOL BIOSYST, V8, P1078, DOI 10.1039/c2mb05486h; Wang SS, 2013, IEEE J-STSP, V7, P1101, DOI 10.1109/JSTSP.2013.2272240; Wang Z, 2016, CANC GENE THER; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Wen W, 2012, HEPATOLOGY, V55, P1787, DOI 10.1002/hep.25596; Wu CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113887; Yi XF, 2005, INT J GYNECOL CANCER, V15, P850, DOI 10.1111/j.1525-1438.2005.00147.x; Yin G, 2015, ANTICANCER RES, V35, P3193; Yu PN, 2014, INT J CANCER, V134, P542, DOI 10.1002/ijc.28399; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109814; Zhang LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep08693; Zhao BY, 2014, P NATL ACAD SCI USA, V111, P10773, DOI 10.1073/pnas.1323934111; Zhao L, 2015, MOL CARCINOG; Zhou W, 2012, CANCER LETT, V316, P178, DOI 10.1016/j.canlet.2011.10.033	46	16	17	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168892	10.1371/journal.pone.0168892	http://dx.doi.org/10.1371/journal.pone.0168892			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036353	Green Published, Green Submitted, gold			2022-12-26	WOS:000391229300037
J	Denholm, SJ; Hoyle, AS; Shinn, AP; Paladini, G; Taylor, NGH; Norman, RA				Denholm, Scott J.; Hoyle, Andrew S.; Shinn, Andrew P.; Paladini, Giuseppe; Taylor, Nick G. H.; Norman, Rachel A.			Predicting the Potential for Natural Recovery of Atlantic Salmon (Salmo solar L.) Populations following the Introduction of Gyrodactylus salaris Malmberg, 1957 (Monogenea)	PLOS ONE			English	Article							RAINBOW-TROUT; COMPARATIVE SUSCEPTIBILITY; FISH; PLATYHELMINTHES; RIVER; RISK; RESISTANCE; TRANSMISSION; INFECTIONS; STOCKS	Gyrodactylus salaris (Monogenea, Platyhelminthes) is a notifiable freshwater pathogen responsible for causing catastrophic damage to wild Atlantic salmon stocks, most notably in Norway. In some strains of Baltic salmon (e.g., from the river Neva) however, the impact is greatly reduced due to some form of innate resistance that regulates parasite numbers, resulting in fewer host mortalities. Gyrodactylus salaris is known from 17 European states; its status in a further 35 states remains unknown; the UK, the Republic of Ireland and certain watersheds in Finland are free of the parasite. Thus, the parasite poses a serious threat if it emerges in Atlantic salmon rearing regions throughout Europe. At present, infections are generally controlled via extreme measures such as the treatment of entire river catchments with the biocide rotenone, in order to remove all hosts, before restocking with the original genetic stock. The use of rotenone in this way in EU countries is unlikely as it would be in contravention of the Water Framework Directive. Not only are such treatments economically and environmentally costly, they also eradicate the potential for any host/parasite evolutionary process to occur. Based on previous studies, UK salmon stocks have been shown to be highly susceptible to infection, analogous to Norwegian stocks. The present study investigates the impact of a G. salaris outbreak within a naive salmon population in order to determine long-term consequences of infection and the likelihood of coexistence. Simulation of the salmon/ G. salaris system was carried out via a deterministic mathematical modelling approach to examine the dynamics of host-pathogen interactions. Results indicated that in order for highly susceptible Atlantic strains to evolve a resistance, both a moderate-strong deceleratingly costly trade-off on birth rate and a lower overall cost of the immune response are required. The present study provides insights into the potential long term impact of G. salaris if introduced into G. salaris-free territories and suggests that in the absence of external controls salmon populations are likely to recover to high densities nearing 90% of that observed pre-infection.	[Denholm, Scott J.] Scotlands Rural Coll SRUC, Integrat Anim Sci Anim & Vet Sci Res Grp, Edinburgh, Midlothian, Scotland; [Denholm, Scott J.; Hoyle, Andrew S.; Norman, Rachel A.] Univ Stirling, Comp Sci & Math, Sch Nat Sci, Stirling, Scotland; [Shinn, Andrew P.; Paladini, Giuseppe; Norman, Rachel A.] Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling, Scotland; [Taylor, Nick G. H.] Weymouth Lab, Ctr Environm Fisheries & Aquaculture CEFAS, Weymouth, England	Scotland's Rural College; University of Stirling; University of Stirling	Denholm, SJ (corresponding author), Scotlands Rural Coll SRUC, Integrat Anim Sci Anim & Vet Sci Res Grp, Edinburgh, Midlothian, Scotland.; Denholm, SJ (corresponding author), Univ Stirling, Comp Sci & Math, Sch Nat Sci, Stirling, Scotland.	scott.denholm@sruc.awuk	Norman, R/AFT-9458-2022; Norman, R/AAI-8164-2021; Denholm, Scott J/L-2520-2015	Norman, R/0000-0002-7398-6064; Norman, R/0000-0002-7398-6064; Denholm, Scott J/0000-0002-6291-8269	Department for Environment, Food and Rural affairs PhD studentship grant [FC1197]; Biotechnology and Biological Sciences Research Council [BB/K002260/1] Funding Source: researchfish; BBSRC [BB/K002260/1] Funding Source: UKRI	Department for Environment, Food and Rural affairs PhD studentship grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a Department for Environment, Food and Rural affairs PhD studentship grant awarded to NGHT and RAN (Defra grant no. FC1197, www.gov.uk/government/organisations/department-for-environment-food-rural-affairs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Bakke TA, 2007, ADV PARASIT, V64, P161, DOI 10.1016/S0065-308X(06)64003-7; BAKKE TA, 1992, J FISH BIOL, V41, P499, DOI 10.1111/j.1095-8649.1992.tb02677.x; Bakke TA, 2004, DIS AQUAT ORGAN, V58, P171, DOI 10.3354/dao058171; Bakke TA, 2002, INT J PARASITOL, V32, P281, DOI 10.1016/S0020-7519(01)00331-9; BAKKE TA, 1993, FISH RES, V17, P69, DOI 10.1016/0165-7836(93)90008-U; BAKKE TA, 1990, J FISH BIOL, V37, P577, DOI 10.1111/j.1095-8649.1990.tb05890.x; BLISS CI, 1953, BIOMETRICS, V9, P176, DOI 10.2307/3001850; Buchmann K, 1997, DIS AQUAT ORGAN, V28, P125, DOI 10.3354/dao028125; Cable J, 2000, PARASITOLOGY, V121, P621, DOI 10.1017/S0031182000006971; Cipriano RC, 2002, AQUACULTURE, V206, P1, DOI 10.1016/S0044-8486(01)00863-8; Crisp D.T., 2000, TROUT SALMON ECOLOGY; Cunningham CO, 2003, DIS AQUAT ORGAN, V57, P237, DOI 10.3354/dao057237; Cunningham CO, 2001, SYST PARASITOL, V48, P141, DOI 10.1023/A:1006407428666; Dalgaard MB, 2004, J AQUAT ANIM HEALTH, V16, P109, DOI 10.1577/H03-004.1; Dalgaard MB, 2003, DIS AQUAT ORGAN, V53, P173, DOI 10.3354/dao053173; Defra, 2008, CONT PLAN COMB GYR S; Denholm SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078909; Des Clers Sophie, 1993, Fisheries Research (Amsterdam), V17, P237, DOI 10.1016/0165-7836(93)90023-Z; European Commission, 2006, EUROPEAN COMMISSION; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Fromm B, 2014, INT J PARASITOL, V44, P787, DOI 10.1016/j.ijpara.2014.05.010; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Hansen H, 2003, INT J PARASITOL, V33, P1471, DOI 10.1016/S0020-7519(03)00200-5; Hansen H, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1727-7; Hedger RD, 2013, ECOL MODEL, V248, P119, DOI 10.1016/j.ecolmodel.2012.10.003; Hogasen HR, 2009, DIS AQUAT ORGAN, V87, P217, DOI 10.3354/dao02109; Hogasen HR, 2003, DIS AQUAT ORGAN, V57, P247, DOI 10.3354/dao057247; Holm A, 2003, J CHROMATOGR A, V983, P43, DOI 10.1016/S0021-9673(02)01693-X; Hytterod S, 2015, SURVEILLANCE PROGRAM; IPCS-INCHEM, 1992, INT PROGR CHEM SAF R; JANSEN PA, 1991, PARASITOLOGY, V102, P105, DOI 10.1017/S0031182000060406; Jansen PA, 2007, DIS AQUAT ORGAN, V74, P139, DOI 10.3354/dao074139; JOHNSEN B O, 1978, Astarte, V11, P7; JOHNSEN BO, 1991, AQUACULTURE, V98, P289, DOI 10.1016/0044-8486(91)90393-L; JOHNSEN BO, 1986, J FISH BIOL, V29, P233, DOI 10.1111/j.1095-8649.1986.tb04941.x; JOHNSEN BO, 1999, NINA OPPDRAGSMELDING, V617, P1; KEENLEYSIDE MILES H. A., 1962, BEHAVIOUR, V19, P139, DOI 10.1163/156853961X00231; KENNEDY CEJ, 1987, BEHAV ECOL SOCIOBIOL, V21, P291, DOI 10.1007/BF00299966; Lautraite A, 1999, B FR PECHE PISCIC, P305, DOI 10.1051/kmae:1999001; Lindenstrom T, 2003, PARASITOLOGY, V127, P165, DOI 10.1017/S003118200300341X; MALMBERG G., 1957, Skrifter utgivna av Sodra Sveriges Fiskeriforening, P19; MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; Mo T.A., 1994, P43; Nielsen CV, 2001, BULL EUR ASSN FISH P, V21, P19; OIE, 2016, MAN DIAGN TESTS AQ A, P499; Paisley LG, 1999, DIS AQUAT ORGAN, V37, P145, DOI 10.3354/dao037145; Paladini G, 2012, ASPECTS SYSTEMATICS; Paladini G, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0576-5; Paladini G, 2009, VET PARASITOL, V165, P290, DOI 10.1016/j.vetpar.2009.07.025; Peeler E, 2006, AQUACULTURE, V258, P187, DOI 10.1016/j.aquaculture.2005.07.042; Peeler EJ, 2004, PREV VET MED, V64, P175, DOI 10.1016/j.prevetmed.2004.05.005; Peeler EJ, 2004, DIS AQUAT ORGAN, V62, P103, DOI 10.3354/dao062103; PLATTEN M, 1994, VET REC, V135, P411, DOI 10.1136/vr.135.17.411; Ramirez R, 2012, INT J PARASITOL, V42, P809, DOI 10.1016/j.ijpara.2012.05.012; Riddington G, 2006, SAQ00105; Rokicka M, 2007, ACTA PARASITOL, V52, P185, DOI 10.2478/s11686-007-0032-1; Salte R, 2010, CAN J FISH AQUAT SCI, V67, P121, DOI 10.1139/F09-168; Scott M.E., 1985, Linnean Society Symposium Series, P21; SCOTT ME, 1984, PARASITOLOGY, V89, P159, DOI 10.1017/S0031182000001207; Shaw DJ, 1995, PARASITOLOGY, V111, pS111, DOI 10.1017/S0031182000075855; Shearer W.M., 1992, ATLANTIC SALMON NATU; SHINN AP, 1995, SYS PARASITOL, V29, P1383; Soleng A, 1999, FOLIA PARASIT, V46, P179; Soleng A, 1998, CAN J FISH AQUAT SCI, V55, P507, DOI 10.1139/cjfas-55-2-507; Soleng A, 1999, PARASITOLOGY, V119, P19, DOI 10.1017/S0031182099004436; The European Commission, 2004, OFFICIAL J EUROPEAN; van Oosterhout C, 2008, INT J PARASITOL, V38, P541, DOI 10.1016/j.ijpara.2007.09.016; Van Oosterhout C, 2003, BIOL J LINN SOC, V79, P645, DOI 10.1046/j.1095-8312.2003.00203.x; Wilsion K, 2002, ECOLOGY WILDLIFE DIS; WWF, 2001, STAT WILD ATL SALM R; Zietara MS, 2007, PARASSITOLOGIA, V49, P119	72	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0169168	10.1371/journal.pone.0169168	http://dx.doi.org/10.1371/journal.pone.0169168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033370	Green Published, Green Submitted, gold			2022-12-26	WOS:000391226900081
J	Gan, G; Liu, YM; Li, XS; Feng, ZH; Xu, JT				Gan, Guang; Liu, Yameng; Li, Xinshu; Feng, Zhihua; Xu, Juntian			An Ocean Acidification Acclimatised Green Tide Alga Is Robust to Changes of Seawater Carbon Chemistry but Vulnerable to Light Stress	PLOS ONE			English	Article							CO2 CONCENTRATING MECHANISMS; ULVA-LACTUCA; ELEVATED CO2; BICARBONATE UTILIZATION; CELL COMPOSITION; ATMOSPHERIC CO2; DIETARY FIBER; GROWTH; PHOTOSYNTHESIS; SEAWEED	Ulva is the dominant genus in the green tide events and is considered to have efficient CO2 concentrating mechanisms (CCMs). However, little is understood regarding the impacts of ocean acidification on the CCMs of Ulva and the consequences of thalli's acclimation to ocean acidification in terms of responding to environmental factors. Here, we grew a cosmopolitan green alga, Ulva linza at ambient (LC) and elevated (HC) CO2 levels and investigated the alteration of CCMs in U. linza grown at HC and its responses to the changed seawater carbon chemistry and light intensity. The inhibitors experiment for photosynthetic inorganic carbon utilization demonstrated that acidic compartments, extracellular carbonic anhydrase (CA) and intracellular CA worked together in the thalli grown at LC and the acquisition of exogenous carbon source in the thalli could be attributed to the collaboration of acidic compartments and extracellular CA. Contrastingly, when U. linza was grown at HC, extracellular CA was completely inhibited, acidic compartments and intracellular CA were also down-regulated to different extents and thus the acquisition of exogenous carbon source solely relied on acidic compartments. The down-regulated CCMs in U. linza did not affect its responses to changes of seawater carbon chemistry but led to a decrease of net photosynthetic rate when thalli were exposed to increased light intensity. This decrease could be attributed to photodamage caused by the combination of the saved energy due to the down-regulated CCMs and high light intensity. Our findings suggest future ocean acidification might impose depressing effects on green tide events when combined with increased light exposure.	[Gan, Guang; Liu, Yameng; Li, Xinshu; Feng, Zhihua; Xu, Juntian] Huaihai Inst Technol, Marine Resources Dev Inst Jiangsu, Lianyungang, Peoples R China	Jiangsu Ocean University	Xu, JT (corresponding author), Huaihai Inst Technol, Marine Resources Dev Inst Jiangsu, Lianyungang, Peoples R China.	jtxu@hhit.edu.cn	Gao, Guang/AAJ-8676-2021; Feng, Zhihua/AAW-4313-2021; Xu, Juntian/AAW-4084-2021; Xu, juntian/ABB-8233-2021	Gao, Guang/0000-0002-9011-9640; 	National Natural Science Foundation of China [41476097]; Natural Science Foundation of Jiangsu Province [BK20161295]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by the National Natural Science Foundation of China (No. 41476097), the Natural Science Foundation of Jiangsu Province (No. BK20161295) and Priority Academic Program Development of Jiangsu Higher Education Institutions. XJ is the recipient for these three grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by the National Natural Science Foundation of China (No. 41476097), the Natural Science Foundation of Jiangsu Province (No. BK20161295) and Priority Academic Program Development of Jiangsu Higher Education Institutions. We sincerely thank Dr Serena Lim for contributing to the improvement of this manuscript.	Al-Hafedh YS, 2015, REV AQUACULT, V7, P161, DOI 10.1111/raq.12060; Axelsson L, 2000, EUR J PHYCOL, V35, P53, DOI 10.1080/09670260010001735621; Axelsson L, 1999, PLANT CELL ENVIRON, V22, P969, DOI 10.1046/j.1365-3040.1999.00470.x; AXELSSON L, 1995, PLANT CELL ENVIRON, V18, P439, DOI 10.1111/j.1365-3040.1995.tb00378.x; Beardall J, 1998, BOT MAR, V41, P113, DOI 10.1515/botm.1998.41.1-6.113; BJORK M, 1993, J PHYCOL, V29, P166, DOI 10.1111/j.0022-3646.1993.00166.x; Bruhn A, 2011, BIORESOURCE TECHNOL, V102, P2595, DOI 10.1016/j.biortech.2010.10.010; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/ngeo1297, 10.1038/NGEO1297]; Chung Ik Kyo, 2002, ALGAE, V17, P187; Chung IK, 2011, J APPL PHYCOL, V23, P877, DOI 10.1007/s10811-010-9604-9; Cyrus MD, 2015, AQUACULT NUTR, V21, P578, DOI 10.1111/anu.12182; Eggert A., 2012, SEAWEED BIOL, P47, DOI [10.1007/978-3-642-28451-9_3, DOI 10.1007/978-3-642-28451-9_3]; El-Waziry A, 2015, TURK J VET ANIM SCI, V39, P81, DOI 10.3906/vet-1403-82; Feng Y, 2010, DEEP-SEA RES PT I, V57, P368, DOI 10.1016/j.dsr.2009.10.013; Fernandez PA, 2015, PHOTOSYNTH RES, V124, P293, DOI 10.1007/s11120-015-0138-5; Fletcher RL., 1996, MARINE BENTHIC VEGET, P7, DOI [10.1007/978-3-642-61398-2_2, DOI 10.1007/978-3-642-61398-2_2]; GAO K, 1993, J APPL PHYCOL, V5, P563, DOI 10.1007/BF02184635; GAO K, 1991, J APPL PHYCOL, V3, P355, DOI 10.1007/BF00026098; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; GARCIASANCHEZ MJ, 1994, PLANTA, V194, P55; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Gordillo FJL, 1998, J APPL PHYCOL, V10, P461, DOI 10.1023/A:1008090402847; Gordillo FJL, 2003, PLANTA, V218, P315, DOI 10.1007/s00425-003-1087-3; Gordillo FJL, 2003, PHYSIOL PLANTARUM, V119, P513, DOI 10.1046/j.1399-3054.2003.00192.x; Gordillo FJL, 2001, PLANTA, V213, P64, DOI 10.1007/s004250000468; Gutow L, 2014, J EXP MAR BIOL ECOL, V453, P84, DOI 10.1016/j.jembe.2014.01.005; Hellblom F, 2003, PHOTOSYNTH RES, V77, P173, DOI 10.1023/A:1025809415048; Hellblom F, 2001, AQUAT BOT, V69, P55, DOI 10.1016/S0304-3770(00)00132-7; Hofmann LC, 2013, J EXP BOT, V64, P899, DOI 10.1093/jxb/ers369; Israel A, 2002, GLOBAL CHANGE BIOL, V8, P831, DOI 10.1046/j.1365-2486.2002.00518.x; Israel A, 1999, J APPL PHYCOL, V11, P447, DOI 10.1023/A:1008122306268; Kaladharan P., 2009, Journal of the Marine Biological Association of India, V51, P107; Kim JH, 2011, J APPL PHYCOL, V23, P421, DOI 10.1007/s10811-010-9590-y; Kubler JE, 1999, PLANT CELL ENVIRON, V22, P1303, DOI 10.1046/j.1365-3040.1999.00492.x; Li XS, 2016, J APPL PHYCOL, V28, P491, DOI 10.1007/s10811-015-0603-8; Liu DY, 2013, ESTUAR COAST SHELF S, V129, P2, DOI 10.1016/j.ecss.2013.05.021; Mercado JM, 2006, PHOTOSYNTH RES, V88, P259, DOI 10.1007/s11120-006-9039-y; Mercado JM, 2003, J EXP MAR BIOL ECOL, V297, P71, DOI 10.1016/S0022-0981(03)00368-X; Mercado JM, 1999, J APPL PHYCOL, V11, P455, DOI 10.1023/A:1008194223558; Neveux N, 2014, BIORESOURCE TECHNOL, V155, P334, DOI 10.1016/j.biortech.2013.12.083; Olischlager M, 2013, J EXP BOT, V64, P5587, DOI 10.1093/jxb/ert329; Ortiz J, 2006, FOOD CHEM, V99, P98, DOI 10.1016/j.foodchem.2005.07.027; PRICE GD, 1985, AUST J PLANT PHYSIOL, V12, P257, DOI 10.1071/PP9850257; Rautenberger R, 2015, ECOL EVOL, V5, P874, DOI 10.1002/ece3.1382; Raven JA, 2014, AQUAT BOT, V118, P24, DOI 10.1016/j.aquabot.2014.05.008; Raven JA, 2011, PHOTOSYNTH RES, V109, P281, DOI 10.1007/s11120-011-9632-6; ROY RN, 1993, MAR CHEM, V44, P249, DOI 10.1016/0304-4203(93)90207-5; Saxe H, 1998, NEW PHYTOL, V139, P395, DOI 10.1046/j.1469-8137.1998.00221.x; Smetacek V, 2013, NATURE, V504, P84, DOI 10.1038/nature12860; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; Stocker T.F., 2013, WORKING GROUP CONTRI, P6; Wallace D, 2006, MS EXCEL PROGRAM DEV; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Wild M, 2012, B AM METEOROL SOC, V93, P27, DOI 10.1175/BAMS-D-11-00074.1; WOODROW IE, 1994, PHOTOSYNTH RES, V39, P401, DOI 10.1007/BF00014594; Xu JT, 2012, PLANT PHYSIOL, V160, P1762, DOI 10.1104/pp.112.206961; Yaich H, 2015, ALGAL RES, V9, P65, DOI 10.1016/j.algal.2015.02.017; Zou DH, 2005, AQUACULTURE, V250, P726, DOI 10.1016/j.aquaculture.2005.05.014	58	34	34	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0169040	10.1371/journal.pone.0169040	http://dx.doi.org/10.1371/journal.pone.0169040			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033367	Green Published, Green Submitted, gold			2022-12-26	WOS:000391226900070
J	Wang, B; Chen, QT; Cao, Y; Ma, X; Yin, CX; Jia, YC; Zang, AM; Fan, WF				Wang, Bei; Chen, Queting; Cao, Yang; Ma, Xia; Yin, Chenxing; Jia, Youchao; Zang, Aimin; Fan, Wufang			LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; DRUG-RESISTANCE; IDENTIFICATION; EXPRESSION; TUMOR; PLURIPOTENCY; POPULATIONS; METASTASIS; EXPANSION; REQUIRES	Background Accumulating evidence supports the hypothesis that cancer stem cells (CSCs) are essential for cancer initiation, metastasis and drug resistance. However, the functional association of gastric CSC markers with stemness and epithelial-mesenchymal transition (EMT) signature genes is unclear. Methods qPCR was performed to measure the expression profiles of stemness and EMT signature genes and their association with putative CSC markers in gastric cancer tissues, cancer cell lines and sphere cells. Western blot analysis was used to confirm the results of the transcript analysis. Cell proliferation, cell migration, drug resistance and sphere cell growth assays were conducted to measure the expansion and invasion abilities of the cells. Tumor xenograft experiments were performed in NOD/SCID mice to test cell stemness in vivo. Flow cytometry and immunofluorescence staining were used to analyze cell subpopulations. Results The expression of LGR5 was strikingly up-regulated in sphere cells but not in cancer tissues or parental adherent cells. The up-regulation of LGR5 was also positively associated with stemness regulators (NANOG, OCT4, SOX2, and AICDA) and EMT inducers (PRRX1, TWIST1, and BMI1). In addition, sphere cells exhibited up-regulated vimentin and down-regulated E-cadherin expression. Using gene-specific primers, we found that the NANOG expression primarily originates from the retrogene NANOGP8. Western blot analysis showed that the expression of both LGR5 and NANOG is significantly higher in sphere cells. LGR5 over-expression significantly enhanced sphere cell growth, cell proliferation, cell migration and drug resistance in MGC803 cells. Tumor xenografts in nude mice showed that sphere cells are at least 10 times more efficient at tumor initiation than adherent cells. Flow cytometry analysis showed that similar to 20% of sphere cells are LGR5+/CD54+, but only similar to 3% of adherent cells are Lgr5+/CD54+. Immunofluorescence staining supports the above results. Conclusion The LGR5-expressing fraction of CD54+ cells represents gastric cancer CSCs, in which LGR5 is closely associated with stemness and EMT core genes, and NANOG expression is mainly contributed by the retrogene NANOGP8. Sphere cells are the best starting materials for the characterization of CSCs.	[Wang, Bei; Cao, Yang; Ma, Xia; Yin, Chenxing; Fan, Wufang] Hebei Univ, Sch Life Sci, Mol Biol Lab Gastr Canc, Baoding, Hebei Province, Peoples R China; [Chen, Queting; Jia, Youchao; Zang, Aimin] Hebei Univ, Dept Med Oncol, Affiliated Hosp, Baoding, Hebei Province, Peoples R China	Hebei University; Hebei University	Fan, WF (corresponding author), Hebei Univ, Sch Life Sci, Mol Biol Lab Gastr Canc, Baoding, Hebei Province, Peoples R China.	wfan6888@yahoo.com			Program for Hundreds Talents of Hebei, China [E2012100011]	Program for Hundreds Talents of Hebei, China	This study was funded by Program for Hundreds Talents of Hebei, China awarded to Dr. Wufang Fan (grant number E2012100011).; This study was funded by the Program for Hundreds Talents of Hebei, China awarded to Dr. Wufang Fan (grant number E2012100011). The authors declare that they have no conflict of interest. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent or a substitute for it was obtained from all patients included in the study.	Abell Amy N, 2014, Curr Pathobiol Rep, V2, P21; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Chen T, 2012, CELL RES, V22, P248, DOI 10.1038/cr.2011.109; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fairbanks DJ, 2012, G3-GENES GENOM GENET, V2, P1447, DOI 10.1534/g3.112.004366; Fujii H, 2009, INT J ONCOL, V34, P1381, DOI 10.3892/ijo_00000265; Gomceli I, 2012, WORLD J GASTROENTERO, V18, P5164, DOI 10.3748/wjg.v18.i37.5164; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Guo JB, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0393-x; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Huang J, 2015, INT J ONCOL, V47, P840, DOI 10.3892/ijo.2015.3084; Ke Yang, 1994, Zhonghua Zhongliu Zazhi, V16, P7; Lazarova DL, 2016, J CELL MOL MED, V20, P989, DOI 10.1111/jcmm.12850; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li R, 2013, ONCOL LETT, V5, P877, DOI 10.3892/ol.2013.1103; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McConkey DJ, 2009, CANCER METAST REV, V28, P335, DOI 10.1007/s10555-009-9194-7; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; Munoz DP, 2013, P NATL ACAD SCI USA, V110, pE2977, DOI 10.1073/pnas.1301021110; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Palla AR, 2014, ONCOGENE, V33, P2513, DOI 10.1038/onc.2013.196; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Rappa G, 2008, EXP CELL RES, V314, P2110, DOI 10.1016/j.yexcr.2008.03.008; Reichert M, 2013, GENE DEV, V27, P288, DOI 10.1101/gad.204453.112; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Serrano-Gomez SJ, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0502-x; Singh SK, 2003, CANCER RES, V63, P5821; Soncin F, 2011, GENES-BASEL, V2, P229, DOI 10.3390/genes2010229; Sugiyama M, 2015, ONCOL REP, V33, P1123, DOI 10.3892/or.2014.3681; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi Y, 2013, BRIT J CANCER, V109, P307, DOI 10.1038/bjc.2013.339; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Wakamatsu Y, 2012, PATHOL INT, V62, P112, DOI 10.1111/j.1440-1827.2011.02760.x; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; Wu C, 2013, GENE, V525, P18, DOI 10.1016/j.gene.2013.04.067; Wu CY, 2012, CLIN EXP PHARMACOL P, V39, P668, DOI 10.1111/j.1440-1681.2011.05594.x; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang CJ, 2011, J CANCER RES CLIN, V137, P1679, DOI 10.1007/s00432-011-1038-5; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhao Y, 2015, WORLD J GASTROENTERO, V21, P112, DOI 10.3748/wjg.v21.i1.112; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	54	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168904	10.1371/journal.pone.0168904	http://dx.doi.org/10.1371/journal.pone.0168904			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033430	Green Submitted, Green Published, gold			2022-12-26	WOS:000391226900056
J	Benzing, V; Heinks, T; Eggenberger, N; Schmidt, M				Benzing, Valentin; Heinks, Theda; Eggenberger, Noemi; Schmidt, Mirko			Acute Cognitively Engaging Exergame-Based Physical Activity Enhances Executive Functions in Adolescents	PLOS ONE			English	Article							EXERCISE CHARACTERISTICS; COORDINATIVE EXERCISE; ACADEMIC-ACHIEVEMENT; AEROBIC EXERCISE; EARLY ADULTHOOD; HEART-RATE; PERFORMANCE; CHILDREN; INTELLIGENCE; FITNESS	The study aimed to elucidate the influence of cognitive engagement comprised in an acute bout of exergame-based physical activity on executive functions (inhibition, cognitive flexibility) in adolescents. Therefore, the level of cognitive engagement and the intensity of physical activity were systematically varied across three experimental conditions. Sixty-five healthy male adolescents (13-16 years) were randomly assigned to one of three conditions: (a) physical activity with high levels of cognitive engagement during active video gaming, (b) physical activity with low levels of cognitive engagement during active video gaming, (c) sedentary with low levels of cognitive engagement during passive video watching. Manipulation checks, including subjective and objective operationalizations of cognitive engagement, were applied. Executive functions were assessed before and after each condition using the D-KEFS design fluency test. Results showed that cognitive engagement, operationalized by subjects' ratings and heart rate variability, differed between conditions. The physical activity condition with a high level of cognitive engagement resulted in significantly better performance in cognitive flexibility compared to conditions with low levels of cognitive engagement. Regarding benefits for executive functions in male adolescents, the results indicate that acute physical activity with high cognitive engagement could be more efficient than physical activity of the same intensity with low cognitive engagement. Even though further evidence is needed, these results extend previous research and suggest a methodological approach for measuring cognitive engagement.	[Benzing, Valentin; Schmidt, Mirko] Univ Bern, Inst Sport Sci, Bern, Switzerland; [Heinks, Theda; Eggenberger, Noemi] Univ Childrens Hosp, Dept Pediat Neurol Dev & Rehabil, Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Benzing, V (corresponding author), Univ Bern, Inst Sport Sci, Bern, Switzerland.	valentin.benzing@ispw.unibe.ch	Schmidt, Mirko/I-4762-2013; Benzing, Valentin/I-4748-2019	Schmidt, Mirko/0000-0003-4859-6547; Benzing, Valentin/0000-0002-9940-5635	Fondation Gaydoul; Swiss Cancer Research foundation	Fondation Gaydoul; Swiss Cancer Research foundation	This work was supported by the Fondation Gaydoul and the Swiss Cancer Research foundation.	Baggetta P, 2016, MIND BRAIN EDUC, V10, P10, DOI 10.1111/mbe.12100; Barenberg J, 2011, EDUC RES REV-NETH, V6, P208, DOI 10.1016/j.edurev.2011.04.002; Barkley J.E., J EXERC PHYSL ONLINE, V12; Berse T, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00196; Best JR, 2013, Z PSYCHOL, V221, P72, DOI 10.1027/2151-2604/a000137; Best JR, 2012, DEV PSYCHOL, V48, P1501, DOI 10.1037/a0026648; Best JR, 2010, DEV REV, V30, P331, DOI 10.1016/j.dr.2010.08.001; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Boudreau B, 2009, SOC INDIC RES, V94, P29, DOI 10.1007/s11205-008-9334-4; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Budde H, 2008, NEUROSCI LETT, V441, P219, DOI 10.1016/j.neulet.2008.06.024; Budde H, 2010, NEUROSCI LETT, V483, P16, DOI 10.1016/j.neulet.2010.07.036; Budde H, 2010, NEUROSCI LETT, V474, P131, DOI 10.1016/j.neulet.2010.03.015; Camm AJ, 1996, EUR HEART J, V17, P354; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chang YK, 2015, MED SCI SPORT EXER, V47, P159, DOI 10.1249/MSS.0000000000000383; Delis D.C., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Donnelly JE, 2016, MED SCI SPORT EXER, V48, P1197, DOI 10.1249/MSS.0000000000000901; Esteban-Cornejo I, 2015, J SCI MED SPORT, V18, P534, DOI 10.1016/j.jsams.2014.07.007; Esteban-Cornejo I, 2014, J SPORT SCI, V32, P1596, DOI 10.1080/02640414.2014.910607; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faulkner MS, 2003, HEART LUNG, V32, P10, DOI 10.1067/mhl.2003.6; Flynn Rachel M, 2014, J Educ Develop Psychol, V4, P209; Fuchs R, 2015, Z GESUNDHEITSPSYCHOL, V23, P60, DOI 10.1026/0943-8149/a000137; Gale CR, 2010, EPIDEMIOLOGY, V21, P70, DOI 10.1097/EDE.0b013e3181c17da8; Gallotta MC, 2015, SCAND J MED SCI SPOR, V25, pe331, DOI 10.1111/sms.12310; Gallotta MC, 2012, MED SCI SPORT EXER, V44, P550, DOI 10.1249/MSS.0b013e3182305552; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Hillman CH, 2009, NEUROSCIENCE, V159, P1044, DOI 10.1016/j.neuroscience.2009.01.057; Hillman CH, 2011, PREV MED, V52, pS21, DOI 10.1016/j.ypmed.2011.01.024; Hogan M, 2013, EXP BRAIN RES, V229, P85, DOI 10.1007/s00221-013-3595-0; Homack S, 2005, J CLIN EXP NEUROPSYC, V27, P599, DOI 10.1080/13803390490918444; Jackson DB, 2015, INT J ENV RES PUB HE, V12, P385, DOI 10.3390/ijerph120100385; Jager K, 2015, MENT HEALTH PHYS ACT, V9, P1, DOI 10.1016/j.mhpa.2015.05.002; Jager K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01473; KAHNEMAN D, 1969, J EXP PSYCHOL, V79, P164, DOI 10.1037/h0026952; Kimhy D, 2013, J PSYCHIATR RES, V47, P628, DOI 10.1016/j.jpsychires.2013.01.018; Kubesch S, 2009, MIND BRAIN EDUC, V3, P235, DOI 10.1111/j.1751-228X.2009.01076.x; Luft CD, 2009, BIOL PSYCHOL, V82, P196, DOI 10.1016/j.biopsycho.2009.07.007; Moodithaya Shailaja, 2012, J Aging Res, V2012, P679345, DOI 10.1155/2012/679345; Mukherjee S, 2011, CLIN NEUROPHYSIOL, V122, P2059, DOI 10.1016/j.clinph.2011.02.032; O'Loughlin EK, 2012, PEDIATRICS, V130, P806, DOI 10.1542/peds.2012-0391; Pendleton DM, 2016, INT J PSYCHOPHYSIOL, V109, P124, DOI 10.1016/j.ijpsycho.2016.08.012; Penko AL, 2010, ANN BEHAV MED, V39, P162, DOI 10.1007/s12160-010-9164-x; Pesce C., 2009, MENT HEALTH PHYS ACT, V2, P16, DOI [10.1016/j.mhpa.2009.02.001, DOI 10.1016/J.MHPA.2009.02.001]; Pesce C, 2013, MENT HEALTH PHYS ACT, V6, P172, DOI 10.1016/j.mhpa.2013.07.001; Pesce C, 2012, J SPORT EXERCISE PSY, V34, P766, DOI 10.1123/jsep.34.6.766; Schmidt M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01474; Schmidt M, 2015, J SPORT EXERCISE PSY, V37, P575, DOI 10.1123/jsep.2015-0069; Schmidt M, 2015, PERCEPT MOTOR SKILL, V121, P431, DOI 10.2466/22.06.PMS.121c22x1; Staiano AE, 2012, DEV PSYCHOL, V48, P337, DOI 10.1037/a0026938; Suchy Y, 2010, J INT NEUROPSYCH SOC, V16, P26, DOI 10.1017/S1355617709990804; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Tomporowski PD, 2008, EDUC PSYCHOL REV, V20, P111, DOI 10.1007/s10648-007-9057-0; Tomporowski PD, 2015, J SPORT HEALTH SCI, V4, P47, DOI 10.1016/j.jshs.2014.09.003; Van Breukelen GJP, 2006, J CLIN EPIDEMIOL, V59, P920, DOI 10.1016/j.jclinepi.2006.02.007; Verburgh L, 2014, BRIT J SPORT MED, V48, P973, DOI 10.1136/bjsports-2012-091441; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Watzlawik M, 2009, DIAGNOSTICA, V55, P55, DOI 10.1026/0012-1924.55.1.55; Wegner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092953; Yeniad N, 2013, LEARN INDIVID DIFFER, V23, P1, DOI 10.1016/j.lindif.2012.10.004	62	64	64	8	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167501	10.1371/journal.pone.0167501	http://dx.doi.org/10.1371/journal.pone.0167501			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030542	gold, Green Published, Green Submitted			2022-12-26	WOS:000391222000009
J	Meikle, WG; Adamczyk, JJ; Weiss, M; Gregorc, A; Johnson, DR; Stewart, SD; Zawislak, J; Carroll, MJ; Lorenz, GM				Meikle, William G.; Adamczyk, John J.; Weiss, Milagra; Gregorc, Ales; Johnson, Don R.; Stewart, Scott D.; Zawislak, Jon; Carroll, Mark J.; Lorenz, Gus M.			Sublethal Effects of Imidacloprid on Honey Bee Colony Growth and Activity at Three Sites in the U.S.	PLOS ONE			English	Article							NEONICOTINOID INSECTICIDES; PESTICIDE EXPOSURE	Imidacloprid is a neonicotinoid pesticide heavily used by the agricultural industry and shown to have negative impacts on honey bees above certain concentrations. We evaluated the effects of different imidacloprid concentrations in sugar syrup using cage and field studies, and across different environments. Honey bee colonies fed sublethal concentrations of imidicloprid (0, 5, 20 and 100 ppb) over 6 weeks in field trials at a desert site (Arizona), a site near intensive agriculture (Arkansas) and a site with little nearby agriculture but abundant natural forage (Mississippi) were monitored with respect to colony metrics, such as adult bee and brood population sizes, as well as pesticide residues. Hive weight and internal hive temperature were monitored continuously over two trials in Arizona. Colonies fed 100 ppb imidacloprid in Arizona had significantly lower adult bee populations, brood surface areas and average frame weights, and reduced temperature control, compared to colonies in one or more of the other treatment groups, and consumption rates of those colonies were lower compared to other colonies in Arizona and Arkansas, although no differences in capped brood or average frame weight were observed among treatments in Arkansas. At the Mississippi site, also rich in alternative forage, colonies fed 5 ppb imidacloprid had less capped brood than control colonies, but contamination of control colonies was detected. In contrast, significantly higher daily hive weight variability among colonies fed 5 ppb imidacloprid in Arizona suggested greater foraging activity during a nectar flow post treatment, than any other treatment group. Imidacloprid concentrations in stored honey corresponded well with the respective syrup concentrations fed to the colonies and remained stable within the hive for at least 7 months after the end of treatment.	[Meikle, William G.; Weiss, Milagra; Carroll, Mark J.] USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ 85719 USA; [Adamczyk, John J.] USDA ARS, Southern Hort Lab, Poplarville, MS USA; [Gregorc, Ales] Mississippi State Univ, South MS Branch Expt Stn, Poplarville, MS USA; [Johnson, Don R.; Lorenz, Gus M.] Univ Arkansas, Div Agr Cooperat Extens Serv, Lonoke Res & Ext Ctr, Lonoke, AR USA; [Stewart, Scott D.] Univ Tennessee, West Tennessee Res & Educ Ctr, 605 Airways Blvd, Jackson, TN USA; [Zawislak, Jon] Univ Arkansas, Div Agr Cooperat Extens Serv, 2301 South Univ, Little Rock, AR 72204 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Mississippi State University; University of Arkansas System; University of Arkansas Fayetteville; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Meikle, WG (corresponding author), USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ 85719 USA.	william.meikle@ars.usda.gov	Gregorc, Aleš/AAH-2476-2019; Serrano, Jose/A-2854-2009; Meikle, William/AAC-2481-2022	Serrano, Jose/0000-0002-1565-5216; Adamczyk, John/0000-0002-6536-7255; Meikle, William/0000-0002-1759-6950	ARS [ARS-0426270] Funding Source: Federal RePORTER	ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Basile R, 2008, ZOOLOGY, V111, P433, DOI 10.1016/j.zool.2007.11.002; Berry JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076536; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Collison E, 2015, BIOL REV; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Dively GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118748; Easton AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054819; El Hassani AK, 2008, ARCH ENVIRON CON TOX, V54, P653, DOI 10.1007/s00244-007-9071-8; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Johnson RM, 2015, ANNU REV ENTOMOL, V60, P415, DOI 10.1146/annurev-ento-011613-162005; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; Kohler A, 2012, J INSECT PHYSIOL, V58, P286, DOI 10.1016/j.jinsphys.2011.12.002; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Meikle WG, 2016, APIDOLOGIE, V47, P1, DOI 10.1007/s13592-015-0370-1; Meikle WG, 2008, APIDOLOGIE, V39, P694, DOI 10.1051/apido:2008055; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Owens CD, 1971, USDA TECHNICAL B, V1429; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pettis JS, 2004, APIDOLOGIE, V35, P605, DOI 10.1051/apido:2004056; Pochi D, 2012, B ENVIRON CONTAM TOX, V89, P354, DOI 10.1007/s00128-012-0664-1; Reetz JE, 2011, APIDOLOGIE, V42, P596, DOI 10.1007/s13592-011-0049-1; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Sandrock C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103592; Singaravelan N, 2006, J CHEM ECOL, V32, P49, DOI 10.1007/s10886-006-9350-2; Stewart SD, 2014, ENVIRON SCI TECHNOL, V48, P9762, DOI 10.1021/es501657w; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; Toth PL, 2009, THESIS; Yang EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049472; Zhu YC, 2015, J ECON ENTOMOL, P1	35	45	47	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168603	10.1371/journal.pone.0168603	http://dx.doi.org/10.1371/journal.pone.0168603			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030617	Green Published, Green Submitted, gold			2022-12-26	WOS:000391222000061
J	Stroe-Kunold, E; Buckert, M; Friederich, HC; Wesche, D; Kopf, S; Herzog, W; Wild, B				Stroe-Kunold, Esther; Buckert, Magdalena; Friederich, Hans-Christoph; Wesche, Daniela; Kopf, Stefan; Herzog, Wolfgang; Wild, Beate			Time Course of Leptin in Patients with Anorexia Nervosa during Inpatient Treatment: Longitudinal Relationships to BMI and Psychological Factors	PLOS ONE			English	Article							SERUM LEPTIN; WEIGHT-GAIN; TEMPORAL RELATIONSHIPS; DEPRESSIVE SYMPTOMS; EATING-DISORDERS; FOOD-INTAKE; DYSREGULATION; CORTISOL; ADIPONECTIN; LINK	Background Leptin, a hormone secreted by adipose tissue, appears to play a major role in the homeostasis of body weight and psychobiological processes associated with anorexia nervosa (AN). However, there is scarce data on its exact influence on this disorder, in particular data over time. Objective The present study addresses whether leptin changes during inpatient treatment play a role for treatment outcome and psychological factors in underweight AN patients. Methods In order to understand whether leptin's role differs in relation to AN severity, data were assessed from 11 patients with a very low BMI and a higher chronicity (high severity group; HSS; mean BMI at the beginning of the study = 13.6; mean duration of illness = 5.1 years) vs. nine with less severe symptoms (LSS; mean BMI = 16.2; mean duration of illness = 3.7 years). During the course of treatment, serum leptin concentrations were assessed weekly while weight (BMI) was assessed twice per week. Concomitantly, psychological variables were obtained by means of electronic diaries. Unconditional linear growth models were calculated to evaluate the temporal course of leptin in relation to BMI. For HSS patients, two phases of treatment (BMI < 16 and BMI >= 16 kg/m(2)) were investigated. Results Leptin increased significantly with BMI in both groups of patients. For HSS patients, the increase of leptin in the first treatment phase did not predict later increases in BMI. Furthermore, the relationship of leptin and psychological factors was modulated by symptom severity. In HSS patients, higher leptin levels were associated with greater feelings of depression, anxiety, and stress whereas in LSS patients a higher leptin level showed the trend to be associated with lower psychological symptom burden. Conclusions Our results suggest that leptin changes are differently associated with weight gain and psychological symptoms depending on the severity of starvation.	[Stroe-Kunold, Esther; Buckert, Magdalena; Wesche, Daniela; Herzog, Wolfgang; Wild, Beate] Med Univ Hosp, Dept Gen Internal Med & Psychosomat, Heidelberg, Germany; [Friederich, Hans-Christoph] Univ Dusseldorf, LVR Clin, Dept Psychosomat Med & Psychotherapy, Dusseldorf, Germany; [Kopf, Stefan] Med Univ Hosp, Dept Endocrinol & Clin Chem, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Heine University Dusseldorf; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Wild, B (corresponding author), Med Univ Hosp, Dept Gen Internal Med & Psychosomat, Heidelberg, Germany.	beate.wild@med.uni-heidelberg.de			Medical Faculty of the University of Heidelberg [F.206808]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Medical Faculty of the University of Heidelberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	This study was supported by the Medical Faculty of the University of Heidelberg (Olympia Morata Programme, F.206808; Postdoctoral Fellowship Programme). This study also received funding from the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg, within the funding programme for Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Ballauff A, 1999, MOL PSYCHIATR, V4, P71, DOI 10.1038/sj.mp.4000478; Bosy-Westphal A, 2005, EUR J NUTR, V44, P355, DOI 10.1007/s00394-005-0533-3; Brockmeyer T, 2012, COMPR PSYCHIAT, V53, P496, DOI 10.1016/j.comppsych.2011.09.003; Burguera B, 2000, NEUROENDOCRINOLOGY, V71, P187, DOI 10.1159/000054536; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Haas V, 2005, AM J CLIN NUTR, V81, P889, DOI 10.1093/ajcn/81.4.889; Hatch A, 2010, EUR EAT DISORD REV, V18, P165, DOI 10.1002/erv.974; Haynos AF, 2011, CLIN PSYCHOL-SCI PR, V18, P183, DOI 10.1111/j.1468-2850.2011.01250.x; Hebebrand J, 2007, MOL PSYCHIATR, V12, P23, DOI 10.1038/sj.mp.4001909; Hebebrand J, 1997, MOL PSYCHIATR, V2, P330, DOI 10.1038/sj.mp.4000282; Hebebrand J, 2012, EUR CHILD ADOLES PSY, V21, P63, DOI 10.1007/s00787-012-0243-3; Herpertz S, 2000, EUR J ENDOCRINOL, V142, P373, DOI 10.1530/eje.0.1420373; Hilbert A, 2007, DIAGNOSTICA, V53, P144, DOI 10.1026/0012-1924.53.3.144; Holtkamp K, 2004, PSYCHONEUROENDOCRINO, V29, P791, DOI 10.1016/S0306-4530(03)00143-4; Holtkamp K, 2003, J CLIN ENDOCR METAB, V88, P5169, DOI 10.1210/jc.2003-030569; Holtkamp K, 2003, J NEURAL TRANSM, V110, P427, DOI 10.1007/s00702-002-0800-x; Janas-Kozik M, 2011, REGUL PEPTIDES, V168, P5, DOI 10.1016/j.regpep.2011.02.005; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Lawson EA, 2012, CLIN ENDOCRINOL, V76, P520, DOI 10.1111/j.1365-2265.2011.04182.x; Liu J, 2015, INT J NEUROPSYCHOPHA; Lob S, 2003, EXP CLIN ENDOCR DIAB, V111, P278, DOI 10.1055/s-2003-41286; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Lu XY, 2007, CURR OPIN PHARMACOL, V7, P648, DOI 10.1016/j.coph.2007.10.010; Lu XY, 2006, P NATL ACAD SCI USA, V103, P1593, DOI 10.1073/pnas.0508901103; Miller KK, 2011, J CLIN ENDOCR METAB, V96, P2939, DOI 10.1210/jc.2011-1222; Modan-Moses D, 2007, J CLIN ENDOCR METAB, V92, P1843, DOI 10.1210/jc.2006-1683; Monteleone P, 2008, REGUL PEPTIDES, V149, P39, DOI 10.1016/j.regpep.2007.10.007; Monteleone P, 2013, PSYCHONEUROENDOCRINO, V38, P312, DOI 10.1016/j.psyneuen.2012.10.021; Morrison CD, 2009, BBA-MOL BASIS DIS, V1792, P401, DOI 10.1016/j.bbadis.2008.12.004; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Naylor C, 2016, TRENDS MOL MED, V22, P88, DOI 10.1016/j.molmed.2015.12.001; Oldershaw A, 2011, NEUROSCI BIOBEHAV R, V35, P970, DOI 10.1016/j.neubiorev.2010.11.001; Paz G, 2010, INT J CLIN PRACT, V64, P1808, DOI 10.1111/j.1742-1241.2010.02536.x; Procaccini C, 2016, DEV COMP IMMUNOL, DOI [10.1038/nri1350, DOI 10.1038/NRI1350]; Procaccini C, 2015, METABOLISM, V64, P92, DOI 10.1016/j.metabol.2014.10.014; Ruscica M, 2015, ENDOCRINE, P1; Rybakowski F, 2014, NEUROENDOCRINOL LETT, V35, P64; Seitz J, 2016, EUR CHILD ADOLES PSY, V25, P1019, DOI 10.1007/s00787-016-0819-4; Serpell L, 2004, INT J EAT DISORDER, V36, P416, DOI 10.1002/eat.20040; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Sodersten P, 2008, FRONT NEUROENDOCRIN, V29, P445, DOI 10.1016/j.yfrne.2008.06.001; Stieg MR, 2015, PSYCHONEUROENDOCRINO, V51, P47, DOI 10.1016/j.psyneuen.2014.09.004; Stroe-Kunold E, 2012, INT J PSYCHIAT MED, V44, P53, DOI 10.2190/PM.44.1.d; Tortorella A, 2014, EUR EAT DISORD REV, V22, P307, DOI 10.1002/erv.2303; Treasure J, 2012, EUR EAT DISORD REV, V20, P431, DOI 10.1002/erv.2181; Wild B, 2016, INT J PSYCHOPHYSIOL, V102, P25, DOI 10.1016/j.ijpsycho.2016.03.002; Wild B, 2014, INT J PSYCHOPHYSIOL, V94, P272, DOI 10.1016/j.ijpsycho.2014.09.010	49	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0166843	10.1371/journal.pone.0166843	http://dx.doi.org/10.1371/journal.pone.0166843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030575	Green Published, gold			2022-12-26	WOS:000391222000003
J	Lu, YZ; Wan, J; Yang, ZF; Lei, XL; Niu, Q; Jiang, LX; Passtoors, WM; Zang, AP; Fraering, PC; Wu, F				Lu, Yinzhong; Wan, Jun; Yang, Zhifeng; Lei, Xiling; Niu, Qi; Jiang, Lanxin; Passtoors, Willemijn M.; Zang, Aiping; Fraering, Patrick C.; Wu, Fang			Regulated intramembrane proteolysis of the AXL receptor kinase generates an intracellular domain that localizes in the nucleus of cancer cells	FASEB JOURNAL			English	Article						receptor tyrosine kinase; presenilin; gamma-secretase; protein processing; nuclear translocation	NUCLEOTIDE-BINDING SITE; TYROSINE KINASE; GAMMA-SECRETASE; ALZHEIMERS-DISEASE; BREAST-CANCER; DOWN-REGULATION; LUNG-CANCER; RESISTANCE; CLEAVAGE; THERAPY	Deregulation of the TAM (TYRO3, AXL, and MERTK) family of receptor tyrosine kinases (RTKs) has recently been demonstrated to predominately promote survival and chemoresistance of cancer cells. Intramembrane proteolysis mediated by presenilin/gamma-secretase is known to regulate the homeostasis of some RTKs. In the present study, we demonstrate that AXL, but not TYRO3 or MERTK, is efficiently and sequentially cleaved by alpha-and g-secretases in various types of cancer cell lines. Proteolytic processing of AXL redirected signaling toward a secretase-mediated pathway, away from the classic, well-known, ligand-dependent canonical RTK signaling pathway. TheAXL intracellular domain cleavage product, but not full-length AXL, was further shown to translocate into the nucleus via a nuclear localization sequence that harbored a basic HRRKK motif. Of interest, we found that the g-secretase-uncleavable AXL mutant caused an elevated chemoresistance in non-small-cell lung cancer cells. Altogether, our findings suggest thatAXL can undergo sequential processing mediated by various proteases kept in a homeostatic balance. This newly discovered post-translational processing ofAXL may provide an explanation for the diverse functions of AXL, especially in the context of drug resistance in cancer cells.-Lu, Y., Wan, J., Yang, Z., Lei, X., Niu, Q., Jiang, L., Passtoors, W. M., Zang, A., Fraering, P. C., Wu, F. Regulated intramembrane proteolysis of the AXL receptor kinase generates an intracellular domain that localizes in the nucleus of cancer cells. FASEB J. 31, 1382-1397 (2017). www.fasebj.org	[Lu, Yinzhong; Wan, Jun; Lei, Xiling; Niu, Qi; Passtoors, Willemijn M.; Zang, Aiping; Wu, Fang] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Key Lab Syst Biomed, Shanghai, Peoples R China; [Yang, Zhifeng; Jiang, Lanxin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai, Peoples R China; [Fraering, Patrick C.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Sch Life Sci, Lausanne, Switzerland; [Fraering, Patrick C.] Fdn Eclos, Plan Les Ouates, Switzerland; [Fraering, Patrick C.] Campus Biotech Innovat Pk, Geneva, Switzerland	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Wu, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	fang.wu@sjtu.edu.cn	Wu, Fang/B-1945-2008	Wu, Fang/0000-0002-4194-2243; LU, Yinzhong/0000-0003-2164-0157; Fraering, Patrick/0000-0002-5841-5327	National Natural Science Foundation of China [31270853, 31300640]; Research Fund of Medicine and Engineering of Shanghai Jiao Tong University [YG2013MS22]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund of Medicine and Engineering of Shanghai Jiao Tong University	This work was supported by the National Natural Science Foundation of China (31270853, 31300640) and the Research Fund of Medicine and Engineering of Shanghai Jiao Tong University (Grant YG2013MS22). The authors thank Dr. B. De Strooper (University of Leuven) for providing WT and PS1 KO, PS2 KO, and PS DKO mouse embryonic fibroblasts; Dr. X. Lin (Institute of Oceanology, Chinese Academy of Sciences, Qingdao, China) for Panc-28 cells; Dr. H. Gehring (University of Zurich, Zurich, Switzerland) for HEK293T, Hela, LN-18, and LN-229 cells; and Dr. Y. Zhang (Shanghai Jiao Tong University) for SGC7901 and A549 cells. The authors also thank Dr. Rik Derynck (University of California San Francisco, San Francisco, CA, USA) for pRK5F-TACE and pRK5M-ADAM10 plasmids. The authors declare no conflicts of interest.	Axelrod H, 2014, ONCOTARGET, V5, P1, DOI 10.18632/oncotarget.2422; Bae SY, 2015, ONCOTARGET, V6, P10146, DOI 10.18632/oncotarget.3380; Brand TM, 2014, CANCER RES, V74, P5152, DOI 10.1158/0008-5472.CAN-14-0294; Braunger J, 1997, ONCOGENE, V14, P2619, DOI 10.1038/sj.onc.1201123; Budagian V, 2005, MOL CELL BIOL, V25, P9324, DOI 10.1128/MCB.25.21.9324-9339.2005; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Carpenter G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008979; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Flood F, 2005, BIOCHEM J, V385, P545, DOI 10.1042/BJ20041145; Foveau B, 2009, MOL BIOL CELL, V20, P2495, DOI 10.1091/mbc.E08-09-0969; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Guo L, 2002, MOL CELL PROTEOMICS, V1, P30, DOI 10.1074/mcp.M100020-MCP200; Gutwein P, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-3; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Kao SC, 2004, J BIOL CHEM, V279, P1942, DOI 10.1074/jbc.M309219200; Koorstra JBM, 2009, CANCER BIOL THER, V8, P618, DOI 10.4161/cbt.8.7.7923; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Korshunov VA, 2012, CLIN SCI, V122, P361, DOI 10.1042/CS20110411; Krishnamoorthy GP, 2013, J BIOL CHEM, V288, P17481, DOI 10.1074/jbc.M112.439422; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Miller MA, 2016, CANCER DISCOV, V6, P382, DOI 10.1158/2159-8290.CD-15-0933; OBRYAN JP, 1995, J BIOL CHEM, V270, P551, DOI 10.1074/jbc.270.2.551; Paolino M, 2014, NATURE, V507, P508, DOI 10.1038/nature12998; Pomara N, 2013, NEW ENGL J MED, V369, P1661, DOI 10.1056/NEJMc1310845; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Scaltriti M, 2016, CLIN CANCER RES, V22, P1313, DOI 10.1158/1078-0432.CCR-15-1458; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Song SM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009001; Song XZ, 2011, CANCER-AM CANCER SOC, V117, P734, DOI 10.1002/cncr.25483; Vahidi A, 2014, BIOCHEM BIOPH RES CO, V450, P782, DOI 10.1016/j.bbrc.2014.06.061; Valverde P, 2005, BIOCHEM BIOPH RES CO, V333, P180, DOI 10.1016/j.bbrc.2005.05.086; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wang JH, 2001, J IMMUNOL, V167, P289, DOI 10.4049/jimmunol.167.1.289; Wu F, 2010, FASEB J, V24, P2464, DOI 10.1096/fj.09-148031; Wu XL, 2014, ONCOTARGET, V5, P9546, DOI 10.18632/oncotarget.2542; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	50	21	21	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1382	1397		10.1096/fj.201600702R	http://dx.doi.org/10.1096/fj.201600702R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28034848	Green Published, hybrid			2022-12-26	WOS:000398504300011
J	Munkacsi, AB; Hammond, N; Schneider, RT; Senanayake, DS; Higaki, K; Lagutin, K; Bloor, SJ; Ory, DS; Maue, RA; Chen, FW; Hernandez-Ono, A; Dahlson, N; Repa, JJ; Ginsberg, HN; Ioannou, YA; Sturleyj, SL				Munkacsi, Andrew B.; Hammond, Natalie; Schneider, Remy T.; Senanayake, Dinindu S.; Higaki, Katsumi; Lagutin, Kirill; Bloor, Stephen J.; Ory, Daniel S.; Maue, Robert A.; Chen, Fannie W.; Hernandez-Ono, Antonio; Dahlson, Nicole; Repa, Joyce J.; Ginsberg, Henry N.; Ioannou, Yiannis A.; Sturleyj, Stephen L.			Normalization of Hepatic Homeostasis in the Npc1(nmf164) Mouse Model of Niemann-Pick Type C Disease Treated with the Histone Deacetylase Inhibitor Vorinostat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL ACCUMULATION; FATTY-ACIDS; LIVER; GENE; EXPRESSION; TARGET; MURINE; BIOMARKERS; SECRETION; DATABASE	Niemann-Pick type C (NP-C) disease is a fatal genetic lipidosis for which there is no Food and Drug Administration (FDA)approved therapy. Vorinostat, an FDA-approved inhibitor of histone deacetylases, ameliorates lysosomal lipid accumulation in cultured NP-C patient fibroblasts. To assess the therapeutic potential of histone deacetylase inhibition, we pursued these in vitro observations in two murine models of NP-C disease. Npc1(nmf164) mice, which express a missense mutation in the Npc1 gene, were treated intraperitoneally, from weaning, with the maximum tolerated dose of vorinostat (150 mg/kg, 5 days/week). Disease progression was measured via gene expression, liver function and pathology, serum and tissue lipid levels, body weight, and life span. Transcriptome analyses of treated livers indicated multiple changes consistent with reversal of liver dysfunction that typifies NP-C disease. Significant improvements in liver pathology and function were achieved by this treatment regimen; however, NPC1 protein maturation and levels, disease progression, weight loss, and animal morbidity were not detectably altered. Vorinostat concentrations were > 200 mu M in the plasma compartment of treated animals but were almost 100fold lower in brain tissue. Apolipoprotein B metabolism and the expression of key components of lipid homeostasis in primary hepatocytes from null (Npc1(-/-)) and missense (Npc1(nmf164)) mutant mice were altered by vorinostat treatment, consistent with a response by these cells independent of the status of the Npc1 locus. These results suggest that HDAC inhibitors have utility to treat visceral NP-C disease. However, it is clear that improved blood-brain barrier penetration will be required to alleviate the neurological symptoms of human NP-C disease.	[Munkacsi, Andrew B.; Hammond, Natalie; Schneider, Remy T.; Senanayake, Dinindu S.] Victoria Univ Wellington, Sch Biol Sci, Alan MacDiarmid Bldg,Rm 322, Wellington 6012, New Zealand; [Munkacsi, Andrew B.] Victoria Univ Wellington, Ctr Biodiscovery, Wellington 6012, New Zealand; [Higaki, Katsumi] Tottori Univ, Res Ctr Biosci & Technol, Div Funct Genom, Yonago, Tottori 6838503, Japan; [Lagutin, Kirill; Bloor, Stephen J.] Callaghan Innovat, Lower Hutt 5040, New Zealand; [Ory, Daniel S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Maue, Robert A.] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Hanover, NH 03755 USA; [Maue, Robert A.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Chen, Fannie W.; Ioannou, Yiannis A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Dahlson, Nicole; Repa, Joyce J.] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Dahlson, Nicole; Repa, Joyce J.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Ginsberg, Henry N.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Sturleyj, Stephen L.] Columbia Univ, Dept Genet & Dev, Med Ctr, 630 W 168th St, New York, NY 10032 USA	Victoria University Wellington; Victoria University Wellington; Tottori University; Callaghan Innovation; Washington University (WUSTL); Dartmouth College; Dartmouth College; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University; Columbia University	Munkacsi, AB (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Alan MacDiarmid Bldg,Rm 322, Wellington 6012, New Zealand.; Sturleyj, SL (corresponding author), Columbia Univ, Dept Genet & Dev, Med Ctr, 630 W 168th St, New York, NY 10032 USA.	andrew.munkacsi@vuw.ac.nz; sls37@columbia.edu		Lagutin, Kirill/0000-0001-5276-844X; Repa, Joyce/0000-0001-5740-1954; Munkacsi, Andrew/0000-0003-3033-395X	Ara Parseghian Medical Research Foundation; Dana's Angels Research Trust; National Institutes of Health [DK54320, DK082712, NS092653, HL55638]; Victoria University of Wellington University Research Fund; Ministry of Education, Culture, Science, Sports, and Technology of Japan [20790728];  [T32 HL07343]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090260] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK082712, R01DK054320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092653] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [17K10051] Funding Source: KAKEN	Ara Parseghian Medical Research Foundation; Dana's Angels Research Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victoria University of Wellington University Research Fund; Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ara Parseghian Medical Research Foundation (to S. L. S. and J. J. R.) and Dana's Angels Research Trust (to S. L. S.) and by National Institutes of Health Grants DK54320 (to S. L. S.), DK082712 (to Y. A. I.), NS092653 (to D. S. O.), and HL55638 (to H. N. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported as a Peter Pentchev Research Fellow of the National Niemann-Pick Disease Foundation, a Senior Fellow in Biomedical Sciences of the Charles Revson Foundation, and a National Institutes of Health Postdoctoral Fellow in Arteriosclerosis (Grant T32 HL07343) and recipient of support from the Victoria University of Wellington University Research Fund. To whom correspondence may be addressed: School of Biological Sciences, Victoria University of Wellington, Alan MacDiarmid Bldg., Rm. 322, Wellington 6012, NewZealand. Tel.: 64-463-5171; Fax: 64-463-5331; E-mail: andrew.munkacsi@vuw.ac.nz.; Supported by Ministry of Education, Culture, Science, Sports, and Technology of Japan Grant 20790728.	Alam MS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9407; Alam MS, 2014, J BIOL CHEM, V289, P8051, DOI 10.1074/jbc.M113.526392; Alam MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048273; Aqul A, 2011, J NEUROSCI, V31, P9404, DOI 10.1523/JNEUROSCI.1317-11.2011; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Butovich IA, 2009, J LIPID RES, V50, P501, DOI 10.1194/jlr.M800426-JLR200; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chen FW, 2005, BIOCHEM J, V390, P549, DOI 10.1042/BJ20050236; Chuang JC, 2008, MOL ENDOCRINOL, V22, P2353, DOI 10.1210/me.2007-0568; Claerhout S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024662; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; Conlon DM, 2016, J CLIN INVEST, V126, P3852, DOI 10.1172/JCI86028; Davidson CD, 2016, ANN CLIN TRANSL NEUR, V3, P366, DOI 10.1002/acn3.306; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; DIXON JL, 1991, J BIOL CHEM, V266, P5080; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Fan M, 2013, J LIPID RES, V54, P2800, DOI 10.1194/jlr.M040618; Garver WS, 2007, AM J MED GENET A, V143A, P1204, DOI 10.1002/ajmg.a.31735; Gelsthorpe ME, 2008, J BIOL CHEM, V283, P8229, DOI 10.1074/jbc.M708735200; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; Halsall JA, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0021-9; Han YP, 2013, J GASTROEN HEPATOL, V28, P49, DOI 10.1111/jgh.12016; Hanson JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069964; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Kulinski A, 2007, J BIOL CHEM, V282, P1627, DOI 10.1074/jbc.M610001200; Li JZ, 2012, J CLIN INVEST, V122, P4130, DOI 10.1172/JCI65179; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Liu YB, 2013, TOXICOL LETT, V221, P23, DOI 10.1016/j.toxlet.2013.05.643; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lopez ME, 2013, DIS MODEL MECH, V6, P1089, DOI 10.1242/dmm.012385; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Maue RA, 2012, HUM MOL GENET, V21, P730, DOI 10.1093/hmg/ddr505; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mielcarek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027746; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Munkacsi AB, 2007, FUTURE LIPIDOL, V2, P357, DOI 10.2217/17460875.2.3.357; Munkacsi AB, 2011, J BIOL CHEM, V286, P23842, DOI 10.1074/jbc.M111.227645; Nemeth J, 2009, HEPATOLOGY, V50, P1251, DOI 10.1002/hep.23099; Nunes MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053394; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Palmieri D, 2009, CLIN CANCER RES, V15, P6148, DOI 10.1158/1078-0432.CCR-09-1039; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; Pontikis CC, 2013, J INHERIT METAB DIS, V36, P491, DOI 10.1007/s10545-012-9583-x; Praggastis M, 2015, J NEUROSCI, V35, P8091, DOI 10.1523/JNEUROSCI.4173-14.2015; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Runz H, 2008, HUM MUTAT, V29, P345, DOI 10.1002/humu.20636; Sandhu Punam, 2007, Drug Metab Lett, V1, P153, DOI 10.2174/187231207780363642; Sayre NL, 2010, J LIPID RES, V51, P2372, DOI 10.1194/jlr.M007211; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; SMEDSROD B, 1985, J LEUKOCYTE BIOL, V38, P213, DOI 10.1002/jlb.38.2.213; Stampfer M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-35; Stimson L, 2009, CANCER LETT, V280, P177, DOI 10.1016/j.canlet.2009.03.016; Su L, 2010, ONCOGENE, V29, P4352, DOI 10.1038/onc.2010.204; Taylor AM, 2012, J LIPID RES, V53, P2331, DOI 10.1194/jlr.M028241; Tian J, 2016, P NATL ACAD SCI USA, V113, P8182, DOI 10.1073/pnas.1608987113; Van den Bossche J, 2014, BIOCHEM BIOPH RES CO, V455, P396, DOI 10.1016/j.bbrc.2014.11.029; Vance DE, 2009, J LIPID RES, V50, pS132, DOI 10.1194/jlr.R800048-JLR200; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Vite CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010101; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang MD, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700326200; Wehrmann ZT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048561; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Xie XF, 2011, P NATL ACAD SCI USA, V108, P15330, DOI 10.1073/pnas.1112751108; Yang H, 2015, NAT METHODS, V12, P841, DOI [10.1038/NMETH.3484, 10.1038/nmeth.3484]; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yu Y, 2010, GENOMICS, V96, P281, DOI 10.1016/j.ygeno.2010.08.003	74	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4395	4410		10.1074/jbc.M116.770578	http://dx.doi.org/10.1074/jbc.M116.770578			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28031458	hybrid, Green Published			2022-12-26	WOS:000397585100002
J	Barrette, RW; Rowland, JM; Grau, FR; Mclntosh, MT				Barrette, Roger W.; Rowland, Jessica M.; Grau, Frederic R.; Mclntosh, Michael T.			Development of a Feature and Template-Assisted Assembler and Application to the Analysis of a Foot-and-Mouth Disease Virus Genotyping Microarray	PLOS ONE			English	Article							SWINE	Several RT-PCR and genome sequencing strategies exist for the resolution of Foot-and Mouth Disease virus (FMDV). While these approaches are relatively straightforward, they can be vulnerable to failure due to the unpredictable nature of FMDV genome sequence variations. Sequence independent single primer amplification (SISPA) followed by geno-typing microarray offers an attractive unbiased approach to FMDV characterization. Here we describe a custom FMDV microarray and a companion feature and template-assisted assembler software (FAT-assembler) capable of resolving virus genome sequence using a moderate number of conserved microarray features. The results demonstrate that this approach may be used to rapidly characterize naturally occurring FMDV as well as an engineered chimeric strain of FMDV. The FAT-assembler, while applied to resolving FMDV genomes, represents a new bioinformatics approach that should be broadly applicable to interpreting microarray genotyping data for other viruses or target organisms.	[Barrette, Roger W.; Grau, Frederic R.; Mclntosh, Michael T.] USDA, Anim & Plant Hlth Inspect Serv, Foreign Anim Dis Diagnost Lab, Plum Isl Anim Dis Ctr, Orient, NY 11957 USA; [Rowland, Jessica M.] Univ Florida, Emerging Pathogens Inst, Dept Environm & Global Hlth, Gainesville, FL USA	United States Department of Agriculture (USDA); State University System of Florida; University of Florida	Barrette, RW (corresponding author), USDA, Anim & Plant Hlth Inspect Serv, Foreign Anim Dis Diagnost Lab, Plum Isl Anim Dis Ctr, Orient, NY 11957 USA.	roger.w.barrette@aphis.usda.gov			USDA APHIS; Science and Technology Directorate of the U.S. Department of Homeland Security [HSHQDC-08-X-00501, HSHQDC-10-X-00133]	USDA APHIS(United States Department of Agriculture (USDA)); Science and Technology Directorate of the U.S. Department of Homeland Security(United States Department of Homeland Security (DHS))	FMDV genotyping features exist as a subset of a larger panviral microarray supported by the USDA APHIS and interagency agreements with the Science and Technology Directorate of the U.S. Department of Homeland Security (awards HSHQDC-08-X-00501 and HSHQDC-10-X-00133).	Baner J, 2007, J VIROL METHODS, V143, P200, DOI 10.1016/j.jviromet.2007.03.004; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Berthet N, 2013, J CLIN VIROL, V56, P238, DOI 10.1016/j.jcv.2012.10.022; Berthet N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015243; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Domingo E, 2002, COMP IMMUNOL MICROB, V25, P297, DOI 10.1016/S0147-9571(02)00027-9; Jack PJM, 2009, VET MICROBIOL, V133, P145, DOI 10.1016/j.vetmic.2008.05.030; Lung O, 2011, J VIROL METHODS, V175, P236, DOI 10.1016/j.jviromet.2011.05.023; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; RIEDER E, 1994, J VIROL, V68, P7092, DOI 10.1128/JVI.68.11.7092-7098.1994; Sobrino F, 2001, VET RES, V32, P1, DOI 10.1051/vetres:2001106; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Warrington JA, 2002, HUM MUTAT, V19, P402, DOI 10.1002/humu.10075	14	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0166870	10.1371/journal.pone.0166870	http://dx.doi.org/10.1371/journal.pone.0166870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045937	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300005
J	Goh, LL; Lim, CW; Sim, WC; Toh, LX; Leong, KP				Goh, Liuh Ling; Lim, Chia Wei; Sim, Wey Cheng; Toh, Li Xian; Leong, Khai Pang			Analysis of Genetic Variation in CYP450 Genes for Clinical Implementation	PLOS ONE			English	Article							CONSORTIUM CPIC GUIDELINES; GENOMIC MEDICINE; CYP2D6 GENOTYPE; CODEINE THERAPY; PHARMACOGENETICS; CYTOCHROME-P450; POLYMORPHISMS; METABOLISM; WARFARIN; ENZYMES	Background Genetic determinants of drug response remain stable throughout life and offer great promise to patient-tailored drug therapy. The adoption of pharmacogenetic (PGx) testing in patient care requires accurate, cost effective and rapid genotyping with clear guidance on the use of the results. Hence, we evaluated a 32 SNPs panel for implementing PGx testing in clinical laboratories. Methods We designed a 32-SNP panel for PGx testing in clinical laboratories. The variants were selected using the clinical annotations of the Pharmacogenomics Knowledgebase (PharmGKB) and include polymorphisms of CYP2C9, CYP2C19, CYP2D6, CYP3A5 and VKORC1 genes. The CYP2D6 gene allele quantification was determined simultaneously with TaqMan copy number assays targeting intron 2 and exon 9 regions. The genotyping results showed high call rate accuracy according to concordance with genotypes identified by independent analyses on Sequenome massarray and droplet digital PCR. Furthermore, 506 genomic samples across three major ethnic groups of Singapore (Malay, Indian and Chinese) were analysed on our workflow. Results We found that 98% of our study subjects carry one or more CPIC actionable variants. The major alleles detected include CYP2C9*3, CYP2C19*2, CYP2D6*10, CYP2D6*36, CYP2D6*41, CYP3A5*3 and VKORC1*2. These translate into a high percentage of intermediate (IM) and poor metabolizer (PM) phenotypes for these genes in our population. Conclusion Genotyping may be useful to identify patients who are prone to drug toxicity with standard doses of drug therapy in our population. The simplicity and robustness of this PGx panel is highly suitable for use in a clinical laboratory.	[Goh, Liuh Ling; Lim, Chia Wei; Sim, Wey Cheng; Toh, Li Xian; Leong, Khai Pang] Tan Tock Seng Hosp, Clin Res & Innovat Off, TTSH Res Lab, Singapore, Singapore; [Leong, Khai Pang] Tan Tock Seng Hosp, Dept Rheumatol Allergy & Immunol, Singapore, Singapore	Tan Tock Seng Hospital; Tan Tock Seng Hospital	Toh, LX (corresponding author), Tan Tock Seng Hosp, Clin Res & Innovat Off, TTSH Res Lab, Singapore, Singapore.	grace_lx_toh@ttsh.com.sg			Singapore National Medical Research Council [NMRC/CG/017/2013]	Singapore National Medical Research Council(National Medical Research Council, Singapore)	This work is supported by the research fund from the Singapore National Medical Research Council (NMRC/CG/017/2013). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the research fund from the Singapore National Medical Research Council (NMRC/CG/017/2013) and the authors appreciate the team for recruiting the healthy control samples for this study.	Birdwell KA, 2015, CLIN PHARMACOL THER, V98, P19, DOI 10.1002/cpt.113; Brunham LR, 2014, PHARMACOGENOMICS J, V14, P555, DOI 10.1038/tpj.2014.22; Chanakira M, 2012, INT J APPL BEHAV ECO, V1, P1, DOI 10.4018/ijabe.2012040101; Crews KR, 2012, CLIN PHARMACOL THER, V91, P321, DOI 10.1038/clpt.2011.287; Crews KR, 2015, CLIN CHEM, V61, P775, DOI 10.1373/clinchem.2014.237412; Furge LL, 2006, BIOCHEM MOL BIOL EDU, V34, P66, DOI 10.1002/bmb.2006.49403402066; Furuta Takahisa, 2005, Drug Metab Pharmacokinet, V20, P153, DOI 10.2133/dmpk.20.153; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Gurbel PA, 2010, J THROMB HAEMOST, V8, P43, DOI 10.1111/j.1538-7836.2009.03648.x; Hicks JK, 2015, CLIN PHARMACOL THER, V98, P127, DOI 10.1002/cpt.147; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Ingelman-Sundberg M, 2004, TRENDS PHARMACOL SCI, V25, P193, DOI 10.1016/j.tips.2004.02.007; Ji Y, 2016, J MOL DIAGN, V18, P438, DOI 10.1016/j.jmoldx.2016.01.003; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; KIMURA S, 1989, AM J HUM GENET, V45, P889; Lamba JK, 2002, ADV DRUG DELIVER REV, V54, P1271, DOI 10.1016/S0169-409X(02)00066-2; Lim JSL, 2011, BRIT J CLIN PHARMACO, V71, P737, DOI 10.1111/j.1365-2125.2011.03905.x; Ramamoorthy A, 2010, PHARMACOGENET GENOM, V20, P451, DOI 10.1097/FPC.0b013e32833a1083; Relling MV, 2015, NATURE, V526, P343, DOI 10.1038/nature15817; Scott SA, 2013, CLIN PHARMACOL THER, V94, P317, DOI 10.1038/clpt.2013.105; Sim SC, 2013, PHARMACOGENOMICS J, V13, P1, DOI 10.1038/tpj.2012.45; Sim Sarah C, 2013, Methods Mol Biol, V987, P251, DOI 10.1007/978-1-62703-321-3_21; Sistonen J, 2005, CLIN CHEM, V51, P1291, DOI 10.1373/clinchem.2004.046466; Tan DSY, 2014, INT J CARDIOL, V171, pE21, DOI 10.1016/j.ijcard.2013.11.126; Thorn CF, 2012, PHARMACOGENET GENOM, V22, P466, DOI 10.1097/FPC.0b013e32834aeedb; van der Weide J, 1999, ANN CLIN BIOCHEM, V36, P722, DOI 10.1177/000456329903600604; Wadelius M, 2007, PHARMACOGENOMICS J, V7, P99, DOI 10.1038/sj.tpj.6500417; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600; Weinshilboum RM, 2006, ANNU REV GENOM HUM G, V7, P223, DOI 10.1146/annurev.genom.6.080604.162315; Wu AC, 2008, CLIN PHARMACOL THER, V84, P272, DOI 10.1038/clpt.2008.127; Zhou SF, 2009, CLIN PHARMACOKINET, V48, P689, DOI 10.2165/11318030-000000000-00000	31	46	49	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169233	10.1371/journal.pone.0169233	http://dx.doi.org/10.1371/journal.pone.0169233			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046094	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300150
J	Huynh, E; Coroller, TP; Narayan, V; Agrawal, V; Romano, J; Franco, I; Parmar, C; Hou, Y; Mak, RH; Aerts, HJWL				Huynh, Elizabeth; Coroller, Thibaud P.; Narayan, Vivek; Agrawal, Vishesh; Romano, John; Franco, Idalid; Parmar, Chintan; Hou, Ying; Mak, Raymond H.; Aerts, Hugo J. W. L.			Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT	PLOS ONE			English	Article							STEREOTACTIC BODY RADIOTHERAPY; PROSPECTIVE PHASE-II; RADIATION-THERAPY; EARLY-STAGE; COMPUTED-TOMOGRAPHY; FEATURES; OUTCOMES; VARIABILITY; CARCINOMA; TEXTURE	Radiomics aims to quantitatively capture the complex tumor phenotype contained in medical images to associate them with clinical outcomes. This study investigates the impact of different types of computed tomography (CT) images on the prognostic performance of radiomic features for disease recurrence in early stage non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiation therapy (SBRT). 112 early stage NSCLC patients treated with SBRT that had static free breathing (FB) and average intensity projection (AIP) images were analyzed. Nineteen radiomic features were selected from each image type (FB or AIP) for analysis based on stability and variance. The selected FB and AIP radiomic feature sets had 6 common radiomic features between both image types and 13 unique features. The prognostic performances of the features for distant metastasis (DM) and locoregional recurrence (LRR) were evaluated using the concordance index (CI) and compared with two conventional features (tumor volume and maximum diameter). P-values were corrected for multiple testing using the false discovery rate procedure. None of the FB radiomic features were associated with DM, however, seven AIP radiomic features, that described tumor shape and heterogeneity, were (CI range: 0.638-0.676). Conventional features from FB images were not associated with DM, however, AIP conventional features were (CI range: 0.643-0.658). Radiomic and conventional multivariate models were compared between FB and AIP images using cross validation. The differences between the models were assessed using a permutation test. AIP radiomic multivariate models (median CI = 0.667) outperformed all other models (median CI range: 0.601-0.630) in predicting DM. None of the imaging features were prognostic of LRR. Therefore, image type impacts the performance of radiomic models in their association with disease recurrence. AIP images contained more information than FB images that were associated with disease recurrence in early stage NSCLC patients treated with SBRT, which suggests that AIP images may potentially be more optimal for the development of an imaging biomarker.	[Huynh, Elizabeth; Coroller, Thibaud P.; Narayan, Vivek; Agrawal, Vishesh; Romano, John; Franco, Idalid; Parmar, Chintan; Hou, Ying; Mak, Raymond H.; Aerts, Hugo J. W. L.] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Aerts, Hugo J. W. L.] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	Huynh, E (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA.	ehuynh@lroc.harvard.edu	Aerts, Hugo/P-6350-2015; Aerts, Hugo/ABF-2821-2020; parmar, chintan/J-2977-2019	Aerts, Hugo/0000-0002-2122-2003; Aerts, Hugo/0000-0002-2122-2003; parmar, chintan/0000-0002-2140-814X; Mak, Raymond/0000-0002-8754-0565	National Institute of Health [NIH-USA U24CA194354, NIH-USA U01CA190234]; Kaye Scholar Award; Brigham and Women's Hospital Department of Radiation Oncology Clinical Translational Grant; Varian Medical Research Collaborations	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kaye Scholar Award; Brigham and Women's Hospital Department of Radiation Oncology Clinical Translational Grant; Varian Medical Research Collaborations	Authors acknowledge financial support from the National Institute of Health (NIH-USA U24CA194354, and NIH-USA U01CA190234). This project was partially funded by the Kaye Scholar Award, the Brigham and Women's Hospital Department of Radiation Oncology Clinical Translational Grant and Varian Medical Research Collaborations. The study sponsors had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Baumann P, 2009, J CLIN ONCOL, V27, P3290, DOI 10.1200/JCO.2008.21.5681; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen YS, 2008, RADIOTHER ONCOL, V88, P351, DOI 10.1016/j.radonc.2008.07.013; Cheng NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150509; Chi A, 2010, RADIOTHER ONCOL, V94, P1, DOI 10.1016/j.radonc.2009.12.008; Christensen JD, 2015, CLIN CHEST MED, V36, P147, DOI 10.1016/j.ccm.2015.02.002; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Coroller TP, 2015, RADIOTHER ONCOL, V114, P345, DOI 10.1016/j.radonc.2015.02.015; Coroller TP, 2016, RADIOTHER ONCOL; Crino L, 2010, ANN ONCOL, V21, pv103, DOI 10.1093/annonc/mdq207; Cunliffe A, 2015, INT J RADIAT ONCOL, V91, P1048, DOI 10.1016/j.ijrobp.2014.11.030; Fakiris AJ, 2009, INT J RADIAT ONCOL, V75, P677, DOI 10.1016/j.ijrobp.2008.11.042; Fave X, 2015, COMPUT MED IMAG GRAP, V44, P54, DOI 10.1016/j.compmedimag.2015.04.006; Gamer M, 2012, IRR VARIOUS COEFFICI; Grills IS, 2010, J CLIN ONCOL, V28, P928, DOI 10.1200/JCO.2009.25.0928; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Huang YQ, 2016, J CLIN ONCOL, V34, P2157, DOI 10.1200/JCO.2015.65.9128; Husson F, 2015, FACTOMINER MULTIVARI; Huynh E, 2016, RADIOTHER ONCOL; Jameson JL, 2015, NEW ENGL J MED, V372, P2229, DOI 10.1056/NEJMsb1503104; Jia Wu, 2016, RADIOLOGY; Kramer GM, 2016, MOL IMAGING BIOL; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Li H, 2016, RADIOLOGY, V281, P382, DOI 10.1148/radiol.2016152110; Lo A, 2015, P NATL ACAD SCI USA, V112, P13892, DOI 10.1073/pnas.1518285112; Mackin D, 2015, INVEST RADIOL, V50, P757, DOI 10.1097/RLI.0000000000000180; Mak RH, 2015, CLIN LUNG CANCER, V16, P24, DOI 10.1016/j.cllc.2014.09.005; Nie K, 2016, CLIN CANC RES; Onishi H, 2004, CANCER-AM CANCER SOC, V101, P1623, DOI 10.1002/cncr.20539; Pan H, 2011, CANCER-AM CANCER SOC, V117, P4566, DOI 10.1002/cncr.26067; Parmar C, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00272; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11044; Pieper S, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P632; Rietzel E, 2005, MED PHYS, V32, P874, DOI 10.1118/1.1869852; Schroder MS, 2011, BIOINFORMATICS, V27, P3206, DOI 10.1093/bioinformatics/btr511; Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306; Solda F, 2013, RADIOTHER ONCOL, V109, P1, DOI 10.1016/j.radonc.2013.09.006; Steck H., 2008, ADV NEURAL INFORM PR, P1209; Team RC, 2015, R LANG ENV STAT COMP; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Yip SSF, 2016, PHYS MED BIOL, V61, P906, DOI 10.1088/0031-9155/61/2/906; Zhao BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23428; Zhao BS, 2009, RADIOLOGY, V252, P263, DOI 10.1148/radiol.2522081593; Zinn PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025451	46	58	61	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169172	10.1371/journal.pone.0169172	http://dx.doi.org/10.1371/journal.pone.0169172			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046060	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300135
J	Li, C; Ni, J; Liu, YX; Wang, H; Liang, ZQ; Wang, X				Li, Chao; Ni, Juan; Liu, Yao-Xian; Wang, Han; Liang, Zi-Qing; Wang, Xu			Response of MiRNA-22-3p and MiRNA-149-5p to Folate Deficiency and the Differential Regulation of MTHFR Expression in Normal and Cancerous Human Hepatocytes	PLOS ONE			English	Article							TUMOR SUPPRESSIVE ROLE; HEPATOCELLULAR-CARCINOMA; DIETARY-FOLATE; URACIL MISINCORPORATION; MICRORNA EXPRESSION; CELL-PROLIFERATION; COLORECTAL-CANCER; PERIPHERAL-BLOOD; OXIDATIVE STRESS; GASTRIC-CANCER	Background/Aims Folic acid (FA) is a core micronutrient involved in DNA synthesis/methylation, and the metabolism of FA is responsible for genomic stability. MicroRNAs may affect gene expression during folate metabolism when cellular homeostasis is changed. This study aimed to reveal the relationship between FA deficiency and the expression of miR-22-p/miR-149-5p and the targeted regulation of miR-22-3p/miR-149-5p on the key folate metabolic gene Methylenetetrahydrofolate reductase (MTHFR). Methods Normal (HL-7702 cells) and cancerous (QGY-7703 cells) human hepatocytes were intervened in modified RPMI 1640 with FA deficiency for 21 days. The interaction between MTHFR and the tested miRNAs was verified by Dual-Luciferase Reporter Assays. The changes in the expression of miR-22-3p/miR-149-5p in response to FA deficiency were detected by Poly (A) Tailing RT-qPCR, and the expression of MTHFR at both the transcriptional and translational levels was determined by RT-qPCR and Western blotting, respectively. Result MiR-22-3p/miR-149-5p directly targeted the 3'UTR sequence of the MTHFR gene. FA deficiency led to an upregulation of miR-22-3p/miR-149-5p expression in QGY-7703/HL-7702 cells, while the transcription of MTHFR was decreased in QGY-7703 cells but elevated in HL-7702 cells. Western blotting showed that FA deficiency resulted in a decline of the MTHFR protein in QGY-7703 cells, whereas in HL-7702 cells, the MTHFR protein level remained constant. Conclusion The results suggested that miR-22-3p/miR-149-5p exert different post-transcriptional effects on MTHFR under conditions of FA deficiency in normal and cancerous human hepatocytes. The results also implied that miR-22-3p/miR-149-5p might exert anticancer effects in cases of long-term FA deficiency.	[Li, Chao; Ni, Juan; Liu, Yao-Xian; Wang, Han; Liang, Zi-Qing; Wang, Xu] Yunnan Normal Univ, Sch Life Sci, Engn Res Ctr Sustainable Dev & Utilizat Biomass E, Minist Educ, Kunming, Yunnan, Peoples R China	Yunnan Normal University	Wang, X (corresponding author), Yunnan Normal Univ, Sch Life Sci, Engn Res Ctr Sustainable Dev & Utilizat Biomass E, Minist Educ, Kunming, Yunnan, Peoples R China.	wangxu@fudan.edu.cn		Li, Chao/0000-0002-1900-8008	National Natural Science Foundation of China [31260268, 31560307]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 31260268; 31560307).; This work was supported by the National Natural Science Foundation of China (NO. 31260268; 31560307). We appreciate the technical support from Prof. Yong-Tang Zheng and Dr. Rong-Hua Luo, at the Kunming Institute of Zoology, CAS, Kunming, China.	Al-Ejeh F, 2010, ONCOGENE, V29, P6085, DOI 10.1038/onc.2010.407; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Bull CF, 2014, CANCER PREV RES, V7, P128, DOI 10.1158/1940-6207.CAPR-13-0264; Burr NE, 2016, J CLIN GASTROENTEROL; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Cartron PF, 2012, EUR J CANCER, V48, P2431, DOI 10.1016/j.ejca.2012.01.002; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chen QY, 2015, CELL PHYSIOL BIOCHEM, V36, P622, DOI 10.1159/000430125; Chern CL, 2001, BIOMED PHARMACOTHER, V55, P434, DOI 10.1016/S0753-3322(01)00095-6; Ding XL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002729; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Ghattas M, 2014, MOL BIOL REP, V41, P683, DOI 10.1007/s11033-013-2906-7; GHOSHAL AK, 1987, CANCER LETT, V36, P289, DOI 10.1016/0304-3835(87)90022-X; GHOSHAL AK, 1993, LAB INVEST, V68, P255; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Ho CT, 2015, ONCOTARGET; Holmes MV, 2011, LANCET, V378, P584, DOI 10.1016/S0140-6736(11)60872-6; Huang RFS, 2001, J NUTR, V131, P33, DOI 10.1093/jn/131.1.33; Izquierdo L, 2014, BJU INT, V113, P813, DOI 10.1111/bju.12551; James SJ, 2003, J NUTR, V133, p3740S, DOI 10.1093/jn/133.11.3740S; Jia HJ, 2016, MINERVA MED, V107, P259; Jiang X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11452; Kim YI, 2007, MOL NUTR FOOD RES, V51, P267, DOI 10.1002/mnfr.200600191; Koturbash I, 2013, MOL CARCINOGEN, V52, P318, DOI 10.1002/mc.21861; Koufaris C, 2016, ONCOGENE, V35, P2766, DOI 10.1038/onc.2015.333; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kuo CS, 2008, BRIT J NUTR, V100, P596, DOI 10.1017/S0007114508911557; Kuo CS, 2014, MOL NUTR FOOD RES, V58, P329, DOI 10.1002/mnfr.201200479; Li M, 2015, J BIOL CHEM, V290, P19541, DOI 10.1074/jbc.A115.410405; Li SR, 2014, MOL MED REP, V9, P2393, DOI 10.3892/mmr.2014.2123; Lin L, 2016, TUMOUR BIOL J INT SO; Liu XX, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/276410; Liu ZH, 2007, J NUTR, V137, P2701, DOI 10.1093/jn/137.12.2701; Lu XD, 2015, EXP THER MED, V10, P1829, DOI 10.3892/etm.2015.2758; Lubecka-Pietruszewska K, 2013, BIOCHEM BIOPH RES CO, V430, P623, DOI 10.1016/j.bbrc.2012.11.103; Luo G, 2015, ONCOTARGET, V6, P37808, DOI 10.18632/oncotarget.5676; Melnyk S, 1999, CANCER LETT, V146, P35, DOI 10.1016/S0304-3835(99)00213-X; Mikael LG, 2013, MOL NUTR FOOD RES, V57, P661, DOI 10.1002/mnfr.201200152; Ni J, 2010, ENVIRON MOL MUTAGEN, V51, P15, DOI 10.1002/em.20502; POGRIBNY IP, 1995, CANCER RES, V55, P1894; Pogribny IP, 1997, CANCER LETT, V115, P31, DOI 10.1016/S0304-3835(97)04708-3; Qi YH, 2014, CLIN RES HEPATOL GAS, V38, P172, DOI 10.1016/j.clinre.2013.10.002; Saadi H, 2015, BIOCHIMIE, V118, P44, DOI 10.1016/j.biochi.2015.07.024; Shane B, 2008, FOOD NUTR BULL, V29, pS5, DOI 10.1177/15648265080292S103; Shi CL, 2013, BIOMED PHARMACOTHER, V67, P375, DOI 10.1016/j.biopha.2013.03.002; Song SJ, 2014, CELL CYCLE, V13, P11, DOI 10.4161/cc.27027; Starlard-Davenport A, 2010, WORLD REV NUTR DIET, V101, P123, DOI 10.1159/000314517; Stone N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021851; Su Y, 2016, ONCOTARGET; Tannapfel A, 2006, PATHOLOGE, V27, P284, DOI 10.1007/s00292-006-0837-y; VARELAMOREIRAS G, 1992, J NUTR, V122, P986, DOI 10.1093/jn/122.4.986; Verhaar MC, 1998, CIRCULATION, V97, P237, DOI 10.1161/01.CIR.97.3.237; Wan WN, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0178-8; Welzel TM, 2007, CANCER EPIDEM BIOMAR, V16, P1279, DOI 10.1158/1055-9965.EPI-06-0853; Weng WH, 2011, BIOCHEM BIOPH RES CO, V405, P278, DOI 10.1016/j.bbrc.2011.01.028; Wu C, 2013, NUTR METAB CARDIOVAS, V23, P693, DOI 10.1016/j.numecd.2012.02.009; Wu JT, 2015, INT J CLIN EXP MED, V8, P13628; Xin M, 2016, ONCOTARGET; Xu Q, 2015, MUTAT RES-REV MUTAT, V763, P148, DOI 10.1016/j.mrrev.2014.09.004; Xu QF, 2014, BRAIN PATHOL, V24, P568, DOI 10.1111/bpa.12136; Yang C, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0138-0; Yang F, 2015, J BIOL CHEM, V290, P6507, DOI 10.1074/jbc.M114.620369; Yang M, 2016, BIOL CHEM; Yu MC, 2008, J GASTROEN HEPATOL, V23, pS92, DOI 10.1111/j.1440-1746.2007.05293.x; Zekri AN, 2016, TUMOUR BIOL J INT SO; Zhang H, 2015, TUMOR BIOL, V36, P997, DOI 10.1007/s13277-014-2725-z; Zhang HH, 2015, CANCER LETT, V356, P781, DOI 10.1016/j.canlet.2014.10.029; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895; Zhang YQ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-253; Zhou L, 2013, J INT MED RES, V41, P1009, DOI 10.1177/0300060513484436; Zuo QF, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.297	75	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168049	10.1371/journal.pone.0168049	http://dx.doi.org/10.1371/journal.pone.0168049			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045918	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300013
J	Li, D; Zhang, L; Zuo, L; Jin, CG; Li, WG; Chen, JB				Li, Duo; Zhang, Ling; Zuo, Li; Jin, Cheng Gang; Li, Wen Ge; Chen, Jin-Bor			Association of CKD-MBD Markers with All-Cause Mortality in Prevalent Hemodialysis Patients: A Cohort Study in Beijing	PLOS ONE			English	Article							PERITONEAL-DIALYSIS PATIENTS; MINERAL METABOLISM; PARATHYROID-HORMONE; SECONDARY HYPERPARATHYROIDISM; MAINTENANCE HEMODIALYSIS; VASCULAR CALCIFICATION; BONE-DISEASE; SURVIVAL; CALCIUM; PHOSPHORUS	The relationships between all-cause mortality and serum intact parathyroid hormone (iPTH), calcium, and phosphate are fairly diverse in patients on maintenance hemodialysis according to prior studies. This study evaluated the association of chronic kidney disease-mineral and bone disorder (CKD-MBD) markers with all-cause mortality in prevalent hemodialysis patients from 2007 to 2012 in Beijing, China. A cohort, involving 8530 prevalent hemodialysis patients who had undergone a 6-70 months follow-up program (with median as 40 months) was formed. Related data was recorded from the database in 120 hemodialysis centers of Beijing Health Bureau (2007 to 2012). Information regarding baseline demographics, blood CKD-MBD markers and all-cause mortality was retrospectively reviewed. By using multivariate Cox regression model analysis, patients with a low iPTH level at baseline were found to have greater risk of mortality (< 75pg/ml, HR = 1.36, 95% confidence interval (CI) 1.16-1.60) than those with a baseline iPTH level within 150-300 pg/ml. Similarly, death risk showed an increase when the baseline serum calcium presented a low level (<2.1mmol/L, HR = 1.54; 95% CI 1.37-1.74). Levels of baseline serum phosphorus were not associated with the risk of death. Similar results appeared through the baseline competing risks regression analysis. Patients with a lower level of serum iPTH or calcium are at a higher risk of all-cause mortality compared with those within the range recommended by Kidney Disease Outcome Quality Initiative (KDOQI) guidelines.	[Li, Duo] Wenzhou Med Univ, Dept Nephrol, Affiliated Hosp 1, Wenzhou, Peoples R China; [Zhang, Ling; Li, Wen Ge] China Japan Friendship Hosp, Dept Nephrol, Beijing, Peoples R China; [Zuo, Li] Peking Univ, Peoples Hosp, Dept Nephrol, Beijing, Peoples R China; [Jin, Cheng Gang] Beijing Normal Univ, Sch Social Dev & Publ Policy, Beijing 100875, Peoples R China; [Chen, Jin-Bor] Kaohsiung Chang Gung Mem Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Jin-Bor] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Wenzhou Medical University; China-Japan Friendship Hospital; Peking University; Beijing Normal University; Chang Gung Memorial Hospital; Chang Gung University	Zhang, L (corresponding author), China Japan Friendship Hosp, Dept Nephrol, Beijing, Peoples R China.	zhangling5@medmail.com.cn			Ten Major Diseases in the Capital of Science and Technology Promotion Project, Beijing Municipal Science and Technology Commission Program [Z151100004015244]	Ten Major Diseases in the Capital of Science and Technology Promotion Project, Beijing Municipal Science and Technology Commission Program	The study was supported by the Ten Major Diseases in the Capital of Science and Technology Promotion Project, Beijing Municipal Science and Technology Commission Program, Grant No.Z151100004015244. URL http://www.bjkw.gov.cn/n8785584/n8904761/index.html. The funders play a role in study design, data collection and analysis.	Avram MM, 2001, AM J KIDNEY DIS, V38, P1351, DOI 10.1053/ajkd.2001.29254; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Chen JB, 2016, AM J SURG, DOI [10.1038/sj.bjc.6602102, DOI 10.1038/SJ.BJC.6602102]; Cheng XY, 2013, NEPHROL DIAL TRANSPL, V28, P724, DOI 10.1093/ndt/gfs326; Coen G, 2008, KIDNEY INT, V74, P1229, DOI 10.1038/ki.2008.417; Floege J, 2011, NEPHROL DIAL TRANSPL, V26, P1948, DOI 10.1093/ndt/gfq219; Fouque D, 2013, NEPHROL DIAL TRANSPL, V28, P360, DOI 10.1093/ndt/gfs404; Fukagawa M, 2014, AM J KIDNEY DIS, V63, P979, DOI 10.1053/j.ajkd.2013.08.011; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Kim SC, 2011, NEPHRON CLIN PRACT, V117, pC113, DOI 10.1159/000319658; Komaba H, 2015, KIDNEY INT, V88, P350, DOI 10.1038/ki.2015.72; Liu ZH, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0132-3; Naves-Diaz M, 2011, NEPHROL DIAL TRANSPL, V26, P1938, DOI 10.1093/ndt/gfq304; Neves KR, 2007, KIDNEY INT, V71, P1262, DOI 10.1038/sj.ki.5002241; Sarnak MJ, 2000, AM J KIDNEY DIS, V35, pS117, DOI 10.1016/S0272-6386(00)70239-3; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Wald R, 2008, AM J KIDNEY DIS, V52, P531, DOI 10.1053/j.ajkd.2008.05.020; Wang AYM, 2003, J AM SOC NEPHROL, V14, P159, DOI 10.1097/01.ASN.0000038685.95946.83; Zuo L, 2006, ETHN DIS S2, V16	20	12	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168537	10.1371/journal.pone.0168537	http://dx.doi.org/10.1371/journal.pone.0168537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045985	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300029
J	Ma, XY; Zhu, LJ; Wu, X; Bao, H; Wang, XN; Chang, ZL; Sheo, YW; Wang, ZX				Ma, Xiangyuan; Zhu, Liangjun; Wu, Xue; Bao, Hua; Wang, Xiaonan; Chang, Zhili; Sheo, Yang W.; Wang, Zhenxin			Cell-Free DNA Provides a Good Representation of the Tumor Genome Despite Its Biased Fragmentation Patterns	PLOS ONE			English	Article							PLASMA DNA; ACQUIRED-RESISTANCE; CIRCULATING DNA; CANCER-PATIENTS; QUANTIFICATION; ABERRATIONS; INHIBITION; EVOLUTION; BIOPSIES; ORIGIN	Cell-free DNA (cfDNA) is short, extracellular, fragmented double-stranded DNA found in plasma. Plasma of patients with solid tumor has been found to show significantly increased quantities of cfDNA. Although currently poorly understood, the mechanism of cfDNA generation is speculated to be a product of genomic DNA fragmentation during cellular apoptosis and necrosis. Sequencing of cfDNA with tumor origin has identified tumor biomarkers, elucidating molecular pathology and assisting in accurate diagnosis. In this study, we performed whole-genome sequencing ofcfDNA samples with matching tumor and whole blood samples from five patients diagnosed with stage IV gastric or lung cancer. We analyzed the coverage spectrum of the human genome in our cfDNA samples. cfDNA exhibited no large regions with significant under-coverage, although we observed unbalanced coverage depth in cfDNA at transcription start sites and exon boundaries as a consequence of biased fragmentation due to ordered nucleosome positioning. We also analyzed the copy number variant status based on the whole-genome sequencing results and found high similarity between copy number profile constructed from tumor samples and cfDNA samples. Overall, we conclude that cfDNA comprises a good representation of the tumor genome in late stage gastric and lung cancer.	[Ma, Xiangyuan; Wu, Xue; Bao, Hua; Sheo, Yang W.] Geneseeq Technology Inc, MaRS Ctr, Suite 300,S Tower, Toronto, ON, Canada; [Zhu, Liangjun] Jiangsu Canc Hosp, 42 Baiziting, Nanjing, Jiangsu, Peoples R China; [Wang, Xiaonan; Chang, Zhili] Nanjing Shihe Jiyin Biotechnol Inc, 17th Floor,Bldg B,Sinodanish Life Sci Pk, Nanjing, Jiangsu, Peoples R China; [Wang, Zhenxin] Soochow Univ, Affiliated Hosp 1, Dept Med Oncol, Suzhou, Jiangsu, Peoples R China	University of Toronto; Nanjing Medical University; Soochow University - China	Sheo, YW (corresponding author), Geneseeq Technology Inc, MaRS Ctr, Suite 300,S Tower, Toronto, ON, Canada.; Wang, ZX (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Med Oncol, Suzhou, Jiangsu, Peoples R China.	yang.shao@geneseeq.com; zhenxw316@163.com			Geneseeq Technology Inc.; Nanjing Shihe Jiyin Biotechnology Inc.	Geneseeq Technology Inc.; Nanjing Shihe Jiyin Biotechnology Inc.	Geneseeq Technology Inc. and Nanjing Shihe Jiyin Biotechnology Inc. provided support in the form of salaries for authors XM, X. Wu, HB, X. Wang, ZC, and YWS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author Contributions" section.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Anker P, 1999, CANCER METAST REV, V18, P65, DOI 10.1023/A:1006260319913; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boni L, 2007, SURG ONCOL, V16, pS29, DOI 10.1016/j.suronc.2007.10.004; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Burrell RA, 2014, CURR OPIN GENET DEV, V24, P61, DOI 10.1016/j.gde.2013.11.011; Catarino R, 2008, DNA CELL BIOL, V27, P415, DOI 10.1089/dna.2008.0744; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Chang CPY, 2003, CLIN CHIM ACTA, V327, P95, DOI 10.1016/S0009-8981(02)00337-6; Chang HW, 2002, JNCI-J NATL CANCER I, V94, P1697; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; De Mattos-Arruda L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9839; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Galeazzi M, 2003, AUTOIMMUN REV, V2, P50, DOI 10.1016/S1568-9972(02)00101-5; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm434; Jahr S, 2001, CANCER RES, V61, P1659; Jiang PY, 2015, P NATL ACAD SCI USA, V112, pE1317, DOI 10.1073/pnas.1500076112; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Lee J, 2014, CLIN GENET, V86, P37, DOI 10.1111/cge.12408; LEON SA, 1977, CANCER RES, V37, P646; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu K, 2015, ONCOL LETT, V10, P2003, DOI 10.3892/ol.2015.3601; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Ma MW, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.09.29; Mouliere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023418; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Nagata S, 2003, CELL DEATH DIFFER, V10, P108, DOI 10.1038/sj.cdd.4401161; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Paci M, 2009, LUNG CANCER, V64, P92, DOI 10.1016/j.lungcan.2008.07.012; Polivka J, 2015, EXPERT REV MOL DIAGN, V15, P1631, DOI 10.1586/14737159.2015.1110021; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2021, R LANGUAGE ENV STAT; Rothe F, 2014, ANN ONCOL, V25, P1959, DOI 10.1093/annonc/mdu288; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Sugano T, 2015, MOL CANCER THER, V14, P2433, DOI 10.1158/1535-7163.MCT-15-0050; Thierry AR, 2010, NUCLEIC ACIDS RES, V38, P6159, DOI 10.1093/nar/gkq421; Underhill HR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006162; Wang BG, 2003, CANCER RES, V63, P3966; Zachariah RR, 2008, OBSTET GYNECOL, V112, P843, DOI 10.1097/AOG.0b013e3181867bc0	49	25	28	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169231	10.1371/journal.pone.0169231	http://dx.doi.org/10.1371/journal.pone.0169231			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046008	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300149
J	Peavey, MC; Reynolds, CL; Szwarc, MM; Gibbons, WE; Valdese, CT; DeMayo, FJ; Lydon, JP				Peavey, Mary C.; Reynolds, Corey L.; Szwarc, Maria M.; Gibbons, William E.; Valdese, Cecilia T.; DeMayo, Francesco J.; Lydon, John P.			Three-Dimensional High-Frequency Ultrasonography for Early Detection and Characterization of Embryo Implantation Site Development in the Mouse	PLOS ONE			English	Article							RECURRENT PREGNANCY LOSS; ULTRASOUND; GROWTH; MICE; SCIENCE; MODELS; CANCER; 3RS	Ultrasonography is a powerful tool to non-invasively monitor in real time the development of the human fetus in utero. Although genetically engineered mice have served as valuable in vivo models to study both embryo implantation and pregnancy progression, such studies usually require sacrifice of parous mice for subsequent phenotypic analysis. To address this issue, we used three-dimensional (3-D) reconstruction in silico of high-frequency ultrasound (HFUS) imaging data for early detection and characterization of murine embryo implantation sites and their development in utero. With HFUS imaging followed by 3-D reconstruction, we were able to precisely quantify embryo implantation site number and embryonic developmental progression in pregnant C57BL6J/129S mice from as early as 5.5 days post coitus (d.p.c.) through to 9.5 d.p.c. using a VisualSonics Vevo 2100 (MS550S) transducer. In addition to measurements of implantation site number, location, volume and spacing, embryo viability via cardiac activity monitoring was also achieved. A total of 12 dams were imaged with HFUS with approximately 100 embryos examined per embryonic day. For the post implantation period (5.5 to 8.5 d.p.c.), 3-D reconstruction of the gravid uterus in mesh or solid overlay format enabled visual representation in silico of implantation site location, number, spacing distances, and site volume within each uterine horn. Therefore, this short technical report describes the feasibility of using 3-D HFUS imaging for early detection and analysis of post-implantation events in the pregnant mouse with the ability to longitudinally monitor the development of these early pregnancy events in a non-invasive manner. As genetically engineered mice continue to be used to characterize female reproductive phenotypes, we believe this reliable and non-invasive method to detect, quantify, and characterize early implantation events will prove to be an invaluable investigative tool for the study of female infertility and subfertility phenotypes based on a defective uterus.	[Peavey, Mary C.; Szwarc, Maria M.; Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Peavey, Mary C.; Gibbons, William E.; Valdese, Cecilia T.] Baylor Coll Med, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Houston, TX 77030 USA; [Reynolds, Corey L.] Baylor Coll Med, Mouse Phenotyping Core, Houston, TX 77030 USA; [DeMayo, Francesco J.] NIEHS, Reprod & Dev Biol Lab, POB 12233, Res Triangle Pk, NC 27709 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Lydon, JP (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; DeMayo, FJ (corresponding author), NIEHS, Reprod & Dev Biol Lab, POB 12233, Res Triangle Pk, NC 27709 USA.	francesco.demayo@nih.gov; jlydon@bcm.tmc.edu	DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336	NIH/NICHD [RO1: HD-042311]; Burroughs Wellcome Fund; NIH [U54 HG006348]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103311] Funding Source: NIH RePORTER	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was supported by NIH/NICHD RO1: HD-042311 (to JPL) and the Burroughs Wellcome Fund (to FJD). Ultrasound imaging was conducted in the Mouse Phenotyping Core at Baylor College of Medicine with funding from the NIH (U54 HG006348). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen E, 2016, PEDIATR RES, V79, P821, DOI 10.1038/pr.2016.24; Demianczuk Nestor N, 2003, J Obstet Gynaecol Can, V25, P864; Ding YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045364; Flores LE, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-38; Franco NH, 2014, LAB ANIM-UK, V48, P50, DOI 10.1177/0023677213498717; Greco A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077205; Grotegut CA, 2016, MOL ENDOCRINOL, V30, P455, DOI 10.1210/me.2015-1147; Hirate Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep24171; Ji RP, 2003, CIRC RES, V92, P133, DOI 10.1161/01.RES.0000056532.18710.C0; Kusakabe K, 2008, FERTIL STERIL, V90, P1451, DOI 10.1016/j.fertnstert.2007.07.1331; Kutteh WH, 2015, SEMIN REPROD MED, V33, P161, DOI 10.1055/s-0035-1552586; Landi MS, 2015, J AM ASSOC LAB ANIM, V54, P224; Li SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15897; Lin Y, 2009, J REPROD IMMUNOL, V83, P95, DOI 10.1016/j.jri.2009.09.004; Liu L, 2015, CANCER LETT, V361, P147, DOI 10.1016/j.canlet.2015.02.052; Liu LJ, 2015, CANCER LETT, V356, P891, DOI 10.1016/j.canlet.2014.10.036; Mu JW, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-34; Nallasamy S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002500; Nguyen TM, 2012, LAB ANIM-UK, V46, P225, DOI 10.1258/la.2012.011117; Ni J, 2016, TRANSL ONCOL, V9, P41, DOI 10.1016/j.tranon.2015.11.011; Page JM, 2016, CLIN OBSTET GYNECOL, V59, P498, DOI 10.1097/GRF.0000000000000217; Pierce SL, 2010, PHYSIOL GENOMICS, V42, P310, DOI 10.1152/physiolgenomics.00058.2010; Pratap K, 2016, ATLA-ALTERN LAB ANIM, V44, P21, DOI 10.1177/026119291604400109; Singh S, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0091-9; Song H, 2002, DEVELOPMENT, V129, P2879; Srinivasan S, 1998, CIRCULATION, V98, P912, DOI 10.1161/01.CIR.98.9.912; THOMPSON H M, 1974, Clinical Obstetrics and Gynecology, V17, P1, DOI 10.1097/00003081-197412000-00001; Unterscheider J, 2013, AM J OBSTET GYNECOL, V208, DOI [10. 1016/j. ajog. 2013. 02. 007, DOI 10.1016/J.AJ0G.2013.02.007]; Wang TS, 2015, BIOL OPEN, V4, P893, DOI 10.1242/bio.011890; Zhang JH, 2009, COMPARATIVE MED, V59, P527	30	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169312	10.1371/journal.pone.0169312	http://dx.doi.org/10.1371/journal.pone.0169312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046063	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300164
J	Wu, WB; Ma, JY; Shao, N; Shi, YW; Liu, RM; Li, W; Lin, Y; Wang, SM				Wu, Weibin; Ma, Jieyi; Shao, Nan; Shi, Yawei; Liu, Ruiming; Li, Wen; Lin, Yin; Wang, Shenming			Co-Targeting IGF-1R and Autophagy Enhances the Effects of Cell Growth Suppression and Apoptosis Induced by the IGF-1R Inhibitor NVP-AEW541 in Triple-Negative Breast Cancer Cells	PLOS ONE			English	Article							FACTOR 1 RECEPTOR; FACTOR-I; MONOCLONAL-ANTIBODY; DRUG-RESISTANCE; INSULIN; PROLIFERATION; MIGRATION; RECURRENT; SYSTEM; KINASE	Background Triple-negative breast cancer (TNBC) is the most intractable type of breast cancer, and there is a lack of effective targeted therapy. Insulin-like growth factor-1 receptor (IGF-1R) is reportedly a potential target for TNBC treatment. However, satisfying treatment outcomes in breast cancer patients have yet to be achieved with IGF-1R-targeted agents. Methods To confirm whether inhibiting IGF-1R could induce autophagy, we detected autophagy-related proteins by western blotting and immunofluorescence staining of LC3-II. The IGF-1R inhibitor NVP-AEW541, autophagy inhibitor 3-methyladenine (3-MA) and Atg7 small interfering RNA (siRNA) were used to further investigate the effects of autophagy induced by IGF-1R inhibition in TNBC cells. The CCK8 assay, EdU assay, apoptosis and cell cycle analyses were applied to test cell function after treatment. Results NVP-AEW541 markedly induced autophagy in TNBC cells by increasing the levels of the autophagy-related protein Beclin-1 and the LC3-II/LC-I ratio and reducing the selective autophagy substrate p62. Joint application of 3-MA or Atg7 siRNA enhanced the cell growth inhibition and apoptosis effects of NVP-AEW541 by arresting cells at G1/G0 phase and increasing Bax expression and decreasing that of Bcl-2. Conclusion Targeting IGF-1R in TNBC induces cell-protective autophagy, thereby weakening the therapeutic effect of agents directed toward IGF-1R. Our findings reveal that combined use autophagy-disrupting agents can enhance the therapeutic efficacy of IGF-1R inhibitors in TNBC cells and may provide a valuable treatment strategy for IGF-1R inhibitor-based therapies for TNBC and other IGF-1 signaling-associated tumors.	[Wu, Weibin; Shao, Nan; Shi, Yawei; Lin, Yin; Wang, Shenming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Breast Surg, Guangzhou, Guangdong, Peoples R China; [Wu, Weibin; Li, Wen; Wang, Shenming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc Surg, Guangzhou, Guangdong, Peoples R China; [Ma, Jieyi; Liu, Ruiming] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Gen Surg, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Lin, Y; Wang, SM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Breast Surg, Guangzhou, Guangdong, Peoples R China.; Wang, SM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc Surg, Guangzhou, Guangdong, Peoples R China.	frostlin@hotmail.com; shenmingwang@hotmail.com	Shao, Nan/AAX-7528-2020		Guangzhou Science and Technology Plan Projects [20136021800260]	Guangzhou Science and Technology Plan Projects	This work was supported by Guangzhou Science and Technology Plan Projects (20136021800260; http://apply.gzkj.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaro A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00030; Atzori F, 2011, CLIN CANCER RES, V17, P6304, DOI 10.1158/1078-0432.CCR-10-3336; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Christopoulos PF, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0291-7; Davison Z, 2011, NEOPLASIA, V13, P504, DOI 10.1593/neo.101590; Debnath J, 2011, J MAMMARY GLAND BIOL, V16, P173, DOI 10.1007/s10911-011-9223-3; Diehm C, 2009, CIRCULATION, V120, P2053, DOI 10.1161/CIRCULATIONAHA.109.865600; Ding ZB, 2008, CANCER RES, V68, P9167, DOI 10.1158/0008-5472.CAN-08-1573; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Helen X, 2013, CHIN J CANCER, V32, P243; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hu XD, 2016, TRENDS GENET, V32, P127, DOI 10.1016/j.tig.2015.11.003; Huo YY, 2013, CANCER DISCOV, V3, P894, DOI 10.1158/2159-8290.CD-13-0011; IARC IAfcR, 2013, LAT WORLD CANC STAT; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Kim WY, 2012, CANCER-AM CANCER SOC, V118, P3993, DOI 10.1002/cncr.26656; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; Li RS, 2009, J MED CHEM, V52, P4981, DOI 10.1021/jm9002395; Libson S, 2014, INT REV PSYCHIATR, V26, P4, DOI 10.3109/09540261.2013.852971; Mancini M, 2014, BRIT J CANCER, V110, P2865, DOI 10.1038/bjc.2014.269; Maycotte P, 2014, WORLD J CLIN ONCOL, V5, P224, DOI 10.5306/wjco.v5.i3.224; Murakami H, 2012, CANCER CHEMOTH PHARM, V70, P407, DOI 10.1007/s00280-012-1924-9; Noguchi K, 2009, ADV DRUG DELIVER REV, V61, P26, DOI 10.1016/j.addr.2008.07.003; Pandini G, 1999, CLIN CANCER RES, V5, P1935; Pappo AS, 2011, J CLIN ONCOL, V29, P4541, DOI 10.1200/JCO.2010.34.0000; Rajan A, 2014, LANCET ONCOL, V15, P191, DOI 10.1016/S1470-2045(13)70596-5; Saldana SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073406; Subramani R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097016; Tomao F, 2015, ONCOTARGETS THER, V8, P177, DOI 10.2147/OTT.S67673; Wang M, 2011, ARTERIOSCL THROM VAS, V31, P2046, DOI 10.1161/ATVBAHA.111.229559; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Xu JH, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0290-9; Yang Y., 2016, BIOCH BIOPHYSICAL RE; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Zheng JH, 2015, FEBS J; Zhu XF, 2015, CELL PHYSIOL BIOCHEM, V36, P1359, DOI 10.1159/000430302	37	19	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169229	10.1371/journal.pone.0169229	http://dx.doi.org/10.1371/journal.pone.0169229			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046018	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300148
J	Pena, JJ; Adema, CM				Pena, Janeth J.; Adema, Coen M.			The Planorbid Snail Biomphalaria glabrata Expresses a Hemocyanin-Like Sequence in the Albumen Gland	PLOS ONE			English	Article							EGG MASSES; SCHISTOSOMA-MANSONI; GENE; EVOLUTION; ORIGIN; PHENOLOXIDASE; KENYA; IDENTIFICATION; TRANSMISSION; CONVERSION	The parasitic flatworm Schistosoma mansoni, causative agent of human intestinal schistosomiasis in South America, relies importantly on the freshwater snail Biomphalaria glabrata as intermediate host to achieve development of cercariae that infect humans. The recommendation from the World Health Organization (WHO) to integrate snail control in efforts to counter schistosomiasis transmission provides impetus for in depth study of B. glabrata biology. Our analysis indicates that two distinct hemocyanin-like genes (hcl-1 and hcl-2 are present in B. glabrata, a snail that uses hemoglobin for oxygen transport. Characterization of BAC clones yielded the full length hcl-1 gene, which is comprised of three functional unit (FU) domains at the amino acid level. Database searches and in silico analyses identified the second hdgene (hcl-2), composed of six FU domains. Both genes are unusual for lacking canonical residues and having fewer FU domains than typical molluscan hemocyanins that contain 7-8 FUs. Reverse transcription PCR demonstrated that Hcl-1 is expressed in a manner that correlates with reproductive maturity in the albumen gland (AG), an immune- and reproduction-relevant organ. Immune cross-reactivity with anti-keyhole limpet hemocyanin (alpha-KLH) antiserum and tandem-mass spectrometry validated the presence of Hcl-1 protein in the AG and egg mass fluid (EMF). The evolutionary conservation of hemocyanin-like sequences in B. glabrata in the presence of the oxygen carrier hemoglobin, combined with our results, suggest that the Hcl-1protein has a functional role in general and/or reproductive biology. Further investigations are needed to explore Hcl-1 as a potential target for snail control.	[Pena, Janeth J.; Adema, Coen M.] Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, MSCO3 2020, Albuquerque, NM 87131 USA	University of New Mexico	Pena, JJ (corresponding author), Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, MSCO3 2020, Albuquerque, NM 87131 USA.	jjcortez@unm.edu			NIH [IP20RR18754]; Latin American and Iberian Institute (LAII) at UNM; Alvin R. and Caroline G. Grove scholarship; Department of Biology, UNM; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060201, P30GM110907] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Latin American and Iberian Institute (LAII) at UNM; Alvin R. and Caroline G. Grove scholarship; Department of Biology, UNM; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH grant IP20RR18754. JJP recognizes the Latin American and Iberian Institute (LAII) at UNM for stipend, the Alvin R. and Caroline G. Grove scholarship, and a research scholarship from the Department of Biology, UNM.	Adema CM, 2006, MEM I OSWALDO CRUZ, V101, P167, DOI 10.1590/S0074-02762006000900027; Aguilera F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-96; Altenhein B, 2002, GENE, V301, P53, DOI 10.1016/S0378-1119(02)01081-8; Babenko VN, 2004, NUCLEIC ACIDS RES, V32, P3724, DOI 10.1093/nar/gkh686; Bai GX, 1997, COMP BIOCHEM PHYS B, V118, P463, DOI 10.1016/S0305-0491(97)00159-4; Bai GX, 1997, J PARASITOL, V83, P852, DOI 10.2307/3284280; Baron OL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003792; Bastide H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0179-y; Bergmann S, 2006, J MOL EVOL, V62, P362, DOI 10.1007/s00239-005-0160-x; Bergmann S, 2007, J MOL EVOL, V64, P500, DOI 10.1007/s00239-006-0036-8; Binggeli O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004067; Boelee E, 2004, TROP MED INT HEALTH, V9, P997, DOI 10.1111/j.1365-3156.2004.01301.x; Brugge J, 1999, AM J PHYSIOL-REG I, V276, pR347, DOI 10.1152/ajpregu.1999.276.2.R347; Bruun B, 2008, SOCIAL CONTEXT SCHIS, P1; Burmester T, 2002, J COMP PHYSIOL B, V172, P95, DOI 10.1007/s00360-001-0247-7; Burmester T, 2015, INSECT BIOCHEM MOLEC, V62, P226, DOI 10.1016/j.ibmb.2014.11.009; Cardoso-Moreira M, 2012, METHODS MOL BIOL, V856, P161, DOI 10.1007/978-1-61779-585-5_7; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Coates CJ, 2014, DEV COMP IMMUNOL, V45, P43, DOI 10.1016/j.dci.2014.01.021; Coelho PMZ, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0153-6; Decker H, 2000, TRENDS BIOCHEM SCI, V25, P392, DOI 10.1016/S0968-0004(00)01602-9; Decker H, 2007, GENE, V398, P183, DOI 10.1016/j.gene.2007.02.051; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gaze S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004033; Guillou F, 2007, DEV COMP IMMUNOL, V31, P657, DOI 10.1016/j.dci.2006.10.001; Guo DY, 2009, EXP PARASITOL, V123, P277, DOI 10.1016/j.exppara.2009.07.013; Hanington PC, 2010, INT J PARASITOL, V40, P819, DOI 10.1016/j.ijpara.2009.12.005; Hathaway JJM, 2010, DEV COMP IMMUNOL, V34, P425, DOI 10.1016/j.dci.2009.12.001; HOFKIN BV, 1991, AM J TROP MED HYG, V45, P339, DOI 10.4269/ajtmh.1991.45.339; HOFKIN BV, 1991, ACTA TROP, V49, P37, DOI 10.1016/0001-706X(91)90028-I; Jaenicke E, 2004, MICRON, V35, P89, DOI 10.1016/j.micron.2003.10.027; Jorger KM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-323; Kariuki HC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-107; Katju Vaishali, 2012, Int J Evol Biol, V2012, P341932; King CH, 2011, SCHISTOSOMIASIS CHAL, P323; Kokkinopoulou M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101078; Kondrashov FA, 2012, P ROY SOC B-BIOL SCI, V279, P5048, DOI 10.1098/rspb.2012.1108; Lieb B, 2001, P NATL ACAD SCI USA, V98, P4546, DOI 10.1073/pnas.071049998; Lieb B, 2008, MOL PHYLOGENET EVOL, V49, P382, DOI 10.1016/j.ympev.2008.06.005; Lieb B, 2006, P NATL ACAD SCI USA, V103, P12011, DOI 10.1073/pnas.0601861103; Lieb B, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-14; LING JS, 1994, J AM CHEM SOC, V116, P7682, DOI 10.1021/ja00096a027; LOKER ES, 1987, J PARASITOL, V73, P503, DOI 10.2307/3282128; Markl J, 2001, J CANCER RES CLIN, V127, pR3, DOI 10.1007/BF01470992; Markl J, 2013, BBA-PROTEINS PROTEOM, V1834, P1840, DOI 10.1016/j.bbapap.2013.02.020; Martins LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077664; MCCULLOUGH FS, 1980, B WORLD HEALTH ORGAN, V58, P681; Musuva RM, 2014, AM J TROP MED HYG, V90, P646, DOI 10.4269/ajtmh.13-0488; Mutuku MW, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0533-3; Nagai T, 2001, J BIOL CHEM, V276, P27166, DOI 10.1074/jbc.M102596200; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pick C, 2009, INSECT MOL BIOL, V18, P673, DOI 10.1111/j.1365-2583.2009.00910.x; Rapoport EH, 1969, GLOGERS RULE PIGMENT; Secor W Evan, 2015, F1000Res, V4, DOI 10.12688/f1000research.6826.1; Serafini L, 2011, COMP BIOCHEM PHYS D, V6, P322, DOI 10.1016/j.cbd.2011.07.002; Sokolow SH, 2015, P NATL ACAD SCI USA, V112, P9650, DOI 10.1073/pnas.1502651112; Sutthangkul J, 2015, J BIOL CHEM, V290, P6470, DOI 10.1074/jbc.M114.605568; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ulmer M. J., 1970, P143; WHO (World Health Organization), 2013, SCHIST PROGR REP 200; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314; Woodruff DS, 1997, BIOL J LINN SOC, V60, P505, DOI 10.1006/bijl.1996.0116; Yu X, 2014, MOL BIOL REP, V41, P5403, DOI 10.1007/s11033-014-3412-2	63	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168665	10.1371/journal.pone.0168665	http://dx.doi.org/10.1371/journal.pone.0168665			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036345	gold, Green Published, Green Submitted			2022-12-26	WOS:000391229300019
J	Price, DN; McBride, AA; Anton, M; Kusewitt, DF; Norenberg, JP; MacKenzie, DA; Thompson, TA; Muttil, P				Price, Dominique N.; McBride, Amber A.; Anton, Martina; Kusewitt, Donna F.; Norenberg, Jeffrey P.; MacKenzie, Debra A.; Thompson, Todd A.; Muttil, Pavan			Longitudinal Assessment of Lung Cancer Progression in Mice Using the Sodium Iodide Symporter Reporter Gene and SPECT/CT Imaging	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HUMAN SODIUM/IODIDE SYMPORTER; TRANSGENE EXPRESSION; ANIMAL-MODELS; MOUSE MODEL; IN-VIVO; CELLS; PET; XENOGRAFTS; METASTASES	Lung cancer has the highest mortality rate of any tissue-specific cancer in both men and women. Research continues to investigate novel drugs and therapies to mitigate poor treatment efficacy, but the lack of a good descriptive lung cancer animal model for preclinical drug evaluation remains an obstacle. Here we describe the development of an orthotopic lung cancer animal model which utilizes the human sodium iodide symporter gene (hNIS; SLC5A5) as an imaging reporter gene for the purpose of non-invasive, longitudinal tumor quantification. hNIS is a glycoprotein that naturally transports iodide (I-) into thyroid cells and has the ability to symport the radiotracer Tc-99m-pertechnetate ((TcO4-)-Tc-99m). A549 lung adenocarcinoma cells were genetically modified with plasmid or lentiviral vectors to express hNIS. Modified cells were implanted into athymic nude mice to develop two tumor models: a subcutaneous and an orthotopic xenograft tumor model. Tumor progression was longitudinally imaged using SPECT/CT and quantified by SPECT voxel analysis. hNIS expression in lung tumors was analyzed by quantitative real-time PCR. Additionally, hematoxylin and eosin staining and visual inspection of pulmonary tumors was performed. We observed that lentiviral transduction provided enhanced and stable hNIS expression in A549 cells. Furthermore, (TcO4-)-Tc-99m uptake and accumulation was observed within lung tumors allowing for imaging and quantification of tumor mass at two-time points. This study illustrates the development of an orthotopic lung cancer model that can be longitudinally imaged throughout the experimental timeline thus avoiding inter-animal variability and leading to a reduction in total animal numbers. Furthermore, our orthotopic lung cancer animal model is clinically relevant and the genetic modification of cells for SPECT/CT imaging can be translated to other tissue-specific tumor animal models.	[Price, Dominique N.; McBride, Amber A.; MacKenzie, Debra A.; Thompson, Todd A.; Muttil, Pavan] Univ New Mexico, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA; [McBride, Amber A.] Sandia Natl Labs, Albuquerque, NM USA; [Anton, Martina] Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol Expt Oncol & Therapy Res, Munich, Germany; [Kusewitt, Donna F.] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA; [Norenberg, Jeffrey P.] New Mexico Ctr Isotopes Med, Albuquerque, NM USA; [Norenberg, Jeffrey P.; Thompson, Todd A.; Muttil, Pavan] Univ New Mexico, Ctr Comprehens Canc, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; United States Department of Energy (DOE); Sandia National Laboratories; Technical University of Munich; University of New Mexico; University of New Mexico	Muttil, P (corresponding author), Univ New Mexico, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA.; Muttil, P (corresponding author), Univ New Mexico, Ctr Comprehens Canc, Albuquerque, NM 87131 USA.	pmuttil@salud.unm.edu	Norenberg, Jeffrey/AAL-1725-2021	McBride, Amber/0000-0002-4566-0382	inviCRO; Takeda; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER	inviCRO; Takeda(Takeda Pharmaceutical Company Ltd); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Norenberg has research grants sponsored by inviCRO and Takeda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers GD, 2010, J ULTRAS MED, V29, P891, DOI 10.7863/jum.2010.29.6.891; Barton KN, 2003, MOL THER, V8, P508, DOI 10.1016/S1525-0016(03)00153-9; Bengel FM, 2003, CIRCULATION, V108, P2127, DOI 10.1161/01.CIR.0000091401.26280.A0; Braber S, 2010, AM J PHYSIOL-LUNG C, V299, pL843, DOI 10.1152/ajplung.00192.2010; Brader P, 2013, J NUCL MED, V54, P167, DOI 10.2967/jnumed.111.099788; Briat Arnaud, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000044; Chen LB, 2006, NUCL MED BIOL, V33, P575, DOI 10.1016/j.nucmedbio.2006.01.011; Chung JK, 2002, J NUCL MED, V43, P1188; Dadachova E, 2004, SEMIN NUCL MED, V34, P23, DOI 10.1053/j.semnuclmed.2003.09.004; de Jong M, 2014, NAT REV CANCER, V14, P481, DOI 10.1038/nrc3751; de Kemp RA, 2010, J NUCL MED, V51, p18S, DOI 10.2967/jnumed.109.068148; Deroose CM, 2007, J NUCL MED, V48, P295; Dobrucki LW, 2010, NAT REV CARDIOL, V7, P38, DOI 10.1038/nrcardio.2009.201; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Groot-Wassink T, 2002, HUM GENE THER, V13, P1723, DOI 10.1089/104303402760293565; Guo R, 2010, NUCL MED COMMUN, V31, P916, DOI 10.1097/MNM.0b013e32833dedd7; Haddad D, 2015, MOL THER-ONCOLYTICS, V2, DOI 10.1038/mto.2014.7; Hickey RD, 2015, LIVER TRANSPLANT, V21, P442, DOI 10.1002/lt.24057; Higuchi T, 2009, J NUCL MED, V50, P1088, DOI 10.2967/jnumed.108.060665; Hindie E, 2007, ENDOCR-RELAT CANCER, V14, P799, DOI 10.1677/ERC-07-0120; Hoffman RM, 2015, NAT REV CANCER, V15, P451, DOI 10.1038/nrc3972; Howlader N., 2016, SEER CANC STAT REV; Ichite N, 2009, CLIN CANCER RES, V15, P543, DOI 10.1158/1078-0432.CCR-08-1558; Inubushi M, 2003, CIRCULATION, V107, P326, DOI 10.1161/01.CIR.0000044385.60972.AE; Jensen SM, 2016, FASEB J, V30; Kang JH, 2008, J NUCL MED, V49, p164S, DOI 10.2967/jnumed.107.045955; Kang YH, 2010, ONCOL REP, V23, P1463, DOI 10.3892/or_00000785; Kooreman NG, 2014, NAT MATER, V13, P106, DOI 10.1038/nmat3868; KUO TH, 1993, ANTICANCER RES, V13, P627; KYRIAZIS AA, 1980, CANCER RES, V40, P4509; Lee WW, 2004, NUCL MED BIOL, V31, P31, DOI 10.1016/S0969-8051(03)00100-8; Li H, 2016, CANCER IMMUNOL RES, V4, DOI 10.1158/2326-6074.CRICIMTEATIAACR15-A122; Miyagawa M, 2005, EUR J NUCL MED MOL I, V32, P1108, DOI 10.1007/s00259-005-1854-4; Olive KP, 2006, CLIN CANCER RES, V12, P5277, DOI 10.1158/1078-0432.CCR-06-0436; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Peng L, 2014, NANOMED-NANOTECHNOL, V10, P1497, DOI 10.1016/j.nano.2014.03.016; Phalen RF, 2008, J AEROSOL MED PULM D, V21, P113, DOI 10.1089/jamp.2007.0673; Riesco-Eizaguirre G, 2006, EUR J ENDOCRINOL, V155, P495, DOI 10.1530/eje.1.02257; Ruggeri BA, 2014, BIOCHEM PHARMACOL, V87, P150, DOI 10.1016/j.bcp.2013.06.020; Saha D, 2010, RADIAT RES, V174, P62, DOI 10.1667/RR2157.1; Spitzweg C, 2001, GENE THER, V8, P1524, DOI 10.1038/sj.gt.3301558; Syrigos KN, 2006, TUMORS OF THE CHEST; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; van Kuppevelt TH, 2000, EUR RESPIR J, V15, P771, DOI 10.1034/j.1399-3003.2000.15d23.x; WANG XO, 1992, INT J CANCER, V51, P992; Youn H, 2013, AM J ROENTGENOL, V201, pW206, DOI 10.2214/AJR.13.10555	47	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169107	10.1371/journal.pone.0169107	http://dx.doi.org/10.1371/journal.pone.0169107			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036366	Green Published, Green Submitted, gold			2022-12-26	WOS:000391229300055
J	Scholz, HC; Muhldorter, K; Shilton, C; Benedict, S; Whatmore, AM; Blom, J; Eisenberg, T				Scholz, Holger C.; Muehldorter, Kristin; Shilton, Cathy; Benedict, Suresh; Whatmore, Adrian M.; Blom, Jochen; Eisenberg, Tobias			The Change of a Medically Important Genus: Worldwide Occurrence of Genetically Diverse Novel Brucella Species in Exotic Frogs	PLOS ONE			English	Article							IDENTIFICATION	The genus Brucella comprises various species of both veterinary and human medical importance. All species are genetically highly related to each other, sharing intra-species average nucleotide identities (ANI) of >99%. Infections occur among various warm-blooded animal species, marine mammals, and humans. Until recently, amphibians had not been recognized as a host for Brucella. In this study, however, we show that novel Brucella species are distributed among exotic frogs worldwide. Comparative recA gene analysis of 36 frog isolates from various continents and different frog species revealed an unexpected high genetic diversity, not observed among classical Brucella species. In phylogenetic reconstructions the isolates consequently formed various clusters and grouped together with atypical more distantly related brucellae, like B. inopinata, strain BO2, and Australian isolates from rodents, some of which were isolated as human pathogens. Of one frog isolate (10RB9215) the genome sequence was determined. Comparative genome analysis of this isolate and the classical Brucella species revealed additional genetic material, absent from classical Brucella species but present in Ochrobactrum, the closest genetic neighbor of Brucella, and in other soil associated genera of the Alphaproteobacteria. The presence of gene clusters encoding for additional metabolic functions, flanked by tRNAs and mobile genetic elements, as well as by bacteriophages is suggestive for a different ecology compared to classical Brucella species. Furthermore it suggests that amphibian isolates may represent a link between free living soil saprophytes and the pathogenic Brucella with a preferred intracellular habitat. We therefore assume that brucellae from frogs have a reservoir in soil and, in contrast to classical brucellae, undergo extensive horizontal gene transfer.	[Scholz, Holger C.] Bundeswehr Inst Microbiol, Neuherbergstr 11, Munich, Germany; [Scholz, Holger C.] German Ctr Infect Res DZIF, Munich, Germany; [Muehldorter, Kristin] Leibniz Inst Zoo & Wildlife Res, Dept Wildlife Dis, Berlin, Germany; [Shilton, Cathy; Benedict, Suresh] Northern Terr Govt, Berrimah Vet Labs, Berrimah, NT, Australia; [Whatmore, Adrian M.] Anim & Plant Hlth Agcy, Woodham Lane, Addlestone, Surrey, England; [Blom, Jochen] Univ Bielefeld, CeBiTec, Ctr Biotechnol, Bielefeld, Germany; [Eisenberg, Tobias] Hessian State Lab LHL, Schubertstr 60, Giessen, Germany	Bundeswehr Institute of Microbiology (IMB); German Center for Infection Research; Leibniz Institut fur Zoo und Wildtierforschung; Northern Territory Government; Animal & Plant Health Agency UK; University of Bielefeld	Scholz, HC (corresponding author), Bundeswehr Inst Microbiol, Neuherbergstr 11, Munich, Germany.; Scholz, HC (corresponding author), German Ctr Infect Res DZIF, Munich, Germany.	holger1scholz@bundeswehr.org	Eisenberg, Tobias/AAL-9117-2020; Whatmore, Adrian M/C-7744-2011	Eisenberg, Tobias/0000-0002-2888-5475; Whatmore, Adrian M/0000-0003-4218-156X	Robert Koch-Institute; Federal Ministry of Health [FKZ 1369-448]	Robert Koch-Institute; Federal Ministry of Health	The project was partially supported by the Robert Koch-Institute with funding from the Federal Ministry of Health under project number FKZ 1369-448. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; De BK, 2008, J CLIN MICROBIOL, V46, P43, DOI 10.1128/JCM.01494-07; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisenberg T, 2012, APPL ENVIRON MICROB, V78, P3753, DOI 10.1128/AEM.07509-11; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fischer D, 2012, J ZOO WILDLIFE MED, V43, P625, DOI 10.1638/2011-0005R2.1; Gee JE, 2004, J CLIN MICROBIOL, V42, P3649, DOI 10.1128/jcm.42.8.3649-3654.2004; Kuhlmann AU, 2011, J BACTERIOL, V193, P4699, DOI 10.1128/JB.05270-11; Muhldorfer K, 2016, J APPL MICROBIOL; Scholz HC, 2008, SYST APPL MICROBIOL, V31, P1, DOI 10.1016/j.syapm.2007.10.004; Scholz HC, 2016, INT J SYST EVOL MICR, V66, P2090, DOI 10.1099/ijsem.0.000998; Scholz HC, 2010, INT J SYST EVOL MICR, V60, P801, DOI 10.1099/ijs.0.011148-0; Shilton CM, 2008, VET PATHOL, V45, P85, DOI 10.1354/vp.45-1-85; Sohn AH, 2003, EMERG INFECT DIS, V9, P485, DOI 10.3201/eid0904.020576; Soler-Llorens PF, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00116; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tiller RV, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-23; Whatmore AM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-34; Whatmore AM, 2015, JMM CASE REP	19	27	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168872	10.1371/journal.pone.0168872	http://dx.doi.org/10.1371/journal.pone.0168872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036367	gold, Green Published, Green Submitted			2022-12-26	WOS:000391229300036
J	Wen, Q; Wang, YQ; Tang, JX; Cheng, CY; Liu, YX				Wen, Qing; Wang, Yuqian; Tang, Jixin; Cheng, C. Yan; Liu, Yi-Xun			Sertoli Cell Wt1 Regulates Peritubular Myoid Cell and Fetal Leydig Cell Differentiation during Fetal Testis Development	PLOS ONE			English	Article							MOUSE TESTIS; CORD ORGANIZATION; SEX DETERMINATION; XY GONAD; FATE; GENE; SOX9; MICE; VASCULARIZATION; PROLIFERATION	Sertoli cells play a significant role in regulating fetal testis compartmentalization to generate testis cords and interstitium during development. The Sertoli cell Wilms' tumor 1 (Wt1) gene, which encodes similar to 24 zinc finger-containing transcription factors, is known to play a crucial role in fetal testis cord assembly and maintenance. However, whether Wt1 regulates fetal testis compartmentalization by modulating the development of peritubular myoid cells (PMCs) and/or fetal Leydig cells (FLCs) remains unknown. Using a Wt1(-/flox); Amh-Cre mouse model by deleting Wt1 in Sertoli cells (Wt1(SC-cKO)) at embryonic day 14.5 (E14.5), Wt1 was found to regulate PMC and FLC development. Wt1 deletion in fetal testis Sertoli cells caused aberrant differentiation and proliferation of PMCs, FLCs and interstitial progenitor cells from embryo to newborn, leading to abnormal fetal testis interstitial development. Specifically, the expression of PMC marker genes alpha-Sma, Myh11 and Des, and interstitial progenitor cell marker gene Vcam1 were down-regulated, whereas FLC marker genes StAR, Cyp11a1, Cyp17a1 and Hsd3b1 were up-regulated, in neonatal Wt1(SC-cKO) testes. The ratio of PMC: FLC were also reduced in Wt1(SC-cKO) testes, concomitant with a down-regulation of Notch signaling molecules Jag 1, Notch 2, Notch 3, and Hes1 in neonatal Wt1(SC-cKO) testes, illustrating changes in the differentiation status of FLC from their interstitial progenitor cells during fetal testis development. In summary, Wt1 regulates the development of FLC and interstitial progenitor cell lineages through Notch signaling, and it also plays a role in PMC development. Collectively, these effects confer fetal testis compartmentalization.	[Wen, Qing; Wang, Yuqian; Tang, Jixin; Liu, Yi-Xun] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cells & Reprod Biol, Beijing, Peoples R China; [Wen, Qing; Wang, Yuqian; Liu, Yi-Xun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wen, Qing; Cheng, C. Yan] Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10021 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Population Council	Liu, YX (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cells & Reprod Biol, Beijing, Peoples R China.; Liu, YX (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10021 USA.	y-cheng@popcbr.rockefeller.edu; liuyx@ioz.ac.cn		Cheng, C Yan/0000-0003-3117-3791	Major Research Plan "973" Project [2011CB944302, 2012CB944702]; National Technology Support Project [2012DA1131608]; National Nature Science Foundation of China [31471352, 31471400, 31171380]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056034, U54HD029990] Funding Source: NIH RePORTER	Major Research Plan "973" Project(National Basic Research Program of China); National Technology Support Project; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the Major Research Plan "973" Project (2011CB944302 and 2012CB944702), the National Technology Support Project (2012DA1131608), and the National Nature Science Foundation of China (31471352, 31471400 and 31171380).	Archambeault DR, 2010, P NATL ACAD SCI USA, V107, P10526, DOI 10.1073/pnas.1000318107; Barrionuevo F, 2009, DEV BIOL, V327, P301, DOI 10.1016/j.ydbio.2008.12.011; Bott RC, 2006, BIOL REPROD, V75, P56, DOI 10.1095/biolreprod.105.047225; Brennan J, 2003, GENE DEV, V17, P800, DOI 10.1101/gad.1052503; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Chang H, 2008, DEVELOPMENT, V135, P1875, DOI 10.1242/dev.018572; Chen LY, 2016, P NATL ACAD SCI USA, V113, P1829, DOI 10.1073/pnas.1517994113; Chen LY, 2014, ENDOCRINOLOGY, V155, P4964, DOI 10.1210/en.2014-1406; Chen SR, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105379; Clark AM, 2000, BIOL REPROD, V63, P1825, DOI 10.1095/biolreprod63.6.1825; Combes AN, 2009, DEV BIOL, V326, P112, DOI 10.1016/j.ydbio.2008.10.040; Cool J, 2008, SEX DEV, V2, P128, DOI 10.1159/000143430; Cool J, 2011, P NATL ACAD SCI USA, V108, P167, DOI 10.1073/pnas.1010299108; Coveney D, 2008, P NATL ACAD SCI USA, V105, P7212, DOI 10.1073/pnas.0707674105; DeFalco T, 2014, P NATL ACAD SCI USA, V111, pE2384, DOI 10.1073/pnas.1400057111; DeFalco T, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106138; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Georg I, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101907; Hoeben E, 1999, ENDOCRINOLOGY, V140, P2216, DOI 10.1210/en.140.5.2216; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Jeanes A, 2005, REPRODUCTION, V130, P509, DOI 10.1530/rep.1.00718; KERR JB, 1988, DEVELOPMENT, V103, P535; Kilcoyne KR, 2014, P NATL ACAD SCI USA, V111, pE1924, DOI 10.1073/pnas.1320735111; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Lin YT, 2015, CURR OPIN GENET DEV, V32, P144, DOI 10.1016/j.gde.2015.03.003; Maekawa M, 1996, ARCH HISTOL CYTOL, V59, P1, DOI 10.1679/aohc.59.1; Meeks JJ, 2003, DEVELOPMENT, V130, P1029, DOI 10.1242/dev.00316; Nurmio Mirja, 2012, Spermatogenesis, V2, P79; Oatley JM, 2009, DEVELOPMENT, V136, P1191, DOI 10.1242/dev.032243; ORTH JM, 1982, ANAT REC, V203, P485, DOI 10.1002/ar.1092030408; Pierucci-Alves F, 2001, BIOL REPROD, V65, P1392, DOI 10.1095/biolreprod65.5.1392; Qian Y, 2013, DEVELOPMENT, V140, P1751, DOI 10.1242/dev.093641; Rebourcet D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105687; Rebourcet D, 2014, DEVELOPMENT, V141, P2139, DOI 10.1242/dev.107029; Scharnhorst V, 2001, GENE, V273, P141, DOI 10.1016/S0378-1119(01)00593-5; Schmahl J, 2000, DEVELOPMENT, V127, P65; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; SKINNER MK, 1985, J CELL BIOL, V100, P1941, DOI 10.1083/jcb.100.6.1941; Svingen T, 2013, GENE DEV, V27, P2409, DOI 10.1101/gad.228080.113; Tang H, 2008, DEVELOPMENT, V135, P3745, DOI 10.1242/dev.024786; Ungewitter EK, 2013, SEX DEV, V7, P7, DOI 10.1159/000338612; Verhoeven G, 2000, ANDROLOGIA, V32, P42; Welsh M, 2009, FASEB J, V23, P4218, DOI 10.1096/fj.09-138347; Wen Q., 2011, FRONT BIOL, V6, P12; Wen Q, 2016, SEMIN CELL DEV BIOL; Wen Q, 2014, AM J PHYSIOL-ENDOC M, V307, pE1131, DOI 10.1152/ajpendo.00425.2014; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202; Zhang LJ, 2015, P NATL ACAD SCI USA, V112, P4003, DOI 10.1073/pnas.1422371112; Zheng QS, 2014, REPRODUCTION, V147, P45, DOI 10.1530/REP-13-0299	52	25	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0167920	10.1371/journal.pone.0167920	http://dx.doi.org/10.1371/journal.pone.0167920			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036337	Green Submitted, Green Published, gold			2022-12-26	WOS:000391229300009
J	Gavish, Y; Ziv, Y				Gavish, Yoni; Ziv, Yaron			Joint Effect of Habitat Identity and Spatial Distance on Spiders' Community Similarity in a Fragmented Transition Zone	PLOS ONE			English	Article							ECOLOGICAL COMMUNITIES; SCALE; DIVERSITY; DISPERSAL; DYNAMICS; RAINFALL; ARANEAE; ISRAEL; DECAY; AGROECOSYSTEM	Understanding the main processes that affect community similarity have been the focus of much ecological research. However, the relative effects of environmental and spatial aspects in structuring ecological communities is still unresolved and is probably scale dependent. Here, we examine the effect of habitat identity and spatial distance on fine-grained community similarity within a biogeographic transition zone. We compared four hypotheses: i) habitat identity alone, ii) spatial proximity alone, iii) non-interactive effects of both habitat identity and spatial proximity, and iv) interactive effect of habitat identity and spatial proximity. We explored these hypotheses for spiders in three fragmented landscapes located along the sharp climatic gradient of Southern Judea Lowlands (SJL), Israel. We sampled 14,854 spiders (from 199 species or morphospecies) in 644 samples, taken in 35 patches and stratified to nine different habitats. We calculated the Bray-Curtis similarity between all samples-pairs. We divided the pairwise values to four functional distance categories (same patch, different patches from the same landscape, adjacent landscapes and distant landscapes) and two habitat categories (same or different habitats) and compared them using non-parametric MANOVA. A significant interaction between habitat identity and spatial distance was found, such that the difference in mean similarity between same-habitat pairs and different-habitat pairs decreases with spatial distance. Additionally, community similarity decayed with spatial distance. Furthermore, at all distances, same-habitat pairs had higher similarity than different-habitats pairs. Our results support the fourth hypothesis of interactive effect of habitat identity and spatial proximity. We suggest that the environmental complexity of habitats or increased habitat specificity of species near the edge of their distribution range may explain this pattern. Thus, in transitions zones care should be taken when using habitats as surrogate of community composition in conservation planning since similar habitats in different locations are more likely to support different communities.	[Gavish, Yoni; Ziv, Yaron] Ben Gurion Univ Negev, Dept Life Sci, Spatial Ecol Lab, Beer Sheva, Israel; [Gavish, Yoni] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England	Ben Gurion University; University of Leeds	Gavish, Y (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Spatial Ecol Lab, Beer Sheva, Israel.; Gavish, Y (corresponding author), Univ Leeds, Sch Biol, Leeds, W Yorkshire, England.	gavishyoni@gmail.com	Gavish, Yoni/J-2173-2019	Gavish, Yoni/0000-0002-6025-5668; Ziv, Yaron/0000-0002-6369-9803	Israel Science Foundation [751/09]	Israel Science Foundation(Israel Science Foundation)	YZ was supported by the Israel Science Foundation, grant 751/09 (https://www.isf.org.il/#/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2021, LANG ENV STAT COMP; Bestelmeyer BT, 2001, ECOGRAPHY, V24, P381, DOI 10.1034/j.1600-0587.2001.d01-194.x; Bonte D, 2003, P ROY SOC B-BIOL SCI, V270, P1601, DOI 10.1098/rspb.2003.2432; Bonte D, 2003, OECOLOGIA, V135, P227, DOI 10.1007/s00442-003-1195-6; Boulangeat I, 2012, ECOL LETT, V15, P584, DOI 10.1111/j.1461-0248.2012.01772.x; Carvalho JC, 2011, DIVERS DISTRIB, V17, P225, DOI 10.1111/j.1472-4642.2010.00731.x; Carvalho JC, 2011, BIODIVERS CONSERV, V20, P873, DOI 10.1007/s10531-011-0001-8; Chase JM, 2005, FUNCT ECOL, V19, P182, DOI 10.1111/j.0269-8463.2005.00937.x; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; CODDINGTON JA, 1991, ANNU REV ECOL SYST, V22, P565, DOI 10.1146/annurev.es.22.110191.003025; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; EHMANN WJ, 1994, J ARACHNOL, V22, P77; EHMANN WJ, 1994, AM MIDL NAT, V131, P301, DOI 10.2307/2426256; Gavish Y, 2012, CONSERV BIOL, V26, P150, DOI 10.1111/j.1523-1739.2011.01799.x; Giladi I, 2011, J VEG SCI, V22, P983, DOI 10.1111/j.1654-1103.2011.01309.x; Goldreich Y., 1998, CLIMATE ISRAEL OBSER; Gorley C.K., 2006, GETTING STARTED PRIM; Heikkinen MW, 2004, J ARACHNOL, V32, P313, DOI 10.1636/M02-1; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Kadmon R, 1997, FLORA, V192, P341; Kadmon R, 1999, J VEG SCI, V10, P421, DOI 10.2307/3237071; Kiss B, 2000, EUR J ENTOMOL, V97, P191, DOI 10.14411/eje.2000.036; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lennon JJ, 2002, GLOBAL ECOL BIOGEOGR, V11, P103, DOI 10.1046/j.1466-822X.2002.00279.x; Levin N, 2007, ISR J ECOL EVOL, V53, P33, DOI 10.1560/IJEE_53_1_33; Lightfoot DC, 2008, WEST N AM NATURALIST, V68, P83, DOI 10.3398/1527-0904(2008)68[83:GPOGAA]2.0.CO;2; Lisewski V, 2010, BIODIVERS CONSERV, V19, P3935, DOI 10.1007/s10531-010-9938-2; Marc P, 1999, AGR ECOSYST ENVIRON, V74, P229, DOI 10.1016/S0167-8809(99)00038-9; May F, 2013, ECOGRAPHY, V36, P842, DOI 10.1111/j.1600-0587.2012.07793.x; McNett BJ, 2000, ECOL ENTOMOL, V25, P423, DOI 10.1046/j.1365-2311.2000.00279.x; Morlon H, 2008, ECOL LETT, V11, P904, DOI 10.1111/j.1461-0248.2008.01202.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Oksanen J, 2022, R PACKAGE VERSION; Oliver T, 2009, ECOL LETT, V12, P1091, DOI 10.1111/j.1461-0248.2009.01367.x; RIECHERT SE, 1975, ECOLOGY, V56, P265, DOI 10.2307/1934960; ROBINSON JV, 1981, ECOLOGY, V62, P73, DOI 10.2307/1936670; Rotem G, 2016, OECOLOGIA, V180, P231, DOI 10.1007/s00442-015-3435-y; Rotem G, 2013, BIOL CONSERV, V167, P349, DOI 10.1016/j.biocon.2013.08.028; Roughgarden J, 2009, BIOL PHILOS, V24, P521, DOI 10.1007/s10539-009-9164-z; Rypstra AL, 1999, J ARACHNOL, V27, P371; Sarkar S, 2002, J BIOSCIENCES, V27, P299, DOI 10.1007/BF02704961; Schmidt H, 2000, INT J REMOTE SENS, V21, P997, DOI 10.1080/014311600210399; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Steinbauer MJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P1203, DOI 10.1111/j.1466-8238.2012.00772.x; STEWART AJA, 1995, ECOL ENTOMOL, V20, P98, DOI 10.1111/j.1365-2311.1995.tb00434.x; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; Thorbek P, 2002, J ARACHNOL, V30, P57, DOI 10.1636/0161-8202(2002)030[0057:VOASMF]2.0.CO;2; Uetz G.W., 1991, P325; Whitehouse MEA, 2002, ECOGRAPHY, V25, P395, DOI 10.1034/j.1600-0587.2002.250402.x; Yaacobi G, 2007, LANDSCAPE ECOL, V22, P687, DOI 10.1007/s10980-006-9061-7	53	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168417	10.1371/journal.pone.0168417	http://dx.doi.org/10.1371/journal.pone.0168417			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033386	Green Published, gold			2022-12-26	WOS:000391226900024
J	Ghosh, K; De, S; Das, S; Mukherjee, S; Bandyopadhyay, SS				Ghosh, Kamalini; De, Soumasree; Das, Sayantani; Mukherjee, Srimoyee; Bandyopadhyay, Sumita Sengupta			Withaferin A Induces ROS-Mediated Paraptosis in Human Breast Cancer Cell-Lines MCF-7 and MDA-MB-231	PLOS ONE			English	Article							MESSENGER-RNA; ER STRESS; DEATH; APOPTOSIS; INHIBITION; INDUCTION; FORM	Advancement in cancer therapy requires a better understanding of the detailed mechanisms that induce death in cancer cells. Besides apoptosis, themode of other types of cell death has been increasingly recognized in response to therapy. Paraptosis is a non-apoptotic alternative form of programmed cell death, morphologically) distinct from apoptosis and autophagy. In the present study, Withaferin-A (WA) induced hyperpolarization of mitochondria) membrane potential and formation of many cytoplasmic vesicles. This was due to progressive swelling and fusion of mitochondria and dilation of endoplasmic reticulum (ER), forming large vacuolar structures that eventually filled the cytoplasm in human breast cancer cell-lines MCF-7 and MDA-MB-231. The level of indigenous paraptosis inhibitor, Alix/AIP-1 (Actin Interacting Protein-1) was down-regulated by WA treatment. Additionally, prevention of WA-induced cell death and vacuolation on co-treatment with protein-synthesis inhibitor indicated requirement of de-novo protein synthesis. Co-treatment with apoptosis inhibitor resulted in significant augmentation of WA-induced death in MCF-7 cells, while partial inhibition in MDA-MB-231 cells; implyingthat apoptosis was not solely responsible for the process.WA-mediated cytoplasmic vacuolationcould not be prevented by autophagy inhibitor wortmanninas well, claiming this process to be a non-autophagic one. Early induction of ROS (Reactive Oxygen Species)by WA in both the cell-lines was observed. ROS inhibitor abrogated the effect of WA on: cell-death, expression of proliferation-associated factor andER-stress related proteins,splicing of XBP-1 (X Box Binding Protein-1) mRNA and formation of paraptotic vacuoles.All these results conclusively indicate thatWA induces deathin bothMCF-7 and MDA-MB-231 cell lines byROS-mediated paraptosis.	[Ghosh, Kamalini; De, Soumasree; Das, Sayantani; Mukherjee, Srimoyee; Bandyopadhyay, Sumita Sengupta] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, W Bengal, India	University of Calcutta	Bandyopadhyay, SS (corresponding author), Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, W Bengal, India.	bandyops@gmail.com	MUKHERJEE, SRIMOYEE/W-3180-2019	De, Soumasree/0000-0002-2406-7483; Mukherjee, Srimoyee/0000-0002-7521-2812	DST [SR/SO/BB-58/2007]; UGC [UGC-37-398/2009]; UGC-DSA; UGC-RFSMS; ICMR; CSIR; Indian Council of Medical research [45/57/2009/BMS/TRM]	DST(Department of Science & Technology (India)); UGC(University Grants Commission, India); UGC-DSA; UGC-RFSMS; ICMR(Indian Council of Medical Research (ICMR)); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical research(Indian Council of Medical Research (ICMR))	This work was supported by grants from DST (SR/SO/BB-58/2007), UGC (UGC-37-398/2009) to SS(B), UGC-DSA. We would like to acknowledge for providing fellowship to KG (UGC-RFSMS and ICMR), SM (UGC-RFSMS), S. De (CSIR), S. Das (CSIR). Indian Council of Medical research (Sanction No: 45/57/2009/BMS/TRM) for funding.	Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Bury M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.85; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Dasgupta P, 2013, NUTR CANCER, V65, P611, DOI 10.1080/01635581.2013.776090; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Gandin V, 2012, J CELL MOL MED, V16, P142, DOI 10.1111/j.1582-4934.2011.01292.x; Hahm ER, 2013, CURR CANCER DRUG TAR, V13, P640, DOI 10.2174/15680096113139990039; Hoa N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004631; Kitanaka C, 1999, CELL DEATH DIFFER, V6, P508, DOI 10.1038/sj.cdd.4400526; Lee WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10420; Liu Y, 2009, CELL ADHES MIGR, V3, P94, DOI 10.4161/cam.3.1.7516; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Okada K, 1999, J BIOL CHEM, V274, P23787, DOI 10.1074/jbc.274.34.23787; Saha S, 2016, J CELL BIOCHEM, V117, P988, DOI 10.1002/jcb.25384; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Tang Y, 2016, CLIN BREAST CANCER, V8209, P30108; Tardito S, 2009, J BIOL CHEM, V284, P24306, DOI 10.1074/jbc.M109.026583; Tor YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127441; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Vanden Berghe W, 2012, BIOCHEM PHARMACOL, V84, P1282, DOI 10.1016/j.bcp.2012.08.027; Wang Y, 2004, J CELL SCI, V117, P1525, DOI 10.1242/jcs.00994; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yoon MJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.85; Yoon MJ, 2010, FREE RADICAL BIO MED, V48, P713, DOI 10.1016/j.freeradbiomed.2009.12.016; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zamzami N, 2005, CELL DEATH DIFFER, V12, P1478, DOI 10.1038/sj.cdd.4401682	30	40	43	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168488	10.1371/journal.pone.0168488	http://dx.doi.org/10.1371/journal.pone.0168488			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033383	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900027
J	VanGilder, P; Shi, Y; Apker, G; Dyson, K; Buneo, CA				VanGilder, Paul; Shi, Ying; Apker, Gregory; Dyson, Keith; Buneo, Christopher A.			Multisensory Interactions Influence Neuronal Spike Train Dynamics in the Posterior Parietal Cortex	PLOS ONE			English	Article							VENTRAL INTRAPARIETAL AREA; ARM MOVEMENT VARIABILITY; SUPERIOR TEMPORAL SULCUS; 3-DIMENSIONAL SPACE; AUDITORY-CORTEX; PREMOTOR CORTEX; WORKING-MEMORY; INTEGRATION; MONKEY; OSCILLATIONS	Although significant progress has been made in understanding multisensory interactions at the behavioral level, their underlying neural mechanisms remain relatively poorly understood in cortical areas, particularly during the control of action. In recent experiments where animals reached to and actively maintained their arm position at multiple spatial locations while receiving either proprioceptive or visual-proprioceptive position feedback, multisensory interactions were shown to be associated with reduced spiking (i.e. subadditivity) as well as reduced intra-trial and across-trial spiking variability in the superior parietal lobule (SPL). To further explore the nature of such interaction-induced changes in spiking variability we quantified the spike train dynamics of 231 of these neurons. Neurons were classified as Poisson, bursty, refractory, or oscillatory (in the 13-30 Hz "beta-band") based on their spike train power spectra and autocorrelograms. No neurons were classified as Poisson-like in either the proprioceptive or visual-proprioceptive conditions. Instead, oscillatory spiking was most commonly observed with many neurons exhibiting these oscillations under only one set of feedback conditions. The results suggest that the SPL may belong to a putative beta-synchronized network for arm position maintenance and that position estimation may be subserved by different subsets of neurons within this network depending on available sensory information. In addition, the nature of the observed spiking variability suggests that models of multisensory interactions in the SPL should account for both Poisson-like and non-Poisson variability.	[VanGilder, Paul; Shi, Ying; Apker, Gregory; Dyson, Keith; Buneo, Christopher A.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA	Arizona State University; Arizona State University-Tempe	Buneo, CA (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA.	cbuneo@asu.edu		VanGilder, Paul/0000-0003-3066-3713	National Science Foundation [0746398]; Arizona Biomedical Research Commission [0813]; Science Foundation Arizona	National Science Foundation(National Science Foundation (NSF)); Arizona Biomedical Research Commission; Science Foundation Arizona	This work was supported by National Science Foundation Award 0746398 (nsf.gov), Arizona Biomedical Research Commission Award 0813 (www.azdhs.gov/biomedical/), Science Foundation Arizona (www.sfaz.org/). The funders had no role in study design, data, collection and analysis, decision to publish, or preparation of the manuscript.	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Apker GA, 2012, J NEUROPHYSIOL, V107, P90, DOI 10.1152/jn.00495.2011; Apker GA, 2010, J NEUROPHYSIOL, V104, P2654, DOI 10.1152/jn.00590.2010; Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Bagesteiro LB, 2006, EXP BRAIN RES, V171, P358, DOI 10.1007/s00221-005-0272-y; BAIR W, 1994, J NEUROSCI, V14, P2870; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; Barraclough NE, 2005, J COGNITIVE NEUROSCI, V17, P377, DOI 10.1162/0898929053279586; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Bremmer F, 2002, EUR J NEUROSCI, V16, P1569, DOI 10.1046/j.1460-9568.2002.02206.x; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Buneo CA, 2003, EXP BRAIN RES, V153, P134, DOI 10.1007/s00221-003-1586-2; Buneo CA, 2012, J NEUROPHYSIOL, V108, P187, DOI 10.1152/jn.00137.2011; Chabrol FP, 2015, NAT NEUROSCI, V18, P718, DOI 10.1038/nn.3974; Compte A, 2003, J NEUROPHYSIOL, V90, P3441, DOI 10.1152/jn.00949.2002; Dehner LR, 2004, CEREB CORTEX, V14, P387, DOI 10.1093/cercor/bhg135; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Fetsch CR, 2013, NAT REV NEUROSCI, V14, P429, DOI 10.1038/nrn3503; GEORGOPOULOS AP, 1984, EXP BRAIN RES, V54, P446; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2008, J NEUROSCI, V28, P4457, DOI 10.1523/JNEUROSCI.0541-08.2008; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Joelving FC, 2007, J NEUROPHYSIOL, V97, P2254, DOI 10.1152/jn.00977.2006; Kayser C, 2010, CURR BIOL, V20, P19, DOI 10.1016/j.cub.2009.10.068; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Koehler SD, 2011, EUR J NEUROSCI, V33, P409, DOI 10.1111/j.1460-9568.2010.07547.x; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; LACQUANITI F, 1995, CEREB CORTEX, V5, P391, DOI 10.1093/cercor/5.5.391; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lloyd DM, 2003, NAT NEUROSCI, V6, P17, DOI 10.1038/nn991; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Maier JX, 2008, CURR BIOL, V18, P963, DOI 10.1016/j.cub.2008.05.043; Maimon G, 2009, NEURON, V62, P426, DOI 10.1016/j.neuron.2009.03.021; McIntyre J, 1998, J NEUROSCI, V18, P8423, DOI 10.1523/JNEUROSCI.18-20-08423.1998; McIntyre J, 1997, J NEUROPHYSIOL, V78, P1601, DOI 10.1152/jn.1997.78.3.1601; Morgan ML, 2008, NEURON, V59, P662, DOI 10.1016/j.neuron.2008.06.024; Nawrot MP, 2008, J NEUROSCI METH, V169, P374, DOI 10.1016/j.jneumeth.2007.10.013; Ohshiro T, 2011, NAT NEUROSCI, V14, P775, DOI 10.1038/nn.2815; Parkinson A, 2010, NEUROPSYCHOLOGIA, V48, P3228, DOI 10.1016/j.neuropsychologia.2010.06.039; Pellijeff A, 2006, NEUROPSYCHOLOGIA, V44, P2685, DOI 10.1016/j.neuropsychologia.2006.01.009; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; ROSSETTI Y, 1995, J NEUROPHYSIOL, V74, P457, DOI 10.1152/jn.1995.74.1.457; Scott SH, 1997, J NEUROPHYSIOL, V78, P2413, DOI 10.1152/jn.1997.78.5.2413; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Shi Y, 2013, J NEUROPHYSIOL, V109, P2097, DOI 10.1152/jn.00223.2012; Stanford TR, 2005, J NEUROSCI, V25, P6499, DOI 10.1523/JNEUROSCI.5095-04.2005; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Sugihara T, 2006, J NEUROSCI, V26, P11138, DOI 10.1523/JNEUROSCI.3550-06.2006; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; Torres EB, 2013, FRONT INTEGR NEUROSC, V7, P1; VanGilder P, 2014, CHARACTERIZATION PAR; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Witham CL, 2007, J PHYSIOL-LONDON, V580, P801, DOI 10.1113/jphysiol.2006.124503; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Zhang WH, 2016, J NEUROSCI, V36, P532, DOI 10.1523/JNEUROSCI.0578-15.2016; Zhou YD, 2000, P NATL ACAD SCI USA, V97, P9777, DOI 10.1073/pnas.97.17.9777	60	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0166786	10.1371/journal.pone.0166786	http://dx.doi.org/10.1371/journal.pone.0166786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033334	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900008
J	Aperce, CC; Amachawadi, R; Van Bibber-Krueger, CL; Nagaraja, TG; Scott, HM; Vinasco-Torre, J; Drouillard, JS				Aperce, C. C.; Amachawadi, R.; Van Bibber-Krueger, C. L.; Nagaraja, T. G.; Scott, H. M.; Vinasco-Torre, J.; Drouillard, J. S.			Effects of Menthol Supplementation in Feedlot Cattle Diets on the Fecal Prevalence of Antimicrobial-Resistant Escherichia coli	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE; GENES; ANTIBIOTICS; PERFORMANCE; EPIDEMIOLOGY; FERMENTATION; MICROFLORA; ANIMALS; STRAINS; STEERS	The pool of antimicrobial resistance determinants in the environment and in the gut flora of cattle is a serious public health concern. In addition to being a source of human exposure, these bacteria can transfer antibiotic resistance determinants to pathogenic bacteria and endanger the future of antimicrobial therapy. The occurrence of antimicrobial resistance genes on mobile genetic elements, such as plasmids, facilitates spread of resistance. Recent work has shown in vitro anti-plasmid activity of menthol, a plant-based compound with the potential to be used as a feed additive to beneficially alter ruminal fermentation. The present study aimed to determine if menthol supplementation in diets of feedlot cattle decreases the prevalence of multidrug-resistant bacteria in feces. Menthol was included in diets of steers at 0.3% of diet dry matter. Fecal samples were collected weekly for 4 weeks and analyzed for total coliforms counts, antimicrobial susceptibilities, and the prevalence of tet genes in E. coli isolates. Results revealed no effect of menthol supplementation on total coliforms counts or prevalence of E. coli resistant to amoxicillin, ampicillin, azithromycin, cefoxitin, ceftiofur, ceftriaxone, chloramphenicol, ciprofloxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfisoxazole, and sulfamethoxazole; however, 30 days of menthol addition to steer diets increased the prevalence of tetracycline-resistant E. coli (P < 0.02). Although the mechanism by which menthol exerts its effects remains unclear, results of our study suggest that menthol may have an impact on antimicrobial resistance in gut bacteria.	[Aperce, C. C.; Van Bibber-Krueger, C. L.; Drouillard, J. S.] Kansas State Univ, Dept Anim Sci, Manhattan, KS 66506 USA; [Aperce, C. C.; Van Bibber-Krueger, C. L.; Drouillard, J. S.] Kansas State Univ, Dept Ind, Manhattan, KS 66506 USA; [Amachawadi, R.; Nagaraja, T. G.; Scott, H. M.; Vinasco-Torre, J.] Kansas State Univ, Diagnost Med & Pathobiol, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; Kansas State University	Drouillard, JS (corresponding author), Kansas State Univ, Dept Anim Sci, Manhattan, KS 66506 USA.; Drouillard, JS (corresponding author), Kansas State Univ, Dept Ind, Manhattan, KS 66506 USA.	jdrouill@ksu.edu	Scott, Harvey/ABC-9935-2020; Amachawadi, Raghavendra/AIA-9957-2022	Scott, Harvey/0000-0002-0538-5961; Amachawadi, Raghavendra/0000-0001-9689-1124				Agarwal N, 2009, ANIM FEED SCI TECH, V148, P321, DOI 10.1016/j.anifeedsci.2008.04.004; Alexander TW, 2009, APPL ENVIRON MICROB, V75, P7125, DOI 10.1128/AEM.00944-09; Ando S, 2003, LIVEST PROD SCI, V82, P245, DOI 10.1016/S0301-6226(03)00012-5; Benchaar C, 2008, ANIM FEED SCI TECH, V145, P209, DOI 10.1016/j.anifeedsci.2007.04.014; Blake DP, 2003, J APPL MICROBIOL, V94, P1087, DOI 10.1046/j.1365-2672.2003.01937.x; Branham LA, 2007, THESIS; Bryan A, 2004, APPL ENVIRON MICROB, V70, P2503, DOI 10.1128/AEM.70.4.2503-2507.2004; Chopra I, 2002, DRUG RESIST UPDATE, V5, P119, DOI 10.1016/S1368-7646(02)00051-1; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; El-Mansi M, 2000, RES MICROBIOL, V151, P201, DOI 10.1016/S0923-2508(00)00140-6; Gaggia F, 2010, INT J FOOD MICROBIOL, V141, pS15, DOI 10.1016/j.ijfoodmicro.2010.02.031; GILMORE A, 1986, CAN MED ASSOC J, V134, P423; Gow SP, 2008, APPL ENVIRON MICROB, V74, P3658, DOI 10.1128/AEM.02505-07; Harvey R, 2009, AM J VET RES, V70, P198, DOI 10.2460/ajvr.70.2.198; Hosoda K, 2005, J ANIM SCI, V18, P1721; JONES CS, 1992, MOL CELL PROBE, V6, P313, DOI 10.1016/0890-8508(92)90007-K; Landau E, 2012, APPL ENVIRON MICROB, V78, P5361, DOI 10.1128/AEM.00894-12; Levy SB, 2001, CLIN INFECT DIS, V33, pS124, DOI 10.1086/321837; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P44, DOI 10.1111/j.1574-6976.2008.00142.x; Ma YP, 2006, J DAIRY SCI, V89, P4573, DOI 10.3168/jds.S0022-0302(06)72507-3; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Medeiros AA, 1997, CLIN INFECT DIS, V24, pS19, DOI 10.1093/clinids/24.Supplement_1.S19; Medina A, 2011, J VET DIAGN INVEST, V23, P91, DOI 10.1177/104063871102300114; Minutolo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015899; Mirzaagha P, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-78; NURU S, 1972, CORNELL VET, V62, P242; Ocak N, 2008, CZECH J ANIM SCI, V53, P169, DOI 10.17221/373-CJAS; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Patel T, 2007, J AM ACAD DERMATOL, V57, P873, DOI 10.1016/j.jaad.2007.04.008; Sawant AA, 2007, APPL ENVIRON MICROB, V73, P156, DOI 10.1128/AEM.01551-06; Schelz Z, 2006, FITOTERAPIA, V77, P279, DOI 10.1016/j.fitote.2006.03.013; Sharifi SD, 2013, VET ARHIV, V83, P69; Thaker M, 2010, CELL MOL LIFE SCI, V67, P419, DOI 10.1007/s00018-009-0172-6; Toghyani M, 2010, LIVEST SCI, V129, P173, DOI 10.1016/j.livsci.2010.01.021; Trombetta D, 2005, ANTIMICROB AGENTS CH, V49, P2474, DOI 10.1128/AAC.49.6.2474-2478.2005; Van Bibber-Krueger CL, 2016, J ANIM SCI, V94, P1170, DOI 10.2527/jas.2015-8779; van den Bogaard AE, 2000, INT J ANTIMICROB AG, V14, P327, DOI 10.1016/S0924-8579(00)00145-X; White DG, 2000, J CLIN MICROBIOL, V38, P4593, DOI 10.1128/JCM.38.12.4593-4598.2000; WHO, 2001, WHO GLOB STRAT CONT; YAMAGUCHI A, 1990, J BIOL CHEM, V265, P15525	41	11	12	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168983	10.1371/journal.pone.0168983	http://dx.doi.org/10.1371/journal.pone.0168983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030622	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000094
J	Roberts, D; Hillstrom, H; Kim, JH				Roberts, Dustyn; Hillstrom, Howard; Kim, Joo H.			Instantaneous Metabolic Cost of Walking: Joint-Space Dynamic Model with Subject Specific Heat Rate	PLOS ONE			English	Article							TO-STEP TRANSITIONS; ENERGY-EXPENDITURE; MECHANICAL WORK; MUSCLE ACTIVATION; ISB RECOMMENDATION; SWING PHASE; OPTIMIZATION; ENERGETICS; MOTION; GAIT	A subject-specific model of instantaneous cost of transport (ICOT) is introduced from the joint-space formulation of metabolic energy expenditure using the laws of thermodynamics and the principles of multibody system dynamics. Work and heat are formulated in generalized coordinates as functions of joint kinematic and dynamic variables. Generalized heat rates mapped from muscle energetics are estimated from experimental walking metabolic data for the whole body, including upper-body and bilateral data synchronization. Identified subject-specific energetic parameters mass, height, (estimated) maximum oxygen uptake, and (estimated) maximum joint torques are incorporated into the heat rate, as opposed to the traditional in vitro and subject-invariant muscle parameters. The total model metabolic energy expenditure values are within 5.7 4.6% error of the measured values with strong (R-2> 0.90) inter- and intra-subject correlations. The model reliably predicts the characteristic convexity and magnitudes (0.326-0.348) of the experimental total COT (0.311-0.358) across different subjects and speeds. The ICOT as a function of time provides insights into gait energetic causes and effects (e.g., normalized comparison and sensitivity with respect to walking speed) and phase-specific COT, which are unavailable from conventional metabolic measurements or muscle models. Using the joint-space variables from commonly measured or simulated data, the models enable real-time and phase-specific evaluations of transient or non-periodic general tasks that use a range of (aerobic) energy pathway similar to that of steady-state walking.	[Roberts, Dustyn; Kim, Joo H.] NYU, Dept Mech & Aerosp Engn, Brooklyn, NY 11201 USA; [Hillstrom, Howard] Hosp Special Surg, Leon Root MD Mot Anal Lab, 535 E 70th St, New York, NY 10021 USA	New York University; New York University Tandon School of Engineering	Kim, JH (corresponding author), NYU, Dept Mech & Aerosp Engn, Brooklyn, NY 11201 USA.	joo.h.kim@nyu.edu	Kim, Joo/I-9517-2012; Roberts, Dustyn/E-9493-2010	Roberts, Dustyn/0000-0002-5898-8555	U.S. National Science Foundation [CMMI-1436636, IIS-1427193, DGE-1104522]; International Society of Biomechanics (ISB) Student Matching Dissertation Grant	U.S. National Science Foundation(National Science Foundation (NSF)); International Society of Biomechanics (ISB) Student Matching Dissertation Grant	Funded by U.S. National Science Foundation grant numbers CMMI-1436636 and IIS-1427193 to JHK. U.S. National Science Foundation grant number DGE-1104522 to DR. and International Society of Biomechanics (ISB) Student Matching Dissertation Grant to DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2010, J BIOMECH, V43, P1055, DOI 10.1016/j.jbiomech.2009.12.012; Anderson DE, 2007, J BIOMECH, V40, P3105, DOI 10.1016/j.jbiomech.2007.03.022; Anderson FC, 2001, J BIOMECH ENG-T ASME, V123, P381, DOI 10.1115/1.1392310; Anderson FC, 2001, J BIOMECH, V34, P153, DOI 10.1016/S0021-9290(00)00155-X; Ashby BM, 2006, J BIOMECH, V39, P1726, DOI 10.1016/j.jbiomech.2005.04.017; Au SK, 2009, IEEE T ROBOT, V25, P51, DOI 10.1109/TRO.2008.2008747; Bhargava LJ, 2004, J BIOMECH, V37, P81, DOI 10.1016/S0021-9290(03)00239-2; Bhounsule PA, 2014, INT J ROBOT RES, V33, P1305, DOI 10.1177/0278364914527485; Black W.Z., 1991, THERMODYNAMICS, V2nd ed.; BROCKWAY JM, 1987, HUM NUTR-CLIN NUTR, V41C, P463; Brown AM, 2014, GAIT POSTURE, V39, P915, DOI 10.1016/j.gaitpost.2013.12.007; Brychta R, 2010, IEEE ENG MED BIOL, V29, P42, DOI 10.1109/MEMB.2009.935463; Carr C., 2005, THESIS; Chappell MA, 2009, J EXP BIOL, V212, P610, DOI 10.1242/jeb.025775; DAVY DT, 1987, J BIOMECH, V20, P187, DOI 10.1016/0021-9290(87)90310-1; DEMPSTER WT, 1967, AM J ANAT, V120, P33, DOI 10.1002/aja.1001200104; Dlugosz EM, 2009, J EXP BIOL, V212, P2612, DOI 10.1242/jeb.029058; Doke J, 2007, J EXP BIOL, V210, P2390, DOI 10.1242/jeb.02782; Donelan JM, 2008, SCIENCE, V319, P807, DOI 10.1126/science.1149860; Donelan JM, 2002, J EXP BIOL, V205, P3717; ELIA M, 1992, ENERGY METABOLISM, P61; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; Farris DJ, 2012, J R SOC INTERFACE, V9, P110, DOI 10.1098/rsif.2011.0182; Frey-Law LA, 2012, J APPL BIOMECH, V28, P726, DOI 10.1123/jab.28.6.726; GARG A, 1978, AM IND HYG ASSOC J, V39, P661, DOI 10.1080/0002889778507831; Glass SC, 2006, ACSMS METABOLIC CALC; Gonzalez-Alonso J, 2000, J PHYSIOL-LONDON, V524, P603, DOI 10.1111/j.1469-7793.2000.00603.x; Gordon KE, 2009, ARCH PHYS MED REHAB, V90, P136, DOI 10.1016/j.apmr.2008.07.014; Hall C, 2004, MED SCI SPORT EXER, V36, P2128, DOI 10.1249/01.MSS.0000147584.87788.0E; HANAVAN E P Jr, 1964, AMRL TR, P1; Hawkins D, 1997, ANN BIOMED ENG, V25, P822, DOI 10.1007/BF02684166; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Holzbaur KRS, 2007, J BIOMECH, V40, P2442, DOI 10.1016/j.jbiomech.2006.11.013; Hortobagyi T, 2011, J GERONTOL A-BIOL, V66, P541, DOI 10.1093/gerona/glr008; Joshi V, 2015, P ROY SOC A-MATH PHY, V471, DOI 10.1098/rspa.2014.0662; Kim JA, 2015, COMMUN ALGEBRA, V43, P1983, DOI 10.1080/00927872.2014.881835; Kim JH, 2014, MULTIBODY SYST DYN, V31, P257, DOI 10.1007/s11044-013-9376-5; Kim JH, 2010, MULTIBODY SYST DYN, V24, P1, DOI 10.1007/s11044-010-9193-z; Kramer PA, 2008, GAIT POSTURE, V27, P209, DOI 10.1016/j.gaitpost.2007.03.009; Kuo AD, 2007, IEEE ROBOT AUTOM MAG, V14, P18, DOI 10.1109/MRA.2007.380653; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Langhaar H.L., 1989, ENERGY METHODS APPL, V2nd; Long LL, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0980; Margaria R, 1968, Int Z Angew Physiol, V25, P339; Mian OS, 2006, ACTA PHYSIOL, V186, P127, DOI 10.1111/j.1748-1716.2006.01522.x; Millard M, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023390; Miller RH, 2013, P AM SOC BIOM C OM N; Miller RH, 2014, J BIOMECH, V47, P1373, DOI 10.1016/j.jbiomech.2014.01.049; Morton RH, 2006, EUR J APPL PHYSIOL, V96, P339, DOI 10.1007/s00421-005-0088-2; Mummolo C, 2016, COMPUT METHOD BIOMEC, V19, P1127, DOI 10.1080/10255842.2015.1110146; Mummolo C, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024755; Orendurff MS, 2008, J REHABIL RES DEV, V45, P1077, DOI 10.1682/JRRD.2007.11.0197; Pontzer H, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0935; Prilutsky BI, 1997, J APPL BIOMECH, V13, P466, DOI 10.1123/jab.13.4.466; Rab G, 2002, GAIT POSTURE, V15, P113, DOI 10.1016/S0966-6362(01)00155-2; Radhakrishnan V, 1998, P NATL ACAD SCI USA, V95, P5448, DOI 10.1073/pnas.95.10.5448; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Sasaki K, 2009, J EXP BIOL, V212, P738, DOI 10.1242/jeb.023267; Schwartz MH, 2008, J BIOMECH, V41, P1639, DOI 10.1016/j.jbiomech.2008.03.015; SEALE JL, 1990, AM J CLIN NUTR, V52, P66, DOI 10.1093/ajcn/52.1.66; Selinger JC, 2014, J APPL PHYSIOL, V117, P1406, DOI 10.1152/japplphysiol.00445.2014; Sherman MA, 2014, PROCEEDINGS OF THE ASME INTERNATIONAL DESIGN ENGINEERING TECHNICAL CONFERENCES AND COMPUTERS AND INFORMATION IN ENGINEERING CONFERENCE, 2013, VOL 7B; Silder A, 2007, J BIOMECH, V40, P2628, DOI 10.1016/j.jbiomech.2006.12.017; Slider A, 2012, J BIOMECH, V45, P1842, DOI 10.1016/j.jbiomech.2012.03.032; Sockol MD, 2007, P NATL ACAD SCI USA, V104, P12265, DOI 10.1073/pnas.0703267104; Sohn MH, 2013, J BIOMECH, V46, P1363, DOI 10.1016/j.jbiomech.2013.01.020; Soo CH, 2010, J EXP BIOL, V213, P4265, DOI 10.1242/jeb.044214; Srinivasan M, 2011, J R SOC INTERFACE, V8, P74, DOI 10.1098/rsif.2009.0544; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Thompson W. R., 2009, ACSMS GUIDELINES EXE; Umberger BR, 2007, J EXP BIOL, V210, P3255, DOI 10.1242/jeb.000950; Umberger Brian R., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P99, DOI 10.1080/1025584031000091678; Umberger BR, 2011, EXERC SPORT SCI REV, V39, P59, DOI 10.1097/JES.0b013e31820d7bc5; Umberger BR, 2010, J R SOC INTERFACE, V7, P1329, DOI 10.1098/rsif.2010.0084; Uth N, 2004, EUR J APPL PHYSIOL, V91, P111, DOI 10.1007/s00421-003-0988-y; van Bolhuis BM, 1999, BIOL CYBERN, V81, P249, DOI 10.1007/s004220050560; Vologodskii A, 2006, PHYS LIFE REV, V3, P119, DOI 10.1016/j.plrev.2006.02.002; Walcott S, 2013, CELL MOL BIOENG, V6, P13, DOI 10.1007/s12195-012-0259-2; WARDSMITH AJ, 1985, J BIOMECH, V18, P337, DOI 10.1016/0021-9290(85)90289-1; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Weyand PG, 2010, J EXP BIOL, V213, P3972, DOI 10.1242/jeb.048199; Whittington B, 2008, GAIT POSTURE, V27, P628, DOI 10.1016/j.gaitpost.2007.08.005; Willis WT, 2005, METABOLISM, V54, P793, DOI 10.1016/j.metabol.2005.01.024; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; WINTER DA, 1979, J APPL PHYSIOL, V46, P79, DOI 10.1152/jappl.1979.46.1.79; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Xiang YJ, 2010, STRUCT MULTIDISCIP O, V41, P465, DOI 10.1007/s00158-009-0423-z; Yang JZ, 2009, J BIOMECH, V42, P1762, DOI 10.1016/j.jbiomech.2009.04.048; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359; Zelik KE, 2010, J EXP BIOL, V213, P4257, DOI 10.1242/jeb.044297; Zhang LQ, 2001, J BIOMECH, V34, P1107, DOI 10.1016/S0021-9290(01)00080-X	93	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168070	10.1371/journal.pone.0168070	http://dx.doi.org/10.1371/journal.pone.0168070			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030598	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000033
J	Buijink, MR; Almog, A; Wit, CB; Roethler, O; Engberink, AHOO; Meijer, JH; Garlaschelli, D; Rohling, JHT; Michel, S				Buijink, M. Renate; Almog, Assaf; Wit, Charlotte B.; Roethler, Ori; Engberink, Anneke H. O. Olde; Meijer, Johanna H.; Garlaschelli, Diego; Rohling, Jos H. T.; Michel, Stephan			Evidence for Weakened Intercellular Coupling in the Mammalian Circadian Clock under Long Photoperiod	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; MOUSE; MECHANISMS; RHYTHMS; NEURONS; PHASE; PRECISION; ALTERS; ONSET	For animals living in temperate latitudes, seasonal changes in day length are an important cue for adaptations of their physiology and behavior to the altered environmental conditions. The suprachiasmatic nucleus (SCN) is known as the central circadian clock in mammals, but may also play an important role in adaptations to different photoperiods. The SCN receives direct light input from the retina and is able to encode day-length by approximating the waveform of the electrical activity rhythm to the duration of daylight. Changing the overall waveform requires a reorganization of the neuronal network within the SCN with a change in the degree of synchrony between the neurons; however, the underlying mechanisms are yet unknown. In the present study we used PER2::LUC bioluminescence imaging in cultured SCN slices to characterize network dynamics on the single-cell level and we aimed to provide evidence for a role of modulations in coupling strength in the photoperiodic-induced phase dispersal. Exposure to long photoperiod (LP) induced a larger distribution of peak times of the single-cell PER2::LUC rhythms in the anterior SCN, compared to short photoperiod. Interestingly, the cycle-to-cycle variability in single-cell period of PER2::LUC rhythms is also higher in the anterior SCN in LP, and is positively correlated with peak time dispersal. Applying a new, impartial community detection method on the time series data of the PER2::LUC rhythm revealed two clusters of cells with a specific spatial distribution, which we define as dorsolateral and ventromedial SCN. Post hoc analysis of rhythm characteristics of these clusters showed larger cycle-to-cycle single-cell period variability in the dorsolateral compared to the ventromedial cluster in the anterior SCN. We conclude that a change in coupling strength within the SCN network is a plausible explanation to the observed changes in single-cell period variability, which can contribute to the photoperiod-induced phase distribution.	[Buijink, M. Renate; Wit, Charlotte B.; Roethler, Ori; Engberink, Anneke H. O. Olde; Meijer, Johanna H.; Rohling, Jos H. T.; Michel, Stephan] Leiden Univ, Med Ctr, Neurophysiol Lab, Dept Mol Cell Biol, Leiden, Netherlands; [Almog, Assaf; Garlaschelli, Diego] Leiden Univ, Lorentz Inst Theoret Phys, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Michel, S (corresponding author), Leiden Univ, Med Ctr, Neurophysiol Lab, Dept Mol Cell Biol, Leiden, Netherlands.	s.michel@lumc.nl	Michel, Stephan/ABC-4211-2021; Garlaschelli, Diego/P-2795-2019; Rohling, Jos/AAC-3516-2022; Garlaschelli, Diego/O-4862-2014	Garlaschelli, Diego/0000-0001-6035-1783; Olde Engberink, Anneke/0000-0002-0100-4770; Rohling, Jos H T/0000-0001-5721-2715; Buijink, Renate/0000-0002-0904-139X	Netherlands Foundation of Technology [STW] [ONTIME 12191]	Netherlands Foundation of Technology [STW]	This work was supported by funding from the Netherlands Foundation of Technology [STW, ONTIME 12191] to SM.	Abel JH, 2016, P NATL ACAD SCI USA, V113, P4512, DOI 10.1073/pnas.1521178113; Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Almog A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133679; CHEE CA, 1988, NEUROBIOL AGING, V9, P307, DOI 10.1016/S0197-4580(88)80070-8; Coomans CP, 2015, FRONT NEUROENDOCRIN, V37, P29, DOI 10.1016/j.yfrne.2014.11.002; Daan S, 2003, CHRONOBIOL INT, V20, P209, DOI 10.1081/CBI-120019309; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; DeWoskin D, 2015, P NATL ACAD SCI USA, V112, pE3911, DOI 10.1073/pnas.1420753112; Eilers PHC, 2003, ANAL CHEM, V75, P3631, DOI 10.1021/ac034173t; Evans JA, 2016, NEUROSCIENCE, V320, P259, DOI 10.1016/j.neuroscience.2016.01.072; Evans JA, 2013, NEURON, V80, P973, DOI 10.1016/j.neuron.2013.08.022; Evans JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015869; Farajnia S, 2014, P NATL ACAD SCI USA, V111, P9627, DOI 10.1073/pnas.1319820111; Farajnia S, 2012, J NEUROSCI, V32, P5891, DOI 10.1523/JNEUROSCI.0469-12.2012; Foley NC, 2011, EUR J NEUROSCI, V33, P1851, DOI 10.1111/j.1460-9568.2011.07682.x; Forger DB, 2005, P NATL ACAD SCI USA, V102, P321, DOI 10.1073/pnas.0408465102; Gonze D, 2006, CHAOS, V16, DOI 10.1063/1.2211767; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Hazlerigg DG, 2005, CURR BIOL, V15, pR449, DOI 10.1016/j.cub.2005.06.010; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Honma S, 2004, NEUROSCI LETT, V358, P173, DOI 10.1016/j.neulet.2004.01.022; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Krajnak K, 1998, J NEUROSCI, V18, P4767; Laloux L, 1999, PHYS REV LETT, V83, P1467, DOI 10.1103/PhysRevLett.83.1467; MacMahon M, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021006; Mickman CT, 2008, AM J PHYSIOL-REG I, V295, pR1688, DOI 10.1152/ajpregu.90510.2008; Myung J, 2015, P NATL ACAD SCI USA, V112, pE3920, DOI 10.1073/pnas.1421200112; Myung J, 2012, J NEUROSCI, V32, P8900, DOI 10.1523/JNEUROSCI.5586-11.2012; Naito E, 2008, J BIOL RHYTHM, V23, P140, DOI 10.1177/0748730408314572; Nygard M, 2005, BRAIN RES BULL, V65, P149, DOI 10.1016/j.brainresbull.2004.12.006; Pauls S, 2014, EUR J NEUROSCI, V40, P2528, DOI 10.1111/ejn.12631; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Savelyev SA, 2011, JOVE-J VIS EXP, DOI 10.3791/2439; Schaap J, 2003, P NATL ACAD SCI USA, V100, P15994, DOI 10.1073/pnas.2436298100; Schroder S, 2012, J BIOL RHYTHM, V27, P79, DOI 10.1177/0748730411429659; Sosniyenko S, 2010, AM J PHYSIOL-REG I, V298, pR959, DOI 10.1152/ajpregu.00561.2009; VanderLeest HT, 2007, CURR BIOL, V17, P468, DOI 10.1016/j.cub.2007.01.048; vanderLeest HT, 2009, CHRONOBIOL INT, V26, P1075, DOI 10.1080/07420520903227746; Yan L, 2007, COLD SH Q B, V72, P527, DOI 10.1101/sqb.2007.72.037; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775	41	30	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168954	10.1371/journal.pone.0168954	http://dx.doi.org/10.1371/journal.pone.0168954			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006027	Green Submitted, Green Published, gold			2022-12-26	WOS:000392843200115
J	Sun, YJ; Dong, LN; Yu, SQ; Wang, XX; Zheng, H; Zhang, P; Meng, CC; Zhan, Y; Tan, L; Song, CP; Qiu, XS; Wang, GJ; Liao, Y; Ding, C				Sun, Yingjie; Dong, Luna; Yu, Shengqing; Wang, Xiaoxu; Zheng, Hang; Zhang, Pin; Meng, Chunchun; Zhan, Yuan; Tan, Lei; Song, Cuiping; Qiu, Xusheng; Wang, Guijun; Liao, Ying; Ding, Chan			Newcastle disease virus induces stable formation of bona fide stress granules to facilitate viral replication through manipulating host protein translation	FASEB JOURNAL			English	Article						stress granules; Newcastle disease virus; replication; TIA-1; TIAR	HEPATITIS-C VIRUS; MESSENGER-RNA; NUCLEOCAPSID PROTEIN; V-PROTEIN; P-PROTEIN; INITIATION; RECRUITMENT; ACTIVATION; INHIBITION; TIA-1	Mammalian cells respond to various environmental stressors to form stress granules (SGs) by arresting cytoplasmic mRNA, protein translation element, and RNA binding proteins. Virus-induced SGs function in different ways, depending on the species of virus; however, themechanismofSGregulation of virus replication is not well understood. In this study, Newcastle disease virus (NDV) triggered stable formation of bona fide SGs on HeLa cells through activating the protein kinase R (PKR)/eIF2a pathway. NDV-induced SGs contained classic SGmarkers T-cell internal antigen (TIA)(-1), RasGTPase-activatingprotein-binding protein (G3BP)(-1), eukaryotic initiation factors, andsmall ribosomal subunit, which could be disassembled in the presence of cycloheximide. Treatment with nocodazole, amicrotubule disruptiondrug, led to the formation of relatively small and circular granules, indicating that NDV infection induces canonical SGs. Furthermore, the role of SGs on NDV replication was investigated by knockdown of TIA(-1) and TIA(-1)-related (TIAR) protein, the 2 critical components involved in SG formation from the HeLa cells, followed by NDV infection. Results showed that depletion of TIA-1 orTIARinhibitedviral protein synthesis, reducedextracellularvirus yields, but increasedglobal protein translation. FISH revealed that NDV-induced SGs contained predominantly cellular mRNA rather than viral mRNA. Deletion of TIA(-1) or TIAR reduced NP mRNA levels in polysomes. These results demonstrate that NDV triggers stable formationofbonafideSGs, whichbenefit viralprotein translation andvirus replicationbyarresting cellularmRNA.-Sun, Y., Dong, L., Yu, S., Wang, X., Zheng, H., Zhang, P., Meng, C., Zhan, Y., Tan, L., Song, C., Qiu, X., Wang, G., Liao, Y., Ding, C. Newcastle disease virus induces stable formation of bona fide stress granules to facilitate viral replication through manipulating host protein translation.	[Sun, Yingjie; Dong, Luna; Yu, Shengqing; Wang, Xiaoxu; Zheng, Hang; Zhang, Pin; Meng, Chunchun; Zhan, Yuan; Tan, Lei; Song, Cuiping; Qiu, Xusheng; Liao, Ying; Ding, Chan] Chinese Acad Agr Sci, Dept Avian Infect Dis, Shanghai Vet Res Inst, Shanghai, Peoples R China; [Dong, Luna; Zheng, Hang] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Peoples R China; [Wang, Xiaoxu; Wang, Guijun] Anhui Agr Univ, Coll Anim Sci & Technol, Hefei, Peoples R China; [Ding, Chan] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Jilin Agricultural University; Anhui Agricultural University	Ding, C (corresponding author), 518 Ziyue Rd, Shanghai 200241, Peoples R China.	shoveldeen@shvri.ac.cn			National Natural Science Foundation of China [31530074, 31400144]; Chinese Special Fund for Agroscientific Research in the Public Interest [201303033]; Shanghai Youth Scientific and Technological Yang Fan Program [14YF1408000]; China Postdoctoral Special Science Foundation Funded Project [2014M550107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Special Fund for Agroscientific Research in the Public Interest; Shanghai Youth Scientific and Technological Yang Fan Program; China Postdoctoral Special Science Foundation Funded Project	The authors thank Dr. Shilei Zhang (Tsinghua University, Beijing, China) and Dr. Hongjun Chen (Shanghai Veterinary Research Institute) for technical assistance. This work was funded by National Natural Science Foundation of China Grants 31530074 (to C.D.) and 31400144 (to Y.S.); Chinese Special Fund for Agroscientific Research in the Public Interest Grant 201303033 (to C.D.); Shanghai Youth Scientific and Technological Yang Fan Program Grant 14YF1408000 (to Y.S.); and China Postdoctoral Special Science Foundation Funded Project 2014M550107 (to Y.S.). The authors declare no conflicts of interest.	Alexander DJ, 2000, REV SCI TECH OIE, V19, P443, DOI 10.20506/rst.19.2.1231; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; Chernov KG, 2009, J BIOL CHEM, V284, P36569, DOI 10.1074/jbc.M109.042879; Curran J, 1996, VIROLOGY, V221, P130, DOI 10.1006/viro.1996.0359; Dinh PX, 2013, J VIROL, V87, P372, DOI 10.1128/JVI.02305-12; Emara MM, 2012, BIOCHEM BIOPH RES CO, V423, P763, DOI 10.1016/j.bbrc.2012.06.033; Fiola C, 2006, INT J CANCER, V119, P328, DOI 10.1002/ijc.21821; Gainey MD, 2008, J VIROL, V82, P828, DOI 10.1128/JVI.02023-07; Garaigorta U, 2012, J VIROL, V86, P11043, DOI 10.1128/JVI.07101-11; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Horikami SM, 1996, VIROLOGY, V222, P383, DOI 10.1006/viro.1996.0435; Iseni F, 2002, EMBO J, V21, P5141, DOI 10.1093/emboj/cdf513; Ivanov PA, 2003, EXP CELL RES, V290, P227, DOI 10.1016/S0014-4827(03)00290-8; Jiang K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-551; Katoh H, 2013, J VIROL, V87, P489, DOI 10.1128/JVI.02186-12; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Khaperskyy DA, 2012, FASEB J, V26, P1629, DOI 10.1096/fj.11-196915; Kolakofsky D, 1998, J VIROL, V72, P891, DOI 10.1128/JVI.72.2.891-899.1998; Krishnamurthy S, 2006, J VIROL, V80, P5145, DOI 10.1128/JVI.02618-05; Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002; Lindquist ME, 2010, J VIROL, V84, P12274, DOI 10.1128/JVI.00260-10; Liu J, 2015, J VIROL, V89, P1925, DOI 10.1128/JVI.02262-14; MASTERS PS, 1988, J VIROL, V62, P2658, DOI 10.1128/JVI.62.8.2658-2664.1988; Matsuki H, 2013, GENES CELLS, V18, P135, DOI 10.1111/gtc.12023; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; Meng CC, 2012, ARCH VIROL, V157, P1011, DOI 10.1007/s00705-012-1270-6; Meng G, 2014, ONCOTARGET, V5, P6365, DOI 10.18632/oncotarget.2219; Nadezhdina ES, 2010, BBA-MOL CELL RES, V1803, P361, DOI 10.1016/j.bbamcr.2009.12.004; Ng CS, 2013, J VIROL, V87, P9511, DOI 10.1128/JVI.03248-12; NOVER L, 1989, MOL CELL BIOL, V9, P1298, DOI 10.1128/MCB.9.3.1298; Oh SW, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005444; Okonski KM, 2013, J VIROL, V87, P756, DOI 10.1128/JVI.02270-12; Onomoto K, 2014, TRENDS IMMUNOL, V35, P420, DOI 10.1016/j.it.2014.07.006; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Piotrowska J, 2010, J VIROL, V84, P3654, DOI 10.1128/JVI.01320-09; Qin QS, 2009, J VIROL, V83, P11090, DOI 10.1128/JVI.01239-09; Qiu Xusheng, 2014, ScientificWorldJournal, V2014, P934851, DOI 10.1155/2014/934851; REICHARD KW, 1992, J SURG RES, V52, P448, DOI 10.1016/0022-4804(92)90310-V; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Romer-Oberdorfer A, 2003, J GEN VIROL, V84, P3121, DOI 10.1099/vir.0.19416-0; Rozelle DK, 2014, MOL CELL BIOL, V34, P2003, DOI 10.1128/MCB.01630-13; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; Simpson-Holley M, 2011, J VIROL, V85, P1581, DOI 10.1128/JVI.02247-10; Smith EC, 2009, FEBS J, V276, P7217, DOI 10.1111/j.1742-4658.2009.07401.x; Sun YJ, 2014, J VIROL, V88, P525, DOI 10.1128/JVI.01849-13; Takeuchi K, 2008, J VIROL, V82, P10102, DOI 10.1128/JVI.00599-08; Wang XX, 2009, J VIROL, V83, P12462, DOI 10.1128/JVI.01546-09; WEISS SR, 1974, J VIROL, V13, P1220, DOI 10.1128/JVI.13.6.1220-1230.1974; White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006; Willcocks MM, 2011, J VIROL, V85, P4452, DOI 10.1128/JVI.01107-10; Zengel J, 2015, J VIROL, V89, P7338, DOI 10.1128/JVI.00686-15	59	25	32	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1337	1353		10.1096/fj.201600980R	http://dx.doi.org/10.1096/fj.201600980R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28011649				2022-12-26	WOS:000398504300008
J	Gajsiewicz, JM; Smith, SA; Morrissey, JH				Gajsiewicz, Joshua M.; Smith, Stephanie A.; Morrissey, James H.			Polyphosphate and RNA Differentially Modulate the Contact Pathway of Blood Clotting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						coagulation factor; hemostasis; nucleic acid; RNA; thrombosis	MOLECULAR-WEIGHT KININOGEN; COAGULATION-FACTOR-XII; THROMBUS FORMATION; PLASMA PREKALLIKREIN; MYOCARDIAL-INFARCTION; HAGEMAN-FACTOR; IN-VIVO; ACTIVATION; INFLAMMATION; MECHANISMS	The contact pathway of the plasma clotting cascade is dispensable for normal hemostasis, but contributes to thrombosis and serves as a bridge between inflammation and coagulation. This pathway is triggered upon exposure of plasma to certain anionic polymers and artificial surfaces. Recently, extracellular nucleic acids and inorganic polyphosphate (polyP) have been implicated as being important (patho)physiologically relevant activators of this pathway. However, mechanistic details regarding how nucleic acids or polyP modulate the individual reactions of the contact pathway have been lacking. In this study, we investigate the ability of RNA homopolymers and polyP to bind the primary constituents of the contact pathway: factor XIa, factor XIIa, and plasma kallikrein, in the presence and absence of high molecular weight kininogen (HK), an important cofactor in this pathway. We examine seven proteolytic activation reactions within the contact pathway and report that polyP greatly enhances the rate of all seven, while RNA is effective in supporting only a subset of these reactions. HK both enhances and suppresses these proteolytic activation reactions, depending on the specific reaction evaluated. Overall, we find that polyP is a potent mediator of contact pathway activation reactions in general, that RNA secondary structure may be important to its procoagulant activity, and that nucleic acids versus polyP may differentially modulate specific enzyme activation events within the contact pathway.	[Gajsiewicz, Joshua M.; Smith, Stephanie A.; Morrissey, James H.] Univ Illinois, Dept Biochem, 323 Roger Adams Lab,MC-712,600 S Mathews Ave, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Morrissey, JH (corresponding author), Univ Illinois, Dept Biochem, 323 Roger Adams Lab,MC-712,600 S Mathews Ave, Urbana, IL 61801 USA.	jhmorris@illinois.edu	Morrissey, James H./GLR-5645-2022; Morrissey, James H/H-4933-2011	Morrissey, James H/0000-0002-1570-1569	NHLBI of the National Institutes of Health [R01 HL047014, UM1HL120877]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047014, UM1HL120877] Funding Source: NIH RePORTER	NHLBI of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grants R01 HL047014 and UM1HL120877 from the NHLBI of the National Institutes of Health. S.A.S. and J.H.M. are inventors on patents and pending patent applications on medical uses of polyP and polyP inhibitors. The research laboratory of J.H.M. receives revenues from sales of polyP and polyP derivatives through Kerafast, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BERNARDO MM, 1993, J BIOL CHEM, V268, P12477; Bhagirath VC, 2015, SHOCK, V44, P265, DOI 10.1097/SHK.0000000000000397; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cheng QF, 2010, BLOOD, V116, P3981, DOI 10.1182/blood-2010-02-270918; Choi SH, 2011, BLOOD, V118, P6963, DOI 10.1182/blood-2011-07-368811; Choi SH, 2010, BIOCHEMISTRY-US, V49, P9935, DOI 10.1021/bi1014437; Doggen CJM, 2006, BLOOD, V108, P4045, DOI 10.1182/blood-2005-12-023697; Engel R, 2014, J THROMB HAEMOST, V12, P1513, DOI 10.1111/jth.12663; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gansler J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050399; Geng Y, 2013, J THROMB HAEMOST, V11, P2020, DOI 10.1111/jth.12414; Geng YP, 2013, BLOOD, V121, P3962, DOI 10.1182/blood-2012-12-473629; Gould TJ, 2014, ARTERIOSCL THROM VAS, V34, P1977, DOI 10.1161/ATVBAHA.114.304114; GRIFFIN JH, 1976, P NATL ACAD SCI USA, V73, P2554, DOI 10.1073/pnas.73.8.2554; Grundt H, 2004, AM HEART J, V147, P260, DOI 10.1016/j.ahj.2003.07.012; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Kokoye Y, 2016, THROMB RES, V140, P118, DOI 10.1016/j.thromres.2016.02.020; Kuijpers MJE, 2014, ARTERIOSCL THROM VAS, V34, P1674, DOI 10.1161/ATVBAHA.114.303315; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; LEVISON PR, 1982, BIOCHEM J, V205, P529, DOI 10.1042/bj2050529; Long AT, 2016, J THROMB HAEMOST, V14, P427, DOI 10.1111/jth.13235; Maas C, 2008, J CLIN INVEST, V118, P3208, DOI [10.1172/JC135424, 10.1172/JCI35424]; Martinod K, 2014, BLOOD, V123, P2768, DOI 10.1182/blood-2013-10-463646; Matafonov A, 2014, BLOOD, V123, P1739, DOI 10.1182/blood-2013-04-499111; Merlo C, 2002, ATHEROSCLEROSIS, V161, P261, DOI 10.1016/S0021-9150(01)00666-9; MILLER G, 1980, BIOCHEM BIOPH RES CO, V92, P803, DOI 10.1016/0006-291X(80)90774-3; Morrissey JH, 2012, BLOOD, V119, P5972, DOI 10.1182/blood-2012-03-306605; MORRISSEY JH, 1993, BLOOD, V81, P734; Muller F, 2008, CURR OPIN HEMATOL, V15, P516, DOI 10.1097/MOH.0b013e328309ec85; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; NAITO K, 1991, J BIOL CHEM, V266, P7353; Petrovic AG, 2008, J PHYS CHEM B, V112, P2255, DOI 10.1021/jp075873v; RATNOFF OD, 1955, J CLIN INVEST, V34, P602, DOI 10.1172/JCI103109; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Renne Thomas, 2007, Expert Rev Cardiovasc Ther, V5, P733, DOI 10.1586/14779072.5.4.733; Revenko AS, 2011, BLOOD, V118, P5302, DOI 10.1182/blood-2011-05-355248; Schmaier AH, 2007, J THROMB HAEMOST, V5, P2323, DOI 10.1111/j.1538-7836.2007.02770.x; SCOTT CF, 1984, J CLIN INVEST, V73, P954, DOI 10.1172/JCI111319; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Smith SA, 2012, BLOOD, V120, P5103, DOI 10.1182/blood-2012-07-444935; Smith SA, 2010, BLOOD, V116, P4353, DOI 10.1182/blood-2010-01-266791; TANKERSLEY DL, 1984, BIOCHEMISTRY-US, V23, P273, DOI 10.1021/bi00297a016; TANS G, 1987, J BIOL CHEM, V262, P11308; Travers RJ, 2014, BLOOD, V124, P3183, DOI 10.1182/blood-2014-05-577932; van der Meijden PEJ, 2009, BLOOD, V114, P881, DOI 10.1182/blood-2008-07-171066; Vu TT, 2013, THROMB HAEMOSTASIS, V109, P421, DOI 10.1160/TH12-07-0465	46	26	27	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1808	1814		10.1074/jbc.M116.754325	http://dx.doi.org/10.1074/jbc.M116.754325			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28007958	Green Published, hybrid			2022-12-26	WOS:000395515600022
J	Berres, ME; Garic, A; Flentke, GR; Smith, SM				Berres, Mark E.; Garic, Ana; Flentke, George R.; Smith, Susan M.			Transcriptome Profiling Identifies Ribosome Biogenesis as a Target of Alcohol Teratogenicity and Vulnerability during Early Embryogenesis	PLOS ONE			English	Article							NEURAL CREST APOPTOSIS; DAVID BIOINFORMATICS RESOURCES; ETHANOL-INDUCED APOPTOSIS; TREACHER-COLLINS-SYNDROME; DIAMOND-BLACKFAN ANEMIA; LARGE GENE LISTS; SPECTRUM DISORDERS; BIRTH-DEFECTS; ZEBRAFISH MODEL; BETA-CATENIN	Fetal alcohol spectrum disorder (FASD) is a leading cause of neurodevelopmental disability. Individuals with FASD may exhibit a characteristic facial appearance that has diagnostic utility. The mechanism by which alcohol disrupts craniofacial development is incompletely understood, as are the genetic factors that can modify individual alcohol vulnerability. Using an established avian model, we characterized the cranial transcriptome in response to alcohol to inform the mechanism underlying these cells' vulnerability. Gallus gallus embryos having 3-6 somites were exposed to 52 mM alcohol and the cranial transcriptomes were sequenced thereafter. A total of 3422 genes had significantly differential expression. The KEGG pathways with the greatest enrichment of differentially expressed gene clusters were Ribosome (P = 1.2 x 10(-17), 67 genes), Oxidative Phosphorylation (P = 4.8 x 10(-12), 60 genes), RNA Polymerase (P = 2.2 x 10(-3), 15 genes) and Spliceosome (P = 2.6 x 10(-2), 39 genes). The preponderance of transcripts in these pathways were repressed in response to alcohol. These same gene clusters also had the greatest altered representation in our previous comparison of neural crest populations having differential vulnerability to alcohol-induced apoptosis. Comparison of differentially expressed genes in alcohol-exposed (3422) and untreated, alcohol-vulnerable (1201) transcriptomes identified 525 overlapping genes of which 257 have the same direction of transcriptional change. These included 36 ribosomal, 25 oxidative phosphorylation and 7 spliceosome genes. Using a functional approach in zebrafish, partial knockdown of ribosomal proteins zrpl11, zrpl5a, and zrps3a individually heightened vulnerability to alcohol-induced craniofacial deficits and increased apoptosis. In humans, haploinsufficiency of several of the identified ribosomal proteins are causative in craniofacial dysmorphologies such as Treacher Collins Syndrome and Diamond-Blackfan Anemia. This work suggests ribosome biogenesis may be a novel target mediating alcohol's damage to developing neural crest. Our findings are consistent with observations that gene-environment interactions contribute to vulnerability in FASD.	[Berres, Mark E.; Garic, Ana; Flentke, George R.; Smith, Susan M.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA; [Flentke, George R.; Smith, Susan M.] Univ North Carolina Chapel Hill, Dept Nutr, David H Murdoch Nutr Res Inst, Kannapolis, NC 28081 USA	University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill	Smith, SM (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.; Smith, SM (corresponding author), Univ North Carolina Chapel Hill, Dept Nutr, David H Murdoch Nutr Res Inst, Kannapolis, NC 28081 USA.	suesmith@nutrisci.wisc.edu			National Institute on Alcohol Abuse and Alcoholism [R37 AA011085]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA011085, R01AA011085] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Supported by award #R37 AA011085 from the National Institute on Alcohol Abuse and Alcoholism (www.niaaa.nih.gov) to SMS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00158; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aoto K, 2008, BIRTH DEFECTS RES A, V82, P224, DOI 10.1002/bdra.20447; Bjornard K, 2013, BIRTH DEFECTS RES A, V97, P87, DOI 10.1002/bdra.23111; Blader P, 1998, DEV BIOL, V201, P185, DOI 10.1006/dbio.1998.8995; Burd Larry, 2007, Congenit Heart Dis, V2, P250, DOI 10.1111/j.1747-0803.2007.00105.x; Burstyn-Cohen T, 2002, DEV CELL, V3, P383, DOI 10.1016/S1534-5807(02)00221-6; Cartwright MM, 1998, ALCOHOL CLIN EXP RES, V22, P142, DOI 10.1097/00000374-199802000-00019; Cartwright MM, 1995, ALCOHOL CLIN EXP RES, V19, P1454, DOI 10.1111/j.1530-0277.1995.tb01007.x; Carvan MJ, 2004, NEUROTOXICOL TERATOL, V26, P757, DOI 10.1016/j.ntt.2004.06.016; Chakraborty A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004152; Chen XP, 2015, EXP NEUROL, V271, P104, DOI 10.1016/j.expneurol.2015.04.026; Cunningham CC, 2001, BIOL SIGNAL RECEPT, V10, P271; Danilova N, 2014, DIS MODEL MECH, V7, P895, DOI 10.1242/dmm.015495; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Debelak KA, 2000, ALCOHOL CLIN EXP RES, V24, P307, DOI 10.1097/00000374-200003000-00008; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Dixon J, 2006, P NATL ACAD SCI USA, V103, P13403, DOI 10.1073/pnas.0603730103; Downing C, 2012, ALCOHOL CLIN EXP RES, V36, P1519, DOI 10.1111/j.1530-0277.2012.01757.x; Dunty WC, 2001, ALCOHOL CLIN EXP RES, V25, P1523, DOI 10.1111/j.1530-0277.2001.tb02156.x; Dyer LA, 2009, DEV BIOL, V336, P137, DOI 10.1016/j.ydbio.2009.10.009; Flentke GR, 2014, ALCOHOL CLIN EXP RES, V38, P1255, DOI 10.1111/acer.12360; Flentke GR, 2014, J NEUROCHEM, V128, P523, DOI 10.1111/jnc.12464; Flentke GR, 2011, BIRTH DEFECTS RES A, V91, P591, DOI 10.1002/bdra.20833; Fleurie A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004275; Garic A, 2014, ALCOHOL CLIN EXP RES, V38, P1874, DOI 10.1111/acer.12457; Garic-Stankovic A, 2005, ALCOHOL CLIN EXP RES, V29, P1237, DOI 10.1097/01.ALC.0000172460.05756.D9; Green ML, 2007, DEV DYNAM, V236, P613, DOI 10.1002/dvdy.21048; Hong MI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002999; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kietzman HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089448; Klingenberg CP, 2010, ALCOHOL, V44, P649, DOI 10.1016/j.alcohol.2009.10.016; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Lau MCC, 2016, BBA-MOL BASIS DIS, V1862, P1147, DOI 10.1016/j.bbadis.2016.03.005; Lipinski RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043067; Liu D, 2014, J GENET GENOMICS, V41, P43, DOI 10.1016/j.jgg.2013.11.004; Mandrell D, 2012, JALA-J LAB AUTOM, V17, P66, DOI 10.1177/2211068211432197; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mattson SN, 2013, ALCOHOL CLIN EXP RES, V37, P517, DOI 10.1111/j.1530-0277.2012.01952.x; May PA, 2014, PEDIATRICS, V134, P855, DOI 10.1542/peds.2013-3319; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; McCarthy N, 2013, DEVELOPMENT, V140, P3254, DOI 10.1242/dev.094938; McCarver DG, 1997, J PHARMACOL EXP THER, V283, P1095; McCormick ME, 2016, CURR OPIN HEMATOL, V23, P235, DOI 10.1097/MOH.0000000000000240; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miller MW, 2006, BRAIN DEV NORMAL PRO, pxv; Paige SL, 2015, CIRC RES, V116, P341, DOI 10.1161/CIRCRESAHA.116.302752; Rinon A, 2011, DEVELOPMENT, V138, P1827, DOI 10.1242/dev.053645; Ross AP, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00026; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Sloan KE, 2013, CELL REP, V5, P237, DOI 10.1016/j.celrep.2013.08.049; Smith SM, 2014, BIRTH DEFECTS RES C, V102, P210, DOI 10.1002/bdrc.21078; Swartz ME, 2014, ALCOHOL CLIN EXP RES, V38, P694, DOI 10.1111/acer.12286; Tan CH, 2015, MMWR-MORBID MORTAL W, V64, P1042, DOI 10.15585/mmwr.mm6437a3; Trainor PA, 2010, AM J MED GENET A, V152A, P2984, DOI 10.1002/ajmg.a.33454; Uechi T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000037; Valdez BC, 2004, P NATL ACAD SCI USA, V101, P10709, DOI 10.1073/pnas.0402492101; Vlachos A, 2008, BRIT J HAEMATOL, V142, P859, DOI 10.1111/j.1365-2141.2008.07269.x; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7	64	20	20	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169351	10.1371/journal.pone.0169351	http://dx.doi.org/10.1371/journal.pone.0169351			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046103	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300170
J	Giannenas, I; Bonos, E; Anestis, V; Filioussis, G; Papanastasiou, DK; Bartzanas, T; Papaioannou, N; Tzora, A; Skoufos, I				Giannenas, Ilias; Bonos, Eleftherios; Anestis, Vasileios; Filioussis, Georgios; Papanastasiou, Dimitrios K.; Bartzanas, Thomas; Papaioannou, Nikolaos; Tzora, Athina; Skoufos, Ioannis			Effects of Protease Addition and Replacement of Soybean Meal by Corn Gluten Meal on the Growth of Broilers and on the Environmental Performances of a Broiler Production System in Greece	PLOS ONE			English	Article							ESSENTIAL OIL COMPOUNDS; LIFE-CYCLE ASSESSMENT; NUTRIENT DIGESTIBILITY; AMINO-ACIDS; INTESTINAL MICROBIOTA; ANTIOXIDANT STATUS; CHICKEN PRODUCTION; EXOGENOUS ENZYMES; GREENHOUSE-GAS; RAPESEED MEAL	An experimental study was conducted to examine the combined effects of adding a dietary protease, reducing the levels of soybean meal (SBM) and introducing corn gluten meal (CGM) in the ration of a group of broilers reared on a commercial Greek farm. Five hundred forty chicks were divided into three dietary treatments with six replicates of thirty birds each. The first group (Control) was fed a conventional diet based on corn and soybean meal, containing 21% w/w crude protein (CP). The second group (Soy-Prot) was supplied a corn and SBM-based diet containing a lower level of CP (20% w/w) and 200 mg of the protease RONOZYME (R) Proact per kg of feed. The third group (Gluten-Prot) was fed a diet without soybean-related constituents which was based on corn and CGM and with CP and protease contents identical to those of the diet of the Soy-Prot group. Body weight, feed intake, feed conversion ratio (FCR), intestinal microbiota populations and morphology, meat quality and cost were evaluated. Furthermore, a partial life cycle assessment (LCA) was performed in order to assess the potential environmental performance of the systems defined by these three dietary treatments and identify their environmental hot-spots. The growth performance of the broilers supplied the Soy-Prot diet was similar to the broilers supplied the Control diet. However, the broilers which were fed the Gluten-Prot diet at the end of the trial showed a tendency (P <= 0.010) for lower weight gain and feed intake compared to those of the Control diet. When compared to the Control group, lower counts of C. perfringens (P <= 0.05) were detected in the ileum and cecum parts, and lower counts of F. necrophorum (P <= 0.001) were detected in the cecum part of the birds from the Gluten-Prot group. The evaluation of intestinal morphometry showed that the villus height and crypt depth values were not significantly different (P>0.05) among the experimental groups for the duodenum, jejunum and ileum parts. No significant differences (P>0.05) were observed in the quality of the breast and thigh meat and in the feed cost per kg body weight gain for the total duration of the growth period between the Control and Gluten-Prot broiler groups. The LCA suggested that the ammonia and nitrous oxide emissions due to litter handling constitute the farm level hot spots for the Acidification and Eutrophication Potentials of the Control and Soy-Prot systems and the Global Warming Potential of the Gluten-Prot system, respectively. The Latin American soybean production and domestic corn production and lignite mining are important off farm polluting processes for the studied life cycles. The Soy-Prot and Gluten-Prot systems both performed better than the Control system in nine of Environmental Impact Category Indicators assessed, with the respective differences being generally larger for the Gluten Prot system. The environmental impact estimates are regarded as initial, indicative figures due to their inherent uncertainty. Overall, the results could be considered as positive indications in the effort to sustainably replace the conventional, soybean-dependent control diet in the specific broiler production system.	[Giannenas, Ilias] Aristotle Univ Thessaloniki, Sch Vet Med, Lab Nutr, Thessaloniki, Greece; [Bonos, Eleftherios] Res Inst Anim Sci, ELGO Dimitra, Paralimni Giannitsa, Pella, Greece; [Anestis, Vasileios; Papanastasiou, Dimitrios K.; Bartzanas, Thomas] Inst Res & Technol Thessaly, Ctr Res & Technol Hellas, Lab Agr Engn & Environm, Volos, Greece; [Anestis, Vasileios] Univ Thessaly, Sch Agr Sci, Dept Agr Crop Prod & Rural Environm, Lab Agr Construct & Environm Control, Magnisia, Greece; [Filioussis, Georgios] Aristotle Univ Thessaloniki, Sch Vet Med, Lab Microbiol & Infect Dis, Thessaloniki, Greece; [Papaioannou, Nikolaos] Aristotle Univ Thessaloniki, Sch Vet Med, Pathol Lab, Thessaloniki, Greece; [Tzora, Athina; Skoufos, Ioannis] Technol Inst Epirus, Dept Agr Technol, Div Anim Prod, Ana, Greece	Aristotle University of Thessaloniki; Centre for Research & Technology Hellas; University of Thessaly; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki	Giannenas, I (corresponding author), Aristotle Univ Thessaloniki, Sch Vet Med, Lab Nutr, Thessaloniki, Greece.	igiannenas@vet.auth.gr	Ilias, Giannenas/AAA-7522-2022	Anestis, Vasileios/0000-0003-4260-1763; Bonos, Eleftherios/0000-0002-8166-564X; Giannenas, Ilias/0000-0003-3145-3734	NSRF Operational Programme "Competitiveness and Entrepreneurship", General Secretariat for Research and Technology, Ministry of Education and Religious Affairs; Research Committee of Aristotle University [91680]	NSRF Operational Programme "Competitiveness and Entrepreneurship", General Secretariat for Research and Technology, Ministry of Education and Religious Affairs; Research Committee of Aristotle University	This work was supported by the project "GreenPoultry", funded by the national action "COOPERATION 2011 Partnerships of Production and Research Institutions", of the NSRF 2007-2013 Operational Programme "Competitiveness and Entrepreneurship", General Secretariat for Research and Technology, Ministry of Education and Religious Affairs. The authors would also like to thank Mr. Thomas Arabatzis and Ms. Aikaterini Gousiou-Arabatri for kind donation of broiler chickens and feeds. Lecturer Dr. Ilias Giannenas also acknowledges Research Committee of Aristotle University for the economic support for this research through project No. 91680.	Acamovic T, 2001, WORLD POULTRY SCI J, V57, P225, DOI 10.1079/WPS20010016; Angel CR, 2011, POULTRY SCI, V90, P2281, DOI 10.3382/ps.2011-01482; ASAE, 2005, ASAE STAND MAN PROD; Bartali EH, 1999, LIVESTOCK HOUSING 1; Basset-Mens C, 2009, INT J LIFE CYCLE ASS, V14, P630, DOI 10.1007/s11367-009-0108-2; Bedford MR, 2012, ANIM FEED SCI TECH, V173, P76, DOI 10.1016/j.anifeedsci.2011.12.018; Bedford MR, 2000, ANIM FEED SCI TECH, V86, P1, DOI 10.1016/S0377-8401(00)00155-3; Bennett G, 2009, ANAEROBE, V15, P173, DOI 10.1016/j.anaerobe.2009.02.002; Bjorklund AE, 2002, INT J LIFE CYCLE ASS, V7, P64, DOI 10.1065/lca2001.12/071; Blonk Agri-footprint BV, 2014, AGR 2; Blonk Agri-footprint BV, 2014, AGR 1; Bundgaard AM, 2014, J CLEAN PROD, V73, P218, DOI 10.1016/j.jclepro.2013.12.055; Chen J, 1998, LETT APPL MICROBIOL, V27, P369, DOI 10.1046/j.1472-765X.1998.00445.x; Chiang G, 2010, ASIAN AUSTRAL J ANIM, V23, P263; Choi HB, 2015, ASIAN AUSTRAL J ANIM, V28, P1345, DOI 10.5713/ajas.14.0802; Cowieson AJ, 2010, J POULT SCI, V47, P1, DOI 10.2141/jpsa.009045; Cowieson AJ, 2005, ANIM FEED SCI TECH, V119, P293, DOI 10.1016/j.anifeedsci.2004.12.017; da Silva VP, 2014, J ENVIRON MANAGE, V133, P222, DOI 10.1016/j.jenvman.2013.12.011; Dahiya JP, 2006, ANIM FEED SCI TECH, V129, P60, DOI 10.1016/j.anifeedsci.2005.12.003; Silva FCD, 2011, FEMS MICROBIOL ECOL, V78, P285, DOI 10.1111/j.1574-6941.2011.01155.x; Dong H, 2006, CHAPTER 10 EMISSIONS; ecoinvent, 2015, EC VERS 3; EMEP/EEA, 2013, MAN MAN; Eurostat, 2015, DAT DAT 2015; FAOSTAT, 2015, TRAD CROPS LIV PROD; FAOSTAT, 2016, PROD CROPS 2016; Finnveden G, 2009, J ENVIRON MANAGE, V91, P1, DOI 10.1016/j.jenvman.2009.06.018; Funaba M, 2005, CAN J VET RES, V69, P299; Gartner MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119793; Garcia V, 2007, J APPL POULTRY RES, V16, P555, DOI 10.3382/japr.2006-00116; Giannenas I, 2014, ASIAN AUSTRAL J ANIM, V27, P225, DOI 10.5713/ajas.2013.13376; Giannenas I, 2011, ANIM FEED SCI TECH, V165, P218, DOI 10.1016/j.anifeedsci.2011.03.002; Giannenas IA, 2014, J ANIM FEED SCI, V23, P73, DOI 10.22358/jafs/65719/2014; Gonzalez-Garcia S, 2014, J CLEAN PROD, V74, P125, DOI 10.1016/j.jclepro.2014.03.067; Guinee JB, 2002, HB LIFE CYCLE ASSESS; Halberg N, 2005, LIVEST PROD SCI, V96, P33, DOI 10.1016/j.livprodsci.2005.05.013; HMEECC, 2014, CLIM CHANG EM INV AN; IEA, 2015, GREEC EL HEAT 2013; IndexMundi, 2015, SOYB MEAL MONTHL PRI; Johnson ML, 2008, POULTRY SCI, V87, P958, DOI 10.3382/ps.2007-00349; JRC, 2015, EPLCA EUR REF LIF CY; Kawase J, 2014, JPN J INFECT DIS, V67, P441, DOI 10.7883/yoken.67.441; KNABE DA, 1989, J ANIM SCI, V67, P441; LEAP, 2015, GREENH GAS EM FOSS E; LEAP, 2015, ENV PERF AN FEEDS SU; Leinonen I, 2012, POULTRY SCI, V91, P8, DOI 10.3382/ps.2011-01634; Leinonen I, 2015, J SCI FOOD AGR, V95, P3041, DOI 10.1002/jsfa.7202; Leinonen I, 2013, AGR SYST, V121, P33, DOI 10.1016/j.agsy.2013.06.008; Magdelaine P, 2008, WORLD POULTRY SCI J, V64, P53, DOI [10.1017/S0043933907001717, 10.1079/PNS2004409]; Metzler-Zebeli BU, 2010, APPL ENVIRON MICROB, V76, P3692, DOI 10.1128/AEM.00257-10; Miles RD, 2006, POULTRY SCI, V85, P476, DOI 10.1093/ps/85.3.476; National Research Council, 1996, GUIDE CARE USE LAB A; Nguyen TTH, 2012, J CLEAN PROD, V28, P215, DOI 10.1016/j.jclepro.2011.06.029; Nijdam D, 2012, FOOD POLICY, V37, P760, DOI 10.1016/j.foodpol.2012.08.002; NRC, 1994, NUTR REQ POULTR; Oxenboll K. M., 2011, International Journal of Poultry Science, V10, P842; Palika L., 1996, CONSUMERS GUIDE DOG; Pelletier N, 2008, AGR SYST, V98, P67, DOI 10.1016/j.agsy.2008.03.007; PRe, 2014, SIMAPRO DATABASE MAN; PRe A, 2014, SIMAPRO 8 AM; Roos E., 2013, UNCERTAINTIES VARIAT; SASSE CE, 1973, J ANIM SCI, V37, P1351, DOI 10.2527/jas1973.3761351x; Tako E, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-58; Thomassen MA, 2005, AGR ECOSYST ENVIRON, V111, P185, DOI 10.1016/j.agee.2005.06.013; Thomassen MA, 2008, INT J LIFE CYCLE ASS, V13, P339, DOI 10.1007/s11367-008-0007-y; van der Werf HMG, 2002, AGR ECOSYST ENVIRON, V93, P131, DOI 10.1016/S0167-8809(01)00354-1; Van Zeist WJ, 2012, LCI DATA CALCULATION; Vellinga T. V., 2013, METHODOLOGY USED FEE; YANG SI, 1989, COMP BIOCHEM PHYS A, V93, P703, DOI 10.1016/0300-9629(89)90488-X; Zdunczyk Z, 2013, CAN J ANIM SCI, V93, P353, DOI [10.4141/CJAS2012-085, 10.4141/cjas2012-085]	70	22	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169511	10.1371/journal.pone.0169511	http://dx.doi.org/10.1371/journal.pone.0169511			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046072	Green Published, gold			2022-12-26	WOS:000391612300203
J	Mithal, LB; Palac, HL; Yogev, R; Ernst, LM; Mestan, KK				Mithal, Leena B.; Palac, Hannah L.; Yogev, Ram; Ernst, Linda M.; Mestan, Karen K.			Cord Blood Acute Phase Reactants Predict Early Onset Neonatal Sepsis in Preterm Infants	PLOS ONE			English	Article							REACTIVE PROTEIN CONCENTRATIONS; EMPIRICAL ANTIBIOTIC-TREATMENT; SERUM-AMYLOID-A; HISTOLOGICAL CHORIOAMNIONITIS; BIRTH; BIOMARKERS; INFECTION; DIAGNOSIS; NEWBORN; MARKERS	Background Early onset sepsis (EOS) is a major cause of morbidity and mortality in preterm infants, yet diagnosis remains inadequate resulting in missed cases or prolonged empiric antibiotics with adverse consequences. Evaluation of acute phase reactant (APR) biomarkers in umbilical cord blood at birth may improve EOS detection in preterm infants with intrauterine infection. Methods In this nested case-control study, infants (29.7 weeks gestation, IQR: 27.7-32.2) were identified from a longitudinal cohort with archived cord blood and placental histopathology. Patients were categorized using culture, laboratory, clinical, and antibiotic treatment data into sepsis groups: confirmed sepsis (cEOS, n = 12); presumed sepsis (PS, n = 30); and no sepsis (controls, n = 30). Nine APRs were measured in duplicate from cord blood using commercially available multiplex immunoassays (Bio-Plex Pro (TM)). In addition, placental histopathologic data were linked to biomarker results. Results cEOS organisms were Escherichia coli, Streptococcus agalactiae, Proteus mirabilis, Haemophilus influenzae and Listeria monocytogenes. C-reactive protein (CRP), serum amyloid A (SAA), haptoglobin (Hp), serum amyloid P and ferritin were significantly elevated in cEOS compared to controls (p<0.01). SAA, CRP, and Hp were elevated in cEOS but not in PS (p<0.01) and had AUCs of 99%, 96%, and 95% respectively in predicting cEOS. Regression analysis revealed robust associations of SAA, CRP, and Hp with EOS after adjustment for covariates. Procalcitonin, fibrinogen, alpha-2-macroglobulin and tissue plasminogen activator were not significantly different across groups. Placental acute inflammation was associated with APR elevation and was present in all cEOS, 9 PS, and 17 control infants. Conclusion This study shows that certain APRs are elevated in cord blood of premature infants with EOS of intrauterine origin. SAA, CRP, and Hp at birth have potential diagnostic utility for risk stratification and identification of infants with EOS.	[Mithal, Leena B.; Yogev, Ram] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Div Infect Dis, Chicago, IL 60611 USA; [Palac, Hannah L.] Northwestern Univ, Biostat Collaborat Ctr, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Ernst, Linda M.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Mestan, Karen K.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Div Neonatol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Mithal, LB (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pediat, Div Infect Dis, Chicago, IL 60611 USA.	lmithal@luriechildrens.org		Ernst, Linda/0000-0003-0104-5107	Comprehensive Metabolic Core at Northwestern University; Thrasher Research Fund Early Career Award [12573]; National Heart, Lung, Blood Institute [K23 HL093302]; Northwestern Memorial Foundation	Comprehensive Metabolic Core at Northwestern University; Thrasher Research Fund Early Career Award; National Heart, Lung, Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Northwestern Memorial Foundation	This work was supported by the Comprehensive Metabolic Core at Northwestern University; Thrasher Research Fund Early Career Award (#12573), LBM; National Heart, Lung, Blood Institute (K23 HL093302), KM; Northwestern Memorial Foundation (Friends of Prentice Grants Initiative), KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyazicioglu Y, 2007, TURKISH J PEDIATR, V49, P52; ANDREW M, 1988, BLOOD, V72, P1651; ANDREW M, 1992, BLOOD, V80, P1998, DOI 10.1182/blood.V80.8.1998.1998; Arayici S, 2014, J MATERN-FETAL NEO M, V27, P1129, DOI 10.3109/14767058.2013.850668; Arnon S, 2007, J PERINATOL, V27, P297, DOI 10.1038/sj.jp.7211682; Arora P, 2015, J OBSTET GYNAECOL, V35, P235, DOI 10.3109/01443615.2014.958143; Benitz WE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.4.e41; Buhimschi CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026111; Chavez-Bueno S, 2011, J PERINATOL, V31, P500, DOI 10.1038/jp.2010.197; Connell TG, 2007, PEDIATRICS, V119, P891, DOI 10.1542/peds.2006-0440; Cotten CM, 2006, PEDIATRICS, V118, P717, DOI 10.1542/peds.2005-2677; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; Cuna A, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00027; Golden SM, 2005, LAB MED, V36, P357, DOI 10.1309/UPB2B5TATTN6UERT; Green J, 2002, THROMB HAEMOSTASIS, V87, P218; Hamilton BE, 2015, NATL CTR HLTH STAT N, V64, P1; Ho T, 2015, PEDIATRICS, V136, pE482, DOI 10.1542/peds.2015-0737; Hornik CP, 2012, PEDIATR INFECT DIS J, V31, P799, DOI 10.1097/INF.0b013e318256905c; Howman RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051836; Joram N, 2006, ARCH DIS CHILD-FETAL, V91, pF65, DOI 10.1136/adc.2005.074245; Joram N, 2011, EUR J CLIN MICROBIOL, V30, P1005, DOI 10.1007/s10096-011-1187-0; Kacerovsky M, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.882; Kermorvant-Duchemin E, 2008, PEDIATR CRIT CARE ME, V9, P186, DOI 10.1097/PCC.0b013e31816689a8; Kordek A, 2008, CLIN CHEM LAB MED, V46, P1143, DOI 10.1515/CCLM.2008.214; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Kuppala VS, 2011, J PEDIATR-US, V159, P720, DOI 10.1016/j.jpeds.2011.05.033; Lee SYR, 2012, J MATERN-FETAL NEO M, V25, P364, DOI 10.3109/14767058.2011.579208; LLOYD BW, 1982, ARCH DIS CHILD, V57, P233, DOI 10.1136/adc.57.3.233; Matoba N, 2009, PEDIATRICS, V123, P1320, DOI 10.1542/peds.2008-1222; Mestan KK, 2014, PLACENTA, V35, P570, DOI 10.1016/j.placenta.2014.05.003; Mestan K, 2012, EARLY HUM DEV, V88, P683, DOI 10.1016/j.earlhumdev.2012.02.002; Mestan K, 2009, J MATERN-FETAL NEO M, V22, P379, DOI 10.1080/14767050802609759; Mondal Santosh Kumar, 2012, Int J Appl Basic Med Res, V2, P43, DOI 10.4103/2229-516X.96808; Polin RA, 2012, PEDIATRICS, V129, P1006, DOI 10.1542/peds.2012-0541; Ramos Garcia PC, 2007, ACTA PAEDIATR, V96, P1829, DOI 10.1111/j.1651-2227.2007.00564.x; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Reier-Nilsen T, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-5; Sanghvi KP, 1996, J PAEDIATR CHILD H, V32, P333, DOI 10.1111/j.1440-1754.1996.tb02565.x; Schmutz N, 2008, J PERINATOL, V28, P275, DOI 10.1038/sj.jp.7211916; Siddappa AM, 2007, NEONATOLOGY, V92, P73, DOI 10.1159/000100805; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Su H, 2014, J PERINATOL, V34, P268, DOI 10.1038/jp.2013.186; Vandevyver S, 2014, EMBO MOL MED, V6, P2, DOI 10.1002/emmm.201303524; Voller SB, 2014, EARLY HUM DEV, V90, P195, DOI 10.1016/j.earlhumdev.2014.01.003; Weston EJ, 2011, PEDIATR INFECT DIS J, V30, P937, DOI 10.1097/INF.0b013e318223bad2; Yuan HN, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/520294	47	26	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168677	10.1371/journal.pone.0168677	http://dx.doi.org/10.1371/journal.pone.0168677			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045978	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300042
J	Stephan-Otto, C; Siddi, S; Senior, C; Munoz-Samons, D; Ochoa, S; Sanchez-Laforga, AM; Brebion, G				Stephan-Otto, Christian; Siddi, Sara; Senior, Carl; Munoz-Samons, Daniel; Ochoa, Susana; Sanchez-Laforga, Ana Maria; Brebion, Gildas			Visual Imagery and False Memory for Pictures: A Functional Magnetic Resonance Imaging Study in Healthy Participants	PLOS ONE			English	Article							MIDDLE FRONTAL GYRUS; MENTAL-IMAGERY; PERCEPTION; ACTIVATION; REALITY; FMRI; HALLUCINATIONS; SCHIZOPHRENIA; METAANALYSIS; AMYGDALA	Background Visual mental imagery might be critical in the ability to discriminate imagined from perceived pictures. Our aim was to investigate the neural bases of this specific type of reality-monitoring process in individuals with high visual imagery abilities. Methods A reality-monitoring task was administered to twenty-six healthy participants using functional magnetic resonance imaging. During the encoding phase, 45 words designating common items, and 45 pictures of other common items, were presented in random order. During the recall phase, participants were required to remember whether a picture of the item had been presented, or only a word. Two subgroups of participants with a propensity for high vs. low visual imagery were contrasted. Results Activation of the amygdala, left inferior occipital gyrus, insula, and precuneus were observed when high visual imagers encoded words later remembered as pictures. At the recall phase, these same participants activated the middle frontal gyrus and inferior and superior parietal lobes when erroneously remembering pictures. Conclusions The formation of visual mental images might activate visual brain areas as well as structures involved in emotional processing. High visual imagers demonstrate increased activation of a fronto-parietal source-monitoring network that enables distinction between imagined and perceived pictures.	[Stephan-Otto, Christian; Siddi, Sara; Ochoa, Susana; Sanchez-Laforga, Ana Maria; Brebion, Gildas] Univ Barcelona, Parc Sanitari St Joan Deu, Sant Boi De Llobregat, Spain; [Stephan-Otto, Christian; Siddi, Sara; Ochoa, Susana; Brebion, Gildas] Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain; [Siddi, Sara] Univ Cagliari, Dept Educ Psychol & Philosophy, Sect Clin Psychol, Cagliari, Italy; [Siddi, Sara] Univ Barcelona, Fac Med, Barcelona, Spain; [Senior, Carl] Aston Univ, Sch Life & Hlth Sci, Birmingham, W Midlands, England; [Munoz-Samons, Daniel] Hosp St Joan Deu, Esplugas de Llobregat, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Cagliari; University of Barcelona; Aston University	Brebion, G (corresponding author), Univ Barcelona, Parc Sanitari St Joan Deu, Sant Boi De Llobregat, Spain.; Brebion, G (corresponding author), Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain.	gildas.brebion@pssjd.org	SIDDI, SARA/O-5771-2017; Ochoa, "S./E-7362-2015	SIDDI, SARA/0000-0002-1494-9028; Ochoa, "S./0000-0001-6792-1080; Senior, Carl N/0000-0002-2155-4139; Stephan-Otto Attolini, Christian/0000-0002-6326-7648; Brebion, Gildas/0000-0002-7095-4788	Institute de Salud Carlos III Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria [CP09/00292, PI10/02479]; Fondo Europeo de Desarrollo Regional (FEDER); Sardinia Region [PRRMAB-A2011-19251]; Ministerio de Ciencia e Innovacion, Spain [PTA2011-4983-I]; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Institute de Salud Carlos III	Institute de Salud Carlos III Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria; Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Sardinia Region(Regione Sardegna); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Institute de Salud Carlos III	This work was supported by a Miguel Servet contract (CP09/00292) and a grant PI10/02479 from the Institute de Salud Carlos III Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria co-funded by Fondo Europeo de Desarrollo Regional (FEDER), both to GB; a grant PRRMAB-A2011-19251 from the Sardinia Region to SS; and a contract PTA2011-4983-I from the Ministerio de Ciencia e Innovacion, Spain to CS-O. The study was also supported by the Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Institute de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2000, J NERV MENT DIS, V188, P830, DOI 10.1097/00005053-200012000-00007; Andersson M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-41; Bannister PR, 2007, IMAGE VISION COMPUT, V25, P311, DOI 10.1016/j.imavis.2005.10.002; BENTALL RP, 1990, PSYCHOL BULL, V107, P82, DOI 10.1037/0033-2909.107.1.82; Borst JP, 2013, P NATL ACAD SCI USA, V110, P1628, DOI 10.1073/pnas.1221572110; Brebion G, 2008, NEUROPSYCHOLOGY, V22, P383, DOI 10.1037/0894-4105.22.3.383; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cichy RM, 2012, CEREB CORTEX, V22, P372, DOI 10.1093/cercor/bhr106; Daselaar SM, 2010, NEUROIMAGE, V52, P677, DOI 10.1016/j.neuroimage.2010.04.239; Donaldson DI, 2010, J COGNITIVE NEUROSCI, V22, P377, DOI 10.1162/jocn.2009.21242; Fassbender C, 2006, HUM BRAIN MAPP, V27, P819, DOI 10.1002/hbm.20223; Foley MA, 2010, MEMORY, V18, P801, DOI 10.1080/09658211.2010.509731; Ford JM, 2015, SCHIZOPHRENIA BULL, V41, P223, DOI 10.1093/schbul/sbu031; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Ganis G, 2004, COGNITIVE BRAIN RES, V20, P226, DOI 10.1016/j.cogbrainres.2004.02.012; Gomar JJ, 2011, SCHIZOPHR RES, V128, P175, DOI 10.1016/j.schres.2010.11.016; Gonsalves B, 2004, PSYCHOL SCI, V15, P655, DOI 10.1111/j.0956-7976.2004.00736.x; Henson RNA, 2002, NEUROIMAGE, V15, P83, DOI 10.1006/nimg.2001.0940; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Kensinger EA, 2005, NEUROPSYCHOLOGIA, V43, P1429, DOI 10.1016/j.neuropsychologia.2005.01.004; Kensinger EA, 2006, CEREB CORTEX, V16, P1126, DOI 10.1093/cercor/bhj054; Kim H, 2007, J NEUROSCI, V27, P12190, DOI 10.1523/JNEUROSCI.3408-07.2007; Kurkela KA, 2016, NEUROPSYCHOLOGIA, V81, P149, DOI 10.1016/j.neuropsychologia.2015.12.006; LAUNAY G, 1981, PERS INDIV DIFFER, V2, P221, DOI 10.1016/0191-8869(81)90027-1; Leung HC, 2002, J COGNITIVE NEUROSCI, V14, P659, DOI 10.1162/08989290260045882; MacEvoy SP, 2013, J VISION, V13, DOI 10.1167/13.8.21; Markowitsch HJ, 2011, NEUROPSYCHOLOGIA, V49, P718, DOI 10.1016/j.neuropsychologia.2010.10.007; MARKS DF, 1973, BRIT J PSYCHOL, V64, P17, DOI 10.1111/j.2044-8295.1973.tb01322.x; Mier D, 2013, PSYCHIAT RES; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell KJ, 2009, PSYCHOL BULL, V135, P638, DOI 10.1037/a0015849; Oertel V, 2007, PSYCHIAT RES-NEUROIM, V156, P269, DOI 10.1016/j.pscychresns.2007.09.004; Okado Y, 2003, COGN AFFECT BEHAV NE, V3, P323, DOI 10.3758/CABN.3.4.323; Pergolizzi D, 2016, BRAIN COGNITION, V108, P56, DOI 10.1016/j.bandc.2016.06.009; Peters E, 2004, SCHIZOPHRENIA BULL, V30, P1005, DOI 10.1093/oxfordjournals.schbul.a007116; Reinholz J, 2005, COGNITIVE BRAIN RES, V24, P702, DOI 10.1016/j.cogbrainres.2005.04.009; Rohlfing T, 2010, HUM BRAIN MAPP, V31, P798, DOI 10.1002/hbm.20906; Sladky R, 2011, NEUROIMAGE, V58, P588, DOI 10.1016/j.neuroimage.2011.06.078; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van de Ven V, 2003, PERS INDIV DIFFER, V35, P889, DOI 10.1016/S0191-8869(02)00304-5; Vartanian O, 2014, BRAIN COGNITION, V87, P52, DOI 10.1016/j.bandc.2014.03.004; Vickery TJ, 2009, CEREB CORTEX, V19, P916, DOI 10.1093/cercor/bhn140; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Zhang LW, 2016, NEUROPSYCHOLOGIA, V93, P97, DOI 10.1016/j.neuropsychologia.2016.09.020	46	12	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169551	10.1371/journal.pone.0169551	http://dx.doi.org/10.1371/journal.pone.0169551			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046076	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000391612300204
J	Wan, AHL; Wilkes, RJ; Heesch, S; Bermejo, R; Johnson, MP; Morrison, L				Wan, Alex H. L.; Wilkes, Robert J.; Heesch, Svenja; Bermejo, Ricardo; Johnson, Mark P.; Morrison, Liam			Assessment and Characterisation of Ireland's Green Tides (Ulva Species)	PLOS ONE			English	Article							METAL CONTAMINATION; ATLANTIC SALMON; WATER-QUALITY; BLUE MUSSEL; TRACE-METAL; YELLOW SEA; CHLOROPHYTA; ENTEROMORPHA; ULVOPHYCEAE; MACROALGAE	Enrichment of nutrients and metals in seawater associated with anthropogenic activities can threaten aquatic ecosystems. Consequently, nutrient and metal concentrations are parameters used to define water quality. The European Union's Water Framework Directive (WFD) goes further than a contaminant-based approach and utilises indices to assess the Ecological Status (ES) of transitional water bodies (e.g. estuaries and lagoons). One assessment is based upon the abundance of opportunistic Ulva species, as an indication of eutrophication. The objective of this study was to characterise Ireland's Ulva blooms through the use of WFD assessment, metal concentrations and taxonomic identity. Furthermore, the study assessed whether the ecological assessment is related to the metal composition in the Ulva. WFD algal bloom assessment revealed that the largest surveyed blooms had an estimated biomass of 2164 metric tonnes (w/w). DNA sequences identified biomass from all locations as Ulva rigida, with the exception of New Quay, which was Ulva rotundata. Some blooms contained significant amounts of As, Cu, Cr, Pb and Sn. The results showed that all metal concentrations had a negative relationship (except Se) with the Ecological Quality Ratio (EQR). However, only in the case of Mn were these differences significant (p = 0.038). Overall, the metal composition and concentrations found in Ulva were site dependent, and not clearly related to the ES. Nevertheless, sites with a moderate or poor ES had a higher variability in the metals levels than in estuaries with a high ES.	[Wan, Alex H. L.; Heesch, Svenja; Johnson, Mark P.] Natl Univ Ireland, Ryan Inst, Irish Seaweed Res Grp, Galway, Co Galway, Ireland; [Wan, Alex H. L.; Heesch, Svenja; Bermejo, Ricardo; Johnson, Mark P.; Morrison, Liam] Natl Univ Ireland, Sch Nat Sci, Galway, Co Galway, Ireland; [Wilkes, Robert J.] Environm Protect Agcy, Castlebar, Co Mayo, Ireland; [Bermejo, Ricardo; Morrison, Liam] Natl Univ Ireland, Ryan Inst, Earth & Ocean Sci, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Morrison, L (corresponding author), Natl Univ Ireland, Sch Nat Sci, Galway, Co Galway, Ireland.; Morrison, L (corresponding author), Natl Univ Ireland, Ryan Inst, Earth & Ocean Sci, Galway, Ireland.	liam.morrison@nuigalway.ie	wan, Alex/ABC-3711-2020; Johnson, Mark P/B-5017-2009; Bermejo, Ricardo/N-9881-2013; Johnson, Mark/W-4226-2019; Bermejo, Ricardo/GQA-3836-2022	Johnson, Mark P/0000-0002-5078-1410; Bermejo, Ricardo/0000-0003-3838-9093; Johnson, Mark/0000-0002-5078-1410; Bermejo, Ricardo/0000-0003-3838-9093; Heesch, Svenja/0000-0002-4531-0921; Wan, Alex/0000-0003-1703-3725	Department of Agriculture, Food and the Marine [MFFRI/07/01]; Irish National Development Plan; National University of Ireland Galway, Thomas Crawford-Hayes Research Grant; National Geoscience Programme; Beaufort Marine Research Award, Irish National Development Plan; Sea-MAT Environmental Protection Agency	Department of Agriculture, Food and the Marine; Irish National Development Plan; National University of Ireland Galway, Thomas Crawford-Hayes Research Grant; National Geoscience Programme; Beaufort Marine Research Award, Irish National Development Plan; Sea-MAT Environmental Protection Agency	This work was supported by the Department of Agriculture, Food and the Marine MFFRI/07/01, Irish National Development Plan 2007-2013; National University of Ireland Galway, Thomas Crawford-Hayes Research Grant Award 2010; National Geoscience Programme 2007-2013; Beaufort Marine Research Award, Irish National Development Plan 2007-2013; Sea-MAT Environmental Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne S, 1992, IRISH MINERALS IND 1, P39; Allen E, 2013, WASTE MANAGE, V33, P2425, DOI 10.1016/j.wasman.2013.06.017; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Arevalo R, 2007, MAR POLLUT BULL, V55, P104, DOI 10.1016/j.marpolbul.2006.08.023; ARIELI A, 1993, ANIM PROD, V57, P329, DOI 10.1017/S0003356100006978; Asino H, 2011, AQUAC RES, V42, P525, DOI 10.1111/j.1365-2109.2010.02648.x; Australia New Zealand Food Standards Code, 2011, 141 COMM AUSTR; Bermejo R, 2012, ECOL INDIC, V12, P46, DOI 10.1016/j.ecolind.2011.04.008; Caliceti M, 2002, CHEMOSPHERE, V47, P443, DOI 10.1016/S0045-6535(01)00292-2; Canadian Food Inspection Agency, 2012, CANADIAN FOOD INSPEC; Charlier Roger H., 2008, International Journal of Environmental Studies, V65, P197, DOI 10.1080/00207230701791448; Chase ME, 2001, MAR POLLUT BULL, V42, P491; Chiellini E, 2008, BIOMACROMOLECULES, V9, P1007, DOI 10.1021/bm701041e; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Cotton AD., 1911, ROYAL COMMISSION ON, V1, P121; Desideri D, 2016, J TOXICOL ENV HEAL A, V79, P112, DOI 10.1080/15287394.2015.1113598; EPA, 2010, WAT QUAL IR 2007 200; EPA, 2006, EU WAT FRAM DIR MON; FAO WHO, 2011, 1 SESS HAG NETH 21 2; Fingal County Council, 2003, EC MON ROG EST; Gaudry A, 2007, WATER AIR SOIL POLL, V178, P267, DOI 10.1007/s11270-006-9196-9; Gheggour M., 2002, ENVIRON POLLUT, P149; Gilligan M, 2016, MINERAL MAG, V80, P739, DOI 10.1180/minmag.2016.080.019; Griepink B, 1987, 279 CRM COMM EUR COM; Guidone M, 2013, HARMFUL ALGAE, V24, P1, DOI 10.1016/j.hal.2012.12.007; Hartnett M, 2011, MAR POLICY, V35, P810, DOI 10.1016/j.marpol.2011.01.010; Hayden HS, 2004, PHYCOLOGIA, V43, P364, DOI 10.2216/i0031-8884-43-4-364.1; Hayden HS, 2003, EUR J PHYCOL, V38, P277, DOI 10.1080/1364253031000136321; Heesch S, 2016, EUR J PHYCOL, V51, P171, DOI 10.1080/09670262.2015.1115557; Heesch S, 2009, EUR J PHYCOL, V44, P143, DOI 10.1080/09670260802422477; Hering D, 2010, SCI TOTAL ENVIRON, V408, P4007, DOI 10.1016/j.scitotenv.2010.05.031; Hiraoka M, 2004, PHYCOL RES, V52, P17, DOI 10.1111/j.1440-1835.2003.00321.x; Holdt SL, 2011, J APPL PHYCOL, V23, P543, DOI 10.1007/s10811-010-9632-5; Jeffrey DW, 1993, PHYCOLOGIST, V34, P30; Keesing JK, 2011, MAR POLLUT BULL, V62, P1169, DOI 10.1016/j.marpolbul.2011.03.040; Lee WY, 2001, SCI TOTAL ENVIRON, V278, P11, DOI 10.1016/S0048-9697(00)00884-6; Liu DY, 2013, ESTUAR COAST SHELF S, V129, P2, DOI 10.1016/j.ecss.2013.05.021; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Loughnane CJ, 2008, PHYCOLOGIA, V47, P416, DOI 10.2216/PH07-61.1; Malea P, 2014, SCI TOTAL ENVIRON, V494, P144, DOI 10.1016/j.scitotenv.2014.06.134; Malta EJ, 1999, EUR J PHYCOL, V34, P443, DOI 10.1080/09541449910001718801; Mamboya F, 2009, ESTUAR COAST SHELF S, V84, P326, DOI 10.1016/j.ecss.2009.03.034; Marsham S, 2007, FOOD CHEM, V100, P1331, DOI 10.1016/j.foodchem.2005.11.029; Messyasz B, 2011, AQUAT ECOL, V45, P75, DOI 10.1007/s10452-010-9333-9; MHPRC (Ministry of Health of the People's Republic of China), 2005, 27622005 MHPRC GB; Monteiro PMS, 1997, S AFR J MARINE SCI, V18, P1; Morand P, 2005, J COASTAL RES, V21, P1009, DOI 10.2112/04-700A.1; Morrison L, 2012, UND GEOL MED INT ARS; Morrison L, 2008, ENVIRON POLLUT, V152, P293, DOI 10.1016/j.envpol.2007.06.052; Nabulo G, 2011, ENVIRON POLLUT, V159, P368, DOI 10.1016/j.envpol.2010.11.007; Nelson TA, 2008, ECOLOGY, V89, P1287, DOI 10.1890/07-0494.1; Ni Longphuirt S, 2016, ESTUAR COAST, V39, P478, DOI 10.1007/s12237-015-0009-5; Nielsen SL, 2002, ESTUARIES, V25, P1025, DOI 10.1007/BF02691349; NRIAGU JO, 1988, NATURE, V333, P134, DOI 10.1038/333134a0; O'Kelly CJ, 2010, J PHYCOL, V46, P728, DOI 10.1111/j.1529-8817.2010.00860.x; O'Neill A, 2014, SCI TOTAL ENVIRON, V482, P252, DOI 10.1016/j.scitotenv.2014.03.006; Ostapczuk P, 1997, CHEMOSPHERE, V34, P2143, DOI 10.1016/S0045-6535(97)00074-X; Perrot T, 2014, J MARINE SYST, V132, P38, DOI 10.1016/j.jmarsys.2013.12.010; Ratcliff JJ, 2016, AQUACULTURE, V450, P234, DOI 10.1016/j.aquaculture.2015.07.032; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; Rybak A, 2012, CHEMOSPHERE, V89, P1066, DOI 10.1016/j.chemosphere.2012.05.071; Scanlan CM, 2007, MAR POLLUT BULL, V55, P162, DOI 10.1016/j.marpolbul.2006.09.017; Schubert H, 1997, HYDROBIOLOGIA, V349, P75, DOI 10.1023/A:1003097512651; Sea Lettuce Task Force, 2010, SEA LETT TASK FORC R; Shimada Satoshi, 2003, Phycological Research, V51, P99, DOI 10.1046/j.1440-1835.2003.00296.x; Shortle G., 2014, CHALLENGES IMPROVING; SILVER NC, 1987, J APPL PSYCHOL, V72, P146, DOI 10.1037/0021-9010.72.1.146; Smetacek V, 2013, NATURE, V504, P84, DOI 10.1038/nature12860; Teagasc, 2013, AGR CATCHM PROGR PHA; Ustunada M, 2011, ENVIRON MONIT ASSESS, V177, P337, DOI 10.1007/s10661-010-1637-7; Vernet J-P., 1991, HEAVY METALS ENV, V1, P95; Villares R, 2001, HYDROBIOLOGIA, V462, P221, DOI 10.1023/A:1013154821531; Walsh AR, 1997, ECOTOXICOLOGY, V6, P137, DOI 10.1023/A:1018614408367; Wan AHL, 2016, J APPL PHYCOL, V28, P3091, DOI 10.1007/s10811-016-0821-8; Wilson J. G., 2003, Biology and Environment, V103B, P49, DOI 10.3318/BIOE.2003.103.2.49; Yabe T, 2009, LIMNOLOGY, V10, P239, DOI 10.1007/s10201-009-0278-4; Ye NH, 2011, ECOL RES, V26, P477, DOI 10.1007/s11284-011-0821-8	77	38	40	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169049	10.1371/journal.pone.0169049	http://dx.doi.org/10.1371/journal.pone.0169049			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045947	gold, Green Submitted, Green Published			2022-12-26	WOS:000391612300098
J	Johannesen, L; Vicente, J; Hosseini, M; Strauss, DG				Johannesen, Lars; Vicente, Jose; Hosseini, Meisam; Strauss, David G.			Automated Algorithm for J-T-peak and T-peak-T-end Assessment of Drug-Induced Proarrhythmia Risk	PLOS ONE			English	Article							LONG QT SYNDROME; CELLULAR-BASIS; REPOLARIZATION; HEART; WAVES; BLOCK; ECG; RANOLAZINE; DOFETILIDE; RECORDINGS	Background Prolongation of the heart rate corrected QT (QTc) interval is a sensitive marker of torsade de pointes risk; however it is not specific as QTc prolonging drugs that block inward currents are often not associated with torsade. Recent work demonstrated that separate analysis of the heart rate corrected J-T(peak)c (J-T(peak)c) and T-peak-T-end intervals can identify QTc prolonging drugs with inward current block and is being proposed as a part of a new cardiac safety paradigm for new drugs (the "CiPA" initiative). Methods In this work, we describe an automated measurement methodology for assessment of the J-T(peak)c and T-peak-T-end intervals using the vector magnitude lead. The automated measurement methodology was developed using data from one clinical trial and was evaluated using independent data from a second clinical trial. Results Comparison between the automated and the prior semi-automated measurements shows that the automated algorithm reproduces the semi-automated measurements with a mean difference of single-deltas < 1 ms and no difference in intra-time point variability (p for all > 0.39). In addition, the time-profile of the baseline and placebo-adjusted changes are within 1 ms for 63% of the time-points (86% within 2 ms). Importantly, the automated results lead to the same conclusions about the electrophysiological mechanisms of the studied drugs. Conclusions We have developed an automated algorithm for assessment of J-T(peak)c and T-peak-T-end intervals that can be applied in clinical drug trials. Under the CiPA initiative this ECG assessment would determine if there are unexpected ion channel effects in humans compared to preclinical studies. The algorithm is being released as open-source software.	[Johannesen, Lars; Vicente, Jose; Hosseini, Meisam; Strauss, David G.] US FDA, Off Clin Pharmacol, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Vicente, Jose] Univ Zaragoza, BSICoS Grp, Aragon Inst Engn Res I3A, IIS Aragon, Zaragoza, Spain	US Food & Drug Administration (FDA); University of Zaragoza	Johannesen, L; Strauss, DG (corresponding author), US FDA, Off Clin Pharmacol, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.	Iars.johannesen@fda.hhs.gov; david.strauss@fda.hhs.gov	Strauss, David G/A-9211-2012	Vicente, Jose/0000-0001-9963-1205	FDA's Critical Path Initiative, Office of Women's Health	FDA's Critical Path Initiative, Office of Women's Health	This project was supported by FDA's Critical Path Initiative, Office of Women's Health and appointments to the Research Participation Programs at the Oak Ridge Institute for Science and Education through an interagency agreement between the Department of Energy and FDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by FDA's Critical Path Initiative, Office of Women's Health and appointments to the Research Participation Programs at the Oak Ridge Institute for Science and Education through an interagency agreement between the Department of Energy and FDA.	ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Antzelevitch C, 2004, CIRCULATION, V110, P904, DOI 10.1161/01.CIR.0000139333.83620.5D; Badilini F, 2009, ANN NONINVAS ELECTRO, V14, pS22, DOI 10.1111/j.1542-474X.2008.00260.x; Berthold MR, 2007, KNIME KONSTANZ INFOR; Dessertenne F, 1966, Arch Mal Coeur Vaiss, V59, P263; Dubois R, 2007, COMPUT METH PROG BIO, V88, P217, DOI 10.1016/j.cmpb.2007.09.005; Emori T, 2001, J CARDIOVASC ELECTR, V12, P1369, DOI 10.1046/j.1540-8167.2001.01369.x; Fermini B, 2016, J BIOMOL SCREEN, V21, P1, DOI 10.1177/1087057115594589; Fuller MS, 2000, J ELECTROCARDIOL, V33, P171, DOI 10.1016/S0022-0736(00)80073-4; Garnett CE, 2008, J CLIN PHARMACOL, V48, P13, DOI 10.1177/0091270007307881; Grant AO, 2009, CIRC-ARRHYTHMIA ELEC, V2, P185, DOI 10.1161/CIRCEP.108.789081; Green CL, 2012, AM HEART J, V163, P365, DOI 10.1016/j.ahj.2011.11.009; Guldenring D, 2012, IEEE ENG MED BIO, P677, DOI 10.1109/EMBC.2012.6346022; Haarmark C, 2009, J ELECTROCARDIOL, V42, P555, DOI 10.1016/j.jelectrocard.2009.06.009; Johannesen L, 2016, CLIN PHARMACOL THER, V99, P214, DOI 10.1002/cpt.205; Johannesen L, 2014, CLIN PHARMACOL THER, V96, P549, DOI 10.1038/clpt.2014.155; Johannesen L, 2014, CLIN PHARMACOL THER, V95, P501, DOI 10.1038/clpt.2013.238; Johannesen L, 2013, COMPUT CARDIOL CONF, V40, P951; Kligfield P, 2010, AM HEART J, V160, P1023, DOI 10.1016/j.ahj.2010.09.002; LEPESCHKIN E, 1952, CIRCULATION, V6, P378, DOI 10.1161/01.CIR.6.3.378; LIU YM, 1992, BIOPHYS J, V63, P654, DOI 10.1016/S0006-3495(92)81635-1; Lux RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085689; Malik M, 2004, J ELECTROCARDIOL S, V37, P25; Meijborg VMF, 2015, HEART RHYTHM, V12, P1343, DOI 10.1016/j.hrthm.2015.02.026; Meijborg VMF, 2014, CIRC-ARRHYTHMIA ELEC, V7, P524, DOI 10.1161/CIRCEP.113.001622; MEYER CR, 1977, COMPUT BIOMED RES, V10, P459, DOI 10.1016/0010-4809(77)90021-0; Opthof T, 2009, CIRC-ARRHYTHMIA ELEC, V2, P89, DOI 10.1161/CIRCEP.108.825356; Panikkath R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P441, DOI 10.1161/CIRCEP.110.960658; Patel C, 2009, CIRC-ARRHYTHMIA ELEC, V2, P80, DOI 10.1161/CIRCEP.108.791830; Sadrieh A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6069; Sager PT, 2014, AM HEART J, V167, P292, DOI 10.1016/j.ahj.2013.11.004; Stockbridge N, 2013, DRUG SAFETY, V36, P167, DOI 10.1007/s40264-013-0016-z; US Department of Health and Human Services Food and Drug Administration, 2005, GUID IND E14 CLIN EV; Vicente J, PLOS ONE, V11, DOI [10.1371/journal, DOI 10.1371/JOURNAL]; Vicente J, 2015, J ELECTROCARDIOL, V48, P533, DOI 10.1016/j.jelectrocard.2015.03.011; Vicente J, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001615; Vicente J, 2013, COMPUT CARDIOL CONF, V40, P775; Vijayakumar R, 2014, CIRCULATION, V130, P1936, DOI 10.1161/CIRCULATIONAHA.114.011359; Wu L, 2008, CARDIOVASC RES, V77, P481, DOI 10.1093/cvr/cvm069	39	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0166925	10.1371/journal.pone.0166925	http://dx.doi.org/10.1371/journal.pone.0166925			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036330	gold, Green Published, Green Submitted			2022-12-26	WOS:000391229300004
J	Klausenitz, C; Hacker, H; Hesse, T; Kohlmann, T; Endlich, K; Hahnenkamp, K; Usichenko, T				Klausenitz, Catharina; Hacker, Henriette; Hesse, Thomas; Kohlmann, Thomas; Endlich, Karlhans; Hahnenkamp, Klaus; Usichenko, Taras			Auricular Acupuncture for Exam Anxiety in Medical Students-A Randomized Crossover Investigation	PLOS ONE			English	Article							UNIVERSITY-STUDENTS; INTERVENTIONS; PERFORMANCE	Auricular acupuncture (AA) is effective in the treatment of preoperative anxiety. The aim was to investigate whether AA can reduce exam anxiety as compared to placebo and no intervention. Forty-four medical students were randomized to receive AA, placebo, or no intervention in a crossover manner and subsequently completed three comparable oral anatomy exams with an interval of 1 month between the exams/interventions. AA was applied using indwelling fixed needles bilaterally at points MA-IC1, MA-TF1, MA -SC, MA-AT1 and MA-TG one day prior to each exam. Placebo needles were used as control. Levels of anxiety were measured using a visual analogue scale before and after each intervention as well as before each exam. Additional measures included the State-Trait-Anxiety Inventory, duration of sleep at night, blood pressure, heart rate and the extent of participant blinding. All included participants finished the study. Anxiety levels were reduced after AA and placebo intervention compared to baseline and the no intervention condition (p < 0.003). AA was better at reducing anxiety than placebo in the evening before the exam (p = 0.018). Participants were able to distinguish between AA and placebo intervention. Both AA and placebo interventions reduced exam anxiety in medical students. The superiority of AA over placebo may be due to insufficient blinding of participants.	[Klausenitz, Catharina; Hacker, Henriette; Hesse, Thomas; Hahnenkamp, Klaus; Usichenko, Taras] Univ Med Greifswald, Dept Anesthesiol, Greifswald, Germany; [Klausenitz, Catharina] Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Kohlmann, Thomas] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Endlich, Karlhans] Univ Med Greifswald, Inst Anat, Greifswald, Germany; [Usichenko, Taras] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada	Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; McMaster University	Usichenko, T (corresponding author), Univ Med Greifswald, Dept Anesthesiol, Greifswald, Germany.; Usichenko, T (corresponding author), McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada.	usichent@mcmaster.ca		Endlich, Karlhans/0000-0001-6052-6061				Blanch DC, 2008, PATIENT EDUC COUNS, V72, P374, DOI 10.1016/j.pec.2008.05.021; Brockmeyer H, 2005, PRUFUNGSANGST EXPT S, P79; DEFFENBACHER JL, 1988, COUNS PSYCHOL, V16, P9, DOI 10.1177/0011000088161002; DENDATO KM, 1986, J COUNS PSYCHOL, V33, P131; Eisenberg D, 2013, J NERV MENT DIS, V201, P60, DOI 10.1097/NMD.0b013e31827ab077; Hesse T, 2016, ACUPUNCT MED, V34, P14, DOI 10.1136/acupmed-2015-010852; Karst M, 2007, ANESTH ANALG, V104, P295, DOI 10.1213/01.ane.0000242531.12722.fd; Klausenitz C, 2016, ACUPUNCT MED, V34, P90, DOI 10.1136/acupmed-2015-010887; Latas Milan, 2010, Med Pregl, V63, P863; Lundeberg T, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep049; MacPherson H, 2001, COMPLEMENT THER MED, V9, P246, DOI 10.1054/ctim.2001.0488; Maurice-Szamburski A, 2015, JAMA-J AM MED ASSOC, V313, P916, DOI 10.1001/jama.2015.1108; Michalek-Sauberer A, 2012, CLIN ORAL INVEST, V16, P1517, DOI 10.1007/s00784-011-0662-4; Moher D, 2001, ANN INTERN MED, V134, P657, DOI 10.7326/0003-4819-134-8-200104170-00011; Neuderth S, 2009, J NEURAL TRANSM, V116, P785, DOI 10.1007/s00702-008-0123-7; Ogal H., 2004, DTSCH Z AKUPUNKTUR, V47, P6, DOI DOI 10.1078/0415-6412-00048; Ramirez G, 2011, SCIENCE, V331, P211, DOI 10.1126/science.1199427; REED M, 1980, J CLIN PSYCHOL, V36, P683, DOI 10.1002/1097-4679(198007)36:3<683::AID-JCLP2270360313>3.0.CO;2-P; Regehr C, 2013, J AFFECT DISORDERS, V148, P1, DOI 10.1016/j.jad.2012.11.026; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Usichenko TI, 2010, ACUPUNCT MED, V28, P165, DOI 10.1136/aim.2010.003244; Wang SM, 2001, ANESTH ANALG, V93, P1178, DOI 10.1097/00000539-200111000-00024; Zhang ZH, 2011, CLIN EXP HYPERTENS, V33, P281, DOI 10.3109/10641963.2010.531850	23	19	22	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168338	10.1371/journal.pone.0168338	http://dx.doi.org/10.1371/journal.pone.0168338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7KQ	28033320	gold, Green Published, Green Submitted			2022-12-26	WOS:000391226900021
J	Rass, S; Konig, S; Schauer, S				Rass, Stefan; Koenig, Sandra; Schauer, Stefan			Decisions with Uncertain Consequences-A Total Ordering on Loss-Distributions	PLOS ONE			English	Article								Decisions are often based on imprecise, uncertain or vague information. Likewise, the consequences of an action are often equally unpredictable, thus putting the decision maker into a twofold jeopardy. Assuming that the effects of an action can be modeled by a random variable, then the decision problem boils down to comparing different effects (random variables) by comparing their distribution functions. Although the full space of probability distributions cannot be ordered, a properly restricted subset of distributions can be totally ordered in a practically meaningful way. We call these loss-distributions, since they provide a substitute for the concept of loss-functions in decision theory. This article introduces the theory behind the necessary restrictions and the hereby constructible total ordering on random loss variables, which enables decisions under uncertainty of consequences. Using data obtained from simulations, we demonstrate the practical applicability of our approach.	[Rass, Stefan] Univ Klagenfurt, Inst Appl Informat, Klagenfurt, Austria; [Koenig, Sandra; Schauer, Stefan] Austrian Inst Technol, Safety & Secur Dept, Klagenfurt, Austria	University of Klagenfurt	Rass, S (corresponding author), Univ Klagenfurt, Inst Appl Informat, Klagenfurt, Austria.	stefan.rass@aau.at	König, Sandra/AAM-3315-2021	König, Sandra/0000-0003-2881-4519; Rass, Stefan/0000-0003-2821-2489	European Commission [608090]; HyRiM (Hybrid Risk Management for Utility Networks) under the 7th Framework Programme [FP7-SEC-2013-1]	European Commission(European CommissionEuropean Commission Joint Research Centre); HyRiM (Hybrid Risk Management for Utility Networks) under the 7th Framework Programme	This work was supported by the European Commission's Project No. 608090, HyRiM (Hybrid Risk Management for Utility Networks) under the 7th Framework Programme (FP7-SEC-2013-1). The project is online found at https://hyrim.net and http://cordis.europa.eu/project/rcn/185511_en.html.	Bauerle N, 2006, INSUR MATH ECON, V38, P132, DOI 10.1016/j.insmatheco.2005.08.003; Beck A., 2016, ENTWICKLUNG METRIK A; Bundesamt fur Bevolkerungsschutz Bern, 2013, METH RIS KAT NOTL SC; Bundestag D, 2010, VERHANDLUNGEN DTSCH, p17/4178; Buntine W. L., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P46; Busby JS, 2016, EUR J OPER RES, V251, P1029, DOI 10.1016/j.ejor.2015.12.034; Caralli R., 2007, CMUSEI2007TR012; Chiu WH, 2010, GENEVA RISK INS REV, V35, P108, DOI 10.1057/grir.2009.9; Eichner T, 2011, MATH SOC SCI, V61, P109, DOI 10.1016/j.mathsocsci.2010.11.004; Embrechts P., 2003, HDB HEAVY TAILED DIS; Gibbons Robert, 1992, PRIMER GAME THEORY; Goodpasture J., 2004, QUANTITATIVE METHODS; Halpern J. Y., 2003, REASONING UNCERTAINT; Hogg R.V, 1984, WILEY SERIES PROBABI; International Standards Organisation (ISO), 2011, 27005 ISOIEC; International Standards Organisation (ISO), 2009, 31000 ISOIEC; JENSEN FV, 2002, BAYESIAN NETWORKS DE; Karnouskos S, 2011, IEEE IND ELEC, P4490; Konig S., 2016, ARXIV160403558; Koski T., 2009, WILEY SERIES PROBABI; Liu B, 2009, LECT NOTES ARTIF INT, V5476, P302, DOI 10.1007/978-3-642-01307-2_29; McNeil A. J., 2005, QUANTITATIVE RISK MA; Mell P. M., 2007, COMPLETE GUIDE COMMO; Munch I, 2012, DACH SECURITY 2012, P326; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Nolan, 2016, STABLE DISTRIBUTIONS; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; R Development Core Team, 2016, LANG ENV STAT COMP; Rass S., 2015, ARXIV E PRINTS; Rass S., 2015, ARXIV151108591; Rass S., 2015, LNCS, V9406; ROBERT CP, 2001, BAYESIAN CHOICE; Robinson A., 1966, STUDIES LOGIC FDN MA; Shaked M, 2007, SPRINGER SER STAT, P3; Shortliffe E., 1990, READINGS UNCERTAIN R, P259; Silverman BW, 1998, DENSITY ESTIMATION S; Stoyan D, 2002, COMP METHODS STOCHAS; Swedish Civil Contingencies Agency (MSB), 2012, SWED NAT RISK ASS 20; Szekli R., 1995, LECT NOTES STAT, V97, DOI [10.1007/978-1-4612-2528-7, DOI 10.1007/978-1-4612-2528-7]; The Network of Analysts for National Security (ANV), 2011, NAT RISK ASS 2011; Wenner F, 2002, THESIS	42	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168583	10.1371/journal.pone.0168583	http://dx.doi.org/10.1371/journal.pone.0168583			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030572	Green Submitted, Green Published, gold			2022-12-26	WOS:000391222000058
J	Li, GQ; Sun, CJ; Wu, GQ; Shi, FY; Liu, AQ; Yang, N				Li, Guangqi; Sun, Congjiao; Wu, Guiqin; Shi, Fengying; Liu, Aiqiao; Yang, Ning			iTRAQ-Based Quantitative Proteomics Identifies Potential Regulatory Proteins Involved in Chicken Eggshell Brownness	PLoS One			English	Article							SHELL GLAND; BENZODIAZEPINE-RECEPTOR; HEME-BIOSYNTHESIS; 18 KDA; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; JAPANESE-QUAIL; LARGE-SCALE; TSPO; PIGMENTS	Brown eggs are popular in many countries and consumers regard eggshell brownness as an important indicator of egg quality. However, the potential regulatory proteins and detailed molecular mechanisms regulating eggshell brownness have yet to be clearly defined. In the present study, we performed quantitative proteomics analysis with iTRAQ technology in the shell gland epithelium of hens laying dark and light brown eggs to investigate the candidate proteins and molecular mechanisms underlying variation in chicken eggshell brownness. The results indicated 147 differentially expressed proteins between these two groups, among which 65 and 82 proteins were significantly up-regulated in the light and dark groups, respectively. Functional analysis indicated that in the light group, the down-regulated iron-sulfur cluster assembly protein (Iba57) would decrease the synthesis of protoporphyrin IX; furthermore, the up-regulated protein solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 (SLC25A5) and down-regulated translocator protein (TSPO) would lead to increased amounts of protoporphyrin IX transported into the mitochondria matrix to form heme with iron, which is supplied by ovotransferrin protein (TF). In other words, chickens from the light group produce less protoporphyrin IX, which is mainly used for heme synthesis. Therefore, the exported protoporphyrin IX available for eggshell deposition and brownness is reduced in the light group. The current study provides valuable information to elucidate variation of chicken eggshell brownness, and demonstrates the feasibility and sensitivity of iTRAQ-based quantitative proteomics analysis in providing useful insights into the molecular mechanisms underlying brown eggshell pigmentation.	[Li, Guangqi; Sun, Congjiao; Yang, Ning] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing, Peoples R China; [Li, Guangqi; Sun, Congjiao; Yang, Ning] China Agr Univ, Coll Anim Sci & Technol, MOA Key Lab Anim Genet & Breeding, Beijing, Peoples R China; [Wu, Guiqin; Shi, Fengying; Liu, Aiqiao] Beijing Engn Res Ctr Layer, Beijing, Peoples R China	China Agricultural University; China Agricultural University	Yang, N (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing, Peoples R China.; Yang, N (corresponding author), China Agr Univ, Coll Anim Sci & Technol, MOA Key Lab Anim Genet & Breeding, Beijing, Peoples R China.	nyang@cau.edu.cn		Yang, Ning/0000-0001-5772-3320	National High Technology Development Plan of China [2013AA102501]; China Agricultural Technology Research System for Layer [CARS-41]; Programs for Changjiang Scholars and Innovative Research in University [IRT1191]	National High Technology Development Plan of China; China Agricultural Technology Research System for Layer; Programs for Changjiang Scholars and Innovative Research in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the grants from National High Technology Development Plan of China (2013AA102501), China Agricultural Technology Research System for Layer (CARS-41), and Programs for Changjiang Scholars and Innovative Research in University (IRT1191).	Adav SS, 2014, J PROTEOME RES, V13, P4635, DOI 10.1021/pr500754j; AISEN P, 1980, ANNU REV BIOCHEM, V49, P357, DOI 10.1146/annurev.bi.49.070180.002041; Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; [Anonymous], 1997, COLOURLIFE INTRO C; Azuma M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003070; Balsemao-Pires E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-108; Bhosale SV, 2013, EUR J ORG CHEM, V2013, P3939, DOI 10.1002/ejoc.201300240; Bolar NA, 2013, HUM MOL GENET, V22, P2590, DOI 10.1093/hmg/ddt107; BRAESTRUP C, 1977, NATURE, V269, P702, DOI 10.1038/269702a0; BREEN PC, 1969, J MORPHOL, V128, P35, DOI 10.1002/jmor.1051280103; Chen TT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148487; Cho J, 2015, CELL DEATH DIFFER, V22, P1437, DOI 10.1038/cdd.2014.230; Fan J, 2012, CURR MOL MED, V12, P369; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; Giansanti F, 2012, BBA-GEN SUBJECTS, V1820, P218, DOI 10.1016/j.bbagen.2011.08.004; Glibert P, 2015, J PROTEOME RES, V14, P839, DOI 10.1021/pr500889v; Gorchein A, 2012, BIOMED CHROMATOGR, V26, P355, DOI 10.1002/bmc.1665; Gorchein A, 2009, BIOMED CHROMATOGR, V23, P602, DOI 10.1002/bmc.1158; Guo YZ, 2015, SCIENCE, V347, P551, DOI 10.1126/science.aaa1534; Guo ZG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133270; Ishizuka M, 2011, INT IMMUNOPHARMACOL, V11, P358, DOI 10.1016/j.intimp.2010.11.029; Johnston NP, 2011, POULTRY SCI, V90, P1074, DOI 10.3382/ps.2010-00914; JORDAN PM, 1994, CURR OPIN STRUC BIOL, V4, P902, DOI 10.1016/0959-440X(94)90273-9; Kambiranda D, 2014, J PROTEOME RES, V13, P555, DOI 10.1021/pr400731p; KENNEDY GY, 1976, COMP BIOCHEM PHYS B, V55, P117, DOI 10.1016/0305-0491(76)90183-8; LANG MR, 1987, WORLD POULTRY SCI J, V43, P238, DOI 10.1079/WPS19870016; Latosinska A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137048; Li GQ, 2013, POULTRY SCI, V92, P3120, DOI 10.3382/ps.2013-03484; Lossos A, 2015, NEUROLOGY, V84, P659, DOI 10.1212/WNL.0000000000001270; Mann K, 2006, PROTEOMICS, V6, P3801, DOI 10.1002/pmic.200600120; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Morgan J, 2004, BRIT J DERMATOL, V151, P846, DOI 10.1111/j.1365-2133.2004.06198.x; Muhlenhoff U, 2007, EUKARYOT CELL, V6, P495, DOI 10.1128/EC.00191-06; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; PONKA P, 1985, J BIOL CHEM, V260, P4717; PORRA RJ, 1964, BIOCHEM J, V90, P69, DOI 10.1042/bj0900069; Punnett RC, 1920, J GENET, V10, P277, DOI 10.1007/BF02984299; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; SCHAEFFER E, 1987, GENE, V56, P109, DOI 10.1016/0378-1119(87)90163-6; Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772; SNYDER SH, 1987, FASEB J, V1, P282, DOI 10.1096/fasebj.1.4.2820823; SOH T, 1993, J FAC AGR KYUSHU U, V38, P73; SOH T, 1989, POULTRY SCI, V68, P1156, DOI 10.3382/ps.0681156; Sparks NHC, 2011, AVIAN BIOL RES, V4, P162, DOI 10.3184/175815511X13228269481875; Sun CJ, 2013, PROTEOMICS, V13, P3523, DOI 10.1002/pmic.201300286; TAKETANI S, 1994, J BIOL CHEM, V269, P7527; Tamura T., 1966, Journal of the Faculty of Fisheries and Animal Husbandry Hiroshima University, V6, P357; Tamura T., 1965, Journal of the Faculty of Fisheries and Animal Husbandry Hiroshima University, V6, P37; Vanhee C, 2011, PLANT CELL, V23, P785, DOI 10.1105/tpc.110.081570; Veenman L, 2008, J BIOENERG BIOMEMBR, V40, P199, DOI 10.1007/s10863-008-9142-1; Veenman L, 2007, CURR PHARM DESIGN, V13, P2385; Wang XT, 2007, POULTRY SCI, V86, P2236, DOI 10.1093/ps/86.10.2236; Wang ZK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153007; WEI R, 1992, POULTRY SCI, V71, P406, DOI 10.3382/ps.0710406; WILLIAMS J, 1968, BIOCHEM J, V108, P57, DOI 10.1042/bj1080057; With T. K., 1973, BIOCHEM J, V137, P597; Yarian CS, 2006, MECH AGEING DEV, V127, P79, DOI 10.1016/j.mad.2005.09.028; Ye H, 2010, ADV HEMATOL, V2010; Zeno S, 2012, CURR MOL MED, V12, P494; Zhang LC, 2005, POULTRY SCI, V84, P1209, DOI 10.1093/ps/84.8.1209; Zheng AJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1167	62	7	9	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168750	10.1371/journal.pone.0168750	http://dx.doi.org/10.1371/journal.pone.0168750			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006025	Green Submitted, Green Published, gold			2022-12-26	WOS:000392843200089
J	Hu, ZW; Ma, MR; Chen, YX; Zhao, YF; Qiang, W; Li, YM				Hu, Zhi-Wen; Ma, Meng-Rong; Chen, Yong-Xiang; Zhao, Yu-Fen; Qiang, Wei; Li, Yan-Mei			Phosphorylation at Ser(8) as an Intrinsic Regulatory Switch to Regulate the Morphologies and Structures of Alzheimer's 40-residue beta-Amyloid (A beta 40) Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRION-LIKE MECHANISMS; A-BETA; ALKALINE-PHOSPHATASE; PROTEIN; STRAINS; TAU; STATE; POLYMORPHISM; PEPTIDE; PROPAGATION	Polymorphism of amyloid-beta (A beta) fibrils, implying different fibril structures, may play important pathological roles in Alzheimer's disease (AD). Morphologies of A beta fibrils were found to be sensitive to fibrillation conditions. Herein, the Ser(8)-phosphorylated A beta (pA beta), which is assumed to specially associate with symptomatic AD, is reported to modify the morphology, biophysical properties, cellular toxicity, and structures of A beta fibrils. Under the same fibrillation conditions, pA beta favors the formation of fibrils (F-p beta), which are different from the wild-type A beta fibrils (F-beta). Both F-beta and F-p beta fibrils show single predominant morphologies. Compared with F-beta, F-p beta exhibits higher propagation efficiency and higher neuronal cell toxicity. The residue-specific structural differences between the F-beta- and F-p beta-seeded A beta fibrils were identified using magic angle spin NMR. Our results suggest a potential regulatory mechanism of phosphorylation on A beta fibril formation in AD and imply that the posttranslationally modified A beta, especially the phosphorylated A beta, may be an important target for the diagnosis or treatment of AD at specific stages.	[Hu, Zhi-Wen; Ma, Meng-Rong; Chen, Yong-Xiang; Zhao, Yu-Fen; Li, Yan-Mei] Tsinghua Univ, Dept Chem, Minist Educ, Key Lab Bioorgan Phosphorous Chem & Chem Biol, Beijing 100084, Peoples R China; [Qiang, Wei] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA; [Li, Yan-Mei] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China	Tsinghua University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Qiang, W (corresponding author), SUNY Binghamton, B28B,Sci 2,4400 Vestal Pkwy East, Binghamton, NY 13902 USA.; Li, YM (corresponding author), Tsinghua Univ, Dept Chem, Rm 331,New Life Sci Bldg, Beijing 100084, Peoples R China.	wqiang@binghamton.edu; liym@mail.tsinghua.edu.cn	CHEN, YONG-XIANG/D-4792-2017	CHEN, YONG-XIANG/0000-0003-3518-0139; Hu, zhiwen/0000-0002-2615-4900	Major State Basic Research Development Program of China [2013CB910700]; National Natural Science Foundation of China [21472109, 81661148047]; Binghamton University; National Science Foundation Major Research Instrumentation Grant [0922815]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Binghamton University; National Science Foundation Major Research Instrumentation Grant(National Science Foundation (NSF))	This work was supported by Major State Basic Research Development Program of China Grant 2013CB910700, National Natural Science Foundation of China Grants 21472109 and 81661148047, a start-up fund from Binghamton University (to W.Q.), and National Science Foundation Major Research Instrumentation Grant 0922815. The authors declare that they have no conflicts of interest with the contents of this article.	Abelein A, 2016, J AM CHEM SOC, V138, P6893, DOI 10.1021/jacs.6b04511; Akinlolu RD, 2015, BIOCHEMISTRY-US, V54, P3416, DOI 10.1021/acs.biochem.5b00321; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Chaudhuri G, 2013, INDIAN J BIOCHEM BIO, V50, P64; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen M, 2016, PRION, V10, P9, DOI 10.1080/19336896.2015.1123371; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; Du JT, 2007, FEBS J, V274, P5012, DOI 10.1111/j.1742-4658.2007.06018.x; Du JT, 2005, J AM CHEM SOC, V127, P16350, DOI 10.1021/ja054568p; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Gandhi NS, 2015, ANGEW CHEM INT EDIT, V54, P6819, DOI 10.1002/anie.201501898; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Jawhar S, 2011, J BIOL CHEM, V286, P38825, DOI 10.1074/jbc.R111.288308; Julien O, 2014, NAT CHEM BIOL, V10, P969, DOI [10.1038/nchembio.1639, 10.1038/NCHEMBIO.1639]; Kalapothakis JMD, 2015, BIOPHYS J, V108, P2300, DOI 10.1016/j.bpj.2015.03.021; Kardos J, 2015, J PHYS CHEM B, V119, P2946, DOI 10.1021/jp5124234; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kumar S, 2013, ACTA NEUROPATHOL, V125, P699, DOI 10.1007/s00401-013-1107-8; Kumar S, 2012, J BIOL CHEM, V287, P8641, DOI 10.1074/jbc.M111.279133; Kumar S, 2011, AGING-US, V3, P803, DOI 10.18632/aging.100362; Kumar S, 2011, EMBO J, V30, P2255, DOI 10.1038/emboj.2011.138; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Ma MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep37130; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; Matsuzaki K, 2014, ACCOUNTS CHEM RES, V47, P2397, DOI 10.1021/ar500127z; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Milton NGN, 2005, SUB CELL BIOCHEM, V38, P381; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; O'Brien EP, 2009, J PHYS CHEM B, V113, P14421, DOI 10.1021/jp9050098; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Qiang W, 2013, J AM CHEM SOC, V135, P6860, DOI 10.1021/ja311963f; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Qiang W, 2011, J AM CHEM SOC, V133, P4018, DOI 10.1021/ja109679q; Rahman MM, 2015, ACS CHEM BIOL, V10, P766, DOI 10.1021/cb5008663; Rezaei-Ghaleh N, 2016, J BIOL CHEM, V291, P16059, DOI 10.1074/jbc.M116.728956; Rezaei-Ghaleh N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11359; Rezaei-Ghaleh N, 2014, J AM CHEM SOC, V136, P4913, DOI 10.1021/ja411707y; Sanders DW, 2016, NEURON, V89, P433, DOI 10.1016/j.neuron.2016.01.026; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sarroukh R, 2013, BBA-BIOMEMBRANES, V1828, P2328, DOI 10.1016/j.bbamem.2013.04.012; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Sgourakis NG, 2015, STRUCTURE, V23, P216, DOI 10.1016/j.str.2014.10.022; Shim SH, 2009, P NATL ACAD SCI USA, V106, P6614, DOI 10.1073/pnas.0805957106; Spirig T, 2014, NEURODEGENER DIS, V14, P151, DOI 10.1159/000363623; Stohr J, 2014, P NATL ACAD SCI USA, V111, P10329, DOI 10.1073/pnas.1408968111; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Tanaka M, 2015, NAT CHEM BIOL, V11, P373, DOI 10.1038/nchembio.1818; Tycko R, 2015, NEURON, V86, P632, DOI 10.1016/j.neuron.2015.03.017; Upadhaya AR, 2014, BRAIN, V137, P887, DOI 10.1093/brain/awt362; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Xu F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13527; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yin RH, 2014, CURR ALZHEIMER RES, V11, P755, DOI 10.2174/156720501108140910121425; Zalatan JG, 2006, J AM CHEM SOC, V128, P1293, DOI 10.1021/ja056528r; Zhang S, 2013, P NATL ACAD SCI USA, V110, P2798, DOI 10.1073/pnas.1209955110; Zhou LX, 2006, BIOCHEM BIOPH RES CO, V348, P637, DOI 10.1016/j.bbrc.2006.07.099; Zorn JA, 2011, J AM CHEM SOC, V133, P19630, DOI 10.1021/ja208350u	79	20	20	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2611	2623		10.1074/jbc.M116.757179	http://dx.doi.org/10.1074/jbc.M116.757179			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28031462	Green Published, hybrid			2022-12-26	WOS:000395535100005
J	Fairfield, B; Ambrosini, E; Mammarella, N; Montefinese, M				Fairfield, Beth; Ambrosini, Ettore; Mammarella, Nicola; Montefinese, Maria			Affective Norms for Italian Words in Older Adults: Age Differences in Ratings of Valence, Arousal and Dominance	PLOS ONE			English	Article							DISCRETE EMOTIONAL CATEGORIES; SELF-ASSESSMENT MANNEQUIN; ENGLISH WORDS; EUROPEAN PORTUGUESE; RECOGNITION MEMORY; ADAPTATION; LIST; ANEW; ACQUISITION; EXPERIENCE	In line with the dimensional theory of emotional space, we developed affective norms for words rated in terms of valence, arousal and dominance in a group of older adults to complete the adaptation of the Affective Norms for English Words (ANEW) for Italian and to aid research on aging. Here, as in the original Italian ANEW database, participants evaluated valence, arousal, and dominance by means of the Self-Assessment Manikin (SAM) in a paper-and-pencil procedure. We observed high split-half reliabilities within the older sample and high correlations with the affective ratings of previous research, especially for valence, suggesting that there is large agreement among older adults within and across-languages. More importantly, we found high correlations between younger and older adults, showing that our data are generalizable across different ages. However, despite this across-ages accord, we obtained age-related differences on three affective dimensions for a great number of words. In particular, older adults rated as more arousing and more unpleasant a number of words that younger adults rated as moderately unpleasant and arousing in our previous affective norms. Moreover, older participants rated negative stimuli as more arousing and positive stimuli as less arousing than younger participants, thus leading to a less curved distribution of ratings in the valence by arousal space. We also found more extreme ratings for older adults for the relationship between dominance and arousal: older adults gave lower dominance and higher arousal ratings for words rated by younger adults with middle dominance and arousal values. Together, these results suggest that our affective norms are reliable and can be confidently used to select words matched for the affective dimensions of valence, arousal and dominance across younger and older participants for future research in aging.	[Fairfield, Beth; Mammarella, Nicola] Univ G DAnnunzio, Dept Psychol Hlth & Terr Sci, Chieti, Italy; [Ambrosini, Ettore; Montefinese, Maria] Univ Padua, Dept Neurosci, Padua, Italy	G d'Annunzio University of Chieti-Pescara; University of Padua	Montefinese, M (corresponding author), Univ Padua, Dept Neurosci, Padua, Italy.	maria.montefinese@gmail.com	Ambrosini, Ettore/K-5882-2016; Fairfield, Beth/HHM-4985-2022; Ambrosini, Ettore/AAH-5525-2019; Montefinese, Maria/AAA-3325-2019	Ambrosini, Ettore/0000-0002-1439-5491; Ambrosini, Ettore/0000-0002-1439-5491; Montefinese, Maria/0000-0002-7685-1034				[Anonymous], [No title captured], DOI DOI 10.1007/S10257-016-0312-0; Augustine AA, 2011, SOC PSYCHOL PERS SCI, V2, P508, DOI 10.1177/1948550611399154; Backs RW, 2005, EXP AGING RES, V31, P421, DOI 10.1080/03610730500206808; Bradley M.M., 2007, B3 U FLOR; Bradley M. M., 1999, PSYCHOLOGY; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brysbaert M, 2006, VIS COGN, V13, P992, DOI 10.1080/13506280544000165; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; Charles ST, 2001, J PERS SOC PSYCHOL, V80, P136, DOI 10.1037//0022-3514.80.1.136; Charles ST, 2003, J EXP PSYCHOL GEN, V132, P310, DOI 10.1037/0096-3445.132.2.310; Chen SH, 2012, PERSPECT PSYCHOL SCI, V7, P365, DOI 10.1177/1745691612447307; Citron FMM, 2016, BEHAV RES METHODS, V48, P91, DOI 10.3758/s13428-015-0581-4; Citron FMM, 2014, LANG COGN NEUROSCI, V29, P1257, DOI 10.1080/23273798.2014.897734; Citron FMM, 2014, APPL PSYCHOLINGUIST, V35, P313, DOI 10.1017/S0142716412000409; Citron FMM, 2014, NEUROPSYCHOLOGIA, V56, P79, DOI 10.1016/j.neuropsychologia.2014.01.002; Denburg NL, 2003, EMOTION, V3, P239, DOI 10.1037/1528-3542.3.3.239; Eilola TM, 2010, BEHAV RES METHODS, V42, P134, DOI 10.3758/BRM.42.1.134; Fernandes M, 2008, PSYCHOL AGING, V23, P297, DOI 10.1037/0882-7974.23.2.297; Ferre P, 2012, BEHAV RES METHODS, V44, P395, DOI 10.3758/s13428-011-0165-x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fontaine JRJ, 2007, PSYCHOL SCI, V18, P1050, DOI 10.1111/j.1467-9280.2007.02024.x; Gilet AL, 2012, EUR REV APPL PSYCHOL, V62, P173, DOI 10.1016/j.erap.2012.03.003; Gruhn D, 2008, BEHAV RES METHODS, V40, P512, DOI 10.3758/BRM.40.2.512; Gruhn D, 2008, BEHAV RES METHODS, V40, P1088, DOI 10.3758/BRM.40.4.1088; Guasch M, 2015, BEHAV RES METHODS; HARTIGAN PM, 1985, J R STAT SOC C-APPL, V34, P320; Hinojosa JA, 2016, BEHAV RES METHODS, V48, P272, DOI 10.3758/s13428-015-0572-5; Hinojosa JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155866; HOELZER D, 1975, BIOMEDICINE, V22, P285; Hofmann MJ, 2009, COGN AFFECT BEHAV NE, V9, P389, DOI 10.3758/9.4.389; Hsu CT, 2015, BRAIN LANG, V142, P96, DOI 10.1016/j.bandl.2015.01.011; Imbir KK, 2015, BEHAV RES METHODS, V47, P860, DOI 10.3758/s13428-014-0509-4; Kanske P, 2011, BEHAV RES METHODS, V43, P409, DOI 10.3758/s13428-010-0048-6; Kehoe EG, 2013, NEUROBIOL AGING, V34, P809, DOI 10.1016/j.neurobiolaging.2012.07.006; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Keil A, 2009, PSYCHOL AGING, V24, P668, DOI 10.1037/a0016969; Kensinger EA, 2002, EMOTION, V2, P118, DOI 10.1037//1528-3542.2.2.118; Kloumann IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029484; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; Kousta ST, 2009, COGNITION, V112, P473, DOI 10.1016/j.cognition.2009.06.007; Kristensen Christian Haag, 2011, Trends Psychiatry Psychother., V33, P135; Kuchinke L, 2006, NEUROREPORT, V17, P1037, DOI 10.1097/01.wnr.0000221838.27879.fe; Labouvie-Vief G, 2004, MOTIVATION EMOTION C, P237; Lahl O, 2009, BEHAV RES METHODS, V41, P13, DOI 10.3758/BRM.41.1.13; Lang P.J., 2008, A8 U FLOR; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; LAWTON MP, 1992, PSYCHOL AGING, V7, P171, DOI 10.1037/0882-7974.7.2.171; Leu JX, 2011, EMOTION, V11, P994, DOI 10.1037/a0021332; Mather M, 2000, PSYCHOL AGING, V15, P596, DOI 10.1037/0882-7974.15.4.596; Mather M, 2003, PSYCHOL SCI, V14, P409, DOI 10.1111/1467-9280.01455; Mather M, 2005, PSYCHOL AGING, V20, P554, DOI 10.1037/0882-7974.20.4.554; Monnier C, 2014, BEHAV RES METHODS, V46, P1128, DOI 10.3758/s13428-013-0431-1; Montefinese M, 2015, FRONT PSYCHOL, V6; Montefinese M, 2014, TRIEST S PERC COGN E, P121; Montefinese M., 2015, NEUROPSYCHOL TRENDS, V18, P126; Montefinese M, 2015, PSYCHOL RES-PSYCH FO, V79, P785, DOI 10.1007/s00426-014-0615-z; Montefinese M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00418; Montefinese M, 2014, BEHAV RES METHODS, V46, P887, DOI 10.3758/s13428-013-0405-3; Montefinese M, 2014, MEM COGNITION, V42, P355, DOI 10.3758/s13421-013-0365-y; Montefinese M, 2013, BEHAV RES METHODS, V45, P440, DOI 10.3758/s13428-012-0263-4; Moors A, 2013, BEHAV RES METHODS, V45, P169, DOI 10.3758/s13428-012-0243-8; OSGOOD CE, 1955, J EXP PSYCHOL, V50, P325, DOI 10.1037/h0043965; Redondo J, 2007, BEHAV RES METHODS, V39, P600, DOI 10.3758/BF03193031; Robinson MD, 2004, PERS SOC PSYCHOL B, V30, P1472, DOI 10.1177/0146167204266647; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; RUSSELL JA, 1991, PSYCHOL BULL, V110, P426, DOI 10.1037/0033-2909.110.3.426; Schmidtke DS, 2014, BEHAV RES METHODS, V46, P1108, DOI 10.3758/s13428-013-0426-y; Smith DP, 2005, J GERONTOL B-PSYCHOL, V60, pP49, DOI 10.1093/geronb/60.1.P49; Soares AP, 2013, BEHAV RES METHODS, V45, P1168, DOI 10.3758/s13428-012-0310-1; Soares AP, 2012, BEHAV RES METHODS, V44, P256, DOI 10.3758/s13428-011-0131-7; Soderholm C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072859; Stadthagen-Gonzalez H, 2016, BEHAV RES METHODS; Stevenson RA, 2007, BEHAV RES METHODS, V39, P1020, DOI 10.3758/BF03192999; Thomas RC, 2006, PSYCHOL AGING, V21, P821, DOI 10.1037/0882-7974.21.4.821; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Vo MLH, 2006, BEHAV RES METHODS, V38, P606, DOI 10.3758/BF03193892; Warriner AB, 2013, BEHAV RES METHODS, V45, P1191, DOI 10.3758/s13428-012-0314-x; White CN, 2014, COGNITION EMOTION, V28, P867, DOI 10.1080/02699931.2013.858028; Wierzba M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132305; Wieser MJ, 2006, BRAIN RES, V1096, P138, DOI 10.1016/j.brainres.2006.04.028; Wurm LH, 2004, PSYCHOL AGING, V19, P523, DOI 10.1037/0882-7974.19.3.523; Wypych M Z L, 2015, BEHAV RES METHODS; Yao Z, 2016, BEHAV RES METHODS; Yu J, 2008, IEEE INTERNET COMPUT, V12, P44, DOI 10.1109/MIC.2008.114	85	24	26	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169472	10.1371/journal.pone.0169472	http://dx.doi.org/10.1371/journal.pone.0169472			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2QJ	28046070	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300195
J	Lindheim, L; Bashir, M; Munzker, J; Trummer, C; Zachhuber, V; Leber, B; Horvath, A; Pieber, TR; Gorkiewicz, G; Stadlbauer, V; Obermayer-Pietsch, B				Lindheim, Lisa; Bashir, Mina; Muenzker, Julia; Trummer, Christian; Zachhuber, Verena; Leber, Bettina; Horvath, Angela; Pieber, Thomas R.; Gorkiewicz, Gregor; Stadlbauer, Vanessa; Obermayer-Pietsch, Barbara			Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study	PLOS ONE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; OBESITY; METAGENOME; PHENOTYPE; GENETICS	Background Polycystic ovary syndrome (PCOS) is a common female endocrinopathy of unclear origin characterized by hyperandrogenism, oligo-/anovulation, and ovarian cysts. Women with PCOS frequently display overweight, insulin resistance, and systemic low-grade inflammation. We hypothesized that endotoxemia resulting from a leaky gut is associated with inflammation, insulin resistance, fat accumulation, and hyperandrogenemia in PCOS. In this pilot study, we compared the stool microbiome, gut permeability, and inflammatory status of women with PCOS and healthy controls. Methods 16S rRNA gene amplicon sequencing was performed on stool samples from 24 PCOS patients and 19 healthy controls. Data processing and microbiome analysis were conducted in mothur and QIIME using different relative abundance cut-offs. Gut barrier integrity, endotoxemia, and inflammatory status were evaluated using serum and stool markers and associations with reproductive, metabolic, and anthropometric parameters were investigated. Results The stool microbiome of PCOS patients showed a lower diversity and an altered phylogenetic composition compared to controls. We did not observe significant differences in any taxa with a relative abundance>1%. When looking at rare taxa, the relative abundance of bacteria from the phylum Tenericutes, the order ML615J-28 (phylum Tenericutes) and the family S24-7 (phylum Bacteroidetes) was significantly lower and associated with reproductive parameters in PCOS patients. Patients showed alterations in some, but not all markers of gut barrier function and endotoxemia. Conclusion Patients with PCOS have a lower diversity and an altered phylogenetic profile in their stool microbiome, which is associated with clinical parameters. Gut barrier dysfunction and endotoxemia were not driving factors in this patient cohort, but may contribute to the clinical phenotype in certain PCOS patients.	[Lindheim, Lisa; Bashir, Mina; Muenzker, Julia; Trummer, Christian; Zachhuber, Verena; Pieber, Thomas R.; Obermayer-Pietsch, Barbara] Med Univ Graz, Div Endocrinol & Diabetol, Dept Internal Med, Graz, Austria; [Leber, Bettina] Med Univ Graz, Div Transplantat Surg, Dept Surg, Graz, Austria; [Leber, Bettina; Pieber, Thomas R.; Stadlbauer, Vanessa; Obermayer-Pietsch, Barbara] Ctr Biomarker Res Med CBmed, Graz, Austria; [Horvath, Angela; Stadlbauer, Vanessa] Med Univ Graz, Div Gastroenterol & Hepatol, Dept Internal Med, Graz, Austria; [Gorkiewicz, Gregor] Med Univ Graz, Inst Pathol, Graz, Austria; [Gorkiewicz, Gregor] Interuniv Cooperat, BioTechMed, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Lindheim, L (corresponding author), Med Univ Graz, Div Endocrinol & Diabetol, Dept Internal Med, Graz, Austria.	lisa.lindheim@medunigraz.at	Gorkiewicz, Gregor/ABF-1602-2021	Gorkiewicz, Gregor/0000-0003-1149-4782; Pieber, Thomas/0000-0003-3554-0405; Leber, Bettina/0000-0002-2101-7560; Horvath, Angela/0000-0001-7279-0628; Groselj-Strele, Andrea/0000-0002-0709-5458; Stadlbauer, Vanessa/0000-0001-5508-8271	DK-MOLIN [FWF W1241]; Medical University of Graz; Austrian Science Fund (FWF) [P 24362] Funding Source: researchfish	DK-MOLIN; Medical University of Graz; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by the DK-MOLIN (FWF W1241) and the Medical University of Graz.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Beaumont M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1052-7; Brown ZA, 2011, FERTIL STERIL, V96, P1259, DOI 10.1016/j.fertnstert.2011.09.002; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chadwick CA, 2005, ANN CLIN BIOCHEM, V42, P468, DOI 10.1258/000456305774538175; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dumesic DA, 2015, ENDOCR REV, V36, P487, DOI 10.1210/er.2015-1018; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Escobar-Morreale HF, 2011, FERTIL STERIL, V95, P1048, DOI 10.1016/j.fertnstert.2010.11.036; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; Farkas AM, 2015, J IMMUNOL METHODS, V421, P104, DOI 10.1016/j.jim.2015.03.020; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Gayoso-Diz P, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-47; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Guo YW, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0156323, 10.1007/s11468-015-0008-1]; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kelley ST, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146509; Kelly BJ, 2015, BIOINFORMATICS, V31, P2461, DOI 10.1093/bioinformatics/btv183; Kollmann M, 2015, HUM REPROD, V30, P2396, DOI 10.1093/humrep/dev187; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lerchbaum E, 2013, HUM REPROD, V28, P2537, DOI 10.1093/humrep/det255; Lim MY, 2016, GUT; Lizneva D, 2016, FERTIL STERIL; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Mattar R, 2012, CLIN EXP GASTROENTER, V5, P113, DOI 10.2147/CEG.S32368; Mazer NA, 2009, STEROIDS, V74, P512, DOI 10.1016/j.steroids.2009.01.008; Munzker J, 2015, J CLIN ENDOCR METAB, V100, P653, DOI 10.1210/jc.2014-2523; Owen LJ, 2016, ANN CLIN BIOCHEM, V53, P580, DOI 10.1177/0004563215621096; Owen LJ, 2014, ANN CLIN BIOCHEM, V51, P360, DOI 10.1177/0004563213501478; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Sapone A, 2006, DIABETES, V55, P1443, DOI 10.2337/db05-1593; Sze MA, 2016, MBIO, V7, DOI 10.1128/mBio.01018-16; Tremellen K, 2012, MED HYPOTHESES, V79, P104, DOI 10.1016/j.mehy.2012.04.016; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Yang YW, 2015, APPL ENVIRON MICROB, V81, P6749, DOI 10.1128/AEM.01906-15; Yin YS, 2013, ISME J, V7, P615, DOI 10.1038/ismej.2012.128; Zak-Golab A, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/674106; Zhang DM, 2015, EUR J ENDOCRINOL, V172, DOI 10.1530/EJE-14-0589	46	147	174	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168390	10.1371/journal.pone.0168390	http://dx.doi.org/10.1371/journal.pone.0168390			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045919	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300021
J	Mundwiler, J; Schupbach, U; Dieterle, T; Leuppi, JD; Schmidt-Trucksass, A; Wolfer, DP; Miedinger, D; Brighenti-Zogg, S				Mundwiler, Jonas; Schuepbach, Ulla; Dieterle, Thomas; Leuppi, Joerg Daniel; Schmidt-Trucksaess, Arno; Wolfer, David Paul; Miedinger, David; Brighenti-Zogg, Stefanie			Association of Occupational and Leisure-Time Physical Activity with Aerobic Capacity in a Working Population	PLOS ONE			English	Article							ENERGY-EXPENDITURE; CARDIORESPIRATORY FITNESS; OXYGEN-UPTAKE; EXERCISE; MEN; VALIDITY; ADULTS; WOMEN; POWER	Introduction Objective data on the association of maximal aerobic capacity (VO2max) with work related physical activity are sparse. Thus, it is not clear whether occupational physical activity (OPA) contributes to an increase of VO2max. This study examined the association of VO2max with work and non-work related physical activity in a Swiss working population. Methods In this cross-sectional study, a total of 337 healthy and full-time employed adults were recruited. Demographic data, height, weight and BMI were recorded in all subjects. Participants were classified into nine occupational categories (ISCO-88) and merged into three groups with low, moderate, and high OPA. Physical activity was objectively measured by the SenseWear Mini Armband on seven consecutive days (23 hours per day). Participants were regarded as sufficiently active when accumulating >= 30 min of moderate-to-vigorous physical activity per day. VO2max was evaluated using the multistage 20-meter shuttle run test. Results Data of 303 participants were considered for analysis (63% male, age 33 yrs, SD 12). Multiple linear regression analysis (adjusted R-2 = 0.69) revealed significant positive associations of VO2max with leisure-time physical activity (LTPA) at vigorous intensity (beta = 0.212) and sufficient moderate-to-vigorous physical activity ((3 = 0.100) on workdays. Female gender (beta = -0.622), age (beta = -0.264), BMI (beta = -0.220), the ratio of maximum to resting heart rate (beta = 0.192), occupational group (low vs. high OPA, (beta = -0.141), and smoking (beta = -0.133) were also identified as independent predictors of VO2max. Conclusions The present results suggest that VO2max is positively associated with LTPA, but not with OPA on workdays. This finding emphasizes the need for employees to engage in sufficient high-intensity physical activity in recreation for maintaining or improving VO2max with regard to health benefits.	[Mundwiler, Jonas; Schuepbach, Ulla; Dieterle, Thomas; Leuppi, Joerg Daniel; Brighenti-Zogg, Stefanie] Cantonal Hosp Baselland, Univ Clin Internal Med, Liestal, Switzerland; [Mundwiler, Jonas; Schmidt-Trucksaess, Arno] Univ Basel, Dept Sport Exercise & Hlth, Basel, Switzerland; [Dieterle, Thomas; Leuppi, Joerg Daniel; Schmidt-Trucksaess, Arno; Miedinger, David] Univ Basel, Fac Med, Basel, Switzerland; [Wolfer, David Paul; Brighenti-Zogg, Stefanie] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland; [Wolfer, David Paul] Univ Zurich, Inst Anat, Zurich, Switzerland; [Miedinger, David] Swiss Natl Accid Insurance Fund Suva, Dept Occupat Med, Luzern, Switzerland	Kantonsspital Baselland; University of Basel; University of Basel; University of Geneva; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Mundwiler, J (corresponding author), Cantonal Hosp Baselland, Univ Clin Internal Med, Liestal, Switzerland.; Mundwiler, J (corresponding author), Univ Basel, Dept Sport Exercise & Hlth, Basel, Switzerland.	Jonas.Mundwiler@ksbl.ch	Dieterle, Thomas/AAG-3619-2019; Schmidt-Trucksäss, Arno/I-7673-2015; Leuppi, Jörg/W-6798-2019; Wolfer, David P/B-3293-2016; Dieterle, Thomas/CAA-2532-2022	Schmidt-Trucksäss, Arno/0000-0002-4662-3911; Wolfer, David P/0000-0002-5957-1401; Dieterle, Thomas/0000-0002-3740-1903	Swiss National Accident Insurance Fund (Suva); Suva	Swiss National Accident Insurance Fund (Suva)(Swiss National Science Foundation (SNSF)); Suva	This study was financially supported by an unrestricted grant of the Swiss National Accident Insurance Fund (Suva). Grant number: not applicable. URL: http://www.suva.ch. Recipient: JDL. The funder (Suva) provided support in the form of a project grant that covered salaries for the involved personnel at the Cantonal Hospital Baselland Liestal as well as expenses for infrastructure and conducting the study, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript. The participation of DM in the study was independent from the project grant and is covered by the contractual agreement between Suva and DM that permits active participation in independently conducted research projects.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Bradshaw DI, 2005, RES Q EXERCISE SPORT, V76, P426; Castillo-Retamal M, 2011, WORK, V40, P345, DOI 10.3233/WOR-2011-1246; Committee AGA, 2008, NUTR REV, V67, P114; Cooper CB, 2001, EXERCISE TESTING INT, P57; DISHMAN RK, 1994, MED SCI SPORT EXER, V26, P1382; Drenowatz C, 2011, EUR J APPL PHYSIOL, V111, P883, DOI 10.1007/s00421-010-1695-0; Elias Peter, 1997, OCCUPATIONAL CLASSIF; Elliott SA, 2014, J NUTR METAB, V2014, DOI 10.1155/2014/808659; Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Hammermeister J, 2001, PERCEPT MOTOR SKILL, V92, P121, DOI 10.2466/PMS.92.1.121-127; Hirai T, 2006, IND HEALTH, V44, P250, DOI 10.2486/indhealth.44.250; Hooker SP, 2008, STROKE, V39, P2950, DOI 10.1161/STROKEAHA.107.495275; JACKSON AS, 1995, MED SCI SPORT EXER, V27, P113; Jackson AS, 1996, MED SCI SPORT EXER, V28, P884, DOI 10.1097/00005768-199607000-00016; Jang TW, 2012, TOHOKU J EXP MED, V227, P313, DOI 10.1620/tjem.227.313; Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Kenney WL, 2011, PHYSL SPORT EXERCISE, P265; LaMonte MJ, 2005, CIRCULATION, V112, P505, DOI 10.1161/CIRCULATIONAHA.104.503805; LEGER L, 1989, CAN J SPORT SCI, V14, P21; McArdle WD, 2015, EXERCISE PHYSL NUTR, P165; Miller R, 2004, INT J BEHAV MED, V11, P219, DOI 10.1207/s15327558ijbm1104_5; Mutikainen S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005927; ONG TC, 1992, OCCUP MED-OXFORD, V42, P120, DOI 10.1093/occmed/42.3.120; Paradisis GP, 2014, J HUM KINET, V41, P81, DOI 10.2478/hukin-2014-0035; Perkio-Makela M, 1999, Int J Occup Saf Ergon, V5, P381; Pitta F, 2008, RESP MED, V102, P1203, DOI 10.1016/j.rmed.2008.03.004; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Ramsbottom R, 1988, Br J Sports Med, V22, P141; ROWELL LB, 1974, PHYSIOL REV, V54, P75, DOI 10.1152/physrev.1974.54.1.75; Scheers T, 2012, EUR J APPL PHYSIOL, V112, P1653, DOI 10.1007/s00421-011-2131-9; Steele R, 2003, J SCI MED SPORT, V6, P398, DOI 10.1016/S1440-2440(03)80266-9; Suminski RR, 2009, J PHYS ACT HEALTH, V6, P667, DOI 10.1123/jpah.6.5.667; Swain DP, 2002, MED SCI SPORT EXER, V34, P152, DOI 10.1097/00005768-200201000-00023; Uth N, 2004, EUR J APPL PHYSIOL, V91, P111, DOI 10.1007/s00421-003-0988-y; Wasserman K, 1997, CHEST, V112, P1091, DOI 10.1378/chest.112.4.1091; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2; Wetten AA, 2014, J PHYS ACT HEALTH, V11, P638, DOI 10.1123/jpah.2011-0167; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization,, 2015, OB OV; Wultsch G, 2012, SCAND J WORK ENV HEA, V38, P370, DOI 10.5271/sjweh.3195; Zhang Tao, 2004, Yichuan, V26, P219	44	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168683	10.1371/journal.pone.0168683	http://dx.doi.org/10.1371/journal.pone.0168683			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045939	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000391612300044
J	Schregel, K; Behme, D; Tsogkas, I; Knauth, M; Maier, I; Karch, A; Mikolajczyk, R; Hinz, J; Liman, J; Psychogios, MN				Schregel, Katharina; Behme, Daniel; Tsogkas, Ioannis; Knauth, Michael; Maier, Ilko; Karch, Andre; Mikolajczyk, Rafael; Hinz, Jose; Liman, Jan; Psychogios, Marios-Nikos			Effects of Workflow Optimization in Endovascularly Treated Stroke Patients - A Pre-Post Effectiveness Study	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; COMPUTED-TOMOGRAPHY SCORE; INTRAVENOUS T-PA; EARLY CT SCORE; ALBERTA STROKE; INTERVENTIONAL MANAGEMENT; CLINICAL-OUTCOMES; TRIAL; THROMBECTOMY; THERAPY	Endovascular treatment of acute ischemic stroke has become standard of care for patients with large artery occlusion. Early restoration of blood flow is crucial for a good clinical outcome. We introduced an interdisciplinary standard operating procedure (SOP) between neuroradiologists, neurologists and anesthesiologists in order to streamline patient management. This study analyzes the effect of optimized workflow on periprocedural timings and its potential influence on clinical outcome. Data were extracted from a prospectively maintained university hospital stroke database. The standard operating procedure was established in February 2014. Of the 368 acute stroke patients undergoing endovascular treatment between 2008 and 2015, 278 patients were treated prior to and 90 after process optimization. Outcome measures were periprocedural time intervals and residual functional impairment. After implementation of the SOP, time from symptom onset to reperfusion was significantly reduced (median 264 min prior and 211 min after SOP-introduction (IQR 228-32 min and 161-278 min, respectively); P<0.001). Especially faster supply of imaging and prompt transfer of patients to the angiography suite contributed to this effect. Time between hospital admission and groin puncture was reduced by half after process optimization (median 64 min after versus 121 min prior to SOP-introduction (IQR 54-77 min and 96-161 min, respectively); P<0.001). Clinical outcome was significantly better after workflow optimization as measured with the modified Rankin Scale (common odds ratio (OR) 0.56; 95% CI 0.32-0.98; P = 0.038). Optimization of workflow and interdisciplinary teamwork significantly improved the outcome of patients with acute ischemic stroke due to a significant reduction of in-hospital examination, transportation, imaging and treatment times.	[Schregel, Katharina; Behme, Daniel; Tsogkas, Ioannis; Knauth, Michael; Psychogios, Marios-Nikos] Univ Med Goettingen, Dept Neuroradiol, Gottingen, Germany; [Maier, Ilko; Liman, Jan] Univ Med Goettingen, Dept Neurol, Gottingen, Germany; [Karch, Andre; Mikolajczyk, Rafael] Helmholtz Ctr Infect Res, Dept Infectiol, Braunschweig, Germany; [Hinz, Jose] Univ Med Goettingen, Dept Anaesthesiol, Gottingen, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Schregel, K (corresponding author), Univ Med Goettingen, Dept Neuroradiol, Gottingen, Germany.	katharina.schregel@med.uni-goettingen.de; m.psychogios@med.uni-goettingen.de	Karch, André/D-6973-2017; Mikolajczyk, Rafael/ABB-5259-2021; Behme, Daniel/H-4551-2019	Karch, André/0000-0003-3014-8543; Mikolajczyk, Rafael/0000-0003-1271-7204	German Research Foundation; Open Access Publication Funds of the Goettingen University	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the Goettingen University	The authors received no specific funding for this work, but acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Goettingen University.	Almekhlafi MA, 2014, J NEUROINTERV SURG, V6, P729, DOI 10.1136/neurintsurg-2013-011000; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Beuing O, 2014, AM J NEURORADIOL, V35, P1740, DOI 10.3174/ajnr.A3973; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Campbell BC, 2015, N ENGL J MED; Ciccone A, 2013, NEW ENGL J MED, V368, P904, DOI 10.1056/NEJMoa1213701; Goyal M, 2012, AM J NEURORADIOL, V33, P1201, DOI 10.3174/ajnr.A3215; Goyal M, 2016, LANCET LOND ENGL; Goyal M, 2015, N ENGL J MED; Goyal M, 2014, CIRCULATION, V130, P265, DOI 10.1161/CIRCULATIONAHA.113.007826; Goyal M, 2011, STROKE, V42, P93, DOI 10.1161/STROKEAHA.110.594481; HEISS WD, 1983, ANN NEUROL, V14, P294, DOI 10.1002/ana.410140307; Henden PL, 2015, STROKE, V46, P2678, DOI 10.1161/STROKEAHA.115.009808; Higashida Randall, 2003, J Vasc Interv Radiol, V14, pS493; Hill MD, 2003, STROKE, V34, P1925, DOI 10.1161/01.STR.0000082483.37127.D0; Hill MD, 2014, STROKE, V45, P444, DOI 10.1161/STROKEAHA.113.003580; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Khatri P, 2014, LANCET NEUROL, V13, P567, DOI 10.1016/S1474-4422(14)70066-3; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Lovblad KO, 2010, AM J NEURORADIOL, V31, P1470, DOI 10.3174/ajnr.A2088; Mpotsaris Anastasios, 2015, J Vasc Interv Neurol, V8, P39; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Psychogios MN, 2010, AM J NEURORADIOL, V31, P1226, DOI 10.3174/ajnr.A2086; Psychogios MN, 2013, STROKE, V44, P2188, DOI 10.1161/STROKEAHA.113.001068; Puetz V, 2009, INT J STROKE, V4, P354, DOI 10.1111/j.1747-4949.2009.00337.x; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Sheth KN, 2013, J NEUROINTERV SURG, V5, P62, DOI 10.1136/neurintsurg-2012-010512; Soderman M, 2008, NEURORADIOLOGY, V50, P863, DOI 10.1007/s00234-008-0419-1; Tsogkas I, 2016, EUR RADIOL; Zaidat OO, 2013, STROKE, V44, P2650, DOI 10.1161/STROKEAHA.113.001972	32	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169192	10.1371/journal.pone.0169192	http://dx.doi.org/10.1371/journal.pone.0169192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036401	Green Published, Green Submitted, gold			2022-12-26	WOS:000391229300064
J	Perry, B; Ciciurkaite, G; Brady, CF; Garcia, J				Perry, Brea; Ciciurkaite, Gabriele; Brady, Christy Freadreacea; Garcia, Justin			Partner Influence in Diet and Exercise Behaviors: Testing Behavior Modeling, Social Control, and Normative Body Size	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; HEALTH BEHAVIORS; MARITAL-STATUS; WEIGHT STATUS; MASS INDEX; OBESITY; NETWORK; GENDER; NORMS; ACCURACY	Previous research has documented social contagion in obesity and related health behaviors, but less is known about the social processes underlying these patterns. Focusing on married or cohabitating couples, we simultaneously explore three potential social mechanisms influencing obesity: normative body size, social control, and behavior modeling. We analyze the association between partner characteristics and the obesity-related health behaviors of focal respondents, comparing the effects of partners' body type, partners' attempts to manage respondents' eating behaviors, and partners' own health behaviors on respondents' health behaviors (physical activity, fruit and vegetable consumption, and fast food consumption). Data on 215 partners are extracted from a larger study of social mechanisms of obesity in family and community contexts conducted in 2011 in the United States. Negative binomial regression models indicate that partner behavior is significantly related to respondent behavior (p<.001), net of controls. These results are suggestive of a behavior modeling mechanism in obesity-related patterns of consumption and physical activity. In contrast, we find little support for the influence of normative body size or partner social control in this sample, though generalizations about the relevance of these processes may be inappropriate. These results underscore the importance of policies and interventions that target dyads and social groups, suggesting that adoption of exercise or diet modifications in one individual is likely to spread to others, creating a social environment characterized by mutual reinforcement of healthy behavior.	[Perry, Brea] Indiana Univ, Dept Sociol, Bloomington, IN 47405 USA; [Perry, Brea] Indiana Univ, Network Sci Inst, Bloomington, IN 47405 USA; [Ciciurkaite, Gabriele] Utah State Univ, Dept Sociol Social Work & Anthropol, Logan, UT 84322 USA; [Brady, Christy Freadreacea] Univ Kentucky, Dept Sociol, Lexington, KY USA; [Garcia, Justin] Indiana Univ, Dept Gender Studies, Bloomington, IN USA; [Garcia, Justin] Indiana Univ, Kinsey Inst Res Sex Gender & Reprod, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Utah System of Higher Education; Utah State University; University of Kentucky; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Perry, B (corresponding author), Indiana Univ, Dept Sociol, Bloomington, IN 47405 USA.; Perry, B (corresponding author), Indiana Univ, Network Sci Inst, Bloomington, IN 47405 USA.	blperry@indiana.edu		Garcia, Justin/0000-0002-5198-4578; Perry, Brea/0000-0001-7869-7168	Center for Poverty Research at the University of Kentucky; Office of the Vice President for Research at Indiana University; Indiana University Network Science Institute	Center for Poverty Research at the University of Kentucky; Office of the Vice President for Research at Indiana University; Indiana University Network Science Institute	This research was funded by the Center for Poverty Research at the University of Kentucky and by the Office of the Vice President for Research at Indiana University through the Collaborative Research and Creative Activity Fund, and supported by the Indiana University Network Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron A., 2004, CLOSE RELATIONSHIPS, P365; August KJ, 2010, SOC SCI MED, V71, P1831, DOI 10.1016/j.socscimed.2010.08.022; Blanchflower DG, 2009, J EUR ECON ASSOC, V7, P528, DOI 10.1162/JEEA.2009.7.2-3.528; Blankertz L, 1998, AM J EVAL, V19, P307, DOI 10.1016/S1098-2140(99)80214-8; Burke V, 1999, HEALTH EDUC RES, V14, P269, DOI 10.1093/her/14.2.269; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; COLLINS ME, 1991, INT J EAT DISORDER, V10, P199, DOI 10.1002/1098-108X(199103)10:2&lt;199::AID-EAT2260100209&gt;3.0.CO;2-D; Cook T.C., 1979, QUASIEXPERIMENTATION; Craig P. L., 1990, Australian Journal of Nutrition and Dietetics, V47, P42; Etile F, 2007, HEALTH ECON, V16, P945, DOI 10.1002/hec.1251; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Fletcher A, 2011, J EPIDEMIOL COMMUN H, V65, P548, DOI 10.1136/jech.2010.113936; Gorin AA, 2008, INT J OBESITY, V32, P1678, DOI 10.1038/ijo.2008.150; Grzywacz JG, 1999, J FAM ISSUES, V20, P243, DOI 10.1177/019251399020002004; Hammond RA, 2010, CURR OPIN ENDOCRINOL, V17, P467, DOI 10.1097/MED.0b013e32833d4687; He K, 2004, INT J OBESITY, V28, P1569, DOI 10.1038/sj.ijo.0802795; Hruschka DJ, 2011, AM J PUBLIC HEALTH, V101, pS295, DOI 10.2105/AJPH.2010.300053; Jackson SE, 2015, JAMA INTERN MED, V175, P385, DOI 10.1001/jamainternmed.2014.7554; Kogovsek T, 2004, QUAL QUANT, V38, P517; Kraschnewski JL, 2010, INT J OBESITY, V34, P1644, DOI 10.1038/ijo.2010.94; Lewis MA, 1999, HEALTH PSYCHOL, V18, P63, DOI 10.1037/0278-6133.18.1.63; Lowe CF, 2004, EUR J CLIN NUTR, V58, P510, DOI 10.1038/sj.ejcn.1601838; Macdonald-Wallis K, 2012, AM J PREV MED, V43, P636, DOI 10.1016/j.amepre.2012.08.021; Markey C, 2011, J HEALTH PSYCHOL, V16, P217, DOI 10.1177/1359105310375636; Markey CN, 2008, J HEALTH PSYCHOL, V13, P422, DOI 10.1177/1359105307088145; Markey CN, 2014, J SOC PERS RELAT, V31, P162, DOI 10.1177/0265407513489472; Martens MR, 2006, J AM COLL HEALTH, V54, P295, DOI 10.3200/JACH.54.5.295-300; Maximova K, 2008, INT J OBESITY, V32, P1008, DOI 10.1038/ijo.2008.15; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Ogden CL, 2004, MEAN BODY WEIGHT HEI; Okun MA, 2007, BASIC APPL SOC PSYCH, V29, P185, DOI 10.1080/01973530701332245; Pachucki MA, 2011, AM J PUBLIC HEALTH, V101, P2170, DOI 10.2105/AJPH.2011.300282; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Powell LM, 2009, J ADOLESCENT HEALTH, V45, pS57, DOI 10.1016/j.jadohealth.2009.03.003; Prentice A M, 2003, Obes Rev, V4, P187, DOI 10.1046/j.1467-789X.2003.00117.x; Provencher V, 2005, OBES RES, V13, P1624, DOI 10.1038/oby.2005.199; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Rook Karen S, 2011, J Soc Pers Relat, V28, DOI 10.1177/0265407510391335; Salvy SJ, 2012, PHYSIOL BEHAV, V106, P369, DOI 10.1016/j.physbeh.2012.03.022; Schafer RB, 1999, SOC SCI MED, V48, P787, DOI 10.1016/S0277-9536(98)00377-3; Simpkins SD, 2013, J RES ADOLESCENCE, V23, P537, DOI 10.1111/j.1532-7795.2012.00836.x; Skoyen JA, 2013, J SOC PERS RELAT, V30, P1000, DOI 10.1177/0265407513479214; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; SUDMAN S, 1994, AUTOBIOGRAPHICAL MEMORY AND THE VALIDITY OF RETROSPECTIVE REPORTS, P251; U.S. Census Bureau, HOUS INC TABL HINC 0; UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S; Umberson D, 2010, ANNU REV SOCIOL, V36, P139, DOI 10.1146/annurev-soc-070308-120011; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID; White K, 2000, SOC NETWORKS, V22, P337, DOI 10.1016/S0378-8733(00)00030-7	49	18	19	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0169193	10.1371/journal.pone.0169193	http://dx.doi.org/10.1371/journal.pone.0169193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7KQ	28033428	Green Published, Green Submitted, gold			2022-12-26	WOS:000391226900083
J	van Proosdij, ASJ; Raes, N; Wieringa, JJ; Sosef, MSM				van Proosdij, Andre S. J.; Raes, Niels; Wieringa, Jan J.; Sosef, Marc S. M.			Unequal Contribution of Widespread and Narrow-Ranged Species to Botanical Diversity Patterns	PLOS ONE			English	Article							DISTRIBUTION MODELS; CONSERVATION PRIORITIES; PLANT DIVERSITY; RICHNESS; BIODIVERSITY; RARE; RARITY; SIZE; BIAS; DISTRIBUTIONS	In conservation studies, solely widespread species are often used as indicators of diversity patterns, but narrow-ranged species can show different patterns. Here, we assess how well subsets of narrow-ranged, widespread or randomly selected plant species represent patterns of species richness and weighted endemism in Gabon, tropical Africa. Specifically, we assess the effect of using different definitions of widespread and narrow-ranged and of the information content of the subsets. Finally, we test if narrow-ranged species are over-represented in species-rich areas. Based on distribution models of Gabonese plant species, we defined sequential subsets from narrow-ranged-to-widespread, widespread-to-narrow-ranged, and 100 randomly arranged species sequences using the range sizes of species in tropical Africa and within Gabon. Along these sequences, correlations between subsets and the total species richness and total weighted endemism patterns were computed. Random species subsets best represent the total species richness pattern, whereas subsets of narrow-ranged species best represent the total weighted endemism pattern. For species ordered according to their range sizes in tropical Africa, subsets of narrow-ranged species represented the total species richness pattern better than widespread species subsets did. However, the opposite was true when range sizes were truncated by the Gabonese national country borders. Correcting for the information content of the subset results in a skew of the sequential correlations, its direction depending on the range-size frequency distribution. Finally, we find a strong, positive, non-linear relation between weighted endemism and total species richness. Observed differences in the contribution of narrow-ranged, widespread and randomly selected species to species richness and weighted endemism patterns can be explained by the range-size frequency distribution and the use of different definitions of widespread or narrow-ranged. We call for a reconsideration of the use of widespread species as an indicator of diversity patterns, and advocate using the full ranges of species when assessing diversity patterns.	[van Proosdij, Andre S. J.; Wieringa, Jan J.; Sosef, Marc S. M.] Wageningen Univ, Biosystemat Grp, Wageningen, Netherlands; [van Proosdij, Andre S. J.; Raes, Niels; Wieringa, Jan J.] Naturalis Biodivers Ctr, Leiden, Netherlands; [Sosef, Marc S. M.] Bot Garden Meise, Meise, Belgium	Wageningen University & Research; Naturalis Biodiversity Center	van Proosdij, ASJ (corresponding author), Wageningen Univ, Biosystemat Grp, Wageningen, Netherlands.; van Proosdij, ASJ (corresponding author), Naturalis Biodivers Ctr, Leiden, Netherlands.	andrevanproosdij@hotmail.com	Raes, Niels/A-9645-2011; Sosef, Marc SM/N-3655-2017; Wieringa, Jan J./D-9517-2015	Raes, Niels/0000-0002-4329-4892; Sosef, Marc SM/0000-0002-6997-5813; Wieringa, Jan J./0000-0003-0566-372X				Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Calabrese JM, 2014, GLOBAL ECOL BIOGEOGR, V23, P99, DOI 10.1111/geb.12102; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; de la Estrella M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041526; Deblauwe V, 2016, GLOBAL ECOL BIOGEOGR; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Evans KL, 2005, BIOL LETT-UK, V1, P87, DOI 10.1098/rsbl.2004.0251; Fao/Iiasa/Isric/Isscas/Jrc, 2012, HARM WORLD SOIL DAT; Franklin J, 2009, MAPPING SPECIES DIST; Funk C.C., 2014, US GEOL SURV DATA SE, V832, P1; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hardy OJ, 2013, CR GEOSCI, V345, P284, DOI 10.1016/j.crte.2013.05.001; Harris DJ, 2012, PLANT ECOL EVOL, V145, P242, DOI 10.5091/plecevo.2012.641; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jetz W, 2004, ECOL LETT, V7, P1180, DOI 10.1111/j.1461-0248.2004.00678.x; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Kreft H, 2006, ECOGRAPHY, V29, P21, DOI 10.1111/j.2005.0906-7590.04203.x; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Lennon JJ, 2011, ECOGRAPHY, V34, P529, DOI 10.1111/j.1600-0587.2010.06669.x; Lennon JJ, 2004, ECOL LETT, V7, P81, DOI 10.1046/j.1461-0248.2004.00548.x; Linder HP, 2001, J BIOGEOGR, V28, P169, DOI 10.1046/j.1365-2699.2001.00527.x; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; LOMOLINO MV, 2004, FRONTIERS BIOGEOGRAP; Loyola RD, 2007, DIVERS DISTRIB, V13, P389, DOI 10.1111/j.1472-4642.2007.00345.x; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Maley J, 1996, P ROYAL SOC EDINBURG, V104B, P31, DOI 10.1017/S0269727000006114; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mazaris AD, 2013, ECOL INDIC, V32, P9, DOI 10.1016/j.ecolind.2013.02.023; Mazaris A, 2008, BIODIVERS CONSERV, V17, P3567, DOI 10.1007/s10531-008-9480-7; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Perez-Quesada A, 2013, AUSTRAL ECOL, V38, P639, DOI 10.1111/aec.12009; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pitman NCA, 2002, SCIENCE, V298, P989, DOI 10.1126/science.298.5595.989; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Raes N, 2012, NAT CONSERVACAO, V10, P127, DOI 10.4322/natcon.2012.020; Raes N, 2009, ECOGRAPHY, V32, P180, DOI 10.1111/j.1600-0587.2009.05800.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Ricketts T. H., 2001, Animal Biodiversity and Conservation, V24, P91; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sosef M.S.M., 2006, SCRIPTA BOT BELG, V35, P1; Syfert MM, 2014, BIOL CONSERV, V177, P174, DOI 10.1016/j.biocon.2014.06.012; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Vamosi JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003886; van Proosdij ASJ, 2016, ECOGRAPHY, V39, P542, DOI 10.1111/ecog.01509; Vazquez LB, 2004, GLOBAL ECOL BIOGEOGR, V13, P535, DOI 10.1111/j.1466-822X.2004.00126.x; Villalobos F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056073; Walters G, 2016, ORYX, V50, P419, DOI 10.1017/S0030605315000204; WHITE F, 1979, Bulletin du Jardin Botanique National de Belgique, V49, P11, DOI 10.2307/3667815; Wieringa J. J., 2004, Biodiversity of West African forests: an ecological atlas of woody plant species, P61, DOI 10.1079/9780851997346.0061; Wieringa JJ, 2011, PLANT ECOL EVOL, V144, P242, DOI 10.5091/plecevo.2011.588	62	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0169200	10.1371/journal.pone.0169200	http://dx.doi.org/10.1371/journal.pone.0169200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033337	gold, Green Published, Green Submitted			2022-12-26	WOS:000391226900085
J	Baez-Saldana, R; Delgado-Sanchez, G; Garcia-Garcia, L; Cruz-Hervert, LP; Montesinos-Castillo, M; Ferreyra-Reyes, L; Bobadilla-Del-Valle, M; Canizales-Quintero, S; Ferreira-Guerrero, E; Tellez-Vazquez, N; Montero-Campos, R; Yanes-Lane, M; Mongua-Rodriguez, N; Martinez-Gamboa, RA; Sifuentes-Osornio, J; Ponce-de-Leon, A				Baez-Saldana, Renata; Delgado-Sanchez, Guadalupe; Garcia-Garcia, Lourdes; Pablo Cruz-Hervert, Luis; Montesinos-Castillo, Marlene; Ferreyra-Reyes, Leticia; Bobadilla-del-Valle, Miriam; Canizales-Quintero, Sergio; Ferreira-Guerrero, Elizabeth; Tellez-Vazquez, Norma; Montero-Campos, Rogelio; Yanes-Lane, Mercedes; Mongua-Rodriguez, Norma; Martinez-Gamboa, Rosa Areli; Sifuentes-Osornio, Jose; Ponce-de-Leon, Alfredo			Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010	PLOS ONE			English	Article							SHORT-COURSE CHEMOTHERAPY; ACQUIRED DRUG-RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS; NATIONAL-SURVEY; CONSEQUENCES	Background Isoniazid mono-resistance (IMR) is the most common form of mono-resistance; its world prevalence is estimated to range between 0.0 to 9.5% globally. There is no consensus on how these patients should be treated. Objective To describe the impact of IMR tuberculosis (TB) on treatment outcome and survival among pulmonary TB patients treated under programmatic conditions in Orizaba, Veracruz, Mexico. Materials and Methods We conducted a prospective cohort study of pulmonary TB patients in Southern Mexico. From 1995 to 2010 patients with acid-fast bacilli or culture proven Mycobacterium tuberculosis in sputum samples underwent epidemiological, clinical and microbiological evaluation. We included patients who harbored isoniazid mono-resistant (IMR) strains and patients with strains susceptible to isoniazid, rifampicin, ethambutol and streptomycin. All patients were treated following Mexican TB Program guidelines. We performed annual follow-up to ascertain treatment outcome, recurrence, relapse and mortality. Results Between 1995 and 2010 1,243 patients with pulmonary TB were recruited; 902/1,243 (72.57%) had drug susceptibility testing; 716 (79.38%) harbored pan-susceptible and 88 (9.75%) IMR strains. Having any contact with a person with TB (adjusted odds ratio (aOR)) 1.85, 95% Confidence interval (CI) 1.15-2.96) and homelessness (adjusted odds ratio (aOR) 2.76, 95% CI 1.08-6.99) were associated with IMR. IMR patients had a higher probability of failure (adjusted hazard ratio (HR) 12.35, 95% CI 3.38-45.15) and death due to TB among HIV negative patients (aHR 3.30. 95% CI 1.00-10.84). All the models were adjusted for socio-demographic and clinical variables. Conclusions The results from our study provide evidence that the standardized treatment schedule with first line drugs in new and previously treated cases with pulmonary TB and IMR produces a high frequency of treatment failure and death due to tuberculosis. We recommend re-evaluating the optimal schedule for patients harboring IMR. It is necessary to strengthen scientific research for the evaluation of alternative treatment schedules in similar settings.	[Baez-Saldana, Renata; Delgado-Sanchez, Guadalupe; Garcia-Garcia, Lourdes; Pablo Cruz-Hervert, Luis; Montesinos-Castillo, Marlene; Ferreyra-Reyes, Leticia; Canizales-Quintero, Sergio; Ferreira-Guerrero, Elizabeth; Tellez-Vazquez, Norma; Montero-Campos, Rogelio; Yanes-Lane, Mercedes; Mongua-Rodriguez, Norma] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico; [Baez-Saldana, Renata] Univ Nacl Autonoma Mexico, Fac Med, Ciudad De Mexico, Mexico; [Bobadilla-del-Valle, Miriam; Martinez-Gamboa, Rosa Areli; Ponce-de-Leon, Alfredo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Microbiol Lab, Ciudad De Mexico, Mexico; [Yanes-Lane, Mercedes] Univ Autonoma San Luis Potosi, Fac Med, San Luis Potosi, San Luis Potos, Mexico; [Sifuentes-Osornio, Jose] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Direcc Med, Ciudad De Mexico, Mexico	Instituto Nacional de Salud Publica; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Autonoma de San Luis Potosi; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Garcia-Garcia, L (corresponding author), Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.	garcigarml@gmail.com	García, Maria de Lourdes/I-2724-2019; Cruz-Hervert, Luis Pablo/AEI-4595-2022; Bobadilla-del-Valle, Miriam/AAD-6418-2020	García, Maria de Lourdes/0000-0001-5262-1157; Cruz-Hervert, Luis Pablo/0000-0002-6094-958X; BOBADILLA-DEL VALLE, MIRIAM/0000-0003-1184-827X; Ponce-de-Leon, Alfredo/0000-0003-2640-2916; Sifuentes-Osornio, Jose/0000-0001-9584-1360	Mexican Secretariat of Health; National Institute of Health of the United States [A135969, K01TW000001]; Wellcome Trust [176W009]; Howard Hughes Medical Institute [55000632]; Mexican Council of Science and Technology [SALUD 2003-C01-132, SEP-2004-C01-47499/A1, FOSSIS 2005-03 (15203), FOSSIS 2005-2 14475, SALUD-2008-C01-87332, SALUD-2010-01-140178, FOSSEC-2014-1-233506, CB-2014-24175]	Mexican Secretariat of Health; National Institute of Health of the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Mexican Council of Science and Technology(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Mexican Secretariat of Health, by the National Institute of Health of the United States [A135969 and K01TW000001]; by the Wellcome Trust [176W009]; by the Howard Hughes Medical Institute [55000632] and by the Mexican Council of Science and Technology [SALUD 2003-C01-132, SEP-2004-C01-47499/A1, FOSSIS 2005-03 (15203), FOSSIS 2005-2 14475, SALUD-2008-C01-87332, SALUD-2010-01-140178, FOSSEC-2014-1-233506, CB-2014-24175]. The funding agencies did not participate in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The authors do not have any associations that might pose a conflict of interest.	Abebe Gemeda, 2012, BMC Res Notes, V5, P225, DOI 10.1186/1756-0500-5-225; [Anonymous], 1991, Am Rev Respir Dis, V143, P700; [Anonymous], 2001, PREV TRAT CONTR DIAB; [Anonymous], 2005, PREV CONTR TUB AT PR; [Anonymous], 2000, PREV CONTR TUB AT PR; Arias F, 2015, REV CHIL INFECTOL, V32, P382, DOI 10.4067/S0716-10182015000500002; Bang D, 2010, J INFECTION, V60, P452, DOI 10.1016/j.jinf.2010.03.017; Barlow REL, 2001, J CLIN MICROBIOL, V39, P2453, DOI 10.1128/JCM.39.7.2453-2457.2001; Bemer P, 2002, J CLIN MICROBIOL, V40, P150, DOI 10.1128/JCM.40.1.150-154.2002; Bojorquez-Chapela I, 2013, INT J TUBERC LUNG D, V17, P514, DOI 10.5588/ijtld.12.0167; Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689; Chien JY, 2015, CLIN MICROBIOL INFEC, V21, P59, DOI 10.1016/j.cmi.2014.08.008; Cox HS, 2007, CLIN INFECT DIS, V44, P1421, DOI 10.1086/517536; DeRiemer K, 2005, LANCET, V365, P1239, DOI 10.1016/S0140-6736(05)74812-1; DGE INDRE RLSP, 2015, LIN VIG EP TUB LAB; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Fasih N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050551; Fox L, 2011, EUR J CLIN MICROBIOL, V30, P863, DOI 10.1007/s10096-011-1167-4; Garcia-Garcia MD, 2000, ARCH INTERN MED, V160, P630, DOI 10.1001/archinte.160.5.630; Garcia-Garcia MD, 2000, INT J TUBERC LUNG D, V4, P12; Garcia-Garcia MD, 2002, EMERG INFECT DIS, V8, P1327; Instituto Nacional de Estadistica Geografia e Informatica (INEGI), CENS POBL VIV 2010 G; Jimenez-Corona ME, 2006, THORAX, V61, P348, DOI 10.1136/thx.2005.049452; Maguire H, 2011, EURO SURVEILL, V16; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; MITCHISON DA, 1986, AM REV RESPIR DIS, V133, P423; Cruz-Hervert LP, 2012, AGE AGEING, V41, P488, DOI 10.1093/ageing/afs028; PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0; Peyffer GE, 2011, MANUAL CLIN MICROBIO, V1, P472, DOI DOI 10.1128/9781555816728.CH28; Pinto Lancelot, 2011, Infect Drug Resist, V4, P129, DOI 10.2147/IDR.S10332; Quy HTW, 2003, INT J TUBERC LUNG D, V7, P631; Ramarokoto H, 2010, INT J TUBERC LUNG D, V14, P745; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Secretara de Salud, 2009, ENC NAC AD 2008; Seung KJ, 2004, CLIN INFECT DIS, V39, P1321, DOI 10.1086/425005; UNAIDS and Stop AIDS Alliance, 2015, COMM DEL, P23; Varahram Mohammad, 2013, Open Microbiol J, V8, P1, DOI 10.2174/1874285801408010001; Villa-Rosas C, 2015, SALUD PUBLICA MEXICO, V57, P177; Villegas L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152933; Wang TY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086316; WHO, 2016, GLOB TUB REP; World Health Organization, 2007, GUID PROV IN HIV TES; World Health Organization, 2016, FRAM IND TARG LAB ST; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Wright A, 2008, ANTITUBERCULOSIS DRU	47	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168955	10.1371/journal.pone.0168955	http://dx.doi.org/10.1371/journal.pone.0168955			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030600	Green Submitted, Green Published, gold			2022-12-26	WOS:000391222000090
J	Becker, JE; Brown, CA				Becker, Jamie E.; Brown, Christopher A.			Reliable Refuge: Two Sky Island Scorpion Species Select Larger, Thermally Stable Retreat Sites	PLOS ONE			English	Article							CENTRUROIDES-SCULPTURATUS; THERMOREGULATORY BEHAVIOR; BODY TEMPERATURES; FOOD-DEPRIVATION; WATER-LOSS; PREGNANCY; LIZARD; REPRODUCTION; ECTOTHERMS; BIOLOGY	Sky island scorpions shelter under rocks and other surface debris, but, as with other scorpions, it is unclear whether these species select retreat sites randomly. Furthermore, little is known about the thermal preferences of scorpions, and no research has been done to identify whether reproductive condition might influence retreat site selection. The objectives were to (1) identify physical or thermal characteristics for retreat sites occupied by two sky island scorpions (Vaejovis cashi Graham 2007 and V. electrum Hughes 2011) and those not occupied; (2) determine whether retreat site selection differs between the two study species; and (3) identify whether thermal selection differs between species and between gravid and non-gravid females of the same species. Within each scorpion's habitat, maximum dimensions of rocks along a transect line were measured and compared to occupied rocks to determine whether retreat site selection occurred randomly. Temperature loggers were placed under a subset of occupied and unoccupied rocks for 48 hours to compare the thermal characteristics of these rocks. Thermal gradient trials were conducted before parturition and after dispersal of young in order to identify whether gravidity influences thermal preference. Vaejovis cashi and V. electrum both selected larger retreat sites that had more stable thermal profiles. Neither species appeared to have thermal preferences influenced by reproductive condition. However, while thermal selection did not differ among non-gravid individuals, gravid V. electrum selected warmer temperatures than its gravid congener. Sky island scorpions appear to select large retreat sites to maintain thermal stability, although biotic factors (e.g., competition) could also be involved in this choice. Future studies should focus on identifying the various biotic or abiotic factors that could influence retreat site selection in scorpions, as well as determining whether reproductive condition affects thermal selection in other arachnids.	[Becker, Jamie E.] Bowling Green State Univ, Dept Biol, Bowling Green, OH 43403 USA; [Brown, Christopher A.] Tennessee Technol Univ, Dept Biol, Cookeville, TN 38505 USA	University System of Ohio; Bowling Green State University; Tennessee Technological University	Becker, JE (corresponding author), Bowling Green State Univ, Dept Biol, Bowling Green, OH 43403 USA.	jambeck@bgsu.edu			Southwestern Research Station (SWRS)	Southwestern Research Station (SWRS)	The Southwestern Research Station (SWRS) awarded JEB some funds to defray the cost of room and board during her 10-day stay; data collection would not be possible without this aid; http://www.amnh.org/our-research/southwestern-research-station/. The authors received no other funding for this work.	ALEXANDER AJ, 1958, J EXP BIOL, V35, P349; Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; Brown RP, 2005, J THERM BIOL, V30, P79, DOI 10.1016/j.jtherbio.2004.07.005; Brownell P, 2001, SCORPION BIOLOGY AND RESEARCH, P159; Carlson BE, 2009, J ARACHNOL, V37, P321, DOI 10.1636/Hi09-06.1; Croak BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037982; DAUT EF, 1993, J HERPETOL, V27, P6, DOI 10.2307/1564898; Debano LF, 1995, BIODIVERSITY MANAGEM, P669; Dillon ME, 2009, J THERM BIOL, V34, P109, DOI 10.1016/j.jtherbio.2008.11.007; Downes S, 1998, ANIM BEHAV, V55, P1387, DOI 10.1006/anbe.1997.0705; DREISIG H, 1980, OECOLOGIA, V44, P376, DOI 10.1007/BF00545242; Dunham AE, 2013, PHYSIOL ZOOL, V62, P335; Elias R, 1999, INT J INSECT MORPHOL, V28, P337, DOI 10.1016/S0020-7322(99)00035-5; Goldsrough CL, 2004, ECOLOGY, V85, P1635, DOI 10.1890/02-0770; Graham MR, 2007, EUSCORPIUS, P51; HADLEY N F, 1974, Journal of Arachnology, V2, P11; Hadley N. F, 1994, WATER RELATIONS TERR; HADLEY NF, 1982, J EXP BIOL, V101, P343; HADLEY NF, 1970, ECOLOGY, V51, P434, DOI 10.2307/1935378; Hitchcock MA, 2006, J HERPETOL, V40, P185, DOI 10.1670/233-04A.1; Hoshino K, 2006, J VENOM ANIM TOXINS, P59; HUEY RB, 1989, ECOLOGY, V70, P931, DOI 10.2307/1941360; Hughes GB, 2011, J ARACHNOL, V39, P420, DOI 10.1636/Ha11-07.1; HUTCHISON VH, 1979, AM ZOOL, V19, P367; Isaac LA, 2004, J ZOOL, V264, P403, DOI 10.1017/s095283690400593x; Kaib M, 1996, FIRE HIST GALLERY PI, p49p; Li DQ, 1996, J THERM BIOL, V21, P245, DOI 10.1016/0306-4565(96)00009-5; Lighton JRB, 2001, J EXP BIOL, V204, P607; MARSH AC, 1987, J THERM BIOL, V12, P295, DOI 10.1016/0306-4565(87)90031-3; Mathies T, 1997, FUNCT ECOL, V11, P498, DOI 10.1046/j.1365-2435.1997.00119.x; McCormick S., 1990, Biology of scorpion, P145; McReynolds CN, 2008, J ARACHNOL, V36, P557, DOI 10.1636/T07-07.1; NWS Tucson, 2013, ARCH; Polis GA, 1990, BIOL SCORPIONS, P123; Prestwich KN, 2006, J ARACHNOL, V34, P351, DOI 10.1636/S05-75.1; Rock J, 2000, PHYSIOL BIOCHEM ZOOL, V73, P344, DOI 10.1086/316741; Scharf I, 2006, J INSECT BEHAV, V19, P197, DOI 10.1007/s10905-006-9017-4; SHINE R, 1980, Oecologia (Berlin), V46, P92, DOI 10.1007/BF00346972; Skutelsky O, 1996, ANIM BEHAV, V52, P49, DOI 10.1006/anbe.1996.0151; Slip DJ, 1988, COMP BIOCH PHYSL A, P645; Steffenson MM, 2009, THESIS; Stutt AD, 1998, ANIM BEHAV, V55, P1341, DOI 10.1006/anbe.1998.0728; TU MC, 1994, J THERM BIOL, V19, P255, DOI 10.1016/0306-4565(94)90048-5; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; Warburg M.R., 1990, BIOL SCORPIONS, P112; WARBURG MR, 1981, COMP BIOCHEM PHYS A, V68, P277, DOI 10.1016/0300-9629(81)90354-6; Webb JK, 1998, PHYSIOL ZOOL, V71, P680, DOI 10.1086/515979; Webb JK, 1998, BIOL CONSERV, V86, P233, DOI 10.1016/S0006-3207(97)00180-8; Webb JK, 1996, THESIS; Webber MM, 2015, J EVOLUTION BIOL, V28, P368, DOI 10.1111/jeb.12569; Webber M.M., 2012, EUSCORPIUS, V140, P1, DOI [10.18590/euscorpius.2012, DOI 10.18590/EUSCORPIUS.2012]; Webber MM, 2015, J ARID ENVIRON, V121, P40, DOI 10.1016/j.jaridenv.2015.04.014; Webber MM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-197; WHITMORE DH, 1985, PHYSIOL ZOOL, V58, P526, DOI 10.1086/physzool.58.5.30158580; Zari TA, 1998, J ARID ENVIRON, V38, P371, DOI 10.1006/jare.1997.0338	55	1	1	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168105	10.1371/journal.pone.0168105	http://dx.doi.org/10.1371/journal.pone.0168105			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030603	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000035
J	Jonscher, KR; Stewart, MS; Alfonso-Garcia, A; DeFelice, BC; Wang, XXX; Luo, YH; Levi, M; Heerwagen, MJR; Janssen, RC; de la Houssaye, BA; Wiitala, E; Florey, G; Jonscher, RL; Potma, EO; Fiehn, O; Friedman, JE				Jonscher, Karen R.; Stewart, Michael S.; Alfonso-Garcia, Alba; DeFelice, Brian C.; Wang, Xiaoxin X.; Luo, Yuhuan; Levi, Moshe; Heerwagen, Margaret J. R.; Janssen, Rachel C.; de la Houssaye, Becky A.; Wiitala, Ellen; Florey, Garrett; Jonscher, Raleigh L.; Potma, Eric O.; Fiehn, Oliver; Friedman, Jacob E.			Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice	FASEB JOURNAL			English	Article						antioxidant; PGC-1 alpha; ceramide; lipidomics; CARS	PYRROLOQUINOLINE QUINONE DISODIUM; FATTY LIVER-DISEASE; DIET-INDUCED OBESITY; MITOCHONDRIAL DYSFUNCTION; LIPID-ACCUMULATION; INSULIN-RESISTANCE; MASS-SPECTROMETRY; MATERNAL OBESITY; OXIDATIVE STRESS; KAPPA-B	Nonalcoholic fatty liver disease (NAFLD) is widespread in adults and children. Early exposure to maternal obesity or Western-style diet (WD) increases steatosis and oxidative stress in fetal liver and is associated with lifetime disease risk in the offspring. Pyrroloquinoline quinone (PQQ) is a natural antioxidant found in soil, enriched in human breast milk, and essential for development in mammals. We investigated whether a supplemental dose of PQQ, provided prenatally in amousemodel of diet-induced obesity during pregnancy, could protect obese offspring from progression of NAFLD. PQQ treatment given pre-and postnatally in WD-fed offspring had no effect on weight gain but increased metabolic flexibility while reducing body fat and liver lipids, compared with untreated obese offspring. Indices of NAFLD, including hepatic ceramide levels, oxidative stress, and expression of proinflammatory genes (Nos2, Nlrp3, Il6, and Ptgs2), were decreased in WD PQQ-fed mice, concomitant with increased expression of fatty acid oxidation genes and decreased Pparg expression. Notably, these changes persisted even after PQQ withdrawal at weaning. Our results suggest that supplementation with PQQ, particularly during pregnancy and lactation, protects offspring from WD-induced developmental programming of hepatic lipotoxicity and may help slow the advancing epidemic of NAFLD in the next generation.-Jonscher, K. R., Stewart, M. S., Alfonso-Garcia, A., DeFelice, B. C., Wang, X. X., Luo, Y., Levi, M., Heerwagen, M. J. R., Janssen, R. C., de laHoussaye, B. A., Wiitala, E., Florey, G., Jonscher, R. L., Potma, E. O., Fiehn, O. Friedman, J. E. Early PQQ supplementation has persistent long-termprotective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice. FASEB J. 31, 1434-1448 (2017). www.fasebj.org	[Jonscher, Karen R.] Univ Colorado, Dept Anesthesiol, Anschutz Med Campus, Aurora, CO USA; [Stewart, Michael S.; Heerwagen, Margaret J. R.; Janssen, Rachel C.; de la Houssaye, Becky A.; Wiitala, Ellen; Friedman, Jacob E.] Univ Colorado, Dept Pediat, Anschutz Med Campus, Aurora, CO USA; [Wang, Xiaoxin X.; Luo, Yuhuan; Levi, Moshe] Univ Colorado, Div Renal Dis & Hypertens, Dept Med, Anschutz Med Campus, Aurora, CO USA; [Alfonso-Garcia, Alba; Potma, Eric O.] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA USA; [Potma, Eric O.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [DeFelice, Brian C.; Fiehn, Oliver] Univ Calif Davis, West Coast Metabol Ctr, Davis, CA 95616 USA; [Florey, Garrett; Jonscher, Raleigh L.] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [Fiehn, Oliver] King Abdulaziz Univ, Biochem Dept, Jeddah, Saudi Arabia	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Davis; University of Colorado System; University of Colorado Denver; King Abdulaziz University	Jonscher, KR (corresponding author), Univ Colorado, Anschutz Med Campus,12801 E 17th Ave,MS 8016, Aurora, CO 80045 USA.	jonscher@ucdenver.edu		DeFelice, Brian/0000-0001-8243-0300; Alfonso-Garcia, Alba/0000-0002-6748-3751	U.S. National Institutes of Health (NIH)/National Center for Advancing Translational Science Colorado County Technical Services, University of Colorado Anschutz Medical Campus [UL1 TR001082]; Research Center Metabolic Phenotyping Core [NIH P30 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK48520, NIH P50]; National Institute of Child Health and Human Development [HD073063]; NIH NIDDK [R01 DK104351, U24 DK097154, 5R01DK098336, K25DK098615]; NIH National Institute of General Medical Sciences [S10RR031630]; NIH NIGMS [P41-RR01192]; Virtual, Augmented and Mixed Reality [1I01BX001954]; Mitsubishi Gas and Chemical Company; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD073063] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031630, P41RR001192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K25DK098615, P30DK048520, R24DK090964, U24DK097154, P30DK020593, R01DK104351, R01DK098336] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001954] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Center for Advancing Translational Science Colorado County Technical Services, University of Colorado Anschutz Medical Campus; Research Center Metabolic Phenotyping Core [NIH P30 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Virtual, Augmented and Mixed Reality; Mitsubishi Gas and Chemical Company; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Dr. Robert Rucker (University of California, Davis) for invaluable mentorship of K.R.J. and helpful discussions; Greg Glazner and Radu Moldovan [Advanced Light Microscopy Core Facility, U.S. National Institutes of Health (NIH)/National Center for Advancing Translational Science Colorado County Technical Services, University of Colorado Anschutz Medical Campus; Grant UL1 TR001082] for help with the CARS analysis; Matt Jackman and the Nutrition Obesity Research Center Metabolic Phenotyping Core [NIH P30 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant DK48520 and NIH P50 and National Institute of Child Health and Human Development Grant HD073063, University of Colorado Anschutz Medical Campus] for aid with processing data from the metabolic chamber. Funding was received through NIH NIDDK Grant R01 DK104351 (to O.F., which provided funds for B.C.D.); NIH NIDDK Grant U24 DK097154, and the QTOF mass spectrometer was funded by NIH National Institute of General Medical Sciences Grant S10RR031630 (to O.F.); NIH NIGMS Grant P41-RR01192 (Laser Microbeam and Medical Program) (to A.A.G. and E.O.P.); NIH NIDDK Grant 5R01DK098336 and Virtual, Augmented and Mixed Reality Grant 1I01BX001954 (to X.X.W., Y.L., and M.L.); and NIH NIDDK Grant K25DK098615 and an unrestricted grant from the Mitsubishi Gas and Chemical Company (to K.R.J.) The authors declare no conflicts of interest.	Akagawa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26723; Akagawa M, 2016, BIOSCI BIOTECH BIOCH, V80, P13, DOI 10.1080/09168451.2015.1062715; Apostolopoulou M, 2016, DIABETOLOGIA, V59, P2203, DOI 10.1007/s00125-016-4038-9; Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bauerly K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021779; Bikman BT, 2012, CELL MOL LIFE SCI, V69, P2135, DOI 10.1007/s00018-012-0917-5; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Brumbaugh DE, 2013, J PEDIATR-US, V162, P930, DOI 10.1016/j.jpeds.2012.11.017; Cerda S, 1997, MUTAT RES-REV MUTAT, V386, P141, DOI 10.1016/S1383-5742(96)00050-6; Chavez JA, 2014, J BIOL CHEM, V289, P723, DOI 10.1074/jbc.M113.522847; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; Giles ED, 2010, AM J PHYSIOL-REG I, V299, pR1634, DOI 10.1152/ajpregu.00219.2010; Harris CB, 2013, J NUTR BIOCHEM, V24, P2076, DOI 10.1016/j.jnutbio.2013.07.008; Hassanin A, 2014, EXP THER MED, V8, P1551, DOI 10.3892/etm.2014.1963; Hausler N, 2006, BIOCHEM J, V394, P465, DOI 10.1042/BJ20051174; Heerwagen MJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067791; HERRERA PL, 1991, DEVELOPMENT, V113, P1257; Hitchler MJ, 2007, FREE RADICAL BIO MED, V43, P1023, DOI 10.1016/j.freeradbiomed.2007.06.027; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Itoh Y, 2016, ADV EXP MED BIOL, V876, P319, DOI 10.1007/978-1-4939-3023-4_40; Iwakiri Y, 2015, CLIN MOL HEPATOL, V21, P319, DOI 10.3350/cmh.2015.21.4.319; Jackman MR, 2008, AM J PHYSIOL-REG I, V294, pR1117, DOI 10.1152/ajpregu.00808.2007; Jia DW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121939; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; KILLGORE J, 1989, SCIENCE, V245, P850, DOI 10.1126/science.2549636; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Kumar N, 2015, CHEM-BIOL INTERACT, V240, P278, DOI 10.1016/j.cbi.2015.08.027; Lane M, 2015, TRENDS ENDOCRIN MET, V26, P84, DOI 10.1016/j.tem.2014.11.005; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lim RS, 2010, J LIPID RES, V51, P1729, DOI 10.1194/jlr.M003616; Liu WS, 2016, CELL MOL LIFE SCI, V73, P1969, DOI 10.1007/s00018-016-2161-x; Liu ZB, 2016, INFLAMMATION, V39, P248, DOI 10.1007/s10753-015-0245-7; Luo T, 2014, LIPIDS, V49, P495, DOI 10.1007/s11745-014-3889-4; Lytle KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146942; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; MacLean PS, 2004, AM J PHYSIOL-REG I, V287, pR288, DOI 10.1152/ajpregu.00010.2004; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Mitchell AE, 1999, ANAL BIOCHEM, V269, P317, DOI 10.1006/abio.1999.4039; Mouralidarane A, 2013, HEPATOLOGY, V58, P128, DOI 10.1002/hep.26248; Nakano M, 2015, J NUTR SCI VITAMINOL, V61, P241, DOI 10.3177/jnsv.61.241; Nakano M, 2015, J NUTR SCI VITAMINOL, V61, P233, DOI 10.3177/jnsv.61.233; Nakano M, 2013, REGUL TOXICOL PHARM, V67, P189, DOI 10.1016/j.yrtph.2013.07.007; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Odkhuu E, 2012, IMMUNOL LETT, V142, P34, DOI 10.1016/j.imlet.2011.12.001; Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005; Perrone Serafina, 2016, World J Clin Pediatr, V5, P172, DOI 10.5409/wjcp.v5.i2.172; Pruis MGM, 2014, ACTA PHYSIOL, V210, P215, DOI 10.1111/apha.12197; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rees WD, 2000, J NUTR, V130, P1821, DOI 10.1093/jn/130.7.1821; Roberts VHJ, 2014, FASEB J, V28, P2466, DOI 10.1096/fj.13-245472; Rucker R, 2009, ALTERN MED REV, V14, P268; Saben JL, 2016, CELL REP, V16, P1, DOI 10.1016/j.celrep.2016.05.065; Samuel KG, 2015, ANIMAL, V9, P409, DOI 10.1017/S1751731114002328; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Sen S, 2010, DIABETES, V59, P3058, DOI 10.2337/db10-0301; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Steig AJ, 2011, AM J PHYSIOL-REG I, V301, pR656, DOI 10.1152/ajpregu.00212.2011; Steinberg F, 2003, EXP BIOL MED, V228, P160, DOI 10.1177/153537020322800205; Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359; Tao R, 2015, INFLAMMATION, V38, P1546, DOI 10.1007/s10753-015-0129-x; Tchaparian E, 2010, BIOCHEM J, V429, P515, DOI 10.1042/BJ20091649; Thompson LP, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/582748; van de Weijer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051648; Verbeek Jef, 2016, Curr Protoc Mouse Biol, V6, P201, DOI 10.1002/cpmo.1; Wesolowski SR, 2017, NAT REV GASTRO HEPAT, V14, P81, DOI 10.1038/nrgastro.2016.160; Wu LLY, 2010, ENDOCRINOLOGY, V151, P5438, DOI 10.1210/en.2010-0551; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Zhu BQ, 2006, J CARDIOVASC PHARM T, V11, P119, DOI 10.1177/1074248406288757	71	35	37	3	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1434	1448		10.1096/fj.201600906R	http://dx.doi.org/10.1096/fj.201600906R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28007783	Green Published			2022-12-26	WOS:000398504300014
J	Qin, HM; Miyakawa, T; Inoue, A; Nishiyama, R; Nakamura, A; Asano, A; Sawano, Y; Ojima, T; Tanokura, M				Qin, Hui-Min; Miyakawa, Takuya; Inoue, Akira; Nishiyama, Ryuji; Nakamura, Akira; Asano, Atsuko; Sawano, Yoriko; Ojima, Takao; Tanokura, Masaru			Structure and Polymannuronate Specificity of a Eukaryotic Member of Polysaccharide Lyase Family 14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HALIOTIS-DISCUS-HANNAI; ALGINATE LYASE; CRYSTAL-STRUCTURE; CDNA CLONING; ABALONE; RESIDUES; ACID	Alginate is an abundant algal polysaccharide, composed of beta-D-mannuronate and its C5 epimer alpha-L-guluronate, that is a useful biomaterial in cell biology and tissue engineering, with applications in cancer and aging research. The alginate lyase (EC 4.2.2.3) from Aplysia kurodai, AkAly30, is a eukaryotic member of the polysaccharide lyase 14 (PL-14) family and degrades alginate by cleaving the glycosidic bond through a beta-elimination reaction. Here, we present the structural basis for the substrate specificity, with a preference for polymannuronate, of AkAly30. The crystal structure of AkAly30 at a 1.77 angstrom resolution and the putative substrate-binding model show that the enzyme adopts a beta-jelly roll fold at the core of the structure and that Lys-99, Tyr-140, and Tyr-142 form catalytic residues in the active site. Their arrangements allow the carboxyl group of mannuronate residues at subsite +1 to form ionic bonds with Lys-99. The coupled tyrosine forms a hydrogen bond network with the glycosidic bond, and the hydroxy group of Tyr-140 is located near the C5 atom of the mannuronate residue. These interactions could promote the beta-elimination of the mannuronate residue at subsite +1. More interestingly, Gly-118 and the disulfide bond formed by Cys-115 and Cys-124 control the conformation of an active-site loop, which makes the space suitable for substrate entry into subsite -1. The cleavage efficiency of AkAly30 is enhanced relative to that of mutants lacking either Gly-118 or the Cys-115-Cys-124 disulfide bond. The putative binding model and mutagenesis studies provide a novel substrate recognition mode explaining the polymannuronate specificity of PL-14 alginate lyases.	[Qin, Hui-Min; Miyakawa, Takuya; Nakamura, Akira; Asano, Atsuko; Sawano, Yoriko; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Qin, Hui-Min] Tianjin Univ Sci & Technol, Coll Biotechnol, 29,13th Ave, Tianjin 300457, Peoples R China; [Inoue, Akira; Nishiyama, Ryuji; Ojima, Takao] Hokkaido Univ, Grad Sch Fisheries Sci, Lab Marine Biotechnol & Microbiol, 3-1-1 Minato Cho, Hakodate, Hokkaido 0418611, Japan; [Sawano, Yoriko] Tokyo Med & Dent Univ, Coll Liberal Arts & Sci, Chem Lab, 2-8-30 Kounodai, Ichikawa, Chiba 2720827, Japan	University of Tokyo; Tianjin University Science & Technology; Hokkaido University; Tokyo Medical & Dental University (TMDU)	Tanokura, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp	Nakamura, Akira/K-2982-2019	Nakamura, Akira/0000-0001-7733-4007; Tanokura, Masaru/0000-0001-5072-2480	Tohoku Marine Science Project of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; overseas High-level Talents Program of Tianjin University of Science and Technology, China	Tohoku Marine Science Project of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; overseas High-level Talents Program of Tianjin University of Science and Technology, China	This work was supported by the Tohoku Marine Science Project of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan, and the overseas High-level Talents Program of Tianjin University of Science and Technology, China. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Chaki T, 2007, BIOSCI BIOTECH BIOCH, V71, P1819, DOI 10.1271/bbb.60620; Corbeil CR, 2012, J COMPUT AID MOL DES, V26, P775, DOI 10.1007/s10822-012-9570-1; ELYAKOVA LA, 1974, BIOCHIM BIOPHYS ACTA, V358, P341, DOI 10.1016/0005-2744(74)90464-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GACESA P, 1990, APPL ENVIRON MICROB, V56, P2265, DOI 10.1128/AEM.56.7.2265-2267.1990; Gimmestad M, 2009, J BACTERIOL, V191, P4845, DOI 10.1128/JB.00455-09; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hashimoto W, 2003, J BIOL CHEM, V278, P7663, DOI 10.1074/jbc.M208100200; Hata M, 2009, FISHERIES SCI, V75, P755, DOI 10.1007/s12562-009-0079-z; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Inoue A, 2016, J BIOL CHEM, V291, P15551, DOI 10.1074/jbc.M115.713230; Inoue A, 2011, MAR BIOTECHNOL, V13, P256, DOI 10.1007/s10126-010-9290-2; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kumagai Y, 2009, COMP BIOCHEM PHYS B, V154, P113, DOI 10.1016/j.cbpb.2009.05.005; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Labute P, 2009, PROTEINS, V75, P187, DOI 10.1002/prot.22234; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; Mikami B, 2012, ACTA CRYSTALLOGR D, V68, P1207, DOI 10.1107/S090744491202495X; Mochizuki S, 2015, J BIOL CHEM, V290, P30962, DOI 10.1074/jbc.M115.686725; Muramatsu T, 1996, J PROTEIN CHEM, V15, P709, DOI 10.1007/BF01887144; Nishida Y, 2007, BIOCHIMIE, V89, P1002, DOI 10.1016/j.biochi.2007.03.015; Ochiai A, 2010, J BIOL CHEM, V285, P24519, DOI 10.1074/jbc.M110.125450; Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008; Ogura K, 2009, J BIOL CHEM, V284, P35572, DOI 10.1074/jbc.M109.068056; Ootsuka S, 2006, J BIOTECHNOL, V125, P269, DOI 10.1016/j.jbiotec.2006.03.008; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; Park D, 2014, J BIOL CHEM, V289, P8645, DOI 10.1074/jbc.M113.531111; Rahman MM, 2012, CARBOHYD RES, V360, P69, DOI 10.1016/j.carres.2012.05.019; Rahman MM, 2011, BIOCHIMIE, V93, P1720, DOI 10.1016/j.biochi.2011.06.004; Rahman MM, 2010, COMP BIOCHEM PHYS B, V157, P317, DOI 10.1016/j.cbpb.2010.07.006; Sawabe T, 2003, AQUACULTURE, V219, P671, DOI 10.1016/S0044-8486(02)00618-X; Shimizu E, 2003, CARBOHYD RES, V338, P2841, DOI 10.1016/j.carres.2003.08.009; Suda K, 1999, FEMS MICROBIOL LETT, V180, P45, DOI 10.1016/S0378-1097(99)00459-0; Suzuki H, 2006, CARBOHYD RES, V341, P1809, DOI 10.1016/j.carres.2006.04.032; Suzuki K., 2004, MAR BIOTECHNOL, V6, pS502; Thomas F, 2013, J BIOL CHEM, V288, P23021, DOI 10.1074/jbc.M113.467217; Wang L, 2012, FISHERIES SCI, V78, P889, DOI 10.1007/s12562-012-0517-1; WEISSBACH A, 1959, J BIOL CHEM, V234, P705; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509	46	23	24	4	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2182	2190		10.1074/jbc.M116.749929	http://dx.doi.org/10.1074/jbc.M116.749929			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28011642	Green Published, hybrid			2022-12-26	WOS:000395530300012
J	Doherty, O; Casey, V; McGreevy, P; Arkins, S				Doherty, Orla; Casey, Vincent; McGreevy, Paul; Arkins, Sean			Noseband Use in Equestrian Sports - An International Study	PLOS ONE			English	Article							HORSES; HEADSHAKING; NERVE; COMPRESSION	Nosebands are used by riders to prevent the horse from opening its mouth, to increase control and, in some cases, to comply with the competition rules. While equestrian texts traditionally recommend that two adult human fingers should be able to fit under a fastened noseband, noseband tightness levels are not, in general, regulated in competition. Possible detrimental consequences for the horse, of excessively tight nosebands, include discomfort, pain or tissue damage. The current study investigated noseband usage in equestrian competition. Data regarding noseband type, position, width and tightness were collected from 750 horses in eventing (n = 354), dressage (n = 334) and performance hunter (n = 62) competitions in Ireland, England and Belgium. Data were collected immediately before or after the performance. Using the ISES taper gauge as a guide, results were classified according to the number of 'fingers' that could fit under the noseband at the nasal planum, and assigned to six groups: greater than 2 fingers; 2 fingers; 1.5 fingers; 1 finger; 0.5 fingers; zero fingers. A calliper was used to measure noseband width and position relative to the facial crest. The data were not normally distributed so Kruskall-Wallis and Mann-Whitney tests were used. In all, 44% of horses fell into the zero fingers classification while only 7% were in the two fingers classification. Significant differences emerged between disciplines (p<0.001), with the highest levels of noseband tightness measured among eventers followed by dressage horses with lowest levels among performance hunters. Noseband tightness did not differ significantly with horse age (p>0.05), which ranged from 4 to 19 years. The flash noseband was the most commonly used noseband (n = 326) and was significantly tighter than the cavesson (p < 0.001), drop noseband (p < 0.001) and the Micklem (p < 0.005). Noseband width ranged from 10 to 50 mm. Noseband position varied widely with the distance between the facial crest and upper noseband margin ranging from 0 to 70 mm. The high proportion of very tight nosebands found in this study raises concerns regarding the short and long term behavioural and physiological consequences of such tight nosebands are for the horse. Although these data are currently lacking, the findings are of concern.	[Doherty, Orla; Arkins, Sean] Univ Limerick, Dept Life Sci, Limerick, Ireland; [Casey, Vincent] Univ Limerick, Dept Phys, Limerick, Ireland; [McGreevy, Paul] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Limerick; University of Limerick; University of Sydney	Doherty, O (corresponding author), Univ Limerick, Dept Life Sci, Limerick, Ireland.	orladoherty@live.ie	Casey, Vincent/L-1140-2013	Casey, Vincent/0000-0002-0701-526X; McGreevy, Paul/0000-0001-7220-8378	Royal Dublin Society	Royal Dublin Society	This study was carried out as part of the doctoral research carried out by the first author (OD). The Royal Dublin Society (https://www.rds.ie/) as a philanthropic society supports research in science and provided a grant to help finance the doctoral studies of the corresponding author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1956, HORSEMANSHIP PONY CL; Casey V, 2013, J VET BEHAV, V8, P479, DOI 10.1016/j.jveb.2013.06.003; Christensen JW, 2011, EQUINE VET J, V43, P223, DOI 10.1111/j.2042-3306.2010.00151.x; DOBNER JJ, 1982, AM J SPORT MED, V10, P211, DOI 10.1177/036354658201000404; Ekberg J, 2011, INT J INJ CONTROL SA, V18, P261, DOI 10.1080/17457300.2010.545129; FEI, 2016, DRESS RUL; FEI (International Equestrian Federation), 2013, COD COND WELF HORS; Goody P., 2004, HORSE ANATOMY PRACTI; Hagenouw R, 1986, ANESTHESIA ANALGESIA, V65; Heuschmann G., 2006, TUG WAR CLASSICAL VE; Hockenhull J, 2012, APPL ANIM BEHAV SCI, V137, P36, DOI 10.1016/j.applanim.2012.01.007; Huntington P., 2004, HORSE SENSE GUIDE HO, V2nd; ISES (The International Society for Equitation Science), 2012, ISES POS STAT RESTR; Kapitzke G., 2004, BIT REINS DEV GOOD C; Klimke R., 1994, BASIC TRAINING YOUNG; Ladewig J, 2011, J VET BEHAV, V6, P292; Madigan JE, 2001, J AM VET MED ASSOC, V219, P334, DOI 10.2460/javma.2001.219.334; Manfredi JM, 2009, COMP EXERC PHYSIOL, V6, P143, DOI 10.1017/S1755254010000036; McGreevy P., 2010, EQUITATION SCI, V1st ed.; McGreevy PD, 2015, EQUINE VET EDUC, V27, P503, DOI 10.1111/eve.12445; McGreevy P, 2012, J VET BEHAV, V7, P142, DOI 10.1016/j.jveb.2011.08.001; McLean AN, 2010, J VET BEHAV, V5, P187, DOI 10.1016/j.jveb.2010.04.002; McLean AN, 2010, J VET BEHAV, V5, P203, DOI 10.1016/j.jveb.2010.04.003; Micklem W, 2003, COMPLETE HORSE RIDIN; Muir S., 2012, COMPLETE HORSE RIDER; Newton SA, 2000, EQUINE VET J, V32, P208, DOI 10.2746/042516400776563617; Noordin S, 2009, J BONE JOINT SURG AM, V91A, P2958, DOI 10.2106/JBJS.I.00634; Pospisil K, 2014, EQUINE VET J, V46, P46, DOI [10.1111/evj.12267_142, DOI 10.1111/EVJ.12267_142]; Randle H, 2013, J VET BEHAV, V8, P59, DOI 10.1016/j.jveb.2013.02.002; Roberts VLH, 2013, EQUINE VET J, V45, P107, DOI 10.1111/j.2042-3306.2012.00553.x; RORABECK CH, 1980, AM J SPORT MED, V8, P98, DOI 10.1177/036354658000800207; RYDEVIK B, 1977, SCAND J PLAST RECONS, V11, P179, DOI 10.3109/02844317709025516; SHAW JA, 1982, J BONE JOINT SURG AM, V64, P1148, DOI 10.2106/00004623-198264080-00004; Stecken F., 1977, BOOK DRESSAGE TRAINI; Tell A, 2008, VET J, V178, P405, DOI 10.1016/j.tvjl.2008.09.020	35	28	28	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169060	10.1371/journal.pone.0169060	http://dx.doi.org/10.1371/journal.pone.0169060			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045961	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300103
J	Hurteau, MD				Hurteau, Matthew D.			Quantifying the Carbon Balance of Forest Restoration and Wildfire under Projected Climate in the Fire-Prone Southwestern US	PLOS ONE			English	Article							PONDEROSA PINE FORESTS; SIERRA-NEVADA; WATER FLUXES; WESTERN US; DYNAMICS; MANAGEMENT; FUTURE; SEQUESTRATION; DISTURBANCE; SIMULATION	Climate projections for the southwestern US suggest a warmer, drier future and have the potential to impact forest carbon (C) sequestration and post-fire C recovery. Restoring forest structure and surface fire regimes initially decreases total ecosystem carbon (TEC), but can stabilize the remaining C by moderating wildfire behavior. Previous research has demonstrated that fire maintained forests can store more C over time than fire suppressed forests in the presence of wildfire. However, because the climate future is uncertain, I sought to determine the efficacy of forest management to moderate fire behavior and its effect on forest C dynamics under current and projected climate. I used the LANDIS-II model to simulate carbon dynamics under early (2010-2019), mid (2050-2059), and late (2090-2099) century climate projections for a ponderosa pine (Pinus ponderosa) dominated landscape in northern Arizona. I ran 100-year simulations with two different treatments (control, thin and burn) and a 1 in 50 chance of wildfire occurring. I found that control TEC had a consistent decline throughout the simulation period, regardless of climate. Thin and burn TEC increased following treatment implementation and showed more differentiation than the control in response to climate, with late-century climate having the lowest TEC. Treatment efficacy, as measured by mean fire severity, was not impacted by climate. Fire effects were evident in the cumulative net ecosystem exchange (NEE) for the different treatments. Over the simulation period, 32.8-48.9% of the control landscape was either C neutral or a C source to the atmosphere and greater than 90% of the thin and burn landscape was a moderate C sink. These results suggest that in southwestern ponderosa pine, restoring forest structure and surface fire regimes provides a reasonable hedge against the uncertainty of future climate change for maintaining the forest C sink.	[Hurteau, Matthew D.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Hurteau, MD (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	mhurteau@unm.edu	Hurteau, Matthew D/D-2301-2009	Hurteau, Matthew D/0000-0001-8457-8974	US Department of Defense's Strategic Environmental Research and Development Program (SERDP) [RC-2118]	US Department of Defense's Strategic Environmental Research and Development Program (SERDP)	Funding for this research was provided by the US Department of Defense's Strategic Environmental Research and Development Program (SERDP, project RC-2118); https://www.serdp-estcp.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington RN, 2015, INT J WILDLAND FIRE, V24, P778, DOI 10.1071/WF14187; [Anonymous], 1993, CENTURY SOIL ORGANIC; Brown PM, 2005, ECOLOGY, V86, P3030, DOI 10.1890/05-0034; Bureau of Reclamation, 2013, DOWNSC CMIP3 CMIP5 C; Burns R. M., 1990, AGR HDB, V2, P877, DOI DOI 10.1093/JHERED/ESP102; Campbell JL, 2012, FRONT ECOL ENVIRON, V10, P83, DOI 10.1890/110057; Collins BM, 2009, ECOSYSTEMS, V12, P114, DOI 10.1007/s10021-008-9211-7; COVINGTON WW, 1994, J FOREST, V92, P39; Dickson BG, 2006, LANDSCAPE ECOL, V21, P747, DOI 10.1007/s10980-005-5475-x; Dore S, 2008, GLOBAL CHANGE BIOL, V14, P1801, DOI 10.1111/j.1365-2486.2008.01613.x; Dore S, 2010, ECOL APPL, V20, P663, DOI 10.1890/09-0934.1; Dore S, 2012, GLOBAL CHANGE BIOL, V18, P3171, DOI 10.1111/j.1365-2486.2012.02775.x; Dymond CC, 2016, BIOGEOSCIENCES, V13, P1933, DOI 10.5194/bg-13-1933-2016; Earles JM, 2014, ECOL APPL, V24, P732, DOI 10.1890/13-1860.1; Fule PZ, 2012, FOREST ECOL MANAG, V269, P68, DOI 10.1016/j.foreco.2011.12.025; Fule PZ, 1997, ECOL APPL, V7, P895, DOI 10.1890/1051-0761(1997)007[0895:DRCFEM]2.0.CO;2; Gustafson EJ, 2000, CAN J FOREST RES, V30, P32, DOI 10.1139/cjfr-30-1-32; Hijmans RJ., 2012, RASTER GEOGRAPHIC AN; Howard JL, 2003, FIRE EFFECTS INFORM; Hurteau M. D., 2014, Forest Ecology and Management, V327, P280, DOI 10.1016/j.foreco.2013.08.007; Hurteau MD, 2016, ECOL APPL, V26, P382, DOI 10.1890/15-0337; Hurteau MD, 2014, ENVIRON SCI TECHNOL, V48, P2298, DOI 10.1021/es4050133; Hurteau MD, 2011, BIOSCIENCE, V61, P139, DOI 10.1525/bio.2011.61.2.9; Kerhoulas LP, 2013, J APPL ECOL, V50, P1311, DOI 10.1111/1365-2664.12139; Laflower DM, 2016, FOREST ECOL MANAG, V362, P194, DOI 10.1016/j.foreco.2015.12.015; Loudermilk EL, 2013, GLOBAL CHANGE BIOL, V19, P3502, DOI 10.1111/gcb.12310; Martin KL, 2015, ECOSYSTEMS, V18, P76, DOI 10.1007/s10021-014-9813-1; Mast JN, 1999, ECOL APPL, V9, P228, DOI 10.1890/1051-0761(1999)009[0228:ROPASO]2.0.CO;2; Maurer EP, 2010, HYDROL EARTH SYST SC, V14, P1125, DOI 10.5194/hess-14-1125-2010; McDowell NG, 2016, NAT CLIM CHANGE, V6, P295, DOI [10.1038/nclimate2873, 10.1038/NCLIMATE2873]; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Millar CI, 2015, SCIENCE, V349, P823, DOI 10.1126/science.aaa9933; Miller JD, 2009, ECOSYSTEMS, V12, P16, DOI 10.1007/s10021-008-9201-9; Mladenoff D. J., 1999, Spatial modeling of forest landscape change: approaches and applications. Papers presented at a symposium in Albuquerque, New Mexico, USA, 1997., P125; Moritz MA, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00345.1; North MP, 2015, SCIENCE, V349, P1280, DOI 10.1126/science.aab2356; Parks SA, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/035002; Parton W., 1996, EVALUATION SOIL ORGA, P283, DOI DOI 10.1007/978-3-642-61094-3_23; PARTON WJ, 1993, GLOBAL BIOGEOCHEM CY, V7, P785, DOI 10.1029/93GB02042; Prather JW, 2008, FOREST POLICY ECON, V10, P140, DOI 10.1016/j.forpol.2007.07.003; R Core Team, 2013, R LANG ENV STAT COMP; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Scheller RM, 2007, ECOL MODEL, V201, P409, DOI 10.1016/j.ecolmodel.2006.10.009; Scheller RM, 2011, ECOSYSTEMS, V14, P987, DOI 10.1007/s10021-011-9462-6; Scheller RM, 2011, ECOL MODEL, V222, P144, DOI 10.1016/j.ecolmodel.2010.09.009; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Sheffield J, 2013, J CLIMATE, V26, P9209, DOI 10.1175/JCLI-D-12-00592.1; Simonin KA, 2000, FIRE EFFECTS INFORM; Stephens SL, 2013, SCIENCE, V342, P41, DOI 10.1126/science.1240294; Sturtevant B. R., 2009, ECOLOGICAL MODELLING, V220, P3308; Swetnam T. W., 1996, General Technical Report - Rocky Mountain Forest and Range Experiment Station, USDA Forest Service, P11; Van Wagner C. E., 1992, DEV STRUCTURE CANADI; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Westerling AL, 2011, CLIMATIC CHANGE, V109, P445, DOI 10.1007/s10584-011-0329-9; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; Westerling AL, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0178; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Wu T, 2011, RESTOR ECOL, V19, P441, DOI 10.1111/j.1526-100X.2011.00788.x; Wuebbles D, 2014, B AM METEOROL SOC, V95, P571, DOI 10.1175/BAMS-D-12-00172.1	60	15	15	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169275	10.1371/journal.pone.0169275	http://dx.doi.org/10.1371/journal.pone.0169275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046079	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300157
J	Lin, SY; Su, PF; Chung, CH; Hsia, CC; Chang, CH				Lin, Shih-Yun; Su, Pei-Fang; Chung, Chia-Hua; Hsia, Chi-Chun; Chang, Chih-Han			Stiffness Effects in Rocker-Soled Shoes: Biomechanical Implications	PLOS ONE			English	Article							PLANTAR PRESSURE DISTRIBUTION; FOOT STRIKE PATTERNS; GAIT KINEMATICS; RUNNING SHOES; HEEL; WALKING; BAREFOOT; INSOLES; PEOPLE; FORCE	Rocker-soled shoes provide a way to reduce the possible concentration of stress, as well as change movement patterns, during gait. This study attempts to examine how plantar force and spatio-temporal variables are affected by two rocker designs, one with softer and one with denser sole materials, by comparing them with the barefoot condition and with flat soled shoes. Eleven subjects' gait parameters during walking and jogging were recorded. Our results showed that compared with barefoot walking, plantar forces were higher for flat shoes while lower for both types of rocker shoes, the softer-material rocker being the lowest. The plantar force of flat shoes is greater than the vertical ground reaction force, while that of both rocker shoes is much less, 13.87-30.55% body weight. However, as locomotion speed increased to jogging, for all shoe types, except at the second peak plantar force of the denser sole material rocker shoes, plantar forces were greater than for bare feet. More interestingly, because the transmission of force was faster while jogging, greater plantar force was seen in the rocker-soled shoes with softer material than with denser material; results for higher-speed shock absorption in rocker-soled shoes with softer material were thus not as good. In general, the rolling phenomena along the bottom surface of the rocker shoes, as well as an increase in the duration of simultaneous curve rolling and ankle rotation, could contribute to the reduction of plantar force for both rocker designs. The possible mechanism is the conversion of vertical kinetic energy into rotational kinetic energy. To conclude, since plantar force is related to foot-ground interface and deceleration methods, rocker-design shoes could achieve desired plantar force reduction through certain rolling phenomena, shoe-sole stiffness levels, and locomotion speeds.	[Lin, Shih-Yun; Chang, Chih-Han] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan; [Lin, Shih-Yun; Hsia, Chi-Chun] Ind Technol Res Inst, Informat & Commun Res Labs, Tainan, Taiwan; [Su, Pei-Fang; Chung, Chia-Hua] Natl Cheng Kung Univ, Dept Stat, Tainan, Taiwan	National Cheng Kung University; Industrial Technology Research Institute - Taiwan; National Cheng Kung University	Hsia, CC (corresponding author), Ind Technol Res Inst, Informat & Commun Res Labs, Tainan, Taiwan.	shiacj@itri.org.tw			Department of Industrial Technology (DoIT), Ministry of Economic Affairs (MOEA), Taiwan, R.O.C. [100-EC-17-A-99-11-0014]; official institutions of MOEA	Department of Industrial Technology (DoIT), Ministry of Economic Affairs (MOEA), Taiwan, R.O.C.; official institutions of MOEA	This study received financial support from the Department of Industrial Technology (DoIT), Ministry of Economic Affairs (MOEA, http://www.moea.gov.tw/MNS/english/home/English.aspx), Taiwan, R.O.C., under grant No. 100-EC-17-A-99-11-0014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Da Sheng Enterprise Corp., NCKU (National Cheng Kung University), and ITRI (Industrial Technology Research Institute) joined this same project, which was financially supported from the official institutions of MOEA. Da Sheng provided and manufactured the shoes; NCKU provided the verification instrument; ITRI provided the experimental site and experimental instruments. There was no additional external funding received for this study.	American Society for Testing and Materials (ASTM), 2010, D638 ASTM; [Anonymous], 2008, D357508 ASTM; BOBBERT MF, 1992, J BIOMECH, V25, P223, DOI 10.1016/0021-9290(92)90022-S; Bonacci J, 2013, BRIT J SPORT MED, V47, P387, DOI 10.1136/bjsports-2012-091837; Boyer KA, 2009, CLIN BIOMECH, V24, P872, DOI 10.1016/j.clinbiomech.2009.08.003; Castro M, 2013, APPL ERGON, V44, P503, DOI 10.1016/j.apergo.2012.10.016; Chapman JD, 2013, CLIN BIOMECH, V28, P679, DOI 10.1016/j.clinbiomech.2013.05.005; de Castro MP, 2014, APPL ERGON, V45, P1028, DOI 10.1016/j.apergo.2014.01.005; De Wit B, 2000, J BIOMECH, V33, P269, DOI 10.1016/S0021-9290(99)00192-X; Forghany S, 2014, GAIT POSTURE, V39, P205, DOI 10.1016/j.gaitpost.2013.07.009; Hijmans JM, 2007, GAIT POSTURE, V25, P316, DOI 10.1016/j.gaitpost.2006.03.010; Ho IJ, 2010, J SPORT SCI MED, V9, P154; Janisse DJ, 2008, J AM ACAD ORTHOP SUR, V16, P152, DOI 10.5435/00124635-200803000-00006; Keller TS, 1996, CLIN BIOMECH, V11, P253, DOI 10.1016/0268-0033(95)00068-2; Kerrigan DC, 2009, PM&R, V1, P1058, DOI 10.1016/j.pmrj.2009.09.011; Larson P, 2011, J SPORT SCI, V29, P1665, DOI 10.1080/02640414.2011.610347; Leardini A, 2007, GAIT POSTURE, V25, P453, DOI 10.1016/j.gaitpost.2006.05.017; Li-Tung Chang, 2005, Journal of Medical and Biological Engineering, V25, P137; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Liu GH, 1997, BIOMETRICS, V53, P937, DOI 10.2307/2533554; Long JT, 2007, J BIOMECH, V40, P2882, DOI 10.1016/j.jbiomech.2007.03.009; Low DC, 2010, GAIT POSTURE, V32, P664, DOI 10.1016/j.gaitpost.2010.08.002; Melvin JMA, 2014, GAIT POSTURE, V40, P682, DOI 10.1016/j.gaitpost.2014.07.026; Ministry of Health and Welfare, 2016, BMI TEST; Myers KA, 2006, GAIT POSTURE, V24, P323, DOI 10.1016/j.gaitpost.2005.10.006; Nicolopoulos C. S., 2000, FOOT, V10, P124; NIGG BM, 1992, MED SCI SPORT EXER, V24, P595; Postema K, 1998, PROSTHET ORTHOT INT, V22, P35; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; SCHAFF PS, 1990, FOOT ANKLE, V11, P129, DOI 10.1177/107110079001100303; Shorten M, 2011, FOOTWEAR SCI, V3, P41, DOI 10.1080/19424280.2010.542186; Shorten MR., 2002, 4 INT C ENG SPORT KY; Sobhani S, 2016, J SCI MED SPORT; Sobhani S, 2015, J SCI MED SPORT, V18, P133, DOI 10.1016/j.jsams.2014.02.008; Sobhani S, 2013, GAIT POSTURE, V38, P998, DOI 10.1016/j.gaitpost.2013.05.008; Sousa ASF, 2016, HUM MOVEMENT SCI, V45, P142, DOI 10.1016/j.humov.2015.11.015; Squadrone R, 2009, J SPORT MED PHYS FIT, V49, P6; Stewart L, 2007, GAIT POSTURE, V25, P648, DOI 10.1016/j.gaitpost.2006.06.012; Stoggl T, 2010, CLIN BIOMECH, V25, P816, DOI 10.1016/j.clinbiomech.2010.05.012; van Schie C, 2000, FOOT ANKLE INT, V21, P833, DOI 10.1177/107110070002101007; Verdejo R, 2004, J BIOMECH, V37, P1379, DOI 10.1016/j.jbiomech.2003.12.022; Waddington G, 2003, BRIT J SPORT MED, V37, P170, DOI 10.1136/bjsm.37.2.170; Wang L, 2012, J SPORT SCI, V30, P1787, DOI 10.1080/02640414.2012.723819; Wu WL, 2004, MED ENG PHYS, V26, P639, DOI 10.1016/j.medengphy.2004.05.003	44	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169151	10.1371/journal.pone.0169151	http://dx.doi.org/10.1371/journal.pone.0169151			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046009	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300128
J	Wagner, B; Perkins, G; Babasyan, S; Freer, H; Keggan, A; Goodman, LB; Glaser, A; Torsteinsdottir, S; Svansson, V; Bjornsdottir, S				Wagner, Bettina; Perkins, Gillian; Babasyan, Susanna; Freer, Heather; Keggan, Alison; Goodman, Laura B.; Glaser, Amy; Torsteinsdottir, Sigurbjorg; Svansson, Vilhjalmur; Bjornsdottir, Sigriour			Neonatal Immunization with a Single IL-4/Antigen Dose Induces Increased Antibody Responses after Challenge Infection with Equine Herpesvirus Type 1 (EHV-1) at Weanling Age	PLOS ONE			English	Article							IMMUNE-RESPONSES; MONOCLONAL-ANTIBODIES; THOROUGHBRED FOALS; INTERFERON-GAMMA; MATERNAL IGE; CELLS; VACCINATION; BASOPHILS; REVEALS; GLYCOPROTEINS	Neonatal foals respond poorly to conventional vaccines. These vaccines typically target T helper (Th) cell dependent B-cell activation. However, Th2-cell immunity is impaired in foals during the first three months of life. In contrast, neonatal basophils are potent interleukin-4 (IL-4) producers. The purpose of this study was to develop a novel vaccine triggering the natural capacity of neonatal basophils to secrete IL-4 and to evaluate if vaccination resulted in B-cell activation and antibody production against EHV-1 glycoprotein C (gC). Neonatal vaccination was performed by oral biotinylated IgE (IgE-bio) treatment at birth followed by intramuscular injection of a single dose of streptavidin-conjugated gC/IL-4 fusion protein (Sav-gC/IL-4) for crosslinking of receptor-bound IgE-bio (group 1). Neonates in group 2 received the intramuscular Sav-gC/IL-4 vaccine only. Group 3 remained non-vaccinated at birth. After vaccination, gC antibody production was not detectable. The ability of the vaccine to induce protection was evaluated by an EHV-1 challenge infection after weaning at 7 months of age. Groups 1 and 2 responded to EHV-1 infection with an earlier onset and overall significantly increased anti-gC serum antibody responses compared to control group 3. In addition, group 1 weanlings had a decreased initial fever peak after infection indicating partial protection from EHV-1 infection. This suggested that the neonatal vaccination induced a memory B-cell response at birth that was recalled at weanling age after EHV-1 challenge. In conclusion, early stimulation of neonatal immunity via the innate arm of the immune system can induce partial protection and increased antibody responses against EHV-1.	[Wagner, Bettina; Babasyan, Susanna; Freer, Heather; Keggan, Alison; Goodman, Laura B.; Glaser, Amy] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Perkins, Gillian] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA; [Torsteinsdottir, Sigurbjorg; Svansson, Vilhjalmur] Univ Iceland, Inst Expt Pathol, Reykjavik, Iceland; [Bjornsdottir, Sigriour] Icelandic Food & Vet Author, MAST, Off Anim Hlth & Welf, Selfoss, Iceland	Cornell University; Cornell University; University of Iceland	Wagner, B (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	bw73@cornell.edu	Torsteinsdottir, Sigurbjörg/M-1349-2015; Goodman, Laura Brunengraber/E-7781-2015	Torsteinsdottir, Sigurbjörg/0000-0002-3195-4937; Goodman, Laura Brunengraber/0000-0002-8327-3092	Harry M. Zweig Memorial Fund for Equine Research at Cornell University; USDA [2005-01812, 2015-67015-23072]	Harry M. Zweig Memorial Fund for Equine Research at Cornell University; USDA(United States Department of Agriculture (USDA))	Funding for this project was provided by the Harry M. Zweig Memorial Fund for Equine Research at Cornell University 'A Novel Strategy to Boost Antibody Production to EHV-1 in Neonates' (http://vet.cornoll.edu/research/Zweig/). Monoclonal antibody development for horse cell surface markers and cytokines was supported by USDA grant #2005-01812 'The US Veterinary Immune Reagent Network' and #2015-67015-23072 'Equine Immune Reagents: Development of monoclonal antibodies to improve the analysis of immunity in horses' (https://nifa.usda.gov/).	Awasthi S, 2009, VACCINE, V27, P6845, DOI 10.1016/j.vaccine.2009.09.017; Basha S, 2014, EXPERT REV CLIN IMMU, V10, P1171, DOI 10.1586/1744666X.2014.942288; Breathnach CC, 2006, VET IMMUNOL IMMUNOP, V112, P199, DOI 10.1016/j.vetimm.2006.02.010; Chowhury S, 2012, VIROL J, V109, P112; CRABB BS, 1991, J GEN VIROL, V72, P2075, DOI 10.1099/0022-1317-72-9-2075; Elia G, 2006, J VIROL METHODS, V133, P70, DOI 10.1016/j.jviromet.2005.10.024; Foote CE, 2004, EQUINE VET J, V36, P341, DOI 10.2746/0425164044890634; Furr M, 2008, EQUINE NEUROLOGY, P65; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Gilkerson JR, 1999, VET MICROBIOL, V68, P15, DOI 10.1016/S0378-1135(99)00057-7; Goehring LS, 2010, VACCINE, V28, P5203, DOI 10.1016/j.vaccine.2010.05.065; Goehring LS, 2006, J VET INTERN MED, V20, P601, DOI 10.1892/0891-6640(2006)20[601:EHTAMI]2.0.CO;2; Goodman LB, 2012, CLIN VACCINE IMMUNOL, V19, P235, DOI 10.1128/CVI.05522-11; Goodman LB, 2006, VACCINE, V24, P3636, DOI 10.1016/j.vaccine.2006.01.062; Holznagel DL, 2003, EQUINE VET J, V35, P620, DOI 10.2746/042516403775467153; Hook LM, 2008, J VIROL, V82, P6935, DOI 10.1128/JVI.02599-07; Hussey GS, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-23; Keggan A, 2013, VET IMMUNOL IMMUNOP, V153, P187, DOI 10.1016/j.vetimm.2013.02.010; KYDD JH, 1994, EQUINE VET J, V26, P470, DOI 10.1111/j.2042-3306.1994.tb04052.x; Lunn DP, 2009, J VET INTERN MED, V23, P450, DOI 10.1111/j.1939-1676.2009.0304.x; Ma GG, 2013, VET MICROBIOL, V167, P123, DOI 10.1016/j.vetmic.2013.06.018; Mack M, 2005, J IMMUNOL, V174, P735, DOI 10.4049/jimmunol.174.2.735; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Mohr E, 2016, CURR OPIN IMMUNOL, V41, P1, DOI 10.1016/j.coi.2016.04.004; Nugent J, 2006, J VIROL, V80, P4047, DOI 10.1128/JVI.80.8.4047-4060.2006; Oh K, 2007, BLOOD, V109, P2921, DOI 10.1182/blood-2006-07-037739; Packiarajah P, 1998, VET MICROBIOL, V61, P261, DOI 10.1016/S0378-1135(98)00189-8; Paillot R, 2007, DEV COMP IMMUNOL, V31, P202, DOI 10.1016/j.dci.2006.05.010; Patel JR, 2005, VET J, V170, P14, DOI 10.1016/j.tvjl.2004.04.018; PAUL WE, 1987, FASEB J, V1, P456, DOI 10.1096/fasebj.1.6.3315808; Perkins GA, 2015, EQUINE VET J, V47, P267, DOI 10.1111/evj.12387; Perkins GA, 2014, VET IMMUNOL IMMUNOP, V161, P141, DOI 10.1016/j.vetimm.2014.07.009; Perkins GA, 2009, VET MICROBIOL, V139, P375, DOI 10.1016/j.vetmic.2009.06.033; Sheoran AS, 2000, AM J VET RES, V61, P1099, DOI 10.2460/ajvr.2000.61.1099; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; SLATER JD, 1994, J GEN VIROL, V75, P2007, DOI 10.1099/0022-1317-75-8-2007; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Wagner B, 2006, VET IMMUNOL IMMUNOP, V110, P269, DOI 10.1016/j.vetimm.2005.10.007; Wagner B, 2015, VACCINE, V33, P5588, DOI 10.1016/j.vaccine.2015.09.009; Wagner B, 2003, VET IMMUNOL IMMUNOP, V92, P45, DOI 10.1016/S0165-2427(03)00007-2; Wagner B, 2012, VET IMMUNOL IMMUNOP, V146, P125, DOI 10.1016/j.vetimm.2012.02.007; Wagner B, 2011, VET IMMUNOL IMMUNOP, V143, P116, DOI 10.1016/j.vetimm.2011.06.032; Wagner B, 2010, VET RES, V41, DOI 10.1051/vetres/2010019; Wagner B, 2010, DEV COMP IMMUNOL, V34, P436, DOI 10.1016/j.dci.2009.12.002; Wagner B, 2009, VET IMMUNOL IMMUNOP, V127, P242, DOI 10.1016/j.vetimm.2008.10.313	45	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169072	10.1371/journal.pone.0169072	http://dx.doi.org/10.1371/journal.pone.0169072			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045974	gold, Green Submitted, Green Published			2022-12-26	WOS:000391612300107
J	Yohannes, E; Grimm, C; Rothhaupt, KO; Behrmann-Godel, J				Yohannes, Elizabeth; Grimm, Claudia; Rothhaupt, Karl-Otto; Behrmann-Godel, Jasminca			The Effect of Parasite Infection on Stable Isotope Turnover Rates of delta N-15, delta C-13 and delta S-34 in Multiple Tissues of Eurasian Perch Perca fluviatilis	PLOS ONE			English	Article							DISCRIMINATION FACTORS; DIET DISCRIMINATION; TREMATODE INFECTION; IMMUNE DEFENSE; LAKE CONSTANCE; NITROGEN; FISH; GROWTH; CARBON; HOST	Stable isotope analysis of commercially and ecologically important fish can improve understanding of life-history and trophic ecology. However, accurate interpretation of stable isotope values requires knowledge of tissue-specific isotopic turnover that will help to describe differences in the isotopic composition of tissues and diet. We performed a diet-switch experiment using captive-reared parasite-free Eurasian perch (Perca fluviatilis) and wild caught specimens of the same species, infected with the pike tapeworm Triaenophorus nodulosus living in host liver tissue. We hypothesize that metabolic processes related to infection status play a major role in isotopic turnover and examined the influence of parasite infection on isotopic turn-over rate of carbon (delta C-13), nitrogen (delta N-15) and sulphur (delta S-34) in liver, blood and muscle. The delta N-15 and delta C-13 turnovers were fastest in liver tissues, followed by blood and muscle. In infected fish, liver and blood delta N-15 and delta C-13 turnover rates were similar. However, in infected fish, liver and blood delta C-13 turnover was faster than that of delta N-15. Moreover, in infected subjects, liver delta N-15 and delta C-13 turnover rates were three to five times faster than in livers of uninfected subjects (isotopic half-life of ca.3-4 days compared to 16 and 10 days, respectively). Blood delta S-34 turnover rate were about twice faster in non-infected individuals implying that parasite infection could retard the turnover rate of delta S-34 and sulphur containing amino acids. Slower turnover rate of essential amino acid could probably decrease individual immune function. These indicate potential hidden costs of chronic and persistent infections that may have accumulated adverse effects and might eventually impair life-history fitness. For the first time, we were able to shift the isotope values of parasites encapsulated in the liver by changing the dietary source of the host. We also report variability in isotopic turnover rates between tissues, elements and between infected and parasite-free individuals. These results contribute to our understanding of data obtained from field and commercial hatcheries; and strongly improve the applicability of the stable isotope method in understanding life-history and trophic ecology of fish populations.	[Yohannes, Elizabeth; Grimm, Claudia; Rothhaupt, Karl-Otto; Behrmann-Godel, Jasminca] Univ Konstanz, Limnol Inst, Mainaustr 252, Constance, Germany; [Grimm, Claudia] Gesell Marine Aquakultur mbH GMA, Hafentom 3, Busum, Germany	University of Konstanz	Yohannes, E (corresponding author), Univ Konstanz, Limnol Inst, Mainaustr 252, Constance, Germany.	Elizabeth.yohannes@uni-konstan.de	Yohannes, Elizabeth/AAM-4457-2020		University of Konstanz; Gesellschaft fur Marine Aquakultur mbH	University of Konstanz; Gesellschaft fur Marine Aquakultur mbH	This work was funded by the University of Konstanz, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Gesellschaft fur Marine Aquakultur mbH also provided support in the form of salaries for Claudia Grimm, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was conducted as the author (Claudia Grimm) was enrolled for a master thesis program at the University of Konstanz. There are no patents, products in development or marketed products to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Arneson LS, 2006, CAN J ZOOL, V84, P992, DOI 10.1139/Z06-081; Behrmann-Godel J, 2015, J HELMINTHOL, V89, P238, DOI 10.1017/S0022149X13000849; Behrmann-Godel J, 2015, BIOL OF PERCH; Behrmann-Godel J, 2013, PARASITOLOGY, V140, P509, DOI 10.1017/S0031182012001989; Beisel WR, 1987, TRAUMA EMERGENCY SUR, P57; Brinker A, 2007, J FISH BIOL, V71, P129, DOI 10.1111/j.1095-8649.2007.01475.x; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Buchheister A, 2010, CAN J FISH AQUAT SCI, V67, P445, DOI 10.1139/F09-196; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cloutier VB, 2012, J AQUAT ANIM HEALTH, V24, P100, DOI 10.1080/08997659.2012.675934; CROFTON HD, 1971, PARASITOLOGY, V62, P179, DOI 10.1017/S0031182000071420; Cruz VC, 2005, BRIT POULTRY SCI, V46, P382, DOI 10.1080/0071660500126847; de la Higuera M, 1999, AQUACULTURE, V179, P203, DOI 10.1016/S0044-8486(99)00163-5; DeMots RL, 2010, CAN J ZOOL, V88, P961, DOI 10.1139/Z10-063; Deudero S, 2002, DIS AQUAT ORGAN, V52, P77, DOI 10.3354/dao052077; Guelinckx J, 2007, MAR ECOL PROG SER, V341, P205, DOI 10.3354/meps341205; Herzka SZ, 2001, J EXP MAR BIOL ECOL, V265, P49, DOI 10.1016/S0022-0981(01)00324-0; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Johnson MW, 2001, CAN J ZOOL, V79, P1980, DOI 10.1139/cjz-79-11-1980; Kelly DW, 2010, J ANIM ECOL, V79, P445, DOI 10.1111/j.1365-2656.2009.01636.x; Khokhlova IS, 2002, J ZOOL, V258, P349, DOI 10.1017/S0952836902001498; Klein SL, 2004, ANIM BEHAV, V67, P421, DOI 10.1016/j.anbehav.2003.03.022; Kuperman BI, 1981, TAPEWORMS GENUS TRIA; Logan J, 2006, OECOLOGIA, V147, P391, DOI 10.1007/s00442-005-0277-z; MacAvoy SE, 2001, CAN J FISH AQUAT SCI, V58, P923, DOI 10.1139/cjfas-58-5-923; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Miller JF, 2008, CAN J ZOOL, V86, P685, DOI 10.1139/Z08-042; Miller TW, 2006, ENVIRON BIOL FISH, V76, P177, DOI 10.1007/s10641-006-9020-9; Moller AP, 1996, BEHAV ECOL SOCIOBIOL, V39, P317, DOI 10.1007/s002650050295; Morozinska-Gogol J, 2008, HELMINTHOLOGIA, V45, P196, DOI 10.2478/s11687-008-0039-7; Nendick L, 2011, CAN J FISH AQUAT SCI, V68, P241, DOI 10.1139/F10-150; Ostlund-Nilsson S, 2005, MAR ECOL PROG SER, V287, P209, DOI 10.3354/meps287209; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2001, OECOLOGIA, V127, P166, DOI 10.1007/s004420000571; Pulkkinen K, 1999, J FISH BIOL, V55, P115, DOI 10.1006/jfbi.1999.0975; Richards MP, 2002, J AGR FOOD CHEM, V50, P555, DOI 10.1021/jf010562h; Seppanen E, 2009, J FISH BIOL, V74, P553, DOI 10.1111/j.1095-8649.2008.02144.x; Seppanen E, 2008, J FISH BIOL, V72, P1659, DOI 10.1111/j.1095-8649.2008.01832.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Shinagawa K, 2001, DIS AQUAT ORGAN, V45, P141, DOI 10.3354/dao045141; SMITH MAK, 1981, J FISH BIOL, V19, P213, DOI 10.1111/j.1095-8649.1981.tb05825.x; Suzuki KW, 2005, CAN J FISH AQUAT SCI, V62, P671, DOI 10.1139/F04-231; Vander Zanden MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116182; Vander Zanden MJ, 1999, AM NAT, V154, P406, DOI 10.1086/303250; Voutilainen A, 2010, B EUR ASSOC FISH PAT, V30, P106; WANG N, 1994, HYDROBIOLOGIA, V277, P135, DOI 10.1007/BF00007295; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	48	9	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169058	10.1371/journal.pone.0169058	http://dx.doi.org/10.1371/journal.pone.0169058			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046021	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300101
J	Zhou, JT; Li, CL; Tan, LH; Xu, YF; Liu, YH; Mo, ZZ; Dou, YX; Su, R; Su, ZR; Huang, P; Xie, JH				Zhou, Jiang-Tao; Li, Cai-Lan; Tan, Li-Hua; Xu, Yi-Fei; Liu, Yu-Hong; Mo, Zhi-Zhun; Dou, Yao-Xing; Su, Rui; Su, Zi-Ren; Huang, Ping; Xie, Jian-Hui			Inhibition of Helicobacter pylori and Its Associated Urease by Palmatine: Investigation on the Potential Mechanism	PLOS ONE			English	Article							JACK BEAN UREASE; ISOQUINOLINE ALKALOIDS; RHIZOMA-COPTIDIS; ACID RESISTANCE; BERBERINE; DERIVATIVES; DISEASES; EXTRACT	In this paper, we evaluated the anti-Helicobacter pylori activity and the possible inhibitory effect on its associated urease by Palmatine (Pal) from Coptis chinensis, and explored the potential underlying mechanism. Results indicated that Pal exerted inhibitory effect on four tested H. pylori strains (ATCC 43504, NCTC 26695, SS1 and ICDC 111001) by the agar dilution test with minimum inhibitory concentration (MIC) values ranging from 100 to 200 mu g/mL under neutral environment (pH 7.4), and from 75 to 100 mu g/mL under acidic conditions (pH 5.3), respectively. Pal was observed to significantly inhibit both H. pylori urease (HPU) and jack bean urease (JBU) in a dose-dependent manner, with IC50 values of 0.53 0.01 mM and 0.03 +/- 0.00 mM, respectively, as compared with acetohydroxamic acid, a wellknown urease inhibitor (0.07 +/- 0.01 mM for HPU and 0.02 +/- 0.00 mM for JBU, respectively). Kinetic analyses showed that the type of urease inhibition by Pal was noncompetitive for both HPU and JBU. Higher effectiveness of thiol protectors against urease inhibition than the competitive Ni2+ binding inhibitors was observed, indicating the essential role of the active -site sulfhydryl group in the urease inhibition by Pal. DTT reactivation assay indicated that the inhibition on the two ureases was reversible, further supporting that sulfhydryl group should be obligatory for urease inhibition by Pal. Furthermore, molecular docking study indicated that Pal interacted with the important sulfhydryl groups and inhibited the active enzymatic conformation through N -H " u interaction, but did not interact with the active site Ni2+. Taken together, Pal was an effective inhibitor of H. pylori and its urease targeting the sulfhydryl groups, representing a promising candidate as novel urease inhibitor. This investigation also gave additional scientific support to the use of C. chinensis to treat H. pylori-related gastrointestinal diseases in traditional Chinese medicine. Pal might be a potentially beneficial therapy for gastritis and peptic ulcers induced by H. pylori infection and other urease-related diseases.	[Zhou, Jiang-Tao; Li, Cai-Lan; Tan, Li-Hua; Xu, Yi-Fei; Liu, Yu-Hong; Mo, Zhi-Zhun; Su, Rui; Su, Zi-Ren; Huang, Ping] Guangzhou Univ Chinese Med, Sch Chinese Mat Med, Guangdong Prov Key Lab New Drug Dev & Res Chinese, Guangzhou, Guangdong, Peoples R China; [Dou, Yao-Xing] Guangzhou Univ Chinese Med, Affiliated Hosp Chinese Med 1, Guangzhou, Guangdong, Peoples R China; [Xie, Jian-Hui] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Key Lab Clin Res Tradit Chinese Me, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Huang, P (corresponding author), Guangzhou Univ Chinese Med, Sch Chinese Mat Med, Guangdong Prov Key Lab New Drug Dev & Res Chinese, Guangzhou, Guangdong, Peoples R China.; Xie, JH (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Key Lab Clin Res Tradit Chinese Me, Guangzhou, Guangdong, Peoples R China.	hping331@126.com; xiejianhui888@hotmail.com	Liu, Yuhong/Y-4597-2019; Su, Zi-Ren/O-5014-2019; Liu, Yuhong/AAT-9680-2021	Liu, Yuhong/0000-0001-8070-6369; Tan, Lihua/0000-0001-7752-6623	National Natural Science Foundation of China [81503202, 81374043]; Natural Science Foundation of Guangdong Province [2015A030310217]; Science and Technology Planning Project of Guangdong Province [2014A020221042]; Key (Key grant) Science and Technology Planning Project of Guangdong Province [2013A022100001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; Key (Key grant) Science and Technology Planning Project of Guangdong Province	This study was supported by National Natural Science Foundation of China (No. 81503202, No. 81374043), Natural Science Foundation of Guangdong Province (No. 2015A030310217), Science and Technology Planning Project of Guangdong Province (No. 2014A020221042), the Key (Key grant) Science and Technology Planning Project of Guangdong Province (No. 2013A022100001).	Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Burne RA, 2000, MICROBES INFECT, V2, P533, DOI 10.1016/S1286-4579(00)00312-9; Chae SH, 1999, J AGR FOOD CHEM, V47, P934, DOI 10.1021/jf980991o; Chao J, 2009, J ETHNOPHARMACOL, V125, P297, DOI 10.1016/j.jep.2009.06.024; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DIXON NE, 1980, CAN J BIOCHEM CELL B, V58, P481, DOI 10.1139/o80-064; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Follmer C, 2010, J CLIN PATHOL, V63, P424, DOI 10.1136/jcp.2009.072595; Ha NC, 2001, NAT STRUCT BIOL, V8, P505, DOI 10.1038/88563; Han YH, 2009, B KOREAN CHEM SOC, V30, P3147, DOI 10.5012/bkcs.2009.30.12.3147; Islam MM, 2008, J MOL STRUCT, V875, P382, DOI 10.1016/j.molstruc.2007.05.004; Jung J, 2014, TOX RESEARCH, V30, P45, DOI 10.5487/TR.2014.30.1.045; Kim JP, 2000, J AGR FOOD CHEM, V48, P1058, DOI 10.1021/jf9909297; Kim YM, 2009, FOOD CHEM TOXICOL, V47, P2097, DOI 10.1016/j.fct.2009.05.031; Kupeli E, 2002, LIFE SCI, V72, P645, DOI 10.1016/S0024-3205(02)02200-2; Lee JW, 2010, BIOL PHARM BULL, V33, P1733, DOI 10.1248/bpb.33.1733; Li CL, 2016, PLANTA MED, V82, P305, DOI 10.1055/s-0035-1558229; Lin YT, 2005, APPL ENVIRON MICROB, V71, P8558, DOI 10.1128/AEM.71.12.8558-8564.2005; Ma F, 2010, WORLD J GASTROENTERO, V16, P5629, DOI 10.3748/wjg.v16.i44.5629; Matsubara S, 2003, BIOCHEM BIOPH RES CO, V310, P715, DOI 10.1016/j.bbrc.2003.09.066; Mo ZZ, 2015, BMC COMPLEM ALTERN M, V15, P1; MOONEY C, 1990, LANCET, V335, P1232, DOI 10.1016/0140-6736(90)92764-9; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Pharmacopoeia Committee of P. R. China, 2015, PHARM PEOPL REP CHIN, V1; Singh J, 2009, J ETHNOPHARMACOL, V123, P22, DOI 10.1016/j.jep.2009.02.038; Sumner JB, 1926, J BIOL CHEM, V69, P435; Taha M, 2015, BIOORG MED CHEM LETT, V25, P3285, DOI 10.1016/j.bmcl.2015.05.069; Tepes B, 2012, HELICOBACTER, V17, P36, DOI 10.1111/j.1523-5378.2012.00981.x; Wang YQ, 2006, J PHARMACEUT BIOMED, V41, P1041, DOI 10.1016/j.jpba.2006.01.028; Weatherburn MW, ACS PUBLICATIONS; Wu DW, 2013, FITOTERAPIA, V91, P60, DOI 10.1016/j.fitote.2013.08.012; Yi J, 2013, J ETHNOPHARMACOL, V145, P303, DOI 10.1016/j.jep.2012.10.062; Yong Y, 2007, LISHIZHEN MED MAT ME	33	34	37	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168944	10.1371/journal.pone.0168944	http://dx.doi.org/10.1371/journal.pone.0168944			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045966	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300076
J	Pozo, F; Juste, J; Vazquez-Moron, S; Aznar-Lopez, C; Ibanez, C; Garin, I; Aihartza, J; Cases, I; Tenorio, A; Echevarria, JE				Pozo, Francisco; Juste, Javier; Vazquez-Moron, Sonia; Aznar-Lopez, Carolina; Ibanez, Carlos; Garin, Inazio; Aihartza, Joxerra; Cases, Inmaculada; Tenorio, Antonio; Emilio Echevarria, Juan			Identification of Novel Betaherpesviruses in Iberian Bats Reveals Parallel Evolution	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; MAMMALIAN HERPESVIRUSES; FAMILY; GAMMAHERPESVIRUS; CYTOMEGALOVIRUS; RHADINOVIRUSES; PHYLOGENY; DISCOVERY; LINEAGES; HOMOLOGS	A thorough search for bat herpesviruses was carried out in oropharyngeal samples taken from most of the bat species present in the Iberian Peninsula from the Vespertilionidae, Miniopteridae, Molossidae and Rhinolophidae families, in addition to a colony of captive fruit bats from the Pteropodidae family. By using two degenerate consensus PCR methods targeting two conserved genes, distinct and previously unrecognized bat-hosted herpesviruses were identified for the most of the tested species. All together a total of 42 potentially novel bat herpesviruses were partially characterized. Thirty-two of them were tentatively assigned to the Betaherpesvirinae subfamily while the remaining 10 were allocated into the Gammaherpesvirinae subfamily. Significant diversity was observed among the novel sequences when compared with type herpesvirus species of the ICTV-approved genera. The inferred phylogenetic relationships showed that most of the betaherpesviruses sequences fell into a well-supported unique monophyletic clade and support the recognition of a new betaherpes-virus genus. This clade is subdivided into three major clades, corresponding to the families of bats studied. This supports the hypothesis of a species-specific parallel evolution process between the potentially new betaherpesviruses and their bat hosts. Interestingly, two of the betaherpesviruses' sequences detected in rhinolophid bats clustered together apart from the rest, closely related to viruses that belong to the Roseolovirus genus. This suggests a putative third roseolo lineage. On the contrary, no phylogenetic structure was detected among several potentially novel bat-hosted gammaherpesviruses found in the study. Remarkably, all of the possible novel bat herpesviruses described in this study are linked to a unique bat species.	[Pozo, Francisco; Vazquez-Moron, Sonia; Aznar-Lopez, Carolina; Cases, Inmaculada; Tenorio, Antonio; Emilio Echevarria, Juan] Inst Salud Carlos III, Virol Sect, Ctr Nacl Microbiol, Madrid, Spain; [Juste, Javier; Ibanez, Carlos] CSIC, Estn Biol Donana, Seville, Spain; [Vazquez-Moron, Sonia; Aznar-Lopez, Carolina; Emilio Echevarria, Juan] CIBERESP, Madrid, Spain; [Garin, Inazio; Aihartza, Joxerra] Univ Basque Country UPV EHU, Dept Zool & Anim Cell Biol, Leioa, The Basque Coun, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Basque Country	Pozo, F (corresponding author), Inst Salud Carlos III, Virol Sect, Ctr Nacl Microbiol, Madrid, Spain.	pacopozo@isciii.es	Juste, Javier/B-9253-2013; Aihartza, Joxerra/Z-3061-2019; Ibanez, Carlos/H-7577-2015; Garin, Inazio/B-8115-2009; Aihartza, Joxerra/GSO-2446-2022; Echevarria, Juan E./F-7913-2016; Casas, Inmaculada/X-7579-2019; Pozo, Francisco/F-4426-2012; Vázquez-Morón, Sonia/H-7019-2013	Juste, Javier/0000-0003-1383-8462; Aihartza, Joxerra/0000-0003-0882-8964; Ibanez, Carlos/0000-0003-1181-7641; Echevarria, Juan E./0000-0001-7522-850X; Casas, Inmaculada/0000-0003-1840-1198; Pozo, Francisco/0000-0003-1828-733X; Vázquez-Morón, Sonia/0000-0002-0977-741X; Tenorio, Antonio/0000-0002-2163-7612	Spanish Ministry for Education and Science [SAF2006-12784-C02-01]; Spanish Ministry for Science and Innovation [SAF2009-09172]; Ministry of Economy [SAF2013-47194-P]	Spanish Ministry for Education and Science(Spanish Government); Spanish Ministry for Science and Innovation(Spanish Government); Ministry of Economy	This work was supported by the disappeared Spanish Ministry for Education and Science (grant SAF2006-12784-C02-01), the disappeared Spanish Ministry for Science and Innovation (grant SAF2009-09172) and the Ministry of Economy (grant SAF2013-47194-P). SVM was contracted through an agreement between the Public Health Department of the Spanish Ministry of Health and the Institute de Salud Carlos III for the development of "Rabies Surveillance in Spain". CAL was contracted through the internal research program of the Institute de Salud Carlos III. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Arvin A, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P1, DOI 10.2277/ 0521827140; Blanchard TW, 2001, J WILDLIFE DIS, V37, P297, DOI 10.7589/0090-3558-37.2.297; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Campbell AE, 2008, MED MICROBIOL IMMUN, V197, P205, DOI 10.1007/s00430-008-0077-2; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; Ehlers B, 2004, J GEN VIROL, V85, P857, DOI 10.1099/vir.0.79799-0; Ehlers B, 1999, VIRUS GENES, V18, P211, DOI 10.1023/A:1008064118057; Ehlers B, 2008, J VIROL, V82, P3509, DOI 10.1128/JVI.02646-07; Ehlers B, 2007, J VIROL, V81, P8091, DOI 10.1128/JVI.00255-07; Gu WW, 2014, VIROLOGY, V460, P165, DOI 10.1016/j.virol.2014.05.014; Harigs AM, 1999, VET CLIN N AM-SMALL, V29, P1281, DOI 10.1016/S0195-5616(99)50126-5; Hoofer SR, 2003, ACTA CHIROPTEROL, V5, P1, DOI 10.3161/001.005.s101; Ibanez C, 2006, ACTA CHIROPTEROL, V8, P277, DOI 10.3161/1733-5329(2006)8[277:TICTCD]2.0.CO;2; Janoska M, 2011, VET J, V189, P118, DOI 10.1016/j.tvjl.2010.06.020; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kleiboeker SB, 2004, J VET DIAGN INVEST, V16, P67, DOI 10.1177/104063870401600112; Kleiboeker SB, 2002, J CLIN MICROBIOL, V40, P1311, DOI 10.1128/JCM.40.4.1311-1318.2002; Leendertz FH, 2009, J GEN VIROL, V90, P2386, DOI 10.1099/vir.0.011866-0; Li H, 2005, J GEN VIROL, V86, P3021, DOI 10.1099/vir.0.81238-0; Lipscomb TP, 2000, VET PATHOL, V37, P609, DOI 10.1354/vp.37-6-609; MCGEOCH DJ, 1995, J MOL BIOL, V247, P443, DOI 10.1006/jmbi.1995.0152; Miller-Butterworth CM, 2007, MOL BIOL EVOL, V24, P1553, DOI 10.1093/molbev/msm076; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramer JC, 2000, COMPARATIVE MED, V50, P59; Razafindratsimandresy R, 2009, J GEN VIROL, V90, P44, DOI 10.1099/vir.0.006825-0; Richman LK, 1999, SCIENCE, V283, P1171, DOI 10.1126/science.283.5405.1171; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruedi M, 2013, MOL PHYLOGENET EVOL, V69, P437, DOI 10.1016/j.ympev.2013.08.011; Sasaki M, 2014, J VIROL, V88, P9819, DOI 10.1128/JVI.01277-14; Schultz ER, 2000, J VIROL, V74, P4919, DOI 10.1128/JVI.74.10.4919-4928.2000; Simmons NB, 2005, SCIENCE, V307, P527, DOI 10.1126/science.1108871; Springer MS, 2001, P NATL ACAD SCI USA, V98, P6241, DOI 10.1073/pnas.111551998; Staheli JP, 2014, VIROLOGY, V471, P126, DOI 10.1016/j.virol.2014.10.008; Tandler B, 1996, J COMP PATHOL, V114, P1, DOI 10.1016/S0021-9975(96)80057-0; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; von Helversen O, 2001, NATURWISSENSCHAFTEN, V88, P217, DOI 10.1007/s001140100225; Watanabe S, 2010, EMERG INFECT DIS, V16, P986, DOI 10.3201/eid1606.091567; Watanabe S, 2009, VIRUS GENES, V39, P90, DOI 10.1007/s11262-009-0368-8; Wibbelt G, 2007, J GEN VIROL, V88, P2651, DOI 10.1099/vir.0.83045-0; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wu ZQ, 2012, J VIROL, V86, P10999, DOI 10.1128/JVI.01394-12; Zhang HJ, 2012, J VIROL, V86, P8014, DOI 10.1128/JVI.00723-12	45	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169153	10.1371/journal.pone.0169153	http://dx.doi.org/10.1371/journal.pone.0169153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036408	Green Published, gold, Green Submitted			2022-12-26	WOS:000391229300058
J	Molina, GN; Tavarone, E; Taboga, O; Molinari, P				Molina, Guido N.; Tavarone, Eugenia; Taboga, Oscar; Molinari, Paula			Two Distinctive Phenotypes of AcMNPV Display Different Immune Abilities and Intracellular Destiny	PLOS ONE			English	Article							AUTOGRAPHA-CALIFORNICA NUCLEOPOLYHEDROVIRUS; NUCLEAR POLYHEDROSIS-VIRUS; DENDRITIC CELLS; IN-VIVO; CIRCUMSPOROZOITE PROTEIN; IMMUNOLOGICAL-PROPERTIES; ENVELOPE PROTEIN; OCCLUSION BODY; GENE DELIVERY; BACULOVIRUS	The budded phenotype (BV) of the baculovirus AcMNPV has been demonstrated to have strong immunostimulatory properties that are relevant for the development of vaccines and antiviral therapies. Although the occluded phenotype (ODV) shares the main structural proteins and its genome with BV, it has been poorly studied in mammals. In this study, we assessed the capacity of ODV to induce immune responses in mice. In contrast to BVs, ODVs failed to promote the secretion of IFN-gamma, IL-6 and Il-12 and to induce antiviral activity against VSV in the short term. Furthermore, ODVs were unable to induce cellular immunity against a coadministered antigen 7 days after inoculation. By analyzing the interaction of ODVs with BMDCs, we observed that although ODVs entered the cells reaching late and acidic endosomes, they did not induce their maturation. Finally, we also analyzed if BVs and ODVs followed different routes in the cell during the infection. BVs, but not ODVs, colocalized with the protein ovalbumin in compartments with the presence of proteases. The results suggest that structural differences could be responsible for their different destinies in the dendritic cell and this could lead to a different impact on the immune response.	[Molina, Guido N.; Tavarone, Eugenia; Taboga, Oscar; Molinari, Paula] Consejo Nacl Invest Cient & Tecn, Caba, Argentina; [Molina, Guido N.; Tavarone, Eugenia; Taboga, Oscar; Molinari, Paula] INTA Castelar, CNIA, Inst Biotecnol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional de Tecnologia Agropecuaria (INTA)	Taboga, O (corresponding author), Consejo Nacl Invest Cient & Tecn, Caba, Argentina.; Taboga, O (corresponding author), INTA Castelar, CNIA, Inst Biotecnol, Buenos Aires, DF, Argentina.	taboga.oscaralberto@inta.gob.ar	Molina, Guido Nicolás/AAA-6762-2020	, Oscar/0000-0001-9575-3045; Molina, Guido Nicolas/0000-0002-3960-3218	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 2012-395]; Institute Nacional de Tecnologia Agropecuaria (INTA) [PNBIO 1131034]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Institute Nacional de Tecnologia Agropecuaria (INTA)	This work was supported by the following grants: PICT 2012-395 from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, http://www.agencia.mincyt.gob.ar/) and PNBIO 1131034 from Institute Nacional de Tecnologia Agropecuaria (INTA, http://inta.gob.ar/proyectos/PNBIO-1131034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2005, J VIROL, V79, P2847, DOI 10.1128/JVI.79.5.2847-2858.2005; Abe T, 2003, J IMMUNOL, V171, P1133, DOI 10.4049/jimmunol.171.3.1133; Bocca AL, 2013, VIRUS RES, V176, P119, DOI 10.1016/j.virusres.2013.05.015; Braunagel SC, 2003, P NATL ACAD SCI USA, V100, P9797, DOI 10.1073/pnas.1733972100; Chen CY, 2011, BIOTECHNOL ADV, V29, P618, DOI 10.1016/j.biotechadv.2011.04.004; Faulkner P, 1997, J GEN VIROL, V78, P3091, DOI 10.1099/0022-1317-78-12-3091; Gronowski AM, 1999, J VIROL, V73, P9944, DOI 10.1128/JVI.73.12.9944-9951.1999; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Hervas-Stubbs S, 2007, J IMMUNOL, V178, P2361, DOI 10.4049/jimmunol.178.4.2361; Hervas-Stubbs S, 2014, J IMMUNOL, V193, P1151, DOI 10.4049/jimmunol.1301440; Hou DH, 2013, J VIROL, V87, P829, DOI 10.1128/JVI.02329-12; Hu YC, 2008, CURR GENE THER, V8, P54, DOI 10.2174/156652308783688509; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Juan D. G VV Claus, 2012, PRODUCTION INSECTICI; Kitajima M, 2008, MOL THER, V16, P261, DOI 10.1038/sj.mt.6300364; Makela AR, 2008, J BIOTECHNOL, V135, P145, DOI 10.1016/j.jbiotec.2008.03.014; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Molinari P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024108; Moron G, 2002, J EXP MED, V195, P1233, DOI 10.1084/jem.20011930; Niu MS, 2008, INT IMMUNOPHARMACOL, V8, P1609, DOI 10.1016/j.intimp.2008.07.004; Oker-Blom Christian, 2003, Briefings in Functional Genomics & Proteomics, V2, P244, DOI 10.1093/bfgp/2.3.244; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Peralta A, 2007, APPL MICROBIOL BIOT, V75, P407, DOI 10.1007/s00253-006-0825-4; Rohrmann GF, 2013, BACULOVIRUS MOL BIOL, V3rd; Strauss R, 2007, MOL THER, V15, P193, DOI 10.1038/sj.mt.6300008; Tami C, 2000, ARCH VIROL, V145, P1815, DOI 10.1007/s007050070058; Tami C, 2004, VACCINE, V23, P840, DOI 10.1016/j.vaccine.2004.03.070; Tani H, 2003, J VIROL, V77, P9799, DOI 10.1128/JVI.77.18.9799-9808.2003; Vazquez-Calvo A, 2012, VIRUS RES, V167, P125, DOI 10.1016/j.virusres.2012.05.024; VOLKMAN LE, 1983, J VIROL, V46, P221, DOI 10.1128/JVI.46.1.221-229.1983; WHITT MA, 1988, VIROLOGY, V163, P33, DOI 10.1016/0042-6822(88)90231-0; Yang DG, 2007, MOL THER, V15, P1736, DOI 10.1038/sj.mt.6300236; Yang DG, 2007, MOL THER, V15, P989, DOI 10.1038/mt.sj.6300131; Yoshida S, 2003, VIROLOGY, V316, P161, DOI 10.1016/j.virol.2003.08.003	34	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168939	10.1371/journal.pone.0168939	http://dx.doi.org/10.1371/journal.pone.0168939			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033419	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900063
J	Zheng, QL; Wang, T; Jiang, SJ; Han, R; Jin, N; Zhu, J; Zhou, Q; Wang, H; Chen, XZ; Cheng, H				Zheng, Qiaoli; Wang, Tuan; Jiang, Shaojie; Han, Rui; Jin, Na; Zhu, Jiang; Zhou, Qiang; Wang, Hui; Chen, Xianzhen; Cheng, Hao			Production of Polyclonal Antibody to the HPV58 E7 Protein and Its Detection in Cervical Cancer	PLOS ONE			English	Article							PAPILLOMAVIRUS; ONCOPROTEIN; EXPRESSION; WOMEN	The persistent infection of high-risk human papillomavirus (HPV) is one of the most common causes of cervical cancer worldwide, and HPV type 58 is the third most common HPV type in eastern Asia. The E7 oncoprotein is constitutively expressed in HPV58-associated cervical cancer cells and plays a key role during tumorigenesis. To study the biological function of HPV58 E7 and to characterize E7 protein-host cell interactions, we cloned the human HPV58 E7 gene and produced specific E7 antibodies. The HPV58 E7 gene was cloned into a prokaryotic expression vector, pGEX-4T2. The recombinant plasmid pGEX-4T2-(HPV58-E7) was transformed into Escherichia coli DH5 alpha and expressed as a fusion protein containing a GST tag. After purification and removal of the GST affinity tag, the E7 protein was used as an antigen for the production of antiserum in rabbits. The specificity of the purified HPV58 E7 antibody was detected by western blotting, immunofluorescence and immunohistochemistry analysis. These methods demonstrated that the polyclonal antibody could specifically recognize the endogenous and the recombinant HPV58 E7 proteins. Immunohistochemistry analysis indicated that the E7 protein was localized in the nucleus of cervical cancer cells.	[Zheng, Qiaoli; Wang, Tuan; Han, Rui; Jin, Na; Zhu, Jiang; Zhou, Qiang; Chen, Xianzhen; Cheng, Hao] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Dermatol, Hangzhou, Zhejiang, Peoples R China; [Jiang, Shaojie] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Radiol, Hangzhou, Zhejiang, Peoples R China; [Wang, Hui] First Peoples Hosp Fuyang Hangzhou, Dept Pathol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Chen, XZ; Cheng, H (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Dermatol, Hangzhou, Zhejiang, Peoples R China.	xianzhenchen@126.com; hz_chenghao@126.com	Cheng, Hao/AAE-5327-2020		Platform Project of Zhejiang Province Health Department [2015RCB013]	Platform Project of Zhejiang Province Health Department	This work was supported by the Platform Project of Zhejiang Province Health Department (no. 2015RCB013).	Bao YP, 2008, INT J GYNECOL CANCER, V18, P71, DOI 10.1111/j.1525-1438.2007.00959.x; Chan PKS, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-17; Chandra J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152886; Valenca JEC, 2016, REV BRAS GINECOL OBS, V38, P154, DOI 10.1055/s-0036-1580713; Ding TA, 2010, GYNECOL ONCOL, V119, P436, DOI 10.1016/j.ygyno.2010.08.032; DYSON N, 1992, J VIROL, V66, P6893, DOI 10.1128/JVI.66.12.6893-6902.1992; Fan X, 2004, CRIT REV EUKAR GENE, V14, P183, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i3.30; Ghittoni R, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.526; Gonzalez SL, 2001, J VIROL, V75, P7583, DOI 10.1128/JVI.75.16.7583-7591.2001; Gu YS, 2016, ONCOTARGET, V7, P29804, DOI 10.18632/oncotarget.7772; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones DL, 1997, GENE DEV, V11, P2101, DOI 10.1101/gad.11.16.2101; Li J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-368; Wang N, 2014, BRIT J CANCER, V110, P1034, DOI 10.1038/bjc.2013.817; Yang HJ, 2013, CHIN J CANCER, V32, P42, DOI 10.5732/cjc.012.10033; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	17	10	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0169138	10.1371/journal.pone.0169138	http://dx.doi.org/10.1371/journal.pone.0169138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033368	Green Submitted, Green Published, gold			2022-12-26	WOS:000391226900078
J	Mesarwi, OA; Shin, MK; Bevans-Fonti, S; Schlesinger, C; Shaw, J; Polotsky, VY				Mesarwi, Omar A.; Shin, Mi-Kyung; Bevans-Fonti, Shannon; Schlesinger, Christina; Shaw, Janet; Polotsky, Vsevolod Y.			Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; CHRONIC INTERMITTENT HYPOXIA; HEPATIC STELLATE CELLS; LYSYL OXIDASE; OBESE-PATIENTS; MICE; STEATOHEPATITIS; METABOLISM; ACTIVATION; EXPRESSION	Background Obstructive sleep apnea (OSA) is associated with the progression of non-alcoholic fatty liver disease (NAFLD) to steatohepatitis and fibrosis. This progression correlates with the severity of OSA-associated hypoxia. In mice with diet induced obesity, hepatic steatosis leads to liver tissue hypoxia, which worsens with exposure to intermittent hypoxia. Emerging data has implicated hepatocyte cell signaling as an important factor in hepatic fibrogenesis. We hypothesized that hepatocyte specific knockout of the oxygen sensing a subunit of hypoxia inducible factor-1 (HIF-1), a master regulator of the global response to hypoxia, may be protective against the development of liver fibrosis. Methods Wild-type mice and mice with hepatocyte-specific HI F-1 a knockout (Hifla(-/-)hep) were fed a high trans-fat diet for six months, as a model of NAFLD. Hepatic fibrosis was evaluated by Sirius red stain and hydroxyproline assay. Liver enzymes, fasting insulin, and hepatic triglyceride content were also assessed. Hepatocytes were isolated from Hifla(-/-)hep mice and wild-type controls and were exposed to sustained hypoxia (1% 02) or normoxia (16% 02) for 24 hours. The culture media was used to reconstitute type I collagen and the resulting matrices were examined for collagen cross-linking. Results Wild-type mice on a high trans-fat diet had 80% more hepatic collagen than Hifla(-/-)hep mice (2.21 pg collagen/mg liver tissue, versus 1.23 pg collagen/mg liver tissue, p = 0.03), which was confirmed by Sirius red staining. Body weight, liver weight, mean hepatic triglyceride content, and fasting insulin were similar between groups. Culture media from wild-type mouse hepatocytes exposed to hypoxia allowed for avid collagen cross-linking, but very little cross-linking was seen when hepatocytes were exposed to normoxia, or when hepatocytes from Hifla(-/-)hep mice were used in hypoxia or normoxia. Conclusions Hepatocyte HIF-1 mediates an increase in liver fibrosis in a mouse model of NAFLD, perhaps due to liver tissue hypoxia in hepatic steatosis. HIF-1 is necessary for collagen cross linking in an in vitro model of fibrosis.	[Mesarwi, Omar A.] Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA; [Shin, Mi-Kyung; Bevans-Fonti, Shannon; Schlesinger, Christina; Polotsky, Vsevolod Y.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Shaw, Janet] Joint Pathol Ctr, Bethesda, MD USA	University of California System; University of California San Diego; Johns Hopkins University	Mesarwi, OA (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA.	omesarwi@ucsd.edu			National Institutes of Health [R01HL080105, T32HL007534, T32HL110952]; ResMed Foundation [90048207]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133100, R01HL080105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES018176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ResMed Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by: 1. National Institutes of Health (http://www.nhlbi.nih.gov/): R01HL080105 (VP), T32HL007534 (OM, institutional grant), T32HL110952 (OM, institutional grant). 2. ResMed Foundation (http://www.resmedfoundation.org/): 90048207 (VP).	Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Aron-Wisnewsky J, 2012, J HEPATOL, V56, P225, DOI 10.1016/j.jhep.2011.04.022; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Carabelli J, 2011, J CELL MOL MED, V15, P1329, DOI 10.1111/j.1582-4934.2010.01128.x; Carpino G, 2005, DIGEST LIVER DIS, V37, P349, DOI 10.1016/j.dld.2004.11.009; Clapper JR, 2013, AM J PHYSIOL-GASTR L, V305, pG483, DOI 10.1152/ajpgi.00079.2013; Copple BL, 2012, J PHARMACOL EXP THER, V341, P307, DOI 10.1124/jpet.111.189340; Copple BL, 2011, LIVER INT, V31, P230, DOI 10.1111/j.1478-3231.2010.02347.x; Copple BL, 2009, LIVER INT, V29, P1010, DOI 10.1111/j.1478-3231.2009.02015.x; da Rosa DP, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/879419; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Elpek GO, 2014, WORLD J GASTROENTERO, V20, P7260, DOI 10.3748/wjg.v20.i23.7260; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jouet P, 2007, OBES SURG, V17, P478, DOI 10.1007/s11695-007-9085-3; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kallivitz ER, 2007, J CLIN GASTROENTEROL, V41, P918, DOI 10.1097/01.mcg.0000225692.62121.55; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Mantena SK, 2009, BIOCHEM J, V417, P183, DOI 10.1042/BJ20080868; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Mesarwi OA, 2015, SLEEP, V38, P1583, DOI 10.5665/sleep.5052; Moon JO, 2009, AM J PHYSIOL-GASTR L, V296, pG582, DOI 10.1152/ajpgi.90368.2008; MURAWAKI Y, 1991, HEPATOLOGY, V14, P1167, DOI 10.1002/hep.1840140635; NEUMAN RE, 1950, J BIOL CHEM, V184, P299; Nobili V, 2014, AM J RESP CRIT CARE, V189, P66, DOI 10.1164/rccm.201307-1339OC; Ochiai D, 2011, BIOCHEM BIOPH RES CO, V415, P445, DOI 10.1016/j.bbrc.2011.10.089; Polotsky VY, 2009, AM J RESP CRIT CARE, V179, P228, DOI 10.1164/rccm.200804-608OC; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Qu AJ, 2011, HEPATOLOGY, V54, P472, DOI 10.1002/hep.24400; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Reinke C, 2011, J APPL PHYSIOL, V111, P881, DOI 10.1152/japplphysiol.00492.2011; Savransky V, 2007, AM J PHYSIOL-GASTR L, V293, pG871, DOI 10.1152/ajpgi.00145.2007; Savransky V, 2007, HEPATOLOGY, V45, P1007, DOI 10.1002/hep.21593; Semenza GL, 2006, EXP PHYSIOL, V91, P803, DOI 10.1113/expphysiol.2006.033498; SIEGEL RC, 1978, P NATL ACAD SCI USA, V75, P2945, DOI 10.1073/pnas.75.6.2945; Suzuki T, 2014, WORLD J GASTROENTERO, V20, P15087, DOI 10.3748/wjg.v20.i41.15087; Tanne F, 2005, HEPATOLOGY, V41, P1290, DOI 10.1002/hep.20725; Trevaskis JL, 2012, AM J PHYSIOL-GASTR L, V302, pG762, DOI 10.1152/ajpgi.00476.2011; Wei L, 2012, CANCER BIOTHER RADIO, V27, P672, DOI 10.1089/cbr.2012.1241; Wilson GK, 2014, J HEPATOL, V61, P1397, DOI 10.1016/j.jhep.2014.08.025; Wong CCL, 2012, J MOL MED, V90, P803, DOI 10.1007/s00109-011-0855-y; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	45	60	64	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168572	10.1371/journal.pone.0168572	http://dx.doi.org/10.1371/journal.pone.0168572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030556	gold, Green Published, Green Submitted			2022-12-26	WOS:000391222000057
J	Rulifson, IC; Collins, P; Miao, L; Nojima, D; Lee, KJ; Hardy, M; Gupte, J; Hensley, K; Samayoa, K; Cam, C; Rottman, JB; Ollmann, M; Richards, WG; Li, Y				Rulifson, Ingrid C.; Collins, Patrick; Miao, Li; Nojima, Dana; Lee, Ki Jeong; Hardy, Miki; Gupte, Jamila; Hensley, Kelly; Samayoa, Kim; Cam, Cynthia; Rottman, James B.; Ollmann, Mike; Richards, William G.; Li, Yang			In Vitro and in Vivo Analyses Reveal Profound Effects of Fibroblast Growth Factor 16 as a Metabolic Regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipogenesis; bile acid; fibroblast growth factor (FGF); fibroblast growth factor receptor (FGFR); intestinal metabolism; metabolism	BROWN ADIPOSE-TISSUE; SUPPRESSES OSTEOGENIC DIFFERENTIATION; LINKED RECESSIVE FUSION; PROMOTES PROLIFERATION; FGF16; OBESITY; MICE; FAT; IDENTIFICATION; MUTATIONS	The discovery of brown adipose tissue (BAT) as a key regulator of energy expenditure has sparked interest in identifying novel soluble factors capable of activating inducible BAT (iBAT) to combat obesity. Using a high content cell-based screen, we identified fibroblast growth factor 16 (FGF16) as a potent inducer of several physical and transcriptional characteristics analogous to those of both "classical" BAT and iBAT. Overexpression of Fgf16 in vivo recapitulated several of our in vitro findings, specifically the significant induction of the Ucp1 gene and UCP1 protein expression in inguinal white adipose tissue (iWAT), a common site for emergent active iBAT. Despite significant UCP1 up-regulation in iWAT and dramatic weight loss, the metabolic improvements observed due to Fgf16 overexpression in vivo were not the result of increased energy expenditure, as measured by indirect calorimetric assessment. Instead, a pattern of reduced food and water intake, combined with feces replete with lipid and bile acid, indicated a phenotype more akin to that of starvation and intestinal malabsorption. Gene expression analysis of the liver and ileum indicated alterations in several steps of bile acid metabolism, including hepatic synthesis and reabsorption. Histological analysis of intestinal tissue revealed profound abnormalities in support of this conclusion. The in vivo data, together with FGF receptor binding analysis, indicate that the in vivo outcome observed is the likely result of both direct and indirect mechanisms and probably involves multiple receptors. These results highlight the complexity of FGF signaling in the regulation of various metabolic processes.	[Rulifson, Ingrid C.; Miao, Li; Gupte, Jamila; Li, Yang] Amgen Inc, Dept Cardiometabol Disorders, 1120 Vet Blvd, South San Francisco, CA 94080 USA; [Collins, Patrick; Nojima, Dana; Hardy, Miki; Ollmann, Mike] Amgen Inc, Genome Anal Unit, South San Francisco, CA 94080 USA; [Hensley, Kelly; Samayoa, Kim] Amgen Inc, Dept Pathol, South San Francisco, CA 94080 USA; [Cam, Cynthia] Amgen Inc, Dept Comparat Anim Res, South San Francisco, CA 94080 USA; [Lee, Ki Jeong] Amgen Inc, Genome Anal Unit, Thousand Oaks, CA 91320 USA; [Richards, William G.] Amgen Inc, Dept Cardiometabol Disorders, Thousand Oaks, CA 91320 USA; [Rottman, James B.] Amgen Inc, Dept Pathol, Cambridge, MA 02142 USA	Amgen; Amgen; Amgen; Amgen; Amgen; Amgen; Amgen	Rulifson, IC; Li, Y (corresponding author), Amgen Inc, Dept Cardiometabol Disorders, 1120 Vet Blvd, South San Francisco, CA 94080 USA.	ingridr@amgen.com; yangl@amgen.com		Collins, Patrick/0000-0002-7141-7503; , Ki Jeong/0000-0002-8039-7436				Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Cho HH, 2006, TISSUE ENG, V12, P111, DOI 10.1089/ten.2006.12.111; Cypess AM, 2010, CURR OPIN PEDIATR, V22, P478, DOI 10.1097/MOP.0b013e32833a8d6e; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Elsen M, 2014, AM J PHYSIOL-CELL PH, V306, pC431, DOI 10.1152/ajpcell.00290.2013; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Ge HF, 2014, J BIOL CHEM, V289, P30470, DOI 10.1074/jbc.M114.592022; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hotta Y, 2008, DEV DYNAM, V237, P2947, DOI 10.1002/dvdy.21726; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Itoh N, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00154; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jamsheer A, 2014, BIRTH DEFECTS RES A, V100, P314, DOI 10.1002/bdra.23239; Jamsheer A, 2013, J MED GENET, V50, P579, DOI 10.1136/jmedgenet-2013-101659; Jones B, 2014, CLIN DYSMORPHOL, V23, P95, DOI 10.1097/MCD.0000000000000043; Konishi M, 2000, J BIOL CHEM, V275, P12119, DOI 10.1074/jbc.275.16.12119; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Laurell T, 2014, MOL GENET GENOM MED, V2, P402, DOI 10.1002/mgg3.81; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Lu SY, 2008, BIOCHEM BIOPH RES CO, V373, P270, DOI 10.1016/j.bbrc.2008.06.029; Matsumoto E, 2013, GENES CELLS, V18, P544, DOI 10.1111/gtc.12055; Miyake A, 1998, BIOCHEM BIOPH RES CO, V243, P148, DOI 10.1006/bbrc.1998.8073; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute for Laboratory Animal Research (US) and National Academies Press (US), 2011, GUIDE CARE USE LAB A; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Pandol S. J., 2010, EXOCRINE PANCREAS; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Qiu WM, 2007, J BONE MINER RES, V22, P1720, DOI 10.1359/JBMR.070721; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yu W, 2016, DEVELOPMENT, V143, P936, DOI 10.1242/dev.130971; Zhang J, 2014, DRUG DISCOV TODAY, V19, P579, DOI 10.1016/j.drudis.2013.10.021; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	44	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1951	1969		10.1074/jbc.M116.751404	http://dx.doi.org/10.1074/jbc.M116.751404			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28011645	Green Published, hybrid			2022-12-26	WOS:000395515600033
J	Burleson-Lesser, K; Morone, F; DeGuzman, P; Parra, LC; Makse, HA				Burleson-Lesser, Kate; Morone, Flaviano; DeGuzman, Paul; Parra, Lucas C.; Makse, Heirnan A.			Collective Behaviour in Video Viewing: A Thermodynamic Analysis of Gaze Position	PLOS ONE			English	Article							COMMUNITY STRUCTURE; BRAIN ACTIVITY	Videos and commercials produced for large audiences can elicit mixed opinions. We wondered whether this diversity is also reflected in the way individuals watch the videos. To answer this question, we presented 65 commercials with high production value to 25 individuals while recording their eye movements, and asked them to provide preference ratings for each video. We find that gaze positions for the most popular videos are highly correlated. To explain the correlations of eye movements, we model them as "interactions" between individuals. A thermodynamic analysis of these interactions shows that they approach a "critical" point such that any stronger interaction would put all viewers into lock-step and any weaker interaction would fully randomise patterns. At this critical point, groups with similar collective behaviour in viewing patterns emerge while maintaining diversity between groups. Our results suggest that popularity of videos is already evident in the way we look at them, and that we maintain diversity in viewing behaviour even as distinct patterns of groups emerge. Our results can be used to predict popularity of videos and commercials at the population level from the collective behaviour of the eye movements of a few viewers.	[Burleson-Lesser, Kate; Morone, Flaviano; Makse, Heirnan A.] CUNY City Coll, Levich Inst, New York, NY 10031 USA; [Burleson-Lesser, Kate; Morone, Flaviano; Makse, Heirnan A.] CUNY City Coll, Dept Phys, New York, NY 10031 USA; [DeGuzman, Paul] Neuromatters LLC, New York, NY USA; [Parra, Lucas C.] CUNY City Coll, Dept Biomed Engn, New York, NY USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY)	Makse, HA (corresponding author), CUNY City Coll, Levich Inst, New York, NY 10031 USA.; Makse, HA (corresponding author), CUNY City Coll, Dept Phys, New York, NY 10031 USA.	hmakse@lev.ccny.cuny.edu			National Institutes of Health: National Institutes of General Medical Sciences [1R21GM107641]; National Science Foundation: Physics of Living Systems [1305476]; Defense Advanced Research Projects Agency [W31P4Q-13-C-0038]; National Science Foundation [1515022]; Neuromatters LLC; NIH-NIGMS [1R21GM107641]; NSF-PoLS [PHY-1305476, NSF-115 1515022]; DARPA [W31P4Q-13-C-0038]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB022720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R13ES027302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM107641] Funding Source: NIH RePORTER	National Institutes of Health: National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation: Physics of Living Systems; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation(National Science Foundation (NSF)); Neuromatters LLC; NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF-PoLS; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HAM received funding from: National Institutes of Health: National Institutes of General Medical Sciences, Grant # 1R21GM107641 (https.//www.nigms.nih.gov/); National Science Foundation: Physics of Living Systems, Grant # 1305476 (https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=6673&org=PHY&from=home). LP received funding from: Defense Advanced Research Projects Agency, Grant # W31P4Q-13-C-0038 (www.darpa.mil/); National Science Foundation, Grant # 1515022 (www.nsf.gov). Neuromatters LLC provided support in the form of salaries for author PD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.; This work was funded by NIH-NIGMS 1R21GM107641, NSF-PoLS PHY-1305476, NSF-115 1515022, and DARPA W31P4Q-13-C-0038. We thank Saulo Reis, Lev Muchnik, and Paul Sajda for discussions.	Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Arenas A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/053039; Armel KC, 2003, JUDGM DECIS MAK, V3, P396; Bialek W, 2012, P NATL ACAD SCI USA, V109, P4786, DOI 10.1073/pnas.1118633109; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Chaikin P. M., 2000, PRINCIPLES CONDENSED; Dewhurst R, 2012, BEHAV RES METHODS, V44, P1079, DOI 10.3758/s13428-012-0212-2; Dmochowski JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5567; Dmochowski JP, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00112; Dorr M, 2010, J VISION, V10, DOI 10.1167/10.10.28; Gallos LK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00123; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hasson U, 2008, NEURON, V57, P452, DOI 10.1016/j.neuron.2007.12.009; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Ki JJ, 2016, J NEUROSCI, V36, P3092, DOI 10.1523/JNEUROSCI.2942-15.2016; Kotze J, 2008, ARXIV PREPRINT ARXIV; Lahnakoski JM, 2014, NEUROIMAGE, V100, P316, DOI 10.1016/j.neuroimage.2014.06.022; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Le Martelot E, 2013, COMPUT J, V56, P1136, DOI 10.1093/comjnl/bxt002; Lin Z, 2009, INEXACT ALM RPCA; Loschky LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142474; MarketingCharts, 2014, UP BOWL 2014 ADS FAC; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mora T, 2011, J STAT PHYS, V144, P268, DOI 10.1007/s10955-011-0229-4; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nummenmaa L, 2012, P NATL ACAD SCI USA, V109, P9599, DOI 10.1073/pnas.1206095109; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Smith A., 2013, SUPER BOWL AD PRICE; Tkacik G, 2015, P NATL ACAD SCI USA, V112, P11508, DOI 10.1073/pnas.1514188112; Valuch C, 2015, MULTIMED TOOLS APPL, V74, P10161, DOI 10.1007/s11042-015-2806-z; Wang HX, 2012, J VISION, V12, DOI [10.1167/12.1.16, 10.1167/12.6.26]	34	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168995	10.1371/journal.pone.0168995	http://dx.doi.org/10.1371/journal.pone.0168995			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045963	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300084
J	Chen, Q; Weng, ZY; Lu, YS; Jia, YJ; Ding, LL; Bai, F; Ge, MX; Lin, Q; Wu, KJ				Chen, Qing; Weng, Ziyi; Lu, Yunshu; Jia, Yijun; Ding, Longlong; Bai, Fang; Ge, Meixin; Lin, Qing; Wu, Kejin			An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+Breast Cancer Cell Lines and Mouse Tumor Xenografts	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; ADVANCED BREAST-CANCER; ACTIVATED PROTEIN-KINASE; RANDOMIZED PHASE-III; ESTROGEN-RECEPTOR; TAMOXIFEN RESISTANCE; ADJUVANT TRASTUZUMAB; 1ST-LINE TREATMENT; KAPPA-B; HER2	Purpose To investigate the effects of trastuzumab (herceptin) and fulvestrant (falsodex) either in combination or alone, on downstream cell signaling pathways in lab-cultured human HR +/HER2+ breast cancer cell lines ZR-75-1 and BT-474, as well as on protein expression levels in mouse xenograft tissue. Methods Cells were cultivated in the presence of trastuzumab or fulvestrant or both. Molecular events that resulted in an inhibition of cell proliferation and cell cycle progression or in an increased rate of apoptosis were studied. The distribution and abundance of the proteins p-Akt and pErk expressed in these cells in response to single agents or combinatorial treatment were also investigated. In addition, the effects of trastuzumab and fulvestrant, either as single agents or in combination on tumor growth as well as on expression of the protein p-MED1 expressed in in vivo mouse xenograft models was also examined. Results Cell proliferation was increasingly inhibited by trastuzumab or fulvestrant or both, with a Cl<1 and DRI>1 in both human cell lines. The rate of apoptosis increased only in the BT-474 cell line and not in the ZR-75-1 cell line upon treatment with fulvestrant and not trastuzumab as a single agent (P<0.05). Interestingly, fulvestrant, in combination with trastuzumab, did not significantly alter the rate of apoptosis (in comparison with fulvestrant alone), in the BT 474 cell line (P>0.05). Cell accumulation in the G1 phase of cell cycle was investigated in all treatment groups (P<0.05), and the combination of trastuzumab and fulvestrant reversed the effects of fulvestrant alone on p-Akt and p-Erk protein expression levels. Using ZR-75-1 or BT-474 to generate in vivo tumor xenografts in BALB/c athymic mouse models, we showed that a combination of both drugs resulted in a stronger inhibition of tumor growth (P<0.05) and a greater decrease in the levels of activated MED1 (p-MED1) expressed in tumor issues compared with the use of either drug as a single agent. Conclusions We demonstrate that the administration of trastuzumab and fulvestrant in combination results in positive synergistic effects on both, ZR-75-1 and BT-474 cell lines. This combinatorial approach is likely to reduce physiological side effects of both drugs, thus providing a theoretical basis for the use of such combination treatment in order to resolve HR+/HER2+ triple positive breast cancer that has previously been shown to be resistant to endocrine treatment alone.	[Chen, Qing; Lu, Yunshu; Jia, Yijun; Ding, Longlong; Bai, Fang; Ge, Meixin] Shanghai Jiao Tong Univ, XinHua Hosp, Sch Med, Dept Gen Surg, Shanghai, Peoples R China; [Weng, Ziyi] Shanghai Int Med Ctr, Dept Gen Surg, Shanghai, Peoples R China; [Lin, Qing] Tongji Univ, Shanghai Peoples Hosp 10, Dept Radiat Oncol, Shanghai, Peoples R China; [Wu, Kejin] Fudan Univ, Obstet & Gynecol Hosp, Dept Breast Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University; Tongji University; Fudan University	Lin, Q (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Radiat Oncol, Shanghai, Peoples R China.; Wu, KJ (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Dept Breast Surg, Shanghai, Peoples R China.	linqing.linda@163.com; kejinwu1128@163.com			Science and Technology Commission of Shanghai Municipality [14411950206]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The research was funded by Science and Technology Commission of Shanghai Municipality (No.14411950206, http://www.stcsm.gov.cn) and Kejin Wu received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolkar G, 2015, CARDIOVASC ULTRASOUN, V13, DOI 10.1186/s12947-015-0011-x; Alves CL, 2016, CLIN CANC RES; Bartsch R, 2007, CLIN CANCER RES, V13, P4435, DOI 10.1158/1078-0432.CCR-06-3050; Belakavadi M, 2008, MOL CELL BIOL, V28, P3932, DOI 10.1128/MCB.02191-07; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Brockhoff G, 2007, CELL PROLIFERAT, V40, P488, DOI 10.1111/j.1365-2184.2007.00449.x; Canney P, 2015, CLIN ONCOL-UK, V27, P460, DOI 10.1016/j.clon.2015.04.033; Chen Z, 2011, EMBO J, V30, P2405, DOI 10.1038/emboj.2011.154; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Cui JJ, 2012, CANCER RES, V72, P5625, DOI 10.1158/0008-5472.CAN-12-1305; Dowsett M, 2001, ENDOCR-RELAT CANCER, V8, P191, DOI 10.1677/erc.0.0080191; Gee JM, 2005, ENDOCR-RELAT CANCER, V12, pS99, DOI 10.1677/erc.1.01005; Gelmon KA, 2015, J CLIN ONCOL, V33, P1574, DOI 10.1200/JCO.2014.56.9590; Holloway JN, 2004, MOL ENDOCRINOL, V18, P1396, DOI 10.1210/me.2004-0048; Honda K, 2016, BREAST CANC; Hosonaga M, 2014, CANCER SCI, V105, P779, DOI 10.1111/cas.12427; Hurvitz SA, 2015, LANCET ONCOL, V16, P816, DOI 10.1016/S1470-2045(15)00051-0; Ithimakin S, 2013, CANCER RES, V73, P1635, DOI 10.1158/0008-5472.CAN-12-3349; Jiang PP, 2010, P NATL ACAD SCI USA, V107, P6765, DOI 10.1073/pnas.1001814107; Kataoka K, 2015, JPN J CLIN ONCOL, V45, P1082, DOI 10.1093/jjco/hyv134; Krop IE, 2015, J CLIN ONCOL, V33, P1136, DOI 10.1200/JCO.2014.58.7782; Lee WT, 2015, FOOD CHEM TOXICOL, V78, P33, DOI 10.1016/j.fct.2015.01.012; Parra-Palau JL, 2010, CANCER RES, V70, P8537, DOI 10.1158/0008-5472.CAN-10-1701; Luoh SW, 2002, CANCER GENET CYTOGEN, V136, P43, DOI 10.1016/S0165-4608(01)00657-4; Mason JK, 2015, J NUTR BIOCHEM, V26, P16, DOI 10.1016/j.jnutbio.2014.08.001; Mehta A, 2014, BREAST, V23, P2, DOI 10.1016/j.breast.2013.09.006; Mitsui Y, 2015, CANCER CHEMOTH PHARM, V76, P375, DOI 10.1007/s00280-015-2807-7; Nagalingam A, 2012, CARCINOGENESIS, V33, P918, DOI 10.1093/carcin/bgs105; Nakano S, 2016, CARDIOL J, V23, P270, DOI 10.5603/CJ.a2016.0023; Nicholson RI, 2002, ANN NY ACAD SCI, V963, P104, DOI 10.1111/j.1749-6632.2002.tb04101.x; OSBORNE CK, 1994, CANCER CHEMOTH PHARM, V34, P89, DOI 10.1007/BF00685924; Pandey PK, 2005, MOL CELL BIOL, V25, P10695, DOI 10.1128/MCB.25.24.10695-10710.2005; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; Pivot X, 2015, EUR J CANCER, V51, P1660, DOI 10.1016/j.ejca.2015.05.028; Robertson JFR, 2010, ANN ONCOL, V21, P1246, DOI 10.1093/annonc/mdp447; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Schwarz LJ, 2014, J CLIN INVEST, V124, P5490, DOI 10.1172/JCI72573; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Steger GG, 2005, CANCER TREAT REV, V31, pS10, DOI 10.1016/j.ctrv.2005.08.009; Stoica A, 2000, J ENDOCRINOL, V165, P371, DOI 10.1677/joe.0.1650371; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; WRIGHT C, 1992, BRIT J CANCER, V65, P118, DOI 10.1038/bjc.1992.22; Yang SX, 2016, CANCER TREAT REV, V45, P87, DOI 10.1016/j.ctrv.2016.03.004; Yang ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep07758; Zhang L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052384, 10.1371/journal.pone.0066569]; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015; Zhu YJ, 1999, P NATL ACAD SCI USA, V96, P10848, DOI 10.1073/pnas.96.19.10848	49	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168960	10.1371/journal.pone.0168960	http://dx.doi.org/10.1371/journal.pone.0168960			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045951	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300079
J	Crefcoeur, RP; Zgheib, O; Halazonetis, TD				Crefcoeur, Remco P.; Zgheib, Omar; Halazonetis, Thanos D.			A Model to Investigate Single-Strand DNA Responses in G1 Human Cells via a Telomere-Targeted, Nuclease-Deficient CRISPR-Cas9 System	PLOS ONE			English	Article							REPLICATION PROTEIN-A; DAMAGE RESPONSE; GENOMIC LOCI; ATR; STRESS; PHOSPHORYLATION; CANCER; REPAIR; RECOGNITION; HELICASE	DNA replication stress has the potential to compromise genomic stability and, therefore, cells have developed elaborate mechanisms to detect and resolve problems that may arise during DNA replication. The presence of single-stranded DNA (ssDNA) is often associated with DNA replication stress and serves as a signal for both checkpoint and repair responses. In this study, we exploited a CRISPR-Cas9 system to induce regions of ssDNA in the genome. Specifically, single-guide RNAs bearing sequence complementarity to human telomeric repeats, were used to target nuclease-deficient Cas9 (dCas9) to telomeres. Such targeting was associated with the formation of DNA-RNA hybrids, leaving one telomeric DNA strand single-stranded. This ssDNA then recruited DNA repair and checkpoint proteins, such as RPA, ATRIP, BLM and Rad51, at the telomeres. Interestingly, targeting of all these proteins to telomeric ssDNA was observed even in cells that were in the G1 phase of the cell cycle. Therefore, this system has the potential to serve as a platform for further investigation of DNA replication stress responses at specific loci in the human genome and in all phases of the cell cycle.	[Crefcoeur, Remco P.; Zgheib, Omar; Halazonetis, Thanos D.] Univ Geneva, Dept Mol Biol, Geneva, Switzerland	University of Geneva	Halazonetis, TD (corresponding author), Univ Geneva, Dept Mol Biol, Geneva, Switzerland.	thanos.halazonetis@unige.ch						Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Ball HL, 2005, J BIOL CHEM, V280, P31390, DOI 10.1074/jbc.M504961200; Boyer AS, 2016, SEMIN CANCER BIOL, V37-38, P16, DOI 10.1016/j.semcancer.2016.01.001; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Deng WL, 2015, P NATL ACAD SCI USA, V112, P11870, DOI 10.1073/pnas.1515692112; Dereli-Oz A, 2011, MOL ONCOL, V5, P308, DOI 10.1016/j.molonc.2011.05.002; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Fernandez-Capetillo O, 2003, CELL CYCLE, V2, P426, DOI 10.4161/cc.2.5.509; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Itakura E, 2004, BIOCHEM BIOPH RES CO, V323, P1197, DOI 10.1016/j.bbrc.2004.08.228; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Lu HM, 2016, CELL REP, V16, P161, DOI 10.1016/j.celrep.2016.05.079; Macheret M, 2015, ANNU REV PATHOL-MECH, V10, P425, DOI 10.1146/annurev-pathol-012414-040424; Marechal A, 2015, CELL RES, V25, P9, DOI 10.1038/cr.2014.147; Munoz S., 2016, CHROMOSOMA; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shiotani B, 2013, CELL REP, V3, P1651, DOI 10.1016/j.celrep.2013.04.018; Singh DK, 2010, AGING CELL, V9, P358, DOI 10.1111/j.1474-9726.2010.00562.x; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Taylor EM, 2016, FUTURE ONCOL, V12, P221, DOI 10.2217/fon.15.292; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	27	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169126	10.1371/journal.pone.0169126	http://dx.doi.org/10.1371/journal.pone.0169126			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046023	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300122
J	Dias, K; Dvorkin-Gheva, A; Hallett, RM; Wu, Y; Hassell, J; Pond, GR; Levine, M; Whelan, T; Bane, AL				Dias, Kay; Dvorkin-Gheva, Anna; Hallett, Robin M.; Wu, Ying; Hassell, John; Pond, Gregory R.; Levine, Mark; Whelan, Tim; Bane, Anita L.			Claudin-Low Breast Cancer; Clinical & Pathological Characteristics	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-INITIATING CELLS; STEM-CELLS; EXPRESSION; IDENTIFICATION; RECEPTOR; SUBTYPE; IMMUNOHISTOCHEMISTRY; PREDICTOR; SIGNATURE	Claudin-low breast cancer is a molecular type of breast cancer originally identified by gene expression profiling and reportedly associated with poor survival. Claudin-low tumors have been recognised to preferentially display a triple-negative phenotype, however only a minority of triple-negative breast cancers are claudin-low. We sought to identify an immunohistochemical profile for claudin-low tumors that could facilitate their identification in formalin fixed paraffin embedded tumor material. First, an in silico collection of similar to 1600 human breast cancer expression profiles was assembled and all claudin-low tumors identified. Second, genes differentially expressed between claudin-low tumors and all other molecular subtypes of breast cancer were identified. Third, a number of these top differentially expressed genes were tested using immunohistochemistry for expression in a diverse panel of breast cancer cell lines to determine their specificity for claudin-low tumors. Finally, the immunohistochemical panel found to be most characteristic of claudin-low tumors was examined in a cohort of 942 formalin fixed paraffin embedded human breast cancers with > 10 years clinical followup to evaluate the clinico-pathologic and survival characteristics of this tumor subtype. Using this approach we determined that claudin-low breast cancer is typically negative for ER, PR, HER2, claudin 3, claudin 4, claudin 7 and E-cadherin. Claudin-low tumors identified with this immunohistochemical panel, were associated with young age of onset, higher tumor grade, larger tumor size, extensive lymphocytic infiltrate and a circumscribed tumor margin. Patients with claudin-low tumors had a worse overall survival when compared to patients with luminal A type breast cancer. Interestingly, claudin-low tumors were associated with a low local recurrence rate following breast conserving therapy. In conclusion, a limited panel of antibodies can facilitate the identification of claudin-low tumors. Furthermore, claudin-low tumors identified in this manner display similar clinical, pathologic and survival characteristics to claudin-low tumors identified from fresh frozen tumor material using gene expression profiling.	[Dias, Kay; Hassell, John; Bane, Anita L.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Dias, Kay; Wu, Ying; Pond, Gregory R.; Whelan, Tim; Bane, Anita L.] McMaster Univ, Dept Oncol, Hamilton, ON, Canada; [Dvorkin-Gheva, Anna; Hallett, Robin M.; Hassell, John] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Bane, AL (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.; Bane, AL (corresponding author), McMaster Univ, Dept Oncol, Hamilton, ON, Canada.	bane@hhsc.ca	Evans, Diane/F-9258-2017; Whelan, Timothy/D-3185-2017	Whelan, Timothy/0000-0001-9844-2023; Pond, Gregory/0000-0003-1033-0882; Dvorkin-Gheva, Anna/0000-0001-7295-7440	Canadian Breast Cancer Foundation; Canadian Institutes of Health Research [MOP-142353]	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Breast Cancer Foundation (http://www.cbcf.org/ontario/ApplyForGrants/Pages/default.aspx) to ALB, and by the Canadian Institutes of Health Research, grant no. MOP-142353 to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Allred DC, 1998, MODERN PATHOL, V11, P155; Ashworth RE, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.tps1147; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Bane AL, 2014, ANN ONCOL; Bane A, 2013, BREAST CANCER RES TR, V140, P195, DOI 10.1007/s10549-013-2591-1; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; Benjamini Y, 2001, ANN STAT, V29, P1165; Bruna A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2039; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; Denkert C, 2014, J CLIN ONCOL; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Dvorkin-Gheva A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103514; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Hollier BG, 2013, CANCER RES, V73, P1981, DOI 10.1158/0008-5472.CAN-12-2962; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Knezevic J, 2015, ONCOGENE; Lakhani SR, 2012, WHO CLASSIFICATION T; Li CX, 2014, J CLIN INVEST, V124, P2172, DOI 10.1172/JCI71103; Liu CL, 2005, MODERN PATHOL, V18, P1641, DOI 10.1038/modpathol.3800491; Loi S, 2014, ANN ONCOL; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Mohsin SK, 2004, MODERN PATHOL, V17, P1545, DOI 10.1038/modpathol.3800229; Morel AP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002723; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Sabatier R, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-228; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Whelan TJ, 2010, NEW ENGL J MED, V362, P513, DOI 10.1056/NEJMoa0906260; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984	44	81	82	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168669	10.1371/journal.pone.0168669	http://dx.doi.org/10.1371/journal.pone.0168669			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045912	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300040
J	Gilmer, DB; Schmitz, JE; Thandar, M; Euler, CW; Fischetti, VA				Gilmer, Daniel B.; Schmitz, Jonathan E.; Thandar, Mya; Euler, Chad W.; Fischetti, Vincent A.			The Phage Lysin PlySs2 Decolonizes Streptococcus suis from M u rine Intranasal Mucosa	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BACTERIOPHAGE LYTIC ENZYME; ANTIMICROBIAL RESISTANCE; INFECTION; SEROTYPE-2; PIGS; ELIMINATION; TYPE-2; COLONIZATION; PROTECTS	Streptococcus suis infects pigs worldwide and may be zoonotically transmitted to humans with a mortality rate of up to 20%. S. suis has been shown to develop in vitro resistance to the two leading drugs of choice, penicillin and gentamicin. Because of this, we have pursued an alternative therapy to treat these pathogens using bacteriophage lysins. The bacteriophage lysin PlySs2 is derived from an S. suis phage and displays potent lytic activity against most strains of that species including serotypes 2 and 9. At 64 pg/ml, PlySs2 reduced multiple serotypes of S. suis by 5 to 6-logs within 1 hour in vitro and exhibited a minimum inhibitory concentration (MIC) of 32 pg/ml fora S. suisserotype 2 strain and 64 pg/ml fora serotype 9 strain. Using a single 0.1-mg dose, the colonizing S. suis serotype 9 strain was reduced from the murine intranasal mucosa by >4 logs; a 0.1-mg dose of gentamicin reduced S. suis by <3-logs. A combination of 0.05 mg PlySs2 + 0.05 mg gentamicin reduced S. suis by >5-logs. While resistance to gentamicin was induced after systematically increasing levels of gentamicin in an S. suis culture, the same protocol resulted in no observable resistance to PlySs2. Thus, PlySs2 has both broad and high killing activity against multiple serotypes and strains of S. suis, making it a possible tool in the control and prevention of S. suis infections in pigs and humans.	[Gilmer, Daniel B.; Schmitz, Jonathan E.; Thandar, Mya; Euler, Chad W.; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA; [Schmitz, Jonathan E.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, 1211 Med Ctr Dr, Nashville, TN 37235 USA	Rockefeller University; Vanderbilt University	Fischetti, VA (corresponding author), Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA.	vaf@rockefeller.edu			NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by NIH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amass SF, 1996, J VET DIAGN INVEST, V8, P64, DOI 10.1177/104063879600800110; ARENDS JP, 1988, REV INFECT DIS, V10, P131; CANTIN M, 1992, J VET DIAGN INVEST, V4, P170, DOI 10.1177/104063879200400209; Cheng Q, 2005, ANTIMICROB AGENTS CH, V49, P111, DOI 10.1128/AAC.49.1.111-117.2005; CLIFTONHADLEY FA, 1984, VET RES COMMUN, V8, P217, DOI 10.1007/BF02214715; Cloutier G, 2003, VET MICROBIOL, V97, P135, DOI 10.1016/j.vetmic.2003.09.018; Daniel A, 2010, ANTIMICROB AGENTS CH, V54, P1603, DOI 10.1128/AAC.01625-09; Dekker N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061339; Djurkovic S, 2005, ANTIMICROB AGENTS CH, V49, P1225, DOI 10.1128/AAC.49.3.1225-1228.2005; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Gilmer DB, 2013, ANTIMICROB AGENTS CH, V57, P2743, DOI 10.1128/AAC.02526-12; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Harel J, 2003, INFECT IMMUN, V71, P6104, DOI 10.1128/IAI.71.10.6104-6108.2003; Kerdsin A, 2011, EMERG INFECT DIS, V17, P835, DOI 10.3201/eid1705.100754; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Ma YL, 2008, VET MICROBIOL, V132, P340, DOI 10.1016/j.vetmic.2008.05.013; Meng XP, 2011, APPL ENVIRON MICROB, V77, P8272, DOI 10.1128/AEM.05151-11; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Pastagia M, 2011, ANTIMICROB AGENTS CH, V55, P738, DOI 10.1128/AAC.00890-10; PERCH B, 1968, ACTA PATHOL MIC SC, V74, P69; Rashel M, 2007, J INFECT DIS, V196, P1237, DOI 10.1086/521305; ROBERTSON ID, 1989, VET REC, V124, P391, DOI 10.1136/vr.124.15.391; ROBERTSON ID, 1991, EPIDEMIOL INFECT, V107, P119, DOI 10.1017/S0950268800048743; ROBINSON JM, 1979, J BACTERIOL, V137, P1158, DOI 10.1128/JB.137.3.1158-1164.1979; Rouse MS, 2005, ANTIMICROB AGENTS CH, V49, P3187, DOI 10.1128/AAC.49.8.3187-3191.2005; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Schuch R, 2013, J INFECT DIS; Seitz M, 2012, J MED MICROBIOL, V61, P1311, DOI 10.1099/jmm.0.043885-0; Silva LMG, 2006, VET MICROBIOL, V115, P117, DOI 10.1016/j.vetmic.2005.12.013; Sriskandan S, 2006, PLOS MED, V3, P595, DOI 10.1371/journal.pmed.0030187; Swildens B, 2007, VET REC, V160, P619, DOI 10.1136/vr.160.18.619; Tang F, 2015, APPL ENVIRON MICROB, V81, P7377, DOI 10.1128/AEM.02300-15; Torremorell M, 1998, CAN J VET RES, V62, P21; TROTTIER S, 1991, REV INFECT DIS, V13, P1251; Varela NP, 2013, ANIM HEALTH RES REV, V14, P68, DOI 10.1017/S1466252313000029; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Wang Y, 2009, CURR MICROBIOL, V58, P609, DOI 10.1007/s00284-009-9379-x; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wu ZF, 2008, MICROB PATHOGENESIS, V45, P159, DOI 10.1016/j.micpath.2008.04.009; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194	41	23	27	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169180	10.1371/journal.pone.0169180	http://dx.doi.org/10.1371/journal.pone.0169180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046082	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300138
J	Kohyama-Koganeya, A; Kurosawa, M; Hirabayashi, Y				Kohyama-Koganeya, Ayako; Kurosawa, Mizuki; Hirabayashi, Yoshio			Loss of BOSS Causes Shortened Lifespan with Mitochondrial Dysfunction in Drosophila	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; SUPEROXIDE-DISMUTASE; TISSUE HOMEOSTASIS; NEGATIVE GEOTAXIS; OXIDATIVE STRESS; GENE-EXPRESSION; OVEREXPRESSION; METABOLISM; EXTENSION; LONGEVITY	Aging is a universal process that causes deterioration in biological functions of an organism over its lifetime. There are many risk factors that are thought to contribute to aging rate, with disruption of metabolic homeostasis being one of the main factors that accelerates aging. Previously, we identified a new function for the putative G-protein-coupled receptor, Bride of sevenless (BOSS), in energy metabolism. Since maintaining metabolic homeostasis is a critical factor in aging, we investigated whether BOSS plays a role in the aging process. Here, we show that BOSS affects lifespan regulation. boss null mutants exhibit shortened lifespans, and their locomotor performance and gut lipase activity-two age-sensitive markers-are diminished and similar to those of aged control flies. Reactive oxygen species (ROS) production is also elevated in boss null mutants, and their ROS defense system is impaired. The accumulation of protein adducts (advanced lipoxidation end products [ALEs] and advanced glycation end products [AGEs]) caused by oxidative stress are elevated in boss mutant flies. Furthermore, boss mutant flies are sensitive to oxidative stress challenges, leading to shortened lives under oxidative stress conditions. Expression of superoxide dismutase 2 (SOD2), which is located in mitochondria and normally regulates ROS removal, was decreased in boss mutant flies. Systemic overexpression of SOD2 rescued boss mutant phenotypes. Finally, we observed that mitochondrial mass was greater in boss mutant flies. These results suggest that BOSS affects lifespan by modulating the expression of a set of genes related to oxidative stress resistance and mitochondrial homeostasis.	[Kohyama-Koganeya, Ayako; Kurosawa, Mizuki; Hirabayashi, Yoshio] RIKEN, Brain Sci Inst, Mol Membrane Neurosci, Wako, Japan	RIKEN	Hirabayashi, Y (corresponding author), RIKEN, Brain Sci Inst, Mol Membrane Neurosci, Wako, Japan.	hirabaya@riken.jp	香山, 綾子/ABF-4396-2021	香山, 綾子/0000-0002-7632-7953; Hirabayashi, Yoshio/0000-0002-5774-7354	RIKEN Brain Science Institute; Danone Institute of Japan Foundation Research Grant	RIKEN Brain Science Institute; Danone Institute of Japan Foundation Research Grant(Danone Nutricia)	This work was supported by grants from the RIKEN Brain Science Institute to YH, and from the 2013 Danone Institute of Japan Foundation Research Grant to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Boyd O, 2011, FREE RADICAL BIO MED, V50, P1669, DOI 10.1016/j.freeradbiomed.2011.03.011; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Celotto AM, 2012, BRAIN BEHAV, V2, P424, DOI 10.1002/brb3.73; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Cocheme HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; Demontis F, 2013, DIS MODEL MECH, V6, P1339, DOI 10.1242/dmm.012559; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fischer F, 2012, TRENDS BIOCHEM SCI, V37, P284, DOI 10.1016/j.tibs.2012.02.004; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Hansen M, 2013, CELL METAB, V17, P10, DOI 10.1016/j.cmet.2012.12.003; Heck AM, 2000, PHARMACOTHERAPY, V20, P270, DOI 10.1592/phco.20.4.270.34882; Huang H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004844; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; Jacobson J, 2010, AGING CELL, V9, P466, DOI 10.1111/j.1474-9726.2010.00573.x; Jung I, 2011, FEBS LETT, V585, P1973, DOI 10.1016/j.febslet.2011.05.033; Karpac J, 2013, CELL REP, V4, P1250, DOI 10.1016/j.celrep.2013.08.004; Kim YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003149; Kohyama-Koganeya A, 2008, P NATL ACAD SCI USA, V105, P15328, DOI 10.1073/pnas.0807833105; Kohyama-Koganeya A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133083; Landis G, 2012, AGING-US, V4, P768, DOI 10.18632/aging.100499; Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Metpally RPR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-106; Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200; Morrow G, 2015, FRONT GENET, V6, DOI [10.3389/fgene.2015.00103, 10.3389/fpsyg.2015.01652]; Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006; Neretti N, 2009, P NATL ACAD SCI USA, V106, P2277, DOI 10.1073/pnas.0812484106; Nichols CD, 2012, JOVE-J VIS EXP, DOI 10.3791/3795; Oka S, 2015, BIOGERONTOLOGY; Orr WC, 2003, J BIOL CHEM, V278, P26418, DOI 10.1074/jbc.M303095200; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; Rhodenizer D, 2008, EXP GERONTOL, V43, P739, DOI 10.1016/j.exger.2008.04.011; Robbins MJ, 2000, GENOMICS, V67, P8, DOI 10.1006/geno.2000.6226; Sano T, 2011, BIOCHEM BIOPH RES CO, V412, P460, DOI 10.1016/j.bbrc.2011.07.118; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Sieber MH, 2009, CELL METAB, V10, P481, DOI 10.1016/j.cmet.2009.10.010; Smith WW, 2014, PHYSIOL BEHAV, V136, P15, DOI 10.1016/j.physbeh.2014.01.017; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sun JT, 2002, GENETICS, V161, P661; Sun JT, 1999, MOL CELL BIOL, V19, P216; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Tennessen JM, 2014, METHODS, V68, P105, DOI 10.1016/j.ymeth.2014.02.034; Tissenbaum HA, 2002, DEV CELL, V2, P9, DOI 10.1016/S1534-5807(01)00098-3; Yang JS, 2009, J GERONTOL A-BIOL, V64, P828, DOI 10.1093/gerona/glp054; Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011; Zhao YM, 2005, J EXP BIOL, V208, P697, DOI 10.1242/jeb.01439; Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287	60	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169073	10.1371/journal.pone.0169073	http://dx.doi.org/10.1371/journal.pone.0169073			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045997	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300108
J	Lee, H; Kim, EK; Kim, HY; Kim, TI				Lee, Hun; Kim, Eung Kweon; Kim, Hee Young; Kim, Tae-im			Effects of Exposure to Ozone on the Ocular Surface in an Experimental Model of Allergic Conjunctivitis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MANGANOUS SUPEROXIDE-DISMUTASE; AIRWAY HYPERRESPONSIVENESS; INFLAMMATORY RESPONSE; IL-1-ALPHA; LUNG; APOPTOSIS; CELLS	Based on previous findings that ozone can induce an inflammatory response in the ocular surface of an animal model and in cultured human conjunctival epithelial cells, we investigated whether exposure to ozone exacerbates symptoms of allergic conjunctivitis. We evaluated the effects of exposure to ozone on conjunctival chemosis, conjunctival injection, corneal and conjunctival fluorescein staining scores, production of inflammatory cytokines in tears, and aqueous tear production in a mouse model of allergic conjunctivitis. To validate our in vivo results, we used interleukin (IL)-1 alpha-pretreated conjunctival epithelial cells as an in vitro substitute for the mouse model. We evaluated whether exposure to ozone increased the inflammatory response and altered oxidative status and mitochondrial function in IL-1 alpha-pretreated conjunctival epithelial cells. In the in vivo study, ozone induced increases in conjunctival chemosis, conjunctival injection, corneal and conjunctival fluorescein staining scores, and production of inflammatory cytokines, accompanied by a decrease in tear volume. In the in vitro study, exposure to ozone led to additional increases in IL-6 and tumor necrosis factor-alpha mRNA levels, which were already induced by treatment with IL-1 alpha. Ozone did not induce any changes in cell viability. Pretreatment with IL-1 alpha increased the expression of manganese superoxide dismutase, and exposure to ozone led to additional increments in the expression of this antioxidant enzyme. Ozone did not induce any changes in mitochondrial activity or expression of mitochondrial enzymes and proteins related to mitochondrial function, with the exception of phosphor-mammalian target of rapamycin. Treatment with butylated hydroxyanisole, a free radical scavenger, attenuated the ozone-induced increases in IL-6 expression in IL-1 alpha-pretreated conjunctival epithelial cells. Therefore, we conclude that exposure to ozone exacerbates the detrimental effects on the integrity of the ocular surface caused by conjunctival allergic reactions, and further increases the inflammatory response in IL-1 alpha-pretreated conjunctival epithelial cells.	[Lee, Hun] Catholic Kwandong Univ, Coll Med, Int St Marys Hosp, Dept Ophthalmol, Inchon, South Korea; [Lee, Hun; Kim, Eung Kweon; Kim, Hee Young; Kim, Tae-im] Yonsei Univ, Inst Vis Res, Dept Ophthalmol, Coll Med, Seoul, South Korea; [Kim, Eung Kweon; Kim, Hee Young; Kim, Tae-im] Yonsei Univ, Corneal Dystrophy Res Inst, Dept Ophthalmol, Coll Med, Seoul, South Korea	Catholic Kwandong University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, TI (corresponding author), Yonsei Univ, Inst Vis Res, Dept Ophthalmol, Coll Med, Seoul, South Korea.; Kim, TI (corresponding author), Yonsei Univ, Corneal Dystrophy Res Inst, Dept Ophthalmol, Coll Med, Seoul, South Korea.	tikim@yuhs.ac		LEE, HUN/0000-0001-7225-6580; Kim, Tae-im/0000-0001-6414-3842; Kim, Eung Kweon/0000-0002-1453-8042	Basic Science Research Program through the National Research Foundation of Korea (NRF) - the Ministry of Education, Science and Technology [2013R1A1A2058907]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - the Ministry of Education, Science and Technology	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013R1A1A2058907). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman MM, 2015, J ALLERGY CLIN IMMUN, V136, P1099, DOI 10.1016/j.jaci.2015.03.035; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; BONINI S, 1988, J ALLERGY CLIN IMMUN, V82, P462, DOI 10.1016/0091-6749(88)90020-6; Bonnegarde-Bernard A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092307; Broide DH, 2001, J ALLERGY CLIN IMMUN, V108, pS65, DOI 10.1067/mai.2001.116436; Cai JM, 2008, NEUROSCI LETT, V441, P167, DOI 10.1016/j.neulet.2008.05.077; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chen H, 2008, EUR J PHARMACOL, V581, P306, DOI 10.1016/j.ejphar.2007.11.050; Cho HY, 2001, AM J PHYSIOL-LUNG C, V280, pL537, DOI 10.1152/ajplung.2001.280.3.L537; Chung SH, 2012, MOL VIS, V18, P1966; Dursun D, 2002, INVEST OPHTH VIS SCI, V43, P632; Eigenbrod T, 2008, J IMMUNOL, V181, P8194, DOI 10.4049/jimmunol.181.12.8194; Elkon KB, 2007, NAT MED, V13, P778, DOI 10.1038/nm0707-778; Estey T, 2007, EXP EYE RES, V84, P3, DOI 10.1016/j.exer.2006.04.010; Fievez L, 2001, FREE RADICAL BIO MED, V31, P633, DOI 10.1016/S0891-5849(01)00621-9; Fukuda K, 2009, J ALLERGY CLIN IMMUN, V124, P827, DOI 10.1016/j.jaci.2009.06.012; Fukushima A, 2006, BIOCHEM BIOPH RES CO, V339, P1048, DOI 10.1016/j.bbrc.2005.11.114; Hernandez M, 2012, J ALLERGY CLIN IMMUN, V129, P259, DOI 10.1016/j.jaci.2011.11.007; Hernandez ML, 2010, J ALLERGY CLIN IMMUN, V126, P537, DOI 10.1016/j.jaci.2010.06.043; Hwang SH, 2016, JAMA OPHTHALMOL; Johnston RA, 2005, AM J PHYSIOL-LUNG C, V288, pL390, DOI 10.1152/ajplung.00007.2004; Krautbauer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086866; Lee H, 2013, FREE RADICAL BIO MED, V63, P78, DOI 10.1016/j.freeradbiomed.2013.05.006; Lemp Michael A., 1995, CLAO Journal, V21, P221; Manzer R, 2008, AM J RESP CELL MOL, V38, P318, DOI 10.1165/rcmb.2007-0250OC; Metz DP, 1997, J ALLERGY CLIN IMMUN, V100, P817, DOI 10.1016/S0091-6749(97)70279-3; Mudway I. S., 2000, Molecular Aspects of Medicine, V21, P1, DOI 10.1016/S0098-2997(00)00003-0; MUSTAFA MG, 1990, FREE RADICAL BIO MED, V9, P245, DOI 10.1016/0891-5849(90)90035-H; NOGAE C, 1995, J MOL CELL CARDIOL, V27, P2091, DOI 10.1016/S0022-2828(95)91155-3; Onal O, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/792016; Paananen RO, 2015, INVEST OPHTH VIS SCI, V56, P8054, DOI 10.1167/iovs.15-18398; Park JW, 2004, AM J RESP CELL MOL, V30, P830, DOI 10.1165/rcmb.2003-0373OC; PEDEN DB, 1995, AM J RESP CRIT CARE, V151, P1336, DOI 10.1164/ajrccm.151.5.7735583; Scarpa M, 2015, AM J PATHOL, V185, P1624, DOI 10.1016/j.ajpath.2015.02.018; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Shore SA, 2001, AM J RESP CRIT CARE, V164, P602, DOI 10.1164/ajrccm.164.4.2001016; Suwara MI, 2014, MUCOSAL IMMUNOL, V7, P684, DOI 10.1038/mi.2013.87; UPPU RM, 1995, ARCH BIOCHEM BIOPHYS, V319, P257, DOI 10.1006/abbi.1995.1290; Valacchi G, 2002, TOXICOLOGY, V179, P163, DOI 10.1016/S0300-483X(02)00240-8; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; Wu ZX, 2008, RESP PHYSIOL NEUROBI, V164, P300, DOI 10.1016/j.resp.2008.07.019	42	20	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169209	10.1371/journal.pone.0169209	http://dx.doi.org/10.1371/journal.pone.0169209			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046113	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300142
J	Mizuno, M; Suzuki, Y; Higashide, K; Sei, Y; Iguchi, D; Sakata, F; Horie, M; Maruyama, S; Matsuo, S; Morgan, BP; Ito, Y				Mizuno, Masashi; Suzuki, Yasuhiro; Higashide, Keiko; Sei, Yumi; Iguchi, Daiki; Sakata, Fumiko; Horie, Masanobu; Maruyama, Shoichi; Matsuo, Seiichi; Morgan, B. Paul; Ito, Yasuhiko			High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients	PLOS ONE			English	Article							MESOTHELIAL CELLS; REGULATORS; ACTIVATION; THERAPY; MODEL; STILL; CD59	Background We searched for indicators to predict the prognosis of infectious peritonitis by measuring levels of complement proteins and activation products in peritoneal dialysis (PD) fluid (PDF) of patients at early stages of peritonitis. We retrospectively analyzed the relationship between the levels of sC5b-9, C3 and C4 in PDF and the subsequent clinical prognosis. Methods We measured levels of sC5b-9, C3 and C4 in PDF on days 1, 2 and 5 post-onset of peritonitis in 104 episodes of infectious peritonitis in PD patients from 2008 and retrospectively compared levels with clinical outcomes. Further analysis for the presence of causative microorganisms or to demonstrate bacterial culture negative peritonitis was performed and correlated with change of levels of sC5b-9 in PDF. Results When PD patients with peritonitis were divided into groups that either failed to recover from peritonitis and were finally withdrawn from PD (group 1; n = 25) or recovered (group 2; n = 79), levels of sC5b-9, C3 and C4 in PDF were significantly higher in group 1 patients compared to those in group 2 on day5. Analysis of microorganisms showed significantly higher sC5b-9 levels in PDF of peritonitis cases caused by culture negative peritonitis in group 1 compared with group 2 when we analyzed for individual microorganisms. Of note, on day5, the sC5b- 9 levels in PDF were similarly high in peritonitis caused by fungi or other organisms. Conclusion Our results suggested that levels of complement markers in PDF, especially sC5b- 9, have potential as surrogate markers to predict prognosis of PD-related peritonitis.	[Mizuno, Masashi; Ito, Yasuhiko] Nagoya Univ, Grad Sch Med, Renal Replacement Therapy, Nagoya, Aichi, Japan; [Mizuno, Masashi; Suzuki, Yasuhiro; Higashide, Keiko; Sei, Yumi; Iguchi, Daiki; Sakata, Fumiko; Maruyama, Shoichi; Matsuo, Seiichi; Ito, Yasuhiko] Nagoya Univ, Grad Sch Med, Div Nephrol, Nagoya, Aichi, Japan; [Horie, Masanobu] Daiyukai Daiichi Hosp, Ichinomiya, Japan; [Morgan, B. Paul] Cardiff Univ, Sch Med, Div Infect & Immun, Complement Biol Grp, Cardiff, S Glam, Wales	Nagoya University; Nagoya University; Cardiff University	Mizuno, M (corresponding author), Nagoya Univ, Grad Sch Med, Renal Replacement Therapy, Nagoya, Aichi, Japan.; Mizuno, M (corresponding author), Nagoya Univ, Grad Sch Med, Div Nephrol, Nagoya, Aichi, Japan.	masashim1jp@yahoo.co.jp	Mizuno, Masashi/I-7347-2014	Morgan, Paul/0000-0003-4075-7676	Ministry of Education, Culture, Sports, Science and Technology in Japan [24591227, 15K09288]; Japanese association for complement research; Japanese association of dialysis physician (JADP) [2012-07, 2014-03]; Ministry of Health, Labour and Welfare of Japan; Great Britain Sasakawa Foundation [B90]; Medical Research Council [MC_PC_13060] Funding Source: researchfish; MRC [MC_PC_13060] Funding Source: UKRI	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese association for complement research; Japanese association of dialysis physician (JADP); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Great Britain Sasakawa Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was in part supported in part by the Ministry of Education, Culture, Sports, Science and Technology in Japan Grants-in-Aid 24591227 and 15K09288 for Scientific Research, by a research grant of the Japanese association for complement research, by the research grants from Japanese association of dialysis physician (JADP Grants 2012-07 and 2014-03), by a Ministry of Health, Labour and Welfare of Japan grant-in-aid for Progressive Renal Diseases Research, Research on Rare and Intractable Disease, and by the Great Britain Sasakawa Foundation 2015 Butterfield Award for UK-Japan collaboration in Medicine & Health to Mizuno M and Morgan BP (No. B90). Mizuno M, Suzuki Y and Ito Y worked in the Department of Renal Replacement Therapy as positions endowed by Baxter Japan at Nagoya University Graduate School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunke M, 1994, Adv Perit Dial, V10, P174; Choi P, 2004, AM J KIDNEY DIS, V43, P103, DOI 10.1053/j.ajkd.2003.08.046; Chow KM, 2006, CLIN J AM SOC NEPHRO, V1, P768, DOI 10.2215/CJN.01010306; Davenport A, 2009, PERITON DIALYSIS INT, V29, P297; Kubota K, 2013, MICROBES ENVIRON, V28, P3, DOI 10.1264/jsme2.ME12107; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; Lin CY, 2013, J AM SOC NEPHROL; Mactier R, 2009, PERITON DIALYSIS INT, V29, P262; Mizuno M, 2006, CURR MED CHEM, V13, P1707, DOI 10.2174/092986706777441959; Mizuno M., 2004, CURR DRUG TARGETS IN, V3, P85; Mizuno M, 2012, AM J PHYSIOL-RENAL, V302, pF1245, DOI 10.1152/ajprenal.00652.2011; Mizuno M, 2011, CLIN EXP NEPHROL, V15, P727, DOI 10.1007/s10157-011-0471-8; Mizuno M, 2009, J IMMUNOL, V183, P1403, DOI 10.4049/jimmunol.0804245; Mizuno T, 2011, NEPHROL DIAL TRANSPL, V26, P1821, DOI 10.1093/ndt/gfq683; Mizutani M, 2010, AM J PHYSIOL-RENAL, V298, pF721, DOI 10.1152/ajprenal.00368.2009; Mujais S, 2006, KIDNEY INT, V70, pS55, DOI 10.1038/sj.ki.5001916; Sei Y, 2015, MOL IMMUNOL, V65, P302, DOI 10.1016/j.molimm.2015.02.005; Tang S, 2004, CLIN EXP IMMUNOL, V136, P85, DOI 10.1111/j.1365-2249.2004.02407.x; Xu R, 2013, PERITON DIALYSIS INT, V33, P436, DOI 10.3747/pdi.2012.00163; YOUNG GA, 1993, NEPHROL DIAL TRANSPL, V8, P1372; Zweers MM, 1999, J LAB CLIN MED, V134, P124, DOI 10.1016/S0022-2143(99)90116-6	21	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169111	10.1371/journal.pone.0169111	http://dx.doi.org/10.1371/journal.pone.0169111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046064	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000391612300115
J	Torres, LG; Orben, RA; Tolkova, I; Thompson, DR				Torres, Leigh G.; Orben, Rachael A.; Tolkova, Irina; Thompson, David R.			Classification of Animal Movement Behavior through Residence in Space and Time	PLOS ONE			English	Article							AREA-RESTRICTED SEARCH; ECOLOGY; TORTUOSITY; SELECTION; SCALE; PATH	Identification and classification of behavior states in animal movement data can be complex, temporally biased, time-intensive, scale-dependent, and unstandardized across studies and taxa. Large movement datasets are increasingly common and there is a need for efficient methods of data exploration that adjust to the individual variability of each track. We present the Residence in Space and Time (RST) method to classify behavior patterns in movement data based on the concept that behavior states can be partitioned by the amount of space and time occupied in an area of constant scale. Using normalized values of Residence Time and Residence Distance within a constant search radius, RST is able to differentiate behavior patterns that are time-intensive (e.g., rest), time & distance-intensive (e.g., area restricted search), and transit (short time and distance). We use grey-headed albatross (Thalassarche chrysostoma) GPS tracks to demonstrate RST's ability to classify behavior patterns and adjust to the inherent scale and individuality of each track. Next, we evaluate RST's ability to discriminate between behavior states relative to other classical movement metrics. We then temporally sub-sample albatross track data to illustrate RST's response to less resolved data. Finally, we evaluate RST's performance using datasets from four taxa with diverse ecology, functional scales, ecosystems, and data-types. We conclude that RST is a robust, rapid, and flexible method for detailed exploratory analysis and meta-analyses of behavioral states in animal movement data based on its ability to integrate distance and time measurements into one descriptive metric of behavior groupings. Given the increasing amount of animal movement data collected, it is timely and useful to implement a consistent metric of behavior classification to enable efficient and comparative analyses. Overall, the application of RST to objectively explore and compare behavior patterns in movement data can enhance our fine-and broad-scale understanding of animal movement ecology.	[Torres, Leigh G.; Orben, Rachael A.] Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Dept Fisheries & Wildlife, Newport, OR 97365 USA; [Tolkova, Irina] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Tolkova, Irina] Univ Washington, Dept Comp Sci, Seattle, WA 98195 USA; [Thompson, David R.] Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand	Oregon State University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Torres, LG (corresponding author), Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Dept Fisheries & Wildlife, Newport, OR 97365 USA.	Lagh.Torres@oregonstata.edu	Orben, Rachael A./H-9460-2019	Orben, Rachael A./0000-0002-0802-407X	New Zealand's Ministry for Business, Innovation and Employment [C01X0905]; National Science Foundation (NSF) REU Site program [NSF OCE-1263349]; National Geographic Society Waitt Grant [W157-11]; NSF; National Institutes of Health Ecology of Infectious Disease program [DEB-0090323]; Max Plank Institute of Ornithology; NSF [1258062]; Galapagos Conservation Trust; Swiss Friends of Galapagos; e-obs GmbH; Galapagos National Park; Charles Darwin Foundation; Tagging of Pacific Pelagics (TOPP) program of the Census of Marine Life, the Office of Naval Research [9610608, 0010085, 0310861]; National Science Foundation; Alfred P. Sloan Foundation; Moore Foundation; Packard Foundation; National Geographic Society; National Institute of Water and Atmospheric Research, Ltd. (NIWA)	New Zealand's Ministry for Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); National Science Foundation (NSF) REU Site program(National Science Foundation (NSF)); National Geographic Society Waitt Grant(National Geographic Society); NSF(National Science Foundation (NSF)); National Institutes of Health Ecology of Infectious Disease program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Plank Institute of Ornithology; NSF(National Science Foundation (NSF)); Galapagos Conservation Trust; Swiss Friends of Galapagos; e-obs GmbH; Galapagos National Park; Charles Darwin Foundation; Tagging of Pacific Pelagics (TOPP) program of the Census of Marine Life, the Office of Naval Research; National Science Foundation(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Moore Foundation(Gordon and Betty Moore Foundation); Packard Foundation(The David & Lucile Packard Foundation); National Geographic Society(National Geographic Society); National Institute of Water and Atmospheric Research, Ltd. (NIWA)	Funding was provided by New Zealand's Ministry for Business, Innovation and Employment for albatross data collection (C01X0905). The National Science Foundation (NSF) REU Site program (NSF OCE-1263349) supported IT. Funding for collection of the fisher tracking data was provided by National Geographic Society Waitt Grant #W157-11; the African buffalo data collection was supported by NSF and National Institutes of Health Ecology of Infectious Disease program DEB-0090323; collection of the Galapagos tortoise track was funded by the Max Plank Institute of Ornithology, NSF (1258062), The Galapagos Conservation Trust, Swiss Friends of Galapagos, and e-obs GmbH, Galapagos National Park, and The Charles Darwin Foundation; The blue whale research was conducted under U.S. National Marine Fisheries Service permit No. 369-1757 authorizing the close approach and deployment of implantable satellite tags on large whales, issued to Dr. Bruce Mate. Support was provided by the Tagging of Pacific Pelagics (TOPP) program of the Census of Marine Life, the Office of Naval Research (Grants 9610608, 0010085 and 0310861), the National Science Foundation, the Alfred P. Sloan Foundation, the Moore Foundation, the Packard Foundation, the National Geographic Society, and private donors to the Oregon State University Endowed Marine Mammal Institute. The National Institute of Water and Atmospheric Research, Ltd. (NIWA) provided support in the form of salaries for authors LGT and DRT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], [No title captured]; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bailleul F, 2010, ECOL MODEL, V221, P1665, DOI 10.1016/j.ecolmodel.2010.04.001; Bar-David S, 2009, ECOLOGY, V90, P2467, DOI 10.1890/08-1532.1; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014592; Berman GJ, 2014, J R SOC INTERFACE, P11; Blackwell PG, 2016, METHODS ECOL EVOL, V7, P184, DOI 10.1111/2041-210X.12460; Blake S, 2013, J ANIM ECOL, V82, P310, DOI 10.1111/1365-2656.12020; Cross P, 2016, MOVEBANK DATA REPOSI; Dean B, 2012, J R SOC INTERFACE; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Garriga J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151984; Gurarie E, 2016, J ANIM ECOL, V85, P69, DOI 10.1111/1365-2656.12379; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103; Irvine LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102959; Jonsen I, 2016, SCI REP-UK, V6, DOI 10.1038/srep20625; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kahle D, 2013, R J, V5, P144; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; LaPoint S, 2013, MOVEBANK DATA REPOSI; LaPoint S, 2013, LANDSCAPE ECOL, V28, P1615, DOI 10.1007/s10980-013-9910-0; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Liu XF, 2015, J THEOR BIOL, V364, P197, DOI 10.1016/j.jtbi.2014.09.025; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Pedersen MW, 2011, OIKOS, V120, P1281, DOI 10.1111/j.1600-0706.2011.19044.x; Phalan B, 2007, MAR ECOL PROG SER, V340, P271, DOI 10.3354/meps340271; Postlethwaite CM, 2013, J THEOR BIOL, V317, P175, DOI 10.1016/j.jtbi.2012.10.007; Sur M, 2014, ECOL INFORM, V20, P47, DOI 10.1016/j.ecoinf.2014.01.007; Thiebault A, 2013, BEHAV ECOL SOCIOBIOL, V67, P1013, DOI 10.1007/s00265-013-1546-1; Torres LG, 2011, MAR ECOL PROG SER, V428, P289, DOI 10.3354/meps09068; Wakefield ED, 2009, ECOL MONOGR, V79, P663, DOI 10.1890/07-2111.1; Weimerskirch H, 2016, SCIENCE, V353, P74, DOI 10.1126/science.aaf4374; Wilson RR, 2012, WILDLIFE BIOL, V18, P424, DOI 10.2981/12-044	36	29	29	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168513	10.1371/journal.pone.0168513	http://dx.doi.org/10.1371/journal.pone.0168513			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045906	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300027
J	Wang, JC; Liu, LB; Wang, JF; Sun, XX; Yuan, WZ				Wang, Jianchang; Liu, Libing; Wang, Jinfeng; Sun, Xiaoxia; Yuan, Wanzhe			Recombinase Polymerase Amplification Assay-A Simple, Fast and Cost-Effective Alternative to Real Time PCR for Specific Detection of Feline Herpesvirus-1	PLOS ONE			English	Article							FELINE HERPESVIRUS-1 INFECTIONS; CHAIN-REACTION; RESPIRATORY-TRACT; OCULAR DISEASE; CATS; SENSITIVITY; DIAGNOSIS; DNA	Feline herpesvirus 1 (FHV-1), an enveloped dsDNA virus, is one of the major pathogens of feline upper respiratory tract disease (URTD) and ocular disease. Currently, polymerase chain reaction (PCR) remains the gold standard diagnostic tool for FHV-1 infection but is relatively expensive, requires well-equipped laboratories and is not suitable for field tests. Recombinase polymerase amplification (RPA), an isothermal gene amplification technology, has been explored for the molecular diagnosis of infectious diseases. In this study, an exo-RPA assay for FHV-1 detection was developed and validated. Primers targeting specifically the thymidine kinase (TK) gene of FHV-1 were designed. The RPA reaction was performed successfully at 39 degrees C and the results were obtained within 20 min. Using different copy numbers of recombinant plasmid DNA that contains the TK gene as template, we showed the detection limit of exo-RPA was 102 copies DNA/reaction, the same as that of real time PCR. The exo-RPA assay did not cross-detect feline panleukopenia virus, feline calicivirus, bovine herpesvirus-1, pseudorabies virus or chlamydia psittaci, a panel of pathogens important in feline URTD or other viruses in Alphaherpesvirinae, demonstrating high specificity. The assay was validated by testing 120 nasal and ocular conjunctival swabs of cats, and the results were compared with those obtained with real-time PCR. Both assays provided the same testing results in the clinical samples. Compared with real time PCR, the exo-RPA assay uses less-complex equipment that is portable and the reaction is completed much faster. Additionally, commercial RPA reagents in vacuum-sealed pouches can tolerate temperatures up to room temperature for days without loss of activity, suitable for shipment and storage for field tests. Taken together, the exo-RPA assay is a simple, fast and cost-effective alternative to real time PCR, suitable for use in less advanced laboratories and for field detection of FHV-1 infection.	[Wang, Jianchang; Liu, Libing; Wang, Jinfeng; Sun, Xiaoxia] Hebei Entry Exit Inspect & Quarantine Bur, Inspect & Quarantine Tech Ctr, Shijiazhuang, Hebei, Peoples R China; [Yuan, Wanzhe] Agr Univ Hebei, Coll Vet Med, Baoding, Hebei, Peoples R China	Hebei Agricultural University	Yuan, WZ (corresponding author), Agr Univ Hebei, Coll Vet Med, Baoding, Hebei, Peoples R China.	yuanwanzhe2015@126.com			Science and Technology Project Foundation of Animal Husbandry Bureau, Hebei, China [2014-3-03]	Science and Technology Project Foundation of Animal Husbandry Bureau, Hebei, China	Support for this study was provided by the Science and Technology Project Foundation of Animal Husbandry Bureau, Hebei, China (grant number 2014-3-03). The funding agency had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Abd El Wahed A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129682; Abd El Wahed A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071642, 10.1371/currents.outbreaks.62df1c7c75ffc96cd59034531e2e8364]; Amer HM, 2013, J VIROL METHODS, V193, P337, DOI 10.1016/j.jviromet.2013.06.027; Binns S H, 2000, J Feline Med Surg, V2, P123, DOI 10.1053/jfms.2000.0084; Boyle DS, 2013, MBIO, V4, DOI 10.1128/mBio.00135-13; Fernandez M., 2016, J FELINE MED SURG; Gaskell R, 2007, VET RES, V38, P337, DOI 10.1051/vetres:2006063; Helps CR, 2005, VET REC, V156, P669, DOI 10.1136/vr.156.21.669; Maggs DJ, 1999, J AM VET MED ASSOC, V214, P502; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; REUBEL GH, 1993, ARCH VIROL, V132, P409, DOI 10.1007/BF01309549; Sandmeyer LS, 2010, CAN VET J, V51, P629; Sykes JE, 1997, ARCH VIROL, V142, P65, DOI 10.1007/s007050050059; Townsend WM, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-185; Vogtlin A, 2002, J CLIN MICROBIOL, V40, P519, DOI 10.1128/JCM.40.2.519-523.2002; Wang JC, 2016, ARCH VIROL, V161, P1015, DOI 10.1007/s00705-015-2738-y; Weigler BJ, 1997, VET REC, V140, P335, DOI 10.1136/vr.140.13.335; Whiley DM, 2006, J CLIN VIROL, V35, P81, DOI 10.1016/j.jcv.2005.05.002; Zhang FM, 2008, AVIAN DIS, V52, P74, DOI 10.1637/8019-051207-Reg; Zicola A, 2009, J FELINE MED SURG, V11, P1023, DOI 10.1016/j.jfms.2009.05.023	20	20	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0166903	10.1371/journal.pone.0166903	http://dx.doi.org/10.1371/journal.pone.0166903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045956	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300006
J	Wang, J; Wang, YJ; Gao, CJ; Jiang, LW; Guo, DJ				Wang, Jue; Wang, Yejun; Gao, Caiji; Jiang, Liwen; Guo, Dianjing			PPero, a Computational Model for Plant PTS1 Type Peroxisomal Protein Prediction	PLOS ONE			English	Article							TARGETING SIGNAL-1; RECOGNITION; TRIPEPTIDE; EXPRESSION; PEX5	Well-defined motifs often make it easy to investigate protein function and localization. In plants, peroxisomal proteins are guided to peroxisomes mainly by a conserved type 1 (PTS1) or type 2 (PTS2) targeting signal, and the PTS1 motif is commonly used for peroxisome targeting protein prediction. Currently computational prediction of peroxisome targeted PTS1-type proteins are mostly based on the 3 amino acids PTS1 motif and the adjacent sequence which is less than 14 amino acid residue in length. The potential contribution of the adjacent sequences beyond this short region has never been well investigated in plants. In this work, we develop a bi-profile Bayesian SVM method to extract and learn position-based amino acid features for both PTS1 motifs and their extended adjacent sequences in plants. Our proposed model outperformed other implementations with similar applications and achieved the highest accuracy of 93.6% and 92.6% for Arabidosis and other plant species respectively. A large scale analysis for Arabidopsis, Rice, Maize, Potato, Wheat, and Soybean proteome was conducted using the proposed model and a batch of candidate PTS1 proteins were predicted. The DNA segments corresponding to the C-terminal sequences of 9 selected candidates were cloned and transformed into Arabidopsis for experimental validation, and 5 of them demonstrated peroxisome targeting.	[Wang, Jue; Gao, Caiji; Jiang, Liwen; Guo, Dianjing] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Jue; Gao, Caiji; Jiang, Liwen; Guo, Dianjing] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China; [Wang, Yejun] Shenzhen Univ, Hlth Sci Ctr, Dept Med Genet, Shenzhen, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Shenzhen University	Guo, DJ (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China.; Guo, DJ (corresponding author), Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China.	diguo@cuhk.edu.hk	JIANG, Liwen/S-6046-2018	JIANG, Liwen/0000-0002-7829-1472	Shenzhen Science and Technology Committee [JCYJ20140425184428456]; Hong Kong Research Grand Council [CUHK3/CRF/11G]	Shenzhen Science and Technology Committee; Hong Kong Research Grand Council	This work is supported by a grant from Shenzhen Science and Technology Committee (grant no. JCYJ20140425184428456), and partially by a grant from Hong Kong Research Grand Council (project no. CUHK3/CRF/11G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berardini TZ, 2015, GENESIS, V53, P474, DOI 10.1002/dvg.22877; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Emanuelsson O, 2003, J MOL BIOL, V330, P443, DOI 10.1016/S0022-2836(03)00553-9; Fodor K, 2015, TRAFFIC, V16, P85, DOI 10.1111/tra.12238; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Graham IA, 2002, PROG LIPID RES, V41, P156, DOI 10.1016/S0163-7827(01)00022-4; Joachims T, 1999, SVMLIGHT SUPPORT VEC, V19; Kamada T, 2003, PLANT CELL PHYSIOL, V44, P1275, DOI 10.1093/pcp/pcg173; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Neuberger G, 2003, J MOL BIOL, V328, P567, DOI 10.1016/S0022-2836(03)00318-8; Quan S, 2013, PLANT PHYSIOL, V163, P1518, DOI 10.1104/pp.113.223453; Reumann S, 2016, BBA-MOL CELL RES, V1863, P790, DOI 10.1016/j.bbamcr.2016.01.001; Reumann S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00194; Sampathkumar P, 2008, J MOL BIOL, V381, P867, DOI 10.1016/j.jmb.2008.05.089; Schluter A, 2007, NUCLEIC ACIDS RES, V35, pD815, DOI 10.1093/nar/gkl935; Shao JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004920; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Stanley WA, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-24	22	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168912	10.1371/journal.pone.0168912	http://dx.doi.org/10.1371/journal.pone.0168912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045983	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300069
J	Yang, LJ; Zhang, LL; Yu, CX; Li, DP; Gong, P; Xue, Y; Song, YC; Cui, YL; Doane, TA; Wu, ZJ				Yang, Lijie; Zhang, Lili; Yu, Chunxiao; Li, Dongpo; Gong, Ping; Xue, Yan; Song, Yuchao; Cui, Yalan; Doane, Timothy A.; Wu, Zhijie			Nitrogen Fertilizer and Straw Applications Affect Uptake of C-13,N-15-Glycine by Soil Microorganisms in Wheat Growth Stages	PLOS ONE			English	Article							AMINO-ACID UTILIZATION; MICROBIAL DECOMPOSITION; MASS-SPECTROMETRY; ORGANIC NITROGEN; ISOTOPE ANALYSIS; N UPTAKE; CARBON; MINERALIZATION; PLANTS; LEUCINE	This study investigated the influence of nitrogen (N) fertilizer and straw on intact amino acid N uptake by soil microorganisms and the relationship between amino acid turnover and soil properties during the wheat growing season. A wheat pot experiment was carried out with three treatments: control (CK), N fertilizer (NF) and N fertilizer plus rice straw (NS). We used stable isotope compound-specific analysis to determine the uptake of C-13, N-15-glycine by soil microorganisms. In the NF treatment, microbial C-13, N-15-glycine uptake was lower compared with CK, suggesting that inorganic N was the preferred N source for soil microorganisms. However, The application of straw with N fertilizer (in NS treatment) increased microbial C-13, N-15-glycine uptake even with the same amount of N fertilizer application. In this treatment, enzyme activities, soil microbial biomass C and microbial biomass N increased simultaneously because more C was available. Soil mineral N and plant N contents all decreased substantially. The increased uptake of intact C-13, N-15-glycine in the NS treatment can be attributed to direct assimilation by soil microorganisms to satisfy the demand for N when inorganic N was consumed.	[Yang, Lijie; Zhang, Lili; Yu, Chunxiao; Li, Dongpo; Gong, Ping; Xue, Yan; Song, Yuchao; Cui, Yalan; Wu, Zhijie] Chinese Acad Sci, Inst Appl Ecol, Natl Nutr & Engn Lab, Shenyang, Liaoning, Peoples R China; [Yu, Chunxiao; Cui, Yalan] Univ Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Doane, Timothy A.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Davis	Zhang, LL; Wu, ZJ (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Natl Nutr & Engn Lab, Shenyang, Liaoning, Peoples R China.	llzhang@iae.ac.cn; wuzj@iae.ac.cn			State Key Program of China [2016YFD0300904]; National Scientific Foundation Project of China [41571290]; National Science & Technology Pillar Program [2012BAD14B02, 2015BAD05B03]	State Key Program of China(State Key Development Program for Basic Research of China); National Scientific Foundation Project of China; National Science & Technology Pillar Program	This work was financially supported by the State Key Program of China (2016YFD0300904), a grant to Lili Zhang, who designed the experiment, from the National Scientific Foundation Project of China (41571290) and the National Science & Technology Pillar Program (2012BAD14B02; 2015BAD05B03). We are grateful to the National Field Research Station of Shenyang Agro-ecosystems, Chinese Academy of Sciences, for providing the experimental field.; This work was supported by the State Key Program of China (2016YFD0300904), National Scientific Foundation Project of China (41571290) and the National Science & Technology Pillar Program (2012BAD14B02; 2015BAD05B03). We are grateful to the National Field Research Station of Shenyang Agro-ecosystems, Chinese Academy of Sciences, for providing the experimental field.	Allison SD, 2014, SOIL BIOL BIOCHEM, V79, P43, DOI 10.1016/j.soilbio.2014.08.021; An TT, 2015, BIOL FERT SOILS, V51, P605, DOI 10.1007/s00374-015-1006-3; BAATH E, 1994, BIOL FERT SOILS, V17, P147, DOI 10.1007/BF00337747; Barraclough D, 1997, SOIL BIOL BIOCHEM, V29, P101, DOI 10.1016/S0038-0717(96)00241-6; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Cayuela ML, 2009, APPL SOIL ECOL, V41, P118, DOI 10.1016/j.apsoil.2008.10.001; Choudhury ATMA, 2005, COMMUN SOIL SCI PLAN, V36, P1625, DOI 10.1081/CSS-200059104; Clemmensen KE, 2008, OECOLOGIA, V155, P771, DOI 10.1007/s00442-008-0962-9; Farrell M, 2013, ECOSYSTEMS, V16, P133, DOI 10.1007/s10021-012-9601-8; Geisseler D, 2014, SOIL BIOL BIOCHEM, V74, P100, DOI 10.1016/j.soilbio.2014.02.024; Geisseler D, 2012, EUR J SOIL BIOL, V53, P107, DOI 10.1016/j.ejsobi.2012.09.006; Geisseler D, 2009, SOIL BIOL BIOCHEM, V41, P1281, DOI 10.1016/j.soilbio.2009.03.014; Goyal S, 1999, BIOL FERT SOILS, V29, P196, DOI 10.1007/s003740050544; Hadas A, 2004, SOIL BIOL BIOCHEM, V36, P255, DOI 10.1016/j.soilbio.2003.09.012; Harrison KA, 2007, ECOLOGY, V88, P989, DOI 10.1890/06-1018; Jan MT, 2009, SOIL BIOL BIOCHEM, V41, P2272, DOI 10.1016/j.soilbio.2009.08.013; Jansson SL, 1958, TRACER STUDIES NITRO; Jones DL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003250; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; Khalil MI, 2005, SOIL BIOL BIOCHEM, V37, P1507, DOI 10.1016/j.soilbio.2005.01.014; Kielland K, 2007, ECOSYSTEMS, V10, P360, DOI 10.1007/s10021-007-9037-8; Klute A., 1986, METHODS SOIL ANAL 1; Knowles TDJ, 2010, ORG GEOCHEM, V41, P1259, DOI 10.1016/j.orggeochem.2010.09.003; Kuzyakov Y, 2000, J PLANT NUTR SOIL SC, V163, P421, DOI 10.1002/1522-2624(200008)163:4<421::AID-JPLN421>3.0.CO;2-R; Kuzyakov Y, 2013, NEW PHYTOL, V198, P656, DOI 10.1111/nph.12235; LADD J N, 1972, Soil Biology and Biochemistry, V4, P19, DOI 10.1016/0038-0717(72)90038-7; Marx MC, 2001, SOIL BIOL BIOCHEM, V33, P1633, DOI 10.1016/S0038-0717(01)00079-7; MARY B, 1993, SOIL BIOL BIOCHEM, V25, P1005, DOI 10.1016/0038-0717(93)90147-4; Nannipieri P, 2009, SOIL BIOL BIOCHEM, V41, P2357, DOI 10.1016/j.soilbio.2009.07.013; Nasholm T, 2001, NEW PHYTOL, V150, P59, DOI 10.1046/j.1469-8137.2001.00072.x; Nasholm T, 1998, NATURE, V392, P914, DOI 10.1038/31921; Nguyen C, 2003, AGRONOMIE, V23, P375, DOI 10.1051/agro:2003011; Norlin E, 2007, SOIL BIOL BIOCHEM, V39, P550, DOI 10.1016/j.soilbio.2006.09.001; O'Dowd RW, 1999, SOIL BIOL BIOCHEM, V31, P1573, DOI 10.1016/S0038-0717(99)00083-8; Olk DC, 2008, SOIL SCI SOC AM J, V72, P1672, DOI 10.2136/sssaj2007.0406; Pansu M, 2014, BIOGEOSCIENCES, V11, P915, DOI 10.5194/bg-11-915-2014; Perez PG, 2015, J SOIL SEDIMENT, V15, P890, DOI 10.1007/s11368-014-1049-3; Emeterio LS, 2014, EUR J SOIL SCI, V65, P377, DOI 10.1111/ejss.12133; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Smart KF, 2010, NAT PROTOC, V5, P1709, DOI 10.1038/nprot.2010.108; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wanek W, 2010, SOIL BIOL BIOCHEM, V42, P1293, DOI 10.1016/j.soilbio.2010.04.001; Wei LL, 2013, BIOL FERT SOILS, V49, P1247, DOI 10.1007/s00374-013-0818-2; Wild B, 2014, SOIL BIOL BIOCHEM, V75, P143, DOI 10.1016/j.soilbio.2014.04.014; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	46	8	10	6	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169016	10.1371/journal.pone.0169016	http://dx.doi.org/10.1371/journal.pone.0169016			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045989	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300090
J	Zhang, YL; Han, DH; Kim, DY; Lee, CH; Rhee, CS				Zhang, Yu-Lian; Han, Doo Hee; Kim, Dong-Young; Lee, Chul Hee; Rhee, Chae-Seo			Role of Interleukin-1 7A on the Chemotactic Responses to CCL7 in a Murine Allergic Rhinitis Model	PLOS ONE			English	Article							TH17 CELLS; INFLAMMATION; CHEMOKINES; EXPRESSION; RECEPTORS; PROTEIN-3; ASTHMA; IL-17; EOSINOPHILS; EOTAXIN	Background The proinflammatory cytokine interleukin (IL)-17A is associated with eosinophil infiltration into the nasal mucosa in a mouse model of ovalbumin-induced allergic rhinitis. Chemotaxis of eosinophils is mediated primarily through C-C chemokine receptor type 3 (CCR3). However, the mechanism underlying the IL-17A-mediated enhancement of eosinophil recruitment via chemoattractants/chemokines remains unknown. Objectives In this study, we assessed the contribution of IL-17A to eosinophil-related inflammation via the CCL7/CCR3 pathway in experimental allergic rhinitis. Methods IL-17A knockout (KO) and wild-type (WT) BALB/c mice were injected intraperitoneally and challenged intranasally with OVA to induce allergic rhinitis. Various parameters of the allergic response were evaluated, and mRNA and protein levels of CCL7 and CCR3 in nasal tissue and serum were compared between the two groups. The chemotactic response to CCL7 with or without IL-17A in bone marrow-derived eosinophils (bmEos) from BALB/c mice was measured. Results In the allergic rhinitis model, IL-17A deficiency significantly decreased nasal symptoms, serum IgE levels, and eosinophil recruitment to the nasal mucosa. CCL7 and CCR3 mRNA and protein levels were decreased in the nasal mucosa of IL-17A KO mice compared with the WT mice. BmEos showed a significantly increased chemotactic response to-low concentration of CCL7 in the presence of IL-17A compared with its absence. Conclusion The suppression of nasal inflammation due of IL-17A deficiency in allergic rhinitis is partly responsible for the regulation of CCL7 secretion and eosinophil infiltration, which may be regulated via the CCL7/CCR3 pathway.	[Zhang, Yu-Lian; Han, Doo Hee; Kim, Dong-Young; Lee, Chul Hee; Rhee, Chae-Seo] Seoul Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Zhang, Yu-Lian; Lee, Chul Hee; Rhee, Chae-Seo] Res Ctr Sensory Organs, Seoul, South Korea; [Zhang, Yu-Lian; Lee, Chul Hee; Rhee, Chae-Seo] Inst Allergy, Seoul, South Korea; [Lee, Chul Hee; Rhee, Chae-Seo] Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, Gyeonggido, South Korea; [Rhee, Chae-Seo] Seoul Natl Univ, Clin Immunol, Med Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Rhee, CS (corresponding author), Seoul Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea.; Rhee, CS (corresponding author), Res Ctr Sensory Organs, Seoul, South Korea.; Rhee, CS (corresponding author), Inst Allergy, Seoul, South Korea.; Rhee, CS (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, Gyeonggido, South Korea.; Rhee, CS (corresponding author), Seoul Natl Univ, Clin Immunol, Med Res Ctr, Seoul, South Korea.	csrhee@snu.ac.kr			Seoul National University Hospital Research Fund [04-2009-0380]; Seoul National University Bundang Hospital Research Fund [03-2013-012]	Seoul National University Hospital Research Fund; Seoul National University Bundang Hospital Research Fund	This research was supported by Grant No.04-2009-0380 from the Seoul National University Hospital Research Fund and Grant No.03-2013-012 from Seoul National University Bundang Hospital Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2005, J IMMUNOL, V175, P1257, DOI 10.4049/jimmunol.175.2.1257; Bochner BS, 2009, CLIN EXP ALLERGY, V39, P317, DOI 10.1111/j.1365-2222.2008.03173.x; Christodoulopoulos P, 1999, J ALLERGY CLIN IMMUN, V103, P1036, DOI 10.1016/S0091-6749(99)70176-4; Chung IY, 2004, BIOCHEM BIOPH RES CO, V314, P646, DOI 10.1016/j.bbrc.2003.12.134; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Farnesi-de-Assuncao TS, 2012, CELL IMMUNOL, V273, P23, DOI 10.1016/j.cellimm.2011.11.010; Guo CB, 2015, MOL IMMUNOL, V67, P436, DOI 10.1016/j.molimm.2015.07.009; Hammad H, 2006, J ALLERGY CLIN IMMUN, V118, P331, DOI 10.1016/j.jaci.2006.03.041; Humbert M, 1997, AM J RESP CELL MOL, V16, P1; Kawaguchi M, 2001, J ALLERGY CLIN IMMUN, V108, P804, DOI 10.1067/mai.2001.119027; Linden A, 2001, INT ARCH ALLERGY IMM, V126, P179, DOI 10.1159/000049511; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2007, J LEUKOCYTE BIOL, V81, P1258, DOI 10.1189/jlb.1006610; Oboki Keisuke, 2008, Allergol Int, V57, P121, DOI 10.2332/allergolint.R-07-160; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pease JE, 2006, J ALLERGY CLIN IMMUN, V118, P305, DOI 10.1016/j.jaci.2006.06.010; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Polentarutti N, 1997, EUR CYTOKINE NETW, V8, P271; Ponath PD, 1996, J EXP MED, V183, P2437, DOI 10.1084/jem.183.6.2437; Powell N, 1996, EUR RESPIR J, V9, P2454, DOI 10.1183/09031936.96.09122454; Quan SH, 2012, ANN ALLERG ASTHMA IM, V108, P342, DOI 10.1016/j.anai.2012.02.014; Saitoh T, 2010, INT ARCH ALLERGY IMM, V151, P8, DOI 10.1159/000232566; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Smit JJ, 2006, EUR J PHARMACOL, V533, P277, DOI 10.1016/j.ejphar.2005.12.064; Takatsu K, 2008, CURR OPIN IMMUNOL, V20, P288, DOI 10.1016/j.coi.2008.04.001; THIRION S, 1994, BIOCHEM BIOPH RES CO, V201, P493, DOI 10.1006/bbrc.1994.1729; Tran NP, 2011, ALLERGY ASTHMA IMMUN, V3, P148, DOI 10.4168/aair.2011.3.3.148; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Wang M, 2013, CLIN EXP ALLERGY, V43, P956, DOI 10.1111/cea.12123; Willems LI, 2010, MED RES REV, V30, P778, DOI 10.1002/med.20181; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Zhang RX, 2007, J INVEST ALLERG CLIN, V17, P329; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	35	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169353	10.1371/journal.pone.0169353	http://dx.doi.org/10.1371/journal.pone.0169353			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046055	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300172
J	Cabrera-Gaytan, DA; Niebla-Fuentes, MD; Padilla-Velazquez, R; Valle-Alvarado, G; Arriaga-Nieto, L; Rojas-Mendoza, T; Rosado-Quiab, U; Grajales-Muniz, C; Vallejos-Paras, A				Alejandro Cabrera-Gaytan, David; del Rosario Niebla-Fuentes, Maria; Padilla-Velazquez, Rosario; Valle-Alvarado, Gabriel; Arriaga-Nieto, Lumumba; Rojas-Mendoza, Teresita; Rosado-Quiab, Ulises; Grajales-Muniz, Concepcion; Vallejos-Paras, Alfonso			Association of Pulmonary Tuberculosis and HIV in the Mexican Institute of Social Security, 2006-2014	PLOS ONE			English	Article							MORTALITY; PREDICTORS	Background Tuberculosis and HIV remain a public health problem in developed countries. The objective of this study was to analyze the incidence trends of pulmonary TB and HIV comorbidity and treatment outcomes according to HIV during the period 2006 to 2014 in the Mexican Institute of Social Security. Methods Analyzed data from this registry including pulmonary tuberculosis patients aged 15 years and older who had been diagnosed during the years 2006 to 2014 in the Mexican Institute of Social Security. The outcomes that we use were incidents rate, failure to treatment and death. Regression models were used to quantify associations between pulmonary tuberculosis and HIV mortality. Results During the study period, 31,352 patients were registered with pulmonary tuberculosis. The incidence rate observed during 2014 was 11.6 case of PTB per 100,000. The incidence rate for PTB and HIV was 0.345 per 100,000. The PTB incidence rate decreased by 0.07%, differences found in the PTB incidence rate by sex since in women decreased by 5.52% and in man increase by 3.62%. The pulmonary TB with HIV incidence rate decreased by 16.3% during the study period (In women increase 4.81% and in man decrease 21.6%). Analysis of PTB associated with HIV by age groups revealed that the highest incidence rates were observed for the 30 to 44 years old group. Meanwhile, the highest incidence rates of PTB without HIV occurred among the 60 and more years old individuals. We did not find statistically significant differences between treatment failure and PTB patients with HIV and without HIV. The treatment failure was associated with sex and the region of the patient. We found a strong association between HIV and the probability of dying during treatment. Our data suggested that patients suffering from both conditions (PTB and HIV) have no difference in the probability of failure of treatment contrary to other reports. Hypotheses to this is adherence to tuberculosis treatment with people living with HIV/AIDS, detection of PTB in patients suffering from HIV/AIDS or PTB patients on antiretroviral therapy were more likely to have successful treatment outcomes than those not on antiretroviral treatment. We have found that PTB and HIV increases the probability of dying during treatment compared to the cases of PTB without HIV, consistent with published other study HIV increases the mortality rates associated with PTB. Conclusions No association between pulmonary tuberculosis with HIV and treatment failure was observed, but pulmonary tuberculosis and HIV increases the probability of dying during treatment compared to the pulmonary tuberculosis cases without HIV.	[Alejandro Cabrera-Gaytan, David; del Rosario Niebla-Fuentes, Maria; Padilla-Velazquez, Rosario; Valle-Alvarado, Gabriel; Arriaga-Nieto, Lumumba; Rojas-Mendoza, Teresita; Rosado-Quiab, Ulises; Grajales-Muniz, Concepcion; Vallejos-Paras, Alfonso] Inst Mexicano Seguro Social, Coordinac Vigilancia Epidemiol, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social	Vallejos-Paras, A (corresponding author), Inst Mexicano Seguro Social, Coordinac Vigilancia Epidemiol, Mexico City, DF, Mexico.	alfonso.vallejos@imss.gob.mx	; ARRIAGA-NIETO, LUMUMBA/B-7697-2019	, GABRIEL Valle Alvarado/0000-0002-9251-7474; ARRIAGA-NIETO, LUMUMBA/0000-0003-0243-768X; Grajales Muniz, Concepcion/0000-0001-7923-5344; Rojas Mendoza, Teresita/0000-0002-6658-1739; Vallejos Paras, Alfonso/0000-0003-0972-8295				[Anonymous], 2014, CTR NAC PREV CONTR E; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Bauman Z, 2005, ZYGMUNT BAUMAN; Delgado-Sanchez G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129312; Edgar KA, 2003, J PEDIATR PSYCHOL, V28, P485, DOI 10.1093/jpepsy/jsg039; Garcia Ordoi MA, REV CLIN, P279; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Honneth Axel, 1994, PATHOLOGIEN SOZIALEN, P9; Instituto Nacional de Salud Publica, 2000, VIV PROB UT SERV SAL; Kok G, 2004, J HEALTH PSYCHOL, V9, P85, DOI 10.1177/1359105304038379; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Magis-Rodriguez C, 2000, RESPQUESTA MEXICANA, P1322; Magis-Rodriguez C, 2008, SERIE ANGULOS SIDA; Marcy O, 2014, CLIN INFECT DIS, V59, P435, DOI 10.1093/cid/ciu283; Radilla-Chavez P, 2007, INT J TUBERC LUNG D, V11, P289; Rangaka MX, 2015, LANCET, V386, P1, DOI 10.1016/S0140-6736(15)00323-2; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; SabatU E., 2003, ADHERENCE LONG TERM; Saito S, 2016, JAIDS-J ACQ IMM DEF, V71, pe96, DOI 10.1097/QAI.0000000000000896; Sanchez-Barriga JJ, 2015, ARCH BRONCONEUMOL, V51, P16, DOI 10.1016/j.arbres.2014.03.020; Secretaria de Salud Centro Nacional para la Prevencion y el Control del VIH y el SIDA (CENSIDA), 2015, INF NAC AV RESP VIH; Sileshi B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-297; Tweya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056248; UNAIDS, 2015, AIDS NUMB 2015; van den Broek J, 1998, INT J TUBERC LUNG D, V2, P547; World Health Organization, 2011, GLOB TUB CONTR WHO R	26	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168559	10.1371/journal.pone.0168559	http://dx.doi.org/10.1371/journal.pone.0168559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7KQ	28033402	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900030
J	Feng, L; Wang, R; Lian, M; Ma, HZ; He, N; Liu, HG; Wang, HZ; Fang, JG				Feng, Ling; Wang, Ru; Lian, Meng; Ma, Hongzhi; He, Ning; Liu, Honggang; Wang, Haizhou; Fang, Jugao			Integrated Analysis of Long Noncoding RNA and mRNA Expression Profile in Advanced Laryngeal Squamous Cell Carcinoma	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; GASTRIC-CANCER; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; PROTEIN EXPRESSION; METASTASIS; GENE; PROLIFERATION; PROMOTES; PATHWAY	Long non-coding RNA (IncRNA) plays an important role in tumorigenesis. However, the expression pattern and function of IncRNAs in laryngeal squamous cell carcinoma (LSCC) are still unclear. To investigate the aberrantly expressed IncRNAs and mRNAs in advanced LSCC, we screened IncRNA and mRNA expression profiles in 9 pairs of primary Stage IVA LSCC tissues and adjacent non-neoplastic tissues by IncRNA and mRNA integrated micro-arrays. Gene Ontology and pathway analysis were performed to find out the significant function and pathway of the differentially expressed mRNAs, gene-gene functional interaction network and ceRNA network were constructed to select core mRNAs, and IncRNA-mRNA expression correlation network was built to identify the interactions between IncRNA and mRNA. qRT-PCR was performed to further validate the expressions of selected IncRNAs and mRNAs in advanced LSCC. We found 1459 differentially expressed IncRNAs and 2381 differentially expressed mRNAs, including 846 up-regulated IncRNAs and 613 down-regulated IncRNAs, 1542 up-regulated mRNAs and 839 down-regulated mRNAs. The mRNAs ITGB1, HIFI A, and DDIT4 were selected as core mRNAs, which are mainly involved in biological processes, such as matrix organization, cell cycle, adhesion, and metabolic pathway. LncRNA-mRNA expression correlation network showed LncRNA NR_027340, MIR31HG were positively correlated with ITGB1, HIF1A respectively. LncRNA SOX2-OT was negatively correlated with DDIT4. qRT-PCR further validated the expression of these IncRNAs and mRNAs. The work provides convincing evidence that the identified IncRNAs and mRNAs are potential biomarkers in advanced LSCC for further future studies.	[Feng, Ling; Wang, Ru; Lian, Meng; Ma, Hongzhi; He, Ning; Wang, Haizhou; Fang, Jugao] Capital Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Beijing Tongren Hosp, Beijing, Peoples R China; [Feng, Ling; Wang, Ru; Lian, Meng; Ma, Hongzhi; Wang, Haizhou; Fang, Jugao] Minist Educ, Key Lab Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China; [He, Ning] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Head & Neck Surg, Nanning, Guangxi, Peoples R China; [Liu, Honggang; Fang, Jugao] Beijing Key Lab Head & Neck Mol Diagnost Pathol, Beijing, Peoples R China	Capital Medical University	Fang, JG (corresponding author), Capital Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Beijing Tongren Hosp, Beijing, Peoples R China.; Fang, JG (corresponding author), Minist Educ, Key Lab Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China.; Fang, JG (corresponding author), Beijing Key Lab Head & Neck Mol Diagnost Pathol, Beijing, Peoples R China.	fangjg19651110@l63.com			Beijing Municipal Science & Technology Commission Program [Z141107002514003]; Beijing Municipal Administration of Hospitals Clinical medicine Development of special funding support [XMLX201311]; National Natural Science Foundation of China [81072204, 81272267]	Beijing Municipal Science & Technology Commission Program(Beijing Municipal Science & Technology Commission); Beijing Municipal Administration of Hospitals Clinical medicine Development of special funding support; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Beijing Municipal Science & Technology Commission Program (no. Z141107002514003) (http://www.bjkw.gov.cn/n244495/), Beijing Municipal Administration of Hospitals Clinical medicine Development of special funding support (code. XMLX201311) (http://www.bjah.gov.cn/), and National Natural Science Foundation of China (no. 81072204, 81272267) (http://www.nsfc.gov.cn/publish/portal1/). JF received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Askarian-Amiri ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102140; Augoff K, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-5; Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731; Calkovsky V, 2015, ADV EXP MED BIOL, V852, P11, DOI 10.1007/5584_2014_104; Cheung LWT, 2016, PHARMACOGENOMICS, V17, P297, DOI 10.2217/pgs.15.174; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; El-Naggar AM, 2015, CANCER CELL, V27, P682, DOI 10.1016/j.ccell.2015.04.003; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forastiere AA, 2015, J CLIN ONCOL, V33, P3262, DOI 10.1200/JCO.2015.61.2978; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; He B, 2016, SCI REP-UK, V6, DOI 10.1038/srep21955; Hou ZB, 2014, INT J BIOCHEM CELL B, V53, P380, DOI 10.1016/j.biocel.2014.06.004; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Kar S, 2016, CELL SYST, V2, P8, DOI 10.1016/j.cels.2016.01.007; Li DW, 2013, OTOLARYNG HEAD NECK, V148, P75, DOI 10.1177/0194599812464759; Liao XH, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.142; Ling H, 2015, ONCOGENE, V34, P5003, DOI 10.1038/onc.2014.456; Liu YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep10159; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Martinez-Fernandez M, 2015, INT J MOL SCI, V16, P27107, DOI 10.3390/ijms161126000; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Nie FQ, 2016, TUMOR BIOL, V37, P7693, DOI 10.1007/s13277-015-4644-z; Parasramka MA, 2016, PHARMACOL THERAPEUT, V161, P67, DOI 10.1016/j.pharmthera.2016.03.004; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Qi P, 2013, MODERN PATHOL, V26, P155, DOI 10.1038/modpathol.2012.160; Reis EM, 2005, CANCER RES, V65, P1693, DOI 10.1158/0008-5472.CAN-04-3506; Rupaimoole R, 2015, CELL REP, V13, P2395, DOI 10.1016/j.celrep.2015.11.047; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Shahryari A, 2014, STEM CELLS, V32, P126, DOI 10.1002/stem.1542; Shi YG, 2014, BIOCHEM BIOPH RES CO, V446, P448, DOI 10.1016/j.bbrc.2014.02.144; Starska K, 2015, TUMOR BIOL, V36, P2309, DOI 10.1007/s13277-014-2838-4; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Wu TY, 2016, ONCOTARGET, V7, P11553, DOI 10.18632/oncotarget.7270; Wu Y, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.48; Xia T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06088; Yan LX, 2016, INT J ONCOL, V48, P471, DOI 10.3892/ijo.2015.3287; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167; Zhang L, 2015, MOL MED REP, V12, P7869, DOI 10.3892/mmr.2015.4443	48	43	44	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0169232	10.1371/journal.pone.0169232	http://dx.doi.org/10.1371/journal.pone.0169232			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033431	gold, Green Published, Green Submitted			2022-12-26	WOS:000391226900088
J	Ogawa, T; Shoji, E; Suematsu, NJ; Nishimori, H; Izumi, S; Awazu, A; Iima, M				Ogawa, Takuma; Shoji, Erika; Suematsu, Nobuhiko J.; Nishimori, Hiraku; Izumi, Shunsuke; Awazu, Akinori; Iima, Makoto			The Flux of Euglena gracilis Cells Depends on the Gradient of Light Intensity	PLOS ONE			English	Article							BACTERIAL CHEMOTAXIS; ESCHERICHIA-COLI; BIOCONVECTION; PHOTOTAXIS; SENSITIVITY; RESPONSES; RANGE; TRANSDUCTION; FLAGELLATE; MECHANISM	We have quantified the photomovement behavior of a suspension of Euglena gracilis representing a behavioral response to a light gradient. Despite recent measurements of phototaxis and photophobicity, the details of macroscopic behavior of cell photomovements under conditions of light intensity gradients, which are critical to understand recent experiments on spatially localized bioconvection patterns, have not been fully understood. In this paper, the flux of cell number density under a light intensity gradient was measured by the following two experiments. In the first experiment, a capillary containing the cell suspension was illuminated with different light intensities in two regions. In the steady state, the differences of the cell numbers in the two regions normalized by the total number were proportional to the light difference, where the light intensity difference ranged from 0.5-2.0 mu mol m(-2) s(-1). The proportional coefficient was positive (i.e., the bright region contained many microorganisms) when the mean light intensity was weak (1.25 mu mol m(-2) s(-1)), whereas it was negative when the mean intensity was strong (13.75 mu mol m(-2) s(-1)). In the second experiment, a shallow rectangular container of the suspension was illuminated with stepwise light intensities. The cell number density distribution exhibited a single peak at the position where the light intensity was about I-c similar or equal to 3.8 mu mol m(-2) s(-1). These results suggest that the suspension of E. gracilis responded to the light gradient and that the favorable light intensity was I-c.	[Ogawa, Takuma; Shoji, Erika; Nishimori, Hiraku; Izumi, Shunsuke; Awazu, Akinori; Iima, Makoto] Hiroshima Univ, Grad Sch Sci, Hiroshima, Japan; [Suematsu, Nobuhiko J.] Meiji Univ, Meiji Inst Adv Study Math Sci, Tokyo, Japan; [Suematsu, Nobuhiko J.] Meiji Univ, Grad Sch Adv Math Sci, Tokyo, Japan	Hiroshima University; Meiji University; Meiji University	Iima, M (corresponding author), Hiroshima Univ, Grad Sch Sci, Hiroshima, Japan.	makoto@mis.hiroshima-u.ac.jp	iima, makoto/S-5151-2018; Awazu, Akinori/G-8980-2019; Suematsu, Nobuhiko J/L-3409-2017	iima, makoto/0000-0002-1060-4604; Suematsu, Nobuhiko/0000-0001-5860-4147	JSPS KAKENHI [26400396]; CREST [PJ74100011]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST(Core Research for Evolutional Science and Technology (CREST))	This work was supported by JSPS KAKENHI 26400396 MI https://www.jsps.go.jp/english/e-grants/, and CREST PJ74100011 MI http://www.jst.go.jp/kisoken/crest/en/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BLOCK SM, 1982, CELL, V31, P215, DOI 10.1016/0092-8674(82)90421-4; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; BROWN D A, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1388, DOI 10.1073/pnas.71.4.1388; CHANDRASEKHAR S., 1981, HYDRODYNAMIC HYDROMA; Childress S., 1981, MECH SWIMMING FLYING; CREUTZ C, 1976, J PROTOZOOL, V23, P552, DOI 10.1111/j.1550-7408.1976.tb03838.x; DIEHN B, 1973, SCIENCE, V181, P1009, DOI 10.1126/science.181.4104.1009; Ghorai S, 2013, EUR J MECH B-FLUID, V41, P81, DOI 10.1016/j.euromechflu.2012.07.001; Ghorai S, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3457163; Giometto A, 2015, P NATL ACAD SCI USA, V112, P7045, DOI 10.1073/pnas.1422922112; HADER DP, 1981, ARCH MICROBIOL, V130, P78, DOI 10.1007/BF00527076; HADER DP, 1987, ARCH MICROBIOL, V147, P179, DOI 10.1007/BF00415281; Hill NA, 2005, FLUID DYN RES, V37, P1, DOI 10.1016/j.fluiddyn.2005.03.002; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; Lebert M., 2001, COMPREHENSIVE SERIES; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; Matsunaga S, 1998, PROTOPLASMA, V201, P45, DOI 10.1007/BF01280710; Mello BA, 2007, BIOPHYS J, V92, P2329, DOI 10.1529/biophysj.106.097808; MESIBOV R, 1973, J GEN PHYSIOL, V62, P203, DOI 10.1085/jgp.62.2.203; Namba T, 2012, BIOPHYS J, V103, P1390, DOI 10.1016/j.bpj.2012.08.034; PEDLEY TJ, 1992, ANNU REV FLUID MECH, V24, P313, DOI 10.1146/annurev.fluid.24.1.313; PLATT JR, 1961, SCIENCE, V133, P1766, DOI 10.1126/science.133.3466.1766; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Shoji E, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.043001; Suematsu NJ, 2014, RIMS KOKYUROKU, V1900, P85; Suematsu NJ, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.064003; Tu YH, 2008, P NATL ACAD SCI USA, V105, P14855, DOI 10.1073/pnas.0807569105; Vincent RV, 1996, J FLUID MECH, V327, P343, DOI 10.1017/S0022112096008579; Wager H., 1911, PHILOS T R SOC B, V201, P333, DOI [10.1098/rstb.1911.0007, DOI 10.1098/RSTB.1911.0007]; Williams CR, 2011, J FLUID MECH, V678, P41, DOI 10.1017/jfm.2011.100	32	10	10	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168114	10.1371/journal.pone.0168114	http://dx.doi.org/10.1371/journal.pone.0168114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033336	Green Submitted, gold, Green Published			2022-12-26	WOS:000391226900016
J	Teh, LSL; Lam, VWY; Cheung, WWL; Miller, D; Teh, LCL; Sumaila, UR				Teh, Louise S. L.; Lam, Vicky W. Y.; Cheung, William W. L.; Miller, Dana; Teh, Lydia C. L.; Sumaila, U. Rashid			Impact of High Seas Closure on Food Security in Low Income Fish Dependent Countries	PLOS ONE			English	Article							MARINE FISHERIES; CLIMATE-CHANGE; ISLAND; SUSTAINABILITY; PERSPECTIVES; WORLD; CATCH; TUNA	We investigate how high seas closure will affect the availability of commonly consumed food fish in 46 fish reliant, and/or low income countries. Domestic consumption of straddling fish species (fish that would be affected by high seas closure) occurred in 54% of the assessed countries. The majority (70%) of countries were projected to experience net catch gains following high seas closure. However, countries with projected catch gains and that also consumed the straddling fish species domestically made up only 37% of the assessed countries. In contrast, much fewer countries (25%) were projected to incur net losses from high seas closure, and of these, straddling species were used domestically in less than half (45%) of the countries. Our findings suggest that, given the current consumption patterns of straddling species, high seas closure may only directly benefit the supply of domestically consumed food fish in a small number of fish reliant and/or low income countries. In particular, it may not have a substantial impact on improving domestic fish supply in countries with the greatest need for improved access to affordable fish, as only one third of this group used straddling fish species domestically. Also, food security in countries with projected net catch gains but where straddling fish species are not consumed domestically may still benefit indirectly via economic activities arising from the increased availability of non-domestically consumed straddling fish species following high seas closure. Consequently, this study suggests that high seas closure can potentially improve marine resource sustainability as well as contribute to human well-being in some of the poorest and most fish dependent countries worldwide. However, caution is required because high seas closure may also negatively affect fish availability in countries that are already impoverished and fish insecure.	[Teh, Louise S. L.; Miller, Dana; Sumaila, U. Rashid] Univ British Columbia, Inst Oceans & Fisheries, Fisheries Econ Res Unit, Vancouver, BC, Canada; [Lam, Vicky W. Y.; Cheung, William W. L.; Teh, Lydia C. L.] Univ British Columbia, Changing Ocean Res Unit, Vancouver, BC, Canada; [Lam, Vicky W. Y.; Cheung, William W. L.; Teh, Lydia C. L.] Univ British Columbia, Inst Oceans & Fisheries, Nereus Project, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Teh, LSL (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, Fisheries Econ Res Unit, Vancouver, BC, Canada.	l.teh@oceans.ubc.ca	Lam, Vicky/AAX-1684-2020; Sumaila, U. Rashid/ABE-6475-2020		Social Sciences and Humanities Research Council of Canada; Belmont Forum	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Belmont Forum	LSLT, URS and WC acknowledge the Social Sciences and Humanities Research Council of Canada for funding the OceanCanada Partnership. LSLT also acknowledges financial support from the Belmont Forum for funding the project 'Maintaining productivity and incomes in the Tonle Sap fishery in the face of climate change'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabsi N, 2014, MAR POLICY, V50, P89, DOI 10.1016/j.marpol.2014.05.015; Alegre M.-C.C., 2009, NATL OCEAN POLICY SA, VVolume 76; Allan JD, 2005, BIOSCIENCE, V55, P1041, DOI 10.1641/0006-3568(2005)055[1041:OOIW]2.0.CO;2; Allison E., 2011, AQUACULTURE FISHERIE; Allison EH, 2012, FISH FISH, V13, P14, DOI 10.1111/j.1467-2979.2011.00405.x; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Andersen A. B., 2013, FOOD NUTR SECURITY T; [Anonymous], 2001, STATE FOOD INWORLD; [Anonymous], FISHERIES SAO TOME P; [Anonymous], 4881 FAO; [Anonymous], 2014, FISH STAT 2014; [Anonymous], 2015, AFSUN FOOD SECURITY; APEC, 2013, 2 OC FISH WORK GROUP; Aregheore EM, 2009, KIRIBATI COUNTRY PAS; Astuti R., 1995, PEOPLE SEA IDENTITY, V95; Awira R., 2008, KIRIBATI COUNTRY REP; Barnes-Mauthe M, 2013, FISH RES, V147, P175, DOI 10.1016/j.fishres.2013.05.011; Belhabib D., 2013, MARINE FISHERIES C 1, P91; Belhabib D, 2015, FISHERIES CTR WORKIN; Belhabib D, 2013, MARINE FISHERIES C 1, P61; Bell JD, 2015, MAR POLICY, V51, P584, DOI 10.1016/j.marpol.2014.10.005; Bell JD, 2009, MAR POLICY, V33, P64, DOI 10.1016/j.marpol.2008.04.002; Bene C., 2005, NAGA WORLDFISH CTR Q, V28, P8; Bene C, 2015, FOOD SECUR, V7, P261, DOI 10.1007/s12571-015-0427-z; Bene C, 2009, WATER INT, V34, P47, DOI 10.1080/02508060802677838; Bennett NJ, 2014, ECOL SOC, V19, DOI 10.5751/ES-06315-190205; Blythe JL, 2014, ECOL SOC, V19, DOI 10.5751/ES-06408-190206; Boko M, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P433; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Browne S., 2010, LIVELIHOODS ZONING P, P39; Brugu┐re C., 2008, LIVELIHOOD DIVERSIFI; Burke L., 2011, REEFS RISK REVISITED; C3 (Community Centred Conservation), 2010, SOC ASS ID POT UNPUB, P22; Campbell B, 2014, FISH FUTURE FISHERIE; Chavance P, 2011, TROPICAL TUNAS, V2104, P2104; Cheung W, 2016, FISH FISH; Cho Y., 2000, SUSTAINABLE CONTRIBU; Cinner JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011999; Conteh FY, 2015, GOVT REPUBLIC SEYCHE, P103; Cullis-Suzuki S, 2010, MAR POLICY, V34, P1036, DOI 10.1016/j.marpol.2010.03.002; Dabla-Norris M. E., 2015, STAFF DISCUSSION NOT; Daw TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031460; Demmke A., 2011, VULNERABILITY TROPIC, P733; Dey M. M., 2005, AQUACULT ECON MANAG, V9, P89, DOI DOI 10.1080/13657300590961537; Dyck Andrew J., 2010, Journal of Bioeconomics, V12, P227, DOI 10.1007/s10818-010-9088-3; Etim L, 2015, FISHERIES CTR WORKIN; FAO, 2007, FAO FISH AQ FISH AQ; FAO, 2008, CLIM CHANG FOOD SEC; FAO, 2010, TUV NAT FISH SECT OV; FAO, 2009, FAO FISH AQ FISH AQ; FAO, 2014, FAO FISH AQ FISH AQ; FAO, 2003, MYANM AQ INL FISH; FAO, 2007, FAO FISH AQ PROF PEC; FAO, 2008, REP BEN FISH AQ COUN; FAO, 2003, FAO FISH AQ FISH AQ; FAO, 2005, FAO FISH AQ FISH AQ; FAO, 2003, UN COM FISH COUNTR P; FAO, 2002, FAO FISH COUNTR PROF; FAO, 2009, SAM NAT FISH SECT OV; FAO, 2007, FAO FISH COUNTR PROF; FAO, 2011, FAO FISH AQ FISH AQ; FAO, 2006, FAO FISH AQ NAT AQ S; FAO, 2005, FAO FISH AQ NAT AQ S; FAO, 2007, UN REP TANZ NAT FISH; FAO, 2008, FAO FISH AQ PROF PEC; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ; FCWC, 2010, TOGO FISH COMM W CEN; Felix M, 2012, SUPPLY CHAIN ANAL FR; Flores-Palacios X., 2014, SAM C 3 OPP CHALL SU; Food and Agriculture Organization (FAO), 2004, FAO FISH COUNTR PROF; Frid CLJ, 2012, ICES J MAR SCI, V69, P145, DOI 10.1093/icesjms/fsr207; Friedman K, 2002, FIJI ISLANDS COUNTRY; Friedman KJ, 2008, VANUATU COUNTRY REPO; Gehrke P, 2011, VULNERABILITY TROPIC; Gillett R., 2014, PACIFIC PERSPECTIVES, P50; Golden C, 2016, NATURE, V534, P317, DOI 10.1038/534317a; Golub S., 2014, FISHING EXPORTS EC D; Gordon A., 2013, FISH PRODUCTION CONS; Green P.A.S., 2012, UNIV BR COLUMBIA FIS, P90; Hajeb P, 2009, FOOD CONTROL, V20, P79, DOI 10.1016/j.foodcont.2008.02.012; Haputhantri S, 2014, IOTC2014WPTT1632; Hauzer M, 2013, FISH RES, V140, P28, DOI 10.1016/j.fishres.2012.12.001; HLPE, 2020, FOOD SEC NUTR BUILD; Hotta M., 2007, 4881 FAO, P361; IOTC, 2011, IOTC2011SC14NR26; Islam M., 2014, EC INCENTIVES SUSTAI; Jayaweera I., 2010, LIVELIHOOD DIVERSIFI; Jiddawi NS, 2002, AMBIO, V31, P518, DOI 10.1639/0044-7447(2002)031[0518:MFIT]2.0.CO;2; Johnstone G, 2013, AAS201328 WORLDF CTR; Kaufmann D, 2011, HAGUE J RULE LAW, V3, P220, DOI 10.1017/S1876404511200046; Kawarazuka N., 2010, WorldFish Center Working Paper; Kebe M., 2009, 1043 FAO; Krishnamurthy K, 2014, SRI LANKA CONSOLIDAT; Kronen M, 2010, MAR POLICY, V34, P1135, DOI 10.1016/j.marpol.2010.03.013; KUMAR M, 2004, 20043 I APPL SCI, P35; Le Manach F., 2015, FISHERIES CTR RES RE, V23, P99; Lymer D, 2008, RAP PUBLICATION, V2008, P51; McClanahan TR, 2008, CONSERV LETT, V1, P53, DOI 10.1111/j.1755-263X.2008.00008_1.x; MCGREGOR A, PAC EC B, V24, P24; Meyer J, 2006, COMOROS COMPREHENSIV; Mujinga W, 2009, INVENTORY FISH SPECI, P30; Nathan Associates Inc, 2010, COMP MOZ FISH SECT; Ndiaye O, 2003, 708 FAO, P213; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Nguyen H., 2003, 708 FAO, P213; Norse EA, 2012, MAR POLICY, V36, P307, DOI 10.1016/j.marpol.2011.06.008; Persson L, 2014, FISHERIES CTR RES RE, V23, P111; Pickering T. D., 2011, VULNERABILITY TROPIC, P647; Pinca S, 2009, SOLOMON ISLANDS COUN; Pittaluga F, 2007, POVERTY FISHING LIVE; Pouomogne V, 2008, WORLDFISH CTR STUDIE, V1871, P60; Pratchett MS, VULNERABILITY TROPIC, P493; Ricel JC, 2011, ICES J MAR SCI, V68, P1343, DOI 10.1093/icesjms/fsr041; Robinson J, 2006, REV STATE WORLD MARI, P458; Rockefeller Foundation, 2013, SEC LIV NUTR NEEDS F; Sasson A, 2012, AGR FOOD SECURITY, V1, P1, DOI [10.1186/2048-7010-1-2, DOI 10.1186/2048-7010-1-2]; Sauni S, 2008, TUVALU COUNTRY REPOR; Sinan Hussain, BACKGROUND REPORT FI, P8; Sivasubramaniam K., 2000, SUSTAINABLE CONTRIBU; Srinivasan U. Thara, 2010, Journal of Bioeconomics, V12, P183, DOI 10.1007/s10818-010-9090-9; Sumaila UR, 2015, SCI REP-UK, V5, DOI 10.1038/srep08481; Teh LSL, 2015, MAR ECOL PROG SER, V530, P243, DOI 10.3354/meps11049; Teh LSL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065397; Teh LCL, 2009, MAR POLICY, V33, P807, DOI 10.1016/j.marpol.2009.03.001; Tesfamichael D, 2012, FISHERIES CTR RES RE, P51; Tesfamichael D, 2012, FISHERIES CTR RES RE, V20, P105; Tesfamichael D, 2012, FISHERIES CTR RES RE, V20, P71; Thilsted SH, 2016, FOOD POLICY, V61, P126, DOI 10.1016/j.foodpol.2016.02.005; Thorpe A, 2014, FEM ECON, V20, P53, DOI 10.1080/13545701.2014.895403; Tietze U, 2000, 403 FAO, P151; UNCTAD, 2014, FISH SECT GAMB TRAD, P54; Vunisea A., 2008, SAMOA COUNTRY REPORT; Wahab M, 2013, EC INCENTIVES MARINE, P170; White C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001826; World Food Programme, 2006, COM COMPR FOOD SEC V, P62; Zylich Kyrstn, 2014, University of British Columbia Fisheries Centre Research Reports, V22, P147	136	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168529	10.1371/journal.pone.0168529	http://dx.doi.org/10.1371/journal.pone.0168529			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7KQ	28033359	Green Published, Green Submitted, gold			2022-12-26	WOS:000391226900028
J	Zhang, WX; Ming, QZ; Shi, ZT; Niu, J; Su, H				Zhang, Wenxiang; Ming, Qingzhong; Shi, Zhengtao; Niu, Jie; Su, Huai			Climate Change and Drought Events in the Geochemical Records of the Lacustrine Deposits in the Southeastern Tibetan Plateau	PLOS ONE			English	Article							ASIAN MONSOON; HIGH-RESOLUTION; LAKE; HOLOCENE; SUMMER; OSCILLATIONS; TRANSITIONS; PROVENANCE; CHEMISTRY; EVOLUTION	Lacustrine deposits at the margin of the southeastern Tibetan Plateau (SETP) are sensitive indicators for the evolution of the southwest Asian monsoon (SWAM) during the Quaternary. Thus, they can provide insight into the Quaternary climatic history and their relationship with global climatic changes. The results of the geochemical analysis of the Xiaozhongdian Basin section at the SETP suggest that SiO2 had the highest content of the major elements followed by Al2O3. The order of the abundance of the major elements was generally as follows: SiO2 > Al2O3 > Fe2O3 > CaO > MgO > K2O > TiO2 > Na2O > MnO2. The geochemical proxies, such as chemical index of alteration (CIA), the index of compositional variability (ICV) and (CaO+K2O+Na2O)/Al2O3, indicate the weak chemical weathering and the aridification of the margin of the SETP during the Heinrich events. In addition, the aridification of the SETP during the Heinrich events may be closely related to the cold signals transmitted from the high latitudes of the North Atlantic to the TP, and the effect caused the cooling effect to be very strong on the TP as a result of the upper-level westerly jet stream and then reduced the suction action associated with the SWAM, thus accelerating the drying rate of Xiaozhongdian Basin, which was amplifying the degree of drought in Heinrich events.	[Zhang, Wenxiang; Shi, Zhengtao; Niu, Jie; Su, Huai] Key Lab Geog Proc & Environm Change Plateau Yunna, Kunming, Peoples R China; [Zhang, Wenxiang; Niu, Jie] Yunnan Normal Univ, Key Lab Plateau Lake Ecol & Global Change, Kunming, Peoples R China; [Zhang, Wenxiang; Ming, Qingzhong; Niu, Jie] Yunnan Univ Finance & Econ, Kunming, Peoples R China	Yunnan Normal University; Yunnan University of Finance & Economics	Zhang, WX (corresponding author), Key Lab Geog Proc & Environm Change Plateau Yunna, Kunming, Peoples R China.; Zhang, WX (corresponding author), Yunnan Normal Univ, Key Lab Plateau Lake Ecol & Global Change, Kunming, Peoples R China.; Zhang, WX (corresponding author), Yunnan Univ Finance & Econ, Kunming, Peoples R China.	wenxiangzhang@gmail.com			Cultivating Talents of the Middle-aged Academic and Technology Leaders of Yunnan Province [2015HB029]; Open Fund of State Key Laboratory of Loess and Quaternary Geology [SKLLQG1020]; National Natural Science Foundation of China [U0933604]	Cultivating Talents of the Middle-aged Academic and Technology Leaders of Yunnan Province; Open Fund of State Key Laboratory of Loess and Quaternary Geology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Cultivating Talents of the Middle-aged Academic and Technology Leaders of Yunnan Province (No. 2015HB029), the Open Fund of State Key Laboratory of Loess and Quaternary Geology (SKLLQG1020) and the National Natural Science Foundation of China (No. U0933604).	An ZS, 2011, SCIENCE, V333, P719, DOI 10.1126/science.1203752; Bartlein PJ, 2011, CLIM DYNAM, V37, P775, DOI 10.1007/s00382-010-0904-1; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; COX R, 1995, GEOCHIM COSMOCHIM AC, V59, P2919, DOI 10.1016/0016-7037(95)00185-9; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; Fang XM, 2003, QUATERN INT, V106, P79, DOI 10.1016/S1040-6182(02)00163-5; Gallet S, 1998, EARTH PLANET SC LETT, V156, P157, DOI 10.1016/S0012-821X(97)00218-5; Hodell DA, 1999, QUATERNARY RES, V52, P369, DOI 10.1006/qres.1999.2072; Joo YJ, 2005, SEDIMENT GEOL, V177, P97, DOI 10.1016/j.sedgeo.2005.02.003; Kong P, 2012, GEOCHEM GEOPHY GEOSY, V13, P96; Lee MK, 2013, J QUATERNARY SCI, V28, P370, DOI 10.1002/jqs.2626; Leuschner DC, 2000, QUATERNARY SCI REV, V19, P243, DOI 10.1016/S0277-3791(99)00064-5; Li JJ, 1999, CHINESE SCI BULL, V44, P2117, DOI 10.1007/BF03182692; Li MH, 2011, QUATERN INT, V236, P96, DOI 10.1016/j.quaint.2010.12.022; Li Y, 2009, BOREAS, V38, P349, DOI 10.1111/j.1502-3885.2008.00063.x; Liu LW, 2006, GEOCHIM COSMOCHIM AC, V70, pA363, DOI 10.1016/j.gca.2006.06.735; MCLENNAN SM, 1993, J GEOL, V101, P295, DOI 10.1086/648222; [明庆忠 Ming Qingzhong], 2011, [地理学报, Acta Geographica Sinica], V66, P123; Muller J, 2008, QUATERNARY SCI REV, V27, P468, DOI 10.1016/j.quascirev.2007.11.006; NESBITT HW, 1980, GEOCHIM COSMOCHIM AC, V44, P1659, DOI 10.1016/0016-7037(80)90218-5; NESBITT HW, 1982, NATURE, V299, P715, DOI 10.1038/299715a0; Nesbitt HW, 1996, J GEOL, V104, P525, DOI 10.1086/629850; Overpeck J, 1996, CLIM DYNAM, V12, P213, DOI 10.1007/BF00211619; Park J, 2014, QUATERNARY SCI REV, V105, P112, DOI 10.1016/j.quascirev.2014.10.003; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Ponton C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050722; RAHMSTORF S, 1994, NATURE, V372, P82, DOI 10.1038/372082a0; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Roy PD, 2012, J ARID ENVIRON, V81, P47, DOI 10.1016/j.jaridenv.2012.01.008; Sahai AK, 2003, CLIM DYNAM, V20, P855, DOI 10.1007/s00382-003-0306-8; Sinha A, 2011, QUATERNARY SCI REV, V30, P47, DOI 10.1016/j.quascirev.2010.10.005; Stott L, 2002, SCIENCE, V297, P222, DOI 10.1126/science.1071627; Tarasov P, 2005, CLIM DYNAM, V25, P625, DOI 10.1007/s00382-005-0045-0; Taylor S.R., 1985, CONTINENTAL CRUST IT; Vogel H, 2010, J PALEOLIMNOL, V44, P295, DOI 10.1007/s10933-009-9404-x; Wang PX, 2005, QUATERNARY SCI REV, V24, P595, DOI 10.1016/j.quascirev.2004.10.002; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; [汪永进 Wang Yongjin], 2016, [科学通报, Chinese Science Bulletin], V61, P938; Weber ME, 2003, SEDIMENT GEOL, V155, P361, DOI 10.1016/S0037-0738(02)00187-2; [魏志强 Wei Zhiqiang], 2015, [地理科学进展, Progress in Geography], V34, P909; Wu Y.H., 2004, J EARTH SCI ENV, V26, P64; Xu H, 2014, QUATERNARY SCI REV, V89, P85, DOI 10.1016/j.quascirev.2014.02.011; Xu H, 2012, CLIM DYNAM, V39, P2079, DOI 10.1007/s00382-012-1378-0; [殷勇 Yin Yong], 2002, [海洋地质与第四纪地质, Marine Geology & Quaternary Geology], V22, P99; Young GM, 2002, GEOL SOC AM BULL, V114, P387, DOI 10.1130/0016-7606(2002)114<0387:GIOANG>2.0.CO;2; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220; Zhang HC, 2009, SCI CHINA SER D, V52, P1703, DOI 10.1007/s11430-009-0097-9; Zhang WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102167; Zhang WX, 2013, ENVIRON EARTH SCI, V70, P2191, DOI 10.1007/s12665-013-2323-1; [张文翔 Zhang Wenxiang], 2008, [第四纪研究, Quaternary Sciences], V28, P917; Zhao Xitao, 2007, Dizhi Xuebao, V81, P1645; Zhou HY, 2014, QUATERNARY RES, V82, P394, DOI 10.1016/j.yqres.2014.07.006; Zhu LP, 2015, SCI REP-UK, V5, DOI 10.1038/srep13318	55	2	2	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168928	10.1371/journal.pone.0168928	http://dx.doi.org/10.1371/journal.pone.0168928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033377	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900061
J	Lin, J; Chen, DR; Wang, YF; Lai, HW				Lin, Joseph; Chen, Dar-Ren; Wang, Yu-Fen; Lai, Hung-Wen			Oncoplastic Surgery for Upper/Upper Inner Quadrant Breast Cancer	PLOS ONE			English	Article							PARTIAL MASTECTOMY; CONSERVING SURGERY; RADICAL-MASTECTOMY; BODY-IMAGE	Tumors located in the upper/upper inner quadrant of the breast warrant more attention. A small lesion relative to the size of breast in this location may be resolved by performing a level I oncoplastic technique. However, a wide excision may significantly reduce the overall quality of the breast shape by distorting the visible breast line. From June 2012 to April 2015, 36 patients with breast cancer located in the upper/upper inner quadrant underwent breast-conservation surgery with matrix rotation mammoplasty. According to the size and location of the tumor relative to the nipple-areola complex, 11 patients underwent matrix rotation with periareolar de-epithelialization (donut group) and the other 25 underwent matrix rotation only (non-donut group). The cosmetic results were self-assessed by questionnaires. The average weights of the excised breast lumps in the donut and non-donut groups were 104.1 and 84.5 g, respectively. During the 3-year follow-up period, local recurrence was observed in one case and was managed with nipple-sparing mastectomy followed by breast reconstruction with prosthetic implants. In total, 31 patients (88.6%) ranked their postoperative result as either acceptable or satisfactory. The treated breasts were also self-evaluated by 27 patients (77.1%) to be nearly identical to or just slightly different from the untreated side. Matrix rotation is an easy breast-preserving technique for treating breast cancer located in the upper/upper inner quadrant of the breast that requires a relatively wide excision. With this technique, a larger breast tumor could be removed without compromising the breast appearance.	[Lin, Joseph; Chen, Dar-Ren; Lai, Hung-Wen] Changhua Christian Hosp, Dept Surg, Comprehens Breast Canc Ctr, Changhua, Taiwan; [Chen, Dar-Ren] Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan; [Chen, Dar-Ren; Wang, Yu-Fen] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lai, Hung-Wen] Changhua Christian Hosp, Endoscop & Oncoplast Breast Surg Ctr, Changhua, Taiwan; [Lai, Hung-Wen] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan	Changhua Christian Hospital; Changhua Christian Hospital; Chung Shan Medical University; Changhua Christian Hospital; National Yang Ming Chiao Tung University	Chen, DR (corresponding author), Changhua Christian Hosp, Dept Surg, Comprehens Breast Canc Ctr, Changhua, Taiwan.; Chen, DR (corresponding author), Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan.; Chen, DR (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.	darren_chen@cch.org.tw		Lin, Joseph/0000-0003-0623-816X				Al-Ghazal SK, 1999, BREAST, V8, P162, DOI 10.1054/brst.1999.0017; Anderson BO, 2005, LANCET ONCOL, V6, P145, DOI 10.1016/S1470-2045(05)01765-1; Asgeirsson KS, 2005, EJSO-EUR J SURG ONC, V31, P817, DOI 10.1016/j.ejso.2005.05.010; Brierley J D, 1991, Clin Oncol (R Coll Radiol), V3, P3; Chan Sharon W W, 2010, World J Surg, V34, P1447, DOI 10.1007/s00268-009-0278-x; Chen DR, 2014, EUR REV MED PHARMACO, V18, P1748; Clough KB, 2003, ANN SURG, V237, P26, DOI 10.1097/00000658-200301000-00005; Clough KB, 1999, PLAST RECONSTR SURG, V104, P409, DOI 10.1097/00006534-199908000-00014; Clough KB, 2010, ANN SURG ONCOL, V17, P1375, DOI 10.1245/s10434-009-0792-y; Fitoussi AD, 2010, PLAST RECONSTR SURG, V125, P454, DOI 10.1097/PRS.0b013e3181c82d3e; Gabka C J, 1997, Langenbecks Arch Chir Suppl Kongressbd, V114, P1224; Grisotti A., 2006, SURG BREAST PRINCIPL, V2nd, P147; Holmes DR, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/303879; HOPWOOD P, 1993, EUR J CANCER, V29A, P276, DOI 10.1016/0959-8049(93)90193-J; Kaur N, 2005, ANN SURG ONCOL, V12, P539, DOI 10.1245/ASO.2005.12.046; PATTERSON MP, 1985, INT J RADIAT ONCOL, V11, P1849, DOI 10.1016/0360-3016(85)90044-6; ROBBINS TH, 1977, PLAST RECONSTR SURG, V59, P64, DOI 10.1097/00006534-197701000-00011; SCHOVER LR, 1995, CANCER-AM CANCER SOC, V75, P54, DOI 10.1002/1097-0142(19950101)75:1<54::AID-CNCR2820750111>3.0.CO;2-I; Silverstein MJ, 2014, J SURG ONCOL, V110, P82, DOI 10.1002/jso.23641; Silverstein MJ, 2005, J AM COLL SURGEONS, V201, P586, DOI 10.1016/j.jamcollsurg.2005.05.032; VERONESI U, 1977, CANCER, V39, P2822, DOI 10.1002/1097-0142(197706)39:6<2822::AID-CNCR2820390670>3.0.CO;2-#; VERONESI U, 1981, NEW ENGL J MED, V305, P6, DOI 10.1056/NEJM198107023050102; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; von Smitten K, 2008, J SURG ONCOL, V98, P585, DOI 10.1002/jso.21038; *WHO, 1969, M INV EV METH DIAGN	25	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168434	10.1371/journal.pone.0168434	http://dx.doi.org/10.1371/journal.pone.0168434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030581	Green Published, Green Submitted, gold			2022-12-26	WOS:000391222000048
J	Okada, Y; Shirai, K; Miyajima, M; Reinach, PS; Yamanaka, O; Sumioka, T; Kokado, M; Tomoyose, K; Saika, S				Okada, Yuka; Shirai, Kumi; Miyajima, Masayasu; Reinach, Peter S.; Yamanaka, Osamu; Sumioka, Takayoshi; Kokado, Masahide; Tomoyose, Katsuo; Saika, Shizuya			Loss of TRPV4 Function Suppresses Inflammatory Fibrosis Induced by Alkali-Burning Mouse Corneas	PLOS ONE			English	Article							MICE LACKING TRPV4; MYOFIBROBLAST DIFFERENTIATION; LUNG INJURY; TGF-BETA; CHANNELS; INHIBITION; ACTIVATION; SENSATION; CELLS	In humans suffering from pulmonary disease and a mouse model, transient receptor potential vanilloid 4 (TRPV4) channel activation contributes to fibrosis. As a corneal alkali burn induces the same response, we determined if such an effect is also attributable to TRPV4 activation in mice. Accordingly, we determined if the alkali burn wound healing responses in wild-type (WT) mice are different than those in their TRPV4-null (KO) counterpart. Stromal opacification due to fibrosis in KO (n = 128) mice was markedly reduced after 20 days relative to that in WT (n = 157) mice. Immunohistochemistry revealed that increases in polymorphonuclear leukocytes and macrophage infiltration declined in KO mice. Semi-quantitative real time RTPCR of ocular KO fibroblast cultures identified increases in proinflammatory and monocyte chemoattractant protein-1 chemoattractant gene expression after injury. Biomarker gene expression of fibrosis, collagen1a1 and alpha-smooth muscle actin were attenuated along with macrophage release of interleukin-6 whereas transforming growth factor beta, release was unchanged. Tail vein reciprocal bone marrow transplantation between WT and KO chimera mouse models mice showed that reduced scarring and inflammation in KO mice are due to loss of TRPV4 expression on both corneal resident immune cells, fibroblasts and infiltrating polymorphonuclear leukocytes and macrophages. Intraperitoneal TRPV4 receptor antagonist injection of HC-067047 (10 mg/kg, daily) into WT mice reproduced the KO-phenotype. Taken together, alkali-induced TRPV4 activation contributes to inducing fibrosis and inflammation since corneal transparency recovery was markedly improved in KO mice.	[Okada, Yuka; Shirai, Kumi; Yamanaka, Osamu; Sumioka, Takayoshi; Kokado, Masahide; Tomoyose, Katsuo; Saika, Shizuya] Wakayama Med Univ, Ophthalmol, Wakayama, Japan; [Miyajima, Masayasu] Wakayama Med Univ, Lab Anim Ctr, Wakayama, Japan; [Reinach, Peter S.] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Peoples R China	Wakayama Medical University; Wakayama Medical University; Wenzhou Medical University	Okada, Y (corresponding author), Wakayama Med Univ, Ophthalmol, Wakayama, Japan.	yokada@wakayama-med.ac.jp	Reinach, Peter/AAI-3582-2021		Ministry of Education, Science, Sports and Culture of Japan [C15K10878, C15K10877, C25462759, B24791869, C15K10876, C25462730, C254627729]; Grants-in-Aid for Scientific Research [25462729] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Grants from the Ministry of Education, Science, Sports and Culture of Japan (C15K10878 to YO, C15K10877 to KS, C25462759 to OY, B24791869 to TS, C15K10876 to MK, C25462730 to KT, and C254627729 to SS). The funders had no role in the study design, data collection/analysis, decision to publish, or preparation of the manuscript.	Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Arniges M, 2004, J BIOL CHEM, V279, P54062, DOI 10.1074/jbc.M409708200; Balakrishna S, 2014, AM J PHYSIOL-LUNG C, V307, pL158, DOI 10.1152/ajplung.00065.2014; Banner KH, 2011, PHARMACOL THERAPEUT, V130, P371, DOI 10.1016/j.pharmthera.2011.03.005; De Petrocellis L, 2012, ACTA PHYSIOL, V204, P255, DOI 10.1111/j.1748-1716.2011.02338.x; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Groot-Kormelink PJ, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-57; Hamanaka K, 2010, AM J PHYSIOL-LUNG C, V299, pL353, DOI 10.1152/ajplung.00315.2009; Janssen LJ, 2015, AM J RESP CELL MOL, V53, P135, DOI 10.1165/rcmb.2014-0269TR; Jester JV, 2002, EXP EYE RES, V75, P645, DOI 10.1006/exer.2002.2066; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2004, AM J PHYSIOL-LUNG C, V287, pL269, DOI 10.1152/ajplung.00153.2004; Lim RR, 2016, SCI REP-UK, V6, DOI 10.1038/srep20841; Ma FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035144; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; Mergler S, 2011, J CELL PHYSIOL, V226, P1828, DOI 10.1002/jcp.22514; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Okada Y, 2014, LAB INVEST, V94, P1030, DOI 10.1038/labinvest.2014.85; Okada Y, 2011, AM J PATHOL, V178, P2654, DOI 10.1016/j.ajpath.2011.02.043; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Pan Z, 2008, CELL CALCIUM, V44, P374, DOI 10.1016/j.ceca.2008.01.008; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Rahaman SO, 2014, J CLIN INVEST, V124, P5225, DOI 10.1172/JCI75331; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Saika S, 2005, AM J PATHOL, V166, P1393, DOI 10.1016/S0002-9440(10)62357-7; Saika S, 2006, AM J PATHOL, V168, P1848, DOI 10.2353/ajpath.2006.050980; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Yang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077300	32	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167200	10.1371/journal.pone.0167200	http://dx.doi.org/10.1371/journal.pone.0167200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030558	Green Submitted, Green Published, gold			2022-12-26	WOS:000391222000006
J	Wang, S; Zhao, H; Huang, CH; Li, ZR; Li, W; Zhang, XB; Liu, ZG				Wang, Shen; Zhao, Hui; Huang, Caihong; Li, Zhengri; Li, Wei; Zhang, Xiaobo; Liu, Zuguo			Impact of Chronic Smoking on Meibomian Gland Dysfunction	PLOS ONE			English	Article							SURFACE DISEASE INDEX; DRY EYE; OCULAR SURFACE; CIGARETTE-SMOKING; INTERNATIONAL WORKSHOP; CHINESE POPULATION; RISK-FACTORS; PREVALENCE; PATHOPHYSIOLOGY; SUBCOMMITTEE	Purpose The aim of this study was to explore the relationship between chronic cigarette smoking and meibomian gland dysfunction (MGD). Methods This study enrolled 322 smokers with MGD and 2067 non-smokers with MGD. All enrolled subjects were tested in the following sequence: Ocular Surface Disease Index (OSDI), tear film breakup time (TBUT), corneal fluorescein staining (CFS), Schirmer I test (SIT) and finally slit-lamp microscope examination of lid margin abnormalities, meibomian gland expression as well as meibum. Results Compared with the MGD patients without smoking, the MGD patients with smoking had significantly increased scores of lid margin abnormality and meibum (P<0.01 for each comparison). No significant difference was noted in OSDI, TBUT, CFS, SIT or the score of Meibomian gland expressibility between the smokers and non-smokers (P>0.05 for each comparison). In the smokers, the smoking index was significantly correlated with the scores of lid margin abnormality (Both sexes, R = 0.19, P<0.01; Male, R = 0.18, P<0.01) and meibum (Both sexes, R = 0.29, P<0.01; Male, R = 0.20, P<0.01), whereas it was not significantly correlated with OSDI, TBUT, CFS, SIT or score of Meibomian gland expressibility (P>0.05 for each comparison). Conclusion The findings of this study suggest chronic smoking might be associated with MGD.	[Wang, Shen; Zhao, Hui; Huang, Caihong; Li, Zhengri; Li, Wei; Zhang, Xiaobo; Liu, Zuguo] Xiamen Univ, Coll Med, Inst Eye, Xiamen, Fujian, Peoples R China; [Zhang, Xiaobo; Liu, Zuguo] Xiamen Univ, Chengyi Bldg 401,Xiang An Campus, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Zhang, XB; Liu, ZG (corresponding author), Xiamen Univ, Coll Med, Inst Eye, Xiamen, Fujian, Peoples R China.; Zhang, XB; Liu, ZG (corresponding author), Xiamen Univ, Chengyi Bldg 401,Xiang An Campus, Xiamen, Fujian, Peoples R China.	xiaoboz@xmu.edu.cn; zuguoliu@xmu.edu.cn	Li, Wei/P-8985-2015	Li, Wei/0000-0001-7458-2590	Key Clinic Medicine Research Program; Ministry of Health, China [201302015]; National Natural Science Foundation of China [81270978, 81330022, U1205025, 31401180, 81500693]	Key Clinic Medicine Research Program; Ministry of Health, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by grants from the Key Clinic Medicine Research Program, the Ministry of Health, China (No.201302015 to ZL) and National Natural Science Foundation of China (No. 81270978 to ZL, 81330022 to ZL, U1205025 to ZL, 31401180 to ZL and 81500693 to XZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso AA, 1999, OPHTHALMOLOGY, V106, P803, DOI 10.1016/S0161-6420(99)90170-7; Altinors DD, 2006, AM J OPHTHALMOL, V141, P1016, DOI 10.1016/j.ajo.2005.12.047; Arita R, 2015, OCUL SURF, V13, P321, DOI 10.1016/j.jtos.2015.04.005; Arita R, 2013, BRIT J OPHTHALMOL, V97, P725, DOI 10.1136/bjophthalmol-2012-302668; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; BARTECCHI CE, 1994, NEW ENGL J MED, V330, P907, DOI 10.1056/NEJM199403313301307; BARTECCHI CE, 1995, SCI AM, V272, P44, DOI 10.1038/scientificamerican0595-44; Bilkhu PS, 2014, BRIT J OPHTHALMOL, V98, P1707, DOI 10.1136/bjophthalmol-2014-305220; HUGHES DA, 1985, CLIN EXP IMMUNOL, V61, P459; Jie Y, 2008, EYE, V22, P790, DOI 10.1038/sj.eye.6702857; Knop E, 2011, INVEST OPHTH VIS SCI, V52, P1938, DOI 10.1167/iovs.10-6997c; Lee H, 2012, AM J OPHTHALMOL, V154, P949, DOI 10.1016/j.ajo.2012.06.009; Lee KS, 1998, ANN EPIDEMIOL, V8, P31, DOI 10.1016/S1047-2797(97)00113-0; Lekhanont K, 2006, CORNEA, V25, P1162, DOI 10.1097/01.ico.0000244875.92879.1a; Lin PY, 2003, OPHTHALMOLOGY, V110, P1096, DOI 10.1016/S0161-6420(03)00262-8; Loewenstein A, 2000, Harefuah, V139, P280; Miller KL, 2010, ARCH OPHTHALMOL-CHIC, V128, P94, DOI 10.1001/archophthalmol.2009.356; Pflugfelder SC, 2014, EXPERT REV CLIN IMMU, V10, P1137, DOI 10.1586/1744666X.2014.944163; Rummenie VT, 2008, CYTOKINE, V43, P200, DOI 10.1016/j.cyto.2008.05.011; Sayin N, 2014, CUTAN OCUL TOXICOL, V33, P201, DOI 10.3109/15569527.2013.832688; Schaumberg DA, 2011, INVEST OPHTH VIS SCI, V52, P1994, DOI 10.1167/iovs.10-6997e; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; SHIMAZAKI J, 1995, ARCH OPHTHALMOL-CHIC, V113, P1266, DOI 10.1001/archopht.1995.01100100054027; Solberg Y, 1998, SURV OPHTHALMOL, V42, P535, DOI 10.1016/S0039-6257(98)00002-2; Stern ME, 2004, EXP EYE RES, V78, P409, DOI 10.1016/j.exer.2003.09.003; Stern ME, 2013, INT REV IMMUNOL, V32, P19, DOI 10.3109/08830185.2012.748052; THOMAS W, 1973, NATURE, V243, P240, DOI 10.1038/243240a0; Viso E, 2012, INVEST OPHTH VIS SCI, V53, P2601, DOI 10.1167/iovs.11-9228; Zhang XB, 2011, OPHTHALMOLOGY, V118, P902, DOI 10.1016/j.ophtha.2010.08.033	29	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168763	10.1371/journal.pone.0168763	http://dx.doi.org/10.1371/journal.pone.0168763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030610	gold, Green Submitted, Green Published			2022-12-26	WOS:000391222000074
J	Peng, GQ; Yang, Y; Pasquarella, JR; Xu, LQ; Qian, ZH; Holmes, KV; Li, F				Peng, Guiqing; Yang, Yang; Pasquarella, Joseph R.; Xu, Liqing; Qian, Zhaohui; Holmes, Kathryn V.; Li, Fang			Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOEMBRYONIC ANTIGEN FAMILY; RESPIRATORY SYNDROME CORONAVIRUS; VIRUS-BINDING ACTIVITY; HEPATITIS-VIRUS; CRYSTAL-STRUCTURE; SPIKE PROTEIN; AMINOPEPTIDASE N; MHV RECEPTOR; AMINO-ACIDS; CELL ENTRY	Hosts and pathogens are locked in an evolutionary arms race. To infect mice, mouse hepatitis coronavirus (MHV) has evolved to recognize mouse CEACAM1a (mCEACAM1a) as its receptor. To elude MHV infections, mice may have evolved a variant allele from the Ceacam1a gene, called Ceacam1b, producing mCEACAM1b, which is a much poorer MHV receptor than mCEACAM1a. Previous studies showed that sequence differences between mCEACAM1a and mCEACAM1b in a critical MHV-binding CC' loop partially account for the low receptor activity of mCEACAM1b, but detailed structural and molecular mechanisms for the differential MHV receptor activities of mCEACAM1a and mCEACAM1b remained elusive. Here we have determined the crystal structure of mCEACAM1b and identified the structural differences and additional residue differences betweenmCEACAM1a and mCEACAM1b that affect MHV binding and entry. These differences include conformational alterations of the CC' loop as well as residue variations in other MHV-binding regions, including beta-strands C' and C '' and loop C'C ''. Using pseudovirus entry and protein-protein binding assays, we show that substituting the structural and residue features from mCEACAM1b into mCEACAM1a reduced the viral receptor activity of mCEACAM1a, whereas substituting the reverse changes from mCEACAM1a into mCEACAM1b increased the viral receptor activity of mCEACAM1b. These results elucidate the detailed molecular mechanism for how mice may have kept pace in the evolutionary arms race with MHV by undergoing structural and residue changes in the MHV receptor, providing insight into this possible example of pathogen-driven evolution of a host receptor protein.	[Peng, Guiqing; Yang, Yang; Pasquarella, Joseph R.; Xu, Liqing; Li, Fang] Univ Minnesota, Dept Pharmacol, Sch Med, Minneapolis, MN 55455 USA; [Peng, Guiqing] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Xu, Liqing] Huazhong Agr Univ, Key Lab Hort Plant Biol, Wuhan 430070, Peoples R China; [Qian, Zhaohui] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Qian, Zhaohui] Peking Union Med Coll, Beijing 100730, Peoples R China; [Qian, Zhaohui; Holmes, Kathryn V.] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA	University of Minnesota System; University of Minnesota Twin Cities; Huazhong Agricultural University; Huazhong Agricultural University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Colorado System; University of Colorado Anschutz Medical Campus	Li, F (corresponding author), Univ Minnesota, Dept Pharmacol, Sch Med, Minneapolis, MN 55455 USA.	lifang@umn.edu	Qian, Zhaohui/AFR-9488-2022; Yang, Yang/R-7215-2016	Yang, Yang/0000-0001-9061-3828; Qian, Zhaohui/0000-0003-4116-4450	National Institutes of Health [R01AI089728]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01AI089728. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], PYMOL MOL GRAPH SYST; Beauchemin N, 1999, EXP CELL RES, V252, P243; BOYLE JF, 1987, J VIROL, V61, P185, DOI 10.1128/JVI.61.1.185-189.1987; CAVANAGH D, 1986, J GEN VIROL, V67, P1443, DOI 10.1099/0022-1317-67-7-1443; Chen L, 2012, P NATL ACAD SCI USA, V109, P17966, DOI 10.1073/pnas.1210123109; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; Chen YQ, 2013, J VIROL, V87, P10777, DOI 10.1128/JVI.01756-13; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; DVEKSLER GS, 1991, J VIROL, V65, P6881, DOI 10.1128/JVI.65.12.6881-6891.1991; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GODFRAIND C, 1995, LAB INVEST, V73, P615; Hill DJ, 2001, MOL MICROBIOL, V39, P850, DOI 10.1046/j.1365-2958.2001.02233.x; Hirai A, 2010, J VIROL, V84, P6654, DOI 10.1128/JVI.02680-09; Homberger FR, 1997, LAB ANIM, V31, P97, DOI 10.1258/002367797780600189; Jacoby RO, 1997, FASEB J, V11, P609, DOI 10.1096/fasebj.11.8.9240962; Kammerer R, 2004, GENE, V339, P99, DOI 10.1016/j.gene.2004.06.023; Krempl C, 1997, J VIROL, V71, P3285, DOI 10.1128/JVI.71.4.3285-3287.1997; KUBO H, 1994, J VIROL, V68, P5403, DOI 10.1128/JVI.68.9.5403-5410.1994; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301; Li F, 2015, J VIROL, V89, P1954, DOI 10.1128/JVI.02615-14; Li WH, 2006, J VIROL, V80, P4211, DOI 10.1128/JVI.80.9.4211-4219.2006; Liu C, 2015, J VIROL, V89, P6121, DOI 10.1128/JVI.00430-15; Liu C, 2014, J BIOL CHEM, V289, P34520, DOI 10.1074/jbc.M114.566802; Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328; Miura HS, 2004, J VIROL, V78, P216, DOI 10.1128/JVI.78.1.216-223.2004; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Ohtsuka N, 1997, J VIROL, V71, P8860, DOI 10.1128/JVI.71.11.8860-8863.1997; Ohtsuka N, 1996, J GEN VIROL, V77, P1683, DOI 10.1099/0022-1317-77-8-1683; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng GQ, 2012, J BIOL CHEM, V287, P41931, DOI 10.1074/jbc.M112.418210; Peng GQ, 2011, P NATL ACAD SCI USA, V108, P10696, DOI 10.1073/pnas.1104306108; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Promkuntod N, 2014, VIROLOGY, V448, P26, DOI 10.1016/j.virol.2013.09.018; Rao PV, 1997, VIROLOGY, V229, P336, DOI 10.1006/viro.1997.8446; Reguera J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002859; SCHULTZE B, 1992, VIROLOGY, V189, P792, DOI 10.1016/0042-6822(92)90608-R; Schwegmann-Wessels C, 2006, GLYCOCONJUGATE J, V23, P51, DOI 10.1007/s10719-006-5437-9; Tan KM, 2002, EMBO J, V21, P2076, DOI 10.1093/emboj/21.9.2076; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toleman M, 2001, CELL MICROBIOL, V3, P33, DOI 10.1046/j.1462-5822.2001.00089.x; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Voges M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-117; Walls AC, 2016, NATURE, V531, P114, DOI 10.1038/nature16988; Wang NS, 2013, CELL RES, V23, P986, DOI 10.1038/cr.2013.92; Wessner DR, 1998, J VIROL, V72, P1941, DOI 10.1128/JVI.72.3.1941-1948.1998; WILLIAMS RK, 1991, P NATL ACAD SCI USA, V88, P5533, DOI 10.1073/pnas.88.13.5533; Wu KL, 2009, P NATL ACAD SCI USA, V106, P19970, DOI 10.1073/pnas.0908837106; Yang Y, 2014, P NATL ACAD SCI USA, V111, P12516, DOI 10.1073/pnas.1405889111	50	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2174	2181		10.1074/jbc.M116.764266	http://dx.doi.org/10.1074/jbc.M116.764266			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28035001	Green Published, hybrid			2022-12-26	WOS:000395530300011
J	Zhang, J; Jiang, HY; Zhang, LK; Xu, WL; Qiao, YT; Zhu, XG; Liu, W; Zheng, QQ; Hua, ZC				Zhang, Jing; Jiang, Heng-yi; Zhang, Lin-kai; Xu, Wen-ling; Qiao, Yi-ting; Zhu, Xu-guo; Liu, Wan; Zheng, Qian-qian; Hua, Zi-Chun			C-FLIPL Modulated Wnt/beta-Catenin Activation via Association with TIP49 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING COMPLEX; NF-KAPPA-B; RUVB DNA HELICASE; CANCER CELL-DEATH; BETA-CATENIN; NUCLEAR-LOCALIZATION; APOPTOSIS; TRANSCRIPTION; TIP60; GENE	Cellular FLICE-like inhibitory protein (c-FLIPL) is a key inhibitory protein in the extrinsic apoptotic pathway. Recent studies showed that c-FLIPL could translocate into the nucleus and might be involved in the Wnt signaling pathway. The nuclear function of c-FLIPL was still unclear. Here we found a novel c-FLIPL-associated protein TIP49, which is a nuclear protein identified as a cofactor in the transcriptional regulation of beta-catenin. They had co-localization in the nucleus and the DED domain of c-FLIPL was required for the association with TIP49. By performing ChIP experiments, C-FLIPL was detected in the ITF-2 locus and facilitated TIP49 accumulation in the formation of complexes at the T-cell-specific transcription factor site of human ITF-2 promoter. When TIP49 knockdown, c-FLIP(L)driven Wnt activation, and cell proliferation were inhibited, suggesting that a role of nuclear c-FLIPL involved in modulation of theWntpathway was in a TIP49-dependent manner. Elevated expression of c-FLIPL and TIP49 that coincided in human lung cancers were analyzed in silico using the Oncomine database. Their high expressions were reconfirmed in six lung cancer cell lines and correlated with cell growth. The association of c-FLIPL and TIP49 provided an additional mechanism involved in c-FLIPL-mediated functions, including Wnt activation.	[Zhang, Jing; Jiang, Heng-yi; Zhang, Lin-kai; Xu, Wen-ling; Qiao, Yi-ting; Zhu, Xu-guo; Liu, Wan; Zheng, Qian-qian; Hua, Zi-Chun] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Jiangsu, Peoples R China; [Zhang, Jing; Hua, Zi-Chun] Nanjing Univ, Changzhou High Tech Res Inst, Changzhou 213164, Jiangsu, Peoples R China; [Zhang, Jing; Hua, Zi-Chun] Jiangsu Target Pharma Labs Inc, Changzhou 213164, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Zhang, J; Hua, ZC (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Jiangsu, Peoples R China.; Zhang, J (corresponding author), Nanjing Univ, Changzhou High Tech Res Inst, Changzhou 213164, Jiangsu, Peoples R China.; Zhang, J (corresponding author), Jiangsu Target Pharma Labs Inc, Changzhou 213164, Jiangsu, Peoples R China.	jzhang08@nju.edu.cn; zchua@nju.edu.cn			Chinese National Natural Sciences Foundation [81421091]; Doctoral Station Science Foundation from the Chinese Ministry of Education Grant [20130091130003]; Jiangsu Provincial Nature Science Foundation [BK20161477, BE2013630]; Open Project Programs from the State Key Laboratory of Natural and Biomimetic Drugs [K20140201]; Bureau of Science and Technology of Changzhou [CZ20130011, CE20135013]	Chinese National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Doctoral Station Science Foundation from the Chinese Ministry of Education Grant; Jiangsu Provincial Nature Science Foundation; Open Project Programs from the State Key Laboratory of Natural and Biomimetic Drugs; Bureau of Science and Technology of Changzhou	This work was supported by Chinese National Natural Sciences Foundation Grant 81421091, Doctoral Station Science Foundation from the Chinese Ministry of Education Grant 20130091130003, Jiangsu Provincial Nature Science Foundation Grants BK20161477 and BE2013630, Open Project Programs from the State Key Laboratory of Natural and Biomimetic Drugs Grant K20140201, and Bureau of Science and Technology of Changzhou Grants CZ20130011 and CE20135013. The authors declare that they have no conflicts of interest with the contents of this article.	Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; Chau H, 2005, J EXP MED, V202, P405, DOI 10.1084/jem.20050118; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; Dohrman A, 2005, J IMMUNOL, V174, P5270, DOI 10.4049/jimmunol.174.9.5270; Dugan KA, 2002, ONCOGENE, V21, P5835, DOI 10.1038/sj.onc.1205763; Feng Y, 2003, CANCER RES, V63, P8726; Gallant P, 2007, TRENDS CELL BIOL, V17, P187, DOI 10.1016/j.tcb.2007.02.005; Galligan L, 2005, MOL CANCER THER, V4, P2026, DOI 10.1158/1535-7163.MCT-05-0262; Gohshi T, 1999, J BIOCHEM, V125, P939, DOI 10.1093/oxfordjournals.jbchem.a022372; Gstaiger M, 2003, SCIENCE, V302, P1208, DOI 10.1126/science.1088401; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Katayama R, 2010, J CELL SCI, V123, P23, DOI 10.1242/jcs.058602; Kikuchi N, 1999, J BIOCHEM, V125, P487, DOI 10.1093/oxfordjournals.jbchem.a022312; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Longley DB, 2006, ONCOGENE, V25, P838, DOI 10.1038/sj.onc.1209122; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Naito M, 2004, MOL CELL BIOL, V24, P8418, DOI 10.1128/MCB.24.19.8418-8427.2004; Nakagiri S, 2005, MOL CELL BIOL, V25, P9249, DOI 10.1128/MCB.25.21.9249-9258.2005; Qiu XB, 1998, J BIOL CHEM, V273, P27786, DOI 10.1074/jbc.273.43.27786; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Riley JS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.481; Safa A. R., 2012, Experimental Oncology, V34, P176; Safa A. R., 2013, J CARCINOG MUTAGEN, V6; Safa Ahmad R, 2011, Cancers (Basel), V3, P1639, DOI 10.3390/cancers3021639; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X; Xiao C, 2002, J BIOL CHEM, V277, P25020, DOI 10.1074/jbc.M202946200; Zhang J, 2009, INT J BIOCHEM CELL B, V41, P1678, DOI 10.1016/j.biocel.2009.02.008; Zhang N, 2005, J EXP MED, V202, P395, DOI 10.1084/jem.20050117	37	6	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2132	2142		10.1074/jbc.M116.753251	http://dx.doi.org/10.1074/jbc.M116.753251			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28028178	hybrid, Green Published			2022-12-26	WOS:000395530300008
J	Emanuel, S; Libersat, F				Emanuel, Stay; Libersat, Frederic			Do Quiescence and Wasp Venom-Induced Lethargy Share Common Neuronal Mechanisms in Cockroaches?	PLOS ONE			English	Article							CENTRAL COMPLEX; PERIPLANETA-AMERICANA; AMPULEX-COMPRESSA; THORACIC INTERNEURONS; BLABERUS-DISCOIDALIS; LOCOMOTOR BEHAVIOR; ESCAPE BEHAVIOR; NEURAL ACTIVITY; INSECT BRAIN; SLEEP	The escape behavior of a cockroach may not occur when it is either in a quiescent state or after being stung by the jewel wasp (Ampulex compressa). In the present paper, we show that quiescence is an innate lethargic state during which the cockroach is less responsive to external stimuli. The neuronal mechanism of such a state is poorly understood. In contrast to quiescence, the venom-induced lethargic state is not an innate state in cockroaches. The Jewel Wasp disables the escape behavior of cockroaches by injecting its venom directly in the head ganglia, inside a neuropile called the central complex a 'higher center' known to regulate motor behaviors. In this paper we show that the coxal slow motoneuron ongoing activity, known to be involved in posture, is reduced in quiescent animals, as compared to awake animals, and it is further reduced in stung animals. Moreover, the regular tonic firing of the slow motoneuron present in both awake and quiescent cockroaches is lost in stung cockroaches. Injection of procaine to prevent neuronal activity into the central complex to mimic the wasp venom injection produces a similar effect on the activity of the slow motoneuron. In conclusion, we speculate that the neuronal modulation during the quiescence and venom-induced lethargic states may occur in the central complex and that both states could share a common neuronal mechanism.	[Emanuel, Stay; Libersat, Frederic] Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel	Ben Gurion University	Libersat, F (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel.	emanuels@post.bgu.ac.il; libersat@bgu.ac.il	LIBERSAT, FREDERIC/AAL-1437-2020	libersat, frederic/0000-0002-2379-6078	United States-Israel Binational Science Foundation [2015161]	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work is currently supported by United States-Israel Binational Science Foundation (2015161). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Gal Haspel and Maayan Kaiser for commenting on and editing an earlier version of the manuscript and Tova Rapoport for editing the final version of the manuscript. This work is currently supported by the United States-Israel Binational Sciences Foundation (2015161). The experiments performed comply with Principles of Animal Care, NIH publication no. 86-23, revised in 1985, and with the current laws of the State of Israel.	Bender JA, 2010, CURR BIOL, V20, P921, DOI 10.1016/j.cub.2010.03.054; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Cavey M, 2016, NAT NEUROSCI, V19, P587, DOI 10.1038/nn.4263; Donlea JM, 2011, SCIENCE, V332, P1571, DOI 10.1126/science.1202249; FOUAD K, 1994, ZOOL-ANAL COMPLEX SY, V98, P23; Fouad K, 1996, J COMP PHYSIOL A, V178, P91, DOI 10.1007/BF00189593; Greenspan RJ, 2001, TRENDS NEUROSCI, V24, P142, DOI 10.1016/S0166-2236(00)01719-7; Guo PY, 2013, J EXP BIOL, V216, P992, DOI 10.1242/jeb.080473; Harley CM, 2010, J EXP BIOL, V213, P2851, DOI 10.1242/jeb.042499; Haspel G, 2005, J COMP PHYSIOL A, V191, P529, DOI 10.1007/s00359-005-0620-1; Haspel G, 2003, J NEUROBIOL, V56, P287, DOI 10.1002/neu.10238; HOMBERG U, 1994, J COMP PHYSIOL A, V175, P597, DOI 10.1007/BF00199481; Homberg U, 1985, J INSECT PHYSL, V31; Kaiser M, 2015, J EXP BIOL, V218, P1022, DOI 10.1242/jeb.116491; KAISER W, 1988, J COMP PHYSIOL A, V163, P565, DOI 10.1007/BF00603841; Kathman ND, 2014, J EXP BIOL, V217, P4079, DOI 10.1242/jeb.112391; Libersat F, 2014, INTEGR COMP BIOL; Libersat F, 2013, J EXP BIOL, V216, P47, DOI 10.1242/jeb.073999; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; MORALES F, 1981, BRAIN RES, V225, P279, DOI 10.1016/0006-8993(81)90836-2; PEARSON KG, 1970, J EXP BIOL, V52, P139; PEARSON KG, 1971, J EXP BIOL, V54, P215; Pfeiffer K, 2014, ANNU REV ENTOMOL, V59, P165, DOI 10.1146/annurev-ento-011613-162031; Pimentel D, 2016, NATURE, V536, P333, DOI 10.1038/nature19055; Plath JA, 2015, CURR OPIN INSECT SCI, V12, P11, DOI 10.1016/j.cois.2015.08.005; RITZMANN RE, 1986, J COMP PHYSIOL A, V159, P639, DOI 10.1007/BF00612037; RITZMANN RE, 1988, J NEUROBIOL, V19, P589, DOI 10.1002/neu.480190703; Ritzmann RE, 2008, J COMP PHYSIOL A, V194, P341, DOI 10.1007/s00359-007-0310-2; Rosenberg LA, 2007, J EXP BIOL, V210, P4411, DOI 10.1242/jeb.010488; Schaefer PL, 2001, J NEUROBIOL, V49, P9, DOI 10.1002/neu.1062; Strausfeld NJ, 1999, PROG BRAIN RES, V123, P273, DOI 10.1016/S0079-6123(08)62863-0; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; TOBLER I, 1992, J SLEEP RES, V1, P231, DOI 10.1111/j.1365-2869.1992.tb00044.x; USHERWOOD PNR, 1962, J INSECT PHYSIOL, V8, P31, DOI 10.1016/0022-1910(62)90052-5; WATSON JT, 1994, ANIM BEHAV, V48, P476, DOI 10.1006/anbe.1994.1263	36	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168032	10.1371/journal.pone.0168032	http://dx.doi.org/10.1371/journal.pone.0168032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045911	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300012
J	Jekauc, D; Wagner, MO; Herrmann, C; Hegazy, K; Woll, A				Jekauc, Darko; Wagner, Matthias Oliver; Herrmann, Christian; Hegazy, Khaled; Woll, Alexander			Does Physical Self-Concept Mediate the Relationship between Motor Abilities and Physical Activity in Adolescents and Young Adults?	PLOS ONE			English	Article							FUNDAMENTAL MOVEMENT SKILLS; ACTIVITY GUIDELINES; CHILDREN; COMPETENCE; HEALTH; PROFICIENCY; PREVALENCE; OVERWEIGHT; QUESTIONNAIRE; RELIABILITY	The purpose of this study is to examine the reciprocal relationship between motor abilities and physical activity and the mediation effects of physical self-concept in this relationship using longitudinal data. We expect that the effects of motor abilities on physical activity are rather indirect via physical self-concept and that the effects of physical activity on motor abilities are rather direct without involvement of the motor ability self-concept. Data was obtained from the Motorik-Modul (MoMo) Longitudinal Study in which 335 boys and 363 girls aged 11-17 years old at Baseline were examined twice in a period of six years. Physical activity was assessed by the MoMo Physical Activity Questionnaire for adolescents, physical self-concept by Physical Self-Description Questionnaire and motor abilities by MoMo Motor Test which comprised of the dimensions strength, endurance, coordination and flexibility. Multiple regression analyses were used to analyse the direct and indirect effects. The results of the multiple regression analyses show that the effects of motor abilities on physical activity were only indirect for the dimensions strength, coordination, and flexibility. For the dimension endurance, neither direct nor indirect effects were significant. In the opposite direction, the effects of physical activity on motor abilities were partially mediated by the self-concept of strength. For the dimensions endurance, coordination and flexibility, only indirect were significant. The results of this study support the assumption that the relationship between motor abilities and physical activity is mediated by physical self-concept in both directions. Physical self-concept seems to be an important determinant of adolescents A physical activity.	[Jekauc, Darko] Humboldt Univ, Inst Sport Sci, Berlin, Germany; [Jekauc, Darko; Wagner, Matthias Oliver] Univ Konstanz, Dept Sport Sci, Constance, Germany; [Herrmann, Christian] Univ Basel, Dept Sport Exercise & Hlth, Basel, Switzerland; [Hegazy, Khaled; Woll, Alexander] Karlsruhe Inst Technol, Dept Sports & Sports Sci, Karlsruhe, Germany; [Hegazy, Khaled] Univ Alexandria, Fac Sport Educ Abu Qir, Alexandria, Egypt	Humboldt University of Berlin; University of Konstanz; University of Basel; Helmholtz Association; Karlsruhe Institute of Technology; Egyptian Knowledge Bank (EKB); Alexandria University	Jekauc, D (corresponding author), Humboldt Univ, Inst Sport Sci, Berlin, Germany.; Jekauc, D (corresponding author), Univ Konstanz, Dept Sport Sci, Constance, Germany.	darko.jekauc@hu-berlin.de			Federal Ministry of Family Affairs, Senior Citizens, Women and Youth; Federal Ministry of Education and Research [01ER1503]	Federal Ministry of Family Affairs, Senior Citizens, Women and Youth; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Federal Ministry of Family Affairs, Senior Citizens, Women and Youth and by the Federal Ministry of Education and Research, grant no. 01ER1503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all of the children and adolescents who participated in the study. This work has been developed within the Motorik-Modul-Study (MoMo) (2009-2021): Physical fitness and physical activity as determinants of health development in children and adolescents. MoMo is funded by the Federal Ministry of Education and Research (funding reference number: 01ER1503) within the research program 'long-term studies' in public health research.	Ahn S, 2011, J PEDIATR PSYCHOL, V36, P385, DOI 10.1093/jpepsy/jsq107; [Anonymous], [No title captured]; Barnett LM, 2011, MED SCI SPORT EXER, V43, P898, DOI 10.1249/MSS.0b013e3181fdfadd; Barnett LM, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-40; Barnett LM, 2009, J ADOLESCENT HEALTH, V44, P252, DOI 10.1016/j.jadohealth.2008.07.004; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beck J., 1995, NORMWERTE MOTORISCHE; BOUTELLIER U, 1987, J APPL PHYSIOL, V62, P837, DOI 10.1152/jappl.1987.62.2.837; Butcher K, 2008, J ADOLESCENT HEALTH, V42, P360, DOI 10.1016/j.jadohealth.2007.09.025; Castelli DM, 2007, J TEACH PHYS EDUC, V26, P358, DOI 10.1123/jtpe.26.4.358; Dumith SC, 2010, REV SAUDE PUBL, V44, P457, DOI 10.1590/S0034-89102010000300009; Eccles J. S., 1989, RES MOTIVATION ED, V3, P139, DOI DOI 10.1037/0003-066X.48.2.90; Erwin HE, 2008, RES Q EXERCISE SPORT, V79, P495, DOI 10.1080/02701367.2008.10599516; Graf C, 2004, INT J OBESITY, V28, P22, DOI 10.1038/sj.ijo.0802428; Harter S., 1987, CONT TOPICS DEV PSYC, P219; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; JACKSON SA, 1986, J SPORT EXERCISE PSY, V8, P198, DOI 10.1123/jsp.8.3.198; Jago R, 2005, AM J PREV MED, V28, P447, DOI 10.1016/j.amepre.2005.02.007; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Jekauc D, 2014, BEWEGUNGSTHERAPIE GE, V30, P79, DOI 10.1055/s-0033-1361578; Jekauc D., 2015, PSYCHOLOGY, V06, P48, DOI [10.4236/psych.2015.61005, DOI 10.4236/PSYCH.2015.61005]; Jekauc D, 2013, J PUBLIC HEALTH-HEID, V21, P505, DOI 10.1007/s10389-013-0579-2; Jekauc D, 2013, DIAGNOSTICA, V59, P100, DOI 10.1026/0012-1924/a000083; Jekauc D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-714; Jones RA, 2010, J SCI MED SPORT, V13, P589, DOI 10.1016/j.jsams.2010.04.002; Kamtsiuris P, 2007, BUNDESGESUNDHEITSBLA, V50, P547, DOI 10.1007/s00103-007-0215-9; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Larun L., 2006, COCHRANE DATABASE SY, V4; Lord S. E., 1994, J EARLY ADOLESCENCE, V14, P162, DOI DOI 10.1177/027243169401400205; Lubans DR, 2010, SPORTS MED, V40, P1019, DOI 10.2165/11536850-000000000-00000; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Marsh HW, 2007, CHILD DEV, V78, P1640, DOI 10.1111/j.1467-8624.2007.01094.x; MARSH HW, 1994, J SPORT EXERCISE PSY, V16, P43, DOI 10.1123/jsep.16.1.43; Okely AD, 2001, MED SCI SPORT EXER, V33, P1899, DOI 10.1097/00005768-200111000-00015; Pate RR, 2002, ANN EPIDEMIOL, V12, P303, DOI 10.1016/S1047-2797(01)00263-0; Piek JP, 2006, HUM MOVEMENT SCI, V25, P65, DOI 10.1016/j.humov.2005.10.011; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Rauner A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1731-4; Rauner A, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-19; RUDISILL ME, 1993, PERCEPT MOTOR SKILL, V76, P895, DOI 10.2466/pms.1993.76.3.895; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sjostrand T, 1960, CLINICAL CARDIOPULMO, P201; Skinner RA, 2001, HUM MOVEMENT SCI, V20, P73, DOI 10.1016/S0167-9457(01)00029-X; Southall JE, 2004, PEDIATR EXERC SCI, V16, P15, DOI 10.1123/pes.16.1.15; Spinks AB, 2007, J SCI MED SPORT, V10, P156, DOI 10.1016/j.jsams.2006.06.008; Stiller J, 2007, Z SPORTPSYCHOL, V14, P149, DOI 10.1026/1612-5010.14.4.149; Stodden DF, 2008, QUEST, V60, P290, DOI 10.1080/00336297.2008.10483582; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Wagner MO, 2013, INT J EPIDEMIOL, P1; Weiss M. R., 2004, DEV SPORT EXERCISE P, P223; Weiss M.R., 2002, ADV SPORT PSYCHOL, V2nd ed., P101; Wienke B, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01296; Woll A, 2011, EUR J PEDIATR, V170, P1129, DOI 10.1007/s00431-010-1391-4; Wrotniak BH, 2006, PEDIATRICS, V118, pE1758, DOI 10.1542/peds.2006-0742	57	51	51	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168539	10.1371/journal.pone.0168539	http://dx.doi.org/10.1371/journal.pone.0168539			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2QJ	28045914	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300030
J	Keel, S; Foreman, J; Xie, J; van Wijngaarden, P; Taylor, HR; Dirani, M				Keel, Stuart; Foreman, Joshua; Xie, Jing; van Wijngaarden, Peter; Taylor, Hugh R.; Dirani, Mohamed			The Prevalence of Self-Reported Diabetes in the Australian National Eye Health Survey	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; INDIGENOUS AUSTRALIANS; RISK-FACTORS; HYPERTENSION; OBESITY	Objective To present the prevalence of self-reported diabetes in Indigenous and non-Indigenous participants in the National Eye Health Survey. Research Design and Methods 3098 non-Indigenous Australians aged 50-98 years and 1738 Indigenous Australians aged 40-92 years were examined in 30 randomly selected sites, stratified by remoteness. A history of diabetes was obtained using an interviewer-administered questionnaire. Results 13.91% (431/3098) of non-Indigenous Australians and 37.11% (645/1738) of Indigenous Australians had self-reported diabetes. The age-adjusted prevalence of self-reported diabetes for non-Indigenous and Indigenous Australians was 11.49% and 43.77%, respectively (p<0.001). The prevalence of self-reported diabetes increased markedly with age (OR = 1.04 per year, p = 0.017). Indigenous Australians living in very remote areas were more likely to have self-reported diabetes than those in major city areas (OR = 1.61, p = 0.038). Conclusions The prevalence of self-reported diabetes in Australia was high, with the prevalence being almost 4 times higher in Indigenous Australians compared with non-Indigenous Australians. With the prevalence of diabetes likely to increase, the results of this national survey may inform future policy, planning and funding allocation to assist in controlling the diabetes epidemic.	[Keel, Stuart; Foreman, Joshua; Xie, Jing; van Wijngaarden, Peter; Dirani, Mohamed] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Australia; [Foreman, Joshua; van Wijngaarden, Peter] Univ Melbourne, Dept Surg, Ophthalmol, Melbourne, Vic, Australia; [Taylor, Hugh R.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Indigenous Eye Hlth Unit, Melbourne, Vic, Australia	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Melbourne	Foreman, J (corresponding author), Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Australia.; Foreman, J (corresponding author), Univ Melbourne, Dept Surg, Ophthalmol, Melbourne, Vic, Australia.	foreman.j@unimelb.edu.au; mdirani@unimelb.edu.au	xie, jing/GRY-1689-2022	van Wijngaarden, Peter/0000-0002-8800-7834; Foreman, Joshua/0000-0002-3685-4054; /0000-0001-6694-3587	Australian Government Department of Health; Novartis Pharmaceuticals	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); Novartis Pharmaceuticals(Novartis)	Support was provided by Australian Government Department of Health and Novartis Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[AAOO Ophthalmology AAo], 2014, INF STAT SCREEN DIAB; ABS, 2006, NAT AB TORR STRAIT T; [Anonymous], 2015, NAT HLTH SURV 1 RES; Australia D, 2013, NAT DIAB STRAT ACT P; Australian Institute of Aboriginal and Torres Strait Islander Studies, 2022, LIV LANG; Daniel M, 1999, DIABETES CARE, V22, P1993, DOI 10.2337/diacare.22.12.1993; Daniel M, 2002, DIABETES RES CLIN PR, V57, P23, DOI 10.1016/S0168-8227(02)00006-2; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; Gikas A, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-2; Goldman N, 2003, J CLIN EPIDEMIOL, V56, P148, DOI 10.1016/S0895-4356(02)00580-2; Hoy WE, 2007, AUST NZ J PUBL HEAL, V31, P177, DOI 10.1111/j.1753-6405.2007.00038.x; Huerta JM, 2009, REV ESP CARDIOL, V62, P143, DOI 10.1016/S0300-8932(09)70156-3; International Diabetes Federation, 2020, IDF DIABETES ATLAS; Leonard D, 2002, AUST NZ J PUBL HEAL, V26, P144, DOI 10.1111/j.1467-842X.2002.tb00907.x; Magliano DJ, 2008, DIABETOLOGIA, V51, P2179, DOI 10.1007/s00125-008-1150-5; Magliano DJ, 2009, AUST NZ J PUBL HEAL, V33, P540, DOI 10.1111/j.1753-6405.2009.00450.x; McCulloch B, 2003, SELF REPORTED DIABET, P26397; McDermott R, 2000, MED J AUSTRALIA, V172, P480, DOI 10.5694/j.1326-5377.2000.tb124071.x; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; O'Dea K, 2007, MED J AUSTRALIA, V186, P494, DOI 10.5694/j.1326-5377.2007.tb01020.x; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Seuring T, 2015, PHARMACOECONOMICS, V33, P811, DOI 10.1007/s40273-015-0268-9; Shaw J., 2012, DIABETES SILENT PAND; Tanamas S, 2013, AUSTR DIABETES OBESI, P59; Tanamas S.K., 2012, AUSDIAB 2012 AUSTR D; Taylor H, 2013, ROADMAP CLOSE GAP VI, P1; Welborn T, 1995, MJA, V163; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; WHO, 2016, GLOB REP PSOR; Xie J, 2011, CLIN EXP OPHTHALMOL, V39, P487, DOI 10.1111/j.1442-9071.2011.02502.x; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	31	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169211	10.1371/journal.pone.0169211	http://dx.doi.org/10.1371/journal.pone.0169211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2QJ	28045990	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300143
J	Martorelli, L; Garbaccio, S; Vilte, DA; Albanese, AA; Mejias, MP; Palermo, MS; Mercado, EC; Ibarra, CE; Cataldi, AA				Martorelli, Luisina; Garbaccio, Sergio; Vilte, Daniel A.; Albanese, Adriana A.; Mejias, Maria P.; Palermo, Marina S.; Mercado, Elsa C.; Ibarra, Cristina E.; Cataldi, Angel A.			Immune Response in Calves Vaccinated with Type Three Secretion System Antigens and Shiga Toxin 2B Subunit of Escherichia coli O157:H7	PLOS ONE			English	Article							POLYMERIC BACTERIAL PROTEIN; B-SUBUNIT; ANTIBODY-RESPONSES; LUMAZINE SYNTHASE; EXPERIMENTAL-INFECTION; HEMOLYTIC-ACTIVITY; ORAL IMMUNIZATION; MULTIPLE DISPLAY; GAMMA-INTIMIN; O157-H7	Ruminants are the primary reservoir of Shiga-toxin producing Escherichia coli (STEC) O157:H7 and the main source of infection for humans. The aim of this study was to assess the immunogenic properties of a candidate vaccine consisting on the recombinant proteins of E. coli O157:H7 IntiminC(280), the carboxy-terminal fraction of Intimin y, EspB and the fusion protein between the B subunit of Stx2 and Brucella Lumazine Synthase (BLS)(BLSStx2B), in Holstein Fresian calves.To accomplish this goal we vaccinated calves with two doses of different vaccine formulations: 2 antigens (IntiminC(280), EspB), 3 antigens (IntiminC280, EspB, BLS-Stx2B), BLS-Stx2B alone and a control non-vaccinated group. All antigens were expressed as recombinant proteins in E. coli. Specific IgG titres increased in vaccinated calves and the inclusion of BLS-Stx2B in the formulation seems to have a stimulatory effect on the humoral response to IntiminC280 and EspB after the booster. The neutralizing activity of antibodies against these two antigens was assessed in Red Blood Cell lysis assays and adherence to Hep-2 cells as a correlate of T355 activity. Both sera from animals vaccinated with 2 or 3 antigens inhibited both virulence properties. Serological response to Stx2 was observed in animals vaccinated only with BLS-Stx2B and with 3 antigens and neutralization of Stx2 cytotoxicity was also observed in both groups. In conclusion, immunization of calves with BLS-Stx2B, IntiminC280 and EspB elicited a potent humoral response able to neutralize Shiga toxin 2 cytotoxity and the T3SS virulence properties in vitro. These results suggest that this formulation is a good candidate vaccine to reduce STEC shedding in cattle and needs to be further assessed in vivo.	[Martorelli, Luisina; Garbaccio, Sergio; Vilte, Daniel A.; Mercado, Elsa C.] Inst Nacl Tecnol Agr, Inst Patobiol, Ctr Invest Ciencias Vet & Agron, Hurlingham, Argentina; [Albanese, Adriana A.] Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Fisiopatogenia, Buenos Aires, DF, Argentina; [Mejias, Maria P.; Palermo, Marina S.] Acad Nacl Med Buenos Aires, CONICET, Inst Med Expt, IMEX,Lab Patogenesis & Inmunol Proc Infecciosos, Buenos Aires, DF, Argentina; [Cataldi, Angel A.] Inst Nacl Tecnol Agr, Ctr Invest Ciencias Vet & Agron, Inst Biotecnol, Hurlingham, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); University of Buenos Aires; Buenos Aires National Academy of Medicine; IMEX - Instituto de Medicina Experimental; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional de Tecnologia Agropecuaria (INTA)	Cataldi, AA (corresponding author), Inst Nacl Tecnol Agr, Ctr Invest Ciencias Vet & Agron, Inst Biotecnol, Hurlingham, Argentina.	cataldi.angeladrian@inta.gob.ar		Ibarra, Cristina/0000-0001-8182-501X	ANPCYT-FONCYT [2012-0118]	ANPCYT-FONCYT(ANPCyTFONCyT)	This work was supported by the grant ANPCYT-FONCYT Grant number: 2012-0118 Finished in Octobre 2015 (www.agencia.mincyt. gob.ar/frontend/agencia/fondo/foncyt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agin TS, 2005, INFECT IMMUN, V73, P6608, DOI 10.1128/IAI.73.10.6608-6619.2005; Alvarez P, 2013, VACCINE, V31, P806, DOI 10.1016/j.vaccine.2012.11.072; Asper DJ, 2011, CLIN VACCINE IMMUNOL, V18, P1052, DOI 10.1128/CVI.00068-11; Basu I, 2003, INFECT IMMUN, V71, P327, DOI 10.1128/IAI.71.1.327-334.2003; Bergner PM, 2006, J IMMUNOL, V176, P2366, DOI 10.4049/jimmunol.176.4.2366; Bretschneider G, 2007, VET IMMUNOL IMMUNOP, V118, P229, DOI 10.1016/j.vetimm.2007.06.005; Carvalho HM, 2005, INFECT IMMUN, V73, P2541, DOI 10.1128/IAI.73.4.2541-2546.2005; Cataldi A, 2008, VACCINE, V26, P5662, DOI 10.1016/j.vaccine.2008.07.027; Craig PO, 2005, PROTEINS, V61, P1089, DOI 10.1002/prot.20635; CRAY WC, 1995, APPL ENVIRON MICROB, V61, P1586, DOI 10.1128/AEM.61.4.1586-1590.1995; Creydt VP, 2006, MICROBES INFECT, V8, P410, DOI 10.1016/j.micinf.2005.07.005; Creydt VP, 2004, BRAZ J MED BIOL RES, V37, P799, DOI 10.1590/S0100-879X2004000600004; Daniell SJ, 2003, MOL MICROBIOL, V49, P301, DOI 10.1046/j.1365-2958.2003.03555.x; Dean-Nystrom EA, 2002, INFECT IMMUN, V70, P2414, DOI 10.1128/IAI.70.5.2414-2418.2002; Dziva F, 2007, VET MICROBIOL, V123, P254, DOI 10.1016/j.vetmic.2007.02.016; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Fragoso G, 2011, CLIN VACCINE IMMUNOL, V18, P1067, DOI 10.1128/CVI.05030-11; Frohlich J, 2009, APPL ENVIRON MICROB, V75, P3695, DOI 10.1128/AEM.02869-08; Gansheroff LJ, 1999, INFECT IMMUN, V67, P6409; Girard F, 2005, INFECT IMMUN, V73, P6005, DOI 10.1128/IAI.73.9.6005-6016.2005; Grauke LJ, 2002, APPL ENVIRON MICROB, V68, P2269, DOI 10.1128/AEM.68.5.2269-2277.2002; Hoffman MA, 2006, CLIN VACCINE IMMUNOL, V13, P1322, DOI 10.1128/CVI.00205-06; Hussein HS, 2005, J FOOD PROTECT, V68, P2224, DOI 10.4315/0362-028X-68.10.2224; JACKSON MP, 1987, FEMS MICROBIOL LETT, V44, P109, DOI 10.1016/0378-1097(87)90210-2; Johnson RP, 1996, INFECT IMMUN, V64, P1879, DOI 10.1128/IAI.64.5.1879-1883.1996; Joris MA, 2013, APPL ENVIRON MICROB, V79, P3677, DOI 10.1128/AEM.01029-13; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; Karpman D, 1997, J INFECT DIS, V175, P611, DOI 10.1093/infdis/175.3.611; Kerner K, 2015, VET RES, V46, DOI 10.1186/s13567-015-0175-2; Kitova EN, 2005, J AM SOC MASS SPECTR, V16, P1957, DOI 10.1016/j.jasms.2005.07.016; Knappstein S, 2004, INFECT IMMUN, V72, P4344, DOI 10.1128/IAI.72.8.4344-4350.2004; Kudva IT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-103; Laplagne DA, 2004, PROTEINS, V57, P820, DOI 10.1002/prot.20248; Li YL, 2000, INFECT IMMUN, V68, P5090, DOI 10.1128/IAI.68.9.5090-5095.2000; Marcato P, 2001, J INFECT DIS, V183, P435, DOI 10.1086/318080; Martinez MB, 1999, J INFECT DIS, V179, P269, DOI 10.1086/314549; Martorelli L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/290679; Matthews L, 2013, P NATL ACAD SCI USA, V110, P16265, DOI 10.1073/pnas.1304978110; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; McKee ML, 1996, INFECT IMMUN, V64, P2225, DOI 10.1128/IAI.64.6.2225-2233.1996; McNeilly TN, 2010, VACCINE, V28, P1422, DOI 10.1016/j.vaccine.2009.10.076; Meichtri L, 2004, INT J FOOD MICROBIOL, V96, P189, DOI 10.1016/j.ijfoodmicro.2004.03.018; Mejias MP, 2013, J IMMUNOL, V191, P2403, DOI 10.4049/jimmunol.1300999; Menge C, 1999, INFECT IMMUN, V67, P2209, DOI 10.1128/IAI.67.5.2209-2217.1999; Menge C, 2004, INFECT IMMUN, V72, P1896, DOI 10.1128/IAI.72.4.1896-1905.2004; Miyazawa H, 1999, CLIN DIAGN LAB IMMUN, V6, P701, DOI 10.1128/CDLI.6.5.701-704.1999; Naylor SW, 2007, APPL ENVIRON MICROB, V73, P3765, DOI 10.1128/AEM.02670-06; Nougayrede JP, 2003, CELL MICROBIOL, V5, P359, DOI 10.1046/j.1462-5822.2003.00281.x; Ochoa TJ, 2003, INFECT IMMUN, V71, P5149, DOI 10.1128/IAI.71.9.5149-5155.2003; Olsen SJ, 2002, EMERG INFECT DIS, V8, P370, DOI 10.3201/eid0804.000218; Mejias MP, 2014, INFECT IMMUN, V82, P1491, DOI 10.1128/IAI.00027-14; PIRRO F, 1995, VET MICROBIOL, V43, P131, DOI 10.1016/0378-1135(94)00089-F; Potter AA, 2004, VACCINE, V22, P362, DOI 10.1016/j.vaccine.2003.08.007; Rabinovitz BC, 2014, VACCINE, V32, P3823, DOI 10.1016/j.vaccine.2014.04.073; Rabinovitz BC, 2012, J DAIRY SCI, V95, P3318, DOI 10.3168/jds.2011-5093; Repetto HA, 2005, KIDNEY INT, V68, pS102, DOI 10.1111/j.1523-1755.2005.09717.x; Robinson CM, 2006, P NATL ACAD SCI USA, V103, P9667, DOI 10.1073/pnas.0602359103; Rosas G, 2006, MICROBES INFECT, V8, P1277, DOI 10.1016/j.micinf.2005.12.006; Sanderson MW, 1999, VET MICROBIOL, V69, P199, DOI 10.1016/S0378-1135(99)00106-6; Smith DR, 2008, FOODBORNE PATHOG DIS, V5, P589, DOI 10.1089/fpd.2008.0080; TAKAHARA H, 1983, TOHOKU J EXP MED, V139, P265, DOI 10.1620/tjem.139.265; TESH VL, 1991, MOL MICROBIOL, V5, P1817, DOI 10.1111/j.1365-2958.1991.tb00805.x; van Diemen PM, 2007, VET IMMUNOL IMMUNOP, V116, P47, DOI 10.1016/j.vetimm.2006.12.009; Vilte DA, 2012, VET IMMUNOL IMMUNOP, V146, P169, DOI 10.1016/j.vetimm.2012.03.002; Vilte DA, 2008, CLIN VACCINE IMMUNOL, V15, P1208, DOI 10.1128/CVI.00027-08; Vilte DA, 2011, VACCINE, V29, P3962, DOI 10.1016/j.vaccine.2011.03.079; Warawa J, 1999, INFECT IMMUN, V67, P5538, DOI 10.1128/IAI.67.10.5538-5540.1999; Wen SX, 2006, VACCINE, V24, P1142, DOI 10.1016/j.vaccine.2005.08.094	69	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169422	10.1371/journal.pone.0169422	http://dx.doi.org/10.1371/journal.pone.0169422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046078	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300188
J	Roy, S; Das, KP				Roy, Sujit; Das, Kali Pada			Homologous Recombination Defective Arabidopsis Mutants Exhibit Enhanced Sensitivity to Abscisic Acid	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-POLYMERASE LAMBDA; HISTONE H2AX; GENOTOXIC STRESS; GENE-EXPRESSION; ATPOL-LAMBDA; CELL-CYCLE; REPAIR; ATM; GENOME	Abscisic acid (ABA) acts as an important plant hormone in regulating various aspects of plant growth and developmental processes particularly under abiotic stress conditions. An increased ABA level in plant cells inhibits DNA replication and cell division, causing plant growth retardation. In this study, we have investigated the effects of ABA on the growth responses of some major loss-of-function mutants of DNA double-stand break (DSB) repair genes in Arabidopsis during seed germination and early stages of seedling growth for understanding the role of ABA in the induction of genome instability in plants. A comparative analysis of ABA sensitivity of wild-type Arabidopsis and the knockout mutant lines related to DSB sensors, including atatm, atatr, the non-homologous end joining (NHEJ) pathway genes, and mutants related to homologous recombination (HR) pathway genes showed relatively enhanced sensitivity of atatr and HR-related mutants to ABA treatment. The expression levels of HR-related genes were increased in wild type Arabidopsis (Col-O) during seed germination and early stages of seedling growth. Immunoblotting experiments detected phosphorylation of histone H2AX in wild-type (Col-O) and DSB repair gene mutants after ABA treatment, indicating the activation of DNA damage response due to ABA treatment. Analyses of DSB repair kinetics using comet assay under neutral condition have revealed comparatively slower DSB repair activity in HR mutants. Overall, our results have provided comprehensive information on the possible effect of ABA on DNA repair machinery in plants and also indicated potential functional involvement of HR pathway in repairing ABA induced DNA damage in Arabidopsis.	[Roy, Sujit; Das, Kali Pada] Bose Inst, Dept Chem, Prot Chem Lab, Kolkata, India; [Roy, Sujit] Univ Burdwan, Dept Bot, UGC Ctr Adv Study, Golapbag Campus, Burdwan, W Bengal, India	Department of Science & Technology (India); Bose Institute; University of Burdwan	Roy, S (corresponding author), Bose Inst, Dept Chem, Prot Chem Lab, Kolkata, India.; Roy, S (corresponding author), Univ Burdwan, Dept Bot, UGC Ctr Adv Study, Golapbag Campus, Burdwan, W Bengal, India.	sujitroy2006@gmail.com		Das, Kali/0000-0001-7686-9077	Council of Scientific and Industrial Research (CSIR), Govt. of India [13(8611-A)/2013-Pool]; Bose Institute	Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); Bose Institute(Department of Science & Technology (India))	This work was supported by a research grant from the Council of Scientific and Industrial Research (CSIR) (ref. no. 13(8611-A)/2013-Pool), Govt. of India to SR and funding from Bose Institute to KPD.	Albinsky D, 1999, PLANT J, V17, P73, DOI 10.1046/j.1365-313X.1999.00354.x; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Amiard S, 2010, PLANT CELL, V22, P3020, DOI 10.1105/tpc.110.078527; Bailly C, 2008, CR BIOL, V331, P806, DOI 10.1016/j.crvi.2008.07.022; Barzel A, 2008, NAT REV GENET, V9, P27, DOI 10.1038/nrg2224; BOSTOCK RM, 1992, PLANT PHYSIOL, V98, P1356, DOI 10.1104/pp.98.4.1356; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Bradbury JM, 2003, CURR BIOL, V13, pR468, DOI 10.1016/S0960-9822(03)00403-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Charbonnel C, 2010, PLANT J, V64, P280, DOI 10.1111/j.1365-313X.2010.04331.x; Culligan KM, 2008, PLANT J, V55, P629, DOI 10.1111/j.1365-313X.2008.03530.x; Culligan KM, 2006, PLANT J, V48, P947, DOI 10.1111/j.1365-313X.2006.02931.x; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dewitte W, 2003, ANNU REV PLANT BIOL, V54, P235, DOI 10.1146/annurev.arplant.54.031902.134836; Dona M, 2013, PLANT CELL REP, V32, P1043, DOI 10.1007/s00299-013-1410-9; Doutriaux MP, 1998, MOL GEN GENET, V257, P283, DOI 10.1007/s004380050649; Edlinger B, 2011, J EXP BOT, V62, P1545, DOI 10.1093/jxb/erq421; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Farah JA, 2005, GENETICS, V169, P1261, DOI 10.1534/genetics.104.037515; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Friesner JD, 2005, MOL BIOL CELL, V16, P2566, DOI 10.1091/mbc.E04-10-0890; Gallego ME, 2003, PLANT CELL, V15, P782, DOI 10.1105/tpc.008623; Hauser F, 2011, CURR BIOL, V21, pR346, DOI 10.1016/j.cub.2011.03.015; He JN, 2012, PLANT CELL, V24, P1815, DOI 10.1105/tpc.112.098707; Heacock M, 2004, EMBO J, V23, P2304, DOI 10.1038/sj.emboj.7600236; Hettiarachchi GHCM, 2005, PLANT CELL PHYSIOL, V46, P1154, DOI 10.1093/pcp/pci114; Jeggo PA, 2011, RADIOTHER ONCOL, V101, P7, DOI 10.1016/j.radonc.2011.06.019; Jenik PD, 2005, PLANT CELL, V17, P3362, DOI 10.1105/tpc.105.036889; Kim J, 2010, PLANT PHYSIOL, V154, P611, DOI 10.1104/pp.110.162271; Kobayashi J, 2008, J RADIAT RES, V49, P93, DOI 10.1269/jrr.07130; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; Kozak J, 2009, DNA REPAIR, V8, P413, DOI 10.1016/j.dnarep.2008.11.012; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Lang J, 2012, NEW PHYTOL, V194, P353, DOI 10.1111/j.1469-8137.2012.04062.x; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Li J, 2007, GENETICS, V176, P1469, DOI 10.1534/genetics.106.062604; Li WX, 2004, P NATL ACAD SCI USA, V101, P10596, DOI 10.1073/pnas.0404110101; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu PF, 2008, BBA-GENE REGUL MECH, V1779, P402, DOI 10.1016/j.bbagrm.2008.05.002; Liu PF, 2008, BIOCHIM BIOPHYS ACTA, V1769, P443; Liu Y, 2010, J BUS RES, V63, P3, DOI 10.1016/j.jbusres.2009.01.005; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Orel N, 2003, PLANT J, V35, P604, DOI 10.1046/j.1365-313X.2003.01832.x; Osakabe K, 2006, PLANT J, V48, P827, DOI 10.1111/j.1365-313X.2006.02927.x; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Reidt W, 2006, EMBO J, V25, P4326, DOI 10.1038/sj.emboj.7601313; Riha K, 2002, EMBO J, V21, P2819, DOI 10.1093/emboj/21.11.2819; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roy S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00487; Roy S, 2013, PLANT PHYSIOL, V162, P1195, DOI 10.1104/pp.113.219022; Roy S, 2011, PLANT CELL PHYSIOL, V52, P448, DOI 10.1093/pcp/pcr002; Samach A, 2011, PLANT CELL, V23, P4266, DOI 10.1105/tpc.111.091744; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanchez MD, 2005, J EXP BOT, V56, P515, DOI 10.1093/jxb/eri029; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Sinha M, 2009, EPIGENOMICS-UK, V1, P371, DOI 10.2217/epi.09.22; STEWART GR, 1972, J EXP BOT, V23, P875, DOI 10.1093/jxb/23.4.875; Swiatek A, 2002, PLANT PHYSIOL, V128, P201, DOI 10.1104/pp.010592; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004; Wang H, 2000, PLANT J, V24, P613, DOI 10.1046/j.1365-313x.2000.00899.x; Wang L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002172; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Waterworth WM, 2011, NEW PHYTOL, V192, P805, DOI 10.1111/j.1469-8137.2011.03926.x; West CE, 2004, BIOCHEM SOC T, V32, P964, DOI 10.1042/BST0320964; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yao TX, 2013, J GENET GENOMICS, V40, P465, DOI 10.1016/j.jgg.2013.05.006; Yin HB, 2009, PLANT CELL, V21, P386, DOI 10.1105/tpc.108.061549; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zucca E, 2013, NUCLEIC ACIDS RES, V41, P229, DOI 10.1093/nar/gks1016	74	7	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169294	10.1371/journal.pone.0169294	http://dx.doi.org/10.1371/journal.pone.0169294			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046013	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300161
J	Lee, H; Ku, HJ; Lee, DH; Kim, YT; Shin, H; Ryu, S; Lee, JH				Lee, Heyn; Ku, Hye-Jin; Lee, Dong-Hoon; Kim, You-Tae; Shin, Hakdong; Ryu, Sangryeol; Lee, Ju-Hoon			Characterization and Genomic Study of the Novel Bacteriophage HY01 Infecting Both Escherichia coli O157:H7 and Shigella flexneri: Potential as a Biocontrol Agent in Food	PLOS ONE			English	Article							SALMONELLA-ENTERICA; PHAGE; SEQUENCE; INACTIVATION; ARTEMIS; PROTEIN; BLAST	Background Escherichia coli O157:H7 and Shigella flexneri are well-known food-borne pathogens causing severe food poisoning at low infectious doses. Bacteriophages have been approved for food applications by the US Food and Drug Administration (FDA) and have been suggested as natural food preservatives to control specific food-borne pathogens. To develop a novel natural food preservative against E. coli O157:H7 and S. flexneri, a new bacteriophage needs to be isolated and characterized. Methodology/Principal Findings Bacteriophage HY01 infecting both E. coli O157:H7 and S. flexneri was isolated from a swine fecal sample. HY01 belongs to the family Myoviridae and is stable under various temperature and pH conditions. One-step growth curve analysis showed relatively short eclipse and latent periods as well as large burst size. The 167-kb genome sequence of HY01 was sequenced, and a comparative genome analysis with T4 for non-O157:H7 E. coli suggests that the receptor recognition protein of HY01 plays an important role in determination of host recognition and specificity. In addition, food applications using edible cabbage were conducted with two E. coli O157:H7 strains (ATCC 43890 and ATCC 43895), showing that treatment with HY01 inhibits these clinical and food isolates with > 2 log reductions in bacterial load during the first 2 h of incubation. Conclusions/Significance HY01 can inhibit both E. coli O157:H7 and S. flexneri with large burst size and stability under stress conditions. The ability of HY01 to infect both E. coli O157:H7 and S. flexneri may be derived from the presence of two different host specificity-associated tail genes in the genome. Food applications revealed the specific ability of HY01 to inhibit both pathogens in food, suggesting its potential as a novel biocontrol agent or novel natural food preservative against E. coli O157:H7 and potentially S. flexneri.	[Lee, Heyn; Ku, Hye-Jin; Lee, Dong-Hoon; Kim, You-Tae; Lee, Ju-Hoon] Kyung Hee Univ, Dept Food Sci & Biotechnol, Yongin, South Korea; [Lee, Heyn; Ku, Hye-Jin; Lee, Dong-Hoon; Kim, You-Tae; Lee, Ju-Hoon] Kyung Hee Univ, Inst Life Sci & Resources, Yongin, South Korea; [Shin, Hakdong; Ryu, Sangryeol] Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Food & Anim Biotechnol, Dept Agr Biotechnol, Seoul, South Korea; [Shin, Hakdong] Sejong Univ, Fac Food Sci & Biotechnol, Coll Life Sci, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Seoul National University (SNU); Sejong University	Lee, JH (corresponding author), Kyung Hee Univ, Dept Food Sci & Biotechnol, Yongin, South Korea.; Lee, JH (corresponding author), Kyung Hee Univ, Inst Life Sci & Resources, Yongin, South Korea.	juhlee@khu.ac.kr	Lee, Ju-Hoon/AAK-7256-2020	Kim, You-Tae/0000-0002-3787-6730	Public Welfare & Safety research program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2012M3A2A1051681]	Public Welfare & Safety research program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by the Public Welfare & Safety research program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2012M3A2A1051681).	Abuladze T, 2008, APPL ENVIRON MICROB, V74, P6230, DOI 10.1128/AEM.01465-08; Altermann Eric, 2003, OMICS A Journal of Integrative Biology, V7, P161, DOI 10.1089/153623103322246557; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Brodie R, 2004, BIOINFORMATICS, V20, P279, DOI 10.1093/bioinformatics/btg406; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; DUCKWORTH DH, 1976, BACTERIOL REV, V40, P793, DOI 10.1128/MMBR.40.4.793-802.1976; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Huang GF, 2013, J NANOMATER, V2013, DOI 10.1155/2013/371356; Hudson JA, 2015, FOOD SCI TECHNOL INT, V21, P104, DOI 10.1177/1082013213513031; Jensen EC, 1998, APPL ENVIRON MICROB, V64, P575; Kim M, 2012, MOL MICROBIOL, V86, P411, DOI 10.1111/j.1365-2958.2012.08202.x; Kim M, 2011, APPL ENVIRON MICROB, V77, P2042, DOI 10.1128/AEM.02504-10; Kropinski Andrew M., 2009, V501, P69, DOI 10.1007/978-1-60327-164-6_7; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Liao WC, 2011, J VIROL, V85, P6567, DOI 10.1128/JVI.02378-10; LOESSNER MJ, 1994, J GEN VIROL, V75, P701, DOI 10.1099/0022-1317-75-4-701; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Mcvay CS, 2007, ANTIMICROB AGENTS CH, V51, P1934, DOI 10.1128/AAC.01028-06; Monk AB, 2010, LETT APPL MICROBIOL, V51, P363, DOI 10.1111/j.1472-765X.2010.02916.x; O'Flynn G, 2004, APPL ENVIRON MICROB, V70, P3417, DOI 10.1128/AEM.70.6.3417-3424.2004; Park M, 2012, APPL ENVIRON MICROB, V78, P58, DOI 10.1128/AEM.06231-11; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Wilcox SA, 1996, CHROMOSOME RES, V4, P397, DOI 10.1007/BF02257276; Yu SL, 2000, J BACTERIOL, V182, P5962, DOI 10.1128/JB.182.21.5962-5968.2000; Zhang H, 2013, POULTRY SCI, V92, P211, DOI 10.3382/ps.2011-02037	31	34	36	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168985	10.1371/journal.pone.0168985	http://dx.doi.org/10.1371/journal.pone.0168985			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036349	Green Submitted, Green Published, gold			2022-12-26	WOS:000391229300044
J	Klauke, N; Schaefer, HM; Bauer, M; Segelbacher, G				Klauke, Nadine; Schaefer, H. Martin; Bauer, Michael; Segelbacher, Gernot			Limited Dispersal and Significant Fine - Scale Genetic Structure in a Tropical Montane Parrot Species	PLOS ONE			English	Article							RAIN-FOREST BIRD; MULTILOCUS GENOTYPE DATA; ALLELE FREQUENCY DATA; POPULATION-STRUCTURE; CLIMATE-CHANGE; HABITAT FRAGMENTATION; CLOUD FORESTS; LANDSCAPE GENETICS; PYRRHURA-ORCESI; AMAZONIAN BIRDS	Tropical montane ecosystems are biodiversity hotspots harbouring many endemics that are confined to specific habitat types within narrow altitudinal ranges. While deforestation put these ecosystems under threat, we still lack knowledge about how heterogeneous environments like the montane tropics promote population connectivity and persistence. We investigated the fine-scale genetic structure of the two largest subpopulations of the endangered El Oro parakeet (Pyrrhura orcesi) endemic to the Ecuadorian Andes. Specifically, we assessed the genetic divergence between three sites separated by small geographic distances but characterized by a heterogeneous habitat structure. Although geographical distances between sites are small (3-17 km), we found genetic differentiation between all sites. Even though dispersal capacity is generally high in parrots, our findings indicate that dispersal is limited even on this small geographic scale. Individual genotype assignment revealed similar genetic divergence across a valley (similar to 3 km distance) compared to a continuous mountain range (similar to 13 km distance). Our findings suggest that geographic barriers promote genetic divergence even on small spatial scales in this endangered endemic species. These results may have important implications for many other threatened and endemic species, particularly given the upslope shift of species predicted from climate change.	[Klauke, Nadine; Schaefer, H. Martin; Bauer, Michael] Univ Freiburg, Fac Biol, Anim Ecol & Evolut, Freiburg, Germany; [Segelbacher, Gernot] Univ Freiburg, Fac Environm & Nat Resources, Wildlife Ecol & Management, Freiburg, Germany	University of Freiburg; University of Freiburg	Klauke, N (corresponding author), Univ Freiburg, Fac Biol, Anim Ecol & Evolut, Freiburg, Germany.	nadineklauke@gmail.com	Segelbacher, Gernot/F-3633-2011	Segelbacher, Gernot/0000-0002-8024-7008	Volkswagen Foundation; DFG [Scha 1008/7-1]; Loro Parque Fundacion	Volkswagen Foundation(Volkswagen); DFG(German Research Foundation (DFG)); Loro Parque Fundacion	NK was funded by the Volkswagen Foundation, HMS by the DFG (Scha 1008/7-1). Loro Parque Fundacion (http://www.loroparque-funacion.org/) provided financial support for the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all field assistants for their great help in data acquisition. We are grateful to Cesar Garzon (Museo Ecuatoriano de Ciencias Naturales, Quito) who conducted the global population monitoring and provided valuable information about the parakeets' recent distribution range. We thank Claudia Hermes who generously provided the geo-referenced layer of forest patches. In addition, we thank the team of the Fundacion Jocotoco (FJ) for their help and support during field work and Loro Parque Fundacion, the VW Foundation and the DFG for funding.	[Anonymous], 1992, THREATENED BIRDS AM; Bates JM, 2002, J AVIAN BIOL, V33, P276, DOI 10.1034/j.1600-048X.2002.330310.x; BirdLife International, 2014, SPEC FACTSH PYRRH OR; Botero-Delgadillo E, 2012, BIRD CONSERV INT, V22, P445, DOI 10.1017/S0959270912000196; Callens T, 2011, MOL ECOL, V20, P1829, DOI 10.1111/j.1365-294X.2011.05028.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cornuet JM, 1996, GENETICS, V144, P2001; Coulon A, 2008, MOL ECOL, V17, P1685, DOI 10.1111/j.1365-294X.2008.03705.x; Crochet PA, 2000, MOL ECOL, V9, P1463, DOI 10.1046/j.1365-294x.2000.01026.x; Dietrich M., 2003, THESIS; Dixo M, 2009, BIOL CONSERV, V142, P1560, DOI 10.1016/j.biocon.2008.11.016; DODSON CH, 1991, ANN MO BOT GARD, V78, P273, DOI 10.2307/2399563; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Falush D, 2003, GENETICS, V164, P1567; Fernandes AM, 2012, J BIOGEOGR, V39, P1524, DOI 10.1111/j.1365-2699.2012.02712.x; Foster P, 2001, EARTH-SCI REV, V55, P73, DOI 10.1016/S0012-8252(01)00056-3; Francisco MR, 2007, MOL ECOL, V16, P4908, DOI 10.1111/j.1365-294X.2007.03519.x; Frankham R., 2002, CONSERVATION GENETIC; Freeman BG, 2014, P NATL ACAD SCI USA, V111, P4490, DOI 10.1073/pnas.1318190111; Gelman A., 2007, DATA ANAL USING REGR; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guarnizo CE, 2009, MOL PHYLOGENET EVOL, V50, P84, DOI 10.1016/j.ympev.2008.10.005; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Gutierrez-Pinto N, 2012, MOL PHYLOGENET EVOL, V64, P156, DOI 10.1016/j.ympev.2012.03.011; Haas SE, 2010, SOUTHEAST NAT, V9, P743, DOI 10.1656/058.009.0409; Ibarra-Macias A, 2011, BIOL CONSERV, V144, P703, DOI 10.1016/j.biocon.2010.08.006; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kekkonen J, 2011, HEREDITY, V106, P183, DOI 10.1038/hdy.2010.32; Keller I, 2004, MOL ECOL, V13, P2983, DOI 10.1111/j.1365-294X.2004.02310.x; Keller LF, 2001, P ROY SOC B-BIOL SCI, V268, P1387, DOI 10.1098/rspb.2001.1607; Klauke N, 2014, BEHAV ECOL SOCIOBIOL, V68, P1037, DOI 10.1007/s00265-014-1716-9; Klauke N, 2013, MOL ECOL, V22, P2011, DOI 10.1111/mec.12219; Kupper C, 2012, MOL ECOL, V21, P5864, DOI 10.1111/mec.12064; Lawton RO, 2001, SCIENCE, V294, P584; Leite KCE, 2008, GENET MOL RES, V7, P819, DOI 10.4238/vol7-3gmr474; Loader C., 1999, LOCAL REGRESSION LIK; Mila B, 2009, MOL ECOL, V18, P2979, DOI 10.1111/j.1365-294X.2009.04251.x; Moore IT, 2005, BEHAV ECOL, V16, P755, DOI 10.1093/beheco/ari049; Moore RP, 2008, ECOL LETT, V11, P960, DOI 10.1111/j.1461-0248.2008.01196.x; Morueta-Holme N, 2015, P NATL ACAD SCI USA, V112, P12741, DOI 10.1073/pnas.1509938112; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; Nielsen JF, 2012, MOL ECOL, V21, P2788, DOI 10.1111/j.1365-294X.2012.05565.x; Nogueira DM, 2014, CONSERV GENET, V15, P1151, DOI 10.1007/s10592-014-0607-y; PATTON JL, 1992, EVOLUTION, V46, P174, DOI 10.1111/j.1558-5646.1992.tb01992.x; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Pavlacky DC, 2009, MOL ECOL, V18, P2945, DOI 10.1111/j.1365-294X.2009.04226.x; Paz-Vinas I, 2013, MOL ECOL, V22, P3279, DOI 10.1111/mec.12321; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2013, TRACER V1 5; RIDGELY RS, 1988, WILSON BULL, V100, P173; Robinson WD, 2012, J ORNITHOL, V153, pS141, DOI 10.1007/s10336-011-0806-y; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Ryman N, 2009, MOL ECOL, V18, P2084, DOI 10.1111/j.1365-294X.2009.04187.x; Salisbury CL, 2012, ECOL LETT, V15, P847, DOI 10.1111/j.1461-0248.2012.01806.x; Schaefer HM, 2003, CYANOPSITTA, V71, P10; Segelbacher G, 2003, MOL ECOL, V12, P1773, DOI 10.1046/j.1365-294X.2003.01873.x; Segelbacher G, 2002, MOL ECOL, V11, P1669, DOI 10.1046/j.1365-294X.2002.01565.x; Segelbacher G, 2008, MOL ECOL, V17, P2356, DOI 10.1111/j.1365-294X.2008.03767.x; Smith BJ, 2007, J STAT SOFTW, V21, P1; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Still CJ, 1999, NATURE, V398, P608, DOI 10.1038/19293; Storz JF, 2002, EVOLUTION, V56, P154; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Valderrama E, 2014, J BIOGEOGR, V41, P1533, DOI 10.1111/jbi.12317; Van Houtan KS, 2007, ECOL LETT, V10, P219, DOI 10.1111/j.1461-0248.2007.01004.x; Velo-Anton G, 2013, MOL ECOL, V22, P3261, DOI 10.1111/mec.12310; Weir JT, 2009, ANN MO BOT GARD, V96, P410, DOI 10.3417/2008011; Wilcove D.S., 1984, American Birds, V38, P10; Wilson GA, 2003, GENETICS, V163, P1177; Woltmann S, 2012, CONSERV GENET, V13, P925, DOI 10.1007/s10592-012-0341-2; Woxvold IA, 2006, MOL ECOL, V15, P3139, DOI 10.1111/j.1365-294X.2006.03009.x; Wright TF, 2005, MOL ECOL, V14, P1197, DOI 10.1111/j.1365-294X.2005.02466.x	81	11	11	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0169165	10.1371/journal.pone.0169165	http://dx.doi.org/10.1371/journal.pone.0169165			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033364	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900080
J	Stephen, AS; Millhouse, E; Sherry, L; Aduse-Opoku, J; Culshaw, S; Ramage, G; Bradshaw, DJ; Burnett, GR; Allaker, RP				Stephen, Abish S.; Millhouse, Emma; Sherry, Leighann; Aduse-Opoku, Joseph; Culshaw, Shauna; Ramage, Gordon; Bradshaw, David J.; Burnett, Gary R.; Allaker, Robert P.			In Vitro Effect of Porphyromonas gingivalis Methionine Gamma Lyase on Biofilm Composition and Oral Inflammatory Response	PLOS ONE			English	Article							EPITHELIAL-CELL RESPONSES; FUSOBACTERIUM-NUCLEATUM; METHYL MERCAPTAN; HYDROGEN-SULFIDE; SULFUR; MODEL; GINGIPAINS; COMMUNITY; BACTERIA; GROWTH	Methanethiol (methyl mercaptan) is an important contributor to oral malodour and periodontal tissue destruction. Porphyromonas gingivalis, Prevotella intermedia and Fusobacterium nucleatum are key oral microbial species that produce methanethiol via methionine gamma lyase (mgl) activity. The aim of this study was to compare an mgl knockout strain of P. gingivalis with its wild type using a 10-species biofilm co-culture model with oral keratinocytes and its effect on biofilm composition and inflammatory cytokine production. A P. gingivalis mgl knockout strain was constructed using insertion mutagenesis from wild type W50 with gas chromatographic head space analysis confirming lack of methanethiol production. 10-species biofilms consisting of Streptococcus mitis, Streptococcus oralis, Streptococcus intermedius, Fusobacterium nucleatum ssp polymorphum, Fusobacterium nucleatum ssp vincentii, Veillonella dispar, Actinomyces naeslundii, Prevotella intermedia and Aggregatibacter actinomycetemcomitans with either the wild type or mutant P. gingivalis were grown on Thermanox cover slips and used to stimulate oral keratinocytes (OKF6-TERT2), under anaerobic conditions for 4 and 24 hours. Biofilms were analysed by quantitative PCR with SYBR Green for changes in microbial ecology. Keratinocyte culture supernatants were analysed using a multiplex bead immunoassay for cytokines. Significant population differences were observed between mutant and wild type biofilms; V. dispar proportions increased (p<0.001), whilst A. naeslundii (p<0.01) and Streptococcus spp. (p<0.05) decreased in mutant biofilms. Keratinocytes produced less IL-8, IL-6 and IL-1 alpha when stimulated with the mutant biofilms compared to wild type. Lack of mgl in P. gingivalis has been shown to affect microbial ecology in vitro, giving rise to a markedly different biofilm composition, with a more pro-inflammatory cytokine response from the keratinocytes observed. A possible role for methanethiol in biofilm formation and cytokine response with subsequent effects on oral malodor and periodontitis is suggested.	[Stephen, Abish S.; Aduse-Opoku, Joseph; Allaker, Robert P.] Queen Mary Univ London, Blizard Inst, Res Ctr Clin & Diagnost Oral Sci, London, England; [Millhouse, Emma; Sherry, Leighann; Culshaw, Shauna; Ramage, Gordon] Univ Glasgow, Sch Dent, Infect & Immun Res Grp, Glasgow, Lanark, Scotland; [Bradshaw, David J.; Burnett, Gary R.] GlaxoSmithKline Consumer Healthcare, Weybridge, Surrey, England	University of London; Queen Mary University London; University of Glasgow; GlaxoSmithKline	Stephen, AS (corresponding author), Queen Mary Univ London, Blizard Inst, Res Ctr Clin & Diagnost Oral Sci, London, England.	a.s.stephen@qmul.ac.uk	Ramage, Gordon/AAX-1315-2020; Aduse-Opoku, Joseph/CAF-0056-2022	opoku, anita/0000-0001-7243-8157; Sherry, Leighann/0000-0002-0493-6135; Stephen, Abish/0000-0002-7912-7084	Biotechnology and Biological Sciences Research Council;  [Biotechnology and Biological Sciences Research Council and GlaxoSmithKline]; Biotechnology and Biological Sciences Research Council [1122532] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Biotechnology and Biological Sciences Research Council and GlaxoSmithKline. Biotechnology and Biological Sciences Research Council had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GlaxoSmithKline provided support in the form of salaries for authors [DB, GB]. The specific roles of these authors are articulated in the 'author contributions'.	Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Aduse-Opoku J, 2000, MICROBIOL-UK, V146, P1933, DOI 10.1099/00221287-146-8-1933; BAKKEN V, 1989, SCAND J DENT RES, V97, P42; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bostanci N, 2007, CYTOKINE, V39, P147, DOI 10.1016/j.cyto.2007.07.002; Bostanci N, 2007, ORAL MICROBIOL IMMUN, V22, P52; Bradshaw DJ, 1998, INFECT IMMUN, V66, P4729, DOI 10.1128/IAI.66.10.4729-4732.1998; Calkins CC, 1998, J BIOL CHEM, V273, P6611, DOI 10.1074/jbc.273.12.6611; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Dommisch H, 2012, J CLIN PERIODONTOL, V39, P913, DOI 10.1111/j.1600-051X.2012.01933.x; Engstrom KK, 2015, MOL ORAL MICROBIOL, V30, P62, DOI 10.1111/omi.12067; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Fletcher J, 1998, CURR MICROBIOL, V36, P216, DOI 10.1007/s002849900297; GHARBIA SE, 1989, CURR MICROBIOL, V19, P231, DOI 10.1007/BF01570167; Grein F, 2013, BBA-BIOENERGETICS, V1827, P145, DOI 10.1016/j.bbabio.2012.09.001; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hamedi M, 2009, CYTOKINE, V45, P99, DOI 10.1016/j.cyto.2008.11.005; Hendrickson EL, 2014, MICROBIOLOGYOPEN, V3, P729, DOI 10.1002/mbo3.204; Iciek M, 2001, POL J PHARMACOL, V53, P215; Kistler JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071227; Landaud S, 2008, APPL MICROBIOL BIOT, V77, P1191, DOI 10.1007/s00253-007-1288-y; Lee SF, 2009, INFECT IMMUN, V77, P694, DOI 10.1128/IAI.01004-08; Loozen G, 2011, MOL ORAL MICROBIOL, V26, P253, DOI 10.1111/j.2041-1014.2011.00615.x; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Malcolm J, 2016, J DENT RES, P1; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Merritt J, 2009, APPL ENVIRON MICROB, V75, P7725, DOI 10.1128/AEM.00916-09; Millhouse E, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-80; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; NG W, 1984, J DENT RES, V63, P994, DOI 10.1177/00220345840630071701; Park SN, 2011, J MICROBIOL, V49, P315, DOI 10.1007/s12275-011-1028-y; Periasamy S, 2009, J BACTERIOL, V191, P6804, DOI 10.1128/JB.01006-09; Periasamy S, 2009, APPL ENVIRON MICROB, V75, P3250, DOI 10.1128/AEM.02901-08; PERSSON S, 1990, ORAL MICROBIOL IMMUN, V5, P195, DOI 10.1111/j.1399-302X.1990.tb00645.x; Peyyala R, 2013, J DENT RES, V92, P235, DOI 10.1177/0022034512472508; Peyyala R, 2012, CYTOKINE, V58, P65, DOI 10.1016/j.cyto.2011.12.016; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Rangarajan M, 1997, BIOCHEM J, V323, P701, DOI 10.1042/bj3230701; Sanchez MC, 2014, J PERIODONTAL RES, V49, P20, DOI 10.1111/jre.12073; Sato D, 2009, IUBMB LIFE, V61, P1019, DOI 10.1002/iub.255; Stephen AS, 2014, ANAEROBE, V26, P53, DOI 10.1016/j.anaerobe.2014.01.007; Tada H, 2003, J DENT RES, V82, P796, DOI 10.1177/154405910308201007; Takeuchi H, SERINE PHOSPHATASE S; TANAKA H, 1985, ENZYME MICROB TECH, V7, P530, DOI 10.1016/0141-0229(85)90094-8; Tanaka T, 2014, COLD SPRING HARB PER, V6, P1; van der Reijden WA, 2010, INFECT GENET EVOL, V10, P1124, DOI 10.1016/j.meegid.2010.07.011; Wang M., 2010, COMP APPL SYST MOD I, V3, pV3; Yoshimura M, 2002, FEBS LETT, V523, P119, DOI 10.1016/S0014-5793(02)02958-7; Yoshimura M, 2000, INFECT IMMUN, V68, P6912, DOI 10.1128/IAI.68.12.6912-6916.2000; Zhang XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056346, 10.1371/journal.pone.0057885]	51	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0169157	10.1371/journal.pone.0169157	http://dx.doi.org/10.1371/journal.pone.0169157			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033374	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000391226900079
J	Hansen, GM; Belstrom, D; Nilsson, M; Helqvist, S; Nielsen, CH; Holmstrup, P; Tolker-Nielsen, T; Givskov, M; Hansen, PR				Hansen, Gorm Mork; Belstrom, Daniel; Nilsson, Martin; Helqvist, Steffen; Nielsen, Claus Henrik; Holmstrup, Palle; Tolker-Nielsen, Tim; Givskov, Michael; Hansen, Peter Riis			Pseudomonas aeruginosa Microcolonies in Coronary Thrombi from Patients with ST-Segment Elevation Myocardial Infarction	PLOS ONE			English	Article							POLYMORPHONUCLEAR LEUKOCYTES; ATHEROSCLEROTIC PLAQUES; IN-VIVO; INFECTION; BIOFILM; BACTERIA; DISEASE; PERIODONTITIS; INFLAMMATION; COHORT	Chronic infection is associated with an increased risk of atherothrombotic disease and direct bacterial infection of arteries has been suggested to contribute to the development of unstable atherosclerotic plaques. In this study, we examined coronary thrombi obtained in vivo from patients with ST-segment elevation myocardial infarction (STEMI) for the presence of bacterial DNA and bacteria. Aspirated coronary thrombi from 22 patients with STEMI were collected during primary percutaneous coronary intervention and arterial blood control samples were drawn from radial or femoral artery sheaths. Analyses were performed using 16S polymerase chain reaction and with next-generation sequencing to determine bacterial taxonomic classification. In selected thrombi with the highest relative abundance of Pseudomonas aeruginosa DNA, peptide nucleic acid fluorescence in situ hybridization (PNA-FISH) with universal and species specific probes was performed to visualize bacteria within thrombi. From the taxonomic analysis we identified a total of 55 different bacterial species. DNA from Pseudomonas aeruginosa represented the only species that was significantly associated with either thrombi or blood and was >30 times more abundant in thrombi than in arterial blood (p<0.0001). Whole and intact bacteria present as biofilm microcolonies were detected in selected thrombi using universal and P. aeruginosa-specific PNA-FISH probes. P. aeruginosa and vascular biofilm infection in culprit lesions may play a role in STEMI, but causal relationships remain to be determined.	[Hansen, Gorm Mork; Hansen, Peter Riis] Herlev & Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark; [Hansen, Gorm Mork; Nilsson, Martin; Tolker-Nielsen, Tim; Givskov, Michael] Univ Copenhagen, Fac Hlth & Med Sci, Dept Immunol & Microbiol, Costerton Biofilm Ctr, Copenhagen, Denmark; [Belstrom, Daniel; Holmstrup, Palle] Univ Copenhagen, Fac Hlth & Med Sci, Sect Periodontol, Dept Odontol, Copenhagen, Denmark; [Helqvist, Steffen] Rigshosp, Dept Cardiol, Univ Hosp, Copenhagen, Denmark; [Nielsen, Claus Henrik] Rigshosp, Inst Inflammat Res, Dept Infect Dis & Rheumatol, Univ Hosp, Copenhagen, Denmark; [Givskov, Michael] Nanyang Technol Univ, SCELSE, Singapore, Singapore	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Hansen, GM (corresponding author), Herlev & Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark.; Hansen, GM (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Immunol & Microbiol, Costerton Biofilm Ctr, Copenhagen, Denmark.	gorm.moerk.hansen@regionh.dk	Nilsson, Martin/AHH-2943-2022; Hansen, Peter Riis/AAR-7659-2020	Tolker-Nielsen, Tim/0000-0002-9751-474X; Nielsen, Claus Henrik/0000-0001-7543-9016; Givskov, Michael/0000-0001-5004-8609; Mork Hansen, Gorm/0000-0002-6000-8835; Hansen, Peter Riis/0000-0002-9056-535X	University of Copenhagen, Faculty of Health and Medical Sciences [624-0013/12-3000]; Danish Heart Foundation [14-R97-A5031-22857]; LEO Foundation	University of Copenhagen, Faculty of Health and Medical Sciences; Danish Heart Foundation; LEO Foundation(LEO Pharma)	This work was supported by grants from University of Copenhagen, Faculty of Health and Medical Sciences (http://www.ku.dk/english; 624-0013/12-3000; Receiver MG); The Danish Heart Foundation (http://www.hjerteforeningen.dk/; 14-R97-A5031-22857; Receiver GMH). PRH was supported by an unrestricted grant from the LEO Foundation (http://leo-foundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi G, 2015, ATHEROSCLEROSIS, V241, P555, DOI 10.1016/j.atherosclerosis.2015.04.819; Abbood HM, 2016, J PERIODONTOL, V13, P1; Alhede M, 2009, MICROBIOL-SGM, V155, P3500, DOI 10.1099/mic.0.031443-0; Anderson JL, 2004, TEX HEART I J, V31, P33; Belstrom D, 2014, J CLIN PERIODONTOL, V41, P104, DOI 10.1111/jcpe.12190; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; Calandrini CA, 2014, ORAL DIS, V20, pe128, DOI 10.1111/odi.12205; Campbell LA, 2015, ARCH MED RES, V46, P339, DOI 10.1016/j.arcmed.2015.05.006; Chiang WC, 2013, ANTIMICROB AGENTS CH, V57, P2352, DOI 10.1128/AAC.00001-13; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Coumbe AG, 2014, AM J MED, V127, P12, DOI 10.1016/j.amjmed.2013.08.013; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Erlinge D, 2015, EUR HEART J-CARD IMG, V16, P316, DOI 10.1093/ehjci/jeu180; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Fazli M, 2014, METHODS MOL BIOL, V1211, P261, DOI 10.1007/978-1-4939-1459-3_21; Hansen GM, 2016, AM J CARDIOL, V118, P489, DOI 10.1016/j.amjcard.2016.05.036; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hirsch EB, 2010, EXPERT REV PHARM OUT, V10, P441, DOI [10.1586/erp.10.49, 10.1586/ERP.10.49]; Huber P, 2016, ENV MICROBI IN PRESS; Kozarov EV, 2005, ARTERIOSCL THROM VAS, V25, pE17, DOI 10.1161/01.ATV.0000155018.67835.1a; Lanter BB, 2014, MBIO, V5, DOI 10.1128/mBio.01206-14; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Mitra S, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0100-y; Nurmohamed MT, 2015, NAT REV RHEUMATOL, V11, P693, DOI 10.1038/nrrheum.2015.112; Ohki T, 2012, AM HEART J, V163, P164, DOI 10.1016/j.ahj.2011.10.012; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Pessi T, 2013, CIRCULATION, V127, P1219, DOI 10.1161/CIRCULATIONAHA.112.001254; Qadri SM, 2016, J CELL MOL MED, V20, P710, DOI 10.1111/jcmm.12778; Reyes L, 2013, J PERIODONTOL, V84, pS30, DOI [10.1902/jop.2013.1340012, 10.1111/jcpe.12079]; Rosenfeld ME, 2011, THROMB HAEMOSTASIS, V106, P858, DOI 10.1160/TH11-06-0392; Rybtke M, 2015, J MOL BIOL, V427, P3628, DOI 10.1016/j.jmb.2015.08.016; Silva WSE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109761; Sessa R, 2014, WORLD J CLIN CASES, V2, P240, DOI 10.12998/wjcc.v2.i7.240; Snow DE, 2016, J WOUND CARE, V25, pS16, DOI 10.12968/jowc.2016.25.Sup2.S16; Souto R, 2014, BRAZ J MICROBIOL, V45, P495, DOI 10.1590/S1517-83822014000200017; Turkay C, 2004, CLIN MICROBIOL INFEC, V10, P705, DOI 10.1111/j.1469-0691.2004.00920.x; van Gennip M, 2012, INFECT IMMUN, V80, P2601, DOI 10.1128/IAI.06215-11; Van Gennip M, 2009, APMIS, V117, P537, DOI 10.1111/j.1600-0463.2009.02466.x; Velsko IM, 2011, PLOS ONE, V9; Wang LX, 2016, INT J CARDIOL, V223, P121, DOI 10.1016/j.ijcard.2016.07.260	42	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168771	10.1371/journal.pone.0168771	http://dx.doi.org/10.1371/journal.pone.0168771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030624	Green Published, Green Submitted, gold			2022-12-26	WOS:000391222000076
J	Shi, CS; Kehrl, JH				Shi, Chong-Shan; Kehrl, John H.			Cytochrome c Negatively Regulates NLRP3 Inflammasomes	PLOS ONE			English	Article							ACTIVATION; APOPTOSIS; MITOCHONDRIA; CARDIOLIPIN; PLATFORM; NEK7; COMPONENT; PROTEIN	The release of cytochrome c from the inner mitochondrial membrane, where it is anchored by caridolipin, triggers the formation of the Apaf-1 apoptosome. Cardiolipin also interacts with NLRP3 recruiting NLRP3 to mitochondria and facilitating inflammasome assembly. In this study we investigated whether cytosolic cytochrome c impacts NLRP3 inflammasome activation in macrophages. We report that cytochrome c binds to the LRR domain of NLRP3 and that cytochrome c reduces the interactions between NLRP3 and cardiolipin and between NLRP3 and NEK7, a recently recognized component of the NLRP3 inflammasome needed for NLRP3 oligomerization. Protein transduction of cytochrome c impairs NLRP3 inflammasome activation, while partially silencing cytochrome c expression enhances it. The addition of cytochrome c to an in vitro inflammasome assay severely limited caspase-1 activation. We propose that there is a crosstalk between the NLRP3 inflammasome and apoptosome pathways mediated by cytochrome c, whose release during apoptosis acts to limit NLRP3 inflammasome activation.	[Shi, Chong-Shan; Kehrl, John H.] NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shi, CS (corresponding author), NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	cshi@niaid.nih.gov	Kehrl, John/AAE-6292-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000739] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Germain M, 2002, J BIOL CHEM, V277, P18053, DOI 10.1074/jbc.M201235200; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Labbe K, 2011, IMMUNITY, V35, P897, DOI 10.1016/j.immuni.2011.10.016; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Shi HX, 2016, NAT IMMUNOL, V17, P250, DOI 10.1038/ni.3333; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Sutterwala FS, 2014, ANN NY ACAD SCI, P2014; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wang XD, 2001, GENE DEV, V15, P2922; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	24	14	15	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167636	10.1371/journal.pone.0167636	http://dx.doi.org/10.1371/journal.pone.0167636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030552	gold, Green Published, Green Submitted			2022-12-26	WOS:000391222000013
J	Pereira, N; Cardone, C; Lassoued, S; Galloux, M; Fix, J; Assrir, N; Lescop, E; Bontems, F; Eleouet, JF; Sizun, C				Pereira, Nelson; Cardone, Christophe; Lassoued, Safa; Galloux, Marie; Fix, Jenna; Assrir, Nadine; Lescop, Ewen; Bontems, Francois; Eleouet, Jean-Francois; Sizun, Christina			New Insights into Structural Disorder in Human Respiratory Syncytial Virus Phosphoprotein and Implications for Binding of Protein Partners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARAMAGNETIC RELAXATION ENHANCEMENT; MULTIPLE SEQUENCE ALIGNMENTS; P-PROTEIN; N-PROTEIN; FUNCTIONAL-CHARACTERIZATION; POLYMERASE COMPLEX; INFECTED CELLS; M2-1 PROTEIN; RNA; IDENTIFICATION	Phosphoprotein is the main cofactor of the viral RNA polymerase of Mononegavirales. It is involved in multiple interactions that are essential for the polymerase function. Most prominently it positions the polymerase complex onto the nucleocapsid, but also acts as a chaperone for the nucleoprotein. Mononegavirales phosphoproteins lack sequence conservation, but contain all large disordered regions. We show here that Nand Cterminal intrinsically disordered regions account for 80% of the phosphoprotein of the respiratory syncytial virus. But these regions display marked dynamic heterogeneity. Whereas almost stable helices are formed C terminally to the oligomerization domain, extremely transient helices are present in the N terminal region. They all mediate internal long range contacts in this non globular protein. Transient secondary elements together with fully disordered regions also provide protein binding sites recognized by the respiratory syncytial virus nucleoprotein and compatible with weak interactions required for the processivity of the polymerase.	[Pereira, Nelson; Cardone, Christophe; Lassoued, Safa; Assrir, Nadine; Lescop, Ewen; Bontems, Francois; Sizun, Christina] Univ Paris Saclay, CNRS, UPR2301, Inst Chim Subst Nat, F-91190 Gif Sur Yvette, France; [Galloux, Marie; Fix, Jenna; Eleouet, Jean-Francois] INRA, UR892, Unite Virol & Immunol Mol, F-78350 Jouy En Josas, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Sizun, C (corresponding author), CNRS, ICSN, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	christina.sizun@cnrs.fr	Lescop, Ewen/AAA-8700-2019; Eléouët, Jean-François/AAD-1994-2019	ELeouet, Jean-Francois/0000-0002-7361-4885; ASSRIR, Nadine/0000-0003-1693-7263; Lescop, Ewen/0000-0002-2623-9365; Sizun, Christina/0000-0002-5760-2614	Agence Nationale de la Recherche [ANR-11-BSV8-024-02, ANR-13-ISV3-0007-04]; Institut de Chimie des Substances Naturelles; Region Ile-de-France DIM Malinf	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut de Chimie des Substances Naturelles; Region Ile-de-France DIM Malinf(Region Ile-de-France)	This work was supported by Agence Nationale de la Recherche Grants ANR-11-BSV8-024-02 and ANR-13-ISV3-0007-04 and doctoral fellowships from Institut de Chimie des Substances Naturelles (to N. P.) and Region Ile-de-France DIM Malinf (to S. L. and C. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonso CL, 2016, ARCH VIROL, V161, P2351, DOI 10.1007/s00705-016-2880-1; Asenjo A, 2008, VIRUS RES, V132, P160, DOI 10.1016/j.virusres.2007.11.013; Asenjo A, 2006, J GEN VIROL, V87, P3637, DOI 10.1099/vir.0.82165-0; Asenjo A, 2016, VIRUS RES, V211, P117, DOI 10.1016/j.virusres.2015.10.011; Bakker SE, 2013, J GEN VIROL, V94, P1734, DOI 10.1099/vir.0.053025-0; Blondot ML, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002734; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Castagne N, 2004, J GEN VIROL, V85, P1643, DOI 10.1099/vir.0.79830-0; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Collins P.L., 2013, FIELDS VIROLOGY, P1086; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; Cox R, 2016, EXPERT OPIN DRUG DIS, V11, P543, DOI 10.1517/17460441.2016.1174212; Cox R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00459; Cox R, 2014, P NATL ACAD SCI USA, V111, P15208, DOI 10.1073/pnas.1413268111; Cox R, 2013, J VIROL, V87, P7558, DOI 10.1128/JVI.00653-13; CURRAN J, 1995, J VIROL, V69, P849, DOI 10.1128/JVI.69.2.849-855.1995; Galloux M, 2015, J VIROL, V89, P3484, DOI 10.1128/JVI.03666-14; Galloux M, 2012, J VIROL, V86, P8375, DOI 10.1128/JVI.00058-12; GARCIA J, 1993, VIROLOGY, V195, P243, DOI 10.1006/viro.1993.1366; GarciaBarreno B, 1996, J VIROL, V70, P801; Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GROSFELD H, 1995, J VIROL, V69, P5677, DOI 10.1128/JVI.69.9.5677-5686.1995; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Heinrich BS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000958; Karlin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031719; Khattar SK, 2001, J GEN VIROL, V82, P775, DOI 10.1099/0022-1317-82-4-775; Kosol S, 2013, MOLECULES, V18, P10802, DOI 10.3390/molecules180910802; Lahaye X, 2009, J VIROL, V83, P7948, DOI 10.1128/JVI.00554-09; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Leyrat C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080371; Lietzow MA, 2002, J MOL BIOL, V322, P655, DOI 10.1016/S0022-2836(02)00847-1; Llorente MT, 2008, PROTEINS, V72, P946, DOI 10.1002/prot.21988; Llorente MT, 2006, J GEN VIROL, V87, P159, DOI 10.1099/vir.0.81430-0; Lu B, 2002, J VIROL, V76, P2871, DOI 10.1128/JVI.76.6.2871-2880.2002; Mason SW, 2003, J VIROL, V77, P10670, DOI 10.1128/JVI.77.19.10670-10676.2003; Mazur N, 2015, LANCET RESP MED, V3, P888, DOI 10.1016/S2213-2600(15)00255-6; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Munday DC, 2015, J VIROL, V89, P917, DOI 10.1128/JVI.01783-14; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Noval MG, 2016, BIOCHEMISTRY-US, V55, P1441, DOI 10.1021/acs.biochem.5b01332; Ouizougun-Oubari M, 2015, J VIROL, V89, P11129, DOI 10.1128/JVI.01612-15; Renner M, 2016, ELIFE, V5, DOI 10.7554/eLife.12627; Ruigrok RWH, 2011, CURR OPIN MICROBIOL, V14, P504, DOI 10.1016/j.mib.2011.07.011; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrodinger L., 2010, AXPYMOL MOL GRPHICS; Shapiro AB, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0191-2; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simabuco FM, 2011, BRAZ J MICROBIOL, V42, P340, DOI 10.1590/S1517-83822011000100043; Slack MS, 1998, VIRUS RES, V55, P167, DOI 10.1016/S0168-1702(98)00042-2; Sourimant J, 2015, J VIROL, V89, P4421, DOI 10.1128/JVI.03619-14; Tran TL, 2007, J GEN VIROL, V88, P196, DOI 10.1099/vir.0.82282-0; Tran TL, 2009, J VIROL, V83, P6363, DOI 10.1128/JVI.00335-09; Villanueva N, 2000, J GEN VIROL, V81, P129, DOI 10.1099/0022-1317-81-1-129; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; YU QZ, 1995, J VIROL, V69, P2412, DOI 10.1128/JVI.69.4.2412-2419.1995	58	26	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2120	2131		10.1074/jbc.M116.765958	http://dx.doi.org/10.1074/jbc.M116.765958			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28031463	Green Published, hybrid			2022-12-26	WOS:000395530300007
J	Shafiee, A; Patel, J; Wong, HY; Donovan, P; Hutmacher, DW; Fisk, NM; Khosrotehrani, K				Shafiee, Abbas; Patel, Jatin; Wong, Ho Yi; Donovan, Prudence; Hutmacher, Dietmar W.; Fisk, Nicholas M.; Khosrotehrani, Kiarash			Priming of endothelial colony-forming cells in a mesenchymal niche improves engraftment and vasculogenic potential by initiating mesenchymal transition orchestrated by NOTCH signaling	FASEB JOURNAL			English	Article						ECFC; vacularization; primed ECFC	STEM-CELLS; PROGENITOR CELLS; IN-VIVO; RISK-FACTORS; BLOOD; ORIGIN; ANGIOGENESIS; FETAL; ACTIVATION; PROLIFERATION	The prospect of using endothelial progenitors is currently hampered by their low engraftment upon transplantation. We report that mesenchymal stem/stromal cells (MSCs), independent of source and age, improve the engraftment of endothelial colony forming cells (ECFCs). MSC coculture altered ECFC appearance to an elongated mesenchymal morphology with reduced proliferation. ECFC primed via MSC contact had reduced self-renewal potential, but improved capacity to form tube structures in vitro and engraftment in vivo. Primed ECFCs displayed major differences in transcriptome compared to ECFCs never exposed to MSCs, affecting genes involved in the cell cycle, up-regulating of genes influencing mesenchymal transition, adhesion, extracellular matrix. Inhibition of NOTCH signaling, a potential upstream regulator of mesenchymal transition, in large part modulated this gene expression pattern and functionally reversed the mesenchymal morphology of ECFCs. The collective results showed that primed ECFCs survive better and undergo a mesenchymal transition that is dependent on NOTCH signaling, resulting in significantly increased vasculogenic potential.	[Shafiee, Abbas; Patel, Jatin; Wong, Ho Yi; Fisk, Nicholas M.; Khosrotehrani, Kiarash] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Donovan, Prudence; Khosrotehrani, Kiarash] Univ Queensland, UQ Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Hutmacher, Dietmar W.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Fisk, Nicholas M.] Royal Brisbane & Womens Hosp, Ctr Adv Prenatal Care, Brisbane, Qld, Australia	University of Queensland; University of Queensland; Queensland University of Technology (QUT); Royal Brisbane & Women's Hospital	Khosrotehrani, K (corresponding author), Univ Queensland, Royal Brisbane & Womens Hosp, UQ Ctr Clin Res, Bldg 71-918, Brisbane, Qld 4029, Australia.	k.khosrotehrani@uq.edu.au	Khosrotehrani, Kiarash/M-8025-2015; Fisk, Nicholas M/B-2126-2009; shafiee, Abbas/H-9230-2019; Patel, Jatin/P-2668-2016	Khosrotehrani, Kiarash/0000-0002-6406-4076; Fisk, Nicholas M/0000-0003-0031-7975; shafiee, Abbas/0000-0002-8885-9025; Patel, Jatin/0000-0002-6731-0009; Hutmacher, Dietmar Werner/0000-0001-5678-2134; Wong, Ho Yi/0000-0002-1245-4056; Patel, Jatin/0000-0002-3511-0029	National Health and Medical Research Council [1023368]; American Society for Reproductive Medicine; National Health and Medical Research Council Career Development Fellowship Grant [1023371]; National Heart Foundation of Australia Postdoctoral Fellowship	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); American Society for Reproductive Medicine; National Health and Medical Research Council Career Development Fellowship Grant; National Heart Foundation of Australia Postdoctoral Fellowship(National Heart Foundation of Australia)	The authors thank Paula Hall and Grace Chojnowski [Queensland Institute of Medical Research (QIMR), Berghofer Flow Cytometry Unit] for assistance with FACS, Susan Brown and Royal Brisbane and Women's Hospital midwifery staffs for contribution in placenta collection, and the mothers who donated placenta for the research. This study was supported by National Health and Medical Research Council Project Grant 1023368 and American Society for Reproductive Medicine; National Health and Medical Research Council Career Development Fellowship Grant 1023371 (to K. K); and National Heart Foundation of Australia Postdoctoral Fellowship (to J.P.). K.K., N.M.F., and J.P. are coinventors on a patent regarding the placental isolation of ECFC and fPL-MSC.	Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Bautch VL, 2011, NAT MED, V17, P1437, DOI 10.1038/nm.2539; Bennis Y, 2012, J THROMB HAEMOST, V10, P1914, DOI 10.1111/j.1538-7836.2012.04835.x; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Carvalho JL, 2013, J CELL MOL MED, V17, P617, DOI 10.1111/jcmm.12036; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Cheng L., 2014, BLOOD, V124, P2765; Chong MSK, 2016, STEM CELL TRANSL MED, V5, P530, DOI 10.5966/sctm.2015-0227; Corselli M, 2010, ARTERIOSCL THROM VAS, V30, P1104, DOI 10.1161/ATVBAHA.109.191643; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Crist CG, 2012, CELL STEM CELL, V11, P118, DOI 10.1016/j.stem.2012.03.011; Danieli P, 2015, STEM CELL TRANSL MED, V4, P448, DOI 10.5966/sctm.2014-0253; Ezzati M, 2015, NAT REV CARDIOL, V12, P508, DOI 10.1038/nrcardio.2015.82; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Feng JF, 2011, P NATL ACAD SCI USA, V108, P6503, DOI 10.1073/pnas.1015449108; Foubert P, 2007, J CLIN INVEST, V117, P1527, DOI 10.1172/JCI28338; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kim CJ, 2011, INT J ONCOL, V38, P1759, DOI 10.3892/ijo.2011.997; Kim H, 2015, MICROVASC RES, V101, P72, DOI 10.1016/j.mvr.2015.06.006; Kim H, 2015, CYTOTHERAPY, V17, P579, DOI 10.1016/j.jcyt.2014.12.003; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978; Lin RZ, 2012, ANGIOGENESIS, V15, P443, DOI 10.1007/s10456-012-9272-2; Liu YC, 2012, STEM CELLS, V30, P1911, DOI 10.1002/stem.1164; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Parant O, 2009, LAB INVEST, V89, P915, DOI 10.1038/labinvest.2009.55; Patel J, 2014, PLACENTA, V35, P969, DOI 10.1016/j.placenta.2014.09.001; Patel J, 2016, STEM CELLS, V34, P902, DOI 10.1002/stem.2262; Patel J, 2013, STEM CELL TRANSL MED, V2, P839, DOI 10.5966/sctm.2013-0092; Pedersen TO, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt412; Poitevin S, 2014, CARDIOVASC RES, V103, P121, DOI 10.1093/cvr/cvu104; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Rapp BM, 2011, CELL MED, V2, P85, DOI 10.3727/215517911X617888; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; Samatov TR, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-107; Schmidt D, 2007, EMBO J, V26, P710, DOI 10.1038/sj.emboj.7601539; Segarra M, 2012, BLOOD, V120, P4104, DOI 10.1182/blood-2012-02-410076; Shabbir A, 2015, STEM CELLS DEV, V24, P1635, DOI 10.1089/scd.2014.0316; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Sun Y, 2015, P NATL ACAD SCI USA, V112, P10401, DOI 10.1073/pnas.1504387112; Tasev D, 2016, TISSUE ENG PART B-RE, V22, P371, DOI 10.1089/ten.teb.2016.0050; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Zemani F, 2008, ARTERIOSCL THROM VAS, V28, P644, DOI 10.1161/ATVBAHA.107.160044; Zhang ZY, 2009, STEM CELLS, V27, P126, DOI 10.1634/stemcells.2008-0456	59	27	27	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					610	624		10.1096/fj.201600937	http://dx.doi.org/10.1096/fj.201600937			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	28045376				2022-12-26	WOS:000394235400015
J	Kim, T; Park, AY; Baek, Y; Cha, S				Kim, Taehyeung; Park, Ah Yeon; Baek, Younghwa; Cha, Seongwon			Genome-Wide Association Study Reveals Four Loci for Lipid Ratios in the Korean Population and the Constitutional Subgroup	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; TRIGLYCERIDE-RICH LIPOPROTEINS; LOW-DENSITY-LIPOPROTEIN; SASANG CONSTITUTION; RISK-FACTOR; CHOLESTEROL; PREDICTION; VARIANT; APOLIPOPROTEINS; VISUALIZATION	Circulating lipid ratios are considered predictors of cardiovascular risks and metabolic syndrome, which cause coronary heart diseases. One constitutional type of Korean medicine prone to weight accumulation, the Tae-Eum type, predisposes the consumers to metabolic syndrome, hypertension, diabetes mellitus, etc. Here, we aimed to identify genetic variants for lipid ratios using a genome-wide association study (GWAS) and followed replication analysis in Koreans and constitutional subgroups. GWASs in 5,292 individuals of the Korean Genome and Epidemiology Study and replication analyses in 2,567 subjects of the Korea medicine Data Center were performed to identify genetic variants associated with triglyceride (TG) to HDL cholesterol (HDLC), LDL cholesterol (LDLC) to HDLC, and non-HDLC to HDLC ratios. For subgroup analysis, a computer-based constitution analysis tool was used to categorize the constitutional types of the subjects. In the discovery stage, seven variants in four loci, three variants in three loci, and two variants in one locus were associated with the ratios of log-transformed TG: HDLC (log[TG]: HDLC), LDLC: HDLC, and non-HDLC: HDLC, respectively. The associations of the GWAS variants with lipid ratios were replicated in the validation stage: for the log[TG]: HDLC ratio, rs6589566 near APOA5 and rs4244457 and rs6586891 near LPL; for the LDLC: HDLC ratio, rs4420638 near APOC1 and rs17445774 near C2orf47; and for the non-HDLC: HDLC ratio, rs6589566 near APOA5. Five of these six variants are known to be associated with TG, LDLC, and/or HDLC, but rs17445774 was newly identified to be involved in lipid level changes in this study. Constitutional subgroup analysis revealed effects of variants associated with log[TG]: HDLC and non-HDLC: HDLC ratios in both the Tae-Eum and non-Tae-Eum types, whereas the effect of the LDLC: HDLC ratio-associated variants remained only in the Tae-Eum type. In conclusion, we identified three log[TG]: HDLC ratio-associated variants, two LDLC: HDLC ratioassociated variants, and one non-HDLC: HDLC-associated variant in Koreans and the constitutional subgroups.	[Kim, Taehyeung; Park, Ah Yeon; Baek, Younghwa; Cha, Seongwon] Korea Inst Oriental Med, Mibyeong Res Ctr, Daejeon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Cha, S (corresponding author), Korea Inst Oriental Med, Mibyeong Res Ctr, Daejeon, South Korea.	scha@kiom.re.kr	Cha, Seongwon/A-2377-2012	Cha, Seongwon/0000-0001-9012-8718	Bio&Medical Technology Development Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2014M3A9D7034335]; Korea Institute of Oriental Medicine [K16091]	Bio&Medical Technology Development Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Korea Institute of Oriental Medicine	This research was supported by the Bio&Medical Technology Development Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2014M3A9D7034335) and by the research program of Korea Institute of Oriental Medicine (No. K16091). This study was provided with bioresources from National Biobank of Korea, the Centers for Disease Control and Prevention, Republic of Korea (4845-301, 4851-302 and -307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aavik E, 2015, EUR HEART J, V36, P993, DOI 10.1093/eurheartj/ehu437; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; CASTELLI WP, 1988, CAN J CARDIOL, V4, pA5; Caussy C, 2014, AM J HUM GENET, V94, P129, DOI 10.1016/j.ajhg.2013.12.001; Cha S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053013; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Chung SK, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-230; Cui GC, 2014, CHINA HIGHER MED ED, V4, P3; Cui GL, 2014, J AM COLL CARDIOL, V64, P267, DOI 10.1016/j.jacc.2014.03.050; da Luz PL, 2008, CLINICS, V63, P427, DOI 10.1590/S1807-59322008000400003; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Do JH, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-85; Eicher JD, 2015, NUCLEIC ACIDS RES, V43, pD799, DOI 10.1093/nar/gku1202; Eliasson B, 2011, DIABETES CARE, V34, P2095, DOI 10.2337/dc11-0209; GINSBERG HN, 1986, J CLIN INVEST, V78, P1287, DOI 10.1172/JCI112713; Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200; Hanak V, 2004, AM J CARDIOL, V94, P219, DOI 10.1016/j.amjcard.2004.03.069; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Jang E, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/492941; Jang E, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-72; Jeong S, 2011, J BIOTECHNOL, V154, P321, DOI 10.1016/j.jbiotec.2011.05.017; Kim SW, 2013, INT J CARDIOL, V168, P2678, DOI 10.1016/j.ijcard.2013.03.027; Kyungju C, 2011, DIABETES RES CLIN PR, V91, pE57, DOI 10.1016/j.diabres.2010.11.017; Lee J, 2009, EVID-BASED COMPL ALT, V6, P31, DOI 10.1093/ecam/nep086; Lee TG, 2009, EVID-BASED COMPL ALT, V6, P99, DOI 10.1093/ecam/nep054; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramos EM, 2014, EUR J HUM GENET, V22, P144, DOI 10.1038/ejhg.2013.96; Richardson K, 2013, AM J HUM GENET, V92, P5, DOI 10.1016/j.ajhg.2012.10.020; Song KH, 2012, EVIDENCE BASED COMPL; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; WINDLER E, 1985, J LIPID RES, V26, P556; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yokokawa H, 2011, J ATHEROSCLER THROMB, V18, P89, DOI 10.5551/jat.5215	36	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168137	10.1371/journal.pone.0168137	http://dx.doi.org/10.1371/journal.pone.0168137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046027	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300014
J	Parr, WV; Valentin, D; Reedman, P; Grose, C; Green, JA				Parr, Wendy V.; Valentin, Dominique; Reedman, Phil; Grose, Claire; Green, James A.			Expectation or Sensorial Reality? An Empirical Investigation of the Biodynamic Calendar for Wine Drinkers	PLOS ONE			English	Article							QUALITY; COLOR	The study's aim was to investigate a central tenet of biodynamic philosophy as applied to wine tasting, namely that wines taste different in systematic ways on days determined by the lunar cycle. Nineteen New Zealand wine professionals tasted blind 12 Pinot noir wines at times determined within the biodynamic calendar for wine drinkers as being favourable (Fruit day) and unfavourable (Root day) for wine tasting. Tasters rated each wine four times, twice on a Fruit day and twice on a Root day, using 20 experimenter-provided descriptors. Wine descriptors spanned a range of varietal-relevant aroma, taste, and mouthfeel characteristics, and were selected with the aim of elucidating both qualitative and quantitative aspects of each wine's perceived aromatic, taste, and structural aspects including overall wine quality and liking. A post-experimental questionnaire was completed by each participant to determine their degree of knowledge about the purpose of the study, and their awareness of the existence of the biodynamic wine drinkers' calendar. Basic wine physicochemical parameters were determined for the wines tasted on each of a Fruit day and a Root day. Results demonstrated that the wines were judged differentially on all attributes measured although type of day as determined by the biodynamic calendar for wine drinkers did not influence systematically any of the wine characteristics evaluated. The findings highlight the importance of testing experimentally practices that are based on anecdotal evidence but that lend themselves to empirical investigation.	[Parr, Wendy V.] Lincoln Univ, AGLS Fac, Christchurch, New Zealand; [Valentin, Dominique] Univ Bourgogne Franche Comte, CNRS, Ctr Sci Gout & Alimentat, INRA, Dijon, France; [Reedman, Phil] Phil Reedman, Adelaide, SA, Australia; [Grose, Claire] Inst Plant & Food Res, Marlborough, New Zealand; [Green, James A.] Univ Otago, Dunedin, New Zealand	Lincoln University - New Zealand; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; University of Otago	Parr, WV (corresponding author), Lincoln Univ, AGLS Fac, Christchurch, New Zealand.	wendy.parr@lincoln.ac.nz	Green, James A/A-8615-2008; Grose, Claire H/I-7116-2018	Green, James A/0000-0002-7309-0751; Grose, Claire H/0000-0003-1175-0600	Cresswell Jackson Wine Competition Trust of New Zealand	Cresswell Jackson Wine Competition Trust of New Zealand	We thank the Cresswell Jackson Wine Competition Trust of New Zealand for a funding award to Wendy Parr and Phil Reedman. This was the first award made by the Trust; http://www.spiegelauiwc.co.nz/assets/cjnzwt-review-february-2016.pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, PHYS REQ GUID SENS E; [Anonymous], 2009, BBC NEWS; Blackadder JH, 2014, ENJOYING WINE BIODYN; Blasberg M., 2014, WEREWOLF NAPA MOON A; Booth R, 2009, GUARDIAN; Delmas MA, 2016, 190 AAWE; Doring J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138445; Foss, 7A FOSS; Gallagher P., 2015, INDEPENDENT; Goode J., 2009, JAMIE GOODES WINE AN; ISO, 1977, 3591 ISO; Keats B., 2014, 2014 ANTIPODEAN ASTR; Kennedy B., 2014, TASTING BIODYNAMICAL; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Morrot G, 2001, BRAIN LANG, V79, P309, DOI 10.1006/brln.2001.2493; PANGBORN RM, 1963, AM J PSYCHOL, V76, P492, DOI 10.2307/1419795; Parr WV, 2015, P OENO2015 10 INT WI; Piqueras-Fiszman B, 2012, FOOD QUAL PREFER, V25, P41, DOI 10.1016/j.foodqual.2012.01.001; Reeve JR, 2005, AM J ENOL VITICULT, V56, P367; Robinson J., 2006, MOODY BURGUNDY OTHER; Spence C., 2014, PERFECT MEAL MULTISE; Steiner R, 1924, SPIRITUAL FDN RENEWA; Thun M, 2013, WINE TASTES BEST 201; Valentin D, 2016, FOOD QUAL PREFER, V48, P251, DOI 10.1016/j.foodqual.2015.10.003	24	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169257	10.1371/journal.pone.0169257	http://dx.doi.org/10.1371/journal.pone.0169257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046047	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300154
J	Amaral, PD; Mariz, LDS; Benedeti, PD; da Silva, LG; de Paula, EM; Monteiro, HF; Shenkoru, T; Santos, SA; Poulson, SR; Faciola, AP				Amaral, Paloma de Melo; Silva Mariz, Lays Debora; Benedeti, Pedro Del Bianco; da Silva, Lorrayny Galoro; de Paula, Eduardo Marostegan; Monteiro, Hugo Fernando; Shenkoru, Teshome; Santos, Stefanie Alvarenga; Poulson, Simon Roger; Faciola, Antonio Pinheiro			Effects of Static or Oscillating Dietary Crude Protein Levels on Fermentation Dynamics of Beef Cattle Diets Using a Dual-Flow Continuous Culture System	PLOS ONE			English	Article							NITROGEN-METABOLISM; RUMINAL FERMENTATION; RUMEN; FEEDLOT; DIGESTIBILITY; RETENTION; EXCRETION; DIGESTION; PROTOZOA; BALANCE	The objective of this study was to evaluate the effects of increasing dietary crude protein (CP) levels and also comparing the effects of static versus oscillating dietary CP on ruminal nutrient digestibility, ruminal fermentation, nitrogen (N) metabolism, and microbial efficiency in beef cattle diets using a dual-flow continuous culture system. Eight fermenters (1,223 + 21 mL) were used in a replicated 4 x 4 Latin square design with periods lasting 12 d each (8 d for adaptation and 4 d for sampling). Dietary treatments were: 1) 10% CP, 2) 12% CP, 3) 14% CP, and 4) 10 and 14% CP diets oscillating at 48-h intervals. Experimental diets consisted of 50% orchard hay and 50% concentrate. Fermenters were fed 72 g/d and solid and liquid dilution rates were adjusted to 5.5 and 11%/h, respectively. Data were analyzed using the MIXED procedure in SAS with alpha = 0.05. Apparent and true ruminal digestibilities of dry matter and organic matter were not affected (P > 0.05) by increasing dietary CP, nor by oscillating dietary CP. Total volatile fatty acids concentration and molar proportions of acetate, propionate, butyrate, valerate, iso-butyrate and iso-valerate were not affected (P > 0.05) by increasing or oscillating dietary CP. Ruminal NH3-N concentration increased linearly (P < 0.01) in response to increasing dietary CP. Total N, non-ammonia N, and rumen undegraded protein flows did not differ among treatments or between oscillating dietary CP and static 12% CP. Microbial N and NH3-N flows and microbial efficiency did not differ when comparing oscillating versus static CP (P > 0.05). However, there was a quadratic effect (P < 0.05) for these variables when dietary CP was increased. These results indicate that either ruminal microorganisms do not respond to oscillating CP levels or are capable of coping with 48-h periods of undernourishment.	[Amaral, Paloma de Melo; Silva Mariz, Lays Debora; Benedeti, Pedro Del Bianco; da Silva, Lorrayny Galoro; de Paula, Eduardo Marostegan; Monteiro, Hugo Fernando; Shenkoru, Teshome; Faciola, Antonio Pinheiro] Univ Nevada, Dept Agr Nutr & Vet Sci, Reno, NV 89557 USA; [Amaral, Paloma de Melo; Silva Mariz, Lays Debora; Benedeti, Pedro Del Bianco] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Monteiro, Hugo Fernando] Univ Estadual Maringa, Dept Anim Sci, Maringa, Parana, Brazil; [Santos, Stefanie Alvarenga] Univ Fed Bahia, Dept Anim Sci, Salvador, BA, Brazil; [Poulson, Simon Roger] Univ Nevada, Dept Geol Sci & Engn, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Universidade Federal de Vicosa; Universidade Estadual de Maringa; Universidade Federal da Bahia; Nevada System of Higher Education (NSHE); University of Nevada Reno	Faciola, AP (corresponding author), Univ Nevada, Dept Agr Nutr & Vet Sci, Reno, NV 89557 USA.	afaciola@cabnr.unr.edu	Santos, Stefanie Alvarenga/D-8281-2014; Faciola, Antonio/AAF-3865-2019; Faciola, Antonio/U-4800-2018; Del Bianco Benedeti, Pedro/C-3120-2016; Monteiro, Hugo/ADT-8240-2022; da Silva, Lorrayny Galoro/H-2312-2019; de Paula, Eduardo Marostegan/S-8509-2019	Santos, Stefanie Alvarenga/0000-0003-4680-1412; Faciola, Antonio/0000-0003-0935-6233; Faciola, Antonio/0000-0003-0935-6233; Del Bianco Benedeti, Pedro/0000-0003-2515-8974; da Silva, Lorrayny Galoro/0000-0002-7843-1623; de Paula, Eduardo Marostegan/0000-0002-1891-6303	National Institute of Food and Agriculture (NIFA) [1003089]; Coordination for the Improvement of Higher Education Personnel (CAPES)	National Institute of Food and Agriculture (NIFA); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by the National Institute of Food and Agriculture (NIFA), project number 1003089, and Coordination for the Improvement of Higher Education Personnel (CAPES). The funding agencies had no role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	AOAC, 1990, OFFICIAL METHODS ANA, V15; Archibeque SL, 2007, J ANIM SCI, V85, P1496, DOI 10.2527/jas.2006-208; Bach A, 2008, J ANIM SCI, V86, P1364, DOI 10.2527/jas.2007-0736; Benedeti PD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143201; Bierman S, 1999, J ANIM SCI, V77, P1645; Calsamiglia S, 1996, J ANIM SCI, V74, P1375; CHANEY AL, 1962, CLIN CHEM, V8, P130; Chanthakhoun V, 2012, LIVEST SCI, V144, P197, DOI 10.1016/j.livsci.2011.11.011; Chantiratikul A, 2009, J ANIM VET ADV, V8, P297; Chen SC, 2010, J ANIM VET ADV, V9, P2396, DOI 10.3923/javaa.2010.2396.2400; Cole N, 2012, 4 INT S BEEF CATTL P; Cole NA, 2003, J ANIM SCI, V81, P2660; Cole NA, 1999, J ANIM SCI, V77, P215; de Veth MJ, 2001, J DAIRY SCI, V84, P1449, DOI 10.3168/jds.S0022-0302(01)70178-6; Doranalli K, 2011, J NUTR, V141, P560, DOI 10.3945/jn.110.133876; GALYEAN ML, 2001, SUMMARY 2000 TEXAS T; Gerrard D. E., 2003, PRINCIPLES ANIMAL GR; Neto SG, 2011, ASIAN AUSTRAL J ANIM, V24, P791, DOI 10.5713/ajas.2011.10417; Hoch T, 2003, PROD ANIM, V16, P49; HOOVER WH, 1976, J ANIM SCI, V43, P528, DOI 10.2527/jas1976.432528x; HOOVER WH, 1986, J DAIRY SCI, V69, P2755, DOI 10.3168/jds.S0022-0302(86)80724-X; Karsli MA, 2002, TURK J VET ANIM SCI, V26, P201; Kiran D, 2009, ANIM FEED SCI TECH, V152, P33, DOI 10.1016/j.anifeedsci.2009.03.009; Koenig KM, 2013, J ANIM SCI, V91, P2310, DOI [10.2527/jas2012-5653, 10.2527/jas.2012-5653]; Krehbiel CR, 1998, J ANIM SCI, V76, P2464; Littell RC, 1998, J ANIM SCI, V76, P1216; Ludden P. A., 2003, Professional Animal Scientist, V19, P30; MEHREZ AZ, 1977, BRIT J NUTR, V38, P437, DOI 10.1079/BJN19770108; Millen DD, 2009, J ANIM SCI, V87, P3427, DOI 10.2527/jas.2009-1880; NRC (National Research Council), 2000, NUTR REQ BEEF CATTL, DOI DOI 10.17226/19014; Oh YK, 2008, ASIAN AUSTRAL J ANIM, V21, P392, DOI 10.5713/ajas.2008.70342; OWENS FN, 1983, J ANIM SCI, V57, P498; Reynal SM, 2005, J DAIRY SCI, V88, P4045, DOI 10.3168/jds.S0022-0302(05)73090-3; Satter L, 1981, RECENT DEV RUMINANT, P115; Soder KJ, 2013, J DAIRY SCI, V96, P3228, DOI 10.3168/jds.2012-6307; Soder K. J., 2010, Professional Animal Scientist, V26, P290; Van Dung D., 2014, J ANIM SCI, V27, P797, DOI DOI 10.5713/ajas.2013.13560; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Vasconcelos JT, 2007, J ANIM SCI, V85, P2772, DOI 10.2527/jas.2007-0261; WELLER RA, 1974, BRIT J NUTR, V32, P341, DOI 10.1079/BJN19740087; Werner RA, 1999, RAPID COMMUN MASS SP, V13, P1237, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1237::AID-RCM633>3.0.CO;2-C; Wessels RH, 1997, J ANIM SCI, V75, P3278; Yuangklang C, 2010, J ANIM VET ADV, V9, P1776	43	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169170	10.1371/journal.pone.0169170	http://dx.doi.org/10.1371/journal.pone.0169170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036405	Green Published, Green Submitted, gold			2022-12-26	WOS:000391229300061
J	Nguyen, VK; Klawonn, F; Mikolajczyk, R; Hernandez-Vargas, EA				Van Kinh Nguyen; Klawonn, Frank; Mikolajczyk, Rafael; Hernandez-Vargas, Esteban A.			Analysis of Practical Identifiability of a Viral Infection Model	PLOS ONE			English	Article							INFLUENZA-VIRUS INFECTION; PARAMETER-ESTIMATION; MATHEMATICAL-MODELS; MAXIMUM-LIKELIHOOD; BIOLOGY; ESTIMATOR; CELLS	Mathematical modelling approaches have granted a significant contribution to life sciences and beyond to understand experimental results. However, incomplete and inadequate assessments in parameter estimation practices hamper the parameter reliability, and consequently the insights that ultimately could arise from a mathematical model. To keep the diligent works in modelling biological systems from being mistrusted, potential sources of error must be acknowledged. Employing a popular mathematical model in viral infection research, existing means and practices in parameter estimation are exemplified. Numerical results show that poor experimental data is a main source that can lead to erroneous parameter estimates despite the use of innovative parameter estimation algorithms. Arbitrary choices of initial conditions as well as data asynchrony distort the parameter estimates but are often overlooked in modelling studies. This work stresses the existence of several sources of error buried in reports of modelling biological systems, voicing the need for assessing the sources of error, consolidating efforts in solving the immediate difficulties, and possibly reconsidering the use of mathematical modelling to quantify experimental data.	[Van Kinh Nguyen; Hernandez-Vargas, Esteban A.] Helmholtz Ctr Infect Res, Dept Syst Immunol, Syst Med Infect Dis, Braunschweig, Germany; [Van Kinh Nguyen; Hernandez-Vargas, Esteban A.] Helmholtz Ctr Infect Res, Braunschweig Integrated Ctr Syst Biol, Braunschweig, Germany; [Van Kinh Nguyen] Ho Chi Minh Univ Med & Pharm, Dept Epidemiol, Ho Chi Minh, Vietnam; [Van Kinh Nguyen] PhD Programme Epidemiol, Braunschweig, Germany; [Klawonn, Frank] Helmholtz Ctr Infect Res, Biostat, Braunschweig, Germany; [Klawonn, Frank] Osffalia Univ, Dept Comp Sci, Wolfenbuttel, Germany; [Mikolajczyk, Rafael] Helmholtz Ctr Infect Res, Epidemiol & Stat Methods, Braunschweig, Germany; [Mikolajczyk, Rafael] German Ctr Infect Res, Site Hannover Braunschweig, Hannover, Germany; [Mikolajczyk, Rafael] Hannover Med Sch, Hannover, Germany; [Mikolajczyk, Rafael] Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biometry & Informat, Halle, Saale, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; German Center for Infection Research; Hannover Medical School; Martin Luther University Halle Wittenberg	Hernandez-Vargas, EA (corresponding author), Helmholtz Ctr Infect Res, Dept Syst Immunol, Syst Med Infect Dis, Braunschweig, Germany.; Hernandez-Vargas, EA (corresponding author), Helmholtz Ctr Infect Res, Braunschweig Integrated Ctr Syst Biol, Braunschweig, Germany.	esteban.vargas@helmholtz-hzi.de	Mikolajczyk, Rafael/ABB-5259-2021; Klawonn, Frank/HFH-5887-2022	Klawonn, Frank/0000-0001-9613-182X; Hernandez-Vargas, Esteban/0000-0002-3645-435X; Mikolajczyk, Rafael/0000-0003-1271-7204; Nguyen, Van Kinh/0000-0001-8912-5288	iMed (the Helmholtz Initiative on Personalized Medicine); Helmholtz Association of German Research Centres (HGF) [VH-GS-202]	iMed (the Helmholtz Initiative on Personalized Medicine); Helmholtz Association of German Research Centres (HGF)(Helmholtz Association)	This work was supported by iMed (the Helmholtz Initiative on Personalized Medicine) to EHV and the Helmholtz Association of German Research Centres (HGF, Grant: VH-GS-202) to VKN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althubaiti A, 2012, STAT METHODS MED RES; Altrock PM, 2015, NAT REV CANCER, V15, P730, DOI 10.1038/nrc4029; [Anonymous], 2013, TEXTS STAT SCI SERIE; [Anonymous], 2014, R LANG ENV STAT COMP; Ashyraliyev M, 2009, FEBS J, V276, P886, DOI 10.1111/j.1742-4658.2008.06844.x; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Beauchemin CAA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S7; BERKSON J, 1950, J AM STAT ASSOC, V45, P164, DOI 10.2307/2280676; Boianelli A, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00060; Boianelli A, 2015, VIRUSES-BASEL, V7, P5274, DOI 10.3390/v7102875; Boianelli A, 2013, IEEE DECIS CONTR P, P7205, DOI 10.1109/CDC.2013.6761032; Brun R, 2001, WATER RESOUR RES, V37, P1015, DOI 10.1029/2000WR900350; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Cedersund G., 2016, PREDICTION UNCERTAIN, P449; Chis OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027755; Dobrovolny HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057088; Duffin RP, 2002, J THEO MED, V4, P215, DOI [10.1080/1027366021000051772, DOI 10.1080/1027366021000051772]; Duvigneau S, 2016, SCI REP-UK, V6, DOI 10.1038/srep37045; EFRON B, 1978, BIOMETRIKA, V65, P457, DOI 10.2307/2335893; Gershenfeld N., 1999, NATURE MATH MODELING; Girolami M, 2011, J R STAT SOC B, V73, P123, DOI 10.1111/j.1467-9868.2010.00765.x; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Hagen DR, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0008; Handel A, 2010, J R SOC INTERFACE, V7, P35, DOI 10.1098/rsif.2009.0067; HASTIE T, 2009, SPRINGER SERIES STAT; Heldt FS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003372; Hernandez-Vargas EA, 2014, J VIROL, V88, P4123, DOI 10.1128/JVI.03644-13; Hernandez-Vargas EA, 2013, J THEOR BIOL, V320, P33, DOI 10.1016/j.jtbi.2012.11.028; Holder BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014767; Kirschner D., 1996, NOTICES AM MATH SOC, V43, P191; Li P, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-91; Liang H, 2008, J AM STAT ASSOC, V103, P1570, DOI 10.1198/016214508000000797; Ma SG, 2005, J MULTIVARIATE ANAL, V96, P190, DOI 10.1016/j.jmva.2004.09.008; Miao HY, 2011, SIAM REV, V53, P3, DOI 10.1137/090757009; Mohler L, 2005, BIOTECHNOL BIOENG, V90, P46, DOI 10.1002/bit.20363; Mullen KM, 2011, J STAT SOFTW, V40, P1; N. Quantitative and Logic Modelling of Molecular And Gene Networks, 2015, NATURE REV GENETICS, V16, P146, DOI [10.1038/nra3885, DOI 10.1038/NRG3885]; Nguyen VK, 2015, 17 IFAC S SYST ID OC; Pawelek KA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002588; Perelson AS, 2015, NAT REV GASTRO HEPAT, V12, P437, DOI 10.1038/nrgastro.2015.97; Peter J.H, 2009, ROBUST STAT, V2nd; Petrie SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064098; Pinilla LT, 2012, J VIROL, V86, P10651, DOI 10.1128/JVI.07244-11; Pubmed Central, 2016, PMC POL; Ramsay JO, 2007, J ROY STAT SOC B, V69, P741, DOI 10.1111/j.1467-9868.2007.00610.x; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Raue A, 2012, JOINING FORCES BAYES; Rawlins EL, 2008, AM J PHYSIOL-LUNG C, V295, pL231, DOI 10.1152/ajplung.90209.2008; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Simonoff J., 1996, SMOOTHING METHODS ST; Singh K., 2003, SANKHYA, V65, P532; Smith AM, 2011, WIRES SYST BIOL MED, V3, P429, DOI 10.1002/wsbm.129; Smith AM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001081; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; THIEBAUT R, 2006, BMC MED RES METHODOL, V6, P1; Toapanta FR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-112; Tomlin CJ, 2007, NAT REV GENET, V8, P331, DOI 10.1038/nrg2098; Nguyen VK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00257; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wu HL, 1998, STAT MED, V17, P2463, DOI 10.1002/(SICI)1097-0258(19981115)17:21&lt;2463::AID-SIM939&gt;3.0.CO;2-A; Wu HL, 2008, B MATH BIOL, V70, P785, DOI 10.1007/s11538-007-9279-9; Xia X, 2003, IEEE T AUTOMAT CONTR, V48, P330, DOI 10.1109/TAC.2002.808494; Yates A, 2007, PLOS MED, V4, P948, DOI 10.1371/journal.pmed.0040177	64	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0167568	10.1371/journal.pone.0167568	http://dx.doi.org/10.1371/journal.pone.0167568			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036339	Green Published, gold, Green Submitted			2022-12-26	WOS:000391229300005
J	Wu, S; Ning, F; Wu, XL; Wang, W				Wu, Si; Ning, Fen; Wu, Xiaolin; Wang, Wei			Proteomic Characterization of Differential Abundant Proteins Accumulated between Lower and Upper Epidermises of Fleshy Scales in Onion (Allium cepa L.) Bulbs	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEINS; UDP-ARABINOFURANOSE; SALT TOLERANCE; PLANT; TOBACCO; ACID; ARABIDOPSIS; DROUGHT; CELLS; ARABINOPYRANOSE	The onion (Allium cepa L.) is widely planted worldwide as a valuable vegetable crop. The scales of an onion bulb are a modified type of leaf. The one-layer-cell epidermis of onion scales is commonly used as a model experimental material in botany and molecular biology. The lower epidermis (LE) and upper epidermis (UE) of onion scales display obvious differences in microscopic structure, cell differentiation and pigment synthesis; however, associated proteomic differences are unclear. LE and UE can be easily sampled as single-layer-cell tissues for comparative proteomic analysis. In this study, a proteomic approach based on 2-DE and mass spectrometry (MS) was applied to compare LE and UE of fleshy scales from yellow and red onions. We identified 47 differential abundant protein spots (representing 31 unique proteins) between LE and UE in red and yellow onions. These proteins are mainly involved in pigment synthesis, stress response, and cell division. Particularly, the differentially accumulated chalcone-flavanone isomerase and flavone O-methyltransferase 1-like in LE may result in the differences in the onion scale color between red and yellow onions. Moreover, stress-related proteins abundantly accumulated in both LE and UE. In addition, the differential accumulation of UDP-arabinopyranose mutase 1-like protein and beta-1,3-glucanase in the LE may be related to the different cell sizes between LE and UE of the two types of onion. The data derived from this study provides new insight into the differences in differentiation and developmental processes between onion epidermises. This study may also make a contribution to onion breeding, such as improving resistances and changing colors.	[Wu, Si; Ning, Fen; Wu, Xiaolin; Wang, Wei] Henan Agr Univ, Coll Sci, Zhengzhou, Peoples R China	Henan Agricultural University	Wang, W (corresponding author), Henan Agr Univ, Coll Sci, Zhengzhou, Peoples R China.	wangwei@henau.edu.cn	Wang, Wei/R-7323-2016	Wang, Wei/0000-0002-3711-5181	Program for Innovative Research Team (in Science and Technology) in University of Henan Province [15IRTSTHN015]	Program for Innovative Research Team (in Science and Technology) in University of Henan Province	We acknowledge the financial support of the Program for Innovative Research Team (in Science and Technology) in University of Henan Province (grant no. 15IRTSTHN015) (http://www.haedugov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the financial support of the Program for Innovative Research Team (in Science and Technology) in University of Henan Province (Grant No. 15IRTSTHN015).	Bhatt I, 2011, BIOTECHNOL ADV, V29, P850, DOI 10.1016/j.biotechadv.2011.07.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPBELL NA, 2005, BIOLOGY; Chen KT, 2013, PLANT CELL ENVIRON, V36, P892, DOI 10.1111/pce.12027; Choi DS, 2014, PLANT PHYSIOL, V166, P1298, DOI 10.1104/pp.114.246736; Cletus J, 2013, BIOTECHNOL LETT, V35, P1719, DOI 10.1007/s10529-013-1269-4; Dmitrienko SG, 2012, J ANAL CHEM+, V67, P299, DOI 10.1134/S106193481204003X; Fossen T, 1996, J FOOD SCI, V61, P703, DOI 10.1111/j.1365-2621.1996.tb12185.x; Galletti Roberta, 2015, Commun Integr Biol, V8, pe1059979, DOI 10.1080/19420889.2015.1059979; Galletti R, 2015, DEVELOPMENT, V142, P1978, DOI 10.1242/dev.122325; Glover BJ, 2000, J EXP BOT, V51, P497, DOI 10.1093/jexbot/51.344.497; Gong XY, 2014, ANAL CHEM, V86, P3809, DOI 10.1021/ac500882e; Kim BG, 2006, PHYTOCHEMISTRY, V67, P387, DOI 10.1016/j.phytochem.2005.11.022; Kim S, 2004, MOL GENET GENOMICS, V272, P411, DOI 10.1007/s00438-004-1076-7; Konishi T, 2007, GLYCOBIOLOGY, V17, P345, DOI 10.1093/glycob/cwl081; Kumar J, 2011, BIOSENS BIOELECTRON, V26, P4399, DOI 10.1016/j.bios.2011.04.049; Kunze I, 1998, BBA-GENE STRUCT EXPR, V1395, P329, DOI 10.1016/S0167-4781(97)00163-2; LEUBNER-METZGER G, 1995, PLANT PHYSIOL, V109, P751, DOI 10.1104/pp.109.3.751; Lo Cicero L, 2015, PHYTOCHEMISTRY, V116, P69, DOI 10.1016/j.phytochem.2015.03.004; Ma LC, 2014, BIOTECHNOL LETT, V36, P2331, DOI 10.1007/s10529-014-1598-y; Markham KR, FLAVONOIDS, DOI 10.1016/0022-2860(71)87109-0; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mustafiz A, 2011, FUNCT INTEGR GENOMIC, V11, P293, DOI 10.1007/s10142-010-0203-2; Nozaki H, 2007, BIOSCI BIOTECH BIOCH, V71, P3127, DOI 10.1271/bbb.70625; Rautengarten C, 2011, PLANT CELL, V23, P1373, DOI 10.1105/tpc.111.083931; Rhodes MJC, 1996, FOOD CHEM, V57, P113, DOI 10.1016/0308-8146(96)00147-1; SAMUELS AL, 1995, J CELL BIOL, V130, P1345, DOI 10.1083/jcb.130.6.1345; San-Bento R, 2014, PLANT J, V77, P46, DOI 10.1111/tpj.12360; Schmidlin L, 2008, PLANT PHYSIOL, V148, P1630, DOI 10.1104/pp.108.126003; Singla-Pareek SL, 2008, TRANSGENIC RES, V17, P171, DOI 10.1007/s11248-007-9082-2; Slimestad R, 2007, J AGR FOOD CHEM, V55, P10067, DOI 10.1021/jf0712503; Suleria HAR, 2015, CRIT REV FOOD SCI, V55, P50, DOI 10.1080/10408398.2011.646364; Suslov D, 2006, J EXP BOT, V57, P2183, DOI 10.1093/jxb/erj177; Suzuki K, 1998, PLANT PHYSIOL, V116, P725, DOI 10.1104/pp.116.2.725; Tamogami S, 2000, PHYTOCHEMISTRY, V54, P689, DOI 10.1016/S0031-9422(00)00190-4; VANHUIJSDUIJNEN RAMH, 1986, J GEN VIROL, V67, P2135, DOI 10.1099/0022-1317-67-10-2135; VANLOON LC, 1985, PLANT MOL BIOL, V4, P111, DOI 10.1007/BF02418757; Wu XL, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00801; Wu XL, 2014, NAT PROTOC, V9, P362, DOI 10.1038/nprot.2014.022; Xu KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083556; Yu XM, 2001, PHYSIOL PLANTARUM, V112, P78, DOI 10.1034/j.1399-3054.2001.1120111.x; Zhang H, 2015, PLANT CELL ENVIRON, V38, P1178, DOI 10.1111/pce.12472; 배순이, 2009, [Journal of Fashion Business, 패션 비즈니스], V13, P109	43	5	5	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168959	10.1371/journal.pone.0168959	http://dx.doi.org/10.1371/journal.pone.0168959			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036352	Green Published, gold, Green Submitted			2022-12-26	WOS:000391229300041
J	Zhu, F; Zhang, H; Yang, TD; Haslam, SM; Dell, A; Wu, H				Zhu, Fan; Zhang, Hua; Yang, Tiandi; Haslam, Stuart M.; Dell, Anne; Wu, Hui			Engineering and Dissecting the Glycosylation Pathway of a Streptococcal Serine-rich Repeat Adhesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL PROTEIN GLYCOSYLATION; FIMBRIA-ASSOCIATED ADHESIN; GDP-D-RHAMNOSE; BIOFILM FORMATION; UNKNOWN FUNCTION; FUNCTIONAL-CHARACTERIZATION; STAPHYLOCOCCUS-AUREUS; MOLECULAR CHAPERONE; CONSERVED DOMAIN; SURFACE PROTEIN	Serine-rich repeat glycoproteins (SRRPs) are conserved in Gram-positive bacteria. They are crucial for modulating biofilm formation and bacterial-host interactions. Glycosylation of SRRPs plays a pivotal role in the process; thus understanding the glycosyl-transferases involved is key to identifying new therapeutic drug targets. The glycosylation of Fap1, an SRRP of Streptococcus parasanguinis, is mediated by a gene cluster consisting of six genes: gtf1, gtf2, gly, gtf3, dGT1, and galT2. Mature Fap1 glycan possesses the sequence of Rha1-3Glc1-(Glc1-3GlcNAc1)-2,6-Glc1-6GlcNAc. Gtf12, Gtf3, and dGT1 are responsible for the first four steps of the Fap1 glycosylation, catalyzing the transfer of GlcNAc, Glc, Glc, and GlcNAc residues to the protein backbone sequentially. The role of GalT2 and Gly in the Fap1 glycosylation is unknown. In the present study, we synthesized the fully modified Fap1 glycan in Escherichia coli by incorporating all six genes from the cluster. This study represents the first reconstitution of an exogenous stepwise O-glycosylation synthetic pathway in E. coli. In addition, we have determined that GalT2 mediates the fifth step of the Fap1 glycosylation by adding a rhamnose residue, and Gly mediates the final glycosylation step by transferring glucosyl residues. Furthermore, inactivation of each glycosyltransferase gene resulted in differentially impaired biofilms of S. parasanguinis, demonstrating the importance of Fap1 glycosylation in the biofilm formation. The Fap1 glycosylation system offers an excellent model to engineer glycans using different permutations of glycosyltransferases and to investigate biosynthetic pathways of SRRPs because SRRP genetic loci are highly conserved.	[Zhu, Fan; Zhang, Hua; Wu, Hui] Univ Alabama Birmingham, Sch Dent, Dept Pediat Dent, 1919 7th Ave S, Birmingham, AL 35244 USA; [Zhu, Fan; Wu, Hui] Univ Alabama Birmingham, Sch Dent, Dept Microbiol, 1919 7th Ave S, Birmingham, AL 35244 USA; [Zhu, Fan; Zhang, Hua; Wu, Hui] Univ Alabama Birmingham, Sch Med, Dept Pediat Dent, 1919 7th Ave S, Birmingham, AL 35244 USA; [Zhu, Fan; Wu, Hui] Univ Alabama Birmingham, Sch Med, Dept Microbiol, 1919 7th Ave S, Birmingham, AL 35244 USA; [Yang, Tiandi; Haslam, Stuart M.; Dell, Anne] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Imperial College London	Wu, H (corresponding author), Univ Alabama Birmingham, Sch Dent, Dept Pediat Dent, 1919 7th Ave S, Birmingham, AL 35244 USA.; Wu, H (corresponding author), Univ Alabama Birmingham, Sch Dent, Dept Microbiol, 1919 7th Ave S, Birmingham, AL 35244 USA.; Wu, H (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Pediat Dent, 1919 7th Ave S, Birmingham, AL 35244 USA.; Wu, H (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Microbiol, 1919 7th Ave S, Birmingham, AL 35244 USA.; Haslam, SM (corresponding author), Imperial Coll London, Dept Life Sci, London SW7 2AZ, England.	s.haslam@imperial.ac.uk; hwu@uab.edu			National Institutes of Health NIDCR [R01DE17954, F33DE022215]; Biotechnology and Biological Sciences Research Council [BB/K016164/1]; Core Support for Collaborative Research; Wellcome Trust; BBSRC [BB/K016164/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017954, F33DE022215] Funding Source: NIH RePORTER	National Institutes of Health NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Core Support for Collaborative Research; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health NIDCR Grants R01DE17954 and F33DE022215 (to H. W.), Biotechnology and Biological Sciences Research Council Grant BB/K016164/1 (to S. M. H. and A. D.), Core Support for Collaborative Research (to A. D. and S. M. H.), and a Wellcome Trust Senior Investigator Award (to A. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bensing BA, 2004, INFECT IMMUN, V72, P6528, DOI 10.1128/IAI.72.11.6528-6537.2004; Bu S, 2008, J BACTERIOL, V190, P1256, DOI 10.1128/JB.01078-07; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Chen Q, 2004, MOL MICROBIOL, V53, P843, DOI 10.1111/j.1365-2958.2004.04116.x; Cuccui J, 2015, J PHARM PHARMACOL, V67, P338, DOI 10.1111/jphp.12321; Cuccui J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130002; Dell Anne, 2010, Int J Microbiol, V2010, P148178, DOI 10.1155/2010/148178; Echlin H., 2014, THESIS; Echlin H, 2013, J BACTERIOL, V195, P2166, DOI 10.1128/JB.02255-12; Elhenawy W, 2016, GLYCOBIOLOGY, V26, P301, DOI 10.1093/glycob/cwv098; Faridmoayer A, 2007, J BACTERIOL, V189, P8088, DOI 10.1128/JB.01318-07; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Froeliger EH, 2001, INFECT IMMUN, V69, P2512, DOI 10.1128/IAI.69.4.2512-2519.2001; Garcia-Quintanilla F, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00381; Giraud MF, 2000, CURR OPIN STRUC BIOL, V10, P687, DOI 10.1016/S0959-440X(00)00145-7; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Iwashkiw JA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-13; James DBA, 2013, J BACTERIOL, V195, P5469, DOI 10.1128/JB.00715-13; Kampf MM, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0195-7; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; Kremer BHA, 2001, J BACTERIOL, V183, P2543, DOI 10.1128/JB.183.8.2543-2552.2001; Lee IC, 2014, J BACTERIOL, V196, P1671, DOI 10.1128/JB.01401-13; Li YR, 2014, CURR MICROBIOL, V69, P121, DOI 10.1007/s00284-014-0563-2; Li YR, 2008, MOL MICROBIOL, V70, P1094, DOI 10.1111/j.1365-2958.2008.06456.x; Lizcano A, 2012, MOL ORAL MICROBIOL, V27, P257, DOI 10.1111/j.2041-1014.2012.00653.x; Lu QH, 2015, TRENDS MICROBIOL, V23, P630, DOI 10.1016/j.tim.2015.07.003; Nothaft H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26511; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Oka T, 2007, J BIOL CHEM, V282, P5389, DOI 10.1074/jbc.M610196200; Pan C, 2016, MBIO, V7, DOI 10.1128/mBio.00443-16; Peng Z, 2008, ORAL MICROBIOL IMMUN, V23, P70, DOI 10.1111/j.1399-302X.2007.00401.x; Rahim R, 2001, MOL MICROBIOL, V40, P708, DOI 10.1046/j.1365-2958.2001.02420.x; Ravenscroft N, 2016, GLYCOBIOLOGY, V26, P51, DOI 10.1093/glycob/cwv077; Samen U, 2007, INFECT IMMUN, V75, P5405, DOI 10.1128/IAI.00717-07; Schmid J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00182; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Stephenson AE, 2002, MOL MICROBIOL, V43, P147, DOI 10.1046/j.1365-2958.2002.02725.x; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Takamatsu D, 2006, INFECT IMMUN, V74, P1933, DOI 10.1128/IAI.74.3.1933-1940.2006; Tan FYY, 2015, TRENDS BIOCHEM SCI, V40, P342, DOI 10.1016/j.tibs.2015.03.016; Theilacker C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-67; Valguarnera E, 2016, J MOL BIOL, V428, P3206, DOI 10.1016/j.jmb.2016.04.013; Wacker M, 2014, J INFECT DIS, V209, P1551, DOI 10.1093/infdis/jit800; Walter J, 2008, MICROBIOL-SGM, V154, P72, DOI 10.1099/mic.0.2007/010637-0; Wang S, 2015, J BACTERIOL, V197, P2012, DOI 10.1128/JB.02590-14; Wang S, 2013, BIOORG MED CHEM LETT, V23, P3491, DOI 10.1016/j.bmcl.2013.04.051; Wu H, 1998, MOL MICROBIOL, V28, P487, DOI 10.1046/j.1365-2958.1998.00805.x; Wu H, 2007, INFECT IMMUN, V75, P2181, DOI 10.1128/IAI.01544-06; Wu H, 2007, J BACTERIOL, V189, P1390, DOI 10.1128/JB.00836-06; Wu R, 2011, J BIOL CHEM, V286, P34923, DOI 10.1074/jbc.M111.239350; Wu R, 2010, APPL ENVIRON MICROB, V76, P7966, DOI 10.1128/AEM.01434-10; Zegzouti H, 2013, GLYCOBIOLOGY, V23, P1340; Zhang H, 2016, J BIOL CHEM, V291, P22106, DOI 10.1074/jbc.M116.731695; Zhang H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5339; Zhang H, 2013, ACTA CRYSTALLOGR F, V69, P520, DOI 10.1107/S1744309113007161; Zhou MX, 2008, INFECT IMMUN, V76, P5624, DOI 10.1128/IAI.00534-08; Zhou M, 2008, J MICROBIOL METH, V72, P249, DOI 10.1016/j.mimet.2007.12.002; Zhou MX, 2012, MOL MICROBIOL, V83, P866, DOI 10.1111/j.1365-2958.2012.07970.x; Zhou MX, 2011, J BACTERIOL, V193, P6560, DOI 10.1128/JB.05668-11; Zhou MX, 2010, J BIOL CHEM, V285, P12140, DOI 10.1074/jbc.M109.066928; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0; Zhu F, 2015, J DENT RES, V94, P659, DOI 10.1177/0022034515574865; Zhu F, 2016, SCI CHINA LIFE SCI, V59, P11, DOI 10.1007/s11427-015-4980-7; Zhu F, 2011, J BIOL CHEM, V286, P27048, DOI 10.1074/jbc.M110.208629	66	22	22	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27354	27363		10.1074/jbc.M116.752998	http://dx.doi.org/10.1074/jbc.M116.752998			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	28039332	Green Published, hybrid			2022-12-26	WOS:000391576300032
J	Banes, GL; Galdikas, BMF				Banes, Graham L.; Galdikas, Birute M. F.			Effective Characterisation of the Complete Orang-Utan Mitochondrial DNA Control Region, in the Face of Persistent Focus in Many Taxa on Shorter Hypervariable Regions	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; MTDNA CONTROL REGION; BORNEAN ORANGUTANS; POPULATION-STRUCTURE; NATURAL-POPULATIONS; SUMATRAN ORANGUTAN; SEQUENCE-ANALYSIS; PONGO-PYGMAEUS; GUIDELINES; ORIGIN	The hypervariable region I (HVRI) is persistently used to discern haplotypes, to distinguish geographic subpopulations, and to infer taxonomy in a range of organisms. Numerous studies have highlighted greater heterogeneity elsewhere in the mitochondrial DNA control region, however-particularly, in some species, in other understudied hypervariable regions. To assess the abundance and utility of such potential variations in orang-utans, we characterised 36 complete control-region haplotypes, of which 13 were of Sumatran and 23 of Bornean maternal ancestry, and compared polymorphisms within these and within shorter HVRI segments predominantly analysed in prior phylogenetic studies of Sumatran (similar to 385 bp) and Bornean (similar to 323 bp) orang-utans. We amplified the complete control region in a single PCR that proved successful even with highly degraded, non-invasive samples. By using species-specific primers to produce a single large amplicon (similar to 1600 bp) comprising flanking coding regions, our method also serves to better avoid amplification of nuclear mitochondrial insertions (numts). We found the number, length and position of hypervariable regions is inconsistent between orang-utan species, and that prior definitions of the HVRI were haphazard. Polymorphisms occurring outside the predominantly analysed segments were phylogeographically informative in isolation, and could be used to assign haplotypes to comparable clades concordant with geographic subpopulations. The predominantly analysed segments could discern only up to 76% of all haplotypes, highlighting the forensic utility of complete control-region sequences. In the face of declining sequencing costs and our proven application to poor-quality DNA extracts, we see no reason to ever amplify only specific 'hypervariable regions' in any taxa, particularly as their lengths and positions are inconsistent and cannot be reliably defined-yet this strategy predominates widely. Given their greater utility and consistency, we instead advocate analysis of complete control-region sequences in future studies, where any shorter segment might otherwise have proven the region of choice.	[Banes, Graham L.] Univ Cambridge, Dept Archaeol & Anthropol, Div Biol Anthropol, Cambridge, Cambs, England; [Banes, Graham L.] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Banes, Graham L.] CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Galdikas, Birute M. F.] Simon Fraser Univ, Dept Archaeol, Burnaby, BC, Canada	University of Cambridge; Max Planck Society; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Simon Fraser University	Banes, GL (corresponding author), Univ Cambridge, Dept Archaeol & Anthropol, Div Biol Anthropol, Cambridge, Cambs, England.; Banes, GL (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.; Banes, GL (corresponding author), CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China.	graham_banes@eva.mpg.de	Banes, Graham L/H-3537-2011	Banes, Graham L/0000-0003-4382-7684	University of Aberdeen (UoA); Expedition Fund; UoA Small Grants Fund; UoA Alumni Annual Fund; John Reid Trust; Royal Geographical Society; Royal Scottish Geographical Society; Gilchrist Educational Trust; Orangutan Foundation UK; North of England Zoological Society at Chester Zoo; Darwin College, Cambridge; Primate Society of Great Britain, through a Charles A Lockwood Memorial Grant; ARCUS Foundation; Leverhulme Centre for Human Evolutionary Studies, University of Cambridge; Ridgeway-Venn Studentship; Miss Millie Foundation; American Association of Zoo Keepers Los Angeles Chapter; Orangutan Foundation International; Sacramento Zoo Conservation Fund; Como Park Zoo and Conservatory; Orangutan Outreach; Henry Vilas Zoo; Orang-utan Conservation Genetics Trust; Max Planck Society; Chinese Academy of Sciences; National Natural Science Foundation of China [31450110070, 91331203]; Orang Utan Republik Foundation through the LP Jenkins Memorial Fellowship; German Academic Exchange Service (DAAD); Institute of British Geographers	University of Aberdeen (UoA); Expedition Fund; UoA Small Grants Fund; UoA Alumni Annual Fund; John Reid Trust; Royal Geographical Society; Royal Scottish Geographical Society; Gilchrist Educational Trust; Orangutan Foundation UK; North of England Zoological Society at Chester Zoo; Darwin College, Cambridge; Primate Society of Great Britain, through a Charles A Lockwood Memorial Grant; ARCUS Foundation; Leverhulme Centre for Human Evolutionary Studies, University of Cambridge; Ridgeway-Venn Studentship; Miss Millie Foundation; American Association of Zoo Keepers Los Angeles Chapter; Orangutan Foundation International; Sacramento Zoo Conservation Fund; Como Park Zoo and Conservatory; Orangutan Outreach; Henry Vilas Zoo; Orang-utan Conservation Genetics Trust; Max Planck Society(Max Planck SocietyFoundation CELLEX); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Orang Utan Republik Foundation through the LP Jenkins Memorial Fellowship; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Institute of British Geographers	Collection of samples at Camp Leakey was generously supported by the University of Aberdeen (UoA; http://www.abdn.ac.uk/) Expedition Fund; UoA Small Grants Fund; UoA Alumni Annual Fund; the John Reid Trust; the Royal Geographical Society with Institute of British Geographers (http://www.rgs.org/); the Royal Scottish Geographical Society (http://www.rsgs.org/); the Gilchrist Educational Trust (http://www.gilchristgrants.org.uk/); the Orangutan Foundation UK (http://www.orangutan.org.uk); the North of England Zoological Society at Chester Zoo (http://www.chesterzoo.org/); Darwin College, Cambridge (http://www.darwin.cam.ac.uk/); the Primate Society of Great Britain (http://www.psgb.org/), through a Charles A Lockwood Memorial Grant; the ARCUS Foundation (http://www.arcusfoundation.org/); the Leverhulme Centre for Human Evolutionary Studies, University of Cambridge (http://www.human-evol.cam.ac.uk/); the Ridgeway-Venn Studentship; the Miss Millie Foundation and the American Association of Zoo Keepers Los Angeles Chapter. The long-term research conducted at Camp Leakey, which facilitated sample collection in Tanjung Puting National Park, was primarily funded by the Orangutan Foundation International (http://www.orangutan.org/). Collection of samples in the United States, and subsequent laboratory analyses, was funded by the Sacramento Zoo Conservation Fund (http://www.saczoo.org/); Como Park Zoo and Conservatory (http://www.comozooconservatory.org/); Orangutan Outreach (http://www.redapes.org/); Henry Vilas Zoo (http://www.vilaszoo.org/); The Orang-utan Conservation Genetics Trust; the Max Planck Society (http://www.mpg.de); the Chinese Academy of Sciences (http://www.cas.ac.cn) and the National Natural Science Foundation of China (http://www.nsfc.gov.cn/; grant numbers 31450110070 and 91331203). GLB was supported by the Orang Utan Republik Foundation (http://www.orangutanrepublik.org/) through the 2012 LP Jenkins Memorial Fellowship and by the German Academic Exchange Service (DAAD; https://www.daad.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Anthony NM, 2007, MOL PHYLOGENET EVOL, V43, P553, DOI 10.1016/j.ympev.2006.09.013; Arora N, 2010, P NATL ACAD SCI USA, V107, P21376, DOI 10.1073/pnas.1010169107; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Badhan A, 2015, J MED PRIMATOL, V44, P125, DOI 10.1111/jmp.12163; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Banes GL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22026; Banes GL, 2015, BEHAV ECOL SOCIOBIOL, V69, P1785, DOI 10.1007/s00265-015-1991-0; BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0; Brandon-Jones D, 2004, INT J PRIMATOL, V25, P97, DOI 10.1023/B:IJOP.0000014647.18720.32; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Carracedo A, 2013, FORENSIC SCI INT-GEN, V7, P217, DOI 10.1016/j.fsigen.2013.01.001; Changtragoon Suchitra, 2012, P327; Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Das R, 2015, J HERED, V105, P846; Dunn JC, 2014, PRIMATES, V55, P155, DOI 10.1007/s10329-013-0399-6; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fernandes GA, 2013, MOL BIOL REP, V40, P2757, DOI 10.1007/s11033-012-2294-4; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Gonder MK, 1997, NATURE, V388, P337, DOI 10.1038/41005; GREENBERG BD, 1983, GENE, V21, P33, DOI 10.1016/0378-1119(83)90145-2; Groves C.P., 2001, PRIMATE TAXONOMY; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HORAI S, 1992, J MOL EVOL, V35, P32, DOI 10.1007/BF00160258; HORAI S, 1990, AM J HUM GENET, V46, P828; Hsieh HM, 2011, FORENSIC SCI INT-GEN, V5, P303, DOI 10.1016/j.fsigen.2010.06.003; Imes DL, 2012, FORENSIC SCI INT-GEN, V6, P630, DOI 10.1016/j.fsigen.2012.02.004; Ishida Y, 2013, EVOL APPL, V6, P253, DOI 10.1111/j.1752-4571.2012.00286.x; Jalil MF, 2008, MOL ECOL, V17, P2898, DOI 10.1111/j.1365-294X.2008.03793.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lutz S, 1998, INT J LEGAL MED, V111, P67, DOI 10.1007/s004140050117; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Meyer S, 1999, GENETICS, V152, P1103; Miller KWP, 2001, CROAT MED J, V42, P315; Morrogh-Bernard HC, 2011, INT J PRIMATOL, V32, P362, DOI 10.1007/s10764-010-9474-7; Muir CC, 1998, J MOL EVOL, V46, P378, DOI 10.1007/PL00006316; Nater A, 2013, J HERED, V104, P2, DOI 10.1093/jhered/ess065; Paijmans JLA, 2013, MOL PHYLOGENET EVOL, V69, P404, DOI 10.1016/j.ympev.2012.06.002; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Parson W, 2007, FORENSIC SCI INT-GEN, V1, P88, DOI 10.1016/j.fsigen.2007.01.018; Parson W, 2007, FORENSIC SCI INT-GEN, V1, P13, DOI 10.1016/j.fsigen.2006.11.003; Perwitasari-Farajallah Dyah, 2009, Biotropia, V16, P65; Rianti P, 2015, IDENTIFICATION DIAGN; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; RYDER OA, 1993, J HERED, V84, P405, DOI 10.1093/oxfordjournals.jhered.a111362; SEUANEZ HN, 1979, CYTOGENET CELL GENET, V23, P137, DOI 10.1159/000131314; Singleton I., 2004, ORANGUTAN POPULATION; Sorenson L, 2013, CONSERV GENET RESOUR, V5, P293, DOI 10.1007/s12686-012-9747-x; Soto-Calderon ID, 2012, J MOL EVOL, V75, P102, DOI 10.1007/s00239-012-9519-y; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; Tzen JM, 2008, MITOCHONDRION, V8, P146, DOI 10.1016/j.mito.2007.11.002; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; Warren KS, 2001, MOL BIOL EVOL, V18, P472, DOI 10.1093/oxfordjournals.molbev.a003826; WilkinsonHerbots HM, 1996, ANN HUM GENET, V60, P499, DOI 10.1111/j.1469-1809.1996.tb01616.x; Wu H, 2005, FORENSIC SCI INT, V148, P101, DOI 10.1016/j.forsciint.2004.04.072; Xu XF, 1996, J MOL EVOL, V43, P431, DOI 10.1007/PL00006103; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Zhi L, 1996, CURR BIOL, V6, P1326, DOI 10.1016/S0960-9822(02)70719-7	63	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168715	10.1371/journal.pone.0168715	http://dx.doi.org/10.1371/journal.pone.0168715			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033350	Green Published, Green Submitted, gold			2022-12-26	WOS:000391226900039
J	Wong, TH; Chen, HA; Gau, RJ; Yen, JH; Suen, JL				Wong, Tzu-Hsuan; Chen, Hung-An; Gau, Rung-Jiun; Yen, Jeng-Hsien; Suen, Jau-Ling			Heme Oxygenase-1-Expressing Dendritic Cells Promote Foxp3(+) Regulatory T Cell Differentiation and Induce Less Severe Airway Inflammation in Murine Models	PLOS ONE			English	Article							GM-CSF; ACTIVATION; GENERATION; IL-10; EXPRESSION; MATURATION; TOLERANCE; CYTOKINE; REQUIRES; ALPHA	Dendritic cells (DCs) are critical for instructing immune responses toward inflammatory or anti-inflammatory status. Heme oxygenase-1 (HO-1) is known for its cytoprotective effect against oxidative stress and inflammation, suggesting its immune regulatory role in allergic lung inflammation. HO-1 has been implicated in affecting DC maturation; however, its role in DC-mediated T-cell differentiation is unclear. In this study, we demonstrated that HO-1-expressing bone marrow-derived dendritic cells (BM-DCs) displayed tolerogenic phenotypes, including their resistance to lipopolysaccharide (LPS)-induced maturation, high level expression of IL-10, and low T-cell stimulatory activity. In addition, HO-1-expressing DCs were able to induce antigen-specific Foxp3(+) regulatory T cells (Treg) differentiation in vitro and in vivo. Also, HO-1-expressing DCs modulated the severity of lung inflammatory responses in two murine models of airway inflammation. This study provided evidence supporting the role of HO-1-expressing DCs in tolerance induction and as a potential therapeutic target for allergic asthma as well as other inflammatory diseases.	[Wong, Tzu-Hsuan; Yen, Jeng-Hsien; Suen, Jau-Ling] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Chen, Hung-An] Chi Mei Med Ctr, Dept Allergy Immunol Rheumatol, Tainan, Taiwan; [Gau, Rung-Jiun] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Tainan, Taiwan; [Yen, Jeng-Hsien] Kaohsiung Med Univ Hosp, Div Rheumatol, Dept Internal Med, Kaohsiung, Taiwan; [Suen, Jau-Ling] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan; [Suen, Jau-Ling] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan	Kaohsiung Medical University; Chi Mei Hospital; Industrial Technology Research Institute - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Suen, JL (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan.; Suen, JL (corresponding author), Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan.; Suen, JL (corresponding author), Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan.	jlsuen@kmu.edu.tw	Yen, Jeng-Hsien/A-1335-2010; Suen, Jan-Ling/C-7293-2009	Yen, Jeng-Hsien/0000-0002-1291-1739; 	Ministry of Science and Technology [NSC 102-2320-B-037-021-MY3]; Chi-Mei Medical Center [102CM-KMU-04]; Kaohsiung Medical University Hospital [KMUH103-10V07]; Kaohsiung Medical University Aim for the Top Universities Grant [KMU-TP103A25, KMU-TP104A05]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chi-Mei Medical Center; Kaohsiung Medical University Hospital; Kaohsiung Medical University Aim for the Top Universities Grant	This work was supported by the fund NSC 102-2320-B-037-021-MY3 from Ministry of Science and Technology, the grant 102CM-KMU-04 from the Chi-Mei Medical Center, KMUH103-10V07 from Kaohsiung Medical University Hospital, and Kaohsiung Medical University Aim for the Top Universities Grant (KMU-TP103A25, KMU-TP104A05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyanwu AC, 2014, AM J PHYSIOL-LUNG C, V306, pL749, DOI 10.1152/ajplung.00236.2013; Ashour HM, 2007, J LEUKOCYTE BIOL, V82, P1033, DOI 10.1189/jlb.0507310; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Bhattacharya P, 2011, J LEUKOCYTE BIOL, V89, P235, DOI 10.1189/jlb.0310154; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Chappell CP, 2012, J EXP MED, V209, P1825, DOI 10.1084/jem.20120774; Chauveau C, 2005, BLOOD, V106, P1694, DOI 10.1182/blood-2005-02-0494; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen X, 2007, J IMMUNOL, V178, P6123, DOI 10.4049/jimmunol.178.10.6123; Creusot RJ, 2009, BLOOD, V113, P6638, DOI 10.1182/blood-2009-02-204321; Elshabrawy HA, 2014, J VIROL, V88, P4353, DOI 10.1128/JVI.03050-13; Elshabrawy HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050366; Fadilah S A W, 2007, Malays J Pathol, V29, P1; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Karimi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047556; Kikuchi S, 2005, INT ARCH ALLERGY IMM, V137, P7, DOI 10.1159/000085425; Konrad FM, 2014, AM J PHYSIOL-LUNG C, V307, pL707, DOI 10.1152/ajplung.00145.2014; Lambrecht BN, 2000, J IMMUNOL, V164, P2937, DOI 10.4049/jimmunol.164.6.2937; Le Roux D, 2012, BLOOD, V119, P95, DOI 10.1182/blood-2011-02-336123; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Levings MK, 2005, BLOOD, V105, P1162, DOI 10.1182/blood-2004-03-1211; Li N, 2000, J IMMUNOL, V165, P3393, DOI 10.4049/jimmunol.165.6.3393; Mashreghi MF, 2008, J IMMUNOL, V180, P7919, DOI 10.4049/jimmunol.180.12.7919; Namba K, 2002, J LEUKOCYTE BIOL, V72, P946; Newcomb DC, 2013, CURR OPIN IMMUNOL, V25, P755, DOI 10.1016/j.coi.2013.08.002; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Schumacher A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042301; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Unger WWJ, 2009, EUR J IMMUNOL, V39, P3147, DOI 10.1002/eji.200839103; Willart M, 2011, CURR OPIN IMMUNOL, V23, P772, DOI 10.1016/j.coi.2011.09.008; Zhang YJ, 2013, J BIOL CHEM, V288, P34612, DOI 10.1074/jbc.M113.494369; Zhao HL, 2013, FASEB J, V27, P4076, DOI 10.1096/fj.13-232173	40	33	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168919	10.1371/journal.pone.0168919	http://dx.doi.org/10.1371/journal.pone.0168919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033400	Green Published, Green Submitted, gold			2022-12-26	WOS:000391226900060
J	Kale, A; Rimesso, G; Baker, NE				Kale, Abhijit; Rimesso, Gerard; Baker, Nicholas E.			Local Cell Death Changes the Orientation of Cell Division in the Developing Drosophila Wing Imaginal Disc Without Using Fat or Dachsous as Orienting Signals	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PATHWAY; HIPPO PATHWAY; PLANAR POLARITY; GENETIC MOSAICS; REGULATE GROWTH; TISSUE-GROWTH; ORGAN SIZE; COMPETITION; EYE; PROLIFERATION	Drosophila imaginal disc cells exhibit preferred cell division orientations according to location within the disc. These orientations are altered if cell death occurs within the epithelium, such as is caused by cell competition or by genotypes affecting cell survival. Both normal cell division orientations, and their orientations after cell death, depend on the Fat-Dachsous pathway of planar cell polarity (PCP). The hypothesis that cell death initiates a planar polarity signal was investigated. When clones homozygous for the pineapple eye ( pie) mutation were made to initiate cell death, neither Dachsous nor Fat was required in pie cells for the re-orientation of nearby cells, indicating a distinct signal for this PCP pathway. Dpp and Wg were also not needed for pie clones to re-orient cell division. Cell shapes were evaluated in wild type and mosaic wing discs to assess mechanical consequences of cell loss. Although proximal wing disc cells and cells close to the dorso-ventral boundary were elongated in their preferred cell division axes in wild type discs, cell shapes in much of the wing pouch were symmetrical on average and did not predict their preferred division axis. Cells in pie mutant clones were slightly larger than their normal counterparts, consistent with mechanical stretching following cell loss, but no bias in cell shape was detected in the surrounding cells. These findings indicate that an unidentified signal influences PCP-dependent cell division orientation in imaginal discs.	[Kale, Abhijit; Rimesso, Gerard; Baker, Nicholas E.] Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Nyc, NY 10467 USA; [Baker, Nicholas E.] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, 1300 Morris Pk Ave, Nyc, NY 10467 USA; [Baker, Nicholas E.] Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Nyc, NY 10467 USA; [Kale, Abhijit] Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA USA	Yeshiva University; Yeshiva University; Yeshiva University; Buck Institute for Research on Aging	Baker, NE (corresponding author), Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Nyc, NY 10467 USA.; Baker, NE (corresponding author), Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, 1300 Morris Pk Ave, Nyc, NY 10467 USA.; Baker, NE (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Nyc, NY 10467 USA.	Nicholas.baker@einstein.yu.edu	Kale, Abhijit/I-3787-2019	Rimesso, Gerard/0000-0003-0191-3402; Kale, Abhijit/0000-0002-1105-6953	NIH [GM104213]; Research to Prevent Blindness through the Department of Opthalmology and Visual Sciences; NCI cancer center support grant [P30CA013330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104213] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness through the Department of Opthalmology and Visual Sciences; NCI cancer center support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NEB received funding from NIH grant number GM104213 https://www.nigms.nih.gov/Pages/default.aspx. NEB received funding from Research to Prevent Blindness through the Department of Opthalmology and Visual Sciences https://www.rpbusa.org/rpb/?. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank A. Jenny and A. Kumar for comments on the manuscript, H. McNeil, G. Morata for Drosophila strains, and the Developmental Studies Hybridoma Bank for antibodies. Confocal Imaging was performed at the Analytical Imaging Facility, Albert Einstein College of Medicine, supported by NCI cancer center support grant (P30CA013330). This paper includes data from a thesis partially fulfilling of the requirements for the Degree of Doctor of Philosophy in the Graduate Division of Medical Sciences, Albert Einstein College of Medicine, Yeshiva University.	Adler PN, 1998, DEVELOPMENT, V125, P959; Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; Ambegaonkar AA, 2015, ELIFE, V4, DOI 10.7554/eLife.09946; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; BAKER NE, 1988, DEV BIOL, V125, P96, DOI 10.1016/0012-1606(88)90062-0; Baker NE, 2014, METHODS, V68, P252, DOI 10.1016/j.ymeth.2014.04.007; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; Blair SS, 2014, CURR BIOL, V24, pR835, DOI 10.1016/j.cub.2014.08.008; Bosch JA, 2014, ELIFE, V3, DOI 10.7554/eLife.03383; Bosveld F, 2016, NATURE, V530, P495, DOI 10.1038/nature16970; Bosveld F, 2016, DEVELOPMENT, V143, P623, DOI 10.1242/dev.127993; Cadart C, 2014, DEV CELL, V29, P159, DOI 10.1016/j.devcel.2014.04.009; Campinho P, 2013, NAT CELL BIOL, V15, P1405, DOI 10.1038/ncb2869; Carvajal-Gonzalez Jose Maria, 2014, F1000Prime Rep, V6, P98, DOI 10.12703/P6-98; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; CLEGG NJ, 1993, GENETICS, V134, P221; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Devenport D, 2014, J CELL BIOL, V207, P171, DOI 10.1083/jcb.201408039; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; Gaspar P, 2014, CURR OPIN CELL BIOL, V31, P74, DOI 10.1016/j.ceb.2014.09.003; Gillies TE, 2011, CURR BIOL, V21, pR599, DOI 10.1016/j.cub.2011.06.055; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hertwig O, 1884, JENAISCHE Z FUER NAT, V18, P21, DOI DOI 10.1101/GAD.610511; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Jaiswal M, 2006, DEVELOPMENT, V133, P925, DOI 10.1242/dev.02243; Kale A, 2015, CELL DEATH DIFFER, V22, P1300, DOI 10.1038/cdd.2014.218; LeGoff L, 2013, DEVELOPMENT, V140, P4051, DOI 10.1242/dev.090878; Levayer R, 2015, NATURE, V524, P476, DOI 10.1038/nature14684; Li W, 2009, CURR BIOL, V19, P1821, DOI 10.1016/j.cub.2009.09.023; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; Mao YL, 2013, EMBO J, V32, P2790, DOI 10.1038/emboj.2013.197; Mao YL, 2011, GENE DEV, V25, P131, DOI 10.1101/gad.610511; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; Martin FA, 2004, DEVELOPMENT, V131, P4921, DOI 10.1242/dev.01385; Martin FA, 2009, DEVELOPMENT, V136, P3747, DOI 10.1242/dev.038406; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Matakatsu H, 2012, DEVELOPMENT, V139, P1498, DOI 10.1242/dev.070367; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Panousopoulou E, 2014, SEMIN CELL DEV BIOL, V34, P124, DOI 10.1016/j.semcdb.2014.06.013; POSAKONY LG, 1990, MECH DEVELOP, V33, P69, DOI 10.1016/0925-4773(90)90136-A; Ragkousi K, 2014, J CELL BIOL, V207, P181, DOI 10.1083/jcb.201408044; Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035; Rogulja D, 2008, DEV CELL, V15, P309, DOI 10.1016/j.devcel.2008.06.003; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Segalen M, 2009, SEMIN CELL DEV BIOL, V20, P972, DOI 10.1016/j.semcdb.2009.03.018; Shi W, 2003, GENETICS, V165, P1869; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Simon MA, 2004, DEVELOPMENT, V131, P6175, DOI 10.1242/dev.01550; SIMPSON P, 1979, DEV BIOL, V69, P182, DOI 10.1016/0012-1606(79)90284-7; SIMPSON P, 1981, DEV BIOL, V85, P299, DOI 10.1016/0012-1606(81)90261-X; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Strutt H, 2004, DEVELOPMENT, V131, P881, DOI 10.1242/dev.00996; Tyler DM, 2007, GENETICS, V175, P643, DOI 10.1534/genetics.106.061929; Tyler DM, 2007, DEV BIOL, V305, P187, DOI 10.1016/j.ydbio.2007.02.004; VINCENT JP, 1994, DEV BIOL, V164, P328, DOI 10.1006/dbio.1994.1203; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Wu J, 2013, NAT CELL BIOL, V15, P1045, DOI 10.1038/ncb2806; Wyatt TPJ, 2015, P NATL ACAD SCI USA, V112, P5726, DOI 10.1073/pnas.1420585112; Xing YL, 2012, G3-GENES GENOM GENET, V2, P343, DOI 10.1534/g3.111.001651; XU T, 1993, DEVELOPMENT, V117, P1223; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zecca M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000386	68	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167637	10.1371/journal.pone.0167637	http://dx.doi.org/10.1371/journal.pone.0167637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030539	gold, Green Published, Green Submitted			2022-12-26	WOS:000391222000014
J	Kho, ME; Molloy, AJ; Clarke, FJ; Ajami, D; McCaughan, M; Obrovac, K; Murphy, C; Camposilvan, L; Herridge, MS; Koo, KKY; Rudkowski, J; Seely, AJE; Zanni, JM; Mourtzakis, M; Piraino, T; Cook, DJ				Kho, Michelle E.; Molloy, Alexander J.; Clarke, France J.; Ajami, Daana; McCaughan, Magda; Obrovac, Kristy; Murphy, Christina; Camposilvan, Laura; Herridge, Margaret S.; Koo, Karen K. Y.; Rudkowski, Jill; Seely, Andrew J. E.; Zanni, Jennifer M.; Mourtzakis, Marina; Piraino, Thomas; Cook, Deborah J.		Canadian Critical Care Trials Grp	TryCYCLE: A Prospective Study of the Safety and Feasibility of Early In-Bed Cycling in Mechanically Ventilated Patients	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; NEUROMUSCULAR ELECTRICAL-STIMULATION; PHYSICAL FUNCTION; INTEROBSERVER AGREEMENT; FUNCTIONAL DISABILITY; HANDGRIP STRENGTH; ACQUIRED WEAKNESS; ICU SURVIVORS; MUSCLE MASS	Introduction The objective of this study was to assess the safety and feasibility of in-bed cycling started within the first 4 days of mechanical ventilation (MV) to inform a future randomized clinical trial. Methods We conducted a 33-patient prospective cohort study in a 21-bed adult academic medical-surgical intensive care unit (ICU) in Hamilton, ON, Canada. We included adult patients (>= 18 years) receiving MV who walked independently pre-ICU. Our intervention was 30 minutes of in-bed supine cycling 6 days/week in the ICU. Our primary outcome was Safety (termination), measured as events prompting cycling termination; secondary Safety (disconnection or dislodgement) outcomes included catheter/tube dislodgements. Feasibility was measured as consent rate and fidelity to intervention. For our primary outcome, we calculated the binary proportion and 95% confidence interval (CI). Results From 10/2013-8/2014, we obtained consent from 34 of 37 patients approached (91.9%), 33 of whom received in-bed cycling. Of those who cycled, 16(48.4%) were female, the mean (SD) age was 65.8(12.2) years, and APACHE II score was 24.3(6.7); 29(87.9%) had medical admitting diagnoses. Cycling termination was infrequent (2.0%, 95% CI: 0.8%-4.9%) and no device dislodgements occurred. Cycling began a median [IQR] of 3 [2, 4] days after ICU admission; patients received 5 [3, 8] cycling sessions with a median duration of 30.7 [21.6, 30.8] minutes per session. During 205 total cycling sessions, patients were receiving invasive MV (150 [73.1%]), vasopressors (6 [2.9%]), sedative or analgesic infusions (77 [37.6%]) and dialysis (4 [2.0%]). Conclusions Early cycling within the first 4 days of MV among hemodynamically stable patients is safe and feasible. Research to evaluate the effect of early cycling on patient function is warranted.	[Kho, Michelle E.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Kho, Michelle E.; Molloy, Alexander J.; Ajami, Daana; McCaughan, Magda; Obrovac, Kristy; Murphy, Christina; Camposilvan, Laura] St Josephs Healthcare, Dept Physiotherapy, Hamilton, ON, Canada; [Kho, Michelle E.; Zanni, Jennifer M.; Cook, Deborah J.] Johns Hopkins Univ, Dept Phys Med & Rehabil, Baltimore, MD 21218 USA; [Clarke, France J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Herridge, Margaret S.] Univ Toronto, Dept Med, Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Koo, Karen K. Y.] Swedish Early Mobil Program Crit Care, Swedish Med Grp, First Hill Campus, Seattle, WA USA; [Koo, Karen K. Y.] Western Univ, Dept Med, London, ON, Canada; [Rudkowski, Jill] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Seely, Andrew J. E.] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Mourtzakis, Marina] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada; [Piraino, Thomas] St Josephs Healthcare, Resp Therapy Serv, Hamilton, ON, Canada	McMaster University; Johns Hopkins University; McMaster University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Swedish Medical Center; Western University (University of Western Ontario); McMaster University; University of Ottawa; Ottawa Hospital Research Institute; University of Waterloo	Kho, ME (corresponding author), McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada.; Kho, ME (corresponding author), St Josephs Healthcare, Dept Physiotherapy, Hamilton, ON, Canada.; Kho, ME (corresponding author), Johns Hopkins Univ, Dept Phys Med & Rehabil, Baltimore, MD 21218 USA.	khome@mcmaster.ca	, Michelle/W-7414-2019; Piraino, Thomas/AAB-8938-2019	Piraino, Thomas/0000-0002-4887-8686; Kho, Michelle/0000-0003-3170-031X; Herridge, Margaret/0000-0002-2903-1631	Canadian Institutes of Health Research; Institute of Musculoskeletal Health and Arthritis Operating grant [131584]; Canada Research Chairs MEK DJC; Canadian Institutes of Health Research; Institute of Musculoskeletal Health and Arthritis Operating grant [131584]; Canada Research Chairs MEK DJC	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute of Musculoskeletal Health and Arthritis Operating grant; Canada Research Chairs MEK DJC; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute of Musculoskeletal Health and Arthritis Operating grant; Canada Research Chairs MEK DJC	This work was supported by: Canadian Institutes of Health Research (www.cihr-irsc.gc.ca.), Institute of Musculoskeletal Health and Arthritis Operating grant Priority Announcement: IMHA New investigators - Bridge Funding (131584) MEK DJC MSH KK MM JR AS; Canada Research Chairs MEK DJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler Joseph, 2012, Cardiopulm Phys Ther J, V23, P5; Ali NA, 2008, AM J RESP CRIT CARE, V178, P261, DOI 10.1164/rccm.200712-1829OC; [Anonymous], 2002, CRIT CARE MED, V166, P111, DOI [10.1164/rccm.166/1/111, DOI 10.1164/RCCM.166/1/111]; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Brummel NE, 2014, INTENS CARE MED, V40, P370, DOI 10.1007/s00134-013-3136-0; Burtin C, 2009, CRIT CARE MED, V37, P2499, DOI 10.1097/CCM.0b013e3181a38937; Calvo-Ayala E, 2013, CHEST, V144, P1469, DOI 10.1378/chest.13-0779; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Damluji A, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2013.01.006; Dantas Camila Moura, 2012, Rev. bras. ter. intensiva, V24, P173, DOI 10.1590/S0103-507X2012000200013; Daugherty EL, 2009, CRIT CARE MED, V37, P1210, DOI [10.1097/CCM.0b013e3181b6fa29, 10.1097/CCM.0b013e31819d67b5]; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; Denehy L, 2013, PHYS THER, V93, P1636, DOI 10.2522/ptj.20120310; Denehy L, 2013, CRIT CARE, V17, DOI 10.1186/cc12835; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Esteban A, 2013, AM J RESP CRIT CARE, V188, P220, DOI 10.1164/rccm.201212-2169OC; Fan E, 2010, INTENS CARE MED, V36, P1038, DOI 10.1007/s00134-010-1796-6; Gerovasili V, 2009, CRIT CARE, V13, DOI 10.1186/cc8123; Groll DL, 2005, J CLIN EPIDEMIOL, V58, P595, DOI 10.1016/j.jclinepi.2004.10.018; Hermans G, 2012, MUSCLE NERVE, V45, P18, DOI 10.1002/mus.22219; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hickmann CE, 2014, INTENS CARE MED, V40, P548, DOI 10.1007/s00134-014-3218-7; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kayambu G, 2015, INTENS CARE MED, V41, P865, DOI 10.1007/s00134-015-3763-8; Kho ME, 2015, J CRIT CARE, V30, pe1, DOI DOI 10.1016/J.JCRC.2015.07.025; Kho ME, 2015, J CRIT CARE, V30, P32, DOI 10.1016/j.jcrc.2014.09.014; Kho ME, 2012, PHYS THER, V92, P1564, DOI 10.2522/ptj.20110437; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Korupolu R, 2009, CONT CRIT CARE, V6, P1; LEBLANC AD, 1992, J APPL PHYSIOL, V73, P2172, DOI 10.1152/jappl.1992.73.5.2172; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Needham DM, 2005, CRIT CARE MED, V33, P574, DOI [10.1097/01.CCM.0000155992.21174.31, 10.1097/01.ccm.0000155992.21174.31]; Parry SM, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.03.017; Pires-Neto RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074182; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Segers J, 2014, J CRIT CARE; Skinner EH, 2009, CRIT CARE RESUSC, V11, P110; Sricharoenchai T, 2014, J CRIT CARE, V29, P395, DOI 10.1016/j.jcrc.2013.12.012; TEAM Study Investigators, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0765-4; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Vanpee G, 2011, CRIT CARE MED, V39, P1929, DOI 10.1097/CCM.0b013e31821f050b; Vivodtzev I, 2014, CRIT CARE, V18, DOI 10.1186/cc13888; Zanni JM, 2010, J CRIT CARE, V25, P254, DOI 10.1016/j.jcrc.2009.10.010	48	31	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167561	10.1371/journal.pone.0167561	http://dx.doi.org/10.1371/journal.pone.0167561			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030555	gold, Green Published			2022-12-26	WOS:000391222000010
J	Pan, HP; Preisser, EL; Su, Q; Jiao, XG; Xie, W; Wang, SL; Wu, QJ; Zhang, YJ				Pan, Huipeng; Preisser, Evan L.; Su, Qi; Jiao, Xiaoguo; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Zhang, Youjun			Natal Host Plants Can Alter Herbivore Competition	PLOS ONE			English	Article							BEMISIA-TABACI HEMIPTERA; 2 INVASIVE WHITEFLIES; FEEDING-BEHAVIOR; Q-BIOTYPES; ALEYRODIDAE; RESISTANCE; PYRIPROXYFEN; SUITABILITY; PERFORMANCE; RELEVANCE	Interspecific competition between herbivores is widely recognized as an important determinant of community structure. Although researchers have identified a number of factors capable of altering competitive interactions, few studies have addressed the influence of neighboring plant species. If adaptation to/epigenetic effects of an herbivore's natal host plant alter its performance on other host plants, then interspecific herbivore interactions may play out differently in heterogeneous and homogenous plant communities. We tested wether the natal host plant of a whitefly population affected interactions between the Middle-east Asia Minor 1 (MEAM1) and Mediterranean (MED) cryptic species of the whitefly Bemisia tabaci by rearing the offspring of a cabbage-derived MEAM1 population and a poinsettia-derived MED population together on three different host plants: cotton, poinsettia, and cabbage. We found that MED dominated on poinsettia and that MEAM1 dominated on cabbage, results consistent with previous research. MED also dominated when reared with MEAM1 on cotton, however, a result at odds with multiple otherwise-similar studies that reared both species on the same natal plant. Our work provides evidence that natal plants affect competitive interactions on another plant species, and highlights the potential importance of neighboring plant species on herbivore community composition in agricultral systems.	[Pan, Huipeng] South China Agr Univ, Dept Entomol, Guangzhou, Guangdong, Peoples R China; [Pan, Huipeng] Engn Technol Res Ctr Agr Pest Biocontrol Guangdon, Key Lab Biopesticide Innovat & Applicat, Guangzhou, Guangdong, Peoples R China; [Pan, Huipeng; Su, Qi; Jiao, Xiaoguo; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Zhang, Youjun] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing, Peoples R China; [Preisser, Evan L.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA	South China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of Rhode Island	Zhang, YJ (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing, Peoples R China.	zhangyoujun@caas.cn	Zhang, Youjun/AAY-7948-2020	Zhang, Youjun/0000-0003-3508-6695	State Key Program of National Natural Science Foundation of China [31420103919]; 973 Program [2013CB127602]; National Department Public Benefit Research Foundation [201303019]; South China Agricultural University; Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables	State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); National Department Public Benefit Research Foundation; South China Agricultural University; Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables	This work was supported by the State Key Program of National Natural Science Foundation of China (31420103919), the 973 Program (2013CB127602), the National Department Public Benefit Research Foundation (201303019), a start-up fund from the South China Agricultural University, and the Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables. These agencies had no role in study design, data collection/analysis, manuscript preparation, or the decision to publish. The authors declare no competing financial interests.; Comments by D. Crowder, J. Lau, M. Schadler, and an anonymous reviewer greatly improved this manuscript. This work was supported by the State Key Program of National Natural Science Foundation of China (31420103919), the 973 Program (2013CB127602), the National Department Public Benefit Research Foundation (201303019), a start-up fund from the South China Agricultural University, and the Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables. These agencies had no role in study design, data collection/analysis, manuscript preparation, or the decision to publish. The authors declare no competing financial interests.	Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; Bernardo J, 1996, AM ZOOL, V36, P83; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Brown J. K., 1994, FAO (Food and Agriculture Organization of the United Nations) Plant Protection Bulletin, V42, P3; BUTTER NS, 1992, TROP AGR, V69, P119; Cahenzli F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2856; CALATAYUD PA, 1994, ENTOMOL EXP APPL, V72, P219, DOI 10.1007/BF02383809; Chu D, 2012, J ECON ENTOMOL, V105, P930, DOI 10.1603/EC10373; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Crowder DW, 2010, J ANIM ECOL, V79, P563, DOI 10.1111/j.1365-2656.2010.01666.x; Crowder DW, 2010, ANIM BEHAV, V79, P579, DOI 10.1016/j.anbehav.2009.11.025; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; Dunn GA, 2011, ENDOCRINOLOGY, V152, P2228, DOI 10.1210/en.2010-1461; Guo JY, 2013, J ECON ENTOMOL, V106, P1379, DOI 10.1603/EC12401; Herman JJ, 2012, INTEGR COMP BIOL, V52, P77, DOI 10.1093/icb/ics041; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; Iida H, 2009, APPL ENTOMOL ZOOL, V44, P267, DOI 10.1303/aez.2009.267; Inbar M, 2001, OIKOS, V94, P228, DOI 10.1034/j.1600-0706.2001.940203.x; Jiao XG, 2013, ENTOMOL EXP APPL, V147, P1, DOI 10.1111/eea.12040; Jiao XG, 2012, J PEST SCI, V85, P423, DOI 10.1007/s10340-012-0441-2; Karban R, 2010, NEW PHYTOL, V186, P565, DOI 10.1111/j.1469-8137.2010.03263.x; Liu BM, 2013, ENVIRON ENTOMOL, V42, P980, DOI 10.1603/EN13071; Liu BM, 2013, J VIROL, V87, P4929, DOI 10.1128/JVI.03571-12; Liu BM, 2012, INT J BIOL SCI, V8, P697, DOI 10.7150/ijbs.4108; Liu J, 2009, ANN APPL BIOL, V155, P439, DOI 10.1111/j.1744-7348.2009.00366.x; MASTERS GJ, 1993, OIKOS, V66, P148, DOI 10.2307/3545209; Medina-Ortega KJ, 2011, ENTOMOLOGY, P149; MIAO SL, 1991, ECOLOGY, V72, P1634, DOI 10.2307/1940963; Pan HP, 2015, ECOL APPL, V25, P1585, DOI 10.1890/14-0752.1; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034817; Park J, 2012, J ASIA-PAC ENTOMOL, V15, P186, DOI 10.1016/j.aspen.2011.10.005; Price P.W., 2011, INSECT ECOLOGY BEHAV; Qiu BL, 2011, J PEST SCI, V84, P419, DOI 10.1007/s10340-011-0367-0; ROSSITER MC, 1991, OECOLOGIA, V87, P288, DOI 10.1007/BF00325268; Sun DB, 2011, B ENTOMOL RES, V101, P211, DOI 10.1017/S0007485310000416; Sun DB, 2014, B ENTOMOL RES, V104, P334, DOI 10.1017/S0007485314000108; Sun DB, 2013, B ENTOMOL RES, V103, P344, DOI 10.1017/S0007485312000788; Verhoeven KJF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038605; Via S, 2002, AM NAT, V159, pS76, DOI 10.1086/338374; White JA, 2009, HEREDITY, V102, P483, DOI 10.1038/hdy.2009.5; Wilson M, 2007, PEST MANAG SCI, V63, P761, DOI 10.1002/ps.1403; Wu Shu-Wen, 2010, Chinese Bulletin of Entomology, V47, P1118; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445	45	6	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0169142	10.1371/journal.pone.0169142	http://dx.doi.org/10.1371/journal.pone.0169142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030636	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000107
J	Yang, Q; Zhang, Y; Yan, DM; Zhu, SL; Wang, DY; Ji, TJ; Li, XL; Song, Y; Gu, XR; Xu, WB				Yang, Qian; Zhang, Yong; Yan, Dongmei; Zhu, Shuangli; Wang, Dongyan; Ji, Tianjiao; Li, Xiaolei; Song, Yang; Gu, Xinrui; Xu, Wenbo			Two Genotypes of Coxsackievirus A2 Associated with Hand, Foot, and Mouth Disease Circulating in China since 2008	PLOS ONE			English	Article							HUMAN ENTEROVIRUSES; RECOMBINATION; CHILDREN; IDENTIFICATION; DYNAMICS; OUTBREAK	Coxsackievirus A2 (CV-A2) has been frequently detected and commonly associated with hand, foot, and mouth disease (HFMD) in China since 2008. However, limited sequences of CV-A2 are currently available. As a result, we have been focusing on the genetic characteristics of CV-A2 in the mainland of China during 2008-2015 based on national HFMD surveillance. In this study, 20 CV-A2 strains were isolated and phylogenetic analyses of the VP1 sequences were performed. Full-length genome sequences of two representative CV-A2 isolates were acquired and similarity plot and bootscanning analyses were performed. The phylogenetic dendrogram indicated that all CV-A2 strains could be divided into four genotypes (Genotypes A-D). The CV-A2 prototype strain (Fleetwood) was the sole member of genotype A. From 2008 to 2015, the CV-A2 strains isolated in China dispersed into two different genotypes (B and D). And the genotype D became the dominant circulating strains in China. Strains isolated in Russia and India from 2005 to 2011 converged into genotype C. Intertypic recombination occurred between the Chinese CV-A2 strains and other enterovirus-A donor sequences. This result reconfirmed that recombination is a common phenomenon among enteroviruses. This study helps expand the numbers of whole virus genome sequence and entire VP1 sequence of CV-A2 in the GenBank database for further researcher.	[Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Hlth & Family Planning Commiss China, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China; Chinese Ctr Dis Control & Prevent, Natl Hlth & Family Planning Commiss China, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Xu, WB (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Hlth & Family Planning Commiss China, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China.	wenbo_xu1@aliyun.com	ji, tianjiao/HCH-4631-2022	Zhang, Yong/0000-0002-2692-5437	Key Technologies Research and Development Program of National Ministry of Science [2013ZX10004-202]	Key Technologies Research and Development Program of National Ministry of Science	The study was supported by the Key Technologies Research and Development Program of National Ministry of Science (Grant No. 2013ZX10004-202). WBX received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen SP, 2010, J MICROBIOL IMMUNOL, V43, P99, DOI 10.1016/S1684-1182(10)60016-3; Cui AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061451; Feng XB, 2015, SCI REP-UK, V5, DOI 10.1038/srep11700; Gaunt E, 2015, J GEN VIROL, V96, P1067, DOI 10.1099/vir.0.000062; Guo WP, 2015, J CLIN VIROL, V70, P29, DOI 10.1016/j.jcv.2015.06.093; Hu L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06035; Hu YF, 2011, J CLIN MICROBIOL, V49, P2426, DOI 10.1128/JCM.00007-11; Ishiko H, 2002, J INFECT DIS, V185, P744, DOI 10.1086/339298; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Laxmivandana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061650; Lee MH, 2011, J MICROBIOL IMMUNOL, V44, P178, DOI 10.1016/j.jmii.2011.01.018; Liu CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144073; Lukashev AN, 2014, J GEN VIROL, V95, P868, DOI 10.1099/vir.0.060004-0; Oberste MS, 2006, J GEN VIROL, V87, P119, DOI 10.1099/vir.0.81179-0; Oberste MS, 2004, J GEN VIROL, V85, P1597, DOI 10.1099/vir.0.79789-0; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Siafakas N, 2011, MOL CELL PROBE, V25, P249, DOI 10.1016/j.mcp.2011.06.001; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapparel C, 2013, INFECT GENET EVOL, V14, P282, DOI 10.1016/j.meegid.2012.10.016; Tian XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090379; Yip CCY, 2013, EMERG INFECT DIS, V19, P1285, DOI 10.3201/eid1908.121498; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067157; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2010, J INFECT DIS, V202, P1780, DOI 10.1086/657410; Zhang Y, 2010, ARCH VIROL, V155, P197, DOI 10.1007/s00705-009-0564-9; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	29	13	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0169021	10.1371/journal.pone.0169021	http://dx.doi.org/10.1371/journal.pone.0169021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030650	Green Submitted, Green Published, gold			2022-12-26	WOS:000391222000101
J	Cho, SA; Joo, HJ; Cho, JY; Lee, SH; Park, JH; Hong, SJ; Yu, CW; Lim, DS				Cho, Sang-A; Joo, Hyung Joon; Cho, Jae-Young; Lee, Seung Hun; Park, Jae Hyoung; Hong, Soon Jun; Yu, Cheol Woong; Lim, Do-Sun			Visceral Fat Area and Serum Adiponectin Level Predict the Development of Metabolic Syndrome in a Community-Based Asymptomatic Population	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ALL-CAUSE MORTALITY; ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; LONGITUDINAL CHANGES; INSULIN-RESISTANCE; ASSOCIATION; OBESITY; ACCUMULATION; RISK	Background Although it has been demonstrated that visceral adipose tissue content and serum levels of adiponectin are associated with metabolic syndrome, their predictive potential for the development of metabolic syndrome remains to be elucidated. Methods We studied 1,130 participants of the Seoul Metabolic Syndrome cohort. A total of 337 subjects without metabolic syndrome underwent the follow-up evaluation and finally analyzed. Visceral fat area (VFA) was measured using dual bioelectrical impedance analysis. We compared the 1-year incidence rate of metabolic syndrome among four different groups: Group 1 (high adiponectin level and low VFA), Group 2 (low adiponectin level and low VFA), Group 3 (high adiponectin level and high VFA) and Group 4 (low adiponectin level and high VFA). Results Median follow-up duration was 17 months. Cut-off points of adiponectin level and VFA for metabolic syndrome were 7.34 ng/ml and 84 cm(2) for men, and 12.55 and 58 cm(2) ng/ml for women, respectively. The incidence of metabolic syndrome was the highest in Group 4 (Group 1; 16.47%, Group 2; 22.08%, Group 3; 25%, and Group 4; 46.15%, p<0.001). Adjusted logistic regression analyses for metabolic syndrome prediction demonstrated that Group 4 exhibited the highest odds ratio compared with Group 1 (4.918 [2.05-11.795]), which was predominantly affected by waist circumference and serum triglyceride levels. Notably, triglyceride/high-density lipoprotein cholesterol (TG/HDL) ratio was significantly higher in Group 4 (p = 0.017). Conclusion Incidence rate of metabolic syndrome was the highest in subjects with low serum adiponectin levels and high visceral fat area. Higher TG/HDL ratio in these subjects suggested insulin resistance may contribute to the development of metabolic syndrome.	[Cho, Sang-A; Joo, Hyung Joon; Cho, Jae-Young; Lee, Seung Hun; Park, Jae Hyoung; Hong, Soon Jun; Yu, Cheol Woong; Lim, Do-Sun] Korea Univ, Anam Hosp, Cardiovasc Ctr, Dept Cardiol, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Lim, DS (corresponding author), Korea Univ, Anam Hosp, Cardiovasc Ctr, Dept Cardiol, Seoul, South Korea.	dslmd@kumc.or.kr	Cho, Jae Young/AAW-7137-2020	Cho, Jae Young/0000-0001-7972-6223				Abiko A, 2011, INTERNAL MED, V50, P381, DOI 10.2169/internalmedicine.50.4476; Ahonen TM, 2012, NUTR METAB CARDIOVAS, V22, P285, DOI 10.1016/j.numecd.2010.07.001; Baldasseroni S, 2012, NUTR METAB CARDIOVAS, V22, P292, DOI 10.1016/j.numecd.2011.03.012; Bao WH, 1997, JAMA-J AM MED ASSOC, V278, P1749, DOI 10.1001/jama.278.21.1749; Bidulescu A, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-9; Cruz ML, 2004, J CLIN ENDOCR METAB, V89, P108, DOI 10.1210/jc.2003-031188; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; Ding YS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/607364; Druet C, 2008, HORM RES, V70, P22, DOI 10.1159/000129674; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Juge-Aubry CE, 2005, BEST PRACT RES CL EN, V19, P547, DOI 10.1016/j.beem.2005.07.009; Kim JY, 2015, BIOCHEM BIOPH RES CO, V466, P201, DOI 10.1016/j.bbrc.2015.09.007; Kim SH, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0127-7; Koh SB, 2010, METABOLISM, V59, P333, DOI 10.1016/j.metabol.2009.07.031; Koh SB, 2011, YONSEI MED J, V52, P234, DOI 10.3349/ymj.2011.52.2.234; Koh SJ, 2008, CLIN CHIM ACTA, V389, P45, DOI 10.1016/j.cca.2007.11.017; Lee S, 2011, PEDIATR DIABETES, V12, P250, DOI 10.1111/j.1399-5448.2010.00705.x; Li JB, 2014, BIOMED REP, V2, P152, DOI 10.3892/br.2013.206; Lim KI, 2010, CLIN ENDOCRINOL, V73, P588, DOI 10.1111/j.1365-2265.2010.03841.x; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Matsushita Y, 2013, OBESITY, V21, P2126, DOI 10.1002/oby.20347; Matsuzawa Y, 2011, J ATHEROSCLER THROMB, V18, P629, DOI 10.5551/jat.7922; Nakatsuji H, 2013, METABOLISM, V62, P109, DOI 10.1016/j.metabol.2012.06.006; Persson J, 2012, ATHEROSCLEROSIS, V225, P491, DOI 10.1016/j.atherosclerosis.2012.09.036; POULIOT MC, 1992, DIABETES, V41, P826, DOI 10.2337/diabetes.41.7.826; Pyrzak B, 2010, EUR J MED RES, V15, P147; Ryo M, 2005, DIABETES CARE, V28, P451, DOI 10.2337/diacare.28.2.451; Santaniemi M, 2006, EUR J ENDOCRINOL, V155, P745, DOI 10.1530/eje.1.02287; Schraw T, 2008, ENDOCRINOLOGY, V149, P2270, DOI 10.1210/en.2007-1561; Shafiee G, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0220-8; Shah Ravi V, 2014, JACC Cardiovasc Imaging, V7, P1221, DOI 10.1016/j.jcmg.2014.07.017; Sulistyoningrum DC, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-170; Takenouchi Y, 2009, ATHEROSCLEROSIS, V206, P397, DOI 10.1016/j.atherosclerosis.2009.03.005; Timar R, 2014, J INT MED RES, V42, P1131, DOI 10.1177/0300060514541829; Valsamakis G, 2004, DIABETIC MED, V21, P1339, DOI 10.1111/j.1464-5491.2004.01361.x; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x; Won H, 2012, YONSEI MED J, V53, P91, DOI 10.3349/ymj.2012.53.1.91	38	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169289	10.1371/journal.pone.0169289	http://dx.doi.org/10.1371/journal.pone.0169289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046037	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300160
J	Faria, BF; Mostardinha, P; de Abreu, FV				Faria, Bruno Filipe; Mostardinha, Patricia; de Abreu, Fernao Vistulo			Can the Immune System Perform a t-Test?	PLOS ONE			English	Article							NEGATIVE SELECTION ALGORITHM; SELF-NONSELF DISCRIMINATION; MINIMAL MODEL; LYMPH-NODE; PERSPECTIVE; TOLERANCE; CELLS	The self-nonself discrimination hypothesis remains a landmark concept in immunology. It proposes that tolerance breaks down in the presence of nonself antigens. In strike contrast, in statistics, occurrence of nonself elements in a sample (i.e., outliers) is not obligatory to violate the null hypothesis. Very often, what is crucial is the combination of (self) elements in a sample. The two views on how to detect a change seem challengingly different and it could seem difficult to conceive how immunological cellular interactions could trigger responses with a precision comparable to some statistical tests. Here it is shown that frustrated cellular interactions reconcile the two views within a plausible immunological setting. It is proposed that the adaptive immune system can be promptly activated either when non self ligands are detected or self-ligands occur in abnormal combinations. In particular we show that cellular populations behaving in this way could perform location statistical tests, with performances comparable tot or KS tests, or even more general data mining tests such as support vector machines or random forests. In more general terms, this work claims that plausible immunological models should provide accurate detection mechanisms for host protection and, furthermore, that investigation on mechanisms leading to improved detection in "in silico" models can help unveil how the real immune system works.	[Faria, Bruno Filipe; Mostardinha, Patricia; de Abreu, Fernao Vistulo] Univ Aveiro, Dept Phys, Aveiro, Portugal; [Faria, Bruno Filipe; de Abreu, Fernao Vistulo] Univ Aveiro, iBiMED, Inst Biomed, Aveiro, Portugal; [Faria, Bruno Filipe; Mostardinha, Patricia; de Abreu, Fernao Vistulo] I3N Inst Nanostruct Nanomodelling & Nanofabricat, Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro	de Abreu, FV (corresponding author), Univ Aveiro, Dept Phys, Aveiro, Portugal.; de Abreu, FV (corresponding author), Univ Aveiro, iBiMED, Inst Biomed, Aveiro, Portugal.; de Abreu, FV (corresponding author), I3N Inst Nanostruct Nanomodelling & Nanofabricat, Aveiro, Portugal.	fva@ua.pt	; Vistulo de Abreu, Fernao/J-4989-2013	Faria, Bruno/0000-0003-1059-719X; Vistulo de Abreu, Fernao/0000-0003-0452-3493	Fundacao para a Ciencia e a Tecnologia [UID/BIM/04501/2013, SFRH/BD/79865/2011]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia through grants UID/BIM/04501/2013 and SFRH/BD/79865/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A.K., 2010, EFFECT PERSONAL INNO, V3rd; Abi-Haidar A, 2008, LECT NOTES COMPUT SC, V5132, P36, DOI 10.1007/978-3-540-85072-4_4; Agliari E, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/41/415003; Agliari E, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/33/335101; Agliari E, 2015, J THEOR BIOL, V375, P21, DOI 10.1016/j.jtbi.2014.05.006; Agliari E, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.268101; Agliari E, 2011, J THEOR BIOL, V287, P48, DOI 10.1016/j.jtbi.2011.07.027; Almeida CR, 2003, EVOL ECOL RES, V5, P739; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Aydin I, 2010, EXPERT SYST APPL, V37, P5285, DOI 10.1016/j.eswa.2010.01.011; Babayigit B, 2006, J ELECTROMAGNET WAVE, V20, P1007, DOI 10.1163/156939306776930222; Beltman JB, 2007, J EXP MED, V204, P771, DOI 10.1084/jem.20061278; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Bransburg-Zabary S, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/2/025003; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burnet FM, 1949, PRODUCTION ANTIBODIE; Burnet S. F. M., 1959, CLONAL SELECTION THE, V3; Burroughs NJ, 2004, IMMUNOGENETICS, V56, P311, DOI 10.1007/s00251-004-0691-0; Campelo F, 2005, IEEE T MAGN, V41, P1736, DOI 10.1109/TMAG.2005.846043; CELADA F, 1992, IMMUNOL TODAY, V13, P56, DOI 10.1016/0167-5699(92)90135-T; Chakraborty AK, 2010, ANNU REV PHYS CHEM, V61, P283, DOI 10.1146/annurev.physchem.59.032607.093537; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chao DL, 2004, J THEOR BIOL, V228, P227, DOI 10.1016/j.jtbi.2003.12.011; Cohen I. R., 2000, TENDING ADAMS GARDEN; Cohen IR, 2013, TRENDS IMMUNOL, V34, P620, DOI 10.1016/j.it.2013.05.003; Cohn M, 2002, SCAND J IMMUNOL, V55, P318, DOI 10.1046/j.1365-3083.2002.01059.x; COUTINHO A, 1984, IMMUNOL REV, V79, P151, DOI 10.1111/j.1600-065X.1984.tb00492.x; Coutinho A, 1995, CURR OPIN IMMUNOL, V7, P812, DOI 10.1016/0952-7915(95)80053-0; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Dasgupta D, 2004, LECT NOTES COMPUT SC, V3239, P1; Dasgupta D, 2002, IEEE T EVOLUT COMPUT, V6, P281, DOI 10.1109/TEVC.2002.1011541; de Abreu FV, 2009, J R SOC INTERFACE, V6, P321, DOI 10.1098/rsif.2008.0280; DEBOER RJ, 1993, P ROY SOC B-BIOL SCI, V252, P171, DOI 10.1098/rspb.1993.0062; Dembic Z, 2013, SCAND J IMMUNOL, V78, P325, DOI 10.1111/sji.12090; Depoil D, 2005, IMMUNITY, V22, P185, DOI 10.1016/j.immuni.2004.12.010; Efroni S, 2002, CELL IMMUNOL, V216, P23, DOI 10.1016/S0008-8749(02)00504-X; Eichmann K., 2008, NETWORK COLLECTIVE R, P26; FORREST S, 1994, 1994 IEEE COMPUTER SOCIETY SYMPOSIUM ON RESEARCH IN SECURITY AND PRIVACY, PROCEEDINGS, P202; GALE D, 1962, AM MATH MON, V69, P9, DOI 10.2307/2312726; Germain RN, 2001, SCIENCE, V293, P240, DOI 10.1126/science.1062946; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Goldstein M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152173; Golovko V, 2010, NEURAL NETWORK ARTIF, P485; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Gu F, 2013, BIOSYSTEMS, V111, P127, DOI 10.1016/j.biosystems.2013.01.001; Gu YN, 2015, IEEE J SEL AREA COMM, V33, P2156, DOI 10.1109/JSAC.2015.2435361; Gusfield D., 1989, STABLE MARRIAGE PROB; Idris I, 2014, APPL SOFT COMPUT, V22, P11, DOI 10.1016/j.asoc.2014.05.002; Irving RW, 2007, INFORM PROCESS LETT, V103, P1, DOI 10.1016/j.ipl.2007.02.003; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Ji Z, 2007, EVOL COMPUT, V15, P223, DOI 10.1162/evco.2007.15.2.223; Kang MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155781; Kelsey J, 2003, IMMUNE INSPIRED SOMA, P207; Kieber-Emmons T, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00196; King ML, 1990, AUSTR J STAT, V32, P21, DOI DOI 10.1111/J.1467-842X.1990.TB00996.X; Kosmrlj A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.068103; Langman RE, 2000, SEMIN IMMUNOL, V12, P189, DOI 10.1006/smim.2000.0231; Lindo AM, 2012, THEOR BIOSCI, V131, P77, DOI 10.1007/s12064-011-0134-z; Madi A, 2012, ADV EXP MED BIOL, V750, P198, DOI 10.1007/978-1-4614-3461-0_15; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Meyer D, 2015, R NEWS, P1; Mora T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/pnas.1001705107; Mostardinha P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00769; Murugan A, 2012, P NATL ACAD SCI USA, V109, P16161, DOI 10.1073/pnas.1212755109; Neyman J, 1938, CONTRIBUTIONS THEORY; Neyman J, 1936, SUFFICIENT STAT UNIF; PARISI G, 1990, P NATL ACAD SCI USA, V87, P429, DOI 10.1073/pnas.87.1.429; PARISI G, 1988, ANN INST PASTEUR IMM, V139, P177, DOI 10.1016/0769-2625(88)90039-6; Pavone M, 2012, J GLOBAL OPTIM, V53, P769, DOI 10.1007/s10898-011-9736-8; Schulz R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00086; Stibor T, 2005, GECCO 2005: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOLS 1 AND 2, P321; Stibor T, 2006, LECT NOTES COMPUT SC, V4163, P215; TAUBER AI, 1994, IMMUNOL TODAY, V15, P134, DOI 10.1016/0167-5699(94)90157-0; Tauber AI, 2004, GROWING EXPLANATIONS, P199; VARELA FJ, 1991, IMMUNOL TODAY, V12, P159, DOI 10.1016/0167-5699(91)90081-4; de Abreu FV, 2006, LECT NOTES COMPUT SC, V4163, P37; Wang YN, 2005, LECT NOTES COMPUT SC, V3611, P859; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Whitbrook AM, 2007, IEEE T SYST MAN CY B, V37, P1581, DOI 10.1109/TSMCB.2007.907334	82	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169464	10.1371/journal.pone.0169464	http://dx.doi.org/10.1371/journal.pone.0169464			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046042	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300193
J	Leboulanger, C; Agogue, H; Bernard, C; Bouvy, M; Carre, C; Cellamare, M; Duval, C; Fouilland, E; Got, P; Intertaglia, L; Lavergne, C; Le Floc'h, E; Roques, C; Sarazin, G				Leboulanger, Christophe; Agogue, Helene; Bernard, Cecile; Bouvy, Marc; Carre, Claire; Cellamare, Maria; Duval, Charlotte; Fouilland, Eric; Got, Patrice; Intertaglia, Laurent; Lavergne, Celine; Le Floc'h, Emilie; Roques, Cecile; Sarazin, Gerard			Microbial Diversity and Cyanobacterial Production in Dziani Dzaha Crater Lake, a Unique Tropical Thalassohaline Environment	PLOS ONE			English	Article							RIFT-VALLEY LAKES; SALINE LAKES; BOTTOM-UP; ALKALINE; PHYTOPLANKTON; BOGORIA; ARCHAEA; LAGOON; BIODIVERSITY; PATTERNS	This study describes, for the first time, the water chemistry and microbial diversity in Dziani Dzaha, a tropical crater lake located on Mayotte Island (Comoros archipelago, Western Indian Ocean). The lake water had a high level of dissolved matter and high alkalinity (10.614.5 g L-1 eq. CO32-, i.e. 160220 mM compare to around 22.5 in seawater), with salinity up to 52 psu, 1.5 higher than seawater. Hierarchical clustering discriminated Dziani Dzaha water from other alkaline, saline lakes, highlighting its thalassohaline nature. The phytoplankton biomass was very high, with a total chlorophyll a concentration of 524 to 875 mu g chl a L-1 depending on the survey, homogeneously distributed from surface to bottom (4 m). Throughout the whole water column the photosynthetic biomass was dominated (>97% of total biovolume) by the filamentous cyanobacteria Arthrospira sp. with a straight morphotype. In situ daily photosynthetic oxygen production ranged from 17.3 to 22.2 g O-2 m(-2) d(-1), consistent with experimental production / irradiance measurements and modeling. Heterotrophic bacterioplankton was extremely abundant, with cell densities up to 1.5 108 cells mL(-1) in the whole water column. Isolation and culture of 59 Eubacteria strains revealed the prevalence of alkaliphilic and halophilic organisms together with taxa unknown to date, based on 16S rRNA gene analysis. A single cloning-sequencing approach using archaeal 16S rDNA gene primers unveiled the presence of diverse extremophilic Euryarchaeota. The water chemistry of Dziani Dzaha Lake supports the hypothesis that it was derived from seawater and strongly modified by geological conditions and microbial activities that increased the alkalinity. Dziani Dzaha has a unique consortium of cyanobacteria, phytoplankton, heterotrophic Eubacteria and Archaea, with very few unicellular protozoa, that will deserve further deep analysis to unravel its uncommon diversity. A single taxon, belonging to the genus Arthrospira, was found responsible for almost all photosynthetic primary production.	[Leboulanger, Christophe; Bouvy, Marc; Carre, Claire] Inst Rech Dev, UMR MARBEC, Sete Montpellier, France; [Agogue, Helene; Lavergne, Celine] CNRS, UMR LIENSs, La Rochelle, France; [Bernard, Cecile; Cellamare, Maria; Duval, Charlotte] Museum Natl Hist Nat, UMR MCAM, Paris, France; [Fouilland, Eric; Got, Patrice; Le Floc'h, Emilie; Roques, Cecile] CNRS, UMR MARBEC, Sete Montpellier, France; [Intertaglia, Laurent] Univ Paris 06, Observ Oceanol Banyuls Sur Mer, Banyuls Sur Mer, France; [Sarazin, Gerard] Univ Paris Diderot, Inst Phys Globe Paris, UMR7154, Paris, France; [Cellamare, Maria] Phytoquality, 15 Rue Petrarque, Paris, France	Ifremer; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Ifremer; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite	Leboulanger, C (corresponding author), Inst Rech Dev, UMR MARBEC, Sete Montpellier, France.	christophe.leboulanger@ird.fr	Agogué, Hélène/O-4122-2014; Lavergne, Céline/B-4208-2015; Fouilland, Eric/R-1415-2017; Bernard, Cecile/AAE-4242-2022; Leboulanger, Christophe/W-9859-2018	Agogué, Hélène/0000-0002-1078-0130; Lavergne, Céline/0000-0002-2002-8655; Fouilland, Eric/0000-0001-9633-8847; Bernard, Cecile/0000-0001-7032-3989; Leboulanger, Christophe/0000-0001-5836-4294; GOT, Patrice/0000-0001-7528-0770	Universite de Montpellier; Agence Nationale de la Recherche (France) [ANR-13-BS06-0001]; Total Corporate Foundation, project DZAHA	Universite de Montpellier; Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); Total Corporate Foundation, project DZAHA(Total SA)	This work was supported by Universite de Montpellier, www.umontpellier.fr, projects METTRO and MYPROBE (CL); Agence Nationale de la Recherche (France), http://www.agence-nationale-recherche.fr, grant no ANR-13-BS06-0001 (CL); and Total Corporate Foundation, project DZAHA (CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agogue H, 2008, NATURE, V456, P788, DOI 10.1038/nature07535; ALLEN MM, 1968, J GEN MICROBIOL, V51, P199, DOI 10.1099/00221287-51-2-199; Alvarez Cobelas M., 1992, Freshwater Forum, V2, P184; Aminot A., 2004, HYDROLOGIE ECOSYSTEM; Bai J.N., 1985, ARCH HYDROBIOL, P191; Ballot A, 2005, HARMFUL ALGAE, V4, P139, DOI 10.1016/j.hal.2004.01.001; Ballot A, 2004, J PLANKTON RES, V26, P925, DOI 10.1093/plankt/fbh084; Bouvy M, 2004, AQUAT MICROB ECOL, V34, P301, DOI 10.3354/ame034301; Bright DI, 2000, NEW PHYTOL, V146, P301, DOI 10.1046/j.1469-8137.2000.00640.x; Cadeau P, 2015, P 2015 GOLDSCHM C AU; Christian BW, 2006, INT REV HYDROBIOL, V91, P257, DOI 10.1002/iroh.200510838; Cousins M, 2010, LIMNOL OCEANOGR, V55, P172, DOI 10.4319/lo.2010.55.1.0172; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Demergasso C, 2004, FEMS MICROBIOL ECOL, V48, P57, DOI 10.1016/j.femsec.2003.12.013; Dirnitriu PA, 2008, APPL ENVIRON MICROB, V74, P4877, DOI 10.1128/AEM.00455-08; El Hidri D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/648141; Eppley R. W, 1970, Bull. Scripps Instn Oceanogr. tech. Ser., V17, P33; EUROPEAN COMMITTEE FOR STANDARDIZATION (CEN), 2006, 15204 CEN EN; Fontana LF, 2010, AN ACAD BRAS CIENC, V82, P1013, DOI 10.1590/S0001-37652010000400022; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; GEDDES MC, 1981, HYDROBIOLOGIA, V81-2, P201, DOI 10.1007/BF00048717; Gilbert M, 2000, J PLANT PHYSIOL, V157, P307, DOI 10.1016/S0176-1617(00)80052-8; GRAN G, 1952, ANALYST, V77, P661, DOI 10.1039/an9527700661; Grant WD, 2006, ENCY LIFE SUPPORT SY; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HAMMER UT, 1981, HYDROBIOLOGIA, V81-2, P47, DOI 10.1007/BF00048705; Harper DM, 2003, HYDROBIOLOGIA, V500, P259, DOI 10.1023/A:1024722821407; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Irigoien X, 2004, NATURE, V429, P863, DOI 10.1038/nature02593; Jones BE, 1998, EXTREMOPHILES, V2, P191, DOI 10.1007/s007920050060; KEBEDE E, 1994, HYDROBIOLOGIA, V288, P1, DOI 10.1007/BF00006801; Kent AD, 2007, ISME J, V1, P38, DOI 10.1038/ismej.2007.6; Kirchman D.L., 2008, MICROBIAL ECOLOGY OC, Vsecond; Komarek J., 2005, SUSSWASSERFLORA MITT; Komarek J, 1998, SUSSWASSERFLORA MITT; Krienitz L, 2012, PHYCOLOGIA, V51, P22, DOI 10.2216/11-28.1; Kubo K, 2012, ISME J, V6, P1949, DOI 10.1038/ismej.2012.37; Kumar PA, 2012, INT J SYST EVOL MICR, V62, P2252, DOI 10.1099/ijs.0.038604-0; Lanzen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072577; Lenz A, 2008, WASSERWITSCHAFT WASS, V9, P49; Lewis WM, 2011, INLAND WATERS, V1, P1, DOI 10.5268/IW-1.1.384; Lopez-Archilla AI, 2004, EXTREMOPHILES, V8, P109, DOI 10.1007/s00792-003-0369-9; Marie D, APPL ENV MICROBIOL, V63, P186; Masojidek J, 2001, J PLANKTON RES, V23, P57, DOI 10.1093/plankt/23.1.57; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MELACK JM, 1974, LIMNOL OCEANOGR, V19, P743, DOI 10.4319/lo.1974.19.5.0743; MELACK JM, 1981, HYDROBIOLOGIA, V81-2, P71, DOI 10.1007/BF00048707; Merel S, 2013, ENVIRON INT, V59, P303, DOI 10.1016/j.envint.2013.06.013; Milford AD, 2000, ARCH MICROBIOL, V174, P18, DOI 10.1007/s002030000166; Montoya Lilia, 2013, Aquatic Biosystems, V9, P19, DOI 10.1186/2046-9063-9-19; Mwirichia R, 2010, EXTREMOPHILES, V14, P339, DOI 10.1007/s00792-010-0311-x; NOUGIER J, 1979, CR ACAD SCI D NAT, V288, P211; Oduor SO, 2007, HYDROBIOLOGIA, V584, P59, DOI 10.1007/s10750-007-0605-x; Oduor SO, 2007, J PLANKTON RES, V29, P1041, DOI 10.1093/plankt/fbm078; Peduzzi P, 2014, ISME J, V8, P1346, DOI 10.1038/ismej.2013.241; PLATT T, 1980, J MAR RES, V38, P687; Radke LC, 2002, MAR FRESHWATER RES, V53, P941, DOI 10.1071/MF01231; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Ritchie RJ, 2008, PHOTOSYNTH RES, V96, P201, DOI 10.1007/s11120-008-9300-7; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Sala MM, 2006, AQUAT MICROB ECOL, V42, P1, DOI 10.3354/ame042001; Salomo S, 2009, WATER RES, V43, P4569, DOI 10.1016/j.watres.2009.08.009; Shihab AS, 2006, J ENV HYDROL, V14; Sili C, 2013, ECOLOGY CYANOBACTERI, P677; Singh SC, 2002, ACTA PROTOZOOL, V41, P297; Sorokin DY, 2014, EXTREMOPHILES, V18, P791, DOI 10.1007/s00792-014-0670-9; Staehr PA, 2010, LIMNOL OCEANOGR-METH, V8, P628, DOI 10.4319/lom.2010.8.0628; Talling J.F., 1973, FRESHWATER BIOL, V3, P53, DOI DOI 10.1111/J.1365-2427.1973.TB00062.X; Tebbs EJ, 2013, REMOTE SENS ENVIRON, V135, P92, DOI 10.1016/j.rse.2013.03.024; Thomazeau S, 2010, J PHYCOL, V46, P564, DOI 10.1111/j.1529-8817.2010.00836.x; Tilahun G, 2010, LIMNOLOGICA, V40, P330, DOI 10.1016/j.limno.2009.10.005; Tiquia SM, 2010, ENVIRON POLLUT, V158, P1435, DOI 10.1016/j.envpol.2009.12.035; Utermohl H., 1958, MITT INT VER THEOR, V9, P1, DOI DOI 10.1080/05384680.1958.11904091; Watanabe MM, 2000, MICROBIAL CULTURE CO; WOOD RB, 1988, HYDROBIOLOGIA, V158, P29, DOI 10.1007/BF00026266; Zinke J, 2003, SEDIMENT GEOL, V160, P57, DOI 10.1016/S0037-0738(02)00336-6; Zinke J, 2003, MAR GEOL, V194, P181, DOI 10.1016/S0025-3227(02)00705-3	78	28	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168879	10.1371/journal.pone.0168879	http://dx.doi.org/10.1371/journal.pone.0168879			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045976	Green Submitted, gold, Green Published			2022-12-26	WOS:000391612300063
J	Low, LL; Tan, SY; Ng, MJM; Tay, WY; Ng, LB; Balasubramaniam, K; Towle, RM; Lee, KH				Low, Lian Leng; Tan, Shu Yun; Ng, Matthew Joo Ming; Tay, Wei Yi; Ng, Lee Beng; Balasubramaniam, Kanchana; Towle, Rachel Marie; Lee, Kheng Hock			Applying the Integrated Practice Unit Concept to a Modified Virtual Ward Model of Care for Patients at Highest Risk of Readmission: A Randomized Controlled Trial	PLOS ONE			English	Article							REHOSPITALIZATION; INTERVENTION; TRANSITIONS; PROGRAM	Background Emerging evidence from the virtual ward care model showed that multidisciplinary case management are inadequate to reduce readmissions or death for high risk patients. There is consensus that interventions should encompass both pre-hospital discharge and post-discharge transitional care to be effective. Integrated practice units (IPU) had been proposed as an approach of restructuring the organization and work processes of multidisciplinary teams to achieve value in healthcare. Our primary objective is to evaluate if the novel application of the IPU concept to organize a modified virtual ward model incorporating pre-hospital discharge transitional care can reduce readmissions of patients at highest risk for readmission. Methods We conducted an open label, assessor blinded randomized controlled trial on patients with one or more unscheduled readmissions in the prior 90 days and LACE score >= 10. 840 patients were randomized in 1:1 ratio and blocks of 6 to the intervention program (n = 420) or control (n = 420). Allocation concealment was effected via an off-site telephone service maintained by a hospital administrator. Intervention patients received discharge planning, medication reconciliation, coaching on self-management of chronic diseases using standardized action plans and an individualized care plan complete with written discharge instructions, appointments schedule, medication changes and the contact information of the outpatient VW nurse before discharge. At discharge, care is handed over to the outpatient VW team. Patients were closely monitored in the VW for three months that included a telephone review within 72 hours of discharge, home assessment, regular telephone reviews to identify early complications and early review clinics for patients who destabilize. The VW meet daily to discuss new patients and review care plans for patients. Control patients received standard hospital care that included a standardized patient copy of the hospital discharge summary listing their medical diagnoses and medications; and follow up is arranged with a primary care provider or specialist as considered necessary. The primary outcome was the unplanned readmission rate to any hospital within 30 days of discharge. Secondary outcomes included the unplanned readmission rate, emergency department (ED) attendance rate to any hospital and the probability without readmission or death up to 180 days of discharge. Length of stay and mortality rate at 90-day were compared between the two groups. Outcome data were objectively retrieved from the hospital and National Electronic Health Records by a blinded outcome assessor. Findings All patients' outcomes were included in an intention-to-treat analysis. The characteristics of both study groups were similar. Patients in the intervention group had a significant reduction in the number of 30-day readmissions, IRR 0.67 (95% CI, 0.52 to 0.86, p = 0.001) and the number of 30-day emergency department attendances, IRR 0.60 (95% CI, 0.46 to 0.79, p<0.001) compared to those receiving standard hospital care. The effectiveness was sustained at 90 and 180 days. The intervention group utilized 1164 fewer hospital bed days at 90-day post discharge. No adverse events were reported. Conclusion Applying the integrated practice unit concept to the virtual ward program resulted in reduced readmissions in patients who are at highest risk of readmission.	[Low, Lian Leng; Tan, Shu Yun; Ng, Matthew Joo Ming; Tay, Wei Yi; Ng, Lee Beng; Towle, Rachel Marie; Lee, Kheng Hock] Singapore Gen Hosp, Dept Family Med & Continuing Care, Singapore, Singapore; [Low, Lian Leng; Tan, Shu Yun; Ng, Matthew Joo Ming; Tay, Wei Yi; Ng, Lee Beng; Lee, Kheng Hock] Duke NUS Med Sch, Family Med, Singapore, Singapore; [Balasubramaniam, Kanchana] Singapore Gen Hosp, Med Acad Clin Program, Hlth Serv Res, Singapore, Singapore	Singapore General Hospital; National University of Singapore; Singapore General Hospital	Low, LL; Lee, KH (corresponding author), Singapore Gen Hosp, Dept Family Med & Continuing Care, Singapore, Singapore.; Low, LL; Lee, KH (corresponding author), Duke NUS Med Sch, Family Med, Singapore, Singapore.	low.lian.leng@sgh.com.sg; lee.kheng.hock@singhealth.com.sg	; Low, Lian Leng/M-2853-2016	Tan, Shu Yun/0000-0003-0307-9546; Low, Lian Leng/0000-0003-4228-2862	Agency of Integrated Care Singapore [AIC/RPD/RD-OIC/ICCS/010/05-2011]; SingHealth Regional Health System Office	Agency of Integrated Care Singapore; SingHealth Regional Health System Office(SingHealth)	This project was supported by a project grant from the Agency of Integrated Care Singapore (http://www.aic.sg/) AIC/RPD/RD-OIC/ICCS/010/05-2011 and the SingHealth Regional Health System Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, Hosp Peer Rev, V38, P112; [Anonymous], 2007, GUARDIAN; [Anonymous], 2013, AV HOSP INP BILL SIZ; [Anonymous], 2014, SINGAPORE BUDGET 201; Balaban RB, 2015, J GEN INTERN MED, V30, P907, DOI 10.1007/s11606-015-3185-x; Burke RE, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-423; Chan Margaret, 2008, PRIMARY HLTH CARE NO; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Department of Health, 2014, DEL BETT INT CAR; Detsky AS, 2014, JAMA-J AM MED ASSOC, V311, P2160; Dhalla IA, 2014, JAMA-J AM MED ASSOC, V312, P1305, DOI 10.1001/jama.2014.11492; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Health Minister Singapore, 2014, ECONOMIST; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jones CD, 2015, J GEN INTERN MED, V30, P417, DOI 10.1007/s11606-014-3056-x; Kripalani S, 2014, ANNU REV MED, V65, P471, DOI 10.1146/annurev-med-022613-090415; Lee KH, 2015, INT J INTEGR CARE, V15; Lee KH, 2011, J HOSP MED, V6, P115, DOI 10.1002/jhm.821; Lewis G, 2013, INT J INTEGR CARE, V13; Lewis GH, 2013, IMPACT VIRTUAL WARDS; Lim E, 2011, BMC HEALTH SERV RES, V2011, P1; Low LL, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0750-2; Mann Cindy, 2012, INTEGRATED CARE MODE; Mitchell SE, 2012, J HEALTH COMMUN, V17, P325, DOI 10.1080/10810730.2012.715233; Mueller SK, 2012, ARCH INTERN MED, V172, P1057, DOI 10.1001/archinternmed.2012.2246; National Committee for Quality Assurance, 2013, INT CAR PEOPL MED ME; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Porter M.E., 2006, REDEFINING HLTH CARE; Porter ME, 2013, HEALTH AFFAIR, V32, P516, DOI 10.1377/hlthaff.2012.0961; Singapore Ministry of Health, 2015, MED; Tan SY, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-366	32	35	36	6	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168757	10.1371/journal.pone.0168757	http://dx.doi.org/10.1371/journal.pone.0168757			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045940	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300050
J	Makhoul, I; Todorova, VK; Siegel, ER; Erickson, SW; Dhakal, I; Raj, VR; Lee, JY; Orloff, MS; Griffin, RJ; Henry-Tillman, RS; Klimberg, S; Hutchins, LF; Kadlubar, SA				Makhoul, Issam; Todorova, Valentina K.; Siegel, Eric R.; Erickson, Stephen W.; Dhakal, Ishwori; Raj, Vinay R.; Lee, Jeannette Y.; Orloff, Mohammed S.; Griffin, Robert J.; Henry-Tillman, Ronda S.; Klimberg, Suzanne; Hutchins, Laura F.; Kadlubar, Susan A.			Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients	PLOS ONE			English	Article								Background We previously reported improved pathologic complete response (pCR) in a prospective phase II study using neoadjuvant bevacizumab in combination with chemotherapy compared to chemotherapy alone in breast cancer patients (41% vs. 25%, p = 0.0291). In this study, we queried germline single-nucleotide polymorphisms (SNPs) in angiogenesis-related genes for their impact on pCR and overall survival (OS). Methods DNA for genotyping was available from 34 subjects who received bevacizumab in addition to chemotherapy and 29 subjects who did not. Using Illumina (R) technology, we queried 504 SNPs with a minor allele frequency (MAF) of at least 5%, located in 10 angiogenesis-related genes, for their effect on pCR via logistic regression with an additive-inheritance model while adjusting for race and bevacizumab treatment. SNPs that showed significant associations with pCR were selected for additional characterization. Results After adjusting for race and tumor type, patients who had bevacizumab added to their neoadjuvant therapy were found to experience a significantly improved rate of pCR compared to patients who did not (adjusted OR 8.40, 95% CI 1.90-37.1). When patients were analyzed for SNP effects via logistic regression with race and bevacizumab treatment included as covariates, two SNPs in angiopoietin 1 (ANGPT1), six in ANGPT2, three in fibroblast growth factor 2 (FGF2), four in matrix metalloproteinase 9 (MMP9), three in tyrosine kinase, endothelial (TEK) and two in vascular endothelial growth factor A (VEGFA) were associated with pCR (P<0.05). However, when overall survival was considered, there was no difference between treatment groups or between genotypes. Conclusion Genetic variability in TEK, ANGPT1, ANGPT2, FGF2, MMP9 and VEGFA is associated with pCR in bevacizumab-treated patients. Consistent with other studies, adding bevacizumab to standard chemotherapy did not impact OS, likely due to other factors and thus, while SNPs in TEK, ANGPT1, ANGPT2, FGF2, MMP9 and VEGFA were associated with pCR, they were not predictive of OS in this patient population.	[Makhoul, Issam; Hutchins, Laura F.] Univ Arkansas Med Sci, Div Hematol, Div Oncol, Little Rock, AR 72205 USA; [Todorova, Valentina K.; Raj, Vinay R.] Univ Arkansas Med Sci, Div Med Genet, Little Rock, AR 72205 USA; [Siegel, Eric R.; Erickson, Stephen W.; Dhakal, Ishwori; Lee, Jeannette Y.] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; [Orloff, Mohammed S.] Univ Arkansas Med Sci, Dept Epidemiol, Little Rock, AR 72205 USA; [Griffin, Robert J.; Kadlubar, Susan A.] Univ Arkansas Med Sci, Dept Radiat Oncol, Little Rock, AR 72205 USA; [Henry-Tillman, Ronda S.; Klimberg, Suzanne] Univ Arkansas Med Sci, Div Breast Surg Oncol, Little Rock, AR 72205 USA; [Klimberg, Suzanne] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Makhoul, I (corresponding author), Univ Arkansas Med Sci, Div Hematol, Div Oncol, Little Rock, AR 72205 USA.	makhoulissam@uams.edu		Erickson, Stephen/0000-0001-7602-1770; Griffin, Robert/0000-0002-3574-2958; Siegel, Eric/0000-0001-9824-6612	UAMS Translational Research Institute (TRI) [UL 1TR000039-05]; Arkansas Breast Cancer Research Program and University of Arkansas for Medical Sciences [1UL1RR029884]	UAMS Translational Research Institute (TRI); Arkansas Breast Cancer Research Program and University of Arkansas for Medical Sciences	This work was supported by the UAMS Translational Research Institute (TRI), Award number: UL 1TR000039-05, Grant recipient: Issam Makhoul; and the Arkansas Breast Cancer Research Program and University of Arkansas for Medical Sciences, Award number: 1UL1RR029884, Grant recipient: Valentina Todorova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors received salary from the funders.	Cao L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145442; Hein A, 2015, INT J CANCER, V137, P2981, DOI 10.1002/ijc.29656; Iodorova VK, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0160224, DOI 10.1371/JOURNAL.PONE.0160224]; Kumler I, 2014, CANCER TREAT REV, V40, P960, DOI 10.1016/j.ctrv.2014.05.006; Lyman GH, 2012, J CLIN ONCOL, V30, P3448, DOI 10.1200/JCO.2012.43.6931; Makhoul I, 2013, AM J CLIN ONCOL; Makhoul I, 2014, AM J CLIN ONCOL; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Nahleh ZA, 2016, BREAST CANCER RES TR, V158, P485, DOI 10.1007/s10549-016-3889-6; Schneider BP, 2005, J CLIN ONCOL, V23, P1782, DOI 10.1200/JCO.2005.12.017; Schneider BP, 2012, LANCET ONCOL, V13, pE427, DOI 10.1016/S1470-2045(12)70275-9; Schneider BP, 2009, CLIN CANCER RES, V15, P5297, DOI 10.1158/1078-0432.CCR-08-2576; Westbrook K, 2013, PHARMACOL THERAPEUT, V139, P1, DOI 10.1016/j.pharmthera.2013.03.001; Yadav L, 2015, J CLIN DIAGN RES, V9, pXE1, DOI 10.7860/JCDR/2015/12016.6135	14	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168550	10.1371/journal.pone.0168550	http://dx.doi.org/10.1371/journal.pone.0168550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045923	Green Submitted, gold, Green Published			2022-12-26	WOS:000391612300032
J	Picat, MQ; Pellegrin, I; Bitard, J; Wittkop, L; Proust-Lima, C; Liquet, B; Moreau, JF; Bonnet, F; Blanco, P; Thiebaut, R				Picat, Marie-Quitterie; Pellegrin, Isabelle; Bitard, Juliette; Wittkop, Linda; Proust-Lima, Cecile; Liquet, Benoit; Moreau, Jean-Francois; Bonnet, Fabrice; Blanco, Patrick; Thiebaut, Rodolphe		ANRS CO3 Aquitaine Cohort	Integrative Analysis of Immunological Data to Explore Chronic Immune T-Cell Activation in Successfully Treated HIV Patients	PLOS ONE			English	Article							INTERFERON-STIMULATED GENES; STRUCTURAL EQUATION MODELS; MICROBIAL TRANSLOCATION; I INTERFERON; HEPATITIS-B; CYTOMEGALOVIRUS; INFECTION; DISEASE; VIRUS; PERSISTENCE	Objectives To unravel the complex relationships between cytomegalovirus-induced-, autoimmuneinduced responses, microbial translocation and chronic immune activation (CIA) in successfully treated HIV-infected patients and to explore the mediating role of alpha-interferon in these processes. Design Cross-sectional study nested in the ANRS CO3 Aquitaine Cohort, a prospective hospital based cohort of HIV-1-infected patients in South-Western France. Methods Patients initiated antiretroviral therapy between 2005 and 2008 and were treated with sustained virological suppression for at least two years. CIA was defined by the percentage of HLA-DR+/CD38+ among CD8+T-cells. Integrative analyses were performed using structural equation modelling (SEM). Results The main analysis was performed in 57 HLA-A*0201 positive patients, due to availability of percentages of actin-, vimentin-, lamin-specific CD8+T-cells (HLA-A2-restricted tests) to further characterize autoimmune response. Cytomegalovirus-induced response was assessed by Quantiferon and pp-65 ELISPOT. SEM revealed a direct effect of cytomegalovirus-induced response on CIA (standardized estimate (3std = 0.56, p-value = 0.0004). The effect of autoimmune-induced response on CIA was indirect through alpha-interferon pathway, assessed by expression levels of 5 alpha-interferon-stimulated genes ADAR, ISG15, IFIT1, Mx1 and OAS1 (effect of autoimmune response on alpha-interferon: 6std = 0.36, p-value = 0.0401; effect of alpha-interferon on CIA: (3std = 0.39, p-value = 0.0044). There was no direct effect of autoimmune-induced response on CIA (p-value = 0.3169). Microbial translocation as measured by 16SrDNA and sCD14 in plasma was not associated with CIA. Results were consistent in 142 patients in whom cytomegalovirus and auto-immunity responses were measured by Quantiferon and anti-nuclear antibodies, respectively. All analyses performed in HLA-A*0201 positive patients and in the overall population revealed a significant effect of IFN-a latent variable on CIA. Conclusion The role of cytomegalovirus-induced response on CIA was confirmed as well as the involvement of alpha-interferon on CIA. The indirect effect of auto-immunity response on CIA revealed through the alpha-interferon pathway requires further investigation to confirm the potential role of auto-immunity for CIA in HIV-infected patients.	[Picat, Marie-Quitterie; Wittkop, Linda; Proust-Lima, Cecile; Bonnet, Fabrice; Thiebaut, Rodolphe] Ctr INSERM U1219 Bordeaux Populat Hlth, Bordeaux, France; [Picat, Marie-Quitterie; Wittkop, Linda; Proust-Lima, Cecile; Thiebaut, Rodolphe] Univ Bordeaux, ISPED, Bordeaux, France; [Picat, Marie-Quitterie; Wittkop, Linda; Thiebaut, Rodolphe] CHU Bordeaux Pole Sante Publ, USMR, Serv Informat Med, Bordeaux, France; [Picat, Marie-Quitterie; Wittkop, Linda; Thiebaut, Rodolphe] Team SISTM, INRIA, Bordeaux, France; [Picat, Marie-Quitterie; Thiebaut, Rodolphe] Hop Henri Mondor, VRI, Creteil, France; [Pellegrin, Isabelle; Bitard, Juliette; Moreau, Jean-Francois; Blanco, Patrick] CHU Bordeaux, Lab Immunol Immunogenet Pole Biol, Pole Biol, Bordeaux, France; [Liquet, Benoit] Univ Pau & Pays Adour, UMR CNRS 5142, Lab Math & Leurs Applicat, Pau, France; [Liquet, Benoit] Queensland Univ Technol, ARC Ctr Excellence Math & Stat Frontiers, Brisbane, Qld, Australia; [Moreau, Jean-Francois; Bonnet, Fabrice; Blanco, Patrick] Univ Bordeaux, Bordeaux, France; [Moreau, Jean-Francois; Blanco, Patrick] CNRS, UMR 5164, Bordeaux, France; [Bonnet, Fabrice] CHU Bordeaux, Serv Med Interne & Malad Infect, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Inria; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); Universite de Pau et des Pays de l'Adour; Queensland University of Technology (QUT); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Picat, MQ (corresponding author), Ctr INSERM U1219 Bordeaux Populat Hlth, Bordeaux, France.; Picat, MQ (corresponding author), Univ Bordeaux, ISPED, Bordeaux, France.; Picat, MQ (corresponding author), CHU Bordeaux Pole Sante Publ, USMR, Serv Informat Med, Bordeaux, France.; Picat, MQ (corresponding author), Team SISTM, INRIA, Bordeaux, France.; Picat, MQ (corresponding author), Hop Henri Mondor, VRI, Creteil, France.	marie-quitterie.picat@isped.u-bordeaux2.fr	Thiebaut, Rodolphe/T-6803-2019; Proust-Lima, Cécile/E-6670-2014; Wittkop, Linda/E-3319-2014; Bonnet, Fabrice/T-3254-2019	Thiebaut, Rodolphe/0000-0002-5235-3962; Proust-Lima, Cécile/0000-0002-9884-955X; Wittkop, Linda/0000-0003-2403-0960; BITARD, Juliette/0000-0001-6626-3522; BREILH, Dominique/0000-0002-3783-2797; Richert, Laura/0000-0002-7682-2225; liquet, benoit/0000-0002-8136-2294	Sidaction [AI20-2-01629]; CHU of Bordeaux [2009 AO1063-54]; Vaccine Research Institute; Agence nationale de recherches sur le sida et les hepatites virales [ANRS, Cohortes]	Sidaction; CHU of Bordeaux; Vaccine Research Institute; Agence nationale de recherches sur le sida et les hepatites virales [ANRS, Cohortes]	This work was supported by Sidaction [AI20-2-01629], the CHU of Bordeaux [2009 AO1063-54] and the Vaccine Research Institute. The ANRS CO3 Aquitaine cohort was supported by the Agence nationale de recherches sur le sida et les hepatites virales [ANRS, Action Coordonnee no.7, Cohortes].	Abad-Fernandez M, 2013, JAIDS-J ACQ IMM DEF, V64, P149, DOI 10.1097/QAI.0b013e31829a2f12; Acchioni C, 2015, CYTOKINE GROWTH F R, V26, P143, DOI 10.1016/j.cytogfr.2014.10.004; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Appay V, 2011, AIDS, V25, P1813, DOI 10.1097/QAD.0b013e32834640e6; Baltar VT, 2013, EUR J EPIDEMIOL, V28, P677, DOI 10.1007/s10654-013-9793-z; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Benito JM, 2004, AIDS RES HUM RETROV, V20, P227, DOI 10.1089/088922204773004950; Blanco P, 2005, ARTHRITIS RHEUM, V52, P201, DOI 10.1002/art.20745; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brown JR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-349; Carver S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1274-7; Cha L, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.1; Chavance M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-37; Dahly DL, 2009, INT J EPIDEMIOL, V38, P538, DOI 10.1093/ije/dyn242; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Dunson DB, 2007, STAT METHODS MED RES, V16, P399, DOI 10.1177/0962280206075309; Effros RB, 2016, MECH AGEING DEV, V158, P46, DOI 10.1016/j.mad.2015.09.003; Freeman M.L., 2015, CLIN INFECT DIS; Freeman ML, 2016, CURR HIV-AIDS REP, V13, P10, DOI 10.1007/s11904-016-0297-9; Genser B, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0149-9; Genser B, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-27; Gianella S, 2016, J INFECT DIS, V214, pS67, DOI 10.1093/infdis/jiw217; Grace JB, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00048.1; Hanf M, 2014, INFECT GENET EVOL, V21, P497, DOI 10.1016/j.meegid.2013.09.006; Holst KK, 2013, COMPUTATION STAT, V28, P1385, DOI 10.1007/s00180-012-0344-y; Hoyle R.H., 2012, HDB STRUCTURAL EQUAT; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Hsue PY, 2012, J INFECT DIS, V205, pS375, DOI 10.1093/infdis/jis200; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huang CY, 2016, OBESITY, V24, P483, DOI 10.1002/oby.21333; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jiang W, 1999, J INFECT DIS, P1177; Kader M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003530; Kinloch AJ, 2014, ARTHRITIS RHEUMATOL, V66, P3359, DOI 10.1002/art.38888; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Lichtner M, 2015, J INFECT DIS, V211, P178, DOI 10.1093/infdis/jiu417; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Mogensen UB, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0032-9; Nasi M, 2016, CLIN EXP IMMUNOL; Paiardini M, 2013, IMMUNOL REV, V254, P78, DOI 10.1111/imr.12079; Parrinello CM, 2012, J INFECT DIS, V205, P1788, DOI 10.1093/infdis/jis276; Plaeger SF, 2012, AIDS RES HUM RETROV, V28, P469, DOI [10.1089/aid.2011.0213, 10.1089/AID.2011.0213]; Rajasuriar R, 2013, AIDS, V27, P1199, DOI 10.1097/QAD.0b013e32835ecb8b; Rawson PM, 2007, NAT MED, V13, P1431, DOI 10.1038/nm1679; Ries M, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/534929; Sanchez BN, 2005, J AM STAT ASSOC, V100, P1443, DOI 10.1198/016214505000001005; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Shimizu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149327; Stone SF, 2005, AIDS, V19, P555, DOI 10.1097/01.aids.0000163931.68907.7e; Stratton R, 2009, CURR OPIN INFECT DIS, V22, P49, DOI 10.1097/QCO.0b013e3283210006; Tebas P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002021; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Tetard-Jones C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087597; Thiebaut R, 2000, AIDS, V14, P971, DOI 10.1097/00002030-200005260-00008; Thom JT, 2016, CURR OPIN VIROL, V16, P63, DOI 10.1016/j.coviro.2016.01.014; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Wittkop L, 2013, J INFECT DIS, V207, P622, DOI 10.1093/infdis/jis732; Yang SJ, 2005, J VIROL, V79, P5027, DOI 10.1128/JVI.79.8.5027-5034.2005; Younas M, 2016, HIV MED, V17, P89, DOI 10.1111/hiv.12310; Zhou Y, 2014, IMMUNOLOGY, V143, P319, DOI 10.1111/imm.12349	65	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169164	10.1371/journal.pone.0169164	http://dx.doi.org/10.1371/journal.pone.0169164			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046052	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300133
J	Tan, MC; Murrey-Ittmann, J; Nguyen, T; Ketwaroo, GA; El-Serag, HB; Thrift, AP				Tan, Mimi C.; Murrey-Ittmann, Jackson; Nguyen, Theresa; Ketwaroo, Gyanprakash A.; El-Serag, Hashem B.; Thrift, Aaron P.			Risk Profiles for Barrett's Esophagus Differ between New and Prevalent, and Long- and Short-Segment Cases	PLOS ONE			English	Article							INTERNATIONAL BEACON CONSORTIUM; GASTROESOPHAGEAL-REFLUX DISEASE; BODY-MASS INDEX; HELICOBACTER-PYLORI; POOLED ANALYSIS; CLINICAL-PRACTICE; ADENOCARCINOMA; ASSOCIATION; MANAGEMENT; DIAGNOSIS	Background Previous studies on Barrett's esophagus (BE) risk factors have had differing case definitions and control groups. The purpose of this study was to examine differences in risk factors between newly diagnosed vs. prevalent BE, long-vs. short-segment BE, and endoscopy only BE without specialized intestinal metaplasia (SIM). Methods We conducted a cross-sectional study among eligible patients scheduled for elective eso-phagogastroduodenoscopy (EGD) and patients eligible for screening colonoscopy, recruited from primary care clinics at a Veterans Affairs center. All participants completed a survey on demographics, gastroesophageal reflux disease (GERD) symptoms and medication use prior to undergoing study EGD. We compared BE cases separately to two control groups: 503 primary care controls and 1353 endoscopy controls. Associations between risk factors and differing BE case definitions were evaluated with multivariate logistic regression models. Results For comparisons with primary care controls, early onset frequent GERD symptoms were more strongly associated with risk of long-segment BE (OR 19.9; 95% CI 7.96-49.7) than short-segment BE (OR 8.54; 95% CI 3.85-18.9). Likewise, the inverse association with H. pylori infection was stronger for long-segment BE (OR, 0.45; 95% CI, 0.26-0.79) than short-segment BE (OR, 0.71; 95% CI, 0.48-1.05). GERD symptoms and H. pylori infection was also more strongly associated with prevalent BE than newly diagnosed BE. Few differences were observed between BE cases and endoscopy controls. Endoscopy-only BE was associated with GERD symptoms (OR 2.25, 95% CI 1.32-3.85) and PPI/H2RA use (OR 4.44; 95% CI 2.61-7.54) but to a smaller degree than BE with SIM. Conclusion We found differences in the strength and profiles of risk factors for BE. The findings support that epidemiological studies of BE should make a distinction between long and short, new and prevalent, endoscopy-only and BE with SIM as well as type of controls.	[Tan, Mimi C.; Murrey-Ittmann, Jackson; Nguyen, Theresa; Ketwaroo, Gyanprakash A.; El-Serag, Hashem B.; Thrift, Aaron P.] Baylor Coll Med, Dept Med, Sect Gastroenterol & Hepatol, Houston, TX 77030 USA; [Tan, Mimi C.; Murrey-Ittmann, Jackson; Nguyen, Theresa; Ketwaroo, Gyanprakash A.; El-Serag, Hashem B.; Thrift, Aaron P.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Tan, Mimi C.; Nguyen, Theresa; El-Serag, Hashem B.] Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety, Houston, TX USA; [Thrift, Aaron P.] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	El-Serag, HB (corresponding author), Baylor Coll Med, Dept Med, Sect Gastroenterol & Hepatol, Houston, TX 77030 USA.; El-Serag, HB (corresponding author), Michael E DeBakey VA Med Ctr, Houston, TX USA.; El-Serag, HB (corresponding author), Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety, Houston, TX USA.	hasheme@bcm.edu		Thrift, Aaron/0000-0002-0084-5308; Nguyen, Theresa/0000-0002-4021-9774	National Institutes of Health [NCI R01 116845]; Texas Digestive Disease Center [NIH DK58338]; NIDDK [K24-04-107]; VA HSR&D Center for Innovations in Quality, Effectiveness and Safety [CIN 13-413]; Michael E. DeBakey VA Medical Center, Houston, TX	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Digestive Disease Center; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); VA HSR&D Center for Innovations in Quality, Effectiveness and Safety; Michael E. DeBakey VA Medical Center, Houston, TX	This work is funded in part by National Institutes of Health grant NCI R01 116845, and the Texas Digestive Disease Center NIH DK58338. Dr. El-Serag is also supported by NIDDK K24-04-107. This research was supported in part with resources at the VA HSR&D Center for Innovations in Quality, Effectiveness and Safety (#CIN 13-413), at the Michael E. DeBakey VA Medical Center, Houston, TX. The opinions expressed reflect those of the authors and not necessarily those of the Department of Veterans Affairs, the US government or Baylor College of Medicine.	Balasubramanian G, 2012, AM J GASTROENTEROL, V107, P1655, DOI 10.1038/ajg.2012.299; Bhat S, 2011, J NATL CANCER I, V103, P1049, DOI 10.1093/jnci/djr203; Cook MB, 2005, AM J EPIDEMIOL, V162, P1050, DOI 10.1093/aje/kwi325; Cook MB, 2012, GASTROENTEROLOGY, V142, P744, DOI 10.1053/j.gastro.2011.12.049; Corley DA, 2009, GUT, V58, P182, DOI 10.1136/gut.2008.163360; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; El-Serag HB, 2014, GUT, V63, P220, DOI 10.1136/gutjnl-2012-304189; Fischbach LA, 2014, AM J GASTROENTEROL, V109, P357, DOI 10.1038/ajg.2013.443; Fitzgerald RC, 2014, GUT, V63, P7, DOI 10.1136/gutjnl-2013-305372; Hill LD, 1996, GASTROINTEST ENDOSC, V44, P541, DOI 10.1016/S0016-5107(96)70006-8; Kendall BJ, 2016, CLIN GASTROENTEROL H, V14, P1412, DOI 10.1016/j.cgh.2016.05.032; Khandwalla HE, 2014, AM J GASTROENTEROL, V109, P178, DOI 10.1038/ajg.2013.408; Kramer JR, 2013, CLIN GASTROENTEROL H, V11, P373, DOI 10.1016/j.cgh.2012.11.028; Kubo A, 2013, GUT, V62, P1684, DOI 10.1136/gutjnl-2012-303753; Lin D, 2013, AM J GASTROENTEROL, V108, P1576, DOI 10.1038/ajg.2013.222; LOCKE GR, 1994, MAYO CLIN PROC, V69, P539, DOI 10.1016/S0025-6196(12)62245-9; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Rubenstein JH, 2014, CLIN GASTROENTEROL H, V12, P239, DOI 10.1016/j.cgh.2013.08.029; Rubenstein JH, 2013, AM J GASTROENTEROL, V108, P353, DOI 10.1038/ajg.2012.446; Rugge M, 2007, GUT, V56, P631, DOI 10.1136/gut.2006.106666; Shaheen NJ, 2016, AM J GASTROENTEROL, V111, P30, DOI 10.1038/ajg.2015.322; Sharma P, 2006, GASTROENTEROLOGY, V131, P1392, DOI 10.1053/j.gastro.2006.08.032; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1399, DOI 10.1016/j.cgh.2013.05.009; Spechler SJ, 2011, GASTROENTEROLOGY, V140, pE18, DOI 10.1053/j.gastro.2011.01.031; Thrift AP, 2012, ANN ONCOL, V23, P3155, DOI 10.1093/annonc/mds181; Thrift AP, 2016, AM J GASTROENTEROL, V111, P1528, DOI 10.1038/ajg.2016.348; Thrift AP, 2016, CLIN GASTROENTEROL H, V14, P330, DOI 10.1016/j.cgh.2015.10.028; Thrift AP, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju252; Thrift AP, 2014, AM J GASTROENTEROL, V109, P1586, DOI 10.1038/ajg.2014.206; Thrift AP, 2014, CLIN GASTROENTEROL H, V12, P1667, DOI 10.1016/j.cgh.2014.01.039; Thrift AP, 2014, CLIN GASTROENTEROL H, V12, P1267, DOI 10.1016/j.cgh.2013.12.014; Thrift AP, 2014, DIGEST DIS SCI, V59, P108, DOI 10.1007/s10620-013-2892-6; Thrift AP, 2013, AM J GASTROENTEROL, V108, P915, DOI 10.1038/ajg.2013.72; Thrift AP, 2013, CLIN GASTROENTEROL H, V11, P138, DOI 10.1016/j.cgh.2012.10.026; Thrift AP, 2012, CANCER PREV RES, V5, P1115, DOI 10.1158/1940-6207.CAPR-12-0010; Thrift AP, 2012, INT J CANCER, V130, P2407, DOI 10.1002/ijc.26242; Whiteman DC, 2015, J GASTROEN HEPATOL, V30, P804, DOI 10.1111/jgh.12913	37	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169250	10.1371/journal.pone.0169250	http://dx.doi.org/10.1371/journal.pone.0169250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036381	gold, Green Submitted, Green Published			2022-12-26	WOS:000391229300067
J	Chang, HT; Lin, TH				Chang, Hsien-Tsung; Lin, Tsai-Huei			A Database as a Service for the Healthcare System to Store Physiological Signal Data	PLOS ONE			English	Article								Wearable devices that measure physiological signals to help develop self-health management habits have become increasingly popular in recent years. These records are conducive for follow-up health and medical care. In this study, based on the characteristics of the observed physiological signal records- 1) a large number of users, 2) a large amount of data, 3) low information variability, 4) data privacy authorization, and 5) data access by designated users-we wish to resolve physiological signal record-relevant issues utilizing the advantages of the Database as a Service (DaaS) model. Storing a large amount of data using file patterns can reduce database load, allowing users to access data efficiently; the privacy control settings allow users to store data securely. The results of the experiment show that the proposed system has better database access performance than a traditional relational database, with a small difference in database volume, thus proving that the proposed system can improve data storage performance.	[Chang, Hsien-Tsung; Lin, Tsai-Huei] Chang Gung Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan; [Chang, Hsien-Tsung] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital	Chang, HT (corresponding author), Chang Gung Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan.; Chang, HT (corresponding author), Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Taoyuan, Taiwan.	smallpig@widelab.org	Chang, Hsien-Tsung/E-7511-2012	Chang, Hsien-Tsung/0000-0003-4987-5943	Ministry of Science and Technology, Republic of China of Chang Gung University [MOST 104-2221-E-182-069 (NERPD2E0411), 105-2221-E-182-072 (NERPD2F0351)]	Ministry of Science and Technology, Republic of China of Chang Gung University	Financial support furnished by the Ministry of Science and Technology, Republic of China, through Grant MOST 104-2221-E-182-069 (NERPD2E0411) and 105-2221-E-182-072 (NERPD2F0351) of Chang Gung University is gratefully acknowledged.	Baker J., 2011, MEGASTORE PROVIDING; Brucker AD, 2009, P 14 ACM S ACC CONTR; Chang F, 2008, ACM T COMPUT SYST, V26, DOI 10.1145/1365815.1365816; Chang HT, 2014, J SYST SOFTWARE, V93, P102, DOI 10.1016/j.jss.2014.02.057; Curino C., 2010, NEW ENGLAND DATABASE, P1; Curino C., 2011, PROC 5 BIENNIAL C IN; Ghazi Y, 2016, EURASIP J INF SECUR, DOI 10.1186/s13635-016-0040-5; Ghemawat S., 2003, ACM SIGOPS OPERATING; Gonzalez H, 2010, P 2010 ACM SIGMOD IN; Grover P., 2016, CLOUD SYST BIG DAT E; HAHNE EL, 1991, IEEE J SEL AREA COMM, V9, P1024, DOI 10.1109/49.103550; Javanmardi Saeed, 2014, P 5 INT C INN BIOINS; Kim W-I, 2007, 2007 IEEE 66 VEH TEC; Kofler M., 2006, DEFINITIVE GUIDE MYS; Lin C, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0446-0; Lin CH, 2016, INT SER COMPUT ENTER, P95, DOI 10.1007/978-3-319-30146-4_5; Lin T-H, 2014, IEEE EMBS INT C BIOM; Loai AT, 2016, IEEE ACCESS; Martino L, 2010, P 1 ACM INT HLTH INF; Shojafar M, 2015, CLUSTER COMPUT, V18, P829, DOI 10.1007/s10586-014-0420-x; Trojer T, 2012, P 2 ACM SIGHIT INT H; Zhang R, 2010, IEEE ICC	22	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168935	10.1371/journal.pone.0168935	http://dx.doi.org/10.1371/journal.pone.0168935			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033415	Green Submitted, Green Published, gold			2022-12-26	WOS:000391226900062
J	Gabriel, D; Gordon, LB; Djabali, K				Gabriel, Diana; Gordon, Leslie B.; Djabali, Karima			Temsirolimus Partially Rescues the Hutchinson-Gilford Progeria Cellular Phenotype	PLOS ONE			English	Article							MUTANT LAMIN-A; MOUSE MODEL; INHIBITING FARNESYLATION; AMELIORATES DISEASE; CYTOCHROME-C; DNA-REPAIR; LIFE-SPAN; RAPAMYCIN; FIBROBLASTS; ACCUMULATION	Hutchinson-Gilford syndrome (HGPS, OMIM 176670, a rare premature aging disorder that leads to death at an average age of 14.7 years due to myocardial infarction or stroke, is caused by mutations in the LMNA gene. Lamins help maintain the shape and stability of the nuclear envelope in addition to regulating DNA replication, DNA transcription, proliferation and differentiation. The LMNA mutation results in the deletion of 50 amino acids from the carboxy-terminal region of prelamin A, producing the truncated, farnesylated protein progerin. The accumulation of progerin in HGPS nuclei causes numerous morphological and functional changes that lead to premature cellular senescence. Attempts to reverse this HGPS phenotype have identified rapamycin, an inhibitor of mammalian target of rapamycin (mTOR), as a drug that is able to rescue the HGPS cellular phenotype by promoting autophagy and reducing progerin accumulation. Rapamycin is an obvious candidate for the treatment of HGPS disease but is difficult to utilize clinically. To further assess rapamycin's efficacy with regard to proteostasis, mitochondrial function and the degree of DNA damage, we tested temsirolimus, a rapamycin analog with a more favorable pharmacokinetic profile than rapamycin. We report that temsirolimus decreases progerin levels, increases proliferation, reduces misshapen nuclei, and partially ameliorates DNA damage, but does not improve proteasome activity or mitochondrial dysfunction. Our findings suggest that future therapeutic strategies should identify new drug combinations and treatment regimens that target all the dysfunctional hallmarks that characterize HGPS cells.	[Gabriel, Diana; Djabali, Karima] Tech Univ Munich, Sch Med, Dept Dermatol, Epigenet Aging, Garching, Germany; [Gordon, Leslie B.] Brown Univ, Warren Alpert Med Sch, Hasbro Childrens Hosp, Dept Pediat, Providence, RI 02912 USA; [Gordon, Leslie B.] Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesia, Boston, MA USA	Technical University of Munich; Brown University; Hasbro Children's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School	Djabali, K (corresponding author), Tech Univ Munich, Sch Med, Dept Dermatol, Epigenet Aging, Garching, Germany.	djabali@tum.de	Gordon, Leslie B./AAJ-5793-2021	djabali, karima/0000-0003-4067-4977	Progeria Research Foundation; German Research Foundation [598946]; DFG; Technical University of Munich (TUM)	Progeria Research Foundation; German Research Foundation(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Technical University of Munich (TUM)	This work was supported by The Progeria Research Foundation and in part by the German Research Foundation (598946) (to KD), and the DFG and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam SA, 2013, NUCLEUS-PHILA, V4, P142, DOI 10.4161/nucl.24089; Adkins RM, 1996, MOL BIOL EVOL, V13, P1393, DOI 10.1093/oxfordjournals.molbev.a025586; Arriola Apelo SI, 2015, AGING CELL; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Baur B, 2011, TRANSPL P, V43, P1853, DOI 10.1016/j.transproceed.2011.01.174; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Blondel S, 2014, STEM CELL TRANSL MED, V3, P510, DOI 10.5966/sctm.2013-0168; Cadet J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012559; Cao K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002346; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Cenni V, 2011, EUR J HISTOCHEM, V55, P200, DOI 10.4081/ejh.2011.e36; CHAUDHARY N, 1993, J CELL BIOL, V122, P295, DOI 10.1083/jcb.122.2.295; Choi JC, 2013, AUTOPHAGY, V9, P110, DOI 10.4161/auto.22403; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dott W, 2014, REDOX BIOL, V2, P224, DOI 10.1016/j.redox.2013.12.028; Dudkin L, 2001, CLIN CANCER RES, V7, P1758; Ekberg H, 2010, NEPHROL DIAL TRANSPL, V25, P2004, DOI 10.1093/ndt/gfp778; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Evans DS, 2011, AGEING RES REV, V10, P225, DOI 10.1016/j.arr.2010.04.001; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; Gabriel D, 2015, AGING CELL, V14, P78, DOI 10.1111/acel.12300; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gordon LB, 2014, CIRCULATION, V130, P27, DOI 10.1161/CIRCULATIONAHA.113.008285; Gordon LB, 2014, CELL, V156, P400, DOI 10.1016/j.cell.2013.12.028; Graziotto JJ, 2012, AUTOPHAGY, V8, P147, DOI 10.4161/auto.8.1.18331; Hidalgo M, 2006, CLIN CANCER RES, V12, P5755, DOI 10.1158/1078-0432.CCR-06-0118; Ibrahim MX, 2013, SCIENCE, V340, P1330, DOI 10.1126/science.1238880; Johnson SC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007316; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Manju K, 2006, J CELL SCI, V119, P2704, DOI 10.1242/jcs.03009; Marji J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011132; McClintock D, 2006, P NATL ACAD SCI USA, V103, P2154, DOI 10.1073/pnas.0511133103; McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269; Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194; Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674; Osmulski PA, 2013, MOL PHARMACOL, V84, P104, DOI 10.1124/mol.112.083873; Paradisi M, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-27; Pellegrini C, 2015, ONCOTARGET, V6, P29914, DOI 10.18632/oncotarget.4939; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; Richards SA, 2011, HUM MOL GENET, V20, P3997, DOI 10.1093/hmg/ddr327; Rini BI, 2008, CLIN CANCER RES, V14, P1286, DOI 10.1158/1078-0432.CCR-07-4719; Rivera-Torres J, 2013, J PROTEOMICS, V91, P466, DOI 10.1016/j.jprot.2013.08.008; Rodriguez KA, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00083; Rodriguez S, 2009, EUR J HUM GENET, V17, P928, DOI 10.1038/ejhg.2008.270; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Ullrich Nicole J, 2015, Handb Clin Neurol, V132, P249, DOI 10.1016/B978-0-444-62702-5.00018-4; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; Verstraeten VLRM, 2011, P NATL ACAD SCI USA, V108, P4997, DOI 10.1073/pnas.1019532108; Villa-Bellosta R, 2013, CIRCULATION, V127, P2442, DOI 10.1161/CIRCULATIONAHA.112.000571; Viteri G, 2010, MECH AGEING DEV, V131, P2, DOI 10.1016/j.mad.2009.11.006; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Ye L, 2013, AGING-US, V5, P539, DOI 10.18632/aging.100576; Zimmerman M, 2014, TRENDS CELL BIOL, V24, P108, DOI 10.1016/j.tcb.2013.09.003	65	23	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168988	10.1371/journal.pone.0168988	http://dx.doi.org/10.1371/journal.pone.0168988			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033363	gold, Green Submitted, Green Published			2022-12-26	WOS:000391226900067
J	Tserpes, G; Nikolioudakis, N; Maravelias, C; Carvalho, N; Merino, G				Tserpes, George; Nikolioudakis, Nikolaos; Maravelias, Christos; Carvalho, Natacha; Merino, Gorka			Viability and Management Targets of Mediterranean Demersal Fisheries: The Case of the Aegean Sea	PLOS ONE			English	Article							SELECTIVITY; OBJECTIVES; CAPACITY; MESH	Management of the Mediterranean demersal stocks has proven challenging mainly due to the multi-species character of the fisheries. In the present work, we focus on the multi-species demersal fisheries of the Aegean Sea (eastern Mediterranean) aiming to study the effects of different management measures on the main commercial stocks, as well as to explore the economic viability of the fisheries depending upon these resources, by means of simulated projections. Utilizing the limited available data, our results demonstrated that, under the current exploitation pattern, the economic viability of the fleets is threatened, particularly if fuel prices increase. Additionally, the biological targets set for the most exploited species, such as hake, will not be met under the current management regime. The projections also showed that the only management scenario under which both resource sustainability and economic viability of the fisheries are ensured is the decrease of fleet capacity in terms of vessel numbers. In this case, however, measures to support the fisheries-dependent communities need to be implemented to prevent the collapse of local economies due to employment decrease. Scenarios assuming selectivity improvements would be also beneficial for the stocks but they showed low economic performance and their application would threaten the viability of the fleets, particularly that of the trawlers.	[Tserpes, George; Nikolioudakis, Nikolaos] Hellen Ctr Marine Res, Inst Marine Biol Resources & Inland Waters, Iraklion, Greece; [Maravelias, Christos] Hellen Ctr Marine Res, Inst Marine Biol Resources & Inland Waters, Athens, Greece; [Carvalho, Natacha] European Commiss, Joint Res Ctr, Ispra, Varese, Italy; [Merino, Gorka] AZTI Tecnalia, Pasaia, Gipuzkoa, Spain; [Nikolioudakis, Nikolaos] Inst Marine Res, Bergen, Norway; [Nikolioudakis, Nikolaos] Hjort Ctr Marine Ecosyst Dynam, Bergen, Norway	Hellenic Centre for Marine Research; Hellenic Centre for Marine Research; European Commission Joint Research Centre; EC JRC ISPRA Site; AZTI; Institute of Marine Research - Norway	Nikolioudakis, N (corresponding author), Hellen Ctr Marine Res, Inst Marine Biol Resources & Inland Waters, Iraklion, Greece.; Nikolioudakis, N (corresponding author), Inst Marine Res, Bergen, Norway.; Nikolioudakis, N (corresponding author), Hjort Ctr Marine Ecosyst Dynam, Bergen, Norway.	nikolaos.nikolioudakis@imr.no	Tserpes, George/L-6201-2013; Maravelias, Christos/W-4151-2019; Nikolioudakis, Nikolaos/A-9986-2013; Merino, Gorka/D-5979-2018	Tserpes, George/0000-0001-9052-4091; Nikolioudakis, Nikolaos/0000-0002-5029-5164; Merino, Gorka/0000-0001-6170-9396; Maravelias, Christos/0000-0002-2440-3707	European Community's Seventh Framework Programme (FP7) [289257]; commercial company AZTI-Tecnalia	European Community's Seventh Framework Programme (FP7); commercial company AZTI-Tecnalia	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/20072013) under grant agreement MYFISH (number 289257). GM is funded by the commercial company AZTI-Tecnalia. The funder provided support in the form of salaries for authors [GM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. The article does not necessarily reflect the views of the Commission.	[Anonymous], [No title captured]; Colloca F, 2013, FISH FISH, V14, P89, DOI 10.1111/j.1467-2979.2011.00453.x; Damalas D, 2014, REV FISH SCI AQUAC, V22, P112, DOI 10.1080/10641262.2013.839620; EU, 2011, 122011 EU; Gundogdu S, 2016, PAK J ZOOL, V48, P435; Kapiris K, 2007, RAPP COMM INT MER ME, P38; Kell LT, 2007, ICES J MAR SCI, V64, P640, DOI 10.1093/icesjms/fsm012; Lleonart J, 2003, SCI MAR, V67, P37, DOI 10.3989/scimar.2003.67s137; Maravelias CD, 2014, FISHERIES MANAG ECOL, V21, P186, DOI 10.1111/fme.12060; Maravelias CD, 2008, FISH RES, V93, P85, DOI 10.1016/j.fishres.2008.02.013; Mellon-Duval C, 2010, ICES J MAR SCI, V67, P62, DOI 10.1093/icesjms/fsp215; Merino G, 2015, FISH RES, V161, P131, DOI 10.1016/j.fishres.2014.06.010; Ordines F, 2006, AQUAT LIVING RESOUR, V19, P329, DOI 10.1051/alr:2007003; Ozbilgin H, 2012, J APPL ICHTHYOL, V28, P51, DOI 10.1111/j.1439-0426.2011.01916.x; Papaconstantinou C., 2000, Mediterranean Marine Science, V1, P5; Pope J.G., 1972, INT COMMISSION NW AT, V9, P65; Sabatella E, 2014, ADRIAMED TECHNICAL D, P27; Sacchi J, 2011, ANAL EC ACTIVITIES M, P84; Samy-Kamal M, 2015, FISH RES, V172, P303, DOI 10.1016/j.fishres.2015.07.027; Stergiou KI, 2003, FISH RES, V59, P431, DOI 10.1016/S0165-7836(02)00016-4; Tserpes G, 2011, HYDROBIOLOGIA, V670, P267, DOI 10.1007/s10750-011-0667-7; Tserpes G, 2009, FISH RES, V96, P160, DOI 10.1016/j.fishres.2008.10.008; Tsitsika EV, 2008, FISHERIES SCI, V74, P730, DOI 10.1111/j.1444-2906.2008.01583.x; Vasilakopoulos P, 2014, CURR BIOL, V24, P1643, DOI 10.1016/j.cub.2014.05.070	24	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168694	10.1371/journal.pone.0168694	http://dx.doi.org/10.1371/journal.pone.0168694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033348	Green Published, Green Submitted, gold			2022-12-26	WOS:000391226900037
J	Galtan, L; Laderach, P; Graefe, S; Rao, I; van der Hoek, R				Galtan, Lucia; Laderach, Peter; Graefe, Sophie; Rao, Idupulapati; van der Hoek, Rein			Climate-Smart Livestock Systems: An Assessment of Carbon Stocks and GHG Emissions in Nicaragua	PLOS ONE			English	Article							NITRIFICATION INHIBITION BNI; GREENHOUSE-GAS EMISSIONS; PASTURES; FORAGE; SEQUESTRATION; PRODUCTIVITY; EFFICIENCIES; MANAGEMENT; DYNAMICS; NITROGEN	Livestock systems in the tropics can contribute to mitigate climate change by reducing greenhouse gas (GHG) emissions and increasing carbon accumulation. We quantified C stocks and GHG emissions of 30 dual-purpose cattle farms in Nicaragua using farm inventories and lifecycle analysis. Trees in silvo-pastoral systems were the main C stock above-ground (16-24 Mg ha(-1)), compared with adjacent secondary forests (43 Mg C ha(-1)). We estimated that methane from enteric fermentation contributed 1.6 kg CO2-eq., and nitrous oxide from excreta 0.4 kg CO2-eq. per kg of milk produced. Seven farms that we classified as climate-smart agriculture (CSA) out of 16 farms had highest milk yields (6.2 kg cow(-1) day(-1)) and lowest emissions (1.7 kg CO2-eq. per kg milk produced). Livestock on these farms had higher-quality diets, especially during the dry season, and manure was managed better. Increasing the numbers of CSA farms and improving CSA technology will require better enabling policy and incentives such as payments for ecosystem services.	[Galtan, Lucia; Laderach, Peter; van der Hoek, Rein] Int Ctr Trop Agr CIAT, Managua, Nicaragua; [Graefe, Sophie] Georg August Univ Gottingen, Trop Silviculture & Forest Ecol, Gottingen, Germany; [Rao, Idupulapati] Int Ctr Trop Agr CIAT, Cali, Colombia	Alliance; International Center for Tropical Agriculture - CIAT; University of Gottingen; Alliance; International Center for Tropical Agriculture - CIAT	Galtan, L (corresponding author), Int Ctr Trop Agr CIAT, Managua, Nicaragua.	lucia.gaitan.sanchez@gmail.com	Rao, Idupulapati M./H-4838-2019	Rao, Idupulapati M./0000-0002-8381-9358; Laderach, Peter/0000-0001-8708-6318	CGIAR Fund Council; Australia (ACIAR); Irish Aid; European Union; International Fund for Agricultural Development (IFAD), Netherlands, New Zealand, Switzerland, UK; USAID; Bundesministerium fur wirtschaftliche Zusammenarbeit and Entwicklung (BMZ); International Center for Tropical Agriculture [11.7860.7-001.00]; CGIAR Fund	CGIAR Fund Council(CGIAR); Australia (ACIAR); Irish Aid(CGIAR); European Union(European Commission); International Fund for Agricultural Development (IFAD), Netherlands, New Zealand, Switzerland, UK; USAID(United States Agency for International Development (USAID)); Bundesministerium fur wirtschaftliche Zusammenarbeit and Entwicklung (BMZ); International Center for Tropical Agriculture; CGIAR Fund(CGIAR)	We acknowledge the CGIAR Fund Council, Australia (ACIAR), Irish Aid, European Union, International Fund for Agricultural Development (IFAD), Netherlands, New Zealand, Switzerland, UK, USAID and Thailand for funding to the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS) and the Bundesministerium fur wirtschaftliche Zusammenarbeit and Entwicklung (BMZ) http://www.bmz.de/de/index.html <http://www.bmz.de/de/index.html>. Contact #: 81170344, Project Processing #: 11.7860.7-001.00, CIAT (International Center for Tropical Agriculture) Dr. Peter Laderach, Dr. Rein van der Hoek.; This work was implemented by the International Center for Tropical Agriculture (CIAT) under the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS). We thank BMZ for financing this study as part of a project on carbon insetting, and all other donors who supported this work through their contributions to the CGIAR Fund. We thank staff of CATIE, especially Claudia Sepulveda and Diego Tobar, for their advice and contribution to this work, through the project "Competitividad de la came y leche a traves de la intensificacion sostenible y el acceso a mercados especializados en Nicaragua" supported by Solidaridad Network. We also thank Myles Fisher for his comments and suggestions in preparing the manuscript.	Amezquita M. C., 2010, Integrated Crop Management, V11, P153; [Anonymous], DUAL PURPOSE MILK BE; [Anonymous], [No title captured]; Bowman MS, 2012, LAND USE POLICY, V29, P558, DOI 10.1016/j.landusepol.2011.09.009; Cederberg C, 2011, ENVIRON SCI TECHNOL, V45, P1773, DOI 10.1021/es103240z; Centro Internacional de Agricultura Tropical (CIAT), 2014, LIVESTOCKPLUS FAST T; Chacón-León Mario, 2013, Agron. Mesoam, V24, P17; Chandramoni, 2000, ANIM FEED SCI TECH, V83, P287, DOI 10.1016/S0377-8401(99)00132-7; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chuncho G, 2010, THESIS; de Leis CM, 2015, INT J LIFE CYCLE ASS, V20, P46, DOI 10.1007/s11367-014-0813-3; Delgado C, 2001, OUTLOOK AGR, V30, P27, DOI 10.5367/000000001101293427; Douxchamps S, 2014, AGROECOL SUST FOOD, V38, P25, DOI 10.1080/21683565.2013.828667; Ecoinvent, 2010, EC 2 0 DAT; FAO (Food and Agriculture Organization), 2010, CLIM SMART AGR POL P; *FAOSTAT, 2006, STAT DAT; Ferreira CM, 2001, THESIS; Fisher MJ, 2007, TROP GRASSLANDS, V41, P65; FISHER MJ, 1994, NATURE, V371, P236, DOI 10.1038/371236a0; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Food and Agriculture Organization, 2009, STAT FOOD AGR LIV BA, DOI 10.1017/S2078633610001128; Food and Agriculture Organizations (FAO), 2013, CLIM SMART LIV CLIM; Forest Trends and Katoomba Group, 2008, PAYM EC SERV GETT ST; Franco L, 2006, MANEJO UTILIZACION F; GAMMA (Programa de Ganader A o a y manejo del medio ambiente), 2010, PROGR FOM PROD AGR S; Gerber P, 2010, GREENHOUSE GAS EMISS; Gerber P.J., 2013, TACKLING CLIMATE CHA, P139; Gerber P, 2011, LIVEST SCI, V139, P100, DOI 10.1016/j.livsci.2011.03.012; Guerra L, 2010, HOJA CALCULO GEI; Havlik P, 2013, AM J AGR ECON, V95, P442, DOI 10.1093/ajae/aas085; Henderson C, 2014, CARBON INSETTING COF; Herrero M, 2013, ANIMAL, V7, P3, DOI 10.1017/S1751731112001954; Herrero M, 2013, P NATL ACAD SCI USA, V110, P20888, DOI 10.1073/pnas.1308149110; Herrero M, 2009, CURR OPIN ENV SUST, V1, P111, DOI 10.1016/j.cosust.2009.10.003; Holdridge LR, 1987, ECOLOGIA BASADA ZONA; Holmann F, 1993, MILK BEEF PRODUCTION; Hristov AN, 2015, P NATL ACAD SCI USA, V112, P10663, DOI 10.1073/pnas.1504124112; Ibrahim M., 2007, Agroforesteria en las Americas, P27; Intergovernmental Panel on Climate Change (IPCC), 2006, GUID NAT GREEN HOUS, V11; Intergovernmental Panel on Climate Change (IPCC), 2006, GUID NAT GREEN HOUS, V10; Intergovernmental Panel on Climate Change (IPCC), 2006, GUID NAT GREEN HOUS, V4; IPCC, 2019, REF 2006 IPCC GUID N; ISO, 2006, 14044 ISO; Jank L, 2014, CROP PASTURE SCI, V65, P1132, DOI 10.1071/CP13319; Jarvis A., 2008, CGIAR CSI SRTM 90 M, DOI DOI 10.1111/ecog.00774; Malin D, 2013, DESIGNING TRIPLE WIN; McGroddy ME, 2015, BIOTROPICA, V47, P407, DOI 10.1111/btp.12225; Metz ORDB, 2007, CLIMATE CHANGE 2007; Moreta DE, 2014, TROP GRASSL-FORRAJES, V2, P88, DOI 10.17138/TGFT(2)88-91; Murgueitio E, 2011, TROPICAL GRASSLANDS, V1, P137; Nair PKR, 2010, ADV AGRON, V108, P237, DOI 10.1016/S0065-2113(10)08005-3; National Research Council (NRC), 1978, SUBC DAIR CATTL NUTR; Perez E, 2013, NICARAGUA DUAL PURPO; Peters M., 2013, TROP GRASSLANDS, V1, P137, DOI 10.17138/TGFT(1)156-167; Peters M., 2011, ESPECIES FORRAJERAS; Peters M, 2013, ECOEFFICIENCY VISION; Pierrehumbert RT, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/8/085002; Rao I, 2015, TROP GRASSL-FORRAJES, V3, P59, DOI 10.17138/TGFT(3)59-82; Rao I., 2015, INC WORKSH CIAT CAL; Rao I., 2014, RURAL21, V21, P12; Rivera J. E., 2014, LIVESTOCK RES RURAL, V26; Rufino MC, 2007, LIVEST SCI, V112, P273, DOI 10.1016/j.livsci.2007.09.011; Rugnitz M. T., 2009, GUIA DETERMINACION C; Ruviaro CF, 2015, J CLEAN PROD, V96, P435, DOI 10.1016/j.jclepro.2014.01.037; Schultze-Kraft R., 1997, GIESSENER BEITRAGE E, V24, P1; Silver WL, 2004, ECOL APPL, V14, P1115, DOI 10.1890/03-5123; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Steinfeld H, 2013, GREENHOUSE GAS EMISS; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Subbarao GV, 2007, PLANT SOIL, V294, P5, DOI 10.1007/s11104-006-9159-3; Subbarao GV, 2013, TROP GRASSL-FORRAJES, V1, P168, DOI 10.17138/TGFT(1)168-174; Szott L, SERIE TECNICA CATIE; Thomas RJ, 1993, PTECHNICAL PAPERS IN, VII, P277; Thornton PK, 2010, P NATL ACAD SCI USA, V107, P19667, DOI 10.1073/pnas.0912890107; Tobar D, 2012, GUIA METODOLOGIA MON; Tothill J., 1992, BOTANAL COMPREHENSIV; van Rikxoort H, 2014, AGRON SUSTAIN DEV, V34, P887, DOI 10.1007/s13593-014-0223-8; Wachendorf C, 2008, J PLANT NUTR SOIL SC, V171, P171, DOI 10.1002/jpln.200625217; Waghorn GC, 2004, NEW ZEAL VET J, V52, P320, DOI 10.1080/00480169.2004.36448; Weiler V, 2014, CURR OPIN ENV SUST, V8, P29, DOI 10.1016/j.cosust.2014.07.009; Wirsenius Stefan, 2003, Journal of Industrial Ecology, V7, P47, DOI 10.1162/108819803766729195; Woodward S. L., 2004, Proceedings of the New Zealand Society of Animal Production, V64, P160; Zanne A.E., 2009, DRYAD IDENTIFIER HTT, P235	83	21	21	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167949	10.1371/journal.pone.0167949	http://dx.doi.org/10.1371/journal.pone.0167949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030599	Green Submitted, Green Published, gold			2022-12-26	WOS:000391222000027
J	Tekleab, AM; Tadesse, BT; Giref, AZ; Shimelis, D; Gebre, M				Tekleab, Atnafu Mekonnen; Tadesse, Birkneh Tilahun; Giref, Ababi Zergaw; Shimelis, Damte; Gebre, Meseret			Anthropometric Improvement among HIV Infected Pre-School Children Following Initiation of First Line Anti-Retroviral Therapy: Implications for Follow Up	PLOS ONE			English	Article							NUTRITIONAL-STATUS; TREATMENT FAILURE; CD4 COUNT; MORTALITY; PREDICTORS; WEIGHT; IMPACT; UNDERNUTRITION; COTRIMOXAZOLE; MALNUTRITION	Background Antiretroviral therapy (ART) is a lifesaving intervention for HIV infected children. There is a scarcity of data on immunological recovery and its relation with growth indicators among HIV infected young children. The current study aims to assess the pattern of anthropometric Z-score improvement following initiation of first-line ART among under-five children and the relationship between anthropometric Z-score improvement and immunologic recovery. Methods We included under-five children who were on first-line ART at five major hospitals in Addis Ababa, Ethiopia. We measured anthropometry and collected clinical and laboratory data at follow up, and we retrieved clinical and anthropometric data at ART initiation from records. Z-scores for each of the anthropometric indices were calculated based on WHO growth standards using ENA for SMART 2011 software. Linear regression was used to assess the relationship between time on ART and anthropometric Z-score improvement; and the relationship between anthropometric Z-score improvement and immunologic recovery. Multiple linear regression was used to assess the independent predictors of anthropometric Z-score change. Results The median age of the participants was 4.1 (Interquartile range (IQR): 3.3 - 4.9) years. More than half (52.48%) were female. The median duration of follow up was 1.69 (IQR: 1.08 - 2.63) years. There was a significant improvement in all anthropometric indices at any follow up after initiation of first-line ART (underweight; 39.5% vs16.5%, stunting; 71.3% vs 62.9% and wasting; 16.3% vs 1.0%; p-value<0.0001). There was an inverse relationship between improvement in weight for age Z-score (WAZ) and duration of ART (R-2 = 0.04; F (1, 158); p = 0.013). Height for age Z-score (HAZ) both at the time of ART initiation and follow up has a positive linear relationship with CD4 percentage at follow up (Coef. = 1.92; R-2 = 0.05; p-value = 0.002). Duration on ART (Std. Err. = 0.206, t = -1.99, p-value = 0.049) and level of maternal education (Std. Err. = 0.290, t = 2.64, p-value = 0.009) were the only independent predictors of the change in WAZ and change in HAZ at any follow up visit respectively. Conclusion There was a significant improvement in all anthropometric indices at any follow-up after initiation of first-line ART among under-five children. HAZ was linearly related with immunologic recovery following ART initiation. The findings indicate that anthropometric indices	[Tekleab, Atnafu Mekonnen] St Pauls Hosp Millennium Med Coll, Addis Ababa, Ethiopia; [Tadesse, Birkneh Tilahun] Hawassa Univ, Dept Pediat, Hawassa, Ethiopia; [Giref, Ababi Zergaw; Shimelis, Damte] Univ Addis Ababa, Sch Med, Addis Ababa, Ethiopia; [Gebre, Meseret] ALERT Med Ctr, Addis Ababa, Ethiopia	Hawassa University; Addis Ababa University	Tadesse, BT (corresponding author), Hawassa Univ, Dept Pediat, Hawassa, Ethiopia.	birknehtilahun@gmail.com		Tadesse, Birkneh Tilahun/0000-0003-4005-8605; Tekleab, Atnafu/0000-0001-8263-6915				Agarwal D, 2008, INDIAN PEDIATR, V45, P140; Anyabolu HC, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.77.3746; Azzoni L, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-37; Bacha T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-197; Bunupuradah T, 2016, PEDIATR INFECT DIS J, V35, P201, DOI 10.1097/INF.0000000000000961; Castetbon K, 2001, AIDS, V15, P869, DOI 10.1097/00002030-200105040-00007; Chokephaibulkit K, 2014, PEDIATR INFECT DIS J, V33, P291, DOI 10.1097/INF.0b013e3182a18223; Fontana M, 1999, AM J CLIN NUTR, V69, P1282; Gibb DM, 2008, AIDS, V22, P97, DOI 10.1097/01.aids.0000302262.51286.a5; Grinspoon S, 2003, CLIN INFECT DIS, V36, pS69, DOI 10.1086/367561; Guillen S, 2007, PEDIATR INFECT DIS J, V26, P334, DOI 10.1097/01.inf.0000257427.19764.ff; Hughes SM, 2009, PEDIATRICS, V123, pE347, DOI 10.1542/peds.2008-1316; Kariminia A, 2014, JAIDS-J ACQ IMM DEF, V67, P71, DOI 10.1097/QAI.0000000000000227; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Koethe JR, 2010, AM J CLIN NUTR, V91, p1138S, DOI 10.3945/ajcn.2010.28608D; Kosmiski L, 2011, AM J CLIN NUTR, V94, p1677S, DOI 10.3945/ajcn.111.012625; Lewis J, 2012, J INFECT DIS, V205, P548, DOI 10.1093/infdis/jir787; Mukherjee A, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0701-2; Musoke PM, 2011, AM J CLIN NUTR, V94, p1716S, DOI 10.3945/ajcn.111.018374; Nerad J, 2003, CLIN INFECT DIS, V36, pS52, DOI 10.1086/367559; Nsanzimana S, 2015, LANCET HIV, V2, pE376, DOI 10.1016/S2352-3018(15)00112-5; Obimbo EM, 2004, PEDIATR INFECT DIS J, V23, P536, DOI 10.1097/01.inf.0000129692.42964.30; Padmapriyadarsini C, 2009, INT J PEDIAT, V2009, DOI 10.1155/2009/837627; Paton NI, 2006, HIV MED, V7, P323, DOI 10.1111/j.1468-1293.2006.00383.x; Rose AM, 2014, ARCH DIS CHILD, V99, P546, DOI 10.1136/archdischild-2012-303348; Saloojee H, 2007, SCAND J PUBLIC HEALT, V35, P96, DOI 10.1080/14034950701356435; Sharma TS, 2008, AM J CLIN NUTR, V88, P384, DOI 10.1093/ajcn/88.2.384; Sunguya BF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-869; Taye Bineyam, 2010, Ethiop Med J, V48, P1; Villamor E, 2005, INT J EPIDEMIOL, V34, P61, DOI 10.1093/ije/dyh378; Walker AS, 2007, CLIN INFECT DIS, V44, P1361, DOI 10.1086/515396; WHO, 2014, ANT THER HIV INF INF	32	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167565	10.1371/journal.pone.0167565	http://dx.doi.org/10.1371/journal.pone.0167565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030557	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000011
J	Ward, RE; Beauchamp, MK; Latham, NK; Leveille, SG; Percac-Lima, S; Kurlinski, L; Ni, PS; Goldstein, R; Jette, AM; Bean, JF				Ward, Rachel E.; Beauchamp, Marla K.; Latham, Nancy K.; Leveille, Suzanne G.; Percac-Lima, Sanja; Kurlinski, Laura; Ni, Pengsheng; Goldstein, Richard; Jette, Alan M.; Bean, Jonathan F.			A Novel Approach to Identifying Trajectories of Mobility Change in Older Adults	PLoS One			English	Article							LOWER-EXTREMITY FUNCTION; PHYSICAL PERFORMANCE BATTERY; CONFIDENCE ABC SCALE; MINI-MENTAL-STATE; SUBSEQUENT DISABILITY; LATE-LIFE; HEALTH; BALANCE; INDEPENDENCE; POPULATION	Objectives To validate trajectories of late-life mobility change using a novel approach designed to overcome the constraints of modest sample size and few follow-up time points. Methods Using clinical reasoning and distribution-based methodology, we identified trajectories of mobility change (Late Life Function and Disability Instrument) across 2 years in 391 participants age >= 65 years from a prospective cohort study designed to identify modifiable impairments predictive of mobility in late-life. We validated our approach using model fit indices and comparing baseline mobility-related factors between trajectories. Results Model fit indices confirmed that the optimal number of trajectories were between 4 and 6. Mobility-related factors varied across trajectories with the most unfavorable values in poor mobility trajectories and the most favorable in high mobility trajectories. These factors included leg strength, trunk extension endurance, knee flexion range of motion, limb velocity, physical performance measures, and the number and prevalence of medical conditions including osteoarthritis and back pain. Conclusions Our findings support the validity of this approach and may facilitate the investigation of a broader scope of research questions within aging populations of varied sizes and traits.	[Ward, Rachel E.; Bean, Jonathan F.] Boston VA Healthcare Syst, New England GRECC, Boston, MA 02130 USA; [Ward, Rachel E.; Leveille, Suzanne G.; Percac-Lima, Sanja; Kurlinski, Laura; Goldstein, Richard; Bean, Jonathan F.] Harvard Med Sch, Cambridge, MA USA; [Ward, Rachel E.; Kurlinski, Laura; Goldstein, Richard; Bean, Jonathan F.] Spaulding Rehabil Hosp, Cambridge, MA 02138 USA; [Beauchamp, Marla K.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Latham, Nancy K.; Ni, Pengsheng; Jette, Alan M.] Boston Univ, Sch Publ Hlth, Hlth & Disabil Res Inst, Boston, MA USA; [Leveille, Suzanne G.] Univ Massachusetts, Coll Nursing & Hlth Sci, Boston, MA 02125 USA; [Percac-Lima, Sanja] Massachusetts Gen Hosp, Boston, MA 02114 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Spaulding Rehabilitation Hospital; McMaster University; Boston University; University of Massachusetts System; University of Massachusetts Boston; Harvard University; Massachusetts General Hospital	Ward, RE (corresponding author), Boston VA Healthcare Syst, New England GRECC, Boston, MA 02130 USA.; Ward, RE (corresponding author), Harvard Med Sch, Cambridge, MA USA.; Ward, RE (corresponding author), Spaulding Rehabil Hosp, Cambridge, MA 02138 USA.	reward@partners.org	Bean, Jonathan F/F-5798-2017; Beauchamp, Marla/ABC-7901-2021; Leveille, Suzanne G/ACS-6588-2022	Bean, Jonathan F/0000-0001-8385-8210; Beauchamp, Marla/0000-0003-2843-388X; Leveille, Suzanne G/0000-0003-0427-1580	National Institute on Aging [R01 AG032052-03]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [1K24HD070966-01]; National Center for Research Resources [1 UL1 RR025758-01]; National Institute on Disability, Independent Living, and Rehabilitation Research [H133P120001]; Canadian Institutes of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD070966] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Disability, Independent Living, and Rehabilitation Research(United States Department of Health & Human Services); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institute on Aging (R01 AG032052-03, https://www.nia.nih.gov/); the Eunice Kennedy Shriver National Institute of Child Health and Human Development (1K24HD070966-01 to JFB, https://www.nichd.nih.gov/Pages/index.aspx); and the National Center for Research Resources in a grant to the Harvard Clinical and Translational Science Center (1 UL1 RR025758-01, http://sdminutes.cit.nih.gov/about/almanac/organization/NCRR.htm). REW is supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (H133P120001, http://www.acl.gov/programs/NIDILRR/). MKB is supported by a fellowship from the Canadian Institutes of Health Research (http://cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011; Bean JF, 2013, ARCH PHYS MED REHAB, V94, P2381, DOI 10.1016/j.apmr.2013.07.026; Bean JF, 2008, ARCH PHYS MED REHAB, V89, P2278, DOI 10.1016/j.apmr.2008.04.029; Beauchamp MK, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-12; Beauchamp MK, 2014, J GERONTOLOGY A; Callahan D, 2007, AGING CLIN EXP RES, V19, P194, DOI 10.1007/bf03324689; Carpenter JR, 2007, STAT METHODS MED RES, V16, P259, DOI 10.1177/0962280206075303; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; Dodge HH, 2006, J GERONTOL A-BIOL, V61, P1330, DOI 10.1093/gerona/61.12.1330; Eggleston EP, 2004, J QUANT CRIMINOL, V20, P1, DOI 10.1023/B:JOQC.0000016696.02763.ce; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 2000, J GERONTOL A-BIOL, V55, pM43; Gill TM, 2006, J AM GERIATR SOC, V54, P248, DOI 10.1111/j.1532-5415.2005.00586.x; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Haley SM, 2002, J GERONTOL A-BIOL, V57, pM217, DOI 10.1093/gerona/57.4.M217; Han L, 2013, ANN EPIDEMIOL, V23, P87, DOI 10.1016/j.annepidem.2012.11.010; Hardy SE, 2005, AM J EPIDEMIOL, V161, P575, DOI 10.1093/aje/kwi083; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; Holt NE, 2013, ARCH PHYS MED REHAB, V94, P347, DOI 10.1016/j.apmr.2012.08.217; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Lee LW, 2007, NEW FRONTIERS GERI S, P301; Liang J, 2010, J GERONTOL B-PSYCHOL, V65, P470, DOI [10.1093/geronb/gbq114, 10.1093/geronb/gbp114]; Liao YL, 2001, J AM GERIATR SOC, V49, P443, DOI 10.1046/j.1532-5415.2001.49089.x; Mavandadi S, 2007, J GERONTOL B-PSYCHOL, V62, pS361, DOI 10.1093/geronb/62.6.S361; Morley JE, 2003, J GERONTOL A-BIOL, V58, P712; Muthen BO, 1997, PSYCHOL METHODS, V2, P371, DOI 10.1037/1082-989X.2.4.371; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; Nagi SZ, 1991, DISABILITY AM NATL A, P309, DOI DOI 10.17226/1579; Olaleye D, 2001, DIABETES RES CLIN PR, V54, P115, DOI 10.1016/S0168-8227(01)00278-9; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Raghavendra P, 2007, AUGMENT ALTERN COMM, V23, P349, DOI 10.1080/07434610701650928; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Suri P, 2009, PM&R, V1, P916, DOI 10.1016/j.pmrj.2009.09.009; WATKINS MA, 1991, PHYS THER, V71, P90, DOI 10.1093/ptj/71.2.90; Weiss CO, 2007, ARCH PHYS MED REHAB, V88, P1217, DOI 10.1016/j.apmr.2007.07.007; WHO, 2001, WHO INT CLASS FUNCT; Wolf DA, 2015, J GERONTOL B-PSYCHOL, V70, P745, DOI 10.1093/geronb/gbu182	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0169003	10.1371/journal.pone.0169003	http://dx.doi.org/10.1371/journal.pone.0169003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28006024	gold, Green Published, Green Submitted			2022-12-26	WOS:000392843200121
J	Sugio, S; Nagasawa, M; Kojima, I; Ishizaki, Y; Shibasaki, K				Sugio, Shouta; Nagasawa, Masami; Kojima, Itaru; Ishizaki, Yasuki; Shibasaki, Koji			Transient receptor potential vanilloid 2 activation by focal mechanical stimulation requires interaction with the actin cytoskeleton and enhances growth cone motility	FASEB JOURNAL			English	Article						TRP channel; axonal outgrowth; neuron; development; TRPV2	TRPV2 CHANNEL; NERVE GROWTH; ION-CHANNEL; NEURONAL EXCITABILITY; NEURITE OUTGROWTH; CALCIUM; TRANSLOCATION; TEMPERATURE; DYNAMICS; PIEZO1	We have previously reported that transient receptor potential vanilloid 2 (TRPV2) can be activated by mechanical stimulation, which enhances axonal outgrowth in developing neurons; however, the molecular mechanisms that govern the contribution of TRPV2 activation to axonal outgrowth remain unclear. In the present study, we examined thismechanismby using PC12 cells as a neuronalmodel. Overexpression of TRPV2 enhanced axonal outgrowth in a mechanical stimulus-dependent manner. Accumulation of TRPV2 at the cell surface was 4-fold greater in the growth cone compared with the soma. In the growth cone, TRPV2 is not static, but dynamically accumulates (within similar to 100ms) to the site ofmechanical stimulation. The dynamic and acute clustering ofTRPV2 can enhance very weak mechanical stimuli via focal accumulation of TRPV2. Focal application of mechanical stimuli dramatically increasedgrowth conemotility andcausedactin reorganization via activationofTRPV2. Wealso found that TRPV2 physically interacts with actin and that changes in the actin cytoskeleton are required for its activation. Here, we demonstrated for the first time to our knowledge that TRPV2 clustering is induced by mechanical stimulation generated by axonal outgrowth and that TRPV2 activation is triggered by actin rearrangements that result frommechanical stimulation. Moreover, TRPV2activationenhances growthcone motility andactinaccumulationto promote axonal outgrowth. Sugio, S., Nagasawa, M., Kojima, I., Ishizaki, Y., Shibasaki, K. Transient receptor potential vanilloid 2 activation by focal mechanical stimulation requires interaction with the actin cytoskeleton and enhances growth cone motility.	[Sugio, Shouta; Ishizaki, Yasuki; Shibasaki, Koji] Gunma Univ, Dept Mol & Cellular Neurobiol, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Nagasawa, Masami; Kojima, Itaru] Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gunma, Japan	Gunma University; Gunma University	Shibasaki, K (corresponding author), Gunma Univ, Dept Mol & Cellular Neurobiol, Grad Sch Med, Maebashi, Gunma 3718511, Japan.	shibasaki@gunma-u.ac.jp	Shibasaki, Koji/U-8674-2018; Ishizaki, Yasuki/AAB-1209-2020	Shibasaki, Koji/0000-0003-2330-1749; 	Japanese Ministry of Education, Culture, Sports, Science, and Technology; a grant from Uehara Memorial Foundation [15H05934, 21200012, 20399554, 24111507+26111702, 26117502, 15H03000, 23650159]; Takeda Science Foundation (Tokyo, Japan); Sumitomo Foundation; Brain Science Foundation; Narishige Neuroscience Research Foundation; Salt Science Research Foundation; Ichiro Kanehara Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology; a grant from Uehara Memorial Foundation; Takeda Science Foundation (Tokyo, Japan)(Takeda Science Foundation (TSF)); Sumitomo Foundation; Brain Science Foundation; Narishige Neuroscience Research Foundation; Salt Science Research Foundation; Ichiro Kanehara Foundation	The authors thank Y. Kogure (Gunma University) for technical assistance, and our lab members for helpful discussions. This research was supported by Grants-in-Aid for Scientific Research [KAKENHI Project No. 15H05934 (Thermal Biology), 21200012, 20399554, 24111507+26111702 (Brain Environment), 26117502 ( Glial Assembly), 15H03000; to K. S. and 23650159 to Y. I.] from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; a grant from Uehara Memorial Foundation; a grant from Takeda Science Foundation (Tokyo, Japan); a grant from the Sumitomo Foundation; a grant from the Brain Science Foundation; a grant from Narishige Neuroscience Research Foundation; Grant 14C2 from Salt Science Research Foundation; and a grant from the Ichiro Kanehara Foundation (all to K.S.).	Adapala RK, 2013, J MOL CELL CARDIOL, V54, P45, DOI 10.1016/j.yjmcc.2012.10.016; Bagriantsev SN, 2014, J BIOL CHEM, V289, P31673, DOI 10.1074/jbc.R114.612697; Bang SS, 2007, NEUROSCI LETT, V425, P120, DOI 10.1016/j.neulet.2007.08.035; Bender FLP, 2005, CELL PHYSIOL BIOCHEM, V15, P183, DOI 10.1159/000083651; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Cohen MR, 2015, MOL CELL BIOL, V35, P4238, DOI 10.1128/MCB.00549-15; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Ghosh D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07111; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; Gottlieb PA, 2010, NEUROSCI LETT, V481, P115, DOI 10.1016/j.neulet.2010.06.066; GOTTMANN K, 1995, PERSPECT DEV NEUROBI, V2, P371; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huynh KW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11130; Inada H, 2006, BIOCHEM BIOPH RES CO, V350, P762, DOI 10.1016/j.bbrc.2006.09.111; Kalil K, 2014, NAT REV NEUROSCI, V15, P7, DOI 10.1038/nrn3650; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Katanosaka Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4932; Kawashima Y, 2015, PFLUG ARCH EUR J PHY, V467, P85, DOI 10.1007/s00424-014-1582-3; Kerstein PC, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00244; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kuipers AJ, 2012, EUR J CELL BIOL, V91, P834, DOI 10.1016/j.ejcb.2012.05.006; Lu DC, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00025; Mihara H, 2010, J NEUROSCI, V30, P16536, DOI 10.1523/JNEUROSCI.4426-10.2010; Miyamoto T, 2014, J BIOL CHEM, V289, P16565, DOI 10.1074/jbc.M113.528638; Nagasawa M, 2007, J CELL PHYSIOL, V210, P692, DOI 10.1002/jcp.20883; Nagasawa M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12296; Nagasawa M, 2012, CELL CALCIUM, V51, P186, DOI 10.1016/j.ceca.2011.12.012; Peralvarez-Marin A, 2013, FEBS J, V280, P5471, DOI 10.1111/febs.12302; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Raper J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001933; Shibasaki K, 2016, J ANESTH, V30, P1014, DOI 10.1007/s00540-016-2225-y; Shibasaki K, 2016, J PHYSIOL SCI, V66, P359, DOI 10.1007/s12576-016-0434-7; Shibasaki K, 2015, PFLUG ARCH EUR J PHY, V467, P2495, DOI 10.1007/s00424-015-1726-0; Shibasaki K, 2015, BIOCHEM BIOPH RES CO, V458, P168, DOI 10.1016/j.bbrc.2015.01.087; Shibasaki K, 2014, J BIOL CHEM, V289, P14470, DOI 10.1074/jbc.M114.557132; Shibasaki K, 2013, BIOCHEM BIOPH RES CO, V441, P327, DOI 10.1016/j.bbrc.2013.10.046; Shibasaki K, 2010, J NEUROSCI, V30, P4601, DOI 10.1523/JNEUROSCI.5830-09.2010; Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002; Takahashi M, 2002, ATHEROSCLEROSIS, V161, P387, DOI 10.1016/S0021-9150(01)00674-8; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tojima T, 2011, NAT REV NEUROSCI, V12, P191, DOI 10.1038/nrn2996; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vitriol EA, 2012, NEURON, V73, P1068, DOI 10.1016/j.neuron.2012.03.005; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wittmann T, 2001, J CELL SCI, V114, P3795; Yin J, 2010, CELL BIOCHEM BIOPHYS, V56, P1, DOI 10.1007/s12013-009-9067-2; Zhang JY, 2015, ONCOTARGETS THER, V8, P3123, DOI 10.2147/OTT.S92005; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	54	30	31	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1368	1381		10.1096/fj.201600686RR	http://dx.doi.org/10.1096/fj.201600686RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28007781				2022-12-26	WOS:000398504300010
J	Lentucci, C; Belkina, AC; Cederquist, CT; Chan, M; Johnson, HE; Prasad, S; Lopacinski, A; Nikolajczyk, BS; Monti, S; Snyder-Cappione, J; Tanasa, B; Cardamone, MD; Perissi, V				Lentucci, Claudia; Belkina, Anna C.; Cederquist, Carly T.; Chan, Michelle; Johnson, Holly E.; Prasad, Sherry; Lopacinski, Amanda; Nikolajczyk, Barbara S.; Monti, Stefano; Snyder-Cappione, Jennifer; Tanasa, Bogdan; Cardamone, M. Dafne; Perissi, Valentina			Inhibition of Ubc13-mediated Ubiquitination by GPS2 Regulates Multiple Stages of B Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CONJUGATING ENZYME; G-PROTEIN; T-CELL; TRANSCRIPTION FACTOR; STRUCTURAL BASIS; MOLECULAR-BASIS; C-JUN; ACTIVATION; PATHWAY	Non-proteolytic ubiquitin signaling mediated by Lys(63) ubiquitin chains plays a critical role in multiple pathways that are key to the development and activation of immune cells. Our previous work indicates that GPS2 (G-protein Pathway Suppressor 2) is a multifunctional protein regulating TNF alpha signaling and lipid metabolism in the adipose tissue through modulation of Lys63 ubiquitination events. However, the full extent of GPS2-mediated regulation of ubiquitination and the underlying molecular mechanisms are unknown. Here, we report that GPS2 is required for restricting the activation of TLR and BCR signaling pathways and the AKT/FOXO1 pathway in immune cells based on direct inhibition of Ubc13 enzymatic activity. Relevance of this regulatory strategy is confirmed in vivo by B cell-targeted deletion of GPS2, resulting in developmental defects at multiple stages of B cell differentiation. Together, these findings reveal that GPS2 genomic and non-genomic functions are critical for the development and cellular homeostasis of B cells.	[Lentucci, Claudia; Cederquist, Carly T.; Chan, Michelle; Johnson, Holly E.; Prasad, Sherry; Lopacinski, Amanda; Cardamone, M. Dafne; Perissi, Valentina] Boston Univ, Sch Med, Dept Biochem, Silvio Conte Bldg, Boston, MA 02118 USA; [Belkina, Anna C.; Nikolajczyk, Barbara S.; Snyder-Cappione, Jennifer] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Monti, Stefano] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Belkina, Anna C.; Snyder-Cappione, Jennifer] Boston Univ, Sch Med, Flow Cytometry Core Facil, Boston, MA 02118 USA; [Tanasa, Bogdan] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	Boston University; Boston University; Boston University; Boston University; Stanford University	Perissi, V (corresponding author), Boston Univ, Sch Med, Dept Biochem, Silvio Conte Bldg, Boston, MA 02118 USA.	vperissi@bu.edu	Belkina, Anna C/F-4816-2014	Belkina, Anna C/0000-0001-7967-6254; Nikolajczyk, Barbara/0000-0001-5647-5740; Monti, Stefano/0000-0002-9376-0660; Cardamone, Maria/0000-0003-4591-3447; Perissi, Valentina/0000-0002-3716-0003	Grunebaum Cancer Foundation; National Institutes of Health Grant [R01DK100422]; Medicine Department at Boston University School of Medicine; National Research Service Award (NRSA) Individual Predoctoral Fellowship from the National Institutes of Health [F31DK108571]; Genomic Science Institute at Boston University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK108571, R01DK100422] Funding Source: NIH RePORTER	Grunebaum Cancer Foundation; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medicine Department at Boston University School of Medicine; National Research Service Award (NRSA) Individual Predoctoral Fellowship from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genomic Science Institute at Boston University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by awards from the Grunebaum Cancer Foundation and the Genomic Science Institute at Boston University and National Institutes of Health Grant R01DK100422 (to V. P.) and by a seed grant from the Medicine Department at Boston University School of Medicine (to V. P. and S. M.). This work was also supported by a National Research Service Award (NRSA) Individual Predoctoral Fellowship from the National Institutes of Health (F31DK108571) (to C. T. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bianchi K, 2009, MOL CELL, V36, P736, DOI 10.1016/j.molcel.2009.11.029; Branigan E, 2015, NAT STRUCT MOL BIOL, V22, P597, DOI 10.1038/nsmb.3052; Cardamone MD, 2014, CELL REP, V8, P163, DOI 10.1016/j.celrep.2014.05.041; Cardamone MD, 2012, MOL CELL, V46, P91, DOI 10.1016/j.molcel.2012.01.025; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Cederquist CT, 2017, MOL METAB, V6, P125, DOI 10.1016/j.molmet.2016.10.007; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Cheng XW, 2009, J BIOL CHEM, V284, P36395, DOI 10.1074/jbc.M109.062109; Chow KT, 2013, J EXP MED, V210, P1621, DOI 10.1084/jem.20130498; Chu YY, 2011, BLOOD, V117, P2227, DOI 10.1182/blood-2010-09-306019; Chun ACS, 2000, AIDS RES HUM RETROV, V16, P1689, DOI 10.1089/08892220050193155; Cilloni D, 2007, HAEMATOLOGICA, V92, P1224, DOI 10.3324/haematol.11199; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Davis ME, 2015, VIROLOGY, V479, P52, DOI 10.1016/j.virol.2015.02.033; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Diederichs S, 2004, J BIOL CHEM, V279, P33727, DOI 10.1074/jbc.M401708200; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Fabris S, 2008, GENE CHROMOSOME CANC, V47, P781, DOI 10.1002/gcc.20579; Fan RR, 2016, NAT MED, V22, P780, DOI 10.1038/nm.4114; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Giltiay NV, 2013, J EXP MED, V210, P2773, DOI 10.1084/jem.20122798; Guo C, 2015, J BIOL CHEM, V290, P3666, DOI 10.1074/jbc.M114.598797; Habelhah Hasem, 2010, Genes Cancer, V1, P735; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ho YK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005102; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Horikawa M, 2011, J CLIN INVEST, V121, P4268, DOI 10.1172/JCI59266; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Jiang XX, 2015, SCI REP-UK, V5, DOI 10.1038/srep13755; Jiang XX, 2011, IMMUNITY, V35, P883, DOI 10.1016/j.immuni.2011.11.010; Jin DY, 1997, J BIOL CHEM, V272, P25816, DOI 10.1074/jbc.272.41.25816; Jin W, 2007, J BIOL CHEM, V282, P15884, DOI 10.1074/jbc.M609952200; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Katz EJ, 2010, BIOCHEM SOC T, V38, P21, DOI 10.1042/BST0380021; Kobayashi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004736; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Landmann R, 1996, INFECT IMMUN, V64, P1762, DOI 10.1128/IAI.64.5.1762-1769.1996; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee TH, 2006, DNA REPAIR, V5, P32, DOI 10.1016/j.dnarep.2005.07.004; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lino AC, 2013, BLOOD, V122, P209, DOI 10.1182/blood-2012-08-447136; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Malynn BA, 2010, IMMUNITY, V33, P843, DOI 10.1016/j.immuni.2010.12.007; MARCHANT A, 1992, EUR J IMMUNOL, V22, P1663, DOI 10.1002/eji.1830220650; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Moran ST, 2007, J IMMUNOL, V179, P195, DOI 10.4049/jimmunol.179.1.195; Nagy V, 2010, BIOL CHEM, V391, P163, DOI 10.1515/bc.2010.021; Notley CA, 2010, J IMMUNOL, V184, P3386, DOI 10.4049/jimmunol.0902640; Ochiai K, 2012, NAT IMMUNOL, V13, P300, DOI 10.1038/ni.2210; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ori D, 2013, J IMMUNOL, V190, P4037, DOI 10.4049/jimmunol.1300173; Panda S, 2015, IMMUNITY, V43, P647, DOI 10.1016/j.immuni.2015.09.010; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Peng YC, 2000, J VIROL, V74, P5872, DOI 10.1128/JVI.74.13.5872-5879.2000; Peng YC, 2001, MOL CELL BIOL, V21, P5913, DOI 10.1128/MCB.21.17.5913-5924.2001; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Piper RC, 2011, CELL CYCLE, V10, P3067, DOI 10.4161/cc.10.18.17191; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Pulvino M, 2012, BLOOD, V120, P1668, DOI 10.1182/blood-2012-02-406074; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sanyal S, 2007, P NATL ACAD SCI USA, V104, P15665, DOI 10.1073/pnas.0706736104; Sato Y, 2012, J BIOL CHEM, V287, P25860, DOI 10.1074/jbc.M112.364752; Schmidt-Supprian M, 2007, TRANSGENIC RES, V16, P657, DOI 10.1007/s11248-007-9100-4; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Spain BH, 1996, MOL CELL BIOL, V16, P6698; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Sun SC, 1999, ONCOGENE, V18, P6948, DOI 10.1038/sj.onc.1203220; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Szydlowski M, 2014, INT REV IMMUNOL, V33, P146, DOI 10.3109/08830185.2014.885022; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Toubal A, 2013, J CLIN INVEST, V123, P362, DOI 10.1172/JCI64052; Touma M, 2011, J IMMUNOL, V187, P3942, DOI 10.4049/jimmunol.1002109; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; WASSERMAN R, 1995, J IMMUNOL, V155, P644; Weigert O, 2012, BLOOD, V120, P2553, DOI 10.1182/blood-2012-05-414995; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Witt CM, 2003, J IMMUNOL, V171, P2783, DOI 10.4049/jimmunol.171.6.2783; Wu XF, 2015, IMMUNOL REV, V266, P161, DOI 10.1111/imr.12310; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yang YB, 2015, IMMUNOL REV, V263, P240, DOI 10.1111/imr.12247; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Zhang DH, 2008, J BIOL CHEM, V283, P8580, DOI 10.1074/jbc.M708209200; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang XM, 2013, CELL MOL IMMUNOL, V10, P113, DOI 10.1038/cmi.2012.63	111	13	15	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2754	2772		10.1074/jbc.M116.755132	http://dx.doi.org/10.1074/jbc.M116.755132			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28039360	hybrid, Green Published			2022-12-26	WOS:000395535100017
J	Carissimo, G; van den Beek, M; Vernick, KD; Antoniewski, C				Carissimo, Guillaume; van den Beek, Marius; Vernick, Kenneth D.; Antoniewski, Christophe			Metavisitor, a Suite of Galaxy Tools for Simple and Rapid Detection and Discovery of Viruses in Deep Sequence Data	PLOS ONE			English	Article							SHORT DNA-SEQUENCES; VIRAL GENOMES; SMALL RNAS; ALIGNMENT	Metavisitor is a software package that allows biologists and clinicians without specialized bioinformatics expertise to detect and assemble viral genomes from deep sequence datasets. The package is composed of a set of modular bioinformatic tools and workflows that are implemented in the Galaxy framework. Using the graphical Galaxy workflow editor, users with minimal computational skills can use existing Metavisitor workflows or adapt them to suit specific needs by adding or modifying analysis modules. Metavisitor works with DNA, RNA or small RNA sequencing data over a range of read lengths and can use a combination of de novo and guided approaches to assemble genomes from sequencing reads. We show that the software has the potential for quick diagnosis as well as discovery of viruses from a vast array of organisms. Importantly, we provide here executable Metavisitor use cases, which increase the accessibility and transparency of the software, ultimately enabling biologists or clinicians to focus on biological or medical questions.	[Carissimo, Guillaume; Vernick, Kenneth D.] Inst Pasteur, Dept Parasites & Insect Vectors, Unit Insect Vector Genet & Genom, Paris, France; [Carissimo, Guillaume; Vernick, Kenneth D.] CNRS, Unit Hosts Vectors & Pathogens URA3012, Paris, France; [Carissimo, Guillaume] ASTAR, Lab Microbial Immun, Singapore Immunol Network, Biopolis, 8A Biomed Grove, Singapore, Singapore; [van den Beek, Marius; Antoniewski, Christophe] Univ Paris 06, Sorbonne Univ, CNRS, IBPS,Dev Biol Dept, Paris, France; [van den Beek, Marius; Antoniewski, Christophe] Univ Paris 06, Sorbonne Univ, CNRS, IBPS,ARTbio Bioinformat Anal Facil, Paris, France; [Vernick, Kenneth D.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Minnesota System; University of Minnesota Twin Cities	Antoniewski, C (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS, IBPS,Dev Biol Dept, Paris, France.; Antoniewski, C (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS, IBPS,ARTbio Bioinformat Anal Facil, Paris, France.	christophe.antoniewski@upmc.fr	Antoniewski, Christophe/G-4519-2011	Antoniewski, Christophe/0000-0001-7709-2116; Carissimo, Guillaume/0000-0002-9703-9096	Agence Nationale de la Recherche [ANR-13-BSV2-0007]; Universitaire d'Ingenierie en Sante IUIS grant "ARTiMED"; European Research Council; European Commission [228421]; French Laboratoire d'Excellence [ANR-10-LABX-62-IBEID]; Galaxy community;  [323173]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Universitaire d'Ingenierie en Sante IUIS grant "ARTiMED"; European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); French Laboratoire d'Excellence; Galaxy community; 	This work received financial support to CA from the Agence Nationale de la Recherche grant ANR-13-BSV2-0007 "Plastisipi" and from the Institut Universitaire dIngenierie en Sante IUIS grant ARTiMED and to KDV from the European Research Council (http://erc.europa.eu/funding-and-grants). Support for frontier research, Advanced Grant #323173 AnoPath; European Commission (http://ec.europa.eu/research/fp7), FP7 Infrastructures #228421 Infravec; and French Laboratoire d'Excellence (http://www.enseignementsup-recherche.gouv.fr/cid55551/investissements-d-avenir-projets-laboratoires-d-excellence-par-region-et-domaine.html), "Integrative Biology of Emerging Infectious Diseases" #ANR-10-LABX-62-IBEID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Galaxy community for their support, Juliana Pegoraro, Eugeni Belda and Emmanuel Bischoff for helpful discussions and Julie Reveillaud for critical reading of the manuscript. GC, MvdB and CA conceived the project. CA and MvdB developed and implemented tools in the Galaxy framework. GC, MvdB and CA performed bioinformatics analysis. GC, MvdB, KV and CA wrote the manuscript. CA and KV provided funding. All authors read and approved the final manuscript.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carissimo G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153881; Cock PJA, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0080-7; de Andrade RRS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-45; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Aguiar ERGR, 2015, NUCLEIC ACIDS RES, V43, P6191, DOI 10.1093/nar/gkv587; Ho T, 2014, VIROLOGY, V471, P54, DOI 10.1016/j.virol.2014.09.019; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Kim Mincheol, 2013, Genomics & Informatics, V11, P102, DOI 10.5808/GI.2013.11.3.102; Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006; Kloverpris HN, 2016, IMMUNITY, V44, P391, DOI 10.1016/j.immuni.2016.01.006; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Matranga CB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0519-7; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Schwarz E. M., 2013, REFERENCE FREE ALGOR; Seguin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088513; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; van Mierlo JT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002872; Vodovar N, 2011, J VIROL, V85, P11016, DOI 10.1128/JVI.05647-11; Wang Zichen, 2016, F1000Res, V5, P1574, DOI 10.12688/f1000research.9110.1; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Webster CL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002210; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Yozwiak NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001485; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	36	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168397	10.1371/journal.pone.0168397	http://dx.doi.org/10.1371/journal.pone.0168397			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045932	gold, Green Submitted, Green Published			2022-12-26	WOS:000391612300023
J	Perez, C; Ziburkus, J; Ullah, G				Perez, Carlos; Ziburkus, Jokubas; Ullah, Ghanim			Analyzing and Modeling the Dysfunction of Inhibitory Neurons in Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; LONG-TERM POTENTIATION; A-BETA; COGNITIVE IMPAIRMENTS; SECRETED OLIGOMERS; BILAYER-MEMBRANES; CORTICAL-NEURONS; MOUSE MODEL; CHANNELS; EXCITABILITY	Alzheimer's disease (AD) is characterized by the abnormal proteolytic processing of amyloid precursor protein, resulting in increased production of a self-aggregating form of beta amyloid (A beta). Several lines of work on AD patients and transgenic mice with high A beta levels exhibit altered rhythmicity, aberrant neuronal network activity and hyperexcitability reflected in clusters of hyperactive neurons, and spontaneous epileptic activity. Recent studies highlight that abnormal accumulation of A beta changes intrinsic properties of inhibitory neurons, which is one of the main reasons underlying the impaired network activity. However, specific cellular mechanisms leading to interneuronal dysfunction are not completely understood. Using extended Hodgkin-Huxley (HH) formalism in conjunction with patch-clamp experiments, we investigate the mechanisms leading to the impaired activity of interneurons. Our detailed analysis indicates that increased Na+ leak explains several observations in inhibitory neurons, including their failure to reliably produce action potentials, smaller action potential amplitude, increased resting membrane potential, and higher membrane depolarization in response to a range of stimuli in a model of APP(SWE)/PSEN1DeltaE9 (APdE9) AD mice as compared to age-matched control mice. While increasing the conductance of hyperpolarization activated cyclic nucleotide-gated (HCN) ion channel could account for most of the observations, the extent of increase required to reproduce these observations render such changes unrealistic. Furthermore, increasing the conductance of HCN does not account for the observed changes in depolarizability of interneurons from APdE9 mice as compared to those from NTG mice. None of the other pathways tested could lead to all observations about interneuronal dysfunction. Thus we conclude that upregulated sodium leak is the most likely source of impaired interneuronal function.	[Perez, Carlos; Ullah, Ghanim] Univ S Florida, Dept Phys, Tampa, FL 33620 USA; [Ziburkus, Jokubas] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	State University System of Florida; University of South Florida; University of Houston System; University of Houston	Ullah, G (corresponding author), Univ S Florida, Dept Phys, Tampa, FL 33620 USA.	gullah@usf.edu			National Institute of Health on Aging [1R01AG053988]; College of Arts and Sciences at University of Florida; NATIONAL INSTITUTE ON AGING [R01AG053988] Funding Source: NIH RePORTER	National Institute of Health on Aging; College of Arts and Sciences at University of Florida; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Health on Aging, grant number 1R01AG053988 and by a startup grant from College of Arts and Sciences at University of Florida awarded to GU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; Berridge MJ, 2014, J PHYSIOL-LONDON, V592, P281, DOI 10.1113/jphysiol.2013.257527; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Casley CS, 2009, BRAIN RES, V1260, P65, DOI 10.1016/j.brainres.2008.12.082; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P232, DOI 10.1113/jphysiol.1957.sp005888; Corbett BF, 2013, J NEUROSCI, V33, P7020, DOI 10.1523/JNEUROSCI.2325-12.2013; Cressman JR, 2009, J COMPUT NEUROSCI, V26, P159, DOI 10.1007/s10827-008-0132-4; Demuro A, 2011, J CELL BIOL, V195, P515, DOI 10.1083/jcb.201104133; Dougherty JJ, 2003, J NEUROSCI, V23, P6740; Eslamizade MJ, 2015, NEUROSCIENCE, V305, P279, DOI 10.1016/j.neuroscience.2015.07.087; FURUKAWA K, 1994, NEUROREPORT, V5, P2016, DOI 10.1097/00001756-199410270-00006; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hazra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064318; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037629; Hubel N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147060; Hubel N, 2016, J COMPUT NEUROSCI, V40, P177, DOI 10.1007/s10827-016-0591-y; Inoue S, 2008, AMYLOID, V15, P223, DOI 10.1080/13506120802524858; Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kopell N, 2010, SPR SER COMPUT NEURO, V5, P423, DOI 10.1007/978-1-4419-0996-1_15; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Lopez JR, 2008, J NEUROCHEM, V105, P262, DOI 10.1111/j.1471-4159.2007.05135.x; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Owen SF, 2013, NATURE, V500, P458, DOI 10.1038/nature12330; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Pena F, 2010, HIPPOCAMPUS, V20, P78, DOI 10.1002/hipo.20592; POLLARD HB, 1993, ANN NY ACAD SCI, V695, P165, DOI 10.1111/j.1749-6632.1993.tb23046.x; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Roh JH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004291; Saito Y, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-50; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shirwany Najeeb A, 2007, Neuropsychiatr Dis Treat, V3, P597; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Ullah G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137357; Ullah G, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004414; Ullah G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000776; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wei YN, 2014, J NEUROSCI, V34, P11733, DOI 10.1523/JNEUROSCI.0516-14.2014; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008; Ziyatdinova S, 2011, EPILEPSY RES, V94, P75, DOI 10.1016/j.eplepsyres.2011.01.003	52	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168800	10.1371/journal.pone.0168800	http://dx.doi.org/10.1371/journal.pone.0168800			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036398	Green Published, gold, Green Submitted			2022-12-26	WOS:000391229300030
J	Tajeri, S; Razmi, G; Haghparast, A				Tajeri, Shahin; Razmi, Gholamreza; Haghparast, Alireza			Establishment of an Artificial Tick Feeding System to Study Theileria lestoquardi Infection	PLOS ONE			English	Article							HYALOMMA-ANATOLICUM-ANATOLICUM; IN-VITRO; RHIPICEPHALUS-APPENDICULATUS; IXODID TICKS; HARD TICKS; PARVA; TRANSMISSION; BLOOD; SHEEP; DIVERSITY	The establishment of good experimental models for Theileria sp. infection is important for theileriosis research. Routinely, infection of ticks is accomplished by feeding on parasite-infected animals (sheep, cows and horses), which raises practical and ethical problems, driving the search for alternative methods of tick infection. Artificial tick feeding systems are based mainly on rearing ticks on host-derived or hand-made artificial membranes. We developed a modified feeding assay for infecting nymphal stages of Hyalomma anatolicum ticks with Theileria lestoquardi, a highly pathogenic parasite of sheep. We compared two different membranes: an artificial silicone membrane and a natural alternative using mouse skin. We observed high attachment rates with mouse skin, whereas in vitro feeding of H. anatolicum nymphs on silicone membranes was unsuccessful. We could infect H. anatolicum nymphs with T. lestoquardi and the emerging adult ticks transmitted infective parasites to sheep. In contrast, similar infections with Rhipicephalus bursa, a representative tick with short mouth-parts that was proposed as a vector for T. lestoquardi, appeared not to be a competent vector tick species. This is the first report of an experimentally controlled infection of H. anatolicum with T. lestoquardi and opens avenues to explore tick-parasite dynamics in detail.	[Tajeri, Shahin; Razmi, Gholamreza; Haghparast, Alireza] Ferdowsi Univ Mashhad, Dept Pathobiol, Fac Vet Med, Mashhad, Iran; [Haghparast, Alireza] Ferdowsi Univ Mashhad, Inst Biotechnol, Vet Biotechnol Res Grp, Mashhad, Iran	Ferdowsi University Mashhad; Ferdowsi University Mashhad	Razmi, G (corresponding author), Ferdowsi Univ Mashhad, Dept Pathobiol, Fac Vet Med, Mashhad, Iran.	razmi@um.ac.ir	Haghparast, Alireza/F-4972-2018; Razmi, Gholamreza/M-6553-2016	Razmi, Gholamreza/0000-0002-0754-1278; Haghparast, Alireza/0000-0002-1905-6157; Tajeri, Shahin/0000-0002-0482-1194	Vice President of Research and Technology of Ferdowsi University of Mashhad, Iran [29500.3]	Vice President of Research and Technology of Ferdowsi University of Mashhad, Iran	The project was supported by grant number 29500.3 from the Vice President of Research and Technology of Ferdowsi University of Mashhad, Iran, as partial financial support of the Ph.D. dissertation of Shahin Tajeri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi V, 2014, TICKS TICK-BORNE DIS, V5, P239, DOI 10.1016/j.ttbdis.2013.11.008; Aktas M, 2006, VET PARASITOL, V140, P259, DOI 10.1016/j.vetpar.2006.04.005; Andrade JJ, 2014, J MED ENTOMOL, V51, P878, DOI 10.1603/ME13180; Antunes S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-42; Bell-Sakyi L, 2004, VET PARASITOL, V124, P25, DOI 10.1016/j.vetpar.2004.05.027; Bonnet S, 2007, PARASITOLOGY, V134, P197, DOI 10.1017/S0031182006001545; Bonnet S, 2012, ACAROLOGIA, V52, P453, DOI 10.1051/acarologia/20122068; BROWN CGD, 1973, NATURE, V245, P101, DOI 10.1038/245101a0; Dschunkovsky E., 1924, Parasitology Cambridge, V16, P107, DOI 10.1017/S0031182000019922; Duh D, 2008, VET PARASITOL, V151, P327, DOI 10.1016/j.vetpar.2007.11.004; FISCHL R A, 1962, Plast Reconstr Surg Transplant Bull, V30, P607, DOI 10.1097/00006534-196211000-00009; Fourie JJ, 2013, VET PARASITOL, V197, P595, DOI 10.1016/j.vetpar.2013.07.026; Friedhoff K. T., 1997, Parassitologia (Rome), V39, P99; HELLERHAUPT A, 1981, T ROY SOC TROP MED H, V75, P147, DOI 10.1016/0035-9203(81)90048-1; JONGEJAN F, 1980, RES VET SCI, V29, P320, DOI 10.1016/S0034-5288(18)32635-3; Katzer F, 2006, INFECT IMMUN, V74, P5456, DOI 10.1128/IAI.00472-06; Kirvar E, 1998, ANN NY ACAD SCI, V849, P52, DOI 10.1111/j.1749-6632.1998.tb11033.x; Kirvar E, 1998, PARASITOLOGY, V117, P255, DOI 10.1017/S0031182098002960; Krober T, 2007, TRENDS PARASITOL, V23, P445, DOI 10.1016/j.pt.2007.07.010; Krober T, 2007, PEST MANAG SCI, V63, P17, DOI 10.1002/ps.1293; Lew-Tabor AE, 2014, TICKS TICK-BORNE DIS, V5, P500, DOI 10.1016/j.ttbdis.2014.03.005; McKeever DJ, 2009, TRENDS PARASITOL, V25, P269, DOI 10.1016/j.pt.2009.03.005; Musyoki JM, 2004, EXP APPL ACAROL, V32, P51, DOI 10.1023/B:APPA.0000018159.47700.e4; Olds C, 2013, THESIS; PURNELL R E, 1974, Tropical Animal Health and Production, V6, P145, DOI 10.1007/BF02380709; PURNELL RE, 1970, RES VET SCI, V11, P403; Razmi G, 2013, ONDERSTEPOORT J VET, V80, DOI 10.4102/ojvr.v80i1.635; Razmi GR, 2003, VET PARASITOL, V116, P1, DOI 10.1016/S0304-4017(03)00254-1; Salih DA, 2003, VET PARASITOL, V111, P361, DOI 10.1016/S0304-4017(02)00389-8; SCHREUDER BEC, 1976, TROPENMED PARASITOL, V27, P422; Shaw MK, 1994, ADV DIS VECTOR RES, P23; Shayan P, 2005, PARASITOL RES, V97, P281, DOI 10.1007/s00436-005-1434-3; Sinden RE, 2001, TRENDS PARASITOL, V17, P209, DOI 10.1016/S1471-4922(01)01928-6; SINGH DK, 1979, TROP ANIM HEALTH PRO, V11, P87, DOI 10.1007/BF02237776; SISODIA RS, 1983, INDIAN J ANIM SCI, V53, P162; Tajeri S, 2011, VET PARASITOL, V180, P332, DOI 10.1016/j.vetpar.2011.03.014; Violaine C, 2008, EMERG INFECT DIS, V14, P1074, DOI [10.3201/eid1407.071110, DOI 10.3201/EID1407.071110]; VOIGT WP, 1995, PARASITOL RES, V81, P74, DOI 10.1007/BF00932420; VOIGT WP, 1993, PARASITOLOGY, V107, P257, DOI 10.1017/S0031182000079233; WALADDE SM, 1995, PARASITOLOGY, V111, P463, DOI 10.1017/S0031182000065963; Waladde SM, 1996, PARASITOL TODAY, V12, P272, DOI 10.1016/0169-4758(96)10027-2; WALADDE SM, 1993, PARASITOLOGY, V107, P249, DOI 10.1017/S0031182000079221; WALKER AR, 1979, RES VET SCI, V26, P264, DOI 10.1016/S0034-5288(18)32935-7; Woods K, 2013, HIJACKING HOST CELL, P179	44	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							0169053	10.1371/journal.pone.0169053	http://dx.doi.org/10.1371/journal.pone.0169053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036364	gold, Green Submitted, Green Published			2022-12-26	WOS:000391229300050
J	Yang, WM; Min, KH; Lee, W				Yang, Won-Mo; Min, Kyung-Ho; Lee, Wan			Induction of miR-96 by Dietary Saturated Fatty Acids Exacerbates Hepatic Insulin Resistance through the Suppression of INSR and IRS-1	PLOS ONE			English	Article							EXPRESSION PROFILES; LIPID-METABOLISM; OVER-EXPRESSION; GENE-EXPRESSION; PPAR-GAMMA; OBESITY; MICRORNAS; CANCER; LIVER; MECHANISMS	Obesity is defined as the excessive accumulation of body fat that ultimately leads to chronic metabolic diseases. Diets rich in saturated fatty acids (SFA) exacerbate obesity and hepatic steatosis, which increase the risk of hepatic insulin resistance and type 2 diabetes (T2DM). Although microRNAs (miRNAs) play an important role in a range of biological processes, the implications of SFA-induced miRNAs in metabolic dysregulation, particularly in the pathogenesis of hepatic insulin resistance, are not well understood. This study investigated the implications of miR-96, which is induced strongly by SFA, in the development of hepatic insulin resistance. The liver of HFD mice and the palmitate-treated hepatocytes exhibited an impairment of insulin signaling due to the significant decrease in INSR and IRS-1 expression. According to expression profiling and qRT-PCR analysis of the miRNAs, the expression level of miR-96 was higher in hepatocytes treated with palmitate. Moreover, miR-96 was also upregulated in the liver of HFD mice. Interestingly, miR-96 targeted the 3'UTRs of INSR and IRS-1 directly, and repressed the expression of INSR and IRS-1 at the post-transcriptional level. Accordingly, the overexpression of miR-96 was found to cause a significant decrease in INSR and IRS-1 expression, thereby leading to an impairment of insulin signaling and glycogen synthesis in hepatocytes. These results reveal a novel mechanism whereby miR-96 promotes the pathogenesis of hepatic insulin resistance resulted from SFA or obesity.	[Yang, Won-Mo; Min, Kyung-Ho; Lee, Wan] Dongguk Univ, Dept Biochem, Coll Med, Gyeongju, South Korea; [Lee, Wan] Dongguk Univ, Endocrine Channelopathy, Coll Med, Channelopathy Res Ctr, Goyang, South Korea	Dongguk University; Dongguk University	Lee, W (corresponding author), Dongguk Univ, Dept Biochem, Coll Med, Gyeongju, South Korea.; Lee, W (corresponding author), Dongguk Univ, Endocrine Channelopathy, Coll Med, Channelopathy Res Ctr, Goyang, South Korea.	wanlee@dongguk.ac.kr	Lee, Wan/B-6252-2013	Lee, Wan/0000-0002-5181-2135	National Research Foundation of Korea, South Korea (NRF) grants - Ministry of Education [2013R1A1A2057932]; Ministry of Science, ICT and Future Planning, South Korea [2016M2B2A4912473]	National Research Foundation of Korea, South Korea (NRF) grants - Ministry of Education; Ministry of Science, ICT and Future Planning, South Korea	This research was supported by National Research Foundation of Korea, South Korea (NRF) grants funded by Ministry of Education (2013R1A1A2057932) and Ministry of Science, ICT and Future Planning, South Korea (2016M2B2A4912473).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boren J, 2013, J INTERN MED, V274, P25, DOI 10.1111/joim.12071; Capurso C, 2012, VASC PHARMACOL, V57, P91, DOI 10.1016/j.vph.2012.05.003; Crepin D, 2014, MOL CELL ENDOCRINOL, V384, P1, DOI 10.1016/j.mce.2013.12.016; Dambal S, 2015, NUCLEIC ACIDS RES, V43, P7173, DOI 10.1093/nar/gkv703; Fock KM, 2013, J GASTROEN HEPATOL, V28, P59, DOI 10.1111/jgh.12407; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Hennessy Erica, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000781; Hursting SD, 2012, ANN NY ACAD SCI, V1271, P82, DOI 10.1111/j.1749-6632.2012.06737.x; Jeon TI, 2013, CELL METAB, V18, P51, DOI 10.1016/j.cmet.2013.06.010; Jeong H, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00035-13; John E, 2012, NUCLEIC ACIDS RES, V40, P4446, DOI 10.1093/nar/gks025; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kerley-Hamilton JS, 2012, ENVIRON HEALTH PERSP, V120, P1252, DOI 10.1289/ehp.1205003; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Kurtz CL, 2014, DIABETES, V63, P3141, DOI 10.2337/db13-1015; Kusminski CM, 2005, CLIN SCI, V109, P243, DOI 10.1042/CS20050078; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Leti F, 2015, TRANSL RES, V166, P304, DOI 10.1016/j.trsl.2015.04.014; Li GR, 2009, MECH AGEING DEV, V130, P731, DOI 10.1016/j.mad.2009.09.002; Lin HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015797; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Mersey BD, 2005, HUM MOL GENET, V14, P3371, DOI 10.1093/hmg/ddi368; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058; Otsuka M., 2016, J HUM GENET; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Piya MK, 2013, J ENDOCRINOL, V216, pT1, DOI 10.1530/JOE-12-0498; Ress AL, 2015, MOL CARCINOGEN, V54, P1442, DOI 10.1002/mc.22218; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Tanaka M, 2014, ONCOGENE, V33, P2454, DOI 10.1038/onc.2013.204; Tang XW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/354539; TAYLOR SI, 1994, DIABETES, V43, P735, DOI 10.2337/diab.43.6.735; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Um MY, 2013, BRIT J NUTR, V109, P1590, DOI 10.1017/S0007114512005260; Vickers KC, 2013, HEPATOLOGY, V57, P533, DOI 10.1002/hep.25846; Vucenik I, 2012, ANN NY ACAD SCI, V1271, P37, DOI 10.1111/j.1749-6632.2012.06750.x; Wen F, 2015, ACTA ENDOCRINOL-BUCH, V11, P284, DOI 10.4183/aeb.2015.284; Wu JH, 2012, OPHTHALMIC RES, V47, P195, DOI 10.1159/000331992; Xu D, 2013, ONCOL REP, V29, P653, DOI 10.3892/or.2012.2138; Zhang QQ, 2015, MOL MED REP, V12, P668, DOI 10.3892/mmr.2015.3376	52	36	38	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169039	10.1371/journal.pone.0169039	http://dx.doi.org/10.1371/journal.pone.0169039			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036389	Green Submitted, Green Published, gold			2022-12-26	WOS:000391229300047
J	Latorre, E; Layunta, E; Grasa, L; Castro, M; Pardo, J; Gomollon, F; Alcaldet, AI; Mesonero, JE				Latorre, Eva; Layunta, Elena; Grasa, Laura; Castro, Marta; Pardo, Julian; Gomollon, Fernando; Alcaldet, Ana I.; Mesonero, Jose E.			Intestinal Serotonin Transporter Inhibition by Toll-Like Receptor 2 Activation. A Feedback Modulation	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EPITHELIAL-CELLS; CACO-2 CELLS; ENTEROENDOCRINE CELLS; NEGATIVE REGULATION; MONONUCLEAR-CELLS; 5-HT AVAILABILITY; TLR2; EXPRESSION; FLUOXETINE	TLR2 is a microbiota recognition receptor that has been described to contribute to intestinal homeostasis and to ameliorate inflammatory intestinal injury. In this context, serotonin (5-HT) has shown to be an essential intestinal physiological neuromodulator that is also involved in intestinal inflammatory diseases. Since the interaction between TLR2 activation and the intestinal serotoninergic system remains non-investigated, our main aim was to analyze the effect of TLR2 on intestinal serotonin transporter (SERT) activity and expression and the intracellular pathways involved. Caco-2/TC7 cells were used to analyze SERT and TLR2 molecular expression and SERT activity by measuring 5-HT uptake. The results showed that apical TLR2 activation inhibits SERI activity in Caco-211C7 cells mainly by reducing SERI protein level either in the plasma membrane, after short-term TLR2 activation or in both the plasma membrane and cell lysate, after long-term activation. cAMP/PKA pathway appears to mediate short-term inhibitory effect of TLR2 on SERI; however, p38 MAPK pathway has been shown to be involved in both short- and long-term TLR2 effect. Reciprocally, 5-HT long-term treatment yielded TLR2 down regulation in Caco-211C7 cells. Finally, results from in vivo showed an augmented intestinal SERI expression in mice TIr2(/-), thus confirming our inhibitory effect of TLR2 on intestinal SERI in vitro. The present work infers that TLR2 may act in intestinal pathophysiology, not only by its inherent innate immune role, but also by regulating the intestinal serotoninergic system.	[Latorre, Eva; Layunta, Elena; Grasa, Laura; Castro, Marta; Alcaldet, Ana I.; Mesonero, Jose E.] Univ Zaragoza, Dept Farmacol & Fisiol, Fac Vet, Inst Invest Sanitaria Aragon IIS, Zaragoza, Spain; [Latorre, Eva] Univ Exeter, Sch Med, RNA Mediated Mech Dis, Inst Biomed & Clin Sci, Exeter, Devon, England; [Layunta, Elena; Grasa, Laura; Castro, Marta; Alcaldet, Ana I.; Mesonero, Jose E.] Univ Zaragoza, CITA, IA2, Zaragoza, Spain; [Pardo, Julian] Univ Zaragoza, Inst Invest Sanitaria Aragon IIS, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain; [Gomollon, Fernando] Hosp Clin Univ Lozano Blesa, Inst Invest Sanitaria Aragon IIS, Serv Sistema Digest, Zaragoza, Spain; [Gomollon, Fernando] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Sanitaria Aragon IIS, Serv Sistema Digest, Zaragoza, Spain	University of Zaragoza; University of Exeter; University of Zaragoza; University of Zaragoza; Lozano Blesa University Clinical Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Latorre, E (corresponding author), Univ Zaragoza, Dept Farmacol & Fisiol, Fac Vet, Inst Invest Sanitaria Aragon IIS, Zaragoza, Spain.; Latorre, E (corresponding author), Univ Exeter, Sch Med, RNA Mediated Mech Dis, Inst Biomed & Clin Sci, Exeter, Devon, England.	e.latorre@exeter.ac.uk	Grasa, Laura/C-7059-2008; Pardo, Julián/K-6764-2014; Latorre, Eva/Y-7043-2019; Mesonero, Jose Emilio J.E./A-2172-2009; Layunta, Elena/F-8943-2014	Grasa, Laura/0000-0002-5306-9365; Pardo, Julián/0000-0003-0154-0730; Latorre, Eva/0000-0002-5797-3909; Mesonero, Jose Emilio J.E./0000-0003-4758-3998; Layunta, Elena/0000-0001-5573-6144	Spanish Ministry of Science and Innovation; European Regional Development Fund (ERDF/FEDER) [BFU2010-18971]; Zaragoza University [UZ2014-BIO-03]; European Social Found (ESF); Aragon Regional Government [B61]; Foundation for the Study of Inflammatory Bowel Diseases in Aragon (ARAINF) [012/2008]; ARAID Foundation [SAF2014-54763-C2-1-R]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund (ERDF/FEDER)(European Commission); Zaragoza University; European Social Found (ESF)(European Social Fund (ESF)); Aragon Regional Government(Gobierno de Aragon); Foundation for the Study of Inflammatory Bowel Diseases in Aragon (ARAINF); ARAID Foundation	This work was funded by grants from the Spanish Ministry of Science and Innovation and the European Regional Development Fund (ERDF/FEDER) (BFU2010-18971), Zaragoza University (UZ2014-BIO-03), European Social Found (ESF) and the Aragon Regional Government (B61) and the Foundation for the Study of Inflammatory Bowel Diseases in Aragon (ARAINF 012/2008). ARAID Foundation supported J.P. (SAF2014-54763-C2-1-R) and E. Layunta is a PhD student fellow from Aragon Regional Government (B022/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Anand PK, 2011, J BIOL CHEM, V286, P42981, DOI 10.1074/jbc.M111.310599; Andreetta F, 2013, LIFE SCI, V93, P30, DOI 10.1016/j.lfs.2013.05.014; Bertrand PP, 2010, AM J PHYSIOL-GASTR L, V298, pG446, DOI 10.1152/ajpgi.00318.2009; Bertrand PP, 2008, AM J PHYSIOL-GASTR L, V295, pG1228, DOI 10.1152/ajpgi.90375.2008; Bogunovic M, 2007, AM J PHYSIOL-GASTR L, V292, pG1770, DOI 10.1152/ajpgi.00249.2006; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Chang JC, 2012, J NEUROSCI, V32, P8919, DOI 10.1523/JNEUROSCI.0048-12.2012; CHANTRET I, 1994, J CELL SCI, V107, P213; Costedio MM, 2008, J GASTROINTEST SURG, V12, P1439, DOI 10.1007/s11605-008-0536-5; Daghaghzadeh H, 2015, J RES MED SCI, V20, P595, DOI 10.4103/1735-1995.165969; Danese S, 2011, AM J PHYSIOL-GASTR L, V300, pG716, DOI 10.1152/ajpgi.00472.2010; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Foley S, 2011, GASTROENTEROLOGY, V140, P1434, DOI 10.1053/j.gastro.2011.01.052; Forcen R, 2015, NEUROGASTROENTEROL M; Furrie E, 2005, IMMUNOLOGY, V115, P565, DOI 10.1111/j.1365-2567.2005.02200.x; Gershon MD, 2004, ALIMENT PHARM THER, V20, P3, DOI 10.1111/j.1365-2036.2004.02180.x; Hansen MB, 2008, ACTA PHYSIOL, V193, P311, DOI 10.1111/j.1748-1716.2008.01870.x; Hormann N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113080; Iceta R, 2008, ACTA PHYSIOL, V193, P57, DOI 10.1111/j.1748-1716.2007.01793.x; Iceta R, 2006, J PHYSIOL PHARMACOL, V57, P119; Jin JF, 2011, MOL IMMUNOL, V49, P423, DOI 10.1016/j.molimm.2011.08.026; Koh SJ, 2015, DIGEST DIS SCI, V60, P101, DOI 10.1007/s10620-014-3326-9; Latorre E, 2013, CYTOKINE, V61, P778, DOI 10.1016/j.cyto.2013.01.012; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Matheus N, 2009, BIOCHEM PHARMACOL, V78, P1198, DOI 10.1016/j.bcp.2009.06.006; Matsumoto C, 2012, BIOCHEM BIOPH RES CO, V428, P110, DOI 10.1016/j.bbrc.2012.10.016; Mawe GM, 2013, NAT REV GASTRO HEPAT, V10, P473, DOI 10.1038/nrgastro.2013.105; Mendoza C, 2012, CELL PHYSIOL BIOCHEM, V30, P187, DOI 10.1159/000339057; Mendoza C, 2009, INNATE IMMUN-LONDON, V15, P243, DOI 10.1177/1753425909104781; Mikocka-Walus A, 2016, J CROHNS COLITIS; O'Hara JR, 2004, AM J PHYSIOL-GASTR L, V287, pG998, DOI 10.1152/ajpgi.00090.2004; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Pandey SP, 2015, EXP PARASITOL, V154, P82, DOI 10.1016/j.exppara.2015.04.005; Pardo J, 2008, CELL DEATH DIFFER, V15, P567, DOI 10.1038/sj.cdd.4402289; Paulino AD, 2011, J NEUROVIROL, V17, P327, DOI 10.1007/s13365-011-0039-0; Pierik M, 2006, INFLAMM BOWEL DIS, V12, P1, DOI 10.1097/01.MIB.0000195389.11645.ab; Podolsky DK, 2009, GASTROENTEROLOGY, V137, P209, DOI 10.1053/j.gastro.2009.03.007; Qiu YQ, 2013, FIXED POINT THEORY A, DOI 10.1186/1687-1812-2013-4; Ramamoorthy S, 1999, SCIENCE, V285, P763, DOI 10.1126/science.285.5428.763; Sacre S, 2010, ARTHRITIS RHEUM-US, V62, P683, DOI 10.1002/art.27304; Salvador MT, 2000, CAN J PHYSIOL PHARM, V78, P359, DOI 10.1139/cjpp-78-5-359; Scheeren FA, 2014, NAT CELL BIOL, V16, P1238, DOI 10.1038/ncb3058; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; Shin DM, 2010, CELL MICROBIOL, V12, P1648, DOI 10.1111/j.1462-5822.2010.01497.x; Spiller R, 2008, NEUROPHARMACOLOGY, V55, P1072, DOI 10.1016/j.neuropharm.2008.07.016; Waiskopf N, 2014, J MOL NEUROSCI, V53, P306, DOI 10.1007/s12031-013-0174-6; Wang M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000697; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047	52	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0169303	10.1371/journal.pone.0169303	http://dx.doi.org/10.1371/journal.pone.0169303			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033388	Green Published, Green Submitted, gold			2022-12-26	WOS:000391226900090
J	Luzzago, C; Ebranati, E; Cabezon, O; Fernandez-Sirera, L; Lavin, S; Rosell, R; Veo, C; Rossi, L; Cavallero, S; Lanfranchil, P; Marco, I; Zehender, G				Luzzago, Camilla; Ebranati, Erika; Cabezon, Oscar; Fernandez-Sirera, Laura; Lavin, Santiago; Rosell, Rosa; Veo, Carla; Rossi, Luca; Cavallero, Serena; Lanfranchil, Paolo; Marco, Ignasi; Zehender, Gianguglielmo			Spatial and Temporal Phylogeny of Border Disease Virus in Pyrenean Chamois (Rupicapra p. pyrenaica)	PLOS ONE			English	Article							VIRAL DIARRHEA VIRUS; WILD RUMINANTS; PESTIVIRUS; SPAIN; SHEEP; IDENTIFICATION; INFECTION; PIGS; POPULATION; OUTBREAK	Border disease virus (BDV) affects a wide range of ruminants worldwide, mainly domestic sheep and goat. Since 2001 several outbreaks of disease associated to BDV infection have been described in Pyrenean chamois (Rupicapra pyrenaica pyrenaica) in Spain, France and Andorra. In order to reconstruct the most probable places of origin and pathways of dispersion of BDV among Pyrenean chamois, a phylogenetic analysis of 95 BDV 5'untranslated sequences has been performed on chamois and domestic ungulates, including novel sequences and retrieved from public databases, using a Bayesian Markov Chain Monte Carlo method. Discrete and continuous space phylogeography have been applied on chamois sequences dataset, using centroid positions and latitude and longitude coordinates of the animals, respectively. The estimated mean evolutionary rate of BDV sequences was 2.9x10(-3) subs/site/year (95% HPD: 1.5-4.6x10(-3)). All the Pyrenean chamois isolates clustered in a unique highly significant clade, that originated from BDV-4a ovine clade. The introduction from sheep (dated back to the early 90s) generated a founder effect on the chamois population and the most probable place of origin of Pyrenean chamois BDV was estimated at coordinates 42.42 N and 1.9 E. The pathways of virus dispersion showed two main routes: the first started on the early 90s of the past century with a westward direction and the second arise in Central Pyrenees. The virus spread westward for more than 125 km and southward for about 50km and the estimated epidemic diffusion rate was about 13.1 km/year (95% HPD 5.2-21.4 km/year). The strong spatial structure, with strains from a single locality segregating together in homogeneous groups, and the significant pathways of viral dispersion among the areas, allowed to reconstruct both events of infection in a single area and of migrations, occurring between neighboring areas.	[Luzzago, Camilla; Lanfranchil, Paolo] Univ Milan, Dept Vet Med, Milan, Italy; [Luzzago, Camilla; Ebranati, Erika; Zehender, Gianguglielmo] Univ Milan, Ctr Ric Coordinata Epidemiol & Sorveglianza Mol I, Milan, Italy; [Ebranati, Erika; Veo, Carla; Zehender, Gianguglielmo] Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy; [Cabezon, Oscar; Fernandez-Sirera, Laura; Lavin, Santiago; Marco, Ignasi] Univ Autonoma Barcelona, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge, Barcelona, Spain; [Cabezon, Oscar; Fernandez-Sirera, Laura; Rosell, Rosa] UAB, CReSA, IRTA, Ctr Recerca Sanitat Anim, Campus Univ Autonoma Barcelona, Barcelona, Spain; [Rosell, Rosa] Dept Agr Alimentacio & Accio Rural, Barcelona, Spain; [Rossi, Luca] Univ Turin, Dept Vet Sci, Turin, Italy; [Cavallero, Serena] Univ Roma La Sapienza, Sect Parasitol, Dept Publ Hlth & Infect Dis, Rome, Italy	University of Milan; University of Milan; University of Milan; Luigi Sacco Hospital; Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA; University of Turin; Sapienza University Rome	Luzzago, C (corresponding author), Univ Milan, Dept Vet Med, Milan, Italy.; Luzzago, C (corresponding author), Univ Milan, Ctr Ric Coordinata Epidemiol & Sorveglianza Mol I, Milan, Italy.	camilla.luzzago@unimi.it	Marco, Ignasi/E-8633-2015; Lanfranchi, Paolo/K-5976-2017; Luzzago, Camilla/G-2829-2011; CAVALLERO, Serena/AAF-3218-2020; Lavín, Santiago/L-5975-2014; Cabezón, Oscar/AAV-7876-2020; Cabezon, Oscar/L-3812-2014	Marco, Ignasi/0000-0001-7479-3419; Lanfranchi, Paolo/0000-0002-8266-5481; Luzzago, Camilla/0000-0001-9236-2049; CAVALLERO, Serena/0000-0002-2245-9694; Lavín, Santiago/0000-0001-5655-588X; Rosell, Rosa/0000-0002-8294-1159; Cabezon, Oscar/0000-0001-7543-8371	Italian Ministry of Education, Scientific Research PRIN Grant [2010P7LFVV4]; Generalitat de Catalunya; Ministerio de Economia y Competitividad of the Spanish Government [CGL2006-11518/BOS, CGL2009-09071/BOS, CGL2012-40057-C02-01, FAU 2006-00007-C02-02, FAU2008-00017-C02-01]	Italian Ministry of Education, Scientific Research PRIN Grant; Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Economia y Competitividad of the Spanish Government(Spanish Government)	The study was funded by the Italian Ministry of Education, Scientific Research PRIN Grant number: 2010P7LFVV4 (2010-11)"Genomics and host-pathogen interactions: a model study in the One-Health perspective" and by Generalitat de Catalunya and by Ministerio de Economia y Competitividad of the Spanish Government (reference projects CGL2006-11518/BOS, CGL2009-09071/BOS, CGL2012-40057-C02-01, FAU 2006-00007-C02-02 and FAU2008-00017-C02-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal MC, 2004, J GEN VIROL, V85, P3653, DOI 10.1099/vir.0.80235-0; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Becher P, 2003, VIROLOGY, V311, P96, DOI 10.1016/S0042-6822(03)00192-2; Becher P, 1997, J GEN VIROL, V78, P1357, DOI 10.1099/0022-1317-78-6-1357; Biek R, 2007, P NATL ACAD SCI USA, V104, P7993, DOI 10.1073/pnas.0700741104; Braun U, 2013, SCHWEIZ ARCH TIERH, V155, P123, DOI 10.1024/0036-7281/a000428; Cabezon O, 2010, J VET DIAGN INVEST, V22, P744, DOI 10.1177/104063871002200514; Casaubon J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-204; Citterio CV, 2003, VET REC, V153, P592, DOI 10.1136/vr.153.19.592; Cranwell MP, 2007, VET REC, V161, P211, DOI 10.1136/vr.161.6.211-a; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dubois E, 2008, VET MICROBIOL, V130, P69, DOI 10.1016/j.vetmic.2008.01.002; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Fernandez-Sirera L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051031; Fernandez-Sirera L, 2012, J WILDLIFE DIS, V48, P1021, DOI 10.7589/2012-01-002; Finlaison DS, 2009, VET MICROBIOL, V136, P259, DOI 10.1016/j.vetmic.2008.11.026; Gaffuri A, 2006, J WILDLIFE DIS, V42, P685, DOI 10.7589/0090-3558-42.3.685; Giammarioli M, 2011, VET MICROBIOL, V147, P231, DOI 10.1016/j.vetmic.2010.06.027; Hurtado A, 2004, J WILDLIFE DIS, V40, P796, DOI 10.7589/0090-3558-40.4.796; Hurtado A, 2003, VIRUS RES, V92, P67, DOI 10.1016/S0168-1702(02)00315-5; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kirkland PD, 2007, VIRUS RES, V129, P26, DOI 10.1016/j.virusres.2007.05.002; Krametter R, 2004, J WILDLIFE DIS, V40, P791, DOI 10.7589/0090-3558-40.4.791; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Luzzago C, 2012, INFECT GENET EVOL, V12, P324, DOI 10.1016/j.meegid.2011.12.007; Marco I, 2009, RES VET SCI, V87, P149, DOI 10.1016/j.rvsc.2008.10.014; Marco I., 2012, INFECT DIS WILD MAMM, P147; Marco I, 2008, VET MICROBIOL, V127, P29, DOI 10.1016/j.vetmic.2007.08.015; Marco I, 2015, ANIM HEALTH RES REV, V16, P70, DOI 10.1017/S1466252315000055; Marco I, 2011, VET MICROBIOL, V149, P17, DOI 10.1016/j.vetmic.2010.09.032; Marco I, 2009, EMERG INFECT DIS, V15, P448, DOI 10.3201/eid1503.081155; Martin C, 2015, VET MICROBIOL, V175, P341, DOI 10.1016/j.vetmic.2014.11.025; Oguzoglu TC, 2009, VET MICROBIOL, V135, P374, DOI 10.1016/j.vetmic.2008.09.085; Peterhans E, 2010, VET RES, V41, DOI 10.1051/vetres/2010016; Pioz M, 2007, VET MICROBIOL, V119, P19, DOI 10.1016/j.vetmic.2006.09.001; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Riekerink RGMO, 2005, VET MICROBIOL, V108, P297, DOI 10.1016/j.vetmic.2005.04.014; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rosell R, 2014, VET REC, V174, DOI 10.1136/vr.101920; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Serrano E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01307; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Thabti F, 2005, ARCH VIROL, V150, P215, DOI 10.1007/s00705-004-0427-3; Thiel H-J, 2005, VIRUS TAXONOMY, P981; Valdazo-Gonzalez B, 2007, VET J, V174, P316, DOI 10.1016/j.tvjl.2006.10.002; Valdazo-Gonzalez B, 2006, VET MICROBIOL, V117, P141, DOI 10.1016/j.vetmic.2006.06.008; Vega S, 2015, Vet Rec Open, V2, pe000048, DOI 10.1136/vetreco-2014-000048; Vilcek S, 1996, J VIROL METHODS, V60, P103, DOI 10.1016/0166-0934(96)02031-9; VILCEK S, 1994, ARCH VIROL, V136, P309, DOI 10.1007/BF01321060; Xia H, 2007, VIRUS RES, V130, P53, DOI 10.1016/j.virusres.2007.05.017	53	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168232	10.1371/journal.pone.0168232	http://dx.doi.org/10.1371/journal.pone.0168232			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033381	Green Published, Green Submitted, gold			2022-12-26	WOS:000391226900019
J	Bosak, T; Schubotz, F; de Santiago-Torio, A; Kuehl, JV; Carlson, HK; Watson, N; Daye, M; Summons, RE; Arkin, AP; Deutschbauer, AM				Bosak, Tanja; Schubotz, Florence; de Santiago-Torio, Ana; Kuehl, Jennifer V.; Carlson, Hans K.; Watson, Nicki; Daye, Mirna; Summons, Roger E.; Arkin, Adam P.; Deutschbauer, Adam M.			System-Wide Adaptations of Desulfovibrio alaskensis G20 to Phosphate-Limited Conditions	PLOS ONE			English	Article							GLOBAL TRANSCRIPTIONAL ANALYSIS; SULFUR ISOTOPE FRACTIONATION; VULGARIS HILDENBOROUGH; ESCHERICHIA-COLI; BLACK-SEA; SINORHIZOBIUM-MELILOTI; STARVATION RESPONSE; REGULATORY NETWORK; SULFATE REDUCTION; MICROBIAL ECOLOGY	The prevalence of lipids devoid of phosphorus suggests that the availability of phosphorus limits microbial growth and activity in many anoxic, stratified environments. To better understand the response of anaerobic bacteria to phosphate limitation and starvation, this study combines microscopic and lipid analyses with the measurements of fitness of pooled bar-coded transposon mutants of the model sulfate reducing bacterium Desulfovibrio alaskensis G20. Phosphate-limited G20 has lower growth rates and replaces more than 90% of its membrane phospholipids by a mixture of monoglycosyl diacylglycerol (MGDG), glycuronic acid diacylglycerol (GADG) and ornithine lipids, lacks polyphosphate granules, and synthesizes other cellular inclusions. Analyses of pooled and individual mutants reveal the importance of the high-affinity phosphate transport system (the Pst system), PhoR, and glycolipid and ornithine lipid synthases during phosphate limitation. The phosphate-dependent synthesis of MGDG in G20 and the widespread occurrence of the MGDG/GADG synthase among sulfate reducing partial derivative-Proteobacteria implicate these microbes in the production of abundant MGDG in anaerobic environments where the concentrations of phosphate are lower than 10 mu M. Numerous predicted changes in the composition of the cell envelope and systems involved in transport, maintenance of cytoplasmic redox potential, central metabolism and regulatory pathways also suggest an impact of phosphate limitation on the susceptibility of sulfate reducing bacteria to other anthropogenic or environmental stresses.	[Bosak, Tanja; de Santiago-Torio, Ana; Daye, Mirna; Summons, Roger E.] MIT, Dept Earth & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Schubotz, Florence] Univ Bremen, Bremen, Germany; [Schubotz, Florence] MARUM, Bremen, Germany; [Kuehl, Jennifer V.; Carlson, Hans K.; Arkin, Adam P.; Deutschbauer, Adam M.] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA USA; [Watson, Nicki] Whitehead Inst, WM Keck Microscopy Facil, Cambridge, MA 02142 USA; [Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); University of Bremen; University of Bremen; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of California System; University of California Berkeley	Bosak, T (corresponding author), MIT, Dept Earth & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tbosak@mit.edu	Arkin, Adam P/A-6751-2008; Summons, Roger Everett/AAL-3789-2020; Arkin, Adam/M-9941-2019	Arkin, Adam P/0000-0002-4999-2931; Arkin, Adam/0000-0002-4999-2931; Bosak, Tanja/0000-0001-5179-5323	Simons Foundation Collaboration on the Origins of Life [327126]; Early Career Investigator in Marine Microbiology and Evolution [344707]; Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy [DE-AC02-05CH11231]	Simons Foundation Collaboration on the Origins of Life; Early Career Investigator in Marine Microbiology and Evolution; Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy(United States Department of Energy (DOE))	TB received grants from the Simons Foundation Collaboration on the Origins of Life #327126 and Early Career Investigator in Marine Microbiology and Evolution #344707; https:https://www.simonsfoundation.org/life-sciences/simons-collaboration-on-the-origins-of-life/simons-investigators/, https://www.simonsfoundation.org/funding/funding-opportunities/life-sciences/simons-early-career-investigator-in-marine-microbial-ecology-and-evolution-awards/. RES received a grant from the Simons Foundation Collaboration on the Origins of Life. This work conducted by ENIGMA was supported by the Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy under contract no. DE-AC02-05CH11231 (to AMD and APA).	Alonso-Casajus N, 2006, J BACTERIOL, V188, P5266, DOI 10.1128/JB.01566-05; Vences-Guzman MA, 2015, ENVIRON MICROBIOL, V17, P1487, DOI 10.1111/1462-2920.12562; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Bar-Yosef Y, 2010, CURR BIOL, V20, P1557, DOI 10.1016/j.cub.2010.07.032; Benitez-Nelson CR, 2000, EARTH-SCI REV, V51, P109, DOI 10.1016/S0012-8252(00)00018-0; BENNING C, 1995, ARCH BIOCHEM BIOPHYS, V317, P103, DOI 10.1006/abbi.1995.1141; BRANDIS A, 1981, J GEN MICROBIOL, V126, P249; Braun S, 2016, GEOCHIMICA COSMOCHIM; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; Carini P, 2015, P NATL ACAD SCI USA, V112, P7767, DOI 10.1073/pnas.1505034112; Carlson HK, 2015, ENVIRON SCI TECHNOL, V49, P3727, DOI 10.1021/es505843z; Chakraborty S, 2011, J BIOL CHEM, V286, P39417, DOI 10.1074/jbc.M111.295188; Chhabra SR, 2006, J BACTERIOL, V188, P1817, DOI 10.1128/JB.188.5.1817-1828.2006; CLINE JD, 1969, ENVIRON SCI TECHNOL, V3, P838, DOI 10.1021/es60032a004; Daines DA, 2000, FEMS MICROBIOL LETT, V189, P281, DOI 10.1111/j.1574-6968.2000.tb09244.x; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Dowhan W, 2009, J LIPID RES, V50, pS305, DOI 10.1194/jlr.R800041-JLR200; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ELLWOOD DC, 1969, BIOCHEM J, V111, P1; Flohr A, 2014, BIOGEOSCIENCES, V11, P885, DOI 10.5194/bg-11-885-2014; Geiger O, 1999, MOL MICROBIOL, V32, P63, DOI 10.1046/j.1365-2958.1999.01325.x; Godwin CM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00159; He Q, 2006, APPL ENVIRON MICROB, V72, P4370, DOI 10.1128/AEM.02609-05; Hendrickson EL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-185; Hoi LT, 2006, PROTEOMICS, V6, P3582, DOI 10.1002/pmic.200500842; INGALL E, 1994, GEOCHIM COSMOCHIM AC, V58, P2571, DOI 10.1016/0016-7037(94)90033-7; Jendrossek D, 2007, APPL ENVIRON MICROB, V73, P586, DOI 10.1128/AEM.01839-06; Krol E, 2004, MOL GENET GENOMICS, V272, P1, DOI 10.1007/s00438-004-1030-8; Kuehl JV, 2014, MBIO, V5, DOI 10.1128/mBio.01041-14; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Lee MHP, 2010, APPL MICROBIOL BIOT, V87, P1109, DOI 10.1007/s00253-010-2596-1; Li YF, 2007, ANTIMICROB AGENTS CH, V51, P2092, DOI 10.1128/AAC.00052-07; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Lin XJ, 2006, APPL ENVIRON MICROB, V72, P2679, DOI 10.1128/AEM.72.4.2679-2690.2006; Madrid VM, 2001, APPL ENVIRON MICROB, V67, P1663, DOI 10.1128/AEM.67.4.1663-1674.2001; MAKULA RA, 1974, J BACTERIOL, V120, P1279, DOI 10.1128/JB.120.3.1279-1283.1974; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; Meyer B, 2014, ENVIRON MICROBIOL, V16, P3463, DOI 10.1111/1462-2920.12405; Mileykovskaya E, 2009, J BIOL CHEM, V284, P2990, DOI 10.1074/jbc.M805189200; Millero F. J., 2006, CHEM OCEANOGRAPHY; Minnikin D, 1974, REPLACEMENT ACIDIC P; MINNIKIN DE, 1974, FEBS LETT, V43, P257, DOI 10.1016/0014-5793(74)80655-1; Mukhopadhyay A, 2007, J BACTERIOL, V189, P5996, DOI 10.1128/JB.00368-07; Mukhopadhyay A, 2006, J BACTERIOL, V188, P4068, DOI 10.1128/JB.01921-05; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; N'Guessan AL, 2010, ISME J, V4, P253, DOI 10.1038/ismej.2009.115; Oh J, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq419; Oh J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001140; Ovecka M, 2012, PLANT SIGNAL BEHAV, V7, P1146, DOI 10.4161/psb.21370; Paytan A, 2007, CHEM REV, V107, P563, DOI 10.1021/cr0503613; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Price MN, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00577; Rabus R, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P659, DOI 10.1007/0-387-30742-7_22; Rattanapoltee P, 2013, WORLD ACAD SCI ENG T, V7, P889; Romano S, 2015, APPL ENVIRON MICROB, V81, P3518, DOI 10.1128/AEM.04167-14; Rossel PE, 2011, GEOCHIM COSMOCHIM AC, V75, P164, DOI 10.1016/j.gca.2010.09.031; Saeed A, 2003, TIGR MEV MULTIEXPERI; Santos-Beneit F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00402; Schubotz F, NONPHOSPHORUS UNPUB; Schubotz F, 2009, ENVIRON MICROBIOL, V11, P2720, DOI 10.1111/j.1462-2920.2009.01999.x; Sebastian M, 2012, ENVIRON MICROBIOL, V14, P2334, DOI 10.1111/j.1462-2920.2012.02772.x; Seidel M, 2013, ORG GEOCHEM, V59, P133, DOI 10.1016/j.orggeochem.2013.04.004; Semeniuk A, 2014, J BIOL CHEM, V289, P10104, DOI 10.1074/jbc.M113.519298; Sim MS, 2012, APPL ENVIRON MICROB, V78, P8368, DOI 10.1128/AEM.01842-12; Sim MS, 2011, GEOCHIM COSMOCHIM AC, V75, P4244, DOI 10.1016/j.gca.2011.05.021; Sim MS, 2011, SCIENCE, V333, P74, DOI 10.1126/science.1205103; SMITH MW, 1992, FEMS MICROBIOL LETT, V100, P183, DOI 10.1016/0378-1097(92)90207-5; Stewart FJ, 2011, BIOCHEM SOC T, V39, P1859, DOI 10.1042/BST20110708; Stolyar S, 2007, J BACTERIOL, V189, P8944, DOI 10.1128/JB.00284-07; Sturt HF, 2004, RAPID COMMUN MASS SP, V18, P617, DOI 10.1002/rcm.1378; Thingstad TF, 2005, ECOL LETT, V8, P675, DOI 10.1111/j.1461-0248.2005.00768.x; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Wakeham SG, 2007, ORG GEOCHEM, V38, P2070, DOI 10.1016/j.orggeochem.2007.08.003; WEIMER PJ, 1988, APPL ENVIRON MICROB, V54, P386, DOI 10.1128/AEM.54.2.386-396.1988; Wetmore KM, 2015, MBIO, V6, DOI 10.1128/mBio.00306-15; Wormer L, 2013, ORG GEOCHEM, V59, P10, DOI 10.1016/j.orggeochem.2013.03.004; Woo HM, 2010, APPL ENVIRON MICROB, V76, P6910, DOI 10.1128/AEM.01375-10; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Yao M, 2015, ENV MICROBIOLOGY; Yuan ZC, 2006, NUCLEIC ACIDS RES, V34, P2686, DOI 10.1093/nar/gkl365; Yuasa J., 2002, MICROBES ENVIRON, V17, P75; Zane GM, 2010, APPL ENVIRON MICROB, V76, P5500, DOI 10.1128/AEM.00691-10; Zhang WW, 2006, ANTON LEEUW INT J G, V90, P41, DOI 10.1007/s10482-006-9059-9	85	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168719	10.1371/journal.pone.0168719	http://dx.doi.org/10.1371/journal.pone.0168719			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030630	Green Published, Green Submitted, gold			2022-12-26	WOS:000391222000067
J	Chen, YH; Chen, CL; Lu, DW; Liang, CM; Tai, MC; Chen, JT				Chen, Yi-Hao; Chen, Ching-Long; Lu, Da-Wen; Liang, Chang-Min; Tai, Ming-Cheng; Chen, Jiann-Torng			Silibinin Inhibits Platelet-Derived Growth Factor-Driven Cell Proliferation via Downregulation of N-Glycosylation in Human Tenon's Fibroblasts in a Proteasome-Dependent Manner	PLOS ONE			English	Article							MITOMYCIN-C; FILTRATION SURGERY; SIGNALING PATHWAY; CARCINOMA-CELLS; BLEB LEAKAGE; LONG-TERM; TRABECULECTOMY; GLAUCOMA; CANCER; CYCLE	The objective of this study was to evaluate the effects of silibinin on cell proliferation in platelet-derived growth factor (PDGF)-treated human Tenon's fibroblasts (HTFs). The effect of silibinin on cell proliferation in PDGF-treated HTFs was determined by examining the expression of proliferating cell nuclear antigen (PCNA) and performing WST-1 assays. Cell cycle progression was evaluated using flow cytometry. The related cyclins and cyclin-dependent kinases (CDKs) were also analyzed using western blot. A modified rat trabeculectomy model was established to evaluate the effect of silibinin on cell proliferation in vivo. Western blot analysis was carried out to determine the effect of silibinin on the expression of PDGF receptor and on the downstream signaling pathways regulated by PDGF receptor. PDGF elevated the expression of PCNA in HTFs, and this elevation was inhibited by silibinin. The inhibitory effect of silibinin on cell proliferation was also confirmed via WST-1 assay. PDGF-stimulated cell cycle in HTFs was delayed by silibinin, and the related cyclin D1 and CDK4 were also suppressed by silibinin. In the rat model of trabeculectomy, silibinin reduced the expression of PCNA at the site of blebs in vivo. The effects of silibinin on PDGF-stimulated HTFs were mediated via the downregulation of PDGF receptor-regulated signaling pathways, such as ERKs and STATs, which may be partially caused by the downregulation of N-glycosylation of PDGF receptor beta (PDGFR beta). The effect of silibinin on modulation of N-glycosylation of PDGFR beta was mediated in a proteasome-dependent manner. Silibinin inhibited cell proliferation and delayed cell cycle progression in PDGF-treated HTFs in vitro. PDGF also modulated the process of N-glycosylation of the PDGFR beta in a proteasome-dependent manner. Our findings suggest that silibinin has potential therapeutic applications in glaucoma filtering surgery.	[Chen, Yi-Hao; Chen, Ching-Long; Lu, Da-Wen; Liang, Chang-Min; Tai, Ming-Cheng; Chen, Jiann-Torng] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chen, Yi-Hao; Chen, Ching-Long; Lu, Da-Wen; Liang, Chang-Min; Tai, Ming-Cheng; Chen, Jiann-Torng] Triserv Gen Hosp, Dept Ophthalmol, Natl Def Med Ctr, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Chen, JT (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Chen, JT (corresponding author), Triserv Gen Hosp, Dept Ophthalmol, Natl Def Med Ctr, Taipei, Taiwan.	jt66chen@gmail.com			Tri-Service General Hospital, Taiwan [TSGH-C105-099, TSGH-C105-098]; National Science Council, Taiwan [NSC 102-2314-B-016-046-MY3]; Ministry of Science and Technology, Taiwan [MOST 104-2314-B-016-035]	Tri-Service General Hospital, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Yi-Hao Chen was supported by Tri-Service General Hospital, Taiwan-TSGH-C105-099, Da-Wen Lu by Tri-Service General Hospital, Taiwan-TSGH-C105-098, Jiann-Torng Chen by National Science Council, Taiwan-NSC 102-2314-B-016-046-MY3, and Yi-Hao Chen by the Ministry of Science and Technology, Taiwan-MOST 104-2314-B-016-035.	Alvarez RH, 2006, MAYO CLIN PROC, V81, P1241, DOI 10.4065/81.9.1241; Broadway DC, 2001, J GLAUCOMA, V10, P237, DOI 10.1097/00061198-200106000-00017; CHEN CW, 1990, J OCUL PHARMACOL, V6, P175, DOI 10.1089/jop.1990.6.175; Chen Y, 2014, J ASIAN NAT PROD RES, V19, P1, DOI DOI 10.1155/2014/701395; Chen YH, 2013, ACTA OPHTHALMOL, V91, pE506, DOI 10.1111/aos.12160; Cheung CWY, 2010, ANTI-CANCER AGENT ME, V10, P186; CLAESSONWELSH L, 1987, P NATL ACAD SCI USA, V84, P8796, DOI 10.1073/pnas.84.24.8796; COSTA VP, 1993, OPHTHALMIC SURG LAS, V24, P152; Gill RS, 2010, CELL SIGNAL, V22, P285, DOI 10.1016/j.cellsig.2009.09.031; Guo N, 2013, ASIA-PAC J CLIN ONCO, V9, P6, DOI 10.1111/j.1743-7563.2012.01535.x; HART CE, 1987, J BIOL CHEM, V262, P10780; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; HELDIN CH, 1992, EMBO J, V11, P4251, DOI 10.1002/j.1460-2075.1992.tb05523.x; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; HEUER DK, 1984, OPHTHALMOLOGY, V91, P384; Hussain SAR, 2007, J MED FOOD, V10, P543, DOI 10.1089/jmf.2006.089; Jang BC, 2007, J BIOL CHEM, V282, P27622, DOI 10.1074/jbc.M610778200; KHAW PT, 1992, INVEST OPHTH VIS SCI, V33, P2043; Li L, 2010, EXPERT OPIN INV DRUG, V19, P243, DOI 10.1517/13543780903533631; Liang L, 2012, ONCOL REP, V28, P999, DOI 10.3892/or.2012.1874; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Masoumpour Masoumeh B, 2016, Open Ophthalmol J, V10, P68, DOI 10.2174/1874364101610010068; MAUMENEE A E, 1960, Trans Am Ophthalmol Soc, V58, P319; Mietz H, 1998, GRAEF ARCH CLIN EXP, V236, P467, DOI 10.1007/s004170050107; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Momeny M, 2016, TUMOR BIOL, V37, P3913, DOI 10.1007/s13277-015-4220-6; MORI S, 1995, J BIOL CHEM, V270, P29447, DOI 10.1074/jbc.270.49.29447; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Nissen NN, 1998, AM J PATHOL, V152, P1445; PIERCE GF, 1991, J CELL BIOCHEM, V45, P319, DOI 10.1002/jcb.240450403; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Ramasamy K, 2008, CANCER LETT, V269, P352, DOI 10.1016/j.canlet.2008.03.053; Razeghinejad MR, 2012, SURV OPHTHALMOL, V57, P1, DOI 10.1016/j.survophthal.2011.07.005; Sagara H, 2008, EYE, V22, P507, DOI 10.1038/sj.eye.6702674; Shukla SK, 2015, ONCOTARGET, V6, P41146, DOI 10.18632/oncotarget.5843; Singh RR, 2009, CLIN CANCER RES, V15, P613, DOI 10.1158/1078-0432.CCR-08-1846; Son YG, 2007, CANCER RES, V67, P8274, DOI 10.1158/0008-5472.CAN-07-0407; Song JM, 2015, CARCINOGENESIS, V36, P666, DOI 10.1093/carcin/bgv054; Susanna R, 1996, CAN J OPHTHALMOL, V31, P296; Teillet F, 2008, MED RES REV, V28, P715, DOI 10.1002/med.20122; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Trappoliere M, 2009, J HEPATOL, V50, P1102, DOI 10.1016/j.jhep.2009.02.023; Tyagi A, 2004, CARCINOGENESIS, V25, P1711, DOI 10.1093/carcin/bgh180; Van de Velde S, 2015, PROG BRAIN RES, V221, P319, DOI 10.1016/bs.pbr.2015.05.002; Vargas-Mendoza N, 2014, WORLD J HEPATOL, V6, P144, DOI 10.4254/wjh.v6.i3.144; Volti GL, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-62; Yi N, 2012, ANAT REC, V295, P1462, DOI 10.1002/ar.22539; Zhan TZ, 2011, J CELL BIOCHEM, V112, P849, DOI 10.1002/jcb.22984; Zhu XS, 2016, EURASIP J ADV SIG PR, P1, DOI 10.1186/s13634-016-0373-8; Zi ZL, 1999, P NATL ACAD SCI USA, V96, P7490, DOI 10.1073/pnas.96.13.7490	51	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168765	10.1371/journal.pone.0168765	http://dx.doi.org/10.1371/journal.pone.0168765			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030611	Green Submitted, Green Published, gold			2022-12-26	WOS:000391222000075
J	Jesus, S; Huertas, I; Bernal-Bernal, I; Bonilla-Toribio, M; Caceres-Redondo, MT; Vargas-Gonzalez, L; Gomez-Llamas, M; Carrillo, F; Calderon, E; Carballo, M; Gomez-Garre, P; Mir, P				Jesus, Silvia; Huertas, Ismael; Bernal-Bernal, Inmaculada; Bonilla-Toribio, Marta; Teresa Caceres-Redondo, Maria; Vargas-Gonzalez, Laura; Gomez-Llamas, Myriam; Carrillo, Fatima; Calderon, Enrique; Carballo, Manuel; Gomez-Garre, Pilar; Mir, Pablo			GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease	PLOS ONE			English	Article							GLUCOCEREBROSIDASE MUTATIONS; DEMENTIA; COMPLICATIONS; CONFER; RISK; GENE	The presence of mutations in glucocerebrosidase (GBA) gene is a known factor increasing the risk of developing Parkinson's disease (PD). Mutations carriers have earlier disease onset and are more likely to develop neuropsychiatric symptoms than other sporadic PD cases. These symptoms have primarily been observed in Parkinson's patients carrying the most common pathogenic mutations L444P and N370S. However, recent findings suggest that other variants across the gene may have a different impact on the phenotype as well as on the disease progression. We aimed to explore the influence of variants across GBA gene on the clinical features and treatment related complications in PD. In this study, we screened the GBA gene in a cohort of 532 well-characterised PD patients and 542 controls from southern Spain. The potential pathogeniticy of the identified variants was assessed using in-silico analysis and subsequently classified as benign or deleterious. As a result, we observed a higher frequency of GBA variants in PD patients (12.2% vs. 7.9% in controls, p = 0.021), earlier mean age at disease onset in GBA variant carriers (50.6 vs. 56.6 years; p = 0.013), as well as more prevalent motor and non-motor symptoms in patients carrying deleterious variants. In addition, we found that dopaminergic motor complications are influenced by both benign and deleterious variants. Our results highlight the fact that the impact on the phenotype highly depends on the potential pathogenicity of the carried variants. Therefore, the course of motor and non-motor symptoms as well as treatment-related motor complications could be influenced by GBA variants.	[Jesus, Silvia; Huertas, Ismael; Bernal-Bernal, Inmaculada; Bonilla-Toribio, Marta; Teresa Caceres-Redondo, Maria; Vargas-Gonzalez, Laura; Gomez-Llamas, Myriam; Carrillo, Fatima; Carballo, Manuel; Gomez-Garre, Pilar; Mir, Pablo] Univ Seville, Unidad Trastornos Movimiento, Hosp Univ Virgen del Rocio,CSIC, Serv Neurol & Neurofisiol Clin,Inst Biomed Sevill, Seville, Spain; [Calderon, Enrique] Univ Seville, Serv Med Interne, Inst Biomed Sevilla, Hosp Univ Virgen del Rocio,CSIC, Seville, Spain; [Calderon, Enrique] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid, Spain; [Gomez-Garre, Pilar; Mir, Pablo] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; CIBERNED	Gomez-Garre, P; Mir, P (corresponding author), Univ Seville, Unidad Trastornos Movimiento, Hosp Univ Virgen del Rocio,CSIC, Serv Neurol & Neurofisiol Clin,Inst Biomed Sevill, Seville, Spain.; Gomez-Garre, P; Mir, P (corresponding author), Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.	mgomez-ibis@us.es; pmir@us.es	Mir, Pablo/C-8662-2013; IBIS, EPIDEMIOLOGIA/O-8791-2015; Termine, Cristinano/AAB-8366-2022; Calderon, Enrique j/A-1997-2013; Gómez-Garre, Pilar/AAG-8048-2020	Mir, Pablo/0000-0003-1656-302X; Calderon, Enrique j/0000-0002-3166-5086; Gómez-Garre, Pilar/0000-0002-0437-6182; Huertas, Ismael/0000-0002-4317-0662; JESUS MAESTRE, SILVIA/0000-0002-1874-4628; BERNAL, INMACULADA/0000-0002-4207-1208; Vargas-Gonzalez, Laura/0000-0003-1173-3704	Ministerio de Economia y Competitividad de Espana [SAF2007-60700]; Instituto de Salud Carlos III [PI10/01674, PI13/01461, PI14/01823]; Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia [CVI-02526, CTS-7685]; Consejeria deIgualdad, Salud y Politicas Sociales de la Junta de Andalucia [PI-0377/2007, PI-0741/2010, PI-0437-2012, PI-0471-2013]; Sociedad Andaluza de Neurologia; Jacques and Gloria Gossweiler Foundation; Fundacion Alicia Koplowitz; Fundacion Mutua Madrilena; Instituto de Salud Carlos III	Ministerio de Economia y Competitividad de Espana(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia(Junta de Andalucia); Consejeria deIgualdad, Salud y Politicas Sociales de la Junta de Andalucia(Junta de Andalucia); Sociedad Andaluza de Neurologia; Jacques and Gloria Gossweiler Foundation; Fundacion Alicia Koplowitz; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by grants from the Ministerio de Economia y Competitividad de Espana [SAF2007-60700]; the Instituto de Salud Carlos III [PI10/01674, PI13/01461, PI14/01823]; the Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia [CVI-02526, CTS-7685]; the Consejeria deIgualdad, Salud y Politicas Sociales de la Junta de Andalucia [PI-0377/2007, PI-0741/2010, PI-0437-2012, PI-0471-2013]; the Sociedad Andaluza de Neurologia; the Jacques and Gloria Gossweiler Foundation; the Fundacion Alicia Koplowitz and the Fundacion Mutua Madrilena. Pilar Gomez-Garre was supported by the "Miguel Servet" programme and Ismael Huertas-Fernandez by "PFIS" programme, both from the Instituto de Salud Carlos III. Silvia Jesus hold an attendant contract through the Servicio Andaluz de Salud.	Adams SM, 2008, AM J HUM GENET, V83, P725, DOI 10.1016/j.ajhg.2008.11.007; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alcalay RN, 2015, GLUCOCEREBROSIDASE A; Alves G, 2006, MOVEMENT DISORD, V21, P1123, DOI 10.1002/mds.20897; Bastide MF, 2015, PROG NEUROBIOL, V132, P96, DOI 10.1016/j.pneurobio.2015.07.002; Bras J, 2009, NEUROBIOL AGING, V30, P1515, DOI 10.1016/j.neurobiolaging.2007.11.016; Brockmann K, 2011, NEUROLOGY, V77, P276, DOI 10.1212/WNL.0b013e318225ab77; Brockmann K, 2014, J INHERIT METAB DIS, V37, P643, DOI 10.1007/s10545-014-9714-7; Clark LN, 2007, NEUROLOGY, V69, P1270, DOI 10.1212/01.wnl.0000276989.17578.02; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gamez-Valero A, 2016, GBA MUTATIONS ARE AS; Gan-Or Z, 2015, NEUROLOGY, V84, P880, DOI 10.1212/WNL.0000000000001315; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Goker-Alpan O, 2008, ARCH NEUROL-CHICAGO, V65, P1353, DOI 10.1001/archneur.65.10.1353; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Horowitz M, 2011, MOL GENET METAB, V104, P35, DOI 10.1016/j.ymgme.2011.07.002; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; Kalinderi K, 2009, NEUROSCI LETT, V452, P87, DOI 10.1016/j.neulet.2009.01.029; Kulisevsky J, 2004, NEUROLOGY, V63, pS28, DOI 10.1212/WNL.63.8_suppl_3.S28; Lesage S, 2011, HUM MOL GENET, V20, P202, DOI 10.1093/hmg/ddq454; Lewis SJG, 2005, J NEUROL NEUROSUR PS, V76, P343, DOI 10.1136/jnnp.2003.033530; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Mata IF, 2016, MOVEMENT DISORD, V31, P95, DOI 10.1002/mds.26359; Mitsui J, 2009, ARCH NEUROL-CHICAGO, V66, P571, DOI 10.1001/archneurol.2009.72; Neikrug AB, 2012, SLEEP MED REV, V16, P415, DOI 10.1016/j.smrv.2011.08.004; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Oeda T, 2015, NEUROBIOL AGING, V36, P3306, DOI 10.1016/j.neurobiolaging.2015.08.027; Pagonabarraga J, 2010, MOVEMENT DISORD, V25, P440, DOI 10.1002/mds.22877; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Puschmann A, 2013, PARKINSONISM RELAT D, V19, P407, DOI 10.1016/j.parkreldis.2013.01.020; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Seto-Salvia N, 2012, MOVEMENT DISORD, V27, P393, DOI 10.1002/mds.24045; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Siebert M, 2014, BRAIN, V137, P1304, DOI 10.1093/brain/awu002; van Rooden SM, 2011, MOVEMENT DISORD, V26, P51, DOI 10.1002/mds.23346; Winder-Rhodes SE, 2013, BRAIN, V136, P392, DOI 10.1093/brain/aws318	40	52	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167749	10.1371/journal.pone.0167749	http://dx.doi.org/10.1371/journal.pone.0167749			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030538	gold, Green Submitted, Green Published			2022-12-26	WOS:000391222000020
J	Sartakhti, JS; Manshaei, MH; Bateni, S; Archetti, M				Sartakhti, Javad Salimi; Manshaei, Mohammad Hossein; Bateni, Soroosh; Archetti, Marco			Evolutionary Dynamics of Tumor-Stroma Interactions in Multiple Myeloma	PLOS ONE			English	Article							GROWTH-FACTOR PRODUCTION; BONE-DISEASE; GAME-THEORY; CELL-LINES; HETEROGENEITY; COOPERATION; BORTEZOMIB; RESISTANCE; SUBCLONES; HALLMARKS	Cancer cells and stromal cells cooperate by exchanging diffusible factors that sustain tumor growth, a form of frequency-dependent selection that can be studied in the framework of evolutionary game theory. In the case of multiple myeloma, three types of cells (malignant plasma cells, osteoblasts and osteoclasts) exchange growth factors with different effects, and tumor-stroma interactions have been analysed using a model of cooperation with pair-wise interactions. Here we show that a model in which growth factors have autocrine and paracrine effects on multiple cells, a more realistic assumption for tumor-stroma interactions, leads to different results, with implications for disease progression and treatment. In particular, the model reveals that reducing the number of malignant plasma cells below a critical threshold can lead to their extinction and thus to restore a healthy balance between osteoclast and osteoblast, a result in line with current therapies against multiple myeloma.	[Sartakhti, Javad Salimi; Manshaei, Mohammad Hossein; Bateni, Soroosh] Isfahan Univ Technol, Dept Elect & Comp Engn, Esfahan, Iran; [Archetti, Marco] Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England	Isfahan University of Technology; University of East Anglia	Manshaei, MH (corresponding author), Isfahan Univ Technol, Dept Elect & Comp Engn, Esfahan, Iran.; Archetti, M (corresponding author), Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England.	manshaei@cc.iut.ac.ir; m.archetti@uea.ac.uk	Bateni, Soroush/Y-9300-2019	Bateni, Soroush/0000-0002-5448-3664				Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Archetti M, 2015, CELL PROLIFERAT, V48, P259, DOI 10.1111/cpr.12169; Archetti M, 2013, BRIT J CANCER, V109, P1056, DOI 10.1038/bjc.2013.336; Archetti M, 2013, EVOL APPL, V6, P1146, DOI 10.1111/eva.12092; Archetti M, 2012, J THEOR BIOL, V299, P9, DOI 10.1016/j.jtbi.2011.06.018; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Bataille R, 1997, NEW ENGL J MED, V336, P1657, DOI 10.1056/NEJM199706053362307; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Curran MP, 2009, DRUGS, V69, P859, DOI 10.2165/00003495-200969070-00006; Dinarello CA, 2009, MAYO CLIN PROC, V84, P105, DOI 10.4065/84.2.105; Dingli D, 2009, BRIT J CANCER, V101, P1130, DOI 10.1038/sj.bjc.6605288; Ehrlich LA, 2005, BLOOD, V106, P1407, DOI 10.1182/blood-2005-03-1080; Epstein Joshua, 2003, Hematol J, V4, P310, DOI 10.1038/sj.thj.6200313; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hashimoto T, 2004, BRIT J HAEMATOL, V125, P38, DOI 10.1111/j.1365-2141.2004.04864.x; Hauert C., 2003, Complexity, V8, P31, DOI 10.1002/cplx.10092; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Jourdan M, 2005, EUR CYTOKINE NETW, V16, P57; KAREY KP, 1988, CANCER RES, V48, P4083; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Lee JW, 2004, BLOOD, V103, P2308, DOI 10.1182/blood-2003-06-1992; Lust JA, 2009, MAYO CLIN PROC, V84, P114, DOI 10.4065/84.2.114; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; Oranger A, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/289458; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Roodman GD, 2009, LEUKEMIA, V23, P435, DOI 10.1038/leu.2008.336; Roodman GD, 2002, J BONE MINER RES, V17, P1921, DOI 10.1359/jbmr.2002.17.11.1921; Terpos E, 2003, BRIT J HAEMATOL, V123, P758, DOI 10.1046/j.1365-2141.2003.04712.x; Terpos E, 2007, BLOOD, V110, P1098, DOI 10.1182/blood-2007-03-067710; Yaccoby S, 2010, BRIT J HAEMATOL, V149, P311, DOI 10.1111/j.1365-2141.2010.08141.x	31	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168856	10.1371/journal.pone.0168856	http://dx.doi.org/10.1371/journal.pone.0168856			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030607	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000391222000080
J	Kim, GA; Park, SH; Ko, J; Lee, SH; Bae, HW; Seong, GJ; Kim, CY				Kim, Gyu Ah; Park, Se Hee; Ko, Jaesang; Lee, Si Hyung; Bae, Hyoung Won; Seong, Gong Je; Kim, Chan Yun			Albuminuria Is Associated with Open-Angle Glaucoma in Nondiabetic Korean Subjects: A Cross-Sectional Study	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; OCULAR PERFUSION-PRESSURE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; EXCRETION; RISK; VARIABILITY; PROTEINURIA; PREVALENCE	Objective Systemic vascular dysfunction has been suggested to contribute to glaucomatous damage. Albuminuria is a surrogate marker of endothelial injury, including vessels. However, their relationship is not well understood. This study aimed to investigate the association between albuminuria and the prevalence of open-angle glaucoma (OAG) in nondiabetic subjects. Methods We conducted a cross-sectional study of 4186 nondiabetic participants aged 19 years or older from the 2011-2012 Korea National Health and Nutrition Examination Survey. OAG was defined based on the criteria of the International Society for Geographic and Epidemiologic Ophthalmology. Urinary albumin excretion was assessed by the urinary albumin-tocreatinine ratio (UACR). A multivariate logistic regression analysis was performed to evaluate the relationship between albuminuria and OAG. Results Among the subjects, 124 had OAG. The weighted prevalences of microalbuminuria (UACR of 30-299 mg/g creatinine [Cr]) and macroalbuminuria (UACR >= 300 mg/g Cr) were 3.2 +/- 0.3% and 0.4 +/- 0.1%, respectively. The percentages of OAG increased in accordance with increasing UACR tertiles. Compared with subjects in the lower UACR tertile, those in the upper tertile showed an increased prevalence of OAG (odds ratio, 1.963; 95% confidence interval 1.072-3.595, P = 0.029) after adjusting for demographic factors, laboratory parameters, kidney function, and intraocular pressure. Furthermore, even after excluding 155 subjects with microalbuminuria and 19 subjects with macroalbuminuria, a positive association persisted between the upper UACR tertile (low-grade albuminuria) and an increased prevalence of OAG (odds ratio, 2.170; 95% confidence interval, 1.174-4.010, P = 0.014). Conclusion Albuminuria, even low-grade, was significantly associated with OAG in nondiabetic subjects. This result implies the role of vascular endothelial dysfunction in the pathogenic mechanism of OAG and suggests that careful monitoring of OAG is required in nondiabetic subjects with albuminuria.	[Kim, Gyu Ah; Ko, Jaesang; Bae, Hyoung Won; Seong, Gong Je; Kim, Chan Yun] Yonsei Univ, Coll Med, Severance Hosp, Inst Vis Res,Dept Ophthalmol, Seoul, South Korea; [Park, Se Hee] Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Lee, Si Hyung] Eulji Univ, Dept Ophthalmol, Daejeon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Eulji University	Kim, CY (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Inst Vis Res,Dept Ophthalmol, Seoul, South Korea.	kcyeye@yuhs.ac	Ko, JaeSang/AAS-6259-2021	Seong, Gong Je/0000-0002-5456-4296; Bae, Hyoung Won/0000-0002-8421-5636; Kim, Chan Yun/0000-0002-8373-9999; Ko, JaeSang/0000-0002-3011-7213	World Class 300 Project of the SMBA, Republic of Korea [10031270]	World Class 300 Project of the SMBA, Republic of Korea	This work was supported by the World Class 300 Project (10031270) of the SMBA, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Bourne RRA, 2014, BRIT J OPHTHALMOL, V98, P629, DOI 10.1136/bjophthalmol-2013-304033; Buckley C, 2002, BRIT J OPHTHALMOL, V86, P227, DOI 10.1136/bjo.86.2.227; Chen HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036718; Choi J, 2006, INVEST OPHTH VIS SCI, V47, P831, DOI 10.1167/iovs.05-1053; Choi JA, 2015, OPHTHALMOLOGY, V122, P976, DOI 10.1016/j.ophtha.2015.01.001; Choi JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096335; Clausen P, 2001, CIRCULATION, V103, P1869; Danziger J, 2008, MAYO CLIN PROC, V83, P806, DOI 10.4065/83.7.806; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fadini GP, 2010, ACTA OPHTHALMOL, V88, P135, DOI 10.1111/j.1755-3768.2009.01573.x; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hong JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118866; KAISER HJ, 1993, OPHTHALMOLOGICA, V207, P6, DOI 10.1159/000310398; Keane WF, 1999, AM J KIDNEY DIS, V33, P1004, DOI 10.1016/S0272-6386(99)70442-7; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Kingman S, 2004, B WORLD HEALTH ORGAN, V82, P887; Konno S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123893; Lee J, 2015, AM J OPHTHALMOL, V160, P522, DOI 10.1016/j.ajo.2015.05.034; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; Mroczkowska S, 2013, JAMA OPHTHALMOL, V131, P36, DOI 10.1001/2013.jamaophthalmol.1; Na KS, 2010, J GLAUCOMA, V19, P377, DOI 10.1097/IJG.0b013e3181c4ae58; Sahebkar A, 2015, ATHEROSCLEROSIS, V241, P433, DOI 10.1016/j.atherosclerosis.2015.05.022; STEHOUWER CDA, 1992, LANCET, V340, P319, DOI 10.1016/0140-6736(92)91401-S; STROMAN GA, 1995, ARCH OPHTHALMOL-CHIC, V113, P168, DOI 10.1001/archopht.1995.01100020050027; Su WW, 2008, OPHTHALMOLOGY, V115, P1173, DOI 10.1016/j.ophtha.2007.10.026; Suzuki J, 2004, JPN J OPHTHALMOL, V48, P340, DOI 10.1007/s10384-004-0072-0; Traverso CE, 2005, BRIT J OPHTHALMOL, V89, P1245, DOI 10.1136/bjo.2005.067355; Won JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083273	34	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168682	10.1371/journal.pone.0168682	http://dx.doi.org/10.1371/journal.pone.0168682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006020	Green Submitted, gold, Green Published			2022-12-26	WOS:000392843200080
J	Posse, V; Gustafsson, CM				Posse, Viktor; Gustafsson, Claes M.			Human Mitochondrial Transcription Factor B2 Is Required for Promoter Melting during Initiation of Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE; IN-VITRO; DNA; TFAM; SPECIFICITY; COMPLEXES; COMPONENT; BINDING; PROTEIN; LIGHT	The mitochondrial transcription initiation machinery in humans consists of three proteins: the RNA polymerase (POLRMT) and two accessory factors, transcription factors A and B2 (TFAM and TFB2M, respectively). This machinery is required for the expression of mitochondrial DNA and the biogenesis of the oxidative phosphorylation system. Previous experiments suggested that TFB2M is required for promoter melting, but conclusive experimental proof for this effect has not been presented. Moreover, the role of TFB2M in promoter unwinding has not been discriminated from that of TFAM. Here we used potassium permanganate footprinting, DNase I footprinting, and in vitro transcription from the mitochondrial light-strand promoter to study the role of TFB2M in transcription initiation. We demonstrate that a complex composed of TFAM and POLRMT was readily formed at the promoter but alone was insufficient for promoter melting, which only occurred when TFB2M joined the complex. We also show that mismatch bubble templates could circumvent the requirement of TFB2M, but TFAM was still required for efficient initiation. Our findings support a model in which TFAM first recruits POLRMT to the promoter, followed by TFB2M binding and induction of promoter melting.	[Posse, Viktor; Gustafsson, Claes M.] Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden	University of Gothenburg	Gustafsson, CM (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.	claes.gustafsson@medkem.gu.se		Posse, Viktor/0000-0003-4936-4967; Gustafsson, Claes/0000-0003-3531-8468	Swedish Research Council [2012-2583]; Swedish Cancer Foundation [CAN 2013/855]; European Research Council [268897]; IngaBritt and Arne Lundberg Foundation; Knut and Alice Wallenbergs Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; European Research Council(European Research Council (ERC)European Commission); IngaBritt and Arne Lundberg Foundation; Knut and Alice Wallenbergs Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by Swedish Research Council Grant 2012-2583; Swedish Cancer Foundation Grant CAN 2013/855; European Research Council Grant 268897; the IngaBritt and Arne Lundberg Foundation; and the Knut and Alice Wallenbergs Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	BOROWIEC JA, 1987, J MOL BIOL, V196, P101, DOI 10.1016/0022-2836(87)90513-4; CHAN B, 1990, FEBS LETT, V267, P46, DOI 10.1016/0014-5793(90)80284-P; DAIRAGHI DJ, 1995, BBA-MOL BASIS DIS, V1271, P127, DOI 10.1016/0925-4439(95)00019-Z; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; FISHER RP, 1992, J BIOL CHEM, V267, P3358; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; FISHER RP, 1987, CELL, V50, P247, DOI 10.1016/0092-8674(87)90220-0; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112; Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; Morozov YI, 2016, J BIOL CHEM, V291, P13432, DOI 10.1074/jbc.C116.727966; Morozov YI, 2015, NUCLEIC ACIDS RES, V43, P3726, DOI 10.1093/nar/gkv235; Morozov YI, 2014, NUCLEIC ACIDS RES, V42, P3884, DOI 10.1093/nar/gkt1356; Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159; Paratkar S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228023; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Posse V, 2015, NUCLEIC ACIDS RES, V43, P2615, DOI 10.1093/nar/gkv105; Posse V, 2014, NUCLEIC ACIDS RES, V42, P3638, DOI 10.1093/nar/gkt1397; Ringel R, 2011, NATURE, V478, P269, DOI 10.1038/nature10435; RUBIN CM, 1980, NUCLEIC ACIDS RES, V8, P4613, DOI 10.1093/nar/8.20.4613; Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160; Shi YH, 2012, P NATL ACAD SCI USA, V109, P16510, DOI 10.1073/pnas.1119738109; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105; XU BJ, 1992, NUCLEIC ACIDS RES, V20, P1053, DOI 10.1093/nar/20.5.1053	30	30	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2637	2645		10.1074/jbc.M116.751008	http://dx.doi.org/10.1074/jbc.M116.751008			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28028173	Green Published, hybrid			2022-12-26	WOS:000395535100007
J	Juillan-Binard, C; Picciocchi, A; Andrieu, JP; Dupuy, J; Petit-Hartlein, I; Caux-Thang, C; Vives, C; Niviere, V; Fieschi, F				Juillan-Binard, Celine; Picciocchi, Antoine; Andrieu, Jean-Pierre; Dupuy, Jerome; Petit-Hartlein, Isabelle; Caux-Thang, Christelle; Vives, Corinne; Niviere, Vincent; Fieschi, Franck			A Two-component NADPH Oxidase (NOX)-like System in Bacteria Is Involved in the Electron Transfer Chain to the Methionine Sulfoxide Reductase MsrP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEIN-STRUCTURE; FAMILY; OXIDOREDUCTASE; BINDING; HEME; IDENTIFICATION; ACTIVATION; DOMAIN; IRON	MsrPQ is a newly identified methionine sulfoxide reductase system found in bacteria, which appears to be specifically involved in the repair of periplasmic proteins oxidized by hypochlorous acid. It involves two proteins: a periplasmic one, MsrP, previously named YedY, carrying out the Msr activity, and MsrQ, an integral b-type heme membrane-spanning protein, which acts as the specific electron donor to MsrP. MsrQ, previously named YedZ, was mainly characterized by bioinformatics as a member of the FRD superfamily of heme-containing membrane proteins, which include the NADPH oxidase proteins (NOX/DUOX). Here we report a detailed biochemical characterization of the MsrQ protein from Escherichia coli. We optimized conditions for the overexpression and membrane solubilization of an MsrQ-GFP fusion and set up a purification scheme allowing the production of pure MsrQ. Combining UV-visible spectroscopy, heme quantification, and site-directed mutagenesis of histidine residues, we demonstrated that MsrQ is able to bind two b-type hemes through the histidine residues conserved between the MsrQ and NOX protein families. In addition, we identify the E. coli flavin reductase Fre, which is related to the dehydrogenase domain of eukaryotic NOX enzymes, as an efficient cytosolic electron donor to the MsrQ heme moieties. Cross-linking experiments as well as surface Plasmon resonance showed that Fre interacts with MsrQ to form a specific complex. Taken together, these data support the identification of the first prokaryotic two-component protein system related to the eukaryotic NOX family and involved in the reduction of periplasmic oxidized proteins.	[Juillan-Binard, Celine; Picciocchi, Antoine; Andrieu, Jean-Pierre; Dupuy, Jerome; Petit-Hartlein, Isabelle; Vives, Corinne; Fieschi, Franck] Univ Grenoble Alpes, IBS, F-38044 Grenoble, France; [Juillan-Binard, Celine; Picciocchi, Antoine; Andrieu, Jean-Pierre; Dupuy, Jerome; Petit-Hartlein, Isabelle; Vives, Corinne; Fieschi, Franck] CEA, IBS, F-38027 Grenoble, France; [Juillan-Binard, Celine; Picciocchi, Antoine; Andrieu, Jean-Pierre; Dupuy, Jerome; Petit-Hartlein, Isabelle; Vives, Corinne; Fieschi, Franck] CNRS, IBS, F-38027 Grenoble, France; [Caux-Thang, Christelle; Niviere, Vincent] Univ Grenoble Alpes, Grenoble, France; [Caux-Thang, Christelle; Niviere, Vincent] CNRS, LCBM, UMR 5249, Grenoble, France; [Caux-Thang, Christelle; Niviere, Vincent] CEA, DRF, BIG, Lab Chim & Biol Metaux, 17 Rue Martyrs, F-38054 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Fieschi, F (corresponding author), Inst Biol Struct, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	fieschi@ibs.fr	Fieschi, Franck/W-2748-2019; Dupuy, Jerome/AAD-3438-2020	Dupuy, Jerome/0000-0002-2721-5365; Niviere, Vincent/0000-0002-5132-457X; FIESCHI, Franck/0000-0003-1194-8107	FRISBI within the Grenoble Partnership for Structural Biology (PSB) [ANR-10INSB-05-02]; GRAL within the Grenoble Partnership for Structural Biology (PSB) [ANR-10-LABX-49-01]	FRISBI within the Grenoble Partnership for Structural Biology (PSB); GRAL within the Grenoble Partnership for Structural Biology (PSB)	We thank Jan Willem de Gier for the gift of the pET28-YedZ-GFP plasmid. This work used the MP3, the Robiomol, and the SPR platforms of the Grenoble Instruct Center (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB).	BIANCHI V, 1993, J BACTERIOL, V175, P1590, DOI 10.1128/JB.175.6.1590-1595.1993; Biberstine-Kinkade KJ, 2001, J BIOL CHEM, V276, P31105, DOI 10.1074/jbc.M103327200; BLASCHKOWSKI HP, 1982, EUR J BIOCHEM, V123, P563; Boschi-Muller S, 2014, BIOORG CHEM, V57, P222, DOI 10.1016/j.bioorg.2014.07.002; Brokx SJ, 2005, BIOCHEMISTRY-US, V44, P10339, DOI 10.1021/bi050621a; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; Drew D, 2002, P NATL ACAD SCI USA, V99, P2690, DOI 10.1073/pnas.052018199; Drew D, 2005, PROTEIN SCI, V14, P2011, DOI 10.1110/ps.051466205; Fieschi F, 1995, J BIOL CHEM, V270, P30392, DOI 10.1074/jbc.270.51.30392; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gennaris A, 2015, NATURE, V528, P409, DOI 10.1038/nature15764; Gray MJ, 2013, ANNU REV MICROBIOL, V67, P141, DOI 10.1146/annurev-micro-102912-142520; Havelius KGV, 2011, INORG CHEM, V50, P741, DOI 10.1021/ic101291j; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; Kleven MD, 2015, J BIOL CHEM, V290, P22558, DOI 10.1074/jbc.M115.664565; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, BIOINFORMATICS, V23, P717, DOI 10.1093/bioinformatics/btm006; Loschi L, 2004, J BIOL CHEM, V279, P50391, DOI 10.1074/jbc.M408876200; Melnyk RA, 2015, MBIO, V6, DOI 10.1128/mBio.00233-15; Niviere V, 1999, J BIOL CHEM, V274, P18252, DOI 10.1074/jbc.274.26.18252; Niviere V, 1996, J BIOL CHEM, V271, P16656, DOI 10.1074/jbc.271.28.16656; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Pushie MJ, 2011, INORG CHEM, V50, P732, DOI 10.1021/ic101280m; Rieske JS, 1967, METHOD ENZYMOL, V10, P488, DOI DOI 10.1016/0076-6879(67)10081-5; Sanchez-Pulido L, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-98; SEGAL AW, 1978, NATURE, V276, P515, DOI 10.1038/276515a0; Sucharitakul J, 2014, ARCH BIOCHEM BIOPHYS, V555, P33, DOI 10.1016/j.abb.2014.05.009; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; von Rozycki T, 2004, J MOL MICROB BIOTECH, V8, P129, DOI 10.1159/000085786; Workun GJ, 2008, MICROBIOL MOL BIOL R, V72, P228, DOI 10.1128/MMBR.00041-07; Zhang XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058126	35	22	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2485	2494		10.1074/jbc.M116.752014	http://dx.doi.org/10.1074/jbc.M116.752014			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28028176	Green Published, hybrid			2022-12-26	WOS:000395530300035
J	Liang, T; Qin, TR; Xie, L; Dolai, S; Zhu, D; Prentice, KJ; Wheeler, M; Kang, YH; Osborne, L; Gaisano, HY				Liang, Tao; Qin, Tairan; Xie, Li; Dolai, Subhankar; Zhu, Dan; Prentice, Kacey J.; Wheeler, Michael; Kang, Youhou; Osborne, Lucy; Gaisano, Herbert Y.			New Roles of Syntaxin-1A in Insulin Granule Exocytosis and Replenishment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; KNOCK-OUT MICE; MEDIATES EXOCYTOSIS; PROTEIN EXPRESSION; HPC-1/SYNTAXIN 1A; SECRETION; SNARE; DOCKING; FUSION; 1ST-PHASE	In type-2 diabetes (T2D), severely reduced islet syntaxin-1A (Syn-1A) levels contribute to insulin secretory deficiency. We generated beta-cell-specific Syn-1A-KO (Syn-1A-beta KO) mice to mimic beta-cell Syn-1A deficiency in T2D. Glucose tolerance tests showed that Syn-1A-beta KO mice exhibited blood glucose elevation corresponding to reduced blood insulin levels. Perifusion of Syn-1A-beta KO islets showed impaired first-and second-phase glucose-stimulated insulin secretion (GSIS) resulting from reduction in readily releasable pool and granule pool refilling. To unequivocally determine the beta-cell exocytotic defects caused by Syn-1A deletion, EM and total internal reflection fluorescence microscopy showed that Syn-1A-KO beta-cells had a severe reduction in the number of secretory granules (SGs) docked onto the plasma membrane (PM) at rest and reduced SG recruitment to the PM after glucose stimulation, the latter indicating defects in replenishment of releasable pools required to sustain second-phase GSIS. Whereas reduced predocked SG fusion accounted for reduced first-phase GSIS, selective reduction of exocytosis of short-dock (but not no-dock) newcomer SGs accounted for the reduced second-phase GSIS. These Syn-1A actions on newcomer SGs were partly mediated by Syn-1A interactions with newcomer SG VAMP8.	[Liang, Tao; Qin, Tairan; Xie, Li; Dolai, Subhankar; Zhu, Dan; Kang, Youhou; Osborne, Lucy; Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Osborne, Lucy] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Liang, Tao; Qin, Tairan; Xie, Li; Dolai, Subhankar; Zhu, Dan; Prentice, Kacey J.; Wheeler, Michael; Kang, Youhou; Gaisano, Herbert Y.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto	Gaisano, HY (corresponding author), Univ Toronto, 1 Kings Coll Circle,Rm 7368, Toronto, ON M5S 1A8, Canada.	herbert.gaisano@utoronto.ca			Canadian Institutes of Health Research [MOP 89889]; 3D (Diet, Digestive Tract, and Disease) Centre - Canadian Foundation for Innovation and Ontario Research Fund [19442]; Banting and Best Diabetes Center of the University of Toronto	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); 3D (Diet, Digestive Tract, and Disease) Centre - Canadian Foundation for Innovation and Ontario Research Fund; Banting and Best Diabetes Center of the University of Toronto	Some equipment used in this study was supported by the 3D (Diet, Digestive Tract, and Disease) Centre funded by the Canadian Foundation for Innovation and Ontario Research Fund, project number 19442, and the Banting and Best Diabetes Center of the University of Toronto.	Andersson SA, 2012, MOL CELL ENDOCRINOL, V364, P36, DOI 10.1016/j.mce.2012.08.009; Andersson SA, 2011, PFLUG ARCH EUR J PHY, V462, P443, DOI 10.1007/s00424-011-0979-5; Chan CB, 1999, DIABETES, V48, P997, DOI 10.2337/diabetes.48.5.997; Covey SD, 2006, CELL METAB, V4, P291, DOI 10.1016/j.cmet.2006.09.005; Dolai S, 2016, DIABETES, V65, P1962, DOI 10.2337/db15-1436; Fex M, 2007, J ENDOCRINOL, V194, P551, DOI 10.1677/JOE-07-0161; Fujiwara T, 2011, J NEUROENDOCRINOL, V23, P1222, DOI 10.1111/j.1365-2826.2011.02214.x; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; Gaisano HY, 2012, DIABETOLOGIA, V55, P877, DOI 10.1007/s00125-012-2483-7; Gaisano HY, 2014, TRENDS ENDOCRIN MET, V25, P381, DOI 10.1016/j.tem.2014.03.005; Gaisano HY, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00349; Gaisano HY, 2002, ENDOCRINOLOGY, V143, P4218, DOI 10.1210/en.2002-220237; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Holz GG, 2013, DIABETES, V62, P2665, DOI 10.2337/db13-0796; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Hoppa MB, 2012, DIABETOLOGIA, V55, P1001, DOI 10.1007/s00125-011-2400-5; HOSKER JP, 1989, METABOLISM, V38, P767, DOI 10.1016/0026-0495(89)90064-4; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Kasai K, 2008, TRAFFIC, V9, P1191, DOI 10.1111/j.1600-0854.2008.00744.x; Kwan EP, 2005, DIABETES, V54, P2734, DOI 10.2337/diabetes.54.9.2734; Lam PPL, 2013, DIABETES, V62, P2416, DOI 10.2337/db12-1380; Lam PPL, 2005, DIABETES, V54, P2744, DOI 10.2337/diabetes.54.9.2744; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Mishima T, 2012, J NEUROSCI, V32, P381, DOI 10.1523/JNEUROSCI.2911-11.2012; Oh E, 2012, J BIOL CHEM, V287, P25821, DOI 10.1074/jbc.M112.361501; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Prentice KJ, 2014, CELL METAB, V19, P653, DOI 10.1016/j.cmet.2014.03.008; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Song WJ, 2011, CELL METAB, V13, P308, DOI 10.1016/j.cmet.2011.02.002; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Takahashi N, 2004, J CELL BIOL, V165, P255, DOI 10.1083/jcb.200312033; Takahashi N, 2010, CELL METAB, V12, P19, DOI 10.1016/j.cmet.2010.05.013; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Xie L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147862; Xie L, 2015, DIABETOLOGIA, V58, P1250, DOI 10.1007/s00125-015-3545-4; Yasuda T, 2010, CELL METAB, V12, P117, DOI 10.1016/j.cmet.2010.05.017; Zhu D, 2013, DIABETOLOGIA, V56, P359, DOI 10.1007/s00125-012-2757-0; Zhu D, 2015, MOL METAB, V4, P418, DOI 10.1016/j.molmet.2015.02.004; Zhu D, 2012, CELL METAB, V16, P238, DOI 10.1016/j.cmet.2012.07.001	46	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2203	2216		10.1074/jbc.M116.769885	http://dx.doi.org/10.1074/jbc.M116.769885			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28031464	hybrid, Green Published			2022-12-26	WOS:000395530300014
J	Schauwecker, SM; Kim, JJ; Licht, JD; Clevenger, CV				Schauwecker, Suzanne M.; Kim, J. Julie; Licht, Jonathan D.; Clevenger, Charles V.			Histone H1 and Chromosomal Protein HMGN2 Regulate Prolactin-induced STAT5 Transcription Factor Recruitment and Function in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-GLAND DEVELOPMENT; PLASMA PROLACTIN; GENE-EXPRESSION; TYROSINE PHOSPHORYLATION; TRANSACTIVATION DOMAIN; CHROMATIN COMPACTION; ACTIVATION; RECEPTOR; VARIANTS; BINDING	The hormone prolactin (PRL) contributes to breast cancer pathogenesis through various signaling pathways, one of the most notable being the JAK2/signal transducer and activator of transcription 5 (STAT5) pathway. PRL-induced activation of the transcription factor STAT5 results in the up-regulation of numerous genes implicated in breast cancer pathogenesis. However, the molecular mechanisms that enable STAT5 to access the promoters of these genes are not well understood. Here, we show thatPRLsignaling induces chromatin decompaction at promoter DNA, corresponding with STAT5 binding. The chromatin-modifying protein high mobility group nucleosomal binding domain 2 (HMGN2) specifically promotes STAT5 accessibility at promoter DNA by facilitating the dissociation of the linker histone H1 in response to PRL. Knockdown of H1 rescues the decrease in PRL-induced transcription following HMGN2 knockdown, and it does so by allowing increased STAT5 recruitment. Moreover, H1 and STAT5 are shown to function antagonistically in regulating PRL-induced transcription as well as breast cancer cell biology. While reduced STAT5 activation results in decreased PRL-induced transcription and cell proliferation, knockdown of H1 rescues both of these effects. Taken together, we elucidate a novel mechanism whereby the linker histone H1 prevents STAT5 binding at promoter DNA, and the PRL-induced dissociation of H1 mediated by HMGN2 is necessary to allow full STAT5 recruitment and promote the biological effects of PRL signaling.	[Schauwecker, Suzanne M.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Kim, J. Julie] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Div Reprod Sci Med,Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Licht, Jonathan D.] Univ Florida, Hlth Canc Ctr, Dept Med, Div Hematol & Oncol, Gainesville, FL 32610 USA; [Clevenger, Charles V.] Virginia Commonwealth Univ, Dept Pathol, 1101 E Marshall St,Sanger 4-006A,POB 980662, Richmond, VA 23298 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; State University System of Florida; University of Florida; Virginia Commonwealth University	Clevenger, CV (corresponding author), Virginia Commonwealth Univ, Dept Pathol, 1101 E Marshall St,Sanger 4-006A,POB 980662, Richmond, VA 23298 USA.	charles.clevenger@vcuhealth.org	Licht, Jonathan/L-4239-2019; Licht, Jonathan/AAL-9184-2020	Licht, Jonathan/0000-0002-3942-1369; Kim, J Julie/0000-0001-9834-8213	NCI, National Institutes of Health [R01CA173305]; National Research Service Award [F30CA171858]; Lynn Sage Foundation; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; NATIONAL CANCER INSTITUTE [R01CA173305, P30CA060553, F30CA171858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008152] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lynn Sage Foundation; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI, National Institutes of Health, Grant R01CA173305 (to C.V.C.) and National Research Service Award F30CA171858 (to S.M.S.), by grants from the Lynn Sage Foundation (to C.V.C.), and by a Malkin Scholar Award from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University (to S.M.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksamitiene E, 2011, CELL SIGNAL, V23, P1794, DOI 10.1016/j.cellsig.2011.06.014; ALFONSO PJ, 1994, J MOL BIOL, V236, P189, DOI 10.1006/jmbi.1994.1128; Ballare C, 2013, MOL CELL, V49, P67, DOI 10.1016/j.molcel.2012.10.019; Brockman JL, 2002, MOL ENDOCRINOL, V16, P774, DOI 10.1210/me.16.4.774; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Cao Kaixiang, 2013, PLoS Genet, V9, pe1003417, DOI 10.1371/journal.pgen.1003417; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Deng T, 2017, NUCLEIC ACIDS RES, V45, P3031, DOI 10.1093/nar/gkw1222; Deng T, 2015, GENOME RES, V25, P1295, DOI 10.1101/gr.192229.115; Ding HF, 1997, MOL CELL BIOL, V17, P5843, DOI 10.1128/MCB.17.10.5843; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eliassen AH, 2007, INT J CANCER, V120, P1536, DOI 10.1002/ijc.22482; Fang F, 2010, J MOL ENDOCRINOL, V44, P319, DOI 10.1677/JME-09-0140; Fang F, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-11; Fiorillo AA, 2013, AM J PATHOL, V182, P217, DOI 10.1016/j.ajpath.2012.09.021; Fiorillo AA, 2011, MOL ENDOCRINOL, V25, P1550, DOI 10.1210/me.2011-0106; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gervais AL, 2010, NUCLEIC ACIDS RES, V38, pW308, DOI 10.1093/nar/gkq485; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Hankinson SE, 1999, J NATL CANCER I, V91, P629, DOI 10.1093/jnci/91.7.629; Harshman SW, 2014, J PROTEOME RES, V13, P2453, DOI 10.1021/pr401248f; Hedrich CM, 2014, P NATL ACAD SCI USA, V111, P13457, DOI 10.1073/pnas.1408023111; Hodge LS, 2014, BLOOD, V123, P1055, DOI 10.1182/blood-2013-08-521963; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Iavnilovitch E, 2004, INT J CANCER, V112, P607, DOI 10.1002/ijc.20484; Iwafuchi-Doi M, 2016, MOL CELL, V62, P79, DOI 10.1016/j.molcel.2016.03.001; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kang K, 2014, MOL CELL BIOL, V34, P464, DOI 10.1128/MCB.00988-13; Kim JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16714; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; LEBRUN JJ, 1994, J BIOL CHEM, V269, P14021; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Maus MV, 1999, ENDOCRINOLOGY, V140, P5447, DOI 10.1210/en.140.11.5447; Medler TR, 2016, MOL CANCER RES, V14, P994, DOI 10.1158/1541-7786.MCR-16-0109; Metser G, 2016, NUCLEIC ACIDS RES, V44, P1052, DOI 10.1093/nar/gkv999; Millan-Arino L, 2014, NUCLEIC ACIDS RES, V42, P4474, DOI 10.1093/nar/gku079; Moon HG, 2015, BREAST CANCER RES TR, V154, P13, DOI 10.1007/s10549-015-3585-y; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Ormandy CJ, 1997, J MAMMARY GLAND BIOL, V2, P355, DOI 10.1023/A:1026395229025; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Perks CC, 2004, BRIT J CANCER, V91, P305, DOI 10.1038/sj.bjc.6601947; Pezet A, 1997, J BIOL CHEM, V272, P25043, DOI 10.1074/jbc.272.40.25043; Pinz S, 2015, NUCLEIC ACIDS RES, V43, P3524, DOI 10.1093/nar/gkv188; Raccurt M, 2003, BRIT J CANCER, V89, P524, DOI 10.1038/sj.bjc.6601115; Rasmussen LM, 2010, ENDOCR-RELAT CANCER, V17, P809, DOI 10.1677/ERC-09-0326; Ren SX, 2002, ONCOGENE, V21, P4335, DOI 10.1038/sj.onc.1205484; Rijnkels M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053270; Rose-Hellekant TA, 2003, ONCOGENE, V22, P4664, DOI 10.1038/sj.onc.1206619; RUI H, 1994, J BIOL CHEM, V269, P5364; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Sato T, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-59; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Shan L, 2014, ONCOGENE, V33, P3205, DOI 10.1038/onc.2013.270; Shin HY, 2016, NAT GENET, V48, P904, DOI 10.1038/ng.3606; Nacht AS, 2016, EMBO J, V35, P1822, DOI 10.15252/embj.201593260; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Sugathan A, 2013, MOL CELL BIOL, V33, P3594, DOI 10.1128/MCB.00280-13; Tang JZ, 2010, ENDOCRINOLOGY, V151, P43, DOI 10.1210/en.2009-0651; Tworoger SS, 2007, J CLIN ONCOL, V25, P1482, DOI 10.1200/JCO.2006.07.6356; Tworoger SS, 2013, CANCER RES, V73, P4810, DOI 10.1158/0008-5472.CAN-13-0665; Ueda T, 2006, J BIOL CHEM, V281, P10182, DOI 10.1074/jbc.M600821200; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Vomachka AJ, 2000, ONCOGENE, V19, P1077, DOI 10.1038/sj.onc.1203348; WAKAO H, 1995, EMBO J, V14, P854, DOI 10.1002/j.1460-2075.1995.tb07064.x; Yamaji D, 2013, NUCLEIC ACIDS RES, V41, P1622, DOI 10.1093/nar/gks1310; Yang CW, 2006, CANCER RES, V66, P11649, DOI 10.1158/0008-5472.CAN-06-1645	68	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2237	2254		10.1074/jbc.M116.764233	http://dx.doi.org/10.1074/jbc.M116.764233			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28035005	hybrid, Green Published			2022-12-26	WOS:000395530300017
J	Zhai, XH; Gao, YG; Mishra, SK; Simanshu, DK; Boldyrev, IA; Benson, LM; Bergen, HR; Malinina, L; Mundy, J; Molotkovsky, JG; Patel, DJ; Brown, RE				Zhai, Xiuhong; Gao, Yong-Guang; Mishra, Shrawan K.; Simanshu, Dhirendra K.; Boldyrev, Ivan A.; Benson, Linda M.; Bergen, H. Robert, III; Malinina, Lucy; Mundy, John; Molotkovsky, Julian G.; Patel, Dinshaw J.; Brown, Rhoderick E.			Phosphatidylserine Stimulates Ceramide 1-Phosphate (C1P) Intermembrane Transfer by C1P Transfer Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOLIPID TRANSFER PROTEIN; OXYSTEROL-BINDING PROTEINS; PROGRAMMED CELL-DEATH; AMPHITROPIC PROTEINS; MEMBRANE INTERACTION; GLYCOSPHINGOLIPID SYNTHESIS; TRANSBILAYER DISTRIBUTION; TRYPTOPHAN FLUORESCENCE; PHOSPHOLIPID-BINDING; MEDIATED TRANSFER	Genetic models for studying localized cell suicide that halt the spread of pathogen infection and immune response activation in plants include Arabidopsis accelerated-cell-death 11 mutant (acd11). In this mutant, sphingolipid homeostasis is disrupted via depletion of ACD11, a lipid transfer protein that is specific for ceramide 1-phosphate (C1P) and phyto-C1P. The C1P binding site in ACD11 and in human ceramide-1-phosphate transfer protein (CPTP) is surrounded by cationic residues. Here, we investigated the functional regulation of ACD11 and CPTP by anionic phosphoglycerides and found that 1-palmitoyl-2-oleoyl-phosphatidic acid or 1-palmitoyl-2-oleoyl-phosphatidylglycerol (<= 15 mol %) in C1P source vesicles depressed C1P intermembrane transfer. Bycontrast, replacement with 1-palmitoyl-2-oleoyl-phosphatidylserine stimulated C1P transfer by ACD11 and CPTP. Notably, "soluble" phosphatidylserine (dihexanoyl-phosphatidylserine) failed to stimulate C1P transfer. Also, none of the anionic phosphoglycerides affected transfer action by human glycolipid lipid transfer protein (GLTP), which is glycolipid-specific and has few cationic residues near its glycolipid binding site. These findings provide the first evidence for a potential phosphoglyceride headgroup-specific regulatory interaction site(s) existing on the surface of any GLTP-fold and delineate new differences between GLTP superfamily members that are specific for C1P versus glycolipid.	[Zhai, Xiuhong; Gao, Yong-Guang; Mishra, Shrawan K.; Malinina, Lucy; Brown, Rhoderick E.] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Simanshu, Dhirendra K.; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Boldyrev, Ivan A.; Molotkovsky, Julian G.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Benson, Linda M.; Bergen, H. Robert, III] Mayo Fdn, Med Genom Facil, Prote Core, Rochester, MN 55905 USA; [Mundy, John] Univ Copenhagen, BioCtr, Dept Biol, DK-2200 Copenhagen N, Denmark; [Simanshu, Dhirendra K.] NCI Frederick, Frederick Natl Lab Canc Res, NIH, 8560 Progress Dr,C1012, Frederick, MD 21702 USA	University of Minnesota System; Memorial Sloan Kettering Cancer Center; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Mayo Clinic; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Zhai, XH; Brown, RE (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zhai@hi.umn.edu; reb@umn.edu	Mishra, Shrawan K/J-7972-2013; mundy, john/A-2361-2013; Gao, Yongguang/B-8546-2012; Boldyrev, Ivan/L-7879-2017; Mishra, Shrawan/N-1592-2019	mundy, john/0000-0001-7490-4588; Gao, Yongguang/0000-0002-9359-4252; Mishra, Shrawan/0000-0001-5513-9876; Simanshu, Dhirendra/0000-0002-9717-4618; Malinina, Lucy/0000-0001-7973-1831; Brown, Rhoderick/0000-0002-7337-3604	NIGMS, National Institutes of Health (NIH) [GM45928]; NHLBI, NIH [HL125353, NCI CA121493]; Russian Foundation for Basic Research [015-04-07415]; Danish Strategic Research Council [09-067148]; Abby Rockefeller Mauze Trust; Maloris and Hormel Foundations; NATIONAL CANCER INSTITUTE [P30CA015083, R01CA121493, P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045928] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Abby Rockefeller Mauze Trust; Maloris and Hormel Foundations; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or part by NIGMS, National Institutes of Health (NIH), Grant GM45928 and NHLBI, NIH, Grants HL125353 and NCI CA121493; Russian Foundation for Basic Research Grant 015-04-07415; Danish Strategic Research Council Grant 09-067148; the Abby Rockefeller Mauze Trust; and the Maloris and Hormel Foundations. Portions of this work were presented at the 2015 American Chemical Society and 2015 American Society for Biochemistry and Molecular Biology Annual Meetings. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Airenne TT, 2006, J MOL BIOL, V355, P224, DOI 10.1016/j.jmb.2005.10.031; BERGELSON LD, 1985, CHEM PHYS LIPIDS, V37, P165, DOI 10.1016/0009-3084(85)90083-0; Berkey R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00068; Boldyrev IA, 2013, RUSS J BIOORG CHEM+, V39, P539, DOI 10.1134/S106816201305004X; Boscia AL, 2014, CHEM PHYS LIPIDS, V178, P1, DOI 10.1016/j.chemphyslip.2013.12.010; Brodersen P, 2002, GENE DEV, V16, P490, DOI 10.1101/gad.218202; Brown R E, 1990, Subcell Biochem, V16, P333; BROWN RE, 1992, BIOCHIM BIOPHYS ACTA, V1113, P375, DOI 10.1016/0304-4157(92)90007-W; BROWN RE, 1990, BIOCHIM BIOPHYS ACTA, V1044, P77, DOI 10.1016/0005-2760(90)90221-I; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; BURN P, 1988, TRENDS BIOCHEM SCI, V13, P79, DOI 10.1016/0968-0004(88)90043-6; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Corbalan-Garcia S, 2014, BBA-BIOMEMBRANES, V1838, P1536, DOI 10.1016/j.bbamem.2014.01.008; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; D'Angelo G, 2013, NATURE, V501, DOI 10.1038/nature12423; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Drin G, 2014, ANNU REV BIOCHEM, V83, P51, DOI 10.1146/annurev-biochem-060713-035307; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hankins HM, 2015, TRAFFIC, V16, P35, DOI 10.1111/tra.12233; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; Kamlekar RK, 2013, BBA-MOL CELL BIOL L, V1831, P417, DOI 10.1016/j.bbalip.2012.10.010; Kamlekar RK, 2010, BIOPHYS J, V99, P2626, DOI 10.1016/j.bpj.2010.08.038; Kenoth R, 2010, J BIOL CHEM, V285, P13066, DOI 10.1074/jbc.M109.093203; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kooijman EE, 2009, BBA-MOL CELL BIOL L, V1791, P881, DOI 10.1016/j.bbalip.2009.04.001; Koppaka V, 1996, BIOCHEMISTRY-US, V35, P7482, DOI 10.1021/bi952063d; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Li LB, 2013, J PHYS CHEM B, V117, P11906, DOI 10.1021/jp405418y; Li XM, 2004, BIOCHEMISTRY-US, V43, P10285, DOI 10.1021/bi0495432; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Lin X, 2000, J BIOL CHEM, V275, P5104, DOI 10.1074/jbc.275.7.5104; MacCallum JL, 2011, TRENDS BIOCHEM SCI, V36, P653, DOI 10.1016/j.tibs.2011.08.003; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Malakhova ML, 2005, J BIOL CHEM, V280, P26312, DOI 10.1074/jbc.M500481200; Malewicz B, 2005, BIOPHYS J, V88, P2670, DOI 10.1529/biophysj.104.057059; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Malinina L, 2006, PLOS BIOL, V4, P1996, DOI 10.1371/journal.pbio.0040362; Malinina L, 2015, Q REV BIOPHYS, V48, P281, DOI 10.1017/S003358351400016X; Mattjus P, 2003, BIOCHEMISTRY-US, V42, P535, DOI 10.1021/bi026896x; Mattjus P, 1999, ANAL BIOCHEM, V268, P297, DOI 10.1006/abio.1998.3065; Mattjus P, 2000, BIOCHEMISTRY-US, V39, P1067, DOI 10.1021/bi991810u; Mattjus P, 2002, J BIOL CHEM, V277, P19476, DOI 10.1074/jbc.M201305200; MOLOTKOVSKY JG, 1991, CHEM PHYS LIPIDS, V58, P199, DOI 10.1016/0009-3084(91)90093-Q; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; NORDLUND JR, 1981, BIOCHEMISTRY-US, V20, P6415, DOI 10.1021/bi00525a020; Nylund M, 2007, LANGMUIR, V23, P11726, DOI 10.1021/la701927u; Ohvo-Rekila H, 2011, BBA-BIOMEMBRANES, V1808, P47, DOI 10.1016/j.bbamem.2010.08.018; Olkkonen VM, 2013, PROG LIPID RES, V52, P529, DOI 10.1016/j.plipres.2013.06.004; Olkkonen VM, 2013, MOLECULES, V18, P13666, DOI 10.3390/molecules181113666; Petersen NHT, 2008, FEBS J, V275, P4378, DOI 10.1111/j.1742-4658.2008.06584.x; Rao CS, 2005, BIOPHYS J, V89, P4017, DOI 10.1529/biophysj.105.070631; Rao CS, 2004, BIOCHEMISTRY-US, V43, P13805, DOI 10.1021/bi0492197; Samygina VR, 2011, STRUCTURE, V19, P1644, DOI 10.1016/j.str.2011.09.011; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Simanshu DK, 2014, CELL REP, V6, P388, DOI 10.1016/j.celrep.2013.12.023; Simanshu DK, 2013, NATURE, V500, P463, DOI 10.1038/nature12332; Stahelin RV, 2014, CHEM PHYS LIPIDS, V182, P3, DOI 10.1016/j.chemphyslip.2014.02.002; Stahelin RV, 2009, J LIPID RES, V50, pS299, DOI 10.1194/jlr.R800078-JLR200; Tong J, 2013, STRUCTURE, V21, P1203, DOI 10.1016/j.str.2013.05.007; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhai XH, 2009, J BIOL CHEM, V284, P13620, DOI 10.1074/jbc.M809089200; Zou XQ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-72	73	16	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2531	2541		10.1074/jbc.M116.760256	http://dx.doi.org/10.1074/jbc.M116.760256			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28011644	Green Published, hybrid			2022-12-26	WOS:000395530300039
J	Xu, K; Chen, X; Yang, H; Xu, YW; He, YL; Wang, CF; Huang, H; Liu, BD; Liu, WQ; Li, JY; Kou, XC; Zhao, YH; Zhao, K; Zhang, LF; Hou, ZZ; Wang, H; Wang, HL; Li, J; Fan, HY; Wang, FC; Gao, YW; Zhang, Y; Chen, JY; Gao, SR				Xu, Kai; Chen, Xia; Yang, Hui; Xu, Yiwen; He, Yuanlin; Wang, Chenfei; Huang, Hua; Liu, Baodong; Liu, Wenqiang; Li, Jingyi; Kou, Xiaochen; Zhao, Yanhong; Zhao, Kun; Zhang, Linfeng; Hou, Zhenzhen; Wang, Hong; Wang, Hailin; Li, Jing; Fan, Hengyu; Wang, Fengchao; Gao, Yawei; Zhang, Yong; Chen, Jiayu; Gao, Shaorong			Maternal Sall4 Is Indispensable for Epigenetic Maturation of Mouse Oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA methylation; embryo; histone methylation; meiosis; oocyte	EMBRYONIC STEM-CELLS; HISTONE MODIFICATIONS; OKIHIRO-SYNDROME; GENE; TRANSCRIPTION; PLURIPOTENCY; METHYLATION; MEIOSIS; GROWTH; PLZF	Sall4 (Splat-like 4) plays important roles in maintaining pluripotency of embryonic stem cells and in various developmental processes. Here, we find that Sall4 is highly expressed in oocytes and early embryos. To investigate the roles of SALL4 in oogenesis, we generated Sall4 maternal specific knock-out mice by using CRISPR/Cas9 system, and we find that the maternal deletion of Sall4 causes developmental arrest of oocytes at germinal vesicle stage with non-surrounded nucleus, and the subsequent meiosis resumption is prohibited. We further discover that the loss of maternal Sall4 causes failure in establishment of DNA methylation in oocytes. Furthermore, we find that Sall4 modulates H3K4me3 and H3K27me3 modifications by regulating the expression of key histone demethylases coding genes Kdm5b, Kdm6a, and Kdm6b in oocytes. Moreover, we demonstrate that the aberrant H3K4me3 and H3K27me3 cause mis-expression of genes that are critical for oocytes maturation and meiosis resumption. Taken together, our study explores a pivotal role of Sall4 in regulating epigenetic maturation of mouse oocytes.	[Xu, Kai; Chen, Xia; Yang, Hui; Wang, Chenfei; Liu, Wenqiang; Li, Jingyi; Kou, Xiaochen; Zhao, Yanhong; Zhao, Kun; Zhang, Linfeng; Hou, Zhenzhen; Wang, Hong; Gao, Yawei; Zhang, Yong; Chen, Jiayu; Gao, Shaorong] Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Clin & Translat Res Ctr,Shanghai Matern & Infant, Shanghai 200092, Peoples R China; [Xu, Yiwen; Fan, Hengyu] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Xu, Yiwen; Fan, Hengyu] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [He, Yuanlin; Li, Jing] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Huang, Hua; Liu, Baodong; Wang, Hailin] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Chem & Ecotoxicol, Beijing 100085, Peoples R China; [Wang, Fengchao] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Tongji University; Zhejiang University; Zhejiang University; Nanjing Medical University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); National Institute of Biological Sciences, Beijing	Chen, JY; Gao, SR (corresponding author), 1239 Siping Rd, Shanghai 200092, Peoples R China.	chenjiayu@tongji.edu.cn; gaoshaorong@tongji.edu.cn	Chen, Jiayu/ABF-3722-2021; Zhang, Yong/B-4838-2011; zhao, yan/GWC-9174-2022; gao, yawei/AAS-3512-2021	Chen, Jiayu/0000-0003-4755-8901; Zhang, Yong/0000-0001-6316-2734; gao, yawei/0000-0001-8946-9697; Wang, Chenfei/0000-0001-7573-3768; huang, hua/0000-0002-9881-4197; Yang, Hui/0000-0003-0043-8793	National Natural Science Foundation of China [31401247, 81630035, 31325019, 31430056, 31471392, 31401266, 31501196, 31501197, 31501183]; Ministry of Science and Technology of China [2016YFA0100400, 2015CB964503, 2015CB964800, 2014CB964601]; Science and Technology Commission of Shanghai Municipality [15XD1503500, YF1403900, 16YF140940, 14CG16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Natural Science Foundation of China Grants 31401247, 81630035, 31325019, 31430056, 31471392, 31401266, 31501196, 31501197, and 31501183; Ministry of Science and Technology of China Grants 2016YFA0100400, 2015CB964503, 2015CB964800, and 2014CB964601; and the Science and Technology Commission of Shanghai Municipality Grants 15XD1503500, YF1403900, 16YF140940 and 14CG16. The authors declare that they have no conflicts of interest with the contents of this article.	Agopiantz M, 2017, REPROD FERT DEVELOP, V29, P824, DOI 10.1071/RD15367; Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Brind'Amour J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7033; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Dole G, 2008, REPRODUCTION, V135, P671, DOI 10.1530/REP-07-0405; Gu L, 2010, CELL CYCLE, V9, P1942, DOI 10.4161/cc.9.10.11599; Guo HS, 2015, NAT PROTOC, V10, P645, DOI 10.1038/nprot.2015.039; Guo WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-774; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Huntriss J, 2006, MOL HUM REPROD, V12, P283, DOI 10.1093/molehr/gal035; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kawamura K, 2008, DEV BIOL, V315, P189, DOI 10.1016/j.ydbio.2007.12.029; Lopez E, 2015, THROMB HAEMOSTASIS, V114, P969, DOI 10.1160/TH14-09-0727; Lovelace DL, 2016, DEVELOPMENT, V143, P1893, DOI 10.1242/dev.132761; Ma PP, 2015, CELL REP, V13, P1552, DOI 10.1016/j.celrep.2015.10.031; Ma PP, 2012, P NATL ACAD SCI USA, V109, pE481, DOI 10.1073/pnas.1118403109; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Pfender S, 2015, NATURE, V524, P239, DOI 10.1038/nature14568; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Sleer LS, 2007, BIOL REPROD, V76, P391, DOI 10.1095/biolreprod.106.053934; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Stewart KR, 2015, GENE DEV, V29, P2449, DOI 10.1101/gad.271353.115; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van den Hurk R, 2005, THERIOGENOLOGY, V63, P1717, DOI 10.1016/j.theriogenology.2004.08.005; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Yamaguchi YL, 2015, STEM CELLS, V33, P289, DOI 10.1002/stem.1853; Yang JC, 2012, J BIOL CHEM, V287, P1996, DOI 10.1074/jbc.M111.308734; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	35	24	27	3	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1798	1807		10.1074/jbc.M116.767061	http://dx.doi.org/10.1074/jbc.M116.767061			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28031467	Green Published, hybrid			2022-12-26	WOS:000395515600021
J	Happel, MFK; Ohl, FW				Happel, Max F. K.; Ohl, Frank W.			Compensating Level-Dependent Frequency Representation in Auditory Cortex by Synaptic Integration of Corticocortical Input	PLOS ONE			English	Article							STIMULUS-SPECIFIC ADAPTATION; BROAD-BAND NOISE; INFERIOR COLLICULUS; MONGOLIAN GERBIL; THALAMOCORTICAL SYSTEM; SPECTRAL INTEGRATION; COCHLEAR NUCLEUS; FUNCTIONAL-ORGANIZATION; FEEDFORWARD INHIBITION; PYRAMIDAL NEURONS	Robust perception of auditory objects over a large range of sound intensities is a fundamental feature of the auditory system. However, firing characteristics of single neurons across the entire auditory system, like the frequency tuning, can change significantly with stimulus intensity. Physiological correlates of level-constancy of auditory representations hence should be manifested on the level of larger neuronal assemblies or population patterns. In this study we have investigated how information of frequency and sound level is integrated on the circuit level in the primary auditory cortex (Al) of the Mongolian gerbil. We used a combination of pharmacological silencing of corticocortically relayed activity and laminar current source density (CSD) analysis. Our data demonstrate that with increasing stimulus intensities progressively lower frequencies lead to the maximal impulse response within cortical input layers at a given cortical site inherited from thalamocortical synaptic inputs. We further identified a temporally precise intercolumnar synaptic convergence of early thalamocortical and horizontal corticocortical inputs. Later tone-evoked activity in upper layers showed a preservation of broad tonotopic tuning across sound levels without shifts towards lower frequencies. Synaptic integration within corticocortical circuits may hence contribute to a level-robust representation of auditory information on a neuronal population level in the auditory cortex.	[Happel, Max F. K.; Ohl, Frank W.] Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany; [Happel, Max F. K.; Ohl, Frank W.] Otto Von Guericke Univ, Inst Biol, D-39120 Magdeburg, Germany; [Ohl, Frank W.] CBBS, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University	Happel, MFK; Ohl, FW (corresponding author), Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany.; Happel, MFK; Ohl, FW (corresponding author), Otto Von Guericke Univ, Inst Biol, D-39120 Magdeburg, Germany.; Ohl, FW (corresponding author), CBBS, Magdeburg, Germany.	mhappel@lin-magdeburg.de; frank.ohl@lin-magdeburg.de		Happel, Max/0000-0002-9581-5856	Deutsche Forschungsgemeinschaft DFG	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	The work was supported by grants from the Deutsche Forschungsgemeinschaft DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LA, 2013, EUR J NEUROSCI, V37, P52, DOI 10.1111/ejn.12018; Ayala YA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10383; Bauerle P, 2011, J NEUROSCI, V31, P9708, DOI 10.1523/JNEUROSCI.5814-10.2011; Bandyopadhyay S, 2010, NAT NEUROSCI, V13, P361, DOI 10.1038/nn.2490; Barbour DL, 2011, NEUROSCI BIOBEHAV R, V35, P2064, DOI 10.1016/j.neubiorev.2011.04.009; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; Edeline JM, 2002, NEUROBIOL LEARN MEM, V78, P100, DOI 10.1006/nlme.2001.4035; Egorova M, 2008, EUR J NEUROSCI, V28, P675, DOI 10.1111/j.1460-9568.2008.06376.x; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; GEISLER CD, 1974, J NEUROPHYSIOL, V37, P1156, DOI 10.1152/jn.1974.37.6.1156; GIVRE SJ, 1994, VISION RES, V34, P415, DOI 10.1016/0042-6989(94)90156-2; Gopfert MC, 2003, P NATL ACAD SCI USA, V100, P5514, DOI 10.1073/pnas.0737564100; Grimsley CA, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00174; Happel MFK, 2014, J NEUROSCI, V34, P1234, DOI 10.1523/JNEUROSCI.1990-13.2014; Happel MFK, 2010, J NEUROSCI, V30, P11114, DOI 10.1523/JNEUROSCI.0689-10.2010; HARDING GW, 1992, EXP BRAIN RES, V90, P29; Hess A, 1996, NEUROREPORT, V7, P2643, DOI 10.1097/00001756-199611040-00047; HIND JE, 1963, J NEUROPHYSIOL, V26, P321, DOI 10.1152/jn.1963.26.2.321; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; Kadia SC, 2003, J NEUROPHYSIOL, V89, P1603, DOI 10.1152/jn.00271.2001; Kanold PO, 2014, TRENDS NEUROSCI, V37, P502, DOI 10.1016/j.tins.2014.06.003; Kanwal JS, 1999, J NEUROPHYSIOL, V82, P2327, DOI 10.1152/jn.1999.82.5.2327; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; Kurt S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001735; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; Linden JF, 2003, CEREB CORTEX, V13, P83, DOI 10.1093/cercor/13.1.83; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Lopez-Poveda EA, 2007, J ACOUST SOC AM, V121, P3646, DOI 10.1121/1.2722046; Luo F, 2011, J NEUROPHYSIOL, V105, P107, DOI 10.1152/jn.00546.2010; Manzoor NF, 2012, J NEUROPHYSIOL, V108, P976, DOI 10.1152/jn.00833.2011; Mesgarani N, 2010, J ACOUST SOC AM, V127, P1991; Metherate R, 2005, HEARING RES, V206, P146, DOI 10.1016/j.heares.2005.01.014; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; Miller LM, 2001, J NEUROSCI, V21, P8136, DOI 10.1523/JNEUROSCI.21-20-08136.2001; MILLS JH, 1990, HEARING RES, V46, P201, DOI 10.1016/0378-5955(90)90002-7; MITANI A, 1985, J COMP NEUROL, V235, P430, DOI 10.1002/cne.902350403; Mitzdorf U., 1985, AM PHYSL SOC, V65, P37; Moeller CK, 2010, EUR J NEUROSCI, V31, P49, DOI 10.1111/j.1460-9568.2009.07039.x; MOLLER AR, 1977, J ACOUST SOC AM, V62, P135, DOI 10.1121/1.381495; Nadrowski Bjoern, 2009, Communicative & Integrative Biology, V2, P7; Ohl FW, 1997, P NATL ACAD SCI USA, V94, P9440, DOI 10.1073/pnas.94.17.9440; Ohl FW, 2000, J NEUROPHYSIOL, V83, P3123, DOI 10.1152/jn.2000.83.5.3123; Ohl FW, 2000, J PHYSIOLOGY-PARIS, V94, P549, DOI 10.1016/S0928-4257(00)01091-3; Ojima H, 1991, CEREB CORTEX, V1, P80, DOI 10.1093/cercor/1.1.80; Orton LD, 2014, ELIFE, V3, DOI 10.7554/eLife.03764; Otazu GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024270; Oviedo HV, 2010, NAT NEUROSCI, V13, P1413, DOI 10.1038/nn.2659; PANTEV C, 1989, ELECTROEN CLIN NEURO, V72, P225, DOI 10.1016/0013-4694(89)90247-2; PHILLIPS DP, 1994, EXP BRAIN RES, V102, P210; Pienkowski M, 2011, J NEUROPHYSIOL, V106, P1016, DOI 10.1152/jn.00291.2011; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Rabinowitz NC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001710; Rabinowitz NC, 2011, NEURON, V70, P1178, DOI 10.1016/j.neuron.2011.04.030; RHODE WS, 1986, J NEUROPHYSIOL, V56, P261, DOI 10.1152/jn.1986.56.2.261; Robinson BL, 2009, CURR OPIN NEUROBIOL, V19, P402, DOI 10.1016/j.conb.2009.07.006; ROSE JE, 1971, J NEUROPHYSIOL, V34, P685, DOI 10.1152/jn.1971.34.4.685; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; RYAN A, 1976, J ACOUST SOC AM, V59, P1222, DOI 10.1121/1.380961; Sadagopan S, 2008, J NEUROSCI, V28, P3415, DOI 10.1523/JNEUROSCI.2743-07.2008; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Saldeitis K, 2014, J COMP NEUROL, V522, P2397, DOI 10.1002/cne.23540; SAMSDODD F, 1994, HEARING RES, V76, P16, DOI 10.1016/0378-5955(94)90083-3; SCHREINER CE, 1992, EXP BRAIN RES, V92, P105; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; Schulze H, 1997, J COMP PHYSIOL A, V181, P651, DOI 10.1007/s003590050147; Sharpee TO, 2011, CURR OPIN NEUROBIOL, V21, P761, DOI 10.1016/j.conb.2011.05.027; Smith PH, 2001, J COMP NEUROL, V436, P508, DOI 10.1002/cne.1084; STEINSCHNEIDER M, 1992, ELECTROEN CLIN NEURO, V84, P196, DOI 10.1016/0168-5597(92)90026-8; Stoelzel CR, 2008, J NEUROSCI, V28, P5018, DOI 10.1523/JNEUROSCI.4726-07.2008; Stufflebeam SM, 1998, NEUROREPORT; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; Tan AYY, 2007, NEUROSCIENCE, V146, P449, DOI 10.1016/j.neuroscience.2007.01.019; TENKE CE, 1993, EXP BRAIN RES, V94, P183; Teschner MJ, 2016, J NEUROSCI, V36, P2743, DOI 10.1523/JNEUROSCI.2079-15.2016; Willmore BDB, 2014, J PHYSIOL-LONDON, V592, P3371, DOI 10.1113/jphysiol.2014.274886; Winer J., 2011, PROFILE AUDITORY FOR; WINER JA, 1984, J COMP NEUROL, V224, P535, DOI 10.1002/cne.902240405; Winkowski DE, 2013, J NEUROSCI, V33, P18134, DOI 10.1523/JNEUROSCI.0180-13.2013; WINTER IM, 1995, J NEUROPHYSIOL, V73, P141, DOI 10.1152/jn.1995.73.1.141; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Wu GY, 2006, NEURON, V52, P705, DOI 10.1016/j.neuron.2006.10.009	82	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169461	10.1371/journal.pone.0169461	http://dx.doi.org/10.1371/journal.pone.0169461			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046062	Green Published, gold			2022-12-26	WOS:000391612300192
J	Hollenbaugh, JA; Shelton, J; Tao, SJ; Amiralaei, S; Liu, P; Lu, X; Goetze, RW; Zhou, LH; Nettles, JH; Schinazi, RF; Kim, B				Hollenbaugh, Joseph A.; Shelton, Jadd; Tao, Sijia; Amiralaei, Sheida; Liu, Peng; Lu, Xiao; Goetze, Russell W.; Zhou, Longhu; Nettles, James H.; Schinazi, Raymond F.; Kim, Baek			Substrates and Inhibitors of SAMHD1	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; RESTRICTION FACTOR SAMHD1; MONOCYTE-DERIVED MACROPHAGES; DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE; IMMUNODEFICIENCY-VIRUS TYPE-1; HEPATITIS-C VIRUS; HIV-1 RESTRICTION; RIBONUCLEOTIDE REDUCTASE; DNA-SYNTHESIS; DNTP LEVELS	SAMHD1 hydrolyzes 2'-deoxynucleoside-5'-triphosphates (dNTPs) into 2'-deoxynucleosides and inorganic triphosphate products. In this paper, we evaluated the impact of 2' sugar moiety substitution for different nucleotides on being substrates for SAMHD1 and mechanisms of actions for the results. We found that dNTPs ((2'R)-2'-H) are only permissive in the catalytic site of SAMHD1 due to L150 exclusion of (2'R)-2'-F and (2'R)-2'-OH nucleotides. However, arabinose ((2'S)-2'-OH) nucleoside-5'-triphosphates analogs are permissive to bind in the catalytic site and be hydrolyzed by SAMHD1. Moreover, when the (2'S)-2' sugar moiety is increased to a (2'S)-2'-methyl as with the SMDU-TP analog, we detect inhibition of SAMHD1's dNTPase activity. Our computational modeling suggests that (2'S)-2' methyl sugar moiety clashing with the Y374 of SAMHD1. We speculate that SMDU-TP mechanism of action requires that the analog first docks in the catalytic pocket of SAMHD1 but prevents the A351-V378 helix conformational change from being completed, which is needed before hydrolysis can occur. Collectively we have identified stereoselective 2' substitutions that reveal nucleotide substrate specificity for SAMHD1, and a novel inhibitory mechanism for the dNTPase activity of SAMHD1. Importantly, our data is beneficial for understanding if FDA-approved antiviral and anticancer nucleosides are hydrolyzed by SAMHD1 in vivo.	[Hollenbaugh, Joseph A.; Shelton, Jadd; Tao, Sijia; Amiralaei, Sheida; Liu, Peng; Lu, Xiao; Goetze, Russell W.; Zhou, Longhu; Schinazi, Raymond F.; Kim, Baek] Emory Univ, Sch Med, Dept Pediat, Ctr AIDS Res,Lab Biochem Pharmacol, Atlanta, GA 30322 USA; [Nettles, James H.] Emory Univ, Sch Med, Dept Biomed Informat, Atlanta, GA USA; [Nettles, James H.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Kim, Baek] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Kim, Baek] Kyung Hee Univ, Coll Pharm, Seoul, South Korea	Emory University; Emory University; Emory University; Children's Healthcare of Atlanta (CHOA); Kyung Hee University	Kim, B (corresponding author), Emory Univ, Sch Med, Dept Pediat, Ctr AIDS Res,Lab Biochem Pharmacol, Atlanta, GA 30322 USA.; Kim, B (corresponding author), Childrens Healthcare Atlanta, Atlanta, GA 30322 USA.; Kim, B (corresponding author), Kyung Hee Univ, Coll Pharm, Seoul, South Korea.	baek.kim@emory.edu			NIH [Al049781, GM104198, MH100999]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104198, T32GM008602] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Al049781 (B.K.), GM104198 (B.K.), and MH100999 (R.F.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari M, 2009, DNA REPAIR, V8, P834, DOI 10.1016/j.dnarep.2009.04.002; Amie SM, 2014, J BIOL CHEM, V289, P16641, DOI 10.1074/jbc.A113.493619; Amie SM, 2013, J BIOL CHEM, V288, P20683, DOI 10.1074/jbc.M113.472159; Arnold LH, 2015, ANTIMICROB AGENTS CH, V59, P186, DOI 10.1128/AAC.03903-14; Ballana E, 2014, ANTIMICROB AGENTS CH, V58, P4804, DOI 10.1128/AAC.03145-14; Balzarini J, 2000, PHARMACOL THERAPEUT, V87, P175, DOI 10.1016/S0163-7258(00)00050-4; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Brandariz-Nunez A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-131; Brandariz-Nunez A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-49; Chen ZM, 2014, BIOCHEM BIOPH RES CO, V450, P1462, DOI 10.1016/j.bbrc.2014.07.023; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; GAO WY, 1993, P NATL ACAD SCI USA, V90, P8925, DOI 10.1073/pnas.90.19.8925; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Guo Huai-Hong, 2013, CHINESE PHYS B, V23, P1; Hansen EC, 2014, P NATL ACAD SCI USA, V111, pE1843, DOI 10.1073/pnas.1401706111; Hollenbaugh JA, 2015, VIROLOGY, V485, P313, DOI 10.1016/j.virol.2015.08.006; Hollenbaugh JA, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0063-2; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Hu WS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006882; Huber AD, 2014, ANTIMICROB AGENTS CH, V58, P4915, DOI 10.1128/AAC.02745-14; Hurwitz SJ, 2013, CURR OPIN HIV AIDS, V8, P556, DOI 10.1097/COH.0000000000000007; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Kim ET, 2013, J VIROL, V87, P12949, DOI 10.1128/JVI.02291-13; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Li NS, 2003, J ORG CHEM, V68, P6799, DOI 10.1021/jo034263y; Lloyd SB, 2014, AIDS RES HUM RETROV, V30, P8, DOI [10.1089/aid.2013.0153, 10.1089/AID.2013.0153]; Mathews CK, 2015, NAT REV CANCER, V15, P528, DOI 10.1038/nrc3981; Matsuda A, 2004, CANCER SCI, V95, P105, DOI 10.1111/j.1349-7006.2004.tb03189.x; Miazzi C, 2014, J BIOL CHEM, V289, P18339, DOI 10.1074/jbc.M114.571091; Neuberger MS, 2005, NAT REV IMMUNOL, V5, P171, DOI 10.1038/nri1553; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Parker WB, 2009, CHEM REV, V109, P2880, DOI 10.1021/cr900028p; Pauls E, 2014, J IMMUNOL, V193, P1988, DOI 10.4049/jimmunol.1400873; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Rampazzo C, 2016, CANCER CHEMOTH PHARM, V77, P883, DOI 10.1007/s00280-015-2921-6; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; Ruiz A, 2015, CELL CYCLE, V14, P1657, DOI 10.1080/15384101.2015.1030558; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Salguero I, 2012, CURR BIOL, V22, P720, DOI 10.1016/j.cub.2012.02.070; Seamon KJ, 2014, J AM CHEM SOC, V136, P9822, DOI 10.1021/ja5035717; SHEWACH DS, 1992, MOL PHARMACOL, V42, P518; Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x; Sommer AFR, 2016, SCI REP-UK, V6, DOI 10.1038/srep26616; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; WEINBERG G, 1981, P NATL ACAD SCI-BIOL, V78, P2447, DOI 10.1073/pnas.78.4.2447; Welbourn S, 2013, J VIROL, V87, P11516, DOI 10.1128/JVI.01642-13; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; White TE, 2013, VIROLOGY, V436, P81, DOI 10.1016/j.virol.2012.10.029; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhou LH, 2015, J MED CHEM, V58, P3445, DOI 10.1021/jm501874e; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722	56	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169052	10.1371/journal.pone.0169052	http://dx.doi.org/10.1371/journal.pone.0169052			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046007	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300100
J	Kulabhusan, PK; Rajwade, JM; Sugumar, V; Taju, G; Hameed, ASS; Paknikar, KM				Kulabhusan, Prabir Kumar; Rajwade, Jyutika M.; Sugumar, Vimal; Taju, Gani; Hameed, A. S. Sahul; Paknikar, Kishore M.			Field-Usable Lateral Flow Immunoassay for the Rapid Detection of White Spot Syndrome Virus (WSSV)	PLOS ONE			English	Article							SHRIMP PENAEUS-JAPONICUS; MONOCLONAL-ANTIBODIES; IMMUNOCHROMATOGRAPHIC TEST; ASSAY; PCR; MONODON; STRIP; INDIA; VP28	Background White spot disease (WSD), a major threat to sustainable aquaculture worldwide, is caused by White spot syndrome virus (WSSV). The diagnosis of WSD relies heavily on molecular detection of the virus by one-step PCR. These procedures are neither field-usable nor rapid enough considering the speed at which the virus spreads. Thus, development of a rapid, reliable and field-usable diagnostic method for the detection of WSSV infection is imperative to prevent huge economic losses. Methods/Principal Findings Here, we report on the development of a lateral flow immunoassay (LFIA) employing gold nanoparticles conjugated to a polyclonal antibody against VP28 (envelope protein of WSSV). The LFIA detected WSSV in similar to 20 min and showed no cross-reactivity with other shrimp viruses, viz. Monodon Baculovirus (MBV), Hepatopancreatic parvovirus (HPV) and Infectious Hypodermal and Hematopoietic Necrosis virus (IHHNV). The limit of detection (LOD) of the assay, as determined by real-time PCR, was 10(3) copies of WSSV. In a time course infectivity experiment, similar to 10(4) WSSV particles were injected in Litopenaeus vannamei. The LFIA could rapidly (similar to 20 min) detect the virus in different tissues after 3 h (hemolymph), 6 h (gill tissue) and 12 h (head soft tissue, eye stalk, and pleopod) of infection. Based on these findings, a validation study was performed using 75 field samples collected from different geographical locations in India. The LFIA results obtained were compared with the conventional "gold standard test", viz. one-step PCR. The analysis of results in 2x2 matrix indicated very high sensitivity (100%) and specificity (96.77%) of LFIA. Similarly, Cohen's kappa coefficient of 0.983 suggested "very good agreement" between the developed LFIA and the conventional one-step PCR. Conclusion The LFIA developed for the rapid detection of WSSV has an excellent potential for use in the field and could prove to be a boon to the aquaculture industry.	[Kulabhusan, Prabir Kumar; Rajwade, Jyutika M.; Paknikar, Kishore M.] Agharkar Res Inst, Nanobiosci Grp, Pune, Maharashtra, India; [Sugumar, Vimal; Taju, Gani; Hameed, A. S. Sahul] C Abdul Hakeem Coll, OIE Reference Lab WTD, Melvisharam, Tamil Nadu, India	Department of Science & Technology (India); Agharkar Research Institute (ARI)	Paknikar, KM (corresponding author), Agharkar Res Inst, Nanobiosci Grp, Pune, Maharashtra, India.; Hameed, ASS (corresponding author), C Abdul Hakeem Coll, OIE Reference Lab WTD, Melvisharam, Tamil Nadu, India.	cah_sahul@hotmail.com; kpaknikar@gmail.com	KULABHUSAN, PRABIR KUMAR/H-2553-2017; Rajwade, J/P-7813-2019; Paknikar, Kishore/A-4963-2010	KULABHUSAN, PRABIR KUMAR/0000-0001-7184-0988; Paknikar, Kishore/0000-0001-5602-7518; sugumar, vimal/0000-0003-2344-2218; Hameed, A S Sahul/0000-0001-6561-6648; Rajwade, Jyutika/0000-0001-9465-3595	Department of Biotechnology, Government of India [BT/PR7244/AAQ/3/621/2012]; Indian Council of Medical Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	The work was supported by the Department of Biotechnology, Government of India (Grant No. BT/PR7244/AAQ/3/621/2012). PK is thankful to the Indian Council of Medical Research, Government of India for awarding a research fellowship.	Ambrosi A, 2010, ANAL CHEM, V82, P1151, DOI 10.1021/ac902492c; Anil TM, 2002, DIS AQUAT ORGAN, V51, P67, DOI 10.3354/dao051067; Baron J, 2014, TRANSBOUND EMERG DIS, V61, P390, DOI 10.1111/tbed.12266; Choi DH, 2010, BIOSENS BIOELECTRON, V25, P1999, DOI 10.1016/j.bios.2010.01.019; Durand S, 1997, DIS AQUAT ORGAN, V29, P205, DOI 10.3354/dao029205; Flegel TW, 1997, WORLD J MICROB BIOT, V13, P433, DOI 10.1023/A:1018580301578; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Hasson KW, 2006, DIS AQUAT ORGAN, V71, P91, DOI 10.3354/dao071091; Hou WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122952; Karunasagar I, 1997, AQUACULTURE, V153, P9, DOI 10.1016/S0044-8486(97)00011-2; Liu BH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138207; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Melena J., 2015, Brazilian Journal of Veterinary Pathology, V8, P51; Okumura T, 2004, J VIROL METHODS, V119, P11, DOI 10.1016/j.jviromet.2004.02.010; Poulos BT, 2001, DIS AQUAT ORGAN, V47, P13, DOI 10.3354/dao047013; Powell JWB, 2006, AQUACULTURE, V257, P167, DOI 10.1016/j.aquaculture.2006.03.010; Sanchez-Paz A, 2010, VET RES, V41, DOI 10.1051/vetres/2010015; Sithigorngul P, 2011, J VIROL METHODS, V173, P85, DOI 10.1016/j.jviromet.2011.01.011; Sithigorngul W, 2006, DIS AQUAT ORGAN, V72, P101, DOI 10.3354/dao072101; Srisala J, 2008, J VIROL METHODS, V153, P129, DOI 10.1016/j.jviromet.2008.07.027; TAKAHASHI Y, 1994, FISH PATHOL, V29, P121, DOI 10.3147/jsfp.29.121; Thilly W., 1993, GENOME RES, V3, pS18; Vaniksampanna A, 2016, AQUACULT RE IN PRESS; Vlak JM, 2005, 8 REP INT COMM TAX V, P187; Wang XJ, 2006, AQUACULTURE, V255, P196, DOI 10.1016/j.aquaculture.2006.01.021; Yang M, 2015, J VIROL METHODS, V221, P119, DOI 10.1016/j.jviromet.2015.05.001; Yi GH, 2004, J BIOCHEM MOL BIOL, V37, P726; Yoganandhan K, 2007, DIS AQUAT ORGAN, V73, P193, DOI 10.3354/dao073193; Yoganandhan K, 2004, J FISH DIS, V27, P517, DOI 10.1111/j.1365-2761.2004.00564.x; Yoganandhan K, 2003, AQUACULTURE, V215, P21, DOI 10.1016/S0044-8486(02)00123-0	30	26	26	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169012	10.1371/journal.pone.0169012	http://dx.doi.org/10.1371/journal.pone.0169012			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046005	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300089
J	Li, Y; Hou, X; Wei, DT; Du, X; Zhang, QL; Liu, GY; Qiu, J				Li, Yu; Hou, Xin; Wei, Dongtao; Du, Xue; Zhang, Qinglin; Liu, Guangyuan; Qiu, Jiang			Long-Term Effects of Acute Stress on the Prefrontal-Limbic System in the Healthy Adult	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; POSTTRAUMATIC-STRESS; RESTING-STATE; AUTOBIOGRAPHICAL MEMORY; PATTERN-RECOGNITION; EMOTIONAL MEMORY; HUMAN BRAIN; MAJOR DEPRESSION; VIETNAM VETERANS; COMBAT VETERANS	Most people are exposed to at least one traumatic event during the course of their lives, but large numbers of people do not develop posttraumatic stress disorders. Although previous studies have shown that repeated and chronic stress change the brain's structure and function, few studies have focused on the long-term effects of acute stressful exposure in a nonclinical sample, especially the morphology and functional connectivity changes in brain regions implicated in emotional reactivity and emotion regulation. Forty-one months after the 5/12 Wenchuan earthquake, we investigated the effects of trauma exposure on the structure and functional connectivity of the brains of trauma-exposed healthy individuals compared with healthy controls matched for age, sex, and education. We then used machine-learning algorithms with the brain structural features to distinguish between the two groups at an individual level. In the trauma-exposed healthy individuals, our results showed greater gray matter density in prefrontal-limbic brain systems, including the dorsal anterior cingulate cortex, medial prefrontal cortex, amygdala and hippocampus, than in the controls. Further analysis showed stronger amygdala-hippocampus functional connectivity in the trauma-exposed healthy compared to the controls. Our findings revealed that survival of traumatic experiences, without developing PTSD, was associated with greater gray matter density in the prefrontal-limbic systems related to emotional regulation.	[Li, Yu; Hou, Xin; Wei, Dongtao; Du, Xue; Zhang, Qinglin; Qiu, Jiang] Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China; [Li, Yu; Hou, Xin; Wei, Dongtao; Du, Xue; Zhang, Qinglin; Qiu, Jiang] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Liu, Guangyuan] Coll Elect & Informat Engn, Chongqing, Peoples R China	Southwest University - China	Qiu, J (corresponding author), Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China.; Qiu, J (corresponding author), Southwest Univ, Sch Psychol, Chongqing, Peoples R China.	qiuj318@swu.edu.cn	Hou, Xin/AAK-7733-2020	Hou, Xin/0000-0003-0695-4019	National Natural Science Foundation of China [31271087]; National High-level personnel of special support program [31571137]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-level personnel of special support program	This research was supported by the National Natural Science Foundation of China (31271087, Jiang Qiu) and the National High-level personnel of special support program (31571137, Jiang Qiu).	Admon R, 2012, CEREBRAL CORTEX; Admon R, 2009, P NATL ACAD SCI USA, V106, P14120, DOI 10.1073/pnas.0903183106; Almeida JRC, 2013, BRIT J PSYCHIAT, V203, P310, DOI 10.1192/bjp.bp.112.122838; Ansell EB, 2012, BIOL PSYCHIAT; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Bechdolf A, 2010, ACTA PSYCHIAT SCAND, V121, P377, DOI 10.1111/j.1600-0447.2010.01542.x; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BOEHNLEIN JK, 1989, PERSPECT BIOL MED, V32, P455; Brambilla P, 2002, NEUROPSYCHOPHARMACOL, V27, P792, DOI 10.1016/S0893-133X(02)00352-4; Bremner J Douglas, 2002, Curr Psychiatry Rep, V4, P254, DOI 10.1007/s11920-996-0044-9; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Breslau N, 2009, TRAUMA VIOLENCE ABUS, V10, P198, DOI 10.1177/1524838009334448; Brohawn KH, 2010, BIOL PSYCHIAT, V68, P1023, DOI 10.1016/j.biopsych.2010.07.018; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Carp J, 2013, NEUROIMAGE, V76, P436, DOI 10.1016/j.neuroimage.2011.12.061; Chepenik LG, 2010, PSYCHIAT RES-NEUROIM, V182, P207, DOI 10.1016/j.pscychresns.2010.04.002; Cisler JM, 2013, PSYCHOL MED, V43, P507, DOI 10.1017/S0033291712001390; Coccaro EF, 2007, BIOL PSYCHIAT, V62, P168, DOI 10.1016/j.biopsych.2006.08.024; Cohen JE, 2013, HUM BRAIN MAPP, V34, P1344, DOI 10.1002/hbm.21516; Cunningham-Bussel AC, 2009, PSYCHONEUROENDOCRINO, V34, P694, DOI 10.1016/j.psyneuen.2008.11.011; Douglas J., 1992, AM J PSYCHIAT, V149, P328, DOI DOI 10.1176/AJP.149.3.328; Eckart C, 2011, J PSYCHIATR NEUROSCI, V36, P176, DOI 10.1503/jpn.100010; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; Epifani I, 2008, ELECTRON J STAT, V2, P774, DOI 10.1214/08-EJS259; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etzel JA, 2015, PATT REC NEUR PRNI 2; Fink GR, 1996, J NEUROSCI, V16, P4275; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Frodl T, 2010, NEUROPSYCHOPHARMACOL, V35, P1383, DOI 10.1038/npp.2010.8; Fu CHY, 2008, BIOL PSYCHIAT, V63, P656, DOI 10.1016/j.biopsych.2007.08.020; Ganzel BL, 2008, NEUROIMAGE, V40, P788, DOI 10.1016/j.neuroimage.2007.12.010; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; Goenjian AK, 2000, AM J PSYCHIAT, V157, P911, DOI 10.1176/appi.ajp.157.6.911; Gold AL, 2011, PSYCHOL MED, V41, P2563, DOI 10.1017/S0033291711000730; Golland P., 2003, PERMUTATION TESTS CL; Greenberg DL, 2005, NEUROPSYCHOLOGIA, V43, P659, DOI 10.1016/j.neuropsychologia.2004.09.002; Hahn A, 2011, NEUROIMAGE, V56, P881, DOI 10.1016/j.neuroimage.2011.02.064; Hamann S, 2001, TRENDS COGN SCI, V5, P394, DOI 10.1016/S1364-6613(00)01707-1; Harley M, 2010, PSYCHOL MED, V40, P1627, DOI 10.1017/S0033291709991966; Heim C, 2006, ARCH GEN PSYCHIAT, V63, P1258, DOI 10.1001/archpsyc.63.11.1258; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Herringa R, 2012, PSYCHIAT RES-NEUROIM, V203, P139, DOI 10.1016/j.pscychresns.2012.02.005; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Liu X., 1998, CHINESE J BEHAV MED, V7, P93, DOI DOI 10.1177/1524838015585313; Lui S, 2013, J PSYCHIATR NEUROSCI, V38, P381, DOI 10.1503/jpn.120244; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McEwen BS, 2000, BIOL PSYCHIAT, V48, P721, DOI 10.1016/S0006-3223(00)00964-1; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; McIntyre CK, 2005, P NATL ACAD SCI USA, V102, P10718, DOI 10.1073/pnas.0504436102; McNally RJ, 2006, TRENDS COGN SCI, V10, P271, DOI 10.1016/j.tics.2006.04.007; MCNALLY RJ, 1995, BEHAV RES THER, V33, P619, DOI 10.1016/0005-7967(95)00007-K; Modinos G, 2012, NEUROIMAGE, V59, P3033, DOI 10.1016/j.neuroimage.2011.10.048; Nutt D.J., 2004, J CLIN PSYCHIAT; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; PAIGE SR, 1990, BIOL PSYCHIAT, V27, P419, DOI 10.1016/0006-3223(90)90552-D; Papagni SA, 2011, STRESS, V14, P227, DOI 10.3109/10253890.2010.522279; Pavlides C, 2002, HIPPOCAMPUS, V12, P245, DOI 10.1002/hipo.1116; Peruggia M, 1997, J AM STAT ASSOC, V92, P199, DOI 10.2307/2291464; Pfeifer S, 2009, SCHIZOPHRENIA BULL, V35, P766, DOI 10.1093/schbul/sbn004; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Power JD, 2013, NEUROIMAGE, V76, P439, DOI 10.1016/j.neuroimage.2012.03.017; Ressler KJ, 2010, BIOL PSYCHIAT, V67, P1117, DOI 10.1016/j.biopsych.2010.04.027; Roozendaal B, 2002, NEUROBIOL LEARN MEM, V78, P578, DOI 10.1006/nlme.2002.4080; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Schrouff J, 2013, NEUROINFORMATICS, V11, P319, DOI 10.1007/s12021-013-9178-1; Sekiguchi A, 2013, MOL PSYCHIATR, V18, P618, DOI 10.1038/mp.2012.51; Shapiro ML, 1999, HIPPOCAMPUS, V9, P365, DOI 10.1002/(SICI)1098-1063(1999)9:4<365::AID-HIPO4>3.3.CO;2-K; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Smith APR, 2006, NEURON, V49, P631, DOI 10.1016/j.neuron.2005.12.025; Smith APR, 2004, NEUROIMAGE, V22, P868, DOI 10.1016/j.neuroimage.2004.01.049; Smith ME, 2005, HIPPOCAMPUS, V15, P798, DOI 10.1002/hipo.20102; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spielberger CD., 2010, STATE TRAIT ANXIETY; Sripada RK, 2012, J PSYCHIATR NEUROSCI, V37, P241, DOI 10.1503/jpn.110069; St Jacques PL, 2011, J PSYCHIATR RES, V45, P630, DOI 10.1016/j.jpsychires.2010.10.011; Steel Z, 2002, LANCET, V360, P1056, DOI 10.1016/S0140-6736(02)11142-1; Stelzer J, 2013, NEUROIMAGE, V65, P69, DOI 10.1016/j.neuroimage.2012.09.063; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Strakowski SM, 2011, BIOL PSYCHIAT, V69, P381, DOI 10.1016/j.biopsych.2010.09.019; Takeuchi H, 2012, CEREBRAL CORTEX; Tsoory M, 2008, PROGR BRAIN RES, P167; Turner RJ, 1995, J HEALTH SOC BEHAV, V36, P360, DOI 10.2307/2137325; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; van Marle HJF, 2010, NEUROIMAGE, V53, P348, DOI 10.1016/j.neuroimage.2010.05.070; van Marle HJF, 2009, BIOL PSYCHIAT, V66, P649, DOI 10.1016/j.biopsych.2009.05.014; Veer IM, 2011, NEUROIMAGE, V57, P1534, DOI 10.1016/j.neuroimage.2011.05.074; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Weber DL, 2005, PSYCHIAT RES-NEUROIM, V140, P27, DOI 10.1016/j.pscychresns.2005.07.003; Weiss DS, 1997, ASSESSING PSYCHOL TR, V2, P168, DOI DOI 10.1007/978-0-387; Williams LM, 2006, NEUROIMAGE, V29, P347, DOI 10.1016/j.neuroimage.2005.03.047; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yin Y, 2011, BRAIN RES, V1411, P98, DOI 10.1016/j.brainres.2011.07.016	107	17	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168315	10.1371/journal.pone.0168315	http://dx.doi.org/10.1371/journal.pone.0168315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2QJ	28045980	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300019
J	Lopez-Tello, J; Arias-Alvarez, M; Jimenez-Martinez, MA; Garcia-Garcia, RM; Rodriguez, M; Gonzalez, PLL; Bermejo-Poza, R; Gonzalez-Bulnes, A; Rebollar, PG				Lopez-Tello, Jorge; Arias-Alvarez, Maria; Angeles Jimenez-Martinez, Maria; Maria Garcia-Garcia, Rosa; Rodriguez, Maria; Lorenzo Gonzalez, Pedro Luis; Bermejo-Poza, Ruben; Gonzalez-Bulnes, Antonio; Garcia Rebollar, Pilar			Competition for Materno-Fetal Resource Partitioning in a Rabbit Model of Undernourished Pregnancy	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; FEED RESTRICTION; FOOD RESTRICTION; GENE-EXPRESSION; DEVELOPMENTAL ORIGINS; PLACENTAL EFFICIENCY; NUTRIENT RESTRICTION; GLUCOSE-METABOLISM; EARLY GESTATION; GUINEA-PIG	The major goal of animal production is to obtain abundant and healthy meat for consumers. Maternal food restriction (MFR) is often applied in farms to reduce production costs. However, the suitability of MFR in livestock animals is questionable, as this management may compromise maternal fitness due to a severe negative energetic balance and can induce Intrauterine Growth Restriction (IUGR) and prenatal programming in the offspring. Here, we sought to determine, using pregnant rabbits, the consequences of MFR on maternal endocrine and metabolic status and conceptus development. Pregnant dams were distributed into three groups: CONTROL (ad libitum feeding throughout the entire pregnancy; mean pregnancy length being around 31 days), UNDERFED (50% MFR during the entire pregnancy) and EARLY-UNDERFED (50% MFR only during the preimplantation period, Days 0-7). Maternal leptin concentrations and glycemic and lipid profiles were determined throughout pregnancy, whilst conceptus development was assessed ex-vivo at Day 28. Placental parameters were determined by macroscopic and histological evaluations and apoptotic assessments (TUNEL and Caspase-3). The main results of the study showed that, despite MFR altered maternal plasma lipid concentration (P<0.05), there were no effects on maternal bodyweight, plasma leptin concentration or glycemic profile. Fetal crown-rump lengths were reduced in both undernourished groups (P<0.001), but a significant reduction in fetal weight was only observed in the UNDERFED group (P<0.001). Growth in both undernourished groups was asymmetrical, with reduced liver weight (P<0.001) and significantly increased brain: fetal weight-ratio (P<0.001) and brain: liver weight-ratio (P<0.001) when compared to the CONTROL group. A significant reduction in placental weight was only observed in the UNDERFED group (P<0.001), despite both undernourished groups showing higher apoptotic rates at decidua and labyrinth zone (P<0.05) than the CONTROL group. Thus, these groups evidenced signs of placental degeneration, necrosis and stromal collapse. In summary, MFR may encourage the mother to make strategic decisions to safeguard her metabolic status and fitness at the expense of growth reduction in the litter, resulting in enhanced apoptotic and pathological processes at placental level and IUGR.	[Lopez-Tello, Jorge; Arias-Alvarez, Maria; Bermejo-Poza, Ruben] Univ Complutense Madrid, Fac Vet, Dept Anim Prod, Ciudad Univ, Madrid, Spain; [Angeles Jimenez-Martinez, Maria] Univ Complutense Madrid, Fac Vet, Dept Anim Med & Surg, Ciudad Univ, Madrid, Spain; [Maria Garcia-Garcia, Rosa; Lorenzo Gonzalez, Pedro Luis] Univ Complutense Madrid, Fac Vet, Dept Physiol Anim Physiol, Ciudad Univ, Madrid, Spain; [Rodriguez, Maria; Garcia Rebollar, Pilar] ETSIAAB Polytech Univ Madrid, Dept Agrarian Prod, Ciudad Univ, Madrid, Spain; [Gonzalez-Bulnes, Antonio] SGIT INIA, Comparat Physiol Grp, Avda Puerta Hierro, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid	Lopez-Tello, J (corresponding author), Univ Complutense Madrid, Fac Vet, Dept Anim Prod, Ciudad Univ, Madrid, Spain.	jorlop01@ucm.es	Rebollar, Pilar G/K-9599-2014; Bermejo-Poza, Rubén/K-7312-2017; Gonzalez-Bulnes, Antonio/K-7691-2015; , Pilar/L-3778-2019; Garcia-Garcia, Rosa M./L-1998-2014; Arias Alvarez, Maria/L-6169-2014; LORENZO, PEDRO L/F-1015-2011	Rebollar, Pilar G/0000-0003-4418-0157; Bermejo-Poza, Rubén/0000-0003-2608-0750; Gonzalez-Bulnes, Antonio/0000-0002-0917-4475; , Pilar/0000-0003-4418-0157; Garcia-Garcia, Rosa M./0000-0002-3393-8906; Arias Alvarez, Maria/0000-0001-7907-7454; Jimenez Martinez, Maria Angeles/0000-0001-6352-8978; LORENZO, PEDRO L/0000-0001-7955-4206; Rodriguez, Maria/0000-0001-5168-6629	Spanish Ministry of Science and Technology [AGL2011-23822, AGL2015-65572-C2-1-R]; Comunidad de Madrid [S2013/ABI-2913]	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This research was supported by funding from the Spanish Ministry of Science and Technology (AGL2011-23822; AGL2015-65572-C2-1-R) and Comunidad de Madrid (S2013/ABI-2913). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albu A R, 2014, J Med Life, V7, P165; Allain D, 2010, ANIMAL, V4, P1472, DOI 10.1017/S1751731110000029; Antonow-Schlorke I, 2011, P NATL ACAD SCI USA, V108, P3011, DOI 10.1073/pnas.1009838108; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Barker DJP, 2004, PHILOS T R SOC B, V359, P1359, DOI 10.1098/rstb.2004.1518; Bassan H, 2000, PEDIATR NEPHROL, V15, P192, DOI 10.1007/s004670000457; Bassan H, 2010, J MATERN-FETAL NEO M, V23, P595, DOI [10.1080/14767050903197068, 10.3109/14767050903197068]; Belkacemi L, 2009, PLACENTA, V30, P739, DOI 10.1016/j.placenta.2009.06.003; Belkacemi L, 2010, BIOL REPROD, V83, P325, DOI 10.1095/biolreprod.110.084517; Boden G, 1996, J CLIN ENDOCR METAB, V81, P3419, DOI 10.1210/jc.81.9.3419; Camm EJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.046; Campos PHRF, 2012, ANIMAL, V6, P797, DOI 10.1017/S1751731111002242; Cappon GD, 2005, BIRTH DEFECTS RES B, V74, P424, DOI 10.1002/bdrb.20058; Carney Edward W, 2004, Birth Defects Res C Embryo Today, V72, P345, DOI 10.1002/bdrc.20027; Chandi A, 2015, ARCH GYNECOL OBSTET, V292, P1135, DOI 10.1007/s00404-015-3706-1; Chavatte-Palmer P, 2015, ANIM REPROD, V12, P505; Chavatte-Palmer P, 2016, REPROD FERT DEVELOP, V28, P94, DOI 10.1071/RD15353; Chen Lian-Hui, 2015, Zhongguo Dang Dai Er Ke Za Zhi, V17, P1124; Clarke L, 1998, BRIT J NUTR, V79, P359, DOI 10.1079/BJN19980060; Coan PM, 2010, J PHYSIOL-LONDON, V588, P527, DOI 10.1113/jphysiol.2009.181214; Coan PM, 2006, DEV DYNAM, V235, P3280, DOI 10.1002/dvdy.20981; Cohen E, 2015, NEONATOLOGY, V108, P269, DOI 10.1159/000438451; Cox P, 2009, BEST PRACT RES CL OB, V23, P751, DOI 10.1016/j.bpobgyn.2009.06.006; de Rooij SR, 2010, P NATL ACAD SCI USA, V107, P16881, DOI 10.1073/pnas.1009459107; Debus N, 2012, THERIOGENOLOGY, V77, P1453, DOI 10.1016/j.theriogenology.2011.11.015; Derrick M, 2009, INT J DEV NEUROSCI, V27, P549, DOI 10.1016/j.ijdevneu.2009.06.008; DEVOS P, 1995, J BIOL CHEM, V270, P15958, DOI 10.1074/jbc.270.27.15958; Dwyer CM, 1995, REPROD FERT DEVELOP, V7, P1285, DOI 10.1071/RD9951285; Eixarch E, 2011, PLACENTA, V32, P304, DOI 10.1016/j.placenta.2011.01.014; Eixarch E, 2009, FETAL DIAGN THER, V26, P203, DOI 10.1159/000264063; Eixarch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031497; Figueroa H, 2016, PRENAT DIAGN; Fischer B, 2012, REPRODUCTION, V144, P1, DOI 10.1530/REP-12-0091; Ford SP, 2007, J ANIM SCI, V85, P1285, DOI 10.2527/jas.2005-624; Fowden AL, 2012, PLACENTA, V33, pE11, DOI 10.1016/j.placenta.2012.05.002; Fowden AL, 2009, J PHYSIOL-LONDON, V587, P3459, DOI 10.1113/jphysiol.2009.173013; Fowden AL, 2006, J PHYSIOL-LONDON, V572, P5, DOI 10.1113/jphysiol.2005.104141; George LA, 2012, AM J PHYSIOL-REG I, V302, pR795, DOI 10.1152/ajpregu.00241.2011; Goliomytis M, 2016, ANIMAL, V10, P157, DOI 10.1017/S1751731115001871; Gonzalez-Bulnes A, 2016, EUPA OPEN PROTEOMICS; Gonzalez-Tendero A, 2013, AM J PHYSIOL-HEART C, V305, pH1752, DOI 10.1152/ajpheart.00514.2013; HAREL S, 1985, BRAIN DEV-JPN, V7, P575, DOI 10.1016/S0387-7604(85)80004-8; Henson MC, 2006, BIOL REPROD, V74, P218, DOI 10.1095/biolreprod.105.045120; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; Hoffman LH, 1999, EMBRYO IMPLANTATION, P151; Illa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076453; Jelks A, 2009, REPROD SCI, V16, P665, DOI 10.1177/1933719109334257; JONES AP, 1982, SCIENCE, V215, P1518, DOI 10.1126/science.7063860; Kavitha JV, 2014, FASEB J, V28, P1294, DOI 10.1096/fj.13-242271; Khan H, 2012, J REPROD DEVELOP, V58, P231, DOI 10.1262/jrd.11-128T; Kind KL, 2002, EXP PHYSIOL, V87, P469, DOI 10.1111/j.1469-445X.2002.tb00060.x; Kirat D., 2015, International Journal of Biology, V7, P113; Kondo Akira, 2003, J Atheroscler Thromb, V10, P72; Kwon H, 2004, BIOL REPROD, V71, P901, DOI 10.1095/biolreprod.104.029645; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; LARSEN JORGEN FALCK, 1963, JOUR ULTRASTRUCTURE RES, V8, P327, DOI 10.1016/S0022-5320(63)90011-X; Lecarpentier E, 2012, PLACENTA, V33, P769, DOI 10.1016/j.placenta.2012.06.013; Lesage J, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740037; Lippi G, 2007, CLIN LAB, V53, P173; Lopez-Tello J, 2015, J DEV ORIG HLTH DIS, V6, P454, DOI 10.1017/S2040174415001385; Lopez-Tello J, 2016, REPROD FERTIL DEV; Manal AF, 2010, ANIM REPROD SCI, V120, P179, DOI 10.1016/j.anireprosci.2010.03.010; Matsuoka T, 2012, J TOXICOL SCI, V37, P207, DOI 10.2131/jts.37.207; MATSUZAWA T, 1981, TOXICOLOGY, V22, P255, DOI 10.1016/0300-483X(81)90088-3; Menchetti L, 2015, WORLD RABBIT SCI, V23, P1, DOI 10.4995/wrs.2015.1703; Menchetti L, 2015, RES VET SCI, V98, P7, DOI 10.1016/j.rvsc.2014.11.017; Mu J, 2002, PLACENTA, V23, P215, DOI 10.1053/plac.2001.0759; Musial B, 2016, DIABETES, V65, P851, DOI 10.2337/db15-1531; Nafeaa Abeer, 2011, Vet Med Int, V2011, P839737, DOI 10.4061/2011/839737; PETRERE JA, 1993, FUND APPL TOXICOL, V21, P517, DOI 10.1006/faat.1993.1128; Polisca A, 2010, THERIOGENOLOGY, V73, P358, DOI 10.1016/j.theriogenology.2009.09.019; REYNOLDS SRM, 1946, ANAT REC, V95, P283, DOI 10.1002/ar.1090950303; Rodriguez JS, 2012, REPROD SCI, V19, P493, DOI 10.1177/1933719111424439; Rommers JM, 2004, ANIM REPROD SCI, V81, P151, DOI 10.1016/j.anireprosci.2003.09.001; SAMUEL CA, 1975, J REPROD FERTIL, V45, P9, DOI 10.1530/jrf.0.0450009; Sandovici I, 2012, REPROD BIOMED ONLINE, V25, P68, DOI 10.1016/j.rbmo.2012.03.017; Sankaran S, 2009, BEST PRACT RES CL OB, V23, P765, DOI 10.1016/j.bpobgyn.2009.05.003; Satterfield MC, 2010, J NUTR, V140, P251, DOI 10.3945/jn.109.114678; Schlitt JM, 2012, ENDOCRINE, V41, P227, DOI 10.1007/s12020-011-9548-0; Schroder HJ, 2003, EUR J OBSTET GYN R B, V110, pS29, DOI 10.1016/S0301-2115(03)00170-2; Schulz LC, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.103218; Sferruzzi-Perri AN, 2011, ENDOCRINOLOGY, V152, P3202, DOI 10.1210/en.2011-0240; Sferruzzi-Perri AN, 2016, P NATL ACAD SCI USA, V113, P11255, DOI 10.1073/pnas.1602012113; Sferruzzi-Perri AN, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00033; Simitzis PE, 2015, PHYSIOL BEHAV, V141, P172, DOI 10.1016/j.physbeh.2015.01.025; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P57, DOI 10.1016/S0002-9378(97)70438-1; Sookoian S, 2013, PEDIATR RES, V73, P531, DOI 10.1038/pr.2013.2; Symeon GK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118259; Tarrade A, 2014, PLACENTA, V35, P254, DOI 10.1016/j.placenta.2014.01.013; Thakur A, 2000, J PEDIATR SURG, V35, P898, DOI 10.1053/jpsu.2000.6914; Torre I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113067; Wilson ME, 2001, J REP FER S, P223; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Zotte A. dalle, 2014, Animal Frontiers, V4, P62, DOI 10.2527/af.2014-0035	95	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169194	10.1371/journal.pone.0169194	http://dx.doi.org/10.1371/journal.pone.0169194			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046002	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300139
J	Mcrae, L; Deinet, S; Freeman, R				McRae, Louise; Deinet, Stefanie; Freeman, Robin			The Diversity-Weighted Living Planet Index: Controlling for Taxonomic Bias in a Global Biodiversity Indicator	PLOS ONE			English	Article							CONSERVATION; PROGRESS; TRENDS; MAP	As threats to species continue to increase, precise and unbiased measures of the impact these pressures are having on global biodiversity are urgently needed. Some existing indicators of the status and trends of biodiversity largely rely on publicly available data from the scientific and grey literature, and are therefore prone to biases introduced through overrepresentation of well-studied groups and regions in monitoring schemes. This can give misleading estimates of biodiversity trends. Here, we report on an approach to tackle taxonomic and geographic bias in one such indicator (Living Planet Index) by accounting for the estimated number of species within biogeographical realms, and the relative diversity of species within them. Based on a proportionally weighted index, we estimate a global population decline in vertebrate species between 1970 and 2012 of 58% rather than 20% from an index with no proportional weighting. From this data set, comprising 14,152 populations of 3,706 species from 3,095 data sources, we also find that freshwater populations have declined by 81%, marine populations by 36%, and terrestrial populations by 38% when using proportional weighting (compared to trends of-46%, +12% and +15% respectively). These results not only show starker declines than previously estimated, but suggests that those species for which there is poorer data coverage may be declining more rapidly.	[McRae, Louise; Deinet, Stefanie; Freeman, Robin] Zool Soc London, Inst Zool, Indicators & Assessments Res Unit, London, England	Zoological Society of London	Mcrae, L (corresponding author), Zool Soc London, Inst Zool, Indicators & Assessments Res Unit, London, England.	louise.mcrae@ioz.ac.uk	Deinet, Stefanie/AFV-1478-2022	Deinet, Stefanie/0000-0003-0710-1165; McRae, Louise/0000-0003-1076-0874	WWF International	WWF International	LM was funded by WWF International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; [Anonymous], 2016, LIV PLAN REP 2016 RI; Baillie J.E.M., 2010, EVOLUTION LOST STATU; Bland LM, 2015, CONSERV BIOL, V29, P250, DOI 10.1111/cobi.12372; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Buckland ST, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00186.1; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Collen B, 2014, SCIENCE, V346, P166, DOI 10.1126/science.1255772; Collen B, 2011, PHILOS T R SOC B, V366, P2577, DOI 10.1098/rstb.2011.0015; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Collen B, 2008, TROP CONSERV SCI, V1, P75, DOI 10.1177/194008290800100202; De Vos JM, 2015, CONSERV BIOL, V29, P452, DOI 10.1111/cobi.12380; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Huang XL, 2011, TRENDS ECOL EVOL, V26, P377, DOI 10.1016/j.tree.2011.05.006; Isaac NJB, 2014, METHODS ECOL EVOL, V5, P1052, DOI 10.1111/2041-210X.12254; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jones JPG, 2011, CONSERV BIOL, V25, P450, DOI 10.1111/j.1523-1739.2010.01605.x; Kissling W. Daniel, 2015, Biodiversity (Ottawa), V16, P99, DOI 10.1080/14888386.2015.1068709; Loh J, 2005, PHILOS T R SOC B, V360, P289, DOI 10.1098/rstb.2004.1584; Loh J., 1998, LIVING PLANET REPORT; Martin LJ, 2012, FRONT ECOL ENVIRON, V10, P195, DOI 10.1890/110154; McRae L, 2016, DRYAD DIGITAL REPOSI; McRae L., 2014, LIVING PLANET REPORT; Nicholson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041128; OBIS, 2014, DISTR REC MAR VERT S; ONU, 2015, RESOLUTION ADOPTED G, DOI DOI 10.1007/S13398-014-0173-7.2; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Pereira HM, 2012, ANNU REV ENV RESOUR, V37, P25, DOI 10.1146/annurev-environ-042911-093511; Pettorelli N, 2016, REMOTE SENSING ECOLO; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Proenca V, BIOL CONSERVATION; Pysek P, TRENDS ECOLOGY EVOLU, V23, P237; Santini L, BIOL CONSERVATION; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; van Swaay CAM, 2008, BIODIVERS CONSERV, V17, P3455, DOI 10.1007/s10531-008-9491-4; Walpole M, 2009, SCIENCE, V325, P1503, DOI 10.1126/science.1175466; *WORLD WILDL FUND, 2006, WILDFINDER ONL DAT S; Yesson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001124	44	95	97	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169156	10.1371/journal.pone.0169156	http://dx.doi.org/10.1371/journal.pone.0169156			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045977	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300130
J	Pifferi, S				Pifferi, Simone			Permeation Mechanisms in the TMEM16B Calcium-Activated Chloride Channels	PLOS ONE			English	Article							CA2+-ACTIVATED CL-CHANNELS; INDEPENDENT ACTIVATION; ANION PERMEATION; ION CONDUCTION; SMOOTH-MUSCLE; SELECTIVITY; SCRAMBLASE; CURRENTS; NEURONS; BINDING	TMEM16A and TMEM16B encode for Ca2+-activated CI- channels (CaCC) and are expressed in many cell types and play a relevant role in many physiological processes. Here, I performed a site-directed mutagenesis study to understand the molecular mechanisms of ion permeation of TMEM16B. I mutated two positive charged residues R573 and K540, respectively located at the entrance and inside the putative channel pore and I measured the properties of wild-type and mutant TMEM16B channels expressed in HEK-293 cells using whole-cell and excised inside-out patch clamp experiments. I found evidence that R573 and K540 control the ion permeability of TMEM16B depending both on which side of the membrane the ion substitution occurs and on the level of channel activation. Moreover, these residues contribute to control blockage or activation by permeant anions. Finally, R573 mutation abolishes the anomalous mole fraction effect observed in the presence of a permeable anion and it alters the apparent Ca2+-sensitivity of the channel. These findings indicate that residues facing the putative channel pore are responsible both for controlling the ion selectivity and the gating of the channel, providing an initial understanding of molecular mechanism of ion permeation in TMEM16B.	[Pifferi, Simone] SISSA, Neurobiol Grp, Trieste, Italy	International School for Advanced Studies (SISSA)	Pifferi, S (corresponding author), SISSA, Neurobiol Grp, Trieste, Italy.	spifferi@sissa.it		Pifferi, Simone/0000-0002-3687-3984	European Union Marie Curie Reintegration Grant [334404]	European Union Marie Curie Reintegration Grant	This study was supported by a European Union Marie Curie Reintegration Grant to Simone Pifferi (OLF-STOM no. 334404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi A, 2015, J PHYSIOL-LONDON, V593, P4129, DOI 10.1113/JP270575; Adomaviciene A, 2013, J PHYSIOL-LONDON, V591, P3487, DOI 10.1113/jphysiol.2013.251660; Betto G, 2014, J GEN PHYSIOL, V143, P703, DOI 10.1085/jgp.201411182; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Fallah G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004697; Francia S., 2014, NEUROBIOLOGY CHEM CO; Gillespie D, 2008, BIOPHYS J, V94, P1169, DOI [10.1529/biophysj.107.116798, 10.1529/biophysj.107.113084]; Gillespie D, 2009, BIOPHYS J, V97, P2212, DOI 10.1016/j.bpj.2009.08.009; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hille B., 2001, ION CHANNEL EXCITABL; Huang F, 2013, NAT NEUROSCI, V16, P1284, DOI 10.1038/nn.3468; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; JAFFE LA, 1986, ANNU REV PHYSIOL, V48, P191, DOI 10.1146/annurev.ph.48.030186.001203; Jeng G, 2016, J GEN PHYSIOL, V148, P393, DOI 10.1085/jgp.201611651; Jun I, 2016, J PHYSIOL-LONDON, V594, P2929, DOI 10.1113/JP271311; Leblanc N, 2005, CAN J PHYSIOL PHARM, V83, P541, DOI 10.1139/Y05-040; Leblanc N, 2015, PULM CIRC, V5, P244, DOI 10.1086/680189; Lee RJ, 2014, CELL CALCIUM, V55, P325, DOI 10.1016/j.ceca.2014.02.001; Lim NK, 2016, J GEN PHYSIOL, V148, P375, DOI 10.1085/jgp.201611650; MacKinnon R, 2004, BIOSCIENCE REP, V24, P75, DOI 10.1007/s10540-004-7190-2; Milenkovic VM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-319; Neurnaier F, 2015, PROG NEUROBIOL, V129, P1, DOI 10.1016/j.pneurobio.2014.12.003; Ni YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086734; Nonner W, 2000, BIOPHYS J, V79, P1976, DOI 10.1016/S0006-3495(00)76446-0; Nonner W, 1998, BIOPHYS J, V74, P2327, DOI 10.1016/S0006-3495(98)77942-1; Perez-Cornejo P, 2004, J MEMBRANE BIOL, V198, P125, DOI 10.1007/s00232-004-0659-x; Peters CJ, 2015, P NATL ACAD SCI USA, V112, P3547, DOI 10.1073/pnas.1502291112; Pifferi S., 2010, NEUROBIOLOGY OLFACTI; Pifferi S, 2012, EXP PHYSIOL, V97, P193, DOI 10.1113/expphysiol.2011.058230; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Qu ZQ, 2000, J GEN PHYSIOL, V116, P825, DOI 10.1085/jgp.116.6.825; Reyes JP, 2014, PFLUG ARCH EUR J PHY, V466, P1769, DOI 10.1007/s00424-013-1415-9; Saidu SP, 2013, J GEN PHYSIOL, V141, P691, DOI 10.1085/jgp.201210937; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; SESTI F, 1995, J PHYSIOL-LONDON, V487, P17, DOI 10.1113/jphysiol.1995.sp020858; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Terashima H, 2013, P NATL ACAD SCI USA, V110, P19354, DOI 10.1073/pnas.1312014110; Tien J, 2014, ELIFE, V3, DOI 10.7554/eLife.02772; Tien J, 2013, P NATL ACAD SCI USA, V110, P6352, DOI 10.1073/pnas.1303672110; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2014, J GEN PHYSIOL, V143, P253, DOI 10.1085/jgp.201311047; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440	48	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169572	10.1371/journal.pone.0169572	http://dx.doi.org/10.1371/journal.pone.0169572			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046119	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300206
J	Pollara, G; Murray, MJ; Heather, JM; Byng-Maddick, R; Guppy, N; Ellis, M; Turner, CT; Chain, BM; Noursadeghi, M				Pollara, Gabriele; Murray, Matthew J.; Heather, James M.; Byng-Maddick, Rachel; Guppy, Naomi; Ellis, Matthew; Turner, Carolin T.; Chain, Benjamin M.; Noursadeghi, Mandad			Validation of Immune Cell Modules in Multicellular Transcriptomic Data	PLOS ONE			English	Article							DELAYED-TYPE HYPERSENSITIVITY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANALYSIS REVEALS; GENE-EXPRESSION; SIGNATURES; INFLAMMATION; POPULATIONS; ACTIVATION; COMPENDIUM; BIOLOGY	Numerous gene signatures, or modules have been described to evaluate the immune cell composition in transcriptomes of multicellular tissue samples. However, significant diversity in module gene content for specific cell types is associated with heterogeneity in their performance. In order to rank modules that best reflect their purported association, we have generated the modular discrimination index (MDI) score that assesses expression of each module in the target cell type relative to other cells. We demonstrate that MDI scores predict modules that best reflect independently validated differences in cellular composition, and correlate with the covariance between cell numbers and module expression in human blood and tissue samples. Our analyses demonstrate that MDI scores provide an ordinal summary statistic that reliably ranks the accuracy of gene expression modules for deconvolution of cell type abundance in transcriptional data.	[Pollara, Gabriele; Murray, Matthew J.; Heather, James M.; Byng-Maddick, Rachel; Turner, Carolin T.; Chain, Benjamin M.; Noursadeghi, Mandad] UCL, Div Infect & Immun, London, England; [Guppy, Naomi] UCL, UCL Adv Diagnost, London, England; [Ellis, Matthew] UCL, UCL Inst Neurol, Dept Neurodegenerat Dis, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Pollara, G (corresponding author), UCL, Div Infect & Immun, London, England.	g.pollara@ucl.ac.uk	Heather, James/I-1123-2019	Heather, James/0000-0002-1783-5181; Turner, Carolin/0000-0002-1905-2834; Noursadeghi, Mahdad/0000-0002-4774-0853; Chain, Benny/0000-0002-7417-3970; Murray, Matthew/0000-0002-0379-7161; Ellis, Matthew/0000-0002-5264-0531; Guppy, Naomi/0000-0003-1004-3605	Wellcome Trust Postdoctoral Clinical Research Fellowship [WT101766/Z/13/Z]; Medical Research Council Bench to Bedside PhD programme [1486672]; Arthritis Research UK Clinical Research Fellowship [20131]; Medical Research Council [MR/M003833/1]; National Institute for Health Research University College London Hospitals Biomedical Research Centre; BBSRC [BB/L025302/1] Funding Source: UKRI; MRC [MR/M003833/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L025302/1] Funding Source: researchfish; Cancer Research UK [20256] Funding Source: researchfish; Medical Research Council [960507, 1486672] Funding Source: researchfish; National Institute for Health Research [CL-2016-18-011, ACF-2010-20-001] Funding Source: researchfish; Rosetrees Trust [M470] Funding Source: researchfish; Versus Arthritis [20131] Funding Source: researchfish	Wellcome Trust Postdoctoral Clinical Research Fellowship; Medical Research Council Bench to Bedside PhD programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK Clinical Research Fellowship(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); Versus Arthritis(Versus Arthritis)	GP is the recipient of a Wellcome Trust Postdoctoral Clinical Research Fellowship (WT101766/Z/13/Z), MM is the recipient of Medical Research Council Bench to Bedside PhD programme (1486672) and RBM is the recipient of an Arthritis Research UK Clinical Research Fellowship (20131). This work was also supported by the Medical Research Council (MR/M003833/1) and by the National Institute for Health Research University College London Hospitals Biomedical Research Centre.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Ardura MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005446; Artyomov MN, 2015, J EXP MED, V212, P743, DOI 10.1084/jem.20131675; Bell LCK, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005469; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Chain B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-344; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chaussabel D, 2014, NAT REV IMMUNOL, V14, P271, DOI 10.1038/nri3642; DePianto DJ, 2015, THORAX, V70, P48, DOI 10.1136/thoraxjnl-2013-204596; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnson-Huang LM, 2012, J INVEST DERMATOL, V132, P1177, DOI 10.1038/jid.2011.458; Lee DJ, 2010, J INFECT DIS, V201, P558, DOI 10.1086/650318; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Mabbott NA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-632; Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; PLATT JL, 1983, J EXP MED, V158, P1227, DOI 10.1084/jem.158.4.1227; POULTER LW, 1982, CELL IMMUNOL, V74, P358, DOI 10.1016/0008-8749(82)90036-3; Roe JK, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87238; Tomlinson GS, 2011, EUR J IMMUNOL, V41, P3253, DOI 10.1002/eji.201141841; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Wilkens J, 2013, J IMMUNOL, V191, P2226, DOI 10.4049/jimmunol.1300958; Wood O, 2016, ONCOTARGET, V7, P56781, DOI 10.18632/oncotarget.10788; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006	27	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169271	10.1371/journal.pone.0169271	http://dx.doi.org/10.1371/journal.pone.0169271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045996	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000391612300155
J	Stemeseder, T; Schweidler, B; Doppler, P; Klinglmayr, E; Moser, S; Lueftenegger, L; Himly, M; Lang, R; Zumbach, J; Oostingh, GJ; Hawranek, T; Bathke, AC; Gadermaier, G				Stemeseder, Teresa; Schweidler, Bettina; Doppler, Patrick; Klinglmayr, Eva; Moser, Stephanie; Lueftenegger, Lisa; Himly, Martin; Lang, Roland; Zumbach, Joerg; Oostingh, Gertie J.; Hawranek, Thomas; Bathke, Arne C.; Gadermaier, Gabriele			Exposure to Indoor Allergens in Different Residential Settings and Its Influence on IgE Sensitization in a Geographically Confined Austrian Cohort	PLOS ONE			English	Article							HOUSE-DUST MITES; FARMING ENVIRONMENTS; PET OWNERSHIP; INNER-CITY; ASTHMA; CAT; CHILDREN; RISK; ALTITUDE; ADULTS	Background Exposure to indoor allergens is crucial for IgE sensitization and development of allergic symptoms. Residential settings influence the allergen amount in house dust and hence allergic sensitization. Within this study, we investigated allergen exposure and molecule based IgE levels in a geographically confined region and evaluated the impact of housing, pets and cleaning. Methods 501 adolescents from Salzburg, Austria participated in this cross-sectional study. House dust samples were examined regarding major mite, cat, dog, and mold allergens using a multiplex assay. Serum samples of participants were analyzed for specific IgE to Der p 1, Der p 2, Fel d 1, Can f 1 and Alt a 1 using the multiplex array ImmunoCAP ISAC. Information on allergies, living areas, dwelling form (house, flat, farm), pets, and household cleanliness were obtained by a questionnaire. Results In investigated house dust samples, the concentration of cat allergen was highest while the prevalence of mold allergens was very low. Participants showed IgE sensitization to Der p 1 (13.2%), Der p 2 (18.2%), Fel d 1 (14.4%), Can f 1 (2.4%) and Alt a 1 (2.0%). In alpine regions, lower mite allergen concentrations were detected which correlated with reduced IgE levels. A trend for increased sensitization prevalence from rural to alpine to urban regions was noted. Living on farms resulted in lower sensitization prevalence to mite and cat allergens, even though exposure to mites was significantly elevated. The presence of cats was associated with a lower sensitization rate and IgE levels to cat and mite allergens, and less frequent allergic diseases. Cleaning did not impact allergen concentrations, while IgE reactivity to mites and allergic diseases were more pronounced when living in cleaner homes. Conclusion Allergen exposure to indoor allergens was influenced by setting of homes. Living in a farm environment and having a cat at home showed a protective effect for IgE sensitization and allergies. This cross-sectional study in combination with hereditary and lifestyle factors enables development of risk schemes for a more efficient management and potential prevention of allergic diseases.	[Stemeseder, Teresa; Schweidler, Bettina; Klinglmayr, Eva; Himly, Martin; Gadermaier, Gabriele] Salzburg Univ, Dept Mol Biol, Salzburg, Austria; [Doppler, Patrick; Zumbach, Joerg; Bathke, Arne C.] Salzburg Univ, Dept Math, Salzburg, Austria; [Moser, Stephanie] Salzburg Univ, Sch Educ, Salzburg, Austria; [Moser, Stephanie] Tech Univ Munich, TUM Sch Educ, Munich, Germany; [Lueftenegger, Lisa; Lang, Roland; Hawranek, Thomas] Paracelsus Med Univ Salzburg, Dept Dermatol, Salzburg, Austria; [Lueftenegger, Lisa; Oostingh, Gertie J.] Salzburg Univ Appl Sci, Biomed Sci, Puch Salzburg, Austria	Salzburg University; Salzburg University; Salzburg University; Technical University of Munich; Paracelsus Private Medical University	Gadermaier, G (corresponding author), Salzburg Univ, Dept Mol Biol, Salzburg, Austria.	Gabriele.Gadermaier@sbg.ac.at	Oostingh, Gertie Janneke/HHC-1098-2022; Gadermaier, Gabriele/L-5997-2015; Zumbach, Joerg/AAF-6550-2020; Himly, Martin/D-1568-2015	Gadermaier, Gabriele/0000-0002-4886-417X; Himly, Martin/0000-0001-5416-085X; Oostingh, Gertie Janneke/0000-0001-5083-217X	Sparkling Science, a program of the Federal Ministry of Science, Research and Economy of Austria [SPA 04/065-Alraune]; Open Access Publication Fund of the University of Salzburg	Sparkling Science, a program of the Federal Ministry of Science, Research and Economy of Austria; Open Access Publication Fund of the University of Salzburg	The study was funded by Sparkling Science (www.sparklingscience.at), a program of the Federal Ministry of Science, Research and Economy of Austria (SPA 04/065-Alraune). The funding is assigned to the University of Salzburg; GG is the project head; TS, EK and GG received grant money. The authors acknowledge financial support by the Open Access Publication Fund of the University of Salzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2014, GLOBAL ATLAS ALLERGY; Arruda LK, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0428-6; Arshad SH, 2010, CURR ALLERGY ASTHM R, V10, P49, DOI 10.1007/s11882-009-0082-6; Asarnoj A, 2016, J ALLERGY CLIN IMMUN, V137, P813, DOI 10.1016/j.jaci.2015.09.052; Bjerg A, 2016, CLIN EXPT ALLERGY J; Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; Carlsten C, 2010, PEDIAT ALLERG IMM-UK, V21, pE740, DOI 10.1111/j.1399-3038.2010.01021.x; Chapman MD, 1998, ALLERGY, V53, P48, DOI 10.1111/j.1398-9995.1998.tb04939.x; CHARPIN D, 1991, AM REV RESPIR DIS, V143, P983, DOI 10.1164/ajrccm/143.5_Pt_1.983; Choi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013423; Custovic A, 2003, J ALLERGY CLIN IMMUN, V111, P402, DOI 10.1067/mai.2003.55; Custovic A, 1996, J ALLERGY CLIN IMMUN, V98, P64, DOI 10.1016/S0091-6749(96)70227-0; Dallongeville A, 2015, SCI TOTAL ENVIRON, V536, P964, DOI 10.1016/j.scitotenv.2015.06.039; Elholm G, 2016, CLIN EXP ALLERGY, V46, P103, DOI 10.1111/cea.12583; Eller E, 2008, ALLERGY, V63, P1491, DOI 10.1111/j.1398-9995.2008.01790.x; Fujimura KE, 2014, P NATL ACAD SCI USA, V111, P805, DOI 10.1073/pnas.1310750111; Grafetstatter C, 2016, ALLERGY ASTHMA IMMUN, V8, P312, DOI 10.4168/aair.2016.8.4.312; Gruchalla RS, 2005, J ALLERGY CLIN IMMUN, V115, P478, DOI 10.1016/j.jaci.2004.12.006; Hamilton RG, 2005, CURR ALLERGY ASTHM R, V5, P394, DOI 10.1007/s11882-005-0013-0; Heinrich J, 2006, ALLERGY CLIN IMMUNOL, V118; Hirsch T, 2000, CLIN EXP ALLERGY, V30, P529, DOI 10.1046/j.1365-2222.2000.00785.x; Horak E, 2014, WIEN KLIN WOCHENSCHR, V126, P532, DOI 10.1007/s00508-014-0571-z; IVERSEN M, 1990, CLIN EXP ALLERGY, V20, P211, DOI 10.1111/j.1365-2222.1990.tb02670.x; King EM, 2013, J IMMUNOL METHODS, V387, P89, DOI 10.1016/j.jim.2012.09.015; KLEINETEBBE J, 1993, CLIN EXP ALLERGY, V23, P211, DOI 10.1111/j.1365-2222.1993.tb00884.x; Konieczny A, 1997, IMMUNOLOGY, V92, P577, DOI 10.1046/j.1365-2567.1997.00386.x; Lau S, 2005, ALLERGY, V60, P766, DOI 10.1111/j.1398-9995.2005.00781.x; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Lee A, 2006, INT ARCH ALLERGY IMM, V141, P396, DOI 10.1159/000095467; Majkowska-Wojciechowska B, 2007, ALLERGY, V62; Matricardi PM, 2016, PEDIAT ALLERG IMM-UK, V27, P1, DOI 10.1111/pai.12563; Olivieri M, 2012, J ALLERGY CLIN IMMUN, V129, P420, DOI 10.1016/j.jaci.2011.10.044; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Perzanowski MS, 2002, AM J RESP CRIT CARE, V166, P696, DOI 10.1164/rccm.2201035; Perzanowski MS, 2016, J ALLERGY CLIN IMMUN; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; Pomes A, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0622-9; Radon K, 2000, ALLERGY, V55, P219, DOI 10.1034/j.1398-9995.2000.00461.x; Rao D, 2011, CURR ALLERGY ASTHM R, V11, P414, DOI 10.1007/s11882-011-0206-7; Ronmark E, 2009, J ALLERGY CLIN IMMUN, V124, P357, DOI 10.1016/j.jaci.2009.05.011; Ruokolainen L, 2014, ALLERGY; Salo PM, 2014, J ALLERGY CLIN IMMUN, V134, P350, DOI 10.1016/j.jaci.2013.12.1071; Salo PM, 2005, J ALLERGY CLIN IMMUN, V116, P623, DOI 10.1016/j.jaci.2005.05.030; Schoos AMM, 2016, ALLERGY, V71, P684, DOI 10.1111/all.12853; Schoos AM, 2016, ALLERGY; Schram-Bijkerk D, 2006, ALLERGY, V61, P640, DOI 10.1111/j.1398-9995.2006.01079.x; Simons E, 2007, J URBAN HEALTH, V84, P577, DOI 10.1007/s11524-007-9205-3; Sozanska B, 2014, J ALLERGY CLIN IMMUN, V133, P1347, DOI 10.1016/j.jaci.2013.10.035; SPIEKSMA FT, 1971, BMJ-BRIT MED J, V1, P82, DOI 10.1136/bmj.1.5740.82; Stemeseder T, 2016, ALLERGY; Valdivieso R, 2011, ALLERGOL IMMUNOPATH, V39, P10, DOI 10.1016/j.aller.2010.02.010; van Ree R, 1999, J ALLERGY CLIN IMMUN, V104, P1223, DOI 10.1016/S0091-6749(99)70017-5; VERVLOET D, 1982, J ALLERGY CLIN IMMUN, V69, P290, DOI 10.1016/S0091-6749(82)80006-7; von Mutius E., 2016, J ALLERGY CLIN IMMUN; Wahn U, 1997, J ALLERGY CLIN IMMUN, V99, P763, DOI 10.1016/S0091-6749(97)80009-7; Wardzynska A, 2012, WORLD ALLERGY ORGAN, V5, P22, DOI 10.1097/WOX.0b013e3182447fa8; Williams AH, 2011, J ASTHMA, V48, P674, DOI 10.3109/02770903.2011.599909; Zahradnik E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00076; Zahradnik E, 2011, J ENVIRON MONITOR, V13, P2638, DOI 10.1039/c1em10430f	60	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168686	10.1371/journal.pone.0168686	http://dx.doi.org/10.1371/journal.pone.0168686			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045938	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300045
J	Yang, DD; Yang, HL; Wang, LM; Zhou, YC; Zhang, ZY; Wang, R; Liu, Y				Yang, Dongdong; Yang, Hailong; Wang, Luming; Zhou, Yucong; Zhang, Zhiyuan; Wang, Rui; Liu, Yi			Performance Optimization of Marine Science and Numerical Modeling on HPC Cluster	PLOS ONE			English	Article							PARALLEL OCEAN PROGRAM; WAVE MODEL; SYSTEM; DECOMPOSITION; VALIDATION	Marine science and numerical modeling (MASNUM) is widely used in forecasting ocean wave movement, through simulating the variation tendency of the ocean wave. Although efforts have been devoted to improve the performance of MASNUM from various aspects by existing work, there is still large space unexplored for further performance improvement. In this paper, we aim at improving the performance of propagation solver and data access during the simulation, in addition to the efficiency of output I/O and load balance. Our optimizations include several effective techniques such as the algorithm redesign, load distribution optimization, parallel I/O and data access optimization. The experimental results demonstrate that our approach achieves higher performance compared to the state-of-the-art work, about 3.5x speedup without degrading the prediction accuracy. In addition, the parameter sensitivity analysis shows our optimizations are effective under various topography resolutions and output frequencies.	[Yang, Dongdong; Yang, Hailong; Wang, Luming; Zhou, Yucong; Wang, Rui; Liu, Yi] Beihang Univ, Sch Comp Sci & Engn, Beijing, Peoples R China; [Zhang, Zhiyuan] Tsinghua Univ, Dept Comp Sci & Technol, Beijing, Peoples R China; [Liu, Yi] State Key Lab Math Engn & Adv Comp, Wuxi, Peoples R China	Beihang University; Tsinghua University	Wang, R (corresponding author), Beihang Univ, Sch Comp Sci & Engn, Beijing, Peoples R China.	wangrui@buaa.edu.cn	yang, hailong/GXH-9625-2022; zhang, zhiyuan/GRS-2141-2022		National Natural Science Foundation of China [61502019]; National Key Research and Development Program of China [2016YFB1000304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work is supported by National Natural Science Foundation of China (Grant No. 61502019) and National Key Research and Development Program of China (Grant No. 2016YFB1000304).	Bao Q, 2010, ADV ATMOS SCI, V27, P1131, DOI 10.1007/s00376-010-9177-1; Bonan GB, 2013, GLOBAL CHANGE BIOL, V19, P957, DOI 10.1111/gcb.12031; Booij N, 1999, J GEOPHYS RES-OCEANS, V104, P7649, DOI 10.1029/98JC02622; Coutsias EA, 2004, J COMPUT CHEM, V25, P1849, DOI 10.1002/jcc.20110; Cowles GW, 2008, INT J HIGH PERFORM C, V22, P177, DOI 10.1177/1094342007083804; Dean J, 2008, COMMUN ACM, V51, P107, DOI 10.1145/1327452.1327492; Dennis J., 2007, IEEE INT PAR DISTR P, P1; Dennis JM, 2008, IBM J RES DEV, V52, P117, DOI 10.1147/rd.521.0117; Donner LJ, 2011, J CLIMATE, V24, P3484, DOI 10.1175/2011JCLI3955.1; Fangli Q., 2007, FRONTIER SCI, V3; Ghysels P, 2014, PARALLEL COMPUT, V40, P224, DOI 10.1016/j.parco.2013.06.001; HASSELMANN S, 1988, J PHYS OCEANOGR, V18, P1775; Hu Y, 2015, P INT C HIGH PERF CO, P42; Jones PW, 2005, CONCURR COMP-PRACT E, V17, P1317, DOI 10.1002/cpe.894; Kerbyson DJ, 2005, INT J HIGH PERFORM C, V19, P261, DOI 10.1177/1094342005056114; Li J., 2003, PROC ACMIEEE C SUPER, P39, DOI DOI 10.1109/SC.2003.10053; Neale R. B., 2010, NCARTN486STR; Nitta T, 2014, J CLIMATE, V27, P3318, DOI 10.1175/JCLI-D-13-00310.1; Smith R, 2010, PARALLEL OCEAN PROGR, V141; Turner AK, 2015, J GEOPHYS RES-OCEANS, V120, P1253, DOI 10.1002/2014JC010358; Valcke S, 2013, GEOSCI MODEL DEV, V6, P373, DOI 10.5194/gmd-6-373-2013; Wang GS, 2016, ACTA OCEANOL SIN, V35, P19, DOI 10.1007/s13131-016-0810-4; [王关锁 WANG Guansuo], 2007, [海洋科学进展, Advances in Marine Science], V25, P401; Webb MJ, 2013, CLIM DYNAM, V41, P1923, DOI 10.1007/s00382-012-1608-5; Worley PH, 2011, HIGH PERF COMP NETW, P1; [杨永增 Yang Yongzeng], 2005, [海洋学报, Acta Oceanologica Sinica], V27, P1; Yeli Y, 1991, ACTA OCEANOL SIN, V11, P13; Yuan Y., 1991, ACTA OCEANOL SIN, V10, P483; Zhang Li-lun, 2009, Computer Engineering and Applications, V45, P189, DOI 10.3778/j.issn.1002-8331.2009.05.056; [张志远 Zhang Zhiyuan], 2015, [计算机研究与发展, Journal of Computer Research and Development], V52, P851; Zhao W, 2014, SCI CHINA EARTH SCI, V57, P1869, DOI 10.1007/s11430-014-4842-3; Zou Q, 2015, BIOINFORMATICS, V31, P2475, DOI 10.1093/bioinformatics/btv177; Zou Q, 2014, BRIEF BIOINFORM, V15, P637, DOI 10.1093/bib/bbs088	33	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169130	10.1371/journal.pone.0169130	http://dx.doi.org/10.1371/journal.pone.0169130			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045972	Green Submitted, gold, Green Published			2022-12-26	WOS:000391612300123
J	Estep, CM; Galtieri, DJ; Zampese, E; Goldberg, JA; Brichta, L; Greengard, P; Surmeier, DJ				Estep, Chad M.; Galtieri, Daniel J.; Zampese, Enrico; Goldberg, Joshua A.; Brichta, Lars; Greengard, Paul; Surmeier, D. James			Transient Activation of GABA(B) Receptors Suppresses SK Channel Currents in Substantia Nigra Pars Compacta Dopaminergic Neurons	PLOS ONE			English	Article							BASAL GANGLIA; MIDBRAIN NEURONS; IN-VITRO; INOSITOL 1,4,5-TRISPHOSPHATE; MEDIATED INHIBITION; MEMBRANE-PROPERTIES; ADENYLYL-CYCLASE; CALCIUM-CHANNELS; FIRING PATTERN; GIRK CHANNELS	Dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc) are richly innervated by GABAergic neurons. The postsynaptic effects of GABA on SNc DA neurons are mediated by a mixture of GABA(A) and GABA(B) receptors. Although activation of GABA(A) receptors inhibits spike generation, the consequences of GABA(B) receptor activation are less well characterized. To help fill this gap, perforated patch recordings were made from young adult mouse SNc DA neurons. Sustained stimulation of GABA(B) receptors hyperpolarized SNc DA neurons, as previously described. However, transient stimulation of GABA(B) receptors by optical uncaging of GABA did not; rather, it reduced the opening of small-conductance, calcium-activated K+ (SK) channels and increased the irregularity of spiking. This modulation was attributable to inhibition of adenylyl cyclase and protein kinase A. Thus, because suppression of SK channel activity increases the probability of burst spiking, transient co-activation of GABA(A) and GABA(B) receptors could promote a pause-burst pattern of spiking.	[Estep, Chad M.; Galtieri, Daniel J.; Zampese, Enrico; Surmeier, D. James] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Goldberg, Joshua A.] Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Med Neurobiol, Fac Med, Jerusalem, Israel; [Brichta, Lars; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Northwestern University; Feinberg School of Medicine; Hebrew University of Jerusalem; Rockefeller University	Surmeier, DJ (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Goldberg, Joshua/B-3398-2009	Goldberg, Joshua/0000-0002-5740-4087; Zampese, Enrico/0000-0002-8851-2566; Greengard, Paul/0000-0002-4437-0893	JPB Foundation; National Institutes of Health [P50N5047085]; Fisher Center for Alzheimer's Research; Leon Black Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS047085] Funding Source: NIH RePORTER	JPB Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fisher Center for Alzheimer's Research; Leon Black Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by JPB Foundation [www.jpbfoundation.org] (DJS PG), National Institutes of Health (P50N5047085) (DJS), The Fisher Center for Alzheimer's Research [https://www.alzinfo.org/] (PG), and Leon Black Family Foundation (PG).	Amendola J, 2012, J NEUROSCI, V32, P2166, DOI 10.1523/JNEUROSCI.5297-11.2012; Berlin S, 2010, J BIOL CHEM, V285, P6179, DOI 10.1074/jbc.M109.085944; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Blythe SN, 2009, J NEUROSCI, V29, P15531, DOI 10.1523/JNEUROSCI.2961-09.2009; BOLAM JP, 1990, BRAIN RES, V529, P57, DOI 10.1016/0006-8993(90)90811-O; Boyes J, 2003, EUR J NEUROSCI, V18, P3279, DOI 10.1111/j.1460-9568.2003.03076.x; Brichta L, 2015, NAT NEUROSCI, V18, P1325, DOI 10.1038/nn.4070; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; CARDOZO DL, 1995, J NEUROPHYSIOL, V74, P1137, DOI 10.1152/jn.1995.74.3.1137; Chaloux B, 2007, BIOL CELL, V99, P379, DOI 10.1042/BC20060121; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Charara A, 2000, NEUROSCIENCE, V95, P127; Clarysse L, 2014, PFLUG ARCH EUR J PHY, V466, P1921, DOI 10.1007/s00424-013-1435-5; Cui GH, 2007, J NEUROSCI, V27, P4776, DOI 10.1523/JNEUROSCI.0139-07.2007; Deignan J, 2012, NEUROSCIENCE, V217, P67, DOI 10.1016/j.neuroscience.2012.04.053; Deister CA, 2009, J NEUROSCI, V29, P15888, DOI 10.1523/JNEUROSCI.4053-09.2009; deSouza N, 2002, J BIOL CHEM, V277, P39397, DOI 10.1074/jbc.M207059200; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; Fernandez-Fernandez JM, 2001, EUR J NEUROSCI, V14, P283, DOI 10.1046/j.0953-816x.2001.01642.x; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Gulacsi A, 2003, J NEUROSCI, V23, P8237; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; HARRIS NC, 1989, NEUROSCIENCE, V31, P355, DOI 10.1016/0306-4522(89)90379-5; Henny P, 2012, NAT NEUROSCI, V15, P613, DOI 10.1038/nn.3048; Howe MW, 2016, NATURE, V535, P505, DOI 10.1038/nature18942; Hunter J. D., 2007, MATPLOTLIB 2D GRAPHI; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Ji H, 2006, NEUROSCIENCE, V140, P623, DOI 10.1016/j.neuroscience.2006.02.020; Ji HF, 2009, EUR J NEUROSCI, V29, P1883, DOI 10.1111/j.1460-9568.2009.06735.x; Johnson SW, 2004, BRAIN RES, V1019, P293, DOI 10.1016/j.brainres.2004.06.022; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; KITA T, 1986, BRAIN RES, V372, P21, DOI 10.1016/0006-8993(86)91454-X; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; LACEY MG, 1989, J NEUROSCI, V9, P1233; LACEY MG, 1988, J PHYSIOL-LONDON, V401, P437, DOI 10.1113/jphysiol.1988.sp017171; Lee CR, 2009, J NEURAL TRANSM-SUPP, P71, DOI 10.1007/978-3-211-92660-4_6; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; LLINAS R, 1984, BRAIN RES, V294, P127, DOI 10.1016/0006-8993(84)91316-7; Lobb CJ, 2011, J NEUROPHYSIOL, V105, P2501, DOI 10.1152/jn.01076.2010; Lobb CJ, 2010, J NEUROPHYSIOL, V104, P403, DOI 10.1152/jn.00204.2010; Morikawa H, 2003, J NEUROSCI, V23, P149; Morikawa H, 2000, J NEUROSCI, V20, part. no.; NEDERGAARD S, 1993, THE JOURNAL OF PHYSI, V466, P727; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Nishikawa M, 1997, NEUROCHEM INT, V31, P21, DOI 10.1016/S0197-0186(96)00138-6; Padgett CL, 2010, ADV PHARMACOL, V58, P123, DOI 10.1016/S1054-3589(10)58006-2; Paladini CA, 2014, NEUROSCIENCE, V282, P109, DOI 10.1016/j.neuroscience.2014.07.032; Paladini CA, 1999, BRAIN RES, V832, P145, DOI 10.1016/S0006-8993(99)01484-5; Paladini CA, 1999, NEUROSCIENCE, V89, P799, DOI 10.1016/S0306-4522(98)00355-8; Paladini CA, 1999, SYNAPSE; Pearlstein E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00210; Ping HX, 1996, NEUROREPORT, V7, P809, DOI 10.1097/00001756-199602290-00031; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Schultz W, 1997, SCIENCE; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; SHEPARD PD, 1991, EXP BRAIN RES, V86, P141, DOI 10.1007/BF00231048; Suzuki J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5153; Tateno T, 2010, NEUROREPORT, V21, P667, DOI 10.1097/WNR.0b013e32833add56; TEPPER JM, 1995, J NEUROSCI, V15, P3092; Ueno S, 1997, J NEUROSCI, V17, P625; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Verde EMR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.002.2008; VILLACRES EC, 1995, J BIOL CHEM, V270, P14352, DOI 10.1074/jbc.270.24.14352; Wang Y, 2010, BRAIN RES, V1324, P54, DOI 10.1016/j.brainres.2010.02.008; Watts AE, 1996, J NEUROPHYSIOL, V76, P2262, DOI 10.1152/jn.1996.76.4.2262; WESTCOTT KR, 1979, P NATL ACAD SCI USA, V76, P204, DOI 10.1073/pnas.76.1.204; Wise RA, 2009, TRENDS NEUROSCI, V32, P517, DOI 10.1016/j.tins.2009.06.004; Wolfart J, 2001, J NEUROSCI, V21, P3443, DOI 10.1523/JNEUROSCI.21-10-03443.2001; Wolfart J, 2002, J NEUROSCI, V22, P3404; YUNG WH, 1991, J PHYSIOL-LONDON, V436, P643, DOI 10.1113/jphysiol.1991.sp018571; Zhao Q, 2003, MOL PHARMACOL, V64, P1085, DOI 10.1124/mol.64.5.1085	74	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169044	10.1371/journal.pone.0169044	http://dx.doi.org/10.1371/journal.pone.0169044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036359	Green Published, gold, Green Submitted			2022-12-26	WOS:000391229300048
J	Del Bene, VA; Foxe, JJ; Ross, LA; Krakowski, MI; Czobor, P; De Sanctis, P				Del Bene, Victor A.; Foxe, John J.; Ross, Lars A.; Krakowski, Menahem I.; Czobor, Pal; De Sanctis, Pierfilippo			Neuroanatomical Abnormalities in Violent Individuals with and without a Diagnosis of Schizophrenia	PLOS ONE			English	Article							ANTISOCIAL PERSONALITY-DISORDER; COGNITIVE NEUROSCIENCE PERSPECTIVE; BARRATT IMPULSIVENESS SCALE; SUPERIOR TEMPORAL SULCUS; AGGRESSION QUESTIONNAIRE; AUTOMATED SEGMENTATION; ALZHEIMERS-DISEASE; AMYGDALA VOLUMES; SERIOUS VIOLENCE; CHILDHOOD ABUSE	Several structural brain abnormalities have been associated with aggression in patients with schizophrenia. However, little is known about shared and distinct abnormalities underlying aggression in these subjects and non-psychotic violent individuals. We applied a region-of interest volumetric analysis of the amygdala, hippocampus, and thalamus bilaterally, as well as whole brain and ventricular volumes to investigate violent (n = 37) and non-violent chronic patients (n = 26) with schizophrenia, non-psychotic violent (n = 24) as well as healthy control subjects (n = 24). Shared and distinct volumetric abnormalities were probed by analysis of variance with the factors violence (non-violent versus violent) and diagnosis (non-psychotic versus psychotic), adjusted for substance abuse, age, academic achievement and negative psychotic symptoms. Patients showed elevated vCSF volume, smaller left hippocampus and smaller left thalamus volumes. This was particularly the case for non-violent individuals diagnosed with schizophrenia. Furthermore, patients had reduction in right thalamus size. With regard to left amygdala, we found an interaction between violence and diagnosis. More specifically, we report a double dissociation with smaller amygdala size linked to violence in non-psychotic individuals, while for psychotic patients smaller size was linked to non-violence. Importantly, the double dissociation appeared to be mostly driven by substance abuse. Overall, we found widespread morphometric abnormalities in subcortical regions in schizophrenia. No evidence for shared volumetric abnormalities in individuals with a history of violence was found. Finally, left amygdala abnormalities in non-psychotic violent individuals were largely accounted for by substance abuse. This might be an indication that the association between amygdala reduction and violence is mediated by substance abuse. Our results indicate the importance of structural abnormalities in aggressive individuals.	[Del Bene, Victor A.; Foxe, John J.; Ross, Lars A.; De Sanctis, Pierfilippo] Albert Einstein Coll Med, Dept Pediat, Sheryl & Daniel R Tishman Cognit Neurophysiol Lab, CERC, Van Etten, NY USA; [Del Bene, Victor A.; Foxe, John J.; Ross, Lars A.; De Sanctis, Pierfilippo] Albert Einstein Coll Med, Dept Neurosci, Sheryl & Daniel R Tishman Cognit Neurophysiol Lab, CERC, Van Etten, NY USA; [Del Bene, Victor A.] Albert Einstein Coll Med, Ferkauf Grad Sch Psychol, Bronx, NY 10467 USA; [Foxe, John J.; Krakowski, Menahem I.; De Sanctis, Pierfilippo] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; [Foxe, John J.] Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Ernest J Del Monte Inst Neuromed, Rochester, NY 14642 USA; [Krakowski, Menahem I.] NYU, Dept Psychiat, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Czobor, Pal] Semmelweis Univ, Dept Psychiat, UlloiWay 26, Budapest, Hungary; [Czobor, Pal] Semmelweis Univ, Dept Psychotherapy, UlloiWay 26, Budapest, Hungary; [De Sanctis, Pierfilippo] Feinstein Inst Med Res, Ctr Psychiat Neurosci, Manhasset, NY 11030 USA; [De Sanctis, Pierfilippo] Zucker Hillside Hosp, Hofstra Northwell Sch Med, Dept Psychiat, Glen Oaks, NY 11004 USA	Yeshiva University; Albert Einstein College of Medicine; Nathan Kline Institute for Psychiatric Research; University of Rochester; New York University; NYU Langone Medical Center; Semmelweis University; Semmelweis University; Northwell Health; Northwell Health	Foxe, JJ; De Sanctis, P (corresponding author), Albert Einstein Coll Med, Dept Pediat, Sheryl & Daniel R Tishman Cognit Neurophysiol Lab, CERC, Van Etten, NY USA.; Foxe, JJ; De Sanctis, P (corresponding author), Albert Einstein Coll Med, Dept Neurosci, Sheryl & Daniel R Tishman Cognit Neurophysiol Lab, CERC, Van Etten, NY USA.; Foxe, JJ; De Sanctis, P (corresponding author), Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA.; Foxe, JJ (corresponding author), Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Ernest J Del Monte Inst Neuromed, Rochester, NY 14642 USA.; De Sanctis, P (corresponding author), Feinstein Inst Med Res, Ctr Psychiat Neurosci, Manhasset, NY 11030 USA.; De Sanctis, P (corresponding author), Zucker Hillside Hosp, Hofstra Northwell Sch Med, Dept Psychiat, Glen Oaks, NY 11004 USA.	John_Foxe@urmc.rochester.edu; pierfilippo.sanctis@einstein.yu.edu	Del Bene, Victor/AAD-8017-2021		U.S. National Institute of Mental Health [R01, MH74767];  [MH85322]	U.S. National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); 	Primary support for this work was provided by an R01 grant from the U.S. National Institute of Mental Health (MH74767). Additional support was derived from MH85322.	AGGLETON JP, 1980, BRAIN RES, V190, P347, DOI 10.1016/0006-8993(80)90279-6; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Barkataki I, 2006, BEHAV BRAIN RES, V169, P239, DOI 10.1016/j.bbr.2006.01.009; BAYLIS GC, 1985, BRAIN RES, V342, P91, DOI 10.1016/0006-8993(85)91356-3; Bilder RM, 2002, BIOL PSYCHIAT, V52, P701, DOI 10.1016/S0006-3223(02)01416-6; Blair RJR, 2005, DEV PSYCHOPATHOL, V17, P865, DOI 10.1017/S0954579405050418; Bobes Leon MA, 2013, PSYCHOPHYSIOLOGY; Bora E, 2011, SCHIZOPHR RES, V127, P46, DOI 10.1016/j.schres.2010.12.020; Buckholtz JW, 2008, TRENDS NEUROSCI, V31, P120, DOI 10.1016/j.tins.2007.12.006; Bufkin JL, 2005, TRAUMA VIOLENCE ABUS, V6, P176, DOI 10.1177/1524838005275089; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Chen YB, 2012, HUM GENET, V131, P1081, DOI 10.1007/s00439-011-1131-5; Coccaro EF, 1997, PSYCHIAT RES, V73, P147, DOI 10.1016/S0165-1781(97)00119-4; Coccaro EF, 1996, ANN NY ACAD SCI, V794, P82, DOI 10.1111/j.1749-6632.1996.tb32511.x; Coccaro EF, 2015, CNS SPECTRUMS, V20, P295, DOI 10.1017/S1092852915000310; Davatzikos C, 2005, ARCH GEN PSYCHIAT, V62, P1218, DOI 10.1001/archpsyc.62.11.1218; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; de Jong LW, 2008, BRAIN, V131, P3277, DOI 10.1093/brain/awn278; De Luca V, 2006, BRAIN RES, V1097, P26, DOI 10.1016/j.brainres.2006.04.053; Denson TF, 2012, CURR DIR PSYCHOL SCI, V21, P20, DOI 10.1177/0963721411429451; Derogatis L. R., 1977, SCL 90 MANUAL SCORIN; DeWall CN, 2011, SOC PERSONAL PSYCHOL, V5, P458; Ermer E, 2012, J ABNORM PSYCHOL, V121, P649, DOI 10.1037/a0026371; Fairchild G, 2011, AM J PSYCHIAT, V168, P624, DOI 10.1176/appi.ajp.2010.10081184; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; First MB., 1997, USERS GUIDE STRUCTUR; Foxe J., 2012, SOCIAL COGNITIVE AFF; Frazzetto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000486; Harris JA, 1997, BEHAV RES THER, V35, P1047, DOI 10.1016/S0005-7967(97)00064-8; Heatherton TF, 2011, ANNU REV PSYCHOL, V62, P363, DOI 10.1146/annurev.psych.121208.131616; Hoptman MJ, 2014, AM J PSYCHIAT, V171, P939, DOI 10.1176/appi.ajp.2014.13111553; Hoptman MJ, 2010, SCHIZOPHRENIA BULL, V36, P1020, DOI 10.1093/schbul/sbp012; Hygen BW, 2015, DEV PSYCHOL, V51, P1098, DOI 10.1037/dev0000020; Iidaka T, 2014, JPN PSYCHOL RES, V56, P33, DOI 10.1111/jpr.12018; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jonsson EG, 2003, SCHIZOPHR RES, V61, P31, DOI 10.1016/S0920-9964(02)00224-4; Kane JA, 2003, J CLIN PSYCHIAT, V64, P5; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kiehl KA, 2006, PSYCHIAT RES, V142, P107, DOI 10.1016/j.psychres.2005.09.013; Kim JJ, 2003, SCHIZOPHR RES, V60, P173, DOI 10.1016/S0920-9964(02)00299-2; Kotler M, 1999, AM J MED GENET, V88, P628, DOI 10.1002/(SICI)1096-8628(19991215)88:6<628::AID-AJMG10>3.0.CO;2-E; Krakowski M., 2003, J NEUROPSYCHIATRY CL; Krakowski MI, 2016, SCHIZOPHRENIA BULL, V42, P963, DOI 10.1093/schbul/sbw005; Krakowski MI, 2014, SCHIZOPHRENIA BULL, V40, P886, DOI 10.1093/schbul/sbt117; Kumari V, 2013, EUR PSYCHIAT, V28, P225, DOI 10.1016/j.eurpsy.2012.03.002; Kumari V, 2009, PSYCHIAT RES-NEUROIM, V173, P39, DOI 10.1016/j.pscychresns.2008.09.003; Kumari V, 2009, SCHIZOPHR RES, V110, P47, DOI 10.1016/j.schres.2009.01.009; Li T, 1996, PSYCHIAT GENET, V6, P131, DOI 10.1097/00041444-199623000-00005; Matthies S, 2012, WORLD J BIOL PSYCHIA, V13, P75, DOI 10.3109/15622975.2010.541282; Morey RA, 2010, HUM BRAIN MAPP, V31, P1751, DOI 10.1002/hbm.20973; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Mullen PE, 2000, LANCET, V355, P614, DOI 10.1016/S0140-6736(99)05082-5; Nederlof AF, 2013, AGGRESS VIOLENT BEH, V18, P183, DOI 10.1016/j.avb.2012.11.018; Niu L, 2004, PSYCHIAT RES-NEUROIM, V132, P41, DOI 10.1016/j.pscychresns.2004.06.002; Pardini DA, 2014, BIOL PSYCHIAT, V75, P73, DOI 10.1016/j.biopsych.2013.04.003; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; PERALTA V, 1994, PSYCHIAT RES, V53, P31, DOI 10.1016/0165-1781(94)90093-0; Raine A, 2006, AGGRESSIVE BEHAV, V32, P159, DOI 10.1002/ab.20115; Rajarethinam RP, 2000, SCHIZOPHR RES, V41, P303, DOI 10.1016/S0920-9964(99)00083-3; Roalf DR, 2016, SCHIZOPHRENIA B; Roberton T, 2012, AGGRESS VIOLENT BEH, V17, P72, DOI 10.1016/j.avb.2011.09.006; Rogers JC, 2016, JAMA PSYCHIAT, V73, P64, DOI 10.1001/jamapsychiatry.2015.2423; Salekin RT, 1996, CLIN PSYCHOL-SCI PR, V3, P203, DOI 10.1111/j.1468-2850.1996.tb00071.x; Sexton CE, 2010, PSYCHIAT RES-NEUROIM, V184, P57, DOI 10.1016/j.pscychresns.2010.07.005; Shepherd AM, 2012, NEUROSCI BIOBEHAV R, V36, P1342, DOI 10.1016/j.neubiorev.2011.12.015; Shifman S, 2004, AM J MED GENET B, V128B, P61, DOI 10.1002/ajmg.b.30032; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NEUROIMAGE, V36, P1200, DOI 10.1016/j.neuroimage.2007.04.035; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Swanson JW, 2006, ARCH GEN PSYCHIAT, V63, P490, DOI 10.1001/archpsyc.63.5.490; Tanskanen P, 2009, PSYCHIAT RES-NEUROIM, V174, P116, DOI 10.1016/j.pscychresns.2009.04.009; van Elst LT, 2000, BRAIN, V123, P234, DOI 10.1093/brain/123.2.234; van Erp TGM, 2016, MOL PSYCHIATR, V21, P547, DOI 10.1038/mp.2015.63; Velakoulis D, 2006, ARCH GEN PSYCHIAT, V63, P139, DOI 10.1001/archpsyc.63.2.139; Veroude K, 2015, AM J MED GENETICS B; Widom CS, 2006, BIOL PSYCHIAT, V60, P684, DOI 10.1016/j.biopsych.2006.03.039; Wilkinson G., 2006, REHABIL COUNS BULL, V52, P57, DOI [DOI 10.1177/0034355208320076, 10.1177/0034355208320076]; WONG MTH, 1994, ACTA PSYCHIAT SCAND, V90, P97, DOI 10.1111/j.1600-0447.1994.tb01562.x; Yang YL, 2010, PSYCHIAT RES-NEUROIM, V182, P9, DOI 10.1016/j.pscychresns.2009.10.013; Yang YL, 2009, ARCH GEN PSYCHIAT, V66, P986, DOI 10.1001/archgenpsychiatry.2009.110; Zammit S, 2004, AM J MED GENET B, V128B, P19, DOI 10.1002/ajmg.b.30021	88	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168100	10.1371/journal.pone.0168100	http://dx.doi.org/10.1371/journal.pone.0168100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030584	gold, Green Submitted, Green Published			2022-12-26	WOS:000391222000034
J	Grellety, E; Golden, MH				Grellety, Emmanuel; Golden, Michael H.			The Effect of Random Error on Diagnostic Accuracy Illustrated with the Anthropometric Diagnosis of Malnutrition	PLOS ONE			English	Article							AGE MISSTATEMENT; YOUNG-CHILDREN; RELIABILITY; NUTRITION; QUALITY	Background It is often thought that random measurement error has a minor effect upon the results of an epidemiological survey. Theoretically, errors of measurement should always increase the spread of a distribution. Defining an illness by having a measurement outside an established healthy range will lead to an inflated prevalence of that condition if there are measurement errors. Methods and results A Monte Carlo simulation was conducted of anthropometric assessment of children with malnutrition. Random errors of increasing magnitude were imposed upon the populations and showed that there was an increase in the standard deviation with each of the errors that became exponentially greater with the magnitude of the error. The potential magnitude of the resulting error of reported prevalence of malnutrition were compared with published international data and found to be of sufficient magnitude to make a number of surveys and the numerous reports and analyses that used these data unreliable. Conclusions The effect of random error in public health surveys and the data upon which diagnostic cutoff points are derived to define "health" has been underestimated. Even quite modest random errors can more than double the reported prevalence of conditions such as malnutrition. Increasing sample size does not address this problem, and may even result in less accurate estimates. More attention needs to be paid to the selection, calibration and maintenance of instruments, measurer selection, training & supervision, routine estimation of the likely magnitude of errors using standardization tests, use of statistical likelihood of error to exclude data from analysis and full reporting of these procedures in order to judge the reliability of survey reports.	[Grellety, Emmanuel] Univ Libre Bruxelles, Sch Publ Hlth, Res Ctr Hlth Policy & Syst Int Hlth, Brussels, Belgium; [Golden, Michael H.] Univ Aberdeen, Dept Med & Therapeut, Aberdeen, Scotland	Universite Libre de Bruxelles; University of Aberdeen	Grellety, E (corresponding author), Univ Libre Bruxelles, Sch Publ Hlth, Res Ctr Hlth Policy & Syst Int Hlth, Brussels, Belgium.	Emmanuel.Grellety.Bosviel@ulb.ac.be	Golden, Michael/AAB-8989-2020	Golden, Michael/0000-0002-4039-7538; Grellety Bosviel, Emmanuel/0000-0001-9736-414X	Nutriset	Nutriset	Nutriset provided a PhD maintenance studentship to Universite Libre de Bruxelles in support of EG. No funds were provided to support any aspect of research or publication. Nutriset had no role in any aspect of this research including data collection, design, analysis, interpretation or writing of the article and does not require prior notification of publication.	[Anonymous], 1995, PHYS STAT US INT ANT; BAIRAGI R, 1987, AM J PUBLIC HEALTH, V77, P280, DOI 10.2105/AJPH.77.3.280; BAIRAGI R, 1982, DEMOGRAPHY, V19, P447, DOI 10.2307/2061012; BAIRAGI R, 1986, AM J EPIDEMIOL, V123, P185, DOI 10.1093/oxfordjournals.aje.a114213; BAIRAGI R, 1982, AM J PHYS ANTHROPOL, V58, P331, DOI 10.1002/ajpa.1330580311; BAIRAGI R, 1991, Genus, V47, P193; Bakwin H, 1931, J CLIN INVEST, V10, P369, DOI 10.1172/JCI100357; Bayley N, 1935, BIOMETRIKA, V27, P26, DOI 10.1093/biomet/27.1-2.26; BYERLEE D, 1981, POP STUD-J DEMOG, V35, P455, DOI 10.1080/00324728.1981.11878517; CALDWELL JC, 1966, DEMOGRAPHY, V3, P477, DOI 10.2307/2060173; Crowe S, 2014, PEERJ, V2, DOI 10.7717/peerj.380; Onis M, 2006, ACTA PAEDIATR, V95, P7, DOI 10.1080/08035320500495407; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; Dunlop JC, 1923, J R STAT SOC, V86, P547, DOI 10.2307/2341695; Edmonston B, 1981, Rural Demogr, V8, P63; ELLOZY M, 1976, AM J CLIN NUTR, V29, P585, DOI 10.1093/ajcn/29.5.585; Erhardt J, ENA FOR SMART 2016; Fabic MS, 2012, B WORLD HEALTH ORGAN, V90, P604, DOI 10.2471/BLT.11.095513; Golden MH, 2015, SMART PLAUSIBILITY C; Golden MH, 2002, POPULATION NUTR STAT; Golden MH, 2006, SMART METHODOLOGY ME; Grellety E, 2016, BMC NUTR, V2; Harris EF, 2009, ARCH ORAL BIOL, V54, pS107, DOI 10.1016/j.archoralbio.2008.04.010; HESSEL PA, 1986, INT J EPIDEMIOL, V15, P122, DOI 10.1093/ije/15.1.122; HIMES JH, 1989, AM J PHYS ANTHROPOL, V79, P77, DOI 10.1002/ajpa.1330790108; Hood GM, 2016, POPTOOLS VERSION 3 2; Kostermans K, 1993, 101 WORLD BANK; Kouchi M, 1999, J Hum Ergol (Tokyo), V28, P15; Kouchi M, 1996, J Hum Ergol (Tokyo), V25, P155; Lipman TH, 2004, ARCH DIS CHILD, V89, P342, DOI 10.1136/adc.2003.030072; Matsumoto M, 2016, MERSENNE TWISTER ALG; Mei ZG, 2007, B WORLD HEALTH ORGAN, V85, P441, DOI 10.2471/BLT.06.034421; Mueller WH, 1988, ANTHROPOMETRIC STAND, P83; MURPHY EA, 1964, J CHRON DIS, V17, P301, DOI 10.1016/0021-9681(64)90073-6; Myatt M, 2004, RESPONSE SURVEY SD V; Onyango AW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035320500494464; OSHAUG A, 1994, J NUTR, V124, P636, DOI 10.1093/jn/124.5.636; Prudhon C, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-10; Pullum TW, 2008, ASSESSMENT QUALITY D; SENG YP, 1959, POP STUD-J DEMOG, V13, P164, DOI 10.2307/2172409; Siklar Z, 2005, PEDIATR INT, V47, P645, DOI 10.1111/j.1442-200x.2005.02144.x; Spiegel PB, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-12; Spiegel PB, 2004, JAMA-J AM MED ASSOC, V292, P613, DOI 10.1001/jama.292.5.613; Stoddard GD, 1933, REV EDUC RES, V3, P130; SWEEHOCK S, 1967, DEMOGRAPHY, V4, P859, DOI 10.2307/2060325; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; Ulijaszek SJ, 1997, COLLEGIUM ANTROPOL, V21, P429; WHO, 2016, WHO GLOB DAT CHILD G; WHO, 2006, WHO CHILD GROWTH STA; World Health Organization, 2000, MAN NUTR MAJ EM; World Health Organization, 2016, WHO CHILD GROWTH STA	51	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168585	10.1371/journal.pone.0168585	http://dx.doi.org/10.1371/journal.pone.0168585			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030627	Green Submitted, Green Published, gold			2022-12-26	WOS:000391222000059
J	Satani, N; Lin, YH; Hammoudi, N; Raghavan, S; Georgiou, DK; Muller, FL				Satani, Nikunj; Lin, Yu-Hsi; Hammoudi, Naima; Raghavan, Sudhir; Georgiou, Dimitra K.; Muller, Florian L.			ENOblock Does Not Inhibit the Activity of the Glycolytic Enzyme Enolase	PLOS ONE			English	Article							COMPLEX; CANCER	Inhibition of glycolysis is of great potential for the treatment of cancer. However, inhibitors of glycolytic enzymes with favorable pharmacological profiles have not been forthcoming. Due to the nature of their active sites, most high-affinity transition-state analogue inhibitors of glycolysis enzymes are highly polar with poor cell permeability. A recent publication reported a novel, non-active site inhibitor of the glycolytic enzyme Enolase, termed ENOblock (N-[2-[2-2-aminoethoxy)ethoxy]ethyl]4-4-cyclohexylmethyl)amino]6-4-fluorophenyl) methyl]amino]1,3,5-triazin-2-yl]amino]benzeneacetamide). This would present a major advance, as this is heterocyclic and fully cell permeable molecule. Here, we present evidence that ENOblock does not inhibit Enolase enzymatic activity in vitro as measured by three different assays, including a novel P-31 NMR based method which avoids complications associated with optical interferences in the UV range. Indeed, we note that due to strong UV absorbance, ENOblock interferes with the direct spectrophotometric detection of the product of Enolase, phosphoenolpyruvate. Unlike established Enolase inhibitors, ENOblock does not show selective toxicity to ENO1-deleted glioma cells in culture. While our data do not dispute the biological effects previously attributed to ENOblock, they indicate that such effects must be caused by mechanisms other than direct inhibition of Enolase enzymatic activity.	[Satani, Nikunj] UTHealth, Dept Neurol, McGovern Med Sch, Houston, TX USA; [Satani, Nikunj; Lin, Yu-Hsi; Hammoudi, Naima; Raghavan, Sudhir; Georgiou, Dimitra K.; Muller, Florian L.] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Muller, FL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA.	fmuller@mdanderson.org	Satani, Nikunj/U-1119-2017; Raghavan, Sudhir/C-8871-2011	Satani, Nikunj/0000-0003-3908-3731; Muller, Florian/0000-0001-7568-2948; Raghavan, Sudhir/0000-0001-5449-362X	CPRIT Grant [RP140612]; NIH CDP SPORE Grant [P50CA12700107];  [RSG1514501CDD]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA127001] Funding Source: NIH RePORTER	CPRIT Grant; NIH CDP SPORE Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by: 1) CPRIT Grant: RP140612 (Ronald DePinho); 2) NIH CDP SPORE Grant: P50CA12700107 (F.L.M.); 3) Research Scholar Grant: RSG1514501CDD (F.L.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahuhta M, 2010, PROTEINS, V78, P1878, DOI 10.1002/prot.22701; ANDERSON VE, 1984, BIOCHEMISTRY-US, V23, P2779, DOI 10.1021/bi00307a038; Dax C, 2006, J MED CHEM, V49, P1499, DOI 10.1021/jm050237b; Duncan CG, 2010, ONCOTARGET, V1, P265, DOI 10.18632/oncotarget.137; Erion DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097139; Gomes Dias SM, 2007, FEBS J, V274, P5077, DOI [10.1111/j.1742-4658.2007.06027.x, DOI 10.1111/J.1742-4658.2007.06027.X]; Hanaya T, 2011, HETEROCYCLES, V82, P1675, DOI 10.3987/COM-10-S(E)80; Jung DW, 2013, ACS CHEM BIOL, V8, P1271, DOI 10.1021/cb300687k; Leonard PG, 2016, NAT CHEM BIOL; Locasale JW, 2010, CELL CYCLE, V9, P4253, DOI 10.4161/cc.9.21.13925; Muller F, 2012, VITRO ENZYMATIC ACTI; Muller F, 2016, US patent, Patent No. [WO2016145113 A1, 2016145113]; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; POYNER RR, 1992, BIOCHEMISTRY-US, V31, P7166, DOI 10.1021/bi00146a020; Pradere U, 2014, CHEM REV, V114, P9154, DOI 10.1021/cr5002035; THOMPSON J, 1984, J BACTERIOL, V158, P791, DOI 10.1128/JB.158.3.791-800.1984; Watanabe H., 1986, SCI REPORTS MEIJI SE, V25, P12	18	17	17	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168739	10.1371/journal.pone.0168739	http://dx.doi.org/10.1371/journal.pone.0168739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030597	Green Submitted, gold, Green Published			2022-12-26	WOS:000391222000071
J	Schulze, U; Brast, S; Grabner, A; Albiker, C; Snieder, B; Holle, S; Schlatter, E; Schroter, R; Pavenstadt, H; Herrmann, E; Lambert, C; Spoden, GA; Florin, L; Saftig, P; Ciarimboli, G				Schulze, Ulf; Brast, Sabine; Grabner, Alexander; Albiker, Christian; Snieder, Beatrice; Holle, Svenja; Schlatter, Eberhard; Schroeter, Rita; Pavenstaedt, Hermann; Herrmann, Edwin; Lambert, Carsten; Spoden, Gilles A.; Florin, Luise; Saftig, Paul; Ciarimboli, Giuliano			Tetraspanin CD63 controls basolateral sorting of organic cation transporter 2 in renal proximal tubules	FASEB JOURNAL			English	Article						regulation; trafficking; transport	MONOAMINE NEUROTRANSMITTERS; PROTEIN TRAFFICKING; ENDOTHELIAL-CELLS; PLASMA-MEMBRANE; IN-VIVO; METFORMIN; OCT2; CISPLATIN; POLYMORPHISMS; CD151	CD63 is a ubiquitously expressed member of the tetraspanin superfamily. Using a mating-based splitubiquitin-yeast 2-hybrid system, pull-down experiments, total internal reflection fluorescence microscopy, F oorster resonance energy transfer, and biotinylation assays, we found that CD63 interacts with human organic cation transporter 2 (hOCT2), which transports endogenous and exogenous substrates, such as neurotransmitters and drugs in several epithelial cells. CD63 overexpression affects cellular localization of hOCT2 expressed inhuman embryonic kidney (HEK) 293 cells. Studies with CD63-knockout mice indicate that in renal proximal tubules, CD63 determines the insertion of the mouse ortholog of the transporter into the proper membrane domain and mediates transporter regulation by trafficking processes. In polarized Madin-Darby kidney canine kidney (MDCK) epithelial cells, CD63 and hOCT2 colocalize with the small GTPase Rab4, which controls the rapid recycling from sorting end osomes back to the cell surface. Suitable negative and positive control experiments were performed for each experimental approach. Empty vector transfected cells and wild-type mice were used as control. CD63 seems to play a role in the recycling of hOCT2 from endosomes to the basolateral membrane in polarized epithelia. These data indicate that CD63 has a previously uncharacterized function in regulating trafficking of specific membrane proteins in polarized cells.-Schulze, U., Brast, S., Grabner, A., Albiker, C., Snieder, B., Holle, S., Schlatter, E., Schroter, R., Pavenstadt, H., Herrmann, E., Lambert, C., Spoden, G. A., Florin, L., Saftig, P., Ciarimboli, G. Tetraspanin CD63 controls basolateral sorting of organic cation transporter 2 in renal proximal tubules. FASEB J. 31, 1421-1433 (2017). www.fasebj.org	[Schulze, Ulf; Brast, Sabine; Grabner, Alexander; Albiker, Christian; Snieder, Beatrice; Holle, Svenja; Schlatter, Eberhard; Schroeter, Rita; Pavenstaedt, Hermann; Ciarimboli, Giuliano] Westfal Wilhelms Univ, Expt Nephrol, Med Klin D, Munster, Germany; [Herrmann, Edwin] Westfal Wilhelms Univ, Klin & Poliklin Urol, Munster, Germany; [Lambert, Carsten; Spoden, Gilles A.; Florin, Luise] Johannes Gutenberg Univ Mainz, Inst Med Mikrobiol & Hyg, Mainz, Germany; [Saftig, Paul] Univ Kiel, Med Fak, Biochem Inst, Kiel, Germany	University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; Johannes Gutenberg University of Mainz; University of Kiel	Ciarimboli, G (corresponding author), Med Klin D, Expt Nephrol, Albert Schweitzer Campus 1-A14, D-48149 Munster, Germany.	gciari@uni-muenster.de	Saftig, Paul/A-7966-2010		Deutsche Forschungsgemeinschaft [CI 107/4-1-3, DFG SCHL 277/12-3, DFG SA687/7-1, DFG FL 696/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors are grateful to A. Dirks, B. Gelschefarth, D. Guckel, J. Humberg, U. Neugebauer, and A. Stober for technical assistance. This work was supported in part by the Deutsche Forschungsgemeinschaft (CI 107/4- 1-3 to G.C. and E.S.; DFG SCHL 277/12-3 to E. S.; DFG SA687/7-1 to P. S.; and DFG FL 696/2-1 to L.F.).	ALEKSUNES LM, 2016, ORGANIC CATION TRANS, P171; Aperia AC, 2000, ANNU REV PHYSIOL, V62, P621, DOI 10.1146/annurev.physiol.62.1.621; Arribas M, 2000, TRAFFIC, V1, P783, DOI 10.1034/j.1600-0854.2000.011005.x; Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; Becker ML, 2010, PHARMACOGENET GENOM, V20, P38, DOI 10.1097/FPC.0b013e328333bb11; Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; Biermann J, 2006, AM J PHYSIOL-CELL PH, V290, pC1521, DOI 10.1152/ajpcell.00622.2005; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Brast S, 2012, FASEB J, V26, P976, DOI 10.1096/fj.11-180679; Busch AE, 1998, MOL PHARMACOL, V54, P342, DOI 10.1124/mol.54.2.342; Ciarimboli G, 2005, AM J PATHOL, V167, P1477, DOI 10.1016/S0002-9440(10)61234-5; Ciarimboli G, 2005, PFLUG ARCH EUR J PHY, V449, P423, DOI 10.1007/s00424-004-1355-5; Ciarimboli G, 2011, EXPERT OPIN DRUG MET, V7, P159, DOI 10.1517/17425255.2011.547474; Ciarimboli G, 2011, MOL PHARMACEUT, V8, P270, DOI 10.1021/mp100329u; Ciarimboli G, 2010, AM J PATHOL, V176, P1169, DOI 10.2353/ajpath.2010.090610; Duan HC, 2010, J PHARMACOL EXP THER, V335, P743, DOI 10.1124/jpet.110.170142; Duffield A, 2003, P NATL ACAD SCI USA, V100, P15560, DOI 10.1073/pnas.2536699100; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; Ernst S, 2004, CELL MOL LIFE SCI, V61, P1684, DOI 10.1007/s00018-004-4116-x; Grabner A, 2011, CELL MOL LIFE SCI, V68, P4079, DOI 10.1007/s00018-011-0694-6; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Grefen Christopher, 2007, Curr Protoc Neurosci, VChapter 5, DOI 10.1002/0471142301.ns0527s41; Guckel D, 2012, CELL PHYSIOL BIOCHEM, V30, P269, DOI 10.1159/000339063; Hochdorfer D, 2016, J VIROL, V90, P6430, DOI 10.1128/JVI.00145-16; Holle SK, 2011, PFLUG ARCH EUR J PHY, V462, P359, DOI 10.1007/s00424-011-0969-7; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kimura N, 2009, BIOCHEM PHARMACOL, V77, P1429, DOI 10.1016/j.bcp.2009.01.010; Kobayashi T, 2000, MOL BIOL CELL, V11, P1829, DOI 10.1091/mbc.11.5.1829; Lanvers-Kaminsky C, 2015, PHARMACOGENOMICS, V16, P323, DOI [10.2217/pgs.14.182, 10.2217/PGS.14.182]; Lazar A, 2006, CLIN EXP HYPERTENS, V28, P645, DOI 10.1080/10641960600946411; Lee M, 2005, J BIOL CHEM, V280, P125, DOI 10.1074/jbc.M408858200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Marc DT, 2011, NEUROSCI BIOBEHAV R, V35, P635, DOI 10.1016/j.neubiorev.2010.07.007; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Montpellier C, 2011, J BIOL CHEM, V286, P13954, DOI 10.1074/jbc.M111.220103; Motohashi H, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134866; Muth TR, 2003, ANNU REV CELL DEV BI, V19, P333, DOI 10.1146/annurev.cellbio.19.110701.161425; Ogasawara M, 2006, J PHARMACOL SCI, V101, P24, DOI 10.1254/jphs.FMJ06001X6; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Sallinen R, 2010, ANN MED, V42, P296, DOI 10.3109/07853891003777109; Scheffer KD, 2014, VIRUSES-BASEL, V6, P893, DOI 10.3390/v6020893; Scheffer KD, 2013, J VIROL, V87, P3435, DOI 10.1128/JVI.02906-12; SCHLATTER E, 2016, ORGANIC CATION TRANS, P139, DOI DOI 10.1016/J.TIBS.2015.12.001; Schneider E, 2005, J EXP MED, V202, P387, DOI 10.1084/jem.20050195; Schroder J, 2009, MOL CELL BIOL, V29, P1083, DOI 10.1128/MCB.01163-08; Shikata E, 2007, J HUM GENET, V52, P117, DOI 10.1007/s10038-006-0087-0; Spiro DJ, 1996, MOL BIOL CELL, V7, P355, DOI 10.1091/mbc.7.3.355; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Tajika Y, 2004, ENDOCRINOLOGY, V145, P4375, DOI 10.1210/en.2004-0073; Taubert D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000385; Tzvetkov MV, 2009, CLIN PHARMACOL THER, V86, P299, DOI 10.1038/clpt.2009.92; Umehara KI, 2007, XENOBIOTICA, V37, P618, DOI 10.1080/00498250701397705; Wang DS, 2003, MOL PHARMACOL, V63, P844, DOI 10.1124/mol.63.4.844; Wang DS, 2002, J PHARMACOL EXP THER, V302, P510, DOI 10.1124/jpet.102.034140; Wessler I, 2001, BRIT J PHARMACOL, V134, P951, DOI 10.1038/sj.bjp.0704335; Wilde S, 2009, CELL MOL LIFE SCI, V66, P1729, DOI 10.1007/s00018-009-9145-z; Yonezawa A, 2006, J PHARMACOL EXP THER, V319, P879, DOI 10.1124/jpet.106.110346; Zhang SZ, 2006, CANCER RES, V66, P8847, DOI 10.1158/0008-5472.CAN-06-0769; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200	60	15	15	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1421	1433		10.1096/fj.201600901R	http://dx.doi.org/10.1096/fj.201600901R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28031320				2022-12-26	WOS:000398504300013
J	Parasuraman, P; Mulligan, P; Walker, JA; Li, BH; Boukhali, M; Haas, W; Bernards, A				Parasuraman, Prasanna; Mulligan, Peter; Walker, James A.; Li, Bihua; Boukhali, Myriam; Haas, Wilhelm; Bernards, Andre			Interaction of p190A RhoGAP with eIF3A and Other Translation Preinitiation Factors Suggests a Role in Protein Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; INITIATION-FACTOR 3; RNA-POLYMERASE-II; MASS-SPECTROMETRY; TYROSINE KINASES; PHOSPHORYLATION; P190RHOGAP; DOMAINS; RAS; COMPLEX	The negative regulator of Rho family GTPases, p190A RhoGAP, is one of six mammalian proteins harboring so-called FF motifs. To explore the function of these and other p190A segments, we identified interacting proteins by tandem mass spectrometry. Here we report that endogenous human p190A, but not its 50% identical p190B paralog, associates with all 13 eIF3 subunits and several other translational preinitiation factors. The interaction involves the first FF motif of p190A and the winged helix/PCI domain of eIF3A, is enhanced by serum stimulation and reduced by phosphatase treatment. The p190A/eIF3A interaction is unaffected by mutating phosphorylated p190A-Tyr(308), but disrupted by a S296A mutation, targeting the only other known phosphorylated residue in the first FF domain. The p190A-eIF3 complex is distinct from eIF3 complexes containing S6K1 or mammalian target of rapamycin (mTOR), and appears to represent an incomplete preinitiation complex lacking several subunits. Based on these findings we propose that p190A may affect protein translation by controlling the assembly of functional preinitiation complexes. Whether such a role helps to explain why, unique among the large family of RhoGAPs, p190A exhibits a significantly increased mutation rate in cancer remains to be determined.	Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; Harvard Med Sch, Charlestown, MA 02129 USA; [Mulligan, Peter] Univ Lyon, Epigenet & Canc Team, Ctr Cancerol Lyon, INSERM U1052,CNRS UMR5286,Ctr Leon Berard, F-69008 Lyon, France	Harvard University; Massachusetts General Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Bernards, A (corresponding author), 149 13th St, Charlestown, MA 02129 USA.	abernards@partners.org		Mulligan, Peter/0000-0003-0737-2328	National Institutes of Health NIGMS [1R01GM087386]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087386] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NIGMS Grant 1R01GM087386 (to A. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bedford MT, 1999, TRENDS BIOCHEM SCI, V24, P264, DOI 10.1016/S0968-0004(99)01417-6; Bernards A, 2005, GROWTH FACTORS, V23, P143, DOI 10.1080/08977190500130480; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bernards A, 2007, GROWTH FACTORS, V25, P355, DOI 10.1080/08977190701830375; Biname F, 2016, J CELL BIOL, V214, P859, DOI 10.1083/jcb.201601063; Carty SM, 2000, P NATL ACAD SCI USA, V97, P9015, DOI 10.1073/pnas.160266597; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Csibi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008994; Damoc E, 2007, MOL CELL PROTEOMICS, V6, P1135, DOI 10.1074/mcp.M600399-MCP200; des Georges A, 2015, NATURE, V525, P491, DOI 10.1038/nature14891; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Ellisdon Andrew M, 2012, Bioarchitecture, V2, P118, DOI 10.4161/bioa.21131; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FOSTER R, 1994, MOL CELL BIOL, V14, P7173, DOI 10.1128/MCB.14.11.7173; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kusama T, 2006, CANCER SCI, V97, P848, DOI 10.1111/j.1349-7006.2006.00242.x; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Levay M, 2013, CELL SIGNAL, V25, P1388, DOI 10.1016/j.cellsig.2013.03.004; Levay M, 2009, BIOCHEMISTRY-US, V48, P8615, DOI 10.1021/bi900667y; Liu JX, 2013, J BIOL CHEM, V288, P10890, DOI 10.1074/jbc.M113.460238; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; MORAN MF, 1991, MOL CELL BIOL, V11, P1804, DOI 10.1128/MCB.11.4.1804; Pincheira R, 2001, EUR J CELL BIOL, V80, P410, DOI 10.1078/0171-9335-00176; Querol-Audi J, 2013, STRUCTURE, V21, P920, DOI 10.1016/j.str.2013.04.002; Saletta F, 2010, BBA-REV CANCER, V1806, P275, DOI 10.1016/j.bbcan.2010.07.005; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tatsis N, 1998, J BIOL CHEM, V273, P34631, DOI 10.1074/jbc.273.51.34631; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Wagner S, 2014, MOL CELL BIOL, V34, P3041, DOI 10.1128/MCB.00663-14; Wang DZM, 1997, CANCER RES, V57, P2478; Wei J, 2005, MOL CELL, V17, P23, DOI 10.1016/j.molcel.2004.11.024; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wolf RM, 2003, GENE DEV, V17, P476, DOI 10.1101/gad.1040003; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k	48	9	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2679	2689		10.1074/jbc.M116.769216	http://dx.doi.org/10.1074/jbc.M116.769216			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28007963	Green Published, hybrid			2022-12-26	WOS:000395535100011
J	Hofmeister, EK; Lund, M; Shearn-Bochsler, V; Balakrishnan, CN				Hofmeister, Erik K.; Lund, Melissa; Shearn-Bochsler, Valerie; Balakrishnan, Christopher N.			Susceptibility and Antibody Response of the Laboratory Model Zebra Finch (Taeniopygia guttata) to West Nile Virus	PLOS ONE			English	Article							CHICKENS GALLUS-GALLUS; EXPERIMENTAL-INFECTION; AGE-DEPENDENCY; WILD BIRDS; MOSQUITOS; SPARROWS; VECTOR; HOST; PATHOGENICITY; COMPETENCE	Since the introduction of West Nile virus (WNV) into North America in 1999 a number of passerine bird species have been found to play a role in the amplification of the virus. Arbovirus surveillance, observational studies and experimental studies have implicated passerine birds (songbirds, e.g., crows, American robins, house sparrows, and house finches) as significant reservoirs of WNV in North America, yet we lack a tractable passerine animal model for controlled studies of the virus. The zebra finch (Taeniopygia guttata) serves as a model system across a diversity of fields, and here we develop the zebra finch a songbird model for WNV. Like many natural hosts of WNV, we found that zebra finches developed sufficient viremia to serve as a competent host, yet in general resisted mortality from infection. In the Australian zebra finch (AZF) T. g. castanotis, we detected WNV in the majority of sampled tissues by 4 days post injection (dpi). However, WNV was not detected in tissues of sacrificed birds at 14 dpi, shortly after the development of detectable anti-WNV antibodies in the majority of birds indicating successful viral clearance. We compared susceptibility between the two zebra finch subspecies AZF and Timor zebra finch (TZF) T. g. guttata. Compared to AZF, WNV RNA was detected in a larger proportion of challenged TZF and molecular detection of virus in the serum of TZF was significantly higher than in AZF. Given the observed moderate host competence and disease susceptibility, we suggest that zebra finches are appropriate as models for the study of WNV and although underutilized in this respect, may be ideal models for the study of the many diseases carried and transmitted by songbirds.	[Hofmeister, Erik K.; Lund, Melissa; Shearn-Bochsler, Valerie] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA; [Balakrishnan, Christopher N.] East Carolina Univ, Greenville, NC USA	United States Department of the Interior; United States Geological Survey; University of North Carolina; East Carolina University	Hofmeister, EK (corresponding author), US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA.	ehotmeister@usgs.gov			USGS (U.S. Geological Survey)	USGS (U.S. Geological Survey)	This study was funded by the USGS (U.S. Geological Survey).	Agate RJ, 2009, P NATL ACAD SCI USA, V106, P17963, DOI 10.1073/pnas.0909139106; [Anonymous], 2014, R LANG ENV STAT COMP; Balakrishnan CN, 2009, GENETICS, V181, P645, DOI 10.1534/genetics.108.094250; Beaty BJ, 1989, DIAGNOSTIC PROCEDURE, P797; Bowen RA, 2007, CURR OPIN INFECT DIS, V20, P293, DOI 10.1097/QCO.0b013e32816b5cad; Burgan SC, 2015, INTEGR COMP BIOL, V55, pE226; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Del Amo J, 2014, VET MICROBIOL, V172, P542, DOI 10.1016/j.vetmic.2014.06.005; Del Amo J, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-33; Ebel GD, 2002, EMERG INFECT DIS, V8, P979, DOI 10.3201/eid0809.020152; Fair JM, 2011, POULTRY SCI, V90, P328, DOI 10.3382/ps.2010-00809; Fang Y, 2006, AM J TROP MED HYG, V75, P480, DOI 10.4269/ajtmh.2006.75.480; Fassbinder-Orth CA, 2009, AVIAN DIS, V53, P502, DOI 10.1637/8688-031009-Reg.1; FRAZIER CL, 1979, J CLIN MICROBIOL, V10, P583, DOI 10.1128/JCM.10.4.583-585.1979; Gervasi SS, 2015, INTEGR COMP BIOL, V55, pE64; Griffith SC, 2010, EMU, V110, pV, DOI 10.1071/MUv110n3_ED; Hart B, 1988, NEUROSCI RES REV, V12, P151; Hofmeister EK, 2016, J WILDLIFE DIS, V52, P345, DOI 10.7589/2015-06-148; Hofmeister EK, 2016, J WILDLIFE DIS, V52, P354, DOI 10.7589/2015-06-137; Itoh Y, 2011, IN VITRO CELL DEV-AN, V47, P280, DOI 10.1007/s11626-011-9392-9; Kilpatrick AM, 2007, AUK, V124, P1121, DOI 10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Langevin SA, 2001, EMERG INFECT DIS, V7, P726, DOI 10.3201/eid0704.010422; LaPointe DA, 2009, J WILDLIFE DIS, V45, P257, DOI 10.7589/0090-3558-45.2.257; Lin YC, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00409; Lord CC, 2006, J MED ENTOMOL, V43, P623, DOI 10.1603/0022-2585(2006)43[623:RBHVAV]2.0.CO;2; Morand S, 2014, INFECT GENET EVOL, V24, P76, DOI 10.1016/j.meegid.2014.02.013; Nemeth N, 2009, ARCH VIROL, V154, P783, DOI 10.1007/s00705-009-0369-x; Nemeth NM, 2007, AM J TROP MED HYG, V76, P310, DOI 10.4269/ajtmh.2007.76.310; Nemeth NM, 2009, AM J TROP MED HYG, V80, P864, DOI 10.4269/ajtmh.2009.80.864; Newhouse DJ, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0546-3; Newhouse DJ, TRANSCRIPTI IN PRESS; Oesterle PT, 2009, AM J TROP MED HYG, V81, P1159, DOI 10.4269/ajtmh.2009.09-0136; Owen-Ashley NT, 2007, J ORNITHOL, V148, pS583, DOI 10.1007/s10336-007-0197-2; Perez-Ramirez E, 2014, VIRUSES-BASEL, V6, P752, DOI 10.3390/v6020752; Reisen WK, 2007, J MED ENTOMOL, V44, P316, DOI 10.1603/0022-2585(2007)44[316:DFOIMD]2.0.CO;2; Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2; Senne DA, 2000, AVIAN DIS, V44, P642, DOI 10.2307/1593105; Singhal S, 2015, SCIENCE, V350, P928, DOI 10.1126/science.aad0843; Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132; Swayne DE, 2000, AVIAN DIS, V44, P932, DOI 10.2307/1593067; TAYLOR RM, 1956, AM J TROP MED HYG, V5, P579, DOI 10.4269/ajtmh.1956.5.579; Turell MJ, 2002, CURR TOP MICROBIOL, V267, P241; VanDalen KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068537; Warnes G.R., Various R Programming Tools for Plotting Data 2020; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Wheeler SS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001860; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WORK TH, 1955, AM J TROP MED HYG, V4, P872, DOI 10.4269/ajtmh.1955.4.872	49	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0167876	10.1371/journal.pone.0167876	http://dx.doi.org/10.1371/journal.pone.0167876			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045891	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300009
J	Seidemann, T; Spies, C; Morgenstern, R; Wernecke, KD; Netzhammer, N				Seidemann, Thomas; Spies, Claudia; Morgenstern, Rudolf; Wernecke, Klaus-Dieter; Netzhammer, Nicolai			Influence of Volatile Anesthesia on the Release of Glutamate and other Amino Acids in the Nucleus Accumbens in a Rat Model of Alcohol Withdrawal: A Pilot Study	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; PROTEIN-KINASE-C; TRANSPORTER TYPE-3; ETHANOL WITHDRAWAL; EXTRACELLULAR GLUTAMATE; DELIRIUM-TREMENS; INDUCED INCREASE; ANIMAL-MODELS; WISTAR RATS; IN-VIVO	Background Alcohol withdrawal syndrome is a potentially life-threatening condition, which can occur when patients with alcohol use disorders undergo general anesthesia. Excitatory amino acids, such as glutamate, act as neurotransmitters and are known to play a key role in alcohol withdrawal syndrome. To understand this process better, we investigated the influence of isoflurane, sevoflurane, and desflurane anesthesia on the profile of excitatory and inhibitory amino acids in the nucleus accumbens (NAcc) of alcohol-withdrawn rats (AWR). Methods Eighty Wistar rats were randomized into two groups of 40, pair-fed with alcoholic or nonalcoholic nutrition. Nutrition was withdrawn and microdialysis was performed to measure the activity of amino acids in the NAcc. The onset time of the withdrawal syndrome was first determined in an experiment with 20 rats. Sixty rats then received isoflurane, sevoflurane, or desflurane anesthesia for three hours during the withdrawal period, followed by one hour of elimination. Amino acid concentrations were measured using chromatography and results were compared to baseline levels measured prior to induction of anesthesia. Results Glutamate release increased in the alcohol group at five hours after the last alcohol intake (p = 0.002). After 140 min, desflurane anesthesia led to a lower release of glutamate (p < 0.001) and aspartate (p = 0.0007) in AWR compared to controls. GABA release under and after desflurane anesthesia was also significantly lower in AWR than controls (p = 0.023). Over the course of isoflurane anesthesia, arginine release decreased in AWR compared to controls (p < 0.001), and aspartate release increased after induction relative to controls (P-20min = 0.015 and P-40min = 0.006). However, amino acid levels did not differ between the groups as a result of sevoflurane anesthesia. Conclusions Each of three volatile anesthetics we studied showed different effects on excitatory and inhibitory amino acid concentrations. Under desflurane anesthesia, both glutamate and aspartate showed a tendency to be lower in AWR than controls over the whole timecourse. The inhibitory amino acid arginine increased in AWR compared to controls, whereas GABA levels decreased. However, there were no significant differences in amino acid concentrations under or after sevoflurane anesthesia. Under isoflurane, aspartate release increased in AWR following induction, and from 40 min to 140 min arginine release in controls was elevated. The precise mechanisms through which each of the volatile anesthetics affected amino acid concentrations are still unclear and further experimental research is required to draw reliable conclusions.	[Seidemann, Thomas; Spies, Claudia; Netzhammer, Nicolai] Charite, Dept Anesthesiol & Intens Care Med, Campus Charite Mitte, Berlin, Germany; [Seidemann, Thomas; Spies, Claudia; Netzhammer, Nicolai] Charite, Campus Virchow Klinikum, Berlin, Germany; [Morgenstern, Rudolf] Charite, Inst Pharmacol, Campus Charite Mitte, Berlin, Germany; [Wernecke, Klaus-Dieter] SOSTANA, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Spies, C (corresponding author), Charite, Dept Anesthesiol & Intens Care Med, Campus Charite Mitte, Berlin, Germany.; Spies, C (corresponding author), Charite, Campus Virchow Klinikum, Berlin, Germany.	claudia.spies@charite.de	Spies, Claudia/AAJ-5412-2020	Spies, Claudia/0000-0002-1062-0495				Awissi DK, 2013, INTENS CARE MED, V39, P16, DOI 10.1007/s00134-012-2758-y; Baum SS, 2006, ALCOHOL CLIN EXP RES, V30, P1414, DOI 10.1111/j.1530-0277.2006.00169.x; Chen G, 2011, ALCOHOL CLIN EXP RES, V35, P1739, DOI 10.1111/j.1530-0277.2011.01520.x; Chen PE, 2005, MOL PHARMACOL, V67, P1470, DOI 10.1124/mol.104.008185; Christian DT, 2013, NEUROPHARMACOLOGY, V65, P134, DOI 10.1016/j.neuropharm.2012.09.004; Cippitelli A, 2012, PHARMACOL BIOCHEM BE, V100, P522, DOI 10.1016/j.pbb.2011.10.016; Dahchour A, 2003, EUR J PHARMACOL, V459, P171, DOI 10.1016/S0014-2999(02)02851-0; Dahchour A, 2000, PHARMACOL BIOCHEM BE, V65, P345, DOI 10.1016/S0091-3057(99)00197-5; Do SH, 2002, ANESTHESIOLOGY, V96, P1492, DOI 10.1097/00000542-200206000-00032; Eyer F, 2011, ALCOHOL ALCOHOLISM, V46, P427, DOI 10.1093/alcalc/agr053; Fliegel Sarah, 2013, In Silico Pharmacology, V1, P7, DOI 10.1186/2193-9616-1-7; Hapfelmeier G, 2001, EUR J ANAESTH, V18, P377, DOI 10.1046/j.0265-0215.2001.00848.x; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Hendricson AW, 2007, J PHARMACOL EXP THER, V321, P60, DOI 10.1124/jpet.106.111419; Hollmann MW, 2001, ANESTH ANALG, V92, P1182; Huang YM, 2006, J BIOL CHEM, V281, P38133, DOI 10.1074/jbc.M603885200; Kim JH, 2005, ALCOHOL CLIN EXP RES, V29, P2046, DOI 10.1097/01.alc.0000187594.92476.07; Larsen M, 1997, BRIT J ANAESTH, V78, P55, DOI 10.1093/bja/78.1.55; Larsen M, 1998, TOXICOL LETT, V101, P59, DOI 10.1016/S0378-4274(98)00165-9; Lee SN, 2010, NEUROSCIENCE, V171, P788, DOI 10.1016/j.neuroscience.2010.09.044; Lee SA, 2009, ANESTH ANALG, V109, P1506, DOI 10.1213/ANE.0b013e3181b6709a; LIEBER CS, 1989, ALCOHOL ALCOHOLISM, V24, P197; Mathews GC, 2003, J NEUROSCI, V23, P2040; Mawhinney LJ, 2012, BRAIN RES, V1431, P23, DOI 10.1016/j.brainres.2011.11.004; McBride WJ, 1998, CRIT REV NEUROBIOL, V12, P339, DOI 10.1615/CritRevNeurobiol.v12.i4.40; Mehta Ashish Jitendra, 2016, World J Crit Care Med, V5, P27, DOI 10.5492/wjccm.v5.i1.27; Moe MC, 2002, J NEUROSURG ANESTH, V14, P180, DOI 10.1097/00008506-200207000-00002; MOORE RD, 1989, JAMA-J AM MED ASSOC, V261, P403, DOI 10.1001/jama.261.3.403; MUCHA RF, 1975, PHARMACOL BIOCHEM BE, V3, P765, DOI 10.1016/0091-3057(75)90104-5; Nadler JV, 2011, NEUROCHEM RES, V36, P668, DOI 10.1007/s11064-010-0291-3; Nath V, 2012, ALCOHOL, V46, P3, DOI 10.1016/j.alcohol.2011.08.003; Ouyang W, 2005, J PHARMACOL EXP THER, V312, P801, DOI 10.1124/jpet.104.074609; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Quintero GC, 2013, NEUROPSYCH DIS TREAT, V9, P1499, DOI 10.2147/NDT.S45963; Rossetti ZL, 1999, NEUROSCIENCE, V93, P1135, DOI 10.1016/S0306-4522(99)00250-X; Sancho-Tello M, 2008, ALCOHOL ALCOHOLISM, V43, P254, DOI 10.1093/alcalc/agn006; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Spies CD, 1996, INTENS CARE MED, V22, P286, DOI 10.1007/s001340050082; Trevisan LA, 1998, ALCOHOL HEALTH RES W, V22, P61; Yan JZ, 2011, J BIOL CHEM, V286, P25187, DOI 10.1074/jbc.M110.192708	40	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169017	10.1371/journal.pone.0169017	http://dx.doi.org/10.1371/journal.pone.0169017			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045949	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300091
J	Studzinska, M; Jablonska, A; Wisniewska-Ligier, M; Nowakowska, D; Gaj, Z; Lesnikowski, ZJ; Wozniakowska-Gesicka, T; Wilczynski, J; Paradowska, E				Studzinska, Miroslawa; Jablonska, Agnieszka; Wisniewska-Ligier, Malgorzata; Nowakowska, Dorota; Gaj, Zuzanna; Lesnikowski, Zbigniew J.; Wozniakowska-Gesicka, Teresa; Wilczynski, Jan; Paradowska, Edyta			Association of TLR3 L412F Polymorphism with Cytomegalovirus Infection in Children	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; CHRONIC HEPATITIS-C; NATURAL-RESISTANCE; IMMUNE-RESPONSE; RIG-I; RECOGNITION; SUSCEPTIBILITY; CELLS; DISEASE	Intracellular Toll-like receptor 3 (TLR3) recognizes viral double-stranded RNA (dsRNA) and activates antiviral immune responses through the production of type I interferons (IFNs) and inflammatory cytokines. This receptor binds to dsRNA molecules produced during human cytomegalovirus (HCMV) replication. TLR7 senses viral single-stranded RNA (ssRNA) in endosomes, and it can interact with endogenous RNAs. We determined the genotype distribution of single-nucleotide polymorphisms (SNPs) within the TLR3 and TLR7 genes in children with HCMV infection and the relationship between TLR polymorphisms and viral infection. We genotyped 59 children with symptomatic HCMV infection and 78 healthy individuals for SNPs in the TLR3 (rs3775290, c.1377C>T, F459F; rs3775291, c.1234C>T, L412F; rs3775296, c.-7C>A) and TLR7 (rs179008, c.32A>T, Q11 L; rs5741880, c.3+1716G>T) genes. SNP genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and capillary electrophoresis. The HCMV DNA load was quantified by real-time PCR. We found an increased frequency of the heterozygous genotype TLR3 L412F in children with HCMV infection compared with uninfected cases. In individuals with a mutation present in at least one allele of the L412F SNP, an increased risk of HCMV disease was found, and this result remained highly significant after Bonferroni's correction for multiple testing (Pc < 0.001). The heterozygous genotype of this SNP was associated with the increased risk of HCMV disease in an adjusted model that included the HCMV DNA copy number in whole blood and urine (P< 0.001 and P = 0.008, respectively). Moreover, those with a heterozygous genotype of rs3775296 showed an increased relative risk of HCMV infection (P = 0.042), but this association did not reach statistical significance after correction for multiple testing. In contrast, the rs3775290 SNP of TLR3 and TLR7 SNPs were not related to viral infection. A moderate linkage disequilibrium (LD) was observed between the SNPs rs3775291 and rs3775296 (r(2) = 0.514). We suggest that the L412F polymorphism in the TLR3 gene could be a genetic risk factor for the development of HCMV disease.	[Studzinska, Miroslawa; Jablonska, Agnieszka; Lesnikowski, Zbigniew J.; Paradowska, Edyta] Polish Acad Sci, Inst Med Biol, Lab Mol Virol & Biol Chem, Lodz, Poland; [Wisniewska-Ligier, Malgorzata] Polish Mothers Mem Hosp, Res Inst, Dept Pediat Immunol & Nephrol, Lodz, Poland; [Nowakowska, Dorota; Gaj, Zuzanna] Polish Mothers Mem Hosp, Res Inst, Dept Perinatol & Gynecol, Lodz, Poland; [Wozniakowska-Gesicka, Teresa] Polish Mothers Mem Hosp, Res Inst, Dept Pediat 3, Lodz, Poland; [Wilczynski, Jan] Med Univ Warsaw, Dept Obstet & Gynecol 2, Warsaw, Poland	Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; Polish Mother's Memorial Hospital - Research Institute; Polish Mother's Memorial Hospital - Research Institute; Polish Mother's Memorial Hospital - Research Institute; Medical University of Warsaw	Paradowska, E (corresponding author), Polish Acad Sci, Inst Med Biol, Lab Mol Virol & Biol Chem, Lodz, Poland.	eparadowska@cbm.pan.al	Jabłońska, Agnieszka/AAG-8207-2021; Lesnikowski, Zbigniew/AAG-7006-2020; Jabłońska, Agnieszka/AAF-8078-2019; Gaj, Zuzanna/O-3749-2014	Lesnikowski, Zbigniew/0000-0003-3158-5796; Jabłońska, Agnieszka/0000-0002-6688-043X; Gaj, Zuzanna/0000-0002-1803-1935; Studzinska, Miroslawa/0000-0002-4851-2190; Paradowska, Edyta/0000-0001-9446-0136	National Science Centre of Poland [2014/13/B/NZ7/02317]	National Science Centre of Poland(National Science Centre, Poland)	This work was supported in part by the National Science Centre of Poland (No. 2014/13/B/NZ7/02317) (http://www.ncn.gov.pl/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arav-Boger Ravit, 2012, BMC Res Notes, V5, P140, DOI 10.1186/1756-0500-5-140; Arslan S, 2015, J MED VIROL, V87, P1090, DOI 10.1002/jmv.24174; Askar E, 2010, J MED VIROL, V82, P1859, DOI 10.1002/jmv.21893; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bell JK, 2006, J ENDOTOXIN RES, V12, P375, DOI 10.1179/096805106X118780; Biyani S, 2015, J NEUROIMMUNOL, V286, P71, DOI 10.1016/j.jneuroim.2015.07.010; Carvalho A, 2009, EXP HEMATOL, V37, P1022, DOI 10.1016/j.exphem.2009.06.004; Cervera C, 2007, TRANSPLANTATION, V83, P1493, DOI 10.1097/01.tp.0000264999.71318.2b; Cheng PL, 2007, TRANSL RES, V150, P311, DOI 10.1016/j.trsl.2007.03.010; Crane MJ, PLOS; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Gorbea C, 2010, J BIOL CHEM, V285, P23206, DOI 10.1074/jbc.M109.047464; Griffiths P, 2015, J PATHOL, V235, P288, DOI 10.1002/path.4437; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Hardarson HS, 2007, AM J PHYSIOL-HEART C, V292, pH251, DOI 10.1152/ajpheart.00398.2006; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Jablonska A, 2014, INT J INFECT DIS, V25, P11, DOI 10.1016/j.ijid.2014.04.001; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kang SH, 2012, J INFECT DIS, V205, P639, DOI 10.1093/infdis/jir819; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Kijpittayarit S, 2007, CLIN INFECT DIS, V44, P1315, DOI 10.1086/514339; Kruger B, 2010, CLIN SCI, V119, P535, DOI 10.1042/CS20100190; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lee SO, 2013, TRANSPL INFECT DIS, V15, P111, DOI 10.1111/tid.12033; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Martin HJ, 2007, J VIROL, V81, P9748, DOI 10.1128/JVI.01122-07; Mezger M, 2009, VIRAL IMMUNOL, V22, P343, DOI 10.1089/vim.2009.0011; Nahum A, 2012, AUTOIMMUN REV, V11, P341, DOI 10.1016/j.autrev.2011.10.007; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Noguchi E, 2004, CLIN EXP ALLERGY, V34, P177, DOI 10.1111/j.1365-2222.2004.01839.x; Nuolivirta K, 2012, PEDIATR INFECT DIS J, V31, P920, DOI 10.1097/INF.0b013e31825aff25; Paradowska E, 2006, APMIS, V114, P764, DOI 10.1111/j.1600-0463.2006.apm_31.x; Paradowska E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154100; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P17696, DOI 10.1074/jbc.M700209200; Seo S., 2015, BLOOD, V124, P182, DOI [10.1182/blood.V124.21.182.182, DOI 10.1182/BLOOD.V124.21.182.182]; Sironi M, 2012, J IMMUNOL, V188, P818, DOI 10.4049/jimmunol.1102179; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; Svensson A, 2012, J GEN VIROL, V93, P1717, DOI 10.1099/vir.0.042572-0; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Taniguchi R, 2013, INT J INFECT DIS, V17, pE1092, DOI 10.1016/j.ijid.2013.06.004; Varani S, 2007, J IMMUNOL, V179, P7767, DOI 10.4049/jimmunol.179.11.7767; Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085; Willmann O, 2010, EUR NEUROL, V63, P249, DOI 10.1159/000287585; Wujcicka W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122831; Xiao HW, 2014, BONE MARROW TRANSPL, V49, P241, DOI 10.1038/bmt.2013.160; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang CA, 2012, HUM IMMUNOL, V73, P844, DOI 10.1016/j.humimm.2012.04.008; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhou P, 2011, FASEB J, V25, P3489, DOI 10.1096/fj.11-189258; Zucchini N, 2008, J IMMUNOL, V180, P5799, DOI 10.4049/jimmunol.180.9.5799	58	23	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169420	10.1371/journal.pone.0169420	http://dx.doi.org/10.1371/journal.pone.0169420			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046022	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300187
J	Tornack, J; Reece, ST; Bauer, WM; Vogelzang, A; Bandermann, S; Zedler, U; Stingl, G; Kaufmann, SHE; Melchers, F				Tornack, Julia; Reece, Stephen T.; Bauer, Wolfgang M.; Vogelzang, Alexis; Bandermann, Silke; Zedler, Ulrike; Stingl, Georg; Kaufmann, Stefan H. E.; Melchers, Fritz			Human and Mouse Hematopoietic Stem Cells Are a Depot for Dormant Mycobacterium tuberculosis	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; IN-VIVO; LATENT TUBERCULOSIS; PERIPHERAL-BLOOD; SIDE-POPULATION; HYPOXIC NICHE; C-KIT; INFECTION; IS6110; VITRO	An estimated third of the world's population is latently infected with Mycobacterium tuberculosis (Mtb), with no clinical signs of tuberculosis (TB), but lifelong risk of reactivation to active disease. The niches of persisting bacteria during latent TB infection remain unclear. We detect Mtb DNA in peripheral blood selectively in long-term repopulating pluripotent hematopoietic stem cells (LT-pHSCs) as well as in mesenchymal stem cells from latently infected human donors. In mice infected with low numbers of Mtb, that do not develop active disease we, again, find LT-pHSCs selectively infected with Mtb. In human and mouse LT-pHSCs Mtb are stressed or dormant, non-replicating bacteria. Intratracheal injection of Mtb-infected human and mouse LT-pHSCs into immune-deficient mice resuscitates Mtb to replicating bacteria within the lung, accompanied by signs of active infection. We conclude that LT-pHSCs, together with MSCs of Mtb-infected humans and mice serve as a hitherto unappreciated quiescent cellular depot for Mtb during latent TB infection.	[Tornack, Julia; Melchers, Fritz] Max Planck Inst Infect Biol, Senior Grp Lymphocyte Dev, Berlin, Germany; [Reece, Stephen T.; Vogelzang, Alexis; Bandermann, Silke; Zedler, Ulrike; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Bauer, Wolfgang M.; Stingl, Georg] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria; [Reece, Stephen T.] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge Biomed Campus, Cambridge, England; [Vogelzang, Alexis] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan	Max Planck Society; Max Planck Society; Medical University of Vienna; University of Cambridge; RIKEN	Tornack, J (corresponding author), Max Planck Inst Infect Biol, Senior Grp Lymphocyte Dev, Berlin, Germany.	tornack@mpiib-berlin.mpg.de	Vogelzang, Alexis/C-5440-2017	Bauer, Wolfgang/0000-0002-0155-1176; Vogelzang, Alexis/0000-0002-2921-1755	European Union's Seventh Framework Programme (EU FP7) project "ADITEC" [HEALTH-F4-2011-280873]; EU Horizon 2020 project "TBVAC 2020" [643381]; Reinhard Koselleck-Grant of the Deutsche Forschungsgemeinschaft [ME 2764/1-1]	European Union's Seventh Framework Programme (EU FP7) project "ADITEC"; EU Horizon 2020 project "TBVAC 2020"; Reinhard Koselleck-Grant of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the European Union's Seventh Framework Programme (EU FP7) project "ADITEC" (HEALTH-F4-2011-280873); and EU Horizon 2020 project "TBVAC 2020" (grant 643381) to SHEK. In addition, the work was supported in parts by a Reinhard Koselleck-Grant of the Deutsche Forschungsgemeinschaft ME 2764/1-1 to FM.	Aljurf M, 1999, BONE MARROW TRANSPL, V24, P551, DOI 10.1038/sj.bmt.1701930; Bloom BR, 1999, NAT MED, V5, P872, DOI 10.1038/11309; Brosch R, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P19; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Das B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004912; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Dietrich G, 2000, FEMS MICROBIOL LETT, V186, P177, DOI 10.1016/S0378-1097(00)00138-5; ELLIS RC, 1993, J CLIN PATHOL, V46, P559, DOI 10.1136/jcp.46.6.559; FOMUKONG NG, 1994, TUBERCLE LUNG DIS, V75, P435, DOI 10.1016/0962-8479(94)90117-1; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Garhyan J, 2015, AM J PATHOL, V185, P1924, DOI 10.1016/j.ajpath.2015.03.028; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Goodell MA, 2002, CYTOTHERAPY, V4, P507, DOI 10.1080/146532402761624638; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; HERBEIN G, 1994, STEM CELLS, V12, P187, DOI 10.1002/stem.5530120207; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Jakob U., 2013, OXIDATIVE STRESRED; Kerridge I, 2003, INTERN MED J, V33, P619, DOI 10.1111/j.1445-5994.2003.00451.x; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kindler T, 2001, BONE MARROW TRANSPL, V27, P217, DOI 10.1038/sj.bmt.1702737; Kuci S, 2010, HAEMATOL-HEMATOL J, V95, P651, DOI 10.3324/haematol.2009.015065; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Lin KK, 2006, METHOD ENZYMOL, V420, P255, DOI 10.1016/S0076-6879(06)20011-9; Lok KH, 2002, EMERG INFECT DIS, V8, P1310, DOI 10.3201/eid0811.020291; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; OKADA S, 1992, BLOOD, V80, P3044; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Quirici N, 2002, EXP HEMATOL, V30, P783, DOI 10.1016/S0301-472X(02)00812-3; Reece ST, 2010, J CLIN INVEST, V120, P3365, DOI 10.1172/JCI42796; Rienksma RA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1197-2; Russo RL, 2010, INT J INFECT DIS, V14, pE187, DOI 10.1016/j.ijid.2009.08.001; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Steensels D, 2013, J CLIN MICROBIOL, V51, P366, DOI 10.1128/JCM.02524-12; THIERRY D, 1990, NUCLEIC ACIDS RES, V18, P188, DOI 10.1093/nar/18.1.188; Woolhiser L, 2007, INFECT IMMUN, V75, P2621, DOI 10.1128/IAI.00918-06; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005; Young JS, 2005, APPL ENVIRON MICROB, V71, P1946, DOI 10.1128/AEM.71.4.1946-1952.2005; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zumarraga M, 1999, MICROBIOL-SGM, V145, P893, DOI 10.1099/13500872-145-4-893	48	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169119	10.1371/journal.pone.0169119	http://dx.doi.org/10.1371/journal.pone.0169119			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046053	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300119
J	Faraji, A; Manshadi, HRD; Mobaraki, M; Zare, M; Houshmand, M				Faraji, Abolfazl; Manshadi, Hamid Reza Dehghan; Mobaraki, Maryam; Zare, Mahkameh; Houshmand, Massoud			Association of ABCB1 and SLC22A16 Gene Polymorphisms with Incidence of Doxorubicin-Induced Febrile Neutropenia: A Survey of Iranian Breast Cancer Patients	PLOS ONE			English	Article							CHEMOTHERAPY; DOCETAXEL	Breast cancer is the most common cancer in women worldwide. Doxorubicin-based chemotherapy is used to treat breast cancer patients; however, neutropenia is a common hematologic side effect and can be life-threatening. The ABCB1 and SLC22A16 genes encode proteins that are essential for doxorubicin transport. In this study, we explored the effect of 2 common polymorphisms in ABCB1 (rs10276036 C/T) and SLC22A16 (rs12210538 A/G) on the development of grade 3/4 febrile neutropenia in Iranian breast cancer patients. Our results showed no significant association between these polymorphisms and grade 3/4 febrile neutropenia; however, allele C of ABCB1 (rs10276036 C/T) (p = 0.315, OR = 1.500, 95% CI = 0.679-3.312) and allele A of SLC22A16 (rs12210538 A/G) (p = 0.110, OR= 2.984, 95% CI = 0.743-11.988) tended to have a greater association with grade 3/4 febrile neutropenia, whereas allele T of ABCB1 (rs10276036) (p = 0.130, OR = 0.515, 95% CI = 0.217-1.223) and allele G of SLC22A16 (rs12210538) (p = 0.548, OR = 0.786, 95% CI = 0.358-1.726) tended to protect against this condition. In addition to breast cancer, a statistically significant association was also observed between the development of grade 3/4 febrile neutropenia and other clinical manifestations such as stage IIIC cancer (p = 0.037) and other diseases (p = 0.026). Our results indicate that evaluation of the risk of grade 3/4 neutropenia development and consideration of molecular and clinical findings may be of value when screening for high-risk breast cancer patients.	[Faraji, Abolfazl; Mobaraki, Maryam; Houshmand, Massoud] Natl Inst Genet Engn & Biotechnol, Dept Med Genet, Tehran, Iran; [Manshadi, Hamid Reza Dehghan; Zare, Mahkameh] Iran Univ Med Sci, Dept Radiat Oncol, Tir Hosp 7, Tehran, Iran	Iran University of Medical Sciences	Houshmand, M (corresponding author), Natl Inst Genet Engn & Biotechnol, Dept Med Genet, Tehran, Iran.; Manshadi, HRD (corresponding author), Iran Univ Med Sci, Dept Radiat Oncol, Tir Hosp 7, Tehran, Iran.	denghanhamidreza@gmail.com; massoudh@nigeb.ac.ir	Houshmand, Massoud/AEG-9909-2022	Houshmand, Massoud/0000-0002-2198-223X; , Masoud/0000-0001-7687-7464				[Anonymous], 1986, P NATL ACAD SCI US, V83, P4514; [Anonymous], 1993, PHARM THER, V60, P185; [Anonymous], 2007, PHARMACOGENOMICS, V8, P567, DOI [10.2217/14622416.8.6.567, DOI 10.2217/14622416.8.6.567]; [Anonymous], 2007, INT J GYNECOL PATHOL, V26, P334, DOI [10.1097/01.pgp.0000236951.33914.1b, DOI 10.1097/01.PGP.0000236951.33914.1B]; [Anonymous], 1997, J BIOL CHEM, V272, P10685; [Anonymous], 2015, CANCER CHEMOTH PHARM, V75, P207, DOI [10.1007/s00280-014-2632-4, DOI 10.1007/S00280-014-2632-4]; [Anonymous], 1987, CANC RES, V47, P5141; [Anonymous], 2010, BRIT J CANCER, V102, P1003, DOI [10.1038/sj.bjc.6605587, DOI 10.1038/SJ.BJC.6605587]; [Anonymous], 1998, CLIN CANC RES, V4, P389; [Anonymous], 2014, CRIT REV ONCOL HEMAT, V90, P190, DOI [10.1016/j.critrevonc.2013.12.006, DOI 10.1016/J.CRITREVONC.2013.12.006]; [Anonymous], 2005, BIOCHEM BIOPH RES CO, V333, P754, DOI [10.1016/j.bbrc.2005.05.174, DOI 10.1016/J.BBRC.2005.05.174]; [Anonymous], 2008, METHOD MOL BIOL, V448, P41, DOI [10.1007/978-1-59745-205-2_4, DOI 10.1007/978-1-59745-205-2_4]; [Anonymous], 2000, BIOTECHNOL BIOENG, V11, P1101; [Anonymous], 1999, TRENDS PHARM SCI, V20, P342; [Anonymous], 2006, NATL COMPR CANC NETW, V4, P649; [Anonymous], 2008, LANCET, V371, P1551, DOI DOI 10.1016/S0140-6736(08)60069-0; [Anonymous], 2001, BIOCHEM BIOPH RES CO, V281, P1256, DOI [10.1006/bbrc.2001.4524, DOI 10.1006/BBRC.2001.4524]; [Anonymous], 1999, BLOOD, V94, P1086; [Anonymous], 1988, BIOCH BIOPHYS ACTA, V948, P87; [Anonymous], 1994, MOL PHARM, V45, P649; [Anonymous], 2001, CLIN PHARMACOL THER, V70, P189, DOI [10.1067/mcp.2001.117412, DOI 10.1067/MCP.2001.117412]; Biolabs NE, PROTOCOL ROUTINE TAQ; Hodges LM, 2011, PHARMACOGENET GENOM, V21, P152, DOI 10.1097/FPC.0b013e3283385a1c; Kim CG, 2016, J BREAST CANCER, V19, P76, DOI 10.4048/jbc.2016.19.1.76; Kim HJ, 2015, CANCER SCI, V106, P86, DOI 10.1111/cas.12560; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006	26	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168519	10.1371/journal.pone.0168519	http://dx.doi.org/10.1371/journal.pone.0168519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036387	Green Submitted, Green Published, gold			2022-12-26	WOS:000391229300015
J	Koval, T; Ostergaard, LH; Lehmbeck, J; Norgaard, A; Lipovova, P; Duskova, J; Skalova, T; Trundova, M; Kolenko, P; Fejfarova, K; Stransky, J; Svecova, L; Hasek, J; Dohnalek, J				Koval, Tomas; Ostergaard, Lars H.; Lehmbeck, Jan; Norgaard, Allan; Lipovova, Petra; Duskova, Jarmila; Skalova, Tereza; Trundova, Maria; Kolenko, Petr; Fejfarova, Karla; Stransky, Jan; Svecova, Leona; Hasek, Jindrich; Dohnalek, Jan			Structural and Catalytic Properties of S1 Nuclease from Aspergillus oryzae Responsible for Substrate Recognition, Cleavage, Non-Specificity, and Inhibition	PLOS ONE			English	Article							MACROMOLECULAR CRYSTALLOGRAPHY; CRYSTAL-STRUCTURES; RESOLUTION; PURIFICATION; REFINEMENT; MECHANISM; FEATURES; TBN1; DNA; P1	The single-strand-specific S1 nuclease from Aspergillus oryzae is an archetypal enzyme of the S1-P1 family of nucleases with a widespread use for biochemical analyses of nucleic acids. We present the first X-ray structure of this nuclease along with a thorough analysis of the reaction and inhibition mechanisms and of its properties responsible for identification and binding of ligands. Seven structures of S1 nuclease, six of which are complexes with products and inhibitors, and characterization of catalytic properties of a wild type and mutants reveal unknown attributes of the S1-P1 family. The active site can bind phosphate, nucleosides, and nucleotides in several distinguished ways. The nucleoside binding site accepts bases in two binding modes-shallow and deep. It can also undergo remodeling and so adapt to different ligands. The amino acid residue Asp65 is critical for activity while Asn154 secures interaction with the sugar moiety, and Lys68 is involved in interactions with the phosphate and sugar moieties of ligands. An additional nucleobase binding site was identified on the surface, which explains the absence of the Tyr site known from P1 nuclease. For the first time ternary complexes with ligands enable modeling of ssDNA binding in the active site cleft. Interpretation of the results in the context of the whole S1-P1 nuclease family significantly broadens our knowledge regarding ligand interaction modes and the strategies of adjustment of the enzyme surface and binding sites to achieve particular specificity.	[Koval, Tomas; Duskova, Jarmila; Skalova, Tereza; Trundova, Maria; Kolenko, Petr; Fejfarova, Karla; Stransky, Jan; Svecova, Leona; Hasek, Jindrich; Dohnalek, Jan] CAS, Inst Biotechnol, Lab Struct & Funct Biomol, Biocev,Vvi, Vestec, Czech Republic; [Ostergaard, Lars H.] Novozymes AS, Dept Agile Prot Screening, Bagsvaerd, Denmark; [Lehmbeck, Jan] Novozymes AS, Dept Fungal Strain Technol, Bagsvaerd, Denmark; [Norgaard, Allan] Novozymes AS, Dept Prot Biochem & Stabil, Bagsvaerd, Denmark; [Lipovova, Petra] Univ Chem & Technol, Dept Biochem & Microbiol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Novozymes; Novozymes; Novozymes; University of Chemistry & Technology, Prague	Koval, T (corresponding author), CAS, Inst Biotechnol, Lab Struct & Funct Biomol, Biocev,Vvi, Vestec, Czech Republic.	koval.tomas@gmail.com; jan.dohnalek@ibt.cas.cz	Trundová, Mária/H-1722-2014; Stransky, Jan/G-6778-2014; Stransky, Jan/AAD-6220-2020; Kolenko, Petr/G-5732-2014; Hasek, Jindrich/G-3267-2014; Skalova, Tereza/G-6422-2014; Ostergaard, Lars/AAA-3020-2020; Østergaard, Lars/H-1427-2014; Fejfarova, Karla/M-2115-2013; Duskova, Jarmila/G-5922-2014; Lipovova, Petra/Q-7187-2017; Kovaľ, Tomáš/G-9499-2014; Švecová, Leona/ABE-4145-2021	Stransky, Jan/0000-0001-5139-2567; Stransky, Jan/0000-0001-5139-2567; Kolenko, Petr/0000-0002-4619-9276; Hasek, Jindrich/0000-0001-7973-1815; Skalova, Tereza/0000-0003-3186-2431; Ostergaard, Lars/0000-0003-2459-0511; Østergaard, Lars/0000-0003-4210-2374; Lipovova, Petra/0000-0003-2275-3479; Kovaľ, Tomáš/0000-0002-2836-3765; Lehmbeck, Jan/0000-0002-3545-6062; Ostergaard, Lars/0000-0002-7619-605X; Svecova, Leona/0000-0002-2078-5277	Academy of Sciences; Charles University from the European Regional Development Fund [CZ.1.05/1.1.00/02.0109]; Ministry of Education, Youth and Sports of the Czech Republic [LG14009, LM2015043]; Czech Science Foundation [15-05228S]; BioStruct-X (EC FP7 project) [283570]; Novozymes	Academy of Sciences(Egyptian Academy of Scientific Research & Technology (ASRT)); Charles University from the European Regional Development Fund; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); BioStruct-X (EC FP7 project); Novozymes	This work was supported by the project BIOCEV Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (CZ.1.05/1.1.00/02.0109) from the European Regional Development Fund; by the Ministry of Education, Youth and Sports of the Czech Republic grant No. LG14009 (to JD); support of large infrastructures by the Ministry of Education, Youth and Sports CR, CIISB - LM2015043; by the Czech Science Foundation, project 15-05228S (to JD); and by BioStruct-X (EC FP7 project 283570). Novozymes provided support in the form of salaries for authors LHO, JL, and AN. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the "Author contributions" section.	Balabanova L. A., 2012, OPEN J MAR SCI, V2, P188, DOI DOI 10.4236/ojms.2012.24022; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chou TL, 2013, BIOCATAL AGRIC BIOTE, V2, P191, DOI 10.1016/j.bcab.2013.03.006; Copeland R. A., 2000, ENZYMES, V2nd; Desai NA, 2003, FEMS MICROBIOL REV, V26, P457, DOI 10.1016/S0168-6445(02)00129-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; GITE S, 1992, BIOCHEM J, V285, P489, DOI 10.1042/bj2850489; GITE S, 1992, EUR J BIOCHEM, V210, P437, DOI 10.1111/j.1432-1033.1992.tb17439.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kieseritzky G, 2008, PROTEINS, V71, P1335, DOI 10.1002/prot.21820; Ko CY, 2012, J AGR FOOD CHEM, V60, P5169, DOI 10.1021/jf300945c; Koval' T, 2013, ACTA CRYSTALLOGR D, V69, P213, DOI 10.1107/S0907444912043697; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; Lesniewicz K, 2013, PLANT CELL PHYSIOL, V54, P1064, DOI 10.1093/pcp/pct061; Liao RZ, 2010, INORG CHEM, V49, P6883, DOI 10.1021/ic100266n; Matousek J, 2010, NEOPLASMA, V57, P339, DOI 10.4149/neo_2010_04_339; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OLESON AE, 1980, ARCH BIOCHEM BIOPHYS, V204, P361, DOI 10.1016/0003-9861(80)90044-2; Pimkin M, 2006, BIOCHEM BIOPH RES CO, V343, P77, DOI 10.1016/j.bbrc.2006.02.117; Podzimek T, 2011, PLANT SCI, V180, P343, DOI 10.1016/j.plantsci.2010.10.006; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Romier C, 1998, PROTEINS, V32, P414, DOI 10.1002/(SICI)1097-0134(19980901)32:4<414::AID-PROT2>3.3.CO;2-5; Rushizky G W, 1981, Gene Amplif Anal, V2, P205; Stransky J, 2006, ACTA CRYSTALLOGR, V71, P1408; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; VOGT VM, 1973, EUR J BIOCHEM, V33, P192, DOI 10.1111/j.1432-1033.1973.tb02669.x; VOLBEDA A, 1991, EMBO J, V10, P1607, DOI 10.1002/j.1460-2075.1991.tb07683.x; Wilson KA, 2014, NUCLEIC ACIDS RES, V42, P6726, DOI 10.1093/nar/gku269; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Yu TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105821	36	11	12	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168832	10.1371/journal.pone.0168832	http://dx.doi.org/10.1371/journal.pone.0168832			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036383	Green Published, gold, Green Submitted			2022-12-26	WOS:000391229300034
J	Sun, HW; Yu, XJ; Wu, WC; Chen, J; Shi, M; Zheng, LM; Xu, J				Sun, Hong-Wei; Yu, Xing-Juan; Wu, Wen-Chao; Chen, Jing; Shi, Ming; Zheng, Limin; Xu, Jing			GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma	PLOS ONE			English	Article							GLUTAMINE UPTAKE; POOR-PROGNOSIS; CELL-GROWTH; EXPRESSION; SLC1A5; COMPETITION; METABOLISM; ACTIVATION; TRANSPORT; AXIS	An emerging hallmark of cancer is reprogrammed cellular metabolism, and several cancers involve increased glucose intake and glutamine addiction. Hepatocellular carcinoma (HCC) is one of the most fatal cancers, and its molecular basis needs to be delineated to identify biomarkers for its potential treatment without resection. Therefore, this study aimed to determine the metabolism status of HCC by evaluating the expression of the glucose transporter GLUT1 and glutamine transporter ASCT2. We enrolled 192 patients with surgically resected HCC in this study. Their tissue samples were subjected to immunohistochemistry to detect GLUT1 and ASCT2 expression. The prognostic value of GLUT1 and ASCT2 expression and their combined metabolic index was determined by Kaplan-Meier analysis and the Cox proportional hazards model. We found that GLUT1 and ASCT2 expression was significantly upregulated in tumor tissues as compared to adjacent non-tumor tissues and was positively associated with tumor size. Survival analysis revealed that patients with high GLUT1 or ASCT2 expression had poor overall survival (OS) and recurrence-free survival (RFS). In HCC patients, ASCT2 expression was an independent negative prognostic factor for OS (hazard ratio [HR], 1.760; 95% confidence interval [CI] = 1.124-2.755; p = 0.013) and the metabolic index was an independent negative prognostic factor for OS (HR = 1.672, 95% CI = 1.275-2.193, p < 0.001) and RFS (HR = 1.362, 95% CI = 1.066-1.740, p = 0.013). In conclusion, the tumor metabolism status determined by expression of GLUT1 and ASCT2 and their metabolic index is a promising prognostic predictor for HCC patients.	[Sun, Hong-Wei; Yu, Xing-Juan; Wu, Wen-Chao; Chen, Jing; Zheng, Limin; Xu, Jing] Sun Yat Sen Univ, Ctr Canc, Ctr State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Chen, Jing; Zheng, Limin] Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Shi, Ming] Sun Yat Sen Univ, Dept Hepatobiliary Oncol, Ctr Canc, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Xu, J (corresponding author), Sun Yat Sen Univ, Ctr Canc, Ctr State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	xujing@sysucc.org.cn	zheng, limin/HGB-2510-2022; Sun, Hong-Wei/U-6711-2018	Sun, Hong-Wei/0000-0001-6236-2064; Zheng, Limin/0000-0002-8281-1450	National Natural Science Foundation of China [81301793, 81502455]; Health Medical Collaborative Innovation Program of Guangzhou [201400000001-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Medical Collaborative Innovation Program of Guangzhou	This work was supported by grants from National Natural Science Foundation of China (JX, No.81301793; W-CW, No.81502455) and Health Medical Collaborative Innovation Program of Guangzhou (LZ, No. 201400000001-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann T, 2009, AM J PATHOL, V174, P1544, DOI 10.2353/ajpath.2009.080596; Bode BP, 2002, AM J PHYSIOL-GASTR L, V283, pG1062, DOI 10.1152/ajpgi.00031.2002; Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassanein M, 2013, CLIN CANCER RES, V19, P560, DOI 10.1158/1078-0432.CCR-12-2334; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Huang F, 2014, INT J CLIN EXP PATHO, V7, P6006; Huang W, 2013, HUM PATHOL, V44, P29, DOI 10.1016/j.humpath.2012.05.009; Klysz D, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab2610; Li L, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0247-1; Li S., 2011, COMMUN INF SCI MANAG, V1, P1, DOI DOI 10.5812/K0WSAR.1735143X.771; Liu YD, 2015, SCI REP-UK, V5, DOI 10.1038/srep16954; Llovet JM, 2015, NAT REV CLIN ONCOL, V12, P408, DOI [10.1038/nrclinonc.2015.103, 10.1038/nrclinonc.2015.121]; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; McGivan JD, 2007, FRONT BIOSCI, V12, P874, DOI 10.2741/2109; Perez-Escuredo J, 2016, CELL CYCLE, V15, P72, DOI 10.1080/15384101.2015.1120930; Pinheiro C, 2011, HISTOL HISTOPATHOL, V26, P1279, DOI 10.14670/HH-26.1279; Qu W, 2016, FEBS OPEN BIO, V6, P735, DOI 10.1002/2211-5463.12086; Rudlowski C, 2003, AM J CLIN PATHOL, V120, P691, DOI 10.1309/4KYNQM5862JW2GD7; Shen YM, 2011, INT J BIOL MARKER, V26, P166, DOI 10.5301/JBM.2011.8550; Shimizu K, 2014, BRIT J CANCER, V110, P2030, DOI 10.1038/bjc.2014.88; Sukumar M, 2015, CELL, V162, P1206, DOI 10.1016/j.cell.2015.08.064; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; van Geldermalsen M, 2016, ONCOGENE, V35, P3201, DOI 10.1038/onc.2015.381; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Villanueva Augusto, 2011, Gastroenterology, V140, P1501, DOI 10.1053/j.gastro.2011.02.006; Xu J, 2012, J HEPATOL, V57, P313, DOI 10.1016/j.jhep.2012.03.027; Zhao ED, 2016, NAT IMMUNOL, V17, P95, DOI 10.1038/ni.3313	35	52	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168907	10.1371/journal.pone.0168907	http://dx.doi.org/10.1371/journal.pone.0168907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036362	Green Published, Green Submitted, gold			2022-12-26	WOS:000391229300038
J	Parsons, E; Otieno, JA; Ong'echa, JM; Nixon, CE; Vulule, J; Munz, C; Stewart, VA; Moormann, AM				Parsons, Emily; Otieno, Juliana A.; Ong'echa, John Michael; Nixon, Christina E.; Vulule, John; Munz, Christian; Stewart, V. Ann; Moormann, Ann M.			Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HODGKIN-LYMPHOMA; NASOPHARYNGEAL CARCINOMA; EFFECTOR FUNCTIONS; IMMUNE-RESPONSE; KENYAN CHILDREN; MALARIA; CANCER; INFECTION; SURVIVAL	Deficiencies in Epstein-Barr virus (EBV)-specific T cell immunosurveillance appear to precede the development of endemic Burkitt lymphoma (eBL), a malaria-associated pediatric cancer common in sub-Saharan Africa. However, T cell contributions to eBL disease progression and survival have not been characterized. Our objective was to investigate regulatory and inflammatory T cell responses in eBL patients associated with clinical outcomes. By multi-parameter flow cytometry, we examined peripheral blood mononuclear cells from 38 eBL patients enrolled in a prospective cohort study in Kisumu, Kenya from 2008-2010, and 14 healthy age-matched Kenyan controls. Children diagnosed with eBL were prospectively followed and outcomes categorized as 2-year event-free survivors, cases of relapses, or those who died. At the time of diagnosis, eBL children with higher CD25(+)Foxp3(+) regulatory T (Treg) cell frequencies were less likely to survive than patients with lower Treg frequencies (p = 0.0194). Non-survivors also had higher absolute counts of CD45RA(+)Foxp3(lo) naive and CD45RA(-)Foxp3(hi) effector Treg subsets compared to survivors and healthy controls. Once patients went into clinical remission, Treg frequencies remained low in event-free survivors. Patients who relapsed, however, showed elevated Treg frequencies months prior to their adverse event. Neither concurrent peripheral blood EBV load nor malaria infection could explain higher Treg cell frequencies. CD8(+) T cell PD-1 expression was elevated in all eBL patients at time of diagnosis, but relapse patients tended to have persistently high PD-1 expression compared to long-term survivors. Non-survivors produced more CD4(+) T-cell IL-10 in response to both Epstein-Barr Nuclear Antigen-1 (EBNA-1) (p = 0.026) and the malaria antigen Plasmodium falciparum Schizont Egress Antigen-1 (p = 0.0158) compared to survivors, and were concurrently deficient in (EBNA-1)-specific CD8(+) T-cell derived IFN-gamma production (p = 0.002). In addition, we identified the presence of Foxp3(-)lL10(+) regulatory Type 1 cells responding to EBNA-1 in contrast to the malaria antigen tested. These novel findings suggest that poor outcomes in eBL patients are associated with a predominantly immuno-regulatory environment. Therefore, Treg frequencies could be a predictive biomarker of disease progression and manipulation of Treg activity has potential as a therapeutic target to improve eBL survival.	[Parsons, Emily; Stewart, V. Ann] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Otieno, Juliana A.] Jaramogi Oginga Odinga Teaching & Referral Hosp, Minist Hlth, Kisumu, Kenya; [Ong'echa, John Michael; Vulule, John] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Nixon, Christina E.] Rhode Isl Hosp, Ctr Int Hlth, Providence, RI USA; [Nixon, Christina E.] Rhode Isl Hosp, Dept Pathol, Providence, RI 02902 USA; [Munz, Christian] Univ Zurich, Dept Viral Immunobiol, Inst Expt Immunol, Zurich, Switzerland; [Moormann, Ann M.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA	Uniformed Services University of the Health Sciences - USA; Kenya Medical Research Institute; Lifespan Health Rhode Island; Rhode Island Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; University of Zurich; University of Massachusetts System; University of Massachusetts Worcester	Moormann, AM (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA.	ann.moormann@umassmed.edu	Münz, Christian/W-4881-2017	Nixon, Christina/0000-0003-1934-958X; Moormann, Ann/0000-0003-1113-2829; Ong'echa, John/0000-0003-3928-6774; Munz, Christian/0000-0001-6419-1940	National Institutes of Health [R01 CA134051, R01 CA189806]; Thrasher Research Fund [9135]; National Naval Medical Center [HT9404-13- 1-0022]; NATIONAL CANCER INSTITUTE [R01CA189806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thrasher Research Fund; National Naval Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the following: National Institutes of Health R01 CA134051 (AMM, JMO); National Institutes of Health R01 CA189806 (AMM), http://www.nih.gov/; Thrasher Research Fund Award #9135 (AMM); Thrasher Research Fund Early Career Award (CN), https://www.thrasherresearch.org; National Naval Medical Center HT9404-13- 1-0022 (AS), http://www.med.navy.mil/sites/nmrc/Pages/NMRD.aspx.	Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Assis MCG, 2012, MED ONCOL, V29, P3614, DOI 10.1007/s12032-012-0299-4; Badoual C, 2006, CLIN CANCER RES, V12, P465, DOI 10.1158/1078-0432.CCR-05-1886; BIGGAR RJ, 1978, INT J CANCER, V22, P244, DOI 10.1002/ijc.2910220305; Buckle G, 2016, INT J CANCER, V139, P1231, DOI 10.1002/ijc.30170; Chattopadhyay PK, 2013, J VIROL, V87, P1779, DOI 10.1128/JVI.02158-12; Chene A, 2007, PLOS PATHOG, V3, P826, DOI 10.1371/journal.ppat.0030080; Fogg M, 2013, VIROLOGY, V441, P107, DOI 10.1016/j.virol.2013.03.016; FRISAN T, 1995, BLOOD, V86, P1493, DOI 10.1182/blood.V86.4.1493.bloodjournal8641493; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; GREGORY CD, 1990, J GEN VIROL, V71, P1481, DOI 10.1099/0022-1317-71-7-1481; Lau KM, 2007, BRIT J CANCER, V96, P617, DOI 10.1038/sj.bjc.6603580; Magrath I, 2012, BRIT J HAEMATOL, V156, P744, DOI 10.1111/j.1365-2141.2011.09013.x; Marshall NA, 2004, BLOOD, V103, P1755, DOI 10.1182/blood-2003-07-2594; Marshall NA, 2003, J IMMUNOL, V170, P6183, DOI 10.4049/jimmunol.170.12.6183; Marshall NA, 2007, BRIT J HAEMATOL, V139, P81, DOI 10.1111/j.1365-2141.2007.06765.x; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Moormann AM, 2007, J INFECT DIS, V195, P799, DOI 10.1086/511984; Moormann AM, 2009, INT J CANCER, V124, P1721, DOI 10.1002/ijc.24014; Morales O, 2014, BRIT J HAEMATOL, V166, P875, DOI 10.1111/bjh.12980; Mulama DH, 2014, INT J CANCER, V134, P645, DOI 10.1002/ijc.28378; MURPHY SB, 1989, J CLIN ONCOL, V7, P186, DOI 10.1200/JCO.1989.7.2.186; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Pagano JS, 1999, P ASSOC AM PHYSICIAN, V111, P573, DOI 10.1046/j.1525-1381.1999.t01-1-99220.x; Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X; Piriou E, 2012, J INFECT DIS, V205, P906, DOI 10.1093/infdis/jir872; Raj DK, 2014, SCIENCE, V344, P871, DOI 10.1126/science.1254417; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Voo KS, 2005, CANCER RES, V65, P1577, DOI 10.1158/0008-5472.CAN-04-2552; Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883	35	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0167841	10.1371/journal.pone.0167841	http://dx.doi.org/10.1371/journal.pone.0167841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033393	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000391226900012
J	Chen, L; Bromberger, PD; Nieuwenhuiys, G; Hatti-Kaul, R				Chen, Lu; Bromberger, Paul David; Nieuwenhuiys, Gavin; Hatti-Kaul, Rajni			Redox Balance in Lactobacillus reuteri DSM20016: Roles of Iron-Dependent Alcohol Dehydrogenases in Glucose/ Glycerol Metabolism	PLOS ONE			English	Article							PYRUVATE-FORMATE-LYASE; MOLECULAR CHARACTERIZATION; DIOL DEHYDRATASE; 3-HYDROXYPROPIONALDEHYDE; PATHWAY; PROTEIN; ACID; BIOTRANSFORMATION; 1,3-PROPANEDIOL; 1,2-PROPANEDIOL	Lactobacillus reuteri, a heterofermentative bacterium, metabolizes glycerol via a Pdu (propanediol-utilization) pathway involving dehydration to 3-hydroxypropionaldehyde (3-HPA) followed by reduction to 1,3-propandiol (1,3-PDO) with concomitant generation of an oxidized cofactor, NAD(+) that is utilized to maintain cofactor balance required for glucose metabolism and even for oxidation of 3-HPA by a Pdu oxidative branch to 3-hydroxypropionic acid (3-HP). The Pdu pathway is operative inside Pdu microcompartment that encapsulates different enzymes and cofactors involved in metabolizing glycerol or 1,2-propanediol, and protects the cells from the toxic effect of the aldehyde intermediate. Since L. reuteri excretes high amounts of 3-HPA outside the microcompartment, the organism is likely to have alternative alcohol dehydrogenase(s) in the cytoplasm for transformation of the aldehyde. In this study, diversity of alcohol dehydrogenases in Lactobacillus species was investigated with a focus on L. reuteri. Nine ADH enzymes were found in L. reuteriDSM20016, out of which 3 (PduQ, ADH6 and ADH7) belong to the group of iron-dependent enzymes that are known to transform aldehydes/ketones to alcohols. L. reuteri mutants were generated in which the three ADHs were deleted individually. The lagging growth phenotype of these deletion mutants revealed that limited NAD(+)/NADH recycling could be restricting their growth in the absence of ADHs. Notably, it was demonstrated that PduQ is more active in generating NAD(+) during glycerol metabolism within the microcompartment by resting cells, while ADH7 functions to balance NAD(+)/NADH by converting 3-HPA to 1,3-PDO outside the microcompartment in the growing cells. Moreover, evaluation of ADH6 deletion mutant showed strong decrease in ethanol level, supporting the role of this bifuctional alcohol/aldehyde dehydrogenase in ethanol production. To the best of our knowledge, this is the first report revealing both internal and external recycling for cofactor homeostasis during 3-HPA conversion in L. reuteri.	[Chen, Lu; Bromberger, Paul David; Nieuwenhuiys, Gavin; Hatti-Kaul, Rajni] Lund Univ, Ctr Chem & Chem Engn, Biotechnol, Lund, Sweden; [Bromberger, Paul David] Univ Appl Sci Wiener Neustadt, Biotechnol Proc, Campus Tulln,Konrad Lorenz Str 10, Tulln, Austria	Lund University	Chen, L (corresponding author), Lund Univ, Ctr Chem & Chem Engn, Biotechnol, Lund, Sweden.	lu.chen@biotek.lu.se		CHEN, LU/0000-0001-8867-5851	Erasmus Mundus Action 2 programme; Erasmus+ programme	Erasmus Mundus Action 2 programme; Erasmus+ programme	Erasmus Mundus Action 2 programme and Erasmus+ programme are acknowledged for financial support to Lu Chen and Paul Bromberger, respectively.	Abdel-Rahman MA, 2013, BIOTECHNOL ADV, V31, P877, DOI 10.1016/j.biotechadv.2013.04.002; [Anonymous], THESIS; Antranikian G., 2013, OA ALCOHOL, V1, P3, DOI DOI 10.13172/2053-0285-1-1-489; Arskold E, 2008, J BACTERIOL, V190, P206, DOI 10.1128/JB.01227-07; Asanuma N, 2004, APPL ENVIRON MICROB, V70, P5244, DOI 10.1128/AEM.70.9.5244-5251.2004; Atteia A, 2003, PLANT MOL BIOL, V53, P175, DOI 10.1023/B:PLAN.0000009274.19340.36; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brooijmans RJW, 2009, APPL ENVIRON MICROB, V75, P3580, DOI 10.1128/AEM.00147-09; Burge G, 2015, J MICROBIOL, V53, P702, DOI 10.1007/s12275-015-5056-x; Cai F, 2015, ACS SYNTH BIOL, V4, P444, DOI 10.1021/sb500226j; Cheng SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047144; Chowdhury C, 2015, P NATL ACAD SCI USA, V112, P2990, DOI 10.1073/pnas.1423672112; CIRCLE SJ, 1945, IND ENG CHEM, V17, P259, DOI 10.1021/i560140a021; da Silva GP, 2009, BIOTECHNOL ADV, V27, P30, DOI 10.1016/j.biotechadv.2008.07.006; Dishisha T., 2013, THESIS; Dishisha T, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-76; Doleyres Y, 2005, APPL MICROBIOL BIOT, V68, P467, DOI 10.1007/s00253-005-1895-4; Edenberg HJ, 2007, ALCOHOL RES HEALTH, V30, P5; Espinosa A, 2009, J ANTIMICROB CHEMOTH, V63, P675, DOI 10.1093/jac/dkp015; Evans GA, 1990, CELL, V61, P17, DOI DOI 10.1016/0092-8674(90)90210-6; HARDING JW, 1975, BIOCH J, V146; Heravi R. M., 2012, Biotechnology, V11, P50, DOI 10.3923/biotech.2012.50.54; KESSLER D, 1991, FEBS LETT, V281, P59, DOI 10.1016/0014-5793(91)80358-A; Kok J, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-I1; Lambert JM, 2007, APPL ENVIRON MICROB, V73, P1126, DOI 10.1128/AEM.01473-06; Man H, 2014, TOP CATAL, V57, P356, DOI 10.1007/s11244-013-0191-2; Patnaik R, 2002, NAT BIOTECHNOL, V20, P707, DOI 10.1038/nbt0702-707; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugl S, 2014, BIORESOURCE TECHNOL, V152, P499, DOI 10.1016/j.biortech.2013.11.041; Price-Carter M, 2001, J BACTERIOL, V183, P2463, DOI 10.1128/JB.183.8.2463-2475.2001; Radianingtyas H, 2003, FEMS MICROBIOL REV, V27, P593, DOI 10.1016/S0168-6445(03)00068-8; REID MF, 1994, CRIT REV MICROBIOL, V20, P13, DOI 10.3109/10408419409113545; Sabet-Azad R, 2013, ENZYME MICROB TECH, V53, P235, DOI 10.1016/j.enzmictec.2013.05.007; Santos FB dos, 2008, VITAMIN B12 SYNTHESI; Sardari RRR, 2013, J BIOTECHNOL, V168, P534, DOI 10.1016/j.jbiotec.2013.09.009; Sardari RRR, 2013, BIOTECHNOL BIOENG, V110, P1243, DOI 10.1002/bit.24787; Sauvageot N, 2002, FEMS MICROBIOL LETT, V209, P69, DOI 10.1111/j.1574-6968.2002.tb11111.x; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Spinler JK, 2008, ANAEROBE, V14, P166, DOI 10.1016/j.anaerobe.2008.02.001; Sriramulu DD, 2008, J BACTERIOL, V190, P4559, DOI 10.1128/JB.01535-07; TALARICO TL, 1990, APPL ENVIRON MICROB, V56, P943, DOI 10.1128/AEM.56.4.943-948.1990; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van der Oost J, 2001, EUR J BIOCHEM, V268, P3062, DOI 10.1046/j.1432-1327.2001.02201.x; ZENG AP, 1993, ENZYME MICROB TECH, V15, P770, DOI 10.1016/0141-0229(93)90008-P	44	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168107	10.1371/journal.pone.0168107	http://dx.doi.org/10.1371/journal.pone.0168107			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030590	Green Published, Green Submitted, gold			2022-12-26	WOS:000391222000036
J	Kovacs, G; Avian, A; Foris, V; Tscherner, M; Kqiku, X; Douschan, P; Bachmaier, G; Olschewski, A; Matucci-Cerinic, M; Olschewski, H				Kovacs, Gabor; Avian, Alexander; Foris, Vasile; Tscherner, Maria; Kqiku, Xhylsime; Douschan, Philipp; Bachmaier, Gerhard; Olschewski, Andrea; Matucci-Cerinic, Marco; Olschewski, Horst			Use of ECG and Other Simple Non-Invasive Tools to Assess Pulmonary Hypertension	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; ARTERIAL-HYPERTENSION; FOLLOW-UP; PROGNOSTIC-FACTORS; MORTALITY; DIAGNOSIS; GUIDELINES; PRESSURE; SURVIVAL	Background There is a broad consensus that pulmonary hypertension (PH) is to be diagnosed by right heart catheterization (RHC) and that the most important non-invasive tool is echocardiography. However, the role of simple non-invasive tools in the work-up of PH is not clearly defined. We hypothesized that the use of simple non-invasive techniques may help to guide important decisions in the diagnostics of pulmonary hypertension. Objectives We aimed to develop an algorithm with the use of simple, non-invasive tools in order to identify patients with very high or very low likelihood of PH. Methods We retrospectively analyzed all consecutive patients undergoing RHC between 2005 and 2010 in our center and performed logistic regression of simple non-invasive parameters regarding detection and exclusion of PH and derived a two-step algorithm. In a prospective study we evaluated this algorithm between 2011 and 2013. Results The retrospective cohort consisted of n = 394 patients of which 49% presented with PH. Right axis deviation in the ECG was present in 90/394 patients and had a positive predictive value (PPV) of 93% for PH. The combination of non-right axis deviation, N-terminal pro brain natriuretic peptide (NT-proBNP)<333pg/ml, arterial oxygen saturation (SO2)>= 95.5% and WHO functional class I-II was present in 69/394 patients and excluded PH with a negative predictive value (NPV) of 96%. The prospective study confirmed these results in a cohort of n = 168 patients (PPV: 92%, NPV: 97%). Taken together, simple non-invasive tools allowed a prediction regarding the presence or absence of PH in 42% of patients with suspected PH. Conclusion ECG, NT-proBNP, SO2 and WHO functional class may predict the presence or absence of PH in almost half of the patients with suspected PH, suggesting an important role for these variables in the work-up of patients at risk for PH.	[Kovacs, Gabor; Foris, Vasile; Tscherner, Maria; Kqiku, Xhylsime; Douschan, Philipp; Olschewski, Horst] Med Univ Graz, Div Pulmonol, Dept Internal Med, Graz, Austria; [Kovacs, Gabor; Avian, Alexander; Foris, Vasile; Tscherner, Maria; Douschan, Philipp; Olschewski, Andrea; Olschewski, Horst] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria; [Avian, Alexander; Bachmaier, Gerhard] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Olschewski, Andrea] Med Univ Graz, Inst Physiol, Graz, Austria; [Matucci-Cerinic, Marco] Univ Florence, Dept Biomed, Div Rheumatol, AOUC, Florence, Italy; [Matucci-Cerinic, Marco] Univ Florence, Dept Expt & Clin Med, Florence, Italy	Medical University of Graz; Ludwig Boltzmann Institute; Medical University of Graz; Medical University of Graz; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence	Kovacs, G (corresponding author), Med Univ Graz, Div Pulmonol, Dept Internal Med, Graz, Austria.; Kovacs, G (corresponding author), Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria.	gabor.kovacs@klinikum-graz.at	Olschewski, Horst/L-3547-2019; CERINIC, marco MATUCCI/AAO-2769-2020	Olschewski, Horst/0000-0002-2834-7466; Bachmaier, Gerhard/0000-0002-8291-7255; Avian, Alexander/0000-0003-1084-5763; Olschewski, Andrea/0000-0002-8189-3634				ABRAMSON SV, 1992, ANN INTERN MED, V116, P888, DOI 10.7326/0003-4819-116-11-888; Al-Naamani K, 2008, INT J CARDIOL, V127, P214, DOI 10.1016/j.ijcard.2007.06.005; [Anonymous], 2002, CRIT CARE MED, V166, P111, DOI [10.1164/rccm.166/1/111, DOI 10.1164/RCCM.166/1/111]; Benza RL, 2012, CHEST, V141, P354, DOI 10.1378/chest.11-0676; Bonderman D, 2011, EUR RESPIR J, V37, P1096, DOI 10.1183/09031936.00089610; Coghlan JG, 2014, ANN RHEUM DIS, V73, P1340, DOI 10.1136/annrheumdis-2013-203301; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Foris V, 2013, CHEST, V144, P274, DOI 10.1378/chest.12-1246; Fritz JS, 2013, CHEST, V143, P315, DOI 10.1378/chest.12-0270; Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8; Galie N, 2004, EUR HEART J, V25, P2243, DOI 10.1016/j.ehj.2004.09.014; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Henkens IR, 2008, CHEST, V134, P1250, DOI 10.1378/chest.08-0461; Hoeper MM, 2007, EUR RESPIR J, V29, P944, DOI 10.1183/09031936.00134506; Kane GC, 2011, CHEST, V139, P1285, DOI 10.1378/chest.10-1293; Kovacs G, 2016, PULMONARY CIRCULATIO, P186; Lam CSP, 2009, CIRCULATION, V119, P2663, DOI 10.1161/CIRCULATIONAHA.108.838698; Leuchte HH, 2007, CHEST, V131, P402, DOI 10.1378/chest.06-1758; Leuchte HH, 2005, CHEST, V128, P2368, DOI 10.1378/chest.128.4.2368; Leuchte HH, 2004, J AM COLL CARDIOL, V43, P764, DOI 10.1016/j.jacc.2003.09.051; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; Nickel N, 2012, EUR RESPIR J, V39, P589, DOI 10.1183/09031936.00092311; Olsson KM, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0194-6; OSWALDMAMMOSSER M, 1995, CHEST, V107, P1193, DOI 10.1378/chest.107.5.1193; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Thakkar V, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4383; Tonelli AR, 2014, ANN NONINVAS ELECTRO, V19, P258, DOI 10.1111/anec.12125	29	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168706	10.1371/journal.pone.0168706	http://dx.doi.org/10.1371/journal.pone.0168706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030578	Green Published, Green Submitted, gold			2022-12-26	WOS:000391222000064
J	Pokrzywinski, KL; Biel, TG; Kryndushkin, D; Rao, VA				Pokrzywinski, Kaytee L.; Biel, Thomas G.; Kryndushkin, Dmitry; Rao, V. Ashutosh			Therapeutic Targeting of the Mitochondria Initiates Excessive Superoxide Production and Mitochondrial Depolarization Causing Decreased mtDNA Integrity	PLOS ONE			English	Article							DNA COPY NUMBER; OXIDATIVE STRESS; DAMAGE; TWINKLE; PROTEIN; TRANSCRIPTION; MAINTENANCE; METABOLISM; AUTOPHAGY; DELETIONS	Mitochondrial dysregulation is closely associated with excessive reactive oxygen species (ROS) production. Altered redox homeostasis has been implicated in the onset of several diseases including cancer. Mitochondrial DNA (mtDNA) and proteins are particularly sensitive to ROS as they are in close proximity to the respiratory chain (RC). Mitoquinone (MitoQ), a mitochondria-targeted redox agent, selectively damages breast cancer cells possibly through damage induced via enhanced ROS production. However, the effects of MitoQ and other triphenylphosphonium (TPP+) conjugated agents on cancer mitochondrial homeostasis remain unknown. The primary objective of this study was to determine the impact of mitochondria-targeted agent [(MTAs) conjugated to TPP+: mitoTEMPOL, mitoquinone and mitochromanol-acetate] on mitochondrial physiology and mtDNA integrity in breast (MDA-MB-231) and lung (H23) cancer cells. The integrity of the mtDNA was assessed by quantifying the degree of mtDNA fragmentation and copy number, as well as by measuring mitochondrial proteins essential to mtDNA stability and maintenance (TFAM, SSBP1, TWINKLE, POLG and POLRMT). Mitochondrial status was evaluated by measuring superoxide production, mitochondrial membrane depolarization, oxygen consumption, extracellular acidification and mRNA or protein levels of the RC complexes along with TCA cycle activity. In this study, we demonstrated that all investigated MTAs impair mitochondrial health and decrease mtDNA integrity in MDA-MB-231 and H23 cells. However, differences in the degree of mitochondrial damage and mtDNA degradation suggest unique properties among each MTA that may be cell line, dose and time dependent. Collectively, our study indicates the potential for TPP+ conjugated molecules to impair breast and lung cancer cells by targeting mitochondrial homeostasis.	[Pokrzywinski, Kaytee L.; Biel, Thomas G.; Kryndushkin, Dmitry; Rao, V. Ashutosh] US FDA, Lab Appl Biochem, Div Biotechnol Res & Review 3, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Rao, VA (corresponding author), US FDA, Lab Appl Biochem, Div Biotechnol Res & Review 3, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Silver Spring, MD USA.	ashutosh.rao@fda.hhs.gov	Rao, V Ashutosh/A-3569-2013	Rao, V Ashutosh/0000-0001-6817-8049				Beckham TH, 2013, J PHARMACOL EXP THER, V344, P167, DOI 10.1124/jpet.112.199216; Biel TG, 2016, CELL DEATH DIFFER, V23, P279, DOI 10.1038/cdd.2015.96; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Cheng G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-285; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Dickey JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070575; El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6; Enright H, 1996, CARCINOGENESIS, V17, P1175, DOI 10.1093/carcin/17.5.1175; ENRIGHT HU, 1992, NUCLEIC ACIDS RES, V20, P3341, DOI 10.1093/nar/20.13.3341; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Furda A, 2014, METHODS MOL BIOL, V1105, P419, DOI 10.1007/978-1-62703-739-6_31; Fuste JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004832; Gane EJ, 2010, LIVER INT, V30, P1019, DOI 10.1111/j.1478-3231.2010.02250.x; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gonzalez Y, 2014, ONCOTARGET, V5, P1526, DOI 10.18632/oncotarget.1715; Gui YX, 2015, PARKINSONISM RELAT D, V21, P282, DOI 10.1016/j.parkreldis.2014.12.030; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Hunter SE, 2010, METHODS, V51, P444, DOI 10.1016/j.ymeth.2010.01.033; Ikeda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119687; Jin H, 2014, BBA-MOL BASIS DIS, V1842, P1282, DOI 10.1016/j.bbadis.2013.09.007; Khiati S, 2014, MOL PHARMACOL, V86, P193, DOI 10.1124/mol.114.092833; Kuhl I, 2014, NATURE, V514, pE7, DOI 10.1038/nature13690; Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523; Linkowska K, 2015, ANN HUMAN GENETICS; Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051; Minczuk M, 2011, NUCLEIC ACIDS RES, V39, P4284, DOI 10.1093/nar/gkq1224; MIQUEL J, 1992, MUTAT RES, V275, P209, DOI 10.1016/0921-8734(92)90024-J; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Naponelli V, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/121826; Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Oyewole AO, 2015, FASEB J, V29, P4766, DOI 10.1096/fj.15-275404; Paramasivam A, 2016, MITOCHONDRION, V26, P81, DOI 10.1016/j.mito.2015.12.006; Pezzini I, 2016, EXPERT OPIN DRUG DEL, P1; Rao VA, 2010, J BIOL CHEM, V285, P34447, DOI 10.1074/jbc.M110.133579; Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3; Ruhanen H, 2010, BBA-MOL CELL RES, V1803, P931, DOI 10.1016/j.bbamcr.2010.04.008; Shadel GS, 2005, TRENDS BIOCHEM SCI, V30, P294, DOI 10.1016/j.tibs.2005.04.007; Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100; Shokolenko IN, 2015, BBA-MOL BASIS DIS, V1852, P1805, DOI 10.1016/j.bbadis.2015.05.016; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Snow BJ, 2010, MOVEMENT DISORD, V25, P1670, DOI 10.1002/mds.23148; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342; Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Warburg O, 1928, SCIENCE, V68, P437, DOI 10.1126/science.68.1767.437; Wojtala A, 2014, METHOD ENZYMOL, V542, P243, DOI 10.1016/B978-0-12-416618-9.00013-3; Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824; Yang Y., 2016, J CELLULAR PHYSL	55	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168283	10.1371/journal.pone.0168283	http://dx.doi.org/10.1371/journal.pone.0168283			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030582	gold, Green Published, Green Submitted			2022-12-26	WOS:000391222000042
J	Ferreira, RC; Popova, EY; James, J; Briones, MRS; Zhang, SS; Barnstable, CJ				Ferreira, Renata C.; Popova, Evgenya Y.; James, Jessica; Briones, Marcelo R. S.; Zhang, Samuel S.; Barnstable, Colin J.			Histone Deacetylase 1 Is Essential for Rod Photoreceptor Differentiation by Regulating Acetylation at Histone H3 Lysine 9 and Histone H4 Lysine 12 in the Mouse Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIME PCR DATA; SODIUM-BUTYRATE; CLASS-I; NEURONAL DIFFERENTIATION; STAT3 ACTIVATION; GENE-EXPRESSION; CELL FATE; ROLES; INHIBITION; PROLIFERATION	Histone acetylation has a regulatory role in gene expression and is necessary for proper tissue development. To investigate the specific roles of histone deacetylases (HDACs) in rod differentiation in neonatal mouse retinas, we used a pharmacological approach that showed that inhibition of class I but not class IIa HDACs caused the same phenotypic changes seen with broad spectrum HDAC inhibitors, most notably a block in the differentiation of rod photoreceptors. Inhibition of HDAC1 resulted in increase of acetylation of lysine 9 of histone 3 (H3K9) and lysine 12 of histone 4 (H4K12) but not lysine 27 of histone 3 (H3K27) and led to maintained expression of progenitor-specific genes such as Vsx2 and Hes1 with concomitant block of expression of rod-specific genes. ChiP experiments confirmed these changes in the promoters of a group of progenitor genes. Based on our results, we suggest that HDAC1-specific inhibition prevents progenitor cells of the retina from exiting the cell cycle and differentiating. HDAC1 may be an essential epigenetic regulator of the transition from progenitor cells to terminally differentiated photoreceptors.	[Ferreira, Renata C.; Popova, Evgenya Y.; James, Jessica; Zhang, Samuel S.; Barnstable, Colin J.] Penn State Univ, Coll Med, Dept Neural & Behav Sci, 500 Univ Dr, Hershey, PA 17033 USA; [Popova, Evgenya Y.; Zhang, Samuel S.; Barnstable, Colin J.] Penn State Hershey Eye Ctr, Hershey, PA 17033 USA; [Ferreira, Renata C.; Briones, Marcelo R. S.] Univ Fed Sao Paulo, Escola Paulista Med, Lab Evolutionary Genom & Biocomplex, BR-04039032 Sao Paulo, Brazil	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Universidade Federal de Sao Paulo (UNIFESP)	Barnstable, CJ (corresponding author), Penn State Univ, Coll Med, Dept Neural & Behav Sci, 500 Univ Dr, Hershey, PA 17033 USA.	cbarnstable@hmc.psu.edu	Barnstable, Colin/ABB-4822-2021; Briones, Marcelo RS/C-5760-2013; Barnstable, Colin/GLU-9219-2022; Ferreira, Renata/S-7590-2019	Carmona e Ferreira, Renata/0000-0003-1481-2926; Briones, Marcelo/0000-0001-8045-2477; Barnstable, Colin/0000-0002-7011-4068	National Council for Scientific and Technological Development of Brazil [206445/2014-8]; Sao Paulo Research Foundation (FAPESP) [2013/078380, 2014/256026]; Macula Vision Research Foundation	National Council for Scientific and Technological Development of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Macula Vision Research Foundation	Supported by Fellowship 206445/2014-8 from the National Council for Scientific and Technological Development of Brazil.; Supported by Sao Paulo Research Foundation (FAPESP) Fellowships 2013/078380 and 2014/256026.; Supported by a grant from Macula Vision Research Foundation.	Anderson KW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126592; Balasubramaniyan V, 2006, NEUROSCIENCE, V143, P939, DOI 10.1016/j.neuroscience.2006.08.082; BARNSTABLE CJ, 1980, NATURE, V286, P231, DOI 10.1038/286231a0; Barrios AP, 2014, MOL CELL BIOL, V34, P2760, DOI 10.1128/MCB.00083-14; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; Chen B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-78; Cho Y, 2014, CURR OPIN NEUROBIOL, V27, P118, DOI 10.1016/j.conb.2014.03.008; Colletti SL, 2001, BIOORG MED CHEM LETT, V11, P107, DOI 10.1016/S0960-894X(00)00604-1; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Cosgrove MS, 2005, BIOCHEM CELL BIOL, V83, P468, DOI 10.1139/O05-137; Cunliffe VT, 2004, DEVELOPMENT, V131, P2983, DOI 10.1242/dev.01166; DarkinRattray SJ, 1996, P NATL ACAD SCI USA, V93, P13143, DOI 10.1073/pnas.93.23.13143; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; DAVIE JR, 1978, P NATL ACAD SCI USA, V75, P3574, DOI 10.1073/pnas.75.8.3574; Duong V, 2008, MOL CANCER RES, V6, P1908, DOI 10.1158/1541-7786.MCR-08-0299; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Saez JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131760; Fan J, 2016, EXP EYE RES, V146, P269, DOI 10.1016/j.exer.2016.03.026; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Furumai R, 2002, CANCER RES, V62, P4916; Galletti M, 2014, BIOCHEM PHARMACOL, V91, P181, DOI 10.1016/j.bcp.2014.07.011; Greene TT, 2016, ELIFE, V5, DOI 10.7554/eLife.14749; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; HAGUE A, 1993, INT J CANCER, V55, P498, DOI 10.1002/ijc.2910550329; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hao H, 2012, PLOS GENET, V8, P380, DOI 10.1371/journal.pgen.1002649; Hojo M, 2000, DEVELOPMENT, V127, P2515; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jung M, 1999, J MED CHEM, V42, P4669, DOI 10.1021/jm991091h; Kelly RDW, 2013, BIOCHEM SOC T, V41, P741, DOI 10.1042/BST20130010; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; Kim HJ, 2009, J NEUROCHEM, V110, P1226, DOI 10.1111/j.1471-4159.2009.06212.x; Kranenburg O, 1996, EMBO J, V15, P46, DOI 10.1002/j.1460-2075.1996.tb00332.x; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lamb TD, 2013, PROG RETIN EYE RES, V36, P52, DOI 10.1016/j.preteyeres.2013.06.001; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Liu Mu-Gen, 2008, J Ocul Biol Dis Infor, V1, P59, DOI 10.1007/s12177-008-9009-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Mitrousis N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00483; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Morris MJ, 2013, INT J DEV NEUROSCI, V31, P370, DOI 10.1016/j.ijdevneu.2013.02.005; Mu XQ, 2008, P NATL ACAD SCI USA, V105, P6942, DOI 10.1073/pnas.0802627105; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nambiar RM, 2007, MECH DEVELOP, V124, P682, DOI 10.1016/j.mod.2007.07.003; Newbold A, 2008, MOL CANCER THER, V7, P1066, DOI 10.1158/1535-7163.MCT-07-2256; Ozawa Y, 2004, MOL CELL NEUROSCI, V26, P258, DOI 10.1016/j.mcn.2004.02.001; Pinzon-Guzman C, 2011, J NEUROSCI, V31, P18606, DOI 10.1523/JNEUROSCI.2578-11.2011; POGO BGT, 1968, P NATL ACAD SCI USA, V59, P1337, DOI 10.1073/pnas.59.4.1337; Popova EY, 2016, MOL NEUROBIOL, V53, P4563, DOI 10.1007/s12035-015-9395-8; Popova EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046867; Reichert N, 2012, CELL MOL LIFE SCI, V69, P2173, DOI 10.1007/s00018-012-0921-9; RIGGS MG, 1977, NATURE, V268, P462, DOI 10.1038/268462a0; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scognamiglio A, 2008, BBA-MOL CELL RES, V1783, P2030, DOI 10.1016/j.bbamcr.2008.07.007; Shi P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1518; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sun GQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/835968; Tatamiya Takayuki, 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P567; Tiwari P, 2015, CHEM-BIOL INTERACT, V226, P1, DOI 10.1016/j.cbi.2014.11.018; Tiwari S, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-30; Togi S, 2009, BIOCHEM BIOPH RES CO, V379, P616, DOI 10.1016/j.bbrc.2008.12.132; Tummala P, 2010, MOL VIS, V16, P252; VanderMolen KM, 2011, J ANTIBIOT, V64, P525, DOI 10.1038/ja.2011.35; Wallace DM, 2006, INVEST OPHTH VIS SCI, V47, P2765, DOI 10.1167/iovs.05-1383; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wilken MS, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-8; Yamaguchi M, 2005, DEVELOPMENT, V132, P3027, DOI 10.1242/dev.01881; Yokoyama A, 2008, MOL CELL BIOL, V28, P3995, DOI 10.1128/MCB.02030-07; Zhang SSM, 2005, EXP EYE RES, V81, P103, DOI 10.1016/j.exer.2005.01.016; Zhang SSM, 2004, INVEST OPHTH VIS SCI, V45, P2407, DOI 10.1167/iovs.04-0003; Zhang SSM, 2002, METHODS, V28, P439, DOI 10.1016/S1046-2023(02)00263-3	82	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2422	2440		10.1074/jbc.M116.756643	http://dx.doi.org/10.1074/jbc.M116.756643			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28028172	Green Published, hybrid			2022-12-26	WOS:000395530300031
J	Hayakawa, M; Hayakawa, H; Petrova, T; Ritprajak, P; Sutavani, RV; Jimenez-Andrade, GY; Sano, Y; Choo, MK; Seavitt, J; Venigalla, RKC; Otsu, K; Georgopoulos, K; Arthur, JSC; Park, JM				Hayakawa, Morisada; Hayakawa, Hiroko; Petrova, Tsvetana; Ritprajak, Patcharee; Sutavani, Ruhcha V.; Jimenez-Andrade, Guillermina Yanek; Sano, Yasuyo; Choo, Min-Kyung; Seavitt, John; Venigalla, Ram K. C.; Otsu, Kinya; Georgopoulos, Katia; Arthur, J. Simon C.; Park, Jin Mo			Loss of Functionally Redundant p38 Isoforms in T Cells Enhances Regulatory T Cell Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; mouse; p38; signal transduction; T-cell	ACTIVATED PROTEIN-KINASE; IN-VIVO; GENE-EXPRESSION; DENDRITIC CELLS; INNATE IMMUNITY; P38-ALPHA; RECEPTOR; PATHWAY; PHOSPHORYLATION; MAPK	The evolutionarily conserved protein kinase p38 mediates innate resistance to environmental stress and microbial infection. Four p38 isoforms exist in mammals and may have been co-opted for new roles in adaptive immunity. Murine T cells deficient in p38, the ubiquitously expressed p38 isoform, showed no readily apparent cell-autonomous defects while expressing elevated amounts of another isoform, p38. Mice with T cells simultaneously lacking p38 and p38 displayed lymphoid atrophy and elevated Foxp3(+) regulatory T cell frequencies. Double deficiency of p38 and p38 in naive CD4(+) T cells resulted in an attenuation of MAPK-activated protein kinase (MK)-dependent mTOR signaling after T cell receptor engagement, and enhanced their differentiation into regulatory T cells under appropriate inducing conditions. Pharmacological inhibition of the p38-MK-mTOR signaling module produced similar effects, revealing potential for therapeutic applications.	[Hayakawa, Morisada; Hayakawa, Hiroko; Ritprajak, Patcharee; Jimenez-Andrade, Guillermina Yanek; Sano, Yasuyo; Choo, Min-Kyung; Seavitt, John; Georgopoulos, Katia; Park, Jin Mo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, 149 13th St, Charlestown, MA 02129 USA; [Hayakawa, Morisada; Hayakawa, Hiroko; Ritprajak, Patcharee; Jimenez-Andrade, Guillermina Yanek; Sano, Yasuyo; Choo, Min-Kyung; Seavitt, John; Georgopoulos, Katia; Park, Jin Mo] Harvard Med Sch, 149 13th St, Charlestown, MA 02129 USA; [Hayakawa, Morisada; Hayakawa, Hiroko] Jichi Med Univ, Dept Biochem, Shimotsuke, Tochigi 3290498, Japan; [Petrova, Tsvetana; Sutavani, Ruhcha V.; Arthur, J. Simon C.] Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Wellcome Trust Bldg, Dundee DD1 5EH, Scotland; [Venigalla, Ram K. C.] Univ Dundee, Prot Phosphorylat Unit, MRC, Sch Life Sci,Sir James Black Ctr, Dundee DD1 5EH, Scotland; [Ritprajak, Patcharee] Chulalongkorn Univ, Dept Microbiol & Immunol, Fac Dent, Bangkok 10330, Thailand; [Ritprajak, Patcharee] Chulalongkorn Univ, Res Unit Oral Microbiol, Fac Dent, Bangkok 10330, Thailand; [Otsu, Kinya] Kings Coll London, Div Cardiovasc, London SE5 9NU, England	Harvard University; Massachusetts General Hospital; Jichi Medical University; University of Dundee; University of Dundee; Chulalongkorn University; Chulalongkorn University; University of London; King's College London	Park, JM (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, 149 13th St, Charlestown, MA 02129 USA.; Park, JM (corresponding author), Harvard Med Sch, 149 13th St, Charlestown, MA 02129 USA.	jmpark@cbrc2.mgh.harvard.edu		Petrova, Tsvetana/0000-0003-2425-2459; Hayakawa, Morisada/0000-0002-1869-2450; Arthur, Simon/0000-0002-8135-1958	National Institutes of Health [AI074957]; Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a National Institutes of Health Grant AI074957 (to J.M.P.) and by a Medical Research Council grant (to J.S.C.A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alam MS, 2014, J EXP MED, V211, P1257, DOI 10.1084/jem.20131917; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Atherly LO, 2006, J IMMUNOL, V176, P1571, DOI 10.4049/jimmunol.176.3.1571; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Berenson LS, 2006, J IMMUNOL, V176, P4616, DOI 10.4049/jimmunol.176.8.4616; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Caballero-Franco C, 2013, J BIOL CHEM, V288, P23788, DOI 10.1074/jbc.M113.452029; Chang X, 2011, IMMUNITY, V34, P201, DOI 10.1016/j.immuni.2011.01.017; Degols G, 1996, MOL CELL BIOL, V16, P2870; Barrantes IDB, 2011, P NATL ACAD SCI USA, V108, P12764, DOI 10.1073/pnas.1015013108; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Diehl NL, 2000, J EXP MED, V191, P321, DOI 10.1084/jem.191.2.321; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Gomez-Rodriguez J, 2014, J EXP MED, V211, P529, DOI 10.1084/jem.20131459; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Hale KK, 1999, J IMMUNOL, V162, P4246; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han SJ, 1998, J BIOL CHEM, V273, P369, DOI 10.1074/jbc.273.1.369; Han ZQS, 1998, MOL CELL BIOL, V18, P3527, DOI 10.1128/MCB.18.6.3527; Hernandez G, 2011, EXP CELL RES, V317, P2938, DOI 10.1016/j.yexcr.2011.09.011; Hsu SC, 2003, BLOOD, V101, P970, DOI 10.1182/blood-2002-03-0744; Huang GH, 2012, NAT IMMUNOL, V13, P152, DOI 10.1038/ni.2207; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Jirmanova L, 2011, BLOOD, V118, P3280, DOI 10.1182/blood-2011-01-333039; Jirmanova L, 2009, BLOOD, V113, P2229, DOI 10.1182/blood-2008-04-153304; Katholnig K, 2013, J IMMUNOL, V190, P1519, DOI 10.4049/jimmunol.1202683; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kim JM, 2005, J IMMUNOL, V174, P1239, DOI 10.4049/jimmunol.174.3.1239; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; McGuire VA, 2013, MOL CELL BIOL, V33, P4152, DOI 10.1128/MCB.01691-12; Merritt C, 2000, MOL CELL BIOL, V20, P936, DOI 10.1128/MCB.20.3.936-946.2000; Mittelstadt PR, 2009, J BIOL CHEM, V284, P15469, DOI 10.1074/jbc.M901004200; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Noubade R, 2011, BLOOD, V118, P3290, DOI 10.1182/blood-2011-02-336552; Otsuka M, 2010, GASTROENTEROLOGY, V138, P1255, DOI 10.1053/j.gastro.2010.01.005; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Ritprajak P, 2012, P NATL ACAD SCI USA, V109, P9089, DOI 10.1073/pnas.1202984109; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Sano Y, 2014, J INVEST DERMATOL, V134, P2231, DOI 10.1038/jid.2014.153; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Tanaka N, 2002, EMBO REP, V3, P785, DOI 10.1093/embo-reports/kvf153; Wu XN, 2011, J BIOL CHEM, V286, P31501, DOI 10.1074/jbc.M111.233122; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517	49	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1762	1772		10.1074/jbc.M116.764548	http://dx.doi.org/10.1074/jbc.M116.764548			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28011639	Green Published, hybrid			2022-12-26	WOS:000395515600018
J	Karlamangla, AS; Lachman, ME; Han, WJ; Huang, MH; Greendale, GA				Karlamangla, Arun S.; Lachman, Margie E.; Han, WeiJuan; Huang, MeiHua; Greendale, Gail A.			Evidence for Cognitive Aging in Midlife Women: Study of Women's Health Across the Nation	PLOS ONE			English	Article							MENOPAUSAL TRANSITION; PROCESSING-SPEED; OLDER-ADULTS; AGE; DECLINE; MEMORY; PERFORMANCE; ATTRITION; COMMUNITY; SYMPTOMS	Although cross-sectional studies suggest that cognitive aging starts in midlife, few longitudinal studies have documented within-individual declines in cognitive performance before the seventh decade. Learning from repeat testing, or practice effects, can mask the decline in younger cohorts. In women, the menopause transition also affects test performance and can confound estimates of underlying decline. We designed this study to determine if, after controlling for practice effects, the menopause transition, and the symptoms associated with it, there is evidence of cognitive aging in midlife women. We used data from a longitudinal observational study in 2,124 participants from the Study of Women's Health Across the Nation. Outcomes examined were scores on annual tests of processing speed, verbal episodic memory (immediate and delayed), and working memory. To reduce the impact of practice effects and of the menopause transition, we used the third cognition testing visit as the baseline. Average age at this baseline was 54 years, and the majority of the women were postmenopausal; half the cohort was 2 or more years beyond the final menstrual period. There were 7,185 cognition assessments with median follow-up time of 6.5 years. In mixed effects regression, adjusted for practice effects, retention, menopause symtoms (depressive, anxiety, vasomotor, and sleep disturbance), and covariates, scores on 2 of 4 cognition tests declined. Mean decline in cognitive speed was 0.28 per year (95% confidence interval [CI] 0.20 to 0.36) or 4.9% in 10 years, and mean decline in verbal episodic memory (delayed testing) was 0.02 per year (95% CI: 0.00 to 0.03) or 2% in 10 years. Our results provide strong, longitudinal evidence of cognitive aging in midlife women, with substantial within-woman declines in processing speed and memory. Further research is needed to identify factors that influence decline rates and to develop interventions that slow cognitive aging.	[Karlamangla, Arun S.; Han, WeiJuan; Huang, MeiHua; Greendale, Gail A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Geriatr, Los Angeles, CA 90095 USA; [Lachman, Margie E.] Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Brandeis University	Karlamangla, AS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Geriatr, Los Angeles, CA 90095 USA.	akarlamangla@mednet.ucla.edu		Lachman, Margie/0000-0003-3027-8735	National Institutes of Health (NIH), DHHS, through the National Institute on Aging (NIA); National Institute of Nursing Research (NINR); NIH Office of Research on Women's Health (ORWH) [U01NR004061, U01AG012505, U01AG012535, U01AG012531, U01AG012539, U01AG012546, U01AG012553, U01AG012554, U01AG012495]; NATIONAL INSTITUTE OF NURSING RESEARCH [U01NR004061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG012531, U01AG012495, U01AG012546, U01AG012554, U01AG012539, U01AG012535, U01AG012505] Funding Source: NIH RePORTER	National Institutes of Health (NIH), DHHS, through the National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Nursing Research (NINR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NIH Office of Research on Women's Health (ORWH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Study of Women's Health Across the Nation has grant support from the National Institutes of Health (NIH), DHHS, through the National Institute on Aging (NIA), the National Institute of Nursing Research (NINR) and the NIH Office of Research on Women's Health (ORWH) (Grants U01NR004061; U01AG012505, U01AG012535, U01AG012531, U01AG012539, U01AG012546, U01AG012553, U01AG012554, U01AG012495). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIA, NINR, ORWH or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT M, 1991, INT J NEUROSCI, V57, P167, DOI 10.3109/00207459109150691; Bailey ME, 2011, NEUROSCIENCE, V191, P148, DOI 10.1016/j.neuroscience.2011.05.045; Bartels C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-118; Becker PM, 2006, PSYCHIAT CLIN N AM, V29, P855, DOI 10.1016/j.psc.2006.08.001; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Deary IJ, 2009, BRIT MED BULL, V92, P135, DOI 10.1093/bmb/ldp033; Finkel D, 2007, PSYCHOL AGING, V22, P558, DOI 10.1037/0882-7974.22.3.558; Fuh JL, 2006, MATURITAS, V53, P447, DOI 10.1016/j.maturitas.2005.07.009; Gold EB, 2006, AM J PUBLIC HEALTH, V96, P1226, DOI 10.2105/AJPH.2005.066936; Greendale GA, 2009, NEUROLOGY, V72, P1850, DOI 10.1212/WNL.0b013e3181a71193; Greendale GA, 2012, J BONE MINER RES, V27, P111, DOI 10.1002/jbmr.534; Greendale GA, 2010, AM J EPIDEMIOL, V171, P1214, DOI 10.1093/aje/kwq067; Hahn EA, 2015, AGING NEUROPSYCHOL C, V22, P25, DOI 10.1080/13825585.2014.888391; HALBREICH U, 1995, J PSYCHIAT RES, V29, P153, DOI 10.1016/0022-3956(95)00005-P; Henderson VW, 2011, WOMENS HEALTH, V7, P81, DOI 10.2217/WHE.10.87; Janssen I, 2008, ARCH INTERN MED, V168, P1568, DOI 10.1001/archinte.168.14.1568; Karlamangla AS, 2009, AM J EPIDEMIOL, V170, P331, DOI 10.1093/aje/kwp154; Lamar M, 2003, NEUROLOGY, V60, P82, DOI 10.1212/WNL.60.1.82; Lindenberger U, 2014, SCIENCE, V346, P572, DOI 10.1126/science.1254403; Matthews KA, 2009, J AM COLL CARDIOL, V54, P2366, DOI 10.1016/j.jacc.2009.10.009; Mitchell ES, 2001, J WOMEN HEALTH GEN-B, V10, P351, DOI 10.1089/152460901750269670; Nilsson J, 2014, J INT NEUROPSYCH SOC, V20, P262, DOI 10.1017/S1355617713001458; Rabbitt P, 2008, J GERONTOL B-PSYCHOL, V63, pP271, DOI 10.1093/geronb/63.5.P271; Rabbitt P, 2008, J GERONTOL B-PSYCHOL, V63, pP235, DOI 10.1093/geronb/63.4.P235; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ramscar M, 2014, TOP COGN SCI, V6, P5, DOI 10.1111/tops.12078; Randolph JF, 2011, J CLIN ENDOCR METAB, V96, P746, DOI 10.1210/jc.2010-1746; Ronnlund M, 2005, PSYCHOL AGING, V20, P3, DOI 10.1037/0882-7974.20.1.3; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Salthouse TA., 2014, J GERONTOLOGY B; Salthouse TA, 2014, PSYCHOL ASSESSMENT, V26, P1063, DOI 10.1037/pas0000007; Salthouse TA, 2014, J GERONTOL B-PSYCHOL, V69, P567, DOI 10.1093/geronb/gbt046; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Schroeder DH, 2004, PERS INDIV DIFFER, V36, P393, DOI 10.1016/S0191-8869(03)00104-1; Singh-Manoux A., 2012, BMJ, V344; Sliwinski MJ, 2003, PSYCHOL AGING, V18, P658, DOI 10.1037/0882-7974.18.4.658; Smith A., 1982, SYMBOL DIGIT MODALIT; Sowers M, 2000, MENOPAUSE BIOL PATHO, V175, P175; The Psychological Corporation, 1997, WAIS 3 WMS 3 TECHN M	39	46	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169008	10.1371/journal.pone.0169008	http://dx.doi.org/10.1371/journal.pone.0169008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2QJ	28045986	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300088
J	Pelz, JO; Weinreich, A; Karlas, T; Saur, D				Pelz, Johann Otto; Weinreich, Anna; Karlas, Thomas; Saur, Dorothee			Evaluation of Freehand B-Mode and Power-Mode 3D Ultrasound for Visualisation and Grading of Internal Carotid Artery Stenosis	PLOS ONE			English	Article							3-DIMENSIONAL ULTRASOUND; DOPPLER SONOGRAPHY; DIAGNOSTIC STRATEGIES; COST-EFFECTIVENESS; ISCHEMIC-STROKE; ENDARTERECTOMY; ANGIOGRAPHY; DISEASE	Background Currently, colour-coded duplex sonography (2D-CDS) is clinical standard for detection and grading of internal carotid artery stenosis (ICAS). However, unlike angiographic imaging modalities, 2D-CDS assesses ICAS by its hemodynamic effects rather than luminal changes. Aim of this study was to evaluate freehand 3D ultrasound (3DUS) for direct visualisation and quantification of ICAS. Methods Thirty-seven patients with 43 ICAS were examined with 2D-CDS as reference standard and with freehand B-mode respectively power-mode 3DUS. Stenotic value of 3D reconstructed ICAS was calculated as distal diameter respectively distal cross-sectional area (CSA) reduction percentage and compared with 2D-CDS. Results There was a trend but no significant difference in successful 3D reconstruction of ICAS between B-mode and power mode (examiner 1 {Ex1} 81% versus 93%, examiner 2 {Ex2} 84% versus 88%). Inter-rater agreement was best for power-mode 3DUS and assessment of stenotic value as distal CSA reduction percentage (intraclass correlation coefficient {ICC} 0.90) followed by power-mode 3DUS and distal diameter reduction percentage (ICC 0.81). Inter-rater agreement was poor for B-mode 3DUS (ICC, distal CSA reduction 0.36, distal diameter reduction 0.51). Intra-rater agreement for power-mode 3DUS was good for both measuring methods (ICC, distal CSA reduction 0.88 {Ex1} and 0.78 {Ex2}; ICC, distal diameter reduction 0.83 {Ex1} and 0.76 {Ex2}). In comparison to 2D-CDS inter-method agreement was good and clearly better for power-mode 3DUS (ICC, distal diameter reduction percentage: Ex1 0.85, Ex2 0.78; distal CSA reduction percentage: Ex1 0.63, Ex2 0.57) than for B-mode 3DUS (ICC, distal diameter reduction percentage: Ex1 0.40, Ex2 0.52; distal CSA reduction percentage: Ex1 0.15, Ex2 0.51). Conclusions Non-invasive power-mode 3DUS is superior to B-mode 3DUS for imaging and quantification of ICAS. Thereby, further studies are warranted which should now compare power-mode 3DUS with the angiographic gold standard imaging modalities for quantification of ICAS, i.e. with CTA or CE-MRA.	[Pelz, Johann Otto; Weinreich, Anna; Saur, Dorothee] Leipzig Univ Hosp, Dept Neurol, Leipzig, Germany; [Karlas, Thomas] Leipzig Univ Hosp, Dept Gastroenterol & Rheumatol, Leipzig, Germany	Leipzig University; Leipzig University	Pelz, JO (corresponding author), Leipzig Univ Hosp, Dept Neurol, Leipzig, Germany.	johann.pelz@medizin.uni-leipzig.de	Karlas, Thomas/I-1782-2019; Saur, Dorothee/Q-1684-2017; Saur, Dorothee/C-5900-2019	Karlas, Thomas/0000-0002-8109-8526; Saur, Dorothee/0000-0002-1808-0913; Saur, Dorothee/0000-0002-1808-0913				ALEXANDROV AV, 1993, STROKE, V24, P1292, DOI 10.1161/01.STR.24.9.1292; Arning C, 2010, ULTRASCHALL MED, V31, P251, DOI 10.1055/s-0029-1245336; Bendick PJ, 1998, AM J SURG, V176, P183, DOI 10.1016/S0002-9610(98)00165-2; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bucek RA, 2003, AM J NEURORADIOL, V24, P1294; Buskens E, 2004, RADIOLOGY, V233, P101, DOI 10.1148/radiol.2331030863; Dodds SR, 2002, EUR J VASC ENDOVASC, V24, P332, DOI 10.1053/ejvs.2002.1729; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Fenster A, 2011, INTERFACE FOCUS, V1, P503, DOI 10.1098/rsfs.2011.0019; Grau AJ, 2001, STROKE, V32, P2559, DOI 10.1161/hs1101.098524; Halliday A, 2013, EUR J VASC ENDOVASC, V46, P510, DOI 10.1016/j.ejvs.2013.07.020; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kaufmann TJ, 2007, RADIOLOGY, V243, P812, DOI 10.1148/radiol.2433060536; Keberle M, 2000, J CLIN ULTRASOUND, V28, P441, DOI 10.1002/1097-0096(200011/12)28:9<441::AID-JCU1>3.3.CO;2-4; Kozakova M, 2001, J AM SOC ECHOCARDIOG, V14, P1203, DOI 10.1067/mje.2001.115619; MAYBERG MR, 1991, JAMA-J AM MED ASSOC, V266, P3289, DOI 10.1001/jama.266.23.3289; Merz E, 2015, ULTRASCHALL MED, V36, P3, DOI 10.1055/s-0034-1398866; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ota H, 2005, RADIOGRAPHICS, V25, P1141, DOI 10.1148/rg.255055014; Pelz JO, 2015, ULTRASCHALL MED, V36, P487, DOI 10.1055/s-0034-1398749; Pfister K, 2009, CLIN HEMORHEOL MICRO, V41, P103, DOI 10.3233/CH-2009-1161; Portney L.G., 2000, FDN CLIN RES APPL PR, P560; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; U-King-Im JM, 2005, ANN NEUROL, V58, P506, DOI 10.1002/ana.20591; Vicenzini E, 2011, EUR NEUROL, V65, P309, DOI 10.1159/000327694; von Reutern GM, 2012, STROKE, V43, P916, DOI 10.1161/STROKEAHA.111.636084; Wardlaw JM, 2006, LANCET, V367, P1503, DOI 10.1016/S0140-6736(06)68650-9; Wessels T, 2004, STROKE, V35, P1847, DOI 10.1161/01.STR.0000133248.71808.38; Widder B, 2004, DOPPLER DUPLEXSONOGR, P65; Widder B, 2004, DOPPLER DUPLEXSONOGR, P166; Yao JF, 1998, STROKE, V29, P2026, DOI 10.1161/01.STR.29.10.2026; Zhang WW, 2006, J ENDOVASC THER, V13, P723, DOI 10.1583/06-1921.1	34	12	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0167500	10.1371/journal.pone.0167500	http://dx.doi.org/10.1371/journal.pone.0167500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045903	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300007
J	Pesek, M; Leonardis, A; Marolt, M				Pesek, Matevz; Leonardis, Ales; Marolt, Matija			Robust Real-Time Music Transcription with a Compositional Hierarchical Model	PLOS ONE			English	Article							AUTOMATIC GAIN-CONTROL; PITCH; PERCEPTION; PATTERNS; CHORDS	The paper presents a new compositional hierarchical model for robust music transcription. Its main features are unsupervised learning of a hierarchical representation of input data, transparency, which enables insights into the learned representation, as well as robustness and speed which make it suitable for real-world and real-time use. The model consists of multiple layers, each composed of a number of parts. The hierarchical nature of the model corresponds well to hierarchical structures in music. The parts in lower layers correspond to low-level concepts (e.g. tone partials), while the parts in higher layers combine lower-level representations into more complex concepts (tones, chords). The layers are learned in an unsupervised manner from music signals. Parts in each layer are compositions of parts from previous layers based on statistical co-occurrences as the driving force of the learning process. In the paper, we present the model's structure and compare it to other hierarchical approaches in the field of music information retrieval. We evaluate the model's performance for the multiple fundamental frequency estimation. Finally, we elaborate on extensions of the model towards other music information retrieval tasks.	[Pesek, Matevz; Leonardis, Ales; Marolt, Matija] Univ Ljubljana, Fac Comp & Informat Sci, Lab Comp Graph & Multimedia, Ljubljana, Slovenia; [Leonardis, Ales] Univ Birmingham, Sch Comp Sci, Ctr Computat Neurosci & Cognit Robot, Birmingham B15 2TT, W Midlands, England	University of Ljubljana; University of Birmingham	Pesek, M (corresponding author), Univ Ljubljana, Fac Comp & Informat Sci, Lab Comp Graph & Multimedia, Ljubljana, Slovenia.	matevz.pesek@fri.uni-lj-si		Pesek, Matevz/0000-0001-9101-0471	Engineering and Physical Sciences Research Council [EP/N019415/1] Funding Source: researchfish; EPSRC [EP/N019415/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Anglade  Amelie, 2009, P INT C MUS INF RETR, P669; [Anonymous], 2010, P 11 INT SOC MUS INF; [Anonymous], 2013, 6 INT WORKSH MACH LE; Au WWL, 2003, NATURE, V423, P861, DOI 10.1038/nature01727; Balaguer-Ballester E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000301; Barbancho AM, 2012, IEEE T AUDIO SPEECH, V20, P915, DOI 10.1109/TASL.2011.2174227; Battenberg E., 2012, P ISMIR, P37; Benetos E, 2015, 11 ANN MUS INF RETR, P1; Benetos E., 2015, P 16 INT SOC MUS INF, P701; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Bittner R. M., 2015, P ISMIR, P500; Bock S, 2012, INT CONF ACOUST SPEE, P121, DOI 10.1109/ICASSP.2012.6287832; Boulanger- Lewandowski N., 2012, ISMIR, P205; Boulanger-Lewandowski N, 2013, P INT C MUS INF RETR; Clarkson MG, 1996, INFANT BEHAV DEV, V19, P191, DOI 10.1016/S0163-6383(96)90018-1; Conklin D, 2010, INTELL DATA ANAL, V14, P547, DOI 10.3233/IDA-2010-0438; Di Russo F, 2001, VISION RES, V41, P2435, DOI 10.1016/S0042-6989(01)00134-1; Dieleman S, 2011, P INT C MUS INF RETR, P24; Durand S, 2015, ACOUSTICS SPEECH SIG, P409; Emiya V, 2010, IEEE T AUDIO SPEECH, V18, P1643, DOI 10.1109/TASL.2009.2038819; Engell A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149933; Farbood M, 2010, P INT C MUS PERC COG; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fidler S, 2014, LEARNING HIERARCHICA; Fidler S., 2007, 2007 IEEE C COMP VIS, P1, DOI [10.1109/CVPR.2007.383269, DOI 10.1109/CVPR.2007.383269]; Gerhard D., 2003, PITCH EXTRACTION FUN; Grindlay G, 2011, IEEE J-STSP, V5, P1159, DOI 10.1109/JSTSP.2011.2162395; Harte C, 2005, P INT C MUS INF RETR; Holzapfel A, 2012, IEEE T AUDIO SPEECH, V20, P2539, DOI 10.1109/TASL.2012.2205244; Humphrey EJ, 2012, INT CONF ACOUST SPEE, P453, DOI 10.1109/ICASSP.2012.6287914; Humphrey Eric J., 2012, P INT C MUS INF RETR; Kelz R., 2016, P INT SOC MUS INF RE, P475; Klapuri A., 2006, SIGNAL PROCESSING ME; Klapuri AP, 2004, J NEW MUSIC RES, V33, P269, DOI 10.1080/0929821042000317840; Kusy B, 2009, 2009 INTERNATIONAL CONFERENCE ON INFORMATION PROCESSING IN SENSOR NETWORKS (IPSN 2009), P109; Laurier C, 2010, MULTIMED TOOLS APPL, V48, P161, DOI 10.1007/s11042-009-0360-2; Lerdahl F., 1983, GENERATIVE THEORY TO; Marolt M, 2004, IEEE T MULTIMEDIA, V6, P439, DOI 10.1109/TMM.2004.827507; McDermott JH, 2008, CURR OPIN NEUROBIOL, V18, P452, DOI 10.1016/j.conb.2008.09.005; Meredith D, 2002, J NEW MUSIC RES, V31, P321, DOI 10.1076/jnmr.31.4.321.14162; Mirex, 2016, MULT FUND FREQ EST R; Papadopoulos H, 2007, INT WORK CONTENT MUL, P53; Pertusa A, 2012, EURASIP J ADV SIG PR, P1, DOI 10.1186/1687-6180-2012-27; Pesek M, 2015, 11 ANN MUS INF RETR, P1; Pesek M, 2014, P INT C MUS INF RETR, P131; Pikrakis A., 2013, 6 INT WORKSH MACH LE, P1; Rigaud F., 2016, ISMIR, P737; Ryynanen MP, 2008, COMPUT MUSIC J, V32, P72, DOI 10.1162/comj.2008.32.3.72; Sapp C.S., 2005, COMPUT ENTERTAINMENT, V3, P1, DOI [10.1145/1095534.1095544, DOI 10.1145/1095534.1095544]; Schmidt E. M., 2013, P 14 ISMIR C CUR BRA, P21; Schmidt EM, 2011, 2011 IEEE WORKSHOP ON APPLICATIONS OF SIGNAL PROCESSING TO AUDIO AND ACOUSTICS (WASPAA), P65, DOI 10.1109/ASPAA.2011.6082328; Sigtia S., 2015, P 16 INT SOC MUSIC I, P127; Su L, 2015, INT S COMP MUS MUTL; Tzanetakis G, 2002, IEEE T SPEECH AUDI P, V10, P293, DOI 10.1109/TSA.2002.800560; Ullrich K., 2014, ISMIR, P417; Vincent E, 2010, IEEE T AUDIO SPEECH, V18, P528, DOI 10.1109/TASL.2009.2034186; Wang Ci, 2015, P ISMIR, V2, P176; Weninger F, 2013, INT CONF ACOUST SPEE, P6, DOI 10.1109/ICASSP.2013.6637598; Woolhouse M, 2006, P INT C MUS PERC COG; Yeh C, 2010, IEEE T AUDIO SPEECH, V18, P1116, DOI 10.1109/TASL.2009.2030006; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53	64	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169411	10.1371/journal.pone.0169411	http://dx.doi.org/10.1371/journal.pone.0169411			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046074	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300185
J	Piccirilli, M; Doretto, G; Adjeroh, D				Piccirilli, Marco; Doretto, Gianfranco; Adjeroh, Donald			A Framework for Analyzing the Whole Body Surface Area from a Single View	PLOS ONE			English	Article							NORMAL-WEIGHT; MASS INDEX; RECONSTRUCTION; IMAGE; PHARMACOKINETICS; CHILDREN; VALIDITY; FORMULA; HEIGHT; SYSTEM	We present a virtual reality (VR) framework for the analysis of whole human body surface area. Usual methods for determining the whole body surface area (WBSA) are based on well known formulae, characterized by large errors when the subject is obese, or belongs to certain subgroups. For these situations, we believe that a computer vision approach can overcome these problems and provide a better estimate of this important body indicator. Unfortunately, using machine learning techniques to design a computer vision system able to provide a new body indicator that goes beyond the use of only body weight and height, entails a long and expensive data acquisition process. A more viable solution is to use a dataset composed of virtual subjects. Generating a virtual dataset allowed us to build a population with different characteristics (obese, underweight, age, gender). However, synthetic data might differ from a real scenario, typical of the physician's clinic. For this reason we develop a new virtual environment to facilitate the analysis of human subjects in 3D. This framework can simulate the acquisition process of a real camera, making it easy to analyze and to create training data for machine learning algorithms. With this virtual environment, we can easily simulate the real setup of a clinic, where a subject is standing in front of a camera, or may assume a different pose with respect to the camera. We use this newly designated environment to analyze the whole body surface area (WBSA). In particular, we show that we can obtain accurate WBSA estimations with just one view, virtually enabling the possibility to use inexpensive depth sensors (e.g., the Kinect) for large scale quantification of the WBSA from a single view 3D map.	[Piccirilli, Marco; Doretto, Gianfranco; Adjeroh, Donald] West Virginia Univ, Lane Dept Comp Sci & Elect Engn, Morgantown, WV 26506 USA	West Virginia University	Piccirilli, M; Doretto, G; Adjeroh, D (corresponding author), West Virginia Univ, Lane Dept Comp Sci & Elect Engn, Morgantown, WV 26506 USA.	mpiccir1@mix.wvu.edu; Gianfranco.Doretto@mail.wvu.edu; Danald.Adjeroh@mail.wvu.edu		Piccirilli, Marco/0000-0001-6466-8358				Adler AC, 2012, CRIT CARE, V16, DOI 10.1186/cc11876; Agarwal P, 2010, INDIAN J PLAST SURG, V43, P49, DOI 10.4103/0970-0358.63962; Anguelov D, 2005, ACM T GRAPHIC, V24, P408, DOI 10.1145/1073204.1073207; [Anonymous], 1994, VITAL HLTH STAT, V1, P1; Appel Arthur, 1968, AFIPS, DOI DOI 10.1145/1468075.1468082; Baker SD, 2002, JNCI-J NATL CANCER I, V94, P1883, DOI 10.1093/jnci/94.24.1883; BANERJEE S, 1961, J APPL PHYSIOL, V16, P969, DOI 10.1152/jappl.1961.16.6.969; Bastioni M., 2008, P 1 BANG ANN COMP C, P1; Buys K, 2013, P INT DIG HUM MOD C; Buys K, 2014, J VIS COMMUN IMAGE R, V25, P39, DOI 10.1016/j.jvcir.2013.03.011; Cohen-Steiner D, 2004, VISUAL COMPUT, V20, P4, DOI 10.1007/s00371-003-0217-z; Daniell N, 2012, AM J PHYS ANTHROPOL, V148, P148, DOI 10.1002/ajpa.22051; Du Bois D, 1989, Nutrition, V5, P303; Felici A, 2002, EUR J CANCER, V38, P1677, DOI 10.1016/S0959-8049(02)00151-X; Hartley R, 2003, MULTIPLE VIEW GEOMET, DOI 10.1016/S0143-8166(01)00145-2; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Herrera D, 2011, LECT NOTES COMPUT SC, V6855, P437, DOI 10.1007/978-3-642-23678-5_52; Hettiaratchy S, 2004, BMJ-BRIT MED J, V329, P101, DOI 10.1136/bmj.329.7457.101; Holz D, 2013, ADV INTELL SYST, V194, P61; Holzer S, 2012, IEEE INT C INT ROBOT, P2684, DOI 10.1109/IROS.2012.6385999; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; Jander N, 2014, HEART, V100, P28, DOI 10.1136/heartjnl-2013-304443; Kaplan SH Center SHKE, 1988, PHARM BASIC MED SCI; Katzmarzyk PT, 1998, AM J PHYS ANTHROPOL, V106, P483, DOI 10.1002/(SICI)1096-8644(199808)106:4<483::AID-AJPA4>3.0.CO;2-K; Kazhdan M., 2006, P 4 EUROGRAPHICS S G, P61; Lapid O, 2007, ANN PLAS SURG, V58, P706, DOI 10.1097/01.sap.0000263355.49718.49; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee YA, 2006, FAM CONSUM SCI RES J, V34, P366, DOI 10.1177/1077727X06286458; Li J, 2012, NORTHEAST BIOENGIN C, P426, DOI 10.1109/NEBC.2012.6206923; Lindblad J., 2002, Discrete Geometry for Computer Imagery. 10th International Conference, DGCI 2002. Proceedings (Lecture Notes in Computer Science Vol.2301), P267; Lippiello Vincenzo, 2009, 2009 IEEE International Conference on Robotics and Automation (ICRA), P2400, DOI 10.1109/ROBOT.2009.5152652; Livingston EH, 2001, AM J PHYSIOL-ENDOC M, V281, pE586, DOI 10.1152/ajpendo.2001.281.3.E586; Loper MM, 2014, LECT NOTES COMPUT SC, V8695, P154, DOI 10.1007/978-3-319-10584-0_11; Lorensen William E., 1987, P ACM SIGGRAPH, P163, DOI [10.1145/37401.37422, DOI 10.1145/37401.37422]; Lu JM, 2008, EXPERT SYST APPL, V35, P407, DOI 10.1016/j.eswa.2007.07.008; Mei ZG, 2002, AM J CLIN NUTR, V75, P978, DOI 10.1093/ajcn/75.6.978; Microsoft Corporation, 2011, KIN WIND SD IN PRESS; Milani S, 2012, 3DTV C TRUE VIS CAPT, P1; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Nguyen CV, 2012, SECOND JOINT 3DIM/3DPVT CONFERENCE: 3D IMAGING, MODELING, PROCESSING, VISUALIZATION & TRANSMISSION (3DIMPVT 2012), P524, DOI 10.1109/3DIMPVT.2012.84; Palmero C., 2016, INT J COMPUT VISION, V2016, P1; Parsons S., 2012, PHARM CALCULATIONS; Pedersini F., 1998, 3D Structure from Multiple Images of Large-Scale Environments. European Workshop, SMILE'98. Proceedings, P124; Pierard S, 2011, LECT NOTES COMPUT SC, V6915, P519, DOI 10.1007/978-3-642-23687-7_47; R Core Team, 2021, R LANGUAGE ENV STAT; Remondino F, 2004, COMPUT VIS IMAGE UND, V93, P65, DOI 10.1016/j.cviu.2003.08.006; Robinette K. M., 1999, 2 INT C 3D DIG IM MO, DOI DOI 10.1109/IM.1999.805368; Sacco JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008933; Salvendy G, 2012, HUM FACTORS ERGON, pXIII; Sardinha LB, 2006, PHYSIOL MEAS, V27, P1197, DOI 10.1088/0967-3334/27/11/012; Sawyer M, 2001, INVEST NEW DRUG, V19, P171, DOI 10.1023/A:1010639201787; Shotton J, 2011, PROC CVPR IEEE, P1297, DOI 10.1109/CVPR.2011.5995316; Soni N, 2008, CLASSIC PAPERS CRITI; Sparreboom A, 2003, J CLIN ONCOL, V21, P2803, DOI 10.1200/JCO.2003.99.038; Van Deun D, 2011, INT S DIG HUM MOD LY; Verbraecken J, 2006, METABOLISM, V55, P515, DOI 10.1016/j.metabol.2005.11.004; Weiss A, 2011, IEEE I CONF COMP VIS, P1951, DOI 10.1109/ICCV.2011.6126465; Wells J C K, 2007, WHOLE BODY 3 DIMENSI; Yu CY, 2010, BURNS, V36, P616, DOI 10.1016/j.burns.2009.05.013; Yu CY, 2003, APPL ERGON, V34, P273, DOI 10.1016/S0003-6870(03)00007-3; Yu W., 2008, DEV 3 DIMENSIONAL AN; Yu WR, 2010, IMAGE VISION COMPUT, V28, P605, DOI 10.1016/j.imavis.2009.09.015; Zhang CH, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/841054; Zhengyou Zhang, 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P666, DOI 10.1109/ICCV.1999.791289	64	6	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0166749	10.1371/journal.pone.0166749	http://dx.doi.org/10.1371/journal.pone.0166749			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045895	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300004
J	Byosiere, SE; Espinosa, J; Marshall-Pescini, S; Smuts, B; Range, F				Byosiere, Sarah-Elizabeth; Espinosa, Julia; Marshall-Pescini, Sarah; Smuts, Barbara; Range, Friederike			Investigating the Function of Play Bows in Dog and Wolf Puppies (Canis lupus familiaris, Canis lupus occidentalis)	PLOS ONE			English	Article							SOCIAL PLAY; DOMESTIC DOG	Animals utilize behavioral signals across a range of different contexts in order to communicate with others and produce probable behavioral outcomes. During play animals frequently adopt action patterns used in other contexts. Researchers have therefore hypothesized that play signals have evolved to clarify communicative intent. One highly stereotyped play signal is the canid play bow, but its function remains contested. In order to clarify how canid puppies use play bows, we used data on play bows in immature wolves (ages 2.7-7.8 months) and dogs (ages 2 to 5 months) to test hypotheses evaluated in a previous study of adult dogs. We found that young dogs used play bows similarly to adult dogs; play bows most often occurred after a brief pause in play followed by complementary highly active play states. However, while the relative number of play bows and total observation time was similar between dog and wolf puppies, wolves did not follow this behavioral pattern, as play bows were unsuccessful in eliciting further play activity by the partner. While some similarities for the function of play bows in dog and wolf puppies were documented, it appears that play bows may function differently in wolf puppies in regards to re-initiating play.	[Byosiere, Sarah-Elizabeth; Espinosa, Julia; Smuts, Barbara] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Marshall-Pescini, Sarah; Range, Friederike] Univ Vienna, Med Univ Vienna, Univ Vet Med Vienna, Comparat Cognit,Messerli Res Inst, Vienna, Austria; [Marshall-Pescini, Sarah; Range, Friederike] Wolf Sci Ctr, Ernstbrunn, Austria	University of Michigan System; University of Michigan; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Byosiere, SE (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	sarahbyo@umich.edu	Byosiere, Sarah-Elizabeth/S-2737-2019; Byosiere, Sarah-Elizabeth/S-2736-2019	Byosiere, Sarah-Elizabeth/0000-0002-3583-6778; Range, Friederike/0000-0003-3127-5536; Marshall-Pescini, Sarah/0000-0002-5944-4701	European Research Council under the European Union's Seventh Framework Program by ERC [311870]; Austrian Science Fund [P21244-B17, P24840]; Royal Canin; Austrian Science Fund (FWF) [P 24840] Funding Source: researchfish	European Research Council under the European Union's Seventh Framework Program by ERC; Austrian Science Fund(Austrian Science Fund (FWF)); Royal Canin; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was financially supported by the European Research Council under the European Union's Seventh Framework Program (https://ec.europa.eu/research/fp7/index_en.cfm) by ERC Grant Agreement n. [311870] and the Austrian Science Fund (https://www.fwf.ac.at/en/) project P21244-B17 & P24840. The authors further thank many private sponsors including Royal Canin for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bauer E., 2009, J VET BEHAV, V4, P68, DOI [10.1017/CBO9780511608575, DOI 10.1017/CBO9780511608575, DOI 10.1016/j.jveb.2008.10.013]; BEKOFF M, 1972, Q REV BIOL, V47, P412, DOI 10.1086/407400; BEKOFF M, 1974, AM ZOOL, V14, P323; Bekoff M, 1997, PLAYING PLAY WHAT CA; Bekoff M, 1995, BEHAVIOUR; Bekoff M, 1998, ANIMAL PLAY, P97, DOI [10.1017/CBO9780511608575.006, DOI 10.1017/CBO9780511608575.006]; Bradbury Jack W., 1998, pi; Bradshaw JWS, 2015, BEHAV PROCESS, V110, P82, DOI 10.1016/j.beproc.2014.09.023; Byosiere SE, 2016, BEHAV PROCESS, V125, P106, DOI 10.1016/j.beproc.2016.02.007; Cafazzo S, 2010, BEHAV ECOL, V21, P443, DOI 10.1093/beheco/arq001; Cordoni G, 2016, UNVEILING SECRET PLA; Darwin C., 1872, P374; Endler John A., 2000, P11; Essler JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154150; Fagen RM, 1981, ANIMAL PLAY BEHAV; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Horowitz A, 2009, ANIM COGN, V12, P107, DOI 10.1007/s10071-008-0175-y; Markl H., 1983, P332; Molenberghs G, 2005, SPR S STAT, P687; Otte D., 1974, Annual Rev Ecol Syst, V5, P385, DOI 10.1146/annurev.es.05.110174.002125; Palagi E, 2006, AM J PHYS ANTHROPOL, V129, P418, DOI 10.1002/ajpa.20289; Palagi E., 2015, BIOL REV; Palagi E, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150505; Partan S, 1999, SCIENCE, V283, P1272, DOI 10.1126/science.283.5406.1272; Pellegrini AD., 2009, ROLE PLAY HUMAN DEV, DOI [10.1093/acprof:oso/9780195367324.001.0001, DOI 10.1093/ACPROF:OSO/9780195367324.001.0001]; Pellis S.M, 1993, J PLAY THEORY RES, V1, P56; Pellis SM, 1996, AGGRESS VIOLENT BEH, V1, P249, DOI 10.1016/1359-1789(95)00016-X; Rooney NJ, 2000, APPL ANIM BEHAV SCI, V66, P235, DOI 10.1016/S0168-1591(99)00078-7; SCHALLER G B, 1972, P480; SMITH PK, 1982, BEHAV BRAIN SCI, V5, P172, DOI 10.1017/S0140525X00011146; Smuts B, 2014, THE SOCIAL DOG, P105; Spinka M, 2001, Q REV BIOL, V76, P141, DOI 10.1086/393866; Ward C, 2008, ANIM BEHAV, V76, P1187, DOI 10.1016/j.anbehav.2008.06.004	33	8	8	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168570	10.1371/journal.pone.0168570	http://dx.doi.org/10.1371/journal.pone.0168570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7KQ	28033358	Green Submitted, Green Published, gold			2022-12-26	WOS:000391226900031
J	Lu, L; Ehmke, RC; Schwartz, LH; Zhao, BS				Lu, Lin; Ehmke, Ross C.; Schwartz, Lawrence H.; Zhao, Binsheng			Assessing Agreement between Radiomic Features Computed for Multiple CT Imaging Settings	PLOS ONE			English	Article							VOLUMETRIC MEASUREMENTS; TUMOR MEASUREMENTS; GENE-EXPRESSION; TEST-RETEST; LUNG; VARIABILITY; SCANS; RADIOGENOMICS	Objectives Radiomics utilizes quantitative image features (QIFs) to characterize tumor phenotype. In practice, radiological images are obtained from different vendors' equipment using various imaging acquisition settings. Our objective was to assess the inter-setting agreement of QIFs computed from CT images by varying two parameters, slice thickness and reconstruction algorithm. Materials and Methods CT images from an IRB-approved/HIPAA-compliant study assessing thirty-two lung cancer patients were included for the analysis. Each scan's raw data were reconstructed into six imaging series using combinations of two reconstruction algorithms (Lung[L] and Standard[S]) and three slice thicknesses (1.25mm, 2.5mm and 5mm), i.e., 1.25L, 1.25S, 2.5L, 2.5S, 5L and 5S. For each imaging-setting, 89 well-defined QIFs were computed for each of the 32 tumors (one tumor per patient). The six settings led to 15 inter-setting comparisons (combinatorial pairs). To reduce QIF redundancy, hierarchical clustering was done. Concordance correlation coefficients (CCCs) were used to assess inter-setting agreement of the non-redundant feature groups. The CCC of each group was assessed by averaging CCCs of QIFs in the group. Results Twenty-three non-redundant feature groups were created. Across all feature groups, the best inter-setting agreements (CCCs>0.8) were 1.25S vs 2.5S, 1.25L vs 2.5L, and 2.5S vs 5S; the worst (CCCs<0.51) belonged to 1.25L vs 5S and 2.5L vs 5S. Eight of the feature groups related to size, shape, and coarse texture had an average CCC>0.8 across all imaging settings. Conclusions Varying degrees of inter-setting disagreements of QIFs exist when features are computed from CT images reconstructed using different algorithms and slice thicknesses. Our findings highlight the importance of harmonizing imaging acquisition for obtaining consistent QIFs to study tumor imaging phonotype.	[Lu, Lin; Schwartz, Lawrence H.; Zhao, Binsheng] Columbia Univ, Med Ctr, Dept Radiol, New York, NY 10027 USA; [Ehmke, Ross C.] Columbia Univ, Dept Med, Med Ctr, New York, NY USA	Columbia University; Columbia University	Zhao, BS (corresponding author), Columbia Univ, Med Ctr, Dept Radiol, New York, NY 10027 USA.	bz2166@cumc.columbia.edu			National Cancer Institute (NCI) [R01 CA149490]; NATIONAL CANCER INSTITUTE [R01CA149490] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Grant R01 CA149490 from the National Cancer Institute (NCI).	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Balagurunathan Y, 2014, J DIGIT IMAGING, V27, P805, DOI 10.1007/s10278-014-9716-x; Coroller TP, 2016, RADIOTHERAPY ONCOLOG; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gevaert O, 2012, RADIOLOGY, V264, P387, DOI 10.1148/radiol.12111607; Hunter LA, 2013, MED PHYS, V40, DOI 10.1118/1.4829514; Karlo CA, 2014, RADIOLOGY, V270, P464, DOI 10.1148/radiol.13130663; Kuo MD, 2014, RADIOLOGY, V270, P320, DOI 10.1148/radiol.13132195; Lambin P, 2013, NAT REV CLIN ONCOL, V10, P27, DOI 10.1038/nrclinonc.2012.196; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Leijenaar RTH, 2013, ACTA ONCOL, V52, P1391, DOI 10.3109/0284186X.2013.812798; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Liu Y, 2016, CLIN LUNG CANC; Mackin D, 2015, INVEST RADIOL, V50, P757, DOI 10.1097/RLI.0000000000000180; Oxnard GR, 2011, J CLIN ONCOL, V29, P3114, DOI 10.1200/JCO.2010.33.7071; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11044; Parmar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102107; Pope WB, 2008, RADIOLOGY, V249, P268, DOI 10.1148/radiol.2491072000; Tan YQ, 2013, MED PHYS, V40, DOI 10.1118/1.4793409; Tan YQ, 2012, CANCER IMAGING, V12, P497, DOI 10.1102/1470-7330.2012.0046; Wu J, 2016, RADIOLOGY, V281, P270, DOI 10.1148/radiol.2016151829; Yip C, 2014, RADIOLOGY, V270, P141, DOI 10.1148/radiol.13122869; Yoon HJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001753; Zhao BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23428; Zhao BS, 2014, TRANSL ONCOL, V7, P88, DOI 10.1593/tlo.13865; Zhao BS, 2013, EUR J RADIOL, V82, P959, DOI 10.1016/j.ejrad.2013.02.018; Zhao BS, 2009, RADIOLOGY, V252, P263, DOI 10.1148/radiol.2522081593; Zhu YT, 2015, SCI REP-UK, V5, DOI 10.1038/srep17787	29	87	93	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0166550	10.1371/journal.pone.0166550	http://dx.doi.org/10.1371/journal.pone.0166550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033372	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900006
J	Machuca, A; Martinez, V				Machuca, Alvaro; Martinez, Victor			Transcriptome Analysis of the Intracellular Facultative Pathogen Piscirickettsia salmonis: Expression of Putative Groups of Genes Associated with Virulence and Iron Metabolism	PLOS ONE			English	Article							LEGIONELLA-PNEUMOPHILA; RNA-SEQ; FRANCISELLA-TULARENSIS; ANTIBIOTIC-RESISTANCE; BACTERIAL PATHOGEN; CAUSATIVE AGENT; SIGMA-FACTORS; FERROUS IRON; PROTEIN; IDENTIFICATION	The intracellular facultative bacteria Piscirickettsia salmonis is one of the most important pathogens of the Chilean aquaculture. However, there is a lack of information regarding the whole genomic transcriptional response according to different extracellular environments. We used next generation sequencing (NGS) of RNA (RNA-seq) to study the whole transcriptome of an isolate of P. salmonis (FAVET-INBIOGEN) using a cell line culture and a modified cell-free liquid medium, with or without iron supplementation. This was done in order to obtain information about the factors there are involved in virulence and iron acquisition. First, the isolate was grown in the Sf21 cell line; then, the bacteria were cultured into a cell-free liquid medium supplemented or not with iron. We identified in the transcriptome, genes associated with type IV secretion systems, genes related to flagellar structure assembly, several proteases and sigma factors, and genes related to the development of drug resistance. Additionally, we identified for the first time several iron-metabolism associated genes including at least two iron uptake pathways (ferrous iron and ferric iron uptake) that are actually expressed in the different conditions analyzed. We further describe putative genes that are related with the use and storage of iron in the bacteria, which have not been previously described. Several sets of genes related to virulence were expressed in both the cell line and cell-free culture media (for example those related to flagellar structure; such as basal body, MS-ring, C-ring, proximal and distal rod, and filament), which may play roles in other basic processes rather than been restricted to virulence.	[Machuca, Alvaro; Martinez, Victor] Univ Chile, FAVET INBIOGEN, Fac Vet Sci, Santiago, Chile	Universidad de Chile	Martinez, V (corresponding author), Univ Chile, FAVET INBIOGEN, Fac Vet Sci, Santiago, Chile.	vmartine@uchile.cl	Martinez, Victor/S-7638-2019; Machuca, Alvaro/AAH-3789-2019		Chilean Government through FONDEF-IDEA [14110090]; CONICYT	Chilean Government through FONDEF-IDEA; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was financially supported by the Chilean Government through FONDEF-IDEA (14110090) to V. Martinez. Alvaro Machuca acknowledges the support of scholarships for National PhD students from CONICYT.	Abby SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002983; Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Almiron MA, 2010, J MICROBIOL, V48, P668, DOI 10.1007/s12275-010-0145-3; Amin SA, 2009, INORG CHEM, V48, P11451, DOI 10.1021/ic9016883; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bashyam MD, 2004, INFECT GENET EVOL, V4, P301, DOI 10.1016/j.meegid.2004.04.003; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; Birkbeck TH, 2004, INFECT IMMUN, V72, P3693, DOI 10.1128/IAI.72.6.3693-3694.2004; Butcher J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079475; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Cartron ML, 2006, BIOMETALS, V19, P143, DOI 10.1007/s10534-006-0003-2; Cheng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076400; Chu BCH, 2007, BIOMETALS, V20, P467, DOI 10.1007/s10534-006-9049-4; Chung CH, 2014, APPL ENVIRON MICROB, V80, P7398, DOI 10.1128/AEM.02701-14; Cianciotto NP, 2007, BIOMETALS, V20, P323, DOI 10.1007/s10534-006-9057-4; Clarke TE, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-27; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; Crow A, 2009, J AM CHEM SOC, V131, P6808, DOI 10.1021/ja8093444; De Buck E, 2007, MICROBIOL-SGM, V153, P3948, DOI 10.1099/mic.0.2007/012039-0; Dettleff P, 2015, FISH SHELLFISH IMMUN, V45, P67, DOI 10.1016/j.fsi.2015.03.039; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Evstigneeva Z. G., 2001, Prikladnaya Biokhimiya i Mikrobiologiya, V37, P5; Ewann F, 2006, APPL ENVIRON MICROB, V72, P3993, DOI 10.1128/AEM.00684-06; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Fillat MF, 2014, ARCH BIOCHEM BIOPHYS, V546, P41, DOI 10.1016/j.abb.2014.01.029; Frees Dorte, 2013, Subcell Biochem, V66, P161, DOI 10.1007/978-94-007-5940-4_7; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; FRYER JL, 1992, INT J SYST BACTERIOL, V42, P120, DOI 10.1099/00207713-42-1-120; Fryer JL, 2003, J FISH DIS, V26, P251, DOI 10.1046/j.1365-2761.2003.00460.x; Gomez FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054934; Gomez FA, 2011, FEMS MICROBIOL LETT, V317, P83, DOI 10.1111/j.1574-6968.2011.02218.x; Henriquez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071830; House ML, 1999, DIS AQUAT ORGAN, V35, P107, DOI 10.3354/dao035107; Humphrys MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080597; Ingmer H, 2009, RES MICROBIOL, V160, P704, DOI 10.1016/j.resmic.2009.08.017; Isla A, 2014, VET MICROBIOL, V173, P390, DOI 10.1016/j.vetmic.2014.08.014; Jacobi S, 2004, J BACTERIOL, V186, P2540, DOI 10.1128/JB.186.9.2540-2547.2004; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kim H, 2012, BIOCHEM BIOPH RES CO, V423, P733, DOI 10.1016/j.bbrc.2012.06.027; Kress W, 2009, RES MICROBIOL, V160, P618, DOI 10.1016/j.resmic.2009.08.006; LANNAN CN, 1994, J FISH DIS, V17, P545, DOI 10.1111/j.1365-2761.1994.tb00251.x; Li XH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-54; Lifshitz Z, 2014, INFECT IMMUN, V82, P3740, DOI 10.1128/IAI.01729-14; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lim CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039139; Liu RY, 2007, J BACTERIOL, V189, P7098, DOI 10.1128/JB.00643-07; Maezawa K, 2006, J BACTERIOL, V188, P6539, DOI 10.1128/JB.00561-06; Marshall SH, 2012, RES MICROBIOL, V163, P557, DOI 10.1016/j.resmic.2012.08.002; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; McGettigan PA, 2013, CURR OPIN CHEM BIOL, V17, P4, DOI 10.1016/j.cbpa.2012.12.008; Meibom KL, 2008, MOL MICROBIOL, V67, P1384, DOI 10.1111/j.1365-2958.2008.06139.x; Michan C, 1999, J BACTERIOL, V181, P2759; Miethke M, 2013, METALLOMICS, V5, P15, DOI 10.1039/c2mt20193c; Mikael LG, 2002, MICROBIOL-SGM, V148, P2869, DOI 10.1099/00221287-148-9-2869; Mikalsen J, 2008, FEMS MICROBIOL LETT, V278, P43, DOI 10.1111/j.1574-6968.2007.00977.x; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Naikare H, 2006, INFECT IMMUN, V74, P5433, DOI 10.1128/IAI.00052-06; Neckers L, 2008, CELL HOST MICROBE, V4, P519, DOI 10.1016/j.chom.2008.10.011; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; Oh E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087312; Ohtsu I, 2010, J BIOL CHEM, V285, P17479, DOI 10.1074/jbc.M109.081356; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Palyada K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-481; Pinto AC, 2011, GENET MOL RES, V10, P1707, DOI 10.4238/vol10-3gmr1554; Poole K, 2012, TRENDS MICROBIOL, V20, P227, DOI 10.1016/j.tim.2012.02.004; Rajas V, 2009, J CELL BIOCHEM, V108, P631, DOI 10.1002/jcb.22295; Ramakrishnan G, 2012, J BIOL CHEM, V287, P25191, DOI 10.1074/jbc.M112.371856; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Rojas ME, 2013, J FISH DIS, V36, P703, DOI 10.1111/jfd.12019; Rojas V, 2010, J CELL BIOCHEM, V110, P468, DOI 10.1002/jcb.22560; Rozas M, 2014, J FISH DIS, V37, P163, DOI 10.1111/jfd.12211; Shah DH, 2014, APPL ENVIRON MICROB, V80, P896, DOI 10.1128/AEM.02740-13; Shvyreva U. S., 2011, Biophysics, V56, P795, DOI 10.1134/S0006350911050204; Smith PA, 2004, DIS AQUAT ORGAN, V61, P53, DOI 10.3354/dao061053; Smith PA, 1999, DIS AQUAT ORGAN, V37, P165, DOI 10.3354/dao037165; Stokes HW, 2011, FEMS MICROBIOL REV, V35, P790, DOI 10.1111/j.1574-6976.2011.00273.x; Tanabe T, 2003, J BACTERIOL, V185, P6938, DOI 10.1128/JB.185.23.6938-6949.2003; Toft C, 2008, MOL BIOL EVOL, V25, P2069, DOI 10.1093/molbev/msn153; Trotter V, 2009, MOL MICROBIOL, V74, P1527, DOI 10.1111/j.1365-2958.2009.06954.x; Troxell B, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00059; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Velayudhan J, 2007, MOL MICROBIOL, V63, P1495, DOI 10.1111/j.1365-2958.2007.05600.x; Weissenmayer BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017570; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; Wollers S, 2010, J BIOL CHEM, V285, P23329, DOI 10.1074/jbc.M110.127449; Yanez AJ, 2012, DIS AQUAT ORGAN, V97, P197, DOI 10.3354/dao02403; Yanez AJ, 2014, GENOME ANNOUNC, V2; Zamora-Pantoja DR, 2013, REV MED MICROBIOL, V24, P41, DOI 10.1097/MRM.0b013e32835a1f02; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638; Zink SD, 2002, INFECT IMMUN, V70, P1657, DOI 10.1128/IAI.70.3.1657-1663.2002	98	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168855	10.1371/journal.pone.0168855	http://dx.doi.org/10.1371/journal.pone.0168855			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033422	Green Submitted, Green Published, gold			2022-12-26	WOS:000391226900051
J	Reitman, AJ; Chapman, R; Stein, JE; Paquette, L; Panigrahy, A; Nelson, MD; Friedlich, P; Wisnowski, JL; Bluml, S				Reitman, Aaron J.; Chapman, Rachel; Stein, James E.; Paquette, Lisa; Panigrahy, Ashok; Nelson, Marvin D.; Friedlich, Philippe; Wisnowski, Jessica L.; Bluml, Stefan			The Impact of Venoarterial and Venovenous Extracorporeal Membrane Oxygenation on Cerebral Metabolism in the Newborn Brain	PLOS ONE			English	Article							CONGENITAL DIAPHRAGMATIC-HERNIA; MAGNETIC-RESONANCE SPECTROSCOPY; IN-VIVO; RESPIRATORY-FAILURE; MR SPECTROSCOPY; SERUM CYTOKINE; HEART-DISEASE; PROTON MRS; ECMO; CHILDREN	Background Extracorporeal membrane oxygenation (ECMO) is an effective therapy for supporting infants with reversible cardiopulmonary failure. Still, survivors are at risk for long-term neurodevelopmental impairments, the cause of which is not fully understood. Objective To elucidate the effects of ECMO on the newborn brain. We hypothesized that the cerebral metabolic profile of neonates who received ECMO would differ from neonates who did not receive ECMO. To address this, we used magnetic resonance spectroscopy (H-1-MRS) to investigate the effects of venoarterial and venovenous ECMO on cerebral metabolism. Methods 41 neonates treated with ECMO were contrasted to 38 age-matched neonates. Results All 1 H-MRS data were acquired from standardized grey matter and white matter regions of interest using a short-echo (TE = 35 milliseconds), point-resolved spectroscopy sequence (PRESS) and quantitated using LCModel. Metabolite concentrations (mmol/kg) were compared across groups using multivariate analysis of covariance. Elevated creatine (p = 0.002) and choline (p = 0.005) concentrations were observed in the grey matter among neonates treated with ECMO relative to the reference group. Likewise, choline concentrations were elevated in the white matter (p = 0.003) while glutamate was reduced (p = 0.03). Contrasts between ECMO groups revealed lower osmolite concentrations (e.g. myoinositol) among the venovenous ECMO group. Conclusion Neonates who underwent ECMO were found to have an abnormal cerebral metabolic profile, with the pattern of abnormalities suggestive of an underlying inflammatory process. Additionally, neonates who underwent venovenous ECMO had low cerebral osmolite concentrations as seen in vasogenic edema.	[Reitman, Aaron J.; Chapman, Rachel; Paquette, Lisa; Friedlich, Philippe; Wisnowski, Jessica L.] Childrens Hosp Los Angeles, Ctr Fetal & Neonatal Med, Los Angeles, CA 90027 USA; [Reitman, Aaron J.; Chapman, Rachel; Paquette, Lisa; Friedlich, Philippe] Univ Southern Calif, Dept Pediat, Div Neonatal Med, Los Angeles, CA USA; [Reitman, Aaron J.] Los Angeles Cty Univ Southern Calif, Med Ctr, Dept Pediat, Div Neonatal Med, Los Angeles, CA USA; [Stein, James E.] Childrens Hosp Los Angeles, Dept Surg, Los Angeles, CA 90027 USA; [Stein, James E.] Univ Southern Calif, Dept Surg, Los Angeles, CA USA; [Panigrahy, Ashok; Nelson, Marvin D.; Wisnowski, Jessica L.; Bluml, Stefan] Childrens Hosp Los Angeles, Dept Radiol, Los Angeles, CA 90027 USA; [Panigrahy, Ashok; Wisnowski, Jessica L.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA; [Wisnowski, Jessica L.; Bluml, Stefan] Rudi Schulte Res Inst, Santa Barbara, CA 93101 USA	Children's Hospital Los Angeles; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wisnowski, JL (corresponding author), Childrens Hosp Los Angeles, Ctr Fetal & Neonatal Med, Los Angeles, CA 90027 USA.; Wisnowski, JL (corresponding author), Childrens Hosp Los Angeles, Dept Radiol, Los Angeles, CA 90027 USA.; Wisnowski, JL (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA.; Wisnowski, JL (corresponding author), Rudi Schulte Res Inst, Santa Barbara, CA 93101 USA.	jwisnowski@chla.usc.edu		Bluml, Stefan/0000-0003-2124-797X	Los Angeles Basin Clinical Translational Research Institute [UL1TR000130]; Gerber Foundation; Rudi Schulte Research Institute	Los Angeles Basin Clinical Translational Research Institute; Gerber Foundation; Rudi Schulte Research Institute	This work was supported by: 1. Los Angeles Basin Clinical Translational Research Institute (UL1TR000130): AJR; 2. The Gerber Foundation: AJR; and 3. Rudi Schulte Research Institute: JLW SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderliesten T, 2011, RADIOLOGY, V261, P235, DOI 10.1148/radiol.11110213; ANDERSON HL, 1993, J PEDIATR SURG, V28, P530, DOI 10.1016/0022-3468(93)90611-N; Bitsch A, 1999, AM J NEURORADIOL, V20, P1619; Bluml S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085829; Bluml S, 2013, CEREB CORTEX, V23, P2944, DOI 10.1093/cercor/bhs283; Bonavita S, 1999, EUR J RADIOL, V30, P125, DOI 10.1016/S0720-048X(99)00051-0; BRUNBERG JA, 1993, AM J NEURORADIOL, V14, P595; Bulas D, 2005, SEMIN PERINATOL, V29, P58, DOI 10.1053/j.semperi.2005.02.009; Chen QY, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-186; Degaonkar MN, 2002, NMR BIOMED, V15, P293, DOI 10.1002/nbm.771; ELSO, 2015, NEON ECMO REG EXTR L; Field D, 1996, LANCET, V348, P75; Fleck S, 2013, PEDIATR RES, V74, P290, DOI 10.1038/pr.2013.98; Fortenberry JD, 1996, J PEDIATR-US, V128, P670, DOI 10.1016/S0022-3476(96)80133-8; Girard N, 2006, EUR J RADIOL, V57, P217, DOI 10.1016/j.ejrad.2005.11.021; GLASS P, 1995, J PEDIATR-US, V127, P447, DOI 10.1016/S0022-3476(95)70082-X; Glass P, 1997, DEV MED CHILD NEUROL, V39, P441; Graulich J, 2002, MEDIAT INFLAMM, V11, P69, DOI 10.1080/09629350220131908; GULLANS SR, 1993, ANNU REV MED, V44, P289, DOI 10.1146/annurev.me.44.020193.001445; HAHN JS, 1993, NEUROPEDIATRICS, V24, P19, DOI 10.1055/s-2008-1071507; Hervey-Jumper SL, 2011, J NEUROSURG-PEDIATR, V7, P338, DOI 10.3171/2011.1.PEDS10443; HUPPI PS, 1995, PEDIATR RES, V37, P145; LAZAR EL, 1994, J PEDIATR SURG, V29, P186, DOI 10.1016/0022-3468(94)90315-8; Loh TP, 2015, PATHOLOGY, V47, P452, DOI 10.1097/PAT.0000000000000274; LOHR JW, 1988, LIFE SCI, V43, P271, DOI 10.1016/0024-3205(88)90317-7; Machado JR, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/269681; Madderom MJ, 2013, ARCH DIS CHILD-FETAL, V98, pF316, DOI 10.1136/archdischild-2012-303020; Marino BS, 2012, CIRCULATION, V126, P1143, DOI 10.1161/CIR.0b013e318265ee8a; Okazaki K, 2008, PEDIATRICS, V121, pE748, DOI 10.1542/peds.2007-1697; Paden ML, 2014, SEMIN PERINATOL, V38, P65, DOI 10.1053/j.semperi.2013.11.002; Pan JW, 1996, MAGNET RESON MED, V36, P7, DOI 10.1002/mrm.1910360103; Paquette LB, 2013, AM J NEURORADIOL, V34, P2026, DOI 10.3174/ajnr.A3528; Polito A, 2013, INTENS CARE MED, V39, P1594, DOI 10.1007/s00134-013-2985-x; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Raets MMA, 2013, PEDIATR CRIT CARE ME, V14, P884, DOI 10.1097/PCC.0b013e3182a555ac; Rais-Bahrami K, 2014, SEMIN PERINATOL, V38, P71, DOI 10.1053/j.semperi.2013.11.003; Roelants-van Rijn AM, 2001, ACTA PAEDIATR, V90, P1288; Rollins MD, 2012, J PEDIATR SURG, V47, P76, DOI 10.1016/j.jpedsurg.2011.10.016; RUBIN DA, 1990, PEDIATR RADIOL, V21, P12, DOI 10.1007/BF02010805; Schaible T, 2011, KLIN PADIATR, V223, P414, DOI 10.1055/s-0031-1295436; Thayyil S, 2010, PEDIATRICS, V125, pE382, DOI 10.1542/peds.2009-1046; Wisnowski JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056880; Wisnowski JL, 2015, J CEREBRAL BLOOD FLO; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Zwiers AJM, 2013, CRIT CARE, V17, DOI 10.1186/cc12830	45	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168578	10.1371/journal.pone.0168578	http://dx.doi.org/10.1371/journal.pone.0168578			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033354	Green Published, Green Submitted, gold			2022-12-26	WOS:000391226900032
J	Stoperka, F; Karger, C; Beige, J				Stoperka, Felix; Karger, Claudia; Beige, Joachim			Limited Accuracy of Colour Doppler Ultrasound Dynamic Tissue Perfusion Measurement in Diabetic Adults	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; BLOOD-FLOW; INTESTINAL WALL; DAIRY-COWS; OXYTOCIN; TOOL	Dynamic tissue perfusion measurement (DTPM) is a pre-described and available method in pediatric ultrasound to quantify tissue perfusion in renal Doppler ultrasound by particular video analysis software. This study evaluates DTPM during single and between repeated visits after 6 months, calibrates repeated DTPM within different region of interest (ROI) and compares DTPM with kidney function markers in adult patients with early diabetic nephropathy (n = 17). During repeated measurements, no association of readings at the same patients in the same (n = 3 readings) as well as repeated visit (n = 2 visits) could be retrieved. No association between DTPM, MDRD-GFR, albuminuria, age and duration of diabetes was observed. These negative results are presumably related to inconsistency of DTPM due to non-fixed ROI position as could be shown in calibrating series. Further development of the method should be performed to enable reproducible DTPM readings in adults.	[Stoperka, Felix; Karger, Claudia; Beige, Joachim] Hosp St Georg, Dept Nephrol, Leipzig, Germany; [Stoperka, Felix; Karger, Claudia; Beige, Joachim] Hosp St Georg, Kuratorium Dialysis & Transplantat KfH Renal Unit, Leipzig, Germany; [Beige, Joachim] Martin Luther Univ Halle Wittenberg, Halle, Germany	Martin Luther University Halle Wittenberg	Beige, J (corresponding author), Hosp St Georg, Dept Nephrol, Leipzig, Germany.; Beige, J (corresponding author), Hosp St Georg, Kuratorium Dialysis & Transplantat KfH Renal Unit, Leipzig, Germany.; Beige, J (corresponding author), Martin Luther Univ Halle Wittenberg, Halle, Germany.	Joachim.Beige@kfh-dialyse.de	Beige, Joachim/A-3446-2017	Beige, Joachim/0000-0002-1907-825X				BRANDT TD, 1982, J ULTRAS MED, V1, P49, DOI 10.7863/jum.1982.1.2.49; Brozos CN, 2012, J VET SCI, V13, P67, DOI 10.4142/jvs.2012.13.1.67; CHRISTIANSEN JS, 1981, DIABETOLOGIA, V20, P451; Herzog K, 2010, THERIOGENOLOGY, V73, P691, DOI 10.1016/j.theriogenology.2009.11.016; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lubas A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/137868; Ma F, 2012, NEPHROL DIAL TRANSPL, V27, P2891, DOI 10.1093/ndt/gfr789; Magata F, 2013, VET J, V196, P76, DOI 10.1016/j.tvjl.2012.08.010; Rosenbaum C, 2013, UROL INT, V90, P87, DOI 10.1159/000341262; Scholbach T, 2006, TRANSPLANTATION, V81, P751, DOI 10.1097/01.tp.0000201928.04266.d2; Scholbach T, 2005, TRANSPLANTATION, V79, P1711, DOI 10.1097/01.TP.0000164145.89275.02; Scholbach T, 2004, J PEDIATR GASTR NUTR, V39, P524, DOI 10.1097/00005176-200411000-00014; Scholbach T, 2010, J MED ULTRASOUND, V18, P62, DOI 10.1016/S0929-6441(10)60009-4; Scholbach T, 2009, J MED ULTRASOUND, V17, P71, DOI 10.1016/S0929-6441(09)60114-4; Schwartz GJ, 2009, CLIN J AM SOC NEPHRO, V4, P1832, DOI 10.2215/CJN.01640309; Starke A, 2011, J DAIRY SCI, V94, P2964, DOI 10.3168/jds.2011-4156; Thomas S, 2009, J MED ULTRASOUND, V17, P9, DOI 10.1016/S0929-6441(09)60010-2	17	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168905	10.1371/journal.pone.0168905	http://dx.doi.org/10.1371/journal.pone.0168905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033403	Green Published, Green Submitted, gold			2022-12-26	WOS:000391226900057
J	Chen, YX; Zhang, J; Morgan, IG; He, MG				Chen, Yanxian; Zhang, Jian; Morgan, Ian G.; He, Mingguang			Identifying Children at Risk of High Myopia Using Population Centile Curves of Refraction	PLOS ONE			English	Article							OUTDOOR ACTIVITY; ORTHOKERATOLOGY; PREVALENCE; SINGAPORE; SCHOOLCHILDREN; METAANALYSIS; PROGRESSION; ETHNICITY; ATROPINE; SYDNEY	Purpose To construct reference centile curves of refraction based on population-based data as an age-specific severity scale to evaluate their efficacy as a tool for identifying children at risk of developing high myopia in a longitudinal study. Methods Data of 4218 children aged 5-15 years from the Guangzhou Refractive Error Study in Children (RESC) study, and 354 first-born twins from the Guangzhou Twin Eye Study (GTES) with annual visit were included in the analysis. Reference centile curves for refraction were constructed using a quantile regression model based on the cycloplegic refraction data from the RESC. The risk of developing high myopia (spherical equivalent <=-6 diopters [D]) was evaluated as a diagnostic test using the twin follow-up data. Results The centile curves suggested that the 3 rd, 5 th, and 10 th percentile decreased from -0.25 D, 0.00 D and 0.25 D in 5 year-olds to -6.00 D, -5.65D and -4.63 D in 15 year-olds in the population- based data from RESC. In the GTES cohort, the 5 th centile showed the most effective diagnostic value with a sensitivity of 92.9%, a specificity of 97.9% and a positive predictive value (PPV) of 65.0% in predicting high myopia onset (<=-6.00D) before the age of 15 years. The PPV was highest (87.5%) in 3 rd centile but with only 50.0% sensitivity. The Mathew's correlation coefficient of 5 th centile in predicting myopia of -6.0D/-5.0D/-4.0D by age of 15 was 0.77/0.51/0.30 respectively. Conclusions Reference centile curves provide an age-specific estimation on a severity scale of refractive error in school-aged children. Children located under lower percentiles at young age were more likely to have high myopia at 15 years or probably in adulthood.	[Chen, Yanxian; Zhang, Jian; He, Mingguang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Morgan, Ian G.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [He, Mingguang] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia	Sun Yat Sen University; Australian National University; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne	He, MG (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.; He, MG (corresponding author), Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia.	mingguang_he@yahoo.com	Morgan, Ian G/D-1190-2009; He, Mingguang/AAY-5239-2020	Morgan, Ian G/0000-0002-4548-3574; He, Mingguang/0000-0002-6912-2810	Fundamental Research Funds of the State Key Laboratory in Ophthalmology, Science and Technology Planning Project of Guangdong Province [2013B20400003]; National Natural Science Foundation of China [81300795]; University of Melbourne Research at Melbourne Accelerator Program Professorship	Fundamental Research Funds of the State Key Laboratory in Ophthalmology, Science and Technology Planning Project of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Melbourne Research at Melbourne Accelerator Program Professorship	This work was supported by the Fundamental Research Funds of the State Key Laboratory in Ophthalmology, Science and Technology Planning Project of Guangdong Province 2013B20400003, National Natural Science Foundation of China 81300795. Dr He receives support from the University of Melbourne Research at Melbourne Accelerator Program Professorship. The Centre for Eye Research Australia receives operational infrastructural support from the Victorian government. The sponsor or funding organizations had no role in the design or conduct of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird PN, 2010, PROG RETIN EYE RES, V29, P520, DOI 10.1016/j.preteyeres.2010.05.004; Bowditch H P, 1917, GROWTH CHILDREN STUD, VII; Chan TCY, 2014, AM J OPHTHALMOL, V158, P1130, DOI 10.1016/j.ajo.2014.08.026; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Dirani M, 2009, BRIT J OPHTHALMOL, V93, P997, DOI 10.1136/bjo.2008.150979; Fledelius HC, 2010, ACTA OPHTHALMOL, V88, P472, DOI 10.1111/j.1755-3768.2008.01472.x; French AN, 2013, OPHTHAL PHYSL OPT, V33, P318, DOI 10.1111/opo.12045; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2006, TWIN RES HUM GENET, V9, P753, DOI 10.1375/183242706779462561; Li SM, 2016, CURR EYE RES, V41, P600, DOI 10.3109/02713683.2015.1050743; Li SM, 2014, OPTOMETRY VISION SCI, V91, P342, DOI 10.1097/OPX.0000000000000178; Lim HT, 2012, JPN J OPHTHALMOL, V56, P76, DOI 10.1007/s10384-011-0090-7; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Mills NL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1533; Neelam K, 2012, PROG RETIN EYE RES, V31, P495, DOI 10.1016/j.preteyeres.2012.04.001; Negrel AD, 2000, AM J OPHTHALMOL, V129, P421, DOI 10.1016/S0002-9394(99)00455-9; Nijman RG, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4224; Rose KA, 2008, ARCH OPHTHALMOL-CHIC, V126, P527, DOI 10.1001/archopht.126.4.527; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Sankaridurg P, 2011, INVEST OPHTH VIS SCI, V52, P9362, DOI 10.1167/iovs.11-7260; Santodomingo-Rubido J, 2012, INVEST OPHTH VIS SCI, V53, P5060, DOI 10.1167/iovs.11-8005; Saw SM, 2008, OPHTHALMOLOGY, V115, P1713, DOI 10.1016/j.ophtha.2008.03.016; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Shih YF, 1999, J OCUL PHARMACOL TH, V15, P85, DOI 10.1089/jop.1999.15.85; StataCorp, 2011, STAT STAT SOFTW REL; Stehouwer CD, 2000, ANAL TWINS HYPERTENS, V36, P1008, DOI DOI 10.1161/01.HYP.36.6.1008; Sung RYT, 2007, INT J OBESITY, V31, P550, DOI 10.1038/sj.ijo.0803452; Tokoro T, 1988, Acta Ophthalmol Suppl, V185, P107; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Zhang MZ, 2011, INVEST OPHTH VIS SCI, V52, P5836, DOI 10.1167/iovs.10-5592	31	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167642	10.1371/journal.pone.0167642	http://dx.doi.org/10.1371/journal.pone.0167642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030593	gold, Green Submitted, Green Published			2022-12-26	WOS:000391222000015
J	De Castro, O; Innangi, M; Di Maio, A; Menale, B; Bacchetta, G; Pires, M; Noble, V; Gestri, G; Conti, F; Peruzzi, L				De Castro, Olga; Innangi, Michele; Di Maio, Antonietta; Menale, Bruno; Bacchetta, Gianluigi; Pires, Mathias; Noble, Virgile; Gestri, Giovanni; Conti, Fabio; Peruzzi, Lorenzo			Disentangling Phylogenetic Relationships in a Hotspot of Diversity: The Butterworts (Pinguicula L., Lentibulariaceae) Endemic to Italy	PLOS ONE			English	Article							DNA-SEQUENCES; PLASTID DNA; EVOLUTION; PLANTS; INHERITANCE; MORPHOLOGY; INVENTORY; INFERENCE; SUPPORT; MRBAYES	The genus Pinguicula (Lentibulariaceae) consists of about 100 carnivorous species, also known as butterworts. Eleven taxa are endemic to Italy, which represents a biodiversity hotspot for butterworts in Europe. The aim of our study was to provide a phylogenetic framework for the Italian endemics, in order to: a) investigate the relationships between species in this group; b) evaluate their actual taxonomic value. To achieve this, we analysed all the taxa endemic to Italy, along with several other species, by means of ITS nrDNA analysis. Our results clarify the relationships between Italian endemics and other Pinguicula taxa identifying a basal polytomy defined by five clades. All of the Italian endemics (with the exception of P. lavalvae) fall within a single large clade, which includes P. vulgaris and allied species. Among them, P. poldinii represents the most isolated lineage. Other taxa show strong molecular similarities and form a single subclade, although their taxonomic ranks can be retained. Pinguicula lattanziae sp. nov., seemingly endemic to Liguria (NW Italy), is also described.	[De Castro, Olga; Di Maio, Antonietta; Menale, Bruno] Univ Naples Federico II, Dipartimento Biol, Naples, Italy; [Innangi, Michele] Seconda Univ Napoli, Dipartimento Sci & Tecnol Ambientali Biol & Farma, Caserta, Italy; [Bacchetta, Gianluigi] Univ Cagliari, Ctr Conservaz Biodiversita, Dipartimento Sci Vitae & Ambiente, Cagliari, Italy; [Pires, Mathias; Noble, Virgile] Conservatoire Bot Natl Mediterraneen, Hyeres, France; [Gestri, Giovanni] Abitazione, Prato, Italy; [Conti, Fabio] Univ Camerino, Scuola Biosci & Med Vet, Ctr Ric Florist Appennino, Parco Nazl Gran Sasso & Monti della Laga, Laquila, Italy; [Peruzzi, Lorenzo] Univ Pisa, Dipartimento Biol, Pisa, Italy	University of Naples Federico II; Universita della Campania Vanvitelli; University of Cagliari; University of Camerino; University of Pisa	De Castro, O (corresponding author), Univ Naples Federico II, Dipartimento Biol, Naples, Italy.	olga.decastro@unina.it	Conti, Fabio/K-4846-2015; Peruzzi, Lorenzo/A-4127-2012; Innangi, Michele/M-2205-2015; Bacchetta, Gianluigi/AAD-5329-2020	Conti, Fabio/0000-0001-7391-6691; Peruzzi, Lorenzo/0000-0001-9008-273X; Innangi, Michele/0000-0003-2362-6025; DE CASTRO, Olga/0000-0002-4861-3960				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 1966, BIBLIOTHECA BOT; Ansaldi M, 2009, WULFENIA, V16, P1; Bacchetta G, 2014, PHYTOTAXA, V186, P279, DOI 10.11646/phytotaxa.186.5.5; Beatty GE, 2014, J BIOGEOGR, V41, P2185, DOI 10.1111/jbi.12371; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Blanca G, 1999, FOLIA GEOBOT, V34, P337, DOI 10.1007/BF02912819; Blanca G., 2001, FLORA IBERICA, V14, P81; Caparelli KF, 2008, FLORA MEDIT, V18, P594; Casper SJ, 2009, PLANT SYST EVOL, V277, P21, DOI 10.1007/s00606-008-0097-9; Casper SJ, 2006, HAUSSKNECHTIA, V11, P3; Casper SJ., 2001, WULFENIA, V8, P27; Cieslak T, 2005, AM J BOT, V92, P1723, DOI 10.3732/ajb.92.10.1723; Conti F, 2006, ANN BOT FENN, V43, P321; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Castro O, 2013, ANN BOT-LONDON, V112, P589, DOI 10.1093/aob/mct134; Degtjareva GV, 2006, PLANT BIOLOGY, V8, P778, DOI 10.1055/s-2006-924560; Degtjareva Galina, 2004, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V125, P431, DOI 10.1127/0006-8152/2004/0125-0431; Di Maio A, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200158; DOULAT E, 1947, CR HEBD ACAD SCI, V225, P354; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fleischmann A., 2015, CARNIV PL NEWSLETT, V44, P48; Fleischmann A, 2010, MOL PHYLOGENET EVOL, V56, P768, DOI 10.1016/j.ympev.2010.03.009; Gargiulo R, 2015, TAXON, V64, P754, DOI 10.12705/644.7; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Greiner S, 2015, BIOESSAYS, V37, P80, DOI 10.1002/bies.201400110; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutierrez Jr R, 2003, MOL PHYLOGENY UNPUB; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hansen AK, 2007, AM J BOT, V94, P42, DOI 10.3732/ajb.94.1.42; Heslop-Harrison Y, 2004, J ECOL, V92, P1071, DOI 10.1111/j.0022-0477.2004.00942.x; Hodac L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103003; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUELSENBECK JP, 2001, BIOMETRICS, V17, P754, DOI [DOI 10.1093/BIOINFORMATICS/17.8.754, DOI 10.1093/BI0INF0RMATICS/17.8.754]; Innangi M, 2015, PLANT BIOSYST, V149, P990, DOI 10.1080/11263504.2014.920426; Innangi M, 2007, DELPINOA, V49, P77; J. IAPT/IOPB chromosome data 21, 2016, TAXON, V65, P673; Jobson RW, 2003, SYST BOT, V28, P157; Kondo Katsuhiko, 2006, APG Acta Phytotaxonomica et Geobotanica, V57, P155; Legendre L, 2000, ACTA BOT GALLICA, V147, P77, DOI 10.1080/12538078.2000.10515837; Mikeladse T., 1996, CRYSTALLINA HIRTIFLO; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Muller KF, 2006, PLANT BIOLOGY, V8, P748, DOI 10.1055/s-2006-924706; Muller K, 2005, PLANT SYST EVOL, V250, P39, DOI 10.1007/s00606-004-0224-1; Muller K, 2004, PLANT BIOLOGY, V6, P477, DOI 10.1055/s-2004-817909; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Peruzzi L, 2013, PLANT BIOSYST, V147, P692, DOI 10.1080/11263504.2012.756073; Peruzzi L, 2006, CARNIV PL NEWSLETT, V35, P89; Peruzzi L., 2004, CARNIVOROUS PLANT NE, V33, P68; Peruzzi L, 2015, PHYTOTAXA, V196, P1; Peruzzi L, 2014, PHYTOTAXA, V168, P1; Pinguicula Steiger J., 1998, 2 C INT CARN PLANT S, P12; Pysek P, 2012, PRESLIA, V84, P155; Sbragia P, 2014, PL BIOSYST; Schmidt AR, 1998, THESIS; Shimai H., 2007, CHROMOSOME BOT, V2, P67, DOI 10.3199/iscb.2.67; Shimai H, 2007, CHROMOSOME BOT, V2, P151, DOI DOI 10.3199/ISCB.2.151; Shuka L, 2007, WULFENIA, V14, P15; Siljak-Yakovlev S, 2012, PLANT BIOSYST, V146, P694, DOI 10.1080/11263504.2012.716796; TAMMARO F, 1987, Informatore Botanico Italiano, V19, P429; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson JD., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Vargas P, 2009, J BIOGEOGR, V36, P1297, DOI 10.1111/j.1365-2699.2008.02059.x; Veleba A, 2014, NEW PHYTOL, V203, P22, DOI 10.1111/nph.12790; Vijayan K, 2009, AM J BOT, V96, P1348, DOI 10.3732/ajb.0800205; Yildirim H, 2012, PHYTOTAXA, V64, P46	67	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167610	10.1371/journal.pone.0167610	http://dx.doi.org/10.1371/journal.pone.0167610			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030566	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000012
J	Liebl, ME; Elmer, N; Schroeder, I; Schwedtke, C; Baack, A; Reisshauer, A				Liebl, Max E.; Elmer, Nancy; Schroeder, Isabelle; Schwedtke, Christine; Baack, Angelika; Reisshauer, Anett			Introduction of the Charite A Mobility Index (CHARMI) - A Novel Clinical Mobility Assessment for Acute Care Rehabilitation	PLOS ONE			English	Article							CONTENT VALIDITY; SKELETAL-MUSCLE; BED REST; ELDERLY-PATIENTS; BRAIN-INJURY; OLDER-ADULTS; ACUTE STROKE; UNIT; DISABILITY; WEAKNESS	Introduction Mobility is an essential part of a person's functioning and independence. It encompasses locomotive functions, but also the more basic functions of positioning and transferring. Despite the availability of several mobility-related assessment instruments to date, there is a need for assessment instruments with the specific capability to display the full range of mobilisation. Our aim was to develop and validate a scoring instrument with hierarchical composition where every score value stands for a defined mobility level. Participants and Methods A previously developed and validated pilot instrument was applied to assess patients (n = 113) admitted to an acute rehabilitation programme. Mobility was assessed during admission, subsequently at weekly intervals and at discharge to acquire a detailed status of mobility at multiple time points and individual mobilisation profiles over time. The scoring instrument was then remodelled based on clinical criteria to establish an easy-to-use scoring system with hierarchical composition. Psychometric properties were calculated using an independent sample of 87 consecutive patients. Results Content validity could be affirmed. The psychometric tests demonstrated excellent convergent validity with the three mobility items of the Barthel Index (r = 0.93), despite an adequately lower correlation with the whole Barthel Index (r = 0.63). Adequate floor and ceiling effects (20%) and a large responsiveness to change (vertical bar d vertical bar = 1.7, p < 0.001) between admission and discharge values were demonstrated. Inter-rater reliability was excellent (kappa = 0.88). Conclusions The Charite A Mobility Index (CHARMI) is a promising, easy-to-use hierarchical scoring instrument assessing the full individual spectrum from immobility to unlimited mobility, including positioning, transfer and locomotion items. It allows for monitoring of mobilisation.	[Liebl, Max E.; Elmer, Nancy; Schroeder, Isabelle; Schwedtke, Christine; Baack, Angelika; Reisshauer, Anett] Charite, Dept Phys Med & Rehabil, Berlin, Germany; [Baack, Angelika; Reisshauer, Anett] Charite, Charite Physiotherapy & Prevent Ctr, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Liebl, ME (corresponding author), Charite, Dept Phys Med & Rehabil, Berlin, Germany.	max.liebl@charite.de		Liebl, Max Emanuel/0000-0002-6608-4281				Adams SA, 1997, CLIN REHABIL, V11, P42, DOI 10.1177/026921559701100107; Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; [Anonymous], 2019, J HUM NUTR DIET, DOI [DOI 10.1186/1477-7525-6-63, DOI 10.1111/jhn.12659]; Ayre C, 2014, MEAS EVAL COUNS DEV, V47, P79, DOI 10.1177/0748175613513808; Berg HE, 1997, J APPL PHYSIOL, V82, P182, DOI 10.1152/jappl.1997.82.1.182; BERG K, 1995, SCAND J REHABIL MED, V27, P27; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Beyer J, 2015, PHYS MED REHAB KUROR, V25, P260, DOI 10.1055/s-0035-1564089; Blottner D, 2006, EUR J APPL PHYSIOL, V97, P261, DOI 10.1007/s00421-006-0160-6; Cameron S, 2015, J CRIT CARE, V30, P664, DOI 10.1016/j.jcrc.2015.03.032; Collen F M, 1991, Int Disabil Stud, V13, P50; Collen F M, 1990, Int Disabil Stud, V12, P6; de Morton NA, 2008, ARCH PHYS MED REHAB, V89, P641, DOI 10.1016/j.apmr.2007.10.021; de Morton Natalie A, 2013, J Appl Meas, V14, P159; Fitzpatrick R, 1998, Health Technol Assess, V2, pi; Gosselink R, 2008, INTENS CARE MED, V34, P1188, DOI 10.1007/s00134-008-1026-7; GRANGER CV, 1995, INT J TECHNOL ASSESS, V11, P262, DOI 10.1017/S0266462300006875; GUYATT GH, 1992, J CLIN EPIDEMIOL, V45, P1341, DOI 10.1016/0895-4356(92)90194-R; Hardy SE, 2007, J AM GERIATR SOC, V55, P1727, DOI 10.1111/j.1532-5415.2007.01413.x; HOLDEN MK, 1986, PHYS THER, V66, P1530, DOI 10.1093/ptj/66.10.1530; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kelly-Hayes M, 1998, STROKE, V29, P1274, DOI 10.1161/01.STR.29.6.1274; Kortebein P, 2007, JAMA-J AM MED ASSOC, V297, P1772, DOI 10.1001/jama.297.16.1772-b; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LAWSHE CH, 1975, PERS PSYCHOL, V28, P563, DOI 10.1111/j.1744-6570.1975.tb01393.x; Liebl M, 2011, 7 EFSMA EUR C SPORTS; Liebl ME, 2016, CHARITE ARBEITSBEREI; Lincoln N, 1979, Physiotherapy, V65, P48; MAHONEY F I, 1965, Md State Med J, V14, P61; Martin BJ., 1996, CLIN REHABIL, V10, P44, DOI [10.1177/026921559601000109, DOI 10.1177/026921559601000109]; Needham DM, 2008, JAMA-J AM MED ASSOC, V300, P1685, DOI 10.1001/jama.300.14.1685; Nosova EV, 2014, J SURG RES, V190, P672, DOI 10.1016/j.jss.2014.02.001; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Schweickert WD, 2007, CHEST, V131, P1541, DOI 10.1378/chest.06-2065; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Smith R., 1994, PHYSIOTHERAPY, V80, P5, DOI [10.1016/S0031-9406(10)60612-8, DOI 10.1016/S0031-9406(10)60612-8]; Sosnowski K, 2015, AUST CRIT CARE, V28, P216, DOI 10.1016/j.aucc.2015.05.002; Sourdet S, 2015, J AM MED DIR ASSOC, V16, P674, DOI 10.1016/j.jamda.2015.03.011; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Trudel G, 2000, ARCH PHYS MED REHAB, V81, P6, DOI 10.1053/apmr.2000.0810006; Williams GP, 2009, BRAIN INJURY, V23, P307, DOI 10.1080/02699050902774170; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; World Health Organisation (WHO), 2001, INT CLASS FUNCT DIS; Yosef-Brauner O, 2015, CLIN RESPIR J, V9, P1, DOI 10.1111/crj.12091	44	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0169010	10.1371/journal.pone.0169010	http://dx.doi.org/10.1371/journal.pone.0169010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28006023	Green Submitted, gold, Green Published			2022-12-26	WOS:000392843200123
J	Mir, S; Cai, WK; Andres, DA				Mir, Sajad; Cai, Weikang; Andres, Douglas A.			RIT1 GTPase Regulates Sox2 Transcriptional Activity and Hippocampal Neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL STEM-CELLS; ELEMENT-BINDING PROTEIN; ADULT NEUROGENESIS; NEURONAL DIFFERENTIATION; MOUSE FIBROBLASTS; DIRECT CONVERSION; BRAIN; ACTIVATION; MAINTENANCE; ASTROCYTES	Adult neurogenesis, the process of generating mature neurons from neuronal progenitor cells, makes critical contributions to neural circuitry and brain function in both healthy and disease states. Neurogenesis is a highly regulated process in which diverse environmental and physiological stimuli are relayed to resident neural stem cell populations to control the transcription of genes involved in self-renewal and differentiation. Understanding the molecular mechanisms governing neurogenesis is necessary for the development of translational strategies to harness this process for neuronal repair. Here we report that the Ras-related GTPase RIT1 serves to control the sequential proliferation and differentiation of adult hippocampal neural progenitor cells, with in vivo expression of active RIT1 driving robust adult neurogenesis. Gene expression profiling analysis demonstrates increased expression of a specific set of transcription factors known to govern adult neurogenesis in response to active RIT1 expression in the hippocampus, including sex-determining region Y-related HMG box 2 (Sox2), a well established regulator of stem cell self-renewal and neurogenesis. In adult hippocampal neuronal precursor cells, RIT1 controls an Akt-dependent signaling cascade, resulting in the stabilization and transcriptional activation of phosphorylated Sox2. This study supports a role for RIT1 in relaying niche-derived signals to neural/stem progenitor cells to control transcription of genes involved in self-renewal and differentiation.	[Mir, Sajad; Cai, Weikang; Andres, Douglas A.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, B283 BBSRB,741 S Limestone St, Lexington, KY 40536 USA; [Cai, Weikang] Harvard Med Sch, Joslin Diabet Ctr, Boston, MA 02215 USA	University of Kentucky; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Andres, DA (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, B283 BBSRB,741 S Limestone St, Lexington, KY 40536 USA.	dandres@uky.edu	Cai, Weikang/K-2394-2019	Cai, Weikang/0000-0001-5638-0805	NINDS, National Institutes of Health [R01 NS045103]; Kentucky Spinal Cord and Head Injury Research Trust Grant [12-1A]; Kentucky Lung Cancer research grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045103] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Kentucky Spinal Cord and Head Injury Research Trust Grant; Kentucky Lung Cancer research grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NINDS, National Institutes of Health Grant R01 NS045103, Kentucky Spinal Cord and Head Injury Research Trust Grant 12-1A, and a Kentucky Lung Cancer research grant. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; Alunni A, 2016, DEVELOPMENT, V143, P741, DOI 10.1242/dev.122796; Amador-Arjona A, 2015, P NATL ACAD SCI USA, V112, pE1936, DOI 10.1073/pnas.1421480112; Archer TC, 2011, DEV BIOL, V350, P429, DOI 10.1016/j.ydbio.2010.12.013; Berger AH, 2014, ONCOGENE, V33, P4418, DOI 10.1038/onc.2013.581; Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cai WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115602; Cai WK, 2012, J NEUROSCI, V32, P9887, DOI 10.1523/JNEUROSCI.0375-12.2012; Cimadamore F, 2013, P NATL ACAD SCI USA, V110, pE3017, DOI 10.1073/pnas.1220176110; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Conover JC, 2008, CELL TISSUE RES, V331, P211, DOI 10.1007/s00441-007-0503-6; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Gao X, 2016, SCI REP-UK, V6, DOI 10.1038/srep22490; Gotz M., 2016, COLD SPRING HARB PER, V8, P1; Guo WX, 2012, NAT PROTOC, V7, P2005, DOI 10.1038/nprot.2012.123; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Heinrich C, 2014, STEM CELL REP, V3, P1000, DOI 10.1016/j.stemcr.2014.10.007; Heng JCD, 2010, ADV EXP MED BIOL, V695, P76, DOI 10.1007/978-1-4419-7037-4_6; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Lee CHJ, 1996, J NEUROSCI, V16, P6784; Lein PJ, 2007, J NEUROSCI, V27, P4725, DOI 10.1523/JNEUROSCI.5633-06.2007; Liu KC, 2013, CELL SIGNAL, V25, P1264, DOI 10.1016/j.cellsig.2013.02.013; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mir S, 2014, MOL CELL, V56, P786, DOI 10.1016/j.molcel.2014.10.019; Miyagi S, 2009, CELL MOL LIFE SCI, V66, P3675, DOI 10.1007/s00018-009-0097-0; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Niu WZ, 2015, STEM CELL REP, V4, P780, DOI 10.1016/j.stemcr.2015.03.006; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Park DH, 2014, CELL REP, V8, P1290, DOI 10.1016/j.celrep.2014.07.060; Poulou M, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00127; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Rusyn EV, 2000, ONCOGENE, V19, P4685, DOI 10.1038/sj.onc.1203836; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Shi GX, 2013, CELL SIGNAL, V25, P2060, DOI 10.1016/j.cellsig.2013.06.002; Shi GX, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.384248; Shi GX, 2011, MOL CELL BIOL, V31, P1938, DOI 10.1128/MCB.01380-10; Shi GX, 2005, MOL CELL BIOL, V25, P830, DOI 10.1128/MCB.25.2.830-846.2005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Telley L, 2016, SCIENCE, V351, P1443, DOI 10.1126/science.aad8361; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Wang J, 2016, CELL DEATH DIFFER, V23, P393, DOI 10.1038/cdd.2015.106; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070306; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	57	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2054	2064		10.1074/jbc.M116.749770	http://dx.doi.org/10.1074/jbc.M116.749770			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28007959	Green Published, hybrid			2022-12-26	WOS:000395530300001
J	Baron, MG; Mintram, KS; Owen, SF; Hetheridge, MJ; Moody, AJ; Purcell, WM; Jackson, SK; Jha, AN				Baron, Matthew G.; Mintram, Kate S.; Owen, Stewart F.; Hetheridge, Malcolm J.; Moody, A. John; Purcell, Wendy M.; Jackson, Simon K.; Jha, Awadhesh N.			Pharmaceutical Metabolism in Fish: Using a 3-D Hepatic In Vitro Model to Assess Clearance	PLOS ONE			English	Article							ENVIRONMENTAL RISK-ASSESSMENT; BIOACCUMULATION ASSESSMENTS; PROPRANOLOL METABOLISM; BIOTRANSFORMATION DATA; XENOBIOTIC METABOLISM; VIVO EXTRAPOLATION; DRUG-METABOLISM; N-DEMETHYLATION; IDENTIFICATION; TROUT	At high internal doses, pharmaceuticals have the potential for inducing biological/pharmacological effects in fish. One particular concern for the environment is their potential to bioaccumulate and reach pharmacological levels; the study of these implications for environmental risk assessment has therefore gained increasing attention. To avoid unnecessary testing on animals, in vitro methods for assessment of xenobiotic metabolism could aid in the ecotoxicological evaluation. Here we report the use of a 3-D in vitro liver organoid culture system (spheroids) derived from rainbow trout to measure the metabolism of seven pharmaceuticals using a substrate depletion assay. Of the pharmaceuticals tested, propranolol, diclofenac and phenylbutazone were metabolised by trout liver spheroids; atenolol, metoprolol, diazepam and carbamazepine were not. Substrate depletion kinetics data was used to estimate intrinsic hepatic clearance by this spheroid model, which was similar for diclofenac and approximately 5 fold higher for propranolol when compared to trout liver microsomal fraction (S9) data. These results suggest that liver spheroids could be used as a relevant and metabolically competent in vitro model with which to measure the biotransformation of pharmaceuticals in fish; and propranolol acts as a reproducible positive control.	[Baron, Matthew G.; Mintram, Kate S.; Moody, A. John; Jha, Awadhesh N.] Univ Plymouth, Sch Biol Sci, Plymouth PL4 8AA, Devon, England; [Baron, Matthew G.; Mintram, Kate S.; Owen, Stewart F.; Hetheridge, Malcolm J.] AstraZeneca, Alderley Pk, Macclesfield, Cheshire, England; [Purcell, Wendy M.; Jackson, Simon K.] Univ Plymouth, Sch Biomed & Healthcare Sci, Plymouth PL4 8AA, Devon, England	University of Plymouth; AstraZeneca; University of Plymouth	Jha, AN (corresponding author), Univ Plymouth, Sch Biol Sci, Plymouth PL4 8AA, Devon, England.; Owen, SF (corresponding author), AstraZeneca, Alderley Pk, Macclesfield, Cheshire, England.	Stewart.Owen@AstraZeneca.com; a.jha@plymouth.ac.uk	Owen, Stewart/ABF-1216-2021; PURCELL, WENDY M/O-4082-2018	PURCELL, WENDY M/0000-0002-9820-1526; Moody, John/0000-0002-1994-7419; Jha, Awadhesh/0000-0001-9660-4308; Mintram, Kate/0000-0001-7180-9200; Owen, Stewart/0000-0003-1398-7142	Biotechnology and Biological Sciences Research Council (BBSRC) Research Grant [BB/H53903/1]; IPA [BB/L01016X/1]; AstraZeneca Global Safety, Health and Environment research programme; AstraZeneca Global Safety, Health and Environment research programme scholarship; AstraZeneca [115735-iPiE]; European Union's Seventh Framework Programme (FP7); European Federation of Pharmaceutical Industries and Associations (EFPIA) companies'; Biotechnology and Biological Sciences Research Council [BB/L01016X/1] Funding Source: researchfish; BBSRC [BB/L01016X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC) Research Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); IPA; AstraZeneca Global Safety, Health and Environment research programme; AstraZeneca Global Safety, Health and Environment research programme scholarship; AstraZeneca(AstraZeneca); European Union's Seventh Framework Programme (FP7); European Federation of Pharmaceutical Industries and Associations (EFPIA) companies'; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a Biotechnology and Biological Sciences Research Council (BBSRC) Research Grant (BB/H53903/1) and IPA (BB/L01016X/1), co-funded by the AstraZeneca Global Safety, Health and Environment research programme, to ANJ and SKJ supporting MGJB. KSM was supported by an AstraZeneca Global Safety, Health and Environment research programme scholarship. SFO is an employee of AstraZeneca; and MJH was also an AstraZeneca employee. AstraZeneca provided support in the form of salaries for authors SFO and MJH and grant to ANJ and SKJ supporting MGJB and KSM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This work represents an AstraZeneca contribution in kind to the Innovative Medicines Initiative (IMI) under grant agreement no.115735-iPiE: Intelligent led assessment of Pharmaceuticals in the Environment; resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2015-2018) and European Federation of Pharmaceutical Industries and Associations (EFPIA) companies' in kind contribution.	Aarbakke J, 1997, EUROPEAN J CLIN PHAR, V11, P359; Akutsu T, 2007, DRUG METAB DISPOS, V35, P72, DOI 10.1124/dmd.106.012088; Alderton W, 2010, XENOBIOTICA, V40, P547, DOI 10.3109/00498254.2010.493960; Arnot JA, 2008, ENVIRON TOXICOL CHEM, V27, P341, DOI 10.1897/07-310R.1; Baron MG, 2012, ECOTOXICOLOGY, V21, P2419, DOI 10.1007/s10646-012-0965-5; Bartram A, 2012, ENVIRON TOXICOL, V10, P573; Benet LZ, 2011, AAPS J, V13, P519, DOI 10.1208/s12248-011-9290-9; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; BOURNE GR, 1981, PROGR DRUG METABOLIS, V6, P77; Brodin T, 2013, SCIENCE, V339, P814, DOI 10.1126/science.1226850; Brooks BW, 2005, ENVIRON TOXICOL CHEM, V24, P464, DOI 10.1897/04-081R.1; Buhler DR, 1998, COMP BIOCHEM PHYS C, V121, P107, DOI 10.1016/S0742-8413(98)10033-6; Burkhard LP, 2012, INTEGR ENVIRON ASSES, V8, P17, DOI 10.1002/ieam.260; Connors KA, 2013, ENVIRON TOXICOL CHEM, V32, P1810, DOI 10.1002/etc.2240; Corcoran J, 2010, CRIT REV TOXICOL, V40, P287, DOI 10.3109/10408440903373590; Costanza J, 2012, ENVIRON TOXICOL CHEM, V31, P2261, DOI 10.1002/etc.1944; Cowan-Ellsberry CE, 2008, CHEMOSPHERE, V70, P1804, DOI 10.1016/j.chemosphere.2007.08.030; FLOURIOT G, 1995, MAR ENVIRON RES, V39, P293, DOI 10.1016/0141-1136(94)00027-M; Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643; Gomez CF, 2010, CHEMOSPHERE, V81, P1189, DOI 10.1016/j.chemosphere.2010.09.043; Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173; Huggett DB, 2004, PHARM ENV SOURCES FA, P373; Iwatsubo T, 1997, PHARMACOL THERAPEUT, V73, P147, DOI 10.1016/S0163-7258(96)00184-2; Johanning K, 2012, IN VITRP METABOLISM; Jung F, 1997, DRUG METAB DISPOS, V25, P133; Kallio JM, 2010, ENVIRON SCI TECHNOL, V44, P7213, DOI 10.1021/es903402c; Lacy C, 2007, DRUG INFORM HDB COMP; Lahti M, 2011, ENVIRON TOXICOL CHEM, V30, P1403, DOI 10.1002/etc.501; Langan LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149492; Lee MD, 2006, XENOBIOTICA, V36, P1013, DOI 10.1080/00498250600861785; LENNARD MS, 1982, NEW ENGL J MED, V307, P1558, DOI 10.1056/NEJM198212163072505; MASUBUCHI Y, 1994, DRUG METAB DISPOS, V22, P909; Mehinto AC, 2010, ENVIRON SCI TECHNOL, V44, P2176, DOI 10.1021/es903702m; Miners JO, 1998, BRIT J CLIN PHARMACO, V45, P525, DOI 10.1046/j.1365-2125.1998.00721.x; Nichols J, 2007, HUM ECOL RISK ASSESS, V13, P1164, DOI 10.1080/10807030701655897; Nichols JW, 2007, ENVIRON TOXICOL CHEM, V26, P1304, DOI 10.1897/06-259R.1; Nichols JW, 2006, AQUAT TOXICOL, V78, P74, DOI 10.1016/j.aquatox.2006.01.017; Owen SF, 2007, AQUAT TOXICOL, V82, P145, DOI 10.1016/j.aquatox.2007.02.007; Owen SF, 2009, AQUAT TOXICOL, V93, P217, DOI 10.1016/j.aquatox.2009.05.009; Ramirez AJ, 2009, ENVIRON TOXICOL CHEM, V28, P2587, DOI 10.1897/08-561.1; Rand-Weaver M, 2013, ENVIRON SCI TECHNOL, V47, P11384, DOI 10.1021/es402065a; Riley RJ, 2005, DRUG METAB DISPOS, V33, P1304, DOI 10.1124/dmd.105.004259; Scholz S, 2013, REGUL TOXICOL PHARM, V67, P506, DOI 10.1016/j.yrtph.2013.10.003; Smith EM, 2010, CHEMOSPHERE, V79, P26, DOI 10.1016/j.chemosphere.2010.01.058; Stadnicka J, 2012, ENVIRON SCI TECHNOL, V46, P3273, DOI 10.1021/es2043728; Stadnicka-Michalak J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092303; Stott LC, 2015, AQUAT TOXICOL, V159, P127, DOI 10.1016/j.aquatox.2014.12.007; TOBIN T, 1986, J VET PHARMACOL THER, V9, P1, DOI 10.1111/j.1365-2885.1986.tb00008.x; Uchea C, 2015, TOXICOL RES-UK, V4, P494, DOI 10.1039/c4tx00160e; Uchea C, 2013, XENOBIOTICA, V43, P421, DOI 10.3109/00498254.2012.730644; WALLE T, 1985, DRUG METAB DISPOS, V13, P204; WARD SA, 1989, CLIN PHARMACOL THER, V45, P72, DOI 10.1038/clpt.1989.11; Weisbrod AV, 2009, ENVIRON TOXICOL CHEM, V28, P86, DOI 10.1897/08-015.1; Winter Matthew J., 2010, Integrated Environmental Assessment and Management, V6, P38, DOI 10.1897/IEAM_2009-044.1; YASUMORI T, 1993, PHARMACOGENETICS, V3, P291, DOI 10.1097/00008571-199312000-00003; YASUMORI T, 1994, PHARMACOGENETICS, V4, P323, DOI 10.1097/00008571-199412000-00005; YOSHIMOTO K, 1995, BRIT J CLIN PHARMACO, V39, P421, DOI 10.1111/j.1365-2125.1995.tb04472.x	57	24	25	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168837	10.1371/journal.pone.0168837	http://dx.doi.org/10.1371/journal.pone.0168837			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045944	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300058
J	Qiu, R; Cao, WT; Tian, HY; He, J; Chen, GD; Chen, YM				Qiu, Rui; Cao, Wen-ting; Tian, Hui-yuan; He, Juan; Chen, Geng-dong; Chen, Yu-ming			Greater Intake of Fruit and Vegetables Is Associated with Greater Bone Mineral Density and Lower Osteoporosis Risk in Middle-Aged and Elderly Adults	PLOS ONE			English	Article							DIETARY-INTAKE; HIP FRACTURE; BLOOD-PRESSURE; CHINESE WOMEN; MEN; CONSUMPTION; METABOLISM; POTASSIUM; SUPPLEMENTATION; QUESTIONNAIRE	Objective A few studies have suggested that the consumption of fruit and vegetables (FV) may benefit bone health, but limited data are available in Asian subjects. We examined the association between FV intake and bone mineral density (BMD) and osteoporosis in Chinese adults. Methods This population-based cross-sectional study involved 2083 women and 1006 men aged 4075 years in Guangzhou, China. Habitual dietary data was collected from a 79-item food frequency questionnaire by face-to-face interviews. The BMD was measured for the whole body (WB), lumbar spine (LS), total hip (TH) and femur neck (FN) with dual-energy X-ray absorptiometry. Results After adjustment for potential covariates, we observed dose-dependent associations between total FV intake and BMD and osteoporosis risk. The mean BMD was higher in tertile 3 vs. tertile 1 by 1.33% (TH) and 1.31% (FN) for FV, and 1.10% (WB), 1.57% (TH), and 2.05% (FN) for fruit (all P-trends < 0.05). Significant beneficial associations with BMD at some sites were also found in most fruit categories but not in total vegetables or their subgroups. The odds ratios (95% confidence interval) of osteoporosis (T-score = -2.5) in tertile 3 (vs. 1) were 0.73 (0.580.92), 0.37 (0.220.60), and 0.71 (0.520.97) for FV; 0.82 (0.661.03), 0.48 (0.300.77) and 0.89 (0.611.12) for fruit; and 0.80 (0.641.01), 0.57 (0.350.92) and 0.76 (0.551.05) for vegetables at the LS, TH, and FN, respectively. The favorable association between FV intake and the occurrence of osteoporosis was evident only in subjects with lower BMI (<24.0 kg/m(2), P-trends < 0.05). Conclusions Greater intake of FV was independently associated with a higher BMD and a lower presence of osteoporosis in middle-aged and elderly Chinese subjects with lower BMI. Fruit tended to have more contribution to the favorable association than vegetables.	[Qiu, Rui; Cao, Wen-ting; Tian, Hui-yuan; He, Juan; Chen, Geng-dong; Chen, Yu-ming] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Chen, YM (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Guangdong, Peoples R China.	chenyum@mail.sysu.edu.cn	Chen, Yi/HIR-2608-2022; Chen, Yu/Y-3292-2019	chen, Yu-ming/0000-0003-1658-5528; Chen, Gengdong/0000-0001-7180-8099	5010 Program for Clinical Researches by Sun Yat-sen University, Guangzhou, China [2007032]; National Natural Science Foundation of China [81072299, 81273049]	5010 Program for Clinical Researches by Sun Yat-sen University, Guangzhou, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was jointly supported by the 5010 Program for Clinical Researches by Sun Yat-sen University, Guangzhou, China (No. 2007032), the National Natural Science Foundation of China (No. 81072299) and the National Natural Science Foundation of China(No.81273049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benetou V, 2013, OSTEOPOROSIS INT, V24, P1587, DOI 10.1007/s00198-012-2187-3; Benetou V, 2011, EUR J CLIN NUTR, V65, P132, DOI 10.1038/ejcn.2010.226; Benetou V, 2016, J BONE MINER RES, V31, P1743, DOI 10.1002/jbmr.2850; Benzie IFF, 2003, COMP BIOCHEM PHYS A, V136, P113, DOI 10.1016/S1095-6433(02)00368-9; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Byberg L, 2015, J BONE MINER RES, V30, P976, DOI 10.1002/jbmr.2384; Cashman KD, 2007, J NUTR, V137, p2507S, DOI 10.1093/jn/137.11.2507S; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Chen YM, 2006, BRIT J NUTR, V96, P745, DOI 10.1079/BJN20061883; Dai ZL, 2014, J BONE MINER RES, V29, P408, DOI 10.1002/jbmr.2041; Djousse L, 2004, AM J CLIN NUTR, V79, P213; Ebrahimof S, 2006, BONE, V38, pS25, DOI 10.1016/j.bone.2006.01.108; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Kaptoge S, 2003, OSTEOPOROSIS INT, V14, P418, DOI 10.1007/s00198-003-1391-6; Lambert H, 2015, OSTEOPOROSIS INT, V26, P1311, DOI 10.1007/s00198-014-3006-9; Lee SA, 2010, BRIT J NUTR, V104, P265, DOI 10.1017/S0007114510000383; Lee SA, 2009, AM J CLIN NUTR, V89, P1920, DOI 10.3945/ajcn.2008.27361; Leslie WD, 2007, ARCH INTERN MED, V167, P1641, DOI 10.1001/archinte.167.15.1641; Li JJ, 2013, PUBLIC HEALTH NUTR, V16, P78, DOI 10.1017/S1368980012001127; Liu B, 2001, INT J FOOD SCI NUTR, V52, P269, DOI 10.1080/09637480120044138; Liu YT, 2012, CANCER CAUSE CONTROL, V23, P589, DOI 10.1007/s10552-012-9923-z; Liu ZM, 2015, J AM MED DIR ASSOC, V16, P309, DOI 10.1016/j.jamda.2014.11.001; Looker AC, 2012, OSTEOPOROSIS INT, V23, P1351, DOI 10.1007/s00198-011-1693-z; Ma WJ., 2004, DIETARY NUTR STATUS; Macdonald HM, 2008, AM J CLIN NUTR, V88, P465, DOI 10.1093/ajcn/88.2.465; Mizoue T, 2006, CANCER EPIDEM BIOMAR, V15, P582, DOI 10.1158/1055-9965.EPI-05-0658; Neville CE, 2014, OSTEOPOROSIS INT, V25, P223, DOI 10.1007/s00198-013-2402-x; New SA, 2000, AM J CLIN NUTR, V71, P142; New SA, 2003, AM J CLIN NUTR, V77, P1340, DOI 10.1093/ajcn/77.5.1340; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Tucker KL, 1999, AM J CLIN NUTR, V69, P727; Wang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032736; Westerterp KR, 2002, CURR OPIN CLIN NUTR, V5, P489, DOI 10.1097/00075197-200209000-00006; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Woo J, 2009, J HUM HYPERTENS, V23, P451, DOI 10.1038/jhh.2008.156; Xie HL, 2013, OSTEOPOROSIS INT, V24, P2827, DOI 10.1007/s00198-013-2383-9; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Zhang CX, 2009, ASIA PAC J CLIN NUTR, V18, P240; Zhang ZQ, 2014, OSTEOPOROSIS INT, V25, P497, DOI 10.1007/s00198-013-2418-2	39	34	36	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168906	10.1371/journal.pone.0168906	http://dx.doi.org/10.1371/journal.pone.0168906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045945	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300067
J	Wei, SG; Ma, XJ; Pan, LM; Miao, JH; Fu, JN; Bai, LH; Zhang, ZL; Guan, YH; Mo, CM; Huang, H; Chen, MS				Wei, Shugen; Ma, Xiaojun; Pan, Limei; Miao, Jianhua; Fu, Jine; Bai, Longhua; Zhang, Zhonglian; Guan, Yanhong; Mo, Changming; Huang, Hao; Chen, Maoshan			Transcriptome Analysis of Taxillusi chinensis (DC.) Danser Seeds in Response to Water Loss	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; ZINC-FINGER PROTEIN; MONITORING EXPRESSION PROFILES; HIGH-SALINITY STRESSES; RNA-SEQ DATA; GENE-EXPRESSION; DROUGHT STRESS; HEAT-SHOCK; BRASSICA-NAPUS; MESSENGER-RNA	Background Taxillus chinensis (DC.) Danser, the official species of parasitic loranthus that grows by parasitizing other plants, is used in various traditional Chinese medicine prescriptions. ABA dependent and ABA-independent pathways are two major pathways in response to drought stress for plants and some genes have been reported to play a key role during the dehydration including dehydration-responsive protein RD22, late embryogenesis abundant (LEA) proteins, and various transcription factors (TFs) like MYB and WRKY. However, genes responding to dehydration are still unknown in loranthus. Methods and Results Initially, loranthus seeds were characterized as recalcitrant seeds. Then, biological replicates of fresh loranthus seeds (CK), and seeds after being dehydrated for 16 hours (Tac16) and 36 hours (Tac-36) were sequenced by RNA-Seq, generating 386,542,846 high quality reads. A total of 164,546 transcripts corresponding to 114,971 genes were assembled by Trinity and annotated by mapping them to NCBI non-redundant (NR), UniProt, GO, KEGG pathway and COG databases. Transcriptome profiling identified 60,695, 56,027 and 66,389 transcripts (>1 FPKM) in CK, Tac-16 and Tac-36, respectively. Compared to CK, we obtained 2,102 up-regulated and 1,344 down-regulated transcripts in Tac-16 and 1,649 up-regulated and 2,135 down-regulated transcripts in Tac-36 by using edgeR. Among them some have been reported to function in dehydration process, such as RD22, heat shock proteins (HSP) and various TFs (MYB, WRKY and ethylene-responsive transcription factors). Interestingly, transcripts encoding ribosomal proteins peaked in Tac-16. It is indicated that HSPs and ribosomal proteins may function in early response to drought stress. Raw sequencing data can be accessed in NCBI SRA platform under the accession number SRA309567. Conclusions This is the first time to profile transcriptome globally in loranthus seeds. Our findings provide insights into the gene regulations of loranthus seeds in response to water loss and expand our current understanding of drought tolerance and germination of seeds.	[Wei, Shugen; Ma, Xiaojun] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China; [Wei, Shugen; Ma, Xiaojun] Peking Union Med Coll, Beijing, Peoples R China; [Wei, Shugen; Pan, Limei; Miao, Jianhua; Fu, Jine; Mo, Changming; Huang, Hao] Guangxi Bot Garden Med Plants, Nanning, Guangxi, Peoples R China; [Bai, Longhua; Zhang, Zhonglian; Guan, Yanhong] Chinese Acad Med Sci, Inst Med Plant Dev, Yunnan Branch, Jinghong, Peoples R China; [Chen, Maoshan] La Trobe Univ, La Trobe Inst Mol Sci LIMS, Dept Biochem & Genet, Melbourne, Vic, Australia	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; La Trobe University	Ma, XJ (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China.; Ma, XJ (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Fu, JN (corresponding author), Guangxi Bot Garden Med Plants, Nanning, Guangxi, Peoples R China.	mayixuan10@163.com; duanwei3014@163.com		CHEN, MAOSHAN/0000-0002-3827-4969; Wei, Shugen/0000-0003-3233-8017	National Youth Science Foundation of China [81403045]; Guangxi Youth Science Foundation [2014GXNSFBA118204]; National Science and Technology Major Project of China [2012ZX09304006]	National Youth Science Foundation of China; Guangxi Youth Science Foundation; National Science and Technology Major Project of China	This study was funded by National Youth Science Foundation of China (81403045), Guangxi Youth Science Foundation (2014GXNSFBA118204) and National Science and Technology Major Project of China (2012ZX09304006).	Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; ADAMS CA, 1980, INT REV CYTOL, V68, P1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barrero JM, 2010, PLANT J, V61, P611, DOI 10.1111/j.1365-313X.2009.04088.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bayley M, 2001, J INSECT PHYSIOL, V47, P1197, DOI 10.1016/S0022-1910(01)00104-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berjak P, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00177, 10.3389/fpls.2013.00478]; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Breeze E, 2004, PLANT BIOTECHNOL J, V2, P155, DOI 10.1111/j.1467-7652.2004.00059.x; Cabaco S, 2010, MAR ECOL-EVOL PERSP, V31, P300, DOI 10.1111/j.1439-0485.2009.00331.x; Channeliere S, 2002, FEBS LETT, V515, P35, DOI 10.1016/S0014-5793(02)02413-4; Chen LM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-687; Chen SL, 2009, WORLD SCI TECHNOL MO, V5, P5; Commission CP, 2010, CHINESE PHARMACOPOEI, P280; CONACHER CA, 1994, AQUAT BOT, V49, P47, DOI 10.1016/0304-3770(94)90005-1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dekkers BJW, 2013, PLANT PHYSIOL, V163, P205, DOI 10.1104/pp.113.223511; Delahaie J, 2013, J EXP BOT, V64, P4559, DOI 10.1093/jxb/ert274; Delmas F, 2013, P NATL ACAD SCI USA, V110, pE3888, DOI 10.1073/pnas.1308114110; Ding B, 2013, FITOTERAPIA, V86, P1, DOI 10.1016/j.fitote.2013.01.017; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Fath A, 2000, PLANT MOL BIOL, V44, P255, DOI 10.1023/A:1026584207243; Fei HM, 2007, GENOMICS, V89, P419, DOI 10.1016/j.ygeno.2006.11.008; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Gao B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1633-y; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; Gutterman Y, 2010, PLANTA, V231, P1475, DOI 10.1007/s00425-010-1124-y; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hayward SAL, 2004, J EXP BIOL, V207, P963, DOI 10.1242/jeb.00842; Hoeberichts FA, 2007, J EXP BOT, V58, P2873, DOI 10.1093/jxb/erm076; Hsing YC, 1995, PLANT MOL BIOL, V29, P863, DOI 10.1007/BF00041175; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Ji H, 2014, DEEP SEQUENCING RNA, V9, DOI [10.1371/journal.pone.0110314, DOI 10.1371/JOURNAL.PONE.0110314]; Jones AM, 2001, PLANT PHYSIOL, V125, P94, DOI 10.1104/pp.125.1.94; Jonsson KI, 2007, COMP BIOCHEM PHYS B, V146, P456, DOI 10.1016/j.cbpb.2006.10.111; Kalifa Y, 2004, PLANT CELL ENVIRON, V27, P1459, DOI 10.1111/j.1365-3040.2004.01251.x; Kawaguchi R, 2004, PLANT J, V38, P823, DOI 10.1111/j.1365-313X.2004.02090.x; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kido EA, 2012, SCI WORLD J, DOI 10.1100/2012/821062; King M, 1979, STORAGE RECALCITRANT; KIYOSUE T, 1994, PLANT MOL BIOL, V25, P791, DOI 10.1007/BF00028874; Kiyosue T, 1998, BBA-BIOMEMBRANES, V1370, P187, DOI 10.1016/S0005-2736(98)00007-8; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee SC, 2002, GENE DEV, V16, P646, DOI 10.1101/gad.969002; Leeggangers HACF, 2015, PHYSIOL PLANTARUM, V153, P318, DOI 10.1111/ppl.12231; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin RC, 2008, MOL PLANT, V1, P42, DOI 10.1093/mp/ssm004; Liu CY, 2012, AM J CHINESE MED, V40, P335, DOI 10.1142/S0192415X12500267; Liu CQ, 2015, INT J MOL SCI, V16, P18752, DOI 10.3390/ijms160818752; Liu KM, 2007, PLANTA, V226, P1007, DOI 10.1007/s00425-007-0548-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Martinez G, 2009, J COMP PHYSIOL B, V179, P481, DOI 10.1007/s00360-008-0334-0; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MAUCH F, 1988, PLANT PHYSIOL, V88, P936, DOI 10.1104/pp.88.3.936; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Morran S, 2011, PLANT BIOTECHNOL J, V9, P230, DOI 10.1111/j.1467-7652.2010.00547.x; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; O'Neil ST, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-465; Oono Y, 2003, PLANT J, V34, P868, DOI 10.1046/j.1365-313X.2003.01774.x; PARCY F, 1994, PLANT CELL, V6, P1567, DOI 10.1105/tpc.6.11.1567; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Qin F, 2007, PLANT J, V50, P54, DOI 10.1111/j.1365-313X.2007.03034.x; Rabara RC, 2013, BIOCHEM BIOPH RES CO, V431, P409, DOI 10.1016/j.bbrc.2012.12.156; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; REDDY ASN, 1990, PLANT MOL BIOL, V14, P127, DOI 10.1007/BF00018554; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; SENARATNA T, 1983, PLANT PHYSIOL, V72, P620, DOI 10.1104/pp.72.3.620; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; SMITH FE, 1951, SCIENCE, V113, P751, DOI 10.1126/science.113.2948.751-a; Soeda Y, 2005, PLANT PHYSIOL, V137, P354, DOI 10.1104/pp.104.051664; Song YH, 2013, TRENDS PLANT SCI, V18, P575, DOI 10.1016/j.tplants.2013.05.003; Tammariello SP, 1999, J INSECT PHYSIOL, V45, P933, DOI 10.1016/S0022-1910(99)00073-6; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vacca RA, 2004, PLANT PHYSIOL, V134, P1100, DOI 10.1104/pp.103.035956; Walia H, 2005, PLANT PHYSIOL, V139, P822, DOI 10.1104/pp.105.065961; Wang WB, 2009, PLANT PHYSIOL BIOCH, V47, P570, DOI 10.1016/j.plaphy.2009.02.009; Wang Y, 2008, J ETHNOPHARMACOL, V118, P473, DOI 10.1016/j.jep.2008.05.016; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Wu HM, 2000, PLANT MOL BIOL, V44, P267, DOI 10.1023/A:1026536324081; Xu DQ, 2008, FEBS LETT, V582, P1037, DOI 10.1016/j.febslet.2008.02.052; Xueying S, 2005, PHARM CLIN CHINESE M, V6; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang HL, 2014, GENE, V538, P113, DOI 10.1016/j.gene.2013.12.057; Yang ZB, 2002, PLANT CELL, V14, pS375, DOI 10.1105/tpc.001065; Yu SC, 2012, PLANT MOL BIOL REP, V30, P17, DOI 10.1007/s11105-011-0313-6; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054762; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	102	25	27	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169177	10.1371/journal.pone.0169177	http://dx.doi.org/10.1371/journal.pone.0169177			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046012	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300136
J	Zhang, ZH; Van Poucke, S				Zhang, Zhongheng; Van Poucke, Sven			Citations for Randomized Controlled Trials in Sepsis Literature: The Halo Effect Caused by Journal Impact Factor	PLOS ONE			English	Article							WEB	Citations for randomized controlled trials (RCT) are important for the dissemination of study results. However, predictors of citations for RCTs have not been investigated. The study aimed to investigate the predictors of citations for RCTs in sepsis literature. RCTs that investigated the efficacy of treatment strategies on clinical outcomes in sepsis patients were included, and publication dates were restricted to the period from 2000 to 2016. Risk of bias was assessed using the Cochrane handbook for systematic reviews and interventions. A multivariable linear regression model was built to investigate the independent variables associated with total citations. In total, 160 RCTs met our inclusion criteria and were included for analysis. The median of total citations was 28.5 (IQR: 6-76). The journal impact factor (IF) for articles was 6.312 (IQR: 3.143-7.214). The dependent variable was transformed by the square root to improve normality and meet the assumption of homoscedasticity. The journal IF (coefficient: 0.2; 95% CI: 0.16, 0.25) was independently associated with total citations. Large samples were associated with more total citations (coefficient: 0.0026; 95% CI: 0.0013, 0.0039). The study demonstrated that the journal IF was a major determinant of the RCT's total citation number.	[Zhang, Zhongheng] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Emergency Med, Hangzhou, Zhejiang, Peoples R China; [Van Poucke, Sven] Ziekenhuis Oost Limburg, Dept Anesthesia Crit Care Emergency Med & Pain Th, Genk, Belgium	Zhejiang University; East Limburg Hospital	Zhang, ZH (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Emergency Med, Hangzhou, Zhejiang, Peoples R China.	zh_zhang1984@hotmail.com	zhang, zh/GWV-4677-2022; Zhang, Zhongheng/E-1282-2011; Van Poucke, Sven/K-5999-2016	Zhang, Zhongheng/0000-0002-2336-5323; Van Poucke, Sven/0000-0001-8070-8786				Antoniou GA, 2015, ANN VASC SURG, V29, P286, DOI 10.1016/j.avsg.2014.09.017; Bhandari M, 2007, CAN J SURG, V50, P119; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Falagas ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049476; Golder W, 1998, ROFO-FORTSCHR RONTG, V169, P220, DOI 10.1055/s-2007-1015082; Ha TC, 2006, ANN ACAD MED SINGAP, V35, P911; Kulkarni AV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000403; Kulkarni AV, 2009, JAMA-J AM MED ASSOC, V302, P1092, DOI 10.1001/jama.2009.1307; Kumar V, 2009, SINGAP MED J, V50, P752; Lucena C, 2016, INT ENDOD J; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Manriquez J, 2015, AN BRAS DERMATOL, V90, P646, DOI 10.1590/abd1806-4841.20153979; NISBETT RE, 1977, J PERS SOC PSYCHOL, V35, P250, DOI 10.1037//0022-3514.35.4.250; Pastorino R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154217; Puche RC, 2011, MEDICINA-BUENOS AIRE, V71, P484; Richardson M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151818; Rosopa PJ, 2013, PSYCHOL METHODS, V18, P335, DOI 10.1037/a0032553; Royle P, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-74; Sanclemente G, 2016, ACTAS DERMO-SIFILOGR, V107, P44, DOI 10.1016/j.ad.2015.07.008; Sugimoto CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062403; Weale Andy R, 2004, BMC Med Res Methodol, V4, P14, DOI 10.1186/1471-2288-4-14; Willis DL, 2011, BJU INT, V107, P1876, DOI 10.1111/j.1464-410X.2010.10028.x; Wrafter PF, 2016, SURGEON; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.03.35; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.02.11	25	14	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169398	10.1371/journal.pone.0169398	http://dx.doi.org/10.1371/journal.pone.0169398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046105	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300182
J	Alfaro, A; Juarez-Torres, E; Medina-Martinez, I; Mateos-Guerrero, N; Bautista-Huerta, M; Roman-Bassaure, E; Villegas-Sepulveda, N; Berumen, J				Alfaro, Ana; Juarez-Torres, Eligia; Medina-Martinez, Ingrid; Mateos-Guerrero, Norma; Bautista-Huerta, Maura; Roman-Bassaure, Edgar; Villegas-Sepulveda, Nicolas; Berumen, Jaime			Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; PHYSICAL STATE; TYPE-16; E6; WOMEN; PREVALENCE; DNA; CLASSIFICATION; INTEGRATION; EXPRESSION	The median age of cervical cancer (CC) presentation coincides with the mean age of menopause presentation (49 years) in Mexico. Here, we investigated the association between different HPV16 variants and early (<= 49 years) or delayed (>= 50 years) CC presentation. We conducted a case-case study that included 462 CCs, 386 squamous cell carcinomas (SCC), 63 adenocarcinomas (ACC), and 13 additional cell types. Variants were identified by PCR and DNA sequencing. The risk conferred by each variant for developing CC earlier than 50 years was analyzed using a univariate logistic regression model considering old aged patients (>= 50 years) and non-HPV16 cases as the reference variables. Overall, the frequency of HPV16 was 50.9%, and the only identified variants were the European A1/2 (31.2%) and the Asian-American D2 (10.8%), and D3 (8.9%). D2 was mainly associated with <= 49-year-old patients (15.9%); A1/2 was uniformly distributed between the two age groups (similar to 31%), whereas D3 increased with age to a frequency of 11.8% in the older group. Only the D2 variant conferred a 3.3-fold increase in the risk of developing CC before 50 years of age (OR = 3.3, 95% Cl = 1.7-6.6, p < 0.001) in relation with non-HPV16 cases. Remarkably, this risk was higher for ACC (OR = 6.0, 95% CI = 1.1-33, p < 0.05) than for SCC (OR = 2.8, 95% Cl = 1.3-5.9, p < 0.01). Interestingly, when analyzing only the HPV16-positive CC, D2 increases (OR = 2.5, 95% CI = 1.2-5, p < 0.05) and D3 decreases (OR = 0.45, 95% CI 0.2-0.9, p < 0.05) the risk to develop CC before 50 years old in relation with A1/2 variant. These results indicated that D2 variant is associated with early and D3 with delayed CC presentation, whereas A1/2 variant was uniformly distributed between the two age groups.	[Alfaro, Ana; Juarez-Torres, Eligia; Medina-Martinez, Ingrid; Mateos-Guerrero, Norma; Bautista-Huerta, Maura; Berumen, Jaime] Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Fac Med, Unidad Med Genom, Mexico City, DF, Mexico; [Roman-Bassaure, Edgar] Hosp Gen Mexico City, Serv Oncol, Mexico City, DF, Mexico; [Villegas-Sepulveda, Nicolas] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City, DF, Mexico; [Berumen, Jaime] Univ Nacl Autonoma Mexico, Fac Med, Dept Med Expt, Mexico City, DF, Mexico	Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; Hospital General de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Berumen, J (corresponding author), Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Fac Med, Unidad Med Genom, Mexico City, DF, Mexico.; Berumen, J (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Med Expt, Mexico City, DF, Mexico.	jaimeberumen@hotmail.com	Berumen, Jaime/F-7914-2018; Berumen, Jaime/AAL-5577-2020	Berumen, Jaime/0000-0001-6707-3317; Berumen, Jaime/0000-0001-6707-3317; Villegas-Sepulveda, Nicolas/0000-0001-9489-2545	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [261540, 215696]; Universidad Nacional Autonoma de Mexico [SDI.PTID.05.02]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	This work was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACyT, www.conacyt.mx), grant number 261540 (to JB), Universidad Nacional Autonoma de Mexico (www.unam.mx), grant number SDI.PTID.05.02 (to JB), and Consejo Nacional de Ciencia y Tecnologia (CONACyT, www.conacyt.mx) scholarship number 215696 (to AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gurgel APAD, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/130828; BERUMEN J, 1994, INT J CANCER, V56, P640, DOI 10.1002/ijc.2910560506; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Boulet GAV, 2009, CANCER EPIDEM BIOMAR, V18, P2992, DOI 10.1158/1055-9965.EPI-09-0025; Broccolo F, 2013, J MED VIROL, V85, P472, DOI 10.1002/jmv.23487; Bruni L, ICO INFORM CTR HPV C; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Casas L, 1999, INT J CANCER, V83, P449, DOI 10.1002/(SICI)1097-0215(19991112)83:4&lt;449::AID-IJC3&gt;3.0.CO;2-0; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Chan PKS, 2010, INT J CANCER, V126, P297, DOI 10.1002/ijc.24731; Chansaenroj J, 2012, ASIAN PAC J CANCER P, V13, P599, DOI 10.7314/APJCP.2012.13.2.599; Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12; CULLEN AP, 1991, J VIROL, V65, P606, DOI 10.1128/JVI.65.2.606-612.1991; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Franceschi S, 2006, INT J CANCER, V119, P2677, DOI 10.1002/ijc.22241; Goetz LH, 2014, HUM HERED, V77, P73, DOI 10.1159/000362233; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guan Peng, 2012, Int J Cancer, V131, P2349, DOI 10.1002/ijc.27485; Guardado-Estrada M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109406; Hammer A, 2016, INT J CANCER, V138, P2795, DOI 10.1002/ijc.29959; Hang D, 2014, J MED VIROL, V86, P618, DOI 10.1002/jmv.23792; Hubert WG, 2005, J VIROL, V79, P5914, DOI 10.1128/JVI.79.10.5914-5922.2005; Hudelist G, 2004, GYNECOL ONCOL, V92, P873, DOI 10.1016/j.ygyno.2003.11.035; Huertas-Salgado A, 2011, VIROLOGY, V410, P201, DOI 10.1016/j.virol.2010.10.039; Ines B, 2015, INFECT GENET EVOL, V29, P103, DOI 10.1016/j.meegid.2014.11.013; Jackson R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101540; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lichtig H, 2006, VIROLOGY, V350, P216, DOI 10.1016/j.virol.2006.01.038; Lu XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097588; Moodley M, 2003, INT J GYNECOL CANCER, V13, P834, DOI 10.1111/j.1525-1438.2003.13380.x; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Niccoli S, 2012, J VIROL, V86, P12384, DOI 10.1128/JVI.01512-12; Ordonez RM, 2004, J GEN VIROL, V85, P1433, DOI 10.1099/vir.0.19317-0; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Pientong C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-30; Pillai MR, 2009, INT J CANCER, V125, P91, DOI 10.1002/ijc.24322; Richard C, 2010, ONCOGENE, V29, P3435, DOI 10.1038/onc.2010.93; Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smith JA, 2014, VIROLOGY, V468, P311, DOI 10.1016/j.virol.2014.08.022; Tjalma WA, 2013, INT J CANCER, V132, P854, DOI 10.1002/ijc.27713; Tornesello ML, 2011, GYNECOL ONCOL, V121, P32, DOI 10.1016/j.ygyno.2010.12.005; Vinokurova S, 2008, CANCER RES, V68, P307, DOI 10.1158/0008-5472.CAN-07-2754; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	47	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169315	10.1371/journal.pone.0169315	http://dx.doi.org/10.1371/journal.pone.0169315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036379	Green Submitted, Green Published, gold			2022-12-26	WOS:000391229300071
J	Karalija, A; Novikova, LN; Oradd, G; Wiberg, M; Novikov, LN				Karalija, Amar; Novikova, Liudmila N.; Oradd, Greger; Wiberg, Mikael; Novikov, Lev N.			Differentiation of Pre- and Postganglionic Nerve Injury Using MRI of the Spinal Cord	PLOS ONE			English	Article							BRACHIAL-PLEXUS INJURIES; VENTRAL ROOT AVULSION; ADULT RATS; NEURON DEATH; NEUROTROPHIC FACTOR; MOTONEURONS; REGENERATION; SURVIVAL; REPAIR; AXOTOMY	Brachial plexus injury (BPI) is a devastating type of nerve injury, potentially causing loss of motor and sensory function. Principally, BPI is either categorized as preganglionic or postganglionic, with the early establishment of injury level being crucial for choosing the correct treatment strategy. Despite diagnostic advances, the need for a reliable, non-invasive method for establishing the injury level remains. We studied the usefulness of in vivo magnetic resonance imaging (MRI) of the spinal cord for determination of injury level. The findings were related to neuronal and glial changes. Rats underwent unilateral L4 & L5 ventral roots avulsion or sciatic nerve axotomy. The injuries served as models for pre- and postganglionic BPI, respectively. MRI of the L4/L5 spinal cord segments 4 weeks after avulsion showed ventral horn (VH) shrinkage on the injured side compared to the uninjured side. Axotomy induced no change in the VH size on MRI. Following avulsion, histological sections of L4/L5 revealed shrinkage in the VH grey matter area occupied by NeuN-positive neurons, loss of microtubular-associated protein-2 positive dendritic branches (MAP2), pan-neurofilament positive axons (PanNF), synaptophysin-positive synapses (SYN) and increase in immunoreactivity for the microglial OX42 and astroglial GFAP markers. Axotomy induced no changes in NeuN-reactivity, modest decrease of MAP2 immunoreactivity, no changes in SYN and PanNF labelling, and a modest increase in OX42 and SYN labeling. Histological and radiological findings were congruent when assessing changes after axotomy, while MRI somewhat underestimated the shrinkage. This study indicates a potential diagnostic value of structural spinal cord MRI following BPI.	[Karalija, Amar; Novikova, Liudmila N.; Wiberg, Mikael; Novikov, Lev N.] Umea Univ, Sect Anat, Dept Integrat Med Biol, Umea, Sweden; [Karalija, Amar; Wiberg, Mikael] Umea Univ, Sect Hand & Plast Surg, Dept Surg & Perioperat Sci, Umea, Sweden; [Oradd, Greger] Umea Univ, Physiol Sect, Dept Integrat Med Biol, Umea, Sweden; [Oradd, Greger] Umea Univ, Umea Ctr Comparat Biol, Umea, Sweden	Umea University; Umea University; Umea University; Umea University	Karalija, A (corresponding author), Umea Univ, Sect Anat, Dept Integrat Med Biol, Umea, Sweden.; Karalija, A (corresponding author), Umea Univ, Sect Hand & Plast Surg, Dept Surg & Perioperat Sci, Umea, Sweden.	amar.karalija@umu.se		Novikov, Lev/0000-0001-5520-3890	Swedish Research Council [2014-2306]; Umea University; Vasterbotten County Council (ALF) [VLL-298311]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea University; Vasterbotten County Council (ALF)	This study was financed thanks to the support of the Swedish Research Council (grant 2014-2306, Medicine and Health to Lev Novikov), the financial support provided through a regional agreement between Umea University and Vasterbotten County Council (ALF; grant VLL-298311 to Mikael Wiberg), and financial support from Umea University (from the Insamlingsstiftelsen to Lev Novikov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aralasmak A, 2010, AM J NEURORADIOL, V31, P410, DOI 10.3174/ajnr.A1700; Bhandari PS, 2014, INDIAN J PLAST SURG, V47, P191, DOI 10.4103/0970-0358.138941; Brannstrom T, 1998, EXP BRAIN RES, V118, P1, DOI 10.1007/s002210050249; Caranci F, 2013, Musculoskelet Surg, V97 Suppl 2, pS181, DOI 10.1007/s12306-013-0281-0; Castillo M, 2005, AM J ROENTGENOL, V185, pS196, DOI 10.2214/AJR.05.1014; Chai H, 2000, NEUROREPORT, V11, P1249, DOI 10.1097/00001756-200004270-00021; Chew DJ, 2008, NEUROSCI LETT, V433, P231, DOI 10.1016/j.neulet.2008.01.012; Doi K, 2002, J NEUROSURG, V96, P277, DOI 10.3171/spi.2002.96.3.0277; Gu HY, 2004, EUR J NEUROSCI, V19, P2123, DOI 10.1111/j.0953-816X.2004.03295.x; Jivan S, 2006, EXP BRAIN RES, V170, P245, DOI 10.1007/s00221-005-0207-7; Jivan S, 2009, J PLAST RECONSTR AES, V62, P472, DOI 10.1016/j.bjps.2007.11.027; Kaiser R, 2012, ACTA NEUROCHIR, V154, P1293, DOI 10.1007/s00701-012-1291-7; KOLIATSOS VE, 1994, J COMP NEUROL, V342, P35, DOI 10.1002/cne.903420105; Ma JJ, 2003, SCAND J PLAST RECONS, V37, P1; Ma JJ, 2001, EXP BRAIN RES, V139, P216, DOI 10.1007/s002210100769; MCKAY HA, 2002, EXP BRAIN RES, V142, P308; Novikov LN, 2000, NEUROSCIENCE, V100, P171, DOI 10.1016/S0306-4522(00)00256-6; Ohlsson M, 2006, EXP BRAIN RES, V170, P52, DOI 10.1007/s00221-005-0188-6; Oliveira ALR, 2002, J COMP NEUROL, V447, P381, DOI 10.1002/cne.10248; Ouzounian JG, 2014, SEMIN PERINATOL, V38, P219, DOI 10.1053/j.semperi.2014.04.008; Piehl F, 1999, J NEUROIMMUNOL, V101, P87, DOI 10.1016/S0165-5728(99)00136-8; Ruven C, 2014, NEURAL REGEN RES, V9, P117, DOI 10.4103/1673-5374.125338; Sakellariou VI, 2014, ISRN ORTHOP, V2014, P726103, DOI [10.1155/2014/726103, DOI 10.1155/2014/726103]; Silbermann-Hoffman O, 2013, Diagn Interv Imaging, V94, P925, DOI 10.1016/j.diii.2013.08.013; Somashekar D, 2014, AM J NEURORADIOL, V35, P1209, DOI 10.3174/ajnr.A3820; Wang LL, 2011, NEUROSCIENCE, V189, P397, DOI 10.1016/j.neuroscience.2011.04.070; West CA, 2007, EXP NEUROL, V203, P22, DOI 10.1016/j.expneurol.2006.07.013; West CA, 2013, NEUROSURGERY, V73, P632, DOI 10.1227/NEU.0000000000000066; West CA, 2012, NEUROSURGERY, V70, P1183, DOI 10.1227/NEU.0b013e318241ace1; Zhang CG, 2005, BRIT J PLAST SURG, V58, P765, DOI 10.1016/j.bjps.2005.04.012	30	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168807	10.1371/journal.pone.0168807	http://dx.doi.org/10.1371/journal.pone.0168807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036395	Green Published, gold, Green Submitted			2022-12-26	WOS:000391229300032
J	Kim, MK; Kim, WT; Lee, HM; Choi, HS; Jo, YR; Lee, Y; Jeong, J; Choi, D; Chang, HJ; Kim, DS; Jang, YJ; Ryu, CJ				Kim, Min Kyu; Kim, Won-Tae; Lee, Hyun Min; Choi, Hong Seo; Jo, Yu Ra; Lee, Yangsoon; Jeong, Jaemin; Choi, Dongho; Chang, Hee Jin; Kim, Dae Shick; Jang, Young-Joo; Ryu, Chun Jeih			Mapping of a Mycoplasma-Neutralizing Epitope on the Mycoplasmal p37 Protein	PLOS ONE			English	Article							MOUSE SARCOMA-CELLS; PROSTATE-CANCER; MEMBRANE GLYCOPROTEIN; INVASIVENESS; HYORHINIS; ANTIBODIES; INFECTION; CARCINOMA; INVITRO	Many studies have shown that the mycoplasmal membrane protein p37 enhances cancer cell migration, invasion, and metastasis. Previously, we generated 6 monoclonal antibodies (MAbs) against the mycoplasmal protein p37 and showed the presence of mycoplasmainfected circulating tumor cells in the blood of hepatocellular carcinoma patients by using CA27, one of the six MAbs. When mycoplasmas were incubated with cancer cells in the presence of CA27, mycoplasma infection was completely inhibited, suggesting that CA27 is a neutralizing antibody inhibiting mycoplasma infection. To examine the neutralizing epitope of CA27, we generated a series of glutathione S-transferase (GST)-fused p37 deletion mutant proteins in which p37 was partly deleted. To express p37-coding sequences in E. coli, mycoplasmal TGA codons were substituted with TGG in the p37 deletion mutant genes. GST-fused p37 deletion mutant proteins were then screened to identify the epitope targeted by CA27. Western blots showed that CA27 bound to the residues 216-246 on the middle part of the p37 protein while it did not bind to the residues 183-219 and 216-240. Fine mapping showed that CA27 was able to bind to the residues 226-246, but its binding activity was relatively weakened as compared to that to the residues 216-246, suggesting that the residues 226-246 is essential for optimal binding activity of CA27. Interestingly, the treatment of the purified GST-tagged epitopes with urea showed that CA27 binding to the epitope was sodium dodecyl sulfate-resistant but urea-sensitive. The same 226-246 residues were also recognized by two other anti-p37 MAbs, suggesting that the epitope is immunodominant. The identification of the novel neutralizing epitope may provide new insight into the interaction between the p37 protein and host receptors.	[Kim, Min Kyu; Kim, Won-Tae; Lee, Hyun Min; Choi, Hong Seo; Jo, Yu Ra; Ryu, Chun Jeih] Sejong Univ, Inst Anticanc Med Dev, Dept Integrat Biosci & Biotechnol, Seoul, South Korea; [Lee, Yangsoon] Hanyang Univ, Dept Lab Med, Coll Med, Seoul, South Korea; [Jeong, Jaemin; Choi, Dongho] Hanyang Univ, Dept Surg, Coll Med, Seoul, South Korea; [Chang, Hee Jin] Natl Canc Ctr, Ctr Colorectal Canc, Res Inst & Hosp, Goyang Si, South Korea; [Kim, Dae Shick] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Jang, Young-Joo] Dankook Univ, Dept Nanobiomed Sci, PLUS Global Res Ctr Regenerat Med BK21, Cheonan, South Korea	Sejong University; Hanyang University; Hanyang University; National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU); Samsung Medical Center; Dankook University	Ryu, CJ (corresponding author), Sejong Univ, Inst Anticanc Med Dev, Dept Integrat Biosci & Biotechnol, Seoul, South Korea.	cjryp@sejong.ac.kr	Jeong, Jaemin/AAD-8899-2021		National Research Foundation of Korea [NRF-2016918220, 2016008610, 2016903249]; Ministry of Education, Science and Technology [2013K000272]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported in part by the National Research Foundation of Korea (NRF-2016918220, 2016008610 and 2016903249 to CJR) and the Converging Research Center Program funded by the Ministry of Education, Science and Technology (project no. 2013K000272 to CJR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi H. S., 2013, STEM CELLS; Choi HS, 2014, BIOCHEM BIOPH RES CO, V446, P620, DOI 10.1016/j.bbrc.2014.03.024; Dennis LK, 2002, UROLOGY, V60, P78, DOI 10.1016/S0090-4295(02)01637-0; Duan HY, 2014, CANCER RES, V74, P5782, DOI 10.1158/0008-5472.CAN-14-0650; DUDLER R, 1988, EMBO J, V7, P3963, DOI 10.1002/j.1460-2075.1988.tb03283.x; Gomersall AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140753; Gong MM, 2008, MOL CANCER THER, V7, P530, DOI 10.1158/1535-7163.MCT-07-2191; Goodison S, 2007, CYTOGENET GENOME RES, V118, P204, DOI 10.1159/000108302; Huang S, 2001, WORLD J GASTROENTERO, V7, P266; Ketcham CM, 2005, MOL CANCER THER, V4, P1031, DOI 10.1158/1535-7163.MCT-05-0040; Kim WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130670; Kim WT, 2014, STEM CELLS, V32, P2626, DOI 10.1002/stem.1765; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Ning Jin-Ying, 2004, Ai Zheng, V23, P602; Pehlivan M, 2005, UROLOGY, V65, P411, DOI 10.1016/j.urology.2004.10.015; SCHMIDHAUSER C, 1990, J CELL SCI, V95, P499; Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062216; Sippel KH, 2008, ACTA CRYSTALLOGR D, V64, P1172, DOI 10.1107/S0907444908030175; Sippel KH, 2009, J BACTERIOL, V191, P2585, DOI 10.1128/JB.01680-08; STEINEMANN C, 1984, INT J CANCER, V34, P407, DOI 10.1002/ijc.2910340319; STEINEMANN C, 1984, P NATL ACAD SCI-BIOL, V81, P3747, DOI 10.1073/pnas.81.12.3747; Urbanek C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-233	22	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169091	10.1371/journal.pone.0169091	http://dx.doi.org/10.1371/journal.pone.0169091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036384	Green Published, Green Submitted, gold			2022-12-26	WOS:000391229300052
J	Huang, YS; Chang, SY; Sheng, WH; Sun, HY; Lee, KY; Chuang, YC; Su, YC; Liu, WC; Hung, CC; Chang, SC				Huang, Yu-Shan; Chang, Sui-Yuan; Sheng, Wang-Huei; Sun, Hsin-Yun; Lee, Kuan-Yeh; Chuang, Yu-Chung; Su, Yi-Ching; Liu, Wen-Chun; Hung, Chien-Ching; Chang, Shan-Chwen			Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; RECEIVING LAMIVUDINE; HBV-HIV; EMTRICITABINE; EFFICACY; OUTCOMES; SURFACE; IMPACT; COHORT	Background Sequential addition of tenofovir disoproxil fumarate (TDF) is often needed for patients coinfected with HIV and hepatitis B virus (HBV) who develop HBV resistance to lamivudine after combination antiretroviral therapy (cART) containing only lamivudine for HBV. We aimed to assess the virological response of HBV to add-on TDF in patients coinfected with lamivudine-resistant HBV. Methods Between November 2010 and December 2014, 33 HIV/HBV-coinfected patients with lamivudine-resistant HBV and 56 with lamivudine-susceptible HBV were prospectively included. TDF plus lamivudine was used to substitute zidovudine or abacavir plus lamivudine contained in cART in patients with lamivudine-resistant HBV infection, while patients with lamivudine-susceptible HBV infection received TDF plus lamivudine as backbone of cART. Serial determinations of plasma HBV DNA load, HBV serologic markers, and liver and renal functions were performed after initiation of TDF-containing cART. Results Of 89 patients included, 38.6% tested positive for HBV envelope antigen (HBeAg) at baseline. The plasma HBV DNA level at enrollment of lamivudine-resistant and lamivudine-susceptible group were 6.1 +/- 2.2 log(10) and 6.0 +/- 2.2 log(10) copies/mL, respectively (p = 0.895). The cumulative percentage of HBV viral suppression in lamivudine-resistant and lamivudine-susceptible group was 81.8% and 91.1% at 48 weeks, respectively (p = 0.317), which increased to 86.7% and 96.2% at 96 weeks, respectively (p = 0.185). At 48 weeks, 11 patients testing HBeAg-positive at baseline failed to achieve viral suppression. In multivariate analysis, the only factor associated with failure to achieve viral suppression at 48 weeks was higher HBV DNA load at baseline (odds ratio, per 1-log(10) copies/mL increase, 1.861; 95% CI, 1.204-2.878). At 48 weeks, HBeAg seroconversion was observed in 5 patients (1 in the lamivudine-resistant group and 4 in the lamivudine-susceptible group; p = 0.166). During the study period, HBsAg levels decreased over time, regardless of lamivudine resistance. Loss of HBsAg was observed in 3 (3.4%) patients in the lamivudine-susceptible group. Conclusions Add-on TDF-containing cART in patients coinfected with lamivudine-resistant HBV achieved a similar rate of HBV viral suppression compared to TDF-containing cART as initial regimen in patients coinfected with lamivudine-susceptible HBV. A higher baseline HBV DNA load and HBeAg positivity were associated with failure to achieve HBV viral suppression.	[Huang, Yu-Shan; Lee, Kuan-Yeh] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Internal Med, Hsinchu, Taiwan; [Chang, Sui-Yuan] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Chang, Sui-Yuan] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Chang, Sui-Yuan] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei, Taiwan; [Sheng, Wang-Huei; Sun, Hsin-Yun; Chuang, Yu-Chung; Su, Yi-Ching; Liu, Wen-Chun; Hung, Chien-Ching; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Sheng, Wang-Huei; Sun, Hsin-Yun; Chuang, Yu-Chung; Su, Yi-Ching; Liu, Wen-Chun; Hung, Chien-Ching; Chang, Shan-Chwen] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Hung, Chien-Ching] Natl Taiwan Univ, Coll Med, Dept Parasitol, Taipei, Taiwan; [Hung, Chien-Ching] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hung, Chien-Ching] China Med Univ, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Hung, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Hung, CC (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.; Hung, CC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Parasitol, Taipei, Taiwan.; Hung, CC (corresponding author), China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.; Hung, CC (corresponding author), China Med Univ, Taichung, Taiwan.	hcc0401@ntu.edu.tw	; CHUANG, YU-CHUNG/F-4627-2016	CHANG, SHAN-CHWEN/0000-0001-6505-4139; Huang, Yu-Shan/0000-0002-9047-5709; SHENG, WANG-HUEI/0000-0002-5605-7853; SUN, HSIN-YUN/0000-0003-0074-7721; CHANG, SUI-YUAN/0000-0002-6009-6724; Hung, Chien-Ching/0000-0001-7345-0836; CHUANG, YU-CHUNG/0000-0003-3094-8276	Taiwan Centers for Disease Control	Taiwan Centers for Disease Control	We would like to thank the patients for participation in this study and Taiwan Centers for Disease Control for the research grant support.	Baran B, 2013, ANTIMICROB AGENTS CH, V57, P1790, DOI 10.1128/AAC.02600-12; Boyd A, 2015, J GASTROENTEROLOGY H; Boyd A, 2015, LIVER INT, V35, P795, DOI 10.1111/liv.12521; Brahmania M, 2016, LANCET INFECT DIS, V16, DOI 10.1016/S1473-3099(15)00436-3; Chang TT, 2004, J GASTROEN HEPATOL, V19, P1276, DOI 10.1111/j.1440-1746.2004.03428.x; de Vries-Sluijs TEMS, 2010, GASTROENTEROLOGY, V139, P1934, DOI 10.1053/j.gastro.2010.08.045; Fung S, 2014, GASTROENTEROLOGY, V146, P980, DOI 10.1053/j.gastro.2013.12.028; Gu LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134539; Gutierrez S, 2008, CLIN INFECT DIS, V46, pE28, DOI 10.1086/525857; Hamers RL, 2013, JAIDS-J ACQ IMM DEF, V64, P174, DOI 10.1097/QAI.0b013e3182a60f7d; Khamduang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042184; Kim HN, 2014, JAIDS-J ACQ IMM DEF, V66, P96, DOI 10.1097/QAI.0000000000000126; Kosi L, 2012, J VIRAL HEPATITIS, V19, P801, DOI 10.1111/j.1365-2893.2012.01601.x; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Liu Y, 2014, J MED VIROL, V86, P1473, DOI 10.1002/jmv.23982; Martin-Carbonero L, 2011, AIDS, V25, P73, DOI 10.1097/QAD.0b013e328340fde2; Matthews GV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061297; Matthews GV, 2013, CLIN INFECT DIS, V56, pE87, DOI 10.1093/cid/cit002; Miailhes P, 2007, CLIN INFECT DIS, V45, P624, DOI 10.1086/520752; Nikolopoulos GK, 2015, J MED VIROLOGY; Nunez M, 2002, AIDS, V16, P2352, DOI 10.1097/00002030-200211220-00023; Panel of Antiretroviral Guidelines for Adults and Adolescents, GUIDELINES USE ANTIR; Plaza Z, 2013, AIDS, V27, P2219, DOI 10.1097/QAD.0b013e328362fe42; Price H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068152; Ristig MB, 2002, J INFECT DIS, V186, P1844, DOI 10.1086/345770; Schmutz G, 2006, AIDS, V20, P1951, DOI 10.1097/01.aids.0000247116.89455.5d; Sheng WH, 2012, CLIN INFECT DIS, V54, P548, DOI 10.1093/cid/cir851; Sheng WH, 2004, CLIN INFECT DIS, V38, P1471, DOI 10.1086/420744; Sun HY, 2014, WORLD J GASTROENTERO, V20, P14598, DOI 10.3748/wjg.v20.i40.14598; Sun HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090194; Sun HY, 2009, AM J GASTROENTEROL, V104, P877, DOI 10.1038/ajg.2008.159; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; van Griensven J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088552; Wang HL, 2015, CLIN RES HEPATOLOGY; Wolters LMM, 2002, J CLIN VIROL, V24, P173, DOI 10.1016/S1386-6532(01)00245-1; Zoutendijk R, 2012, J INFECT DIS, V206, P974, DOI 10.1093/infdis/jis439	36	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0169228	10.1371/journal.pone.0169228	http://dx.doi.org/10.1371/journal.pone.0169228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033344	Green Submitted, Green Published, gold			2022-12-26	WOS:000391226900087
J	Lohse, I; Kumareswaran, R; Cao, PJ; Pitcher, B; Gallinger, S; Bristow, RG; Hedley, DW				Lohse, Ines; Kumareswaran, Ramya; Cao, Pinjiang; Pitcher, Bethany; Gallinger, Steven; Bristow, Robert G.; Hedley, David W.			Effects of Combined Treatment with Ionizing Radiation and the PARP Inhibitor Olaparib in BRCA Mutant and Wild Type Patient-Derived Pancreatic Cancer Xenografts	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; PROSTATE-CANCER; DNA-DAMAGE; COMBINATION; TUMORS; DRUGS; CELLS	Background The BRCA2 gene product plays an important role in DNA double strand break repair. Therefore, we asked whether radiation sensitivity of pancreatic cancers developing in individuals with germline BRCA2 mutations can be enhanced by agents that inhibit poly (ADP-ribose) polymerase (PARP). Methods We compared the sensitivity of two patient-derived pancreatic cancer xenografts, expressing a truncated or wild type BRCA 2, to ionizing radiation alone or in combination with olaparib (AZD-2281). Animals were treated with either a single dose of 12Gy, 7 days of olaparib or 7 days of olaparib followed by a single dose of 12Gy. Response was assessed by tumour growth delay and the activation of damage response pathways. Results The BRCA2 mutated and wild type tumours showed similar radiation sensitivity, and treatment with olaparib did not further sensitize either model when compared to IR alone. Conclusions While PARP inhibition has been shown to be effective in BRCA-mutated breast and ovarian cancers, it is less well established in pancreatic cancer patients. Our results show no radiosensitization in a germline BRCA 2 mutant and suggest that combining PARP inhibition and IR may not be beneficial in BRCA 2 related pancreatic tumors.	[Lohse, Ines; Kumareswaran, Ramya; Cao, Pinjiang; Pitcher, Bethany; Bristow, Robert G.; Hedley, David W.] Princess Margaret Canc Ctr, Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Lohse, Ines; Kumareswaran, Ramya; Cao, Pinjiang; Pitcher, Bethany; Bristow, Robert G.; Hedley, David W.] Princess Margaret Canc Ctr, Univ Hlth Network, Campbell Family Canc Res Inst, Toronto, ON, Canada; [Gallinger, Steven] Mt Sinai Hosp, Joseph & Wolf Lebovic Hlth Complex, Toronto, ON, Canada; [Gallinger, Steven] Ontario Inst Canc Res, Translat Res Initiat Pancreas Canc, Toronto, ON, Canada; [Hedley, David W.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Hedley, David W.] Princess Margaret Canc Ctr, Dept Med Oncol & Haematol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Hedley, DW (corresponding author), Princess Margaret Canc Ctr, Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada.; Hedley, DW (corresponding author), Princess Margaret Canc Ctr, Univ Hlth Network, Campbell Family Canc Res Inst, Toronto, ON, Canada.; Hedley, DW (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Hedley, DW (corresponding author), Princess Margaret Canc Ctr, Dept Med Oncol & Haematol, Toronto, ON, Canada.	david.hedley@uhn.on.ca		Bristow, Robert/0000-0002-8553-9544; Hedley, David/0000-0003-1323-2655	Farb Family Fund; Princess Margaret Cancer Foundation; Ontario Ministry of Health and Long Term Care (OMHLTC), Terry Fox Program Project Grant; Ontario Institute for Cancer Research; OICR [399980]; Canadian Cancer Society; Canadian Cancer Society Research Institute (CCSRI)	Farb Family Fund; Princess Margaret Cancer Foundation(University of Toronto); Ontario Ministry of Health and Long Term Care (OMHLTC), Terry Fox Program Project Grant; Ontario Institute for Cancer Research; OICR; Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS))	This work was supported by the Farb Family Fund, Princess Margaret Cancer Foundation, the Ontario Ministry of Health and Long Term Care (OMHLTC), Terry Fox Program Project Grant, the Ontario Institute for Cancer Research http://oicr.on.ca/ Translational Research Initiative, OICR number 399980 and the Canadian Cancer Society Research Institute Impact Grant: "Hallmarks and Therapeutic Implications of "BRCAness" in Pancreatic Cancer" http://www.cancer.ca/research/ grant support for experimental work. The views expressed do not necessarily reflect those of the OMHLTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Farb Family Fund, Princess Margaret Cancer Foundation, the Ontario Ministry of Health and Long Term Care (OMHLTC), Terry Fox Program Project Grant and grants from the Ontario Institute for Cancer Research and the Canadian Cancer Society Research Institute (CCSRI). The views expressed do not necessarily reflect those of the OMHLTC.	Albert JM, 2007, CLIN CANCER RES, V13, P3033, DOI 10.1158/1078-0432.CCR-06-2872; Barreto-Andrade JC, 2011, MOL CANCER THER, V10, P1185, DOI 10.1158/1535-7163.MCT-11-0061; Basu A, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/201367; Bourton EC, PARP 1 INHIBITOR OLA; Chang Q, 2011, CANCER RES, V71, P3110, DOI 10.1158/0008-5472.CAN-10-4049; Chatterjee P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060408; Chen Alice, 2011, Chin J Cancer, V30, P463, DOI 10.5732/cjc.011.10111; Couch FJ, 2007, CANCER EPIDEM BIOMAR, V16, P342, DOI 10.1158/1055-9965.EPI-06-0783; De Lorenzo SB, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00228; Gani C, 2015, RADIOTHER ONCOL, V116, P486, DOI 10.1016/j.radonc.2015.08.003; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Karnak D, 2014, CLIN CANCER RES, V20, P5085, DOI 10.1158/1078-0432.CCR-14-1038; Ko HL, 2012, BIOMOLECULES, V2, P524, DOI 10.3390/biom2040524; Lohse I, 2015, BR J CANC; Lohse I, 2014, CANCERS, V6, P459, DOI 10.3390/cancers6010459; Lowery Maeve, 2011, J Gastrointest Cancer, V42, P160, DOI 10.1007/s12029-010-9197-1; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Muggia F, 2014, ANTICANCER RES, V34, P551; Patel AG, 2011, P NATL ACAD SCI USA, V108, P3406, DOI 10.1073/pnas.1013715108; Rottenberg S, 2008, P NATL ACAD SCI USA, V105, P17079, DOI 10.1073/pnas.0806092105; Rubin MA, 2011, J CLIN ONCOL, V29, P3659, DOI 10.1200/JCO.2011.35.1916; Schultz N, 2003, NUCLEIC ACIDS RES, V31, P4959, DOI 10.1093/nar/gkg703; Sonnenblick A, 2011, CANCER BIOL THER, V12, P165, DOI 10.4161/cbt.12.3.16292; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Swindall Amanda F, 2013, Cancers (Basel), V5, P943, DOI 10.3390/cancers5030943; Venkitaraman AR, 2001, J CELL SCI, V114, P3591; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Weil MK, 2011, CURR PROB CANCER, V35, P50; Woods D, 2013, CANCER BIOL THER, V14, P379, DOI 10.4161/cbt.23761	30	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0167272	10.1371/journal.pone.0167272	http://dx.doi.org/10.1371/journal.pone.0167272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033382	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900010
J	Sun, Q; Wei, W; Sha, W				Sun, Qin; Wei, Wei; Sha, Wei			Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-gamma Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation	PLOS ONE			English	Article							RELEASE ASSAYS; IMMUNOLOGICAL BIOMARKERS; T-CELLS; DIAGNOSIS; IP-10; ACCURACY	Interferon gamma release assays (IGRAs) could accurately diagnose Mycobacterium tuberculosis (M. tuberculosis) infection. However, these assays do not discriminate between latent tuberculosis infection (LTBI) and active tuberculosis disease (ATB). Here, a total of 177 subjects, including 65 patients with ATB, 43 subjects with LTBI, and 69 TB-uninfected controls (CON group) were enrolled. The concentration of IFN-gamma, IP-10, and IL-2 was determined in peripheral blood mononuclear cells (PBMCs) after short-term (24h) or long-term (72h) stimulation with TB antigens including ESAT-6/CFP-10 (EC) and purified protein derivative (PPD). EC-stimulated IL-2 and gamma interferon-inducible protein 10 (IP-10) release (24h and 72h) showed a good diagnostic performance in distinguishing between TB-infected and TB-uninfected individuals, but failed to discriminate between ATB and LTBI. After 72h of incubation, the release of IL-2 was higher in LTBI patients after stimulation with EC and PPD. The PPD-stimulated IL-2/IFN-gamma ratio after 72h incubation had the diagnostic potential to discriminate between ATB and LTBI, with a sensitivity of 90.8% and a specificity of 97.7%. In addition, these new biomarkers, combined with T-SPOT test in a two-step strategy, were validated with high levels of accuracy in a prospective clinical-based cohort. Collectively, the PPD-stimulated IL-2/IFN-gamma ratio after long-term incubation may be an alternative diagnostic biomarker in distinguishing between active TB patients and subjects with latent infection.	[Sun, Qin; Wei, Wei; Sha, Wei] Tongji Univ, Sch Med, Clin & Res Ctr TB, Shanghai Key Lab TB,Shanghai Pulm Hosp, Shanghai, Peoples R China	Tongji University	Sha, W (corresponding author), Tongji Univ, Sch Med, Clin & Res Ctr TB, Shanghai Key Lab TB,Shanghai Pulm Hosp, Shanghai, Peoples R China.	shaweitjcen@163.com			Tongji University School of Medicine Research Fund [11-046]	Tongji University School of Medicine Research Fund	This work is supported by the Tongji University School of Medicine Research Fund (11-046, To W.S.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Biselli R, 2010, CLIN MICROBIOL INFEC, V16, P1282, DOI 10.1111/j.1469-0691.2009.03104.x; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Diel R, 2011, EUR RESPIR J, V38, P1238, DOI 10.1183/09031936.00099111; Goyal N, 2016, SCAND J IMMUNOL, V83, P338, DOI 10.1111/sji.12424; Hur YG, 2014, CLIN VACCINE IMMUNOL, V21, P133, DOI 10.1128/CVI.00620-13; Kabeer BSA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-135; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Mamishi S, 2014, EUR J CLIN MICROBIOL, V33, P2111, DOI 10.1007/s10096-014-2190-z; Mendoza OM, 2011, EUR RESPIR J, V38, P1237, DOI 10.1183/09031936.00182710; Metcalfe John Z, 2011, J Infect Dis, V204 Suppl 4, pS1120, DOI 10.1093/infdis/jir410; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Nemeth J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035290; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Ruhwald M, 2012, EXPERT REV MOL DIAGN, V12, P175, DOI [10.1586/ERM.11.97, 10.1586/erm.11.97]; Ruhwald M, 2011, TUBERCULOSIS, V91, P260, DOI 10.1016/j.tube.2011.01.001; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sester U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017813; Sutherland JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012365; Thillai M, 2014, EXPERT REV RESP MED, V8, P67, DOI 10.1586/17476348.2014.852471; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051338; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	28	19	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0166501	10.1371/journal.pone.0166501	http://dx.doi.org/10.1371/journal.pone.0166501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033330	gold, Green Published, Green Submitted			2022-12-26	WOS:000391226900005
J	Varolo, E; Zanotelli, D; Montagnani, L; Tagliavini, M; Zerbe, S				Varolo, Elisa; Zanotelli, Damiano; Montagnani, Leonardo; Tagliavini, Massimo; Zerbe, Stefan			Colonization of a Deglaciated Moraine: Contrasting Patterns of Carbon Uptake and Release from C3 and CAM Plants	PLOS ONE			English	Article							CRASSULACEAN ACID METABOLISM; ECOSYSTEM CO2 EXCHANGE; GAS-EXCHANGE; PHOSPHOENOLPYRUVATE CARBOXYLASE; LITTER DECOMPOSITION; GLACIER FORELAND; DIOXIDE EXCHANGE; NY-ALESUND; SOIL; VEGETATION	Introduction Current glacier retreat makes vast mountain ranges available for vegetation establishment and growth. As a result, carbon (C) is accumulated in the soil, in a negative feedback to climate change. Little is known about the effective C budget of these new ecosystems and how the presence of different vegetation communities influences CO2 fluxes. Methods On the Matsch glacier forefield (Alps, Italy) we measured over two growing seasons the Net Ecosystem Exchange (NEE) of a typical grassland, dominated by the C3 Festuca halleri All., and a community dominated by the CAM rosettes Sempervivum montanum L. Using transparent and opaque chambers, with air temperature as the driver, we partitioned NEE to calculate Ecosystem Respiration (Reco) and Gross Ecosystem Exchange (GEE). In addition, soil and vegetation samples were collected from the same sites to estimate the Net Ecosystem Carbon Balance (NECB). Results The two communities showed contrasting GEE but similar Reco patterns, and as a result they were significantly different in NEE during the period measured. The grassland acted as a C sink, with a total cumulated value of -46.4 +/- 35.5 g C m(-2) NEE, while the plots dominated by the CAM rosettes acted as a source, with 31.9 +/- 22.4 g C m(-2). In spite of the different NEE, soil analysis did not reveal significant differences in carbon accumulation of the two plant communities (1770 +/- 130 for F. halleri and 2080 +/- 230 g C m(-2) for S. montanum), suggesting that processes often neglected, like lateral flows and winter respiration, can have a similar relevance as NEE in the determination of the Net Ecosystem Carbon Balance.	[Varolo, Elisa; Zanotelli, Damiano; Montagnani, Leonardo; Tagliavini, Massimo; Zerbe, Stefan] Free Univ Bozen Bolzano, Fac Sci & Technol, Bolzano, Italy; [Varolo, Elisa] Univ Hildesheim, Inst Biol & Chem, Hildesheim, Germany; [Montagnani, Leonardo] Autonomous Prov Bolzano, Forest Serv, Bolzano, Italy	Free University of Bozen-Bolzano; University of Hildesheim	Montagnani, L (corresponding author), Free Univ Bozen Bolzano, Fac Sci & Technol, Bolzano, Italy.; Montagnani, L (corresponding author), Autonomous Prov Bolzano, Forest Serv, Bolzano, Italy.	Leonardo.montagnani@unibz.it	Zanotelli, Damiano/AAL-7337-2021; Montagnani, Leonardo/F-1837-2016	Zanotelli, Damiano/0000-0002-7700-5761; Montagnani, Leonardo/0000-0003-2957-9071	project "The influence of vegetation on carbon fluxes and soil carbon accumulation after glacier retreat' - Free University of Bozen-Bolzano; Dr. Erich-Ritter and Dr. Sellenberg Foundation within the Stifterverband fur die Deutsche Wissenschaft	project "The influence of vegetation on carbon fluxes and soil carbon accumulation after glacier retreat' - Free University of Bozen-Bolzano; Dr. Erich-Ritter and Dr. Sellenberg Foundation within the Stifterverband fur die Deutsche Wissenschaft	This study has been funded by the project "The influence of vegetation on carbon fluxes and soil carbon accumulation after glacier retreat', funded by the Free University of Bozen-Bolzano (https://www.unibz.it/en/public/research/ committee/default.html), and the research consortium "Retreating glacier and emerging ecosystem in the southern Alps (EMERGE)", funded by the Dr. Erich-Ritter and Dr. Sellenberg Foundation within the Stifterverband fur die Deutsche Wissenschaft (https://www.deutsches-stiftungszentrum.de/stiftungen/dr-erichntter-stiftung). No grant number exists for these two projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific funding for this work other than what is mentioned above.	Alejandra Matiz, 2013, PHOTOSYNTHESIS; Bekku Y.S., 2004, POLAR BIOSCI, V17, P36; Belshe EF, 2013, ECOL LETT, V16, P1307, DOI 10.1111/ele.12164; Black CC, 2003, PHOTOSYNTH RES, V76, P329, DOI 10.1023/A:1024978220193; Boxall SF, 2005, PLANT PHYSIOL, V137, P969, DOI 10.1104/pp.104.054577; Brodie CR, 2011, CHEM GEOL, V282, P67, DOI 10.1016/j.chemgeo.2011.01.007; Bubier J, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001946; Bubier JL, 2006, CAN J BOT, V84, P910, DOI 10.1139/B06-044; Burga CA, 2010, FLORA, V205, P561, DOI 10.1016/j.flora.2009.10.001; Ceusters J, 2014, J EXP BOT, V65, P3705, DOI 10.1093/jxb/eru185; Chapin FS, 2006, ECOSYSTEMS, V9, P1041, DOI 10.1007/s10021-005-0105-7; Chapin FS, 2003, ANN BOT-LONDON, V91, P455, DOI 10.1093/aob/mcg041; Christensen TR, 2000, GLOBAL BIOGEOCHEM CY, V14, P701, DOI 10.1029/1999GB001134; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Dodd AN, 2002, J EXP BOT, V53, P569, DOI 10.1093/jexbot/53.369.569; Egli M, 2010, CATENA, V82, P61, DOI 10.1016/j.catena.2010.05.001; Eugster W, 2010, AGR ECOSYST ENVIRON, V139, P346, DOI 10.1016/j.agee.2010.09.001; Flanagan LB, 2005, AGR FOREST METEOROL, V130, P237, DOI 10.1016/j.agrformet.2005.04.002; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Gilmanov TG, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002023; Glenn AJ, 2006, AGR FOREST METEOROL, V140, P115, DOI 10.1016/j.agrformet.2006.03.020; Habler G, 2009, MINER PETROL, V97, P149, DOI 10.1007/s00710-009-0094-x; Heinemeyer A, 2013, ECOL EVOL, V3, P4998, DOI 10.1002/ece3.879; Herrera A, 2009, ANN BOT-LONDON, V103, P645, DOI 10.1093/aob/mcn145; Hinzman LD, 2013, ECOL APPL, V23, P1837, DOI 10.1890/11-1498.1; Hirota M, 2010, J PLANT RES, V123, P531, DOI 10.1007/s10265-010-0315-8; JANSSEN PHM, 1995, ECOL MODEL, V83, P55, DOI 10.1016/0304-3800(95)00084-9; Kindler R, 2011, GLOBAL CHANGE BIOL, V17, P1167, DOI 10.1111/j.1365-2486.2010.02282.x; Kirschbaum MUF, 2011, BIOGEOSCIENCES, V8, P3687, DOI 10.5194/bg-8-3687-2011; Knoll C, 2009, ANN GLACIOL, V50, P46, DOI 10.3189/172756410790595903; Korner C., 2003, ALPINE PLANT LIFE, P344, DOI [10.1007/978-3-642-18970-8, DOI 10.1007/978-3-642-18970-8]; Kutzbach L, 2007, CO2 FLUX DETERMINATI, P1005; LEUNING R, 1995, PLANT CELL ENVIRON, V18, P1183, DOI 10.1111/j.1365-3040.1995.tb00628.x; Li YL, 2008, AGR FOREST METEOROL, V148, P51, DOI 10.1016/j.agrformet.2007.09.002; Lloyd CR, 2001, GLOBAL CHANGE BIOL, V7, P405, DOI 10.1046/j.1365-2486.2001.00422.x; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Lovett G, 2006, ECOSYSTEMS, V9, P152, DOI 10.1007/s10021-005-0036-3; Luttge U, 2006, NEW PHYTOL, V171, P7, DOI 10.1111/j.1469-8137.2006.01755.x; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Luyssaert S, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003377; Malone SL, 2013, GLOBAL CHANGE BIOL, V19, P2511, DOI 10.1111/gcb.12211; Matthews JA., 1992, ECOLOGY RECENTLY DEG; McGuire AD, 2012, BIOGEOSCIENCES, V9, P3185, DOI 10.5194/bg-9-3185-2012; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Nakatsubo T, 2005, J PLANT RES, V118, P173, DOI 10.1007/s10265-005-0211-9; Nakatsubo T, 1998, POLAR RES-SWEDEN, V17, P53, DOI 10.1111/j.1751-8369.1998.tb00258.x; NOBEL PS, 1991, NEW PHYTOL, V119, P183, DOI 10.1111/j.1469-8137.1991.tb01022.x; O'Leary B, 2011, BIOCHEM J, V436, P15, DOI 10.1042/BJ20110078; OECHEL WC, 1993, NATURE, V361, P520, DOI 10.1038/361520a0; Oerlemans J, 2005, SCIENCE, V308, P675, DOI 10.1126/science.1107046; Ogle K, 2015, J GEOPHYS RES-BIOGEO, V120, P221, DOI 10.1002/2014JG002794; OSMOND CB, 1978, ANNU REV PLANT PHYS, V29, P379, DOI 10.1146/annurev.pp.29.060178.002115; Otieno DO, 2009, ECOSYSTEMS, V12, P590, DOI 10.1007/s10021-009-9245-5; Page-Dumroese DS, 1999, SOIL SCI SOC AM J, V63, P379, DOI 10.2136/sssaj1999.03615995006300020016x; Penna D, 2014, HYDROL EARTH SYST SC, V18, P5271, DOI 10.5194/hess-18-5271-2014; Polley HW, 2008, GLOBAL CHANGE BIOL, V14, P1620, DOI 10.1111/j.1365-2486.2008.01599.x; Raffl C, 2004, PHYTOCOENOLOGIA, V34, P225, DOI 10.1127/0340-269X/2004/0034-0225; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Schmitt M, 2010, BIOGEOSCIENCES, V7, P2297, DOI 10.5194/bg-7-2297-2010; Schuur EAG, 2015, NATURE, V520, P171, DOI 10.1038/nature14338; Silvera K, 2014, J EXP BOT, V65, P3623, DOI 10.1093/jxb/eru234; Smittenberg RH, 2012, GLOBAL CHANGE BIOL, V18, P1941, DOI 10.1111/j.1365-2486.2012.02654.x; Sun JD, 2014, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2014-23; Swanson RV, 2001, AGR FOREST METEOROL, V108, P165, DOI 10.1016/S0168-1923(01)00243-X; WAGNER J, 1981, OECOLOGIA, V50, P88, DOI 10.1007/BF00378798; Wang T, 2011, BIOGEOSCIENCES, V8, P2009, DOI 10.5194/bg-8-2009-2011; Ward SE, 2015, ECOLOGY, V96, P113, DOI 10.1890/14-0292.1; Ward SE, 2013, ECOL LETT, V16, P1285, DOI 10.1111/ele.12167; Wehr R, 2016, NATURE, V534, P680, DOI 10.1038/nature17966; WILKINS MB, 1992, NEW PHYTOL, V121, P347, DOI 10.1111/j.1469-8137.1992.tb02936.x; Wohlfahrt G, 2003, ECOL MODEL, V170, P407, DOI 10.1016/S0304-3800(03)00242-4; Wohlfahrt G, 2008, ECOSYSTEMS, V11, P1338, DOI 10.1007/s10021-008-9196-2	72	1	1	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168741	10.1371/journal.pone.0168741	http://dx.doi.org/10.1371/journal.pone.0168741			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033605	gold, Green Published, Green Submitted			2022-12-26	WOS:000391226900041
J	Chen, XY; Li, N; Bi, S; Wang, XG; Wang, BN				Chen, Xianyang; Li, Ning; Bi, Shuai; Wang, Xiaoguang; Wang, Beinan			Co-Activation of Th17 and Antibody Responses Provides Efficient Protection against Mucosal Infection by Group A Streptococcus	PLOS ONE			English	Article							LYMPHOID-TISSUE; PYOGENES; NEUTROPHILS; VACCINE; CELLS; COLONIZATION; INFILTRATION; ACTIVATION; CLEARANCE; PROTEINS	Conserved protein antigens among serotypes of group A Streptococcus pyogenes (GAS) have been focused for vaccine development because of the diversity of GAS serotypes and risks of autoimmunity post-GAS infection. Precise delineation of protective immune response to each of GAS antigens is critical for vaccine efficacy and safety. We recently reported that immunization with SrtA of GAS provides Th17-dependent clearance of heterologous serotypes of GAS in NALT. SCPA is a surface virulence molecule of GAS and known to induce antibody-mediated protection against GAS. We hypothesized that co-immunization with SrtA and SCPA would provide more efficient protection by eliciting combined Th17 and antibody responses. The present study showed that mice that were intranasally coimmunized with SrtA/SCPA cleared GAS more efficiently than the mice that were immunized with either SrtA or SCPA individually, and as efficient as the mice that experienced repeated GAS infections. The co-immunization induced Th17 and robust SCPA antibody responses, accompanied by a rapid influx of neutrophils and high myeloperoxidase activity in NALT, suggesting that simultaneous induction of mucosal Th17 and neutralizing antibody responses offers more effective GAS elimination through rapid infiltration and activation of neutrophils. Moreover, Th17 response was strongly induced in mice that experienced repeated GAS-infection and maintained at a high level even after the bacteria were cleared; whereas, it was moderately induced and promptly returned to baseline following bacterial elimination in SrtA/SCPA co-immunized mice. Additional results showed that the survival rate of systemic challenge was significantly higher in infection experienced than in co-immunized mice, indicating that more immune elements are required for protection against systemic than mucosal GAS infection.	[Chen, Xianyang; Li, Ning; Bi, Shuai; Wang, Xiaoguang; Wang, Beinan] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Wang, BN (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	wangbn@im.ac.cn		Wang, Beinan/0000-0002-9260-7197	National Natural Science Foundation of China [31370928]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China Grant 31370928 to BW (http://www.nsfc.gov.cn). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohnsack JF, 1997, J INFECT DIS, V175, P847, DOI 10.1086/513981; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Christensen D, 2016, MUCOSAL IMMUNOL; Dale JB, 2008, ADV EXP MED BIOL, V609, P53, DOI 10.1007/978-0-387-73960-1_5; Dale JB, 2013, VACCINE, V31, pB216, DOI 10.1016/j.vaccine.2012.09.045; Dileepan T, 2016, J CLIN INVEST, V126, P303, DOI 10.1172/JCI80792; Fan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107638; HEINECKE JW, 1993, J CLIN INVEST, V91, P2866, DOI 10.1172/JCI116531; Jeyaseelan S, 2004, INFECT IMMUN, V72, P7247, DOI 10.1128/IAI.72.12.7247-7256.2004; Ji YD, 1996, INFECT IMMUN, V64, P503, DOI 10.1128/IAI.64.2.503-510.1996; Ji YD, 1997, INFECT IMMUN, V65, P2080, DOI 10.1128/IAI.65.6.2080-2087.1997; Ji YD, 1998, INFECT IMMUN, V66, P5399, DOI 10.1128/IAI.66.11.5399-5405.1998; Kumar P, 2013, CURR OPIN IMMUNOL, V25, P373, DOI 10.1016/j.coi.2013.03.011; Kunisawa J, 2008, TRENDS IMMUNOL, V29, P505, DOI 10.1016/j.it.2008.07.008; Kwinn LA, 2007, FUTURE MICROBIOL, V2, P75, DOI 10.2217/17460913.2.1.75; Laan M, 2003, EUR RESPIR J, V21, P387, DOI 10.1183/09031936.03.00303503; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Li YM, 2002, J IMMUNOL, V168, P816, DOI 10.4049/jimmunol.168.2.816; OCONNOR SP, 1987, J INFECT DIS, V156, P495, DOI 10.1093/infdis/156.3.495; Park HS, 2005, INFECT IMMUN, V73, P7878, DOI 10.1128/IAI.73.12.7878-7886.2005; Park HS, 2003, J IMMUNOL, V171, P2532, DOI 10.4049/jimmunol.171.5.2532; Perry M, 1998, IMMUNOL TODAY, V19, P414, DOI 10.1016/S0167-5699(98)01307-3; Raz A, 2008, P NATL ACAD SCI USA, V105, P18549, DOI 10.1073/pnas.0808301105; Reglinski M, 2016, J INFECTION, V72, P450, DOI 10.1016/j.jinf.2016.02.002; Roberts Samantha, 2006, Curr Protoc Microbiol, VChapter 9, DOI 10.1002/9780471729259.mc09d05s02; Ruiz-Romeu E, 2016, J ALLERGY CLIN IMMUN, V138, P491, DOI 10.1016/j.jaci.2016.02.008; Shet A, 2004, INDIAN J MED RES, V119, P95; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; Wang BN, 2010, P NATL ACAD SCI USA, V107, P5937, DOI 10.1073/pnas.0904831107; Wang W, 2014, INFECT IMMUN, V82, P2368, DOI 10.1128/IAI.00006-14; Wilson R, 2015, MUCOSAL IMMUNOL, V8, P627, DOI 10.1038/mi.2014.95; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814	32	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168861	10.1371/journal.pone.0168861	http://dx.doi.org/10.1371/journal.pone.0168861			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030629	Green Submitted, gold, Green Published			2022-12-26	WOS:000391222000082
J	Jiang, JP; Gao, YH; Hou, YL; Li, WH; Zhang, SL; Zhang, Q; Sun, DX				Jiang, Jianping; Gao, Yahui; Hou, Yali; Li, Wenhui; Zhang, Shengli; Zhang, Qin; Sun, Dongxiao			Whole-Genome Resequencing of Holstein Bulls for Indel Discovery and Identification of Genes Associated with Milk Composition Traits in Dairy Cattle	PLOS ONE			English	Article							WIDE ASSOCIATION; TUMOR-SUPPRESSOR; BREAST-CANCER; CENP-E; VARIANTS; PATTERNS; NUCLEOTIDE; DELETION; OBESITY; IMPACT	The use of whole-genome resequencing to obtain more information on genetic variation could produce a range of benefits for the dairy cattle industry, especially with regard to increasing milk production and improving milk composition. In this study, we sequenced the genomes of eight Holstein bulls from four half-or full-sib families, with high and low estimated breeding values (EBVs) of milk protein percentage and fat percentage at an average effective depth of 10x, using Illumina sequencing. Over 0.9 million nonredundant short insertions and deletions (indels) [1-49 base pairs (bp)] were obtained. Among them, 3,625 indels that were polymorphic between the high and low groups of bulls were revealed and subjected to further analysis. The vast majority (76.67%) of these indels were novel. Followup validation assays confirmed that most (70%) of the randomly selected indels represented true variations. The indels that were polymorphic between the two groups were annotated based on the cattle genome sequence assembly (UMD3.1.69); as a result, nearly 1,137 of them were found to be located within 767 annotated genes, only 5 (0.138%) of which were located in exons. Then, by integrated analysis of the 767 genes with known quantitative trait loci (QTL); significant single-nucleotide polymorphisms (SNPs) previously identified by genome-wide association studies (GWASs) to be associated with bovine milk protein and fat traits; and the well-known pathways involved in protein, fat synthesis, and metabolism, we identified a total of 11 promising candidate genes potentially affecting milk composition traits. These were FCGR2B, CENPE, RETSAT, ACSBG2, NFKB2, TBC1D1, NLK, MAP3K1, SLC30A2, ANGPT1 and UGDH. Our findings provide a basis for further study and reveal key genes for milk composition traits in dairy cattle.	[Jiang, Jianping; Gao, Yahui; Li, Wenhui; Zhang, Shengli; Zhang, Qin; Sun, Dongxiao] China Agr Univ, Dept Anim Genet & Breeding, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding,Minist Agr,Key Lab An, Beijing, Peoples R China; [Hou, Yali] Chinese Acad Sci, Beijing Inst Genom, Lab Dis Genom & Individualized Med, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Sun, DX (corresponding author), China Agr Univ, Dept Anim Genet & Breeding, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding,Minist Agr,Key Lab An, Beijing, Peoples R China.	sundx@cau.edu.cn			National Science and Technology Programs of China [2013AA102504, 2011BAD28602, 2014ZX08009-053B]; Beijing Natural Science Foundation [6152013]; Beijing Dairy Industry Innovation Team [BAIC06-2016]; earmarked fund for Modern Agro-industry Technology Research System [CARS-37]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]	National Science and Technology Programs of China; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Dairy Industry Innovation Team; earmarked fund for Modern Agro-industry Technology Research System; Program for Changjiang Scholar and Innovation Research Team in University	This work was financially supported by the National Science and Technology Programs of China (2013AA102504, 2011BAD28602, 2014ZX08009-053B), Beijing Natural Science Foundation (6152013), the Beijing Dairy Industry Innovation Team (BAIC06-2016), the earmarked fund for Modern Agro-industry Technology Research System (CARS-37) and the Program for Changjiang Scholar and Innovation Research Team in University (IRT1191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2015, J MAMMARY GLAND BIOL, V20, P159, DOI 10.1007/s10911-015-9338-z; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Blott S, 2003, GENETICS, V163, P253; Boussaha M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135931; Chen L, 2016, P NATL ACAD SCI USA, V113, P7219, DOI 10.1073/pnas.1600581113; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Choi JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101127; Choi JW, 2013, MOL CELLS, V36, P203, DOI 10.1007/s10059-013-2347-0; Clemente-Ruiz M, 2014, CELL CYCLE, V13, P1450, DOI 10.4161/cc.28417; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; COLLINS FS, 1987, SCIENCE, V235, P1046, DOI 10.1126/science.2950591; Cuevas BD, 2006, ONCOGENE, V25, P4998, DOI 10.1038/sj.onc.1209507; D'Andre HC, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-43; Dempsey C, 2012, J NUTR, V142, P655, DOI 10.3945/jn.111.150623; Doan R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-78; Fan WL, 2013, GENOME BIOL EVOL, V5, P1376, DOI 10.1093/gbe/evt097; Fan Z, 2014, MOL BIOL EVOL; Flisikowski K, 2009, GENOME BIOL, V10, P1; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; GEORGES M, 1995, GENETICS, V139, P907; Glubb DM, 2015, AM J HUM GENET, V96, P5, DOI 10.1016/j.ajhg.2014.11.009; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Guo JZ, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-82; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077940; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; Kung PP, 2014, MOL CANCER THER, V13, P2104, DOI 10.1158/1535-7163.MCT-14-0083-T; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lee S, 2015, J BIOL CHEM, V290, P13064, DOI 10.1074/jbc.M115.637439; Lee SST, 2004, J LIPID RES, V45, P2025, DOI 10.1194/jlr.M400078-JLR200; Li C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096186; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lopez V, 2009, BIOCHEM J, V422, P43, DOI 10.1042/BJ20081189; Mai MD, 2010, J ANIM SCI, V88, P3522, DOI 10.2527/jas.2009-2713; Meredith BK, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-21; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Minozzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080219; Moise AR, 2010, FASEB J, V24, P1261, DOI 10.1096/fj.09-147207; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pei YF, 2014, HUM MOL GENET, V23, P820, DOI 10.1093/hmg/ddt464; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Prosser CG, 1996, J DAIRY SCI, V79, P1184, DOI 10.3168/jds.S0022-0302(96)76472-X; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schopen GCB, 2011, J DAIRY SCI, V94, P3148, DOI 10.3168/jds.2010-4030; Seo YA, 2010, PHYSIOL GENOMICS, V42A, P219, DOI 10.1152/physiolgenomics.00137.2010; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Sun CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137145; Sun X-F, 2007, NFKB NFKBI POLYMORPH; Supakankul P, 2016, MEAT SCI, V118, P61, DOI 10.1016/j.meatsci.2016.03.025; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WARREN ST, 1987, SCIENCE, V237, P420, DOI 10.1126/science.3603029; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu Q, 2012, BMC GENOMICS, V13, P1; Yan YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104652; Zheng LY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r114	67	17	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168946	10.1371/journal.pone.0168946	http://dx.doi.org/10.1371/journal.pone.0168946			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030618	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000088
J	Michaud, K; de Tayrac, M; D'Astous, M; Duval, C; Paquet, C; Samassekou, O; Gould, PV; Saikali, S				Michaud, Karine; de Tayrac, Marie; D'Astous, Myreille; Duval, Celine; Paquet, Claudie; Samassekou, Oumar; Gould, Peter Vincent; Saikali, Stephan			Contribution of 1p, 19q, 9p and 10q Automated Analysis by FISH to the Diagnosis and Prognosis of Oligodendroglial Tumors According to WHO 2016 Guidelines	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; COMPARATIVE GENOMIC HYBRIDIZATION; ANAPLASTIC OLIGODENDROGLIOMAS; 1P/19Q CODELETION; ASTROCYTIC TUMORS; IDH2 MUTATIONS; FREQUENT ATRX; GLIOMAS; CLASSIFICATION; CHROMOSOMES	Objective To study the feasibility and the diagnostic and prognostic interest of automated analysis of 1p, 19q, 9p and 10q status by FISH technique in oligodendroglial tumors. Methods We analyzed a retrospective series of 33 consecutive gliomas with oligodendroglial histology (originally diagnosed as 24 oligodendrogliomas and 9 oligoastrocytomas). For all cases, automated FISH analysis of 1p, 19q, 9p and 10q status were performed and compared to clinical and histological data, ATRX, IDH1R132H and alpha-internexin status (studied by immunohistochemistry) and overall survival (OS). Manual analysis of 9p and 10q status were also performed and compared to automated analysis to verify the concordance of the two methods. Results The 33 gliomas were reclassified into 13 low-grade oligodendrogliomas (OII), 10 anaplastic oligodendrogliomas (OIII), 3 diffuse astrocytomas (AII), 3 anaplastic astrocytomas (AIII) and 4 glioblastomas (GBM) according to the WHO 2016 histological criteria. The 1p and/or 19q imbalanced status were restricted to astrocytomas with no correlation to their grade or their OS. Chromosome 9p deletion was restricted to OIII (70%) and GBM (100%) and was correlated with a shorter OS in the total cohort (p = 0.0007), the oligodendroglioma cohort (p = 0.03) and the astrocytoma cohort (p = 0.001). Concordance between 9p manual and automated analysis was satisfactory (81%, kappa = 0.69). Chromosome 10q deletion was restricted to GBMs (50%) and was correlated with a poor OS in both the total cohort (p = 0.003) and the astrocytoma (AS) cohort (p = 0.04). Concordance between manual and automated analysis was satisfactory (79%, kappa = 0.62). Conclusion Automated analysis of 1p, 19q, 9p and 10q status by FISH is a reliable technique which allows for refined classification of oligodendroglial tumors. 1p and/or 19q imbalanced status is evidence of astrocytic differentiation. 9p deletion is found in high grade oligodendrogliomas and astrocytomas with a poor OS. 10q is related to GBM status and a poor OS.	[Michaud, Karine; D'Astous, Myreille] Ctr Hosp Univ Quebec, Dept Neurosurg, Quebec City, PQ, Canada; [de Tayrac, Marie] Ctr Hosp Univ Rennes, Dept Genom & Mol Genet, Rennes, France; [Duval, Celine; Paquet, Claudie; Samassekou, Oumar; Gould, Peter Vincent; Saikali, Stephan] Ctr Hosp Univ Quebec, Dept Pathol, Quebec City, PQ, Canada	Laval University; CHU Rennes; Universite de Rennes; Laval University	Saikali, S (corresponding author), Ctr Hosp Univ Quebec, Dept Pathol, Quebec City, PQ, Canada.	stephan.saikali.cha@ssss.gouv.qc.ca	de Tayrac, Marie/AAG-7800-2020; Michaud, Karine/AAM-3026-2020		Fondation du CHU de Quebec [2139]	Fondation du CHU de Quebec	The first author KM received a funding from "The Fondation du CHU de Quebec": grant#2139. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alentorn A, 2015, NEUROLOGY, V85, P1325, DOI 10.1212/WNL.0000000000002014; Ambros PF, 2001, MED PEDIATR ONCOL, V37, P492, DOI 10.1002/mpo.1242; Belaud-Rotureau MA, 2006, ACTA NEUROPATHOL, V111, P255, DOI 10.1007/s00401-005-0001-4; Bigner SH, 1999, AM J PATHOL, V155, P375, DOI 10.1016/S0002-9440(10)65134-6; Brat DJ, 2004, NEURO-ONCOLOGY, V6, P96, DOI 10.1215/S1152851703000231; Cairncross G, 2013, J CLIN ONCOL, V31, P337, DOI 10.1200/JCO.2012.43.2674; Cairncross G, 2008, CANCER J, V14, P352, DOI 10.1097/PPO.0b013e31818d8178; Crespo I, 2011, J MOL DIAGN, V13, P634, DOI 10.1016/j.jmoldx.2011.06.003; Duijf PHG, 2013, INT J CANCER, V132, P2316, DOI 10.1002/ijc.27924; Duval C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132125; Fallon KB, 2004, J NEUROPATH EXP NEUR, V63, P314, DOI 10.1093/jnen/63.4.314; Figarella-Branger D, 2014, NEURO-ONCOLOGY, V16, P1244, DOI 10.1093/neuonc/nou047; Fuller CE, 2002, BRAIN PATHOL, V12, P67; Giannini C, 2001, J NEUROPATH EXP NEUR, V60, P248, DOI 10.1093/jnen/60.3.248; Giannini C, 2008, BRAIN PATHOL, V18, P360, DOI 10.1111/j.1750-3639.2008.00129.x; Godraind C, 2003, NEUROPATH APPL NEURO, V29, P462, DOI 10.1046/j.1365-2990.2003.00484.x; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Hayashi S, 2015, ONCOTARGET, V6, P15871, DOI 10.18632/oncotarget.3869; Horbinski C, 2012, J NEUROPATH EXP NEUR, V71, P73, DOI 10.1097/NEN.0b013e318240fa65; Houillier C, 2010, NEURO-ONCOLOGY, V12, P2, DOI 10.1093/neuonc/nop002; Jiao YC, 2012, ONCOTARGET, V3, P709, DOI 10.18632/oncotarget.588; Kitange G, 2005, GENE CHROMOSOME CANC, V42, P68, DOI 10.1002/gcc.20108; Koschny R, 2006, PATHOL RES PRACT, V202, P23, DOI 10.1016/j.prp.2005.10.010; Kros JM, 2007, J NEUROPATH EXP NEUR, V66, P545, DOI 10.1097/01.jnen.0000263869.84188.72; Liu XY, 2012, ACTA NEUROPATHOL, V124, P615, DOI 10.1007/s00401-012-1031-3; Louis DN, 2016, ACTA NEUROPATHOL, V5, P429; MARTIN F, 1952, AM J PATHOL, V28, P1107; Mokhtari K, 2011, CANCER-AM CANCER SOC, V117, P3014, DOI 10.1002/cncr.25827; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Qaddoumi I, 2016, ACTA NEUROPATHOL, V131, P833, DOI 10.1007/s00401-016-1539-z; Ramirez C, 2010, NEURO-ONCOLOGY, V12, P490, DOI 10.1093/neuonc/nop071; Reifenberger G, 2003, J NEUROPATH EXP NEUR, V62, P111, DOI 10.1093/jnen/62.2.111; Reyes-Botero G, 2014, NEURO-ONCOLOGY, V16, P662, DOI 10.1093/neuonc/not235; Sahm F, 2014, ACTA NEUROPATHOL, V128, P551, DOI 10.1007/s00401-014-1326-7; Sasaki H, 2007, AJP, V159, P359; Senetta R, 2013, J NEUROPATH EXP NEUR, V72, P432, DOI 10.1097/NEN.0b013e3182901f41; SHIMIZU KT, 1993, RADIOLOGY, V186, P569, DOI 10.1148/radiology.186.2.8421767; Snuderl M, 2009, CLIN CANCER RES, V15, P6430, DOI 10.1158/1078-0432.CCR-09-0867; The WHO, 2020, CLASSIFICATION TUMOU; Wesseling P, 2015, ACTA NEUROPATHOL, V129, P809, DOI 10.1007/s00401-015-1424-1; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Wiens AL, 2012, J NEUROPATH EXP NEUR, V71, P618, DOI 10.1097/NEN.0b013e31825b5f7a; Wiestler B, 2013, ACTA NEUROPATHOL, V126, P443, DOI 10.1007/s00401-013-1156-z; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao JX, 2014, NEURO-ONCOLOGY, V16, P103, DOI 10.1093/neuonc/not145; Zlatescu MC, 2001, CANCER RES, V61, P6713; Zulfiqar M, 2012, AM J NEURORADIOL, V33, P858, DOI 10.3174/ajnr.A2862	48	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168728	10.1371/journal.pone.0168728	http://dx.doi.org/10.1371/journal.pone.0168728			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030632	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000068
J	Saville, AC; Martin, MD; Ristaino, JB				Saville, Amanda C.; Martin, Michael D.; Ristaino, Jean B.			Historic Late Blight Outbreaks Caused by a Widespread Dominant Lineage of Phytophthora infestans (Mont.) de Bary	PLOS ONE			English	Article							IRISH POTATO FAMINE; EASTERN UNITED-STATES; DNA-SEQUENCE; POPULATION-STRUCTURE; PCR AMPLIFICATION; PATHOGEN; INFERENCE; POLYMORPHISMS; MIGRATION; PROGRAM	Phytophthora infestans (Mont.) de Bary, the causal agent of potato late blight, was responsible for the Irish potato famine of the 1840s. Initial disease outbreaks occurred in the US in 1843, two years prior to European outbreaks. We examined the evolutionary relationships and source of the 19th-century outbreaks using herbarium specimens of P. infestans from historic (1846 - 1970) and more recent isolates (1992 - 2014) of the pathogen. The same unique SSR multilocus genotype, named here as FAM-1, caused widespread outbreaks in both US and Europe. The FAM-1 lineage shared allelic diversity and grouped with the oldest specimens collected in Colombia and Central America. The FAM-1 lineage of P. infestans formed a genetic group that was distinct from more recent aggressive lineages found in the US. The US-1 lineage formed a second, mid-20th century group. Recent modern US lineages and the oldest Mexican lineages formed a genetic group with recent Mexican lineages, suggesting a Mexican origin of recent US lineages. A survey of mitochondrial haplotypes in a larger set of global herbarium specimens documented the more frequent occurrence of the HERB-1 (type Ia) mitochondrial haplotype in archival collections from 1866-75 and 1906-1915 and the rise of the Ib mitochondrial lineage (US-1) between 1946-1955. The FAM-1 SSR lineage survived for almost 100 years in the US, was geographically widespread, and was displaced first in the mid-20th century by the US-1 lineage and then by distinct new aggressive lineages that migrated from Mexico.	[Saville, Amanda C.; Ristaino, Jean B.] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA; [Martin, Michael D.] Norwegian Univ Sci & Technol NTNU, NTNU Univ Museum, Dept Nat Hist, Trondheim, Norway; [Martin, Michael D.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark	University of North Carolina; North Carolina State University; Norwegian University of Science & Technology (NTNU); University of Copenhagen	Ristaino, JB (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA.	jbr@ncsu.edu	Ristaino, Jean Beagle/N-3616-2018	Ristaino, Jean Beagle/0000-0002-9458-0514; Martin, Michael/0000-0002-2010-5139	National Institute of Food and Agriculture, U.S. Department of Agriculture [2011-68004-30154]; North Carolina Agricultural Research Service	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); North Carolina Agricultural Research Service	This work was partially supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture (https://nifa.usda.gov/), under award number 2011-68004-30154 to JBR and by the North Carolina Agricultural Research Service to JBR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad ZG, 1997, PLANT DIS, V81, P682, DOI 10.1094/PDIS.1997.81.6.682; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Andrivon D, 1996, PLANT PATHOL, V45, P1027, DOI 10.1046/j.1365-3059.1996.d01-196.x; [Anonymous], J ROYAL AGR SOC; Avila-Adame C, 2006, CURR GENET, V49, P39, DOI 10.1007/s00294-005-0016-3; Aylor DL, 2006, BIOINFORMATICS, V22, P1399, DOI 10.1093/bioinformatics/btl136; Berkeley M.J., 1846, J HORTICULT SOC LOND, V1, P9; Birch PRJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00954; BOURKE PMA, 1964, NATURE, V203, P805, DOI 10.1038/203805a0; Bowden LC, 2008, SNAP CLADE MATRIX VE; Brurberg MB, 2011, FUNGAL BIOL-UK, V115, P335, DOI 10.1016/j.funbio.2011.01.003; Cardenas M, 2011, BMC GENET, P12; Chen Y, 1996, GENE, V181, P89, DOI 10.1016/S0378-1119(96)00469-6; Cooke DEL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002940; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Danies G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116354; DRENTH A, 1993, PHYTOPATHOLOGY, V83, P1087, DOI 10.1094/Phyto-83-1087; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flier WG, 2003, PHYTOPATHOLOGY, V93, P382, DOI 10.1094/PHYTO.2003.93.4.382; Forbes GA, 2013, CABI PLANT PROT SER, P48, DOI 10.1079/9781780640938.0048; Fry WE, 2015, PHYTOPATHOLOGY, V105, P966, DOI 10.1094/PHYTO-01-15-0005-FI; Fry WE, 2013, PLANT DIS, V97, P296, DOI 10.1094/PDIS-08-12-0791-FE; Fu YX, 1997, GENETICS, V147, P915; Gavino PD, PLANT DIS, V200, P731; Gilroy EM, 2011, NEW PHYTOL, V191, P763, DOI 10.1111/j.1469-8137.2011.03736.x; Gomez-Alpizar L, 2008, MYCOLOGIA, V100, P590, DOI 10.3852/07-074R1; Gomez-Alpizar L, 2007, P NATL ACAD SCI USA, V104, P3306, DOI 10.1073/pnas.0611479104; Goodwin SB, 1998, PHYTOPATHOLOGY, V88, P939, DOI 10.1094/PHYTO.1998.88.9.939; GOODWIN SB, 1994, P NATL ACAD SCI USA, V91, P11591, DOI 10.1073/pnas.91.24.11591; Goss EM, 2011, PLOS ONE, P6; Goss EM, 2014, P NATL ACAD SCI USA, V111, P8791, DOI 10.1073/pnas.1401884111; Griffith GW, 1998, APPL ENVIRON MICROB, V64, P4007; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; Gronberg L, 2012, PHYTOPATHOLOGY, V102, P429, DOI 10.1094/PHYTO-07-11-0192; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; Gunter R., GARDENERS CHRONICLES, V39, P657; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hu CH, 2012, PLANT DIS, V96, P1323, DOI 10.1094/PDIS-03-11-0156-RE; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; HUDSON RR, 1992, GENETICS, V132, P583; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Lassiter ES, 2015, CURR GENET, V61, P567, DOI 10.1007/s00294-015-0480-3; Li Y, 2013, J MICROBIOL METH, V92, P316, DOI 10.1016/j.mimet.2012.11.021; Lyngso RB, 2005, LECT NOTES COMPUT SC, V3692, P239; Martin MD, 2016, MOL BIOL EVOL, V33, P478, DOI 10.1093/molbev/msv241; Martin MD, 2014, MOL BIOL EVOL, V31, P1414, DOI 10.1093/molbev/msu086; Martin MD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3172; May KJ, 2004, MYCOL RES, V108, P471, DOI [10.1017/S0953756204009876, 10.1017/s0953756204009876]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Monacell JT, 2014, BIOINFORMATICS, V30, P1488, DOI 10.1093/bioinformatics/btu055; National Research Council of the National Academies, 2002, COUNT AGR BIOT; Niederhauser J.S., 1991, PHYTOPHTHORA, P25; Oliva RF, 2010, PLANT PATHOL, V59, P613, DOI 10.1111/j.1365-3059.2010.02287.x; Pritchard JK, 2000, GENETICS, V155, P945; REDDICK D., 1939, CHRON BOT, V5, P410; Ristaino JB, 2009, ACTA HORTIC, V834, P27, DOI 10.17660/ActaHortic.2009.834.2; Ristaino JB, 2001, NATURE, V411, P695, DOI 10.1038/35079606; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Saville A, 2015, PLANT DIS, V99, P659, DOI 10.1094/PDIS-05-14-0452-RE; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Teschemacher J. E., 1845, GARDENERS CHRONICLE, P125; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOOLEY PW, 1989, PHYTOPATHOLOGY, V79, P478, DOI 10.1094/Phyto-79-478; WANG H, 1993, NUCLEIC ACIDS RES, V21, P4153, DOI 10.1093/nar/21.17.4153; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Yoshida K, 2014, PLOS PATHOG, P10; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731; Yuen JE, 2013, PLANT PATHOL, V62, P485, DOI 10.1111/j.1365-3059.2012.02685.x	75	29	30	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168381	10.1371/journal.pone.0168381	http://dx.doi.org/10.1371/journal.pone.0168381			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030580	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000045
J	Szmydynger-Chodobska, J; Shan, RZ; Thomasian, N; Chodobski, A				Szmydynger-Chodobska, Joanna; Shan, Rongzi; Thomasian, Nicole; Chodobski, Adam			The Involvement of Pial Microvessels in Leukocyte Invasion after Mild Traumatic Brain Injury	PLOS ONE			English	Article							NEUTROPHIL INFILTRATION; MONOCLONAL-ANTIBODY; ENDOTHELIAL-CELLS; HEAD-INJURY; P-SELECTIN; EXPRESSION; BARRIER; MODEL; INFLAMMATION; RECRUITMENT	The pathophysiological mechanisms underlying mild traumatic brain injury (mTBI) are not well understood, but likely involve neuroinflammation. Here the controlled cortical impact model of mTBI in rats was used to test this hypothesis. Mild TBI caused a rapid (within 6 h post-mTBI) upregulation of synthesis of TNF-alpha and IL-1 beta in the cerebral cortex and hippocampus, followed by an increase in production of neutrophil (CXCL1 - 3) and monocyte (CCL2) chemoattractants. While astrocytes were not a significant source of CXC chemokines, they highly expressed CCL2. An increase in production of CXC chemokines coincided with the influx of neutrophils into the injured brain. At 6 h post-mTBI, we observed a robust influx of CCL2-expressing neutrophils across pial microvessels into the subarachnoid space (SAS) near the injury site. Mild TBI was not accompanied by any significant influx of neutrophils into the brain parenchyma until 24 h after injury. This was associated with an early induction of expression of intercellular adhesion molecule 1 on the endothelium of the ipsilateral pial, but not intraparenchymal, microvessels. At 6 h post-mTBI, we also observed a robust influx of neutrophils into the ipsilateral cistern of velum interpositum (CVI), a slit-shaped cerebrospinal fluid space located above the 3rd ventricle with highly vascularized pia mater. From SAS and CVI, neutrophils appeared to move along the perivascular spaces to enter the brain parenchyma. The monocyte influx was not observed until 24 h post-mTBI, and these inflammatory cells predominantly entered the ipsilateral SAS and CVI, with a limited invasion of brain parenchyma. These observations indicate that the endothelium of pial microvessels responds to injury differently than that of intraparenchymal microvessels, which may be associated with the lack of astrocytic ensheathment of cerebrovascular endothelium in pial microvessels. These findings also suggest that neuroinflammation represents the potential therapeutic target in mTBI.	[Szmydynger-Chodobska, Joanna; Shan, Rongzi; Thomasian, Nicole; Chodobski, Adam] Brown Univ, Alpert Med Sch, Dept Emergency Med, Neurotrauma & Brain Barriers Res Lab, Providence, RI 02912 USA	Brown University	Szmydynger-Chodobska, J (corresponding author), Brown Univ, Alpert Med Sch, Dept Emergency Med, Neurotrauma & Brain Barriers Res Lab, Providence, RI 02912 USA.	Joanna_Szmydynger-Chodobska@brown.edu		Thomasian, Nicole/0000-0001-9563-4580	NIH [NS94440, NS99605]; Department of Emergency Medicine at the Alpert Medical School of Brown University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094440, R21NS099605] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Emergency Medicine at the Alpert Medical School of Brown University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants NS94440 and NS99605 from NIH (to AC), and by funds from Diane N. Weiss and from the Department of Emergency Medicine at the Alpert Medical School of Brown University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allt G, 1997, BRAIN RES REV, V24, P67, DOI 10.1016/S0165-0173(97)00011-8; Alvarez JI, 2006, J NEUROIMMUNOL, V173, P45, DOI 10.1016/j.jneuroim.2005.11.020; ANDERSSON PB, 1992, J EXP MED, V176, P255, DOI 10.1084/jem.176.1.255; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Bonneh-Barkay D, 2010, J NEUROTRAUM, V27, P1215, DOI 10.1089/neu.2010.1310; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cera MR, 2009, J CELL SCI, V122, P268, DOI 10.1242/jcs.037127; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Didier N, 2003, J NEUROCHEM, V86, P246, DOI 10.1046/j.1471-4159.2003.01829.x; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; GOTSCH U, 1994, CELL ADHES COMMUN, V2, P7, DOI 10.3109/15419069409014198; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Kawada M, 2012, ONCOGENE, V31, P3111, DOI 10.1038/onc.2011.498; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; Mishra PK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002099; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Rot A, 2009, METHOD ENZYMOL, V461, P191, DOI 10.1016/S0076-6879(09)05409-3; Royo NC, 1999, NEUROREPORT, V10, P1363, DOI 10.1097/00001756-199904260-00038; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tran ND, 1999, STROKE, V30, P1671, DOI 10.1161/01.STR.30.8.1671; Utagawa A, 2008, BRAIN RES, V1207, P155, DOI 10.1016/j.brainres.2008.02.057; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Villapol S, 2015, AM J PATHOL, V185, P2641, DOI 10.1016/j.ajpath.2015.06.016; Walker-Caulfield ME, 2015, J NEUROIMMUNOL, V278, P112, DOI 10.1016/j.jneuroim.2014.12.009; Walter UM, 1997, HYBRIDOMA, V16, P249, DOI 10.1089/hyb.1997.16.249; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; ZHANG ET, 1990, J ANAT, V170, P111	41	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167677	10.1371/journal.pone.0167677	http://dx.doi.org/10.1371/journal.pone.0167677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030563	gold, Green Published, Green Submitted			2022-12-26	WOS:000391222000017
J	Shu, ST; Emert-Sedlak, LA; Smithgall, TE				Shu, Sherry T.; Emert-Sedlak, Lori A.; Smithgall, Thomas E.			Cell-based Fluorescence Complementation Reveals a Role for HIV-1 Nef Protein Dimerization in AP-2 Adaptor Recruitment and CD4 Co-receptor Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 NEF; CRYSTAL-STRUCTURE; SH3 DOMAIN; T-LYMPHOCYTES; INFECTION; SURFACE; REPLICATION; DETERMINANT; BINDING; AIDS	The HIV-1 Nef accessory factor enhances viral infectivity, immune evasion, and AIDS progression. Nef triggers rapid down-regulation of CD4 via the endocytic adaptor protein 2 ( AP-2) complex, a process linked to enhanced viral infectivity and immune escape. Here, we describe a bimolecular fluorescence complementation ( BiFC) assay to visualize the interaction of Nef with AP-2 and CD4 in living cells. Interacting protein pairs were fused to complementary non-fluorescent fragments of YFP and co-expressed in 293T cells. Nef interactions with both CD4 and AP-2 resulted in complementation of YFP and a bright fluorescent signal by confocal microcopy that localized to the cell periphery. Co-expression of the AP-2 alpha subunit enhanced the Nef.AP-2 sigma 2 subunit BiFC signal and vice versa, suggesting that the AP-2 alpha-sigma 2 hemicomplex interacts cooperatively with Nef. Mutagenesis of Nef amino acids Arg-134, Glu-174, and Asp-175, which stabilize Nef for AP-2 alpha-sigma 2 binding in a recent co-crystal structure, substantially reduced AP-2 interaction without affecting CD4 binding. A dimerization-defective mutant of Nef failed to interact with either CD4 or AP-2 in the BiFC assay, indicating that Nef quaternary structure is required for CD4 and AP-2 recruitment as well as CD4 down-regulation. A small molecule previously shown to bind the Nef dimerization interface also reduced Nef interactions with AP-2 and CD4 and restored CD4 expression to the surface of HIV-infected cells. Our findings provide a mechanistic explanation for previous observations that dimerization-defective Nef mutants fail to down-regulate CD4 and validate the Nef dimerization interface as a target site for antiretroviral drug development.	[Shu, Sherry T.; Emert-Sedlak, Lori A.; Smithgall, Thomas E.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Bridgeside Point 2,Ste 523,450 Technol Dr, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Smithgall, TE (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Bridgeside Point 2,Ste 523,450 Technol Dr, Pittsburgh, PA 15219 USA.	tsmithga@pitt.edu			National Institutes of Health [AI057083, AI102704, K01 OD018431]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102724, R01AI057083] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD018431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants AI057083 and AI102704 (to T.E.S.) and K01 OD018431 (to S.T.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Alvarado JJ, 2014, J BIOL CHEM, V289, P28539, DOI 10.1074/jbc.M114.600031; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; BENSON RE, 1993, J EXP MED, V177, P1561, DOI 10.1084/jem.177.6.1561; Chaudhuri R, 2009, J VIROL, V83, P2518, DOI 10.1128/JVI.02227-08; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Doria M, 2011, CURR HIV RES, V9, P490, DOI 10.2174/157016211798842125; Emert-Sedlak LA, 2013, CHEM BIOL, V20, P82, DOI 10.1016/j.chembiol.2012.11.005; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; Gondim MV, 2015, J VIROL, V89, P12518, DOI 10.1128/JVI.01838-15; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Jolicoeur P, 2011, CURR HIV RES, V9, P524, DOI 10.2174/157016211798842062; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lindwasser OW, 2008, J VIROL, V82, P1166, DOI 10.1128/JVI.01874-07; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Paczkowski JE, 2015, TRENDS CELL BIOL, V25, P408, DOI 10.1016/j.tcb.2015.02.005; Pawlak EN, 2015, BBA-GEN SUBJECTS, V1850, P733, DOI 10.1016/j.bbagen.2015.01.003; Pham TNQ, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-15; Poe JA, 2014, J BIOMOL SCREEN, V19, P556, DOI 10.1177/1087057113513640; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Ren XF, 2014, ELIFE, V3, DOI 10.7554/eLife.01754; Richard J, 2015, P NATL ACAD SCI USA, V112, pE2687, DOI 10.1073/pnas.1506755112; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; Saksela K, 2011, CURR HIV RES, V9, P531, DOI 10.2174/157016211798842107; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; Sloan RD, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-44; Smithgall T. E., 2013, DRUG DISCOV TODAY TE, V10, P523; Tarafdar S, 2014, J BIOL CHEM, V289, P15718, DOI 10.1074/jbc.M114.572099; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Watkins RL, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0187-z; Zou W, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-44	41	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2670	2678		10.1074/jbc.M116.770016	http://dx.doi.org/10.1074/jbc.M116.770016			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28031466	Green Published, hybrid			2022-12-26	WOS:000395535100010
J	Frissen, A; van Os, J; Habets, P; Gronenschild, E; Marcelis, M				Frissen, Aleida; van Os, Jim; Habets, Petra; Gronenschild, Ed; Marcelis, Machteld		Genetic Risk Outcome Psychosis	No Evidence of Association between Childhood Urban Environment and Cortical Thinning in Psychotic Disorder	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; VOXEL-BASED MORPHOMETRY; SURFACE-BASED ANALYSIS; GRAY-MATTER VOLUME; EARLY-LIFE STRESS; FAMILIAL LIABILITY; SCHIZOPHRENIA RISK; BRAIN VOLUME; MRI; THICKNESS	Background The alterations in cortical morphology, such as cortical thinning, observed in psychotic disorder, may be the outcome of interacting genetic and environmental effects. It has been suggested that urban upbringing may represent a proxy environmental effect impacting cortical thickness (CT). Therefore, the current study examined whether the association between group as a proxy genetic variable (patients with psychotic disorder [high genetic risk], healthy siblings of patients [intermediate risk] and healthy control subjects [average risk]) and CT was conditional on different levels of the childhood urban environment and whether this was sex-dependent. Methods T1-weighted MRI scans were acquired from 89 patients with a psychotic disorder, 95 non psychotic siblings of patients with psychotic disorder and 87 healthy control subjects. Free surfer software was used to measure CT. Developmental urban exposure was classified as low, medium, and high, reflecting the population density and the number of moves between birth and the 15th birthday, using data from the Dutch Central Bureau of Statistics and the equivalent database in Belgium. Multilevel regression analyses were used to examine the association between group, sex, and urban upbringing (as well as their interactions) and cortical CT as the dependent variable. Results CT was significantly smaller in the patient group compared to the controls (B=-0.043, p<0.001), but not in the siblings compared to the controls (B=-0.013, p=0.31). There was no main effect of developmental urbanicity on CT (B = 0.001, p = 0.91). Neither the three-way group x urbanicity x sex interaction (chi(2) = 3.73, p = 0.16), nor the two-way group x urbanicity interaction was significant (chi(2) = 0.51, p = 0.77). Conclusion The negative association between (familial risk for) psychotic disorder and CT was not moderated by developmental urbanicity, suggesting that reduced CT is not the outcome of familial sensitivity to the proxy environmental factor 'urban upbringing'.	[Frissen, Aleida; van Os, Jim; Habets, Petra; Gronenschild, Ed; Marcelis, Machteld] Maastricht Univ, Dept Psychiat & Psychol, Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, Kings Hlth Partners, London, England; [Marcelis, Machteld] Inst Mental Hlth Care Eindhoven GGzE, Eindhoven, Netherlands	Maastricht University; University of London; King's College London	Marcelis, M (corresponding author), Maastricht Univ, Dept Psychiat & Psychol, Maastricht, Netherlands.; Marcelis, M (corresponding author), Inst Mental Hlth Care Eindhoven GGzE, Eindhoven, Netherlands.	m.marcelis@maastrichtuniversity.nl	Habets, Petra/AAZ-1258-2021; van Os, Jim/C-2113-2014; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/V-8884-2019	Habets, Petra/0000-0001-9184-517X; van Os, Jim/0000-0002-7245-1586; Marcelis, Machteld/0000-0003-0045-9244	Dutch organization for scientific research NWO (Genetic Risk and Outcome of Psychosis [G.R.O.U.P.]); European Community's Seventh Framework Programme (European Network of National Schizophrenia Networks Studying Gene Environment Interactions Consortium) [HEALTH-F2-2009-241909]	Dutch organization for scientific research NWO (Genetic Risk and Outcome of Psychosis [G.R.O.U.P.])(Netherlands Organization for Scientific Research (NWO)); European Community's Seventh Framework Programme (European Network of National Schizophrenia Networks Studying Gene Environment Interactions Consortium)	This work was sponsored by the Dutch organization for scientific research NWO (Genetic Risk and Outcome of Psychosis [G.R.O.U.P.]) and the European Community's Seventh Framework Programme under Grant Agreement No. HEALTH-F2-2009-241909 (European Network of National Schizophrenia Networks Studying Gene Environment Interactions Consortium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen NC, 2013, AM J PSYCHIAT, V170, P609, DOI 10.1176/appi.ajp.2013.12050674; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; APA, 2000, DIAGN STAT MAN MENT; Bernstein DP, 1997, J AM ACAD CHILD PSY, V36, P340, DOI 10.1097/00004583-199703000-00012; Boos HBM, 2012, SCHIZOPHRENIA BULL, V38, P814, DOI 10.1093/schbul/sbq147; Bora E, 2012, PSYCHOL MED, V42, P295, DOI 10.1017/S0033291711001450; Byun MS, 2012, SCHIZOPHR RES, V141, P197, DOI 10.1016/j.schres.2012.08.028; Cahn W, 2002, ARCH GEN PSYCHIAT, V59, P1002, DOI 10.1001/archpsyc.59.11.1002; Cannon TD, 2002, ARCH GEN PSYCHIAT, V59, P35, DOI 10.1001/archpsyc.59.1.35; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Duque A, 2012, BRAIN STRUCT FUNCT, V217, P459, DOI 10.1007/s00429-011-0350-9; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fornito A, 2009, SCHIZOPHR RES, V108, P104, DOI 10.1016/j.schres.2008.12.011; Frissen A, 2014, SOC PSYCH PSYCH EPID, V49, P1579, DOI 10.1007/s00127-014-0859-3; Frodl T, 2010, J PSYCHIATR RES, V44, P799, DOI 10.1016/j.jpsychires.2010.01.006; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Goghari VM, 2007, CEREB CORTEX, V17, P415, DOI 10.1093/cercor/bhj158; Goldman AL, 2008, BIOL PSYCHIAT, V63, P475, DOI 10.1016/j.biopsych.2007.06.006; Goldman AL, 2009, ARCH GEN PSYCHIAT, V66, P467, DOI 10.1001/archgenpsychiatry.2009.24; Gutierrez-Galve L, 2010, BIOL PSYCHIAT, V68, P51, DOI 10.1016/j.biopsych.2010.03.019; Habets P, 2011, BIOL PSYCHIAT, V69, P487, DOI 10.1016/j.biopsych.2010.08.010; Haddad L, 2014, SCHIZOPHRENIA B; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P592, DOI 10.1001/jama.284.5.592; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Honea RA, 2008, BIOL PSYCHIAT, V63, P465, DOI 10.1016/j.biopsych.2007.05.027; Howes OD, 2014, LANCET, V383, P1677, DOI 10.1016/S0140-6736(13)62036-X; Jackowski A, 2011, PSYCHIAT RES-NEUROIM, V192, P37, DOI 10.1016/j.pscychresns.2010.11.006; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Jung WH, 2011, SCHIZOPHRENIA BULL, V37, P839, DOI 10.1093/schbul/sbp151; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kelly BD, 2010, SCHIZOPHR RES, V116, P75, DOI 10.1016/j.schres.2009.10.015; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Kuepper R, 2010, SCHIZOPHR RES, V121, P107, DOI 10.1016/j.schres.2010.05.031; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lu SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069350; Luo YQ, 1999, MOL PHARMACOL, V56, P254, DOI 10.1124/mol.56.2.254; Luo YQ, 1998, J BIOL CHEM, V273, P3756, DOI 10.1074/jbc.273.6.3756; Marcelis M, 1998, PSYCHOL MED, V28, P871, DOI 10.1017/S0033291798006898; Marcelis M, 1999, PSYCHOL MED, V29, P1197, DOI 10.1017/S0033291799008983; March D, 2008, EPIDEMIOL REV, V30, P84, DOI 10.1093/epirev/mxn006; Maxwell ME, 1992, GENETICS INITIATIVE; McGrath J, 2006, EPIDEMIOL PSICHIAT S, V15, P243, DOI 10.1017/S1121189X00002104; McGrath J, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-13; Moncrieff J, 2010, PSYCHOL MED, V40, P1409, DOI 10.1017/S0033291709992297; Navari S, 2009, PSYCHOL MED, V39, P1763, DOI 10.1017/S0033291709005315; Oertel-Knochel V, 2013, CEREB CORTEX, V23, P61, DOI 10.1093/cercor/bhr380; Pedersen CB, 2006, EPIDEMIOL PSICHIAT S, V15, P247, DOI 10.1017/S1121189X00002116; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Schmidt-Kastner R, 2006, SCHIZOPHR RES, V84, P253, DOI 10.1016/j.schres.2006.02.022; Schubert MI, 2009, NEUROSCIENCE, V159, P21, DOI 10.1016/j.neuroscience.2008.12.019; Schwartz JE, 1998, HEALTH PSYCHOL, V17, P6, DOI 10.1037/0278-6133.17.1.6; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Selten JP, 2007, BRIT J PSYCHIAT, V191, pS9, DOI 10.1192/bjp.191.51.s9; Spinelli S, 2009, ARCH GEN PSYCHIAT, V66, P658, DOI 10.1001/archgenpsychiatry.2009.52; Stone JM, 2009, BIOL PSYCHIAT, V66, P533, DOI 10.1016/j.biopsych.2009.05.006; Tomoda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052528; Tomoda A, 2009, NEUROIMAGE, V47, pT66, DOI 10.1016/j.neuroimage.2009.03.005; van Os J, 2003, AM J PSYCHIAT, V160, P477, DOI 10.1176/appi.ajp.160.3.477; Van Os J, 2000, BRIT J PSYCHIAT, V176, P243, DOI 10.1192/bjp.176.3.243; van Os J, 2004, AM J PSYCHIAT, V161, P2312, DOI 10.1176/appi.ajp.161.12.2312; Vassos E, 2012, SCHIZ B IN PRESS; Walker EF, 1997, PSYCHOL REV, V104, P667, DOI 10.1037/0033-295X.104.4.667; Weiser M, 2007, BRIT J PSYCHIAT, V191, P320, DOI 10.1192/bjp.bp.106.031328; Wersinger C, 2004, MOL CELL NEUROSCI, V25, P124, DOI 10.1016/j.mcn.2003.10.002; White T, 2003, BIOL PSYCHIAT, V54, P418, DOI 10.1016/S0006-3223(03)00065-9; World Health Organization, 1990, COMP INT DIAGN INT	74	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0166651	10.1371/journal.pone.0166651	http://dx.doi.org/10.1371/journal.pone.0166651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2QJ	28045900	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300003
J	Hamza, F; Abd Ei-Latief, A; Khatan, W				Hamza, F.; Abd EI-Latief, A.; Khatan, W.			Thermomechanical Fractional Model of TEMHD Rotational Flow	PLOS ONE			English	Article							ORDER THEORY; 2ND-GRADE FLUID; COUETTE-FLOW; THERMOELASTICITY; CYLINDER; BEHAVIOR; ANNULUS; SPACE	In this work, the fractional mathematical model of an unsteady rotational flow of Xanthan gum (XG) between two cylinders in the presence of a transverse magnetic field has been studied. This model consists of two fractional parameters alpha and beta representing thermomechanical effects. The Laplace transform is used to obtain the numerical solutions. The fractional parameter influence has been discussed graphically for the functions field distribution (temperature, velocity, stress and electric current distributions). The relationship between the rotation of both cylinders and the fractional parameters has been discussed on the functions field distribution for small and large values of time.	[Hamza, F.; Abd EI-Latief, A.] Univ Alexandria, Dept Math, Fac Sci, Alexandria, Egypt; [Khatan, W.] Univ Damanhour, Dept Math, Fac Sci, Damanhour, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Damanhour University	Abd Ei-Latief, A (corresponding author), Univ Alexandria, Dept Math, Fac Sci, Alexandria, Egypt.	naladellatief@yahoo.com			Alexandria University	Alexandria University(Alexandria University)	Alexandria University is the only funder of this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Latief AM, 2015, ZAMM-Z ANGEW MATH ME, V95, P511, DOI 10.1002/zamm.201300174; Ali F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065223; Ali F, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.064402; [Anonymous], ADV OPER RES, DOI DOI 10.1371/J0URNAL.P0NE.0090280; [Anonymous], 1998, FRACTIONAL DIFFERENT; Anwar MI, 2014, INDIAN J CHEM TECHN, V21, P199; Asghar S, 2005, INT J HEAT MASS TRAN, V48, P599, DOI 10.1016/j.ijheatmasstransfer.2004.08.023; Athar M, 2011, NONLINEAR ANAL-MODEL, V16, P135, DOI 10.15388/NA.16.2.14101; Ezzat MA, 2012, HEAT MASS TRANSFER, V48, P71, DOI 10.1007/s00231-011-0830-8; Ezzat MA, 2010, PHYSICA B, V405, P4188, DOI 10.1016/j.physb.2010.07.009; Fetecau C, 2010, COMPUT MATH APPL, V59, P2836, DOI 10.1016/j.camwa.2010.02.002; Gul T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103843; Hamza F, 2015, ADV MATER SCI ENG, V2015, DOI 10.1155/2015/391454; Hamza F, 2014, J THERM STRESSES, V37, P1080, DOI 10.1080/01495739.2014.936196; Hemeda A. A., 2013, ABSTR APPL ANAL, V2013, P1, DOI DOI 10.1155/2013/717540; HONIG G, 1984, J COMPUT APPL MATH, V10, P113, DOI 10.1016/0377-0427(84)90075-X; Hussanan A, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14046-x; Imran M, 2011, NONLINEAR ANAL-MODEL, V16, P47, DOI 10.15388/NA.16.1.14114; Jamil M., 2012, ISRN MATH PHYS, P1, DOI [10.5402/2012/908386, DOI 10.5402/2012/908386]; Jumarie G, 2010, COMPUT MATH APPL, V59, P1142, DOI 10.1016/j.camwa.2009.05.015; Khajohnsaksumeth N, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/858597; Khalid A., 2015, ENG SCI TECHNOL, V80, P1; Khalid A, 2015, EUR PHYS J PLUS, V130, DOI 10.1140/epjp/i2015-15057-9; Mahmood A, 2011, ACTA MECH SINICA-PRC, V27, P222, DOI 10.1007/s10409-011-0443-y; Mohyuddin MR, 2005, INT J NUMER METH FL, V49, P837, DOI 10.1002/fld.1026; Navarrete R., 2000, SPE PERM BAS OIL GAS; Nemir D, 2010, J ELECTRON MATER, V39, P1897, DOI 10.1007/s11664-009-1060-4; Orczykowska M, 2012, CHEM PROCESS ENG-INZ, V33, P141, DOI 10.2478/v10176-012-0013-2; Owen JM, 2012, J TURBOMACH, V134, DOI 10.1115/1.4003071; Pereira FAR, 2010, LAT AM APPL RES, V40, P53; Ruzic DN, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/10/102002; Samiulhaq, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088766; Shah SHAM, 2010, MECCANICA, V45, P143, DOI 10.1007/s11012-009-9233-z; Sharma R., 2011, J PURE APPL SCI TECH, V1, P36; SHERCLIFF JA, 1979, J FLUID MECH, V91, P231, DOI 10.1017/S0022112079000136; Sherief H, 2013, INT J MECH SCI, V74, P185, DOI 10.1016/j.ijmecsci.2013.05.016; Sherief HH, 2014, APPL MATH COMPUT, V248, P584, DOI 10.1016/j.amc.2014.10.019; Sherief HH, 2014, ZAMM-Z ANGEW MATH ME, V94, P509, DOI 10.1002/zamm.201200173; Sherief HH, 2010, INT J SOLIDS STRUCT, V47, P269, DOI 10.1016/j.ijsolstr.2009.09.034; Sherief HH, 2004, J THERM STRESSES, V27, P885, DOI 10.1080/01495730490498331; SHERIEF HH, 1988, INT J ENG SCI, V26, P301, DOI 10.1016/0020-7225(88)90079-1; Sukumar A., 2010, 2010 2 INT C COMPUTI, P1, DOI DOI 10.1109/ICCCNT.2010.5591733; Tan WC, 2004, ACTA MECH SINICA-PRC, V20, P471, DOI 10.1007/BF02484269; Tan WC, 2003, INT J NONLINEAR MECH, V38, P645, DOI 10.1016/S0020-7462(01)00121-4; Tong DK, 2005, SCI CHINA SER G, V48, P485, DOI 10.1360/04yw0105; Neto JLV, 2014, BRAZ J CHEM ENG, V31, P829, DOI 10.1590/0104-6632.20140314s00002871; Xu MY, 2001, SCI CHINA SER A, V44, P1387, DOI 10.1007/BF02877067	47	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168530	10.1371/journal.pone.0168530	http://dx.doi.org/10.1371/journal.pone.0168530			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045941	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300028
J	Hossain, MG; Ueda, K				Hossain, Md. Golzar; Ueda, Keiji			Investigation of a Novel Hepatitis B Virus Surface Antigen (HBsAg) Escape Mutant Affecting Immunogenicity	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; S-GENE MUTANTS; BLOOD-DONORS; IMMUNE-ESCAPE; IMMUNOPROPHYLAXIS FAILURE; MOLECULAR EPIDEMIOLOGY; DRUG-RESISTANT; GENOTYPE-D; IN-VITRO; HBV DNA	Mutation in the hepatitis B virus surface antigen (HBsAg) may affect the efficiency of diagnostic immunoassays or success of vaccinations using HBsAg. Thus, antigenicity and immuno-genicity analyses of the mutated HBsAg are necessary to develop novel diagnostic tools and efficient vaccinations. Here, the in vitro antigenicity of three wild-type HBsAg open reading frames (ORFs) (adr4, W1S [subtype adr] and W3S [subtype adr]) isolated from clinically infected patients and nineteen synthesized single/double/multiple amino acid-substituted mutants were tested with commercial ELISA kits. Immunofluorescence staining of transfected cells and Western blot analysis confirmed that these ORFs were expressed at comparable levels in HEK-293 cells. W1S and adr4 were clearly detected, whereas W3S could not be detected. Using the same commercial immunoassay kit, we found that the single mutants, K120P and D123T, were marginally reactive, whereas W3S-aW1S and the double mutant, K120P/D123T, exhibited antigenicity roughly equivalent to the wild-type wako1S. On the other hand, the single mutants of W1S, P120K and T123D, significantly impaired the reactivity, while W1S-aW3S and the double mutant of W1S, P120K/T123D, resulted in a complete loss of antigenicity. In addition, ELISA revealed reduced HBs antigenicity of two mutants, W1S N146G and W1S Q129R/G145R. These commercial ELISA-based antigenic reactivities of HBsAg were also strongly correlated with the predicted Aialterations of affected amino acids due to the specific mutation. In conclusion, this study showed for the first time that lysine (K120) and aspartate (D123) simultaneously affected HBsAg antigenicity, leading to diagnostic failure. These findings will improve diagnostic assays and vaccine development.	[Hossain, Md. Golzar; Ueda, Keiji] Osaka Univ, Div Virol, Dept Microbiol & Immunol, Grad Sch Med, Suita, Osaka, Japan	Osaka University	Ueda, K (corresponding author), Osaka Univ, Div Virol, Dept Microbiol & Immunol, Grad Sch Med, Suita, Osaka, Japan.	kueda@virus.med.osaka-u.ac.jp	Hossain, Golzar/N-7468-2019	Hossain, Golzar/0000-0002-1487-5444	Wako Pure Chemicals Research Fund [J120701101, J1607799316]; Research Program on Hepatitis from the Japan Agency for Medical Research and Development (AMED) [15fk0310006h0004]	Wako Pure Chemicals Research Fund; Research Program on Hepatitis from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was funded by the Wako Pure Chemicals Research Fund to K.U. (J120701101, J1607799316); the Research Program on Hepatitis from the Japan Agency for Medical Research and Development (AMED) to K.U. (15fk0310006h0004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Jaoude G, 2005, J VIROL, V79, P10460, DOI 10.1128/JVI.79.16.10460-10644.2005; Baclig MO, 2014, J MED VIROL, V86, P209, DOI 10.1002/jmv.23717; Biswas S, 2013, J VIROL, V87, P7882, DOI 10.1128/JVI.00710-13; Caligiuri P, 2012, NEW MICROBIOL, V35, P97; Candotti D, 2008, J HEPATOL, V49, P537, DOI 10.1016/j.jhep.2008.04.017; Candotti D, 2012, GUT, V61, P1744, DOI 10.1136/gutjnl-2011-301281; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; Carman WF, 1997, J VIRAL HEPATITIS, V4, P11, DOI 10.1111/j.1365-2893.1997.tb00155.x; Chaiteerakij R, 2010, SE ASIAN J TROP MED, V41, P867; Chen WN, 2000, J CLIN MICROBIOL, V38, P2793, DOI 10.1128/JCM.38.7.2793-2794.2000; Chotiyaputta W, 2009, NAT REV GASTRO HEPAT, V6, P453, DOI 10.1038/nrgastro.2009.107; Cooreman MP, 2001, J BIOMED SCI, V8, P237, DOI 10.1007/BF02256597; Dandri M, 2013, SEMIN IMMUNOPATHOL, V35, P7, DOI 10.1007/s00281-012-0335-7; El Chaar M, 2010, HEPATOLOGY, V52, P1600, DOI 10.1002/hep.23886; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Gerlich WH, 2015, MED MICROBIOL IMMUN, V204, P39, DOI 10.1007/s00430-014-0373-y; Ghany MG, 1998, HEPATOLOGY, V27, P213, DOI 10.1002/hep.510270133; Harrison A, 2011, VIRUSES-BASEL, V3, P83, DOI 10.3390/v3020083; Hass M, 2005, HEPATOLOGY, V42, P93, DOI 10.1002/hep.20748; Hayden CA, 2015, VACCINE, V33, P2881, DOI 10.1016/j.vaccine.2015.04.080; Hsu CW, 2011, HEPATOLOGY, V54, P101, DOI 10.1002/hep.24363; Hsu HY, 1999, HEPATOLOGY, V30, P1312, DOI 10.1002/hep.510300511; Huang CH, 2012, J HEPATOL, V57, P720, DOI 10.1016/j.jhep.2012.05.009; Ie SI, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-326; Ireland JH, 2000, HEPATOLOGY, V31, P1176, DOI 10.1053/he.2000.6407; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; Jazayeri SM, 2013, MOL VARIANTS HEPATIT, P107; Julithe R, 2014, J VIROL, V88, P9049, DOI 10.1128/JVI.01161-14; Kalinina T, 2003, HEPATOLOGY, V38, P1274, DOI 10.1053/jhep.2003.50484; Kang WY, 2014, VACCINE, V32, P3362, DOI 10.1016/j.vaccine.2014.04.045; Kao Jia-Horng, 2008, Expert Rev Gastroenterol Hepatol, V2, P553, DOI 10.1586/17474124.2.4.553; KARTHIGESU VD, 1994, J GEN VIROL, V75, P443, DOI 10.1099/0022-1317-75-2-443; Kaymakoglu S, 2014, ACTA GASTRO-ENT BELG, V77, P262; Khan N, 2004, J VIROL, V78, P3262, DOI 10.1128/JVI.78.7.3262-3270.2004; Kim KH, 2014, CLIN MOL HEPATOL, V20, P251, DOI 10.3350/cmh.2014.20.3.251; Lai MW, 2012, GASTROENTEROLOGY, V143, P400, DOI 10.1053/j.gastro.2012.05.002; Lin XF, 2014, PEDIATR INFECT DIS J, V33, P897, DOI 10.1097/INF.0000000000000315; Lin YM, 2013, SCI WORLD J, DOI 10.1155/2013/571875; Liu YJ, 2007, VIROLOGY, V365, P10, DOI 10.1016/j.virol.2007.03.042; Locarnini S, 2004, SEMIN LIVER DIS, V24, P3, DOI 10.1055/s-2004-828672; Locarnini SA, 2010, ANTIVIR THER, V15, P451, DOI 10.3851/IMP1499; Luongo M, 2015, J CLIN VIROL, V62, P89, DOI 10.1016/j.jcv.2014.11.029; Magnius LO, 1995, INTERVIROLOGY, V38, P24, DOI 10.1159/000150411; Mancini-Bourgine M, 2006, VACCINE, V24, P4482, DOI 10.1016/j.vaccine.2005.08.013; Moradi A, 2012, VIRUS GENES, V44, P382, DOI 10.1007/s11262-012-0715-z; Motta-Castro A, 2008, ARCH VIROL, V153, P2197, DOI 10.1007/s00705-008-0237-0; Pei RJ, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-9; Pivert A, 2015, J MED VIROL, V87, P529, DOI 10.1002/jmv.24064; Poovorawan Y, 1998, Int J Infect Dis, V2, P216, DOI 10.1016/S1201-9712(98)90056-X; Romano L, 2015, HUM VACC IMMUNOTHER, V11, P53, DOI 10.4161/hv.34306; Seeger C, 2007, FIELDS VIROLOGY; Sheldon J, 2006, J VIRAL HEPATITIS, V13, P427, DOI 10.1111/j.1365-2893.2005.00713.x; Shi Y, 2012, J MED VIROL, V84, P1901, DOI 10.1002/jmv.23419; Siegler VD, 2013, J VIROL, V87, P1491, DOI 10.1128/JVI.02500-12; STIRK HJ, 1992, INTERVIROLOGY, V33, P148, DOI 10.1159/000150244; Tian YJ, 2007, J CLIN MICROBIOL, V45, P2971, DOI 10.1128/JCM.00508-07; Torresi J, 2002, VIROLOGY, V293, P305, DOI 10.1006/viro.2001.1246; UEDA K, 1991, J VIROL, V65, P3521, DOI 10.1128/JVI.65.7.3521-3529.1991; Vaezjalali M, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.6590; Wang CJ, 1996, VIROLOGY, V220, P28, DOI 10.1006/viro.1996.0282; Weinberger KM, 2000, J GEN VIROL, V81, P1165, DOI 10.1099/0022-1317-81-5-1165; Wu CC, 2012, J VIROL, V86, P4658, DOI 10.1128/JVI.06353-11; Wu CC, 2010, J GEN VIROL, V91, P483, DOI 10.1099/vir.0.012740-0; YAMANAKA T, 1990, MOL IMMUNOL, V27, P443; Ye Q, 2015, HUM VACC IMMUNOTHER, V11, P407, DOI 10.4161/21645515.2014.994461; Yu DM, 2014, J HEPATOL, V60, P515, DOI 10.1016/j.jhep.2013.11.004; Zhang MS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-292; Zheng X, 2004, VIROLOGY, V329, P454, DOI 10.1016/j.virol.2004.08.033	68	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0167871	10.1371/journal.pone.0167871	http://dx.doi.org/10.1371/journal.pone.0167871			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045894	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300008
J	Kwon, YH; Kim, N; Nam, RH; Park, JH; Lee, SM; Kim, SK; Lee, HS; Kim, YS; Lee, DH				Kwon, Yong Hwan; Kim, Nayoung; Nam, Ryoung Hee; Park, Ji Hyun; Lee, Sun Min; Kim, Sung Kook; Lee, Hye Seung; Kim, Yong Sung; Lee, Dong Ho			Change in the Interstitial Cells of Cajal and nNOS Positive Neuronal Cells with Aging in the Stomach of F344 Rats	PLOS ONE			English	Article							NITRERGIC NEUROMUSCULAR-TRANSMISSION; SLOW-TRANSIT CONSTIPATION; ENTERIC NERVOUS-SYSTEM; NITRIC-OXIDE; GASTROINTESTINAL-TRACT; INHIBITORY NEUROTRANSMISSION; MYENTERIC PLEXUS; GASTRIC FUNDUS; MOTOR-NEURONS; MOTILITY	The gastric accommodation reflex is an important mechanism in gastric physiology. However, the aging-associated structural and functional changes in gastric relaxation have not yet been established. Thus, we evaluated the molecular changes of interstitial cell of Cajal (ICC) and neuronal nitric oxide synthase (nNOS) and the function changes in the corpus of F344 rats at different ages (6-, 31-, 74-wk and 2-yr). The proportion of the c-Kit-positive area in the submucosal border (SMB) and myenteric plexus (MP) layer was significantly lower in the older rats, as indicated by immunohistochemistry. The density of the nNOS-positive immunoreactive area also decreased with age in the SMB, circular muscle (CM), and MP. Similarly, the percent of nNOS-positive neuronal cells per total neuronal cells and the proportion of nNOS immunoreactive area of MP also decreased in aged rats. In addition, the mRNA and protein expression of c-Kit and nNOS significantly decreased with age. Expression of stem cell factor (SCF)and the pan-neuronal marker PGP 9.5 mRNA was significantly lower in the older rats than in the younger rats. Barostat studies showed no difference depending on age. Instead, the change of volume was significantly decreased by L-NG63-nitroarginine methyl ester in the 2-yr-old rats compared with the 6-wk-old rats (P = 0.003). Taken together, the quantitative and molecular nNOS changes in the stomach might play a role in the decrease of gastric accommodation with age.	[Kwon, Yong Hwan; Kim, Nayoung; Nam, Ryoung Hee; Lee, Sun Min; Lee, Dong Ho] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Kwon, Yong Hwan; Kim, Sung Kook] Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea; [Kim, Nayoung; Park, Ji Hyun; Lee, Dong Ho] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nayoung; Park, Ji Hyun; Lee, Dong Ho] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, South Korea; [Kim, Yong Sung] Wonkwang Univ, Sch Med, Dept Gastroenterol, Iksan, South Korea; [Kim, Yong Sung] Wonkwang Univ, Sch Med, Digest Dis Res Inst, Iksan, South Korea	Seoul National University (SNU); Kyungpook National University; Kyungpook National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Wonkwang University; Wonkwang University	Kim, N (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea.; Kim, N (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Kim, N (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.	nayoungkim49@empas.com	Kim, Yong Sung/GMW-8652-2022; Lee, Hye Seung/G-6419-2011	Kim, Yong Sung/0000-0001-8836-4818; Lee, Hye Seung/0000-0002-1667-7986; Kim, Nayoung/0000-0002-9397-0406	Seoul National University Bundang Hospital Research [14-2014-003]	Seoul National University Bundang Hospital Research	This work was supported by grant no 14-2014-003 from the Seoul National University Bundang Hospital Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2007, CURR GENE THER, V7, P89, DOI 10.2174/156652307780363134; AZPIROZ F, 1986, AM J PHYSIOL, V251, pG727, DOI 10.1152/ajpgi.1986.251.6.G727; Bernard CE, 2009, NEUROGASTROENT MOTIL, V21, P746, DOI 10.1111/j.1365-2982.2008.01245.x; Burns AJ, 1996, P NATL ACAD SCI USA, V93, P12008, DOI 10.1073/pnas.93.21.12008; Chapman IM, 2004, BEST PRACT RES CL EN, V18, P437, DOI 10.1016/j.beem.2004.02.004; Chen H, 2007, AM J PHYSIOL-CELL PH, V292, pC497, DOI 10.1152/ajpcell.00147.2006; Chial HJ, 2003, AM J PHYSIOL-GASTR L, V284, pG130, DOI 10.1152/ajpgi.00266.2002; Choi KM, 2008, GASTROENTEROLOGY, V135, P2055, DOI 10.1053/j.gastro.2008.09.003; Clarkston WK, 1997, AM J PHYSIOL-REG I, V272, pR243, DOI 10.1152/ajpregu.1997.272.1.R243; Coulie B, 1999, AM J PHYSIOL-GASTR L, V276, pG373, DOI 10.1152/ajpgi.1999.276.2.G373; Cowen T, 2000, GUT, V47, P653, DOI 10.1136/gut.47.5.653; Curro D, 2008, EUR REV MED PHARMACO, V12, P53; D'allard D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060961; De Man JG, 2007, BRIT J PHARMACOL, V150, P88, DOI 10.1038/sj.bjp.0706964; Dixit D, 2006, AM J PHYSIOL-GASTR L, V291, pG1129, DOI 10.1152/ajpgi.00518.2005; Farrugia G, 2008, NEUROGASTROENT MOTIL, V20, P54, DOI 10.1111/j.1365-2982.2008.01109.x; Geramizadeh B, 2009, HEPATO-GASTROENTEROL, V56, P1670; Gomez-Pinilla PJ, 2011, NEUROGASTROENT MOTIL, V23, P36, DOI 10.1111/j.1365-2982.2010.01590.x; Groneberg D, 2013, GASTROENTEROLOGY, V145, P188, DOI 10.1053/j.gastro.2013.03.042; Groneberg D, 2011, GASTROENTEROLOGY, V140, P1608, DOI 10.1053/j.gastro.2011.01.038; He CL, 2000, GASTROENTEROLOGY, V118, P14, DOI 10.1016/S0016-5085(00)70409-4; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Iino S, 2008, NEUROSCIENCE, V152, P437, DOI 10.1016/j.neuroscience.2007.12.044; Iino S, 2009, NEUROGASTROENT MOTIL, V21, P553, DOI 10.1111/j.1365-2982.2008.01236.x; Jeong LJ, 2008, WORLD J GASTROENTERO, V14, P6388, DOI 10.3748/wjg.14.6388; Jo HJ, 2014, AM J PHYSIOL-GASTR L, V306, pG659, DOI 10.1152/ajpgi.00304.2012; Kang JM, 2010, AM J PHYSIOL-GASTR L, V299, pG1147, DOI 10.1152/ajpgi.00218.2010; Kashyap PC, 2010, AM J PHYSIOL-GASTR L, V298, pG1013, DOI 10.1152/ajpgi.00069.2010; Kim SJ, 2011, J NEUROGASTROENTEROL, V17, P372, DOI 10.5056/jnm.2011.17.4.372; Kindt S, 2006, GUT, V55, P1685, DOI 10.1136/gut.2005.085365; Klein S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2626; Kuiken SD, 2002, GUT, V51, P212, DOI 10.1136/gut.51.2.212; Lies B, 2014, NEUROGASTROENT MOTIL, V26, P901, DOI 10.1111/nmo.12367; MAEDA H, 1992, DEVELOPMENT, V116, P369; McKay CM, 2006, J PHARMACOL EXP THER, V319, P1112, DOI 10.1124/jpet.106.109322; Min YW, 2014, J NEUROGASTROENTEROL, V20, P318, DOI 10.5056/jnm13098; Mogami S, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12122; Nakahara M, 2002, J GASTROEN HEPATOL, V17, P666, DOI 10.1046/j.1440-1746.2002.02756.x; Olsson C, 2001, COMP BIOCHEM PHYS A, V128, P481, DOI 10.1016/S1095-6433(00)00330-5; Ordog T, 2009, Minerva Gastroenterol Dietol, V55, P315; Phillips RJ, 2003, AUTON NEUROSCI-BASIC, V106, P69, DOI 10.1016/S1566-0702(03)00072-9; Piessevaux H, 2009, NEUROGASTROENT MOTIL, V21, P378, DOI 10.1111/j.1365-2982.2009.01262.x; Salles N, 2009, BEST PRACT RES CL GA, V23, P805, DOI 10.1016/j.bpg.2009.09.002; Sanders KM, 2014, J NEUROGASTROENTEROL, V20, P171, DOI [10.5056/jnm.20.2.171, 10.5056/jnm.2014.20.2.171]; Sanders KM, 1996, GASTROENTEROLOGY, V111, P492, DOI 10.1053/gast.1996.v111.pm8690216; Sivarao DV, 2001, GASTROENTEROLOGY, V121, P34, DOI 10.1053/gast.2001.25541; Tack J, 2003, ALIMENT PHARM THER, V17, P603, DOI 10.1046/j.1365-2036.2003.01469.x; Takahashi T, 2000, BRAIN RES, V883, P15, DOI 10.1016/S0006-8993(00)02867-5; Terauchi A, 2005, AM J PHYSIOL-GASTR L, V289, pG291, DOI 10.1152/ajpgi.00005.2005; Uchida Masayuki, 2012, Journal of Smooth Muscle Research, V48, P97; Vetri T., 2007, Autonomic & Autacoid Pharmacology, V27, P151, DOI 10.1111/j.1474-8673.2007.00406.x; Villanova N, 1997, AM J PHYSIOL-GASTR L, V273, pG464, DOI 10.1152/ajpgi.1997.273.2.G464; Wade PR, 2004, NEUROGASTROENT MOTIL, V16, P19, DOI 10.1111/j.1743-3150.2004.00469.x; Wang XY, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01336.x; Ward SM, 2001, AM J PHYSIOL-GASTR L, V281, pG602, DOI 10.1152/ajpgi.2001.281.3.G602; Wiley JW, 2002, AM J PHYSIOL-GASTR L, V283, pG1020, DOI 10.1152/ajpgi.00224.2002; Yamamoto T, 2008, J GASTROEN HEPATOL, V23, P660, DOI 10.1111/j.1440-1746.2008.05326.x; Yin J, 2008, J CELL MOL MED, V12, P1118, DOI 10.1111/j.1582-4934.2008.00352.x; Zhang Y, 2010, AM J PHYSIOL-GASTR L, V298, pG14, DOI 10.1152/ajpgi.00266.2009	59	9	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169113	10.1371/journal.pone.0169113	http://dx.doi.org/10.1371/journal.pone.0169113			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045993	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300116
J	Moll, U; Olsson, H; Landin-Olsson, M				Moll, Ulrika; Olsson, Hakan; Landin-Olsson, Mona			Impact of Pregestational Weight and Weight Gain during Pregnancy on Long-Term Risk for Diseases	PLOS ONE			English	Article							BODY-MASS INDEX; YOUNG ADULTHOOD; MENTAL-DISORDERS; OBESITY; PREPREGNANCY; WOMEN; ASSOCIATIONS; CHILDHOOD; BMI	Objective The aim of this study was to analyse the impact of maternal BMI at start of pregnancy and maternal weight gain during pregnancy on the risk of various diseases later in life. Methods In a population-based cohort from southern Sweden, women with at least one delivery registered in the Swedish Medical Birth Register ten or more years before answering a health questionnaire were identified (n = 13,608). Complete data were found in 3,539 women. Results Women with BMI > 25 at start of pregnancy had increased risk of developing obesity (OR 21.9), diabetes (OR 6.4), cardiac disease (OR 2.7), endocrine diseases (OR 2.3), and other morbidity (OR 1.4), compared with women of normal weight. A high weight gain (> 15 kg) during pregnancy was associated to later risk of overweight (OR 2.0) and obesity (OR 2.2), but not diabetes, cardiac disease, or endocrine diseases. A positive association was found between low weight gain and the risk of developing psychiatric disorders (OR 1.6). Conclusions A high BMI at start of pregnancy significantly increased the risk of several diseases later in life. However, a high weight gain during pregnancy was only significant for future overweight and obesity. These findings have implications for both pregestational intervention and post gestational follow up of obese and overweight women.	[Moll, Ulrika; Olsson, Hakan; Landin-Olsson, Mona] Lund Univ, Dept Clin Sci, Lund, Sweden; [Moll, Ulrika; Landin-Olsson, Mona] Skane Univ Hosp, Dept Endocrinol, Lund, Sweden; [Olsson, Hakan] Skane Univ Hosp, Dept Oncol, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Landin-Olsson, M (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.; Landin-Olsson, M (corresponding author), Skane Univ Hosp, Dept Endocrinol, Lund, Sweden.	mona.landin-olsson@med.lu.se		Olsson, Hakan/0000-0002-8794-9635	Lund University and University Hospital	Lund University and University Hospital	The study was funded by research funds from Lund University and University Hospital. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mamun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075679; Amorim AR, 2007, OBESITY, V15, P1278, DOI 10.1038/oby.2007.149; Asbjornsdottir B, 2013, DIABETES CARE, V36, P1102, DOI 10.2337/dc12-1232; Atkinson L, 2016, MATERN CHILD HLTH J, V20, P88, DOI 10.1007/s10995-015-1806-y; Bahadoer S, 2015, EUR J OBSTET GYN R B, V193, P51, DOI 10.1016/j.ejogrb.2015.06.031; Basen-Engquist K, 2011, CURR ONCOL REP, V13, P71, DOI 10.1007/s11912-010-0139-7; Biondi B, 2010, J CLIN ENDOCR METAB, V95, P3614, DOI 10.1210/jc.2010-1245; Bliddal M, 2015, J AFFECT DISORDERS, V183, P322, DOI 10.1016/j.jad.2015.04.053; Cedergren M, 2006, INT J GYNECOL OBSTET, V93, P269, DOI 10.1016/j.ijgo.2006.03.002; Cosson E, 2015, DIABETES METAB; Ertel KA, 2015, HEALTH PSYCHOL, V34, P274, DOI 10.1037/hea0000137; Garnerone L, 2010, MINERVA MED, V101, P363; Groth SW, 2013, JOGNN-J OBST GYN NEO, V42, P541, DOI 10.1111/1552-6909.12230; Guo LH, 2015, J EPIDEMIOL, V25, P536, DOI 10.2188/jea.JE20140149; Harris HE, 1998, J NURSE-MIDWIFERY, V43, P97, DOI 10.1016/S0091-2182(97)00159-6; Haugen M, 2014, BMC PREGNANCY CHILDB, V14, P201, DOI DOI 10.1186/1471-2393-14-201; Holowko N, 2015, SOCIAL INEQUALITY PR; Johnson W, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001828; Juonala M, 2011, J CLIN ENDOCR METAB, V96, pE1542, DOI 10.1210/jc.2011-1243; Kallen B.K., 2003, SWEDISH MED BIRTH RE; Kapadia MZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132650; Kirkegaard H, 2015, OBESITY, V23, P870, DOI 10.1002/oby.21022; Kishi S, 2014, JACC-HEART FAIL, V2, P500, DOI 10.1016/j.jchf.2014.03.001; Lindqvist PG, 2014, J INTERN MED, V276, P77, DOI 10.1111/joim.12251; Linne Y, 2004, Obes Rev, V5, P137, DOI 10.1111/j.1467-789X.2004.00147.x; Linne Y, 2004, OBES RES, V12, P1166, DOI 10.1038/oby.2004.146; McClure CK, 2013, AM J CLIN NUTR, V98, P1218, DOI 10.3945/ajcn.112.055772; Moll U, 2014, J DIABETES MELLITUS, P341; Molyneaux E, 2014, OBSTET GYNECOL, V123, P857, DOI 10.1097/AOG.0000000000000170; Muktabhant Benja, 2015, Cochrane Database Syst Rev, pCD007145, DOI 10.1002/14651858.CD007145.pub3; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; Poston L, 2015, LANCET DIABETES ENDO, V3, P767, DOI 10.1016/S2213-8587(15)00227-2; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Schmidt M, 2014, ANN EPIDEMIOL, V24, P356, DOI 10.1016/j.annepidem.2014.01.011; Schmiegelow MD, 2014, CIRCULATION, V129, P330, DOI 10.1161/CIRCULATIONAHA.113.003142; Schummers L, 2015, OBSTET GYNECOL, V125, P133, DOI 10.1097/AOG.0000000000000591; Silventoinen K, 2014, INT J EPIDEMIOL, V43, P1197, DOI 10.1093/ije/dyu091; Vernini JM, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0206-0; Vicennati V, 2014, HORM MOL BIOL CLIN I, V17, P63, DOI 10.1515/hmbci-2013-0068; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Willis K, 2015, BEST PRACT RES CL OB, V29, P133, DOI 10.1016/j.bpobgyn.2014.04.015	41	23	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168543	10.1371/journal.pone.0168543	http://dx.doi.org/10.1371/journal.pone.0168543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045917	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300031
J	Mori, D; Shibata, K; Yamasaki, S				Mori, Daiki; Shibata, Kensuke; Yamasaki, Sho			C-Type Lectin Receptor Dectin-2 Binds to an Endogenous Protein beta-Glucuronidase on Dendritic Cells	PLOS ONE			English	Article							DAMAGED CELLS; RECOGNITION; MUCOPOLYSACCHARIDOSES; MACROPHAGES; MANNOSE; MINCLE; PHOSPHORYLATION; GLYCOSYLATION; INVOLVEMENT; ACTIVATION	C-type lectin receptors (CLRs) recognize pathogen-derived ligands and abnormal self that trigger protective immune responses. However, the precise nature of self ligands recognized by CLRs remains to be determined. Here, we found that Dectin-2 recognizes bone marrow-derived dendritic cells (BMDCs) using Dectin-2-expressing reporter cells. This activity was inhibited by an excessive amount of mannose, and by the mutation of man nose-binding motif in Dectin-2. beta-glucuronidase (Gusb) was identified as a protein bound to Dectin-2 and mutations of N-glycosylation sites in Gusb impaired the binding of Gusb to Dectin-2. Overexpression of Gusb in a macrophage cell line conferred an ability to stimulate Dectin-2-expressing reporter cells. Our study suggests that a glycosylated protein with man nose-related structure is recognized by Dectin-2.	[Mori, Daiki; Shibata, Kensuke] Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Fukuoka, Japan; [Yamasaki, Sho] Chiba Univ, Med Mycol Res Ctr, Dept Mol Immunol, Chiba, Japan	Kyushu University; Chiba University	Shibata, K (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Fukuoka, Japan.; Yamasaki, S (corresponding author), Chiba Univ, Med Mycol Res Ctr, Dept Mol Immunol, Chiba, Japan.	k_shibata@bioreg.kyuhsu-u.ac.jp; yamasaki@bioreg.kyuhsu-u.ac.jp		MORI, Daiki/0000-0002-3596-0840	MEXT [26293099, 26110009]; Ministry of Health, Labour and Welfare (MHLW); Research on Development of New Drugs and AMED-CREST, AMED	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); Research on Development of New Drugs and AMED-CREST, AMED	This work was supported by Grant-in-Aid for Scientific Research (26293099), Grant-in-Aid for Scientific Research on Innovative Areas (26110009) from MEXT, Grants from the Ministry of Health, Labour and Welfare (MHLW), the Research on Development of New Drugs and AMED-CREST, AMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Aragane Y, 2003, J IMMUNOL, V171, P3801, DOI 10.4049/jimmunol.171.7.3801; Ausseil J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002296; BIRKENMEIER EH, 1989, J CLIN INVEST, V83, P1258, DOI 10.1172/JCI114010; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Depke M, 2014, J PROTEOMICS, V103, P72, DOI 10.1016/j.jprot.2014.03.027; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Drickamer K, 2015, CURR OPIN STRUC BIOL, V34, P26, DOI 10.1016/j.sbi.2015.06.003; GOLDBERG DE, 1981, J BIOL CHEM, V256, P3060; Green RS, 2007, IMMUNITY, V27, P308, DOI 10.1016/j.immuni.2007.06.008; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Ishikawa T, 2013, CELL HOST MICROBE, V13, P477, DOI 10.1016/j.chom.2013.03.008; Kiyotake R, 2015, J BIOL CHEM, V290, P25322, DOI 10.1074/jbc.M115.645234; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Muenzer J, 2011, RHEUMATOLOGY, V50, pV4, DOI 10.1093/rheumatology/ker394; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Schlickeiser S, 2011, J IMMUNOL, V186, P5201, DOI 10.4049/jimmunol.1003410; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; SHIPLEY JM, 1993, J BIOL CHEM, V268, P12193; Simonaro CM, 2008, AM J PATHOL, V172, P112, DOI 10.2353/ajpath.2008.070564; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; Triggiani M, 2000, J IMMUNOL, V164, P4908, DOI 10.4049/jimmunol.164.9.4908; Wittmann A, 2016, J BIOL CHEM, V291, P17629, DOI 10.1074/jbc.M116.741256; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yonekawa A, 2014, IMMUNITY, V41, P402, DOI 10.1016/j.immuni.2014.08.005; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009	30	9	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169562	10.1371/journal.pone.0169562	http://dx.doi.org/10.1371/journal.pone.0169562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046067	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300205
J	Shingyochi, Y; Kanazawa, S; Tajima, S; Tanaka, R; Mizuno, H; Tobita, M				Shingyochi, Yoshiaki; Kanazawa, Shigeyuki; Tajima, Satoshi; Tanaka, Rica; Mizuno, Hiroshi; Tobita, Morikuni			A Low-Level Carbon Dioxide Laser Promotes Fibroblast Proliferation and Migration through Activation of Akt, ERK, and JNK	PLOS ONE			English	Article							LIGHT-EMITTING DIODE; GROWTH-FACTOR BETA-1; CELL-PROLIFERATION; CO2-LASER IRRADIATION; HORMESIS INDUCTION; THERAPY; MECHANISMS; SENESCENCE; VIABILITY; MOTILITY	Background Low-level laser therapy (LLLT) with various types of lasers promotes fibroblast proliferation and migration during the process of wound healing. Although LLLT with a carbon dioxide (CO2) laser was also reported to promote wound healing, the underlying mechanisms at the cellular level have not been previously described. Herein, we investigated the effect of LLLT with a CO2 laser on fibroblast proliferation and migration. Materials and Methods Cultured human dermal fibroblasts were prepared. MTS and cell migration assays were performed with fibroblasts after LLLT with a CO2 laser at various doses (0.1, 0.5, 1.0, 2.0, or 5.0 J/cm2) to observe the effects of LLLT with a CO2 laser on the proliferation and migration of fibroblasts. The non-irradiated group served as the control. Moreover, western blot analysis was performed using fibroblasts after LLLT with a CO2 laser to analyze changes in the activities of Akt, extracellular signal-regulated kinase (ERK), and Jun N terminal kinase (JNK), which are signaling molecules associated with cell proliferation and migration. Finally, the MTS assay, a cell migration assay, and western blot analysis were performed using fibroblasts treated with inhibitors of Akt, ERK, or JNK before LLLT with a CO2 laser. Results In MTS and cell migration assays, fibroblast proliferation and migration were promoted after LLLT with a CO2 laser at 1.0 J/cm(2). Western blot analysis revealed that Akt, ERK, and JNK activities were promoted in fibroblasts after LLLT with a CO2 laser at 1.0 J/cm(2). Moreover, inhibition of Akt, ERK, or JNK significantly blocked fibroblast proliferation and migration. Conclusions These findings suggested that LLLT with a CO2 laser would accelerate wound healing by promoting the proliferation and migration of fibroblasts. Activation of Akt, ERK, and JNK was essential for CO2 laser-induced proliferation and migration of fibroblasts.	[Shingyochi, Yoshiaki; Kanazawa, Shigeyuki; Tajima, Satoshi; Tanaka, Rica; Mizuno, Hiroshi; Tobita, Morikuni] Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, Hongo, Tokyo, Japan	Juntendo University	Tobita, M (corresponding author), Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, Hongo, Tokyo, Japan.	mtobita@juntendo.ac.jp			Yoshida Dental MFG. Co., Ltd	Yoshida Dental MFG. Co., Ltd	This work was supported by The Yoshida Dental MFG. Co., Ltd (http://www.yoshida-net.co.jp/en/index.html) Funding to this project and preparation of the carbon dioxide Laser machine to HM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksic V, 2010, LASER MED SCI, V25, P559, DOI 10.1007/s10103-010-0761-5; Choudhury GG, 1997, AM J PHYSIOL-RENAL, V273, pF931, DOI 10.1152/ajprenal.1997.273.6.F931; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Esmaeelinejad M, 2014, LASER MED SCI, V29, P121, DOI 10.1007/s10103-013-1289-2; Evans Denise Hawkins, 2008, Photodermatol Photoimmunol Photomed, V24, P199, DOI 10.1111/j.1600-0781.2008.00362.x; Feutz AC, 2008, J CELL SCI, V121, P1435, DOI 10.1242/jcs.018689; Fujiwara T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092168; Furuuchi Y, 1987, JPN J ORAL MAXILLOFA, V33, P53; Fushimi T, 2012, WOUND REPAIR REGEN, V20, P226, DOI 10.1111/j.1524-475X.2012.00771.x; Gao XJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-4; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hawkins DH, 2007, J PHOTOCH PHOTOBIO B, V88, P147, DOI 10.1016/j.jphotobiol.2007.07.003; Hawkins DH, 2006, LASER SURG MED, V38, P74, DOI 10.1002/lsm.20271; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Iwasaka K, 2011, IN VIVO, V25, P787; Iwasaka K, 2011, IN VIVO, V25, P93; Jiang X, 2014, LASER MED SCI, V29, P681, DOI 10.1007/s10103-013-1383-5; Jiang X, 2012, LASER MED SCI, V27, P599, DOI 10.1007/s10103-011-0996-9; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kanazawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012228; KARU T, 1989, HEALTH PHYS, V56, P691, DOI 10.1097/00004032-198905000-00015; Khan MH, 2005, LASER SURG MED, V36, P270, DOI 10.1002/lsm.20142; Lilge L, 2000, J CLIN LASER MED SUR, V18, P235, DOI 10.1089/clm.2000.18.235; Lin F, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-16; Ling QZ, 2014, J CELL PHYSIOL, V229, P108, DOI 10.1002/jcp.24425; Manolis EN, 2007, WOUND REPAIR REGEN, V15, P252, DOI 10.1111/j.1524-475X.2007.00212.x; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Medrado ARAP, 2003, LASER SURG MED, V32, P239, DOI 10.1002/lsm.10126; MESTER E, 1985, LASER SURG MED, V5, P31, DOI 10.1002/lsm.1900050105; Mester E, 1975, Z Exp Chir, V8, P258; MESTER E, 1971, AM J SURG, V122, P532, DOI 10.1016/0002-9610(71)90482-X; Nowak KC, 2000, PLAST RECONSTR SURG, V105, P2039, DOI 10.1097/00006534-200005000-00019; Pant V, 2004, J PERIODONTAL RES, V39, P373, DOI 10.1111/j.1600-0765.2004.00751.x; Pereira AN, 2002, LASER SURG MED, V31, P263, DOI 10.1002/lsm.10107; Pinheiro ALB, 2002, J CLIN LASER MED SUR, V20, P23, DOI 10.1089/104454702753474977; Posten W, 2005, DERMATOL SURG, V31, P334, DOI 10.1097/00042728-200503000-00016; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Saito S, 1997, AM J ORTHOD DENTOFAC, V111, P525, DOI 10.1016/S0889-5406(97)70152-5; Schindl A, 2000, PHOTODERMATOL PHOTO, V16, P34, DOI 10.1034/j.1600-0781.2000.160109.x; Sepe L, 2013, CELL PHYSIOL BIOCHEM, V31, P123, DOI 10.1159/000343355; Sharon-Buller A, 2004, ORAL SURG ORAL MED O, V97, P332, DOI 10.1016/j.tripleo.2003.11.012; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tam G, 1999, J CLIN LASER MED SUR, V17, P29, DOI 10.1089/clm.1999.17.29; Thomson PJ, 2002, INT J ORAL MAX SURG, V31, P145, DOI 10.1054/ijom.2001.0189; Tsai CL, 1997, LASER SURG MED, V20, P172; Vinck EM, 2003, LASER MED SCI, V18, P95, DOI 10.1007/s10103-003-0262-x; Walker MD, 2000, LASER SURG MED, V26, P41, DOI 10.1002/(SICI)1096-9101(2000)26:1<41::AID-LSM7>3.0.CO;2-M; Wedlock P, 1996, PHYSIOL BEHAV, V59, P445, DOI 10.1016/0031-9384(95)02080-2; Wells A, 1998, MICROSC RES TECHNIQ, V43, P395, DOI 10.1002/(SICI)1097-0029(19981201)43:5<395::AID-JEMT6>3.0.CO;2-T; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Whelan HT, 2003, J CLIN LASER MED SUR, V21, P67, DOI 10.1089/104454703765035484; Yamasaki A, 2008, LASER SURG MED, V40, P695, DOI 10.1002/lsm.20712; Yu W, 1997, PHOTOCHEM PHOTOBIOL, V66, P866, DOI 10.1111/j.1751-1097.1997.tb03239.x; Zhang LL, 2009, J CELL PHYSIOL, V219, P553, DOI 10.1002/jcp.21697	56	25	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168937	10.1371/journal.pone.0168937	http://dx.doi.org/10.1371/journal.pone.0168937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045948	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300075
J	Walsh, WR; Oliver, RA; Christou, C; Lovric, V; Walsh, ER; Prado, GR; Haider, T				Walsh, William Robert; Oliver, Rema A.; Christou, Chris; Lovric, Vedran; Walsh, Emma Rose; Prado, Gustavo R.; Haider, Thomas			Critical Size Bone Defect Healing Using Collagen-Calcium Phosphate Bone Graft Materials	PLOS ONE			English	Article							DONOR-SITE MORBIDITY; CALVARIAL DEFECTS; ALLOGRAFT BONE; NATURAL BONE; BETA-TCP; MODEL; HYDROXYAPATITE; SUBSTITUTES; RABBITS; TISSUE	The need for bone graft materials to fill bony voids or gaps that are not related to the intrinsic stability of the bone that arise due to trauma, tumors or osteolysis remains a clinically relevant and significant issue. The in vivo response of collagen-tricalcium phosphate bone graft substitutes was evaluated in a critical size cancellous defect model in skeletally mature rabbits. While the materials were chemically virtually identical, new bone formation, implant resorption and local in vivo responses were significantly different. Differences in the in vivo response may be due, in part, collagen source and processing which influences resorption profiles. Continued improvements in processing and manufacturing techniques of collagen -tricalcium phosphate bone graft substitutes can result in osteoconductive materials that support healing of critical size bone defects even in challenging pre-clinical models.	[Walsh, William Robert; Oliver, Rema A.; Christou, Chris; Lovric, Vedran; Walsh, Emma Rose] UNSW Australia, Prince Wales Hosp, Prince Wales Clin Sch, Surg & Orthopaed Res Labs, Sydney, NSW, Australia; [Prado, Gustavo R.; Haider, Thomas] Haider Biol, San Diego, CA USA	University of New South Wales Sydney	Walsh, WR (corresponding author), UNSW Australia, Prince Wales Hosp, Prince Wales Clin Sch, Surg & Orthopaed Res Labs, Sydney, NSW, Australia.	W.Walsh@unsw.edu.au		Walsh, William/0000-0002-5023-6148; Christou, Chris/0000-0003-3231-0356	Haider Biologics	Haider Biologics	Haider Biologics provided support for this study as well as support in the form of salaries for authors GRP and TH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson MLC, 1999, CLIN ORTHOP RELAT R, P231; Bailey AJ, 2000, WOUND REPAIR REGEN, V8, P5, DOI 10.1046/j.1524-475x.2000.00005.x; BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012; Bauer TW, 2000, CLIN ORTHOP RELAT R, P10; Christou C, 2014, COMPARATIVE MED, V64, P377; CHVAPIL M, 1977, J BIOMED MATER RES, V11, P721, DOI 10.1002/jbm.820110508; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; DELUSTRO F, 1990, CLIN ORTHOP RELAT R, P263; Figueiredo MM, 2012, CHARACTERIZATION BON; Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040; Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020; Fujibayashi S, 2003, BIOMATERIALS, V24, P1349, DOI 10.1016/S0142-9612(02)00511-2; Garnero P, 2003, J BONE MINER RES, V18, P859, DOI 10.1359/jbmr.2003.18.5.859; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029; Gibson IR, 2000, J MATER SCI-MATER M, V11, P799, DOI 10.1023/A:1008905613182; Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871; Goulet JA, 1997, CLIN ORTHOP RELAT R, P76; Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007; Hannink G, 2008, J BIOMED MATER RES B, V85B, P478, DOI 10.1002/jbm.b.30969; Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011; Laurencin C, 2014, EXPERT REV MED DEVIC; Lee CH, 2001, INT J PHARMACEUT, V221, P1, DOI 10.1016/S0378-5173(01)00691-3; Lindley EM, 2010, J BIOMED MATER RES B, V94B, P463, DOI 10.1002/jbm.b.31676; Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096; Lyons FG, 2014, CLIN ORTHOP RELAT R, V472, P1318, DOI 10.1007/s11999-013-3438-0; Malhotra A, 2014, FRONTIERS SURG, V1, P7, DOI [10.3389/fsurg.2014.00007, DOI 10.3389/FSURG.2014.00007]; Malhotra A, 2014, TISSUE ENG PT A, V20, P2614, DOI [10.1089/ten.TEA.2013.0737, 10.1089/ten.tea.2013.0737]; Moreira-Gonzalez A, 2005, J CRANIOFAC SURG, V16, P63, DOI 10.1097/00001665-200501000-00013; Mushipe MT, 2002, BIOMATERIALS, V23, P365, DOI 10.1016/S0142-9612(01)00114-4; Oonishi H, 1997, CLIN ORTHOP RELAT R, P316; Oronsky AL, 1973, PHAGOCYTIC RELEASE A; Orr TE, 2001, BIOMATERIALS, V22, P1953, DOI 10.1016/S0142-9612(00)00370-7; Pashley DH, 2004, J DENT RES, V83, P216, DOI 10.1177/154405910408300306; Russell N, 2013, BIOMATERIALS, V34, P8185, DOI 10.1016/j.biomaterials.2013.07.022; Sawin PD, 1998, J NEUROSURG, V88, P255, DOI 10.3171/jns.1998.88.2.0255; SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, V205, P299, DOI DOI 10.1097/00003086-198604000-00036; Sonnabend DH, 2001, J SHOULDER ELB SURG, V10, P109, DOI 10.1067/mse.2001.112882; Stubbs D, 2004, BIOMATERIALS, V25, P5037, DOI 10.1016/j.biomaterials.2004.02.014; SUMMERS BN, 1989, J BONE JOINT SURG BR, V71, P677, DOI 10.1302/0301-620X.71B4.2768321; Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5; Tsai CH, 2008, BIOMATERIALS, V29, P984, DOI 10.1016/j.biomaterials.2007.10.014; Vogel M, 2001, BIOMATERIALS, V22, P357, DOI 10.1016/S0142-9612(00)00191-5; Voor MJ, 2004, J BIOMED MATER RES B, V71B, P398, DOI 10.1002/jbm.b.30109; Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06; Walsh WR, 2008, BIOMATERIALS, V29, P266, DOI 10.1016/j.biomaterials.2007.09.035; Walsh WR, 2009, EUR SPINE J, V18, P1610, DOI 10.1007/s00586-009-1034-5; Walsh WR, 2003, CLIN ORTHOP RELAT R, P228, DOI 10.1097/01.blo.0000030062.92399.6a; Walsh WR, 2003, J ORTHOP RES, V21, P655, DOI 10.1016/S0736-0266(03)00012-3; Walsh WR, 2000, CLIN ORTHOP RELAT R, P258; WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815; Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002; Yu Y, 2002, J BIOMED MATER RES, V60, P392, DOI 10.1002/jbm.1289; Yu Y, 1997, B HOSP JOINT DIS, V57, P23; Yuan H, 2006, J BIOMED MATER RES A, V78A, P139, DOI 10.1002/jbm.a.30707; Yuan HP, 2001, J MATER SCI-MATER M, V12, P7, DOI 10.1023/A:1026792615665; Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047; Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7; Yuan HP, 2006, TISSUE ENG, V12, P1607, DOI 10.1089/ten.2006.12.1607; Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107	60	39	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168883	10.1371/journal.pone.0168883	http://dx.doi.org/10.1371/journal.pone.0168883			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28045946	gold, Green Submitted, Green Published			2022-12-26	WOS:000391612300064
J	Kim, NH; Park, JH; Choi, DP; Lee, JY; Kim, HC				Kim, Na Hyun; Park, Ji Hye; Choi, Dong Phil; Lee, Joo Young; Kim, Hyeon Chang			Secondhand Smoke Exposure and Depressive Symptoms among Korean Adolescents: JS High School Study	PLOS ONE			English	Article							TOBACCO-SMOKE; MENTAL-HEALTH; MAJOR DEPRESSION; YOUNG ADULTHOOD; DOPAMINE; CHILDREN; ASSOCIATION; NICOTINE; ANXIETY; ASTHMA	Introduction Increasing evidence suggests that secondhand smoke exposure (SHSE) may affect not only physical health, but also mental health. Therefore, we evaluated the association between SHSE and depressive symptoms among Korean adolescents. Methods The JS High School Study enrolled 1071 high school freshmen from a rural community of South Korea. The current analysis was limited to 989 adolescents (495 male and 494 female adolescents), after excluding 48 ever-smokers, 3 students with physician-diagnosed depression, and 31 students who did not complete the depression questionnaire. SHSE was assessed using a self-reported questionnaire and was classified into three groups: none, occasional exposure, and regular exposure. Depressive symptoms were assessed according to the Beck Depression Inventory (BDI) score, ranging from 0 to 63, and the presence of depressive symptoms was defined as a BDI score >= 10. Results Overall, adolescents with SHSE were more likely to have depressive symptoms than those without SHSE (p = 0.042). In a sex-specific analysis treating the BDI score as a continuous variable, regular SHSE was independently associated with higher BDI scores in male adolescents (beta = 2.25, p = 0.026), but not in female adolescents (beta = 1.11, p = 0.253). Compared to no SHSE, the odds ratio for having depressive symptoms among male adolescents with regular SHSE was 2.17 (95% confidence interval, 1.11 to 4.25) after adjusting for age, body mass index, and study year, and 3.65 (95% confidence interval, 1.52 to 8.73) after adjusting for age, body mass index, study year, exercise, and household income. Conclusion Regular exposure to secondhand smoke was associated with having depressive symptoms among Korean male adolescents.	[Kim, Na Hyun] Korean Human Resource Dev Inst Hlth & Welf, Cheongju, South Korea; [Park, Ji Hye] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea; [Choi, Dong Phil] Natl Acad Agr Sci, Rural Dev Adm, Jeonju, South Korea; [Lee, Joo Young; Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul, South Korea	Yonsei University; Rural Development Administration (RDA); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, HC (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.; Kim, HC (corresponding author), Yonsei Univ, Coll Med, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul, South Korea.	hckim@yuhs.ac	Kim, Hyeon Chang/F-8796-2019	Kim, Hyeon Chang/0000-0001-7867-1240	Basic Science Research Program through the National Research Foundation of Korea (NRF) grant - Ministry of Education, Science and Technology (MEST) [2010-0007860, 2015R1D1A1A09057301]	Basic Science Research Program through the National Research Foundation of Korea (NRF) grant - Ministry of Education, Science and Technology (MEST)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (MEST) (No. 2010-0007860, No. 2015R1D1A1A09057301). URL http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none.	Adams T, 2015, CHEST; Bahk JY, 2002, PROG NEURO-PSYCHOPH, V26, P1095, DOI 10.1016/S0278-5846(02)00243-9; Bandiera FC, 2011, ARCH PEDIAT ADOL MED, V165, P332, DOI 10.1001/archpediatrics.2011.30; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bot M, 2013, J PSYCHOSOM RES, V75, P431, DOI 10.1016/j.jpsychores.2013.08.016; Cho SC, 2010, J CHILD PSYCHOL PSYC, V51, P1050, DOI 10.1111/j.1469-7610.2010.02250.x; Choi DP, 2017, INT J EPIDEMIOL, V46, P393, DOI 10.1093/ije/dyv064; Control CfD Prevention, 2008, MMWR-MORBID MORTAL W, V57, P744; Dailly E, 2004, FUND CLIN PHARMACOL, V18, P601, DOI 10.1111/j.1472-8206.2004.00287.x; Danielson K, 2014, SYNAPSE, V68, P45, DOI 10.1002/syn.21715; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Eisenberger NI, 2010, BIOL PSYCHIAT, V68, P748, DOI 10.1016/j.biopsych.2010.06.010; Ekblad M, 2010, ARCH GEN PSYCHIAT, V67, P841, DOI 10.1001/archgenpsychiatry.2010.92; Fergusson DM, 2002, ARCH GEN PSYCHIAT, V59, P225, DOI 10.1001/archpsyc.59.3.225; Hamer M, 2011, ARCH PEDIAT ADOL MED, V165, P326, DOI 10.1001/archpediatrics.2010.243; Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938; Health UDo Services H, 2010, REP SURG GEN TOB SMO; Health UDo Services H, 2014, HLTH CONSMOK 50 YE; Ho SY, 2010, J PEDIATR-US, V157, P1012, DOI 10.1016/j.jpeds.2010.06.013; Hughes SC, 2008, ASIAN PAC J CANCER P, V9, P491; Iniguez SD, 2009, NEUROPSYCHOPHARMACOL, V34, P1609, DOI 10.1038/npp.2008.220; Jefferis BJ, 2010, ATHEROSCLEROSIS, V208, P550, DOI 10.1016/j.atherosclerosis.2009.07.044; Jo SA, 2007, INT J GERIATR PSYCH, V22, P218, DOI 10.1002/gps.1664; Kandel DB, 2006, NICOTINE TOB RES, V8, P525, DOI 10.1080/14622200600672732; Kit BK, 2013, PEDIATRICS, V131, P407, DOI 10.1542/peds.2012-2328; Lai HK, 2009, PEDIATRICS, V124, P1306, DOI 10.1542/peds.2009-0669; Lee KJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003734; Li SJ, 2004, ASIAN J WATER ENV PO, V1, P1, DOI DOI 10.1152/AJPCELL.00020.2004; McKenzie M, 2010, ADDICTION, V105, P1652, DOI 10.1111/j.1360-0443.2010.03002.x; Pasco JA, 2010, BRIT J PSYCHIAT, V197, P372, DOI 10.1192/bjp.bp.109.076430; Pattenden S, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015065; Sobocki P, 2007, EUR PSYCHIAT, V22, P146, DOI 10.1016/j.eurpsy.2006.10.006; Wang CW, 2008, PEDIATRICS, V122, pE107, DOI 10.1542/peds.2007-3370; Weitzman M, 2005, CIRCULATION, V112, P862, DOI 10.1161/CIRCULATIONAHA.104.520650; WHO, 2011, IMP EC CRIS MENT HLT; Xu XH, 2010, PEDIATRICS, V126, P705, DOI 10.1542/peds.2009-3589; Yolton K, 2010, PEDIATRICS, V125, pE261, DOI 10.1542/peds.2009-0690	38	15	15	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168754	10.1371/journal.pone.0168754	http://dx.doi.org/10.1371/journal.pone.0168754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7LN	28036385	Green Published, Green Submitted, gold			2022-12-26	WOS:000391229300024
J	Kim, SH; Lee, HS; Kang, BJ; Song, BJ; Kim, HB; Lee, H; Jin, MS; Lee, A				Kim, Sung Hun; Lee, Hyeon Sil; Kang, Bong Joo; Song, Byung Joo; Kim, Hyun-Bin; Lee, Hyunyong; Jin, Min-Sun; Lee, Ahwon			Dynamic Contrast-Enhanced MRI Perfusion Parameters as Imaging Biomarkers of Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BREAST-CANCER PATIENTS; PROGNOSTIC-FACTORS; PROLIFERATION; SUBTYPES	Hypoxia in the tumor microenvironment is the leading factor in angiogenesis. Angiogenesis can be identified by dynamic contrast-enhanced breast MRI (DCE MRI). Here we investigate the relationship between perfusion parameters on DCE MRI and angiogenic and prognostic factors in patients with invasive ductal carcinoma (IDC). Perfusion parameters (K-trans, k(ep) and V-e) of 81 IDC were obtained using histogram analysis. Twenty-fifth, 50th and 75th percentile values were calculated and were analyzed for association with microvessel density (MVD), vascular endothelial growth factor (VEGF) and conventional prognostic factors. Correlation between MVD and v(e50) was positive (r = 0.33). K-50(trans) was higher in tumors larger than 2 cm than in tumors smaller than 2 cm. In multivariate analysis, K-50(trans) was affected by tumor size and MVD with 12.8% explanation. There was significant association between K-50(trans) and tumor size and MVD. Therefore we conclude that DCE MRI perfusion parameters are potential imaging biomarkers for prediction of tumor angiogenesis and aggressiveness.	[Kim, Sung Hun; Lee, Hyeon Sil; Kang, Bong Joo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Radiol, Seoul, South Korea; [Song, Byung Joo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Gen Surg, Seoul, South Korea; [Kim, Hyun-Bin; Lee, Hyunyong] Catholic Univ Korea, Coll Med, Dept Biostat, Clin Res Coordinating Ctr, Seoul, South Korea; [Jin, Min-Sun; Lee, Ahwon] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Hosp Pathol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Lee, A (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Hosp Pathol, Seoul, South Korea.	klee@catholic.ac.kr		Jin, Min-Sun/0000-0001-8412-3363; Lee, Hyunyong/0000-0002-6132-9577	Research Fund of Seoul St. Mary's Hospital; Catholic University of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2014R1A1A3049554]	Research Fund of Seoul St. Mary's Hospital; Catholic University of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This study was supported by the Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2014R1A1A3049554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin G, 2006, BRIT J SURG, V93, P992, DOI 10.1002/bjs.5352; Bharti JN, 2015, J CLIN DIAGN RES, V9, pEC5, DOI 10.7860/JCDR/2015/10591.5447; BLACK R, 1983, CLIN ONCOL, V9, P311; Bluff JE, 2009, BRIT J CANCER, V101, P666, DOI 10.1038/sj.bjc.6605196; Dekker TJA, 2013, BREAST CANCER RES TR, V139, P371, DOI 10.1007/s10549-013-2571-5; Ferrara N, 2009, EUR CYTOKINE NETW, V20, P158, DOI 10.1684/ecn.2009.0170; George ML, 2001, BRIT J SURG, V88, P1628, DOI 10.1046/j.0007-1323.2001.01947.x; Haldorsen IS, 2014, BRIT J CANCER, V110, P107, DOI 10.1038/bjc.2013.694; Just N, 2014, BRIT J CANCER, V111, P2205, DOI 10.1038/bjc.2014.512; Khalifa F, 2014, MED PHYS, V41, DOI 10.1118/1.4898202; Kim JY, 2015, MAGN RESON IMAGING, V33, P72, DOI 10.1016/j.mri.2014.08.034; Klein M, 2001, J CLIN ENDOCR METAB, V86, P656, DOI 10.1210/jc.86.2.656; Koo HR, 2012, J MAGN RESON IMAGING, V36, P145, DOI 10.1002/jmri.23635; Kumar R, 2001, SEMIN ONCOL, V28, P27, DOI 10.1016/S0093-7754(01)90279-9; Li L, 2015, MED SCI MONITOR, V21, P376, DOI 10.12659/MSM.892534; Li SP, 2011, RADIOLOGY, V260, P68, DOI 10.1148/radiol.11102493; Li SP, 2011, EUR RADIOL, V21, P1364, DOI 10.1007/s00330-011-2061-2; Ludovini V, 2003, BREAST CANCER RES TR, V81, P159, DOI 10.1023/A:1025755717912; O'Connor JPB, 2015, CLIN CANCER RES, V21, P249, DOI 10.1158/1078-0432.CCR-14-0990; O'Connor JPB, 2012, NAT REV CLIN ONCOL, V9, P167, DOI 10.1038/nrclinonc.2012.2; Oto A, 2011, AM J ROENTGENOL, V197, P1382, DOI 10.2214/AJR.11.6861; RAK J, 1995, CANCER RES, V55, P4575; Saranathan M, 2014, J MAGN RESON IMAGING, V40, P1392, DOI 10.1002/jmri.24490; Smeazzetto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052744; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Yeo DM, 2015, J MAGN RESON IMAGING, V41, P474, DOI 10.1002/jmri.24541; Yim H, 2016, MAGN RESON IMAGING, V34, P60, DOI 10.1016/j.mri.2015.07.010	27	27	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168632	10.1371/journal.pone.0168632	http://dx.doi.org/10.1371/journal.pone.0168632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036342	gold, Green Published, Green Submitted			2022-12-26	WOS:000391229300018
J	Perez-Cruz, C; Canas, MA; Gimenez, R; Badia, J; Mercade, E; Baldoma, L; Aguilera, L				Perez-Cruz, Carla; Canas, Maria-Alexandra; Gimenez, Rosa; Badia, Josefa; Mercade, Elena; Baldoma, Laura; Aguilera, Laura			Membrane Vesicles Released by a hypervesiculating Escherichia coli Nissle 1917 tolR Mutant Are Highly Heterogeneous and Show Reduced Capacity for Epithelial Cell Interaction and Entry	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; EXTRACELLULAR VESICLES; BIOGENESIS; VIRULENCE; IMMUNE; MECHANISM; PROTEINS; ENVELOPE; ENZYME	Membrane vesicles (MVs) produced by Gram-negative bacteria are being explored for novel clinical applications due to their ability to deliver active molecules to distant host cells, where they can exert immunomodulatory properties. MVs released by the probiotic Escherichia coli Nissle 1917 (EcN) are good candidates for testing such applications. However, a drawback for such studies is the low level of MV isolation from in vitro culture supernatants, which may be overcome by the use of mutants in cell envelope proteins that yield a hyperve-siculation phenotype. Here, we confirm that a tolR mutation in EcN increases MV production, as determined by protein, LPS and fluorescent lipid measurements. Transmission electron microscopy (TEM) of negatively stained MVs did not reveal significant differences with wild type EcN MVs. Conversely, TEM observation after high-pressure freezing followed by freeze substitution of bacterial samples, together with cryo-TEM observation of plunge-frozen hydrated isolated MVs showed considerable structural heterogeneity in the EcN tolR samples. In addition to common one-bilayer vesicles (OMVs) and the recently described double-bilayer vesicles (O-IMVs), other types of MVs were observed. Time-course experiments of MV uptake in Caco-2 cells using rhodamine-and DiO-labelled MVs evidenced that EcN tolR MVs displayed reduced internalization levels compared to the wild-type MVs. The low number of intracellular MVs was due to a lower cell binding capacity of the tolR-derived MVs, rather than a different entry pathway or mechanism. These findings indicate that heterogeneity of MVs from tolR mutants may have a major impact on vesicle functionality, and point to the need for conducting a detailed structural analysis when MVs from hypervesiculating mutants are to be used for biotechnological applications.	[Perez-Cruz, Carla; Mercade, Elena] Univ Barcelona, Fac Farm, Dept Biol Sanitat & Medi Ambient, Seccio Microbiol, Barcelona, Spain; [Canas, Maria-Alexandra; Gimenez, Rosa; Badia, Josefa; Baldoma, Laura; Aguilera, Laura] Univ Barcelona, Fac Farm, Dept Bioquim & Fisiol, Seccio Bioquim & Biol Mol, Barcelona, Spain; [Canas, Maria-Alexandra; Gimenez, Rosa; Badia, Josefa; Baldoma, Laura; Aguilera, Laura] Univ Barcelona, Inst Biomed, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona	Baldoma, L (corresponding author), Univ Barcelona, Fac Farm, Dept Bioquim & Fisiol, Seccio Bioquim & Biol Mol, Barcelona, Spain.; Baldoma, L (corresponding author), Univ Barcelona, Inst Biomed, Barcelona, Spain.	lbaldoma@ub.edu	Pacheco, Maria Alexandra C/B-4509-2019; Perez-Cruz, Carla/AAB-3540-2020; Aguilera, Laura/K-4049-2017; Badia, Josefa/G-7292-2015; Baldomà, Laura/G-7301-2015; Giménez, Rosa/V-4777-2017; Aguilera, Laura/AAD-7765-2019; Mercade, Elena/L-5218-2014	Aguilera, Laura/0000-0002-8631-8778; Badia, Josefa/0000-0003-0768-5033; Baldomà, Laura/0000-0002-7678-269X; Giménez, Rosa/0000-0002-4158-7157; Aguilera, Laura/0000-0002-8631-8778; Mercade, Elena/0000-0001-7828-2210	Ministerio de Economia y Competitividad, Spain [AGL2012-34985, CTQ2014-59632-R]; Departament d'Innovacio, Universitats i Empresa from the Autonomous Goverment of Catalonia [2014SGR1017, 2014SGR1325]; Universitat de Barcelona [APIF2015]; European Commission ERDF funds	Ministerio de Economia y Competitividad, Spain; Departament d'Innovacio, Universitats i Empresa from the Autonomous Goverment of Catalonia; Universitat de Barcelona; European Commission ERDF funds	This work received funding from the following sources: grant AGL2012-34985 (co-finaced with European Commission ERDF funds) to LB and grant CTQ2014-59632-R to EM, both from the Ministerio de Economia y Competitividad, Spain; and grants 2014SGR1017 and 2014SGR1325 from the Departament d'Innovacio, Universitats i Empresa from the Autonomous Goverment of Catalonia. CPC was a recipient of the fellowship APIF2015 from the Universitat de Barcelona. The funders has no role in study design, data collection and analysis, decission to publish, or preparation of the manuscript.	Aguilera L, 2014, PROTEOMICS, V14, P222, DOI 10.1002/pmic.201300328; Alves NJ, 2015, ACS APPL MATER INTER, V7, P24963, DOI 10.1021/acsami.5b08811; Bager RJ, 2013, VET MICROBIOL, V167, P565, DOI 10.1016/j.vetmic.2013.09.005; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bielaszewska M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003797; Bielig H, 2011, INFECT IMMUN, V79, P1418, DOI 10.1128/IAI.00754-10; Canas MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160374; Chen DJ, 2010, P NATL ACAD SCI USA, V107, P3099, DOI 10.1073/pnas.0805532107; Deatherage BL, 2009, MOL MICROBIOL, V72, P1395, DOI 10.1111/j.1365-2958.2009.06731.x; Dubuisson JF, 2005, MICROBIOL-SGM, V151, P3337, DOI 10.1099/mic.0.28237-0; Egea L, 2007, INT J BIOCHEM CELL B, V39, P1190, DOI 10.1016/j.biocel.2007.03.008; Ercoli G, 2015, MBIO, V6, DOI 10.1128/mBio.02575-14; Fiocca R, 1999, J PATHOL, V188, P220, DOI 10.1002/(SICI)1096-9896(199906)188:2<220::AID-PATH307>3.0.CO;2-C; Frias A, 2010, MICROB ECOL, V59, P476, DOI 10.1007/s00248-009-9622-9; Gujrati V, 2014, ACS NANO, V8, P1525, DOI 10.1021/nn405724x; Henry T, 2004, RES MICROBIOL, V155, P437, DOI 10.1016/j.resmic.2004.04.007; Jensen GJ, 2007, CURR OPIN STRUC BIOL, V17, P260, DOI 10.1016/j.sbi.2007.03.002; Fabrega MJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00705; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Kaparakis-Liaskos M, 2015, NAT REV IMMUNOL, V15, P375, DOI 10.1038/nri3837; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Kolling GL, 1999, APPL ENVIRON MICROB, V65, P1843; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Kulp AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139200; Kunsmann L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13252; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Llamas MA, 2000, J BACTERIOL, V182, P4764, DOI 10.1128/JB.182.17.4764-4772.2000; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mashburn-Warren L, 2008, GEOBIOLOGY, V6, P214, DOI 10.1111/j.1472-4669.2008.00157.x; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; McBroom AJ, 2006, J BACTERIOL, V188, P5385, DOI 10.1128/JB.00498-06; Moon DC, 2012, J MICROBIOL, V50, P155, DOI 10.1007/s12275-012-1589-4; Nevot M, 2006, MICROB ECOL, V51, P501, DOI 10.1007/s00248-006-9065-5; Nieves W, 2014, CLIN VACCINE IMMUNOL, V21, P747, DOI 10.1128/CVI.00119-14; Nokleby H, 2007, VACCINE, V25, P3080, DOI 10.1016/j.vaccine.2007.01.022; Palsdottir H, 2009, J BACTERIOL, V191, P2077, DOI 10.1128/JB.01333-08; Parker H, 2010, INFECT IMMUN, V78, P5054, DOI 10.1128/IAI.00299-10; Perez-Cruz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116896; Perez-Cruz C, 2013, APPL ENVIRON MICROB, V79, P1874, DOI 10.1128/AEM.03657-12; Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Roier S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10515; Rosenthal JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112802; Schwechheimer C, 2015, NAT REV MICROBIOL, V13, P605, DOI 10.1038/nrmicro3525; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; SONNTAG I, 1978, J BACTERIOL, V136, P280, DOI 10.1128/JB.136.1.280-285.1978; Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1; SUN TP, 1987, J BACTERIOL, V169, P2667, DOI 10.1128/jb.169.6.2667-2674.1987; Turner L, 2015, HELICOBACTER, V20, P269, DOI 10.1111/hel.12196; van der Pol L, 2015, BIOTECHNOL J, V10, P1689, DOI 10.1002/biot.201400395; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Yoon YJ, 2014, BMB REP, V47, P531, DOI 10.5483/BMBRep.2014.47.10.164	56	21	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0169186	10.1371/journal.pone.0169186	http://dx.doi.org/10.1371/journal.pone.0169186			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036403	gold, Green Published, Green Submitted			2022-12-26	WOS:000391229300063
J	Rittiroongrad, S; Charoenlap, N; Giengkam, S; Vattanaviboon, P; Mongkolsuk, S				Rittiroongrad, Surawach; Charoenlap, Nisanart; Giengkam, Suparat; Vattanaviboon, Paiboon; Mongkolsuk, Skorn			Agrobacterium tumefaciens estC, Encoding an Enzyme Containing Esterase Activity, Is Regulated by EstR, a Regulator in the MarR Family	PLOS ONE			English	Article							ORGANIC HYDROPEROXIDE RESISTANCE; TRANSCRIPTIONAL REGULATORS; OHRR; REPRESSOR; STRESS; CLONING; SENSOR; OXYR; PROTECTION; MECHANISM	Analysis of the A. tumefaciens genome revealed estC, which encodes an esterase located next to its transcriptional regulator estR, a regulator of esterase in the MarR family. Inactivation of estC results in a small increase in the resistance to organic hydroperoxides, whereas a high level of expression of estC from an expression vector leads to a reduction in the resistance to organic hydroperoxides and menadione. The estC gene is transcribed divergently from its regulator, estR. Expression analysis showed that only high concentrations of cumene hydroperoxide (CHP, 1 mM) induced expression of both genes in an EstR-dependent manner. The EstR protein acts as a CHP sensor and a transcriptional repressor of both genes. EstR specifically binds to the operator sites OI and OII overlapping the promoter elements of estC and estR. This binding is responsible for transcription repression of both genes. Exposure to organic hydroperoxide results in oxidation of the sensing cysteine (Cys16) residue of EstR, leading to a release of the oxidized repressor from the operator sites, thereby allowing transcription and high levels of expression of both genes. The estC is the first organic hydroperoxide-inducible esterase-encoding gene in alphaproteobacteria.	[Rittiroongrad, Surawach; Charoenlap, Nisanart; Giengkam, Suparat; Vattanaviboon, Paiboon; Mongkolsuk, Skorn] Chulabhorn Res Inst, Biotechnol Lab, Bangkok, Thailand; [Rittiroongrad, Surawach; Mongkolsuk, Skorn] Mahidol Univ, Dept Biotechnol, Fac Sci, Bangkok, Thailand; [Rittiroongrad, Surawach; Mongkolsuk, Skorn] Mahidol Univ, Ctr Emerging Bacterial Infect, Fac Sci, Bangkok, Thailand; [Charoenlap, Nisanart; Vattanaviboon, Paiboon; Mongkolsuk, Skorn] Ctr Excellence Environm Hlth & Toxicol, Bangkok, Thailand; [Vattanaviboon, Paiboon; Mongkolsuk, Skorn] Chulabhorn Grad Inst, Program Appl Biol Sci Environm Hlth, Bangkok, Thailand	Chulabhorn Research Institute; Mahidol University; Mahidol University; Chulabhorn Graduate Institute	Mongkolsuk, S (corresponding author), Chulabhorn Res Inst, Biotechnol Lab, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Mahidol Univ, Dept Biotechnol, Fac Sci, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Mahidol Univ, Ctr Emerging Bacterial Infect, Fac Sci, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Ctr Excellence Environm Hlth & Toxicol, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Chulabhorn Grad Inst, Program Appl Biol Sci Environm Hlth, Bangkok, Thailand.	skorn@cri.or.th	Vattanaviboon, Paiboon/V-1380-2019	Scheu nee Giengkam, Suparat/0000-0003-0747-4316	Chulabhorn Research Institute, Mahidol University; Center of Excellence on Environmental Health and Toxicology (EHT), Ministry of Education, Thailand [EHT-R 1/2556-1]	Chulabhorn Research Institute, Mahidol University; Center of Excellence on Environmental Health and Toxicology (EHT), Ministry of Education, Thailand	This work was supported by grants from the Chulabhorn Research Institute, Mahidol University, and the Center of Excellence on Environmental Health and Toxicology (EHT), Ministry of Education, Thailand (EHT-R 1/2556-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Atichartpongkul S, 2010, J BACTERIOL, V192, P2093, DOI 10.1128/JB.01510-09; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Chuchue T, 2006, J BACTERIOL, V188, P842, DOI 10.1128/JB.188.3.842-851.2006; Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12; Eiamphungporn W, 2003, FEMS MICROBIOL LETT, V225, P167, DOI 10.1016/S0378-1097(03)00511-1; Eiamphungporn W, 2006, J BACTERIOL, V188, P8669, DOI 10.1128/JB.00856-06; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Fuangthong M, 2001, J BACTERIOL, V183, P4134, DOI 10.1128/JB.183.14.4134-4141.2001; Gundogdu O, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00724; Helmann JD, 2011, ANTIOXID REDOX SIGN, V15, P123, DOI 10.1089/ars.2010.3562; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lan LF, 2010, MOL MICROBIOL, V75, P76, DOI 10.1111/j.1365-2958.2009.06955.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Li C, 2008, CHEMBIOCHEM, V9, P71, DOI 10.1002/cbic.200700428; Liu X, 2013, J BIOL CHEM, V288, P3739, DOI 10.1074/jbc.M112.426205; Luo ZQ, 2001, MOL PLANT MICROBE IN, V14, P98, DOI 10.1094/MPMI.2001.14.1.98; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Mongkolsuk S, 2002, MOL MICROBIOL, V44, P793, DOI 10.1046/j.1365-2958.2002.02919.x; Nakjarung K, 2003, BIOCHEM BIOPH RES CO, V304, P41, DOI 10.1016/S0006-291X(03)00535-7; Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016; Ochsner UA, 2001, J BACTERIOL, V183, P773, DOI 10.1128/JB.183.2.773-778.2001; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Oh SY, 2007, J BACTERIOL, V189, P6284, DOI 10.1128/JB.00632-07; Panmanee W, 2006, J BACTERIOL, V188, P1389, DOI 10.1128/JB.188.4.1389-1395.2006; Prapagdee B, 2004, FEMS MICROBIOL LETT, V232, P217, DOI 10.1016/S0378-1097(04)00075-8; Reiter B, 2000, APPL MICROBIOL BIOT, V54, P778, DOI 10.1007/s002530000468; Ro HS, 2004, FEMS MICROBIOL LETT, V233, P97, DOI 10.1016/j.femsle.2004.01.046; Saenkham P, 2007, J BACTERIOL, V189, P8807, DOI 10.1128/JB.00960-07; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Soonsanga S, 2008, J BACTERIOL, V190, P5738, DOI 10.1128/JB.00576-08; Sukchawalit R, 2001, J BACTERIOL, V183, P4405, DOI 10.1128/JB.183.15.4405-4412.2001; SULAVIK MC, 1995, MOL MED, V1, P436, DOI 10.1007/BF03401581; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804	38	4	4	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2016	11	12							e0168791	10.1371/journal.pone.0168791	http://dx.doi.org/10.1371/journal.pone.0168791			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7LN	28036400	Green Published, gold, Green Submitted			2022-12-26	WOS:000391229300029
J	Munguia, R; Urzua, S; Grau, A				Munguia, Rodrigo; Urzua, Sarquis; Grau, Antoni			Delayed Monocular SLAM Approach Applied to Unmanned Aerial Vehicles	PLOS ONE			English	Article							SIMULTANEOUS LOCALIZATION; SOUND SOURCE; CAMERA; VISION; NAVIGATION; IMU	In recent years, many researchers have addressed the issue of making Unmanned Aerial Vehicles (UAVs) more and more autonomous. In this context, the state estimation of the vehicle position is a fundamental necessity for any application involving autonomy. However, the problem of position estimation could not be solved in some scenarios, even when a GPS signal is available, for instance, an application requiring performing precision manoeuvres in a complex environment. Therefore, some additional sensory information should be integrated into the system in order to improve accuracy and robustness. In this work, a novel vision-based simultaneous localization and mapping (SLAM) method with application to unmanned aerial vehicles is proposed. One of the contributions of this work is to design and develop a novel technique for estimating features depth which is based on a stochastic technique of triangulation. In the proposed method the camera is mounted over a servo-controlled gimbal that counteracts the changes in attitude of the quadcopter. Due to the above assumption, the overall problem is simplified and it is focused on the position estimation of the aerial vehicle. Also, the tracking process of visual features is made easier due to the stabilized video. Another contribution of this work is to demonstrate that the integration of very noisy GPS measurements into the system for an initial short period of time is enough to initialize the metric scale. The performance of this proposed method is validated by means of experiments with real data carried out in unstructured outdoor environments. A comparative study shows that, when compared with related methods, the proposed approach performs better in terms of accuracy and computational time.	[Munguia, Rodrigo; Urzua, Sarquis] Univ Guadalajara, CUCEI, Dept Comp Sci, Guadalajara, Jalisco, Mexico; [Grau, Antoni] Tech Univ Catalonia, Dept Automat Control, Barcelona 08034, Spain	Universidad de Guadalajara; Universitat Politecnica de Catalunya	Munguia, R (corresponding author), Univ Guadalajara, CUCEI, Dept Comp Sci, Guadalajara, Jalisco, Mexico.; Grau, A (corresponding author), Tech Univ Catalonia, Dept Automat Control, Barcelona 08034, Spain.	rodrigo.munguia@upc.edu; antoni.grau@upc.edu	Grau, Antoni/B-6588-2013	Munguia, Rodrigo/0000-0003-2282-2884; Grau, Antoni/0000-0003-4112-3325	European Union [H2020-ICT-2014-1-644271]	European Union(European Commission)	This research has been funded with European Union AEROARMS Project with reference H2020-ICT-2014-1-644271, http//www.aeroarms-project.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research has been funded with EU Project AEROARMS project with reference H2020-ICT-2014-1-644271, http//www.aeroarms-project.eu/.	Artieda J, 2009, J INTELL ROBOT SYST, V55, P299, DOI 10.1007/s10846-008-9304-8; Bailey T, 2006, IEEE ROBOT AUTOM MAG, V13, P108, DOI 10.1109/MRA.2006.1678144; Bosse M, 2007, IEEE INT CONF ROBOT, P4820, DOI 10.1109/ROBOT.2007.364222; Bouguet J. Y., 2008, CAMERA CALIBRATION T; Caballero F, 2009, J INTELL ROBOT SYST, V54, P137, DOI 10.1007/s10846-008-9257-y; Celik K, 2013, J ELECTR COMPUT ENG, V2013, DOI 10.1155/2013/374165; Chaolei Wang, 2012, Proceedings of the 2012 IEEE International Conference on Robotics and Biomimetics (ROBIO), P896, DOI 10.1109/ROBIO.2012.6491082; Chatterjee C, 2000, MACH VISION APPL, V12, P84, DOI 10.1007/s001380050127; Civera J, 2007, IEEE INT CONF ROBOT, P2778, DOI 10.1109/ROBOT.2007.363892; Civera J, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P3498, DOI 10.1109/IROS.2009.5354410; Cole DM, 2006, ROB AUT 2006 ICRA 20; Davison A.J., 1998, P 5 EUR C COMP VIS E; Davison AJ, 2007, IEEE T PATTERN ANAL, V29, P1052, DOI 10.1109/TPAMI.2007.1049; Durrant-Whyte H, 2006, IEEE ROBOT AUTOM MAG, V13, P99, DOI 10.1109/MRA.2006.1638022; Engel J, 2014, LECT NOTES COMPUT SC, V8690, P834, DOI 10.1007/978-3-319-10605-2_54; Euston M, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P340, DOI 10.1109/IROS.2008.4650766; Fallon MF, 2013, IEEE J OCEANIC ENG, V38, P500, DOI 10.1109/JOE.2012.2235664; Forster Christian, 2013, 2013 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2013), P3962, DOI 10.1109/IROS.2013.6696923; Forster C, 2014, IEEE INT CONF ROBOT, P15, DOI 10.1109/ICRA.2014.6906584; Friedman C., 2011, AIAA GUID NAV CONTR; Ganapathy S., 1984, International Conference on Robotics, P130; Hahnel D, 2004, IEEE INT CONF ROBOT, P1015, DOI 10.1109/ROBOT.2004.1307283; Huh S, 2013, IEEE INT C INT ROBOT, P3158, DOI 10.1109/IROS.2013.6696805; Klein George, 2007, P1; Kleiner A., 2007, IEEE INT WORKSH SAF, P1; Lemaire T, 2007, INT J COMPUT VISION, V74, P343, DOI 10.1007/s11263-007-0042-3; Luo RC, 2010, IEEE INT C INT ROBOT, P1347, DOI 10.1109/IROS.2010.5649993; Magree Daniel, 2014, 2014 American Control Conference, P1900, DOI 10.1109/ACC.2014.6858995; Mirzaei FM, 2008, IEEE T ROBOT, V24, P1143, DOI 10.1109/TRO.2008.2004486; Montemerlo M, 2002, EIGHTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-02)/FOURTEENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE (IAAI-02), PROCEEDINGS, P593; Montiel JMM, 2006, P ROB SCI SYST C; Munguia R, 2008, LECT NOTES COMPUT SC, V5197, P70, DOI 10.1007/978-3-540-85920-8_9; Munguia R, 2014, INT J ADV ROBOT SYST, V11, DOI 10.5772/58463; Munguia R, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/676385; Munguia R, 2009, IEEE T INSTRUM MEAS, V58, P2377, DOI 10.1109/TIM.2009.2016377; Mur-Artal R, 2015, IEEE T ROBOT, V31, P1147, DOI 10.1109/TRO.2015.2463671; Newman P, 2003, IEEE INT CONF ROBOT, P1921, DOI 10.1109/ROBOT.2003.1241875; Nutzi G, 2011, J INTELL ROBOT SYST, V61, P287, DOI 10.1007/s10846-010-9490-z; Parkinson BW., 1996, GLOBAL POSITIONIG SY; Shi J., 1994, COMP VIS PATT REC 19; Strasdat H, 2010, IEEE INT CONF ROBOT, P2657, DOI 10.1109/ROBOT.2010.5509636; Suzuki T., 2011, SICE 2011 - 50th Annual Conference of the Society of Instrument and Control Engineers of Japan, P1656; Ta DN, 2013, IEEE RSJ IROS 13 INT; Tan W, 2013, INT SYM MIX AUGMENT, P209, DOI 10.1109/ISMAR.2013.6671781; Weiss S, 2011, J FIELD ROBOT, V28, P854, DOI 10.1002/rob.20412; Yap TN, 2009, IEEE INT CONF ROBOT, P100; Zhao HJ, 2008, IEEE INT CONF ROBOT, P1455, DOI 10.1109/ROBOT.2008.4543407	47	2	2	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0167197	10.1371/journal.pone.0167197	http://dx.doi.org/10.1371/journal.pone.0167197			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033385	Green Published, gold, Green Submitted			2022-12-26	WOS:000391226900009
J	Papageorgiou, C; Stachtea, X; Papageorgiou, P; Alexandridis, AT; Tsaltas, E; Angelopoulos, E				Papageorgiou, Charalabos; Stachtea, Xanthi; Papageorgiou, Panos; Alexandridis, Antonio T.; Tsaltas, Eleftheria; Angelopoulos, Elias			Aristotle Meets Zeno: Psychophysiological Evidence	PLOS ONE			English	Article							WORKING-MEMORY; NEURAL BASIS; INDIVIDUAL-DIFFERENCES; PREFRONTAL CORTEX; BRAIN; NETWORK; COMMUNICATION; UNCERTAINTY; GENERATION; AMBIGUITY	This study, a tribute to Aristotle's 2400 years, used a juxtaposition of valid Aristotelian arguments to the paradoxes formulated by Zeno the Eleatic, in order to investigate the electrophysiological correlates of attentional and /or memory processing effects in the course of deductive reasoning. Participants undertook reasoning tasks based on visually presented arguments which were either (a) valid (Aristotelian) statements or (b) paradoxes. We compared brain activation patterns while participants maintained the premises / conclusions of either the valid statements or the paradoxes in working memory (WM). Event-related brain potentials (ERPs), specifically the P300 component of ERPs, were recorded during the WM phase, during which participants were required to draw a logical conclusion regarding the correctness of the valid syllogisms or the paradoxes. During the processing of paradoxes, results demonstrated a more positive event-related potential deflection (P300) across frontal regions, whereas processing of valid statements was associated with noticeable P300 amplitudes across parieto-occipital regions. These findings suggest that paradoxes mobilize frontal attention mechanisms, while valid deduction promotes parieto-occipital activity associated with attention and/or subsequent memory processing.	[Papageorgiou, Charalabos; Stachtea, Xanthi; Tsaltas, Eleftheria; Angelopoulos, Elias] Eginit Hosp, Dept Psychiat 1, Athens, Greece; [Papageorgiou, Charalabos; Stachtea, Xanthi; Angelopoulos, Elias] Univ Mental Hlth Res Inst, Athens, Greece; [Papageorgiou, Panos; Alexandridis, Antonio T.] Univ Patras, Dept Elect & Comp Engn, Patras, Greece	University of Patras	Papageorgiou, C (corresponding author), Eginit Hosp, Dept Psychiat 1, Athens, Greece.; Papageorgiou, C (corresponding author), Univ Mental Hlth Res Inst, Athens, Greece.	chpapag@med.uoa.gr		Papageorgiou, Charalabos/0000-0001-7635-1956				Addison P. S., 2002, ILLUSTRATED WAVELET; [Anonymous], 2009, INT; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Atmanspacher H, 2004, BIOL CYBERN, V90, P33, DOI 10.1007/s00422-003-0436-4; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Barnes J., 1995, COMPLETE WORKS ARIST, P39; BARON J, 1988, J PERS SOC PSYCHOL, V54, P569, DOI 10.1037/0022-3514.54.4.569; Blanchette I, 2014, BRAIN COGNITION, V91, P45, DOI 10.1016/j.bandc.2014.08.001; Bocquillon P, 2011, CLIN NEUROPHYSIOL, V122, P1991, DOI 10.1016/j.clinph.2011.03.014; Bonnefond M, 2014, NEUROPSYCHOLOGIA, V56, P255, DOI 10.1016/j.neuropsychologia.2014.01.022; Bonnefond M, 2012, J MEM LANG, V67, P468, DOI 10.1016/j.jml.2012.07.007; Braine M. D. S., 1998, MENTAL LOGIC, DOI [10.4324/9781410603005, DOI 10.4324/9781410603005]; BRAINE MDS, 1978, PSYCHOL REV, V85, P1, DOI 10.1037//0033-295X.85.1.1; Caveing M, 2000, GUIDE CLASSICAL KNOW, P783; Cocchi L, 2013, TRENDS COGN SCI, V17, P493, DOI 10.1016/j.tics.2013.08.006; Cowan N, 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Evans JST, 2003, TRENDS COGN SCI, V7, P454, DOI 10.1016/j.tics.2003.08.012; Evans JST, 2002, PSYCHOL BULL, V128, P978, DOI 10.1037//0033-2909.128.6.978; Fowler HN, 1926, LESSER HIPPIAS; Fox CR, 2002, ORGAN BEHAV HUM DEC, V88, P476, DOI 10.1006/obhd.2001.2990; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Gevins A, 2000, CEREB CORTEX, V10, P829, DOI 10.1093/cercor/10.9.829; Glassman RB, 2000, PROG NEURO-PSYCHOPH, V24, P163, DOI 10.1016/S0278-5846(99)00096-2; Goel V, 2005, CEREB CORTEX, V15, P1170, DOI 10.1093/cercor/bhh217; Goel V, 2003, COGNITION, V87, pB11, DOI 10.1016/S0010-0277(02)00185-3; Goel V, 2007, TRENDS COGN SCI, V11, P435, DOI 10.1016/j.tics.2007.09.003; Goel V, 2009, NEUROPSYCHOLOGIA, V47, P2790, DOI 10.1016/j.neuropsychologia.2009.06.002; GROSSMANN A, 1984, SIAM J MATH ANAL, V15, P723, DOI 10.1137/0515056; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Jarrold C, 2006, NEUROSCIENCE, V139, P39, DOI 10.1016/j.neuroscience.2005.07.002; JOHNSONLAIRD PN, 1994, COGNITION, V50, P189, DOI 10.1016/0010-0277(94)90028-0; Johsnon-Laird P, 1991, DEDUCTION; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Knauff M, 2002, COGNITIVE BRAIN RES, V13, P203, DOI 10.1016/S0926-6410(01)00116-1; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; KNIGHT RT, 1995, ADV NEUROL, V66, P21; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kosslyn SM, 2003, PSYCHOL BULL, V129, P723, DOI 10.1037/0033-2909.129.5.723; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; Linden DEJ, 2007, REV NEUROSCIENCE, V18, P159; Malaia E, 2015, J PSYCHOLINGUIST RES, V44, P533, DOI 10.1007/s10936-014-9297-3; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; Monti MM, 2007, NEUROIMAGE, V37, P1005, DOI 10.1016/j.neuroimage.2007.04.069; Novais-Santos S, 2007, NEUROIMAGE, V37, P361, DOI 10.1016/j.neuroimage.2007.03.077; Oaksford M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00101; Papageorgiou C, 2012, J PSYCHOLINGUIST RES, V41, P129, DOI 10.1007/s10936-011-9181-3; Plutarch, 1916, THE PAR LIV; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Potts GF, 1996, BRAIN TOPOGR, V9, P3, DOI 10.1007/BF01191637; Prado J, 2011, J COGNITIVE NEUROSCI, V23, P3483, DOI 10.1162/jocn_a_00063; Qiu J, 2007, NEUROPSYCHOLOGIA, V45, P1533, DOI 10.1016/j.neuropsychologia.2006.11.014; Qiu J, 2009, BRAIN RES, V1273, P106, DOI 10.1016/j.brainres.2009.03.054; Reverberi C, 2007, NEUROIMAGE, V38, P752, DOI 10.1016/j.neuroimage.2007.07.060; Reverberi C, 2012, NEUROIMAGE, V59, P1752, DOI 10.1016/j.neuroimage.2011.08.027; Rips L.J., 1994, PSYCHOL PROOF DEDUCT; Rodriguez-Moreno D, 2009, NEUROPSYCHOLOGIA, V47, P949, DOI 10.1016/j.neuropsychologia.2008.08.030; Rondik T, 2011, P 4 INCF C NEUR; Ruff CC, 2003, NEUROPSYCHOLOGIA, V41, P1241, DOI 10.1016/S0028-3932(03)00016-2; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Shokri-Kojori E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00411; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Strumia Alberto, 2007, Acta Biomed, V78 Suppl 1, P32; Verbaten MN, 1997, INT J PSYCHOPHYSIOL, V25, P237, DOI 10.1016/S0167-8760(96)00748-9; Verweij M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00332; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wang L, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/108417; Wronka E, 2008, ACTA NEUROBIOL EXP, V68, P362; YAMAGUCHI S, 1991, J NEUROSCI, V11, P2039	70	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168067	10.1371/journal.pone.0168067	http://dx.doi.org/10.1371/journal.pone.0168067			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7KQ	28033333	Green Submitted, Green Published, gold			2022-12-26	WOS:000391226900013
J	Ramaker, K; Bade, S; Rockendorf, N; Meckelein, B; Vollmer, E; Schultz, H; Froschle, GW; Frey, A				Ramaker, Katrin; Bade, Steffen; Roeckendorf, Niels; Meckelein, Barbara; Vollmer, Ekkehard; Schultz, Holger; Froeschle, Guenter-Willi; Frey, Andreas			Absence of the Epithelial Glycocalyx As Potential Tumor Marker for the Early Detection of Colorectal Cancer	PLOS ONE			English	Article							M-CELLS; COLON; SURVIVAL; ADENOMA	Detection of cancer at an early stage is pivotal for successful treatment and long term survival, yet early diagnosis requires sensitive and specific markers that can be easily detected by screening procedures. Differences in the surface structure of tumor and healthy cells, if sufficiently pronounced and discernible, may serve that purpose. We analyzed the luminal surface of healthy and neoplastic human colorectal tissues for the presence and architecture of the glycocalyx a dense network of highly glycosylated proteins using transmission electron microscopy. The ultrastructural analyses showed that 93% of healthy mucosae were covered by an intact glycocalyx. Contrarily, on over 90% of the surface of neoplastic cells the glycocalyx was absent. The sensitivity and specificity of our marker "absence of a glycocalyx" are excellent, being 91% (83-96%) and 96% (89-99%) for adenocarcinomas and 94% (73-100%) and 92% (85-97%) for precancerous polyps (means and 95% confidence intervals). Using a cell culture model we could demonstrate that a particulate probe targeting a cell surface receptor usually concealed beneath the glycocalyx can bind selectively to glycocalyx-free areas of a tumor cell layer. We propose that the absence of a glycocalyx may serve as novel type of tumor marker. If the absence of the glycocalyx can be detected e.g. via binding of imaging probes to non-shielded surface receptors of anomalously differentiated cells, this tumor marker could be used to enable early diagnosis of colorectal cancer.	[Ramaker, Katrin; Bade, Steffen; Roeckendorf, Niels; Meckelein, Barbara; Frey, Andreas] German Ctr Lung Res DZL, ARCN, Div Mucosal Immunol & Diagnost, Prior Area Asthma & Allergy,Res Ctr Borstel, Borstel, Germany; [Vollmer, Ekkehard; Schultz, Holger] German Ctr Lung Res DZL, ARCN, Div Clin & Expt Pathol, Dept Med,Res Ctr Borstel, Borstel, Germany; [Froeschle, Guenter-Willi] Asklepios Clin, Bad Oldesloe, Germany; [Schultz, Holger] Humanpathol Erlangen, Erlangen, Germany; [Froeschle, Guenter-Willi] HELIOS St Marienberg Clin, Helmstedt, Germany	Forschungszentrum Borstel; Forschungszentrum Borstel	Frey, A (corresponding author), German Ctr Lung Res DZL, ARCN, Div Mucosal Immunol & Diagnost, Prior Area Asthma & Allergy,Res Ctr Borstel, Borstel, Germany.	afrey@fz-borstel.de			German Ministry for Education and Research, BMBF [13N8473]; University of Lubeck (Priority Program "Biomedizintechnik: Bildgebung bei Krankheitsprozessen")	German Ministry for Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); University of Lubeck (Priority Program "Biomedizintechnik: Bildgebung bei Krankheitsprozessen")	This work was supported by the German Ministry for Education and Research, BMBF (grant number 13N8473) and by the University of Lubeck (Priority Program "Biomedizintechnik: Bildgebung bei Krankheitsprozessen"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2016, CANC FACTS FIGURES 2; Binefa G, 2014, WORLD J GASTROENTERO, V20, P6786, DOI 10.3748/wjg.v20.i22.6786; Buzug TM, 2012, Z MED PHYS, V22, P323, DOI 10.1016/j.zemedi.2012.07.004; BYE WA, 1984, GASTROENTEROLOGY, V86, P789; CERALLI F, 1976, EXPERIENTIA, V32, P1542, DOI 10.1007/BF01924441; Dame MK, 2014, LAB INVEST, V94, P222, DOI 10.1038/labinvest.2013.145; Frey A, 1996, J EXP MED, V184, P1045, DOI 10.1084/jem.184.3.1045; Gleich B, 2008, PHYS MED BIOL, V53, pN81, DOI 10.1088/0031-9155/53/6/N01; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; Graser A, 2009, GUT, V58, P241, DOI 10.1136/gut.2008.156448; Gupta AK, 2005, CLIN GASTROENTEROL H, V3, P150, DOI 10.1016/S1542-3565(04)00664-0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; ITO S, 1965, J CELL BIOL, V27, P475, DOI 10.1083/jcb.27.3.475; KAYE GI, 1973, GASTROENTEROLOGY, V64, P926; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; MAURY J, 1995, EUR J BIOCHEM, V228, P323; Miller H, 2007, WORLD J GASTROENTERO, V13, P1477, DOI 10.3748/wjg.v13.i10.1477; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Olivier V, 2003, BIOCONJUGATE CHEM, V14, P1203, DOI 10.1021/bc034077z; Rosty C, 2013, J GASTROENTEROL, V48, P287, DOI 10.1007/s00535-012-0720-y; Seidelin JB, 2004, SCAND J GASTROENTERO, V39, P201, DOI 10.1080/00365520310005974; Shanmugathasan M, 2000, PATHOL INT, V50, P273, DOI 10.1046/j.1440-1827.2000.01047.x; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; STENLING R, 1984, ULTRASTRUCT PATHOL, V6, P295, DOI 10.3109/01913128409018588; Tannapfel A, 2010, DTSCH ARZTEBL INT, V107, P760, DOI 10.3238/arztebl.2010.0760; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594	27	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168801	10.1371/journal.pone.0168801	http://dx.doi.org/10.1371/journal.pone.0168801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033349	Green Submitted, gold, Green Published			2022-12-26	WOS:000391226900048
J	Ruggiero, M; Cless, D; Infantolino, B				Ruggiero, Marissa; Cless, Daniel; Infantolino, Benjamin			Upper and Lower Limb Muscle Architecture of a 104 Year-Old Cadaver	PLOS ONE			English	Article							SKELETAL-MUSCLE; LOWER-EXTREMITY; FIBERS; TENDON; LENGTH; PARAMETERS; FOREARM; CROSS; ELBOW; TENSION	Muscle architecture is an important component to typical musculoskeletal models. Previous studies of human muscle architecture have focused on a single joint, two adjacent joints, or an entire limb. To date, no study has presented muscle architecture for the upper and lower limbs of a single cadaver. Additionally, muscle architectural parameters from elderly cadavers are lacking, making it difficult to accurately model elderly populations. Therefore, the purpose of this study was to present muscle architecture of the upper and lower limbs of a 104 year old female cadaver. The major muscles of the upper and lower limbs were removed and the musculotendon mass, tendon mass, musculotendon length, tendon length, pennation angle, optimal fascicle length, physiological cross-sectional area, and tendon cross-sectional area were determined for each muscle. Data from this complete cadaver are presented in table format. The data from this study can be used to construct a musculoskeletal model of a specific individual who was ambulatory, something which has not been possible to date. This should increase the accuracy of the model output as the model will be representing a specific individual, not a synthesis of measurements from multiple individuals. Additionally, an elderly individual can be modeled which will provide insight into muscle function as we age.	[Ruggiero, Marissa; Cless, Daniel; Infantolino, Benjamin] Penn State Univ, Div Sci, Berks Campus, Reading, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Infantolino, B (corresponding author), Penn State Univ, Div Sci, Berks Campus, Reading, PA USA.	bwi100@_psu.edu			Penn State Libraries; Pennsylvania State University Libraries	Penn State Libraries; Pennsylvania State University Libraries	Support for this study was provided by the Penn State Libraries Open Access Publishing Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the anatomical donation that made this research possible. The authors would also like to thank Kathleen Doyle and Jennifer Patton for their assistance with dissection. The authors do not have any conflict of interest to declare. Publication of this article was funded in part by The Pennsylvania State University Libraries Open Access Publishing Fund.	Alexander R.M., 1975, J HUMAN MOVEMENT STU, V1, P115; ALEXANDER RM, 1977, NATURE, V265, P114, DOI 10.1038/265114a0; Amis A. A., 1979, Engineering in Medicine, V8, P41, DOI 10.1243/EMED_JOUR_1979_008_010_02; AN KN, 1981, J BIOMECH, V14, P659, DOI 10.1016/0021-9290(81)90048-8; BRAND PW, 1981, J HAND SURG-AM, V6, P209, DOI 10.1016/S0363-5023(81)80072-X; Carbone V, 2015, J BIOMECH, V48, P734, DOI 10.1016/j.jbiomech.2014.12.034; CUTTS A, 1991, J ANAT, V176, P133; CUTTS A, 1988, J ANAT, V160, P75; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; ELLIOTT DH, 1965, PROC R SOC SER B-BIO, V162, P198, DOI 10.1098/rspb.1965.0033; FRIEDERICH JA, 1990, J BIOMECH, V23, P91, DOI 10.1016/0021-9290(90)90373-B; Gans C., 1965, Ergebnisse der Anatomie und Entwicklungsgeschichte, V38, P115; Horsman MDK, 2007, CLIN BIOMECH, V22, P239, DOI 10.1016/j.clinbiomech.2006.10.003; Infantolino BW, 2010, ANAT REC, V293, P1913, DOI 10.1002/ar.21239; Infantolino BW, 2010, J ANAT, V216, P463, DOI 10.1111/j.1469-7580.2009.01196.x; Kamibayashi LK, 1998, SPINE, V23, P1314, DOI 10.1097/00007632-199806150-00005; KARDEL T, 1990, J BIOMECH, V23, P953, DOI 10.1016/0021-9290(90)90310-Y; KER RF, 1981, J EXP BIOL, V93, P283; Langenderfer J, 2004, CLIN BIOMECH, V19, P664, DOI 10.1016/j.clinbiomech.2004.04.009; Lieber R L, 1993, J Hand Ther, V6, P105; LIEBER RL, 1990, J HAND SURG-AM, V15A, P244, DOI 10.1016/0363-5023(90)90103-X; Lieber RL, 2000, MUSCLE NERVE, V23, P1647, DOI 10.1002/1097-4598(200011)23:11<1647::AID-MUS1>3.0.CO;2-M; LIEBER RL, 1992, J HAND SURG-AM, V17A, P787, DOI 10.1016/0363-5023(92)90444-T; Loram ID, 2006, J APPL PHYSIOL, V100, P1311, DOI 10.1152/japplphysiol.01229.2005; Murray WM, 2000, J BIOMECH, V33, P943, DOI 10.1016/S0021-9290(00)00051-8; Otten E, 1988, Exerc Sport Sci Rev, V16, P89; Ramsey RW, 1940, J CELL COMPAR PHYSL, V15, P11, DOI 10.1002/jcp.1030150103; Veeger HEJ, 1997, J BIOMECH, V30, P647, DOI 10.1016/S0021-9290(97)00011-0; WALKER SM, 1974, ANAT RECORD, V178, P63, DOI 10.1002/ar.1091780107; Ward SR, 2009, CLIN ORTHOP RELAT R, V467, P1074, DOI 10.1007/s11999-008-0594-8; Ward SR, 2005, J BIOMECH, V38, P2317, DOI 10.1016/j.jbiomech.2004.10.001; WICKIEWICZ TL, 1983, CLIN ORTHOP RELAT R, P275, DOI 10.1097/00003086-198310000-00042; Yamaguchi GT., 1990, MULTIPLE MUSCLE SYST, P717; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359	34	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0162963	10.1371/journal.pone.0162963	http://dx.doi.org/10.1371/journal.pone.0162963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033339	gold, Green Submitted, Green Published			2022-12-26	WOS:000391226900001
J	Wang, DS; Peng, SF; Amin, ARMR; Rahman, MA; Nannapaneni, S; Liu, Y; Shin, DM; Saba, NF; Eichler, JF; Chen, ZG				Wang, Dongsheng; Peng, Shifang; Amin, A. R. M. Ruhul; Rahman, Mohammad Aminur; Nannapaneni, Sreenivas; Liu, Yuan; Shin, Dong M.; Saba, Nabil F.; Eichler, Jack F.; Chen, Zhuo G.			Antitumor Activity of 2,9-Di-Sec-Buty1-1,10-Phenanthroline	PLOS ONE			English	Article							GOLD(III) COMPLEXES; LYSOSOMAL IRON; CISPLATIN; CHELATION; CANCER; PHENANTHROLINE; MECHANISM; APOPTOSIS; AUTOPHAGY; PATHWAYS	The anti-tumor effect of a chelating phen-based ligand 2,9-di-sec-butyl-1,10-phenanthroline (dsBPT) and its combination with cisplatin were examined in both lung and head and neck cancer cell lines and xenograft animal models in this study. The effects of this agent on cell cycle and apoptosis were investigated. Protein markers relevant to these mechanisms were also assessed. We found that the inhibitory effect of dsBPT on lung and head and neck cancer cell growth (IC50 ranged between 0.1-0.2 mu M) was 10 times greater than that on normal epithelial cells. dsBPT alone induced autophagy, G1 cell cycle arrest, and apoptosis. Our in vivo studies indicated that dsBPT inhibited tumor growth in a dose-dependent manner in a head and neck cancer xenograft mouse model. The combination of dsBPT with cisplatin synergistically inhibited cancer cell growth with a combination index of 0.3. Moreover, the combination significantly reduced tumor volume as compared with the untreated control (p = 0.0017) in a head and neck cancer xenograft model. No organ related toxicities were observed in treated animals. Our data suggest that dsBPT is a novel and potent antitumor drug that warrants further preclinical and clinical development either as a single agent or in combination with known chemotherapy drugs such as cisplatin.	[Wang, Dongsheng; Peng, Shifang; Amin, A. R. M. Ruhul; Rahman, Mohammad Aminur; Nannapaneni, Sreenivas; Shin, Dong M.; Saba, Nabil F.; Chen, Zhuo G.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30307 USA; [Liu, Yuan] NE, WCI, Dept Biostat & Bioinformat, Biostat & Bioinformat Shared Resource, Atlanta, GA USA; [Eichler, Jack F.] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Peng, Shifang] Cent S Univ, Xiangya Hosp, Hlth Management Ctr, Dept Hepatol & Infect Dis, Chang Sha, Peoples R China	Emory University; University of California System; University of California Riverside; Central South University	Chen, ZG (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30307 USA.	gzchen@emory.edu	Eichler, Jack/AAZ-1356-2021	AMIN, ARM/0000-0001-9144-2960	Georgia Cancer Coalition; Specialized Program of Excellence (SPORE) grant in Head and Neck Cancer [P50CA128613]	Georgia Cancer Coalition; Specialized Program of Excellence (SPORE) grant in Head and Neck Cancer	Funded by Georgia Cancer Coalition to ZC and partially by the Specialized Program of Excellence (SPORE) grant in Head and Neck Cancer (P50CA128613) to DMS.	Alderden RA, 2006, J CHEM EDUC, V83, P728, DOI 10.1021/ed083p728; CERSOSIMO RJ, 1989, CANCER TREAT REV, V16, P195, DOI 10.1016/0305-7372(89)90041-8; COOLEY ME, 1994, CANCER NURS, V17, P173; COOLEY ME, 1994, CANCER NURS, V17, P283; David CN, 2015, ASN NEURO, V7, DOI 10.1177/1759091415572365; De Domenico I, 2010, AUTOPHAGY, V6, P157, DOI 10.4161/auto.6.1.10587; Go RS, 1999, J CLIN ONCOL, V17, P409, DOI 10.1200/JCO.1999.17.1.409; Greene BT, 2002, J BIOL CHEM, V277, P25568, DOI 10.1074/jbc.M110345200; Hancock CN, 2011, FREE RADICAL BIO MED, V50, P110, DOI 10.1016/j.freeradbiomed.2010.10.696; Hatcher HC, 2009, FUTURE MED CHEM, V1, P1643, DOI 10.4155/FMC.09.121; Ho SY, 2005, TIEKINK ERT 2005 MET; Jiao Y, 2009, BLOOD, V113, P462, DOI 10.1182/blood-2008-05-155952; Khan G, 2009, EXPERT OPIN INV DRUG, V18, P541, DOI [10.1517/13543780902845622, 10.1517/13543780902845622 ]; Klein AV, 2009, CHEM REV, V109, P4911, DOI 10.1021/cr9001066; Kontoghiorghes GJ, 2008, HEMOGLOBIN, V32, P217, DOI 10.1080/03630260701727119; Koo JH, 2015, MOL CELL BIOL, V35, P2344, DOI 10.1128/MCB.01525-14; Kurz T, 2009, AUTOPHAGY, V5, P93, DOI 10.4161/auto.5.1.7248; McGinely NL, 2013, J INORG BIOCHEM, V128, P124, DOI 10.1016/j.jinorgbio.2013.07.021; Messori L, 2000, J MED CHEM, V43, P3541, DOI 10.1021/jm990492u; Ng CH, 2014, METALLOMICS, V6, P892, DOI 10.1039/c3mt00276d; Olsen PM, 2014, J INORG BIOCHEM, V141, P121, DOI 10.1016/j.jinorgbio.2014.08.014; Pace A, 2010, NEUROLOGY, V74, P762, DOI 10.1212/WNL.0b013e3181d5279e; Park D, 2013, CANCER RES, V73, P5485, DOI 10.1158/0008-5472.CAN-12-2272; Pivetta T, 2015, J INORG BIOCHEM, V151, P107, DOI 10.1016/j.jinorgbio.2015.05.004; Raja SM, 2008, MOL CANCER THER, V7, P2212, DOI 10.1158/1535-7163.MCT-07-2409; Shi PF, 2006, J BIOL INORG CHEM, V11, P745, DOI 10.1007/s00775-006-0120-y; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Terman A, 2013, ANTIOXID REDOX SIGN, V18, P888, DOI 10.1089/ars.2012.4885; Wainford RD, 2008, TOXICOLOGY, V249, P184, DOI 10.1016/j.tox.2008.05.006; Wein AN, 2011, J INORG BIOCHEM, V105, P663, DOI 10.1016/j.jinorgbio.2011.01.006; Zhang X, 2005, CLIN CANCER RES, V11, P6261, DOI 10.1158/1078-0432.CCR-04-2102; Zhao M, 2011, CLIN CANCER RES, V17, P7248, DOI 10.1158/1078-0432.CCR-11-0690; Zhu TF, 2014, MOL MED REP, V10, P2477, DOI 10.3892/mmr.2014.2519	33	1	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168450	10.1371/journal.pone.0168450	http://dx.doi.org/10.1371/journal.pone.0168450			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7KQ	28033401	Green Submitted, Green Published, gold			2022-12-26	WOS:000391226900026
J	Ge, L; Zhao, YL; Zhou, K; Mu, XM; Yu, HB; Wang, YF; Wang, N; Fan, H; Guo, LQ; Huo, XX				Ge, Liang; Zhao, Youlin; Zhou, Kui; Mu, Xiangming; Yu, Haibo; Wang, Yongfeng; Wang, Ning; Fan, Hong; Guo, Liqiang; Huo, XiXiang			Spatio-Temporal Pattern and Influencing Factors of Hemorrhagic Fever with Renal Syndrome (HFRS) in Hubei Province (China) between 2005 and 2014	PLOS ONE			English	Article								Hemorrhagic Fever with Renal Syndrome (HFRS) is considered as a globally distributed infectious disease, which results in many deaths annually in Hubei Province, China. The outbreak of HFRS is usually characterized with spatio-temporal heterogeneity and is seasonally distributed. Further, it might also be impacted by the influencing factors such as socio-economic and geographical environment. To better understand and predict the outbreak of HFRS in the Hubei Province, the spatio-temporal pattern and influencing factors were investigated in this study. Moran's I Index value was adopted in spatial global autocorrelation analysis to identify the overall spatio-temporal pattern of HFRS outbreak. Kulldorff scan statistical analysis was performed to further identify the changing trends of the clustering patterns of HFRS outbreak. Spearman's rank correlation analysis was used to explore the possible influencing factors on HFRS epidemics such as climate and geographic. The results demonstrated that HFRS outbreak in Hubei Province decreased from 2005 to 2012 in general while increasing slightly from 2012 to 2014. The spatial and temporal scan statistical analysis indicated that HFRS epidemic was temporally clustered in summer and autumn from 2005 to 2014 except 2008 and 2011. The seasonal epidemic pattern of HFRS in Hubei Province was characterized by a bimodal pattern (March to May and September to November) while peaks often occurring in the spring time. SEOV-type HFRS was presumed to influence more on the total number of HFRS incidence than HTNV-type HFRS do. The average humidity and human population density were the main influencing factors during these years. HFRS outbreaks were more in plains than in other areas of Hubei Province. We did not find that whether the terrain of the wetland (water system) plays a significant role in the outbreak of HFRS incidence. With a better understanding of rodent infection rate, socioeconomic status and ecological environment characteristics, this study may help to reduce the outbreak of HFRS disease.	[Ge, Liang; Fan, Hong] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan, Hubei Province, Peoples R China; [Ge, Liang; Zhou, Kui; Yu, Haibo; Wang, Yongfeng; Guo, Liqiang] Tianjin Inst Surveying & Mapping, Tianjin, Peoples R China; [Zhao, Youlin] Hohai Univ, Sch Business, Nanjing, Jiangsu, Peoples R China; [Mu, Xiangming] Univ Wisconsin, Sch Informat Studies, 2025 E Newpot Ave NWQB, Milwaukee, WI 53201 USA; [Wang, Ning] China Earthquake Adm, Crust Deformat Monitoring & Applicat Ctr 1, Tianjin, Peoples R China; [Huo, XiXiang] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Peoples R China	Wuhan University; Hohai University; University of Wisconsin System; University of Wisconsin Milwaukee; China Earthquake Administration	Ge, L (corresponding author), Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan, Hubei Province, Peoples R China.; Ge, L (corresponding author), Tianjin Inst Surveying & Mapping, Tianjin, Peoples R China.	geliang0021@126.com; xixianghuo@163.com	Wang, Yuan/HHC-1520-2022; Wang, Yin/HCI-9352-2022; wang, yan/GSE-6489-2022; Wang, Yanbo/HFZ-8018-2022	Ge, Liang/0000-0002-3365-353X	National Natural Science Foundation of China [71503068]; Fundamental Research Funds in Key Research Areas for the Central Universities [2015B09614]; Fundamental Research Funds for the Central Universities [2014B15114]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds in Key Research Areas for the Central Universities; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funded by National Natural Science Foundation of China, No. 71503068,http://www.nsfc.gov.cn and Fundamental Research Funds in Key Research Areas for the Central Universities, No. 2015B09614; Fundamental Research Funds for the Central Universities, No. 2014B15114 http://www.moe.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China, No. 71503068; Fundamental Research Funds in Key Research Areas for the Central Universities, No. 2015B09614; Fundamental Research Funds for the Central Universities, No. 2014B15114.	Alvarez J, 2016, PREV VET MED, V123, P155, DOI 10.1016/j.prevetmed.2015.11.003; [Anonymous], LANDSCAPE ELEMENTS H; Azage M, 2015, PLOS ONE, V12; Bi P, 1998, AM J EPIDEMIOL, V148, P276, DOI 10.1093/oxfordjournals.aje.a009636; Bi P, 2002, INT J EPIDEMIOL, V31, P189, DOI 10.1093/ije/31.1.189; Chen J, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-57; Cui F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067490; Du H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-191; Fang LQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000789; Fang LQ, 2009, EMERG INFECT DIS, V15, P2043, DOI 10.3201/eid1512.081078; Fang LQ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-77; Ge EJ, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0104-2; Guan P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-109; Hardestam J, 2007, APPL ENVIRON MICROB, V73, P2547, DOI 10.1128/AEM.02869-06; Kelly-Hope L, 2008, ADV GLOB CHANGE RES, V30, P31, DOI 10.1007/978-1-4020-6877-5_3; Lefebvre A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139920; Li Q, 2005, ACTA VIROL, V49, P51; Li S, 2014, INT J ENV RES PUB HE; Li X, 2012, ORG MED CHEM LETT, V2, P2, DOI DOI 10.1371/J0URNAL.P0NE.0044916; Lin HL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-207; Liu J, 2012, VIRUS RES, V163, P439, DOI 10.1016/j.virusres.2011.11.006; Liu Q, 2011, BMC INFECT DIS; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Myers J. L., 2003, RES DESIGN STAT ANAL; Odoi Agricola, 2004, Int J Health Geogr, V3, P11, DOI 10.1186/1476-072X-3-11; Piechotowski I, 2008, PARASITOL RES, V103, pS131, DOI 10.1007/s00436-008-1055-8; Puth MT, 2015, ANIM BEHAV, V102, P77, DOI 10.1016/j.anbehav.2015.01.010; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; Sugumaran R, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-43; Tiwari Neeraj, 2006, Int J Health Geogr, V5, P33, DOI 10.1186/1476-072X-5-33; Wikipedia, 2011, WIK VAND, V3, P35; WU JQGZ W, 2009, EPIDEMIOL INFECT; Wu W, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-229; Xiao H, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-305; XU ZY, 1985, J INFECT DIS, V152, P137, DOI 10.1093/infdis/152.1.137; Zeier M, 2005, VIRUS GENES, V30, P157, DOI 10.1007/s11262-004-5625-2; [张世煌 Zhang Shihuang], 2006, [玉米科学, Maize Science], V14, P1; Zhang WY, 2010, ENVIRON HEALTH PERSP, V118, P915, DOI 10.1289/ehp.0901504; Zhang WY, 2009, AM J TROP MED HYG, V80, P678, DOI 10.4269/ajtmh.2009.80.678; Zhang WY, 2015, PLOS ONE, V7; Zhang YH, 2014, PLOS ONE, V3; Zheng L, 2015, EPIDEMIOL INFECT, V143, P2451, DOI 10.1017/S0950268814003598; Zou Y, 2008, J MED VIROL, V80, P680, DOI 10.1002/jmv.21119; Zuo SQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000945	44	9	15	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167836	10.1371/journal.pone.0167836	http://dx.doi.org/10.1371/journal.pone.0167836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030550	Green Submitted, Green Published, gold			2022-12-26	WOS:000391222000023
J	Liu, HZ; Li, Y; Chen, L; Zhang, Q; Pan, N; Nichols, DH; Zhang, WPJ; Fritzsch, B; He, DZZ				Liu, Huizhan; Li, Yi; Chen, Lei; Zhang, Qian; Pan, Ning; Nichols, David H.; Zhang, Weiping J.; Fritzsch, Bernd; He, David Z. Z.			Organ of Corti and Stria Vascularis: Is there an Interdependence for Survival?	PLOS ONE			English	Article							OUTER HAIR-CELLS; WAARDENBURG SYNDROME; INTERMEDIATE CELLS; FINE-STRUCTURE; COCHLEAR; INNER; POTASSIUM; FUROSEMIDE; MUTATIONS; K+	Cochlear hair cells and the stria vascularis are critical for normal hearing. Hair cells transduce mechanical stimuli into electrical signals, whereas the stria is responsible for generating the endocochlear potential (EP), which is the driving force for hair cell mechanotransduction. We questioned whether hair cells and the stria interdepend for survival by using two mouse models. Atoh1 conditional knockout mice, which lose all hair cells within four weeks after birth, were used to determine whether the absence of hair cells would affect function and survival of stria. We showed that stria morphology and EP remained normal for long time despite a complete loss of all hair cells. We then used a mouse model that has an abnormal stria morphology and function due to mutation of the Mitf gene to determine whether hair cells are able to survive and transduce sound signals without a normal electrochemical environment in the endolymph. A strial defect, reflected by missing intermediate cells in the stria and by reduction of EP, led to systematic outer hair cell death from the base to the apex after postnatal day 18. However, an 18-mV EP was sufficient for outer hair cell survival. Surprisingly, inner hair cell survival was less vulnerable to reduction of the EP. Our studies show that normal function of the stria is essential for adult outer hair cell survival, while the survival and normal function of the stria vascularis do not depend on functional hair cells.	[Liu, Huizhan; Li, Yi; Chen, Lei; Zhang, Qian; Nichols, David H.; He, David Z. Z.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Li, Yi] Beijing Capital Med Univ, Beijing Tongren Hosp, Dept Otorhinolaryngol, Beijing, Peoples R China; [Chen, Lei] Chongqing Acad Anim Sci, Chongqing, Peoples R China; [Pan, Ning; Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Zhang, Weiping J.] Second Mil Med Univ, Dept Pathophysiol, Shanghai, Peoples R China	Creighton University; Capital Medical University; University of Iowa; Naval Medical University	He, DZZ (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA.	hed@creighton.edu		Li (li yi), Yi/0000-0002-9986-6546; He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634; Fritzsch, Bernd/0000-0002-4882-8398	NIH from the NIDCD [R01 DC004696]; National Natural Science Foundation of China [81600798]; NIH from the National Center for Research Resources [G20RR024001, C06RR17417]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004696] Funding Source: NIH RePORTER	NIH from the NIDCD; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work has been supported by NIH grant R01 DC004696 to DZH from the NIDCD and by a grant from National Natural Science Foundation of China (#81600798) to YL. The animal and imaging facility has also been supported by NIH grants G20RR024001 and C06RR17417 from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the NIH.	Ashmore J. F., 1989, COCHLEAR MECH, P107; ASHMORE JF, 1986, NATURE, V322, P368, DOI 10.1038/322368a0; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Cai TT, 2015, J NEUROSCI, V35, P5870, DOI 10.1523/JNEUROSCI.5083-14.2015; Cai TT, 2013, J NEUROSCI, V33, P10110, DOI 10.1523/JNEUROSCI.5606-12.2013; Chen L, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0273-2; Chiba T, 2000, J MEMBRANE BIOL, V174, P167, DOI 10.1007/s002320001041; Cohen-Salmon M, 2002, CURR BIOL, V12, P1106, DOI 10.1016/S0960-9822(02)00904-1; Cohen-Salmon M, 2007, P NATL ACAD SCI USA, V104, P6229, DOI 10.1073/pnas.0605108104; DALLOS P, 1990, J ACOUST SOC AM, V87, P1636, DOI 10.1121/1.399411; Dallos P., 1996, COCHLEA, P1, DOI [10.1007/978-1-4612-0757-3, DOI 10.1007/978-1-4612-0757-3_1]; DAVIS H, 1965, COLD SPRING HARB SYM, V30, P181, DOI 10.1101/SQB.1965.030.01.020; DEOL MS, 1970, PROC R SOC SER B-BIO, V175, P201, DOI 10.1098/rspb.1970.0019; DURRANT JD, 1972, J ACOUST SOC AM, V52, P1725, DOI 10.1121/1.1913307; EVANS EF, 1982, J PHYSIOL-LONDON, V331, P409, DOI 10.1113/jphysiol.1982.sp014379; Farris HE, 2006, J NEUROSCI, V26, P12526, DOI 10.1523/JNEUROSCI.3569-06.2006; Gow A, 2004, J NEUROSCI, V24, P7051, DOI 10.1523/JNEUROSCI.1640-04.2004; He DZZ, 1999, J NEUROPHYSIOL, V81, P1162, DOI 10.1152/jn.1999.81.3.1162; He DZZ, 2004, NATURE, V429, P766, DOI 10.1038/nature02591; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; HOUSLEY GD, 1992, J PHYSIOL-LONDON, V448, P73, DOI 10.1113/jphysiol.1992.sp019030; Jia SP, 2005, NAT NEUROSCI, V8, P1028, DOI 10.1038/nn1509; Johnson SL, 2017, J NEUROSCI, V37, P258, DOI [10.1523/JNEUROSCI.2251-16.2016, 10.1523/JNEUROSCI.2251-16.2017]; Johnson SL, 2011, NEURON, V70, P1143, DOI 10.1016/j.neuron.2011.04.024; Johnstone BM, 1964, ACTA OTO-LARYNGOL, V60, P113; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kikuchi Toshihiko, 2000, Medical Electron Microscopy, V33, P51, DOI 10.1007/s007950070001; Kim HJ, 2013, J NEUROSCI, V33, P14601, DOI 10.1523/JNEUROSCI.2147-13.2013; KONISHI T, 1978, ACTA OTO-LARYNGOL, V86, P22, DOI 10.3109/00016487809124717; KONISHI T, 1979, ACTA OTO-LARYNGOL, V87, P506, DOI 10.3109/00016487909126459; Li Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151291; Liu HZ, 2014, J NEUROSCI, V34, P11085, DOI 10.1523/JNEUROSCI.1690-14.2014; Marcus DC, 1999, HEARING RES, V134, P48, DOI 10.1016/S0378-5955(99)00074-X; Marcus DC, 2002, AM J PHYSIOL-CELL PH, V282, pC403, DOI 10.1152/ajpcell.00312.2001; MARCUS DC, 1984, AM J PHYSIOL, V247, pC240, DOI 10.1152/ajpcell.1984.247.3.C240; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Ni C, 2013, PIGM CELL MELANOMA R, V26, P78, DOI 10.1111/pcmr.12030; Ohlemiller KK, 2006, HEARING RES, V220, P10, DOI 10.1016/j.heares.2006.06.012; Pan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030358; Pan N, 2011, HEARING RES, V275, P66, DOI 10.1016/j.heares.2010.12.002; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; RUGGERO MA, 1991, J NEUROSCI, V11, P1057; RUSSELL IJ, 1983, NATURE, V301, P334, DOI 10.1038/301334a0; RYBAK LP, 1982, HEARING RES, V7, P223, DOI 10.1016/0378-5955(82)90015-6; SALT AN, 1987, LARYNGOSCOPE, V97, P984; SALT AN, 1993, ANN OTO RHINOL LARYN, V102, P64, DOI 10.1177/000348949310200112; SANTOS-SACCHI J, 1989, J NEUROSCI, V9, P2954; Santos-Sacchi J, 2001, HEARING RES, V159, P69, DOI 10.1016/S0378-5955(01)00321-5; Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015; SEWELL WF, 1984, HEARING RES, V14, P305, DOI 10.1016/0378-5955(84)90057-1; Spicer SS, 1996, HEARING RES, V100, P80, DOI 10.1016/0378-5955(96)00106-2; Spicer SS, 1998, HEARING RES, V118, P1, DOI 10.1016/S0378-5955(98)00006-9; STEEL KP, 1989, DEVELOPMENT, V107, P453; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Takeuchi S, 2000, BIOPHYS J, V79, P2572, DOI 10.1016/S0006-3495(00)76497-6; TASAKI I, 1959, J NEUROPHYSIOL, V22, P149, DOI 10.1152/jn.1959.22.2.149; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; WOOLF NK, 1986, AM J PHYSIOL, V250, pR493, DOI 10.1152/ajpregu.1986.250.3.R493; Yang Sienhung, 2012, Evid Based Complement Alternat Med, V2012, P521780, DOI 10.1155/2012/521780; Zdebik AA, 2009, PHYSIOLOGY, V24, P307, DOI 10.1152/physiol.00018.2009; Zhang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112857; Zhang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062786; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; ZIDANIC M, 1990, BIOPHYS J, V57, P1253, DOI 10.1016/S0006-3495(90)82644-8	68	31	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168953	10.1371/journal.pone.0168953	http://dx.doi.org/10.1371/journal.pone.0168953			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030585	Green Published, gold, Green Submitted			2022-12-26	WOS:000391222000089
